1	Tissue-specific	tissue-specific	JJ	JJ	_	2	amod	_	_
2	regulation	regulation	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	7	case	_	_
4	the	the	DT	DT	_	7	det	_	_
5	rabbit	rabbit	JJ	JJ	_	7	amod	_	_
6	15-lipoxygenase	15-lipoxygenase	NN	NN	_	7	compound	_	_
7	gene	gene	NN	NN	_	2	nmod	_	_
8	in	in	IN	IN	_	10	case	_	_
9	erythroid	erythroid	JJ	JJ	_	10	amod	_	_
10	cells	cell	NNS	NNS	_	2	nmod	_	_
11	by	by	IN	IN	_	14	case	_	_
12	a	a	DT	DT	_	14	det	_	_
13	transcriptional	transcriptional	JJ	JJ	_	14	amod	_	_
14	silencer	silencer	NN	NN	_	2	nmod	_	_
15	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	6	det	_	_
2	15-lipoxygenase	15-lipoxygenase	NN	NN	_	6	compound	_	_
3	(	(	-LRB-	-LRB-	_	6	punct	_	_
4	lox	lox	NN	NN	_	6	compound	_	_
5	)	)	-RRB-	-RRB-	_	6	punct	_	_
6	gene	gene	NN	NN	_	8	nsubjpass	_	_
7	is	be	VBZ	VBZ	_	8	auxpass	_	_
8	expressed	express	VBN	VBN	_	0	root	_	_
9	in	in	IN	IN	_	12	case	_	_
10	a	a	DT	DT	_	12	det	_	_
11	tissue-specific	tissue-specific	JJ	JJ	_	12	amod	_	_
12	manner	manner	NN	NN	_	8	nmod	_	_
13	,	,	,	,	_	8	punct	_	_
14	predominantly	predominantly	RB	RB	_	17	advmod	_	_
15	in	in	IN	IN	_	17	case	_	_
16	erythroid	erythroid	JJ	JJ	_	17	amod	_	_
17	cells	cell	NNS	NNS	_	8	nmod	_	_
18	but	but	CC	CC	_	17	cc	_	_
19	also	also	RB	RB	_	23	advmod	_	_
20	in	in	IN	IN	_	23	case	_	_
21	airway	airway	NN	NN	_	23	compound	_	_
22	epithelial	epithelial	JJ	JJ	_	23	amod	_	_
23	cells	cell	NNS	NNS	_	17	conj	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	eosinophils	eosinophil	NNS	NNS	_	23	conj	_	_
26	.	.	.	.	_	8	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
3	in	in	IN	IN	_	5	case	_	_
4	this	this	DT	DT	_	5	det	_	_
5	report	report	NN	NN	_	2	nmod	_	_
6	that	that	IN	IN	_	15	mark	_	_
7	the	the	DT	DT	_	10	det	_	_
8	5'	5'	JJ	JJ	_	10	amod	_	_
9	flanking	flanking	JJ	JJ	_	10	amod	_	_
10	DNA	dna	NN	NN	_	15	nsubj	_	_
11	of	of	IN	IN	_	14	case	_	_
12	the	the	DT	DT	_	14	det	_	_
13	15-lox	15-lox	NN	NN	_	14	compound	_	_
14	gene	gene	NN	NN	_	10	nmod	_	_
15	contains	contain	VBZ	VBZ	_	2	ccomp	_	_
16	sequences	sequence	NNS	NNS	_	15	dobj	_	_
17	which	which	WDT	WDT	_	18	nsubj	_	_
18	down-regulate	down-regulate	VBP	VBP	_	16	acl:relcl	_	_
19	its	its	PRP$	PRP$	_	20	nmod:poss	_	_
20	activity	activity	NN	NN	_	18	dobj	_	_
21	in	in	IN	IN	_	23	case	_	_
22	a	a	DT	DT	_	23	det	_	_
23	variety	variety	NN	NN	_	18	nmod	_	_
24	of	of	IN	IN	_	27	case	_	_
25	non-erythroid	non-erythroid	JJ	JJ	_	27	amod	_	_
26	cell	cell	NN	NN	_	27	compound	_	_
27	lines	line	NNS	NNS	_	23	nmod	_	_
28	but	but	CC	CC	_	23	cc	_	_
29	not	not	RB	RB	_	34	neg	_	_
30	in	in	IN	IN	_	34	case	_	_
31	two	two	CD	CD	_	34	nummod	_	_
32	erythroid	erythroid	JJ	JJ	_	34	amod	_	_
33	cell	cell	NN	NN	_	34	compound	_	_
34	lines	line	NNS	NNS	_	23	conj	_	_
35	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	element	element	NN	NN	_	3	nsubj	_	_
3	has	have	VBZ	VBZ	_	0	root	_	_
4	characteristics	characteristic	NNS	NNS	_	3	dobj	_	_
5	of	of	IN	IN	_	9	case	_	_
6	a	a	DT	DT	_	9	det	_	_
7	transcriptional	transcriptional	JJ	JJ	_	9	amod	_	_
8	'	'	``	``	_	9	punct	_	_
9	silencer	silencer	NN	NN	_	4	nmod	_	_
10	'	'	''	''	_	9	punct	_	_
11	since	since	IN	IN	_	13	mark	_	_
12	it	it	PRP	PRP	_	13	nsubj	_	_
13	functions	function	VBZ	VBZ	_	3	advcl	_	_
14	in	in	IN	IN	_	16	case	_	_
15	both	both	DT	DT	_	16	det	_	_
16	orientations	orientation	NNS	NNS	_	13	nmod	_	_
17	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	main	main	JJ	JJ	_	3	amod	_	_
3	activity	activity	NN	NN	_	9	nsubjpass	_	_
4	of	of	IN	IN	_	6	case	_	_
5	the	the	DT	DT	_	6	det	_	_
6	silencer	silencer	NN	NN	_	3	nmod	_	_
7	has	have	VBZ	VBZ	_	9	aux	_	_
8	been	be	VBN	VBN	_	9	auxpass	_	_
9	mapped	map	VBN	VBN	_	0	root	_	_
10	to	to	TO	TO	_	14	case	_	_
11	the	the	DT	DT	_	14	det	_	_
12	first	first	JJ	JJ	_	14	amod	_	_
13	900	900	CD	CD	_	14	nummod	_	_
14	bp	bp	NN	NN	_	9	nmod	_	_
15	of	of	IN	IN	_	18	case	_	_
16	5'	5'	JJ	JJ	_	18	amod	_	_
17	flanking	flanking	JJ	JJ	_	18	amod	_	_
18	DNA	dna	NN	NN	_	14	nmod	_	_
19	,	,	,	,	_	18	punct	_	_
20	which	which	WDT	WDT	_	21	nsubj	_	_
21	contains	contain	VBZ	VBZ	_	18	acl:relcl	_	_
22	nine	nine	CD	CD	_	24	nummod	_	_
23	binding	bind	VBG	VBG	_	24	amod	_	_
24	sites	site	NNS	NNS	_	21	dobj	_	_
25	for	for	IN	IN	_	28	case	_	_
26	a	a	DT	DT	_	28	det	_	_
27	nuclear	nuclear	JJ	JJ	_	28	amod	_	_
28	factor	factor	NN	NN	_	24	nmod	_	_
29	present	present	JJ	JJ	_	24	amod	_	_
30	in	in	IN	IN	_	32	case	_	_
31	non-erythroid	non-erythroid	JJ	JJ	_	32	amod	_	_
32	cells	cell	NNS	NNS	_	29	nmod	_	_
33	but	but	CC	CC	_	32	cc	_	_
34	not	not	RB	RB	_	37	neg	_	_
35	in	in	IN	IN	_	37	case	_	_
36	erythroid	erythroid	JJ	JJ	_	37	amod	_	_
37	cells	cell	NNS	NNS	_	32	conj	_	_
38	.	.	.	.	_	9	punct	_	_

1	These	these	DT	DT	_	3	det	_	_
2	binding	bind	VBG	VBG	_	3	amod	_	_
3	sites	site	NNS	NNS	_	4	nsubj	_	_
4	have	have	VBP	VBP	_	0	root	_	_
5	similar	similar	JJ	JJ	_	6	amod	_	_
6	sequences	sequence	NNS	NNS	_	4	dobj	_	_
7	and	and	CC	CC	_	4	cc	_	_
8	multiple	multiple	JJ	JJ	_	9	amod	_	_
9	copies	copy	NNS	NNS	_	14	nsubj	_	_
10	of	of	IN	IN	_	13	case	_	_
11	the	the	DT	DT	_	13	det	_	_
12	binding	bind	VBG	VBG	_	13	amod	_	_
13	sites	site	NNS	NNS	_	9	nmod	_	_
14	confer	confer	VBP	VBP	_	4	conj	_	_
15	tissue-specific	tissue-specific	JJ	JJ	_	16	amod	_	_
16	down-regulation	down-regulation	NN	NN	_	14	dobj	_	_
17	when	when	WRB	WRB	_	18	advmod	_	_
18	attached	attach	VBN	VBN	_	14	advcl	_	_
19	to	to	TO	TO	_	24	case	_	_
20	a	a	DT	DT	_	24	det	_	_
21	minimal	minimal	JJ	JJ	_	24	amod	_	_
22	lox	lox	NN	NN	_	24	compound	_	_
23	promoter	promoter	NN	NN	_	24	compound	_	_
24	fragment	fragment	NN	NN	_	18	nmod	_	_
25	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	5'	5'	JJ	JJ	_	4	amod	_	_
3	flanking	flanking	JJ	JJ	_	4	amod	_	_
4	DNA	dna	NN	NN	_	6	nsubj	_	_
5	also	also	RB	RB	_	6	advmod	_	_
6	contains	contain	VBZ	VBZ	_	0	root	_	_
7	a	a	DT	DT	_	8	det	_	_
8	cluster	cluster	NN	NN	_	6	dobj	_	_
9	of	of	IN	IN	_	12	case	_	_
10	three	three	CD	CD	_	12	nummod	_	_
11	binding	bind	VBG	VBG	_	12	amod	_	_
12	sites	site	NNS	NNS	_	8	nmod	_	_
13	for	for	IN	IN	_	16	case	_	_
14	the	the	DT	DT	_	16	det	_	_
15	GATA	gata	NN	NN	_	16	compound	_	_
16	family	family	NN	NN	_	8	nmod	_	_
17	of	of	IN	IN	_	19	case	_	_
18	transcription	transcription	NN	NN	_	19	compound	_	_
19	factors	factor	NNS	NNS	_	16	nmod	_	_
20	.	.	.	.	_	6	punct	_	_

1	Staphylococcal	staphylococcal	JJ	JJ	_	2	amod	_	_
2	enterotoxins	enterotoxin	NNS	NNS	_	3	nsubj	_	_
3	modulate	modulate	VBP	VBP	_	0	root	_	_
4	interleukin	interleukin	NN	NN	_	6	compound	_	_
5	2	2	CD	CD	_	6	nummod	_	_
6	receptor	receptor	NN	NN	_	7	compound	_	_
7	expression	expression	NN	NN	_	3	dobj	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	ligand-induced	ligand-induced	JJ	JJ	_	11	amod	_	_
10	tyrosine	tyrosine	NN	NN	_	11	compound	_	_
11	phosphorylation	phosphorylation	NN	NN	_	7	conj	_	_
12	of	of	IN	IN	_	16	case	_	_
13	the	the	DT	DT	_	16	det	_	_
14	Janus	janus	NN	NN	_	16	compound	_	_
15	protein-tyrosine	protein-tyrosine	NN	NN	_	16	compound	_	_
16	kinase	kinase	NN	NN	_	11	nmod	_	_
17	3	3	CD	CD	_	16	nummod	_	_
18	(	(	-LRB-	-LRB-	_	19	punct	_	_
19	Jak3	jak3	NN	NN	_	16	appos	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	and	and	CC	CC	_	16	cc	_	_
22	signal	signal	NN	NN	_	23	compound	_	_
23	transducers	transducer	NNS	NNS	_	16	conj	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	activators	activator	NNS	NNS	_	27	compound	_	_
26	of	of	IN	IN	_	27	amod	_	_
27	transcription	transcription	NN	NN	_	23	conj	_	_
28	(	(	-LRB-	-LRB-	_	30	punct	_	_
29	Stat	stat	NN	NN	_	30	compound	_	_
30	proteins	protein	NNS	NNS	_	23	appos	_	_
31	)	)	-RRB-	-RRB-	_	30	punct	_	_
32	.	.	.	.	_	3	punct	_	_

1	Staphylococcal	staphylococcal	JJ	JJ	_	2	amod	_	_
2	enterotoxins	enterotoxins	NN	NN	_	6	nsubj	_	_
3	(	(	-LRB-	-LRB-	_	4	punct	_	_
4	SE	se	NNS	NNS	_	2	appos	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	stimulate	stimulate	VBP	VBP	_	0	root	_	_
7	T	t	NN	NN	_	8	compound	_	_
8	cells	cell	NNS	NNS	_	6	dobj	_	_
9	expressing	express	VBG	VBG	_	8	acl	_	_
10	the	the	DT	DT	_	22	det	_	_
11	appropriate	appropriate	JJ	JJ	_	22	amod	_	_
12	variable	variable	JJ	JJ	_	22	amod	_	_
13	region	region	NN	NN	_	22	compound	_	_
14	beta	beta	NN	NN	_	22	compound	_	_
15	chain	chain	NN	NN	_	22	compound	_	_
16	of	of	IN	IN	_	22	amod	_	_
17	(	(	-LRB-	-LRB-	_	22	punct	_	_
18	V	v	NN	NN	_	22	compound	_	_
19	beta	beta	NN	NN	_	22	compound	_	_
20	)	)	-RRB-	-RRB-	_	22	punct	_	_
21	T-cell	t-cell	NN	NN	_	22	compound	_	_
22	receptors	receptor	NNS	NNS	_	9	dobj	_	_
23	and	and	CC	CC	_	6	cc	_	_
24	have	have	VBP	VBP	_	26	aux	_	_
25	been	be	VBN	VBN	_	26	auxpass	_	_
26	implicated	implicate	VBN	VBN	_	6	conj	_	_
27	in	in	IN	IN	_	29	case	_	_
28	the	the	DT	DT	_	29	det	_	_
29	pathogenesis	pathogenesis	NN	NN	_	26	nmod	_	_
30	of	of	IN	IN	_	33	case	_	_
31	several	several	JJ	JJ	_	33	amod	_	_
32	autoimmune	autoimmune	JJ	JJ	_	33	amod	_	_
33	diseases	disease	NNS	NNS	_	29	nmod	_	_
34	.	.	.	.	_	6	punct	_	_

1	Depending	depend	VBG	VBG	_	4	case	_	_
2	on	on	IN	IN	_	4	case	_	_
3	costimulatory	costimulatory	JJ	JJ	_	4	amod	_	_
4	signals	signal	NNS	NNS	_	7	advcl	_	_
5	,	,	,	,	_	7	punct	_	_
6	SE	se	NNS	NNS	_	7	nsubj	_	_
7	induce	induce	VBP	VBP	_	0	root	_	_
8	either	either	CC	CC	_	9	cc:preconj	_	_
9	proliferation	proliferation	NN	NN	_	7	dobj	_	_
10	or	or	CC	CC	_	9	cc	_	_
11	anergy	anergy	NN	NN	_	9	conj	_	_
12	in	in	IN	IN	_	14	case	_	_
13	T	t	NN	NN	_	14	compound	_	_
14	cells	cell	NNS	NNS	_	9	nmod	_	_
15	.	.	.	.	_	7	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	addition	addition	NN	NN	_	6	nmod	_	_
3	,	,	,	,	_	6	punct	_	_
4	SE	se	NNS	NNS	_	6	nsubj	_	_
5	can	can	MD	MD	_	6	aux	_	_
6	induce	induce	VB	VB	_	0	root	_	_
7	an	a	DT	DT	_	13	det	_	_
8	interleukin-2	interleukin-2	NN	NN	_	13	compound	_	_
9	(	(	-LRB-	-LRB-	_	10	punct	_	_
10	IL-2	il-2	NN	NN	_	8	appos	_	_
11	)	)	-RRB-	-RRB-	_	10	punct	_	_
12	nonresponsive	nonresponsive	JJ	JJ	_	13	amod	_	_
13	state	state	NN	NN	_	6	dobj	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	apoptosis	apoptosis	NN	NN	_	13	conj	_	_
16	.	.	.	.	_	6	punct	_	_

1	Here	here	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	show	show	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	7	mark	_	_
6	SE	se	NNS	NNS	_	7	nsubj	_	_
7	induce	induce	VBP	VBP	_	4	ccomp	_	_
8	dynamic	dynamic	JJ	JJ	_	9	amod	_	_
9	changes	change	NNS	NNS	_	7	dobj	_	_
10	in	in	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	expression	expression	NN	NN	_	9	nmod	_	_
13	of	of	IN	IN	_	12	acl	_	_
14	and	and	CC	CC	_	12	cc	_	_
15	signal	signal	NN	NN	_	16	compound	_	_
16	transduction	transduction	NN	NN	_	12	conj	_	_
17	through	through	IN	IN	_	16	acl	_	_
18	the	the	DT	DT	_	20	dep	_	_
19	IL-2	il-2	NN	NN	_	20	compound	_	_
20	receptor	receptor	NN	NN	_	12	dep	_	_
21	(	(	-LRB-	-LRB-	_	22	punct	_	_
22	IL-2R	il-2r	NN	NN	_	20	appos	_	_
23	)	)	-RRB-	-RRB-	_	22	punct	_	_
24	beta	beta	NN	NN	_	20	dep	_	_
25	and	and	CC	CC	_	20	cc	_	_
26	gamma	gamma	NN	NN	_	20	conj	_	_
27	chains	chain	NNS	NNS	_	20	dep	_	_
28	(	(	-LRB-	-LRB-	_	30	punct	_	_
29	IL-2R	il-2r	NN	NN	_	30	compound	_	_
30	beta	beta	NN	NN	_	20	dep	_	_
31	and	and	CC	CC	_	30	cc	_	_
32	IL-2R	il-2r	NN	NN	_	33	compound	_	_
33	gamma	gamma	NN	NN	_	30	conj	_	_
34	)	)	-RRB-	-RRB-	_	30	punct	_	_
35	in	in	IN	IN	_	40	case	_	_
36	human	human	JJ	JJ	_	40	amod	_	_
37	antigen-specific	antigen-specific	JJ	JJ	_	40	amod	_	_
38	CD4+	cd4+	JJ	JJ	_	40	amod	_	_
39	T-cell	t-cell	NN	NN	_	40	compound	_	_
40	lines	line	NNS	NNS	_	9	nmod	_	_
41	.	.	.	.	_	4	punct	_	_

1	Thus	thus	RB	RB	_	19	advmod	_	_
2	,	,	,	,	_	19	punct	_	_
3	after	after	IN	IN	_	5	case	_	_
4	4	4	CD	CD	_	5	nummod	_	_
5	hr	hr	NN	NN	_	19	nmod	_	_
6	of	of	IN	IN	_	7	case	_	_
7	exposure	exposure	NN	NN	_	5	nmod	_	_
8	to	to	TO	TO	_	9	case	_	_
9	SEA	sea	NN	NN	_	7	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	SEB	seb	NN	NN	_	9	conj	_	_
12	,	,	,	,	_	19	punct	_	_
13	the	the	DT	DT	_	14	det	_	_
14	expression	expression	NN	NN	_	19	nsubjpass	_	_
15	of	of	IN	IN	_	17	case	_	_
16	IL-2R	il-2r	NN	NN	_	17	compound	_	_
17	beta	beta	NN	NN	_	14	nmod	_	_
18	was	be	VBD	VBD	_	19	auxpass	_	_
19	down-regulated	down-regulate	VBN	VBN	_	0	root	_	_
20	,	,	,	,	_	19	punct	_	_
21	IL-2R	il-2r	NN	NN	_	22	compound	_	_
22	gamma	gamma	NN	NN	_	25	nsubjpass	_	_
23	was	be	VBD	VBD	_	25	auxpass	_	_
24	slightly	slightly	RB	RB	_	25	advmod	_	_
25	up-regulated	up-regulate	VBN	VBN	_	19	parataxis	_	_
26	,	,	,	,	_	25	punct	_	_
27	while	while	IN	IN	_	30	mark	_	_
28	IL-2R	il-2r	NN	NN	_	29	compound	_	_
29	alpha	alpha	NN	NN	_	30	nsubj	_	_
30	remained	remain	VBD	VBD	_	25	advcl	_	_
31	largely	largely	RB	RB	_	32	advmod	_	_
32	unaffected	unaffected	JJ	JJ	_	30	xcomp	_	_
33	.	.	.	.	_	19	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	changes	change	NNS	NNS	_	9	nsubjpass	_	_
3	in	in	IN	IN	_	5	case	_	_
4	the	the	DT	DT	_	5	det	_	_
5	composition	composition	NN	NN	_	2	nmod	_	_
6	of	of	IN	IN	_	7	case	_	_
7	IL-2Rs	il-2r	NNS	NNS	_	5	nmod	_	_
8	were	be	VBD	VBD	_	9	auxpass	_	_
9	accompanied	accompany	VBN	VBN	_	0	root	_	_
10	by	by	IN	IN	_	11	case	_	_
11	inhibition	inhibition	NN	NN	_	9	nmod	_	_
12	of	of	IN	IN	_	15	case	_	_
13	IL-2-induced	il-2-induced	JJ	JJ	_	15	amod	_	_
14	tyrosine	tyrosine	NN	NN	_	15	compound	_	_
15	phosphorylation	phosphorylation	NN	NN	_	11	nmod	_	_
16	of	of	IN	IN	_	20	case	_	_
17	the	the	DT	DT	_	20	det	_	_
18	Janus	janus	NN	NN	_	20	compound	_	_
19	protein-tyrosine	protein-tyrosine	NN	NN	_	20	compound	_	_
20	kinase	kinase	NN	NN	_	15	nmod	_	_
21	3	3	CD	CD	_	20	nummod	_	_
22	(	(	-LRB-	-LRB-	_	23	punct	_	_
23	Jak3	jak3	NN	NN	_	20	appos	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	and	and	CC	CC	_	20	cc	_	_
26	signal	signal	NN	NN	_	27	compound	_	_
27	transducers	transducer	NNS	NNS	_	20	conj	_	_
28	and	and	CC	CC	_	27	cc	_	_
29	activators	activator	NNS	NNS	_	31	compound	_	_
30	of	of	IN	IN	_	31	amod	_	_
31	transcription	transcription	NN	NN	_	27	conj	_	_
32	called	call	VBN	VBN	_	27	acl	_	_
33	Stat3	stat3	NN	NN	_	32	xcomp	_	_
34	and	and	CC	CC	_	33	cc	_	_
35	Stat5	stat5	NN	NN	_	33	conj	_	_
36	.	.	.	.	_	9	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	parallel	parallel	JJ	JJ	_	3	amod	_	_
3	experiments	experiment	NNS	NNS	_	8	nmod	_	_
4	,	,	,	,	_	8	punct	_	_
5	IL-2-driven	il-2-driven	JJ	JJ	_	6	amod	_	_
6	proliferation	proliferation	NN	NN	_	8	nsubjpass	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	inhibited	inhibit	VBN	VBN	_	0	root	_	_
9	significantly	significantly	RB	RB	_	8	advmod	_	_
10	.	.	.	.	_	8	punct	_	_

1	After	after	IN	IN	_	3	case	_	_
2	16	16	CD	CD	_	3	nummod	_	_
3	hr	hr	NN	NN	_	14	nmod	_	_
4	of	of	IN	IN	_	5	case	_	_
5	exposure	exposure	NN	NN	_	3	nmod	_	_
6	to	to	TO	TO	_	7	case	_	_
7	SE	se	NNS	NNS	_	5	nmod	_	_
8	,	,	,	,	_	14	punct	_	_
9	the	the	DT	DT	_	10	det	_	_
10	expression	expression	NN	NN	_	14	nsubj	_	_
11	of	of	IN	IN	_	13	case	_	_
12	IL-2R	il-2r	NN	NN	_	13	compound	_	_
13	beta	beta	NN	NN	_	10	nmod	_	_
14	remained	remain	VBD	VBD	_	0	root	_	_
15	low	low	JJ	JJ	_	14	xcomp	_	_
16	,	,	,	,	_	14	punct	_	_
17	while	while	IN	IN	_	27	mark	_	_
18	that	that	DT	DT	_	27	nsubjpass	_	_
19	of	of	IN	IN	_	21	case	_	_
20	IL2R	il2r	NN	NN	_	21	compound	_	_
21	alpha	alpha	NN	NN	_	18	nmod	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	IL2R	il2r	NN	NN	_	24	compound	_	_
24	gamma	gamma	NN	NN	_	21	conj	_	_
25	was	be	VBD	VBD	_	27	auxpass	_	_
26	further	further	RB	RB	_	27	advmod	_	_
27	up-regulated	up-regulate	VBN	VBN	_	14	advcl	_	_
28	,	,	,	,	_	14	punct	_	_
29	and	and	CC	CC	_	14	cc	_	_
30	ligand-induced	ligand-induced	JJ	JJ	_	32	amod	_	_
31	tyrosine	tyrosine	NN	NN	_	32	compound	_	_
32	phosphorylation	phosphorylation	NN	NN	_	40	nsubjpass	_	_
33	of	of	IN	IN	_	34	case	_	_
34	Jak3	jak3	NN	NN	_	32	nmod	_	_
35	and	and	CC	CC	_	34	cc	_	_
36	Stat	stat	NN	NN	_	37	compound	_	_
37	proteins	protein	NNS	NNS	_	34	conj	_	_
38	was	be	VBD	VBD	_	40	auxpass	_	_
39	partly	partly	RB	RB	_	40	advmod	_	_
40	normalized	normalize	VBN	VBN	_	14	conj	_	_
41	.	.	.	.	_	14	punct	_	_

1	Yet	yet	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	IL-2-driven	il-2-driven	JJ	JJ	_	4	amod	_	_
4	proliferation	proliferation	NN	NN	_	5	nsubj	_	_
5	remained	remain	VBD	VBD	_	0	root	_	_
6	profoundly	profoundly	RB	RB	_	7	advmod	_	_
7	inhibited	inhibited	JJ	JJ	_	5	xcomp	_	_
8	,	,	,	,	_	5	punct	_	_
9	suggesting	suggest	VBG	VBG	_	5	advcl	_	_
10	that	that	IN	IN	_	20	mark	_	_
11	signaling	signaling	NN	NN	_	12	compound	_	_
12	events	event	NNS	NNS	_	20	nsubjpass	_	_
13	other	other	JJ	JJ	_	12	cc	_	_
14	than	than	IN	IN	_	13	dep	_	_
15	Jak3/Stat	jak3/stat	NN	NN	_	16	compound	_	_
16	activation	activation	NN	NN	_	12	conj	_	_
17	had	have	VBD	VBD	_	20	aux	_	_
18	also	also	RB	RB	_	20	advmod	_	_
19	been	be	VBN	VBN	_	20	auxpass	_	_
20	changed	change	VBN	VBN	_	9	ccomp	_	_
21	following	follow	VBG	VBG	_	23	case	_	_
22	SE	se	NNS	NNS	_	23	compound	_	_
23	stimulation	stimulation	NN	NN	_	20	nmod	_	_
24	.	.	.	.	_	5	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	conclusion	conclusion	NN	NN	_	6	nmod	_	_
3	,	,	,	,	_	6	punct	_	_
4	our	we	PRP$	PRP$	_	5	nmod:poss	_	_
5	data	datum	NNS	NNS	_	6	nsubj	_	_
6	suggest	suggest	VBP	VBP	_	0	root	_	_
7	that	that	IN	IN	_	10	mark	_	_
8	SE	se	NNS	NNS	_	10	nsubj	_	_
9	can	can	MD	MD	_	10	aux	_	_
10	modulate	modulate	VB	VB	_	6	ccomp	_	_
11	IL-2R	il-2r	NN	NN	_	12	compound	_	_
12	expression	expression	NN	NN	_	10	dobj	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	signal	signal	NN	NN	_	15	compound	_	_
15	transduction	transduction	NN	NN	_	12	conj	_	_
16	involving	involve	VBG	VBG	_	15	acl	_	_
17	the	the	DT	DT	_	19	det	_	_
18	Jak/Stat	jak/stat	NN	NN	_	19	compound	_	_
19	pathway	pathway	NN	NN	_	16	dobj	_	_
20	in	in	IN	IN	_	23	case	_	_
21	CD4+	cd4+	JJ	JJ	_	23	amod	_	_
22	T-cell	t-cell	NN	NN	_	23	compound	_	_
23	lines	line	NNS	NNS	_	12	nmod	_	_
24	.	.	.	.	_	6	punct	_	_

1	Mutation	mutation	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	3	case	_	_
3	Jak3	jak3	NN	NN	_	1	nmod	_	_
4	in	in	IN	IN	_	6	case	_	_
5	a	a	DT	DT	_	6	det	_	_
6	patient	patient	NN	NN	_	1	nmod	_	_
7	with	with	IN	IN	_	8	case	_	_
8	SCID	scid	NN	NN	_	6	nmod	_	_
9	:	:	:	:	_	1	punct	_	_
10	essential	essential	JJ	JJ	_	11	amod	_	_
11	role	role	NN	NN	_	1	dep	_	_
12	of	of	IN	IN	_	13	case	_	_
13	Jak3	jak3	NN	NN	_	11	nmod	_	_
14	in	in	IN	IN	_	16	case	_	_
15	lymphoid	lymphoid	JJ	JJ	_	16	amod	_	_
16	development	development	NN	NN	_	13	nmod	_	_
17	.	.	.	.	_	1	punct	_	_

1	Males	male	NNS	NNS	_	10	nsubj	_	_
2	with	with	IN	IN	_	6	case	_	_
3	X-linked	x-linked	JJ	JJ	_	6	amod	_	_
4	severe	severe	JJ	JJ	_	6	amod	_	_
5	combined	combined	JJ	JJ	_	6	amod	_	_
6	immunodeficiency	immunodeficiency	NN	NN	_	1	nmod	_	_
7	(	(	-LRB-	-LRB-	_	8	punct	_	_
8	XSCID	xscid	NN	NN	_	6	appos	_	_
9	)	)	-RRB-	-RRB-	_	8	punct	_	_
10	have	have	VBP	VBP	_	0	root	_	_
11	defects	defect	NNS	NNS	_	10	dobj	_	_
12	in	in	IN	IN	_	23	case	_	_
13	the	the	DT	DT	_	23	det	_	_
14	common	common	JJ	JJ	_	23	amod	_	_
15	cytokine	cytokine	NN	NN	_	23	compound	_	_
16	receptor	receptor	NN	NN	_	23	compound	_	_
17	gamma	gamma	NN	NN	_	23	compound	_	_
18	chain	chain	NN	NN	_	23	compound	_	_
19	(	(	-LRB-	-LRB-	_	23	punct	_	_
20	gamma	gamma	NN	NN	_	23	compound	_	_
21	c	c	NN	NN	_	23	compound	_	_
22	)	)	-RRB-	-RRB-	_	23	punct	_	_
23	gene	gene	NN	NN	_	11	nmod	_	_
24	that	that	WDT	WDT	_	25	nsubj	_	_
25	encodes	encode	VBZ	VBZ	_	23	acl:relcl	_	_
26	a	a	DT	DT	_	30	det	_	_
27	shared	shared	JJ	JJ	_	30	amod	_	_
28	,	,	,	,	_	27	punct	_	_
29	essential	essential	JJ	JJ	_	27	dep	_	_
30	component	component	NN	NN	_	25	dobj	_	_
31	of	of	IN	IN	_	33	case	_	_
32	the	the	DT	DT	_	33	det	_	_
33	receptors	receptor	NNS	NNS	_	30	nmod	_	_
34	of	of	IN	IN	_	35	case	_	_
35	interleukin-2	interleukin-2	NN	NN	_	33	nmod	_	_
36	(	(	-LRB-	-LRB-	_	37	punct	_	_
37	IL-2	il-2	NN	NN	_	35	appos	_	_
38	)	)	-RRB-	-RRB-	_	37	punct	_	_
39	,	,	,	,	_	35	punct	_	_
40	IL-4	il-4	NN	NN	_	35	conj	_	_
41	,	,	,	,	_	35	punct	_	_
42	IL-7	il-7	NN	NN	_	35	conj	_	_
43	,	,	,	,	_	35	punct	_	_
44	IL-9	il-9	NN	NN	_	35	conj	_	_
45	,	,	,	,	_	35	punct	_	_
46	and	and	CC	CC	_	35	cc	_	_
47	IL-15	il-15	NN	NN	_	35	conj	_	_
48	.	.	.	.	_	10	punct	_	_

1	The	the	DT	DT	_	5	det	_	_
2	Janus	janus	NN	NN	_	5	compound	_	_
3	family	family	NN	NN	_	5	compound	_	_
4	tyrosine	tyrosine	NN	NN	_	5	compound	_	_
5	kinase	kinase	NN	NN	_	11	nsubj	_	_
6	Jak3	jak3	NN	NN	_	5	dep	_	_
7	is	be	VBZ	VBZ	_	11	cop	_	_
8	the	the	DT	DT	_	11	det	_	_
9	only	only	JJ	JJ	_	11	amod	_	_
10	signaling	signal	VBG	VBG	_	11	amod	_	_
11	molecule	molecule	NN	NN	_	0	root	_	_
12	known	know	VBN	VBN	_	11	acl	_	_
13	to	to	TO	TO	_	15	mark	_	_
14	be	be	VB	VB	_	15	auxpass	_	_
15	associated	associate	VBN	VBN	_	12	xcomp	_	_
16	with	with	IN	IN	_	18	case	_	_
17	gamma	gamma	NN	NN	_	18	compound	_	_
18	c	c	NN	NN	_	15	nmod	_	_
19	,	,	,	,	_	11	punct	_	_
20	so	so	IN	IN	_	23	mark	_	_
21	it	it	PRP	PRP	_	23	nsubjpass	_	_
22	was	be	VBD	VBD	_	23	auxpass	_	_
23	hypothesized	hypothesize	VBN	VBN	_	11	advcl	_	_
24	that	that	IN	IN	_	29	mark	_	_
25	defects	defect	NNS	NNS	_	29	nsubj	_	_
26	in	in	IN	IN	_	27	case	_	_
27	Jak3	jak3	NN	NN	_	25	nmod	_	_
28	might	might	MD	MD	_	29	aux	_	_
29	cause	cause	VB	VB	_	23	ccomp	_	_
30	an	a	DT	DT	_	32	det	_	_
31	XSCID-like	xscid-like	JJ	JJ	_	32	amod	_	_
32	phenotype	phenotype	NN	NN	_	29	dobj	_	_
33	.	.	.	.	_	11	punct	_	_

1	A	a	DT	DT	_	2	det	_	_
2	girl	girl	NN	NN	_	13	nsubjpass	_	_
3	with	with	IN	IN	_	5	case	_	_
4	immunological	immunological	JJ	JJ	_	5	amod	_	_
5	features	feature	NNS	NNS	_	2	nmod	_	_
6	indistinguishable	indistinguishable	JJ	JJ	_	5	amod	_	_
7	from	from	IN	IN	_	8	case	_	_
8	those	those	DT	DT	_	6	nmod	_	_
9	of	of	IN	IN	_	10	case	_	_
10	XSCID	xscid	NN	NN	_	8	nmod	_	_
11	was	be	VBD	VBD	_	13	auxpass	_	_
12	therefore	therefore	RB	RB	_	13	advmod	_	_
13	selected	select	VBN	VBN	_	0	root	_	_
14	for	for	IN	IN	_	15	case	_	_
15	analysis	analysis	NN	NN	_	13	nmod	_	_
16	.	.	.	.	_	13	punct	_	_

1	An	a	DT	DT	_	9	det	_	_
2	Epstein-Barr	epstein-barr	JJ	JJ	_	9	amod	_	_
3	virus	virus	NN	NN	_	9	compound	_	_
4	(	(	-LRB-	-LRB-	_	9	punct	_	_
5	EBV	ebv	NN	NN	_	9	compound	_	_
6	)	)	-RRB-	-RRB-	_	9	punct	_	_
7	-transformed	-transformed	JJ	JJ	_	9	amod	_	_
8	cell	cell	NN	NN	_	9	compound	_	_
9	line	line	NN	NN	_	14	nsubj	_	_
10	derived	derive	VBN	VBN	_	9	acl	_	_
11	from	from	IN	IN	_	13	case	_	_
12	her	she	PRP$	PRP$	_	13	nmod:poss	_	_
13	lymphocytes	lymphocyte	NNS	NNS	_	10	nmod	_	_
14	had	have	VBD	VBD	_	0	root	_	_
15	normal	normal	JJ	JJ	_	18	amod	_	_
16	gamma	gamma	NN	NN	_	17	compound	_	_
17	c	c	NN	NN	_	18	compound	_	_
18	expression	expression	NN	NN	_	14	dobj	_	_
19	but	but	CC	CC	_	14	cc	_	_
20	lacked	lack	VBD	VBD	_	14	conj	_	_
21	Jak3	jak3	NN	NN	_	22	compound	_	_
22	protein	protein	NN	NN	_	20	dobj	_	_
23	and	and	CC	CC	_	14	cc	_	_
24	had	have	VBD	VBD	_	14	conj	_	_
25	greatly	greatly	RB	RB	_	26	advmod	_	_
26	diminished	diminish	VBN	VBN	_	29	amod	_	_
27	Jak3	jak3	NN	NN	_	29	compound	_	_
28	messenger	messenger	NN	NN	_	29	compound	_	_
29	RNA	rna	NN	NN	_	24	dobj	_	_
30	.	.	.	.	_	14	punct	_	_

1	Sequencing	sequencing	NN	NN	_	2	nsubj	_	_
2	revealed	reveal	VBD	VBD	_	0	root	_	_
3	a	a	DT	DT	_	5	det	_	_
4	different	different	JJ	JJ	_	5	amod	_	_
5	mutation	mutation	NN	NN	_	2	dobj	_	_
6	on	on	IN	IN	_	8	case	_	_
7	each	each	DT	DT	_	8	det	_	_
8	allele	allele	NN	NN	_	5	nmod	_	_
9	:	:	:	:	_	2	punct	_	_
10	a	a	DT	DT	_	13	det	_	_
11	single	single	JJ	JJ	_	13	amod	_	_
12	nucleotide	nucleotide	NN	NN	_	13	compound	_	_
13	insertion	insertion	NN	NN	_	2	dep	_	_
14	resulting	result	VBG	VBG	_	13	acl	_	_
15	in	in	IN	IN	_	18	case	_	_
16	a	a	DT	DT	_	18	det	_	_
17	frame	frame	NN	NN	_	18	compound	_	_
18	shift	shift	NN	NN	_	14	nmod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	premature	premature	JJ	JJ	_	21	amod	_	_
21	termination	termination	NN	NN	_	18	conj	_	_
22	in	in	IN	IN	_	26	case	_	_
23	the	the	DT	DT	_	26	det	_	_
24	Jak3	jak3	NN	NN	_	26	compound	_	_
25	JH4	jh4	NN	NN	_	26	compound	_	_
26	domain	domain	NN	NN	_	18	nmod	_	_
27	and	and	CC	CC	_	18	cc	_	_
28	a	a	DT	DT	_	30	det	_	_
29	nonsense	nonsense	JJ	JJ	_	30	amod	_	_
30	mutation	mutation	NN	NN	_	18	conj	_	_
31	in	in	IN	IN	_	35	case	_	_
32	the	the	DT	DT	_	35	det	_	_
33	Jak3	jak3	NN	NN	_	35	compound	_	_
34	JH2	jh2	NN	NN	_	35	compound	_	_
35	domain	domain	NN	NN	_	30	nmod	_	_
36	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	lack	lack	NN	NN	_	6	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	Jak3	jak3	NN	NN	_	5	compound	_	_
5	expression	expression	NN	NN	_	2	nmod	_	_
6	correlated	correlate	VBD	VBD	_	0	root	_	_
7	with	with	IN	IN	_	11	case	_	_
8	impaired	impaired	JJ	JJ	_	11	amod	_	_
9	B	b	NN	NN	_	11	compound	_	_
10	cell	cell	NN	NN	_	11	compound	_	_
11	signaling	signaling	NN	NN	_	6	nmod	_	_
12	,	,	,	,	_	6	punct	_	_
13	as	as	IN	IN	_	14	mark	_	_
14	demonstrated	demonstrate	VBN	VBN	_	6	advcl	_	_
15	by	by	IN	IN	_	17	case	_	_
16	the	the	DT	DT	_	17	det	_	_
17	inability	inability	NN	NN	_	14	nmod	_	_
18	of	of	IN	IN	_	19	case	_	_
19	IL-4	il-4	NN	NN	_	17	nmod	_	_
20	to	to	TO	TO	_	21	mark	_	_
21	activate	activate	VB	VB	_	17	acl	_	_
22	Stat6	stat6	NN	NN	_	21	dobj	_	_
23	in	in	IN	IN	_	27	case	_	_
24	the	the	DT	DT	_	27	det	_	_
25	EBV-transformed	ebv-transformed	JJ	JJ	_	27	amod	_	_
26	cell	cell	NN	NN	_	27	compound	_	_
27	line	line	NN	NN	_	21	nmod	_	_
28	from	from	IN	IN	_	30	case	_	_
29	the	the	DT	DT	_	30	det	_	_
30	patient	patient	NN	NN	_	27	nmod	_	_
31	.	.	.	.	_	6	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	observations	observation	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	11	mark	_	_
5	the	the	DT	DT	_	6	det	_	_
6	functions	function	NNS	NNS	_	11	nsubj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	gamma	gamma	NN	NN	_	9	compound	_	_
9	c	c	NN	NN	_	6	nmod	_	_
10	are	be	VBP	VBP	_	11	cop	_	_
11	dependent	dependent	JJ	JJ	_	3	ccomp	_	_
12	on	on	IN	IN	_	13	case	_	_
13	Jak3	jak3	NN	NN	_	11	nmod	_	_
14	and	and	CC	CC	_	11	cc	_	_
15	that	that	IN	IN	_	18	mark	_	_
16	Jak3	jak3	NN	NN	_	18	nsubj	_	_
17	is	be	VBZ	VBZ	_	18	cop	_	_
18	essential	essential	JJ	JJ	_	11	conj	_	_
19	for	for	IN	IN	_	21	case	_	_
20	lymphoid	lymphoid	JJ	JJ	_	21	amod	_	_
21	development	development	NN	NN	_	18	nmod	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	signaling	signaling	NN	NN	_	21	conj	_	_
24	.	.	.	.	_	3	punct	_	_

1	Costimulation	costimulation	NN	NN	_	2	compound	_	_
2	requirement	requirement	NN	NN	_	0	root	_	_
3	for	for	IN	IN	_	10	case	_	_
4	AP-1	ap-1	NN	NN	_	10	compound	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	NF-kappa	nf-kappa	NN	NN	_	7	compound	_	_
7	B	b	NN	NN	_	4	conj	_	_
8	transcription	transcription	NN	NN	_	10	compound	_	_
9	factor	factor	NN	NN	_	10	compound	_	_
10	activation	activation	NN	NN	_	2	nmod	_	_
11	in	in	IN	IN	_	13	case	_	_
12	T	t	NN	NN	_	13	compound	_	_
13	cells	cell	NNS	NNS	_	10	nmod	_	_
14	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	transcriptional	transcriptional	JJ	JJ	_	3	amod	_	_
3	activity	activity	NN	NN	_	8	nsubj	_	_
4	of	of	IN	IN	_	7	case	_	_
5	the	the	DT	DT	_	7	det	_	_
6	IL-2	il-2	NN	NN	_	7	compound	_	_
7	promoter	promoter	NN	NN	_	3	nmod	_	_
8	requires	require	VBZ	VBZ	_	0	root	_	_
9	T-cell	t-cell	NN	NN	_	10	compound	_	_
10	costimulation	costimulation	NN	NN	_	8	dobj	_	_
11	delivered	deliver	VBN	VBN	_	10	acl	_	_
12	by	by	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	det	_	_
14	TCR	tcr	NN	NN	_	11	nmod	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	the	the	DT	DT	_	19	det	_	_
17	auxiliary	auxiliary	JJ	JJ	_	19	amod	_	_
18	receptor	receptor	NN	NN	_	19	compound	_	_
19	CD28	cd28	NN	NN	_	14	conj	_	_
20	.	.	.	.	_	8	punct	_	_

1	Several	several	JJ	JJ	_	3	amod	_	_
2	transcription	transcription	NN	NN	_	3	compound	_	_
3	factors	factor	NNS	NNS	_	4	nsubj	_	_
4	participate	participate	VBP	VBP	_	0	root	_	_
5	in	in	IN	IN	_	8	case	_	_
6	IL-2	il-2	NN	NN	_	8	compound	_	_
7	promoter	promoter	NN	NN	_	8	compound	_	_
8	activation	activation	NN	NN	_	4	nmod	_	_
9	,	,	,	,	_	8	punct	_	_
10	among	among	IN	IN	_	11	case	_	_
11	which	which	WDT	WDT	_	14	dep	_	_
12	are	be	VBP	VBP	_	14	cop	_	_
13	AP-1-like	ap-1-like	JJ	JJ	_	14	amod	_	_
14	factors	factor	NNS	NNS	_	8	acl:relcl	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	NF-kappa	nf-kappa	NN	NN	_	17	compound	_	_
17	B	b	NN	NN	_	14	conj	_	_
18	.	.	.	.	_	4	punct	_	_

1	Protein	protein	NN	NN	_	2	compound	_	_
2	phosphorylation	phosphorylation	NN	NN	_	3	nsubj	_	_
3	has	have	VBZ	VBZ	_	0	root	_	_
4	an	a	DT	DT	_	6	det	_	_
5	important	important	JJ	JJ	_	6	amod	_	_
6	role	role	NN	NN	_	3	dobj	_	_
7	in	in	IN	IN	_	9	case	_	_
8	the	the	DT	DT	_	9	det	_	_
9	regulation	regulation	NN	NN	_	3	nmod	_	_
10	of	of	IN	IN	_	13	case	_	_
11	these	these	DT	DT	_	13	det	_	_
12	two	two	CD	CD	_	13	nummod	_	_
13	factors	factor	NNS	NNS	_	9	nmod	_	_
14	:	:	:	:	_	3	punct	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	1	1	LS	LS	_	19	dep	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	it	it	PRP	PRP	_	19	nsubj	_	_
19	induces	induce	VBZ	VBZ	_	3	parataxis	_	_
20	the	the	DT	DT	_	22	det	_	_
21	transactivating	transactivating	NN	NN	_	22	compound	_	_
22	capacity	capacity	NN	NN	_	19	dobj	_	_
23	of	of	IN	IN	_	26	case	_	_
24	the	the	DT	DT	_	26	det	_	_
25	AP-1	ap-1	NN	NN	_	26	compound	_	_
26	protein	protein	NN	NN	_	22	nmod	_	_
27	c-Jun	c-jun	NN	NN	_	26	dep	_	_
28	;	;	:	:	_	19	punct	_	_
29	and	and	CC	CC	_	19	cc	_	_
30	(	(	-LRB-	-LRB-	_	31	punct	_	_
31	2	2	LS	LS	_	35	dep	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	it	it	PRP	PRP	_	35	nsubjpass	_	_
34	is	be	VBZ	VBZ	_	35	auxpass	_	_
35	involved	involve	VBN	VBN	_	19	conj	_	_
36	in	in	IN	IN	_	38	case	_	_
37	the	the	DT	DT	_	38	det	_	_
38	release	release	NN	NN	_	35	nmod	_	_
39	of	of	IN	IN	_	42	case	_	_
40	the	the	DT	DT	_	42	det	_	_
41	cytoplasmic	cytoplasmic	JJ	JJ	_	42	amod	_	_
42	inhibitor	inhibitor	NN	NN	_	38	nmod	_	_
43	,	,	,	,	_	42	punct	_	_
44	I	i	NN	NN	_	46	compound	_	_
45	kappa	kappa	NN	NN	_	46	compound	_	_
46	B	b	NN	NN	_	42	appos	_	_
47	,	,	,	,	_	38	punct	_	_
48	from	from	IN	IN	_	50	case	_	_
49	NF-kappa	nf-kappa	NN	NN	_	50	compound	_	_
50	B	b	NN	NN	_	38	nmod	_	_
51	,	,	,	,	_	35	punct	_	_
52	allowing	allow	VBG	VBG	_	35	advcl	_	_
53	translocation	translocation	NN	NN	_	52	dobj	_	_
54	of	of	IN	IN	_	56	case	_	_
55	the	the	DT	DT	_	56	det	_	_
56	latter	latter	JJ	JJ	_	53	nmod	_	_
57	into	into	IN	IN	_	59	case	_	_
58	the	the	DT	DT	_	59	det	_	_
59	nucleus	nucleus	NN	NN	_	53	nmod	_	_
60	.	.	.	.	_	3	punct	_	_

1	We	we	PRP	PRP	_	4	nsubj	_	_
2	have	have	VBP	VBP	_	4	aux	_	_
3	recently	recently	RB	RB	_	4	advmod	_	_
4	shown	show	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	9	mark	_	_
6	both	both	DT	DT	_	8	det	_	_
7	phosphorylation	phosphorylation	NN	NN	_	8	compound	_	_
8	processes	process	NNS	NNS	_	9	nsubj	_	_
9	require	require	VBP	VBP	_	4	ccomp	_	_
10	T-cell	t-cell	NN	NN	_	11	compound	_	_
11	costimulation	costimulation	NN	NN	_	9	dobj	_	_
12	.	.	.	.	_	4	punct	_	_

1	Furthermore	furthermore	RB	RB	_	17	advmod	_	_
2	,	,	,	,	_	17	punct	_	_
3	in	in	IN	IN	_	6	case	_	_
4	activated	activate	VBN	VBN	_	6	amod	_	_
5	T	t	NN	NN	_	6	compound	_	_
6	cells	cell	NNS	NNS	_	17	nmod	_	_
7	,	,	,	,	_	17	punct	_	_
8	the	the	DT	DT	_	9	det	_	_
9	kinetics	kinetics	NNS	NNS	_	17	nsubj	_	_
10	of	of	IN	IN	_	14	case	_	_
11	the	the	DT	DT	_	14	det	_	_
12	two	two	CD	CD	_	14	nummod	_	_
13	phosphorylation	phosphorylation	NN	NN	_	14	compound	_	_
14	events	event	NNS	NNS	_	9	nmod	_	_
15	are	be	VBP	VBP	_	17	cop	_	_
16	essentially	essentially	RB	RB	_	17	advmod	_	_
17	similar	similar	JJ	JJ	_	0	root	_	_
18	.	.	.	.	_	17	punct	_	_

1	According	accord	VBG	VBG	_	4	case	_	_
2	to	to	TO	TO	_	1	mwe	_	_
3	our	we	PRP$	PRP$	_	4	nmod:poss	_	_
4	results	result	NNS	NNS	_	17	nmod	_	_
5	,	,	,	,	_	17	punct	_	_
6	however	however	RB	RB	_	17	advmod	_	_
7	,	,	,	,	_	17	punct	_	_
8	the	the	DT	DT	_	9	det	_	_
9	kinases	kinase	NNS	NNS	_	17	nsubj	_	_
10	responsible	responsible	JJ	JJ	_	9	amod	_	_
11	for	for	IN	IN	_	14	case	_	_
12	the	the	DT	DT	_	14	det	_	_
13	two	two	CD	CD	_	14	nummod	_	_
14	processes	process	NNS	NNS	_	10	nmod	_	_
15	are	be	VBP	VBP	_	17	cop	_	_
16	distinct	distinct	JJ	JJ	_	17	amod	_	_
17	entities	entity	NNS	NNS	_	0	root	_	_
18	.	.	.	.	_	17	punct	_	_

1	Whereas	whereas	IN	IN	_	3	mark	_	_
2	TPCK	tpck	NN	NN	_	3	nsubj	_	_
3	inhibits	inhibit	VBZ	VBZ	_	20	advcl	_	_
4	phosphorylation	phosphorylation	NN	NN	_	3	dobj	_	_
5	of	of	IN	IN	_	8	case	_	_
6	I	i	NN	NN	_	8	compound	_	_
7	kappa	kappa	NN	NN	_	8	compound	_	_
8	B	b	NN	NN	_	4	nmod	_	_
9	and	and	CC	CC	_	4	cc	_	_
10	,	,	,	,	_	4	punct	_	_
11	consequently	consequently	RB	RB	_	4	advmod	_	_
12	,	,	,	,	_	4	punct	_	_
13	activation	activation	NN	NN	_	4	conj	_	_
14	of	of	IN	IN	_	16	case	_	_
15	NF-kappa	nf-kappa	NN	NN	_	16	compound	_	_
16	B	b	NN	NN	_	13	nmod	_	_
17	,	,	,	,	_	20	punct	_	_
18	it	it	PRP	PRP	_	20	nsubj	_	_
19	markedly	markedly	RB	RB	_	20	advmod	_	_
20	enhances	enhance	VBZ	VBZ	_	0	root	_	_
21	the	the	DT	DT	_	22	det	_	_
22	activity	activity	NN	NN	_	20	dobj	_	_
23	of	of	IN	IN	_	24	case	_	_
24	JNK	jnk	NN	NN	_	22	nmod	_	_
25	,	,	,	,	_	24	punct	_	_
26	the	the	DT	DT	_	29	det	_	_
27	MAP	map	NN	NN	_	29	compound	_	_
28	kinase-related	kinase-related	JJ	JJ	_	29	amod	_	_
29	kinase	kinase	NN	NN	_	24	appos	_	_
30	that	that	WDT	WDT	_	31	nsubj	_	_
31	phosphorylates	phosphorylate	VBZ	VBZ	_	29	acl:relcl	_	_
32	the	the	DT	DT	_	34	det	_	_
33	transactivation	transactivation	NN	NN	_	34	compound	_	_
34	domain	domain	NN	NN	_	31	dobj	_	_
35	of	of	IN	IN	_	36	case	_	_
36	c-Jun	c-jun	NN	NN	_	34	nmod	_	_
37	.	.	.	.	_	20	punct	_	_

1	We	we	PRP	PRP	_	5	nsubj	_	_
2	,	,	,	,	_	1	punct	_	_
3	therefore	therefore	RB	RB	_	5	advmod	_	_
4	,	,	,	,	_	5	punct	_	_
5	propose	propose	VBP	VBP	_	0	root	_	_
6	the	the	DT	DT	_	8	det	_	_
7	activation	activation	NN	NN	_	8	compound	_	_
8	scheme	scheme	NN	NN	_	5	dobj	_	_
9	presented	present	VBN	VBN	_	8	acl	_	_
10	in	in	IN	IN	_	11	case	_	_
11	FIGURE	figure	NN	NN	_	9	nmod	_	_
12	3	3	CD	CD	_	11	nummod	_	_
13	for	for	IN	IN	_	15	case	_	_
14	T-cell	t-cell	NN	NN	_	15	compound	_	_
15	costimulation	costimulation	NN	NN	_	5	nmod	_	_
16	.	.	.	.	_	5	punct	_	_

1	Costimulation	costimulation	NN	NN	_	2	nsubj	_	_
2	results	result	VBZ	VBZ	_	0	root	_	_
3	in	in	IN	IN	_	5	case	_	_
4	the	the	DT	DT	_	5	det	_	_
5	activation	activation	NN	NN	_	2	nmod	_	_
6	of	of	IN	IN	_	9	case	_	_
7	a	a	DT	DT	_	9	det	_	_
8	signaling	signaling	NN	NN	_	9	compound	_	_
9	pathway	pathway	NN	NN	_	5	nmod	_	_
10	that	that	WDT	WDT	_	11	nsubj	_	_
11	leads	lead	VBZ	VBZ	_	5	acl:relcl	_	_
12	to	to	TO	TO	_	15	case	_	_
13	the	the	DT	DT	_	15	det	_	_
14	simultaneous	simultaneous	JJ	JJ	_	15	amod	_	_
15	induction	induction	NN	NN	_	11	nmod	_	_
16	of	of	IN	IN	_	20	case	_	_
17	the	the	DT	DT	_	20	det	_	_
18	two	two	CD	CD	_	20	nummod	_	_
19	transcription	transcription	NN	NN	_	20	compound	_	_
20	factors	factor	NNS	NNS	_	15	nmod	_	_
21	,	,	,	,	_	20	punct	_	_
22	AP-1	ap-1	NN	NN	_	20	appos	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	NF-kappa	nf-kappa	NN	NN	_	25	compound	_	_
25	B	b	NN	NN	_	22	conj	_	_
26	.	.	.	.	_	2	punct	_	_

1	Integration	integration	NN	NN	_	11	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	the	the	DT	DT	_	4	det	_	_
4	signals	signal	NNS	NNS	_	1	nmod	_	_
5	generated	generate	VBN	VBN	_	4	acl	_	_
6	by	by	IN	IN	_	10	case	_	_
7	TCR	tcr	NN	NN	_	10	compound	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	CD28	cd28	NN	NN	_	7	conj	_	_
10	engagement	engagement	NN	NN	_	5	nmod	_	_
11	occurs	occur	VBZ	VBZ	_	0	root	_	_
12	along	along	IN	IN	_	14	case	_	_
13	this	this	DT	DT	_	14	det	_	_
14	pathway	pathway	NN	NN	_	11	nmod	_	_
15	,	,	,	,	_	14	punct	_	_
16	which	which	WDT	WDT	_	18	nsubj	_	_
17	then	then	RB	RB	_	18	advmod	_	_
18	bifurcates	bifurcate	VBZ	VBZ	_	14	acl:relcl	_	_
19	to	to	TO	TO	_	20	mark	_	_
20	induce	induce	VB	VB	_	18	xcomp	_	_
21	I	i	NN	NN	_	23	compound	_	_
22	kappa	kappa	NN	NN	_	23	compound	_	_
23	B	b	NN	NN	_	24	compound	_	_
24	phosphorylation	phosphorylation	NN	NN	_	20	dobj	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	NF-kappa	nf-kappa	NN	NN	_	27	compound	_	_
27	B	b	NN	NN	_	28	compound	_	_
28	activation	activation	NN	NN	_	24	conj	_	_
29	on	on	IN	IN	_	32	case	_	_
30	the	the	DT	DT	_	32	det	_	_
31	one	one	CD	CD	_	32	nummod	_	_
32	hand	hand	NN	NN	_	24	nmod	_	_
33	,	,	,	,	_	24	punct	_	_
34	and	and	CC	CC	_	24	cc	_	_
35	JNK	jnk	NN	NN	_	36	compound	_	_
36	activation	activation	NN	NN	_	24	conj	_	_
37	and	and	CC	CC	_	36	cc	_	_
38	c-Jun	c-jun	NN	NN	_	39	compound	_	_
39	phosphorylation	phosphorylation	NN	NN	_	36	conj	_	_
40	on	on	IN	IN	_	42	case	_	_
41	the	the	DT	DT	_	42	det	_	_
42	other	other	JJ	JJ	_	24	nmod	_	_
43	.	.	.	.	_	11	punct	_	_

1	We	we	PRP	PRP	_	4	nsubjpass	_	_
2	are	be	VBP	VBP	_	4	auxpass	_	_
3	currently	currently	RB	RB	_	4	advmod	_	_
4	engaged	engage	VBN	VBN	_	0	root	_	_
5	in	in	IN	IN	_	6	mark	_	_
6	defining	define	VBG	VBG	_	4	advcl	_	_
7	where	where	WRB	WRB	_	11	advmod	_	_
8	the	the	DT	DT	_	10	det	_	_
9	two	two	CD	CD	_	10	nummod	_	_
10	signals	signal	NNS	NNS	_	11	nsubj	_	_
11	integrate	integrate	VBP	VBP	_	6	advcl	_	_
12	along	along	IN	IN	_	16	case	_	_
13	the	the	DT	DT	_	16	det	_	_
14	AP-1/NF-kappa	ap-1/nf-kappa	NN	NN	_	16	compound	_	_
15	B	b	NN	NN	_	16	compound	_	_
16	pathway	pathway	NN	NN	_	11	nmod	_	_
17	.	.	.	.	_	4	punct	_	_

1	Interleukin-7	interleukin-7	NN	NN	_	3	nsubj	_	_
2	can	can	MD	MD	_	3	aux	_	_
3	induce	induce	VB	VB	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	activation	activation	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	7	case	_	_
7	Jak	jak	NN	NN	_	5	nmod	_	_
8	1	1	CD	CD	_	7	nummod	_	_
9	,	,	,	,	_	7	punct	_	_
10	Jak	jak	NN	NN	_	7	conj	_	_
11	3	3	CD	CD	_	10	nummod	_	_
12	and	and	CC	CC	_	7	cc	_	_
13	STAT	stat	NN	NN	_	15	compound	_	_
14	5	5	CD	CD	_	15	nummod	_	_
15	proteins	protein	NNS	NNS	_	7	conj	_	_
16	in	in	IN	IN	_	19	case	_	_
17	murine	murine	JJ	JJ	_	19	amod	_	_
18	T	t	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	5	nmod	_	_
20	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	activation	activation	NN	NN	_	25	nsubjpass	_	_
3	of	of	IN	IN	_	7	case	_	_
4	Janus	janus	NN	NN	_	7	compound	_	_
5	protein	protein	NN	NN	_	7	compound	_	_
6	tyrosine	tyrosine	NN	NN	_	7	compound	_	_
7	kinases	kinase	NNS	NNS	_	2	nmod	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	Jak	jak	NN	NN	_	7	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	and	and	CC	CC	_	7	cc	_	_
12	STAT	stat	NN	NN	_	15	compound	_	_
13	(	(	-LRB-	-LRB-	_	15	punct	_	_
14	signal	signal	NN	NN	_	15	compound	_	_
15	transducer	transducer	NN	NN	_	7	conj	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	activator	activator	NN	NN	_	21	compound	_	_
18	of	of	IN	IN	_	21	amod	_	_
19	transcription	transcription	NN	NN	_	21	compound	_	_
20	)	)	-RRB-	-RRB-	_	21	punct	_	_
21	proteins	protein	NNS	NNS	_	15	conj	_	_
22	has	have	VBZ	VBZ	_	25	aux	_	_
23	recently	recently	RB	RB	_	25	advmod	_	_
24	been	be	VBN	VBN	_	25	auxpass	_	_
25	linked	link	VBN	VBN	_	0	root	_	_
26	to	to	TO	TO	_	30	case	_	_
27	the	the	DT	DT	_	30	det	_	_
28	signal	signal	NN	NN	_	30	compound	_	_
29	transduction	transduction	NN	NN	_	30	compound	_	_
30	mechanism	mechanism	NN	NN	_	25	nmod	_	_
31	of	of	IN	IN	_	33	case	_	_
32	several	several	JJ	JJ	_	33	amod	_	_
33	cytokines	cytokine	NNS	NNS	_	30	nmod	_	_
34	.	.	.	.	_	25	punct	_	_

1	IL-7	il-7	NN	NN	_	3	nsubjpass	_	_
2	was	be	VBD	VBD	_	3	auxpass	_	_
3	observed	observe	VBN	VBN	_	0	root	_	_
4	to	to	TO	TO	_	5	mark	_	_
5	induce	induce	VB	VB	_	3	xcomp	_	_
6	a	a	DT	DT	_	11	det	_	_
7	rapid	rapid	JJ	JJ	_	11	amod	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	dose-dependent	dose-dependent	JJ	JJ	_	7	conj	_	_
10	tyrosine	tyrosine	NN	NN	_	11	compound	_	_
11	phosphorylation	phosphorylation	NN	NN	_	5	dobj	_	_
12	of	of	IN	IN	_	13	case	_	_
13	Jak	jak	NN	NN	_	11	nmod	_	_
14	1	1	CD	CD	_	13	nummod	_	_
15	and	and	CC	CC	_	13	cc	_	_
16	Jak	jak	NN	NN	_	13	conj	_	_
17	3	3	CD	CD	_	16	nummod	_	_
18	and	and	CC	CC	_	11	cc	_	_
19	concomitantly	concomitantly	RB	RB	_	11	advmod	_	_
20	,	,	,	,	_	11	punct	_	_
21	the	the	DT	DT	_	23	dep	_	_
22	tyrosine	tyrosine	NN	NN	_	23	compound	_	_
23	phosphorylation	phosphorylation	NN	NN	_	11	conj	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	DNA	dna	NN	NN	_	27	compound	_	_
26	binding	binding	NN	NN	_	27	compound	_	_
27	activity	activity	NN	NN	_	23	conj	_	_
28	of	of	IN	IN	_	31	case	_	_
29	multiple	multiple	JJ	JJ	_	31	amod	_	_
30	STAT	stat	NN	NN	_	31	compound	_	_
31	proteins	protein	NNS	NNS	_	23	nmod	_	_
32	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	STAT	stat	NN	NN	_	3	compound	_	_
3	proteins	protein	NNS	NNS	_	8	nsubj	_	_
4	utilized	utilize	VBN	VBN	_	3	acl	_	_
5	by	by	IN	IN	_	6	case	_	_
6	IL-7	il-7	NN	NN	_	4	nmod	_	_
7	were	be	VBD	VBD	_	8	cop	_	_
8	identical	identical	JJ	JJ	_	0	root	_	_
9	to	to	TO	TO	_	10	case	_	_
10	those	those	DT	DT	_	8	nmod	_	_
11	induced	induce	VBN	VBN	_	10	acl	_	_
12	by	by	IN	IN	_	13	case	_	_
13	IL-2	il-2	NN	NN	_	11	nmod	_	_
14	and	and	CC	CC	_	8	cc	_	_
15	could	could	MD	MD	_	17	aux	_	_
16	be	be	VB	VB	_	17	auxpass	_	_
17	identified	identify	VBN	VBN	_	8	conj	_	_
18	as	as	IN	IN	_	22	case	_	_
19	various	various	JJ	JJ	_	22	amod	_	_
20	STAT	stat	NN	NN	_	22	compound	_	_
21	5	5	CD	CD	_	22	nummod	_	_
22	isoforms	isoform	NNS	NNS	_	17	nmod	_	_
23	.	.	.	.	_	8	punct	_	_

1	Moreover	moreover	RB	RB	_	17	advmod	_	_
2	,	,	,	,	_	17	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	induction	induction	NN	NN	_	17	nsubj	_	_
5	of	of	IN	IN	_	7	case	_	_
6	both	both	CC	CC	_	7	cc:preconj	_	_
7	Jak	jak	NN	NN	_	4	nmod	_	_
8	1	1	CD	CD	_	7	dep	_	_
9	and	and	CC	CC	_	7	cc	_	_
10	3	3	CD	CD	_	7	conj	_	_
11	,	,	,	,	_	4	punct	_	_
12	and	and	CC	CC	_	4	cc	_	_
13	STAT	stat	NN	NN	_	15	compound	_	_
14	5	5	CD	CD	_	13	nummod	_	_
15	activity	activity	NN	NN	_	4	conj	_	_
16	strongly	strongly	RB	RB	_	17	advmod	_	_
17	correlated	correlate	VBD	VBD	_	0	root	_	_
18	with	with	IN	IN	_	21	case	_	_
19	the	the	DT	DT	_	21	det	_	_
20	growth-promoting	growth-promoting	JJ	JJ	_	21	amod	_	_
21	effects	effect	NNS	NNS	_	17	nmod	_	_
22	of	of	IN	IN	_	23	case	_	_
23	IL-7	il-7	NN	NN	_	21	nmod	_	_
24	,	,	,	,	_	17	punct	_	_
25	suggesting	suggest	VBG	VBG	_	17	xcomp	_	_
26	that	that	IN	IN	_	32	mark	_	_
27	this	this	DT	DT	_	30	det	_	_
28	signal	signal	NN	NN	_	30	compound	_	_
29	transduction	transduction	NN	NN	_	30	compound	_	_
30	mechanism	mechanism	NN	NN	_	32	nsubj	_	_
31	may	may	MD	MD	_	32	aux	_	_
32	play	play	VB	VB	_	25	ccomp	_	_
33	a	a	DT	DT	_	35	det	_	_
34	key	key	JJ	JJ	_	35	amod	_	_
35	role	role	NN	NN	_	32	dobj	_	_
36	in	in	IN	IN	_	38	case	_	_
37	IL-7-induced	il-7-induced	JJ	JJ	_	38	amod	_	_
38	proliferation	proliferation	NN	NN	_	32	nmod	_	_
39	.	.	.	.	_	17	punct	_	_

1	Oncogenicity	oncogenicity	NN	NN	_	8	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	human	human	JJ	JJ	_	4	amod	_	_
4	papillomavirus-	papillomavirus-	NN	NN	_	1	nmod	_	_
5	or	or	CC	CC	_	4	cc	_	_
6	adenovirus-transformed	adenovirus-transformed	JJ	JJ	_	4	conj	_	_
7	cells	cell	NNS	NNS	_	4	dep	_	_
8	correlates	correlate	VBZ	VBZ	_	0	root	_	_
9	with	with	IN	IN	_	10	case	_	_
10	resistance	resistance	NN	NN	_	8	nmod	_	_
11	to	to	TO	TO	_	12	case	_	_
12	lysis	lysis	NN	NN	_	10	nmod	_	_
13	by	by	IN	IN	_	16	case	_	_
14	natural	natural	JJ	JJ	_	16	amod	_	_
15	killer	killer	NN	NN	_	16	compound	_	_
16	cells	cell	NNS	NNS	_	12	nmod	_	_
17	.	.	.	.	_	8	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	reasons	reason	NNS	NNS	_	19	nsubj	_	_
3	for	for	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	dissimilar	dissimilar	JJ	JJ	_	6	amod	_	_
6	oncogenicities	oncogenicity	NNS	NNS	_	2	nmod	_	_
7	of	of	IN	IN	_	9	case	_	_
8	human	human	JJ	JJ	_	9	amod	_	_
9	adenoviruses	adenovirus	NNS	NNS	_	6	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	human	human	JJ	JJ	_	12	amod	_	_
12	papillomaviruses	papillomavirus	NNS	NNS	_	9	conj	_	_
13	(	(	-LRB-	-LRB-	_	14	punct	_	_
14	HPV	hpv	NNS	NNS	_	12	appos	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	in	in	IN	IN	_	17	case	_	_
17	humans	human	NNS	NNS	_	6	nmod	_	_
18	are	be	VBP	VBP	_	19	cop	_	_
19	unknown	unknown	JJ	JJ	_	0	root	_	_
20	but	but	CC	CC	_	19	cc	_	_
21	may	may	MD	MD	_	22	aux	_	_
22	relate	relate	VB	VB	_	19	conj	_	_
23	to	to	TO	TO	_	24	case	_	_
24	differences	difference	NNS	NNS	_	22	nmod	_	_
25	in	in	IN	IN	_	27	case	_	_
26	the	the	DT	DT	_	27	det	_	_
27	capacities	capacity	NNS	NNS	_	24	nmod	_	_
28	of	of	IN	IN	_	30	case	_	_
29	the	the	DT	DT	_	30	dep	_	_
30	E1A	e1a	NN	NN	_	27	nmod	_	_
31	and	and	CC	CC	_	30	cc	_	_
32	E7	e7	NN	NN	_	33	compound	_	_
33	proteins	protein	NNS	NNS	_	30	conj	_	_
34	to	to	TO	TO	_	35	mark	_	_
35	target	target	VB	VB	_	27	acl	_	_
36	cells	cell	NNS	NNS	_	35	dobj	_	_
37	for	for	IN	IN	_	38	case	_	_
38	rejection	rejection	NN	NN	_	35	nmod	_	_
39	by	by	IN	IN	_	48	case	_	_
40	the	the	DT	DT	_	48	det	_	_
41	host	host	NN	NN	_	47	compound	_	_
42	natural	natural	JJ	JJ	_	47	amod	_	_
43	killer	killer	NN	NN	_	47	compound	_	_
44	(	(	-LRB-	-LRB-	_	47	punct	_	_
45	NK	nk	NN	NN	_	47	compound	_	_
46	)	)	-RRB-	-RRB-	_	47	punct	_	_
47	cell	cell	NN	NN	_	48	compound	_	_
48	response	response	NN	NN	_	38	nmod	_	_
49	.	.	.	.	_	19	punct	_	_

1	As	as	IN	IN	_	3	case	_	_
2	one	one	CD	CD	_	3	nummod	_	_
3	test	test	NN	NN	_	9	nmod	_	_
4	of	of	IN	IN	_	6	case	_	_
5	this	this	DT	DT	_	6	det	_	_
6	hypothesis	hypothesis	NN	NN	_	3	nmod	_	_
7	,	,	,	,	_	9	punct	_	_
8	we	we	PRP	PRP	_	9	nsubj	_	_
9	compared	compare	VBD	VBD	_	0	root	_	_
10	the	the	DT	DT	_	11	det	_	_
11	abilities	ability	NNS	NNS	_	9	dobj	_	_
12	of	of	IN	IN	_	13	case	_	_
13	E1A-	e1a-	NN	NN	_	11	nmod	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	E7-expressing	e7-expressing	JJ	JJ	_	13	conj	_	_
16	human	human	JJ	JJ	_	17	amod	_	_
17	fibroblastic	fibroblastic	JJ	JJ	_	13	dep	_	_
18	or	or	CC	CC	_	13	cc	_	_
19	keratinocyte-derived	keratinocyte-derived	JJ	JJ	_	20	amod	_	_
20	human	human	JJ	JJ	_	13	conj	_	_
21	cells	cell	NNS	NNS	_	13	dep	_	_
22	to	to	TO	TO	_	25	mark	_	_
23	be	be	VB	VB	_	25	auxpass	_	_
24	selectively	selectively	RB	RB	_	25	advmod	_	_
25	killed	kill	VBN	VBN	_	11	acl	_	_
26	by	by	IN	IN	_	28	case	_	_
27	either	either	CC	CC	_	28	cc:preconj	_	_
28	unstimulated	unstimulated	JJ	JJ	_	25	nmod	_	_
29	or	or	CC	CC	_	28	cc	_	_
30	interferon	interferon	NN	NN	_	36	compound	_	_
31	(	(	-LRB-	-LRB-	_	36	punct	_	_
32	IFN	ifn	NN	NN	_	36	compound	_	_
33	)	)	-RRB-	-RRB-	_	36	punct	_	_
34	-activated	-activated	JJ	JJ	_	36	amod	_	_
35	NK	nk	NN	NN	_	36	compound	_	_
36	cells	cell	NNS	NNS	_	28	conj	_	_
37	.	.	.	.	_	9	punct	_	_

1	Cells	cell	NNS	NNS	_	8	nsubjpass	_	_
2	expressing	express	VBG	VBG	_	1	acl	_	_
3	the	the	DT	DT	_	5	det	_	_
4	E1A	e1a	NN	NN	_	5	compound	_	_
5	oncoprotein	oncoprotein	NN	NN	_	2	dobj	_	_
6	were	be	VBD	VBD	_	8	auxpass	_	_
7	selectively	selectively	RB	RB	_	8	advmod	_	_
8	killed	kill	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	_	12	case	_	_
10	unstimulated	unstimulated	JJ	JJ	_	12	amod	_	_
11	NK	nk	NN	NN	_	12	compound	_	_
12	cells	cell	NNS	NNS	_	8	nmod	_	_
13	,	,	,	,	_	8	punct	_	_
14	while	while	IN	IN	_	33	mark	_	_
15	the	the	DT	DT	_	18	det	_	_
16	same	same	JJ	JJ	_	18	amod	_	_
17	parental	parental	JJ	JJ	_	18	amod	_	_
18	cells	cell	NNS	NNS	_	33	nsubj	_	_
19	but	but	CC	CC	_	18	cc	_	_
20	expressing	express	VBG	VBG	_	18	conj	_	_
21	the	the	DT	DT	_	23	dep	_	_
22	HPV	hpv	NNS	NNS	_	23	compound	_	_
23	type	type	NN	NN	_	20	dobj	_	_
24	16	16	CD	CD	_	23	nummod	_	_
25	(	(	-LRB-	-LRB-	_	26	punct	_	_
26	HPV-16	hpv-16	NN	NN	_	23	appos	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	or	or	CC	CC	_	23	cc	_	_
29	HPV-18	hpv-18	NN	NN	_	23	conj	_	_
30	E7	e7	NN	NN	_	31	compound	_	_
31	oncoprotein	oncoprotein	NN	NN	_	29	dep	_	_
32	were	be	VBD	VBD	_	33	cop	_	_
33	resistant	resistant	JJ	JJ	_	8	advcl	_	_
34	to	to	TO	TO	_	37	case	_	_
35	NK	nk	NN	NN	_	37	compound	_	_
36	cell	cell	NN	NN	_	37	compound	_	_
37	lysis	lysis	NN	NN	_	33	nmod	_	_
38	.	.	.	.	_	8	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	ability	ability	NN	NN	_	13	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	IFN-activated	ifn-activated	JJ	JJ	_	6	amod	_	_
5	NK	nk	NN	NN	_	6	compound	_	_
6	cells	cell	NNS	NNS	_	2	nmod	_	_
7	to	to	TO	TO	_	8	case	_	_
8	selectively	selectively	RB	RB	_	2	nmod	_	_
9	kill	kill	VB	VB	_	8	dep	_	_
10	virally	virally	RB	RB	_	12	advmod	_	_
11	transformed	transform	VBN	VBN	_	12	amod	_	_
12	cells	cell	NNS	NNS	_	9	dobj	_	_
13	depends	depend	VBZ	VBZ	_	0	root	_	_
14	on	on	IN	IN	_	17	case	_	_
15	IFN	ifn	NN	NN	_	17	nmod:poss	_	_
16	's	's	POS	POS	_	15	case	_	_
17	ability	ability	NN	NN	_	13	nmod	_	_
18	to	to	TO	TO	_	19	mark	_	_
19	induce	induce	VB	VB	_	17	acl	_	_
20	resistance	resistance	NN	NN	_	19	dobj	_	_
21	to	to	TO	TO	_	24	case	_	_
22	NK	nk	NN	NN	_	24	compound	_	_
23	cell	cell	NN	NN	_	24	compound	_	_
24	lysis	lysis	NN	NN	_	20	nmod	_	_
25	in	in	IN	IN	_	26	case	_	_
26	normal	normal	JJ	JJ	_	19	nmod	_	_
27	(	(	-LRB-	-LRB-	_	31	punct	_	_
28	i.e.	i.e.	FW	FW	_	31	dep	_	_
29	,	,	,	,	_	31	punct	_	_
30	non-viral	non-viral	JJ	JJ	_	31	amod	_	_
31	oncogene-expressing	oncogene-expressing	JJ	JJ	_	26	dep	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	but	but	CC	CC	_	34	cc	_	_
34	not	not	RB	RB	_	26	cc	_	_
35	virally	virally	RB	RB	_	37	advmod	_	_
36	transformed	transform	VBN	VBN	_	37	amod	_	_
37	cells	cell	NNS	NNS	_	26	conj	_	_
38	.	.	.	.	_	13	punct	_	_

1	E1A	e1a	NN	NN	_	2	nsubj	_	_
2	blocked	block	VBD	VBD	_	0	root	_	_
3	IFN	ifn	NN	NN	_	5	nmod:poss	_	_
4	's	's	POS	POS	_	3	case	_	_
5	induction	induction	NN	NN	_	2	dobj	_	_
6	of	of	IN	IN	_	8	case	_	_
7	cytolytic	cytolytic	JJ	JJ	_	8	amod	_	_
8	resistance	resistance	NN	NN	_	5	nmod	_	_
9	,	,	,	,	_	2	punct	_	_
10	resulting	result	VBG	VBG	_	2	advcl	_	_
11	in	in	IN	IN	_	14	case	_	_
12	the	the	DT	DT	_	14	det	_	_
13	selective	selective	JJ	JJ	_	14	amod	_	_
14	lysis	lysis	NN	NN	_	10	nmod	_	_
15	of	of	IN	IN	_	17	case	_	_
16	adenovirus-transformed	adenovirus-transformed	JJ	JJ	_	17	amod	_	_
17	cells	cell	NNS	NNS	_	14	nmod	_	_
18	by	by	IN	IN	_	21	case	_	_
19	IFN-activated	ifn-activated	JJ	JJ	_	21	amod	_	_
20	NK	nk	NN	NN	_	21	compound	_	_
21	cells	cell	NNS	NNS	_	14	nmod	_	_
22	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	extent	extent	NN	NN	_	12	nsubj	_	_
3	of	of	IN	IN	_	7	case	_	_
4	IFN-induced	ifn-induced	JJ	JJ	_	7	amod	_	_
5	NK	nk	NN	NN	_	7	compound	_	_
6	cell	cell	NN	NN	_	7	compound	_	_
7	killing	killing	NN	NN	_	2	nmod	_	_
8	of	of	IN	IN	_	10	case	_	_
9	E1A-expressing	e1a-expressing	JJ	JJ	_	10	amod	_	_
10	cells	cell	NNS	NNS	_	7	nmod	_	_
11	was	be	VBD	VBD	_	12	cop	_	_
12	proportional	proportional	JJ	JJ	_	0	root	_	_
13	to	to	TO	TO	_	15	case	_	_
14	the	the	DT	DT	_	15	det	_	_
15	level	level	NN	NN	_	12	nmod	_	_
16	of	of	IN	IN	_	18	case	_	_
17	E1A	e1a	NN	NN	_	18	compound	_	_
18	expression	expression	NN	NN	_	15	nmod	_	_
19	and	and	CC	CC	_	12	cc	_	_
20	correlated	correlate	VBN	VBN	_	12	conj	_	_
21	with	with	IN	IN	_	23	case	_	_
22	the	the	DT	DT	_	23	det	_	_
23	ability	ability	NN	NN	_	20	nmod	_	_
24	of	of	IN	IN	_	25	case	_	_
25	E1A	e1a	NN	NN	_	23	nmod	_	_
26	to	to	TO	TO	_	27	mark	_	_
27	block	block	VB	VB	_	23	acl	_	_
28	IFN-stimulated	ifn-stimulated	JJ	JJ	_	30	amod	_	_
29	gene	gene	NN	NN	_	30	compound	_	_
30	expression	expression	NN	NN	_	27	dobj	_	_
31	in	in	IN	IN	_	33	case	_	_
32	target	target	NN	NN	_	33	compound	_	_
33	cells	cell	NNS	NNS	_	30	nmod	_	_
34	.	.	.	.	_	12	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	5	nmod	_	_
3	,	,	,	,	_	5	punct	_	_
4	E7	e7	NN	NN	_	5	nsubj	_	_
5	blocked	block	VBD	VBD	_	0	root	_	_
6	neither	neither	CC	CC	_	9	cc:preconj	_	_
7	IFN-stimulated	ifn-stimulated	JJ	JJ	_	9	amod	_	_
8	gene	gene	NN	NN	_	9	compound	_	_
9	expression	expression	NN	NN	_	5	dobj	_	_
10	nor	nor	CC	CC	_	9	cc	_	_
11	IFN	ifn	NN	NN	_	13	nmod:poss	_	_
12	's	's	POS	POS	_	11	case	_	_
13	induction	induction	NN	NN	_	9	conj	_	_
14	of	of	IN	IN	_	16	case	_	_
15	cytolytic	cytolytic	JJ	JJ	_	16	amod	_	_
16	resistance	resistance	NN	NN	_	13	nmod	_	_
17	,	,	,	,	_	5	punct	_	_
18	thereby	thereby	RB	RB	_	19	advmod	_	_
19	precluding	preclude	VBG	VBG	_	5	advcl	_	_
20	the	the	DT	DT	_	22	det	_	_
21	selective	selective	JJ	JJ	_	22	amod	_	_
22	lysis	lysis	NN	NN	_	19	dobj	_	_
23	of	of	IN	IN	_	25	case	_	_
24	HPV-transformed	hpv-transformed	JJ	JJ	_	25	amod	_	_
25	cells	cell	NNS	NNS	_	22	nmod	_	_
26	by	by	IN	IN	_	29	case	_	_
27	IFN-activated	ifn-activated	JJ	JJ	_	29	amod	_	_
28	NK	nk	NN	NN	_	29	compound	_	_
29	cells	cell	NNS	NNS	_	22	nmod	_	_
30	.	.	.	.	_	5	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	conclusion	conclusion	NN	NN	_	6	nmod	_	_
3	,	,	,	,	_	6	punct	_	_
4	E1A	e1a	NN	NN	_	5	compound	_	_
5	expression	expression	NN	NN	_	6	nsubj	_	_
6	marks	mark	VBZ	VBZ	_	0	root	_	_
7	cells	cell	NNS	NNS	_	6	dobj	_	_
8	for	for	IN	IN	_	9	case	_	_
9	destruction	destruction	NN	NN	_	6	nmod	_	_
10	by	by	IN	IN	_	15	case	_	_
11	the	the	DT	DT	_	15	det	_	_
12	host	host	NN	NN	_	15	compound	_	_
13	NK	nk	NN	NN	_	14	compound	_	_
14	cell	cell	NN	NN	_	15	compound	_	_
15	response	response	NN	NN	_	9	nmod	_	_
16	,	,	,	,	_	6	punct	_	_
17	whereas	whereas	IN	IN	_	21	mark	_	_
18	the	the	DT	DT	_	20	det	_	_
19	E7	e7	NN	NN	_	20	compound	_	_
20	oncoprotein	oncoprotein	NN	NN	_	21	nsubj	_	_
21	lacks	lack	VBZ	VBZ	_	6	advcl	_	_
22	this	this	DT	DT	_	23	det	_	_
23	activity	activity	NN	NN	_	21	dobj	_	_
24	.	.	.	.	_	6	punct	_	_

1	Identification	identification	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	9	case	_	_
3	an	a	DT	DT	_	9	det	_	_
4	I	i	NN	NN	_	9	compound	_	_
5	kappa	kappa	NN	NN	_	9	compound	_	_
6	B	b	NN	NN	_	9	compound	_	_
7	alpha-associated	alpha-associated	JJ	JJ	_	9	amod	_	_
8	protein	protein	NN	NN	_	9	compound	_	_
9	kinase	kinase	NN	NN	_	1	nmod	_	_
10	in	in	IN	IN	_	15	case	_	_
11	a	a	DT	DT	_	15	det	_	_
12	human	human	JJ	JJ	_	15	amod	_	_
13	monocytic	monocytic	JJ	JJ	_	15	amod	_	_
14	cell	cell	NN	NN	_	15	compound	_	_
15	line	line	NN	NN	_	9	nmod	_	_
16	and	and	CC	CC	_	1	cc	_	_
17	determination	determination	NN	NN	_	1	conj	_	_
18	of	of	IN	IN	_	21	case	_	_
19	its	its	PRP$	PRP$	_	21	nmod:poss	_	_
20	phosphorylation	phosphorylation	NN	NN	_	21	compound	_	_
21	sites	site	NNS	NNS	_	17	nmod	_	_
22	on	on	IN	IN	_	26	case	_	_
23	I	i	NN	NN	_	26	compound	_	_
24	kappa	kappa	NN	NN	_	26	compound	_	_
25	B	b	NN	NN	_	26	compound	_	_
26	alpha	alpha	NN	NN	_	21	nmod	_	_
27	.	.	.	.	_	1	punct	_	_

1	Nuclear	nuclear	JJ	JJ	_	4	amod	_	_
2	factor	factor	NN	NN	_	4	compound	_	_
3	kappa	kappa	NN	NN	_	4	compound	_	_
4	B	b	NN	NN	_	10	nsubj	_	_
5	(	(	-LRB-	-LRB-	_	7	punct	_	_
6	NF-kappa	nf-kappa	NN	NN	_	7	compound	_	_
7	B	b	NN	NN	_	4	appos	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	is	be	VBZ	VBZ	_	10	cop	_	_
10	stored	stored	JJ	JJ	_	0	root	_	_
11	in	in	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	cytoplasm	cytoplasm	NN	NN	_	10	nmod	_	_
14	as	as	IN	IN	_	17	case	_	_
15	an	a	DT	DT	_	17	det	_	_
16	inactive	inactive	JJ	JJ	_	17	amod	_	_
17	form	form	NN	NN	_	10	nmod	_	_
18	through	through	IN	IN	_	19	case	_	_
19	interaction	interaction	NN	NN	_	10	nmod	_	_
20	with	with	IN	IN	_	23	case	_	_
21	I	i	NN	NN	_	23	compound	_	_
22	kappa	kappa	NN	NN	_	23	compound	_	_
23	B	b	NN	NN	_	19	nmod	_	_
24	.	.	.	.	_	10	punct	_	_

1	Stimulation	stimulation	NN	NN	_	4	nsubj	_	_
2	of	of	IN	IN	_	3	case	_	_
3	cells	cell	NNS	NNS	_	1	nmod	_	_
4	leads	lead	VBZ	VBZ	_	0	root	_	_
5	to	to	TO	TO	_	8	case	_	_
6	a	a	DT	DT	_	8	det	_	_
7	rapid	rapid	JJ	JJ	_	8	amod	_	_
8	phosphorylation	phosphorylation	NN	NN	_	4	nmod	_	_
9	of	of	IN	IN	_	13	case	_	_
10	I	i	NN	NN	_	13	compound	_	_
11	kappa	kappa	NN	NN	_	13	compound	_	_
12	B	b	NN	NN	_	13	compound	_	_
13	alpha	alpha	NN	NN	_	8	nmod	_	_
14	,	,	,	,	_	8	punct	_	_
15	which	which	WDT	WDT	_	17	nsubjpass	_	_
16	is	be	VBZ	VBZ	_	17	auxpass	_	_
17	presumed	presume	VBN	VBN	_	8	acl:relcl	_	_
18	to	to	TO	TO	_	20	mark	_	_
19	be	be	VB	VB	_	20	cop	_	_
20	important	important	JJ	JJ	_	17	xcomp	_	_
21	for	for	IN	IN	_	24	case	_	_
22	the	the	DT	DT	_	24	det	_	_
23	subsequent	subsequent	JJ	JJ	_	24	amod	_	_
24	degradation	degradation	NN	NN	_	20	nmod	_	_
25	.	.	.	.	_	4	punct	_	_

1	We	we	PRP	PRP	_	4	nsubj	_	_
2	have	have	VBP	VBP	_	4	aux	_	_
3	recently	recently	RB	RB	_	4	advmod	_	_
4	reported	report	VBN	VBN	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	establishment	establishment	NN	NN	_	4	dobj	_	_
7	of	of	IN	IN	_	16	case	_	_
8	a	a	DT	DT	_	16	det	_	_
9	lipopolysaccharide	lipopolysaccharide	NN	NN	_	14	nmod:npmod	_	_
10	(	(	-LRB-	-LRB-	_	14	punct	_	_
11	LPS	lps	NN	NN	_	14	nmod:npmod	_	_
12	)	)	-RRB-	-RRB-	_	14	punct	_	_
13	-dependent	-dependent	JJ	JJ	_	14	amod	_	_
14	cell-free	cell-free	JJ	JJ	_	16	amod	_	_
15	activation	activation	NN	NN	_	16	compound	_	_
16	system	system	NN	NN	_	6	nmod	_	_
17	of	of	IN	IN	_	19	case	_	_
18	NF-kappa	nf-kappa	NN	NN	_	19	compound	_	_
19	B	b	NN	NN	_	16	nmod	_	_
20	in	in	IN	IN	_	21	case	_	_
21	association	association	NN	NN	_	16	nmod	_	_
22	with	with	IN	IN	_	24	case	_	_
23	the	the	DT	DT	_	24	det	_	_
24	induction	induction	NN	NN	_	21	nmod	_	_
25	of	of	IN	IN	_	30	case	_	_
26	I	i	NN	NN	_	29	compound	_	_
27	kappa	kappa	NN	NN	_	29	compound	_	_
28	B	b	NN	NN	_	29	compound	_	_
29	alpha	alpha	NN	NN	_	30	compound	_	_
30	phosphorylation	phosphorylation	NN	NN	_	24	nmod	_	_
31	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	study	study	NN	NN	_	7	nmod	_	_
4	,	,	,	,	_	7	punct	_	_
5	we	we	PRP	PRP	_	7	nsubj	_	_
6	have	have	VBP	VBP	_	7	aux	_	_
7	identified	identify	VBN	VBN	_	0	root	_	_
8	a	a	DT	DT	_	9	det	_	_
9	kinase	kinase	NN	NN	_	7	dobj	_	_
10	in	in	IN	IN	_	12	case	_	_
11	cell	cell	NN	NN	_	12	compound	_	_
12	extracts	extract	NNS	NNS	_	9	nmod	_	_
13	from	from	IN	IN	_	19	case	_	_
14	the	the	DT	DT	_	19	det	_	_
15	LPS-stimulated	lps-stimulated	JJ	JJ	_	19	amod	_	_
16	human	human	JJ	JJ	_	19	amod	_	_
17	monocytic	monocytic	JJ	JJ	_	19	amod	_	_
18	cell	cell	NN	NN	_	19	compound	_	_
19	line	line	NN	NN	_	12	nmod	_	_
20	,	,	,	,	_	19	punct	_	_
21	THP-1	thp-1	NN	NN	_	19	appos	_	_
22	,	,	,	,	_	9	punct	_	_
23	that	that	WDT	WDT	_	25	nsubj	_	_
24	specifically	specifically	RB	RB	_	25	advmod	_	_
25	binds	bind	VBZ	VBZ	_	9	acl:relcl	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	phosphorylates	phosphorylate	VBZ	VBZ	_	25	conj	_	_
28	I	i	NN	NN	_	31	compound	_	_
29	kappa	kappa	NN	NN	_	31	compound	_	_
30	B	b	NN	NN	_	31	compound	_	_
31	alpha	alpha	NN	NN	_	25	dobj	_	_
32	.	.	.	.	_	7	punct	_	_

1	LPS	lps	NN	NN	_	2	compound	_	_
2	stimulation	stimulation	NN	NN	_	4	nsubj	_	_
3	transiently	transiently	RB	RB	_	4	advmod	_	_
4	enhanced	enhance	VBD	VBD	_	0	root	_	_
5	the	the	DT	DT	_	11	det	_	_
6	I	i	NN	NN	_	11	compound	_	_
7	kappa	kappa	NN	NN	_	11	compound	_	_
8	B	b	NN	NN	_	11	compound	_	_
9	alpha-bound	alpha-bound	JJ	JJ	_	11	amod	_	_
10	kinase	kinase	NN	NN	_	11	compound	_	_
11	activity	activity	NN	NN	_	4	dobj	_	_
12	in	in	IN	IN	_	14	case	_	_
13	THP-1	thp-1	NN	NN	_	14	compound	_	_
14	cells	cell	NNS	NNS	_	11	nmod	_	_
15	.	.	.	.	_	4	punct	_	_

1	Mutational	mutational	JJ	JJ	_	2	amod	_	_
2	analyses	analysis	NNS	NNS	_	15	nsubj	_	_
3	of	of	IN	IN	_	7	case	_	_
4	I	i	NN	NN	_	6	compound	_	_
5	kappa	kappa	NN	NN	_	6	compound	_	_
6	B	b	NN	NN	_	7	compound	_	_
7	alpha	alpha	NN	NN	_	2	nmod	_	_
8	and	and	CC	CC	_	2	cc	_	_
9	competition	competition	NN	NN	_	10	compound	_	_
10	experiments	experiment	NNS	NNS	_	2	conj	_	_
11	with	with	IN	IN	_	14	case	_	_
12	the	the	DT	DT	_	14	det	_	_
13	synthetic	synthetic	JJ	JJ	_	14	amod	_	_
14	peptides	peptide	NNS	NNS	_	10	nmod	_	_
15	identified	identify	VBD	VBD	_	0	root	_	_
16	major	major	JJ	JJ	_	18	amod	_	_
17	phosphorylation	phosphorylation	NN	NN	_	18	compound	_	_
18	sites	site	NNS	NNS	_	15	dobj	_	_
19	by	by	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	bound	bind	VBN	VBN	_	22	amod	_	_
22	kinase	kinase	NN	NN	_	15	nmod	_	_
23	as	as	IN	IN	_	24	case	_	_
24	Ser	ser	NN	NN	_	15	nmod	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	Thr	thr	NN	NN	_	24	conj	_	_
27	residues	residue	NNS	NNS	_	24	dep	_	_
28	in	in	IN	IN	_	32	case	_	_
29	the	the	DT	DT	_	32	det	_	_
30	C-terminal	c-terminal	JJ	JJ	_	32	amod	_	_
31	acidic	acidic	JJ	JJ	_	32	amod	_	_
32	domain	domain	NN	NN	_	15	nmod	_	_
33	of	of	IN	IN	_	37	case	_	_
34	I	i	NN	NN	_	37	compound	_	_
35	kappa	kappa	NN	NN	_	37	compound	_	_
36	B	b	NN	NN	_	37	compound	_	_
37	alpha	alpha	NN	NN	_	32	nmod	_	_
38	.	.	.	.	_	15	punct	_	_

1	Moreover	moreover	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	show	show	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	21	mark	_	_
6	the	the	DT	DT	_	7	det	_	_
7	peptide	peptide	NN	NN	_	21	nsubj	_	_
8	,	,	,	,	_	7	punct	_	_
9	corresponding	correspond	VBG	VBG	_	21	dep	_	_
10	to	to	TO	TO	_	14	case	_	_
11	the	the	DT	DT	_	14	det	_	_
12	C-terminal	c-terminal	JJ	JJ	_	14	amod	_	_
13	acidic	acidic	JJ	JJ	_	14	amod	_	_
14	domain	domain	NN	NN	_	9	nmod	_	_
15	of	of	IN	IN	_	19	case	_	_
16	I	i	NN	NN	_	19	compound	_	_
17	kappa	kappa	NN	NN	_	19	compound	_	_
18	B	b	NN	NN	_	19	compound	_	_
19	alpha	alpha	NN	NN	_	14	nmod	_	_
20	,	,	,	,	_	21	punct	_	_
21	blocked	block	VBD	VBD	_	4	ccomp	_	_
22	the	the	DT	DT	_	26	det	_	_
23	LPS-induced	lps-induced	JJ	JJ	_	26	amod	_	_
24	NF-kappa	nf-kappa	NN	NN	_	25	compound	_	_
25	B	b	NN	NN	_	26	compound	_	_
26	activation	activation	NN	NN	_	21	dobj	_	_
27	as	as	RB	RB	_	26	cc	_	_
28	well	well	RB	RB	_	27	mwe	_	_
29	as	as	IN	IN	_	27	mwe	_	_
30	inducible	inducible	JJ	JJ	_	31	amod	_	_
31	phosphorylation	phosphorylation	NN	NN	_	26	conj	_	_
32	of	of	IN	IN	_	37	case	_	_
33	endogenous	endogenous	JJ	JJ	_	37	amod	_	_
34	I	i	NN	NN	_	37	compound	_	_
35	kappa	kappa	NN	NN	_	37	compound	_	_
36	B	b	NN	NN	_	37	compound	_	_
37	alpha	alpha	NN	NN	_	31	nmod	_	_
38	in	in	IN	IN	_	41	case	_	_
39	a	a	DT	DT	_	41	det	_	_
40	cell-free	cell-free	JJ	JJ	_	41	amod	_	_
41	system	system	NN	NN	_	21	nmod	_	_
42	using	use	VBG	VBG	_	41	acl	_	_
43	THP-1	thp-1	NN	NN	_	44	compound	_	_
44	cells	cell	NNS	NNS	_	42	dobj	_	_
45	.	.	.	.	_	4	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	suggested	suggest	VBD	VBD	_	0	root	_	_
4	that	that	IN	IN	_	9	mark	_	_
5	the	the	DT	DT	_	7	det	_	_
6	bound	bound	JJ	JJ	_	7	amod	_	_
7	kinase	kinase	NN	NN	_	9	nsubjpass	_	_
8	is	be	VBZ	VBZ	_	9	auxpass	_	_
9	involved	involve	VBN	VBN	_	3	ccomp	_	_
10	in	in	IN	IN	_	13	case	_	_
11	the	the	DT	DT	_	13	det	_	_
12	signaling	signaling	NN	NN	_	13	compound	_	_
13	pathway	pathway	NN	NN	_	9	nmod	_	_
14	of	of	IN	IN	_	15	case	_	_
15	LPS	lps	NN	NN	_	13	nmod	_	_
16	by	by	IN	IN	_	17	mark	_	_
17	inducing	induce	VBG	VBG	_	9	advcl	_	_
18	the	the	DT	DT	_	19	det	_	_
19	phosphorylation	phosphorylation	NN	NN	_	17	dobj	_	_
20	of	of	IN	IN	_	23	case	_	_
21	the	the	DT	DT	_	23	det	_	_
22	C-terminal	c-terminal	JJ	JJ	_	23	amod	_	_
23	region	region	NN	NN	_	19	nmod	_	_
24	of	of	IN	IN	_	28	case	_	_
25	I	i	NN	NN	_	28	compound	_	_
26	kappa	kappa	NN	NN	_	28	compound	_	_
27	B	b	NN	NN	_	28	compound	_	_
28	alpha	alpha	NN	NN	_	23	nmod	_	_
29	and	and	CC	CC	_	19	cc	_	_
30	subsequent	subsequent	JJ	JJ	_	31	amod	_	_
31	dissociation	dissociation	NN	NN	_	19	conj	_	_
32	of	of	IN	IN	_	39	case	_	_
33	the	the	DT	DT	_	39	det	_	_
34	NF-kappa	nf-kappa	NN	NN	_	39	compound	_	_
35	B.I	b.i	NN	NN	_	39	compound	_	_
36	kappa	kappa	NN	NN	_	39	compound	_	_
37	B	b	NN	NN	_	39	compound	_	_
38	alpha	alpha	NN	NN	_	39	compound	_	_
39	complex	complex	NN	NN	_	31	nmod	_	_
40	.	.	.	.	_	3	punct	_	_

1	Triggering	triggering	NN	NN	_	16	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	human	human	JJ	JJ	_	6	amod	_	_
5	interleukin-6	interleukin-6	NN	NN	_	6	compound	_	_
6	gene	gene	NN	NN	_	1	nmod	_	_
7	by	by	IN	IN	_	8	case	_	_
8	interferon-gamma	interferon-gamma	NN	NN	_	1	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	tumor	tumor	NN	NN	_	12	compound	_	_
11	necrosis	necrosis	NN	NN	_	12	compound	_	_
12	factor-alpha	factor-alpha	NN	NN	_	8	conj	_	_
13	in	in	IN	IN	_	15	case	_	_
14	monocytic	monocytic	JJ	JJ	_	15	amod	_	_
15	cells	cell	NNS	NNS	_	8	nmod	_	_
16	involves	involve	VBZ	VBZ	_	0	root	_	_
17	cooperation	cooperation	NN	NN	_	16	dobj	_	_
18	between	between	IN	IN	_	21	case	_	_
19	interferon	interferon	NN	NN	_	21	compound	_	_
20	regulatory	regulatory	JJ	JJ	_	21	amod	_	_
21	factor-1	factor-1	NN	NN	_	17	nmod	_	_
22	,	,	,	,	_	21	punct	_	_
23	NF	nf	NN	NN	_	25	compound	_	_
24	kappa	kappa	NN	NN	_	25	compound	_	_
25	B	b	NN	NN	_	21	conj	_	_
26	,	,	,	,	_	21	punct	_	_
27	and	and	CC	CC	_	21	cc	_	_
28	Sp1	sp1	NN	NN	_	21	conj	_	_
29	transcription	transcription	NN	NN	_	30	compound	_	_
30	factors	factor	NNS	NNS	_	21	dep	_	_
31	.	.	.	.	_	16	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	investigated	investigate	VBD	VBD	_	0	root	_	_
3	the	the	DT	DT	_	5	det	_	_
4	molecular	molecular	JJ	JJ	_	5	amod	_	_
5	basis	basis	NN	NN	_	2	dobj	_	_
6	of	of	IN	IN	_	9	case	_	_
7	the	the	DT	DT	_	9	det	_	_
8	synergistic	synergistic	JJ	JJ	_	9	amod	_	_
9	induction	induction	NN	NN	_	5	nmod	_	_
10	by	by	IN	IN	_	11	case	_	_
11	interferon-gamma	interferon-gamma	NN	NN	_	9	nmod	_	_
12	(	(	-LRB-	-LRB-	_	13	punct	_	_
13	IFN-gamma	ifn-gamma	NN	NN	_	11	appos	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	/tumor	/tumor	NN	NN	_	17	compound	_	_
16	necrosis	necrosis	NN	NN	_	17	compound	_	_
17	factor-alpha	factor-alpha	NN	NN	_	11	dep	_	_
18	(	(	-LRB-	-LRB-	_	19	punct	_	_
19	TNF-alpha	tnf-alpha	NN	NN	_	17	appos	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	of	of	IN	IN	_	27	case	_	_
22	human	human	JJ	JJ	_	27	amod	_	_
23	interleukin-6	interleukin-6	NN	NN	_	27	compound	_	_
24	(	(	-LRB-	-LRB-	_	27	punct	_	_
25	IL-6	il-6	NN	NN	_	27	compound	_	_
26	)	)	-RRB-	-RRB-	_	27	punct	_	_
27	gene	gene	NN	NN	_	11	nmod	_	_
28	in	in	IN	IN	_	31	case	_	_
29	THP-1	thp-1	NN	NN	_	31	compound	_	_
30	monocytic	monocytic	JJ	JJ	_	31	amod	_	_
31	cells	cell	NNS	NNS	_	27	nmod	_	_
32	,	,	,	,	_	2	punct	_	_
33	and	and	CC	CC	_	2	cc	_	_
34	compared	compare	VBD	VBD	_	2	conj	_	_
35	it	it	PRP	PRP	_	34	dobj	_	_
36	with	with	IN	IN	_	38	case	_	_
37	the	the	DT	DT	_	38	det	_	_
38	basis	basis	NN	NN	_	34	nmod	_	_
39	of	of	IN	IN	_	41	case	_	_
40	this	this	DT	DT	_	41	det	_	_
41	induction	induction	NN	NN	_	38	nmod	_	_
42	by	by	IN	IN	_	43	case	_	_
43	lipopolysaccharide	lipopolysaccharide	NN	NN	_	41	nmod	_	_
44	(	(	-LRB-	-LRB-	_	45	punct	_	_
45	LPS	lps	NN	NN	_	43	appos	_	_
46	)	)	-RRB-	-RRB-	_	45	punct	_	_
47	.	.	.	.	_	2	punct	_	_

1	Functional	functional	JJ	JJ	_	2	amod	_	_
2	studies	study	NNS	NNS	_	6	nsubj	_	_
3	with	with	IN	IN	_	5	case	_	_
4	IL-6	il-6	NN	NN	_	5	compound	_	_
5	promoter	promoter	NN	NN	_	2	nmod	_	_
6	demonstrated	demonstrate	VBD	VBD	_	0	root	_	_
7	that	that	IN	IN	_	12	mark	_	_
8	three	three	CD	CD	_	9	nummod	_	_
9	regions	region	NNS	NNS	_	12	nsubj	_	_
10	are	be	VBP	VBP	_	12	cop	_	_
11	the	the	DT	DT	_	12	det	_	_
12	targets	target	NNS	NNS	_	6	ccomp	_	_
13	of	of	IN	IN	_	18	case	_	_
14	the	the	DT	DT	_	18	det	_	_
15	IFN-gamma	ifn-gamma	NN	NN	_	18	compound	_	_
16	and/or	and/or	CC	CC	_	15	cc	_	_
17	TNF-alpha	tnf-alpha	NN	NN	_	15	conj	_	_
18	action	action	NN	NN	_	12	nmod	_	_
19	,	,	,	,	_	12	punct	_	_
20	whereas	whereas	IN	IN	_	26	mark	_	_
21	only	only	RB	RB	_	22	advmod	_	_
22	one	one	CD	CD	_	26	nsubj	_	_
23	of	of	IN	IN	_	25	case	_	_
24	these	these	DT	DT	_	25	det	_	_
25	regions	region	NNS	NNS	_	22	nmod	_	_
26	seemed	seem	VBD	VBD	_	12	advcl	_	_
27	to	to	TO	TO	_	29	mark	_	_
28	be	be	VB	VB	_	29	auxpass	_	_
29	implicated	implicate	VBN	VBN	_	26	xcomp	_	_
30	in	in	IN	IN	_	32	case	_	_
31	LPS	lps	NN	NN	_	32	compound	_	_
32	activation	activation	NN	NN	_	29	nmod	_	_
33	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	three	three	CD	CD	_	3	nummod	_	_
3	regions	region	NNS	NNS	_	5	nsubj	_	_
4	concerned	concern	VBN	VBN	_	3	acl	_	_
5	are	be	VBP	VBP	_	0	root	_	_
6	:	:	:	:	_	5	punct	_	_
7	1	1	LS	LS	_	10	dep	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	a	a	DT	DT	_	10	det	_	_
10	region	region	NN	NN	_	5	dep	_	_
11	between	between	IN	IN	_	12	case	_	_
12	-73	-73	CD	CD	_	10	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	-36	-36	CD	CD	_	12	conj	_	_
15	,	,	,	,	_	10	punct	_	_
16	which	which	WDT	WDT	_	20	nsubj	_	_
17	is	be	VBZ	VBZ	_	20	cop	_	_
18	the	the	DT	DT	_	20	det	_	_
19	minimal	minimal	JJ	JJ	_	20	amod	_	_
20	element	element	NN	NN	_	10	acl:relcl	_	_
21	inducible	inducible	JJ	JJ	_	20	amod	_	_
22	by	by	IN	IN	_	23	case	_	_
23	LPS	lps	NN	NN	_	21	nmod	_	_
24	or	or	CC	CC	_	23	cc	_	_
25	TNF-alpha	tnf-alpha	NN	NN	_	23	conj	_	_
26	;	;	:	:	_	10	punct	_	_
27	2	2	LS	LS	_	30	dep	_	_
28	)	)	-RRB-	-RRB-	_	27	punct	_	_
29	an	a	DT	DT	_	30	det	_	_
30	element	element	NN	NN	_	10	conj	_	_
31	located	located	JJ	JJ	_	30	amod	_	_
32	between	between	IN	IN	_	33	case	_	_
33	-181	-181	CD	CD	_	31	nmod	_	_
34	and	and	CC	CC	_	33	cc	_	_
35	-73	-73	CD	CD	_	33	conj	_	_
36	,	,	,	,	_	30	punct	_	_
37	which	which	WDT	WDT	_	38	nsubj	_	_
38	appeared	appear	VBD	VBD	_	30	acl:relcl	_	_
39	to	to	TO	TO	_	40	mark	_	_
40	regulate	regulate	VB	VB	_	38	xcomp	_	_
41	the	the	DT	DT	_	42	det	_	_
42	response	response	NN	NN	_	40	dobj	_	_
43	to	to	TO	TO	_	44	case	_	_
44	IFN-gamma	ifn-gamma	NN	NN	_	42	nmod	_	_
45	and	and	CC	CC	_	44	cc	_	_
46	TNF-alpha	tnf-alpha	NN	NN	_	44	conj	_	_
47	negatively	negatively	RB	RB	_	40	advmod	_	_
48	;	;	:	:	_	10	punct	_	_
49	and	and	CC	CC	_	10	cc	_	_
50	3	3	LS	LS	_	54	dep	_	_
51	)	)	-RRB-	-RRB-	_	50	punct	_	_
52	a	a	DT	DT	_	54	det	_	_
53	distal	distal	JJ	JJ	_	54	amod	_	_
54	element	element	NN	NN	_	10	conj	_	_
55	upstream	upstream	JJ	JJ	_	54	amod	_	_
56	of	of	IN	IN	_	57	case	_	_
57	-224	-224	CD	CD	_	54	nmod	_	_
58	,	,	,	,	_	54	punct	_	_
59	which	which	WDT	WDT	_	61	nsubj	_	_
60	was	be	VBD	VBD	_	61	cop	_	_
61	inducible	inducible	JJ	JJ	_	54	acl:relcl	_	_
62	by	by	IN	IN	_	63	case	_	_
63	IFN-gamma	ifn-gamma	NN	NN	_	61	nmod	_	_
64	alone	alone	RB	RB	_	63	advmod	_	_
65	.	.	.	.	_	5	punct	_	_

1	LPS	lps	NN	NN	_	2	compound	_	_
2	signaling	signaling	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	found	find	VBN	VBN	_	0	root	_	_
5	to	to	TO	TO	_	6	mark	_	_
6	involve	involve	VB	VB	_	4	xcomp	_	_
7	NF	nf	NN	NN	_	9	compound	_	_
8	kappa	kappa	NN	NN	_	9	compound	_	_
9	B	b	NN	NN	_	10	compound	_	_
10	activation	activation	NN	NN	_	6	dobj	_	_
11	by	by	IN	IN	_	15	case	_	_
12	the	the	DT	DT	_	15	det	_	_
13	p50	p50	NN	NN	_	15	compound	_	_
14	/p65	/p65	NN	NN	_	15	compound	_	_
15	heterodimers	heterodimer	NNS	NNS	_	6	nmod	_	_
16	.	.	.	.	_	4	punct	_	_

1	Synergistic	synergistic	JJ	JJ	_	2	amod	_	_
2	induction	induction	NN	NN	_	16	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	IL-6	il-6	NN	NN	_	6	compound	_	_
6	gene	gene	NN	NN	_	2	nmod	_	_
7	by	by	IN	IN	_	8	case	_	_
8	IFN-gamma	ifn-gamma	NN	NN	_	2	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	TNF-alpha	tnf-alpha	NN	NN	_	8	conj	_	_
11	,	,	,	,	_	2	punct	_	_
12	in	in	IN	IN	_	14	case	_	_
13	monocytic	monocytic	JJ	JJ	_	14	amod	_	_
14	cells	cell	NNS	NNS	_	2	nmod	_	_
15	,	,	,	,	_	2	punct	_	_
16	involved	involve	VBD	VBD	_	0	root	_	_
17	cooperation	cooperation	NN	NN	_	16	dobj	_	_
18	between	between	IN	IN	_	20	case	_	_
19	the	the	DT	DT	_	20	det	_	_
20	IRF-1	irf-1	NN	NN	_	17	nmod	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	NF	nf	NN	NN	_	26	compound	_	_
23	kappa	kappa	NN	NN	_	26	compound	_	_
24	B	b	NN	NN	_	26	compound	_	_
25	p65	p65	NN	NN	_	26	compound	_	_
26	homodimers	homodimer	NNS	NNS	_	20	conj	_	_
27	with	with	IN	IN	_	29	case	_	_
28	concomitant	concomitant	JJ	JJ	_	29	amod	_	_
29	removal	removal	NN	NN	_	16	nmod	_	_
30	of	of	IN	IN	_	33	case	_	_
31	the	the	DT	DT	_	33	det	_	_
32	negative	negative	JJ	JJ	_	33	amod	_	_
33	effect	effect	NN	NN	_	29	nmod	_	_
34	of	of	IN	IN	_	38	case	_	_
35	the	the	DT	DT	_	38	det	_	_
36	retinoblastoma	retinoblastoma	NN	NN	_	38	compound	_	_
37	control	control	NN	NN	_	38	compound	_	_
38	element	element	NN	NN	_	33	nmod	_	_
39	present	present	JJ	JJ	_	38	amod	_	_
40	in	in	IN	IN	_	43	case	_	_
41	the	the	DT	DT	_	43	det	_	_
42	IL-6	il-6	NN	NN	_	43	compound	_	_
43	promoter	promoter	NN	NN	_	39	nmod	_	_
44	.	.	.	.	_	16	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	removal	removal	NN	NN	_	3	nsubj	_	_
3	occurred	occur	VBD	VBD	_	0	root	_	_
4	by	by	IN	IN	_	5	case	_	_
5	activation	activation	NN	NN	_	3	nmod	_	_
6	of	of	IN	IN	_	10	case	_	_
7	the	the	DT	DT	_	10	det	_	_
8	constitutive	constitutive	JJ	JJ	_	10	amod	_	_
9	Sp1	sp1	NN	NN	_	10	compound	_	_
10	factor	factor	NN	NN	_	5	nmod	_	_
11	,	,	,	,	_	10	punct	_	_
12	whose	whose	WP$	WP$	_	15	nmod:poss	_	_
13	increased	increase	VBN	VBN	_	15	amod	_	_
14	binding	binding	NN	NN	_	15	compound	_	_
15	activity	activity	NN	NN	_	19	nsubjpass	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	phosphorylation	phosphorylation	NN	NN	_	15	conj	_	_
18	were	be	VBD	VBD	_	19	auxpass	_	_
19	mediated	mediate	VBN	VBN	_	10	acl:relcl	_	_
20	by	by	IN	IN	_	21	case	_	_
21	IFN-gamma	ifn-gamma	NN	NN	_	19	nmod	_	_
22	.	.	.	.	_	3	punct	_	_

1	Steel	steel	NN	NN	_	2	compound	_	_
2	factor	factor	NN	NN	_	3	nsubj	_	_
3	affects	affect	VBZ	VBZ	_	0	root	_	_
4	SCL	scl	NN	NN	_	5	compound	_	_
5	expression	expression	NN	NN	_	3	dobj	_	_
6	during	during	IN	IN	_	9	case	_	_
7	normal	normal	JJ	JJ	_	9	amod	_	_
8	erythroid	erythroid	JJ	JJ	_	7	dep	_	_
9	differentiation	differentiation	NN	NN	_	3	nmod	_	_
10	.	.	.	.	_	3	punct	_	_

1	Steel	steel	NN	NN	_	2	compound	_	_
2	factor	factor	NN	NN	_	4	nsubj	_	_
3	is	be	VBZ	VBZ	_	4	cop	_	_
4	one	one	CD	CD	_	0	root	_	_
5	of	of	IN	IN	_	8	case	_	_
6	the	the	DT	DT	_	8	det	_	_
7	growth	growth	NN	NN	_	8	compound	_	_
8	factors	factor	NNS	NNS	_	4	nmod	_	_
9	that	that	WDT	WDT	_	10	nsubj	_	_
10	controls	control	VBZ	VBZ	_	4	acl:relcl	_	_
11	the	the	DT	DT	_	12	dep	_	_
12	proliferation	proliferation	NN	NN	_	10	dobj	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	differentiation	differentiation	NN	NN	_	12	conj	_	_
15	of	of	IN	IN	_	17	case	_	_
16	hematopoietic	hematopoietic	JJ	JJ	_	17	amod	_	_
17	cells	cell	NNS	NNS	_	12	nmod	_	_
18	and	and	CC	CC	_	4	cc	_	_
19	SCL	scl	NN	NN	_	31	nsubj	_	_
20	,	,	,	,	_	19	punct	_	_
21	also	also	RB	RB	_	22	advmod	_	_
22	known	know	VBN	VBN	_	19	acl	_	_
23	as	as	IN	IN	_	24	case	_	_
24	Tcl-5	tcl-5	NN	NN	_	22	nmod	_	_
25	or	or	CC	CC	_	24	cc	_	_
26	Tal-1	tal-1	NN	NN	_	24	conj	_	_
27	,	,	,	,	_	19	punct	_	_
28	is	be	VBZ	VBZ	_	31	cop	_	_
29	a	a	DT	DT	_	31	det	_	_
30	transcription	transcription	NN	NN	_	31	compound	_	_
31	factor	factor	NN	NN	_	4	conj	_	_
32	involved	involve	VBN	VBN	_	31	acl	_	_
33	in	in	IN	IN	_	34	case	_	_
34	erythropoiesis	erythropoiesis	NN	NN	_	32	nmod	_	_
35	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	report	report	NN	NN	_	6	nmod	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	studied	study	VBD	VBD	_	0	root	_	_
7	the	the	DT	DT	_	8	det	_	_
8	role	role	NN	NN	_	6	dobj	_	_
9	of	of	IN	IN	_	10	case	_	_
10	SCL	scl	NN	NN	_	8	nmod	_	_
11	in	in	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	proliferation	proliferation	NN	NN	_	8	nmod	_	_
14	of	of	IN	IN	_	19	case	_	_
15	human	human	JJ	JJ	_	19	amod	_	_
16	peripheral	peripheral	JJ	JJ	_	19	amod	_	_
17	blood	blood	NN	NN	_	19	compound	_	_
18	burst-forming	burst-forming	JJ	JJ	_	19	amod	_	_
19	unit-erythroid	unit-erythroid	NN	NN	_	13	nmod	_	_
20	(	(	-LRB-	-LRB-	_	21	punct	_	_
21	BFU-E	bfu-e	NN	NN	_	19	appos	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	and	and	CC	CC	_	8	cc	_	_
24	the	the	DT	DT	_	25	det	_	_
25	effects	effect	NNS	NNS	_	8	conj	_	_
26	of	of	IN	IN	_	28	case	_	_
27	Steel	steel	NN	NN	_	28	compound	_	_
28	factor	factor	NN	NN	_	25	nmod	_	_
29	on	on	IN	IN	_	31	case	_	_
30	SCL	scl	NN	NN	_	31	compound	_	_
31	expression	expression	NN	NN	_	25	nmod	_	_
32	in	in	IN	IN	_	35	case	_	_
33	proliferating	proliferate	VBG	VBG	_	35	amod	_	_
34	erythroid	erythroid	JJ	JJ	_	35	amod	_	_
35	cells	cell	NNS	NNS	_	25	nmod	_	_
36	.	.	.	.	_	6	punct	_	_

1	BFU-E-derived	bfu-e-derived	JJ	JJ	_	2	amod	_	_
2	colonies	colony	NNS	NNS	_	3	nsubj	_	_
3	increase	increase	VBP	VBP	_	0	root	_	_
4	progressively	progressively	RB	RB	_	3	advmod	_	_
5	in	in	IN	IN	_	6	case	_	_
6	size	size	NN	NN	_	3	nmod	_	_
7	,	,	,	,	_	3	punct	_	_
8	as	as	IN	IN	_	9	mark	_	_
9	determined	determine	VBN	VBN	_	3	advcl	_	_
10	by	by	IN	IN	_	12	case	_	_
11	cell	cell	NN	NN	_	12	compound	_	_
12	number	number	NN	NN	_	9	nmod	_	_
13	,	,	,	,	_	3	punct	_	_
14	from	from	IN	IN	_	15	case	_	_
15	day	day	NN	NN	_	3	nmod	_	_
16	7	7	CD	CD	_	15	nummod	_	_
17	to	to	TO	TO	_	18	case	_	_
18	day	day	NN	NN	_	15	nmod	_	_
19	14	14	CD	CD	_	18	nummod	_	_
20	of	of	IN	IN	_	21	case	_	_
21	culture	culture	NN	NN	_	15	nmod	_	_
22	,	,	,	,	_	3	punct	_	_
23	with	with	IN	IN	_	26	case	_	_
24	the	the	DT	DT	_	26	det	_	_
25	greatest	greatest	JJS	JJS	_	26	amod	_	_
26	increase	increase	NN	NN	_	3	nmod	_	_
27	in	in	IN	IN	_	29	case	_	_
28	colony	colony	NN	NN	_	29	compound	_	_
29	size	size	NN	NN	_	26	nmod	_	_
30	(	(	-LRB-	-LRB-	_	32	punct	_	_
31	10-fold	10-fold	JJ	JJ	_	32	amod	_	_
32	expansion	expansion	NN	NN	_	26	appos	_	_
33	)	)	-RRB-	-RRB-	_	32	punct	_	_
34	occurring	occur	VBG	VBG	_	26	acl	_	_
35	between	between	IN	IN	_	36	case	_	_
36	day	day	NN	NN	_	34	nmod	_	_
37	7	7	CD	CD	_	36	nummod	_	_
38	and	and	CC	CC	_	36	cc	_	_
39	day	day	NN	NN	_	36	conj	_	_
40	10	10	CD	CD	_	39	nummod	_	_
41	.	.	.	.	_	3	punct	_	_

1	SCL	scl	NN	NN	_	2	compound	_	_
2	protein	protein	NN	NN	_	3	compound	_	_
3	levels	level	NNS	NNS	_	8	nsubjpass	_	_
4	in	in	IN	IN	_	6	case	_	_
5	BFU-E-derived	bfu-e-derived	JJ	JJ	_	6	amod	_	_
6	cells	cell	NNS	NNS	_	3	nmod	_	_
7	were	be	VBD	VBD	_	8	auxpass	_	_
8	highest	highest	JJS	JJS	_	0	root	_	_
9	in	in	IN	IN	_	12	case	_	_
10	day	day	NN	NN	_	12	compound	_	_
11	7	7	CD	CD	_	12	nummod	_	_
12	cells	cell	NNS	NNS	_	8	nmod	_	_
13	and	and	CC	CC	_	8	cc	_	_
14	decreased	decrease	VBD	VBD	_	8	conj	_	_
15	progressively	progressively	RB	RB	_	14	advmod	_	_
16	from	from	IN	IN	_	17	case	_	_
17	day	day	NN	NN	_	14	nmod	_	_
18	7	7	CD	CD	_	17	nummod	_	_
19	to	to	TO	TO	_	20	case	_	_
20	day	day	NN	NN	_	17	nmod	_	_
21	14	14	CD	CD	_	20	nummod	_	_
22	of	of	IN	IN	_	23	case	_	_
23	culture	culture	NN	NN	_	17	nmod	_	_
24	,	,	,	,	_	8	punct	_	_
25	suggesting	suggest	VBG	VBG	_	8	xcomp	_	_
26	an	a	DT	DT	_	27	det	_	_
27	association	association	NN	NN	_	25	dobj	_	_
28	of	of	IN	IN	_	29	case	_	_
29	SCL	scl	NN	NN	_	27	nmod	_	_
30	with	with	IN	IN	_	32	case	_	_
31	erythroid	erythroid	JJ	JJ	_	32	amod	_	_
32	proliferation	proliferation	NN	NN	_	27	nmod	_	_
33	.	.	.	.	_	8	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	9	nmod	_	_
3	,	,	,	,	_	9	punct	_	_
4	SCL	scl	NN	NN	_	5	compound	_	_
5	mRNA	mrna	NN	NN	_	6	compound	_	_
6	levels	level	NNS	NNS	_	9	nsubj	_	_
7	did	do	VBD	VBD	_	9	aux	_	_
8	not	not	RB	RB	_	9	neg	_	_
9	decrease	decrease	VB	VB	_	0	root	_	_
10	significantly	significantly	RB	RB	_	9	advmod	_	_
11	between	between	IN	IN	_	12	case	_	_
12	day	day	NN	NN	_	9	nmod	_	_
13	7	7	CD	CD	_	12	nummod	_	_
14	and	and	CC	CC	_	12	cc	_	_
15	day	day	NN	NN	_	12	conj	_	_
16	14	14	CD	CD	_	15	nummod	_	_
17	cells	cell	NNS	NNS	_	12	dep	_	_
18	,	,	,	,	_	9	punct	_	_
19	suggesting	suggest	VBG	VBG	_	9	advcl	_	_
20	that	that	IN	IN	_	25	mark	_	_
21	posttranscriptional	posttranscriptional	JJ	JJ	_	22	amod	_	_
22	mechanisms	mechanism	NNS	NNS	_	25	nsubj	_	_
23	are	be	VBP	VBP	_	25	cop	_	_
24	largely	largely	RB	RB	_	25	advmod	_	_
25	responsible	responsible	JJ	JJ	_	19	ccomp	_	_
26	for	for	IN	IN	_	28	case	_	_
27	the	the	DT	DT	_	28	det	_	_
28	decrease	decrease	NN	NN	_	25	nmod	_	_
29	in	in	IN	IN	_	31	case	_	_
30	SCL	scl	NN	NN	_	31	compound	_	_
31	protein	protein	NN	NN	_	28	nmod	_	_
32	observed	observe	VBN	VBN	_	31	acl	_	_
33	.	.	.	.	_	9	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	role	role	NN	NN	_	12	nsubjpass	_	_
3	of	of	IN	IN	_	4	case	_	_
4	SCL	scl	NN	NN	_	2	nmod	_	_
5	in	in	IN	IN	_	9	case	_	_
6	Steel	steel	NN	NN	_	9	compound	_	_
7	factor-induced	factor-induced	JJ	JJ	_	9	amod	_	_
8	erythroid	erythroid	JJ	JJ	_	9	amod	_	_
9	proliferation	proliferation	NN	NN	_	2	nmod	_	_
10	was	be	VBD	VBD	_	12	auxpass	_	_
11	then	then	RB	RB	_	12	advmod	_	_
12	examined	examine	VBN	VBN	_	0	root	_	_
13	.	.	.	.	_	12	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	BFU-E-derived	bfu-e-derived	JJ	JJ	_	3	amod	_	_
3	colonies	colony	NNS	NNS	_	13	nmod	_	_
4	cultured	culture	VBN	VBN	_	3	acl	_	_
5	with	with	IN	IN	_	7	case	_	_
6	Steel	steel	NN	NN	_	7	compound	_	_
7	factor	factor	NN	NN	_	4	nmod	_	_
8	,	,	,	,	_	13	punct	_	_
9	colony	colony	NN	NN	_	10	compound	_	_
10	size	size	NN	NN	_	13	nsubjpass	_	_
11	was	be	VBD	VBD	_	13	auxpass	_	_
12	significantly	significantly	RB	RB	_	13	advmod	_	_
13	increased	increase	VBN	VBN	_	0	root	_	_
14	compared	compare	VBN	VBN	_	16	case	_	_
15	to	to	TO	TO	_	16	case	_	_
16	control	control	NN	NN	_	13	advcl	_	_
17	.	.	.	.	_	13	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	day	day	NN	NN	_	17	nmod	_	_
3	7	7	CD	CD	_	2	nummod	_	_
4	and	and	CC	CC	_	2	cc	_	_
5	day	day	NN	NN	_	2	conj	_	_
6	10	10	CD	CD	_	5	nummod	_	_
7	erythroid	erythroid	JJ	JJ	_	8	amod	_	_
8	precursors	precursor	NNS	NNS	_	2	dep	_	_
9	cultured	culture	VBN	VBN	_	2	acl	_	_
10	with	with	IN	IN	_	12	case	_	_
11	Steel	steel	NN	NN	_	12	compound	_	_
12	factor	factor	NN	NN	_	9	nmod	_	_
13	,	,	,	,	_	17	punct	_	_
14	SCL	scl	NN	NN	_	15	compound	_	_
15	protein	protein	NN	NN	_	17	nsubjpass	_	_
16	was	be	VBD	VBD	_	17	auxpass	_	_
17	increased	increase	VBN	VBN	_	0	root	_	_
18	significantly	significantly	RB	RB	_	17	advmod	_	_
19	compared	compare	VBN	VBN	_	21	case	_	_
20	to	to	TO	TO	_	21	case	_	_
21	control	control	NN	NN	_	17	advcl	_	_
22	.	.	.	.	_	17	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	increase	increase	NN	NN	_	15	nsubj	_	_
3	in	in	IN	IN	_	6	case	_	_
4	SCL	scl	NN	NN	_	6	compound	_	_
5	protein	protein	NN	NN	_	6	compound	_	_
6	levels	level	NNS	NNS	_	2	nmod	_	_
7	in	in	IN	IN	_	10	case	_	_
8	early	early	JJ	JJ	_	10	amod	_	_
9	erythroid	erythroid	JJ	JJ	_	10	amod	_	_
10	precursors	precursor	NNS	NNS	_	6	nmod	_	_
11	stimulated	stimulate	VBD	VBD	_	10	acl	_	_
12	with	with	IN	IN	_	14	case	_	_
13	Steel	steel	NN	NN	_	14	compound	_	_
14	factor	factor	NN	NN	_	11	nmod	_	_
15	suggests	suggest	VBZ	VBZ	_	0	root	_	_
16	one	one	CD	CD	_	17	nummod	_	_
17	mechanism	mechanism	NN	NN	_	15	dobj	_	_
18	through	through	IN	IN	_	19	case	_	_
19	which	which	WDT	WDT	_	23	nmod	_	_
20	Steel	steel	NN	NN	_	21	compound	_	_
21	factor	factor	NN	NN	_	23	nsubj	_	_
22	may	may	MD	MD	_	23	aux	_	_
23	enhance	enhance	VB	VB	_	17	acl:relcl	_	_
24	normal	normal	JJ	JJ	_	26	amod	_	_
25	erythroid	erythroid	JJ	JJ	_	24	dep	_	_
26	proliferation	proliferation	NN	NN	_	23	dobj	_	_
27	.	.	.	.	_	15	punct	_	_

1	SCL	scl	NN	NN	_	2	compound	_	_
2	mRNA	mrna	NN	NN	_	3	compound	_	_
3	levels	level	NNS	NNS	_	14	nsubj	_	_
4	assessed	assess	VBN	VBN	_	3	acl	_	_
5	by	by	IN	IN	_	7	case	_	_
6	Northern	northern	NN	NN	_	7	compound	_	_
7	blot	blot	NN	NN	_	4	nmod	_	_
8	in	in	IN	IN	_	11	case	_	_
9	day	day	NN	NN	_	11	compound	_	_
10	7	7	CD	CD	_	11	nummod	_	_
11	cells	cell	NNS	NNS	_	4	nmod	_	_
12	did	do	VBD	VBD	_	14	aux	_	_
13	not	not	RB	RB	_	14	neg	_	_
14	increase	increase	VB	VB	_	0	root	_	_
15	significantly	significantly	RB	RB	_	14	advmod	_	_
16	in	in	IN	IN	_	17	case	_	_
17	response	response	NN	NN	_	14	nmod	_	_
18	to	to	TO	TO	_	21	case	_	_
19	Steel	steel	NN	NN	_	20	compound	_	_
20	factor	factor	NN	NN	_	21	compound	_	_
21	stimulation	stimulation	NN	NN	_	17	nmod	_	_
22	,	,	,	,	_	14	punct	_	_
23	suggesting	suggest	VBG	VBG	_	14	advcl	_	_
24	that	that	IN	IN	_	30	mark	_	_
25	posttranscriptional	posttranscriptional	JJ	JJ	_	26	amod	_	_
26	mechanisms	mechanism	NNS	NNS	_	30	nsubj	_	_
27	may	may	MD	MD	_	30	aux	_	_
28	also	also	RB	RB	_	30	advmod	_	_
29	be	be	VB	VB	_	30	cop	_	_
30	important	important	JJ	JJ	_	23	ccomp	_	_
31	in	in	IN	IN	_	33	case	_	_
32	the	the	DT	DT	_	33	det	_	_
33	increase	increase	NN	NN	_	30	nmod	_	_
34	in	in	IN	IN	_	36	case	_	_
35	SCL	scl	NN	NN	_	36	compound	_	_
36	protein	protein	NN	NN	_	33	nmod	_	_
37	observed	observe	VBN	VBN	_	36	acl	_	_
38	in	in	IN	IN	_	39	case	_	_
39	response	response	NN	NN	_	37	nmod	_	_
40	to	to	TO	TO	_	41	case	_	_
41	Steel	steel	NN	NN	_	39	nmod	_	_
42	.	.	.	.	_	14	punct	_	_

1	Cross-linking	cross-linking	JJ	JJ	_	2	amod	_	_
2	CD40	cd40	NN	NN	_	7	nsubj	_	_
3	on	on	IN	IN	_	5	case	_	_
4	B	b	NN	NN	_	5	compound	_	_
5	cells	cell	NNS	NNS	_	2	nmod	_	_
6	rapidly	rapidly	RB	RB	_	7	advmod	_	_
7	activates	activate	VBZ	VBZ	_	0	root	_	_
8	nuclear	nuclear	JJ	JJ	_	10	amod	_	_
9	factor-kappa	factor-kappa	NN	NN	_	10	compound	_	_
10	B	b	NN	NN	_	7	dobj	_	_
11	.	.	.	.	_	7	punct	_	_

1	The	the	DT	DT	_	6	det	_	_
2	B	b	NN	NN	_	6	compound	_	_
3	cell-associated	cell-associated	JJ	JJ	_	6	amod	_	_
4	surface	surface	NN	NN	_	6	compound	_	_
5	molecule	molecule	NN	NN	_	6	compound	_	_
6	CD40	cd40	NN	NN	_	7	nsubj	_	_
7	functions	function	VBZ	VBZ	_	0	root	_	_
8	to	to	TO	TO	_	9	mark	_	_
9	regulate	regulate	VB	VB	_	7	xcomp	_	_
10	B	b	NN	NN	_	12	compound	_	_
11	cell	cell	NN	NN	_	12	compound	_	_
12	responses	response	NNS	NNS	_	9	dobj	_	_
13	.	.	.	.	_	7	punct	_	_

1	Cross-linking	cross-linking	JJ	JJ	_	2	amod	_	_
2	CD40	cd40	NN	NN	_	7	nsubj	_	_
3	on	on	IN	IN	_	5	case	_	_
4	B	b	NN	NN	_	5	compound	_	_
5	cells	cell	NNS	NNS	_	2	nmod	_	_
6	can	can	MD	MD	_	7	aux	_	_
7	lead	lead	VB	VB	_	0	root	_	_
8	to	to	TO	TO	_	11	case	_	_
9	homotypic	homotypic	JJ	JJ	_	11	amod	_	_
10	cell	cell	NN	NN	_	11	compound	_	_
11	adhesion	adhesion	NN	NN	_	7	nmod	_	_
12	,	,	,	,	_	11	punct	_	_
13	IL-6	il-6	NN	NN	_	14	compound	_	_
14	production	production	NN	NN	_	11	appos	_	_
15	,	,	,	,	_	11	punct	_	_
16	and	and	CC	CC	_	11	cc	_	_
17	,	,	,	,	_	11	punct	_	_
18	in	in	IN	IN	_	19	case	_	_
19	combination	combination	NN	NN	_	11	conj	_	_
20	with	with	IN	IN	_	21	case	_	_
21	cytokines	cytokine	NNS	NNS	_	19	nmod	_	_
22	,	,	,	,	_	11	punct	_	_
23	to	to	TO	TO	_	26	case	_	_
24	Ig	ig	NN	NN	_	26	compound	_	_
25	isotype	isotype	NN	NN	_	26	compound	_	_
26	switching	switching	NN	NN	_	11	conj	_	_
27	.	.	.	.	_	7	punct	_	_

1	Tyrosine	tyrosine	NN	NN	_	3	compound	_	_
2	kinase	kinase	NN	NN	_	3	compound	_	_
3	activity	activity	NN	NN	_	5	nsubjpass	_	_
4	is	be	VBZ	VBZ	_	5	auxpass	_	_
5	increased	increase	VBN	VBN	_	0	root	_	_
6	shortly	shortly	RB	RB	_	5	advmod	_	_
7	after	after	IN	IN	_	8	case	_	_
8	engagement	engagement	NN	NN	_	5	nmod	_	_
9	of	of	IN	IN	_	11	case	_	_
10	this	this	DT	DT	_	11	det	_	_
11	receptor	receptor	NN	NN	_	8	nmod	_	_
12	.	.	.	.	_	5	punct	_	_

1	Little	little	JJ	JJ	_	3	nsubjpass	_	_
2	is	be	VBZ	VBZ	_	3	auxpass	_	_
3	known	know	VBN	VBN	_	0	root	_	_
4	about	about	IN	IN	_	14	mark	_	_
5	how	how	WRB	WRB	_	14	advmod	_	_
6	the	the	DT	DT	_	9	det	_	_
7	very	very	RB	RB	_	8	advmod	_	_
8	early	early	JJ	JJ	_	9	amod	_	_
9	events	event	NNS	NNS	_	14	nsubj	_	_
10	induced	induce	VBN	VBN	_	9	acl	_	_
11	by	by	IN	IN	_	13	case	_	_
12	CD40	cd40	NN	NN	_	13	compound	_	_
13	cross-linking	cross-linking	NN	NN	_	10	nmod	_	_
14	link	link	VBP	VBP	_	3	advcl	_	_
15	to	to	TO	TO	_	17	case	_	_
16	cellular	cellular	JJ	JJ	_	17	amod	_	_
17	responses	response	NNS	NNS	_	14	nmod	_	_
18	.	.	.	.	_	3	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	study	study	NN	NN	_	6	nmod	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
7	that	that	IN	IN	_	21	mark	_	_
8	nuclear	nuclear	JJ	JJ	_	14	amod	_	_
9	factor	factor	NN	NN	_	14	compound	_	_
10	(	(	-LRB-	-LRB-	_	14	punct	_	_
11	NF	nf	NN	NN	_	14	compound	_	_
12	)	)	-RRB-	-RRB-	_	14	punct	_	_
13	-kappa	-kappa	NN	NN	_	14	compound	_	_
14	B	b	NN	NN	_	21	nsubjpass	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	NF-kappa	nf-kappa	NN	NN	_	19	compound	_	_
17	B-like	b-like	JJ	JJ	_	19	amod	_	_
18	transcription	transcription	NN	NN	_	19	compound	_	_
19	factors	factor	NNS	NNS	_	14	conj	_	_
20	are	be	VBP	VBP	_	21	auxpass	_	_
21	activated	activate	VBN	VBN	_	6	ccomp	_	_
22	after	after	IN	IN	_	24	case	_	_
23	cross-linking	cross-linking	JJ	JJ	_	24	amod	_	_
24	CD40	cd40	NN	NN	_	21	nmod	_	_
25	on	on	IN	IN	_	30	case	_	_
26	resting	rest	VBG	VBG	_	30	amod	_	_
27	human	human	JJ	JJ	_	30	amod	_	_
28	tonsillar	tonsillar	JJ	JJ	_	30	amod	_	_
29	B	b	NN	NN	_	30	compound	_	_
30	cells	cell	NNS	NNS	_	24	nmod	_	_
31	and	and	CC	CC	_	30	cc	_	_
32	on	on	IN	IN	_	35	case	_	_
33	B	b	NN	NN	_	35	compound	_	_
34	cell	cell	NN	NN	_	35	compound	_	_
35	lines	line	NNS	NNS	_	30	conj	_	_
36	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	activation	activation	NN	NN	_	4	nsubj	_	_
3	is	be	VBZ	VBZ	_	4	cop	_	_
4	rapid	rapid	JJ	JJ	_	0	root	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	is	be	VBZ	VBZ	_	7	auxpass	_	_
7	mediated	mediate	VBN	VBN	_	4	conj	_	_
8	through	through	IN	IN	_	12	case	_	_
9	a	a	DT	DT	_	12	det	_	_
10	tyrosine	tyrosine	NN	NN	_	12	compound	_	_
11	kinase-dependent	kinase-dependent	JJ	JJ	_	12	amod	_	_
12	pathway	pathway	NN	NN	_	7	nmod	_	_
13	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	complexes	complex	NNS	NNS	_	9	nsubj	_	_
3	detected	detect	VBN	VBN	_	2	acl	_	_
4	in	in	IN	IN	_	8	case	_	_
5	electrophoretic	electrophoretic	JJ	JJ	_	8	amod	_	_
6	mobility	mobility	NN	NN	_	8	compound	_	_
7	shift	shift	NN	NN	_	8	compound	_	_
8	assays	assay	NNS	NNS	_	3	nmod	_	_
9	contain	contain	VBP	VBP	_	0	root	_	_
10	p50	p50	NN	NN	_	9	dobj	_	_
11	,	,	,	,	_	10	punct	_	_
12	p65	p65	NN	NN	_	10	conj	_	_
13	(	(	-LRB-	-LRB-	_	14	punct	_	_
14	RelA	rela	NN	NN	_	12	appos	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	,	,	,	,	_	10	punct	_	_
17	c-Rel	c-rel	NN	NN	_	10	conj	_	_
18	,	,	,	,	_	10	punct	_	_
19	and	and	CC	CC	_	10	cc	_	_
20	most	most	RBS	RBS	_	21	advmod	_	_
21	likely	likely	RB	RB	_	10	advmod	_	_
22	other	other	JJ	JJ	_	23	amod	_	_
23	components	component	NNS	NNS	_	10	conj	_	_
24	.	.	.	.	_	9	punct	_	_

1	By	by	IN	IN	_	2	mark	_	_
2	using	use	VBG	VBG	_	8	advcl	_	_
3	transient	transient	JJ	JJ	_	5	amod	_	_
4	transfection	transfection	NN	NN	_	5	compound	_	_
5	assays	assay	NNS	NNS	_	2	dobj	_	_
6	,	,	,	,	_	8	punct	_	_
7	we	we	PRP	PRP	_	8	nsubj	_	_
8	found	find	VBD	VBD	_	0	root	_	_
9	that	that	IN	IN	_	12	mark	_	_
10	cross-linking	cross-linking	JJ	JJ	_	11	amod	_	_
11	CD40	cd40	NN	NN	_	12	nsubj	_	_
12	supports	support	VBZ	VBZ	_	8	ccomp	_	_
13	NF-kappa	nf-kappa	NN	NN	_	16	compound	_	_
14	B-dependent	b-dependent	JJ	JJ	_	16	amod	_	_
15	gene	gene	NN	NN	_	16	compound	_	_
16	expression	expression	NN	NN	_	12	dobj	_	_
17	.	.	.	.	_	8	punct	_	_

1	Our	we	PRP$	PRP$	_	2	nmod:poss	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	define	define	VBP	VBP	_	0	root	_	_
4	the	the	DT	DT	_	7	det	_	_
5	NF-kappa	nf-kappa	NN	NN	_	6	compound	_	_
6	B	b	NN	NN	_	7	compound	_	_
7	system	system	NN	NN	_	3	dobj	_	_
8	as	as	IN	IN	_	11	case	_	_
9	an	a	DT	DT	_	11	det	_	_
10	intermediate	intermediate	JJ	JJ	_	11	amod	_	_
11	event	event	NN	NN	_	3	nmod	_	_
12	in	in	IN	IN	_	14	case	_	_
13	CD40	cd40	NN	NN	_	14	compound	_	_
14	signaling	signaling	NN	NN	_	11	nmod	_	_
15	and	and	CC	CC	_	3	cc	_	_
16	suggest	suggest	VBP	VBP	_	3	conj	_	_
17	that	that	IN	IN	_	22	mark	_	_
18	the	the	DT	DT	_	20	det	_	_
19	CD40	cd40	NN	NN	_	20	compound	_	_
20	pathway	pathway	NN	NN	_	22	nsubj	_	_
21	can	can	MD	MD	_	22	aux	_	_
22	influence	influence	VB	VB	_	16	ccomp	_	_
23	the	the	DT	DT	_	24	det	_	_
24	expression	expression	NN	NN	_	22	dobj	_	_
25	of	of	IN	IN	_	28	case	_	_
26	B	b	NN	NN	_	28	compound	_	_
27	cell-associated	cell-associated	JJ	JJ	_	28	amod	_	_
28	genes	gene	NNS	NNS	_	24	nmod	_	_
29	with	with	IN	IN	_	33	case	_	_
30	NF-kappa	nf-kappa	NN	NN	_	33	compound	_	_
31	B	b	NN	NN	_	33	compound	_	_
32	consensus	consensus	NN	NN	_	33	compound	_	_
33	sites	site	NNS	NNS	_	22	nmod	_	_
34	.	.	.	.	_	3	punct	_	_

1	Separation	separation	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	3	case	_	_
3	oxidant-initiated	oxidant-initiated	JJ	JJ	_	1	nmod	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	redox-regulated	redox-regulated	JJ	JJ	_	3	conj	_	_
6	steps	step	NNS	NNS	_	3	dep	_	_
7	in	in	IN	IN	_	13	case	_	_
8	the	the	DT	DT	_	13	det	_	_
9	NF-kappa	nf-kappa	NN	NN	_	10	compound	_	_
10	B	b	NN	NN	_	13	compound	_	_
11	signal	signal	NN	NN	_	13	compound	_	_
12	transduction	transduction	NN	NN	_	13	compound	_	_
13	pathway	pathway	NN	NN	_	3	nmod	_	_
14	.	.	.	.	_	1	punct	_	_

1	Studies	study	NNS	NNS	_	4	nsubj	_	_
2	presented	present	VBN	VBN	_	1	acl	_	_
3	here	here	RB	RB	_	2	advmod	_	_
4	show	show	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	11	mark	_	_
6	overall	overall	JJ	JJ	_	10	amod	_	_
7	NF-kappa	nf-kappa	NN	NN	_	8	compound	_	_
8	B	b	NN	NN	_	10	compound	_	_
9	signal	signal	NN	NN	_	10	compound	_	_
10	transduction	transduction	NN	NN	_	11	nsubj	_	_
11	begins	begin	VBZ	VBZ	_	4	ccomp	_	_
12	with	with	IN	IN	_	15	case	_	_
13	a	a	DT	DT	_	15	det	_	_
14	parallel	parallel	JJ	JJ	_	15	amod	_	_
15	series	series	NN	NN	_	11	nmod	_	_
16	of	of	IN	IN	_	18	case	_	_
17	stimuli-specific	stimuli-specific	JJ	JJ	_	18	amod	_	_
18	pathways	pathway	NNS	NNS	_	15	nmod	_	_
19	through	through	IN	IN	_	20	case	_	_
20	which	which	WDT	WDT	_	47	nmod	_	_
21	cytokines	cytokine	NNS	NNS	_	47	nsubj	_	_
22	(	(	-LRB-	-LRB-	_	26	punct	_	_
23	tumor	tumor	NN	NN	_	26	compound	_	_
24	necrosis	necrosis	NN	NN	_	26	compound	_	_
25	factor	factor	NN	NN	_	26	compound	_	_
26	alpha	alpha	NN	NN	_	21	appos	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	,	,	,	,	_	21	punct	_	_
29	oxidants	oxidant	NNS	NNS	_	21	conj	_	_
30	(	(	-LRB-	-LRB-	_	32	punct	_	_
31	hydrogen	hydrogen	NN	NN	_	32	compound	_	_
32	peroxide	peroxide	NN	NN	_	29	dep	_	_
33	and	and	CC	CC	_	32	cc	_	_
34	mitomycin	mitomycin	NN	NN	_	35	compound	_	_
35	C	c	NN	NN	_	32	conj	_	_
36	)	)	-RRB-	-RRB-	_	32	punct	_	_
37	,	,	,	,	_	21	punct	_	_
38	and	and	CC	CC	_	21	cc	_	_
39	phorbol	phorbol	NN	NN	_	40	compound	_	_
40	ester	ester	NN	NN	_	21	conj	_	_
41	(	(	-LRB-	-LRB-	_	44	punct	_	_
42	phorbol	phorbol	NN	NN	_	44	compound	_	_
43	12-myristate	12-myristate	NN	NN	_	44	compound	_	_
44	13-acetate	13-acetate	NN	NN	_	40	appos	_	_
45	)	)	-RRB-	-RRB-	_	44	punct	_	_
46	individually	individually	RB	RB	_	47	advmod	_	_
47	initiate	initiate	VBP	VBP	_	15	acl:relcl	_	_
48	signaling	signaling	NN	NN	_	47	dobj	_	_
49	.	.	.	.	_	4	punct	_	_

1	These	these	DT	DT	_	3	det	_	_
2	initial	initial	JJ	JJ	_	3	amod	_	_
3	pathways	pathway	NNS	NNS	_	4	nsubj	_	_
4	culminate	culminate	VBP	VBP	_	0	root	_	_
5	in	in	IN	IN	_	8	case	_	_
6	a	a	DT	DT	_	8	det	_	_
7	common	common	JJ	JJ	_	8	amod	_	_
8	pathway	pathway	NN	NN	_	4	nmod	_	_
9	through	through	IN	IN	_	10	case	_	_
10	which	which	WDT	WDT	_	17	nmod	_	_
11	all	all	DT	DT	_	17	nsubj	_	_
12	of	of	IN	IN	_	15	case	_	_
13	the	the	DT	DT	_	15	det	_	_
14	stimulating	stimulate	VBG	VBG	_	15	amod	_	_
15	agents	agent	NNS	NNS	_	11	nmod	_	_
16	ultimately	ultimately	RB	RB	_	17	advmod	_	_
17	signal	signal	VBP	VBP	_	8	acl:relcl	_	_
18	NF-kappa	nf-kappa	NN	NN	_	19	compound	_	_
19	B	b	NN	NN	_	20	compound	_	_
20	activation	activation	NN	NN	_	17	dobj	_	_
21	.	.	.	.	_	4	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	distinguish	distinguish	VBP	VBP	_	0	root	_	_
3	the	the	DT	DT	_	5	det	_	_
4	stimuli-specific	stimuli-specific	JJ	JJ	_	5	amod	_	_
5	pathways	pathway	NNS	NNS	_	2	dobj	_	_
6	by	by	IN	IN	_	7	mark	_	_
7	showing	show	VBG	VBG	_	2	advcl	_	_
8	that	that	IN	IN	_	12	mark	_	_
9	the	the	DT	DT	_	11	det	_	_
10	oxidative	oxidative	JJ	JJ	_	11	amod	_	_
11	stimuli	stimulus	NNS	NNS	_	12	nsubj	_	_
12	trigger	trigger	VBP	VBP	_	7	ccomp	_	_
13	NF-kappa	nf-kappa	NN	NN	_	14	compound	_	_
14	B	b	NN	NN	_	15	compound	_	_
15	activation	activation	NN	NN	_	12	dobj	_	_
16	in	in	IN	IN	_	18	case	_	_
17	only	only	RB	RB	_	18	advmod	_	_
18	one	one	CD	CD	_	12	nmod	_	_
19	of	of	IN	IN	_	23	case	_	_
20	two	two	CD	CD	_	23	nummod	_	_
21	human	human	JJ	JJ	_	23	amod	_	_
22	T-cell	t-cell	NN	NN	_	23	compound	_	_
23	lines	line	NNS	NNS	_	18	nmod	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	Wurzburg	wurzburg	NN	NN	_	23	dep	_	_
26	but	but	CC	CC	_	27	cc	_	_
27	not	not	RB	RB	_	25	cc	_	_
28	Jurkat	jurkat	NN	NN	_	25	conj	_	_
29	)	)	-RRB-	-RRB-	_	25	punct	_	_
30	,	,	,	,	_	12	punct	_	_
31	whereas	whereas	IN	IN	_	41	mark	_	_
32	tumor	tumor	NN	NN	_	35	compound	_	_
33	necrosis	necrosis	NN	NN	_	35	compound	_	_
34	factor	factor	NN	NN	_	35	compound	_	_
35	alpha	alpha	NN	NN	_	41	nsubj	_	_
36	and	and	CC	CC	_	35	cc	_	_
37	phorbol	phorbol	NN	NN	_	39	compound	_	_
38	12-myristate	12-myristate	NN	NN	_	39	compound	_	_
39	13-acetate	13-acetate	NN	NN	_	35	conj	_	_
40	readily	readily	RB	RB	_	41	advmod	_	_
41	stimulate	stimulate	VBP	VBP	_	12	advcl	_	_
42	in	in	IN	IN	_	44	case	_	_
43	both	both	DT	DT	_	44	det	_	_
44	lines	line	NNS	NNS	_	41	nmod	_	_
45	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	propose	propose	VBP	VBP	_	0	root	_	_
3	the	the	DT	DT	_	5	det	_	_
4	common	common	JJ	JJ	_	5	amod	_	_
5	pathway	pathway	NN	NN	_	2	dobj	_	_
6	as	as	IN	IN	_	9	case	_	_
7	the	the	DT	DT	_	9	det	_	_
8	simplest	simplest	JJS	JJS	_	9	amod	_	_
9	way	way	NN	NN	_	2	nmod	_	_
10	of	of	IN	IN	_	11	case	_	_
11	accounting	accounting	NN	NN	_	9	acl	_	_
12	for	for	IN	IN	_	15	case	_	_
13	the	the	DT	DT	_	15	dep	_	_
14	common	common	JJ	JJ	_	15	amod	_	_
15	requirements	requirement	NNS	NNS	_	11	nmod	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	properties	property	NNS	NNS	_	15	conj	_	_
18	of	of	IN	IN	_	21	case	_	_
19	the	the	DT	DT	_	21	det	_	_
20	signaling	signaling	NN	NN	_	21	compound	_	_
21	pathway	pathway	NN	NN	_	15	nmod	_	_
22	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	include	include	VBP	VBP	_	0	root	_	_
3	a	a	DT	DT	_	7	det	_	_
4	redox-regulatory	redox-regulatory	JJ	JJ	_	7	amod	_	_
5	mechanism	mechanism	NN	NN	_	7	compound	_	_
6	(	(	-LRB-	-LRB-	_	7	punct	_	_
7	s	s	NNS	NNS	_	2	dobj	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	in	in	IN	IN	_	12	case	_	_
10	this	this	DT	DT	_	12	det	_	_
11	common	common	JJ	JJ	_	12	amod	_	_
12	pathway	pathway	NN	NN	_	2	nmod	_	_
13	to	to	TO	TO	_	14	mark	_	_
14	account	account	VB	VB	_	2	advcl	_	_
15	for	for	IN	IN	_	20	case	_	_
16	the	the	DT	DT	_	20	det	_	_
17	previously	previously	RB	RB	_	18	advmod	_	_
18	demonstrated	demonstrate	VBN	VBN	_	20	amod	_	_
19	redox	redox	NN	NN	_	20	compound	_	_
20	regulation	regulation	NN	NN	_	14	nmod	_	_
21	of	of	IN	IN	_	24	case	_	_
22	NF-kappa	nf-kappa	NN	NN	_	23	compound	_	_
23	B	b	NN	NN	_	24	compound	_	_
24	activation	activation	NN	NN	_	20	nmod	_	_
25	in	in	IN	IN	_	27	case	_	_
26	Jurkat	jurkat	NN	NN	_	27	compound	_	_
27	cells	cell	NNS	NNS	_	24	nmod	_	_
28	(	(	-LRB-	-LRB-	_	34	punct	_	_
29	in	in	IN	IN	_	30	case	_	_
30	which	which	WDT	WDT	_	34	nmod	_	_
31	oxidants	oxidant	NNS	NNS	_	34	nsubj	_	_
32	do	do	VBP	VBP	_	34	aux	_	_
33	n't	not	RB	RB	_	34	neg	_	_
34	activate	activate	VB	VB	_	27	dep	_	_
35	NF-kappa	nf-kappa	NN	NN	_	36	compound	_	_
36	B	b	NN	NN	_	34	dobj	_	_
37	)	)	-RRB-	-RRB-	_	34	punct	_	_
38	;	;	:	:	_	2	punct	_	_
39	we	we	PRP	PRP	_	40	nsubj	_	_
40	put	put	VBP	VBP	_	2	parataxis	_	_
41	tyrosine	tyrosine	NN	NN	_	42	compound	_	_
42	phosphorylation	phosphorylation	NN	NN	_	40	dobj	_	_
43	in	in	IN	IN	_	46	case	_	_
44	the	the	DT	DT	_	46	det	_	_
45	common	common	JJ	JJ	_	46	amod	_	_
46	pathway	pathway	NN	NN	_	40	nmod	_	_
47	by	by	IN	IN	_	48	mark	_	_
48	showing	show	VBG	VBG	_	40	advcl	_	_
49	that	that	IN	IN	_	62	mark	_	_
50	kinase	kinase	NN	NN	_	51	compound	_	_
51	activity	activity	NN	NN	_	62	nsubjpass	_	_
52	(	(	-LRB-	-LRB-	_	53	punct	_	_
53	inhibitable	inhibitable	JJ	JJ	_	51	dep	_	_
54	by	by	IN	IN	_	56	case	_	_
55	herbimycin	herbimycin	NN	NN	_	56	compound	_	_
56	A	a	NN	NN	_	53	nmod	_	_
57	and	and	CC	CC	_	56	cc	_	_
58	tyrphostin	tyrphostin	NN	NN	_	56	conj	_	_
59	47	47	CD	CD	_	58	nummod	_	_
60	)	)	-RRB-	-RRB-	_	53	punct	_	_
61	is	be	VBZ	VBZ	_	62	auxpass	_	_
62	required	require	VBN	VBN	_	48	ccomp	_	_
63	for	for	IN	IN	_	66	case	_	_
64	NF-kappa	nf-kappa	NN	NN	_	65	compound	_	_
65	B	b	NN	NN	_	66	compound	_	_
66	activation	activation	NN	NN	_	62	nmod	_	_
67	by	by	IN	IN	_	69	case	_	_
68	all	all	DT	DT	_	69	det	_	_
69	stimuli	stimulus	NNS	NNS	_	66	nmod	_	_
70	tested	test	VBN	VBN	_	69	acl	_	_
71	in	in	IN	IN	_	74	case	_	_
72	both	both	DT	DT	_	74	det	_	_
73	cell	cell	NN	NN	_	74	compound	_	_
74	lines	line	NNS	NNS	_	70	nmod	_	_
75	.	.	.	.	_	2	punct	_	_

1	Since	since	IN	IN	_	9	mark	_	_
2	internal	internal	JJ	JJ	_	3	amod	_	_
3	sites	site	NNS	NNS	_	9	nsubjpass	_	_
4	of	of	IN	IN	_	6	case	_	_
5	oxidant	oxidant	NN	NN	_	6	compound	_	_
6	production	production	NN	NN	_	3	nmod	_	_
7	have	have	VBP	VBP	_	9	aux	_	_
8	been	be	VBN	VBN	_	9	auxpass	_	_
9	shown	show	VBN	VBN	_	40	dep	_	_
10	to	to	TO	TO	_	11	mark	_	_
11	play	play	VB	VB	_	9	xcomp	_	_
12	a	a	DT	DT	_	14	det	_	_
13	key	key	JJ	JJ	_	14	amod	_	_
14	role	role	NN	NN	_	11	dobj	_	_
15	in	in	IN	IN	_	18	case	_	_
16	the	the	DT	DT	_	18	det	_	_
17	cytokine-stimulated	cytokine-stimulated	JJ	JJ	_	18	amod	_	_
18	activation	activation	NN	NN	_	11	nmod	_	_
19	of	of	IN	IN	_	21	case	_	_
20	NF-kappa	nf-kappa	NN	NN	_	21	compound	_	_
21	B	b	NN	NN	_	18	nmod	_	_
22	,	,	,	,	_	9	punct	_	_
23	and	and	CC	CC	_	9	cc	_	_
24	since	since	IN	IN	_	31	mark	_	_
25	tyrosine	tyrosine	NN	NN	_	26	compound	_	_
26	kinase	kinase	NN	NN	_	31	nsubjpass	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	phosphatase	phosphatase	NN	NN	_	26	conj	_	_
29	activities	activity	NNS	NNS	_	26	dep	_	_
30	are	be	VBP	VBP	_	31	auxpass	_	_
31	known	know	VBN	VBN	_	9	conj	_	_
32	to	to	TO	TO	_	34	mark	_	_
33	be	be	VB	VB	_	34	auxpass	_	_
34	altered	alter	VBN	VBN	_	31	xcomp	_	_
35	by	by	IN	IN	_	36	case	_	_
36	oxidants	oxidant	NNS	NNS	_	34	nmod	_	_
37	,	,	,	,	_	40	punct	_	_
38	these	these	DT	DT	_	39	det	_	_
39	findings	finding	NNS	NNS	_	40	nsubj	_	_
40	suggest	suggest	VBP	VBP	_	0	root	_	_
41	that	that	IN	IN	_	45	mark	_	_
42	intracellular	intracellular	JJ	JJ	_	44	amod	_	_
43	redox	redox	NN	NN	_	44	compound	_	_
44	status	status	NN	NN	_	45	nsubj	_	_
45	controls	control	VBZ	VBZ	_	40	ccomp	_	_
46	NF-kappa	nf-kappa	NN	NN	_	47	compound	_	_
47	B	b	NN	NN	_	48	compound	_	_
48	activation	activation	NN	NN	_	45	dobj	_	_
49	by	by	IN	IN	_	50	mark	_	_
50	regulating	regulate	VBG	VBG	_	45	advcl	_	_
51	tyrosine	tyrosine	NN	NN	_	55	compound	_	_
52	phosphorylation	phosphorylation	NN	NN	_	55	compound	_	_
53	event	event	NN	NN	_	55	compound	_	_
54	(	(	-LRB-	-LRB-	_	55	punct	_	_
55	s	s	NNS	NNS	_	50	dobj	_	_
56	)	)	-RRB-	-RRB-	_	55	punct	_	_
57	within	within	IN	IN	_	60	case	_	_
58	the	the	DT	DT	_	60	det	_	_
59	common	common	JJ	JJ	_	60	amod	_	_
60	step	step	NN	NN	_	50	nmod	_	_
61	of	of	IN	IN	_	67	case	_	_
62	the	the	DT	DT	_	67	det	_	_
63	NF-kappa	nf-kappa	NN	NN	_	64	compound	_	_
64	B	b	NN	NN	_	67	compound	_	_
65	signal	signal	NN	NN	_	67	compound	_	_
66	transduction	transduction	NN	NN	_	67	compound	_	_
67	pathway	pathway	NN	NN	_	60	nmod	_	_
68	.	.	.	.	_	40	punct	_	_

1	Transcription-independent	transcription-independent	JJ	JJ	_	2	amod	_	_
2	turnover	turnover	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	7	case	_	_
4	I	i	NN	NN	_	7	compound	_	_
5	kappa	kappa	NN	NN	_	7	compound	_	_
6	B	b	NN	NN	_	7	compound	_	_
7	alpha	alpha	NN	NN	_	2	nmod	_	_
8	during	during	IN	IN	_	10	case	_	_
9	monocyte	monocyte	NN	NN	_	10	compound	_	_
10	adherence	adherence	NN	NN	_	2	nmod	_	_
11	:	:	:	:	_	2	punct	_	_
12	implications	implication	NNS	NNS	_	2	dep	_	_
13	for	for	IN	IN	_	16	case	_	_
14	a	a	DT	DT	_	16	det	_	_
15	translational	translational	JJ	JJ	_	16	amod	_	_
16	component	component	NN	NN	_	12	nmod	_	_
17	regulating	regulate	VBG	VBG	_	16	acl	_	_
18	I	i	NN	NN	_	22	compound	_	_
19	kappa	kappa	NN	NN	_	22	compound	_	_
20	B	b	NN	NN	_	22	compound	_	_
21	alpha/MAD-3	alpha/mad-3	NN	NN	_	22	compound	_	_
22	mRNA	mrna	NN	NN	_	23	compound	_	_
23	levels	level	NNS	NNS	_	17	dobj	_	_
24	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	identified	identify	VBD	VBD	_	0	root	_	_
3	I	i	NN	NN	_	6	compound	_	_
4	kappa	kappa	NN	NN	_	6	compound	_	_
5	B	b	NN	NN	_	6	compound	_	_
6	alpha/MAD-3	alpha/mad-3	NN	NN	_	2	dobj	_	_
7	as	as	IN	IN	_	10	case	_	_
8	an	a	DT	DT	_	10	det	_	_
9	immediate-early	immediate-early	JJ	JJ	_	10	amod	_	_
10	gene	gene	NN	NN	_	2	nmod	_	_
11	in	in	IN	IN	_	13	case	_	_
12	human	human	JJ	JJ	_	13	amod	_	_
13	monocytes	monocyte	NNS	NNS	_	10	nmod	_	_
14	that	that	WDT	WDT	_	16	nsubjpass	_	_
15	is	be	VBZ	VBZ	_	16	auxpass	_	_
16	expressed	express	VBN	VBN	_	10	acl:relcl	_	_
17	in	in	IN	IN	_	18	case	_	_
18	response	response	NN	NN	_	16	nmod	_	_
19	to	to	TO	TO	_	21	case	_	_
20	a	a	DT	DT	_	21	det	_	_
21	variety	variety	NN	NN	_	18	nmod	_	_
22	of	of	IN	IN	_	23	case	_	_
23	signals	signal	NNS	NNS	_	21	nmod	_	_
24	,	,	,	,	_	23	punct	_	_
25	including	include	VBG	VBG	_	26	case	_	_
26	adhesion	adhesion	NN	NN	_	23	nmod	_	_
27	,	,	,	,	_	26	punct	_	_
28	lipopolysaccharide	lipopolysaccharide	NN	NN	_	26	conj	_	_
29	,	,	,	,	_	26	punct	_	_
30	and	and	CC	CC	_	26	cc	_	_
31	phorbol	phorbol	NN	NN	_	33	compound	_	_
32	myristate	myristate	NN	NN	_	33	compound	_	_
33	acetate	acetate	NN	NN	_	26	conj	_	_
34	.	.	.	.	_	2	punct	_	_

1	Within	within	IN	IN	_	3	case	_	_
2	5	5	CD	CD	_	3	nummod	_	_
3	min	min	NN	NN	_	19	nmod	_	_
4	of	of	IN	IN	_	6	case	_	_
5	monocyte	monocyte	NN	NN	_	6	compound	_	_
6	adhesion	adhesion	NN	NN	_	3	nmod	_	_
7	,	,	,	,	_	19	punct	_	_
8	the	the	DT	DT	_	9	det	_	_
9	level	level	NN	NN	_	19	nsubjpass	_	_
10	of	of	IN	IN	_	16	case	_	_
11	the	the	DT	DT	_	16	det	_	_
12	I	i	NN	NN	_	16	compound	_	_
13	kappa	kappa	NN	NN	_	16	compound	_	_
14	B	b	NN	NN	_	16	compound	_	_
15	alpha	alpha	NN	NN	_	16	compound	_	_
16	protein	protein	NN	NN	_	9	nmod	_	_
17	is	be	VBZ	VBZ	_	19	auxpass	_	_
18	markedly	markedly	RB	RB	_	19	advmod	_	_
19	diminished	diminish	VBN	VBN	_	0	root	_	_
20	but	but	CC	CC	_	19	cc	_	_
21	is	be	VBZ	VBZ	_	23	auxpass	_	_
22	rapidly	rapidly	RB	RB	_	23	advmod	_	_
23	replaced	replace	VBN	VBN	_	19	conj	_	_
24	in	in	IN	IN	_	27	case	_	_
25	a	a	DT	DT	_	27	det	_	_
26	cycloheximide-sensitive	cycloheximide-sensitive	JJ	JJ	_	27	amod	_	_
27	manner	manner	NN	NN	_	23	nmod	_	_
28	within	within	IN	IN	_	30	case	_	_
29	20	20	CD	CD	_	30	nummod	_	_
30	min	min	NN	NN	_	23	nmod	_	_
31	.	.	.	.	_	19	punct	_	_

1	Accompanying	accompany	VBG	VBG	_	0	root	_	_
2	the	the	DT	DT	_	4	det	_	_
3	rapid	rapid	JJ	JJ	_	4	amod	_	_
4	turnover	turnover	NN	NN	_	1	dobj	_	_
5	of	of	IN	IN	_	11	case	_	_
6	the	the	DT	DT	_	11	det	_	_
7	I	i	NN	NN	_	11	compound	_	_
8	kappa	kappa	NN	NN	_	11	compound	_	_
9	B	b	NN	NN	_	11	compound	_	_
10	alpha	alpha	NN	NN	_	11	compound	_	_
11	protein	protein	NN	NN	_	4	nmod	_	_
12	is	be	VBZ	VBZ	_	1	aux	_	_
13	simultaneous	simultaneous	JJ	JJ	_	14	amod	_	_
14	translocation	translocation	NN	NN	_	1	nsubj	_	_
15	of	of	IN	IN	_	19	case	_	_
16	NF-kappa	nf-kappa	NN	NN	_	19	compound	_	_
17	B-related	b-related	JJ	JJ	_	19	amod	_	_
18	transcription	transcription	NN	NN	_	19	compound	_	_
19	factors	factor	NNS	NNS	_	14	nmod	_	_
20	to	to	TO	TO	_	21	case	_	_
21	nuclei	nucleus	NNS	NNS	_	14	nmod	_	_
22	of	of	IN	IN	_	24	case	_	_
23	adhered	adhered	JJ	JJ	_	24	amod	_	_
24	monocytes	monocyte	NNS	NNS	_	21	nmod	_	_
25	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	demonstration	demonstration	NN	NN	_	18	nsubj	_	_
3	that	that	IN	IN	_	7	mark	_	_
4	NF-kappa	nf-kappa	NN	NN	_	5	compound	_	_
5	B	b	NN	NN	_	7	nsubj	_	_
6	can	can	MD	MD	_	7	aux	_	_
7	regulate	regulate	VB	VB	_	2	ccomp	_	_
8	I	i	NN	NN	_	12	compound	_	_
9	kappa	kappa	NN	NN	_	12	compound	_	_
10	B	b	NN	NN	_	12	compound	_	_
11	alpha/MAD-3	alpha/mad-3	NN	NN	_	12	compound	_	_
12	gene	gene	NN	NN	_	13	compound	_	_
13	transcription	transcription	NN	NN	_	7	dobj	_	_
14	in	in	IN	IN	_	17	case	_	_
15	other	other	JJ	JJ	_	17	amod	_	_
16	cell	cell	NN	NN	_	17	compound	_	_
17	types	type	NNS	NNS	_	7	nmod	_	_
18	suggested	suggest	VBD	VBD	_	0	root	_	_
19	that	that	IN	IN	_	40	mark	_	_
20	the	the	DT	DT	_	22	det	_	_
21	rapid	rapid	JJ	JJ	_	22	amod	_	_
22	increase	increase	NN	NN	_	40	nsubj	_	_
23	in	in	IN	IN	_	30	case	_	_
24	steady-state	steady-state	JJ	JJ	_	30	amod	_	_
25	I	i	NN	NN	_	29	compound	_	_
26	kappa	kappa	NN	NN	_	29	compound	_	_
27	B	b	NN	NN	_	29	compound	_	_
28	alpha/MAD-3	alpha/mad-3	NN	NN	_	29	compound	_	_
29	mRNA	mrna	NN	NN	_	30	compound	_	_
30	levels	level	NNS	NNS	_	22	nmod	_	_
31	we	we	PRP	PRP	_	32	nsubj	_	_
32	observed	observe	VBD	VBD	_	22	acl:relcl	_	_
33	within	within	IN	IN	_	35	case	_	_
34	30	30	CD	CD	_	35	nummod	_	_
35	min	min	NN	NN	_	32	nmod	_	_
36	of	of	IN	IN	_	38	case	_	_
37	monocyte	monocyte	NN	NN	_	38	compound	_	_
38	adherence	adherence	NN	NN	_	35	nmod	_	_
39	would	would	MD	MD	_	40	aux	_	_
40	result	result	VB	VB	_	18	ccomp	_	_
41	from	from	IN	IN	_	45	case	_	_
42	NF-kappa	nf-kappa	NN	NN	_	45	compound	_	_
43	B-dependent	b-dependent	JJ	JJ	_	45	amod	_	_
44	transcriptional	transcriptional	JJ	JJ	_	45	amod	_	_
45	stimulation	stimulation	NN	NN	_	40	nmod	_	_
46	of	of	IN	IN	_	52	case	_	_
47	the	the	DT	DT	_	52	det	_	_
48	I	i	NN	NN	_	52	compound	_	_
49	kappa	kappa	NN	NN	_	52	compound	_	_
50	B	b	NN	NN	_	52	compound	_	_
51	alpha/MAD-3	alpha/mad-3	NN	NN	_	52	compound	_	_
52	gene	gene	NN	NN	_	45	nmod	_	_
53	.	.	.	.	_	18	punct	_	_

1	Nuclear	nuclear	JJ	JJ	_	3	amod	_	_
2	run-on	run-on	JJ	JJ	_	1	dep	_	_
3	analyses	analysis	NNS	NNS	_	4	nsubj	_	_
4	indicated	indicate	VBD	VBD	_	0	root	_	_
5	that	that	IN	IN	_	43	mark	_	_
6	,	,	,	,	_	43	punct	_	_
7	instead	instead	RB	RB	_	43	advmod	_	_
8	,	,	,	,	_	43	punct	_	_
9	while	while	IN	IN	_	29	mark	_	_
10	several	several	JJ	JJ	_	13	amod	_	_
11	immediate-early	immediate-early	JJ	JJ	_	13	amod	_	_
12	cytokine	cytokine	NN	NN	_	13	compound	_	_
13	genes	gene	NNS	NNS	_	29	nsubjpass	_	_
14	,	,	,	,	_	13	punct	_	_
15	such	such	JJ	JJ	_	25	case	_	_
16	as	as	IN	IN	_	15	mwe	_	_
17	the	the	DT	DT	_	25	det	_	_
18	interleukin	interleukin	NN	NN	_	25	compound	_	_
19	1	1	CD	CD	_	25	nummod	_	_
20	beta	beta	NN	NN	_	25	compound	_	_
21	(	(	-LRB-	-LRB-	_	25	punct	_	_
22	IL-1	il-1	NN	NN	_	25	compound	_	_
23	beta	beta	NN	NN	_	25	compound	_	_
24	)	)	-RRB-	-RRB-	_	25	punct	_	_
25	gene	gene	NN	NN	_	13	nmod	_	_
26	,	,	,	,	_	13	punct	_	_
27	were	be	VBD	VBD	_	29	auxpass	_	_
28	transcriptionally	transcriptionally	RB	RB	_	29	advmod	_	_
29	activated	activate	VBN	VBN	_	43	dep	_	_
30	during	during	IN	IN	_	32	case	_	_
31	monocyte	monocyte	NN	NN	_	32	compound	_	_
32	adhesion	adhesion	NN	NN	_	29	nmod	_	_
33	,	,	,	,	_	43	punct	_	_
34	the	the	DT	DT	_	35	det	_	_
35	rate	rate	NN	NN	_	43	nsubj	_	_
36	of	of	IN	IN	_	42	case	_	_
37	I	i	NN	NN	_	41	compound	_	_
38	kappa	kappa	NN	NN	_	41	compound	_	_
39	B	b	NN	NN	_	41	compound	_	_
40	alpha/MAD-3	alpha/mad-3	NN	NN	_	41	compound	_	_
41	gene	gene	NN	NN	_	42	compound	_	_
42	transcription	transcription	NN	NN	_	35	nmod	_	_
43	remained	remain	VBD	VBD	_	4	ccomp	_	_
44	constant	constant	JJ	JJ	_	43	xcomp	_	_
45	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	adherence-dependent	adherence-dependent	JJ	JJ	_	3	amod	_	_
3	increase	increase	NN	NN	_	15	nsubj	_	_
4	in	in	IN	IN	_	10	case	_	_
5	I	i	NN	NN	_	9	compound	_	_
6	kappa	kappa	NN	NN	_	9	compound	_	_
7	B	b	NN	NN	_	9	compound	_	_
8	alpha/MAD-3	alpha/mad-3	NN	NN	_	9	compound	_	_
9	mRNA	mrna	NN	NN	_	10	compound	_	_
10	levels	level	NNS	NNS	_	3	nmod	_	_
11	was	be	VBD	VBD	_	15	cop	_	_
12	also	also	RB	RB	_	15	advmod	_	_
13	not	not	RB	RB	_	15	neg	_	_
14	a	a	DT	DT	_	15	det	_	_
15	consequence	consequence	NN	NN	_	0	root	_	_
16	of	of	IN	IN	_	19	case	_	_
17	mRNA	mrna	NN	NN	_	19	compound	_	_
18	stabilization	stabilization	NN	NN	_	19	compound	_	_
19	events	event	NNS	NNS	_	15	nmod	_	_
20	.	.	.	.	_	15	punct	_	_

1	Interestingly	interestingly	RB	RB	_	30	advmod	_	_
2	,	,	,	,	_	30	punct	_	_
3	while	while	IN	IN	_	17	mark	_	_
4	increases	increase	NNS	NNS	_	17	nsubjpass	_	_
5	in	in	IN	IN	_	8	case	_	_
6	both	both	CC	CC	_	8	cc:preconj	_	_
7	IL-1	il-1	NN	NN	_	8	compound	_	_
8	beta	beta	NN	NN	_	4	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	I	i	NN	NN	_	14	compound	_	_
11	kappa	kappa	NN	NN	_	14	compound	_	_
12	B	b	NN	NN	_	14	compound	_	_
13	alpha/MAD-3	alpha/mad-3	NN	NN	_	14	compound	_	_
14	mRNA	mrna	NN	NN	_	8	conj	_	_
15	levels	level	NNS	NNS	_	8	dep	_	_
16	were	be	VBD	VBD	_	17	auxpass	_	_
17	detected	detect	VBN	VBN	_	30	dep	_	_
18	in	in	IN	IN	_	19	case	_	_
19	nuclei	nucleus	NNS	NNS	_	17	nmod	_	_
20	of	of	IN	IN	_	22	case	_	_
21	adherent	adherent	JJ	JJ	_	22	amod	_	_
22	monocytes	monocyte	NNS	NNS	_	19	nmod	_	_
23	,	,	,	,	_	30	punct	_	_
24	cytoplasmic	cytoplasmic	JJ	JJ	_	25	amod	_	_
25	levels	level	NNS	NNS	_	30	nsubj	_	_
26	of	of	IN	IN	_	29	case	_	_
27	IL-1	il-1	NN	NN	_	29	compound	_	_
28	beta	beta	NN	NN	_	29	compound	_	_
29	mRNA	mrna	NN	NN	_	25	nmod	_	_
30	increased	increase	VBN	VBN	_	0	root	_	_
31	during	during	IN	IN	_	32	case	_	_
32	adherence	adherence	NN	NN	_	30	nmod	_	_
33	whereas	whereas	IN	IN	_	41	mark	_	_
34	those	those	DT	DT	_	41	nsubj	_	_
35	of	of	IN	IN	_	40	case	_	_
36	I	i	NN	NN	_	40	compound	_	_
37	kappa	kappa	NN	NN	_	40	compound	_	_
38	B	b	NN	NN	_	40	compound	_	_
39	alpha/MAD-3	alpha/mad-3	NN	NN	_	40	compound	_	_
40	mRNA	mrna	NN	NN	_	34	nmod	_	_
41	did	do	VBD	VBD	_	30	advcl	_	_
42	not	not	RB	RB	_	41	neg	_	_
43	.	.	.	.	_	30	punct	_	_

1	Taken	take	VBN	VBN	_	0	root	_	_
2	together	together	RB	RB	_	1	advmod	_	_
3	,	,	,	,	_	1	punct	_	_
4	our	we	PRP$	PRP$	_	5	nmod:poss	_	_
5	data	datum	NNS	NNS	_	6	nsubj	_	_
6	suggest	suggest	VBP	VBP	_	1	parataxis	_	_
7	that	that	IN	IN	_	11	mark	_	_
8	two	two	CD	CD	_	10	nummod	_	_
9	interactive	interactive	JJ	JJ	_	10	amod	_	_
10	mechanisms	mechanism	NNS	NNS	_	11	nsubj	_	_
11	regulate	regulate	VBP	VBP	_	6	ccomp	_	_
12	monocytic	monocytic	JJ	JJ	_	17	amod	_	_
13	I	i	NN	NN	_	17	compound	_	_
14	kappa	kappa	NN	NN	_	17	compound	_	_
15	B	b	NN	NN	_	17	compound	_	_
16	alpha/MAD-3	alpha/mad-3	NN	NN	_	17	compound	_	_
17	mRNA	mrna	NN	NN	_	18	compound	_	_
18	levels	level	NNS	NNS	_	11	dobj	_	_
19	.	.	.	.	_	1	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	propose	propose	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	6	mark	_	_
4	adherent	adherent	JJ	JJ	_	5	amod	_	_
5	monocytes	monocyte	NNS	NNS	_	6	nsubj	_	_
6	regulate	regulate	VBP	VBP	_	2	ccomp	_	_
7	nuclear	nuclear	JJ	JJ	_	8	amod	_	_
8	processing	processing	NN	NN	_	6	dobj	_	_
9	(	(	-LRB-	-LRB-	_	11	punct	_	_
10	or	or	CC	CC	_	11	cc	_	_
11	decay	decay	NN	NN	_	8	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	of	of	IN	IN	_	18	case	_	_
14	I	i	NN	NN	_	18	compound	_	_
15	kappa	kappa	NN	NN	_	18	compound	_	_
16	B	b	NN	NN	_	18	compound	_	_
17	alpha/MAD-3	alpha/mad-3	NN	NN	_	18	compound	_	_
18	mRNA	mrna	NN	NN	_	8	nmod	_	_
19	,	,	,	,	_	6	punct	_	_
20	thereby	thereby	RB	RB	_	21	advmod	_	_
21	increasing	increase	VBG	VBG	_	6	advcl	_	_
22	mRNA	mrna	NN	NN	_	23	compound	_	_
23	levels	level	NNS	NNS	_	21	dobj	_	_
24	without	without	IN	IN	_	25	mark	_	_
25	stimulating	stimulate	VBG	VBG	_	21	advcl	_	_
26	I	i	NN	NN	_	30	compound	_	_
27	kappa	kappa	NN	NN	_	30	compound	_	_
28	B	b	NN	NN	_	30	compound	_	_
29	alpha/MAD-3	alpha/mad-3	NN	NN	_	30	compound	_	_
30	gene	gene	NN	NN	_	31	compound	_	_
31	transcription	transcription	NN	NN	_	25	dobj	_	_
32	.	.	.	.	_	2	punct	_	_

1	Moreover	moreover	RB	RB	_	27	advmod	_	_
2	,	,	,	,	_	27	punct	_	_
3	since	since	IN	IN	_	8	mark	_	_
4	inhibition	inhibition	NN	NN	_	8	nsubj	_	_
5	of	of	IN	IN	_	7	case	_	_
6	protein	protein	NN	NN	_	7	compound	_	_
7	synthesis	synthesis	NN	NN	_	4	nmod	_	_
8	leads	lead	VBZ	VBZ	_	27	dep	_	_
9	to	to	TO	TO	_	10	case	_	_
10	accumulation	accumulation	NN	NN	_	8	nmod	_	_
11	of	of	IN	IN	_	16	case	_	_
12	I	i	NN	NN	_	16	compound	_	_
13	kappa	kappa	NN	NN	_	16	compound	_	_
14	B	b	NN	NN	_	16	compound	_	_
15	alpha/MAD-3	alpha/mad-3	NN	NN	_	16	compound	_	_
16	mRNA	mrna	NN	NN	_	10	nmod	_	_
17	without	without	IN	IN	_	18	mark	_	_
18	stimulating	stimulate	VBG	VBG	_	8	advcl	_	_
19	I	i	NN	NN	_	23	compound	_	_
20	kappa	kappa	NN	NN	_	23	compound	_	_
21	B	b	NN	NN	_	23	compound	_	_
22	alpha/MAD-3	alpha/mad-3	NN	NN	_	23	compound	_	_
23	gene	gene	NN	NN	_	24	compound	_	_
24	transcription	transcription	NN	NN	_	18	dobj	_	_
25	,	,	,	,	_	27	punct	_	_
26	we	we	PRP	PRP	_	27	nsubj	_	_
27	suggest	suggest	VBP	VBP	_	0	root	_	_
28	that	that	IN	IN	_	39	mark	_	_
29	low	low	JJ	JJ	_	31	amod	_	_
30	cytoplasmic	cytoplasmic	JJ	JJ	_	31	amod	_	_
31	levels	level	NNS	NNS	_	39	nsubjpass	_	_
32	of	of	IN	IN	_	37	case	_	_
33	I	i	NN	NN	_	37	compound	_	_
34	kappa	kappa	NN	NN	_	37	compound	_	_
35	B	b	NN	NN	_	37	compound	_	_
36	alpha/MAD-3	alpha/mad-3	NN	NN	_	37	compound	_	_
37	mRNA	mrna	NN	NN	_	31	nmod	_	_
38	are	be	VBP	VBP	_	39	auxpass	_	_
39	maintained	maintain	VBN	VBN	_	27	ccomp	_	_
40	by	by	IN	IN	_	44	case	_	_
41	a	a	DT	DT	_	44	det	_	_
42	translation-dependent	translation-dependent	JJ	JJ	_	44	amod	_	_
43	degradation	degradation	NN	NN	_	44	compound	_	_
44	mechanism	mechanism	NN	NN	_	39	nmod	_	_
45	.	.	.	.	_	27	punct	_	_

1	E2F-1	e2f-1	NN	NN	_	12	nsubj	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	a	a	DT	DT	_	7	det	_	_
4	cyclin-like	cyclin-like	JJ	JJ	_	7	amod	_	_
5	DNA	dna	NN	NN	_	7	compound	_	_
6	repair	repair	NN	NN	_	7	compound	_	_
7	enzyme	enzyme	NN	NN	_	1	conj	_	_
8	,	,	,	,	_	7	punct	_	_
9	uracil-DNA	uracil-dna	NN	NN	_	10	compound	_	_
10	glycosylase	glycosylase	NN	NN	_	7	appos	_	_
11	,	,	,	,	_	1	punct	_	_
12	provide	provide	VBP	VBP	_	0	root	_	_
13	evidence	evidence	NN	NN	_	12	dobj	_	_
14	for	for	IN	IN	_	17	case	_	_
15	an	a	DT	DT	_	17	det	_	_
16	autoregulatory	autoregulatory	JJ	JJ	_	17	amod	_	_
17	mechanism	mechanism	NN	NN	_	13	nmod	_	_
18	for	for	IN	IN	_	19	case	_	_
19	transcription	transcription	NN	NN	_	17	nmod	_	_
20	.	.	.	.	_	12	punct	_	_

1	The	the	DT	DT	_	5	det	_	_
2	cell	cell	NN	NN	_	5	compound	_	_
3	cycle-dependent	cycle-dependent	JJ	JJ	_	5	amod	_	_
4	transcription	transcription	NN	NN	_	5	compound	_	_
5	factor	factor	NN	NN	_	9	nsubj	_	_
6	,	,	,	,	_	5	punct	_	_
7	E2F-1	e2f-1	NN	NN	_	5	appos	_	_
8	,	,	,	,	_	5	punct	_	_
9	regulates	regulate	VBZ	VBZ	_	0	root	_	_
10	the	the	DT	DT	_	12	det	_	_
11	cyclin-like	cyclin-like	JJ	JJ	_	12	amod	_	_
12	species	species	NNS	NNS	_	9	dobj	_	_
13	of	of	IN	IN	_	17	case	_	_
14	the	the	DT	DT	_	17	det	_	_
15	DNA	dna	NN	NN	_	17	compound	_	_
16	repair	repair	NN	NN	_	17	compound	_	_
17	enzyme	enzyme	NN	NN	_	12	nmod	_	_
18	uracil-DNA	uracil-dna	NN	NN	_	23	compound	_	_
19	glycosylase	glycosylase	NN	NN	_	23	compound	_	_
20	(	(	-LRB-	-LRB-	_	23	punct	_	_
21	UDG	udg	NN	NN	_	23	compound	_	_
22	)	)	-RRB-	-RRB-	_	23	punct	_	_
23	gene	gene	NN	NN	_	17	dep	_	_
24	in	in	IN	IN	_	30	case	_	_
25	human	human	JJ	JJ	_	30	amod	_	_
26	osteosarcoma	osteosarcoma	NN	NN	_	30	compound	_	_
27	(	(	-LRB-	-LRB-	_	30	punct	_	_
28	Saos-2	saos-2	NN	NN	_	30	compound	_	_
29	)	)	-RRB-	-RRB-	_	30	punct	_	_
30	cells	cell	NNS	NNS	_	9	nmod	_	_
31	.	.	.	.	_	9	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
3	,	,	,	,	_	2	punct	_	_
4	through	through	IN	IN	_	6	case	_	_
5	the	the	DT	DT	_	6	det	_	_
6	deletion	deletion	NN	NN	_	2	nmod	_	_
7	of	of	IN	IN	_	12	case	_	_
8	the	the	DT	DT	_	12	det	_	_
9	human	human	JJ	JJ	_	12	amod	_	_
10	UDG	udg	NN	NN	_	12	compound	_	_
11	promoter	promoter	NN	NN	_	12	compound	_	_
12	sequences	sequence	NNS	NNS	_	6	nmod	_	_
13	,	,	,	,	_	2	punct	_	_
14	that	that	IN	IN	_	18	mark	_	_
15	expression	expression	NN	NN	_	18	nsubj	_	_
16	of	of	IN	IN	_	17	case	_	_
17	E2F-1	e2f-1	NN	NN	_	15	nmod	_	_
18	activates	activate	VBZ	VBZ	_	2	ccomp	_	_
19	the	the	DT	DT	_	21	det	_	_
20	UDG	udg	NN	NN	_	21	compound	_	_
21	promoter	promoter	NN	NN	_	18	dobj	_	_
22	through	through	IN	IN	_	25	case	_	_
23	several	several	JJ	JJ	_	25	amod	_	_
24	E2F	e2f	NN	NN	_	25	compound	_	_
25	sites	site	NNS	NNS	_	18	nmod	_	_
26	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	5	det	_	_
2	major	major	JJ	JJ	_	5	amod	_	_
3	putative	putative	JJ	JJ	_	5	amod	_	_
4	downstream	downstream	JJ	JJ	_	5	amod	_	_
5	site	site	NN	NN	_	15	nsubj	_	_
6	for	for	IN	IN	_	7	case	_	_
7	E2F	e2f	NN	NN	_	5	nmod	_	_
8	,	,	,	,	_	5	punct	_	_
9	located	located	JJ	JJ	_	5	amod	_	_
10	in	in	IN	IN	_	13	case	_	_
11	the	the	DT	DT	_	13	det	_	_
12	first	first	JJ	JJ	_	13	amod	_	_
13	exon	exon	NN	NN	_	9	nmod	_	_
14	,	,	,	,	_	5	punct	_	_
15	serves	serve	VBZ	VBZ	_	0	root	_	_
16	as	as	IN	IN	_	18	case	_	_
17	a	a	DT	DT	_	18	det	_	_
18	target	target	NN	NN	_	15	nmod	_	_
19	for	for	IN	IN	_	22	case	_	_
20	E2F-1/DP1	e2f-1/dp1	NN	NN	_	21	compound	_	_
21	complex	complex	NN	NN	_	22	compound	_	_
22	binding	binding	NN	NN	_	18	nmod	_	_
23	in	in	FW	FW	_	24	compound	_	_
24	vitro	vitro	FW	FW	_	22	advmod	_	_
25	.	.	.	.	_	15	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	provide	provide	VBP	VBP	_	0	root	_	_
4	evidence	evidence	NN	NN	_	3	dobj	_	_
5	for	for	IN	IN	_	8	case	_	_
6	the	the	DT	DT	_	8	det	_	_
7	functional	functional	JJ	JJ	_	8	amod	_	_
8	relationship	relationship	NN	NN	_	4	nmod	_	_
9	between	between	IN	IN	_	14	case	_	_
10	the	the	DT	DT	_	14	det	_	_
11	cyclin-like	cyclin-like	JJ	JJ	_	14	amod	_	_
12	UDG	udg	NN	NN	_	14	compound	_	_
13	gene	gene	NN	NN	_	14	compound	_	_
14	product	product	NN	NN	_	8	nmod	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	E2F	e2f	NN	NN	_	14	conj	_	_
17	.	.	.	.	_	3	punct	_	_

1	High	high	JJ	JJ	_	2	amod	_	_
2	levels	level	NNS	NNS	_	11	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	UDG	udg	NN	NN	_	5	compound	_	_
5	expression	expression	NN	NN	_	2	nmod	_	_
6	in	in	IN	IN	_	10	case	_	_
7	a	a	DT	DT	_	10	det	_	_
8	transient	transient	JJ	JJ	_	10	amod	_	_
9	transfection	transfection	NN	NN	_	10	compound	_	_
10	assay	assay	NN	NN	_	2	nmod	_	_
11	result	result	VBP	VBP	_	0	root	_	_
12	in	in	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	det	_	_
14	down-regulation	down-regulation	NN	NN	_	11	nmod	_	_
15	of	of	IN	IN	_	17	case	_	_
16	transcriptional	transcriptional	JJ	JJ	_	17	amod	_	_
17	activity	activity	NN	NN	_	14	nmod	_	_
18	through	through	IN	IN	_	19	case	_	_
19	elements	element	NNS	NNS	_	17	nmod	_	_
20	specific	specific	JJ	JJ	_	19	amod	_	_
21	for	for	IN	IN	_	23	case	_	_
22	E2F-mediated	e2f-mediated	JJ	JJ	_	23	amod	_	_
23	transcription	transcription	NN	NN	_	20	nmod	_	_
24	.	.	.	.	_	11	punct	_	_

1	Overexpression	overexpression	NN	NN	_	9	nsubjpass	_	_
2	of	of	IN	IN	_	3	case	_	_
3	UDG	udg	NN	NN	_	1	nmod	_	_
4	in	in	IN	IN	_	7	case	_	_
5	Saos	saos	NN	NN	_	7	compound	_	_
6	2	2	CD	CD	_	7	nummod	_	_
7	cells	cell	NNS	NNS	_	1	nmod	_	_
8	was	be	VBD	VBD	_	9	auxpass	_	_
9	observed	observe	VBN	VBN	_	0	root	_	_
10	to	to	TO	TO	_	11	mark	_	_
11	delay	delay	VB	VB	_	9	xcomp	_	_
12	growth	growth	NN	NN	_	11	dobj	_	_
13	late	late	RB	RB	_	11	advmod	_	_
14	in	in	IN	IN	_	16	case	_	_
15	G1	g1	NN	NN	_	16	compound	_	_
16	phase	phase	NN	NN	_	11	nmod	_	_
17	and	and	CC	CC	_	11	cc	_	_
18	transiently	transiently	RB	RB	_	19	advmod	_	_
19	arrest	arrest	VB	VB	_	11	conj	_	_
20	these	these	DT	DT	_	21	det	_	_
21	cells	cell	NNS	NNS	_	19	dobj	_	_
22	from	from	IN	IN	_	23	mark	_	_
23	progressing	progress	VBG	VBG	_	19	advcl	_	_
24	into	into	IN	IN	_	27	case	_	_
25	the	the	DT	DT	_	27	det	_	_
26	S	s	NN	NN	_	27	compound	_	_
27	phase	phase	NN	NN	_	23	nmod	_	_
28	.	.	.	.	_	9	punct	_	_

1	This	this	DT	DT	_	3	det	_	_
2	hypothetical	hypothetical	JJ	JJ	_	3	amod	_	_
3	model	model	NN	NN	_	4	nsubj	_	_
4	integrates	integrate	VBZ	VBZ	_	0	root	_	_
5	one	one	CD	CD	_	6	nummod	_	_
6	mechanism	mechanism	NN	NN	_	4	dobj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	DNA	dna	NN	NN	_	9	compound	_	_
9	repair	repair	NN	NN	_	6	nmod	_	_
10	with	with	IN	IN	_	14	case	_	_
11	the	the	DT	DT	_	14	det	_	_
12	cell	cell	NN	NN	_	14	compound	_	_
13	cycle	cycle	NN	NN	_	14	compound	_	_
14	control	control	NN	NN	_	4	nmod	_	_
15	of	of	IN	IN	_	17	case	_	_
16	gene	gene	NN	NN	_	17	compound	_	_
17	transcription	transcription	NN	NN	_	14	nmod	_	_
18	,	,	,	,	_	4	punct	_	_
19	likely	likely	RB	RB	_	21	advmod	_	_
20	through	through	IN	IN	_	21	case	_	_
21	E2F	e2f	NN	NN	_	4	nmod	_	_
22	.	.	.	.	_	4	punct	_	_

1	This	this	DT	DT	_	2	nsubj	_	_
2	implicates	implicate	VBZ	VBZ	_	0	root	_	_
3	E2F	e2f	NN	NN	_	2	dobj	_	_
4	as	as	IN	IN	_	7	case	_	_
5	a	a	DT	DT	_	7	det	_	_
6	multifunctional	multifunctional	JJ	JJ	_	7	amod	_	_
7	target	target	NN	NN	_	2	nmod	_	_
8	for	for	IN	IN	_	9	case	_	_
9	proteins	protein	NNS	NNS	_	7	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	enzymes	enzyme	NNS	NNS	_	9	conj	_	_
12	,	,	,	,	_	9	punct	_	_
13	possibly	possibly	RB	RB	_	9	advmod	_	_
14	,	,	,	,	_	9	punct	_	_
15	responsive	responsive	JJ	JJ	_	9	amod	_	_
16	to	to	TO	TO	_	18	case	_	_
17	DNA	dna	NN	NN	_	18	compound	_	_
18	damage	damage	NN	NN	_	15	nmod	_	_
19	through	through	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	negative	negative	JJ	JJ	_	22	amod	_	_
22	effect	effect	NN	NN	_	18	nmod	_	_
23	of	of	IN	IN	_	24	case	_	_
24	UDG	udg	NN	NN	_	22	nmod	_	_
25	on	on	IN	IN	_	28	case	_	_
26	E2F-mediated	e2f-mediated	JJ	JJ	_	28	amod	_	_
27	transcriptional	transcriptional	JJ	JJ	_	28	amod	_	_
28	activity	activity	NN	NN	_	22	nmod	_	_
29	.	.	.	.	_	2	punct	_	_

1	Aspirin	aspirin	NN	NN	_	2	nsubj	_	_
2	inhibits	inhibit	VBZ	VBZ	_	0	root	_	_
3	nuclear	nuclear	JJ	JJ	_	5	amod	_	_
4	factor-kappa	factor-kappa	NN	NN	_	5	compound	_	_
5	B	b	NN	NN	_	6	compound	_	_
6	mobilization	mobilization	NN	NN	_	2	dobj	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	monocyte	monocyte	NN	NN	_	9	compound	_	_
9	adhesion	adhesion	NN	NN	_	6	conj	_	_
10	in	in	IN	IN	_	14	case	_	_
11	stimulated	stimulate	VBN	VBN	_	14	amod	_	_
12	human	human	JJ	JJ	_	14	amod	_	_
13	endothelial	endothelial	JJ	JJ	_	14	amod	_	_
14	cells	cell	NNS	NNS	_	6	nmod	_	_
15	.	.	.	.	_	2	punct	_	_

1	BACKGROUND	background	NN	NN	_	0	root	_	_
2	:	:	:	:	_	1	punct	_	_
3	The	the	DT	DT	_	4	det	_	_
4	induction	induction	NN	NN	_	23	nsubjpass	_	_
5	of	of	IN	IN	_	9	case	_	_
6	vascular	vascular	JJ	JJ	_	9	amod	_	_
7	cell	cell	NN	NN	_	9	compound	_	_
8	adhesion	adhesion	NN	NN	_	9	compound	_	_
9	molecule-1	molecule-1	NN	NN	_	4	nmod	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	VCAM-1	vcam-1	NN	NN	_	9	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	and	and	CC	CC	_	9	cc	_	_
14	E-selectin	e-selectin	NN	NN	_	9	conj	_	_
15	by	by	IN	IN	_	18	case	_	_
16	tumor	tumor	NN	NN	_	18	compound	_	_
17	necrosis	necrosis	NN	NN	_	18	compound	_	_
18	factor-alpha	factor-alpha	NN	NN	_	4	nmod	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	TNF	tnf	NN	NN	_	18	appos	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	is	be	VBZ	VBZ	_	23	auxpass	_	_
23	mediated	mediate	VBN	VBN	_	1	dep	_	_
24	by	by	IN	IN	_	25	case	_	_
25	mobilization	mobilization	NN	NN	_	23	nmod	_	_
26	of	of	IN	IN	_	29	case	_	_
27	the	the	DT	DT	_	29	det	_	_
28	transcription	transcription	NN	NN	_	29	compound	_	_
29	factor	factor	NN	NN	_	25	nmod	_	_
30	nuclear	nuclear	JJ	JJ	_	32	amod	_	_
31	factor-kappa	factor-kappa	NN	NN	_	32	compound	_	_
32	B	b	NN	NN	_	29	dep	_	_
33	(	(	-LRB-	-LRB-	_	35	punct	_	_
34	NF-kappa	nf-kappa	NN	NN	_	35	compound	_	_
35	B	b	NN	NN	_	32	appos	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	.	.	.	.	_	23	punct	_	_

1	Since	since	IN	IN	_	5	mark	_	_
2	salicylates	salicylate	NNS	NNS	_	5	nsubjpass	_	_
3	have	have	VBP	VBP	_	5	aux	_	_
4	been	be	VBN	VBN	_	5	auxpass	_	_
5	reported	report	VBN	VBN	_	23	advcl	_	_
6	to	to	TO	TO	_	7	mark	_	_
7	inhibit	inhibit	VB	VB	_	5	xcomp	_	_
8	NF-kappa	nf-kappa	NN	NN	_	9	compound	_	_
9	B	b	NN	NN	_	10	compound	_	_
10	activation	activation	NN	NN	_	7	dobj	_	_
11	by	by	IN	IN	_	12	mark	_	_
12	preventing	prevent	VBG	VBG	_	7	advcl	_	_
13	the	the	DT	DT	_	14	det	_	_
14	degradation	degradation	NN	NN	_	12	dobj	_	_
15	of	of	IN	IN	_	17	case	_	_
16	its	its	PRP$	PRP$	_	17	nmod:poss	_	_
17	inhibitor	inhibitor	NN	NN	_	14	nmod	_	_
18	I	i	NN	NN	_	20	compound	_	_
19	kappa	kappa	NN	NN	_	20	compound	_	_
20	B	b	NN	NN	_	17	dep	_	_
21	,	,	,	,	_	23	punct	_	_
22	we	we	PRP	PRP	_	23	nsubj	_	_
23	studied	study	VBD	VBD	_	0	root	_	_
24	a	a	DT	DT	_	26	det	_	_
25	potential	potential	JJ	JJ	_	26	amod	_	_
26	inhibition	inhibition	NN	NN	_	23	dobj	_	_
27	of	of	IN	IN	_	29	case	_	_
28	this	this	DT	DT	_	29	det	_	_
29	pathway	pathway	NN	NN	_	26	nmod	_	_
30	by	by	IN	IN	_	31	case	_	_
31	acetylsalicylate	acetylsalicylate	NN	NN	_	26	nmod	_	_
32	(	(	-LRB-	-LRB-	_	33	punct	_	_
33	aspirin	aspirin	NN	NN	_	31	appos	_	_
34	)	)	-RRB-	-RRB-	_	33	punct	_	_
35	in	in	IN	IN	_	40	case	_	_
36	human	human	JJ	JJ	_	40	amod	_	_
37	umbilical	umbilical	JJ	JJ	_	40	amod	_	_
38	vein	vein	NN	NN	_	40	compound	_	_
39	endothelial	endothelial	JJ	JJ	_	40	amod	_	_
40	cells	cell	NNS	NNS	_	26	nmod	_	_
41	(	(	-LRB-	-LRB-	_	42	punct	_	_
42	HUVECs	huvec	NNS	NNS	_	40	appos	_	_
43	)	)	-RRB-	-RRB-	_	42	punct	_	_
44	.	.	.	.	_	23	punct	_	_

1	METHODS	method	NNS	NNS	_	0	root	_	_
2	AND	and	CC	CC	_	1	cc	_	_
3	RESULTS	result	NNS	NNS	_	1	conj	_	_
4	:	:	:	:	_	3	punct	_	_
5	Gel-shift	gel-shift	JJ	JJ	_	6	amod	_	_
6	analyses	analysis	NNS	NNS	_	7	nsubj	_	_
7	demonstrated	demonstrate	VBD	VBD	_	1	dep	_	_
8	dose-dependent	dose-dependent	JJ	JJ	_	9	amod	_	_
9	inhibition	inhibition	NN	NN	_	7	dobj	_	_
10	of	of	IN	IN	_	14	case	_	_
11	TNF-induced	tnf-induced	JJ	JJ	_	14	amod	_	_
12	NF-kappa	nf-kappa	NN	NN	_	13	compound	_	_
13	B	b	NN	NN	_	14	compound	_	_
14	mobilization	mobilization	NN	NN	_	9	nmod	_	_
15	by	by	IN	IN	_	16	case	_	_
16	aspirin	aspirin	NN	NN	_	9	nmod	_	_
17	at	at	IN	IN	_	18	case	_	_
18	concentrations	concentration	NNS	NNS	_	16	nmod	_	_
19	ranging	range	VBG	VBG	_	18	acl	_	_
20	from	from	IN	IN	_	23	advmod	_	_
21	1	1	CD	CD	_	23	compound	_	_
22	to	to	TO	TO	_	23	dep	_	_
23	10	10	CD	CD	_	24	nummod	_	_
24	mmol/L	mmol/l	NN	NN	_	19	dobj	_	_
25	.	.	.	.	_	1	punct	_	_

1	Induction	induction	NN	NN	_	12	nsubjpass	_	_
2	of	of	IN	IN	_	3	case	_	_
3	VCAM-1	vcam-1	NN	NN	_	1	nmod	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	E-selectin	e-selectin	NN	NN	_	3	conj	_	_
6	surface	surface	NN	NN	_	7	compound	_	_
7	expression	expression	NN	NN	_	3	dep	_	_
8	by	by	IN	IN	_	9	case	_	_
9	TNF	tnf	NN	NN	_	1	nmod	_	_
10	was	be	VBD	VBD	_	12	auxpass	_	_
11	dose-dependently	dose-dependently	RB	RB	_	12	advmod	_	_
12	reduced	reduce	VBN	VBN	_	0	root	_	_
13	by	by	IN	IN	_	14	case	_	_
14	aspirin	aspirin	NN	NN	_	12	nmod	_	_
15	over	over	IN	IN	_	18	case	_	_
16	the	the	DT	DT	_	18	det	_	_
17	same	same	JJ	JJ	_	18	amod	_	_
18	range	range	NN	NN	_	12	nmod	_	_
19	,	,	,	,	_	12	punct	_	_
20	while	while	IN	IN	_	31	mark	_	_
21	induction	induction	NN	NN	_	31	nsubjpass	_	_
22	of	of	IN	IN	_	25	case	_	_
23	intercellular	intercellular	JJ	JJ	_	25	amod	_	_
24	adhesion	adhesion	NN	NN	_	25	compound	_	_
25	molecule-1	molecule-1	NN	NN	_	21	nmod	_	_
26	(	(	-LRB-	-LRB-	_	27	punct	_	_
27	ICAM-1	icam-1	NN	NN	_	25	appos	_	_
28	)	)	-RRB-	-RRB-	_	27	punct	_	_
29	was	be	VBD	VBD	_	31	auxpass	_	_
30	hardly	hardly	RB	RB	_	31	advmod	_	_
31	affected	affect	VBN	VBN	_	12	advcl	_	_
32	.	.	.	.	_	12	punct	_	_

1	Aspirin	aspirin	NN	NN	_	2	nsubj	_	_
2	appeared	appear	VBD	VBD	_	0	root	_	_
3	to	to	TO	TO	_	4	mark	_	_
4	prevent	prevent	VB	VB	_	2	xcomp	_	_
5	VCAM-1	vcam-1	NN	NN	_	6	compound	_	_
6	transcription	transcription	NN	NN	_	4	dobj	_	_
7	,	,	,	,	_	2	punct	_	_
8	since	since	IN	IN	_	11	mark	_	_
9	it	it	PRP	PRP	_	11	nsubj	_	_
10	dose-dependently	dose-dependently	RB	RB	_	11	advmod	_	_
11	inhibited	inhibit	VBD	VBD	_	2	advcl	_	_
12	induction	induction	NN	NN	_	11	dobj	_	_
13	of	of	IN	IN	_	15	case	_	_
14	VCAM-1	vcam-1	NN	NN	_	15	compound	_	_
15	mRNA	mrna	NN	NN	_	12	nmod	_	_
16	by	by	IN	IN	_	17	case	_	_
17	TNF	tnf	NN	NN	_	12	nmod	_	_
18	.	.	.	.	_	2	punct	_	_

1	As	as	IN	IN	_	4	case	_	_
2	a	a	DT	DT	_	4	det	_	_
3	functional	functional	JJ	JJ	_	4	amod	_	_
4	consequence	consequence	NN	NN	_	15	nmod	_	_
5	,	,	,	,	_	15	punct	_	_
6	adhesion	adhesion	NN	NN	_	15	nsubjpass	_	_
7	of	of	IN	IN	_	9	case	_	_
8	U937	u937	NN	NN	_	9	compound	_	_
9	monocytes	monocyte	NNS	NNS	_	6	nmod	_	_
10	to	to	TO	TO	_	12	case	_	_
11	TNF-stimulated	tnf-stimulated	JJ	JJ	_	12	amod	_	_
12	HUVECs	huvec	NNS	NNS	_	6	nmod	_	_
13	was	be	VBD	VBD	_	15	auxpass	_	_
14	markedly	markedly	RB	RB	_	15	advmod	_	_
15	reduced	reduce	VBN	VBN	_	0	root	_	_
16	by	by	IN	IN	_	17	case	_	_
17	aspirin	aspirin	NN	NN	_	15	nmod	_	_
18	due	due	JJ	JJ	_	20	case	_	_
19	to	to	TO	TO	_	18	mwe	_	_
20	suppression	suppression	NN	NN	_	15	nmod	_	_
21	of	of	IN	IN	_	22	case	_	_
22	VCAM-1	vcam-1	NN	NN	_	20	nmod	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	E-selectin	e-selectin	NN	NN	_	22	conj	_	_
25	upregulation	upregulation	NN	NN	_	24	dep	_	_
26	.	.	.	.	_	15	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	effects	effect	NNS	NNS	_	7	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	aspirin	aspirin	NN	NN	_	2	nmod	_	_
5	were	be	VBD	VBD	_	7	cop	_	_
6	not	not	RB	RB	_	7	neg	_	_
7	related	related	JJ	JJ	_	0	root	_	_
8	to	to	TO	TO	_	10	case	_	_
9	the	the	DT	DT	_	10	det	_	_
10	inhibition	inhibition	NN	NN	_	7	nmod	_	_
11	of	of	IN	IN	_	13	case	_	_
12	cyclooxygenase	cyclooxygenase	NN	NN	_	13	compound	_	_
13	activity	activity	NN	NN	_	10	nmod	_	_
14	,	,	,	,	_	7	punct	_	_
15	since	since	IN	IN	_	18	mark	_	_
16	indomethacin	indomethacin	NN	NN	_	18	nsubj	_	_
17	was	be	VBD	VBD	_	18	cop	_	_
18	ineffective	ineffective	JJ	JJ	_	7	advcl	_	_
19	.	.	.	.	_	7	punct	_	_

1	CONCLUSIONS	conclusion	NNS	NNS	_	0	root	_	_
2	:	:	:	:	_	1	punct	_	_
3	Our	we	PRP$	PRP$	_	4	nmod:poss	_	_
4	data	datum	NNS	NNS	_	5	nsubj	_	_
5	suggest	suggest	VBP	VBP	_	1	dep	_	_
6	that	that	IN	IN	_	8	mark	_	_
7	aspirin	aspirin	NN	NN	_	8	nsubj	_	_
8	inhibits	inhibit	VBZ	VBZ	_	5	ccomp	_	_
9	NF-kappa	nf-kappa	NN	NN	_	10	compound	_	_
10	B	b	NN	NN	_	11	compound	_	_
11	mobilization	mobilization	NN	NN	_	8	dobj	_	_
12	,	,	,	,	_	11	punct	_	_
13	induction	induction	NN	NN	_	11	conj	_	_
14	of	of	IN	IN	_	15	case	_	_
15	VCAM-1	vcam-1	NN	NN	_	13	nmod	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	E-selectin	e-selectin	NN	NN	_	15	conj	_	_
18	,	,	,	,	_	11	punct	_	_
19	and	and	CC	CC	_	11	cc	_	_
20	subsequent	subsequent	JJ	JJ	_	22	amod	_	_
21	monocyte	monocyte	NN	NN	_	22	compound	_	_
22	adhesion	adhesion	NN	NN	_	11	conj	_	_
23	in	in	IN	IN	_	25	case	_	_
24	endothelial	endothelial	JJ	JJ	_	25	amod	_	_
25	cells	cell	NNS	NNS	_	11	nmod	_	_
26	stimulated	stimulate	VBN	VBN	_	25	acl	_	_
27	by	by	IN	IN	_	28	case	_	_
28	TNF	tnf	NN	NN	_	26	nmod	_	_
29	,	,	,	,	_	5	punct	_	_
30	thereby	thereby	RB	RB	_	31	advmod	_	_
31	providing	provide	VBG	VBG	_	5	xcomp	_	_
32	an	a	DT	DT	_	34	det	_	_
33	additional	additional	JJ	JJ	_	34	amod	_	_
34	mechanism	mechanism	NN	NN	_	31	dobj	_	_
35	for	for	IN	IN	_	37	case	_	_
36	therapeutic	therapeutic	JJ	JJ	_	37	amod	_	_
37	effects	effect	NNS	NNS	_	34	nmod	_	_
38	of	of	IN	IN	_	39	case	_	_
39	aspirin	aspirin	NN	NN	_	37	nmod	_	_
40	.	.	.	.	_	1	punct	_	_

1	Cross-linking	cross-linking	NN	NN	_	4	nsubj	_	_
2	of	of	IN	IN	_	3	case	_	_
3	CD30	cd30	NN	NN	_	1	nmod	_	_
4	induces	induce	VBZ	VBZ	_	0	root	_	_
5	HIV	hiv	NN	NN	_	6	compound	_	_
6	expression	expression	NN	NN	_	4	dobj	_	_
7	in	in	IN	IN	_	11	case	_	_
8	chronically	chronically	RB	RB	_	9	advmod	_	_
9	infected	infected	JJ	JJ	_	11	amod	_	_
10	T	t	NN	NN	_	11	compound	_	_
11	cells	cell	NNS	NNS	_	4	nmod	_	_
12	.	.	.	.	_	4	punct	_	_

1	CD30	cd30	NN	NN	_	17	nsubjpass	_	_
2	,	,	,	,	_	1	punct	_	_
3	a	a	DT	DT	_	4	det	_	_
4	member	member	NN	NN	_	1	appos	_	_
5	of	of	IN	IN	_	14	case	_	_
6	the	the	DT	DT	_	14	det	_	_
7	tumor	tumor	NN	NN	_	9	compound	_	_
8	necrosis	necrosis	NN	NN	_	9	compound	_	_
9	factor	factor	NN	NN	_	14	compound	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	TNF	tnf	NN	NN	_	9	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	receptor	receptor	NN	NN	_	14	compound	_	_
14	family	family	NN	NN	_	4	nmod	_	_
15	,	,	,	,	_	1	punct	_	_
16	is	be	VBZ	VBZ	_	17	auxpass	_	_
17	expressed	express	VBN	VBN	_	0	root	_	_
18	constitutively	constitutively	RB	RB	_	17	advmod	_	_
19	on	on	IN	IN	_	21	case	_	_
20	the	the	DT	DT	_	21	det	_	_
21	surface	surface	NN	NN	_	17	nmod	_	_
22	of	of	IN	IN	_	28	case	_	_
23	the	the	DT	DT	_	28	det	_	_
24	human	human	JJ	JJ	_	28	amod	_	_
25	T	t	NN	NN	_	28	compound	_	_
26	cell	cell	NN	NN	_	28	compound	_	_
27	line	line	NN	NN	_	28	compound	_	_
28	ACH-2	ach-2	NN	NN	_	21	nmod	_	_
29	,	,	,	,	_	28	punct	_	_
30	which	which	WDT	WDT	_	33	nsubjpass	_	_
31	is	be	VBZ	VBZ	_	33	auxpass	_	_
32	chronically	chronically	RB	RB	_	33	advmod	_	_
33	infected	infect	VBN	VBN	_	28	acl:relcl	_	_
34	with	with	IN	IN	_	40	case	_	_
35	human	human	JJ	JJ	_	40	amod	_	_
36	immunodeficiency	immunodeficiency	NN	NN	_	40	compound	_	_
37	virus	virus	NN	NN	_	40	compound	_	_
38	type-1	type-1	NN	NN	_	40	compound	_	_
39	(	(	-LRB-	-LRB-	_	40	punct	_	_
40	HIV	hiv	NN	NN	_	33	nmod	_	_
41	)	)	-RRB-	-RRB-	_	40	punct	_	_
42	-1	-1	CD	CD	_	40	nummod	_	_
43	.	.	.	.	_	17	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	26	mark	_	_
4	cross-linking	cross-linking	JJ	JJ	_	26	ccomp	_	_
5	CD30	cd30	NN	NN	_	4	dobj	_	_
6	with	with	IN	IN	_	10	case	_	_
7	an	a	DT	DT	_	10	det	_	_
8	anti-CD30-specific	anti-cd30-specific	JJ	JJ	_	10	amod	_	_
9	monoclonal	monoclonal	JJ	JJ	_	10	amod	_	_
10	antibody	antibody	NN	NN	_	4	nmod	_	_
11	,	,	,	,	_	10	punct	_	_
12	which	which	WDT	WDT	_	13	nsubj	_	_
13	mimics	mimic	VBZ	VBZ	_	10	acl:relcl	_	_
14	the	the	DT	DT	_	17	det	_	_
15	described	describe	VBN	VBN	_	17	amod	_	_
16	biological	biological	JJ	JJ	_	17	amod	_	_
17	activities	activity	NNS	NNS	_	13	dobj	_	_
18	of	of	IN	IN	_	21	case	_	_
19	the	the	DT	DT	_	21	det	_	_
20	CD30	cd30	NN	NN	_	21	compound	_	_
21	ligand	ligand	NN	NN	_	17	nmod	_	_
22	(	(	-LRB-	-LRB-	_	23	punct	_	_
23	CD30L	cd30l	NN	NN	_	21	appos	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	,	,	,	,	_	26	punct	_	_
26	results	result	VBZ	VBZ	_	2	ccomp	_	_
27	in	in	IN	IN	_	29	case	_	_
28	HIV	hiv	NN	NN	_	29	compound	_	_
29	expression	expression	NN	NN	_	26	nmod	_	_
30	.	.	.	.	_	2	punct	_	_

1	CD30	cd30	NN	NN	_	2	compound	_	_
2	cross-linking	cross-linking	NN	NN	_	5	nsubj	_	_
3	does	do	VBZ	VBZ	_	5	aux	_	_
4	not	not	RB	RB	_	5	neg	_	_
5	alter	alter	VB	VB	_	0	root	_	_
6	proliferation	proliferation	NN	NN	_	5	dobj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	ACH-2	ach-2	NN	NN	_	9	compound	_	_
9	cells	cell	NNS	NNS	_	6	nmod	_	_
10	and	and	CC	CC	_	5	cc	_	_
11	the	the	DT	DT	_	12	det	_	_
12	induction	induction	NN	NN	_	18	nsubjpass	_	_
13	of	of	IN	IN	_	15	case	_	_
14	HIV	hiv	NN	NN	_	15	compound	_	_
15	expression	expression	NN	NN	_	12	nmod	_	_
16	is	be	VBZ	VBZ	_	18	auxpass	_	_
17	not	not	RB	RB	_	18	neg	_	_
18	mediated	mediate	VBN	VBN	_	5	conj	_	_
19	by	by	IN	IN	_	22	case	_	_
20	endogenous	endogenous	JJ	JJ	_	22	amod	_	_
21	TNF	tnf	NN	NN	_	22	compound	_	_
22	alpha/beta	alpha/beta	NN	NN	_	18	nmod	_	_
23	.	.	.	.	_	5	punct	_	_

1	Furthermore	furthermore	RB	RB	_	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	cross-linking	cross-linking	NN	NN	_	6	nsubj	_	_
4	of	of	IN	IN	_	5	case	_	_
5	CD30	cd30	NN	NN	_	3	nmod	_	_
6	leads	lead	VBZ	VBZ	_	0	root	_	_
7	to	to	TO	TO	_	10	case	_	_
8	NF-kappa	nf-kappa	NN	NN	_	9	compound	_	_
9	B	b	NN	NN	_	10	compound	_	_
10	activation	activation	NN	NN	_	6	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	enhanced	enhance	VBN	VBN	_	14	amod	_	_
13	HIV	hiv	NN	NN	_	14	compound	_	_
14	transcription	transcription	NN	NN	_	10	conj	_	_
15	.	.	.	.	_	6	punct	_	_

1	Thus	thus	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	CD30-CD30L	cd30-cd30l	JJ	JJ	_	4	amod	_	_
4	interactions	interaction	NNS	NNS	_	5	nsubj	_	_
5	mediate	mediate	VBP	VBP	_	0	root	_	_
6	the	the	DT	DT	_	7	det	_	_
7	induction	induction	NN	NN	_	5	dobj	_	_
8	of	of	IN	IN	_	10	case	_	_
9	HIV	hiv	NN	NN	_	10	compound	_	_
10	expression	expression	NN	NN	_	7	nmod	_	_
11	by	by	IN	IN	_	15	case	_	_
12	a	a	DT	DT	_	15	det	_	_
13	kappa	kappa	NN	NN	_	15	compound	_	_
14	B-dependent	b-dependent	JJ	JJ	_	15	amod	_	_
15	pathway	pathway	NN	NN	_	5	nmod	_	_
16	that	that	WDT	WDT	_	18	nsubj	_	_
17	is	be	VBZ	VBZ	_	18	cop	_	_
18	independent	independent	JJ	JJ	_	15	acl:relcl	_	_
19	of	of	IN	IN	_	20	case	_	_
20	TNF	tnf	NN	NN	_	18	nmod	_	_
21	.	.	.	.	_	5	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	mechanism	mechanism	NN	NN	_	5	nsubj	_	_
3	may	may	MD	MD	_	5	aux	_	_
4	be	be	VB	VB	_	5	cop	_	_
5	important	important	JJ	JJ	_	0	root	_	_
6	in	in	IN	IN	_	8	case	_	_
7	the	the	DT	DT	_	8	det	_	_
8	activation	activation	NN	NN	_	5	nmod	_	_
9	of	of	IN	IN	_	11	case	_	_
10	HIV	hiv	NN	NN	_	11	compound	_	_
11	expression	expression	NN	NN	_	8	nmod	_	_
12	from	from	IN	IN	_	17	case	_	_
13	latently	latently	RB	RB	_	14	advmod	_	_
14	infected	infected	JJ	JJ	_	17	amod	_	_
15	CD4+	cd4+	JJ	JJ	_	17	amod	_	_
16	T	t	NN	NN	_	17	compound	_	_
17	cells	cell	NNS	NNS	_	8	nmod	_	_
18	,	,	,	,	_	17	punct	_	_
19	especially	especially	RB	RB	_	22	advmod	_	_
20	in	in	IN	IN	_	22	case	_	_
21	lymphoid	lymphoid	JJ	JJ	_	22	amod	_	_
22	organs	organ	NNS	NNS	_	17	nmod	_	_
23	where	where	WRB	WRB	_	29	advmod	_	_
24	cell	cell	NN	NN	_	27	compound	_	_
25	to	to	TO	TO	_	26	case	_	_
26	cell	cell	NN	NN	_	24	nmod	_	_
27	contact	contact	NN	NN	_	29	nsubj	_	_
28	is	be	VBZ	VBZ	_	29	cop	_	_
29	conducive	conducive	JJ	JJ	_	22	acl:relcl	_	_
30	to	to	TO	TO	_	32	case	_	_
31	receptor-ligand	receptor-ligand	JJ	JJ	_	32	amod	_	_
32	interactions	interaction	NNS	NNS	_	29	nmod	_	_
33	.	.	.	.	_	5	punct	_	_

1	Integrin-mediated	integrin-mediated	JJ	JJ	_	3	amod	_	_
2	tyrosine	tyrosine	NN	NN	_	3	compound	_	_
3	phosphorylation	phosphorylation	NN	NN	_	0	root	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	cytokine	cytokine	NN	NN	_	7	compound	_	_
6	message	message	NN	NN	_	7	compound	_	_
7	induction	induction	NN	NN	_	3	conj	_	_
8	in	in	IN	IN	_	10	case	_	_
9	monocytic	monocytic	JJ	JJ	_	10	amod	_	_
10	cells	cell	NNS	NNS	_	3	nmod	_	_
11	.	.	.	.	_	3	punct	_	_

1	A	a	DT	DT	_	4	det	_	_
2	possible	possible	JJ	JJ	_	4	amod	_	_
3	signaling	signaling	NN	NN	_	4	compound	_	_
4	role	role	NN	NN	_	0	root	_	_
5	for	for	IN	IN	_	9	case	_	_
6	the	the	DT	DT	_	9	det	_	_
7	Syk	syk	NN	NN	_	9	compound	_	_
8	tyrosine	tyrosine	NN	NN	_	9	compound	_	_
9	kinase	kinase	NN	NN	_	4	nmod	_	_
10	.	.	.	.	_	4	punct	_	_

1	Activation	activation	NN	NN	_	9	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	cytoplasmic	cytoplasmic	JJ	JJ	_	5	amod	_	_
4	tyrosine	tyrosine	NN	NN	_	5	compound	_	_
5	kinases	kinase	NNS	NNS	_	1	nmod	_	_
6	is	be	VBZ	VBZ	_	9	cop	_	_
7	an	a	DT	DT	_	9	det	_	_
8	important	important	JJ	JJ	_	9	amod	_	_
9	aspect	aspect	NN	NN	_	0	root	_	_
10	of	of	IN	IN	_	12	case	_	_
11	signal	signal	NN	NN	_	12	compound	_	_
12	transduction	transduction	NN	NN	_	9	nmod	_	_
13	mediated	mediate	VBN	VBN	_	12	acl	_	_
14	by	by	IN	IN	_	15	case	_	_
15	integrins	integrin	NNS	NNS	_	13	nmod	_	_
16	.	.	.	.	_	9	punct	_	_

1	In	in	IN	IN	_	7	case	_	_
2	the	the	DT	DT	_	7	det	_	_
3	human	human	JJ	JJ	_	7	amod	_	_
4	monocytic	monocytic	JJ	JJ	_	7	amod	_	_
5	cell	cell	NN	NN	_	7	compound	_	_
6	line	line	NN	NN	_	7	compound	_	_
7	THP-1	thp-1	NN	NN	_	23	nmod	_	_
8	,	,	,	,	_	23	punct	_	_
9	either	either	CC	CC	_	12	cc:preconj	_	_
10	integrin-dependent	integrin-dependent	JJ	JJ	_	12	amod	_	_
11	cell	cell	NN	NN	_	12	compound	_	_
12	adhesion	adhesion	NN	NN	_	23	nsubj	_	_
13	to	to	TO	TO	_	14	case	_	_
14	fibronectin	fibronectin	NN	NN	_	12	nmod	_	_
15	or	or	CC	CC	_	12	cc	_	_
16	ligation	ligation	NN	NN	_	12	conj	_	_
17	of	of	IN	IN	_	20	case	_	_
18	beta	beta	NN	NN	_	20	compound	_	_
19	1	1	CD	CD	_	20	nummod	_	_
20	integrins	integrin	NNS	NNS	_	16	nmod	_	_
21	with	with	IN	IN	_	22	case	_	_
22	antibodies	antibody	NNS	NNS	_	16	nmod	_	_
23	causes	cause	VBZ	VBZ	_	0	root	_	_
24	a	a	DT	DT	_	29	det	_	_
25	rapid	rapid	JJ	JJ	_	29	amod	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	intense	intense	JJ	JJ	_	25	conj	_	_
28	tyrosine	tyrosine	NN	NN	_	29	compound	_	_
29	phosphorylation	phosphorylation	NN	NN	_	23	dobj	_	_
30	of	of	IN	IN	_	32	case	_	_
31	two	two	CD	CD	_	32	nummod	_	_
32	sets	set	NNS	NNS	_	29	nmod	_	_
33	of	of	IN	IN	_	34	case	_	_
34	proteins	protein	NNS	NNS	_	32	nmod	_	_
35	of	of	IN	IN	_	37	case	_	_
36	about	about	RB	RB	_	37	advmod	_	_
37	65-75	65-75	CD	CD	_	34	nmod	_	_
38	and	and	CC	CC	_	37	cc	_	_
39	120-125	120-125	CD	CD	_	37	conj	_	_
40	kDa	kda	NN	NN	_	37	dep	_	_
41	.	.	.	.	_	23	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	addition	addition	NN	NN	_	6	nmod	_	_
3	,	,	,	,	_	6	punct	_	_
4	integrin	integrin	NN	NN	_	5	compound	_	_
5	ligation	ligation	NN	NN	_	6	nsubj	_	_
6	leads	lead	VBZ	VBZ	_	0	root	_	_
7	to	to	TO	TO	_	9	case	_	_
8	nuclear	nuclear	JJ	JJ	_	9	amod	_	_
9	translocation	translocation	NN	NN	_	6	nmod	_	_
10	of	of	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	p50	p50	NN	NN	_	9	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	p65	p65	NN	NN	_	15	compound	_	_
15	subunits	subunit	NNS	NNS	_	12	conj	_	_
16	of	of	IN	IN	_	21	case	_	_
17	the	the	DT	DT	_	21	det	_	_
18	NF-kappa	nf-kappa	NN	NN	_	21	compound	_	_
19	B	b	NN	NN	_	21	compound	_	_
20	transcription	transcription	NN	NN	_	21	compound	_	_
21	factor	factor	NN	NN	_	12	nmod	_	_
22	,	,	,	,	_	9	punct	_	_
23	to	to	TO	TO	_	24	case	_	_
24	activation	activation	NN	NN	_	9	conj	_	_
25	of	of	IN	IN	_	28	case	_	_
26	a	a	DT	DT	_	28	det	_	_
27	reporter	reporter	NN	NN	_	28	compound	_	_
28	gene	gene	NN	NN	_	24	nmod	_	_
29	driven	drive	VBN	VBN	_	24	acl	_	_
30	by	by	IN	IN	_	32	case	_	_
31	a	a	DT	DT	_	32	det	_	_
32	promoter	promoter	NN	NN	_	29	nmod	_	_
33	containing	contain	VBG	VBG	_	32	acl	_	_
34	NF-kappa	nf-kappa	NN	NN	_	36	compound	_	_
35	B	b	NN	NN	_	36	compound	_	_
36	sites	site	NNS	NNS	_	33	dobj	_	_
37	,	,	,	,	_	9	punct	_	_
38	and	and	CC	CC	_	9	cc	_	_
39	to	to	TO	TO	_	41	case	_	_
40	increased	increase	VBN	VBN	_	41	amod	_	_
41	levels	level	NNS	NNS	_	9	conj	_	_
42	of	of	IN	IN	_	43	case	_	_
43	mRNAs	mrna	NNS	NNS	_	41	nmod	_	_
44	for	for	IN	IN	_	46	case	_	_
45	immediate-early	immediate-early	JJ	JJ	_	46	amod	_	_
46	genes	gene	NNS	NNS	_	43	nmod	_	_
47	,	,	,	,	_	46	punct	_	_
48	including	include	VBG	VBG	_	56	case	_	_
49	the	the	DT	DT	_	56	det	_	_
50	cytokine	cytokine	NN	NN	_	56	compound	_	_
51	interleukin	interleukin	NN	NN	_	56	compound	_	_
52	(	(	-LRB-	-LRB-	_	56	punct	_	_
53	IL	il	NN	NN	_	56	compound	_	_
54	)	)	-RRB-	-RRB-	_	56	punct	_	_
55	-1	-1	CD	CD	_	56	nummod	_	_
56	beta	beta	NN	NN	_	46	nmod	_	_
57	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	tyrosine	tyrosine	NN	NN	_	4	compound	_	_
3	kinase	kinase	NN	NN	_	4	compound	_	_
4	inhibitors	inhibitor	NNS	NNS	_	9	nsubj	_	_
5	genistein	genistein	NN	NN	_	4	dep	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	herbimycin	herbimycin	NN	NN	_	8	compound	_	_
8	A	a	NN	NN	_	5	conj	_	_
9	block	block	VBP	VBP	_	0	root	_	_
10	both	both	CC	CC	_	13	cc:preconj	_	_
11	integrin-mediated	integrin-mediated	JJ	JJ	_	13	amod	_	_
12	tyrosine	tyrosine	NN	NN	_	13	compound	_	_
13	phosphorylation	phosphorylation	NN	NN	_	9	dobj	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	increases	increase	NNS	NNS	_	13	conj	_	_
16	in	in	IN	IN	_	20	case	_	_
17	IL-1	il-1	NN	NN	_	18	compound	_	_
18	beta	beta	NN	NN	_	20	compound	_	_
19	message	message	NN	NN	_	20	compound	_	_
20	levels	level	NNS	NNS	_	15	nmod	_	_
21	,	,	,	,	_	9	punct	_	_
22	indicating	indicate	VBG	VBG	_	9	advcl	_	_
23	a	a	DT	DT	_	25	det	_	_
24	causal	causal	JJ	JJ	_	25	amod	_	_
25	relationship	relationship	NN	NN	_	22	dobj	_	_
26	between	between	IN	IN	_	29	case	_	_
27	the	the	DT	DT	_	29	det	_	_
28	two	two	CD	CD	_	29	nummod	_	_
29	events	event	NNS	NNS	_	25	nmod	_	_
30	.	.	.	.	_	9	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	components	component	NNS	NNS	_	9	nsubj	_	_
3	tyrosine	tyrosine	NN	NN	_	4	dep	_	_
4	phosphorylated	phosphorylate	VBN	VBN	_	2	acl	_	_
5	subsequent	subsequent	JJ	JJ	_	4	xcomp	_	_
6	to	to	TO	TO	_	8	case	_	_
7	cell	cell	NN	NN	_	8	compound	_	_
8	adhesion	adhesion	NN	NN	_	5	nmod	_	_
9	include	include	VBP	VBP	_	0	root	_	_
10	paxillin	paxillin	NN	NN	_	9	dobj	_	_
11	,	,	,	,	_	10	punct	_	_
12	pp125FAK	pp125fak	NN	NN	_	10	conj	_	_
13	,	,	,	,	_	10	punct	_	_
14	and	and	CC	CC	_	10	cc	_	_
15	the	the	DT	DT	_	21	det	_	_
16	SH2	sh2	NN	NN	_	21	compound	_	_
17	domain	domain	NN	NN	_	21	compound	_	_
18	containing	contain	VBG	VBG	_	21	amod	_	_
19	tyrosine	tyrosine	NN	NN	_	21	compound	_	_
20	kinase	kinase	NN	NN	_	21	compound	_	_
21	Syk	syk	NN	NN	_	10	conj	_	_
22	.	.	.	.	_	9	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	8	nmod	_	_
3	,	,	,	,	_	8	punct	_	_
4	integrin	integrin	NN	NN	_	5	compound	_	_
5	ligation	ligation	NN	NN	_	8	nsubj	_	_
6	with	with	IN	IN	_	7	case	_	_
7	antibodies	antibody	NNS	NNS	_	5	nmod	_	_
8	induces	induce	VBZ	VBZ	_	0	root	_	_
9	tyrosine	tyrosine	NN	NN	_	10	compound	_	_
10	phosphorylation	phosphorylation	NN	NN	_	8	dobj	_	_
11	of	of	IN	IN	_	12	case	_	_
12	Syk	syk	NN	NN	_	10	nmod	_	_
13	but	but	CC	CC	_	12	cc	_	_
14	not	not	RB	RB	_	16	neg	_	_
15	of	of	IN	IN	_	16	case	_	_
16	FAK	fak	NN	NN	_	12	conj	_	_
17	or	or	CC	CC	_	16	cc	_	_
18	paxillin	paxillin	NN	NN	_	16	conj	_	_
19	.	.	.	.	_	8	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	adhering	adhering	JJ	JJ	_	3	amod	_	_
3	cells	cell	NNS	NNS	_	9	nmod	_	_
4	,	,	,	,	_	9	punct	_	_
5	pre-treatment	pre-treatment	NN	NN	_	9	nsubj	_	_
6	with	with	IN	IN	_	8	case	_	_
7	cytochalasin	cytochalasin	NN	NN	_	8	compound	_	_
8	D	d	NN	NN	_	5	nmod	_	_
9	suppresses	suppress	VBZ	VBZ	_	0	root	_	_
10	tyrosine	tyrosine	NN	NN	_	11	compound	_	_
11	phosphorylation	phosphorylation	NN	NN	_	9	dobj	_	_
12	of	of	IN	IN	_	13	case	_	_
13	FAK	fak	NN	NN	_	11	nmod	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	paxillin	paxillin	NN	NN	_	13	conj	_	_
16	but	but	CC	CC	_	13	cc	_	_
17	not	not	RB	RB	_	19	neg	_	_
18	of	of	IN	IN	_	19	case	_	_
19	Syk	syk	NN	NN	_	13	conj	_	_
20	,	,	,	,	_	9	punct	_	_
21	while	while	IN	IN	_	27	mark	_	_
22	IL-1	il-1	NN	NN	_	23	compound	_	_
23	beta	beta	NN	NN	_	25	compound	_	_
24	message	message	NN	NN	_	25	compound	_	_
25	induction	induction	NN	NN	_	27	nsubj	_	_
26	is	be	VBZ	VBZ	_	27	cop	_	_
27	unaffected	unaffected	JJ	JJ	_	9	advcl	_	_
28	.	.	.	.	_	9	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	observations	observation	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	13	mark	_	_
5	the	the	DT	DT	_	8	det	_	_
6	Syk	syk	NN	NN	_	8	compound	_	_
7	tyrosine	tyrosine	NN	NN	_	8	compound	_	_
8	kinase	kinase	NN	NN	_	13	nsubj	_	_
9	may	may	MD	MD	_	13	aux	_	_
10	be	be	VB	VB	_	13	cop	_	_
11	an	a	DT	DT	_	13	det	_	_
12	important	important	JJ	JJ	_	13	amod	_	_
13	component	component	NN	NN	_	3	ccomp	_	_
14	of	of	IN	IN	_	18	case	_	_
15	an	a	DT	DT	_	18	det	_	_
16	integrin	integrin	NN	NN	_	18	compound	_	_
17	signaling	signaling	NN	NN	_	18	compound	_	_
18	pathway	pathway	NN	NN	_	13	nmod	_	_
19	in	in	IN	IN	_	21	case	_	_
20	monocytic	monocytic	JJ	JJ	_	21	amod	_	_
21	cells	cell	NNS	NNS	_	18	nmod	_	_
22	,	,	,	,	_	18	punct	_	_
23	leading	lead	VBG	VBG	_	18	acl	_	_
24	to	to	TO	TO	_	25	case	_	_
25	activation	activation	NN	NN	_	23	nmod	_	_
26	of	of	IN	IN	_	28	case	_	_
27	NF-kappa	nf-kappa	NN	NN	_	28	compound	_	_
28	B	b	NN	NN	_	25	nmod	_	_
29	and	and	CC	CC	_	25	cc	_	_
30	to	to	TO	TO	_	32	case	_	_
31	increased	increase	VBN	VBN	_	32	amod	_	_
32	levels	level	NNS	NNS	_	25	conj	_	_
33	of	of	IN	IN	_	35	case	_	_
34	cytokine	cytokine	NN	NN	_	35	compound	_	_
35	messages	message	NNS	NNS	_	32	nmod	_	_
36	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	Ah	ah	NN	NN	_	3	compound	_	_
3	receptor	receptor	NN	NN	_	4	nsubj	_	_
4	recognizes	recognize	VBZ	VBZ	_	0	root	_	_
5	DNA	dna	NN	NN	_	7	compound	_	_
6	binding	binding	NN	NN	_	7	compound	_	_
7	sites	site	NNS	NNS	_	4	dobj	_	_
8	for	for	IN	IN	_	13	case	_	_
9	the	the	DT	DT	_	13	det	_	_
10	B	b	NN	NN	_	13	compound	_	_
11	cell	cell	NN	NN	_	13	compound	_	_
12	transcription	transcription	NN	NN	_	13	compound	_	_
13	factor	factor	NN	NN	_	7	nmod	_	_
14	,	,	,	,	_	13	punct	_	_
15	BSAP	bsap	NN	NN	_	13	appos	_	_
16	:	:	:	:	_	4	punct	_	_
17	a	a	DT	DT	_	19	det	_	_
18	possible	possible	JJ	JJ	_	19	amod	_	_
19	mechanism	mechanism	NN	NN	_	4	dep	_	_
20	for	for	IN	IN	_	22	case	_	_
21	dioxin-mediated	dioxin-mediated	JJ	JJ	_	22	amod	_	_
22	alteration	alteration	NN	NN	_	19	nmod	_	_
23	of	of	IN	IN	_	26	case	_	_
24	CD19	cd19	NN	NN	_	25	compound	_	_
25	gene	gene	NN	NN	_	26	compound	_	_
26	expression	expression	NN	NN	_	22	nmod	_	_
27	in	in	IN	IN	_	30	case	_	_
28	human	human	JJ	JJ	_	30	amod	_	_
29	B	b	NN	NN	_	30	compound	_	_
30	lymphocytes	lymphocyte	NNS	NNS	_	26	nmod	_	_
31	.	.	.	.	_	4	punct	_	_

1	2,3,7,8-tetrachlorodibenzo-p-dioxin	2,3,7,8-tetrachlorodibenzo-p-dioxin	NN	NN	_	5	nsubj	_	_
2	(	(	-LRB-	-LRB-	_	3	punct	_	_
3	TCDD	tcdd	NN	NN	_	1	appos	_	_
4	)	)	-RRB-	-RRB-	_	3	punct	_	_
5	inhibits	inhibit	VBZ	VBZ	_	0	root	_	_
6	murine	murine	JJ	JJ	_	5	dobj	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	human	human	JJ	JJ	_	6	conj	_	_
9	B	b	NN	NN	_	12	compound	_	_
10	lymphocyte	lymphocyte	NN	NN	_	12	compound	_	_
11	immunoglobulin	immunoglobulin	NN	NN	_	12	compound	_	_
12	production	production	NN	NN	_	6	dep	_	_
13	through	through	IN	IN	_	16	case	_	_
14	an	a	DT	DT	_	16	det	_	_
15	unknown	unknown	JJ	JJ	_	16	amod	_	_
16	mechanism	mechanism	NN	NN	_	5	nmod	_	_
17	.	.	.	.	_	5	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	study	study	NN	NN	_	3	nsubj	_	_
3	investigated	investigate	VBD	VBD	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	effect	effect	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	7	case	_	_
7	TCDD	tcdd	NN	NN	_	5	nmod	_	_
8	on	on	IN	IN	_	9	case	_	_
9	expression	expression	NN	NN	_	5	nmod	_	_
10	of	of	IN	IN	_	13	case	_	_
11	the	the	DT	DT	_	13	det	_	_
12	CD19	cd19	NN	NN	_	13	compound	_	_
13	gene	gene	NN	NN	_	9	nmod	_	_
14	in	in	IN	IN	_	20	case	_	_
15	a	a	DT	DT	_	20	det	_	_
16	human	human	JJ	JJ	_	20	amod	_	_
17	B	b	NN	NN	_	20	compound	_	_
18	lymphocyte	lymphocyte	NN	NN	_	20	compound	_	_
19	cell	cell	NN	NN	_	20	compound	_	_
20	line	line	NN	NN	_	9	nmod	_	_
21	.	.	.	.	_	3	punct	_	_

1	Northern	northern	NN	NN	_	3	compound	_	_
2	blot	blot	NN	NN	_	3	compound	_	_
3	analysis	analysis	NN	NN	_	4	nsubj	_	_
4	showed	show	VBD	VBD	_	0	root	_	_
5	that	that	IN	IN	_	8	mark	_	_
6	TCDD	tcdd	NN	NN	_	7	compound	_	_
7	treatment	treatment	NN	NN	_	8	nsubj	_	_
8	decreased	decrease	VBD	VBD	_	4	ccomp	_	_
9	steady	steady	JJ	JJ	_	11	amod	_	_
10	state	state	NN	NN	_	11	compound	_	_
11	levels	level	NNS	NNS	_	8	dobj	_	_
12	of	of	IN	IN	_	14	case	_	_
13	CD19	cd19	NN	NN	_	14	compound	_	_
14	mRNA	mrna	NN	NN	_	11	nmod	_	_
15	by	by	IN	IN	_	17	case	_	_
16	67	67	CD	CD	_	17	nummod	_	_
17	%	%	NN	NN	_	8	nmod	_	_
18	in	in	IN	IN	_	22	case	_	_
19	the	the	DT	DT	_	22	det	_	_
20	IM-9	im-9	NN	NN	_	22	compound	_	_
21	cell	cell	NN	NN	_	22	compound	_	_
22	line	line	NN	NN	_	8	nmod	_	_
23	.	.	.	.	_	4	punct	_	_

1	Using	use	VBG	VBG	_	0	root	_	_
2	a	a	DT	DT	_	6	det	_	_
3	gel	gel	NN	NN	_	6	compound	_	_
4	mobility	mobility	NN	NN	_	6	compound	_	_
5	shift	shift	NN	NN	_	6	compound	_	_
6	assay	assay	NN	NN	_	1	dobj	_	_
7	,	,	,	,	_	1	punct	_	_
8	we	we	PRP	PRP	_	9	nsubj	_	_
9	identified	identify	VBD	VBD	_	1	parataxis	_	_
10	a	a	DT	DT	_	12	det	_	_
11	DNA-binding	dna-binding	NN	NN	_	12	compound	_	_
12	complex	complex	NN	NN	_	9	dobj	_	_
13	in	in	IN	IN	_	16	case	_	_
14	IM-9	im-9	NN	NN	_	16	compound	_	_
15	nuclear	nuclear	JJ	JJ	_	16	amod	_	_
16	extracts	extract	NNS	NNS	_	12	nmod	_	_
17	that	that	WDT	WDT	_	21	nsubj	_	_
18	by	by	IN	IN	_	20	case	_	_
19	several	several	JJ	JJ	_	20	amod	_	_
20	criteria	criterion	NNS	NNS	_	21	nmod	_	_
21	appears	appear	VBZ	VBZ	_	12	acl:relcl	_	_
22	to	to	TO	TO	_	26	mark	_	_
23	be	be	VB	VB	_	26	cop	_	_
24	the	the	DT	DT	_	26	det	_	_
25	Ah	ah	NN	NN	_	26	compound	_	_
26	receptor	receptor	NN	NN	_	21	xcomp	_	_
27	.	.	.	.	_	1	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	addition	addition	NN	NN	_	8	nmod	_	_
3	,	,	,	,	_	8	punct	_	_
4	the	the	DT	DT	_	7	det	_	_
5	Ah	ah	NN	NN	_	7	compound	_	_
6	receptor	receptor	NN	NN	_	7	compound	_	_
7	complex	complex	NN	NN	_	8	nsubj	_	_
8	recognized	recognize	VBD	VBD	_	0	root	_	_
9	a	a	DT	DT	_	12	det	_	_
10	DNA	dna	NN	NN	_	12	compound	_	_
11	binding	binding	NN	NN	_	12	compound	_	_
12	site	site	NN	NN	_	8	dobj	_	_
13	for	for	IN	IN	_	18	case	_	_
14	B	b	NN	NN	_	18	compound	_	_
15	cell	cell	NN	NN	_	18	compound	_	_
16	lineage-specific	lineage-specific	JJ	JJ	_	18	amod	_	_
17	activator	activator	NN	NN	_	18	compound	_	_
18	protein	protein	NN	NN	_	12	nmod	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	BSAP	bsap	NN	NN	_	18	appos	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	in	in	IN	IN	_	25	case	_	_
23	the	the	DT	DT	_	25	det	_	_
24	promoter	promoter	NN	NN	_	25	compound	_	_
25	region	region	NN	NN	_	18	nmod	_	_
26	of	of	IN	IN	_	30	case	_	_
27	the	the	DT	DT	_	30	det	_	_
28	human	human	JJ	JJ	_	30	amod	_	_
29	CD19	cd19	NN	NN	_	30	compound	_	_
30	gene	gene	NN	NN	_	25	nmod	_	_
31	which	which	WDT	WDT	_	33	nsubj	_	_
32	is	be	VBZ	VBZ	_	33	cop	_	_
33	similar	similar	JJ	JJ	_	12	acl:relcl	_	_
34	to	to	TO	TO	_	41	case	_	_
35	the	the	DT	DT	_	41	det	_	_
36	consensus	consensus	NN	NN	_	41	compound	_	_
37	Ah	ah	NN	NN	_	41	compound	_	_
38	receptor	receptor	NN	NN	_	41	compound	_	_
39	DNA	dna	NN	NN	_	41	compound	_	_
40	binding	binding	NN	NN	_	41	compound	_	_
41	site	site	NN	NN	_	33	nmod	_	_
42	.	.	.	.	_	8	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	8	mark	_	_
5	the	the	DT	DT	_	6	det	_	_
6	AhR	ahr	NN	NN	_	8	nsubj	_	_
7	could	could	MD	MD	_	8	aux	_	_
8	interfere	interfere	VB	VB	_	3	ccomp	_	_
9	with	with	IN	IN	_	13	case	_	_
10	BSAP-stimulated	bsap-stimulated	JJ	JJ	_	13	amod	_	_
11	CD19	cd19	NN	NN	_	12	compound	_	_
12	gene	gene	NN	NN	_	13	compound	_	_
13	transcription	transcription	NN	NN	_	8	nmod	_	_
14	by	by	IN	IN	_	15	case	_	_
15	competition	competition	NN	NN	_	8	nmod	_	_
16	for	for	IN	IN	_	21	case	_	_
17	a	a	DT	DT	_	21	det	_	_
18	common	common	JJ	JJ	_	21	amod	_	_
19	DNA	dna	NN	NN	_	21	compound	_	_
20	binding	binding	NN	NN	_	21	compound	_	_
21	site	site	NN	NN	_	15	nmod	_	_
22	.	.	.	.	_	3	punct	_	_

1	Nitric	nitric	JJ	JJ	_	2	amod	_	_
2	oxide	oxide	NN	NN	_	3	nsubj	_	_
3	decreases	decrease	VBZ	VBZ	_	0	root	_	_
4	cytokine-induced	cytokine-induced	JJ	JJ	_	6	amod	_	_
5	endothelial	endothelial	JJ	JJ	_	6	amod	_	_
6	activation	activation	NN	NN	_	3	dobj	_	_
7	.	.	.	.	_	3	punct	_	_

1	Nitric	nitric	JJ	JJ	_	2	amod	_	_
2	oxide	oxide	NN	NN	_	4	nsubj	_	_
3	selectively	selectively	RB	RB	_	4	advmod	_	_
4	reduces	reduce	VBZ	VBZ	_	0	root	_	_
5	endothelial	endothelial	JJ	JJ	_	6	amod	_	_
6	expression	expression	NN	NN	_	4	dobj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	adhesion	adhesion	NN	NN	_	9	compound	_	_
9	molecules	molecule	NNS	NNS	_	6	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	proinflammatory	proinflammatory	JJ	JJ	_	12	amod	_	_
12	cytokines	cytokine	NNS	NNS	_	9	conj	_	_
13	.	.	.	.	_	4	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	test	test	VB	VB	_	0	root	_	_
3	the	the	DT	DT	_	4	det	_	_
4	hypothesis	hypothesis	NN	NN	_	2	dobj	_	_
5	that	that	IN	IN	_	11	mark	_	_
6	nitric	nitric	JJ	JJ	_	7	amod	_	_
7	oxide	oxide	NN	NN	_	11	nsubj	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	NO	no	NN	NN	_	7	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	limits	limit	VBZ	VBZ	_	4	ccomp	_	_
12	endothelial	endothelial	JJ	JJ	_	13	amod	_	_
13	activation	activation	NN	NN	_	11	dobj	_	_
14	,	,	,	,	_	2	punct	_	_
15	we	we	PRP	PRP	_	16	nsubj	_	_
16	treated	treat	VBD	VBD	_	2	parataxis	_	_
17	cytokine-stimulated	cytokine-stimulated	JJ	JJ	_	22	amod	_	_
18	human	human	JJ	JJ	_	22	amod	_	_
19	saphenous	saphenous	JJ	JJ	_	22	amod	_	_
20	vein	vein	NN	NN	_	22	compound	_	_
21	endothelial	endothelial	JJ	JJ	_	22	amod	_	_
22	cells	cell	NNS	NNS	_	16	dobj	_	_
23	with	with	IN	IN	_	26	case	_	_
24	several	several	JJ	JJ	_	26	amod	_	_
25	NO	no	NN	NN	_	26	compound	_	_
26	donors	donor	NNS	NNS	_	16	nmod	_	_
27	and	and	CC	CC	_	16	cc	_	_
28	assessed	assess	VBD	VBD	_	16	conj	_	_
29	their	they	PRP$	PRP$	_	30	nmod:poss	_	_
30	effects	effect	NNS	NNS	_	28	dobj	_	_
31	on	on	IN	IN	_	34	case	_	_
32	the	the	DT	DT	_	34	det	_	_
33	inducible	inducible	JJ	JJ	_	34	amod	_	_
34	expression	expression	NN	NN	_	30	nmod	_	_
35	of	of	IN	IN	_	39	case	_	_
36	vascular	vascular	JJ	JJ	_	39	amod	_	_
37	cell	cell	NN	NN	_	39	compound	_	_
38	adhesion	adhesion	NN	NN	_	39	compound	_	_
39	molecule-1	molecule-1	NN	NN	_	34	nmod	_	_
40	(	(	-LRB-	-LRB-	_	41	punct	_	_
41	VCAM-1	vcam-1	NN	NN	_	39	appos	_	_
42	)	)	-RRB-	-RRB-	_	41	punct	_	_
43	.	.	.	.	_	2	punct	_	_

1	In	in	IN	IN	_	4	case	_	_
2	a	a	DT	DT	_	4	det	_	_
3	concentration-dependent	concentration-dependent	JJ	JJ	_	4	amod	_	_
4	manner	manner	NN	NN	_	7	nmod	_	_
5	,	,	,	,	_	7	punct	_	_
6	NO	no	NN	NN	_	7	nsubj	_	_
7	inhibited	inhibit	VBD	VBD	_	0	root	_	_
8	interleukin	interleukin	NN	NN	_	10	compound	_	_
9	(	(	-LRB-	-LRB-	_	10	punct	_	_
10	IL	il	NN	NN	_	15	compound	_	_
11	)	)	-RRB-	-RRB-	_	10	punct	_	_
12	-1	-1	CD	CD	_	10	nummod	_	_
13	alpha-stimulated	alpha-stimulated	JJ	JJ	_	15	amod	_	_
14	VCAM-1	vcam-1	NN	NN	_	15	compound	_	_
15	expression	expression	NN	NN	_	7	dobj	_	_
16	by	by	IN	IN	_	18	case	_	_
17	35-55	35-55	CD	CD	_	18	nummod	_	_
18	%	%	NN	NN	_	7	nmod	_	_
19	as	as	IN	IN	_	20	mark	_	_
20	determined	determine	VBN	VBN	_	7	advcl	_	_
21	by	by	IN	IN	_	25	case	_	_
22	cell	cell	NN	NN	_	25	compound	_	_
23	surface	surface	NN	NN	_	25	compound	_	_
24	enzyme	enzyme	NN	NN	_	25	compound	_	_
25	immunoassays	immunoassay	NNS	NNS	_	20	nmod	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	flow	flow	NN	NN	_	28	compound	_	_
28	cytometry	cytometry	NN	NN	_	25	conj	_	_
29	.	.	.	.	_	7	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	inhibition	inhibition	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	paralleled	parallel	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	_	8	case	_	_
6	reduced	reduce	VBN	VBN	_	8	amod	_	_
7	monocyte	monocyte	NN	NN	_	8	compound	_	_
8	adhesion	adhesion	NN	NN	_	4	nmod	_	_
9	to	to	TO	TO	_	11	case	_	_
10	endothelial	endothelial	JJ	JJ	_	11	amod	_	_
11	monolayers	monolayer	NNS	NNS	_	8	nmod	_	_
12	in	in	IN	IN	_	14	case	_	_
13	nonstatic	nonstatic	JJ	JJ	_	14	amod	_	_
14	assays	assay	NNS	NNS	_	8	nmod	_	_
15	,	,	,	,	_	4	punct	_	_
16	was	be	VBD	VBD	_	17	cop	_	_
17	unaffected	unaffected	JJ	JJ	_	4	conj	_	_
18	by	by	IN	IN	_	20	case	_	_
19	cGMP	cgmp	NN	NN	_	20	compound	_	_
20	analogues	analogue	NNS	NNS	_	17	nmod	_	_
21	,	,	,	,	_	4	punct	_	_
22	and	and	CC	CC	_	4	cc	_	_
23	was	be	VBD	VBD	_	25	cop	_	_
24	quantitatively	quantitatively	RB	RB	_	25	advmod	_	_
25	similar	similar	JJ	JJ	_	4	conj	_	_
26	after	after	IN	IN	_	27	case	_	_
27	stimulation	stimulation	NN	NN	_	25	nmod	_	_
28	by	by	IN	IN	_	31	case	_	_
29	either	either	CC	CC	_	31	cc:preconj	_	_
30	IL-1	il-1	NN	NN	_	31	compound	_	_
31	alpha	alpha	NN	NN	_	27	nmod	_	_
32	,	,	,	,	_	31	punct	_	_
33	IL-1	il-1	NN	NN	_	34	compound	_	_
34	beta	beta	NN	NN	_	31	conj	_	_
35	,	,	,	,	_	31	punct	_	_
36	IL-4	il-4	NN	NN	_	31	conj	_	_
37	,	,	,	,	_	31	punct	_	_
38	tumor	tumor	NN	NN	_	40	compound	_	_
39	necrosis	necrosis	NN	NN	_	40	compound	_	_
40	factor	factor	NN	NN	_	31	conj	_	_
41	(	(	-LRB-	-LRB-	_	43	punct	_	_
42	TNF	tnf	NN	NN	_	43	compound	_	_
43	alpha	alpha	NN	NN	_	40	appos	_	_
44	)	)	-RRB-	-RRB-	_	43	punct	_	_
45	,	,	,	,	_	31	punct	_	_
46	or	or	CC	CC	_	31	cc	_	_
47	bacterial	bacterial	JJ	JJ	_	48	amod	_	_
48	lipopolysaccharide	lipopolysaccharide	NN	NN	_	31	conj	_	_
49	.	.	.	.	_	4	punct	_	_

1	NO	no	NN	NN	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	decreased	decrease	VBD	VBD	_	0	root	_	_
4	the	the	DT	DT	_	6	det	_	_
5	endothelial	endothelial	JJ	JJ	_	6	amod	_	_
6	expression	expression	NN	NN	_	3	dobj	_	_
7	of	of	IN	IN	_	11	case	_	_
8	other	other	JJ	JJ	_	11	amod	_	_
9	leukocyte	leukocyte	NN	NN	_	11	compound	_	_
10	adhesion	adhesion	NN	NN	_	11	compound	_	_
11	molecules	molecule	NNS	NNS	_	6	nmod	_	_
12	(	(	-LRB-	-LRB-	_	13	punct	_	_
13	E-selectin	e-selectin	NN	NN	_	11	dep	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	to	to	TO	TO	_	18	case	_	_
16	a	a	DT	DT	_	18	det	_	_
17	lesser	lesser	JJR	JJR	_	18	amod	_	_
18	extent	extent	NN	NN	_	13	conj	_	_
19	,	,	,	,	_	13	punct	_	_
20	intercellular	intercellular	JJ	JJ	_	22	amod	_	_
21	adhesion	adhesion	NN	NN	_	22	compound	_	_
22	molecule-1	molecule-1	NN	NN	_	13	conj	_	_
23	)	)	-RRB-	-RRB-	_	13	punct	_	_
24	and	and	CC	CC	_	11	cc	_	_
25	secretable	secretable	JJ	JJ	_	26	amod	_	_
26	cytokines	cytokine	NNS	NNS	_	11	conj	_	_
27	(	(	-LRB-	-LRB-	_	28	punct	_	_
28	IL-6	il-6	NN	NN	_	26	dep	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	IL-8	il-8	NN	NN	_	28	conj	_	_
31	)	)	-RRB-	-RRB-	_	28	punct	_	_
32	.	.	.	.	_	3	punct	_	_

1	Inhibition	inhibition	NN	NN	_	9	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	endogenous	endogenous	JJ	JJ	_	5	amod	_	_
4	NO	no	NN	NN	_	5	compound	_	_
5	production	production	NN	NN	_	1	nmod	_	_
6	by	by	IN	IN	_	7	case	_	_
7	L-N-monomethyl-arginine	l-n-monomethyl-arginine	NN	NN	_	1	nmod	_	_
8	also	also	RB	RB	_	9	advmod	_	_
9	induced	induce	VBD	VBD	_	0	root	_	_
10	the	the	DT	DT	_	11	det	_	_
11	expression	expression	NN	NN	_	9	dobj	_	_
12	of	of	IN	IN	_	13	case	_	_
13	VCAM-1	vcam-1	NN	NN	_	11	nmod	_	_
14	,	,	,	,	_	9	punct	_	_
15	but	but	CC	CC	_	9	cc	_	_
16	did	do	VBD	VBD	_	18	aux	_	_
17	not	not	RB	RB	_	18	neg	_	_
18	augment	augment	VB	VB	_	9	conj	_	_
19	cytokine-induced	cytokine-induced	JJ	JJ	_	21	amod	_	_
20	VCAM-1	vcam-1	NN	NN	_	21	compound	_	_
21	expression	expression	NN	NN	_	18	dobj	_	_
22	.	.	.	.	_	9	punct	_	_

1	Nuclear	nuclear	JJ	JJ	_	3	amod	_	_
2	run-on	run-on	JJ	JJ	_	3	amod	_	_
3	assays	assay	NNS	NNS	_	20	nsubj	_	_
4	,	,	,	,	_	3	punct	_	_
5	transfection	transfection	NN	NN	_	6	compound	_	_
6	studies	study	NNS	NNS	_	3	conj	_	_
7	using	use	VBG	VBG	_	6	acl	_	_
8	various	various	JJ	JJ	_	13	amod	_	_
9	VCAM-1	vcam-1	NN	NN	_	13	compound	_	_
10	promoter	promoter	NN	NN	_	13	compound	_	_
11	reporter	reporter	NN	NN	_	13	compound	_	_
12	gene	gene	NN	NN	_	13	compound	_	_
13	constructs	construct	NNS	NNS	_	7	dobj	_	_
14	,	,	,	,	_	3	punct	_	_
15	and	and	CC	CC	_	3	cc	_	_
16	electrophoretic	electrophoretic	JJ	JJ	_	19	amod	_	_
17	mobility	mobility	NN	NN	_	19	compound	_	_
18	shift	shift	NN	NN	_	19	compound	_	_
19	assays	assay	NNS	NNS	_	3	conj	_	_
20	indicated	indicate	VBD	VBD	_	0	root	_	_
21	that	that	IN	IN	_	23	mark	_	_
22	NO	no	NN	NN	_	23	nsubj	_	_
23	represses	repress	VBZ	VBZ	_	20	ccomp	_	_
24	VCAM-1	vcam-1	NN	NN	_	26	compound	_	_
25	gene	gene	NN	NN	_	26	compound	_	_
26	transcription	transcription	NN	NN	_	23	dobj	_	_
27	,	,	,	,	_	23	punct	_	_
28	in	in	IN	IN	_	29	case	_	_
29	part	part	NN	NN	_	23	nmod	_	_
30	,	,	,	,	_	23	punct	_	_
31	by	by	IN	IN	_	32	mark	_	_
32	inhibiting	inhibit	VBG	VBG	_	23	advcl	_	_
33	NF-kappa	nf-kappa	NN	NN	_	34	compound	_	_
34	B	b	NN	NN	_	32	dobj	_	_
35	.	.	.	.	_	20	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	propose	propose	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	16	mark	_	_
4	NO	no	NN	NN	_	6	nmod:poss	_	_
5	's	's	POS	POS	_	6	case	_	_
6	ability	ability	NN	NN	_	16	nsubj	_	_
7	to	to	TO	TO	_	8	mark	_	_
8	limit	limit	VB	VB	_	6	acl	_	_
9	endothelial	endothelial	JJ	JJ	_	10	amod	_	_
10	activation	activation	NN	NN	_	8	dobj	_	_
11	and	and	CC	CC	_	8	cc	_	_
12	inhibit	inhibit	VB	VB	_	8	conj	_	_
13	monocyte	monocyte	NN	NN	_	14	compound	_	_
14	adhesion	adhesion	NN	NN	_	12	dobj	_	_
15	may	may	MD	MD	_	16	aux	_	_
16	contribute	contribute	VB	VB	_	2	ccomp	_	_
17	to	to	TO	TO	_	18	case	_	_
18	some	some	DT	DT	_	16	nmod	_	_
19	of	of	IN	IN	_	21	case	_	_
20	its	its	PRP$	PRP$	_	21	nmod:poss	_	_
21	antiatherogenic	antiatherogenic	JJ	JJ	_	18	nmod	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	antiinflammatory	antiinflammatory	JJ	JJ	_	21	conj	_	_
24	properties	property	NNS	NNS	_	21	dep	_	_
25	within	within	IN	IN	_	28	case	_	_
26	the	the	DT	DT	_	28	det	_	_
27	vessel	vessel	NN	NN	_	28	compound	_	_
28	wall	wall	NN	NN	_	21	nmod	_	_
29	.	.	.	.	_	2	punct	_	_

1	Signalling	signalling	NN	NN	_	0	root	_	_
2	via	via	IN	IN	_	3	case	_	_
3	CD28	cd28	NN	NN	_	1	nmod	_	_
4	of	of	IN	IN	_	9	case	_	_
5	human	human	JJ	JJ	_	9	amod	_	_
6	naive	naive	JJ	JJ	_	9	amod	_	_
7	neonatal	neonatal	JJ	JJ	_	9	amod	_	_
8	T	t	NN	NN	_	9	compound	_	_
9	lymphocytes	lymphocyte	NNS	NNS	_	3	nmod	_	_
10	.	.	.	.	_	1	punct	_	_

1	Accessory	accessory	JJ	JJ	_	2	amod	_	_
2	molecules	molecule	NNS	NNS	_	3	nsubj	_	_
3	play	play	VBP	VBP	_	0	root	_	_
4	a	a	DT	DT	_	6	det	_	_
5	crucial	crucial	JJ	JJ	_	6	amod	_	_
6	role	role	NN	NN	_	3	dobj	_	_
7	in	in	IN	IN	_	9	case	_	_
8	the	the	DT	DT	_	9	det	_	_
9	development	development	NN	NN	_	3	nmod	_	_
10	of	of	IN	IN	_	14	case	_	_
11	the	the	DT	DT	_	14	det	_	_
12	T	t	NN	NN	_	14	compound	_	_
13	cell	cell	NN	NN	_	14	compound	_	_
14	response	response	NN	NN	_	9	nmod	_	_
15	to	to	TO	TO	_	17	case	_	_
16	antigenic	antigenic	JJ	JJ	_	17	amod	_	_
17	challenge	challenge	NN	NN	_	14	nmod	_	_
18	.	.	.	.	_	3	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	examined	examine	VBN	VBN	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	role	role	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	7	case	_	_
7	CD28	cd28	NN	NN	_	5	nmod	_	_
8	in	in	IN	IN	_	9	mark	_	_
9	modulating	modulate	VBG	VBG	_	5	acl	_	_
10	the	the	DT	DT	_	17	det	_	_
11	'	'	``	``	_	14	punct	_	_
12	naive	naive	JJ	JJ	_	14	amod	_	_
13	'	'	''	''	_	14	punct	_	_
14	neonatal	neonatal	JJ	JJ	_	17	amod	_	_
15	T	t	NN	NN	_	17	compound	_	_
16	cell	cell	NN	NN	_	17	compound	_	_
17	response	response	NN	NN	_	9	dobj	_	_
18	to	to	TO	TO	_	20	case	_	_
19	anti-CD2-mediated	anti-cd2-mediated	JJ	JJ	_	20	amod	_	_
20	activation	activation	NN	NN	_	17	nmod	_	_
21	.	.	.	.	_	3	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	compare	compare	VB	VB	_	0	root	_	_
3	the	the	DT	DT	_	4	det	_	_
4	role	role	NN	NN	_	2	dobj	_	_
5	of	of	IN	IN	_	6	case	_	_
6	CD28	cd28	NN	NN	_	4	nmod	_	_
7	,	,	,	,	_	2	punct	_	_
8	neonatal	neonatal	JJ	JJ	_	14	nsubjpass	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	adult	adult	JJ	JJ	_	12	amod	_	_
11	T	t	NN	NN	_	12	compound	_	_
12	cells	cell	NNS	NNS	_	8	conj	_	_
13	were	be	VBD	VBD	_	14	auxpass	_	_
14	stimulated	stimulate	VBN	VBN	_	2	parataxis	_	_
15	with	with	IN	IN	_	17	case	_	_
16	a	a	DT	DT	_	17	det	_	_
17	pair	pair	NN	NN	_	14	nmod	_	_
18	of	of	IN	IN	_	21	case	_	_
19	mitogenic	mitogenic	JJ	JJ	_	21	amod	_	_
20	anti-CD2	anti-cd2	JJ	JJ	_	21	amod	_	_
21	antibodies	antibody	NNS	NNS	_	17	nmod	_	_
22	in	in	IN	IN	_	24	case	_	_
23	the	the	DT	DT	_	24	dep	_	_
24	presence	presence	NN	NN	_	14	nmod	_	_
25	or	or	CC	CC	_	24	cc	_	_
26	absence	absence	NN	NN	_	24	conj	_	_
27	of	of	IN	IN	_	29	case	_	_
28	anti-CD28	anti-cd28	JJ	JJ	_	29	amod	_	_
29	MoAb	moab	NN	NN	_	24	nmod	_	_
30	.	.	.	.	_	2	punct	_	_

1	With	with	IN	IN	_	2	case	_	_
2	anti-CD2	anti-cd2	NN	NN	_	8	nmod	_	_
3	alone	alone	RB	RB	_	2	advmod	_	_
4	,	,	,	,	_	8	punct	_	_
5	neonatal	neonatal	JJ	JJ	_	7	amod	_	_
6	T	t	NN	NN	_	7	compound	_	_
7	cells	cell	NNS	NNS	_	8	nsubj	_	_
8	proliferated	proliferate	VBD	VBD	_	0	root	_	_
9	slightly	slightly	RB	RB	_	8	advmod	_	_
10	but	but	CC	CC	_	8	cc	_	_
11	produced	produce	VBD	VBD	_	8	conj	_	_
12	no	no	DT	DT	_	14	neg	_	_
13	detectable	detectable	JJ	JJ	_	14	amod	_	_
14	IL-2	il-2	NN	NN	_	11	dobj	_	_
15	,	,	,	,	_	8	punct	_	_
16	whereas	whereas	IN	IN	_	20	mark	_	_
17	adult	adult	JJ	JJ	_	19	amod	_	_
18	T	t	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	20	nsubj	_	_
20	proliferated	proliferate	VBD	VBD	_	8	advcl	_	_
21	vigorously	vigorously	RB	RB	_	20	advmod	_	_
22	,	,	,	,	_	20	punct	_	_
23	with	with	IN	IN	_	26	case	_	_
24	significant	significant	JJ	JJ	_	26	amod	_	_
25	IL-2	il-2	NN	NN	_	26	compound	_	_
26	production	production	NN	NN	_	20	nmod	_	_
27	.	.	.	.	_	8	punct	_	_

1	Costimulation	costimulation	NN	NN	_	6	nsubj	_	_
2	with	with	IN	IN	_	4	case	_	_
3	anti-CD28	anti-cd28	JJ	JJ	_	4	amod	_	_
4	MoAb	moab	NN	NN	_	1	nmod	_	_
5	greatly	greatly	RB	RB	_	6	advmod	_	_
6	enhanced	enhance	VBD	VBD	_	0	root	_	_
7	the	the	DT	DT	_	9	det	_	_
8	proliferative	proliferative	JJ	JJ	_	9	amod	_	_
9	response	response	NN	NN	_	6	dobj	_	_
10	of	of	IN	IN	_	13	case	_	_
11	neonatal	neonatal	JJ	JJ	_	13	amod	_	_
12	T	t	NN	NN	_	13	compound	_	_
13	cells	cell	NNS	NNS	_	9	nmod	_	_
14	to	to	TO	TO	_	15	case	_	_
15	levels	level	NNS	NNS	_	6	nmod	_	_
16	equivalent	equivalent	JJ	JJ	_	15	amod	_	_
17	to	to	TO	TO	_	18	case	_	_
18	those	those	DT	DT	_	16	nmod	_	_
19	of	of	IN	IN	_	22	case	_	_
20	adult	adult	JJ	JJ	_	22	amod	_	_
21	T	t	NN	NN	_	22	compound	_	_
22	cells	cell	NNS	NNS	_	18	nmod	_	_
23	,	,	,	,	_	6	punct	_	_
24	whereas	whereas	IN	IN	_	28	mark	_	_
25	adult	adult	JJ	JJ	_	27	amod	_	_
26	T	t	NN	NN	_	27	compound	_	_
27	cells	cell	NNS	NNS	_	28	nsubj	_	_
28	showed	show	VBD	VBD	_	6	advcl	_	_
29	only	only	RB	RB	_	30	advmod	_	_
30	slight	slight	JJ	JJ	_	31	amod	_	_
31	increases	increase	NNS	NNS	_	28	dobj	_	_
32	.	.	.	.	_	6	punct	_	_

1	Although	although	IN	IN	_	5	mark	_	_
2	IL-2	il-2	NN	NN	_	3	compound	_	_
3	secretion	secretion	NN	NN	_	5	nsubjpass	_	_
4	was	be	VBD	VBD	_	5	auxpass	_	_
5	increased	increase	VBN	VBN	_	18	advcl	_	_
6	in	in	IN	IN	_	8	case	_	_
7	the	the	DT	DT	_	8	det	_	_
8	presence	presence	NN	NN	_	5	nmod	_	_
9	of	of	IN	IN	_	11	case	_	_
10	anti-CD28	anti-cd28	JJ	JJ	_	11	amod	_	_
11	MoAb	moab	NN	NN	_	8	nmod	_	_
12	,	,	,	,	_	18	punct	_	_
13	neonatal	neonatal	JJ	JJ	_	15	amod	_	_
14	T	t	NN	NN	_	15	compound	_	_
15	cell	cell	NN	NN	_	17	compound	_	_
16	IL-2	il-2	NN	NN	_	17	compound	_	_
17	production	production	NN	NN	_	18	nsubj	_	_
18	remained	remain	VBD	VBD	_	0	root	_	_
19	lower	lower	JJR	JJR	_	18	xcomp	_	_
20	than	than	IN	IN	_	22	case	_	_
21	in	in	IN	IN	_	22	case	_	_
22	adults	adult	NNS	NNS	_	19	nmod	_	_
23	.	.	.	.	_	18	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	12	nmod	_	_
3	,	,	,	,	_	12	punct	_	_
4	enhancement	enhancement	NN	NN	_	12	nsubj	_	_
5	of	of	IN	IN	_	8	case	_	_
6	IL-2	il-2	NN	NN	_	7	compound	_	_
7	mRNA	mrna	NN	NN	_	8	compound	_	_
8	expression	expression	NN	NN	_	4	nmod	_	_
9	in	in	IN	IN	_	10	case	_	_
10	neonates	neonate	NNS	NNS	_	4	nmod	_	_
11	was	be	VBD	VBD	_	12	cop	_	_
12	similar	similar	JJ	JJ	_	0	root	_	_
13	to	to	TO	TO	_	15	case	_	_
14	adult	adult	JJ	JJ	_	15	amod	_	_
15	levels	level	NNS	NNS	_	12	nmod	_	_
16	.	.	.	.	_	12	punct	_	_

1	Anti-CD28	anti-cd28	JJ	JJ	_	3	amod	_	_
2	MoAb	moab	NN	NN	_	3	compound	_	_
3	costimulation	costimulation	NN	NN	_	4	nsubj	_	_
4	increased	increase	VBD	VBD	_	0	root	_	_
5	NF	nf	NN	NN	_	7	compound	_	_
6	kappa	kappa	NN	NN	_	7	compound	_	_
7	B	b	NN	NN	_	8	compound	_	_
8	levels	level	NNS	NNS	_	4	dobj	_	_
9	in	in	IN	IN	_	10	case	_	_
10	neonates	neonate	NNS	NNS	_	8	nmod	_	_
11	,	,	,	,	_	4	punct	_	_
12	albeit	albeit	IN	IN	_	14	case	_	_
13	to	to	TO	TO	_	14	case	_	_
14	levels	level	NNS	NNS	_	4	nmod	_	_
15	lower	lower	JJR	JJR	_	14	amod	_	_
16	than	than	IN	IN	_	17	case	_	_
17	that	that	DT	DT	_	15	nmod	_	_
18	of	of	IN	IN	_	19	case	_	_
19	adults	adult	NNS	NNS	_	17	nmod	_	_
20	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	cellular	cellular	JJ	JJ	_	3	amod	_	_
3	mechanism	mechanism	NN	NN	_	18	nsubj	_	_
4	governing	govern	VBG	VBG	_	3	acl	_	_
5	the	the	DT	DT	_	8	det	_	_
6	diminished	diminish	VBN	VBN	_	8	amod	_	_
7	proliferative	proliferative	JJ	JJ	_	8	amod	_	_
8	response	response	NN	NN	_	4	dobj	_	_
9	of	of	IN	IN	_	12	case	_	_
10	neonatal	neonatal	JJ	JJ	_	12	amod	_	_
11	T	t	NN	NN	_	12	compound	_	_
12	lymphocytes	lymphocyte	NNS	NNS	_	8	nmod	_	_
13	to	to	TO	TO	_	14	case	_	_
14	anti-CD2	anti-cd2	NN	NN	_	8	nmod	_	_
15	may	may	MD	MD	_	18	aux	_	_
16	therefore	therefore	RB	RB	_	18	advmod	_	_
17	be	be	VB	VB	_	18	cop	_	_
18	due	due	JJ	JJ	_	0	root	_	_
19	to	to	TO	TO	_	24	case	_	_
20	decreased	decrease	VBN	VBN	_	24	amod	_	_
21	NF	nf	NN	NN	_	23	compound	_	_
22	kappa	kappa	NN	NN	_	23	compound	_	_
23	B	b	NN	NN	_	24	compound	_	_
24	induction	induction	NN	NN	_	18	nmod	_	_
25	,	,	,	,	_	24	punct	_	_
26	reduced	reduce	VBN	VBN	_	29	amod	_	_
27	IL-2	il-2	NN	NN	_	28	compound	_	_
28	mRNA	mrna	NN	NN	_	29	compound	_	_
29	expression	expression	NN	NN	_	24	conj	_	_
30	and	and	CC	CC	_	24	cc	_	_
31	deficient	deficient	JJ	JJ	_	33	amod	_	_
32	IL-2	il-2	NN	NN	_	33	compound	_	_
33	production	production	NN	NN	_	24	conj	_	_
34	.	.	.	.	_	18	punct	_	_

1	Although	although	IN	IN	_	5	mark	_	_
2	anti-CD28	anti-cd28	JJ	JJ	_	3	amod	_	_
3	MoAb	moab	NN	NN	_	4	compound	_	_
4	costimulation	costimulation	NN	NN	_	5	nsubj	_	_
5	enhances	enhance	VBZ	VBZ	_	18	advcl	_	_
6	all	all	DT	DT	_	5	dobj	_	_
7	of	of	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	above	above	JJ	JJ	_	10	amod	_	_
10	signals	signal	NNS	NNS	_	6	nmod	_	_
11	,	,	,	,	_	18	punct	_	_
12	NF	nf	NN	NN	_	14	compound	_	_
13	kappa	kappa	NN	NN	_	14	compound	_	_
14	B	b	NN	NN	_	18	nsubj	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	IL-2	il-2	NN	NN	_	14	conj	_	_
17	levels	level	NNS	NNS	_	14	dep	_	_
18	remain	remain	VBP	VBP	_	0	root	_	_
19	lower	lower	JJR	JJR	_	18	xcomp	_	_
20	than	than	IN	IN	_	22	case	_	_
21	in	in	IN	IN	_	22	case	_	_
22	adults	adult	NNS	NNS	_	19	nmod	_	_
23	,	,	,	,	_	18	punct	_	_
24	suggesting	suggest	VBG	VBG	_	18	xcomp	_	_
25	the	the	DT	DT	_	26	det	_	_
26	need	need	NN	NN	_	24	dobj	_	_
27	for	for	IN	IN	_	30	case	_	_
28	further	further	JJ	JJ	_	30	amod	_	_
29	activation	activation	NN	NN	_	30	compound	_	_
30	requirements	requirement	NNS	NNS	_	26	nmod	_	_
31	in	in	IN	IN	_	33	case	_	_
32	the	the	DT	DT	_	33	det	_	_
33	neonate	neonate	NN	NN	_	30	nmod	_	_
34	.	.	.	.	_	18	punct	_	_

1	Regulation	regulation	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	11	case	_	_
3	human	human	JJ	JJ	_	6	amod	_	_
4	immunodeficiency	immunodeficiency	NN	NN	_	6	compound	_	_
5	virus	virus	NN	NN	_	6	compound	_	_
6	type	type	NN	NN	_	11	compound	_	_
7	1	1	CD	CD	_	6	nummod	_	_
8	and	and	CC	CC	_	6	cc	_	_
9	cytokine	cytokine	NN	NN	_	10	compound	_	_
10	gene	gene	NN	NN	_	6	conj	_	_
11	expression	expression	NN	NN	_	1	nmod	_	_
12	in	in	IN	IN	_	14	case	_	_
13	myeloid	myeloid	JJ	JJ	_	14	amod	_	_
14	cells	cell	NNS	NNS	_	11	nmod	_	_
15	by	by	IN	IN	_	18	case	_	_
16	NF-kappa	nf-kappa	NN	NN	_	18	compound	_	_
17	B	b	NN	NN	_	18	compound	_	_
18	/Rel	/rel	NN	NN	_	1	nmod	_	_
19	transcription	transcription	NN	NN	_	20	compound	_	_
20	factors	factor	NNS	NNS	_	18	dep	_	_
21	.	.	.	.	_	1	punct	_	_

1	CD4+	cd4+	JJ	JJ	_	2	amod	_	_
2	macrophages	macrophage	NNS	NNS	_	25	nsubj	_	_
3	in	in	IN	IN	_	4	case	_	_
4	tissues	tissue	NNS	NNS	_	2	nmod	_	_
5	such	such	JJ	JJ	_	7	case	_	_
6	as	as	IN	IN	_	5	mwe	_	_
7	lung	lung	NN	NN	_	4	nmod	_	_
8	,	,	,	,	_	7	punct	_	_
9	skin	skin	NN	NN	_	7	conj	_	_
10	,	,	,	,	_	7	punct	_	_
11	and	and	CC	CC	_	7	cc	_	_
12	lymph	lymph	NN	NN	_	13	compound	_	_
13	nodes	node	NNS	NNS	_	7	conj	_	_
14	,	,	,	,	_	4	punct	_	_
15	promyelocytic	promyelocytic	JJ	JJ	_	16	amod	_	_
16	cells	cell	NNS	NNS	_	4	appos	_	_
17	in	in	IN	IN	_	19	case	_	_
18	bone	bone	NN	NN	_	19	compound	_	_
19	marrow	marrow	NN	NN	_	16	nmod	_	_
20	,	,	,	,	_	16	punct	_	_
21	and	and	CC	CC	_	16	cc	_	_
22	peripheral	peripheral	JJ	JJ	_	24	amod	_	_
23	blood	blood	NN	NN	_	24	compound	_	_
24	monocytes	monocyte	NNS	NNS	_	16	conj	_	_
25	serve	serve	VBP	VBP	_	0	root	_	_
26	as	as	IN	IN	_	28	case	_	_
27	important	important	JJ	JJ	_	28	amod	_	_
28	targets	target	NNS	NNS	_	25	nmod	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	reservoirs	reservoir	NNS	NNS	_	28	conj	_	_
31	for	for	IN	IN	_	40	case	_	_
32	human	human	JJ	JJ	_	35	amod	_	_
33	immunodeficiency	immunodeficiency	NN	NN	_	35	compound	_	_
34	virus	virus	NN	NN	_	35	compound	_	_
35	type	type	NN	NN	_	40	compound	_	_
36	1	1	CD	CD	_	35	nummod	_	_
37	(	(	-LRB-	-LRB-	_	38	punct	_	_
38	HIV-1	hiv-1	NN	NN	_	35	appos	_	_
39	)	)	-RRB-	-RRB-	_	38	punct	_	_
40	replication	replication	NN	NN	_	28	nmod	_	_
41	.	.	.	.	_	25	punct	_	_

1	HIV-1-infected	hiv-1-infected	JJ	JJ	_	3	amod	_	_
2	myeloid	myeloid	JJ	JJ	_	3	amod	_	_
3	cells	cell	NNS	NNS	_	6	nsubjpass	_	_
4	are	be	VBP	VBP	_	6	auxpass	_	_
5	often	often	RB	RB	_	6	advmod	_	_
6	diminished	diminish	VBN	VBN	_	0	root	_	_
7	in	in	IN	IN	_	9	case	_	_
8	their	they	PRP$	PRP$	_	9	nmod:poss	_	_
9	ability	ability	NN	NN	_	6	nmod	_	_
10	to	to	TO	TO	_	11	mark	_	_
11	participate	participate	VB	VB	_	9	acl	_	_
12	in	in	IN	IN	_	13	case	_	_
13	chemotaxis	chemotaxis	NN	NN	_	11	nmod	_	_
14	,	,	,	,	_	13	punct	_	_
15	phagocytosis	phagocytosis	NN	NN	_	13	conj	_	_
16	,	,	,	,	_	13	punct	_	_
17	and	and	CC	CC	_	13	cc	_	_
18	intracellular	intracellular	JJ	JJ	_	19	amod	_	_
19	killing	killing	NN	NN	_	13	conj	_	_
20	.	.	.	.	_	6	punct	_	_

1	HIV-1	hiv-1	NN	NN	_	2	compound	_	_
2	infection	infection	NN	NN	_	7	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	myeloid	myeloid	JJ	JJ	_	5	amod	_	_
5	cells	cell	NNS	NNS	_	2	nmod	_	_
6	can	can	MD	MD	_	7	aux	_	_
7	lead	lead	VB	VB	_	0	root	_	_
8	to	to	TO	TO	_	10	case	_	_
9	the	the	DT	DT	_	10	det	_	_
10	expression	expression	NN	NN	_	7	nmod	_	_
11	of	of	IN	IN	_	13	case	_	_
12	surface	surface	NN	NN	_	13	compound	_	_
13	receptors	receptor	NNS	NNS	_	10	nmod	_	_
14	associated	associate	VBN	VBN	_	13	acl	_	_
15	with	with	IN	IN	_	17	case	_	_
16	cellular	cellular	JJ	JJ	_	17	amod	_	_
17	activation	activation	NN	NN	_	14	nmod	_	_
18	and/or	and/or	CC	CC	_	17	cc	_	_
19	differentiation	differentiation	NN	NN	_	17	conj	_	_
20	that	that	WDT	WDT	_	21	nsubj	_	_
21	increase	increase	VBP	VBP	_	10	acl:relcl	_	_
22	the	the	DT	DT	_	23	det	_	_
23	responsiveness	responsiveness	NN	NN	_	21	dobj	_	_
24	of	of	IN	IN	_	26	case	_	_
25	these	these	DT	DT	_	26	det	_	_
26	cells	cell	NNS	NNS	_	23	nmod	_	_
27	to	to	TO	TO	_	28	case	_	_
28	cytokines	cytokine	NNS	NNS	_	23	nmod	_	_
29	secreted	secrete	VBN	VBN	_	28	acl	_	_
30	by	by	IN	IN	_	32	case	_	_
31	neighboring	neighbor	VBG	VBG	_	32	amod	_	_
32	cells	cell	NNS	NNS	_	29	nmod	_	_
33	as	as	RB	RB	_	28	cc	_	_
34	well	well	RB	RB	_	33	mwe	_	_
35	as	as	IN	IN	_	33	mwe	_	_
36	to	to	TO	TO	_	37	case	_	_
37	bacteria	bacterium	NNS	NNS	_	28	conj	_	_
38	or	or	CC	CC	_	37	cc	_	_
39	other	other	JJ	JJ	_	40	amod	_	_
40	pathogens	pathogen	NNS	NNS	_	37	conj	_	_
41	.	.	.	.	_	7	punct	_	_

1	Enhancement	enhancement	NN	NN	_	6	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	HIV-1	hiv-1	NN	NN	_	4	compound	_	_
4	replication	replication	NN	NN	_	1	nmod	_	_
5	is	be	VBZ	VBZ	_	6	cop	_	_
6	related	related	JJ	JJ	_	0	root	_	_
7	in	in	IN	IN	_	8	case	_	_
8	part	part	NN	NN	_	6	nmod	_	_
9	to	to	TO	TO	_	12	case	_	_
10	increased	increase	VBN	VBN	_	12	amod	_	_
11	DNA-binding	dna-binding	JJ	JJ	_	12	amod	_	_
12	activity	activity	NN	NN	_	6	nmod	_	_
13	of	of	IN	IN	_	16	case	_	_
14	cellular	cellular	JJ	JJ	_	16	amod	_	_
15	transcription	transcription	NN	NN	_	16	compound	_	_
16	factors	factor	NNS	NNS	_	12	nmod	_	_
17	such	such	JJ	JJ	_	20	case	_	_
18	as	as	IN	IN	_	17	mwe	_	_
19	NF-kappa	nf-kappa	NN	NN	_	20	compound	_	_
20	B	b	NN	NN	_	16	nmod	_	_
21	.	.	.	.	_	6	punct	_	_

1	NF-kappa	nf-kappa	NN	NN	_	2	compound	_	_
2	B	b	NN	NN	_	3	nsubj	_	_
3	binds	bind	VBZ	VBZ	_	0	root	_	_
4	to	to	TO	TO	_	8	case	_	_
5	the	the	DT	DT	_	8	det	_	_
6	HIV-1	hiv-1	NN	NN	_	7	compound	_	_
7	enhancer	enhancer	NN	NN	_	8	compound	_	_
8	region	region	NN	NN	_	3	nmod	_	_
9	of	of	IN	IN	_	13	case	_	_
10	the	the	DT	DT	_	13	det	_	_
11	long	long	JJ	JJ	_	13	amod	_	_
12	terminal	terminal	JJ	JJ	_	13	amod	_	_
13	repeat	repeat	NN	NN	_	8	nmod	_	_
14	and	and	CC	CC	_	3	cc	_	_
15	contributes	contribute	VBZ	VBZ	_	3	conj	_	_
16	to	to	TO	TO	_	18	case	_	_
17	the	the	DT	DT	_	18	det	_	_
18	inducibility	inducibility	NN	NN	_	15	nmod	_	_
19	of	of	IN	IN	_	22	case	_	_
20	HIV-1	hiv-1	NN	NN	_	22	compound	_	_
21	gene	gene	NN	NN	_	22	compound	_	_
22	expression	expression	NN	NN	_	18	nmod	_	_
23	in	in	IN	IN	_	24	case	_	_
24	response	response	NN	NN	_	18	nmod	_	_
25	to	to	TO	TO	_	28	case	_	_
26	multiple	multiple	JJ	JJ	_	28	amod	_	_
27	activating	activate	VBG	VBG	_	28	amod	_	_
28	agents	agent	NNS	NNS	_	24	nmod	_	_
29	.	.	.	.	_	3	punct	_	_

1	Phosphorylation	phosphorylation	NN	NN	_	15	nsubj	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	degradation	degradation	NN	NN	_	1	conj	_	_
4	of	of	IN	IN	_	7	case	_	_
5	the	the	DT	DT	_	7	det	_	_
6	cytoplasmic	cytoplasmic	JJ	JJ	_	7	amod	_	_
7	inhibitor	inhibitor	NN	NN	_	1	nmod	_	_
8	I	i	NN	NN	_	10	compound	_	_
9	kappa	kappa	NN	NN	_	10	compound	_	_
10	B	b	NN	NN	_	11	compound	_	_
11	alpha	alpha	NN	NN	_	7	dep	_	_
12	are	be	VBP	VBP	_	15	cop	_	_
13	crucial	crucial	JJ	JJ	_	15	amod	_	_
14	regulatory	regulatory	JJ	JJ	_	15	amod	_	_
15	events	event	NNS	NNS	_	0	root	_	_
16	in	in	IN	IN	_	18	case	_	_
17	the	the	DT	DT	_	18	det	_	_
18	activation	activation	NN	NN	_	15	nmod	_	_
19	of	of	IN	IN	_	23	case	_	_
20	NF-kappa	nf-kappa	NN	NN	_	21	compound	_	_
21	B	b	NN	NN	_	23	compound	_	_
22	DNA-binding	dna-binding	JJ	JJ	_	23	amod	_	_
23	activity	activity	NN	NN	_	18	nmod	_	_
24	.	.	.	.	_	15	punct	_	_

1	Both	both	CC	CC	_	2	cc:preconj	_	_
2	N-	n-	NN	NN	_	12	nsubjpass	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	C-terminal	c-terminal	JJ	JJ	_	2	conj	_	_
5	residues	residue	NNS	NNS	_	2	dep	_	_
6	of	of	IN	IN	_	10	case	_	_
7	I	i	NN	NN	_	9	compound	_	_
8	kappa	kappa	NN	NN	_	9	compound	_	_
9	B	b	NN	NN	_	10	compound	_	_
10	alpha	alpha	NN	NN	_	2	nmod	_	_
11	are	be	VBP	VBP	_	12	auxpass	_	_
12	required	require	VBN	VBN	_	0	root	_	_
13	for	for	IN	IN	_	15	case	_	_
14	inducer-mediated	inducer-mediated	JJ	JJ	_	15	amod	_	_
15	degradation	degradation	NN	NN	_	12	nmod	_	_
16	.	.	.	.	_	12	punct	_	_

1	Chronic	chronic	JJ	JJ	_	3	amod	_	_
2	HIV-1	hiv-1	NN	NN	_	3	compound	_	_
3	infection	infection	NN	NN	_	7	nsubj	_	_
4	of	of	IN	IN	_	6	case	_	_
5	myeloid	myeloid	JJ	JJ	_	6	amod	_	_
6	cells	cell	NNS	NNS	_	3	nmod	_	_
7	leads	lead	VBZ	VBZ	_	0	root	_	_
8	to	to	TO	TO	_	13	case	_	_
9	constitutive	constitutive	JJ	JJ	_	13	amod	_	_
10	NF-kappa	nf-kappa	NN	NN	_	11	compound	_	_
11	B	b	NN	NN	_	13	compound	_	_
12	DNA-binding	dna-binding	JJ	JJ	_	13	amod	_	_
13	activity	activity	NN	NN	_	7	nmod	_	_
14	and	and	CC	CC	_	7	cc	_	_
15	provides	provide	VBZ	VBZ	_	7	conj	_	_
16	an	a	DT	DT	_	18	det	_	_
17	intranuclear	intranuclear	JJ	JJ	_	18	amod	_	_
18	environment	environment	NN	NN	_	15	dobj	_	_
19	capable	capable	JJ	JJ	_	18	amod	_	_
20	of	of	IN	IN	_	21	mark	_	_
21	perpetuating	perpetuate	VBG	VBG	_	19	advcl	_	_
22	HIV-1	hiv-1	NN	NN	_	23	compound	_	_
23	replication	replication	NN	NN	_	21	dobj	_	_
24	.	.	.	.	_	7	punct	_	_

1	Increased	increase	VBN	VBN	_	3	amod	_	_
2	intracellular	intracellular	JJ	JJ	_	3	amod	_	_
3	stores	store	NNS	NNS	_	10	nsubj	_	_
4	of	of	IN	IN	_	7	case	_	_
5	latent	latent	JJ	JJ	_	7	amod	_	_
6	NF-kappa	nf-kappa	NN	NN	_	7	compound	_	_
7	B	b	NN	NN	_	3	nmod	_	_
8	may	may	MD	MD	_	10	aux	_	_
9	also	also	RB	RB	_	10	advmod	_	_
10	result	result	VB	VB	_	0	root	_	_
11	in	in	IN	IN	_	13	case	_	_
12	rapid	rapid	JJ	JJ	_	13	amod	_	_
13	inducibility	inducibility	NN	NN	_	10	nmod	_	_
14	of	of	IN	IN	_	19	case	_	_
15	NF-kappa	nf-kappa	NN	NN	_	19	compound	_	_
16	B-dependent	b-dependent	JJ	JJ	_	19	amod	_	_
17	cytokine	cytokine	NN	NN	_	19	compound	_	_
18	gene	gene	NN	NN	_	19	compound	_	_
19	expression	expression	NN	NN	_	13	nmod	_	_
20	.	.	.	.	_	10	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	response	response	NN	NN	_	16	nmod	_	_
3	to	to	TO	TO	_	6	case	_	_
4	secondary	secondary	JJ	JJ	_	6	amod	_	_
5	pathogenic	pathogenic	JJ	JJ	_	6	amod	_	_
6	infections	infection	NNS	NNS	_	2	nmod	_	_
7	or	or	CC	CC	_	6	cc	_	_
8	antigenic	antigenic	JJ	JJ	_	9	amod	_	_
9	challenge	challenge	NN	NN	_	6	conj	_	_
10	,	,	,	,	_	16	punct	_	_
11	cytokine	cytokine	NN	NN	_	13	compound	_	_
12	gene	gene	NN	NN	_	13	compound	_	_
13	expression	expression	NN	NN	_	16	nsubj	_	_
14	is	be	VBZ	VBZ	_	16	cop	_	_
15	rapidly	rapidly	RB	RB	_	16	advmod	_	_
16	induced	induce	VBN	VBN	_	0	root	_	_
17	,	,	,	,	_	16	punct	_	_
18	enhanced	enhance	VBN	VBN	_	16	conj	_	_
19	,	,	,	,	_	16	punct	_	_
20	and	and	CC	CC	_	16	cc	_	_
21	sustained	sustained	JJ	JJ	_	16	conj	_	_
22	over	over	RP	RP	_	24	dep	_	_
23	prolonged	prolonged	JJ	JJ	_	24	amod	_	_
24	periods	period	NNS	NNS	_	21	nmod	_	_
25	in	in	IN	IN	_	28	case	_	_
26	HIV-1-infected	hiv-1-infected	JJ	JJ	_	28	amod	_	_
27	myeloid	myeloid	JJ	JJ	_	28	amod	_	_
28	cells	cell	NNS	NNS	_	16	dep	_	_
29	compared	compare	VBN	VBN	_	32	case	_	_
30	with	with	IN	IN	_	32	case	_	_
31	uninfected	uninfected	JJ	JJ	_	32	amod	_	_
32	cells	cell	NNS	NNS	_	16	dep	_	_
33	.	.	.	.	_	16	punct	_	_

1	Elevated	elevated	JJ	JJ	_	2	amod	_	_
2	levels	level	NNS	NNS	_	9	nsubjpass	_	_
3	of	of	IN	IN	_	6	case	_	_
4	several	several	JJ	JJ	_	6	amod	_	_
5	inflammatory	inflammatory	JJ	JJ	_	6	amod	_	_
6	cytokines	cytokine	NNS	NNS	_	2	nmod	_	_
7	have	have	VBP	VBP	_	9	aux	_	_
8	been	be	VBN	VBN	_	9	auxpass	_	_
9	detected	detect	VBN	VBN	_	0	root	_	_
10	in	in	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	sera	sera	NN	NN	_	9	nmod	_	_
13	of	of	IN	IN	_	15	case	_	_
14	HIV-1-infected	hiv-1-infected	JJ	JJ	_	15	amod	_	_
15	individuals	individual	NNS	NNS	_	12	nmod	_	_
16	.	.	.	.	_	9	punct	_	_

1	Secretion	secretion	NN	NN	_	8	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	myeloid	myeloid	JJ	JJ	_	5	amod	_	_
4	cell-derived	cell-derived	JJ	JJ	_	5	amod	_	_
5	cytokines	cytokine	NNS	NNS	_	1	nmod	_	_
6	may	may	MD	MD	_	8	aux	_	_
7	both	both	CC	CC	_	8	cc:preconj	_	_
8	increase	increase	VB	VB	_	0	root	_	_
9	virus	virus	NN	NN	_	10	compound	_	_
10	production	production	NN	NN	_	8	dobj	_	_
11	and	and	CC	CC	_	8	cc	_	_
12	contribute	contribute	VB	VB	_	8	conj	_	_
13	to	to	TO	TO	_	15	case	_	_
14	AIDS-associated	aids-associated	JJ	JJ	_	15	amod	_	_
15	disorders	disorder	NNS	NNS	_	12	nmod	_	_
16	.	.	.	.	_	8	punct	_	_

1	A	a	DT	DT	_	3	det	_	_
2	central	central	JJ	JJ	_	3	amod	_	_
3	role	role	NN	NN	_	0	root	_	_
4	for	for	IN	IN	_	9	case	_	_
5	a	a	DT	DT	_	9	det	_	_
6	single	single	JJ	JJ	_	9	amod	_	_
7	c-Myb	c-myb	NN	NN	_	9	compound	_	_
8	binding	binding	NN	NN	_	9	compound	_	_
9	site	site	NN	NN	_	3	nmod	_	_
10	in	in	IN	IN	_	15	case	_	_
11	a	a	DT	DT	_	15	det	_	_
12	thymic	thymic	JJ	JJ	_	15	amod	_	_
13	locus	locus	NN	NN	_	15	compound	_	_
14	control	control	NN	NN	_	15	compound	_	_
15	region	region	NN	NN	_	9	nmod	_	_
16	.	.	.	.	_	3	punct	_	_

1	Locus	locus	NN	NN	_	3	compound	_	_
2	control	control	NN	NN	_	3	compound	_	_
3	regions	region	NNS	NNS	_	9	nsubj	_	_
4	(	(	-LRB-	-LRB-	_	5	punct	_	_
5	LCRs	lcr	NNS	NNS	_	3	appos	_	_
6	)	)	-RRB-	-RRB-	_	5	punct	_	_
7	are	be	VBP	VBP	_	9	cop	_	_
8	powerful	powerful	JJ	JJ	_	9	amod	_	_
9	assemblies	assembly	NNS	NNS	_	0	root	_	_
10	of	of	IN	IN	_	12	case	_	_
11	cis	cis	JJ	JJ	_	12	amod	_	_
12	elements	element	NNS	NNS	_	9	nmod	_	_
13	that	that	WDT	WDT	_	14	nsubj	_	_
14	organize	organize	VBP	VBP	_	12	acl:relcl	_	_
15	the	the	DT	DT	_	16	det	_	_
16	actions	action	NNS	NNS	_	14	dobj	_	_
17	of	of	IN	IN	_	20	case	_	_
18	cell-type-specific	cell-type-specific	JJ	JJ	_	20	amod	_	_
19	trans-acting	trans-acting	JJ	JJ	_	20	amod	_	_
20	factors	factor	NNS	NNS	_	16	nmod	_	_
21	.	.	.	.	_	9	punct	_	_

1	A	a	DT	DT	_	3	det	_	_
2	2.3-kb	2.3-kb	JJ	JJ	_	3	amod	_	_
3	LCR	lcr	NN	NN	_	23	nsubjpass	_	_
4	in	in	IN	IN	_	14	case	_	_
5	the	the	DT	DT	_	14	det	_	_
6	human	human	JJ	JJ	_	14	amod	_	_
7	adenosine	adenosine	NN	NN	_	14	compound	_	_
8	deaminase	deaminase	NN	NN	_	14	compound	_	_
9	(	(	-LRB-	-LRB-	_	14	punct	_	_
10	ADA	ada	NN	NN	_	14	compound	_	_
11	)	)	-RRB-	-RRB-	_	14	punct	_	_
12	gene	gene	NN	NN	_	14	compound	_	_
13	first	first	JJ	JJ	_	14	amod	_	_
14	intron	intron	NN	NN	_	3	nmod	_	_
15	,	,	,	,	_	3	punct	_	_
16	which	which	WDT	WDT	_	17	nsubj	_	_
17	controls	control	VBZ	VBZ	_	3	acl:relcl	_	_
18	expression	expression	NN	NN	_	17	dobj	_	_
19	in	in	IN	IN	_	20	case	_	_
20	thymocytes	thymocyte	NNS	NNS	_	17	nmod	_	_
21	,	,	,	,	_	3	punct	_	_
22	is	be	VBZ	VBZ	_	23	auxpass	_	_
23	composed	compose	VBN	VBN	_	0	root	_	_
24	of	of	IN	IN	_	28	case	_	_
25	a	a	DT	DT	_	28	det	_	_
26	200-bp	200-bp	JJ	JJ	_	28	amod	_	_
27	enhancer	enhancer	NN	NN	_	28	compound	_	_
28	domain	domain	NN	NN	_	23	nmod	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	extended	extended	JJ	JJ	_	32	amod	_	_
31	flanking	flanking	NN	NN	_	32	compound	_	_
32	sequences	sequence	NNS	NNS	_	28	conj	_	_
33	that	that	WDT	WDT	_	34	nsubj	_	_
34	facilitate	facilitate	VBP	VBP	_	28	acl:relcl	_	_
35	activation	activation	NN	NN	_	34	dobj	_	_
36	from	from	IN	IN	_	38	case	_	_
37	within	within	IN	IN	_	38	case	_	_
38	chromatin	chromatin	NN	NN	_	34	nmod	_	_
39	.	.	.	.	_	23	punct	_	_

1	Prior	prior	RB	RB	_	2	advmod	_	_
2	analyses	analysis	NNS	NNS	_	4	nsubj	_	_
3	have	have	VBP	VBP	_	4	aux	_	_
4	demonstrated	demonstrate	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	8	mark	_	_
6	the	the	DT	DT	_	7	det	_	_
7	enhancer	enhancer	NN	NN	_	8	nsubj	_	_
8	contains	contain	VBZ	VBZ	_	4	ccomp	_	_
9	a	a	DT	DT	_	12	det	_	_
10	28-bp	28-bp	JJ	JJ	_	12	amod	_	_
11	core	core	NN	NN	_	12	compound	_	_
12	region	region	NN	NN	_	8	dobj	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	local	local	JJ	JJ	_	16	amod	_	_
15	adjacent	adjacent	JJ	JJ	_	16	amod	_	_
16	augmentative	augmentative	JJ	JJ	_	18	amod	_	_
17	cis	cis	JJ	JJ	_	18	amod	_	_
18	elements	element	NNS	NNS	_	12	conj	_	_
19	.	.	.	.	_	4	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	now	now	RB	RB	_	3	advmod	_	_
3	show	show	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	7	mark	_	_
5	the	the	DT	DT	_	6	det	_	_
6	core	core	NN	NN	_	7	nsubj	_	_
7	contains	contain	VBZ	VBZ	_	3	ccomp	_	_
8	a	a	DT	DT	_	13	det	_	_
9	single	single	JJ	JJ	_	13	amod	_	_
10	critical	critical	JJ	JJ	_	13	amod	_	_
11	c-Myb	c-myb	NN	NN	_	13	compound	_	_
12	binding	binding	NN	NN	_	13	compound	_	_
13	site	site	NN	NN	_	7	dobj	_	_
14	.	.	.	.	_	3	punct	_	_

1	In	in	IN	IN	_	6	case	_	_
2	both	both	CC	CC	_	6	cc:preconj	_	_
3	transiently	transiently	RB	RB	_	6	advmod	_	_
4	cotransfected	cotransfect	VBN	VBN	_	6	amod	_	_
5	human	human	JJ	JJ	_	6	amod	_	_
6	cells	cell	NNS	NNS	_	15	nmod	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	stable	stable	JJ	JJ	_	11	amod	_	_
9	chromatin-integrated	chromatin-integrated	JJ	JJ	_	11	amod	_	_
10	yeast	yeast	NN	NN	_	11	compound	_	_
11	cells	cell	NNS	NNS	_	6	conj	_	_
12	,	,	,	,	_	15	punct	_	_
13	c-Myb	c-myb	NN	NN	_	15	nsubj	_	_
14	strongly	strongly	RB	RB	_	15	advmod	_	_
15	transactivated	transactivate	VBD	VBD	_	0	root	_	_
16	reporter	reporter	NN	NN	_	17	compound	_	_
17	constructs	construct	NNS	NNS	_	15	dobj	_	_
18	that	that	WDT	WDT	_	19	nsubj	_	_
19	contained	contain	VBD	VBD	_	17	acl:relcl	_	_
20	polymerized	polymerized	JJ	JJ	_	22	amod	_	_
21	core	core	NN	NN	_	22	compound	_	_
22	sequences	sequence	NNS	NNS	_	19	dobj	_	_
23	.	.	.	.	_	15	punct	_	_

1	c-Myb	c-myb	NN	NN	_	2	compound	_	_
2	protein	protein	NN	NN	_	5	nsubj	_	_
3	was	be	VBD	VBD	_	5	cop	_	_
4	strongly	strongly	RB	RB	_	5	advmod	_	_
5	evident	evident	JJ	JJ	_	0	root	_	_
6	in	in	IN	IN	_	8	case	_	_
7	T	t	NN	NN	_	8	compound	_	_
8	lymphoblasts	lymphoblast	NNS	NNS	_	5	nmod	_	_
9	in	in	IN	IN	_	10	case	_	_
10	which	which	WDT	WDT	_	14	nmod	_	_
11	the	the	DT	DT	_	12	det	_	_
12	enhancer	enhancer	NN	NN	_	14	nsubj	_	_
13	was	be	VBD	VBD	_	14	cop	_	_
14	active	active	JJ	JJ	_	8	acl:relcl	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	was	be	VBD	VBD	_	17	cop	_	_
17	localized	localized	JJ	JJ	_	14	conj	_	_
18	within	within	IN	IN	_	21	case	_	_
19	discrete	discrete	JJ	JJ	_	21	amod	_	_
20	nuclear	nuclear	JJ	JJ	_	21	amod	_	_
21	structures	structure	NNS	NNS	_	17	nmod	_	_
22	.	.	.	.	_	5	punct	_	_

1	Fetal	fetal	JJ	JJ	_	3	amod	_	_
2	murine	murine	NN	NN	_	3	compound	_	_
3	thymus	thymus	NN	NN	_	4	nsubj	_	_
4	exhibited	exhibit	VBD	VBD	_	0	root	_	_
5	a	a	DT	DT	_	7	det	_	_
6	striking	striking	JJ	JJ	_	7	amod	_	_
7	concordance	concordance	NN	NN	_	4	dobj	_	_
8	of	of	IN	IN	_	11	case	_	_
9	endogenous	endogenous	JJ	JJ	_	11	amod	_	_
10	c-myb	c-myb	NN	NN	_	11	compound	_	_
11	expression	expression	NN	NN	_	7	nmod	_	_
12	with	with	IN	IN	_	13	case	_	_
13	that	that	DT	DT	_	7	nmod	_	_
14	of	of	IN	IN	_	16	case	_	_
15	mouse	mouse	NN	NN	_	16	compound	_	_
16	ADA	ada	NN	NN	_	13	nmod	_	_
17	and	and	CC	CC	_	13	cc	_	_
18	human	human	JJ	JJ	_	22	amod	_	_
19	ADA	ada	NN	NN	_	22	compound	_	_
20	LCR-directed	lcr-directed	JJ	JJ	_	22	amod	_	_
21	transgene	transgene	NN	NN	_	22	compound	_	_
22	expression	expression	NN	NN	_	13	conj	_	_
23	.	.	.	.	_	4	punct	_	_

1	Point	point	NN	NN	_	2	compound	_	_
2	mutation	mutation	NN	NN	_	13	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	c-Myb	c-myb	NN	NN	_	6	compound	_	_
6	site	site	NN	NN	_	2	nmod	_	_
7	within	within	IN	IN	_	11	case	_	_
8	the	the	DT	DT	_	11	det	_	_
9	intact	intact	JJ	JJ	_	11	amod	_	_
10	2.3-kb	2.3-kb	JJ	JJ	_	11	amod	_	_
11	LCR	lcr	NN	NN	_	6	nmod	_	_
12	severely	severely	RB	RB	_	13	advmod	_	_
13	attenuated	attenuate	VBD	VBD	_	0	root	_	_
14	enhancer	enhancer	NN	NN	_	15	compound	_	_
15	activity	activity	NN	NN	_	13	dobj	_	_
16	in	in	IN	IN	_	17	case	_	_
17	transfections	transfection	NNS	NNS	_	15	nmod	_	_
18	and	and	CC	CC	_	15	cc	_	_
19	LCR	lcr	NN	NN	_	20	compound	_	_
20	activity	activity	NN	NN	_	15	conj	_	_
21	in	in	IN	IN	_	23	case	_	_
22	transgenic	transgenic	JJ	JJ	_	23	amod	_	_
23	thymocytes	thymocyte	NNS	NNS	_	20	nmod	_	_
24	.	.	.	.	_	13	punct	_	_

1	Within	within	IN	IN	_	3	case	_	_
2	the	the	DT	DT	_	3	det	_	_
3	context	context	NN	NN	_	13	nmod	_	_
4	of	of	IN	IN	_	7	case	_	_
5	a	a	DT	DT	_	7	det	_	_
6	complex	complex	NN	NN	_	7	compound	_	_
7	enhancer	enhancer	NN	NN	_	3	nmod	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	LCR	lcr	NN	NN	_	7	conj	_	_
10	,	,	,	,	_	13	punct	_	_
11	c-Myb	c-myb	NN	NN	_	13	nsubj	_	_
12	can	can	MD	MD	_	13	aux	_	_
13	act	act	VB	VB	_	0	root	_	_
14	as	as	IN	IN	_	16	case	_	_
15	an	a	DT	DT	_	16	det	_	_
16	organizer	organizer	NN	NN	_	13	nmod	_	_
17	of	of	IN	IN	_	20	case	_	_
18	thymocyte-specific	thymocyte-specific	JJ	JJ	_	19	amod	_	_
19	gene	gene	NN	NN	_	20	compound	_	_
20	expression	expression	NN	NN	_	16	nmod	_	_
21	via	via	IN	IN	_	25	case	_	_
22	a	a	DT	DT	_	25	det	_	_
23	single	single	JJ	JJ	_	25	amod	_	_
24	binding	bind	VBG	VBG	_	25	amod	_	_
25	site	site	NN	NN	_	13	nmod	_	_
26	.	.	.	.	_	13	punct	_	_

1	Immunosuppression	immunosuppression	NN	NN	_	0	root	_	_
2	by	by	IN	IN	_	3	case	_	_
3	glucocorticoids	glucocorticoid	NNS	NNS	_	1	nmod	_	_
4	:	:	:	:	_	1	punct	_	_
5	inhibition	inhibition	NN	NN	_	1	dep	_	_
6	of	of	IN	IN	_	9	case	_	_
7	NF-kappa	nf-kappa	NN	NN	_	8	compound	_	_
8	B	b	NN	NN	_	9	compound	_	_
9	activity	activity	NN	NN	_	5	nmod	_	_
10	through	through	IN	IN	_	11	case	_	_
11	induction	induction	NN	NN	_	5	nmod	_	_
12	of	of	IN	IN	_	16	case	_	_
13	I	i	NN	NN	_	15	compound	_	_
14	kappa	kappa	NN	NN	_	15	compound	_	_
15	B	b	NN	NN	_	16	compound	_	_
16	synthesis	synthesis	NN	NN	_	11	nmod	_	_
17	-LSB-	-lsb-	-LRB-	-LRB-	_	18	punct	_	_
18	see	see	VB	VB	_	1	dep	_	_
19	comments	comment	NNS	NNS	_	18	dobj	_	_
20	-RSB-	-rsb-	-RRB-	-RRB-	_	18	punct	_	_

1	Glucocorticoids	glucocorticoid	NNS	NNS	_	10	nsubj	_	_
2	are	be	VBP	VBP	_	10	cop	_	_
3	among	among	IN	IN	_	10	case	_	_
4	the	the	DT	DT	_	10	det	_	_
5	most	most	RBS	RBS	_	6	advmod	_	_
6	potent	potent	JJ	JJ	_	10	amod	_	_
7	anti-inflammatory	anti-inflammatory	JJ	JJ	_	10	amod	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	immunosuppressive	immunosuppressive	JJ	JJ	_	7	conj	_	_
10	agents	agent	NNS	NNS	_	0	root	_	_
11	.	.	.	.	_	10	punct	_	_

1	They	they	PRP	PRP	_	2	nsubj	_	_
2	inhibit	inhibit	VBP	VBP	_	0	root	_	_
3	synthesis	synthesis	NN	NN	_	2	dobj	_	_
4	of	of	IN	IN	_	8	case	_	_
5	almost	almost	RB	RB	_	7	advmod	_	_
6	all	all	DT	DT	_	7	det	_	_
7	known	known	JJ	JJ	_	8	amod	_	_
8	cytokines	cytokine	NNS	NNS	_	3	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	of	of	IN	IN	_	14	case	_	_
11	several	several	JJ	JJ	_	14	amod	_	_
12	cell	cell	NN	NN	_	14	compound	_	_
13	surface	surface	NN	NN	_	14	compound	_	_
14	molecules	molecule	NNS	NNS	_	8	conj	_	_
15	required	require	VBN	VBN	_	14	acl	_	_
16	for	for	IN	IN	_	18	case	_	_
17	immune	immune	JJ	JJ	_	18	amod	_	_
18	function	function	NN	NN	_	15	nmod	_	_
19	,	,	,	,	_	2	punct	_	_
20	but	but	CC	CC	_	2	cc	_	_
21	the	the	DT	DT	_	22	det	_	_
22	mechanism	mechanism	NN	NN	_	28	nsubj	_	_
23	underlying	underlie	VBG	VBG	_	22	acl	_	_
24	this	this	DT	DT	_	25	det	_	_
25	activity	activity	NN	NN	_	23	dobj	_	_
26	has	have	VBZ	VBZ	_	28	aux	_	_
27	been	be	VBN	VBN	_	28	cop	_	_
28	unclear	unclear	JJ	JJ	_	2	conj	_	_
29	.	.	.	.	_	2	punct	_	_

1	Here	here	RB	RB	_	4	advmod	_	_
2	it	it	PRP	PRP	_	4	nsubjpass	_	_
3	is	be	VBZ	VBZ	_	4	auxpass	_	_
4	shown	show	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	9	mark	_	_
6	glucocorticoids	glucocorticoid	NNS	NNS	_	9	nsubj	_	_
7	are	be	VBP	VBP	_	9	cop	_	_
8	potent	potent	JJ	JJ	_	9	amod	_	_
9	inhibitors	inhibitor	NNS	NNS	_	4	ccomp	_	_
10	of	of	IN	IN	_	19	case	_	_
11	nuclear	nuclear	JJ	JJ	_	14	amod	_	_
12	factor	factor	NN	NN	_	14	compound	_	_
13	kappa	kappa	NN	NN	_	14	compound	_	_
14	B	b	NN	NN	_	19	compound	_	_
15	(	(	-LRB-	-LRB-	_	17	punct	_	_
16	NF-kappa	nf-kappa	NN	NN	_	17	compound	_	_
17	B	b	NN	NN	_	14	appos	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	activation	activation	NN	NN	_	9	nmod	_	_
20	in	in	IN	IN	_	21	case	_	_
21	mice	mouse	NNS	NNS	_	9	nmod	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	cultured	culture	VBN	VBN	_	24	amod	_	_
24	cells	cell	NNS	NNS	_	21	conj	_	_
25	.	.	.	.	_	4	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	inhibition	inhibition	NN	NN	_	4	nsubjpass	_	_
3	is	be	VBZ	VBZ	_	4	auxpass	_	_
4	mediated	mediate	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	_	6	case	_	_
6	induction	induction	NN	NN	_	4	nmod	_	_
7	of	of	IN	IN	_	14	case	_	_
8	the	the	DT	DT	_	14	det	_	_
9	I	i	NN	NN	_	11	compound	_	_
10	kappa	kappa	NN	NN	_	11	compound	_	_
11	B	b	NN	NN	_	14	compound	_	_
12	alpha	alpha	NN	NN	_	14	compound	_	_
13	inhibitory	inhibitory	JJ	JJ	_	14	amod	_	_
14	protein	protein	NN	NN	_	6	nmod	_	_
15	,	,	,	,	_	14	punct	_	_
16	which	which	WDT	WDT	_	17	nsubj	_	_
17	traps	trap	VBZ	VBZ	_	14	acl:relcl	_	_
18	activated	activate	VBN	VBN	_	20	amod	_	_
19	NF-kappa	nf-kappa	NN	NN	_	20	compound	_	_
20	B	b	NN	NN	_	17	dobj	_	_
21	in	in	IN	IN	_	24	case	_	_
22	inactive	inactive	JJ	JJ	_	24	amod	_	_
23	cytoplasmic	cytoplasmic	JJ	JJ	_	24	amod	_	_
24	complexes	complex	NNS	NNS	_	17	nmod	_	_
25	.	.	.	.	_	4	punct	_	_

1	Because	because	IN	IN	_	4	mark	_	_
2	NF-kappa	nf-kappa	NN	NN	_	3	compound	_	_
3	B	b	NN	NN	_	4	nsubj	_	_
4	activates	activate	VBZ	VBZ	_	23	advcl	_	_
5	many	many	JJ	JJ	_	7	amod	_	_
6	immunoregulatory	immunoregulatory	JJ	JJ	_	7	amod	_	_
7	genes	gene	NNS	NNS	_	4	dobj	_	_
8	in	in	IN	IN	_	9	case	_	_
9	response	response	NN	NN	_	4	nmod	_	_
10	to	to	TO	TO	_	12	case	_	_
11	pro-inflammatory	pro-inflammatory	JJ	JJ	_	12	amod	_	_
12	stimuli	stimulus	NNS	NNS	_	9	nmod	_	_
13	,	,	,	,	_	23	punct	_	_
14	the	the	DT	DT	_	15	det	_	_
15	inhibition	inhibition	NN	NN	_	23	nsubj	_	_
16	of	of	IN	IN	_	18	case	_	_
17	its	its	PRP$	PRP$	_	18	nmod:poss	_	_
18	activity	activity	NN	NN	_	15	nmod	_	_
19	can	can	MD	MD	_	23	aux	_	_
20	be	be	VB	VB	_	23	cop	_	_
21	a	a	DT	DT	_	23	det	_	_
22	major	major	JJ	JJ	_	23	amod	_	_
23	component	component	NN	NN	_	0	root	_	_
24	of	of	IN	IN	_	27	case	_	_
25	the	the	DT	DT	_	27	det	_	_
26	anti-inflammatory	anti-inflammatory	JJ	JJ	_	27	amod	_	_
27	activity	activity	NN	NN	_	23	nmod	_	_
28	of	of	IN	IN	_	29	case	_	_
29	glucocorticoids	glucocorticoid	NNS	NNS	_	27	nmod	_	_
30	.	.	.	.	_	23	punct	_	_

1	Pathogenesis	pathogenesis	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	3	case	_	_
3	atherosclerosis	atherosclerosis	NN	NN	_	1	nmod	_	_
4	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	earliest	earliest	JJS	JJS	_	3	amod	_	_
3	lesion	lesion	NN	NN	_	14	nsubj	_	_
4	in	in	IN	IN	_	6	case	_	_
5	the	the	DT	DT	_	6	det	_	_
6	development	development	NN	NN	_	3	nmod	_	_
7	of	of	IN	IN	_	10	case	_	_
8	an	a	DT	DT	_	10	det	_	_
9	atherosclerotic	atherosclerotic	JJ	JJ	_	10	amod	_	_
10	plaque	plaque	NN	NN	_	6	nmod	_	_
11	is	be	VBZ	VBZ	_	14	cop	_	_
12	the	the	DT	DT	_	14	det	_	_
13	fatty	fatty	JJ	JJ	_	14	amod	_	_
14	streak	streak	NN	NN	_	0	root	_	_
15	.	.	.	.	_	14	punct	_	_

1	This	this	DT	DT	_	4	det	_	_
2	chronic	chronic	JJ	JJ	_	4	amod	_	_
3	inflammatory	inflammatory	JJ	JJ	_	2	dep	_	_
4	reaction	reaction	NN	NN	_	5	nsubj	_	_
5	results	result	VBZ	VBZ	_	0	root	_	_
6	from	from	IN	IN	_	8	case	_	_
7	a	a	DT	DT	_	8	det	_	_
8	sequence	sequence	NN	NN	_	5	nmod	_	_
9	of	of	IN	IN	_	10	case	_	_
10	events	event	NNS	NNS	_	8	nmod	_	_
11	that	that	WDT	WDT	_	12	nsubj	_	_
12	begins	begin	VBZ	VBZ	_	8	acl:relcl	_	_
13	with	with	IN	IN	_	15	case	_	_
14	the	the	DT	DT	_	15	det	_	_
15	trapping	trapping	NN	NN	_	12	nmod	_	_
16	of	of	IN	IN	_	19	case	_	_
17	low	low	JJ	JJ	_	19	amod	_	_
18	density	density	NN	NN	_	19	compound	_	_
19	lipoprotein	lipoprotein	NN	NN	_	15	nmod	_	_
20	(	(	-LRB-	-LRB-	_	21	punct	_	_
21	LDL	ldl	NN	NN	_	19	appos	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	in	in	IN	IN	_	26	case	_	_
24	the	the	DT	DT	_	26	det	_	_
25	subendothelial	subendothelial	JJ	JJ	_	26	amod	_	_
26	space	space	NN	NN	_	15	nmod	_	_
27	of	of	IN	IN	_	30	case	_	_
28	the	the	DT	DT	_	30	det	_	_
29	artery	artery	NN	NN	_	30	compound	_	_
30	wall	wall	NN	NN	_	26	nmod	_	_
31	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	trapped	trap	VBN	VBN	_	3	amod	_	_
3	LDL	ldl	NN	NN	_	5	nsubjpass	_	_
4	is	be	VBZ	VBZ	_	5	auxpass	_	_
5	seeded	seed	VBN	VBN	_	0	root	_	_
6	with	with	IN	IN	_	8	case	_	_
7	oxidative	oxidative	JJ	JJ	_	8	amod	_	_
8	species	species	NNS	NNS	_	5	nmod	_	_
9	released	release	VBN	VBN	_	8	acl	_	_
10	by	by	IN	IN	_	13	case	_	_
11	the	the	DT	DT	_	13	det	_	_
12	overlying	overlie	VBG	VBG	_	13	amod	_	_
13	endothelium	endothelium	NN	NN	_	9	nmod	_	_
14	,	,	,	,	_	5	punct	_	_
15	and	and	CC	CC	_	5	cc	_	_
16	lipid	lipid	NN	NN	_	17	compound	_	_
17	oxidation	oxidation	NN	NN	_	19	nsubjpass	_	_
18	is	be	VBZ	VBZ	_	19	auxpass	_	_
19	initiated	initiate	VBN	VBN	_	5	conj	_	_
20	within	within	IN	IN	_	23	case	_	_
21	the	the	DT	DT	_	23	det	_	_
22	LDL	ldl	NN	NN	_	23	compound	_	_
23	particle	particle	NN	NN	_	19	nmod	_	_
24	.	.	.	.	_	5	punct	_	_

1	Some	some	DT	DT	_	7	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	the	the	DT	DT	_	4	det	_	_
4	lipids	lipid	NNS	NNS	_	1	nmod	_	_
5	that	that	WDT	WDT	_	6	nsubj	_	_
6	result	result	VBP	VBP	_	1	acl:relcl	_	_
7	lead	lead	VBP	VBP	_	0	root	_	_
8	to	to	TO	TO	_	10	case	_	_
9	the	the	DT	DT	_	10	det	_	_
10	activation	activation	NN	NN	_	7	nmod	_	_
11	of	of	IN	IN	_	14	case	_	_
12	NFkB-like	nfkb-like	JJ	JJ	_	14	amod	_	_
13	transcription	transcription	NN	NN	_	14	compound	_	_
14	factors	factor	NNS	NNS	_	10	nmod	_	_
15	that	that	WDT	WDT	_	16	nsubj	_	_
16	cause	cause	VBP	VBP	_	14	acl:relcl	_	_
17	the	the	DT	DT	_	18	det	_	_
18	expression	expression	NN	NN	_	16	dobj	_	_
19	of	of	IN	IN	_	20	case	_	_
20	genes	gene	NNS	NNS	_	18	nmod	_	_
21	whose	whose	WP$	WP$	_	23	nmod:poss	_	_
22	protein	protein	NN	NN	_	23	compound	_	_
23	products	product	NNS	NNS	_	24	nsubj	_	_
24	mediate	mediate	VBP	VBP	_	20	acl:relcl	_	_
25	monocyte	monocyte	NN	NN	_	26	compound	_	_
26	binding	binding	NN	NN	_	24	dobj	_	_
27	,	,	,	,	_	26	punct	_	_
28	monocyte	monocyte	NN	NN	_	29	compound	_	_
29	chemotaxis	chemotaxis	NN	NN	_	26	conj	_	_
30	into	into	IN	IN	_	33	case	_	_
31	the	the	DT	DT	_	33	det	_	_
32	subendothelial	subendothelial	JJ	JJ	_	33	amod	_	_
33	space	space	NN	NN	_	29	nmod	_	_
34	,	,	,	,	_	26	punct	_	_
35	and	and	CC	CC	_	26	cc	_	_
36	conversion	conversion	NN	NN	_	26	conj	_	_
37	into	into	IN	IN	_	38	case	_	_
38	macrophages	macrophage	NNS	NNS	_	36	nmod	_	_
39	.	.	.	.	_	7	punct	_	_

1	At	at	IN	IN	_	2	case	_	_
2	least	least	JJS	JJS	_	3	nmod:npmod	_	_
3	1	1	CD	CD	_	5	nummod	_	_
4	major	major	JJ	JJ	_	5	amod	_	_
5	gene	gene	NN	NN	_	6	nsubj	_	_
6	modulates	modulate	VBZ	VBZ	_	0	root	_	_
7	the	the	DT	DT	_	8	det	_	_
8	oxidation	oxidation	NN	NN	_	6	dobj	_	_
9	of	of	IN	IN	_	11	case	_	_
10	LDL	ldl	NN	NN	_	11	compound	_	_
11	lipids	lipid	NNS	NNS	_	8	nmod	_	_
12	and/or	and/or	CC	CC	_	8	cc	_	_
13	the	the	DT	DT	_	15	det	_	_
14	biologic	biologic	JJ	JJ	_	15	amod	_	_
15	response	response	NN	NN	_	8	conj	_	_
16	to	to	TO	TO	_	18	case	_	_
17	these	these	DT	DT	_	18	det	_	_
18	lipids	lipid	NNS	NNS	_	15	nmod	_	_
19	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	inverse	inverse	JJ	JJ	_	3	amod	_	_
3	relation	relation	NN	NN	_	18	nsubj	_	_
4	between	between	IN	IN	_	7	case	_	_
5	high	high	JJ	JJ	_	7	amod	_	_
6	density	density	NN	NN	_	7	compound	_	_
7	lipoprotein	lipoprotein	NN	NN	_	3	nmod	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	HDL	hdl	NN	NN	_	7	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	and	and	CC	CC	_	7	cc	_	_
12	atherosclerotic	atherosclerotic	JJ	JJ	_	13	amod	_	_
13	events	event	NNS	NNS	_	7	conj	_	_
14	may	may	MD	MD	_	18	aux	_	_
15	in	in	IN	IN	_	16	case	_	_
16	part	part	NN	NN	_	18	nmod	_	_
17	be	be	VB	VB	_	18	cop	_	_
18	due	due	JJ	JJ	_	0	root	_	_
19	to	to	TO	TO	_	20	case	_	_
20	enzymes	enzyme	NNS	NNS	_	18	nmod	_	_
21	associated	associate	VBN	VBN	_	20	acl	_	_
22	with	with	IN	IN	_	23	case	_	_
23	HDL	hdl	NN	NN	_	21	nmod	_	_
24	that	that	WDT	WDT	_	25	nsubj	_	_
25	destroy	destroy	VBP	VBP	_	20	acl:relcl	_	_
26	the	the	DT	DT	_	29	det	_	_
27	biologically	biologically	RB	RB	_	28	advmod	_	_
28	active	active	JJ	JJ	_	29	amod	_	_
29	lipids	lipid	NNS	NNS	_	25	dobj	_	_
30	generated	generate	VBN	VBN	_	29	acl	_	_
31	in	in	IN	IN	_	32	case	_	_
32	LDL	ldl	NN	NN	_	30	nmod	_	_
33	.	.	.	.	_	18	punct	_	_

1	IFN-gamma	ifn-gamma	NN	NN	_	2	compound	_	_
2	priming	priming	NN	NN	_	5	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	monocytes	monocyte	NNS	NNS	_	2	nmod	_	_
5	enhances	enhance	VBZ	VBZ	_	0	root	_	_
6	LPS-induced	lps-induced	JJ	JJ	_	8	amod	_	_
7	TNF	tnf	NN	NN	_	8	compound	_	_
8	production	production	NN	NN	_	5	dobj	_	_
9	by	by	IN	IN	_	10	mark	_	_
10	augmenting	augment	VBG	VBG	_	5	advcl	_	_
11	both	both	CC	CC	_	12	cc:preconj	_	_
12	transcription	transcription	NN	NN	_	10	dobj	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	MRNA	mrna	NN	NN	_	15	compound	_	_
15	stability	stability	NN	NN	_	12	conj	_	_
16	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	induction	induction	NN	NN	_	21	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	cytokine	cytokine	NN	NN	_	5	compound	_	_
5	expression	expression	NN	NN	_	2	nmod	_	_
6	in	in	IN	IN	_	7	case	_	_
7	monocytes/macrophages	monocytes/macrophages	NNS	NNS	_	2	nmod	_	_
8	by	by	IN	IN	_	10	case	_	_
9	bacterial	bacterial	JJ	JJ	_	10	amod	_	_
10	endotoxin	endotoxin	NN	NN	_	2	nmod	_	_
11	or	or	CC	CC	_	10	cc	_	_
12	lipopolysaccharide	lipopolysaccharide	NN	NN	_	10	conj	_	_
13	is	be	VBZ	VBZ	_	21	cop	_	_
14	a	a	DT	DT	_	21	det	_	_
15	critical	critical	JJ	JJ	_	21	amod	_	_
16	,	,	,	,	_	15	punct	_	_
17	highly	highly	RB	RB	_	18	advmod	_	_
18	regulated	regulate	VBN	VBN	_	15	dep	_	_
19	host	host	NN	NN	_	21	compound	_	_
20	defence	defence	NN	NN	_	21	compound	_	_
21	response	response	NN	NN	_	0	root	_	_
22	.	.	.	.	_	21	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	augmentation	augmentation	NN	NN	_	20	nsubjpass	_	_
3	of	of	IN	IN	_	5	case	_	_
4	LPS	lps	NN	NN	_	5	compound	_	_
5	responses	response	NNS	NNS	_	2	nmod	_	_
6	by	by	IN	IN	_	8	case	_	_
7	interferon	interferon	NN	NN	_	8	compound	_	_
8	gamma	gamma	NN	NN	_	2	nmod	_	_
9	(	(	-LRB-	-LRB-	_	10	punct	_	_
10	IFN-gamma	ifn-gamma	NN	NN	_	8	appos	_	_
11	)	)	-RRB-	-RRB-	_	10	punct	_	_
12	,	,	,	,	_	2	punct	_	_
13	referred	refer	VBN	VBN	_	2	acl	_	_
14	to	to	TO	TO	_	13	nmod	_	_
15	as	as	IN	IN	_	16	case	_	_
16	priming	priming	NN	NN	_	13	nmod	_	_
17	,	,	,	,	_	2	punct	_	_
18	is	be	VBZ	VBZ	_	20	auxpass	_	_
19	well	well	RB	RB	_	20	advmod	_	_
20	established	establish	VBN	VBN	_	0	root	_	_
21	.	.	.	.	_	20	punct	_	_

1	However	however	RB	RB	_	14	advmod	_	_
2	,	,	,	,	_	14	punct	_	_
3	the	the	DT	DT	_	6	det	_	_
4	mechanism	mechanism	NN	NN	_	6	compound	_	_
5	(	(	-LRB-	-LRB-	_	6	punct	_	_
6	s	s	NNS	NNS	_	14	nsubjpass	_	_
7	)	)	-RRB-	-RRB-	_	6	punct	_	_
8	by	by	IN	IN	_	9	case	_	_
9	which	which	WDT	WDT	_	11	nmod	_	_
10	priming	priming	NN	NN	_	11	nsubj	_	_
11	occurs	occur	VBZ	VBZ	_	6	acl:relcl	_	_
12	is	be	VBZ	VBZ	_	14	auxpass	_	_
13	poorly	poorly	RB	RB	_	14	advmod	_	_
14	defined	define	VBN	VBN	_	0	root	_	_
15	.	.	.	.	_	14	punct	_	_

1	Using	use	VBG	VBG	_	0	root	_	_
2	tumour	tumour	NN	NN	_	4	compound	_	_
3	necrosis	necrosis	NN	NN	_	4	compound	_	_
4	factor	factor	NN	NN	_	8	compound	_	_
5	(	(	-LRB-	-LRB-	_	6	punct	_	_
6	TNF	tnf	NN	NN	_	4	appos	_	_
7	)	)	-RRB-	-RRB-	_	6	punct	_	_
8	induction	induction	NN	NN	_	1	dobj	_	_
9	as	as	IN	IN	_	11	case	_	_
10	a	a	DT	DT	_	11	det	_	_
11	model	model	NN	NN	_	1	nmod	_	_
12	,	,	,	,	_	1	punct	_	_
13	experiments	experiment	NNS	NNS	_	15	nsubjpass	_	_
14	were	be	VBD	VBD	_	15	auxpass	_	_
15	designed	design	VBN	VBN	_	1	parataxis	_	_
16	to	to	TO	TO	_	17	mark	_	_
17	analyse	analyse	VB	VB	_	15	xcomp	_	_
18	in	in	IN	IN	_	19	case	_	_
19	detail	detail	NN	NN	_	17	nmod	_	_
20	the	the	DT	DT	_	22	det	_	_
21	priming	priming	NN	NN	_	22	compound	_	_
22	effect	effect	NN	NN	_	17	dobj	_	_
23	on	on	IN	IN	_	26	case	_	_
24	the	the	DT	DT	_	26	det	_	_
25	LPS	lps	NN	NN	_	26	compound	_	_
26	response	response	NN	NN	_	22	nmod	_	_
27	in	in	IN	IN	_	29	case	_	_
28	human	human	JJ	JJ	_	29	amod	_	_
29	monocytes	monocyte	NNS	NNS	_	26	nmod	_	_
30	.	.	.	.	_	1	punct	_	_

1	Priming	priming	NN	NN	_	6	nsubjpass	_	_
2	by	by	IN	IN	_	3	case	_	_
3	IFN-gamma	ifn-gamma	NN	NN	_	1	nmod	_	_
4	was	be	VBD	VBD	_	6	auxpass	_	_
5	primarily	primarily	RB	RB	_	6	advmod	_	_
6	manifested	manifest	VBN	VBN	_	0	root	_	_
7	at	at	IN	IN	_	9	case	_	_
8	the	the	DT	DT	_	9	det	_	_
9	level	level	NN	NN	_	6	nmod	_	_
10	of	of	IN	IN	_	13	case	_	_
11	TNF	tnf	NN	NN	_	12	compound	_	_
12	mRNA	mrna	NN	NN	_	13	compound	_	_
13	accumulation	accumulation	NN	NN	_	9	nmod	_	_
14	.	.	.	.	_	6	punct	_	_

1	IFN-gamma	ifn-gamma	NN	NN	_	2	compound	_	_
2	pre-treatment	pre-treatment	NN	NN	_	3	nsubj	_	_
3	affected	affect	VBD	VBD	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	magnitude	magnitude	NN	NN	_	3	dobj	_	_
6	rather	rather	RB	RB	_	5	cc	_	_
7	than	than	IN	IN	_	6	mwe	_	_
8	the	the	DT	DT	_	9	det	_	_
9	sensitivity	sensitivity	NN	NN	_	5	conj	_	_
10	of	of	IN	IN	_	13	case	_	_
11	the	the	DT	DT	_	13	det	_	_
12	LPS	lps	NN	NN	_	13	compound	_	_
13	response	response	NN	NN	_	5	nmod	_	_
14	.	.	.	.	_	3	punct	_	_

1	Priming	priming	NN	NN	_	2	nsubj	_	_
2	occurred	occur	VBD	VBD	_	0	root	_	_
3	after	after	IN	IN	_	5	case	_	_
4	several	several	JJ	JJ	_	5	amod	_	_
5	hours	hour	NNS	NNS	_	2	nmod	_	_
6	of	of	IN	IN	_	7	case	_	_
7	treatment	treatment	NN	NN	_	5	nmod	_	_
8	,	,	,	,	_	2	punct	_	_
9	and	and	CC	CC	_	2	cc	_	_
10	the	the	DT	DT	_	12	det	_	_
11	primed	primed	JJ	JJ	_	12	amod	_	_
12	state	state	NN	NN	_	14	nsubjpass	_	_
13	was	be	VBD	VBD	_	14	auxpass	_	_
14	induced	induce	VBN	VBN	_	2	conj	_	_
15	by	by	IN	IN	_	17	case	_	_
16	either	either	CC	CC	_	17	cc:preconj	_	_
17	IFN-gamma	ifn-gamma	NN	NN	_	14	nmod	_	_
18	or	or	CC	CC	_	17	cc	_	_
19	GM-CSF	gm-csf	NN	NN	_	17	conj	_	_
20	,	,	,	,	_	17	punct	_	_
21	but	but	CC	CC	_	22	cc	_	_
22	not	not	RB	RB	_	17	cc	_	_
23	M-CSF	m-csf	NN	NN	_	17	conj	_	_
24	.	.	.	.	_	2	punct	_	_

1	Primed	prime	VBN	VBN	_	2	amod	_	_
2	monocytes	monocyte	NNS	NNS	_	3	nsubj	_	_
3	transcribed	transcribe	VBD	VBD	_	0	root	_	_
4	TNF	tnf	NN	NN	_	5	compound	_	_
5	mRNA	mrna	NN	NN	_	3	dobj	_	_
6	at	at	IN	IN	_	9	case	_	_
7	a	a	DT	DT	_	9	det	_	_
8	higher	higher	JJR	JJR	_	9	amod	_	_
9	rate	rate	NN	NN	_	3	nmod	_	_
10	than	than	IN	IN	_	13	case	_	_
11	freshly	freshly	RB	RB	_	12	advmod	_	_
12	isolated	isolate	VBN	VBN	_	13	amod	_	_
13	monocytes	monocyte	NNS	NNS	_	9	nmod	_	_
14	upon	upon	IN	IN	_	15	case	_	_
15	activation	activation	NN	NN	_	3	nmod	_	_
16	with	with	IN	IN	_	17	case	_	_
17	LPS	lps	NN	NN	_	15	nmod	_	_
18	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	increased	increase	VBN	VBN	_	4	amod	_	_
3	transcriptional	transcriptional	JJ	JJ	_	4	amod	_	_
4	rate	rate	NN	NN	_	5	nsubj	_	_
5	correlated	correlate	VBD	VBD	_	0	root	_	_
6	with	with	IN	IN	_	9	case	_	_
7	a	a	DT	DT	_	9	det	_	_
8	marked	marked	JJ	JJ	_	9	amod	_	_
9	increase	increase	NN	NN	_	5	nmod	_	_
10	in	in	IN	IN	_	14	case	_	_
11	nuclear	nuclear	JJ	JJ	_	13	amod	_	_
12	factor-kappa	factor-kappa	NN	NN	_	13	compound	_	_
13	B	b	NN	NN	_	14	compound	_	_
14	activity	activity	NN	NN	_	9	nmod	_	_
15	in	in	IN	IN	_	17	case	_	_
16	these	these	DT	DT	_	17	det	_	_
17	cells	cell	NNS	NNS	_	14	nmod	_	_
18	as	as	IN	IN	_	19	mark	_	_
19	determined	determine	VBN	VBN	_	5	advcl	_	_
20	by	by	IN	IN	_	24	case	_	_
21	electrophoretic	electrophoretic	JJ	JJ	_	24	amod	_	_
22	mobility	mobility	NN	NN	_	24	compound	_	_
23	shift	shift	NN	NN	_	24	compound	_	_
24	assay	assay	NN	NN	_	19	nmod	_	_
25	using	use	VBG	VBG	_	24	acl	_	_
26	a	a	DT	DT	_	30	det	_	_
27	consensus	consensus	NN	NN	_	30	compound	_	_
28	NF-kappa	nf-kappa	NN	NN	_	30	compound	_	_
29	B	b	NN	NN	_	30	compound	_	_
30	oligonucleotide	oligonucleotide	NN	NN	_	25	dobj	_	_
31	.	.	.	.	_	5	punct	_	_

1	An	a	DT	DT	_	4	det	_	_
2	additional	additional	JJ	JJ	_	4	amod	_	_
3	significant	significant	JJ	JJ	_	2	dep	_	_
4	finding	finding	NN	NN	_	5	nsubj	_	_
5	was	be	VBD	VBD	_	0	root	_	_
6	than	than	IN	IN	_	16	mark	_	_
7	TNF	tnf	NN	NN	_	8	compound	_	_
8	mRNA	mrna	NN	NN	_	16	nsubj	_	_
9	induced	induce	VBN	VBN	_	8	acl	_	_
10	in	in	IN	IN	_	12	case	_	_
11	primed	prime	VBN	VBN	_	12	amod	_	_
12	cells	cell	NNS	NNS	_	9	nmod	_	_
13	was	be	VBD	VBD	_	16	cop	_	_
14	much	much	RB	RB	_	15	advmod	_	_
15	more	more	RBR	RBR	_	16	advmod	_	_
16	stable	stable	JJ	JJ	_	5	advcl	_	_
17	than	than	IN	IN	_	20	case	_	_
18	in	in	IN	IN	_	20	case	_	_
19	unprimed	unprimed	JJ	JJ	_	20	amod	_	_
20	cells	cell	NNS	NNS	_	16	nmod	_	_
21	(	(	-LRB-	-LRB-	_	23	punct	_	_
22	T1/2	t1/2	NN	NN	_	23	nsubj	_	_
23	increased	increase	VBN	VBN	_	16	dep	_	_
24	6-8-fold	6-8-fold	RB	RB	_	23	dobj	_	_
25	)	)	-RRB-	-RRB-	_	23	punct	_	_
26	.	.	.	.	_	5	punct	_	_

1	Consistent	consistent	JJ	JJ	_	14	advmod	_	_
2	with	with	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	increased	increase	VBN	VBN	_	6	amod	_	_
5	mRNA	mrna	NN	NN	_	6	compound	_	_
6	stability	stability	NN	NN	_	1	nmod	_	_
7	,	,	,	,	_	14	punct	_	_
8	the	the	DT	DT	_	9	det	_	_
9	duration	duration	NN	NN	_	14	nsubj	_	_
10	of	of	IN	IN	_	12	case	_	_
11	mRNA	mrna	NN	NN	_	12	compound	_	_
12	accumulation	accumulation	NN	NN	_	9	nmod	_	_
13	was	be	VBD	VBD	_	14	cop	_	_
14	longer	longer	RBR	RBR	_	0	root	_	_
15	following	follow	VBG	VBG	_	17	case	_	_
16	LPS	lps	NN	NN	_	17	compound	_	_
17	stimulation	stimulation	NN	NN	_	14	nmod	_	_
18	in	in	IN	IN	_	20	case	_	_
19	primed	prime	VBN	VBN	_	20	amod	_	_
20	monocytes	monocyte	NNS	NNS	_	17	nmod	_	_
21	,	,	,	,	_	14	punct	_	_
22	in	in	IN	IN	_	23	case	_	_
23	addition	addition	NN	NN	_	14	nmod	_	_
24	to	to	TO	TO	_	28	mark	_	_
25	being	be	VBG	VBG	_	28	cop	_	_
26	of	of	IN	IN	_	28	case	_	_
27	greater	greater	JJR	JJR	_	28	amod	_	_
28	magnitude	magnitude	NN	NN	_	23	acl	_	_
29	.	.	.	.	_	14	punct	_	_

1	Finally	finally	RB	RB	_	7	advmod	_	_
2	,	,	,	,	_	7	punct	_	_
3	primed	prime	VBN	VBN	_	7	nsubj	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	unprimed	unprimed	JJ	JJ	_	3	conj	_	_
6	cells	cell	NNS	NNS	_	3	dep	_	_
7	possessed	possess	VBD	VBD	_	0	root	_	_
8	a	a	DT	DT	_	10	det	_	_
9	differential	differential	JJ	JJ	_	10	amod	_	_
10	sensitivity	sensitivity	NN	NN	_	7	dobj	_	_
11	to	to	TO	TO	_	15	case	_	_
12	the	the	DT	DT	_	15	det	_	_
13	kinase	kinase	NN	NN	_	15	compound	_	_
14	inhibitor	inhibitor	NN	NN	_	15	compound	_	_
15	H-89	h-89	NN	NN	_	10	nmod	_	_
16	.	.	.	.	_	7	punct	_	_

1	H-89	h-89	NN	NN	_	3	nsubj	_	_
2	substantially	substantially	RB	RB	_	3	advmod	_	_
3	suppressed	suppress	VBD	VBD	_	0	root	_	_
4	LPS-induced	lps-induced	JJ	JJ	_	7	amod	_	_
5	TNF	tnf	NN	NN	_	6	compound	_	_
6	mRNA	mrna	NN	NN	_	7	compound	_	_
7	accumulation	accumulation	NN	NN	_	3	dobj	_	_
8	in	in	IN	IN	_	10	case	_	_
9	unprimed	unprimed	JJ	JJ	_	10	amod	_	_
10	cells	cell	NNS	NNS	_	7	nmod	_	_
11	,	,	,	,	_	3	punct	_	_
12	but	but	CC	CC	_	3	cc	_	_
13	had	have	VBD	VBD	_	3	conj	_	_
14	no	no	DT	DT	_	15	neg	_	_
15	effect	effect	NN	NN	_	13	dobj	_	_
16	on	on	IN	IN	_	18	case	_	_
17	primed	prime	VBN	VBN	_	18	amod	_	_
18	monocytes	monocyte	NNS	NNS	_	15	nmod	_	_
19	following	follow	VBG	VBG	_	21	case	_	_
20	LPS	lps	NN	NN	_	21	compound	_	_
21	stimulation	stimulation	NN	NN	_	13	nmod	_	_
22	.	.	.	.	_	3	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	ABSTRACT	abstract	NN	NN	_	0	root	_	_
3	TRUNCATED	truncate	VBN	VBN	_	2	acl	_	_
4	AT	at	IN	IN	_	6	case	_	_
5	250	250	CD	CD	_	6	nummod	_	_
6	WORDS	word	NNS	NNS	_	3	nmod	_	_
7	)	)	-RRB-	-RRB-	_	2	punct	_	_

1	Prolactin	prolactin	NN	NN	_	8	nsubj	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	interleukin-2	interleukin-2	NN	NN	_	4	compound	_	_
4	receptors	receptor	NNS	NNS	_	1	conj	_	_
5	in	in	IN	IN	_	7	case	_	_
6	T	t	NN	NN	_	7	compound	_	_
7	lymphocytes	lymphocyte	NNS	NNS	_	1	nmod	_	_
8	signal	signal	VBP	VBP	_	0	root	_	_
9	through	through	IN	IN	_	13	case	_	_
10	a	a	DT	DT	_	13	det	_	_
11	MGF-STAT5-like	mgf-stat5-like	JJ	JJ	_	13	amod	_	_
12	transcription	transcription	NN	NN	_	13	compound	_	_
13	factor	factor	NN	NN	_	8	nmod	_	_
14	.	.	.	.	_	8	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	cell	cell	NN	NN	_	4	compound	_	_
3	surface	surface	NN	NN	_	4	compound	_	_
4	receptors	receptor	NNS	NNS	_	14	nsubj	_	_
5	for	for	IN	IN	_	6	case	_	_
6	PRL	prl	NN	NN	_	4	nmod	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	interleukin-2	interleukin-2	NN	NN	_	6	conj	_	_
9	(	(	-LRB-	-LRB-	_	10	punct	_	_
10	IL-2	il-2	NN	NN	_	8	appos	_	_
11	)	)	-RRB-	-RRB-	_	10	punct	_	_
12	are	be	VBP	VBP	_	14	cop	_	_
13	structurally	structurally	RB	RB	_	14	advmod	_	_
14	distinct	distinct	JJ	JJ	_	0	root	_	_
15	,	,	,	,	_	14	punct	_	_
16	but	but	CC	CC	_	14	cc	_	_
17	share	share	VBP	VBP	_	14	conj	_	_
18	regulatory	regulatory	JJ	JJ	_	19	amod	_	_
19	tasks	task	NNS	NNS	_	17	dobj	_	_
20	in	in	IN	IN	_	22	case	_	_
21	T	t	NN	NN	_	22	compound	_	_
22	lymphocytes	lymphocyte	NNS	NNS	_	19	nmod	_	_
23	.	.	.	.	_	14	punct	_	_

1	They	they	PRP	PRP	_	3	nsubj	_	_
2	can	can	MD	MD	_	3	aux	_	_
3	stimulate	stimulate	VB	VB	_	0	root	_	_
4	proliferation	proliferation	NN	NN	_	3	dobj	_	_
5	and	and	CC	CC	_	3	cc	_	_
6	activate	activate	VB	VB	_	3	conj	_	_
7	transcription	transcription	NN	NN	_	6	dobj	_	_
8	of	of	IN	IN	_	10	case	_	_
9	over-lapping	over-lapping	JJ	JJ	_	10	amod	_	_
10	sets	set	NNS	NNS	_	7	nmod	_	_
11	of	of	IN	IN	_	12	case	_	_
12	genes	gene	NNS	NNS	_	10	nmod	_	_
13	of	of	IN	IN	_	15	case	_	_
14	T	t	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	12	nmod	_	_
16	.	.	.	.	_	3	punct	_	_

1	PRL	prl	NN	NN	_	8	nsubjpass	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	IL-2	il-2	NN	NN	_	1	conj	_	_
4	receptor	receptor	NN	NN	_	5	compound	_	_
5	activation	activation	NN	NN	_	1	dep	_	_
6	are	be	VBP	VBP	_	8	auxpass	_	_
7	both	both	DT	DT	_	8	dep	_	_
8	linked	link	VBN	VBN	_	0	root	_	_
9	to	to	TO	TO	_	20	case	_	_
10	the	the	DT	DT	_	20	det	_	_
11	Jak/Stat	jak/stat	NN	NN	_	20	compound	_	_
12	(	(	-LRB-	-LRB-	_	14	punct	_	_
13	signal	signal	NN	NN	_	14	compound	_	_
14	transducer	transducer	NN	NN	_	11	dep	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	activator	activator	NN	NN	_	18	compound	_	_
17	of	of	IN	IN	_	18	amod	_	_
18	transcription	transcription	NN	NN	_	14	conj	_	_
19	)	)	-RRB-	-RRB-	_	14	punct	_	_
20	pathway	pathway	NN	NN	_	8	nmod	_	_
21	.	.	.	.	_	8	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	investigated	investigate	VBD	VBD	_	0	root	_	_
3	the	the	DT	DT	_	4	det	_	_
4	ability	ability	NN	NN	_	2	dobj	_	_
5	of	of	IN	IN	_	6	case	_	_
6	PRL	prl	NN	NN	_	4	nmod	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	IL-2	il-2	NN	NN	_	6	conj	_	_
9	to	to	TO	TO	_	10	mark	_	_
10	activate	activate	VB	VB	_	4	acl	_	_
11	Stat	stat	NN	NN	_	12	compound	_	_
12	proteins	protein	NNS	NNS	_	10	dobj	_	_
13	in	in	IN	IN	_	17	case	_	_
14	different	different	JJ	JJ	_	17	amod	_	_
15	T	t	NN	NN	_	17	compound	_	_
16	cell	cell	NN	NN	_	17	compound	_	_
17	lines	line	NNS	NNS	_	12	nmod	_	_
18	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	DNA	dna	NN	NN	_	4	compound	_	_
3	binding	binding	NN	NN	_	4	compound	_	_
4	specificities	specificity	NNS	NNS	_	30	nsubjpass	_	_
5	,	,	,	,	_	4	punct	_	_
6	the	the	DT	DT	_	7	det	_	_
7	reactivities	reactivity	NNS	NNS	_	4	conj	_	_
8	toward	toward	IN	IN	_	10	case	_	_
9	Stat-specific	stat-specific	JJ	JJ	_	10	amod	_	_
10	antisera	antisera	NNS	NNS	_	7	nmod	_	_
11	,	,	,	,	_	4	punct	_	_
12	and	and	CC	CC	_	4	cc	_	_
13	the	the	DT	DT	_	15	det	_	_
14	mol	mol	NN	NN	_	15	compound	_	_
15	wt	wt	NN	NN	_	4	conj	_	_
16	of	of	IN	IN	_	17	case	_	_
17	IL-2-	il-2-	NN	NN	_	15	nmod	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	PRL-induced	prl-induced	JJ	JJ	_	21	amod	_	_
20	DNA-binding	dna-binding	JJ	JJ	_	21	amod	_	_
21	proteins	protein	NNS	NNS	_	17	conj	_	_
22	in	in	IN	IN	_	23	case	_	_
23	Nb2	nb2	NN	NN	_	17	nmod	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	C196	c196	NN	NN	_	23	conj	_	_
26	T	t	NN	NN	_	28	compound	_	_
27	cell	cell	NN	NN	_	28	compound	_	_
28	lines	line	NNS	NNS	_	23	dep	_	_
29	were	be	VBD	VBD	_	30	auxpass	_	_
30	investigated	investigate	VBN	VBN	_	0	root	_	_
31	.	.	.	.	_	30	punct	_	_

1	A	a	DT	DT	_	2	det	_	_
2	comparison	comparison	NN	NN	_	21	nsubjpass	_	_
3	with	with	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	Stat	stat	NN	NN	_	6	compound	_	_
6	proteins	protein	NNS	NNS	_	2	nmod	_	_
7	induced	induce	VBN	VBN	_	6	acl	_	_
8	by	by	IN	IN	_	9	case	_	_
9	interferon-gamma	interferon-gamma	NN	NN	_	7	nmod	_	_
10	,	,	,	,	_	9	punct	_	_
11	PRL	prl	NN	NN	_	9	conj	_	_
12	,	,	,	,	_	9	punct	_	_
13	and	and	CC	CC	_	9	cc	_	_
14	IL-6	il-6	NN	NN	_	9	conj	_	_
15	in	in	IN	IN	_	19	case	_	_
16	T47D	t47d	NN	NN	_	19	compound	_	_
17	mammary	mammary	JJ	JJ	_	19	amod	_	_
18	tumor	tumor	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	9	nmod	_	_
20	was	be	VBD	VBD	_	21	auxpass	_	_
21	made	make	VBN	VBN	_	0	root	_	_
22	.	.	.	.	_	21	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	found	find	VBD	VBD	_	0	root	_	_
3	that	that	IN	IN	_	7	mark	_	_
4	these	these	DT	DT	_	5	det	_	_
5	parameters	parameter	NNS	NNS	_	7	nsubj	_	_
6	were	be	VBD	VBD	_	7	cop	_	_
7	indistinguishable	indistinguishable	JJ	JJ	_	2	ccomp	_	_
8	for	for	IN	IN	_	9	case	_	_
9	one	one	CD	CD	_	7	nmod	_	_
10	of	of	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	dep	_	_
12	PRL-	prl-	NN	NN	_	9	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	IL-2-induced	il-2-induced	JJ	JJ	_	12	conj	_	_
15	factors	factor	NNS	NNS	_	12	dep	_	_
16	.	.	.	.	_	2	punct	_	_

1	A	a	DT	DT	_	3	det	_	_
2	transcription	transcription	NN	NN	_	3	compound	_	_
3	factor	factor	NN	NN	_	12	nsubjpass	_	_
4	closely	closely	RB	RB	_	5	advmod	_	_
5	related	related	JJ	JJ	_	3	amod	_	_
6	to	to	TO	TO	_	9	case	_	_
7	mammary	mammary	JJ	JJ	_	9	amod	_	_
8	gland	gland	NN	NN	_	9	compound	_	_
9	factor-Stat5	factor-stat5	NN	NN	_	5	nmod	_	_
10	is	be	VBZ	VBZ	_	12	auxpass	_	_
11	rapidly	rapidly	RB	RB	_	12	advmod	_	_
12	activated	activate	VBN	VBN	_	0	root	_	_
13	upon	upon	IN	IN	_	14	case	_	_
14	interaction	interaction	NN	NN	_	12	nmod	_	_
15	of	of	IN	IN	_	16	case	_	_
16	IL-2	il-2	NN	NN	_	14	nmod	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	PRL	prl	NN	NN	_	16	conj	_	_
19	with	with	IN	IN	_	22	case	_	_
20	their	they	PRP$	PRP$	_	22	nmod:poss	_	_
21	respective	respective	JJ	JJ	_	22	amod	_	_
22	receptors	receptor	NNS	NNS	_	14	nmod	_	_
23	.	.	.	.	_	12	punct	_	_

1	Activation	activation	NN	NN	_	11	nsubjpass	_	_
2	of	of	IN	IN	_	5	case	_	_
3	a	a	DT	DT	_	5	det	_	_
4	second	second	JJ	JJ	_	5	amod	_	_
5	protein	protein	NN	NN	_	1	nmod	_	_
6	related	related	JJ	JJ	_	5	amod	_	_
7	to	to	TO	TO	_	8	case	_	_
8	Stat1	stat1	NN	NN	_	6	nmod	_	_
9	was	be	VBD	VBD	_	11	auxpass	_	_
10	also	also	RB	RB	_	11	advmod	_	_
11	observed	observe	VBN	VBN	_	0	root	_	_
12	.	.	.	.	_	11	punct	_	_

1	Our	we	PRP$	PRP$	_	2	nmod:poss	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	emphasize	emphasize	VBP	VBP	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	role	role	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	7	case	_	_
7	PRL	prl	NN	NN	_	5	nmod	_	_
8	as	as	IN	IN	_	10	case	_	_
9	a	a	DT	DT	_	10	det	_	_
10	regulator	regulator	NN	NN	_	5	nmod	_	_
11	of	of	IN	IN	_	14	case	_	_
12	the	the	DT	DT	_	14	det	_	_
13	immune	immune	JJ	JJ	_	14	amod	_	_
14	response	response	NN	NN	_	10	nmod	_	_
15	and	and	CC	CC	_	3	cc	_	_
16	indicate	indicate	VBP	VBP	_	3	conj	_	_
17	that	that	IN	IN	_	26	mark	_	_
18	the	the	DT	DT	_	20	det	_	_
19	Stat	stat	NN	NN	_	20	compound	_	_
20	factors	factor	NNS	NNS	_	26	nsubj	_	_
21	mammary	mammary	JJ	JJ	_	23	amod	_	_
22	gland	gland	NN	NN	_	23	compound	_	_
23	factor-Stat5	factor-stat5	NN	NN	_	20	dep	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	Stat1	stat1	NN	NN	_	23	conj	_	_
26	play	play	VBP	VBP	_	16	ccomp	_	_
27	a	a	DT	DT	_	28	det	_	_
28	role	role	NN	NN	_	26	dobj	_	_
29	in	in	IN	IN	_	31	case	_	_
30	the	the	DT	DT	_	31	det	_	_
31	regulation	regulation	NN	NN	_	26	nmod	_	_
32	of	of	IN	IN	_	34	case	_	_
33	gene	gene	NN	NN	_	34	compound	_	_
34	expression	expression	NN	NN	_	31	nmod	_	_
35	during	during	IN	IN	_	38	case	_	_
36	T	t	NN	NN	_	38	compound	_	_
37	cell	cell	NN	NN	_	38	compound	_	_
38	development	development	NN	NN	_	31	nmod	_	_
39	.	.	.	.	_	3	punct	_	_

1	CD30	cd30	NN	NN	_	2	compound	_	_
2	ligation	ligation	NN	NN	_	3	nsubj	_	_
3	induces	induce	VBZ	VBZ	_	0	root	_	_
4	nuclear	nuclear	JJ	JJ	_	6	amod	_	_
5	factor-kappa	factor-kappa	NN	NN	_	6	compound	_	_
6	B	b	NN	NN	_	7	compound	_	_
7	activation	activation	NN	NN	_	3	dobj	_	_
8	in	in	IN	IN	_	12	case	_	_
9	human	human	JJ	JJ	_	12	amod	_	_
10	T	t	NN	NN	_	12	compound	_	_
11	cell	cell	NN	NN	_	12	compound	_	_
12	lines	line	NNS	NNS	_	3	nmod	_	_
13	.	.	.	.	_	3	punct	_	_

1	CD30	cd30	NN	NN	_	6	nsubj	_	_
2	is	be	VBZ	VBZ	_	6	cop	_	_
3	a	a	DT	DT	_	6	det	_	_
4	recently	recently	RB	RB	_	5	advmod	_	_
5	described	describe	VBN	VBN	_	6	amod	_	_
6	member	member	NN	NN	_	0	root	_	_
7	of	of	IN	IN	_	15	case	_	_
8	the	the	DT	DT	_	15	det	_	_
9	tumor	tumor	NN	NN	_	15	compound	_	_
10	necrosis	necrosis	NN	NN	_	15	compound	_	_
11	factor/nerve	factor/nerve	NN	NN	_	15	compound	_	_
12	growth	growth	NN	NN	_	15	compound	_	_
13	factor	factor	NN	NN	_	15	compound	_	_
14	receptor	receptor	NN	NN	_	15	compound	_	_
15	superfamily	superfamily	NN	NN	_	6	nmod	_	_
16	.	.	.	.	_	6	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	report	report	NN	NN	_	6	nmod	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	show	show	VBP	VBP	_	0	root	_	_
7	that	that	IN	IN	_	49	mark	_	_
8	following	follow	VBG	VBG	_	9	case	_	_
9	incubation	incubation	NN	NN	_	49	nmod	_	_
10	of	of	IN	IN	_	12	case	_	_
11	L540	l540	NN	NN	_	12	compound	_	_
12	cells	cell	NNS	NNS	_	9	nmod	_	_
13	(	(	-LRB-	-LRB-	_	22	punct	_	_
14	Hodgkin	hodgkin	NN	NN	_	22	nmod:poss	_	_
15	's	's	POS	POS	_	22	case	_	_
16	disease-derived	disease-derived	JJ	JJ	_	22	amod	_	_
17	,	,	,	,	_	22	punct	_	_
18	T	t	NN	NN	_	22	compound	_	_
19	cell-like	cell-like	JJ	JJ	_	22	amod	_	_
20	,	,	,	,	_	22	punct	_	_
21	CD30+	cd30+	JJ	JJ	_	22	amod	_	_
22	cells	cell	NNS	NNS	_	12	appos	_	_
23	)	)	-RRB-	-RRB-	_	22	punct	_	_
24	with	with	IN	IN	_	29	case	_	_
25	the	the	DT	DT	_	29	det	_	_
26	agonistic	agonistic	JJ	JJ	_	29	amod	_	_
27	anti-CD30	anti-cd30	JJ	JJ	_	29	amod	_	_
28	monoclonal	monoclonal	JJ	JJ	_	29	amod	_	_
29	antibodies	antibody	NNS	NNS	_	9	nmod	_	_
30	(	(	-LRB-	-LRB-	_	31	punct	_	_
31	mAb	mab	NN	NN	_	29	appos	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	M44	m44	NN	NN	_	29	dep	_	_
34	and	and	CC	CC	_	33	cc	_	_
35	M67	m67	NN	NN	_	33	conj	_	_
36	,	,	,	,	_	49	punct	_	_
37	two	two	CD	CD	_	47	nummod	_	_
38	nuclear	nuclear	JJ	JJ	_	44	amod	_	_
39	factor	factor	NN	NN	_	44	compound	_	_
40	(	(	-LRB-	-LRB-	_	44	punct	_	_
41	NF	nf	NN	NN	_	44	compound	_	_
42	)	)	-RRB-	-RRB-	_	44	punct	_	_
43	-kappa	-kappa	NN	NN	_	44	compound	_	_
44	B	b	NN	NN	_	47	compound	_	_
45	DNA	dna	NN	NN	_	47	compound	_	_
46	binding	binding	NN	NN	_	47	compound	_	_
47	activities	activity	NNS	NNS	_	49	nsubjpass	_	_
48	were	be	VBD	VBD	_	49	auxpass	_	_
49	induced	induce	VBN	VBN	_	6	ccomp	_	_
50	in	in	IN	IN	_	52	case	_	_
51	nuclear	nuclear	JJ	JJ	_	52	amod	_	_
52	extracts	extract	NNS	NNS	_	49	nmod	_	_
53	,	,	,	,	_	49	punct	_	_
54	as	as	IN	IN	_	55	mark	_	_
55	determined	determine	VBN	VBN	_	49	advcl	_	_
56	in	in	IN	IN	_	59	case	_	_
57	gel	gel	NN	NN	_	59	compound	_	_
58	retardation	retardation	NN	NN	_	59	compound	_	_
59	assays	assay	NNS	NNS	_	55	nmod	_	_
60	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	effect	effect	NN	NN	_	11	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	the	the	DT	DT	_	5	det	_	_
5	mAb	mab	NN	NN	_	2	nmod	_	_
6	towards	towards	IN	IN	_	9	case	_	_
7	NF-kappa	nf-kappa	NN	NN	_	8	compound	_	_
8	B	b	NN	NN	_	9	compound	_	_
9	activation	activation	NN	NN	_	2	nmod	_	_
10	was	be	VBD	VBD	_	11	cop	_	_
11	rapid	rapid	JJ	JJ	_	0	root	_	_
12	,	,	,	,	_	11	punct	_	_
13	as	as	IN	IN	_	15	mark	_	_
14	it	it	PRP	PRP	_	15	nsubj	_	_
15	occurred	occur	VBD	VBD	_	11	advcl	_	_
16	within	within	IN	IN	_	18	case	_	_
17	20	20	CD	CD	_	18	nummod	_	_
18	min	min	NN	NN	_	15	nmod	_	_
19	,	,	,	,	_	15	punct	_	_
20	and	and	CC	CC	_	15	cc	_	_
21	was	be	VBD	VBD	_	22	cop	_	_
22	sustained	sustained	JJ	JJ	_	15	conj	_	_
23	for	for	IN	IN	_	27	case	_	_
24	up	up	RB	RB	_	26	advmod	_	_
25	to	to	TO	TO	_	26	dep	_	_
26	6	6	CD	CD	_	27	nummod	_	_
27	h	h	NN	NN	_	22	nmod	_	_
28	.	.	.	.	_	11	punct	_	_

1	By	by	IN	IN	_	2	case	_	_
2	comparison	comparison	NN	NN	_	7	nmod	_	_
3	,	,	,	,	_	7	punct	_	_
4	an	a	DT	DT	_	6	det	_	_
5	isotype-matched	isotype-matched	JJ	JJ	_	6	amod	_	_
6	antibody	antibody	NN	NN	_	7	nsubj	_	_
7	had	have	VBD	VBD	_	0	root	_	_
8	no	no	DT	DT	_	9	neg	_	_
9	effect	effect	NN	NN	_	7	dobj	_	_
10	on	on	IN	IN	_	13	case	_	_
11	NF-kappa	nf-kappa	NN	NN	_	12	compound	_	_
12	B	b	NN	NN	_	13	compound	_	_
13	activation	activation	NN	NN	_	7	nmod	_	_
14	.	.	.	.	_	7	punct	_	_

1	Moreover	moreover	RB	RB	_	47	advmod	_	_
2	,	,	,	,	_	47	punct	_	_
3	in	in	IN	IN	_	10	case	_	_
4	human	human	JJ	JJ	_	10	amod	_	_
5	T	t	NN	NN	_	10	compound	_	_
6	helper	helper	NN	NN	_	10	compound	_	_
7	(	(	-LRB-	-LRB-	_	10	punct	_	_
8	Th	th	NN	NN	_	10	compound	_	_
9	)	)	-RRB-	-RRB-	_	10	punct	_	_
10	clones	clone	NNS	NNS	_	47	nmod	_	_
11	functionally	functionally	RB	RB	_	12	advmod	_	_
12	characterized	characterize	VBN	VBN	_	10	acl	_	_
13	as	as	IN	IN	_	17	mark	_	_
14	being	be	VBG	VBG	_	17	cop	_	_
15	of	of	IN	IN	_	17	case	_	_
16	the	the	DT	DT	_	17	dep	_	_
17	type	type	NN	NN	_	12	advcl	_	_
18	0	0	CD	CD	_	17	nummod	_	_
19	,	,	,	,	_	17	punct	_	_
20	type	type	NN	NN	_	17	conj	_	_
21	1	1	CD	CD	_	20	nummod	_	_
22	and	and	CC	CC	_	17	cc	_	_
23	type	type	NN	NN	_	17	conj	_	_
24	2	2	CD	CD	_	23	nummod	_	_
25	(	(	-LRB-	-LRB-	_	27	punct	_	_
26	28	28	CD	CD	_	27	nummod	_	_
27	%	%	NN	NN	_	17	dep	_	_
28	,	,	,	,	_	27	punct	_	_
29	&lt;	&lt;	JJR	JJR	_	30	advmod	_	_
30	1	1	CD	CD	_	31	dep	_	_
31	%	%	NN	NN	_	27	conj	_	_
32	und	und	CC	CC	_	27	cc	_	_
33	93	93	CD	CD	_	34	nummod	_	_
34	%	%	NN	NN	_	27	conj	_	_
35	CD30+	cd30+	JJ	JJ	_	27	dep	_	_
36	,	,	,	,	_	27	punct	_	_
37	respectively	respectively	RB	RB	_	27	advmod	_	_
38	)	)	-RRB-	-RRB-	_	27	punct	_	_
39	,	,	,	,	_	47	punct	_	_
40	the	the	DT	DT	_	41	det	_	_
41	extent	extent	NN	NN	_	47	nsubj	_	_
42	of	of	IN	IN	_	46	case	_	_
43	CD30-mediated	cd30-mediated	JJ	JJ	_	46	amod	_	_
44	NF-kappa	nf-kappa	NN	NN	_	45	compound	_	_
45	B	b	NN	NN	_	46	compound	_	_
46	activation	activation	NN	NN	_	41	nmod	_	_
47	correlated	correlate	VBD	VBD	_	0	root	_	_
48	with	with	IN	IN	_	50	case	_	_
49	the	the	DT	DT	_	50	det	_	_
50	proportion	proportion	NN	NN	_	47	nmod	_	_
51	of	of	IN	IN	_	53	case	_	_
52	CD30+	cd30+	JJ	JJ	_	53	amod	_	_
53	cells	cell	NNS	NNS	_	50	nmod	_	_
54	.	.	.	.	_	47	punct	_	_

1	In	in	IN	IN	_	4	case	_	_
2	all	all	DT	DT	_	4	det	_	_
3	cell	cell	NN	NN	_	4	compound	_	_
4	lines	line	NNS	NNS	_	16	nmod	_	_
5	investigated	investigate	VBN	VBN	_	4	acl	_	_
6	,	,	,	,	_	16	punct	_	_
7	the	the	DT	DT	_	10	det	_	_
8	NF-kappa	nf-kappa	NN	NN	_	10	compound	_	_
9	B	b	NN	NN	_	10	compound	_	_
10	complexes	complex	NNS	NNS	_	16	nsubjpass	_	_
11	induced	induce	VBN	VBN	_	10	acl	_	_
12	following	follow	VBG	VBG	_	14	case	_	_
13	CD30	cd30	NN	NN	_	14	compound	_	_
14	engagement	engagement	NN	NN	_	11	nmod	_	_
15	were	be	VBD	VBD	_	16	auxpass	_	_
16	shown	show	VBN	VBN	_	0	root	_	_
17	to	to	TO	TO	_	18	mark	_	_
18	contain	contain	VB	VB	_	16	xcomp	_	_
19	p50	p50	NN	NN	_	21	compound	_	_
20	NF-kappa	nf-kappa	NN	NN	_	21	compound	_	_
21	B1	b1	NN	NN	_	18	dobj	_	_
22	,	,	,	,	_	21	punct	_	_
23	p65	p65	NN	NN	_	24	compound	_	_
24	RelA	rela	NN	NN	_	21	conj	_	_
25	,	,	,	,	_	21	punct	_	_
26	and	and	CC	CC	_	21	cc	_	_
27	possibly	possibly	RB	RB	_	30	advmod	_	_
28	other	other	JJ	JJ	_	30	amod	_	_
29	transcription	transcription	NN	NN	_	30	compound	_	_
30	factors	factor	NNS	NNS	_	21	conj	_	_
31	.	.	.	.	_	16	punct	_	_

1	Collectively	collectively	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	our	we	PRP$	PRP$	_	4	nmod:poss	_	_
4	results	result	NNS	NNS	_	5	nsubj	_	_
5	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
6	that	that	IN	IN	_	14	mark	_	_
7	nuclear	nuclear	JJ	JJ	_	8	amod	_	_
8	translocation	translocation	NN	NN	_	14	nsubj	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	activation	activation	NN	NN	_	8	conj	_	_
11	of	of	IN	IN	_	13	case	_	_
12	NF-kappa	nf-kappa	NN	NN	_	13	compound	_	_
13	B	b	NN	NN	_	8	nmod	_	_
14	rank	rank	NN	NN	_	5	ccomp	_	_
15	among	among	IN	IN	_	19	case	_	_
16	the	the	DT	DT	_	19	det	_	_
17	short-term	short-term	JJ	JJ	_	19	amod	_	_
18	cellular	cellular	JJ	JJ	_	19	amod	_	_
19	responses	response	NNS	NNS	_	14	nmod	_	_
20	elicited	elicit	VBD	VBD	_	19	acl	_	_
21	following	follow	VBG	VBG	_	23	case	_	_
22	CD30	cd30	NN	NN	_	23	compound	_	_
23	ligation	ligation	NN	NN	_	20	nmod	_	_
24	.	.	.	.	_	5	punct	_	_

1	Constitutive	constitutive	JJ	JJ	_	4	amod	_	_
2	NF-kappa	nf-kappa	NN	NN	_	3	compound	_	_
3	B	b	NN	NN	_	4	compound	_	_
4	activation	activation	NN	NN	_	0	root	_	_
5	,	,	,	,	_	4	punct	_	_
6	enhanced	enhance	VBN	VBN	_	7	amod	_	_
7	granulopoiesis	granulopoiesis	NN	NN	_	4	conj	_	_
8	,	,	,	,	_	4	punct	_	_
9	and	and	CC	CC	_	4	cc	_	_
10	neonatal	neonatal	JJ	JJ	_	11	amod	_	_
11	lethality	lethality	NN	NN	_	4	conj	_	_
12	in	in	IN	IN	_	17	case	_	_
13	I	i	NN	NN	_	17	compound	_	_
14	kappa	kappa	NN	NN	_	17	compound	_	_
15	B	b	NN	NN	_	17	compound	_	_
16	alpha-deficient	alpha-deficient	JJ	JJ	_	17	amod	_	_
17	mice	mouse	NNS	NNS	_	4	nmod	_	_
18	.	.	.	.	_	4	punct	_	_

1	Transcription	transcription	NN	NN	_	2	compound	_	_
2	factors	factor	NNS	NNS	_	10	nsubjpass	_	_
3	belonging	belong	VBG	VBG	_	2	acl	_	_
4	to	to	TO	TO	_	8	case	_	_
5	the	the	DT	DT	_	8	det	_	_
6	NF-kappa	nf-kappa	NN	NN	_	8	compound	_	_
7	B	b	NN	NN	_	8	compound	_	_
8	family	family	NN	NN	_	3	nmod	_	_
9	are	be	VBP	VBP	_	10	auxpass	_	_
10	controlled	control	VBN	VBN	_	0	root	_	_
11	by	by	IN	IN	_	16	case	_	_
12	inhibitory	inhibitory	JJ	JJ	_	16	amod	_	_
13	I	i	NN	NN	_	16	compound	_	_
14	kappa	kappa	NN	NN	_	16	compound	_	_
15	B	b	NN	NN	_	16	compound	_	_
16	proteins	protein	NNS	NNS	_	10	nmod	_	_
17	,	,	,	,	_	16	punct	_	_
18	mainly	mainly	RB	RB	_	22	advmod	_	_
19	I	i	NN	NN	_	22	compound	_	_
20	kappa	kappa	NN	NN	_	22	compound	_	_
21	B	b	NN	NN	_	22	compound	_	_
22	alpha	alpha	NN	NN	_	16	appos	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	I	i	NN	NN	_	27	compound	_	_
25	kappa	kappa	NN	NN	_	27	compound	_	_
26	B	b	NN	NN	_	27	compound	_	_
27	beta	beta	NN	NN	_	22	conj	_	_
28	.	.	.	.	_	10	punct	_	_

1	Apparently	apparently	RB	RB	_	2	advmod	_	_
2	normal	normal	JJ	JJ	_	11	advmod	_	_
3	at	at	IN	IN	_	4	case	_	_
4	birth	birth	NN	NN	_	2	nmod	_	_
5	,	,	,	,	_	11	punct	_	_
6	I	i	NN	NN	_	10	compound	_	_
7	kappa	kappa	NN	NN	_	10	compound	_	_
8	B	b	NN	NN	_	10	compound	_	_
9	alpha-/-	alpha-/-	JJ	JJ	_	10	amod	_	_
10	mice	mouse	NNS	NNS	_	11	nsubj	_	_
11	exhibit	exhibit	VBP	VBP	_	0	root	_	_
12	severe	severe	JJ	JJ	_	13	amod	_	_
13	runting	runting	NN	NN	_	11	dobj	_	_
14	,	,	,	,	_	13	punct	_	_
15	skin	skin	NN	NN	_	16	compound	_	_
16	defects	defect	NNS	NNS	_	13	conj	_	_
17	,	,	,	,	_	13	punct	_	_
18	and	and	CC	CC	_	13	cc	_	_
19	extensive	extensive	JJ	JJ	_	20	amod	_	_
20	granulopoiesis	granulopoiesis	NN	NN	_	13	conj	_	_
21	postnatally	postnatally	RB	RB	_	11	advmod	_	_
22	,	,	,	,	_	11	punct	_	_
23	typically	typically	RB	RB	_	24	advmod	_	_
24	dying	die	VBG	VBG	_	11	advcl	_	_
25	by	by	IN	IN	_	27	case	_	_
26	8	8	CD	CD	_	27	nummod	_	_
27	days	day	NNS	NNS	_	24	nmod	_	_
28	.	.	.	.	_	11	punct	_	_

1	Hematopoietic	hematopoietic	JJ	JJ	_	2	amod	_	_
2	tissues	tissue	NNS	NNS	_	6	nsubj	_	_
3	from	from	IN	IN	_	5	case	_	_
4	these	these	DT	DT	_	5	det	_	_
5	mice	mouse	NNS	NNS	_	2	nmod	_	_
6	display	display	VBP	VBP	_	0	root	_	_
7	elevated	elevated	JJ	JJ	_	8	amod	_	_
8	levels	level	NNS	NNS	_	6	dobj	_	_
9	of	of	IN	IN	_	13	case	_	_
10	both	both	CC	CC	_	13	cc:preconj	_	_
11	nuclear	nuclear	JJ	JJ	_	13	amod	_	_
12	NF-kappa	nf-kappa	NN	NN	_	13	compound	_	_
13	B	b	NN	NN	_	8	nmod	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	mRNAs	mrna	NNS	NNS	_	13	conj	_	_
16	of	of	IN	IN	_	17	case	_	_
17	some	some	DT	DT	_	13	nmod	_	_
18	,	,	,	,	_	17	punct	_	_
19	but	but	CC	CC	_	17	cc	_	_
20	not	not	RB	RB	_	21	neg	_	_
21	all	all	DT	DT	_	17	conj	_	_
22	,	,	,	,	_	17	punct	_	_
23	genes	gene	NNS	NNS	_	17	conj	_	_
24	thought	think	VBN	VBN	_	23	acl	_	_
25	to	to	TO	TO	_	27	mark	_	_
26	be	be	VB	VB	_	27	auxpass	_	_
27	regulated	regulate	VBN	VBN	_	24	xcomp	_	_
28	by	by	IN	IN	_	30	case	_	_
29	NF-kappa	nf-kappa	NN	NN	_	30	compound	_	_
30	B	b	NN	NN	_	27	nmod	_	_
31	.	.	.	.	_	6	punct	_	_

1	NF-kappa	nf-kappa	NN	NN	_	2	compound	_	_
2	B	b	NN	NN	_	3	compound	_	_
3	elevation	elevation	NN	NN	_	4	nsubj	_	_
4	results	result	VBZ	VBZ	_	0	root	_	_
5	in	in	IN	IN	_	8	case	_	_
6	these	these	DT	DT	_	8	det	_	_
7	phenotypic	phenotypic	JJ	JJ	_	8	amod	_	_
8	abnormalities	abnormality	NNS	NNS	_	4	nmod	_	_
9	because	because	IN	IN	_	24	mark	_	_
10	mice	mouse	NNS	NNS	_	24	nsubj	_	_
11	lacking	lack	VBG	VBG	_	10	acl	_	_
12	both	both	CC	CC	_	16	cc:preconj	_	_
13	I	i	NN	NN	_	16	compound	_	_
14	kappa	kappa	NN	NN	_	16	compound	_	_
15	B	b	NN	NN	_	16	compound	_	_
16	alpha	alpha	NN	NN	_	11	dobj	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	the	the	DT	DT	_	20	det	_	_
19	p50	p50	NN	NN	_	20	compound	_	_
20	subunit	subunit	NN	NN	_	16	conj	_	_
21	of	of	IN	IN	_	23	case	_	_
22	NF-kappa	nf-kappa	NN	NN	_	23	compound	_	_
23	B	b	NN	NN	_	20	nmod	_	_
24	show	show	VBP	VBP	_	4	advcl	_	_
25	a	a	DT	DT	_	28	det	_	_
26	dramatically	dramatically	RB	RB	_	27	advmod	_	_
27	delayed	delay	VBN	VBN	_	28	amod	_	_
28	onset	onset	NN	NN	_	24	dobj	_	_
29	of	of	IN	IN	_	30	case	_	_
30	abnormalities	abnormality	NNS	NNS	_	28	nmod	_	_
31	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	13	nmod	_	_
3	to	to	TO	TO	_	5	case	_	_
4	hematopoietic	hematopoietic	JJ	JJ	_	5	amod	_	_
5	cells	cell	NNS	NNS	_	2	nmod	_	_
6	,	,	,	,	_	13	punct	_	_
7	I	i	NN	NN	_	12	compound	_	_
8	kappa	kappa	NN	NN	_	12	compound	_	_
9	B	b	NN	NN	_	12	compound	_	_
10	alpha-/-	alpha-/-	JJ	JJ	_	12	amod	_	_
11	embryonic	embryonic	JJ	JJ	_	12	amod	_	_
12	fibroblasts	fibroblast	NNS	NNS	_	13	nsubj	_	_
13	show	show	VBP	VBP	_	0	root	_	_
14	minimal	minimal	JJ	JJ	_	17	amod	_	_
15	constitutive	constitutive	JJ	JJ	_	17	amod	_	_
16	NF-kappa	nf-kappa	NN	NN	_	17	compound	_	_
17	B	b	NN	NN	_	13	dobj	_	_
18	,	,	,	,	_	17	punct	_	_
19	as	as	RB	RB	_	17	cc	_	_
20	well	well	RB	RB	_	19	mwe	_	_
21	as	as	IN	IN	_	19	mwe	_	_
22	normal	normal	JJ	JJ	_	26	amod	_	_
23	signal-dependent	signal-dependent	JJ	JJ	_	22	dep	_	_
24	NF-kappa	nf-kappa	NN	NN	_	25	compound	_	_
25	B	b	NN	NN	_	26	compound	_	_
26	activation	activation	NN	NN	_	17	conj	_	_
27	that	that	WDT	WDT	_	29	nsubj	_	_
28	is	be	VBZ	VBZ	_	29	cop	_	_
29	concomitant	concomitant	JJ	JJ	_	26	acl:relcl	_	_
30	with	with	IN	IN	_	35	case	_	_
31	I	i	NN	NN	_	34	compound	_	_
32	kappa	kappa	NN	NN	_	34	compound	_	_
33	B	b	NN	NN	_	34	compound	_	_
34	beta	beta	NN	NN	_	35	compound	_	_
35	degradation	degradation	NN	NN	_	29	nmod	_	_
36	.	.	.	.	_	13	punct	_	_

1	Our	we	PRP$	PRP$	_	2	nmod:poss	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	18	mark	_	_
5	I	i	NN	NN	_	8	compound	_	_
6	kappa	kappa	NN	NN	_	8	compound	_	_
7	b	b	NN	NN	_	8	compound	_	_
8	beta	beta	NN	NN	_	18	nsubjpass	_	_
9	,	,	,	,	_	8	punct	_	_
10	but	but	CC	CC	_	11	cc	_	_
11	not	not	RB	RB	_	8	cc	_	_
12	I	i	NN	NN	_	15	compound	_	_
13	kappa	kappa	NN	NN	_	15	compound	_	_
14	B	b	NN	NN	_	15	compound	_	_
15	alpha	alpha	NN	NN	_	8	conj	_	_
16	,	,	,	,	_	8	punct	_	_
17	is	be	VBZ	VBZ	_	18	auxpass	_	_
18	required	require	VBN	VBN	_	3	ccomp	_	_
19	for	for	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	signal-dependent	signal-dependent	JJ	JJ	_	22	amod	_	_
22	activation	activation	NN	NN	_	18	nmod	_	_
23	of	of	IN	IN	_	25	case	_	_
24	NF-kappa	nf-kappa	NN	NN	_	25	compound	_	_
25	B	b	NN	NN	_	22	nmod	_	_
26	in	in	IN	IN	_	27	case	_	_
27	fibroblasts	fibroblast	NNS	NNS	_	22	nmod	_	_
28	.	.	.	.	_	3	punct	_	_

1	However	however	RB	RB	_	8	advmod	_	_
2	,	,	,	,	_	8	punct	_	_
3	I	i	NN	NN	_	6	compound	_	_
4	kappa	kappa	NN	NN	_	6	compound	_	_
5	B	b	NN	NN	_	6	compound	_	_
6	alpha	alpha	NN	NN	_	8	nsubjpass	_	_
7	is	be	VBZ	VBZ	_	8	auxpass	_	_
8	required	require	VBN	VBN	_	0	root	_	_
9	for	for	IN	IN	_	12	case	_	_
10	the	the	DT	DT	_	12	det	_	_
11	postinduction	postinduction	JJ	JJ	_	12	amod	_	_
12	repression	repression	NN	NN	_	8	nmod	_	_
13	of	of	IN	IN	_	15	case	_	_
14	NF-kappa	nf-kappa	NN	NN	_	15	compound	_	_
15	B	b	NN	NN	_	12	nmod	_	_
16	in	in	IN	IN	_	17	case	_	_
17	fibroblasts	fibroblast	NNS	NNS	_	12	nmod	_	_
18	.	.	.	.	_	8	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	define	define	VBP	VBP	_	0	root	_	_
4	distinct	distinct	JJ	JJ	_	5	amod	_	_
5	roles	role	NNS	NNS	_	3	dobj	_	_
6	for	for	IN	IN	_	9	case	_	_
7	the	the	DT	DT	_	9	det	_	_
8	two	two	CD	CD	_	9	nummod	_	_
9	forms	form	NNS	NNS	_	5	nmod	_	_
10	of	of	IN	IN	_	13	case	_	_
11	I	i	NN	NN	_	13	compound	_	_
12	kappa	kappa	NN	NN	_	13	compound	_	_
13	B	b	NN	NN	_	9	nmod	_	_
14	and	and	CC	CC	_	3	cc	_	_
15	demonstrate	demonstrate	VBP	VBP	_	3	conj	_	_
16	the	the	DT	DT	_	17	det	_	_
17	necessity	necessity	NN	NN	_	15	dobj	_	_
18	for	for	IN	IN	_	20	case	_	_
19	stringent	stringent	JJ	JJ	_	20	amod	_	_
20	control	control	NN	NN	_	17	nmod	_	_
21	of	of	IN	IN	_	23	case	_	_
22	NF-kappa	nf-kappa	NN	NN	_	23	compound	_	_
23	B	b	NN	NN	_	20	nmod	_	_
24	.	.	.	.	_	3	punct	_	_

1	Attenuation	attenuation	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	6	case	_	_
3	gamma	gamma	NN	NN	_	6	compound	_	_
4	interferon-induced	interferon-induced	JJ	JJ	_	6	amod	_	_
5	tyrosine	tyrosine	NN	NN	_	6	compound	_	_
6	phosphorylation	phosphorylation	NN	NN	_	1	nmod	_	_
7	in	in	IN	IN	_	9	case	_	_
8	mononuclear	mononuclear	JJ	JJ	_	9	amod	_	_
9	phagocytes	phagocyte	NNS	NNS	_	1	nmod	_	_
10	infected	infect	VBN	VBN	_	9	acl	_	_
11	with	with	IN	IN	_	13	case	_	_
12	Leishmania	leishmania	FW	FW	_	13	compound	_	_
13	donovani	donovani	FW	FW	_	10	nmod	_	_
14	:	:	:	:	_	1	punct	_	_
15	selective	selective	JJ	JJ	_	16	amod	_	_
16	inhibition	inhibition	NN	NN	_	1	dep	_	_
17	of	of	IN	IN	_	18	case	_	_
18	signaling	signaling	NN	NN	_	16	nmod	_	_
19	through	through	IN	IN	_	21	case	_	_
20	Janus	janus	NN	NN	_	21	compound	_	_
21	kinases	kinase	NNS	NNS	_	18	nmod	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	Stat1	stat1	NN	NN	_	21	conj	_	_
24	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	induction	induction	NN	NN	_	12	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	gene	gene	NN	NN	_	5	compound	_	_
5	transcription	transcription	NN	NN	_	2	nmod	_	_
6	in	in	IN	IN	_	7	case	_	_
7	response	response	NN	NN	_	2	nmod	_	_
8	to	to	TO	TO	_	10	case	_	_
9	gamma	gamma	NN	NN	_	10	compound	_	_
10	interferon	interferon	NN	NN	_	7	nmod	_	_
11	is	be	VBZ	VBZ	_	12	cop	_	_
12	impaired	impaired	JJ	JJ	_	0	root	_	_
13	in	in	IN	IN	_	15	case	_	_
14	mononuclear	mononuclear	JJ	JJ	_	15	amod	_	_
15	phagocytes	phagocyte	NNS	NNS	_	12	nmod	_	_
16	infected	infect	VBN	VBN	_	15	acl	_	_
17	with	with	IN	IN	_	19	case	_	_
18	Leishmania	leishmania	FW	FW	_	19	compound	_	_
19	donovani	donovani	FW	FW	_	16	nmod	_	_
20	,	,	,	,	_	12	punct	_	_
21	and	and	CC	CC	_	12	cc	_	_
22	the	the	DT	DT	_	23	det	_	_
23	mechanisms	mechanism	NNS	NNS	_	28	nsubjpass	_	_
24	involved	involve	VBN	VBN	_	23	acl	_	_
25	are	be	VBP	VBP	_	28	auxpass	_	_
26	not	not	RB	RB	_	28	neg	_	_
27	fully	fully	RB	RB	_	28	advmod	_	_
28	understood	understand	VBN	VBN	_	12	conj	_	_
29	.	.	.	.	_	12	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	changes	change	NNS	NNS	_	12	nsubjpass	_	_
3	in	in	IN	IN	_	5	case	_	_
4	gene	gene	NN	NN	_	5	compound	_	_
5	expression	expression	NN	NN	_	2	nmod	_	_
6	brought	bring	VBN	VBN	_	2	acl	_	_
7	about	about	RP	RP	_	6	compound:prt	_	_
8	by	by	IN	IN	_	10	case	_	_
9	gamma	gamma	NN	NN	_	10	compound	_	_
10	interferon	interferon	NN	NN	_	6	nmod	_	_
11	are	be	VBP	VBP	_	12	auxpass	_	_
12	thought	think	VBN	VBN	_	0	root	_	_
13	to	to	TO	TO	_	14	mark	_	_
14	involve	involve	VB	VB	_	12	xcomp	_	_
15	transient	transient	JJ	JJ	_	16	amod	_	_
16	increases	increase	NNS	NNS	_	14	dobj	_	_
17	in	in	IN	IN	_	19	case	_	_
18	the	the	DT	DT	_	19	det	_	_
19	activities	activity	NNS	NNS	_	16	nmod	_	_
20	of	of	IN	IN	_	24	case	_	_
21	cellular	cellular	JJ	JJ	_	24	amod	_	_
22	protein	protein	NN	NN	_	24	compound	_	_
23	tyrosine	tyrosine	NN	NN	_	24	compound	_	_
24	kinases	kinase	NNS	NNS	_	19	nmod	_	_
25	,	,	,	,	_	24	punct	_	_
26	including	include	VBG	VBG	_	29	case	_	_
27	the	the	DT	DT	_	29	det	_	_
28	Janus	janus	NN	NN	_	29	compound	_	_
29	kinases	kinase	NNS	NNS	_	24	nmod	_	_
30	Jak1	jak1	NN	NN	_	29	dep	_	_
31	and	and	CC	CC	_	30	cc	_	_
32	Jak2	jak2	NN	NN	_	30	conj	_	_
33	,	,	,	,	_	12	punct	_	_
34	leading	lead	VBG	VBG	_	12	advcl	_	_
35	to	to	TO	TO	_	37	case	_	_
36	tyrosine	tyrosine	NN	NN	_	37	compound	_	_
37	phosphorylation	phosphorylation	NN	NN	_	34	nmod	_	_
38	of	of	IN	IN	_	42	case	_	_
39	the	the	DT	DT	_	42	det	_	_
40	transcription	transcription	NN	NN	_	42	compound	_	_
41	factor	factor	NN	NN	_	42	compound	_	_
42	Stat1	stat1	NN	NN	_	37	nmod	_	_
43	.	.	.	.	_	12	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	investigate	investigate	VB	VB	_	0	root	_	_
3	the	the	DT	DT	_	4	det	_	_
4	mechanisms	mechanism	NNS	NNS	_	2	dobj	_	_
5	accounting	account	VBG	VBG	_	4	acl	_	_
6	for	for	IN	IN	_	9	case	_	_
7	the	the	DT	DT	_	9	det	_	_
8	impaired	impaired	JJ	JJ	_	9	amod	_	_
9	responses	response	NNS	NNS	_	5	nmod	_	_
10	to	to	TO	TO	_	12	case	_	_
11	gamma	gamma	NN	NN	_	12	compound	_	_
12	interferon	interferon	NN	NN	_	9	nmod	_	_
13	,	,	,	,	_	2	punct	_	_
14	a	a	DT	DT	_	16	det	_	_
15	model	model	JJ	JJ	_	16	amod	_	_
16	system	system	NN	NN	_	36	nsubjpass	_	_
17	for	for	IN	IN	_	18	mark	_	_
18	examining	examine	VBG	VBG	_	16	acl	_	_
19	overall	overall	JJ	JJ	_	20	amod	_	_
20	changes	change	NNS	NNS	_	18	dobj	_	_
21	in	in	IN	IN	_	24	case	_	_
22	protein	protein	NN	NN	_	24	compound	_	_
23	tyrosine	tyrosine	NN	NN	_	24	compound	_	_
24	phosphorylation	phosphorylation	NN	NN	_	20	nmod	_	_
25	,	,	,	,	_	20	punct	_	_
26	activation	activation	NN	NN	_	20	conj	_	_
27	of	of	IN	IN	_	28	case	_	_
28	Jak1	jak1	NN	NN	_	26	nmod	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	Jak2	jak2	NN	NN	_	28	conj	_	_
31	and	and	CC	CC	_	20	cc	_	_
32	phosphorylation	phosphorylation	NN	NN	_	20	conj	_	_
33	of	of	IN	IN	_	34	case	_	_
34	Stat1	stat1	NN	NN	_	32	nmod	_	_
35	was	be	VBD	VBD	_	36	auxpass	_	_
36	developed	develop	VBN	VBN	_	2	parataxis	_	_
37	in	in	IN	IN	_	42	case	_	_
38	phorbol	phorbol	NN	NN	_	42	compound	_	_
39	12-myristate	12-myristate	NN	NN	_	42	compound	_	_
40	13-acetate-differentiated	13-acetate-differentiated	JJ	JJ	_	42	amod	_	_
41	U-937	u-937	NN	NN	_	42	compound	_	_
42	cells	cell	NNS	NNS	_	36	nmod	_	_
43	.	.	.	.	_	2	punct	_	_

1	Analysis	analysis	NN	NN	_	8	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	whole-cell	whole-cell	JJ	JJ	_	4	amod	_	_
4	lysates	lysate	NNS	NNS	_	1	nmod	_	_
5	by	by	IN	IN	_	7	case	_	_
6	antiphosphotyrosine	antiphosphotyrosine	NN	NN	_	7	compound	_	_
7	immunoblotting	immunoblotting	NN	NN	_	1	nmod	_	_
8	showed	show	VBD	VBD	_	0	root	_	_
9	that	that	IN	IN	_	14	mark	_	_
10	incubation	incubation	NN	NN	_	14	nsubj	_	_
11	with	with	IN	IN	_	13	case	_	_
12	gamma	gamma	NN	NN	_	13	compound	_	_
13	interferon	interferon	NN	NN	_	10	nmod	_	_
14	brought	bring	VBD	VBD	_	8	ccomp	_	_
15	about	about	RP	RP	_	14	advmod	_	_
16	specific	specific	JJ	JJ	_	17	amod	_	_
17	increases	increase	NNS	NNS	_	14	dobj	_	_
18	in	in	IN	IN	_	20	case	_	_
19	phosphotyrosine	phosphotyrosine	NN	NN	_	20	compound	_	_
20	labeling	labeling	NN	NN	_	17	nmod	_	_
21	of	of	IN	IN	_	23	case	_	_
22	several	several	JJ	JJ	_	23	amod	_	_
23	proteins	protein	NNS	NNS	_	20	nmod	_	_
24	.	.	.	.	_	8	punct	_	_

1	Increased	increase	VBN	VBN	_	2	amod	_	_
2	labeling	labeling	NN	NN	_	6	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	these	these	DT	DT	_	5	det	_	_
5	proteins	protein	NNS	NNS	_	2	nmod	_	_
6	occurred	occur	VBD	VBD	_	0	root	_	_
7	to	to	TO	TO	_	9	case	_	_
8	similar	similar	JJ	JJ	_	9	amod	_	_
9	extents	extent	NNS	NNS	_	6	nmod	_	_
10	in	in	IN	IN	_	12	case	_	_
11	control	control	JJ	JJ	_	12	amod	_	_
12	cells	cell	NNS	NNS	_	6	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	in	in	IN	IN	_	15	case	_	_
15	cells	cell	NNS	NNS	_	12	conj	_	_
16	that	that	WDT	WDT	_	19	nsubjpass	_	_
17	had	have	VBD	VBD	_	19	aux	_	_
18	been	be	VBN	VBN	_	19	auxpass	_	_
19	infected	infect	VBN	VBN	_	15	acl:relcl	_	_
20	with	with	IN	IN	_	22	case	_	_
21	L.	l.	FW	FW	_	22	compound	_	_
22	donovani	donovani	FW	FW	_	19	nmod	_	_
23	for	for	IN	IN	_	25	case	_	_
24	16	16	CD	CD	_	25	nummod	_	_
25	h	h	NN	NN	_	19	nmod	_	_
26	.	.	.	.	_	6	punct	_	_

1	Jak1	jak1	NN	NN	_	8	nsubjpass	_	_
2	,	,	,	,	_	1	punct	_	_
3	Jak2	jak2	NN	NN	_	1	conj	_	_
4	,	,	,	,	_	1	punct	_	_
5	and	and	CC	CC	_	1	cc	_	_
6	Stat1	stat1	NN	NN	_	1	conj	_	_
7	were	be	VBD	VBD	_	8	auxpass	_	_
8	immunoprecipitated	immunoprecipitate	VBN	VBN	_	0	root	_	_
9	from	from	IN	IN	_	10	case	_	_
10	control	control	JJ	JJ	_	8	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	interferon-treated	interferon-treated	JJ	JJ	_	13	amod	_	_
13	cells	cell	NNS	NNS	_	10	conj	_	_
14	,	,	,	,	_	8	punct	_	_
15	and	and	CC	CC	_	8	cc	_	_
16	tyrosine	tyrosine	NN	NN	_	17	compound	_	_
17	phosphorylation	phosphorylation	NN	NN	_	27	nsubjpass	_	_
18	of	of	IN	IN	_	20	case	_	_
19	these	these	DT	DT	_	20	det	_	_
20	proteins	protein	NNS	NNS	_	17	nmod	_	_
21	,	,	,	,	_	17	punct	_	_
22	detected	detect	VBN	VBN	_	17	acl	_	_
23	by	by	IN	IN	_	25	case	_	_
24	antiphosphotyrosine	antiphosphotyrosine	NN	NN	_	25	compound	_	_
25	immunoblotting	immunoblotting	NN	NN	_	22	nmod	_	_
26	was	be	VBD	VBD	_	27	auxpass	_	_
27	used	use	VBN	VBN	_	8	conj	_	_
28	to	to	TO	TO	_	29	mark	_	_
29	measured	measure	VBN	VBN	_	27	xcomp	_	_
30	their	they	PRP$	PRP$	_	31	nmod:poss	_	_
31	activation	activation	NN	NN	_	29	dobj	_	_
32	.	.	.	.	_	8	punct	_	_

1	Tyrosine	tyrosine	NN	NN	_	2	compound	_	_
2	phosphorylation	phosphorylation	NN	NN	_	10	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	Jak1	jak1	NN	NN	_	2	nmod	_	_
5	,	,	,	,	_	4	punct	_	_
6	Jak2	jak2	NN	NN	_	4	conj	_	_
7	,	,	,	,	_	4	punct	_	_
8	and	and	CC	CC	_	4	cc	_	_
9	Stat1	stat1	NN	NN	_	4	conj	_	_
10	increased	increase	VBD	VBD	_	0	root	_	_
11	markedly	markedly	RB	RB	_	10	advmod	_	_
12	,	,	,	,	_	10	punct	_	_
13	in	in	IN	IN	_	16	case	_	_
14	a	a	DT	DT	_	16	det	_	_
15	dose-dependent	dose-dependent	JJ	JJ	_	16	amod	_	_
16	manner	manner	NN	NN	_	10	nmod	_	_
17	,	,	,	,	_	10	punct	_	_
18	in	in	IN	IN	_	20	case	_	_
19	U-937	u-937	NN	NN	_	20	compound	_	_
20	cells	cell	NNS	NNS	_	10	nmod	_	_
21	incubated	incubate	VBN	VBN	_	20	acl	_	_
22	with	with	IN	IN	_	24	case	_	_
23	gamma	gamma	NN	NN	_	24	compound	_	_
24	interferon	interferon	NN	NN	_	21	nmod	_	_
25	.	.	.	.	_	10	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	22	nmod	_	_
3	,	,	,	,	_	22	punct	_	_
4	in	in	IN	IN	_	5	case	_	_
5	cells	cell	NNS	NNS	_	22	nmod	_	_
6	infected	infect	VBN	VBN	_	5	acl	_	_
7	with	with	IN	IN	_	9	case	_	_
8	L.	l.	FW	FW	_	9	compound	_	_
9	donovani	donovani	FW	FW	_	6	nmod	_	_
10	,	,	,	,	_	22	punct	_	_
11	tyrosine	tyrosine	NN	NN	_	12	compound	_	_
12	phosphorylation	phosphorylation	NN	NN	_	22	nsubj	_	_
13	of	of	IN	IN	_	14	case	_	_
14	Jak1	jak1	NN	NN	_	12	nmod	_	_
15	,	,	,	,	_	14	punct	_	_
16	Jak2	jak2	NN	NN	_	14	conj	_	_
17	,	,	,	,	_	14	punct	_	_
18	and	and	CC	CC	_	14	cc	_	_
19	Stat1	stat1	NN	NN	_	14	conj	_	_
20	was	be	VBD	VBD	_	22	cop	_	_
21	markedly	markedly	RB	RB	_	22	advmod	_	_
22	impaired	impaired	JJ	JJ	_	0	root	_	_
23	.	.	.	.	_	22	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	effect	effect	NN	NN	_	4	nsubj	_	_
3	was	be	VBD	VBD	_	4	cop	_	_
4	dependent	dependent	JJ	JJ	_	0	root	_	_
5	upon	upon	IN	IN	_	7	case	_	_
6	the	the	DT	DT	_	7	det	_	_
7	duration	duration	NN	NN	_	4	nmod	_	_
8	of	of	IN	IN	_	9	case	_	_
9	exposure	exposure	NN	NN	_	7	nmod	_	_
10	to	to	TO	TO	_	12	case	_	_
11	L.	l.	FW	FW	_	12	compound	_	_
12	donovani	donovani	FW	FW	_	9	nmod	_	_
13	and	and	CC	CC	_	4	cc	_	_
14	was	be	VBD	VBD	_	15	cop	_	_
15	maximal	maximal	JJ	JJ	_	4	conj	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	complete	complete	JJ	JJ	_	15	conj	_	_
18	at	at	IN	IN	_	20	case	_	_
19	16	16	CD	CD	_	20	nummod	_	_
20	h	h	NN	NN	_	15	nmod	_	_
21	.	.	.	.	_	4	punct	_	_

1	Results	result	NNS	NNS	_	11	nsubjpass	_	_
2	similar	similar	JJ	JJ	_	1	amod	_	_
3	to	to	TO	TO	_	4	case	_	_
4	those	those	DT	DT	_	2	nmod	_	_
5	observed	observe	VBN	VBN	_	4	acl	_	_
6	with	with	IN	IN	_	8	case	_	_
7	U-937	u-937	NN	NN	_	8	compound	_	_
8	cells	cell	NNS	NNS	_	5	nmod	_	_
9	were	be	VBD	VBD	_	11	auxpass	_	_
10	also	also	RB	RB	_	11	advmod	_	_
11	obtained	obtain	VBN	VBN	_	0	root	_	_
12	with	with	IN	IN	_	16	case	_	_
13	human	human	JJ	JJ	_	16	amod	_	_
14	peripheral	peripheral	JJ	JJ	_	16	amod	_	_
15	blood	blood	NN	NN	_	16	compound	_	_
16	monocytes	monocyte	NNS	NNS	_	11	nmod	_	_
17	.	.	.	.	_	11	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	findings	finding	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	13	mark	_	_
5	infection	infection	NN	NN	_	13	nsubj	_	_
6	of	of	IN	IN	_	9	case	_	_
7	human	human	JJ	JJ	_	9	amod	_	_
8	mononuclear	mononuclear	JJ	JJ	_	9	amod	_	_
9	phagocytes	phagocyte	NNS	NNS	_	5	nmod	_	_
10	with	with	IN	IN	_	12	case	_	_
11	L.	l.	FW	FW	_	12	compound	_	_
12	donovani	donovani	FW	FW	_	5	nmod	_	_
13	leads	lead	VBZ	VBZ	_	3	ccomp	_	_
14	to	to	TO	TO	_	19	case	_	_
15	impaired	impaired	JJ	JJ	_	19	amod	_	_
16	gamma	gamma	NN	NN	_	19	compound	_	_
17	interferon-mediated	interferon-mediated	JJ	JJ	_	19	amod	_	_
18	tyrosine	tyrosine	NN	NN	_	19	compound	_	_
19	phosphorylation	phosphorylation	NN	NN	_	13	nmod	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	selective	selective	JJ	JJ	_	22	amod	_	_
22	effects	effect	NNS	NNS	_	19	conj	_	_
23	on	on	IN	IN	_	26	case	_	_
24	the	the	DT	DT	_	26	det	_	_
25	Jak-Stat1	jak-stat1	NN	NN	_	26	compound	_	_
26	pathway	pathway	NN	NN	_	22	nmod	_	_
27	.	.	.	.	_	3	punct	_	_

1	Unresponsiveness	unresponsiveness	NN	NN	_	11	nsubj	_	_
2	to	to	TO	TO	_	4	case	_	_
3	gamma	gamma	NN	NN	_	4	compound	_	_
4	interferon	interferon	NN	NN	_	1	nmod	_	_
5	for	for	IN	IN	_	6	case	_	_
6	activation	activation	NN	NN	_	1	nmod	_	_
7	of	of	IN	IN	_	9	case	_	_
8	this	this	DT	DT	_	9	det	_	_
9	pathway	pathway	NN	NN	_	6	nmod	_	_
10	may	may	MD	MD	_	11	aux	_	_
11	explain	explain	VB	VB	_	0	root	_	_
12	impaired	impaired	JJ	JJ	_	14	amod	_	_
13	transcriptional	transcriptional	JJ	JJ	_	14	amod	_	_
14	responses	response	NNS	NNS	_	11	dobj	_	_
15	in	in	IN	IN	_	17	case	_	_
16	leishmania-infected	leishmania-infected	JJ	JJ	_	17	amod	_	_
17	cells	cell	NNS	NNS	_	14	nmod	_	_
18	.	.	.	.	_	11	punct	_	_

1	Mutually	mutually	RB	RB	_	2	advmod	_	_
2	exclusive	exclusive	JJ	JJ	_	3	amod	_	_
3	interaction	interaction	NN	NN	_	0	root	_	_
4	of	of	IN	IN	_	11	case	_	_
5	a	a	DT	DT	_	11	det	_	_
6	novel	novel	JJ	JJ	_	11	amod	_	_
7	matrix	matrix	NN	NN	_	11	compound	_	_
8	attachment	attachment	NN	NN	_	11	compound	_	_
9	region	region	NN	NN	_	11	compound	_	_
10	binding	binding	NN	NN	_	11	compound	_	_
11	protein	protein	NN	NN	_	3	nmod	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	the	the	DT	DT	_	16	det	_	_
14	NF-muNR	nf-munr	NN	NN	_	16	compound	_	_
15	enhancer	enhancer	NN	NN	_	16	compound	_	_
16	repressor	repressor	NN	NN	_	11	conj	_	_
17	.	.	.	.	_	3	punct	_	_

1	Implications	implication	NNS	NNS	_	0	root	_	_
2	for	for	IN	IN	_	3	case	_	_
3	regulation	regulation	NN	NN	_	1	nmod	_	_
4	of	of	IN	IN	_	8	case	_	_
5	immunoglobulin	immunoglobulin	NN	NN	_	7	compound	_	_
6	heavy	heavy	JJ	JJ	_	7	amod	_	_
7	chain	chain	NN	NN	_	8	compound	_	_
8	expression	expression	NN	NN	_	3	nmod	_	_
9	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	9	det	_	_
2	immunoglobulin	immunoglobulin	NN	NN	_	4	compound	_	_
3	heavy	heavy	NN	NN	_	4	compound	_	_
4	chain	chain	NN	NN	_	9	compound	_	_
5	(	(	-LRB-	-LRB-	_	6	punct	_	_
6	IgH	igh	NN	NN	_	4	appos	_	_
7	)	)	-RRB-	-RRB-	_	6	punct	_	_
8	intronic	intronic	JJ	JJ	_	9	amod	_	_
9	enhancer	enhancer	NN	NN	_	10	nsubj	_	_
10	stimulates	stimulate	VBZ	VBZ	_	0	root	_	_
11	transcription	transcription	NN	NN	_	10	dobj	_	_
12	from	from	IN	IN	_	14	case	_	_
13	functional	functional	JJ	JJ	_	14	amod	_	_
14	promoters	promoter	NNS	NNS	_	11	nmod	_	_
15	in	in	IN	IN	_	17	case	_	_
16	B	b	NN	NN	_	17	compound	_	_
17	lymphocytes	lymphocyte	NNS	NNS	_	14	nmod	_	_
18	but	but	CC	CC	_	19	cc	_	_
19	not	not	RB	RB	_	17	cc	_	_
20	other	other	JJ	JJ	_	22	amod	_	_
21	cell	cell	NN	NN	_	22	compound	_	_
22	types	type	NNS	NNS	_	17	conj	_	_
23	.	.	.	.	_	10	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	observation	observation	NN	NN	_	29	nsubj	_	_
3	that	that	IN	IN	_	17	mark	_	_
4	binding	bind	VBG	VBG	_	5	amod	_	_
5	sites	site	NNS	NNS	_	17	nsubj	_	_
6	for	for	IN	IN	_	16	case	_	_
7	the	the	DT	DT	_	16	det	_	_
8	nuclear	nuclear	JJ	JJ	_	16	amod	_	_
9	factor-mu	factor-mu	NN	NN	_	16	compound	_	_
10	negative	negative	JJ	JJ	_	16	amod	_	_
11	regulator	regulator	NN	NN	_	16	compound	_	_
12	(	(	-LRB-	-LRB-	_	16	punct	_	_
13	NF-muNR	nf-munr	NN	NN	_	16	compound	_	_
14	)	)	-RRB-	-RRB-	_	16	punct	_	_
15	enhancer	enhancer	NN	NN	_	16	compound	_	_
16	repressor	repressor	NN	NN	_	5	nmod	_	_
17	overlap	overlap	VBP	VBP	_	2	ccomp	_	_
18	nuclear	nuclear	JJ	JJ	_	21	amod	_	_
19	matrix	matrix	NN	NN	_	21	compound	_	_
20	attachment	attachment	NN	NN	_	21	compound	_	_
21	regions	region	NNS	NNS	_	17	dobj	_	_
22	(	(	-LRB-	-LRB-	_	23	punct	_	_
23	MARs	mar	NNS	NNS	_	21	appos	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	in	in	IN	IN	_	27	case	_	_
26	this	this	DT	DT	_	27	det	_	_
27	enhancer	enhancer	NN	NN	_	21	nmod	_	_
28	has	have	VBZ	VBZ	_	29	aux	_	_
29	lead	lead	VBN	VBN	_	0	root	_	_
30	to	to	TO	TO	_	32	case	_	_
31	the	the	DT	DT	_	32	det	_	_
32	hypothesis	hypothesis	NN	NN	_	29	nmod	_	_
33	that	that	IN	IN	_	43	mark	_	_
34	the	the	DT	DT	_	37	det	_	_
35	cell	cell	NN	NN	_	37	compound	_	_
36	type	type	NN	NN	_	37	compound	_	_
37	specificity	specificity	NN	NN	_	43	nsubjpass	_	_
38	of	of	IN	IN	_	40	case	_	_
39	the	the	DT	DT	_	40	det	_	_
40	enhancer	enhancer	NN	NN	_	37	nmod	_	_
41	might	might	MD	MD	_	43	aux	_	_
42	be	be	VB	VB	_	43	auxpass	_	_
43	controlled	control	VBN	VBN	_	32	ccomp	_	_
44	by	by	IN	IN	_	45	mark	_	_
45	regulating	regulate	VBG	VBG	_	43	advcl	_	_
46	nuclear	nuclear	JJ	JJ	_	48	amod	_	_
47	matrix	matrix	NN	NN	_	48	compound	_	_
48	attachment	attachment	NN	NN	_	45	dobj	_	_
49	(	(	-LRB-	-LRB-	_	50	punct	_	_
50	Scheuermann	Scheuermann	NNP	NNP	_	29	dep	_	_
51	,	,	,	,	_	50	punct	_	_
52	R.	R.	NNP	NNP	_	53	compound	_	_
53	H.	H.	NNP	NNP	_	50	conj	_	_
54	,	,	,	,	_	50	punct	_	_
55	and	and	CC	CC	_	50	cc	_	_
56	Chen	Chen	NNP	NNP	_	58	compound	_	_
57	,	,	,	,	_	58	punct	_	_
58	U.	U.	NNP	NNP	_	50	conj	_	_
59	(	(	-LRB-	-LRB-	_	60	punct	_	_
60	1989	1989	CD	CD	_	50	appos	_	_
61	)	)	-RRB-	-RRB-	_	60	punct	_	_
62	Genes	Genes	NNP	NNP	_	50	dep	_	_
63	&amp;	&amp;	CC	CC	_	62	cc	_	_
64	Dev.	Dev.	NNP	NNP	_	62	conj	_	_
65	3	3	CD	CD	_	62	nummod	_	_
66	,	,	,	,	_	50	punct	_	_
67	1255-1266	1255-1266	CD	CD	_	50	amod	_	_
68	)	)	-RRB-	-RRB-	_	50	punct	_	_
69	.	.	.	.	_	29	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	understand	understand	VB	VB	_	0	root	_	_
3	the	the	DT	DT	_	4	det	_	_
4	role	role	NN	NN	_	2	dobj	_	_
5	of	of	IN	IN	_	6	case	_	_
6	MARs	mar	NNS	NNS	_	4	nmod	_	_
7	in	in	IN	IN	_	10	case	_	_
8	IgH	igh	NN	NN	_	9	compound	_	_
9	enhancer	enhancer	NN	NN	_	10	compound	_	_
10	regulation	regulation	NN	NN	_	4	nmod	_	_
11	,	,	,	,	_	2	punct	_	_
12	we	we	PRP	PRP	_	14	nsubj	_	_
13	have	have	VBP	VBP	_	14	aux	_	_
14	identified	identify	VBN	VBN	_	2	parataxis	_	_
15	a	a	DT	DT	_	18	det	_	_
16	novel	novel	JJ	JJ	_	18	amod	_	_
17	MAR-binding	mar-binding	JJ	JJ	_	18	amod	_	_
18	protein	protein	NN	NN	_	14	dobj	_	_
19	,	,	,	,	_	18	punct	_	_
20	MAR-BP1	mar-bp1	NN	NN	_	18	appos	_	_
21	,	,	,	,	_	14	punct	_	_
22	from	from	IN	IN	_	26	case	_	_
23	soluble	soluble	JJ	JJ	_	24	amod	_	_
24	nuclear	nuclear	JJ	JJ	_	26	amod	_	_
25	matrix	matrix	NN	NN	_	26	compound	_	_
26	preparations	preparation	NNS	NNS	_	14	nmod	_	_
27	based	base	VBN	VBN	_	30	case	_	_
28	on	on	IN	IN	_	30	case	_	_
29	its	its	PRP$	PRP$	_	30	nmod:poss	_	_
30	ability	ability	NN	NN	_	14	advcl	_	_
31	to	to	TO	TO	_	32	mark	_	_
32	bind	bind	VB	VB	_	30	acl	_	_
33	to	to	TO	TO	_	35	case	_	_
34	the	the	DT	DT	_	35	det	_	_
35	MARs	mar	NNS	NNS	_	32	nmod	_	_
36	associated	associate	VBN	VBN	_	35	acl	_	_
37	with	with	IN	IN	_	40	case	_	_
38	the	the	DT	DT	_	40	det	_	_
39	IgH	igh	NN	NN	_	40	compound	_	_
40	enhancer	enhancer	NN	NN	_	36	nmod	_	_
41	.	.	.	.	_	2	punct	_	_

1	Purified	purify	VBN	VBN	_	2	amod	_	_
2	MAR-BP1	mar-bp1	NN	NN	_	3	nsubj	_	_
3	migrates	migrate	VBZ	VBZ	_	0	root	_	_
4	as	as	IN	IN	_	7	case	_	_
5	a	a	DT	DT	_	7	det	_	_
6	33-kDa	33-kda	JJ	JJ	_	7	amod	_	_
7	protein	protein	NN	NN	_	3	nmod	_	_
8	,	,	,	,	_	3	punct	_	_
9	and	and	CC	CC	_	3	cc	_	_
10	it	it	PRP	PRP	_	13	nsubjpass	_	_
11	can	can	MD	MD	_	13	aux	_	_
12	be	be	VB	VB	_	13	auxpass	_	_
13	found	find	VBN	VBN	_	3	conj	_	_
14	in	in	IN	IN	_	17	case	_	_
15	nuclear	nuclear	JJ	JJ	_	17	amod	_	_
16	matrix	matrix	NN	NN	_	17	compound	_	_
17	preparations	preparation	NNS	NNS	_	13	nmod	_	_
18	from	from	IN	IN	_	20	case	_	_
19	a	a	DT	DT	_	20	det	_	_
20	number	number	NN	NN	_	17	nmod	_	_
21	of	of	IN	IN	_	23	case	_	_
22	different	different	JJ	JJ	_	23	amod	_	_
23	types	type	NNS	NNS	_	20	nmod	_	_
24	of	of	IN	IN	_	27	case	_	_
25	lymphoid	lymphoid	JJ	JJ	_	27	amod	_	_
26	cell	cell	NN	NN	_	27	compound	_	_
27	lines	line	NNS	NNS	_	23	nmod	_	_
28	.	.	.	.	_	3	punct	_	_

1	Although	although	IN	IN	_	7	mark	_	_
2	specific	specific	JJ	JJ	_	4	amod	_	_
3	binding	bind	VBG	VBG	_	4	amod	_	_
4	sites	site	NNS	NNS	_	7	nsubj	_	_
5	have	have	VBP	VBP	_	7	aux	_	_
6	been	be	VBN	VBN	_	7	cop	_	_
7	difficult	difficult	JJ	JJ	_	21	advcl	_	_
8	to	to	TO	TO	_	9	mark	_	_
9	localize	localize	VB	VB	_	7	ccomp	_	_
10	by	by	IN	IN	_	11	case	_	_
11	chemical	chemical	JJ	JJ	_	9	nmod	_	_
12	or	or	CC	CC	_	11	cc	_	_
13	enzymatic	enzymatic	JJ	JJ	_	11	conj	_	_
14	footprinting	footprinting	NN	NN	_	15	compound	_	_
15	procedures	procedure	NNS	NNS	_	11	dep	_	_
16	,	,	,	,	_	21	punct	_	_
17	NF-muNR	nf-munr	NN	NN	_	19	compound	_	_
18	binding	binding	NN	NN	_	19	compound	_	_
19	sites	site	NNS	NNS	_	21	nsubj	_	_
20	are	be	VBP	VBP	_	21	cop	_	_
21	critical	critical	JJ	JJ	_	0	root	_	_
22	for	for	IN	IN	_	25	case	_	_
23	efficient	efficient	JJ	JJ	_	25	amod	_	_
24	MAR-BP1	mar-bp1	NN	NN	_	25	compound	_	_
25	binding	binding	NN	NN	_	21	nmod	_	_
26	.	.	.	.	_	21	punct	_	_

1	Indeed	indeed	RB	RB	_	19	advmod	_	_
2	,	,	,	,	_	19	punct	_	_
3	binding	binding	NN	NN	_	19	nsubj	_	_
4	of	of	IN	IN	_	7	case	_	_
5	the	the	DT	DT	_	7	det	_	_
6	IgH	igh	NN	NN	_	7	compound	_	_
7	enhancer	enhancer	NN	NN	_	3	nmod	_	_
8	to	to	TO	TO	_	3	nmod	_	_
9	either	either	CC	CC	_	8	dep	_	_
10	intact	intact	JJ	JJ	_	11	amod	_	_
11	nuclear	nuclear	JJ	JJ	_	13	amod	_	_
12	matrix	matrix	NN	NN	_	13	compound	_	_
13	preparations	preparation	NNS	NNS	_	8	conj	_	_
14	or	or	CC	CC	_	8	cc	_	_
15	to	to	TO	TO	_	16	case	_	_
16	MAR-BP1	mar-bp1	NN	NN	_	8	conj	_	_
17	is	be	VBZ	VBZ	_	19	cop	_	_
18	mutually	mutually	RB	RB	_	19	advmod	_	_
19	exclusive	exclusive	JJ	JJ	_	0	root	_	_
20	to	to	TO	TO	_	22	case	_	_
21	NF-muNR	nf-munr	NN	NN	_	22	compound	_	_
22	binding	binding	NN	NN	_	19	nmod	_	_
23	.	.	.	.	_	19	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	4	nsubj	_	_
3	are	be	VBP	VBP	_	4	cop	_	_
4	consistent	consistent	JJ	JJ	_	0	root	_	_
5	with	with	IN	IN	_	7	case	_	_
6	a	a	DT	DT	_	7	det	_	_
7	model	model	NN	NN	_	4	nmod	_	_
8	for	for	IN	IN	_	11	case	_	_
9	cell-type	cell-type	JJ	JJ	_	10	amod	_	_
10	specific	specific	JJ	JJ	_	11	amod	_	_
11	regulation	regulation	NN	NN	_	7	nmod	_	_
12	in	in	IN	IN	_	13	case	_	_
13	which	which	WDT	WDT	_	23	nmod	_	_
14	binding	binding	NN	NN	_	23	nsubj	_	_
15	of	of	IN	IN	_	18	case	_	_
16	the	the	DT	DT	_	18	det	_	_
17	NF-muNR	nf-munr	NN	NN	_	18	compound	_	_
18	repressor	repressor	NN	NN	_	14	nmod	_	_
19	to	to	TO	TO	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	IgH	igh	NN	NN	_	22	compound	_	_
22	enhancer	enhancer	NN	NN	_	14	nmod	_	_
23	prevents	prevent	VBZ	VBZ	_	11	acl:relcl	_	_
24	nuclear	nuclear	JJ	JJ	_	26	amod	_	_
25	matrix	matrix	NN	NN	_	26	compound	_	_
26	attachment	attachment	NN	NN	_	23	dobj	_	_
27	in	in	IN	IN	_	29	case	_	_
28	inappropriate	inappropriate	JJ	JJ	_	29	amod	_	_
29	cells	cell	NNS	NNS	_	26	nmod	_	_
30	by	by	IN	IN	_	31	mark	_	_
31	interfering	interfere	VBG	VBG	_	23	advcl	_	_
32	with	with	IN	IN	_	34	case	_	_
33	MAR-BP1/enhancer	mar-bp1/enhancer	NN	NN	_	34	compound	_	_
34	interaction	interaction	NN	NN	_	31	nmod	_	_
35	.	.	.	.	_	4	punct	_	_

1	Multiple	multiple	JJ	JJ	_	2	amod	_	_
2	proteins	protein	NNS	NNS	_	3	nsubj	_	_
3	interact	interact	VBP	VBP	_	0	root	_	_
4	with	with	IN	IN	_	10	case	_	_
5	the	the	DT	DT	_	10	det	_	_
6	nuclear	nuclear	JJ	JJ	_	10	amod	_	_
7	inhibitory	inhibitory	JJ	JJ	_	10	amod	_	_
8	protein	protein	NN	NN	_	10	compound	_	_
9	repressor	repressor	NN	NN	_	10	compound	_	_
10	element	element	NN	NN	_	3	nmod	_	_
11	in	in	IN	IN	_	15	case	_	_
12	the	the	DT	DT	_	15	det	_	_
13	human	human	JJ	JJ	_	15	amod	_	_
14	interleukin-3	interleukin-3	NN	NN	_	15	compound	_	_
15	promoter	promoter	NN	NN	_	10	nmod	_	_
16	.	.	.	.	_	3	punct	_	_

1	T	t	NN	NN	_	3	compound	_	_
2	cell	cell	NN	NN	_	3	compound	_	_
3	expression	expression	NN	NN	_	11	nsubjpass	_	_
4	of	of	IN	IN	_	5	case	_	_
5	interleukin	interleukin	NN	NN	_	3	nmod	_	_
6	3	3	CD	CD	_	5	nummod	_	_
7	(	(	-LRB-	-LRB-	_	8	punct	_	_
8	IL-3	il-3	NN	NN	_	5	appos	_	_
9	)	)	-RRB-	-RRB-	_	8	punct	_	_
10	is	be	VBZ	VBZ	_	11	auxpass	_	_
11	directed	direct	VBN	VBN	_	0	root	_	_
12	by	by	IN	IN	_	13	case	_	_
13	positive	positive	JJ	JJ	_	11	nmod	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	negative	negative	JJ	JJ	_	13	conj	_	_
16	cis-acting	cis-acting	JJ	JJ	_	18	amod	_	_
17	DNA	dna	NN	NN	_	18	compound	_	_
18	elements	element	NNS	NNS	_	13	dep	_	_
19	clustered	clustered	JJ	JJ	_	13	amod	_	_
20	within	within	IN	IN	_	23	case	_	_
21	300	300	CD	CD	_	23	nummod	_	_
22	base	base	NN	NN	_	23	compound	_	_
23	pairs	pair	NNS	NNS	_	19	nmod	_	_
24	of	of	IN	IN	_	28	case	_	_
25	the	the	DT	DT	_	28	det	_	_
26	transcriptional	transcriptional	JJ	JJ	_	28	amod	_	_
27	start	start	NN	NN	_	28	compound	_	_
28	site	site	NN	NN	_	23	nmod	_	_
29	.	.	.	.	_	11	punct	_	_

1	A	a	DT	DT	_	4	det	_	_
2	strong	strong	JJ	JJ	_	4	amod	_	_
3	repressor	repressor	NN	NN	_	4	compound	_	_
4	element	element	NN	NN	_	16	nsubjpass	_	_
5	,	,	,	,	_	4	punct	_	_
6	termed	term	VBN	VBN	_	4	acl	_	_
7	nuclear	nuclear	JJ	JJ	_	9	amod	_	_
8	inhibitory	inhibitory	JJ	JJ	_	9	amod	_	_
9	protein	protein	NN	NN	_	6	xcomp	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	NIP	nip	NN	NN	_	9	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	,	,	,	,	_	4	punct	_	_
14	was	be	VBD	VBD	_	16	auxpass	_	_
15	previously	previously	RB	RB	_	16	advmod	_	_
16	mapped	map	VBN	VBN	_	0	root	_	_
17	to	to	TO	TO	_	19	case	_	_
18	a	a	DT	DT	_	19	det	_	_
19	segment	segment	NN	NN	_	16	nmod	_	_
20	of	of	IN	IN	_	23	case	_	_
21	the	the	DT	DT	_	23	det	_	_
22	IL-3	il-3	NN	NN	_	23	compound	_	_
23	promoter	promoter	NN	NN	_	19	nmod	_	_
24	between	between	IN	IN	_	25	case	_	_
25	nucleotides	nucleotide	NNS	NNS	_	23	nmod	_	_
26	-271	-271	CD	CD	_	25	nummod	_	_
27	and	and	CC	CC	_	25	cc	_	_
28	-250	-250	CD	CD	_	25	conj	_	_
29	.	.	.	.	_	16	punct	_	_

1	Functional	functional	JJ	JJ	_	2	amod	_	_
2	characterization	characterization	NN	NN	_	6	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	this	this	DT	DT	_	5	det	_	_
5	element	element	NN	NN	_	2	nmod	_	_
6	demonstrates	demonstrate	VBZ	VBZ	_	0	root	_	_
7	that	that	IN	IN	_	10	mark	_	_
8	it	it	PRP	PRP	_	10	nsubj	_	_
9	can	can	MD	MD	_	10	aux	_	_
10	mediate	mediate	VB	VB	_	6	ccomp	_	_
11	repression	repression	NN	NN	_	10	dobj	_	_
12	when	when	WRB	WRB	_	13	advmod	_	_
13	linked	link	VBN	VBN	_	10	advcl	_	_
14	in	in	IN	IN	_	15	case	_	_
15	cis	cis	NN	NN	_	13	nmod	_	_
16	to	to	TO	TO	_	19	case	_	_
17	a	a	DT	DT	_	19	det	_	_
18	heterologous	heterologous	JJ	JJ	_	19	amod	_	_
19	promoter	promoter	NN	NN	_	13	nmod	_	_
20	.	.	.	.	_	6	punct	_	_

1	DNA	dna	NN	NN	_	3	compound	_	_
2	binding	binding	NN	NN	_	3	compound	_	_
3	experiments	experiment	NNS	NNS	_	5	nsubjpass	_	_
4	were	be	VBD	VBD	_	5	auxpass	_	_
5	carried	carry	VBN	VBN	_	0	root	_	_
6	out	out	RP	RP	_	5	compound:prt	_	_
7	to	to	TO	TO	_	8	mark	_	_
8	characterize	characterize	VB	VB	_	5	xcomp	_	_
9	the	the	DT	DT	_	11	det	_	_
10	repressor	repressor	NN	NN	_	11	compound	_	_
11	activity	activity	NN	NN	_	8	dobj	_	_
12	.	.	.	.	_	5	punct	_	_

1	Using	use	VBG	VBG	_	0	root	_	_
2	varying	varying	JJ	JJ	_	3	amod	_	_
3	conditions	condition	NNS	NNS	_	1	dobj	_	_
4	,	,	,	,	_	1	punct	_	_
5	three	three	CD	CD	_	7	nummod	_	_
6	distinct	distinct	JJ	JJ	_	7	amod	_	_
7	complexes	complex	NNS	NNS	_	9	nsubjpass	_	_
8	were	be	VBD	VBD	_	9	auxpass	_	_
9	shown	show	VBN	VBN	_	1	parataxis	_	_
10	to	to	TO	TO	_	11	mark	_	_
11	interact	interact	VB	VB	_	9	xcomp	_	_
12	specifically	specifically	RB	RB	_	16	advmod	_	_
13	with	with	IN	IN	_	16	case	_	_
14	the	the	DT	DT	_	16	det	_	_
15	NIP	nip	NN	NN	_	16	compound	_	_
16	region	region	NN	NN	_	11	nmod	_	_
17	,	,	,	,	_	9	punct	_	_
18	although	although	IN	IN	_	20	case	_	_
19	only	only	RB	RB	_	20	advmod	_	_
20	one	one	CD	CD	_	9	nmod	_	_
21	correlates	correlate	VBZ	VBZ	_	20	dep	_	_
22	with	with	IN	IN	_	24	case	_	_
23	repressor	repressor	NN	NN	_	24	compound	_	_
24	activity	activity	NN	NN	_	21	nmod	_	_
25	.	.	.	.	_	1	punct	_	_

1	Complex	complex	NN	NN	_	3	nsubj	_	_
2	1	1	CD	CD	_	1	nummod	_	_
3	results	result	VBZ	VBZ	_	0	root	_	_
4	from	from	IN	IN	_	5	case	_	_
5	binding	binding	NN	NN	_	3	nmod	_	_
6	of	of	IN	IN	_	9	case	_	_
7	a	a	DT	DT	_	9	det	_	_
8	ubiquitous	ubiquitous	JJ	JJ	_	9	amod	_	_
9	polypeptide	polypeptide	NN	NN	_	5	nmod	_	_
10	that	that	WDT	WDT	_	11	nsubj	_	_
11	recognizes	recognize	VBZ	VBZ	_	9	acl:relcl	_	_
12	the	the	DT	DT	_	14	det	_	_
13	3'	3'	JJ	JJ	_	14	amod	_	_
14	portion	portion	NN	NN	_	11	dobj	_	_
15	of	of	IN	IN	_	17	case	_	_
16	this	this	DT	DT	_	17	det	_	_
17	sequence	sequence	NN	NN	_	14	nmod	_	_
18	and	and	CC	CC	_	11	cc	_	_
19	is	be	VBZ	VBZ	_	21	auxpass	_	_
20	not	not	RB	RB	_	21	neg	_	_
21	required	require	VBN	VBN	_	11	conj	_	_
22	for	for	IN	IN	_	23	case	_	_
23	repression	repression	NN	NN	_	21	nmod	_	_
24	.	.	.	.	_	3	punct	_	_

1	Complex	complex	NN	NN	_	3	nsubj	_	_
2	2	2	CD	CD	_	1	nummod	_	_
3	corresponds	correspond	VBZ	VBZ	_	0	root	_	_
4	to	to	TO	TO	_	5	case	_	_
5	binding	binding	NN	NN	_	3	nmod	_	_
6	of	of	IN	IN	_	8	case	_	_
7	transcription	transcription	NN	NN	_	8	compound	_	_
8	factor	factor	NN	NN	_	5	nmod	_	_
9	(	(	-LRB-	-LRB-	_	12	punct	_	_
10	upstream	upstream	JJ	JJ	_	12	amod	_	_
11	stimulatory	stimulatory	JJ	JJ	_	12	amod	_	_
12	factor	factor	NN	NN	_	8	appos	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	to	to	TO	TO	_	17	case	_	_
15	an	a	DT	DT	_	17	det	_	_
16	E-box	e-box	NN	NN	_	17	compound	_	_
17	motif	motif	NN	NN	_	5	nmod	_	_
18	in	in	IN	IN	_	21	case	_	_
19	the	the	DT	DT	_	21	det	_	_
20	5'	5'	JJ	JJ	_	21	amod	_	_
21	portion	portion	NN	NN	_	17	nmod	_	_
22	of	of	IN	IN	_	25	case	_	_
23	the	the	DT	DT	_	25	det	_	_
24	NIP	nip	NN	NN	_	25	compound	_	_
25	region	region	NN	NN	_	21	nmod	_	_
26	.	.	.	.	_	3	punct	_	_

1	DNA	dna	NN	NN	_	3	compound	_	_
2	binding	binding	NN	NN	_	3	compound	_	_
3	specificity	specificity	NN	NN	_	7	nsubj	_	_
4	of	of	IN	IN	_	5	case	_	_
5	complex	complex	NN	NN	_	3	nmod	_	_
6	3	3	CD	CD	_	5	nummod	_	_
7	overlaps	overlap	VBZ	VBZ	_	0	root	_	_
8	with	with	IN	IN	_	9	case	_	_
9	that	that	DT	DT	_	7	nmod	_	_
10	of	of	IN	IN	_	13	case	_	_
11	upstream	upstream	JJ	JJ	_	13	amod	_	_
12	stimulatory	stimulatory	JJ	JJ	_	13	amod	_	_
13	factor	factor	NN	NN	_	9	nmod	_	_
14	but	but	CC	CC	_	7	cc	_	_
15	is	be	VBZ	VBZ	_	17	cop	_	_
16	clearly	clearly	RB	RB	_	17	advmod	_	_
17	distinct	distinct	JJ	JJ	_	7	conj	_	_
18	.	.	.	.	_	7	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	determine	determine	VB	VB	_	0	root	_	_
3	which	which	WDT	WDT	_	9	nsubj	_	_
4	of	of	IN	IN	_	8	case	_	_
5	the	the	DT	DT	_	8	det	_	_
6	latter	latter	JJ	JJ	_	8	amod	_	_
7	two	two	CD	CD	_	8	nummod	_	_
8	complexes	complex	NNS	NNS	_	3	nmod	_	_
9	represents	represent	VBZ	VBZ	_	2	ccomp	_	_
10	NIP	nip	NN	NN	_	11	compound	_	_
11	activity	activity	NN	NN	_	9	dobj	_	_
12	,	,	,	,	_	2	punct	_	_
13	we	we	PRP	PRP	_	14	nsubj	_	_
14	incorporated	incorporate	VBD	VBD	_	2	parataxis	_	_
15	small	small	JJ	JJ	_	16	amod	_	_
16	alterations	alteration	NNS	NNS	_	14	dobj	_	_
17	into	into	IN	IN	_	20	case	_	_
18	the	the	DT	DT	_	20	det	_	_
19	NIP	nip	NN	NN	_	20	compound	_	_
20	site	site	NN	NN	_	14	nmod	_	_
21	of	of	IN	IN	_	26	case	_	_
22	an	a	DT	DT	_	26	det	_	_
23	IL-3	il-3	NN	NN	_	26	compound	_	_
24	promoter-linked	promoter-linked	JJ	JJ	_	26	amod	_	_
25	reporter	reporter	NN	NN	_	26	compound	_	_
26	construct	construct	NN	NN	_	20	nmod	_	_
27	and	and	CC	CC	_	14	cc	_	_
28	examined	examine	VBD	VBD	_	14	conj	_	_
29	their	they	PRP$	PRP$	_	30	nmod:poss	_	_
30	effects	effect	NNS	NNS	_	28	dobj	_	_
31	on	on	IN	IN	_	33	case	_	_
32	NIP-mediated	nip-mediated	JJ	JJ	_	33	amod	_	_
33	repression	repression	NN	NN	_	30	nmod	_	_
34	.	.	.	.	_	2	punct	_	_

1	Functional	functional	JJ	JJ	_	2	amod	_	_
2	specificity	specificity	NN	NN	_	5	nsubj	_	_
3	for	for	IN	IN	_	4	case	_	_
4	repression	repression	NN	NN	_	2	nmod	_	_
5	matches	match	VBZ	VBZ	_	0	root	_	_
6	the	the	DT	DT	_	9	det	_	_
7	DNA	dna	NN	NN	_	9	compound	_	_
8	binding	binding	NN	NN	_	9	compound	_	_
9	specificity	specificity	NN	NN	_	5	dobj	_	_
10	of	of	IN	IN	_	11	case	_	_
11	complex	complex	NN	NN	_	9	nmod	_	_
12	3	3	CD	CD	_	11	nummod	_	_
13	;	;	:	:	_	5	punct	_	_
14	both	both	DT	DT	_	16	cc:preconj	_	_
15	repressor	repressor	NN	NN	_	16	compound	_	_
16	activity	activity	NN	NN	_	21	nsubj	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	complex	complex	NN	NN	_	20	compound	_	_
19	3	3	CD	CD	_	18	nummod	_	_
20	binding	binding	NN	NN	_	16	conj	_	_
21	require	require	VBP	VBP	_	5	parataxis	_	_
22	the	the	DT	DT	_	25	det	_	_
23	consensus	consensus	NN	NN	_	24	compound	_	_
24	sequence	sequence	NN	NN	_	25	compound	_	_
25	CTCACNTNC	ctcacntnc	NN	NN	_	21	dobj	_	_
26	.	.	.	.	_	5	punct	_	_

1	Activation	activation	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	12	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	signal	signal	NN	NN	_	5	compound	_	_
5	transducer	transducer	NN	NN	_	12	compound	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	transcription	transcription	NN	NN	_	5	conj	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	STAT	stat	NN	NN	_	5	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	signaling	signaling	NN	NN	_	12	compound	_	_
12	pathway	pathway	NN	NN	_	1	nmod	_	_
13	in	in	IN	IN	_	18	case	_	_
14	a	a	DT	DT	_	18	det	_	_
15	primary	primary	JJ	JJ	_	18	amod	_	_
16	T	t	NN	NN	_	18	compound	_	_
17	cell	cell	NN	NN	_	18	compound	_	_
18	response	response	NN	NN	_	1	nmod	_	_
19	.	.	.	.	_	1	punct	_	_

1	Critical	critical	JJ	JJ	_	2	amod	_	_
2	role	role	NN	NN	_	0	root	_	_
3	for	for	IN	IN	_	4	case	_	_
4	IL-6	il-6	NN	NN	_	2	nmod	_	_
5	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	T	t	NN	NN	_	4	compound	_	_
3	cell	cell	NN	NN	_	4	compound	_	_
4	activation	activation	NN	NN	_	6	nsubjpass	_	_
5	is	be	VBZ	VBZ	_	6	auxpass	_	_
6	initiated	initiate	VBN	VBN	_	0	root	_	_
7	by	by	IN	IN	_	8	case	_	_
8	interaction	interaction	NN	NN	_	6	nmod	_	_
9	of	of	IN	IN	_	11	case	_	_
10	specific	specific	JJ	JJ	_	11	amod	_	_
11	Ags	ag	NNS	NNS	_	8	nmod	_	_
12	with	with	IN	IN	_	13	case	_	_
13	TCR	tcr	NN	NN	_	8	nmod	_	_
14	,	,	,	,	_	6	punct	_	_
15	followed	follow	VBN	VBN	_	6	advcl	_	_
16	by	by	IN	IN	_	17	case	_	_
17	activation	activation	NN	NN	_	15	nmod	_	_
18	of	of	IN	IN	_	21	case	_	_
19	intracellular	intracellular	JJ	JJ	_	21	amod	_	_
20	biochemical	biochemical	JJ	JJ	_	21	amod	_	_
21	events	event	NNS	NNS	_	17	nmod	_	_
22	leading	lead	VBG	VBG	_	21	acl	_	_
23	to	to	TO	TO	_	24	case	_	_
24	activation	activation	NN	NN	_	22	nmod	_	_
25	of	of	IN	IN	_	27	case	_	_
26	several	several	JJ	JJ	_	27	amod	_	_
27	genes	gene	NNS	NNS	_	24	nmod	_	_
28	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	activation	activation	NN	NN	_	24	nsubjpass	_	_
3	of	of	IN	IN	_	5	case	_	_
4	signal	signal	JJ	JJ	_	5	amod	_	_
5	transducer	transducer	NN	NN	_	2	nmod	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	activator	activator	NN	NN	_	5	conj	_	_
8	of	of	IN	IN	_	13	case	_	_
9	transcription	transcription	NN	NN	_	13	compound	_	_
10	(	(	-LRB-	-LRB-	_	13	punct	_	_
11	STAT	stat	NN	NN	_	13	compound	_	_
12	)	)	-RRB-	-RRB-	_	13	punct	_	_
13	proteins	protein	NNS	NNS	_	5	nmod	_	_
14	in	in	IN	IN	_	18	case	_	_
15	a	a	DT	DT	_	18	det	_	_
16	primary	primary	JJ	JJ	_	18	amod	_	_
17	TCR-mediated	tcr-mediated	JJ	JJ	_	18	amod	_	_
18	activation	activation	NN	NN	_	2	nmod	_	_
19	of	of	IN	IN	_	21	case	_	_
20	T	t	NN	NN	_	21	compound	_	_
21	cells	cell	NNS	NNS	_	18	nmod	_	_
22	have	have	VBP	VBP	_	24	aux	_	_
23	been	be	VBN	VBN	_	24	auxpass	_	_
24	explored	explore	VBN	VBN	_	0	root	_	_
25	.	.	.	.	_	24	punct	_	_

1	In	in	IN	IN	_	7	case	_	_
2	purified	purify	VBN	VBN	_	7	amod	_	_
3	human	human	JJ	JJ	_	7	amod	_	_
4	peripheral	peripheral	JJ	JJ	_	7	amod	_	_
5	blood	blood	NN	NN	_	7	compound	_	_
6	T	t	NN	NN	_	7	compound	_	_
7	cells	cell	NNS	NNS	_	13	nmod	_	_
8	,	,	,	,	_	13	punct	_	_
9	nuclear	nuclear	JJ	JJ	_	11	amod	_	_
10	STAT	stat	NN	NN	_	11	compound	_	_
11	proteins	protein	NNS	NNS	_	13	nsubjpass	_	_
12	were	be	VBD	VBD	_	13	auxpass	_	_
13	activated	activate	VBN	VBN	_	0	root	_	_
14	approximately	approximately	RB	RB	_	15	advmod	_	_
15	3	3	CD	CD	_	16	nummod	_	_
16	h	h	NN	NN	_	13	nmod	_	_
17	after	after	IN	IN	_	16	case	_	_
18	activation	activation	NN	NN	_	16	dep	_	_
19	by	by	IN	IN	_	22	case	_	_
20	cross-linked	cross-linked	JJ	JJ	_	22	amod	_	_
21	anti-CD3	anti-cd3	JJ	JJ	_	22	amod	_	_
22	Abs	ab	NNS	NNS	_	18	nmod	_	_
23	.	.	.	.	_	13	punct	_	_

1	These	these	DT	DT	_	3	det	_	_
2	STAT	stat	NN	NN	_	3	compound	_	_
3	proteins	protein	NNS	NNS	_	5	nsubjpass	_	_
4	were	be	VBD	VBD	_	5	auxpass	_	_
5	detected	detect	VBN	VBN	_	0	root	_	_
6	by	by	IN	IN	_	7	mark	_	_
7	using	use	VBG	VBG	_	5	advcl	_	_
8	the	the	DT	DT	_	10	det	_	_
9	IFN-gamma-activated	ifn-gamma-activated	JJ	JJ	_	10	amod	_	_
10	sequence	sequence	NN	NN	_	7	dobj	_	_
11	(	(	-LRB-	-LRB-	_	12	punct	_	_
12	GAS	gas	NN	NN	_	10	appos	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	and	and	CC	CC	_	10	cc	_	_
15	related	related	JJ	JJ	_	16	amod	_	_
16	oligonucleotides	oligonucleotide	NNS	NNS	_	10	conj	_	_
17	as	as	IN	IN	_	18	case	_	_
18	probes	probe	NNS	NNS	_	7	nmod	_	_
19	in	in	IN	IN	_	23	case	_	_
20	electrophoretic	electrophoretic	JJ	JJ	_	23	amod	_	_
21	mobility	mobility	NN	NN	_	23	compound	_	_
22	shift	shift	NN	NN	_	23	compound	_	_
23	assay	assay	NN	NN	_	7	nmod	_	_
24	.	.	.	.	_	5	punct	_	_

1	Analysis	analysis	NN	NN	_	9	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	nuclear	nuclear	JJ	JJ	_	5	amod	_	_
5	extracts	extract	NNS	NNS	_	1	nmod	_	_
6	with	with	IN	IN	_	8	case	_	_
7	anti-STAT	anti-stat	JJ	JJ	_	8	amod	_	_
8	Abs	ab	NNS	NNS	_	5	nmod	_	_
9	indicated	indicate	VBD	VBD	_	0	root	_	_
10	that	that	IN	IN	_	12	mark	_	_
11	they	they	PRP	PRP	_	12	nsubj	_	_
12	contained	contain	VBD	VBD	_	9	ccomp	_	_
13	STAT-3	stat-3	NN	NN	_	12	dobj	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	additional	additional	JJ	JJ	_	16	amod	_	_
16	proteins	protein	NNS	NNS	_	13	conj	_	_
17	crossreactive	crossreactive	JJ	JJ	_	16	amod	_	_
18	with	with	IN	IN	_	21	case	_	_
19	the	the	DT	DT	_	21	det	_	_
20	STAT	stat	NN	NN	_	21	compound	_	_
21	family	family	NN	NN	_	17	nmod	_	_
22	.	.	.	.	_	9	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	induction	induction	NN	NN	_	7	nsubjpass	_	_
3	of	of	IN	IN	_	5	case	_	_
4	STAT	stat	NN	NN	_	5	compound	_	_
5	activity	activity	NN	NN	_	2	nmod	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	inhibited	inhibit	VBN	VBN	_	0	root	_	_
8	completely	completely	RB	RB	_	10	advmod	_	_
9	by	by	IN	IN	_	10	case	_	_
10	pretreatment	pretreatment	NN	NN	_	7	nmod	_	_
11	with	with	IN	IN	_	13	case	_	_
12	either	either	CC	CC	_	13	cc:preconj	_	_
13	cycloheximide	cycloheximide	NN	NN	_	10	nmod	_	_
14	or	or	CC	CC	_	13	cc	_	_
15	cyclosporin	cyclosporin	NN	NN	_	16	compound	_	_
16	A	a	NN	NN	_	13	conj	_	_
17	,	,	,	,	_	7	punct	_	_
18	thus	thus	RB	RB	_	19	advmod	_	_
19	indicating	indicate	VBG	VBG	_	7	advcl	_	_
20	that	that	IN	IN	_	24	mark	_	_
21	the	the	DT	DT	_	22	det	_	_
22	induction	induction	NN	NN	_	24	nsubj	_	_
23	was	be	VBD	VBD	_	24	cop	_	_
24	due	due	JJ	JJ	_	19	ccomp	_	_
25	to	to	TO	TO	_	28	case	_	_
26	a	a	DT	DT	_	28	det	_	_
27	secondary	secondary	JJ	JJ	_	28	amod	_	_
28	factor	factor	NN	NN	_	24	nmod	_	_
29	produced	produce	VBN	VBN	_	28	acl	_	_
30	by	by	IN	IN	_	34	case	_	_
31	the	the	DT	DT	_	34	det	_	_
32	activated	activate	VBN	VBN	_	34	amod	_	_
33	T	t	NN	NN	_	34	compound	_	_
34	cells	cell	NNS	NNS	_	29	nmod	_	_
35	.	.	.	.	_	7	punct	_	_

1	As	as	IN	IN	_	6	mark	_	_
2	neutralizing	neutralizing	NN	NN	_	4	compound	_	_
3	anti-IL-6	anti-il-6	JJ	JJ	_	4	amod	_	_
4	Abs	ab	NNS	NNS	_	6	nsubj	_	_
5	effectively	effectively	RB	RB	_	6	advmod	_	_
6	down-regulated	down-regulate	VBD	VBD	_	30	dep	_	_
7	the	the	DT	DT	_	9	det	_	_
8	early	early	JJ	JJ	_	9	amod	_	_
9	induction	induction	NN	NN	_	6	dobj	_	_
10	of	of	IN	IN	_	12	case	_	_
11	STAT	stat	NN	NN	_	12	compound	_	_
12	proteins	protein	NNS	NNS	_	9	nmod	_	_
13	and	and	CC	CC	_	6	cc	_	_
14	as	as	IN	IN	_	19	mark	_	_
15	exogenously	exogenously	RB	RB	_	16	advmod	_	_
16	added	add	VBN	VBN	_	17	amod	_	_
17	IL-6	il-6	NN	NN	_	19	nsubj	_	_
18	rapidly	rapidly	RB	RB	_	19	advmod	_	_
19	activated	activate	VBD	VBD	_	6	conj	_	_
20	DNA	dna	NN	NN	_	21	compound	_	_
21	binding	binding	NN	NN	_	19	dobj	_	_
22	similar	similar	JJ	JJ	_	21	amod	_	_
23	to	to	TO	TO	_	25	case	_	_
24	TCR-mediated	tcr-mediated	JJ	JJ	_	25	case	_	_
25	bindings	binding	NNS	NNS	_	22	advcl	_	_
26	,	,	,	,	_	30	punct	_	_
27	it	it	PRP	PRP	_	30	nsubjpass	_	_
28	can	can	MD	MD	_	30	aux	_	_
29	be	be	VB	VB	_	30	auxpass	_	_
30	concluded	conclude	VBN	VBN	_	0	root	_	_
31	that	that	IN	IN	_	35	mark	_	_
32	IL-6	il-6	NN	NN	_	35	nsubj	_	_
33	is	be	VBZ	VBZ	_	35	cop	_	_
34	the	the	DT	DT	_	35	det	_	_
35	factor	factor	NN	NN	_	30	ccomp	_	_
36	responsible	responsible	JJ	JJ	_	35	amod	_	_
37	for	for	IN	IN	_	39	case	_	_
38	the	the	DT	DT	_	39	det	_	_
39	activation	activation	NN	NN	_	36	nmod	_	_
40	of	of	IN	IN	_	42	case	_	_
41	STAT	stat	NN	NN	_	42	compound	_	_
42	proteins	protein	NNS	NNS	_	39	nmod	_	_
43	in	in	IN	IN	_	48	case	_	_
44	a	a	DT	DT	_	48	det	_	_
45	primary	primary	JJ	JJ	_	48	amod	_	_
46	T	t	NN	NN	_	48	compound	_	_
47	cell	cell	NN	NN	_	48	compound	_	_
48	response	response	NN	NN	_	39	nmod	_	_
49	.	.	.	.	_	30	punct	_	_

1	Regulation	regulation	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	5	case	_	_
3	IkB	ikb	NN	NN	_	4	compound	_	_
4	alpha	alpha	NN	NN	_	5	compound	_	_
5	phosphorylation	phosphorylation	NN	NN	_	1	nmod	_	_
6	by	by	IN	IN	_	7	case	_	_
7	PKC-	pkc-	NN	NN	_	1	nmod	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	Ca(2+)-dependent	ca(2+)-dependent	JJ	JJ	_	7	conj	_	_
10	signal	signal	NN	NN	_	12	compound	_	_
11	transduction	transduction	NN	NN	_	12	compound	_	_
12	pathways	pathway	NNS	NNS	_	7	dep	_	_
13	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	Ca(2+)-dependent	ca(2+)-dependent	JJ	JJ	_	3	amod	_	_
3	phosphatase	phosphatase	NN	NN	_	13	nsubj	_	_
4	calcineurin	calcineurin	NN	NN	_	3	dep	_	_
5	,	,	,	,	_	3	punct	_	_
6	a	a	DT	DT	_	7	det	_	_
7	target	target	NN	NN	_	3	appos	_	_
8	of	of	IN	IN	_	9	case	_	_
9	FK506	fk506	NN	NN	_	7	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	CsA	csa	NN	NN	_	9	conj	_	_
12	,	,	,	,	_	3	punct	_	_
13	synergizes	synergize	VBZ	VBZ	_	0	root	_	_
14	with	with	IN	IN	_	16	case	_	_
15	PKC-induced	pkc-induced	JJ	JJ	_	16	amod	_	_
16	activation	activation	NN	NN	_	13	nmod	_	_
17	of	of	IN	IN	_	24	case	_	_
18	nuclear	nuclear	JJ	JJ	_	24	amod	_	_
19	factor	factor	NN	NN	_	24	compound	_	_
20	(	(	-LRB-	-LRB-	_	24	punct	_	_
21	NF	nf	NN	NN	_	24	compound	_	_
22	)	)	-RRB-	-RRB-	_	24	punct	_	_
23	-kappa	-kappa	NN	NN	_	24	compound	_	_
24	B	b	NN	NN	_	16	nmod	_	_
25	in	in	IN	IN	_	28	case	_	_
26	T	t	NN	NN	_	28	compound	_	_
27	cell	cell	NN	NN	_	28	compound	_	_
28	lines	line	NNS	NNS	_	16	nmod	_	_
29	.	.	.	.	_	13	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	investigated	investigate	VBN	VBN	_	0	root	_	_
4	whether	whether	IN	IN	_	8	mark	_	_
5	this	this	DT	DT	_	6	det	_	_
6	synergy	synergy	NN	NN	_	8	nsubj	_	_
7	is	be	VBZ	VBZ	_	8	cop	_	_
8	present	present	JJ	JJ	_	3	dep	_	_
9	in	in	IN	IN	_	12	case	_	_
10	other	other	JJ	JJ	_	12	amod	_	_
11	cell	cell	NN	NN	_	12	compound	_	_
12	types	type	NNS	NNS	_	8	nmod	_	_
13	and	and	CC	CC	_	8	cc	_	_
14	the	the	DT	DT	_	17	det	_	_
15	mechanism	mechanism	NN	NN	_	17	compound	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	s	s	NNS	NNS	_	8	conj	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	by	by	IN	IN	_	20	case	_	_
20	which	which	WDT	WDT	_	24	nmod	_	_
21	these	these	DT	DT	_	23	det	_	_
22	two	two	CD	CD	_	23	nummod	_	_
23	pathways	pathway	NNS	NNS	_	24	nsubj	_	_
24	lead	lead	VBP	VBP	_	17	acl:relcl	_	_
25	to	to	TO	TO	_	28	case	_	_
26	NF-kappa	nf-kappa	NN	NN	_	27	compound	_	_
27	B	b	NN	NN	_	28	compound	_	_
28	activation	activation	NN	NN	_	24	nmod	_	_
29	.	.	.	.	_	3	punct	_	_

1	While	while	IN	IN	_	5	mark	_	_
2	this	this	DT	DT	_	3	det	_	_
3	synergy	synergy	NN	NN	_	5	nsubj	_	_
4	is	be	VBZ	VBZ	_	5	cop	_	_
5	present	present	JJ	JJ	_	20	advcl	_	_
6	in	in	IN	IN	_	9	case	_	_
7	other	other	JJ	JJ	_	9	amod	_	_
8	cell	cell	NN	NN	_	9	compound	_	_
9	types	type	NNS	NNS	_	5	nmod	_	_
10	,	,	,	,	_	20	punct	_	_
11	in	in	IN	IN	_	16	case	_	_
12	the	the	DT	DT	_	16	det	_	_
13	monocytic	monocytic	JJ	JJ	_	16	amod	_	_
14	cell	cell	NN	NN	_	16	compound	_	_
15	line	line	NN	NN	_	16	compound	_	_
16	U937	u937	NN	NN	_	20	nmod	_	_
17	calcineurin	calcineurin	NN	NN	_	20	nsubj	_	_
18	is	be	VBZ	VBZ	_	20	cop	_	_
19	also	also	RB	RB	_	20	advmod	_	_
20	sufficient	sufficient	JJ	JJ	_	0	root	_	_
21	to	to	TO	TO	_	22	mark	_	_
22	activate	activate	VB	VB	_	20	xcomp	_	_
23	NF-kappa	nf-kappa	NN	NN	_	24	compound	_	_
24	B	b	NN	NN	_	22	dobj	_	_
25	.	.	.	.	_	20	punct	_	_

1	Having	have	VBG	VBG	_	3	aux	_	_
2	previously	previously	RB	RB	_	3	advmod	_	_
3	shown	show	VBN	VBN	_	0	root	_	_
4	that	that	IN	IN	_	10	mark	_	_
5	Ca(2+)-	ca(2+)-	NN	NN	_	10	nsubj	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	PKC-	pkc-	NN	NN	_	5	conj	_	_
8	dependent	dependent	JJ	JJ	_	9	amod	_	_
9	pathways	pathway	NNS	NNS	_	5	dep	_	_
10	synergize	synergize	VBP	VBP	_	3	ccomp	_	_
11	by	by	IN	IN	_	12	mark	_	_
12	accelerating	accelerate	VBG	VBG	_	10	advcl	_	_
13	the	the	DT	DT	_	14	det	_	_
14	degradation	degradation	NN	NN	_	12	dobj	_	_
15	of	of	IN	IN	_	17	case	_	_
16	IkB	ikb	NN	NN	_	17	compound	_	_
17	alpha	alpha	NN	NN	_	14	nmod	_	_
18	,	,	,	,	_	3	punct	_	_
19	we	we	PRP	PRP	_	20	nsubj	_	_
20	focused	focus	VBD	VBD	_	3	parataxis	_	_
21	on	on	IN	IN	_	23	case	_	_
22	the	the	DT	DT	_	23	det	_	_
23	regulation	regulation	NN	NN	_	20	nmod	_	_
24	of	of	IN	IN	_	27	case	_	_
25	IkB	ikb	NN	NN	_	26	compound	_	_
26	alpha	alpha	NN	NN	_	27	compound	_	_
27	phosphorylation	phosphorylation	NN	NN	_	23	nmod	_	_
28	.	.	.	.	_	3	punct	_	_

1	While	while	IN	IN	_	5	mark	_	_
2	PKC-dependent	pkc-dependent	JJ	JJ	_	3	amod	_	_
3	pathways	pathway	NNS	NNS	_	5	nsubj	_	_
4	sequentially	sequentially	RB	RB	_	5	advmod	_	_
5	result	result	VBP	VBP	_	26	advcl	_	_
6	in	in	IN	IN	_	8	case	_	_
7	the	the	DT	DT	_	8	det	_	_
8	phosphorylation	phosphorylation	NN	NN	_	5	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	in	in	IN	IN	_	13	case	_	_
11	an	a	DT	DT	_	13	det	_	_
12	incomplete	incomplete	JJ	JJ	_	13	amod	_	_
13	degradation	degradation	NN	NN	_	8	conj	_	_
14	of	of	IN	IN	_	16	case	_	_
15	IkB	ikb	NN	NN	_	16	compound	_	_
16	alpha	alpha	NN	NN	_	8	nmod	_	_
17	in	in	IN	IN	_	20	case	_	_
18	T	t	NN	NN	_	20	compound	_	_
19	cell	cell	NN	NN	_	20	compound	_	_
20	lines	line	NNS	NNS	_	16	nmod	_	_
21	,	,	,	,	_	26	punct	_	_
22	co-activation	co-activation	NN	NN	_	26	nsubj	_	_
23	of	of	IN	IN	_	25	case	_	_
24	Ca(2+)-dependent	ca(2+)-dependent	JJ	JJ	_	25	amod	_	_
25	pathways	pathway	NNS	NNS	_	22	nmod	_	_
26	accelerates	accelerate	VBZ	VBZ	_	0	root	_	_
27	the	the	DT	DT	_	28	det	_	_
28	rate	rate	NN	NN	_	26	dobj	_	_
29	of	of	IN	IN	_	32	case	_	_
30	IkB	ikb	NN	NN	_	31	compound	_	_
31	alpha	alpha	NN	NN	_	32	compound	_	_
32	phosphorylation	phosphorylation	NN	NN	_	28	nmod	_	_
33	and	and	CC	CC	_	26	cc	_	_
34	results	result	VBZ	VBZ	_	26	conj	_	_
35	in	in	IN	IN	_	38	case	_	_
36	its	its	PRP$	PRP$	_	38	nmod:poss	_	_
37	complete	complete	JJ	JJ	_	38	amod	_	_
38	degradation	degradation	NN	NN	_	34	nmod	_	_
39	.	.	.	.	_	26	punct	_	_

1	Activation	activation	NN	NN	_	8	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	Ca(2+)-dependent	ca(2+)-dependent	JJ	JJ	_	4	amod	_	_
4	pathways	pathway	NNS	NNS	_	1	nmod	_	_
5	alone	alone	RB	RB	_	4	advmod	_	_
6	do	do	VBP	VBP	_	8	aux	_	_
7	not	not	RB	RB	_	8	neg	_	_
8	result	result	VB	VB	_	0	root	_	_
9	in	in	IN	IN	_	11	case	_	_
10	the	the	DT	DT	_	11	dep	_	_
11	phosphorylation	phosphorylation	NN	NN	_	8	nmod	_	_
12	and/or	and/or	CC	CC	_	11	cc	_	_
13	degradation	degradation	NN	NN	_	11	conj	_	_
14	of	of	IN	IN	_	16	case	_	_
15	IkB	ikb	NN	NN	_	16	compound	_	_
16	alpha	alpha	NN	NN	_	11	nmod	_	_
17	in	in	IN	IN	_	19	case	_	_
18	Jurkat	jurkat	NN	NN	_	19	compound	_	_
19	T	t	NN	NN	_	16	nmod	_	_
20	or	or	CC	CC	_	19	cc	_	_
21	in	in	IN	IN	_	23	case	_	_
22	U937	u937	NN	NN	_	23	compound	_	_
23	cells	cell	NNS	NNS	_	19	conj	_	_
24	.	.	.	.	_	8	punct	_	_

1	Treatment	treatment	NN	NN	_	11	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	T	t	NN	NN	_	4	compound	_	_
4	cells	cell	NNS	NNS	_	1	nmod	_	_
5	with	with	IN	IN	_	10	case	_	_
6	the	the	DT	DT	_	10	det	_	_
7	selective	selective	JJ	JJ	_	10	amod	_	_
8	PKC	pkc	NN	NN	_	10	compound	_	_
9	inhibitor	inhibitor	NN	NN	_	10	compound	_	_
10	GF109203X	gf109203x	NN	NN	_	1	nmod	_	_
11	abrogates	abrogate	VBZ	VBZ	_	0	root	_	_
12	the	the	DT	DT	_	16	det	_	_
13	PMA-induced	pma-induced	JJ	JJ	_	16	amod	_	_
14	IkB	ikb	NN	NN	_	15	compound	_	_
15	alpha	alpha	NN	NN	_	16	compound	_	_
16	phosphorylation/degradation	phosphorylation/degradation	NN	NN	_	11	dobj	_	_
17	irrespective	irrespective	JJ	JJ	_	16	amod	_	_
18	of	of	IN	IN	_	19	case	_	_
19	activation	activation	NN	NN	_	17	nmod	_	_
20	of	of	IN	IN	_	22	case	_	_
21	Ca(2+)-dependent	ca(2+)-dependent	JJ	JJ	_	22	amod	_	_
22	pathways	pathway	NNS	NNS	_	19	nmod	_	_
23	,	,	,	,	_	16	punct	_	_
24	but	but	CC	CC	_	25	cc	_	_
25	not	not	RB	RB	_	16	cc	_	_
26	the	the	DT	DT	_	27	dep	_	_
27	phosphorylation	phosphorylation	NN	NN	_	16	conj	_	_
28	and	and	CC	CC	_	27	cc	_	_
29	degradation	degradation	NN	NN	_	27	conj	_	_
30	of	of	IN	IN	_	32	case	_	_
31	IkB	ikb	NN	NN	_	32	compound	_	_
32	alpha	alpha	NN	NN	_	27	nmod	_	_
33	induced	induce	VBN	VBN	_	32	acl	_	_
34	by	by	IN	IN	_	35	case	_	_
35	TNF-alpha	tnf-alpha	NN	NN	_	33	nmod	_	_
36	,	,	,	,	_	35	punct	_	_
37	a	a	DT	DT	_	39	det	_	_
38	PKC-independent	pkc-independent	JJ	JJ	_	39	amod	_	_
39	stimulus	stimulus	NN	NN	_	35	appos	_	_
40	.	.	.	.	_	11	punct	_	_

1	Contrary	contrary	JJ	JJ	_	10	advmod	_	_
2	to	to	TO	TO	_	4	case	_	_
3	the	the	DT	DT	_	4	det	_	_
4	interaction	interaction	NN	NN	_	1	nmod	_	_
5	with	with	IN	IN	_	6	case	_	_
6	PKC	pkc	NN	NN	_	4	nmod	_	_
7	,	,	,	,	_	10	punct	_	_
8	Ca(2+)-dependent	ca(2+)-dependent	JJ	JJ	_	9	amod	_	_
9	pathways	pathway	NNS	NNS	_	10	nsubj	_	_
10	synergize	synergize	VBP	VBP	_	0	root	_	_
11	with	with	IN	IN	_	12	case	_	_
12	TNF-alpha	tnf-alpha	NN	NN	_	10	nmod	_	_
13	not	not	RB	RB	_	16	neg	_	_
14	at	at	IN	IN	_	16	case	_	_
15	the	the	DT	DT	_	16	det	_	_
16	level	level	NN	NN	_	10	nmod	_	_
17	of	of	IN	IN	_	20	case	_	_
18	IkB	ikb	NN	NN	_	19	compound	_	_
19	alpha	alpha	NN	NN	_	20	compound	_	_
20	phosphorylation	phosphorylation	NN	NN	_	16	nmod	_	_
21	,	,	,	,	_	16	punct	_	_
22	but	but	CC	CC	_	16	cc	_	_
23	at	at	IN	IN	_	25	case	_	_
24	the	the	DT	DT	_	25	det	_	_
25	level	level	NN	NN	_	16	conj	_	_
26	of	of	IN	IN	_	28	case	_	_
27	its	its	PRP$	PRP$	_	28	nmod:poss	_	_
28	degradation	degradation	NN	NN	_	25	nmod	_	_
29	.	.	.	.	_	10	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	13	mark	_	_
5	Ca(2+)-dependent	ca(2+)-dependent	JJ	JJ	_	6	amod	_	_
6	pathways	pathway	NNS	NNS	_	13	nsubj	_	_
7	,	,	,	,	_	6	punct	_	_
8	including	include	VBG	VBG	_	10	case	_	_
9	the	the	DT	DT	_	10	det	_	_
10	phosphatase	phosphatase	NN	NN	_	6	nmod	_	_
11	calcineurin	calcineurin	NN	NN	_	10	dep	_	_
12	,	,	,	,	_	6	punct	_	_
13	participate	participate	VBP	VBP	_	3	ccomp	_	_
14	in	in	IN	IN	_	16	case	_	_
15	the	the	DT	DT	_	16	det	_	_
16	regulation	regulation	NN	NN	_	13	nmod	_	_
17	of	of	IN	IN	_	19	case	_	_
18	NF-kappa	nf-kappa	NN	NN	_	19	compound	_	_
19	B	b	NN	NN	_	16	nmod	_	_
20	in	in	IN	IN	_	24	case	_	_
21	a	a	DT	DT	_	24	det	_	_
22	cell	cell	NN	NN	_	24	compound	_	_
23	specific	specific	JJ	JJ	_	24	amod	_	_
24	fashion	fashion	NN	NN	_	13	nmod	_	_
25	and	and	CC	CC	_	13	cc	_	_
26	synergize	synergize	VBP	VBP	_	13	conj	_	_
27	with	with	IN	IN	_	28	case	_	_
28	PKC-dependent	pkc-dependent	JJ	JJ	_	26	nmod	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	-independent	-independent	JJ	JJ	_	28	conj	_	_
31	pathways	pathway	NNS	NNS	_	28	dep	_	_
32	at	at	IN	IN	_	34	case	_	_
33	the	the	DT	DT	_	34	det	_	_
34	level	level	NN	NN	_	26	nmod	_	_
35	of	of	IN	IN	_	37	case	_	_
36	IkB	ikb	NN	NN	_	37	compound	_	_
37	alpha	alpha	NN	NN	_	34	nmod	_	_
38	phosphorylation	phosphorylation	NN	NN	_	37	dep	_	_
39	and	and	CC	CC	_	37	cc	_	_
40	degradation	degradation	NN	NN	_	37	conj	_	_
41	.	.	.	.	_	3	punct	_	_

1	Triggering	triggering	NN	NN	_	14	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	complement	complement	NN	NN	_	4	compound	_	_
4	receptors	receptor	NNS	NNS	_	1	nmod	_	_
5	CR1	cr1	NN	NN	_	4	dep	_	_
6	(	(	-LRB-	-LRB-	_	7	punct	_	_
7	CD35	cd35	NN	NN	_	5	appos	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	and	and	CC	CC	_	5	cc	_	_
10	CR3	cr3	NN	NN	_	5	conj	_	_
11	(	(	-LRB-	-LRB-	_	12	punct	_	_
12	CD11b/CD18	cd11b/cd18	NN	NN	_	10	appos	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	induces	induce	VBZ	VBZ	_	0	root	_	_
15	nuclear	nuclear	JJ	JJ	_	16	amod	_	_
16	translocation	translocation	NN	NN	_	14	dobj	_	_
17	of	of	IN	IN	_	19	case	_	_
18	NF-kappa	nf-kappa	NN	NN	_	19	compound	_	_
19	B	b	NN	NN	_	16	nmod	_	_
20	(	(	-LRB-	-LRB-	_	22	punct	_	_
21	p50	p50	NN	NN	_	22	compound	_	_
22	/p65	/p65	NN	NN	_	19	appos	_	_
23	)	)	-RRB-	-RRB-	_	22	punct	_	_
24	in	in	IN	IN	_	26	case	_	_
25	human	human	JJ	JJ	_	26	amod	_	_
26	monocytes	monocyte	NNS	NNS	_	16	nmod	_	_
27	and	and	CC	CC	_	14	cc	_	_
28	enhances	enhance	VBZ	VBZ	_	14	conj	_	_
29	viral	viral	JJ	JJ	_	30	amod	_	_
30	replication	replication	NN	NN	_	28	dobj	_	_
31	in	in	IN	IN	_	34	case	_	_
32	HIV-infected	hiv-infected	JJ	JJ	_	34	amod	_	_
33	monocytic	monocytic	JJ	JJ	_	34	amod	_	_
34	cells	cell	NNS	NNS	_	30	nmod	_	_
35	.	.	.	.	_	14	punct	_	_

1	Monocyte/macrophages	monocyte/macrophages	NNS	NNS	_	3	nsubj	_	_
2	may	may	MD	MD	_	3	aux	_	_
3	harbor	harbor	VB	VB	_	0	root	_	_
4	HIV	hiv	NN	NN	_	3	dobj	_	_
5	in	in	IN	IN	_	8	case	_	_
6	a	a	DT	DT	_	8	det	_	_
7	nonproductive	nonproductive	JJ	JJ	_	8	amod	_	_
8	fashion	fashion	NN	NN	_	3	nmod	_	_
9	for	for	IN	IN	_	11	case	_	_
10	prolonged	prolonged	JJ	JJ	_	11	amod	_	_
11	periods	period	NNS	NNS	_	3	nmod	_	_
12	of	of	IN	IN	_	13	case	_	_
13	time	time	NN	NN	_	11	nmod	_	_
14	.	.	.	.	_	3	punct	_	_

1	Viral	viral	JJ	JJ	_	3	amod	_	_
2	gene	gene	NN	NN	_	3	compound	_	_
3	expression	expression	NN	NN	_	6	nsubjpass	_	_
4	may	may	MD	MD	_	6	aux	_	_
5	be	be	VB	VB	_	6	auxpass	_	_
6	reactivated	reactivate	VBN	VBN	_	0	root	_	_
7	by	by	IN	IN	_	8	case	_	_
8	stimulation	stimulation	NN	NN	_	6	nmod	_	_
9	of	of	IN	IN	_	11	case	_	_
10	the	the	DT	DT	_	11	det	_	_
11	cells	cell	NNS	NNS	_	8	nmod	_	_
12	with	with	IN	IN	_	13	case	_	_
13	LPS	lps	NN	NN	_	8	nmod	_	_
14	or	or	CC	CC	_	13	cc	_	_
15	cytokines	cytokine	NNS	NNS	_	13	conj	_	_
16	such	such	JJ	JJ	_	18	case	_	_
17	as	as	IN	IN	_	16	mwe	_	_
18	TNF-alpha	tnf-alpha	NN	NN	_	15	nmod	_	_
19	in	in	FW	FW	_	20	compound	_	_
20	vitro	vitro	FW	FW	_	6	advmod	_	_
21	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	effect	effect	NN	NN	_	8	nsubjpass	_	_
3	of	of	IN	IN	_	4	case	_	_
4	LPS	lps	NN	NN	_	2	nmod	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	TNF-alpha	tnf-alpha	NN	NN	_	4	conj	_	_
7	is	be	VBZ	VBZ	_	8	auxpass	_	_
8	mediated	mediate	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	_	11	case	_	_
10	their	they	PRP$	PRP$	_	11	nmod:poss	_	_
11	ability	ability	NN	NN	_	8	nmod	_	_
12	to	to	TO	TO	_	13	mark	_	_
13	induce	induce	VB	VB	_	11	acl	_	_
14	nuclear	nuclear	JJ	JJ	_	15	amod	_	_
15	translocation	translocation	NN	NN	_	13	dobj	_	_
16	of	of	IN	IN	_	19	case	_	_
17	the	the	DT	DT	_	19	det	_	_
18	DNA-binding	dna-binding	JJ	JJ	_	19	amod	_	_
19	heterodimer	heterodimer	NN	NN	_	15	nmod	_	_
20	NF-kappa	nf-kappa	NN	NN	_	21	compound	_	_
21	B	b	NN	NN	_	19	dep	_	_
22	(	(	-LRB-	-LRB-	_	24	punct	_	_
23	p50	p50	NN	NN	_	24	compound	_	_
24	/p65	/p65	NN	NN	_	21	appos	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	,	,	,	,	_	19	punct	_	_
27	which	which	WDT	WDT	_	28	nsubj	_	_
28	binds	bind	VBZ	VBZ	_	19	acl:relcl	_	_
29	to	to	TO	TO	_	32	case	_	_
30	a	a	DT	DT	_	32	det	_	_
31	specific	specific	JJ	JJ	_	32	amod	_	_
32	sequence	sequence	NN	NN	_	28	nmod	_	_
33	in	in	IN	IN	_	37	case	_	_
34	the	the	DT	DT	_	37	det	_	_
35	HIV-long	hiv-long	JJ	JJ	_	37	amod	_	_
36	terminal	terminal	JJ	JJ	_	37	amod	_	_
37	repeat	repeat	NN	NN	_	32	nmod	_	_
38	.	.	.	.	_	8	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	present	present	JJ	JJ	_	3	amod	_	_
3	study	study	NN	NN	_	4	nsubj	_	_
4	demonstrates	demonstrate	VBZ	VBZ	_	0	root	_	_
5	that	that	IN	IN	_	19	mark	_	_
6	triggering	triggering	NN	NN	_	19	nsubj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	complement	complement	NN	NN	_	9	compound	_	_
9	receptors	receptor	NNS	NNS	_	6	nmod	_	_
10	CR1	cr1	NN	NN	_	9	dep	_	_
11	(	(	-LRB-	-LRB-	_	12	punct	_	_
12	CD35	cd35	NN	NN	_	10	appos	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	and	and	CC	CC	_	10	cc	_	_
15	CR3	cr3	NN	NN	_	10	conj	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	CD11b/CD18	cd11b/cd18	NN	NN	_	15	appos	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	enhances	enhance	VBZ	VBZ	_	4	ccomp	_	_
20	viral	viral	JJ	JJ	_	21	amod	_	_
21	replication	replication	NN	NN	_	19	dobj	_	_
22	in	in	IN	IN	_	26	case	_	_
23	HIV-infected	hiv-infected	JJ	JJ	_	26	amod	_	_
24	human	human	JJ	JJ	_	26	amod	_	_
25	monocytic	monocytic	JJ	JJ	_	26	amod	_	_
26	cells	cell	NNS	NNS	_	21	nmod	_	_
27	.	.	.	.	_	4	punct	_	_

1	Monocytic	monocytic	JJ	JJ	_	3	amod	_	_
2	cell	cell	NN	NN	_	3	compound	_	_
3	lines	line	NNS	NNS	_	10	nsubjpass	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	normal	normal	JJ	JJ	_	8	amod	_	_
6	peripheral	peripheral	JJ	JJ	_	8	amod	_	_
7	blood	blood	NN	NN	_	8	compound	_	_
8	monocytes	monocyte	NNS	NNS	_	3	conj	_	_
9	were	be	VBD	VBD	_	10	auxpass	_	_
10	infected	infect	VBN	VBN	_	0	root	_	_
11	with	with	IN	IN	_	12	case	_	_
12	HIV-1	hiv-1	NN	NN	_	10	nmod	_	_
13	in	in	FW	FW	_	14	compound	_	_
14	vitro	vitro	FW	FW	_	10	advmod	_	_
15	and	and	CC	CC	_	10	cc	_	_
16	cultured	culture	VBN	VBN	_	10	conj	_	_
17	in	in	IN	IN	_	19	case	_	_
18	the	the	DT	DT	_	19	dep	_	_
19	presence	presence	NN	NN	_	16	nmod	_	_
20	or	or	CC	CC	_	19	cc	_	_
21	absence	absence	NN	NN	_	19	conj	_	_
22	of	of	IN	IN	_	24	case	_	_
23	F(ab')2	f(ab')2	NN	NN	_	24	compound	_	_
24	fragments	fragment	NNS	NNS	_	19	nmod	_	_
25	of	of	IN	IN	_	27	case	_	_
26	monoclonal	monoclonal	JJ	JJ	_	27	amod	_	_
27	anti-CR1	anti-cr1	JJ	JJ	_	24	nmod	_	_
28	or	or	CC	CC	_	27	cc	_	_
29	anti-CR3	anti-cr3	JJ	JJ	_	30	amod	_	_
30	Abs	ab	NNS	NNS	_	27	conj	_	_
31	or	or	CC	CC	_	19	cc	_	_
32	with	with	IN	IN	_	34	case	_	_
33	C3	c3	NN	NN	_	34	compound	_	_
34	fragments	fragment	NNS	NNS	_	19	conj	_	_
35	.	.	.	.	_	10	punct	_	_

1	Stimulation	stimulation	NN	NN	_	6	nsubj	_	_
2	of	of	IN	IN	_	3	case	_	_
3	CR1	cr1	NN	NN	_	1	nmod	_	_
4	or	or	CC	CC	_	3	cc	_	_
5	CR3	cr3	NN	NN	_	3	conj	_	_
6	induces	induce	VBZ	VBZ	_	0	root	_	_
7	a	a	DT	DT	_	11	det	_	_
8	two-	two-	CD	CD	_	10	compound	_	_
9	to	to	TO	TO	_	10	dep	_	_
10	fourfold	fourfold	JJ	JJ	_	11	amod	_	_
11	increase	increase	NN	NN	_	6	dobj	_	_
12	in	in	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	det	_	_
14	amount	amount	NN	NN	_	11	nmod	_	_
15	of	of	IN	IN	_	20	case	_	_
16	cell-associated	cell-associated	JJ	JJ	_	20	amod	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	released	release	VBN	VBN	_	16	conj	_	_
19	p24	p24	NN	NN	_	20	compound	_	_
20	Ag	ag	NN	NN	_	14	nmod	_	_
21	in	in	IN	IN	_	23	case	_	_
22	cell	cell	NN	NN	_	23	compound	_	_
23	cultures	culture	NNS	NNS	_	14	nmod	_	_
24	that	that	WDT	WDT	_	26	nsubj	_	_
25	was	be	VBD	VBD	_	26	cop	_	_
26	equivalent	equivalent	JJ	JJ	_	11	acl:relcl	_	_
27	to	to	TO	TO	_	28	case	_	_
28	that	that	DT	DT	_	26	nmod	_	_
29	observed	observe	VBN	VBN	_	28	acl	_	_
30	in	in	IN	IN	_	32	case	_	_
31	control	control	JJ	JJ	_	32	amod	_	_
32	cultures	culture	NNS	NNS	_	29	nmod	_	_
33	triggered	trigger	VBN	VBN	_	32	acl	_	_
34	with	with	IN	IN	_	35	case	_	_
35	LPS	lps	NN	NN	_	33	nmod	_	_
36	.	.	.	.	_	6	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	further	further	RB	RB	_	3	advmod	_	_
3	observed	observe	VBD	VBD	_	0	root	_	_
4	that	that	IN	IN	_	10	mark	_	_
5	stimulation	stimulation	NN	NN	_	10	nsubj	_	_
6	of	of	IN	IN	_	7	case	_	_
7	CR1	cr1	NN	NN	_	5	nmod	_	_
8	or	or	CC	CC	_	7	cc	_	_
9	CR3	cr3	NN	NN	_	7	conj	_	_
10	induces	induce	VBZ	VBZ	_	3	ccomp	_	_
11	the	the	DT	DT	_	13	det	_	_
12	nuclear	nuclear	JJ	JJ	_	13	amod	_	_
13	translocation	translocation	NN	NN	_	10	dobj	_	_
14	of	of	IN	IN	_	16	case	_	_
15	NF-kappa	nf-kappa	NN	NN	_	16	compound	_	_
16	B	b	NN	NN	_	13	nmod	_	_
17	p50	p50	NN	NN	_	18	compound	_	_
18	/p65	/p65	NN	NN	_	16	dep	_	_
19	in	in	IN	IN	_	21	case	_	_
20	infected	infected	JJ	JJ	_	21	amod	_	_
21	cells	cell	NNS	NNS	_	13	nmod	_	_
22	.	.	.	.	_	3	punct	_	_

1	Translocation	translocation	NN	NN	_	9	nsubjpass	_	_
2	of	of	IN	IN	_	4	case	_	_
3	NF-kappa	nf-kappa	NN	NN	_	4	compound	_	_
4	B	b	NN	NN	_	1	nmod	_	_
5	p50	p50	NN	NN	_	6	compound	_	_
6	/p65	/p65	NN	NN	_	4	dep	_	_
7	was	be	VBD	VBD	_	9	auxpass	_	_
8	also	also	RB	RB	_	9	advmod	_	_
9	observed	observe	VBN	VBN	_	0	root	_	_
10	following	follow	VBG	VBG	_	11	case	_	_
11	stimulation	stimulation	NN	NN	_	9	nmod	_	_
12	of	of	IN	IN	_	13	case	_	_
13	CR1	cr1	NN	NN	_	11	nmod	_	_
14	or	or	CC	CC	_	13	cc	_	_
15	CR3	cr3	NN	NN	_	13	conj	_	_
16	of	of	IN	IN	_	20	case	_	_
17	uninfected	uninfected	JJ	JJ	_	20	amod	_	_
18	peripheral	peripheral	JJ	JJ	_	20	amod	_	_
19	blood	blood	NN	NN	_	20	compound	_	_
20	monocytes	monocyte	NNS	NNS	_	13	nmod	_	_
21	from	from	IN	IN	_	23	case	_	_
22	HIV-seronegative	hiv-seronegative	JJ	JJ	_	23	amod	_	_
23	donors	donor	NNS	NNS	_	20	nmod	_	_
24	.	.	.	.	_	9	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	amount	amount	NN	NN	_	7	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	protein	protein	NN	NN	_	2	nmod	_	_
5	translocated	translocate	VBN	VBN	_	4	acl	_	_
6	was	be	VBD	VBD	_	7	cop	_	_
7	similar	similar	JJ	JJ	_	0	root	_	_
8	to	to	TO	TO	_	9	case	_	_
9	that	that	DT	DT	_	7	nmod	_	_
10	observed	observe	VBN	VBN	_	9	acl	_	_
11	when	when	WRB	WRB	_	14	advmod	_	_
12	cells	cell	NNS	NNS	_	14	nsubjpass	_	_
13	were	be	VBD	VBD	_	14	auxpass	_	_
14	stimulated	stimulate	VBN	VBN	_	10	advcl	_	_
15	with	with	IN	IN	_	16	case	_	_
16	rhTNF-alpha	rhtnf-alpha	NN	NN	_	14	nmod	_	_
17	.	.	.	.	_	7	punct	_	_

1	TNF-alpha	tnf-alpha	NN	NN	_	4	nsubj	_	_
2	did	do	VBD	VBD	_	4	aux	_	_
3	not	not	RB	RB	_	4	neg	_	_
4	mediate	mediate	VB	VB	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	translocation	translocation	NN	NN	_	4	dobj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	NF-kappa	nf-kappa	NN	NN	_	9	compound	_	_
9	B	b	NN	NN	_	6	nmod	_	_
10	p50	p50	NN	NN	_	11	compound	_	_
11	/p65	/p65	NN	NN	_	9	dep	_	_
12	induced	induce	VBN	VBN	_	9	acl	_	_
13	by	by	IN	IN	_	14	case	_	_
14	triggering	triggering	NN	NN	_	12	nmod	_	_
15	of	of	IN	IN	_	17	case	_	_
16	complement	complement	NN	NN	_	17	compound	_	_
17	receptors	receptor	NNS	NNS	_	14	nmod	_	_
18	.	.	.	.	_	4	punct	_	_

1	Taken	take	VBN	VBN	_	0	root	_	_
2	together	together	RB	RB	_	1	advmod	_	_
3	,	,	,	,	_	1	punct	_	_
4	these	these	DT	DT	_	5	det	_	_
5	observations	observation	NNS	NNS	_	6	nsubj	_	_
6	suggest	suggest	VBP	VBP	_	1	parataxis	_	_
7	that	that	IN	IN	_	13	mark	_	_
8	HIV	hiv	NN	NN	_	10	compound	_	_
9	gene	gene	NN	NN	_	10	compound	_	_
10	expression	expression	NN	NN	_	13	nsubjpass	_	_
11	may	may	MD	MD	_	13	aux	_	_
12	be	be	VB	VB	_	13	auxpass	_	_
13	activated	activate	VBN	VBN	_	6	ccomp	_	_
14	in	in	IN	IN	_	16	case	_	_
15	infected	infected	JJ	JJ	_	16	amod	_	_
16	monocytes	monocyte	NNS	NNS	_	13	nmod	_	_
17	through	through	IN	IN	_	18	case	_	_
18	interaction	interaction	NN	NN	_	13	nmod	_	_
19	of	of	IN	IN	_	21	case	_	_
20	the	the	DT	DT	_	21	det	_	_
21	cells	cell	NNS	NNS	_	18	nmod	_	_
22	with	with	IN	IN	_	24	case	_	_
23	complement-opsonized	complement-opsonized	JJ	JJ	_	24	amod	_	_
24	particles	particle	NNS	NNS	_	18	nmod	_	_
25	and	and	CC	CC	_	13	cc	_	_
26	that	that	IN	IN	_	31	mark	_	_
27	enhanced	enhance	VBN	VBN	_	29	amod	_	_
28	viral	viral	JJ	JJ	_	29	amod	_	_
29	replication	replication	NN	NN	_	31	nsubjpass	_	_
30	is	be	VBZ	VBZ	_	31	auxpass	_	_
31	associated	associate	VBN	VBN	_	13	conj	_	_
32	with	with	IN	IN	_	36	case	_	_
33	C3	c3	NN	NN	_	36	compound	_	_
34	receptor-mediated	receptor-mediated	JJ	JJ	_	36	amod	_	_
35	nuclear	nuclear	JJ	JJ	_	36	amod	_	_
36	translocation	translocation	NN	NN	_	31	nmod	_	_
37	of	of	IN	IN	_	41	case	_	_
38	the	the	DT	DT	_	41	det	_	_
39	NF-kappa	nf-kappa	NN	NN	_	41	compound	_	_
40	B	b	NN	NN	_	41	compound	_	_
41	complex	complex	NN	NN	_	36	nmod	_	_
42	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	activation	activation	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	8	case	_	_
4	the	the	DT	DT	_	8	det	_	_
5	Jak-STAT	jak-stat	JJ	JJ	_	8	amod	_	_
6	1	1	CD	CD	_	8	nummod	_	_
7	signaling	signaling	NN	NN	_	8	compound	_	_
8	pathway	pathway	NN	NN	_	2	nmod	_	_
9	by	by	IN	IN	_	10	case	_	_
10	IL-5	il-5	NN	NN	_	2	nmod	_	_
11	in	in	IN	IN	_	12	case	_	_
12	eosinophils	eosinophil	NNS	NNS	_	2	nmod	_	_
13	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	intracellular	intracellular	JJ	JJ	_	4	amod	_	_
3	signal	signal	NN	NN	_	4	compound	_	_
4	transduction	transduction	NN	NN	_	10	nsubj	_	_
5	of	of	IN	IN	_	6	case	_	_
6	IL-5	il-5	NN	NN	_	4	nmod	_	_
7	in	in	IN	IN	_	8	case	_	_
8	eosinophils	eosinophil	NNS	NNS	_	4	nmod	_	_
9	is	be	VBZ	VBZ	_	10	cop	_	_
10	unknown	unknown	JJ	JJ	_	0	root	_	_
11	.	.	.	.	_	10	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	objective	objective	NN	NN	_	6	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	this	this	DT	DT	_	5	det	_	_
5	study	study	NN	NN	_	2	nmod	_	_
6	was	be	VBD	VBD	_	0	root	_	_
7	to	to	TO	TO	_	8	mark	_	_
8	investigate	investigate	VB	VB	_	6	xcomp	_	_
9	the	the	DT	DT	_	10	det	_	_
10	involvement	involvement	NN	NN	_	8	dobj	_	_
11	of	of	IN	IN	_	16	case	_	_
12	the	the	DT	DT	_	16	det	_	_
13	newly	newly	RB	RB	_	14	advmod	_	_
14	discovered	discover	VBN	VBN	_	16	amod	_	_
15	Jak-STAT	jak-stat	JJ	JJ	_	16	amod	_	_
16	pathway	pathway	NN	NN	_	10	nmod	_	_
17	in	in	IN	IN	_	22	case	_	_
18	the	the	DT	DT	_	22	det	_	_
19	IL-5	il-5	NN	NN	_	22	compound	_	_
20	signal	signal	NN	NN	_	22	compound	_	_
21	transduction	transduction	NN	NN	_	22	compound	_	_
22	mechanism	mechanism	NN	NN	_	8	nmod	_	_
23	.	.	.	.	_	6	punct	_	_

1	Eosinophils	eosinophil	NNS	NNS	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	purified	purify	VBN	VBN	_	0	root	_	_
4	from	from	IN	IN	_	6	case	_	_
5	peripheral	peripheral	JJ	JJ	_	6	amod	_	_
6	blood	blood	NN	NN	_	3	nmod	_	_
7	by	by	IN	IN	_	10	case	_	_
8	discontinuous	discontinuous	JJ	JJ	_	10	amod	_	_
9	Percoll	percoll	NN	NN	_	10	compound	_	_
10	gradients	gradient	NNS	NNS	_	3	nmod	_	_
11	and	and	CC	CC	_	3	cc	_	_
12	stimulated	stimulate	VBN	VBN	_	3	conj	_	_
13	with	with	IN	IN	_	14	case	_	_
14	IL-5	il-5	NN	NN	_	12	nmod	_	_
15	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	involvement	involvement	NN	NN	_	7	nsubjpass	_	_
3	of	of	IN	IN	_	4	case	_	_
4	Jak	jak	NN	NN	_	2	nmod	_	_
5	2	2	CD	CD	_	4	nummod	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	investigated	investigate	VBN	VBN	_	0	root	_	_
8	by	by	IN	IN	_	9	case	_	_
9	immunoprecipitation	immunoprecipitation	NN	NN	_	7	nmod	_	_
10	followed	follow	VBN	VBN	_	7	dep	_	_
11	by	by	IN	IN	_	12	case	_	_
12	immunoblotting	immunoblot	VBG	VBG	_	10	nmod	_	_
13	for	for	IN	IN	_	15	case	_	_
14	tyrosine	tyrosine	NN	NN	_	15	compound	_	_
15	phosphorylation	phosphorylation	NN	NN	_	12	nmod	_	_
16	.	.	.	.	_	7	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	activation	activation	NN	NN	_	7	nsubjpass	_	_
3	of	of	IN	IN	_	4	case	_	_
4	Jak	jak	NN	NN	_	2	nmod	_	_
5	2	2	CD	CD	_	4	nummod	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	studied	study	VBN	VBN	_	0	root	_	_
8	by	by	IN	IN	_	9	case	_	_
9	autophosphorylation	autophosphorylation	NN	NN	_	7	nmod	_	_
10	of	of	IN	IN	_	13	case	_	_
11	the	the	DT	DT	_	13	det	_	_
12	immunoprecipitated	immunoprecipitate	VBN	VBN	_	13	amod	_	_
13	kinase	kinase	NN	NN	_	9	nmod	_	_
14	.	.	.	.	_	7	punct	_	_

1	Jak	jak	NN	NN	_	5	nsubj	_	_
2	2	2	CD	CD	_	1	nummod	_	_
3	was	be	VBD	VBD	_	5	cop	_	_
4	tyrosine	tyrosine	NN	NN	_	5	nmod:npmod	_	_
5	phosphorylated	phosphorylated	JJ	JJ	_	0	root	_	_
6	within	within	IN	IN	_	10	case	_	_
7	1	1	CD	CD	_	9	compound	_	_
8	to	to	TO	TO	_	9	dep	_	_
9	3	3	CD	CD	_	10	nummod	_	_
10	min	min	NN	NN	_	5	nmod	_	_
11	after	after	IN	IN	_	12	case	_	_
12	stimulation	stimulation	NN	NN	_	10	nmod	_	_
13	of	of	IN	IN	_	14	case	_	_
14	eosinophils	eosinophil	NNS	NNS	_	12	nmod	_	_
15	with	with	IN	IN	_	16	case	_	_
16	IL-5	il-5	NN	NN	_	12	nmod	_	_
17	.	.	.	.	_	5	punct	_	_

1	Further	further	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	the	the	DT	DT	_	5	det	_	_
4	immunoprecipitated	immunoprecipitate	VBN	VBN	_	5	amod	_	_
5	Jak	jak	NN	NN	_	11	nsubj	_	_
6	2	2	CD	CD	_	5	nummod	_	_
7	obtained	obtain	VBN	VBN	_	5	acl	_	_
8	from	from	IN	IN	_	10	case	_	_
9	IL-5-stimulated	il-5-stimulated	JJ	JJ	_	10	amod	_	_
10	cells	cell	NNS	NNS	_	7	nmod	_	_
11	underwent	undergo	VBD	VBD	_	0	root	_	_
12	autophosphorylation	autophosphorylation	NN	NN	_	11	dobj	_	_
13	.	.	.	.	_	11	punct	_	_

1	Jak	jak	NN	NN	_	3	nsubj	_	_
2	2	2	CD	CD	_	1	nummod	_	_
3	coprecipitated	coprecipitate	VBD	VBD	_	0	root	_	_
4	with	with	IN	IN	_	6	case	_	_
5	the	the	DT	DT	_	6	det	_	_
6	beta-subunit	beta-subunit	NN	NN	_	3	nmod	_	_
7	of	of	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	IL-5	il-5	NN	NN	_	10	compound	_	_
10	receptor	receptor	NN	NN	_	6	nmod	_	_
11	,	,	,	,	_	3	punct	_	_
12	suggesting	suggest	VBG	VBG	_	3	xcomp	_	_
13	a	a	DT	DT	_	15	det	_	_
14	physical	physical	JJ	JJ	_	15	amod	_	_
15	association	association	NN	NN	_	12	dobj	_	_
16	of	of	IN	IN	_	18	case	_	_
17	the	the	DT	DT	_	18	det	_	_
18	kinase	kinase	NN	NN	_	15	nmod	_	_
19	with	with	IN	IN	_	21	case	_	_
20	the	the	DT	DT	_	21	det	_	_
21	receptor	receptor	NN	NN	_	15	nmod	_	_
22	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	nuclear	nuclear	JJ	JJ	_	4	amod	_	_
3	factor	factor	NN	NN	_	4	compound	_	_
4	STAT-1	stat-1	NN	NN	_	9	nsubjpass	_	_
5	(	(	-LRB-	-LRB-	_	6	punct	_	_
6	p91	p91	NN	NN	_	4	appos	_	_
7	)	)	-RRB-	-RRB-	_	6	punct	_	_
8	was	be	VBD	VBD	_	9	auxpass	_	_
9	investigated	investigate	VBN	VBN	_	0	root	_	_
10	by	by	IN	IN	_	11	case	_	_
11	immunoprecipitation	immunoprecipitation	NN	NN	_	9	nmod	_	_
12	followed	follow	VBN	VBN	_	9	dep	_	_
13	by	by	IN	IN	_	14	case	_	_
14	immunoblotting	immunoblot	VBG	VBG	_	12	nmod	_	_
15	for	for	IN	IN	_	17	case	_	_
16	tyrosine	tyrosine	NN	NN	_	17	compound	_	_
17	phosphorylation	phosphorylation	NN	NN	_	14	nmod	_	_
18	.	.	.	.	_	9	punct	_	_

1	STAT-1	stat-1	NN	NN	_	4	nsubj	_	_
2	was	be	VBD	VBD	_	4	cop	_	_
3	tyrosine	tyrosine	NN	NN	_	4	nmod:npmod	_	_
4	phosphorylated	phosphorylated	JJ	JJ	_	0	root	_	_
5	within	within	IN	IN	_	7	case	_	_
6	15	15	CD	CD	_	7	nummod	_	_
7	min	min	NN	NN	_	4	nmod	_	_
8	of	of	IN	IN	_	10	case	_	_
9	IL-5	il-5	NN	NN	_	10	compound	_	_
10	stimulation	stimulation	NN	NN	_	7	nmod	_	_
11	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	presence	presence	NN	NN	_	10	nsubjpass	_	_
3	of	of	IN	IN	_	4	case	_	_
4	STAT-1	stat-1	NN	NN	_	2	nmod	_	_
5	in	in	IN	IN	_	8	case	_	_
6	the	the	DT	DT	_	8	det	_	_
7	nuclear	nuclear	JJ	JJ	_	8	amod	_	_
8	extract	extract	NN	NN	_	2	nmod	_	_
9	was	be	VBD	VBD	_	10	auxpass	_	_
10	studied	study	VBN	VBN	_	0	root	_	_
11	by	by	IN	IN	_	15	case	_	_
12	electrophoretic	electrophoretic	JJ	JJ	_	15	amod	_	_
13	mobility	mobility	NN	NN	_	15	compound	_	_
14	shift	shift	NN	NN	_	15	compound	_	_
15	assay	assay	NN	NN	_	10	nmod	_	_
16	.	.	.	.	_	10	punct	_	_

1	IL-5	il-5	NN	NN	_	2	nsubj	_	_
2	induced	induce	VBD	VBD	_	0	root	_	_
3	two	two	CD	CD	_	4	nummod	_	_
4	proteins	protein	NNS	NNS	_	2	dobj	_	_
5	that	that	WDT	WDT	_	6	nsubj	_	_
6	bound	bind	VBD	VBD	_	4	acl:relcl	_	_
7	to	to	TO	TO	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	gamma-activating	gamma-activating	JJ	JJ	_	10	amod	_	_
10	sequence	sequence	NN	NN	_	6	nmod	_	_
11	.	.	.	.	_	2	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	the	the	DT	DT	_	3	det	_	_
3	presence	presence	NN	NN	_	12	nmod	_	_
4	of	of	IN	IN	_	7	case	_	_
5	an	a	DT	DT	_	7	det	_	_
6	anti-STAT-1	anti-stat-1	JJ	JJ	_	7	amod	_	_
7	Ab	ab	NN	NN	_	3	nmod	_	_
8	,	,	,	,	_	12	punct	_	_
9	the	the	DT	DT	_	10	det	_	_
10	band	band	NN	NN	_	12	nsubjpass	_	_
11	was	be	VBD	VBD	_	12	auxpass	_	_
12	supershifted	supershift	VBN	VBN	_	0	root	_	_
13	.	.	.	.	_	12	punct	_	_

1	Thus	thus	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	demonstrated	demonstrate	VBD	VBD	_	0	root	_	_
5	that	that	IN	IN	_	7	mark	_	_
6	IL-5	il-5	NN	NN	_	7	nsubj	_	_
7	activated	activate	VBD	VBD	_	4	ccomp	_	_
8	the	the	DT	DT	_	13	det	_	_
9	Jak	jak	NN	NN	_	13	compound	_	_
10	2-STAT	2-stat	NN	NN	_	13	compound	_	_
11	1	1	CD	CD	_	13	nummod	_	_
12	signaling	signaling	NN	NN	_	13	compound	_	_
13	pathway	pathway	NN	NN	_	7	dobj	_	_
14	in	in	IN	IN	_	15	case	_	_
15	eosinophils	eosinophil	NNS	NNS	_	7	nmod	_	_
16	.	.	.	.	_	4	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	speculate	speculate	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	11	mark	_	_
4	the	the	DT	DT	_	8	det	_	_
5	Jak	jak	NN	NN	_	8	compound	_	_
6	2-STAT	2-stat	NN	NN	_	8	compound	_	_
7	1	1	CD	CD	_	8	nummod	_	_
8	pathway	pathway	NN	NN	_	11	nsubjpass	_	_
9	may	may	MD	MD	_	11	aux	_	_
10	be	be	VB	VB	_	11	auxpass	_	_
11	involved	involve	VBN	VBN	_	2	ccomp	_	_
12	in	in	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	det	_	_
14	activation	activation	NN	NN	_	11	nmod	_	_
15	of	of	IN	IN	_	17	case	_	_
16	IL-5-inducible	il-5-inducible	JJ	JJ	_	17	amod	_	_
17	genes	gene	NNS	NNS	_	14	nmod	_	_
18	in	in	IN	IN	_	19	case	_	_
19	eosinophils	eosinophil	NNS	NNS	_	14	nmod	_	_
20	.	.	.	.	_	2	punct	_	_

1	Constitutively	constitutively	RB	RB	_	2	advmod	_	_
2	activated	activate	VBN	VBN	_	4	amod	_	_
3	Jak-STAT	jak-stat	JJ	JJ	_	4	amod	_	_
4	pathway	pathway	NN	NN	_	0	root	_	_
5	in	in	IN	IN	_	7	case	_	_
6	T	t	NN	NN	_	7	compound	_	_
7	cells	cell	NNS	NNS	_	4	nmod	_	_
8	transformed	transform	VBN	VBN	_	7	acl	_	_
9	with	with	IN	IN	_	10	case	_	_
10	HTLV-I	htlv-i	NN	NN	_	8	nmod	_	_
11	.	.	.	.	_	4	punct	_	_

1	Human	human	JJ	JJ	_	6	amod	_	_
2	T	t	NN	NN	_	6	compound	_	_
3	cell	cell	NN	NN	_	6	compound	_	_
4	lymphotropic	lymphotropic	JJ	JJ	_	6	amod	_	_
5	virus	virus	NN	NN	_	6	compound	_	_
6	I	i	NN	NN	_	13	nsubj	_	_
7	(	(	-LRB-	-LRB-	_	8	punct	_	_
8	HTLV-I	htlv-i	NN	NN	_	6	appos	_	_
9	)	)	-RRB-	-RRB-	_	8	punct	_	_
10	is	be	VBZ	VBZ	_	13	cop	_	_
11	the	the	DT	DT	_	13	det	_	_
12	etiological	etiological	JJ	JJ	_	13	amod	_	_
13	agent	agent	NN	NN	_	0	root	_	_
14	for	for	IN	IN	_	18	case	_	_
15	adult	adult	JJ	JJ	_	18	amod	_	_
16	T	t	NN	NN	_	18	compound	_	_
17	cell	cell	NN	NN	_	18	compound	_	_
18	leukemia	leukemia	NN	NN	_	13	nmod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	tropical	tropical	JJ	JJ	_	21	amod	_	_
21	spastic	spastic	JJ	JJ	_	22	amod	_	_
22	paraparesis	paraparesis	NN	NN	_	18	conj	_	_
23	(	(	-LRB-	-LRB-	_	25	punct	_	_
24	also	also	RB	RB	_	25	dep	_	_
25	termed	term	VBN	VBN	_	22	dep	_	_
26	HTLV-I-associated	htlv-i-associated	JJ	JJ	_	27	amod	_	_
27	myelopathy	myelopathy	NN	NN	_	25	xcomp	_	_
28	)	)	-RRB-	-RRB-	_	25	punct	_	_
29	.	.	.	.	_	13	punct	_	_

1	HTLV-I-infected	htlv-i-infected	JJ	JJ	_	5	amod	_	_
2	peripheral	peripheral	JJ	JJ	_	5	amod	_	_
3	blood	blood	NN	NN	_	5	compound	_	_
4	T	t	NN	NN	_	5	compound	_	_
5	cells	cell	NNS	NNS	_	6	nsubj	_	_
6	exhibit	exhibit	VBP	VBP	_	0	root	_	_
7	an	a	DT	DT	_	9	det	_	_
8	initial	initial	JJ	JJ	_	9	amod	_	_
9	phase	phase	NN	NN	_	6	dobj	_	_
10	of	of	IN	IN	_	16	case	_	_
11	interleukin-2	interleukin-2	NN	NN	_	16	compound	_	_
12	(	(	-LRB-	-LRB-	_	16	punct	_	_
13	IL-2	il-2	NN	NN	_	16	compound	_	_
14	)	)	-RRB-	-RRB-	_	16	punct	_	_
15	-dependent	-dependent	JJ	JJ	_	16	amod	_	_
16	growth	growth	NN	NN	_	9	nmod	_	_
17	;	;	:	:	_	6	punct	_	_
18	over	over	IN	IN	_	19	case	_	_
19	time	time	NN	NN	_	28	nmod	_	_
20	,	,	,	,	_	28	punct	_	_
21	by	by	IN	IN	_	24	case	_	_
22	an	a	DT	DT	_	24	det	_	_
23	unknown	unknown	JJ	JJ	_	24	amod	_	_
24	mechanism	mechanism	NN	NN	_	28	nmod	_	_
25	,	,	,	,	_	28	punct	_	_
26	the	the	DT	DT	_	27	det	_	_
27	cells	cell	NNS	NNS	_	28	nsubj	_	_
28	become	become	VBP	VBP	_	6	parataxis	_	_
29	IL-2-independent	il-2-independent	JJ	JJ	_	28	xcomp	_	_
30	.	.	.	.	_	6	punct	_	_

1	Whereas	whereas	IN	IN	_	21	mark	_	_
2	the	the	DT	DT	_	4	det	_	_
3	Jak	jak	NN	NN	_	4	compound	_	_
4	kinases	kinase	NNS	NNS	_	21	nsubjpass	_	_
5	Jak1	jak1	NN	NN	_	4	dep	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	Jak3	jak3	NN	NN	_	5	conj	_	_
8	and	and	CC	CC	_	4	cc	_	_
9	the	the	DT	DT	_	10	det	_	_
10	signal	signal	NN	NN	_	4	conj	_	_
11	transducer	transducer	NN	NN	_	10	dep	_	_
12	and	and	CC	CC	_	10	cc	_	_
13	activator	activator	NN	NN	_	10	conj	_	_
14	of	of	IN	IN	_	16	case	_	_
15	transcription	transcription	NN	NN	_	16	compound	_	_
16	proteins	protein	NNS	NNS	_	10	nmod	_	_
17	Stat3	stat3	NN	NN	_	10	dep	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	Stat5	stat5	NN	NN	_	17	conj	_	_
20	are	be	VBP	VBP	_	21	auxpass	_	_
21	activated	activate	VBN	VBN	_	36	advcl	_	_
22	in	in	IN	IN	_	25	case	_	_
23	normal	normal	JJ	JJ	_	25	amod	_	_
24	T	t	NN	NN	_	25	compound	_	_
25	cells	cell	NNS	NNS	_	21	nmod	_	_
26	in	in	IN	IN	_	27	case	_	_
27	response	response	NN	NN	_	21	nmod	_	_
28	to	to	TO	TO	_	29	case	_	_
29	IL-2	il-2	NN	NN	_	27	nmod	_	_
30	,	,	,	,	_	36	punct	_	_
31	this	this	DT	DT	_	33	det	_	_
32	signaling	signaling	NN	NN	_	33	compound	_	_
33	pathway	pathway	NN	NN	_	36	nsubjpass	_	_
34	was	be	VBD	VBD	_	36	auxpass	_	_
35	constitutively	constitutively	RB	RB	_	36	advmod	_	_
36	activated	activate	VBN	VBN	_	0	root	_	_
37	in	in	IN	IN	_	39	case	_	_
38	HTLV-I-transformed	htlv-i-transformed	JJ	JJ	_	39	amod	_	_
39	cells	cell	NNS	NNS	_	36	nmod	_	_
40	.	.	.	.	_	36	punct	_	_

1	In	in	IN	IN	_	5	case	_	_
2	HTLV-I-infected	htlv-i-infected	JJ	JJ	_	5	amod	_	_
3	cord	cord	NN	NN	_	5	compound	_	_
4	blood	blood	NN	NN	_	5	compound	_	_
5	lymphocytes	lymphocyte	NNS	NNS	_	14	nmod	_	_
6	,	,	,	,	_	14	punct	_	_
7	the	the	DT	DT	_	8	det	_	_
8	transition	transition	NN	NN	_	14	nsubj	_	_
9	from	from	IN	IN	_	10	case	_	_
10	IL-2-dependent	il-2-dependent	JJ	JJ	_	8	nmod	_	_
11	to	to	TO	TO	_	13	case	_	_
12	IL-2-independent	il-2-independent	JJ	JJ	_	13	amod	_	_
13	growth	growth	NN	NN	_	8	nmod	_	_
14	correlated	correlate	VBD	VBD	_	0	root	_	_
15	with	with	IN	IN	_	17	case	_	_
16	the	the	DT	DT	_	17	det	_	_
17	acquisition	acquisition	NN	NN	_	14	nmod	_	_
18	of	of	IN	IN	_	23	case	_	_
19	a	a	DT	DT	_	23	det	_	_
20	constitutively	constitutively	RB	RB	_	21	advmod	_	_
21	activated	activated	JJ	JJ	_	23	amod	_	_
22	Jak-STAT	jak-stat	JJ	JJ	_	23	amod	_	_
23	pathway	pathway	NN	NN	_	17	nmod	_	_
24	,	,	,	,	_	14	punct	_	_
25	which	which	WDT	WDT	_	26	nsubj	_	_
26	suggests	suggest	VBZ	VBZ	_	14	ccomp	_	_
27	that	that	IN	IN	_	30	mark	_	_
28	this	this	DT	DT	_	29	det	_	_
29	pathway	pathway	NN	NN	_	30	nsubj	_	_
30	participates	participate	VBZ	VBZ	_	26	ccomp	_	_
31	in	in	IN	IN	_	35	case	_	_
32	HTLV-I-mediated	htlv-i-mediated	JJ	JJ	_	35	amod	_	_
33	T	t	NN	NN	_	35	compound	_	_
34	cell	cell	NN	NN	_	35	compound	_	_
35	transformation	transformation	NN	NN	_	30	nmod	_	_
36	.	.	.	.	_	14	punct	_	_

1	Positive	positive	JJ	JJ	_	0	root	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	negative	negative	JJ	JJ	_	1	conj	_	_
4	regulation	regulation	NN	NN	_	1	dep	_	_
5	of	of	IN	IN	_	10	case	_	_
6	granulocyte-macrophage	granulocyte-macrophage	JJ	JJ	_	8	amod	_	_
7	colony-stimulating	colony-stimulating	JJ	JJ	_	8	amod	_	_
8	factor	factor	NN	NN	_	10	compound	_	_
9	promoter	promoter	NN	NN	_	10	compound	_	_
10	activity	activity	NN	NN	_	1	nmod	_	_
11	by	by	IN	IN	_	14	case	_	_
12	AML1-related	aml1-related	JJ	JJ	_	14	amod	_	_
13	transcription	transcription	NN	NN	_	14	compound	_	_
14	factor	factor	NN	NN	_	1	nmod	_	_
15	,	,	,	,	_	14	punct	_	_
16	PEBP2	pebp2	NN	NN	_	14	appos	_	_
17	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	9	det	_	_
2	granulocyte-macrophage	granulocyte-macrophage	JJ	JJ	_	9	amod	_	_
3	colony-stimulating	colony-stimulating	JJ	JJ	_	9	amod	_	_
4	factor	factor	NN	NN	_	9	compound	_	_
5	(	(	-LRB-	-LRB-	_	9	punct	_	_
6	GM-CSF	gm-csf	NN	NN	_	9	compound	_	_
7	)	)	-RRB-	-RRB-	_	9	punct	_	_
8	gene	gene	NN	NN	_	9	compound	_	_
9	promoter	promoter	NN	NN	_	10	nsubj	_	_
10	contains	contain	VBZ	VBZ	_	0	root	_	_
11	a	a	DT	DT	_	13	det	_	_
12	consensus	consensus	NN	NN	_	13	compound	_	_
13	sequence	sequence	NN	NN	_	10	dobj	_	_
14	for	for	IN	IN	_	24	case	_	_
15	the	the	DT	DT	_	24	det	_	_
16	polyomavirus	polyomavirus	NN	NN	_	24	compound	_	_
17	enhancer	enhancer	NN	NN	_	24	compound	_	_
18	binding-protein	binding-protein	NN	NN	_	24	compound	_	_
19	2	2	CD	CD	_	24	nummod	_	_
20	(	(	-LRB-	-LRB-	_	24	punct	_	_
21	PEBP2	pebp2	NN	NN	_	24	compound	_	_
22	)	)	-RRB-	-RRB-	_	24	punct	_	_
23	transcription	transcription	NN	NN	_	24	compound	_	_
24	factor	factor	NN	NN	_	13	nmod	_	_
25	,	,	,	,	_	24	punct	_	_
26	which	which	WDT	WDT	_	27	nsubj	_	_
27	consists	consist	VBZ	VBZ	_	24	acl:relcl	_	_
28	of	of	IN	IN	_	29	case	_	_
29	alpha	alpha	NN	NN	_	27	nmod	_	_
30	and	and	CC	CC	_	29	cc	_	_
31	beta	beta	NN	NN	_	29	conj	_	_
32	subunits	subunit	NNS	NNS	_	29	dep	_	_
33	.	.	.	.	_	10	punct	_	_

1	There	there	EX	EX	_	2	expl	_	_
2	are	be	VBP	VBP	_	0	root	_	_
3	at	at	IN	IN	_	4	case	_	_
4	least	least	JJS	JJS	_	5	nmod:npmod	_	_
5	two	two	CD	CD	_	6	nummod	_	_
6	genes	gene	NNS	NNS	_	2	nsubj	_	_
7	,	,	,	,	_	6	punct	_	_
8	alpha	alpha	NN	NN	_	9	compound	_	_
9	A	a	NN	NN	_	6	appos	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	alpha	alpha	NN	NN	_	12	compound	_	_
12	B	b	NN	NN	_	9	conj	_	_
13	,	,	,	,	_	6	punct	_	_
14	encoding	encode	VBG	VBG	_	6	acl	_	_
15	the	the	DT	DT	_	17	det	_	_
16	alpha	alpha	NN	NN	_	17	compound	_	_
17	subunit	subunit	NN	NN	_	14	dobj	_	_
18	.	.	.	.	_	2	punct	_	_

1	alpha	alpha	NN	NN	_	2	compound	_	_
2	B	b	NN	NN	_	6	nsubj	_	_
3	is	be	VBZ	VBZ	_	6	cop	_	_
4	the	the	DT	DT	_	6	det	_	_
5	mouse	mouse	NN	NN	_	6	compound	_	_
6	homologue	homologue	NN	NN	_	0	root	_	_
7	of	of	IN	IN	_	10	case	_	_
8	human	human	JJ	JJ	_	10	amod	_	_
9	AML1	aml1	NN	NN	_	10	compound	_	_
10	gene	gene	NN	NN	_	6	nmod	_	_
11	detected	detect	VBN	VBN	_	10	acl	_	_
12	at	at	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	det	_	_
14	breakpoints	breakpoint	NNS	NNS	_	11	nmod	_	_
15	of	of	IN	IN	_	16	case	_	_
16	t	t	NN	NN	_	14	nmod	_	_
17	(	(	-LRB-	-LRB-	_	16	punct	_	_
18	8	8	CD	CD	_	16	nummod	_	_
19	;	;	:	:	_	16	punct	_	_
20	21	21	CD	CD	_	16	nummod	_	_
21	)	)	-RRB-	-RRB-	_	16	punct	_	_
22	and	and	CC	CC	_	16	cc	_	_
23	t	t	NN	NN	_	16	conj	_	_
24	(	(	-LRB-	-LRB-	_	23	punct	_	_
25	3	3	CD	CD	_	23	nummod	_	_
26	;	;	:	:	_	23	punct	_	_
27	21	21	CD	CD	_	23	nummod	_	_
28	)	)	-RRB-	-RRB-	_	23	punct	_	_
29	myeloid	myeloid	JJ	JJ	_	30	amod	_	_
30	leukemias	leukemia	NNS	NNS	_	16	dep	_	_
31	.	.	.	.	_	6	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	examined	examine	VBD	VBD	_	0	root	_	_
3	alpha	alpha	NN	NN	_	4	compound	_	_
4	A1	a1	NN	NN	_	2	dobj	_	_
5	(	(	-LRB-	-LRB-	_	9	punct	_	_
6	an	a	DT	DT	_	9	det	_	_
7	alpha	alpha	NN	NN	_	9	compound	_	_
8	A-gene	a-gene	JJ	JJ	_	9	amod	_	_
9	product	product	NN	NN	_	4	dep	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	and	and	CC	CC	_	4	cc	_	_
12	alpha	alpha	NN	NN	_	13	compound	_	_
13	B1	b1	NN	NN	_	4	conj	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	alpha	alpha	NN	NN	_	16	compound	_	_
16	B2	b2	NN	NN	_	13	conj	_	_
17	(	(	-LRB-	-LRB-	_	21	punct	_	_
18	two	two	CD	CD	_	21	nummod	_	_
19	alpha	alpha	NN	NN	_	21	compound	_	_
20	B-encoded	b-encoded	JJ	JJ	_	21	amod	_	_
21	isomers	isomer	NNS	NNS	_	13	appos	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	for	for	IN	IN	_	25	case	_	_
24	their	they	PRP$	PRP$	_	25	nmod:poss	_	_
25	effects	effect	NNS	NNS	_	2	nmod	_	_
26	on	on	IN	IN	_	29	case	_	_
27	the	the	DT	DT	_	29	det	_	_
28	GM-CSF	gm-csf	NN	NN	_	29	compound	_	_
29	promoter	promoter	NN	NN	_	25	nmod	_	_
30	.	.	.	.	_	2	punct	_	_

1	PEBP2	pebp2	NN	NN	_	3	compound	_	_
2	alpha	alpha	NN	NN	_	3	compound	_	_
3	A1	a1	NN	NN	_	12	nsubj	_	_
4	,	,	,	,	_	3	punct	_	_
5	alpha	alpha	NN	NN	_	6	compound	_	_
6	B1	b1	NN	NN	_	3	conj	_	_
7	,	,	,	,	_	3	punct	_	_
8	and	and	CC	CC	_	3	cc	_	_
9	alpha	alpha	NN	NN	_	11	compound	_	_
10	B2	b2	NN	NN	_	11	compound	_	_
11	proteins	protein	NNS	NNS	_	3	conj	_	_
12	bound	bind	VBD	VBD	_	0	root	_	_
13	the	the	DT	DT	_	15	det	_	_
14	PEBP2	pebp2	NN	NN	_	15	compound	_	_
15	site	site	NN	NN	_	12	dobj	_	_
16	within	within	IN	IN	_	20	case	_	_
17	the	the	DT	DT	_	20	det	_	_
18	mouse	mouse	NN	NN	_	20	compound	_	_
19	GM-CSF	gm-csf	NN	NN	_	20	compound	_	_
20	promoter	promoter	NN	NN	_	15	nmod	_	_
21	.	.	.	.	_	12	punct	_	_

1	PEBP2	pebp2	NN	NN	_	3	compound	_	_
2	alpha	alpha	NN	NN	_	3	compound	_	_
3	A1	a1	NN	NN	_	7	nsubj	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	alpha	alpha	NN	NN	_	6	compound	_	_
6	B1	b1	NN	NN	_	3	conj	_	_
7	enhanced	enhance	VBD	VBD	_	0	root	_	_
8	the	the	DT	DT	_	9	det	_	_
9	expression	expression	NN	NN	_	7	dobj	_	_
10	of	of	IN	IN	_	15	case	_	_
11	the	the	DT	DT	_	15	det	_	_
12	GM-CSF	gm-csf	NN	NN	_	15	compound	_	_
13	promoter-driven	promoter-driven	JJ	JJ	_	15	amod	_	_
14	reporter	reporter	NN	NN	_	15	compound	_	_
15	plasmid	plasmid	NN	NN	_	9	nmod	_	_
16	in	in	IN	IN	_	17	case	_	_
17	unstimulated	unstimulated	JJ	JJ	_	9	nmod	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	12-O-tetradecanoylphorbol	12-o-tetradecanoylphorbol	NN	NN	_	17	conj	_	_
20	13-acetate/phytohemagglutinin-stimulated	13-acetate/phytohemagglutinin-stimulated	JJ	JJ	_	19	amod	_	_
21	human	human	JJ	JJ	_	24	amod	_	_
22	Jurkat	jurkat	NN	NN	_	24	compound	_	_
23	T	t	NN	NN	_	24	compound	_	_
24	cells	cell	NNS	NNS	_	17	dep	_	_
25	.	.	.	.	_	7	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	8	nmod	_	_
3	,	,	,	,	_	8	punct	_	_
4	the	the	DT	DT	_	6	det	_	_
5	promoter	promoter	NN	NN	_	6	compound	_	_
6	activity	activity	NN	NN	_	8	nsubjpass	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	suppressed	suppress	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	_	11	case	_	_
10	alpha	alpha	NN	NN	_	11	compound	_	_
11	B2	b2	NN	NN	_	8	nmod	_	_
12	.	.	.	.	_	8	punct	_	_

1	Coexpression	coexpression	NN	NN	_	8	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	alpha	alpha	NN	NN	_	4	compound	_	_
4	B1	b1	NN	NN	_	1	nmod	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	alpha	alpha	NN	NN	_	7	compound	_	_
7	B2	b2	NN	NN	_	4	conj	_	_
8	showed	show	VBD	VBD	_	0	root	_	_
9	that	that	IN	IN	_	15	mark	_	_
10	the	the	DT	DT	_	12	det	_	_
11	promoter	promoter	NN	NN	_	12	compound	_	_
12	activity	activity	NN	NN	_	15	nsubjpass	_	_
13	could	could	MD	MD	_	15	aux	_	_
14	be	be	VB	VB	_	15	auxpass	_	_
15	determined	determine	VBN	VBN	_	8	ccomp	_	_
16	by	by	IN	IN	_	21	case	_	_
17	the	the	DT	DT	_	21	det	_	_
18	alpha	alpha	NN	NN	_	21	compound	_	_
19	B1/alpha	b1/alpha	NN	NN	_	21	compound	_	_
20	B2	b2	NN	NN	_	21	compound	_	_
21	ratio	ratio	NN	NN	_	15	nmod	_	_
22	.	.	.	.	_	8	punct	_	_

1	Jurkat	jurkat	NN	NN	_	3	compound	_	_
2	cell	cell	NN	NN	_	3	compound	_	_
3	extract	extract	NN	NN	_	4	nsubj	_	_
4	contained	contain	VBD	VBD	_	0	root	_	_
5	PEBP2	pebp2	NN	NN	_	7	compound	_	_
6	site-binding	site-binding	JJ	JJ	_	7	amod	_	_
7	protein	protein	NN	NN	_	9	compound	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	s	s	NNS	NNS	_	4	dobj	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	that	that	WDT	WDT	_	12	nsubj	_	_
12	cross-reacted	cross-react	VBD	VBD	_	9	acl:relcl	_	_
13	with	with	IN	IN	_	17	case	_	_
14	antimouse	antimouse	JJ	JJ	_	17	amod	_	_
15	alpha	alpha	NN	NN	_	17	compound	_	_
16	A1	a1	NN	NN	_	17	compound	_	_
17	antibodies	antibody	NNS	NNS	_	12	nmod	_	_
18	.	.	.	.	_	4	punct	_	_

1	Northern	northern	NN	NN	_	3	compound	_	_
2	blot	blot	NN	NN	_	3	compound	_	_
3	analysis	analysis	NN	NN	_	4	nsubj	_	_
4	indicated	indicate	VBD	VBD	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	expression	expression	NN	NN	_	4	dobj	_	_
7	of	of	IN	IN	_	11	case	_	_
8	human	human	JJ	JJ	_	11	amod	_	_
9	PEBP2	pebp2	NN	NN	_	11	compound	_	_
10	alpha	alpha	NN	NN	_	11	compound	_	_
11	A	a	NN	NN	_	6	nmod	_	_
12	,	,	,	,	_	11	punct	_	_
13	alpha	alpha	NN	NN	_	14	compound	_	_
14	B	b	NN	NN	_	11	conj	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	AML1	aml1	NN	NN	_	14	appos	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	,	,	,	,	_	11	punct	_	_
19	and	and	CC	CC	_	11	cc	_	_
20	beta	beta	NN	NN	_	21	compound	_	_
21	genes	gene	NNS	NNS	_	11	conj	_	_
22	in	in	IN	IN	_	24	case	_	_
23	Jurkat	jurkat	NN	NN	_	24	compound	_	_
24	cells	cell	NNS	NNS	_	6	nmod	_	_
25	.	.	.	.	_	4	punct	_	_

1	Although	although	IN	IN	_	5	mark	_	_
2	further	further	JJ	JJ	_	3	amod	_	_
3	studies	study	NNS	NNS	_	5	nsubjpass	_	_
4	are	be	VBP	VBP	_	5	auxpass	_	_
5	required	require	VBN	VBN	_	22	advcl	_	_
6	to	to	TO	TO	_	7	mark	_	_
7	determine	determine	VB	VB	_	5	xcomp	_	_
8	the	the	DT	DT	_	10	det	_	_
9	precise	precise	JJ	JJ	_	10	amod	_	_
10	role	role	NN	NN	_	7	dobj	_	_
11	of	of	IN	IN	_	12	case	_	_
12	PEBP2	pebp2	NN	NN	_	10	nmod	_	_
13	in	in	IN	IN	_	17	case	_	_
14	the	the	DT	DT	_	17	det	_	_
15	GM-CSF	gm-csf	NN	NN	_	17	compound	_	_
16	promoter	promoter	NN	NN	_	17	compound	_	_
17	activity	activity	NN	NN	_	10	nmod	_	_
18	,	,	,	,	_	22	punct	_	_
19	the	the	DT	DT	_	21	det	_	_
20	present	present	JJ	JJ	_	21	amod	_	_
21	findings	finding	NNS	NNS	_	22	nsubj	_	_
22	suggested	suggest	VBD	VBD	_	0	root	_	_
23	the	the	DT	DT	_	24	det	_	_
24	importance	importance	NN	NN	_	22	dobj	_	_
25	of	of	IN	IN	_	28	case	_	_
26	the	the	DT	DT	_	28	det	_	_
27	relative	relative	JJ	JJ	_	28	amod	_	_
28	ratio	ratio	NN	NN	_	24	nmod	_	_
29	of	of	IN	IN	_	32	case	_	_
30	different	different	JJ	JJ	_	32	amod	_	_
31	PEBP2	pebp2	NN	NN	_	32	compound	_	_
32	isoforms	isoform	NNS	NNS	_	28	nmod	_	_
33	in	in	IN	IN	_	34	mark	_	_
34	regulating	regulate	VBG	VBG	_	24	acl	_	_
35	the	the	DT	DT	_	36	det	_	_
36	levels	level	NNS	NNS	_	34	dobj	_	_
37	of	of	IN	IN	_	40	case	_	_
38	the	the	DT	DT	_	40	det	_	_
39	promoter	promoter	NN	NN	_	40	compound	_	_
40	activity	activity	NN	NN	_	36	nmod	_	_
41	.	.	.	.	_	22	punct	_	_

1	Does	do	VBZ	VBZ	_	7	aux	_	_
2	activation	activation	NN	NN	_	7	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	TAL1	tal1	NN	NN	_	6	compound	_	_
6	gene	gene	NN	NN	_	2	nmod	_	_
7	occur	occur	VB	VB	_	0	root	_	_
8	in	in	IN	IN	_	10	case	_	_
9	a	a	DT	DT	_	10	det	_	_
10	majority	majority	NN	NN	_	7	nmod	_	_
11	of	of	IN	IN	_	12	case	_	_
12	patients	patient	NNS	NNS	_	10	nmod	_	_
13	with	with	IN	IN	_	17	case	_	_
14	T-cell	t-cell	NN	NN	_	17	compound	_	_
15	acute	acute	JJ	JJ	_	17	amod	_	_
16	lymphoblastic	lymphoblastic	JJ	JJ	_	17	amod	_	_
17	leukemia	leukemia	NN	NN	_	12	nmod	_	_
18	?	?	.	.	_	7	punct	_	_

1	A	a	DT	DT	_	5	det	_	_
2	pediatric	pediatric	JJ	JJ	_	5	amod	_	_
3	oncology	oncology	NN	NN	_	5	compound	_	_
4	group	group	NN	NN	_	5	compound	_	_
5	study	study	NN	NN	_	0	root	_	_
6	.	.	.	.	_	5	punct	_	_

1	Almost	almost	RB	RB	_	2	advmod	_	_
2	25	25	CD	CD	_	3	nummod	_	_
3	%	%	NN	NN	_	14	nsubj	_	_
4	of	of	IN	IN	_	5	case	_	_
5	patients	patient	NNS	NNS	_	3	nmod	_	_
6	with	with	IN	IN	_	10	case	_	_
7	T-cell	t-cell	NN	NN	_	10	compound	_	_
8	acute	acute	JJ	JJ	_	10	amod	_	_
9	lymphoblastic	lymphoblastic	JJ	JJ	_	10	amod	_	_
10	leukemia	leukemia	NN	NN	_	5	nmod	_	_
11	(	(	-LRB-	-LRB-	_	12	punct	_	_
12	T-ALL	t-all	NN	NN	_	10	appos	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	have	have	VBP	VBP	_	0	root	_	_
15	tumor-specific	tumor-specific	JJ	JJ	_	16	amod	_	_
16	rearrangements	rearrangement	NNS	NNS	_	14	dobj	_	_
17	of	of	IN	IN	_	20	case	_	_
18	the	the	DT	DT	_	20	det	_	_
19	TAL1	tal1	NN	NN	_	20	compound	_	_
20	gene	gene	NN	NN	_	16	nmod	_	_
21	.	.	.	.	_	14	punct	_	_

1	Although	although	IN	IN	_	7	mark	_	_
2	TAL1	tal1	NN	NN	_	3	compound	_	_
3	expression	expression	NN	NN	_	7	nsubjpass	_	_
4	has	have	VBZ	VBZ	_	7	aux	_	_
5	not	not	RB	RB	_	7	neg	_	_
6	been	be	VBN	VBN	_	7	auxpass	_	_
7	observed	observe	VBN	VBN	_	17	advcl	_	_
8	in	in	IN	IN	_	10	case	_	_
9	normal	normal	JJ	JJ	_	10	amod	_	_
10	lymphocytes	lymphocyte	NNS	NNS	_	7	nmod	_	_
11	,	,	,	,	_	17	punct	_	_
12	TAL1	tal1	NN	NN	_	14	compound	_	_
13	gene	gene	NN	NN	_	14	compound	_	_
14	products	product	NNS	NNS	_	17	nsubjpass	_	_
15	are	be	VBP	VBP	_	17	auxpass	_	_
16	readily	readily	RB	RB	_	17	advmod	_	_
17	detected	detect	VBN	VBN	_	0	root	_	_
18	in	in	IN	IN	_	20	case	_	_
19	leukemic	leukemic	JJ	JJ	_	20	amod	_	_
20	cells	cell	NNS	NNS	_	17	nmod	_	_
21	that	that	WDT	WDT	_	22	nsubj	_	_
22	harbor	harbor	VBP	VBP	_	20	acl:relcl	_	_
23	a	a	DT	DT	_	26	det	_	_
24	rearranged	rearrange	VBN	VBN	_	26	amod	_	_
25	TAL1	tal1	NN	NN	_	26	compound	_	_
26	allele	allele	NN	NN	_	22	dobj	_	_
27	.	.	.	.	_	17	punct	_	_

1	Hence	hence	RB	RB	_	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	it	it	PRP	PRP	_	6	nsubjpass	_	_
4	has	have	VBZ	VBZ	_	6	aux	_	_
5	been	be	VBN	VBN	_	6	auxpass	_	_
6	proposed	propose	VBN	VBN	_	0	root	_	_
7	that	that	IN	IN	_	12	mark	_	_
8	ectopic	ectopic	JJ	JJ	_	9	amod	_	_
9	expression	expression	NN	NN	_	12	nsubj	_	_
10	of	of	IN	IN	_	11	case	_	_
11	TAL1	tal1	NN	NN	_	9	nmod	_	_
12	promotes	promote	VBZ	VBZ	_	6	ccomp	_	_
13	the	the	DT	DT	_	14	det	_	_
14	development	development	NN	NN	_	12	dobj	_	_
15	of	of	IN	IN	_	16	case	_	_
16	T-ALL	t-all	NN	NN	_	14	nmod	_	_
17	.	.	.	.	_	6	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	report	report	NN	NN	_	6	nmod	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	show	show	VBP	VBP	_	0	root	_	_
7	that	that	IN	IN	_	10	mark	_	_
8	TAL1	tal1	NN	NN	_	10	nsubjpass	_	_
9	is	be	VBZ	VBZ	_	10	auxpass	_	_
10	expressed	express	VBN	VBN	_	6	ccomp	_	_
11	in	in	IN	IN	_	14	case	_	_
12	the	the	DT	DT	_	14	det	_	_
13	leukemic	leukemic	JJ	JJ	_	14	amod	_	_
14	cells	cell	NNS	NNS	_	10	nmod	_	_
15	of	of	IN	IN	_	17	case	_	_
16	most	most	JJS	JJS	_	17	amod	_	_
17	patients	patient	NNS	NNS	_	14	nmod	_	_
18	with	with	IN	IN	_	19	case	_	_
19	T-ALL	t-all	NN	NN	_	17	nmod	_	_
20	,	,	,	,	_	14	punct	_	_
21	including	include	VBG	VBG	_	22	case	_	_
22	many	many	JJ	JJ	_	14	nmod	_	_
23	that	that	WDT	WDT	_	26	nsubj	_	_
24	do	do	VBP	VBP	_	26	aux	_	_
25	not	not	RB	RB	_	26	neg	_	_
26	display	display	VB	VB	_	22	acl:relcl	_	_
27	an	a	DT	DT	_	31	det	_	_
28	apparent	apparent	JJ	JJ	_	31	amod	_	_
29	TAL1	tal1	NN	NN	_	30	compound	_	_
30	gene	gene	NN	NN	_	31	compound	_	_
31	alteration	alteration	NN	NN	_	26	dobj	_	_
32	.	.	.	.	_	6	punct	_	_

1	A	a	DT	DT	_	4	det	_	_
2	polymorphic	polymorphic	JJ	JJ	_	4	amod	_	_
3	dinucleotide	dinucleotide	NN	NN	_	4	compound	_	_
4	repeat	repeat	NN	NN	_	12	nsubjpass	_	_
5	in	in	IN	IN	_	8	case	_	_
6	the	the	DT	DT	_	8	det	_	_
7	transcribed	transcribe	VBN	VBN	_	8	amod	_	_
8	sequences	sequence	NNS	NNS	_	4	nmod	_	_
9	of	of	IN	IN	_	10	case	_	_
10	TAL1	tal1	NN	NN	_	8	nmod	_	_
11	was	be	VBD	VBD	_	12	auxpass	_	_
12	used	use	VBN	VBN	_	0	root	_	_
13	to	to	TO	TO	_	14	mark	_	_
14	determine	determine	VB	VB	_	12	xcomp	_	_
15	the	the	DT	DT	_	17	det	_	_
16	allele	allele	NN	NN	_	17	compound	_	_
17	specificity	specificity	NN	NN	_	14	dobj	_	_
18	of	of	IN	IN	_	20	case	_	_
19	TAL1	tal1	NN	NN	_	20	compound	_	_
20	transcription	transcription	NN	NN	_	17	nmod	_	_
21	in	in	IN	IN	_	24	case	_	_
22	primary	primary	JJ	JJ	_	24	amod	_	_
23	T-ALL	t-all	NN	NN	_	24	compound	_	_
24	cells	cell	NNS	NNS	_	20	nmod	_	_
25	.	.	.	.	_	12	punct	_	_

1	Monoallelic	monoallelic	JJ	JJ	_	2	amod	_	_
2	expression	expression	NN	NN	_	6	nsubjpass	_	_
3	of	of	IN	IN	_	4	case	_	_
4	TAL1	tal1	NN	NN	_	2	nmod	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	observed	observe	VBN	VBN	_	0	root	_	_
7	in	in	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	leukemic	leukemic	JJ	JJ	_	10	amod	_	_
10	cells	cell	NNS	NNS	_	6	nmod	_	_
11	of	of	IN	IN	_	13	case	_	_
12	all	all	DT	DT	_	13	det	_	_
13	patients	patient	NNS	NNS	_	10	nmod	_	_
14	(	(	-LRB-	-LRB-	_	17	punct	_	_
15	8	8	CD	CD	_	17	compound	_	_
16	of	of	IN	IN	_	17	advmod	_	_
17	8	8	CD	CD	_	13	dep	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	bearing	bear	VBG	VBG	_	10	acl	_	_
20	a	a	DT	DT	_	23	det	_	_
21	TAL1	tal1	NN	NN	_	22	compound	_	_
22	gene	gene	NN	NN	_	23	compound	_	_
23	rearrangement	rearrangement	NN	NN	_	19	dobj	_	_
24	.	.	.	.	_	6	punct	_	_

1	In	in	IN	IN	_	4	case	_	_
2	the	the	DT	DT	_	4	det	_	_
3	leukemic	leukemic	JJ	JJ	_	4	amod	_	_
4	cells	cell	NNS	NNS	_	14	nmod	_	_
5	of	of	IN	IN	_	6	case	_	_
6	patients	patient	NNS	NNS	_	4	nmod	_	_
7	without	without	IN	IN	_	10	case	_	_
8	detectable	detectable	JJ	JJ	_	10	amod	_	_
9	TAL1	tal1	NN	NN	_	10	compound	_	_
10	rearrangements	rearrangement	NNS	NNS	_	4	nmod	_	_
11	,	,	,	,	_	14	punct	_	_
12	TAL1	tal1	NN	NN	_	13	compound	_	_
13	transcription	transcription	NN	NN	_	14	nsubj	_	_
14	occurred	occur	VBD	VBD	_	0	root	_	_
15	in	in	IN	IN	_	18	case	_	_
16	either	either	CC	CC	_	18	cc:preconj	_	_
17	a	a	DT	DT	_	18	det	_	_
18	monoallelic	monoallelic	JJ	JJ	_	14	nmod	_	_
19	(	(	-LRB-	-LRB-	_	23	punct	_	_
20	3	3	CD	CD	_	22	compound	_	_
21	of	of	IN	IN	_	22	advmod	_	_
22	7	7	CD	CD	_	23	nummod	_	_
23	patients	patient	NNS	NNS	_	18	appos	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	or	or	CC	CC	_	18	cc	_	_
26	a	a	DT	DT	_	27	det	_	_
27	biallelic	biallelic	JJ	JJ	_	18	conj	_	_
28	(	(	-LRB-	-LRB-	_	32	punct	_	_
29	4	4	CD	CD	_	32	compound	_	_
30	of	of	IN	IN	_	32	advmod	_	_
31	7	7	CD	CD	_	32	compound	_	_
32	patients	patient	NNS	NNS	_	27	dep	_	_
33	)	)	-RRB-	-RRB-	_	32	punct	_	_
34	fashion	fashion	NN	NN	_	18	dep	_	_
35	.	.	.	.	_	14	punct	_	_

1	Thus	thus	RB	RB	_	9	advmod	_	_
2	,	,	,	,	_	9	punct	_	_
3	TAL1	tal1	NN	NN	_	4	compound	_	_
4	activation	activation	NN	NN	_	9	nsubj	_	_
5	in	in	IN	IN	_	7	case	_	_
6	these	these	DT	DT	_	7	det	_	_
7	patients	patient	NNS	NNS	_	4	nmod	_	_
8	may	may	MD	MD	_	9	aux	_	_
9	result	result	VB	VB	_	0	root	_	_
10	from	from	IN	IN	_	12	case	_	_
11	subtle	subtle	JJ	JJ	_	12	amod	_	_
12	alterations	alteration	NNS	NNS	_	9	nmod	_	_
13	in	in	IN	IN	_	16	case	_	_
14	cis-acting	cis-acting	JJ	JJ	_	16	amod	_	_
15	regulatory	regulatory	JJ	JJ	_	16	amod	_	_
16	sequences	sequence	NNS	NNS	_	12	nmod	_	_
17	(	(	-LRB-	-LRB-	_	18	punct	_	_
18	affecting	affect	VBG	VBG	_	16	dep	_	_
19	expression	expression	NN	NN	_	18	dobj	_	_
20	of	of	IN	IN	_	24	case	_	_
21	a	a	DT	DT	_	24	det	_	_
22	single	single	JJ	JJ	_	24	amod	_	_
23	TAL1	tal1	NN	NN	_	24	compound	_	_
24	allele	allele	NN	NN	_	19	nmod	_	_
25	)	)	-RRB-	-RRB-	_	18	punct	_	_
26	or	or	CC	CC	_	12	cc	_	_
27	changes	change	NNS	NNS	_	12	conj	_	_
28	in	in	IN	IN	_	30	case	_	_
29	trans-acting	trans-acting	JJ	JJ	_	30	amod	_	_
30	factors	factor	NNS	NNS	_	27	nmod	_	_
31	that	that	WDT	WDT	_	32	nsubj	_	_
32	control	control	VBP	VBP	_	30	acl:relcl	_	_
33	TAL1	tal1	NN	NN	_	34	compound	_	_
34	transcription	transcription	NN	NN	_	32	dobj	_	_
35	(	(	-LRB-	-LRB-	_	36	punct	_	_
36	affecting	affect	VBG	VBG	_	30	dep	_	_
37	expression	expression	NN	NN	_	36	dobj	_	_
38	of	of	IN	IN	_	41	case	_	_
39	both	both	DT	DT	_	41	dep	_	_
40	TAL1	tal1	NN	NN	_	41	compound	_	_
41	alleles	allele	NNS	NNS	_	37	nmod	_	_
42	)	)	-RRB-	-RRB-	_	36	punct	_	_
43	.	.	.	.	_	9	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	interleukin-5/receptor	interleukin-5/receptor	NN	NN	_	3	compound	_	_
3	interaction	interaction	NN	NN	_	4	nsubj	_	_
4	activates	activate	VBZ	VBZ	_	0	root	_	_
5	Lyn	lyn	NN	NN	_	4	dobj	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	Jak2	jak2	NN	NN	_	5	conj	_	_
8	tyrosine	tyrosine	NN	NN	_	9	compound	_	_
9	kinases	kinase	NNS	NNS	_	5	dep	_	_
10	and	and	CC	CC	_	4	cc	_	_
11	propagates	propagate	VBZ	VBZ	_	4	conj	_	_
12	signals	signal	NNS	NNS	_	11	dobj	_	_
13	via	via	IN	IN	_	16	case	_	_
14	the	the	DT	DT	_	16	det	_	_
15	Ras-Raf-1-MAP	ras-raf-1-map	NN	NN	_	16	compound	_	_
16	kinase	kinase	NN	NN	_	11	nmod	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	the	the	DT	DT	_	20	det	_	_
19	Jak-STAT	jak-stat	JJ	JJ	_	20	amod	_	_
20	pathways	pathway	NNS	NNS	_	16	conj	_	_
21	in	in	IN	IN	_	22	case	_	_
22	eosinophils	eosinophil	NNS	NNS	_	16	nmod	_	_
23	.	.	.	.	_	4	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	shown	show	VBN	VBN	_	0	root	_	_
4	that	that	IN	IN	_	16	mark	_	_
5	the	the	DT	DT	_	6	det	_	_
6	interaction	interaction	NN	NN	_	16	nsubj	_	_
7	of	of	IN	IN	_	10	case	_	_
8	interleukin	interleukin	NN	NN	_	10	compound	_	_
9	(	(	-LRB-	-LRB-	_	10	punct	_	_
10	IL	il	NN	NN	_	6	nmod	_	_
11	)	)	-RRB-	-RRB-	_	10	punct	_	_
12	-5	-5	CD	CD	_	10	nummod	_	_
13	with	with	IN	IN	_	15	case	_	_
14	the	the	DT	DT	_	15	det	_	_
15	receptor	receptor	NN	NN	_	6	nmod	_	_
16	activates	activate	VBZ	VBZ	_	3	ccomp	_	_
17	Lyn	lyn	NN	NN	_	19	compound	_	_
18	tyrosine	tyrosine	NN	NN	_	19	compound	_	_
19	kinase	kinase	NN	NN	_	16	dobj	_	_
20	within	within	IN	IN	_	22	case	_	_
21	1	1	CD	CD	_	22	nummod	_	_
22	min	min	NN	NN	_	16	nmod	_	_
23	and	and	CC	CC	_	16	cc	_	_
24	Jak2	jak2	NN	NN	_	26	compound	_	_
25	tyrosine	tyrosine	NN	NN	_	26	compound	_	_
26	kinase	kinase	NN	NN	_	16	conj	_	_
27	within	within	IN	IN	_	29	case	_	_
28	1-3	1-3	CD	CD	_	29	nummod	_	_
29	min	min	NN	NN	_	16	nmod	_	_
30	.	.	.	.	_	3	punct	_	_

1	IL-5	il-5	NN	NN	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	stimulates	stimulate	VBZ	VBZ	_	0	root	_	_
4	GTP	gtp	NN	NN	_	3	dobj	_	_
5	binding	bind	VBG	VBG	_	4	acl	_	_
6	to	to	TO	TO	_	7	case	_	_
7	p21ras	p21ras	NN	NN	_	5	nmod	_	_
8	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	signal	signal	NN	NN	_	5	nsubjpass	_	_
3	is	be	VBZ	VBZ	_	5	auxpass	_	_
4	subsequently	subsequently	RB	RB	_	5	advmod	_	_
5	propagated	propagate	VBN	VBN	_	0	root	_	_
6	through	through	IN	IN	_	8	case	_	_
7	the	the	DT	DT	_	8	det	_	_
8	activation	activation	NN	NN	_	5	nmod	_	_
9	of	of	IN	IN	_	10	case	_	_
10	Raf-1	raf-1	NN	NN	_	8	nmod	_	_
11	,	,	,	,	_	10	punct	_	_
12	MEK	mek	NN	NN	_	10	conj	_	_
13	,	,	,	,	_	10	punct	_	_
14	and	and	CC	CC	_	10	cc	_	_
15	MAP	map	NN	NN	_	16	compound	_	_
16	kinases	kinase	NNS	NNS	_	10	conj	_	_
17	as	as	IN	IN	_	18	mark	_	_
18	shown	show	VBN	VBN	_	5	advcl	_	_
19	by	by	IN	IN	_	22	case	_	_
20	their	they	PRP$	PRP$	_	22	nmod:poss	_	_
21	increased	increase	VBN	VBN	_	22	amod	_	_
22	autophosphorylation	autophosphorylation	NN	NN	_	18	nmod	_	_
23	in	in	FW	FW	_	24	compound	_	_
24	vitro	vitro	FW	FW	_	22	advmod	_	_
25	and	and	CC	CC	_	22	cc	_	_
26	phosphorylation	phosphorylation	NN	NN	_	22	conj	_	_
27	in	in	FW	FW	_	28	compound	_	_
28	situ	situ	FW	FW	_	26	advmod	_	_
29	.	.	.	.	_	5	punct	_	_

1	Jak2	jak2	NN	NN	_	2	compound	_	_
2	kinase	kinase	NN	NN	_	5	nsubjpass	_	_
3	has	have	VBZ	VBZ	_	5	aux	_	_
4	been	be	VBN	VBN	_	5	auxpass	_	_
5	shown	show	VBN	VBN	_	0	root	_	_
6	to	to	TO	TO	_	7	mark	_	_
7	phosphorylate	phosphorylate	VB	VB	_	5	xcomp	_	_
8	STAT	stat	NN	NN	_	10	compound	_	_
9	nuclear	nuclear	JJ	JJ	_	10	amod	_	_
10	proteins	protein	NNS	NNS	_	7	dobj	_	_
11	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	activation	activation	NN	NN	_	8	nsubjpass	_	_
3	of	of	IN	IN	_	6	case	_	_
4	STAT	stat	NN	NN	_	6	compound	_	_
5	nuclear	nuclear	JJ	JJ	_	6	amod	_	_
6	factors	factor	NNS	NNS	_	2	nmod	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	studied	study	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	_	13	case	_	_
10	electrophoretic	electrophoretic	JJ	JJ	_	13	amod	_	_
11	mobility	mobility	NN	NN	_	13	compound	_	_
12	shift	shift	NN	NN	_	13	compound	_	_
13	assay	assay	NN	NN	_	8	nmod	_	_
14	using	use	VBG	VBG	_	13	acl	_	_
15	a	a	DT	DT	_	22	det	_	_
16	gamma	gamma	NN	NN	_	18	compound	_	_
17	activation	activation	NN	NN	_	18	compound	_	_
18	site	site	NN	NN	_	22	compound	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	GAS	gas	NN	NN	_	18	appos	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	probe	probe	NN	NN	_	14	dobj	_	_
23	.	.	.	.	_	8	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	found	find	VBD	VBD	_	0	root	_	_
3	that	that	IN	IN	_	5	mark	_	_
4	IL-5	il-5	NN	NN	_	5	nsubj	_	_
5	induces	induce	VBZ	VBZ	_	2	ccomp	_	_
6	two	two	CD	CD	_	8	nummod	_	_
7	GAS-binding	gas-binding	JJ	JJ	_	8	amod	_	_
8	proteins	protein	NNS	NNS	_	5	dobj	_	_
9	in	in	IN	IN	_	10	case	_	_
10	eosinophils	eosinophil	NNS	NNS	_	8	nmod	_	_
11	,	,	,	,	_	8	punct	_	_
12	one	one	CD	CD	_	16	nsubj	_	_
13	of	of	IN	IN	_	14	case	_	_
14	which	which	WDT	WDT	_	12	nmod	_	_
15	is	be	VBZ	VBZ	_	16	cop	_	_
16	STAT1	stat1	NN	NN	_	8	acl:relcl	_	_
17	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	conclude	conclude	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	8	mark	_	_
4	IL-5	il-5	NN	NN	_	6	compound	_	_
5	induced	induced	JJ	JJ	_	6	amod	_	_
6	signals	signal	NNS	NNS	_	8	nsubjpass	_	_
7	are	be	VBP	VBP	_	8	auxpass	_	_
8	propagated	propagate	VBN	VBN	_	2	ccomp	_	_
9	through	through	IN	IN	_	12	case	_	_
10	two	two	CD	CD	_	12	nummod	_	_
11	distinct	distinct	JJ	JJ	_	12	amod	_	_
12	pathways	pathway	NNS	NNS	_	8	nmod	_	_
13	:	:	:	:	_	2	punct	_	_
14	(	(	-LRB-	-LRB-	_	15	punct	_	_
15	1	1	LS	LS	_	17	dep	_	_
16	)	)	-RRB-	-RRB-	_	15	punct	_	_
17	Lyn	lyn	NN	NN	_	2	dep	_	_
18	--&gt;	--&gt;	TO	TO	_	19	dep	_	_
19	Ras	ras	NN	NN	_	17	amod	_	_
20	--&gt;	--&gt;	TO	TO	_	21	dep	_	_
21	Raf-1	raf-1	NN	NN	_	19	amod	_	_
22	--&gt;	--&gt;	TO	TO	_	23	dep	_	_
23	MEK	mek	NN	NN	_	21	amod	_	_
24	--&gt;	--&gt;	TO	TO	_	26	dep	_	_
25	MAP	map	NN	NN	_	26	compound	_	_
26	kinase	kinase	NN	NN	_	23	amod	_	_
27	and	and	CC	CC	_	17	cc	_	_
28	(	(	-LRB-	-LRB-	_	29	punct	_	_
29	2	2	LS	LS	_	31	dep	_	_
30	)	)	-RRB-	-RRB-	_	29	punct	_	_
31	Jak2	jak2	NN	NN	_	17	conj	_	_
32	--&gt;	--&gt;	TO	TO	_	33	dep	_	_
33	STAT1	stat1	NN	NN	_	31	amod	_	_
34	.	.	.	.	_	2	punct	_	_

1	Thapsigargin	thapsigargin	NN	NN	_	2	nsubj	_	_
2	induces	induce	VBZ	VBZ	_	0	root	_	_
3	IL-2	il-2	NN	NN	_	5	compound	_	_
4	receptor	receptor	NN	NN	_	5	compound	_	_
5	alpha-chain	alpha-chain	NN	NN	_	2	dobj	_	_
6	in	in	IN	IN	_	8	case	_	_
7	human	human	JJ	JJ	_	8	amod	_	_
8	peripheral	peripheral	JJ	JJ	_	5	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	Jurkat	jurkat	NN	NN	_	12	compound	_	_
11	T	t	NN	NN	_	12	compound	_	_
12	cells	cell	NNS	NNS	_	8	conj	_	_
13	via	via	IN	IN	_	18	case	_	_
14	a	a	DT	DT	_	18	det	_	_
15	protein	protein	NN	NN	_	18	compound	_	_
16	kinase	kinase	NN	NN	_	18	compound	_	_
17	C-independent	c-independent	JJ	JJ	_	18	amod	_	_
18	mechanism	mechanism	NN	NN	_	2	nmod	_	_
19	.	.	.	.	_	2	punct	_	_

1	Thapsigargin	thapsigargin	NN	NN	_	11	nsubj	_	_
2	(	(	-LRB-	-LRB-	_	3	punct	_	_
3	TG	tg	NN	NN	_	1	appos	_	_
4	)	)	-RRB-	-RRB-	_	3	punct	_	_
5	,	,	,	,	_	1	punct	_	_
6	an	a	DT	DT	_	7	det	_	_
7	inhibitor	inhibitor	NN	NN	_	1	appos	_	_
8	of	of	IN	IN	_	9	case	_	_
9	Ca(2+)-ATPase	ca(2+)-atpase	NN	NN	_	7	nmod	_	_
10	,	,	,	,	_	1	punct	_	_
11	depletes	deplete	VBZ	VBZ	_	0	root	_	_
12	intracellular	intracellular	JJ	JJ	_	14	amod	_	_
13	Ca2+	ca2+	NN	NN	_	14	compound	_	_
14	stores	store	NNS	NNS	_	11	dobj	_	_
15	and	and	CC	CC	_	11	cc	_	_
16	induces	induce	VBZ	VBZ	_	11	conj	_	_
17	a	a	DT	DT	_	20	det	_	_
18	sustained	sustained	JJ	JJ	_	20	amod	_	_
19	Ca2+	ca2+	NN	NN	_	20	compound	_	_
20	influx	influx	NN	NN	_	16	dobj	_	_
21	without	without	IN	IN	_	22	mark	_	_
22	altering	alter	VBG	VBG	_	11	advcl	_	_
23	phosphatidyl	phosphatidyl	JJ	JJ	_	25	amod	_	_
24	inositol	inositol	NN	NN	_	25	compound	_	_
25	levels	level	NNS	NNS	_	22	dobj	_	_
26	.	.	.	.	_	11	punct	_	_

1	TG	tg	NN	NN	_	13	nsubj	_	_
2	plus	plus	CC	CC	_	1	cc	_	_
3	phorbol	phorbol	NN	NN	_	5	compound	_	_
4	myristate	myristate	NN	NN	_	5	compound	_	_
5	acetate	acetate	NN	NN	_	1	conj	_	_
6	(	(	-LRB-	-LRB-	_	7	punct	_	_
7	PMA	pma	NN	NN	_	5	appos	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	but	but	CC	CC	_	10	cc	_	_
10	not	not	RB	RB	_	1	cc	_	_
11	TG	tg	NN	NN	_	1	conj	_	_
12	alone	alone	RB	RB	_	11	advmod	_	_
13	induced	induce	VBD	VBD	_	0	root	_	_
14	IL-2	il-2	NN	NN	_	13	dobj	_	_
15	in	in	IN	IN	_	18	case	_	_
16	Jurkat	jurkat	NN	NN	_	18	compound	_	_
17	T	t	NN	NN	_	18	compound	_	_
18	cells	cell	NNS	NNS	_	14	nmod	_	_
19	,	,	,	,	_	13	punct	_	_
20	suggesting	suggest	VBG	VBG	_	13	advcl	_	_
21	that	that	IN	IN	_	23	mark	_	_
22	TG	tg	NN	NN	_	23	nsubj	_	_
23	had	have	VBD	VBD	_	20	ccomp	_	_
24	no	no	DT	DT	_	25	neg	_	_
25	effect	effect	NN	NN	_	23	dobj	_	_
26	on	on	IN	IN	_	29	case	_	_
27	protein	protein	NN	NN	_	29	compound	_	_
28	kinase	kinase	NN	NN	_	29	compound	_	_
29	C	c	NN	NN	_	23	nmod	_	_
30	(	(	-LRB-	-LRB-	_	31	punct	_	_
31	PKC	pkc	NN	NN	_	29	appos	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	.	.	.	.	_	13	punct	_	_

1	However	however	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	TG	tg	NN	NN	_	4	nsubj	_	_
4	induced	induce	VBD	VBD	_	0	root	_	_
5	increases	increase	NNS	NNS	_	4	dobj	_	_
6	in	in	IN	IN	_	9	case	_	_
7	IL-2R	il-2r	NN	NN	_	9	compound	_	_
8	alpha	alpha	NN	NN	_	9	compound	_	_
9	protein	protein	NN	NN	_	5	nmod	_	_
10	as	as	RB	RB	_	9	cc	_	_
11	well	well	RB	RB	_	10	mwe	_	_
12	as	as	IN	IN	_	10	mwe	_	_
13	IL-2R	il-2r	NN	NN	_	15	compound	_	_
14	alpha	alpha	NN	NN	_	15	compound	_	_
15	mRNA	mrna	NN	NN	_	9	conj	_	_
16	in	in	IN	IN	_	19	case	_	_
17	Jurkat	jurkat	NN	NN	_	19	compound	_	_
18	T	t	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	9	nmod	_	_
20	in	in	IN	IN	_	23	case	_	_
21	a	a	DT	DT	_	23	det	_	_
22	dose-dependent	dose-dependent	JJ	JJ	_	23	amod	_	_
23	manner	manner	NN	NN	_	4	nmod	_	_
24	.	.	.	.	_	4	punct	_	_

1	A	a	DT	DT	_	3	det	_	_
2	similar	similar	JJ	JJ	_	3	amod	_	_
3	increase	increase	NN	NN	_	11	nsubjpass	_	_
4	in	in	IN	IN	_	6	case	_	_
5	IL-2R	il-2r	NN	NN	_	6	compound	_	_
6	alpha	alpha	NN	NN	_	3	nmod	_	_
7	by	by	IN	IN	_	8	case	_	_
8	TG	tg	NN	NN	_	3	nmod	_	_
9	was	be	VBD	VBD	_	11	auxpass	_	_
10	also	also	RB	RB	_	11	advmod	_	_
11	observed	observe	VBN	VBN	_	0	root	_	_
12	in	in	IN	IN	_	16	case	_	_
13	human	human	JJ	JJ	_	16	amod	_	_
14	peripheral	peripheral	JJ	JJ	_	16	amod	_	_
15	T	t	NN	NN	_	16	compound	_	_
16	cells	cell	NNS	NNS	_	11	nmod	_	_
17	.	.	.	.	_	11	punct	_	_

1	Further	further	RB	RB	_	8	advmod	_	_
2	,	,	,	,	_	8	punct	_	_
3	like	like	IN	IN	_	4	case	_	_
4	PMA	pma	NN	NN	_	8	nmod	_	_
5	,	,	,	,	_	8	punct	_	_
6	TG	tg	NN	NN	_	8	nsubj	_	_
7	markedly	markedly	RB	RB	_	8	advmod	_	_
8	induced	induce	VBD	VBD	_	0	root	_	_
9	NF	nf	NN	NN	_	11	compound	_	_
10	kappa	kappa	NN	NN	_	11	compound	_	_
11	B	b	NN	NN	_	8	dobj	_	_
12	in	in	IN	IN	_	15	case	_	_
13	Jurkat	jurkat	NN	NN	_	15	compound	_	_
14	T	t	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	11	nmod	_	_
16	.	.	.	.	_	8	punct	_	_

1	However	however	RB	RB	_	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	TG	tg	NN	NN	_	6	nsubj	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	PMA	pma	NN	NN	_	3	conj	_	_
6	exhibited	exhibit	VBD	VBD	_	0	root	_	_
7	a	a	DT	DT	_	9	det	_	_
8	synergistic	synergistic	JJ	JJ	_	9	amod	_	_
9	action	action	NN	NN	_	6	dobj	_	_
10	on	on	IN	IN	_	13	case	_	_
11	IL-2R	il-2r	NN	NN	_	12	compound	_	_
12	alpha	alpha	NN	NN	_	13	compound	_	_
13	expression	expression	NN	NN	_	6	nmod	_	_
14	,	,	,	,	_	6	punct	_	_
15	suggesting	suggest	VBG	VBG	_	6	advcl	_	_
16	that	that	IN	IN	_	20	mark	_	_
17	TG	tg	NN	NN	_	20	nsubj	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	PMA	pma	NN	NN	_	17	conj	_	_
20	induce	induce	VBP	VBP	_	15	ccomp	_	_
21	IL-2R	il-2r	NN	NN	_	22	compound	_	_
22	alpha	alpha	NN	NN	_	20	dobj	_	_
23	through	through	IN	IN	_	25	case	_	_
24	distinct	distinct	JJ	JJ	_	25	amod	_	_
25	pathways	pathway	NNS	NNS	_	20	nmod	_	_
26	.	.	.	.	_	6	punct	_	_

1	PMA-	pma-	NN	NN	_	8	nsubjpass	_	_
2	but	but	CC	CC	_	3	cc	_	_
3	not	not	RB	RB	_	1	cc	_	_
4	TG-induced	tg-induced	JJ	JJ	_	1	conj	_	_
5	IL-2R	il-2r	NN	NN	_	6	compound	_	_
6	alpha	alpha	NN	NN	_	1	dep	_	_
7	is	be	VBZ	VBZ	_	8	auxpass	_	_
8	inhibited	inhibit	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	_	13	case	_	_
10	the	the	DT	DT	_	13	det	_	_
11	PKC	pkc	NN	NN	_	13	compound	_	_
12	inhibitor	inhibitor	NN	NN	_	13	compound	_	_
13	H7	h7	NN	NN	_	8	nmod	_	_
14	,	,	,	,	_	8	punct	_	_
15	whereas	whereas	IN	IN	_	23	mark	_	_
16	TG-	tg-	NN	NN	_	23	nsubjpass	_	_
17	but	but	CC	CC	_	18	cc	_	_
18	not	not	RB	RB	_	16	cc	_	_
19	PMA-induced	pma-induced	JJ	JJ	_	16	conj	_	_
20	IL-2R	il-2r	NN	NN	_	21	compound	_	_
21	alpha	alpha	NN	NN	_	16	dep	_	_
22	was	be	VBD	VBD	_	23	auxpass	_	_
23	inhibited	inhibit	VBN	VBN	_	8	advcl	_	_
24	by	by	IN	IN	_	26	case	_	_
25	cholera	cholera	NN	NN	_	26	compound	_	_
26	toxin	toxin	NN	NN	_	23	nmod	_	_
27	,	,	,	,	_	26	punct	_	_
28	forskolin	forskolin	NN	NN	_	26	conj	_	_
29	and	and	CC	CC	_	26	cc	_	_
30	1,9-dideoxy	1,9-dideoxy	JJ	JJ	_	31	amod	_	_
31	forskolin	forskolin	NN	NN	_	26	conj	_	_
32	.	.	.	.	_	8	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	toto	toto	NN	NN	_	6	nmod	_	_
3	,	,	,	,	_	6	punct	_	_
4	these	these	DT	DT	_	5	det	_	_
5	results	result	NNS	NNS	_	6	nsubj	_	_
6	suggest	suggest	VBP	VBP	_	0	root	_	_
7	that	that	IN	IN	_	9	mark	_	_
8	TG	tg	NN	NN	_	9	nsubj	_	_
9	induces	induce	VBZ	VBZ	_	6	ccomp	_	_
10	IL-2R	il-2r	NN	NN	_	11	compound	_	_
11	alpha	alpha	NN	NN	_	9	dobj	_	_
12	in	in	IN	IN	_	15	case	_	_
13	human	human	JJ	JJ	_	15	amod	_	_
14	T	t	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	11	nmod	_	_
16	through	through	IN	IN	_	19	case	_	_
17	a	a	DT	DT	_	19	det	_	_
18	PKC-independent	pkc-independent	JJ	JJ	_	19	amod	_	_
19	pathway	pathway	NN	NN	_	9	nmod	_	_
20	.	.	.	.	_	6	punct	_	_

1	A	a	DT	DT	_	6	det	_	_
2	functional	functional	JJ	JJ	_	6	amod	_	_
3	T-cell	t-cell	NN	NN	_	4	compound	_	_
4	receptor	receptor	NN	NN	_	6	compound	_	_
5	signaling	signaling	NN	NN	_	6	compound	_	_
6	pathway	pathway	NN	NN	_	8	nsubjpass	_	_
7	is	be	VBZ	VBZ	_	8	auxpass	_	_
8	required	require	VBN	VBN	_	0	root	_	_
9	for	for	IN	IN	_	11	case	_	_
10	p95vav	p95vav	NN	NN	_	11	compound	_	_
11	activity	activity	NN	NN	_	8	nmod	_	_
12	.	.	.	.	_	8	punct	_	_

1	Stimulation	stimulation	NN	NN	_	10	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	T-cell	t-cell	NN	NN	_	6	compound	_	_
5	antigen	antigen	NN	NN	_	6	compound	_	_
6	receptor	receptor	NN	NN	_	1	nmod	_	_
7	(	(	-LRB-	-LRB-	_	8	punct	_	_
8	TCR	tcr	NN	NN	_	6	appos	_	_
9	)	)	-RRB-	-RRB-	_	8	punct	_	_
10	induces	induce	VBZ	VBZ	_	0	root	_	_
11	activation	activation	NN	NN	_	10	dobj	_	_
12	of	of	IN	IN	_	15	case	_	_
13	multiple	multiple	JJ	JJ	_	15	amod	_	_
14	tyrosine	tyrosine	NN	NN	_	15	compound	_	_
15	kinases	kinase	NNS	NNS	_	11	nmod	_	_
16	,	,	,	,	_	10	punct	_	_
17	resulting	result	VBG	VBG	_	10	advcl	_	_
18	in	in	IN	IN	_	19	case	_	_
19	phosphorylation	phosphorylation	NN	NN	_	17	nmod	_	_
20	of	of	IN	IN	_	23	case	_	_
21	numerous	numerous	JJ	JJ	_	23	amod	_	_
22	intracellular	intracellular	JJ	JJ	_	23	amod	_	_
23	substrates	substrate	NNS	NNS	_	19	nmod	_	_
24	.	.	.	.	_	10	punct	_	_

1	One	one	CD	CD	_	2	nummod	_	_
2	substrate	substrate	NN	NN	_	4	nsubj	_	_
3	is	be	VBZ	VBZ	_	4	cop	_	_
4	p95vav	p95vav	NN	NN	_	0	root	_	_
5	,	,	,	,	_	4	punct	_	_
6	which	which	WDT	WDT	_	8	nsubjpass	_	_
7	is	be	VBZ	VBZ	_	8	auxpass	_	_
8	expressed	express	VBN	VBN	_	4	acl:relcl	_	_
9	exclusively	exclusively	RB	RB	_	8	advmod	_	_
10	in	in	IN	IN	_	11	case	_	_
11	hematopoietic	hematopoietic	JJ	JJ	_	8	nmod	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	trophoblast	trophoblast	NN	NN	_	11	conj	_	_
14	cells	cell	NNS	NNS	_	11	dep	_	_
15	.	.	.	.	_	4	punct	_	_

1	It	it	PRP	PRP	_	2	nsubj	_	_
2	contains	contain	VBZ	VBZ	_	0	root	_	_
3	a	a	DT	DT	_	4	det	_	_
4	number	number	NN	NN	_	2	dobj	_	_
5	of	of	IN	IN	_	7	case	_	_
6	structural	structural	JJ	JJ	_	7	amod	_	_
7	motifs	motif	NNS	NNS	_	4	nmod	_	_
8	,	,	,	,	_	7	punct	_	_
9	including	include	VBG	VBG	_	15	case	_	_
10	Src	src	NN	NN	_	15	compound	_	_
11	homology	homology	NN	NN	_	15	compound	_	_
12	2	2	CD	CD	_	15	nummod	_	_
13	,	,	,	,	_	15	punct	_	_
14	Src	src	NN	NN	_	15	dep	_	_
15	homology	homology	NN	NN	_	7	nmod	_	_
16	3	3	CD	CD	_	15	nummod	_	_
17	,	,	,	,	_	15	punct	_	_
18	and	and	CC	CC	_	15	cc	_	_
19	pleckstrin	pleckstrin	NN	NN	_	21	compound	_	_
20	homology	homology	NN	NN	_	21	compound	_	_
21	domains	domain	NNS	NNS	_	15	conj	_	_
22	and	and	CC	CC	_	15	cc	_	_
23	a	a	DT	DT	_	28	det	_	_
24	putative	putative	JJ	JJ	_	28	amod	_	_
25	guanine	guanine	NN	NN	_	28	compound	_	_
26	nucleotide	nucleotide	NN	NN	_	28	compound	_	_
27	exchange	exchange	NN	NN	_	28	compound	_	_
28	domain	domain	NN	NN	_	15	conj	_	_
29	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	role	role	NN	NN	_	10	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	p95vav	p95vav	NN	NN	_	2	nmod	_	_
5	in	in	IN	IN	_	8	case	_	_
6	TCR-mediated	tcr-mediated	JJ	JJ	_	8	amod	_	_
7	signaling	signaling	NN	NN	_	8	compound	_	_
8	processes	process	NNS	NNS	_	2	nmod	_	_
9	is	be	VBZ	VBZ	_	10	cop	_	_
10	unclear	unclear	JJ	JJ	_	0	root	_	_
11	.	.	.	.	_	10	punct	_	_

1	Here	here	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	show	show	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	14	mark	_	_
6	overexpression	overexpression	NN	NN	_	14	nsubj	_	_
7	of	of	IN	IN	_	8	case	_	_
8	p95vav	p95vav	NN	NN	_	6	nmod	_	_
9	alone	alone	RB	RB	_	8	advmod	_	_
10	in	in	IN	IN	_	11	case	_	_
11	Jurkat	jurkat	NN	NN	_	6	nmod	_	_
12	T	t	NN	NN	_	13	compound	_	_
13	cells	cell	NNS	NNS	_	11	dep	_	_
14	leads	lead	VBZ	VBZ	_	4	ccomp	_	_
15	to	to	TO	TO	_	16	case	_	_
16	activation	activation	NN	NN	_	14	nmod	_	_
17	of	of	IN	IN	_	20	case	_	_
18	the	the	DT	DT	_	20	det	_	_
19	nuclear	nuclear	JJ	JJ	_	20	amod	_	_
20	factors	factor	NNS	NNS	_	16	nmod	_	_
21	,	,	,	,	_	20	punct	_	_
22	including	include	VBG	VBG	_	23	case	_	_
23	NFAT	nfat	NN	NN	_	20	nmod	_	_
24	,	,	,	,	_	23	punct	_	_
25	involved	involve	VBN	VBN	_	23	acl	_	_
26	in	in	IN	IN	_	28	case	_	_
27	interleukin-2	interleukin-2	NN	NN	_	28	compound	_	_
28	expression	expression	NN	NN	_	25	nmod	_	_
29	.	.	.	.	_	4	punct	_	_

1	Furthermore	furthermore	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	p95vav	p95vav	NN	NN	_	4	nsubj	_	_
4	synergizes	synergize	VBZ	VBZ	_	0	root	_	_
5	with	with	IN	IN	_	7	case	_	_
6	TCR	tcr	NN	NN	_	7	compound	_	_
7	stimulation	stimulation	NN	NN	_	4	nmod	_	_
8	in	in	IN	IN	_	9	mark	_	_
9	inducing	induce	VBG	VBG	_	4	advcl	_	_
10	NFAT-	nfat-	NN	NN	_	9	dobj	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	interleukin-2-dependent	interleukin-2-dependent	JJ	JJ	_	10	conj	_	_
13	transcription	transcription	NN	NN	_	10	dep	_	_
14	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	12	nmod	_	_
3	,	,	,	,	_	12	punct	_	_
4	NFAT	nfat	NN	NN	_	5	compound	_	_
5	activation	activation	NN	NN	_	12	nsubjpass	_	_
6	by	by	IN	IN	_	9	case	_	_
7	a	a	DT	DT	_	9	det	_	_
8	G-protein-coupled	g-protein-coupled	JJ	JJ	_	9	amod	_	_
9	receptor	receptor	NN	NN	_	5	nmod	_	_
10	is	be	VBZ	VBZ	_	12	auxpass	_	_
11	not	not	RB	RB	_	12	neg	_	_
12	modulated	modulate	VBN	VBN	_	0	root	_	_
13	by	by	IN	IN	_	15	case	_	_
14	p95vav	p95vav	NN	NN	_	15	compound	_	_
15	overexpression	overexpression	NN	NN	_	12	nmod	_	_
16	,	,	,	,	_	12	punct	_	_
17	suggesting	suggest	VBG	VBG	_	12	advcl	_	_
18	that	that	IN	IN	_	22	mark	_	_
19	the	the	DT	DT	_	20	det	_	_
20	effect	effect	NN	NN	_	22	nsubj	_	_
21	is	be	VBZ	VBZ	_	22	cop	_	_
22	specific	specific	JJ	JJ	_	17	ccomp	_	_
23	to	to	TO	TO	_	27	case	_	_
24	the	the	DT	DT	_	27	det	_	_
25	TCR	tcr	NN	NN	_	27	compound	_	_
26	signaling	signaling	NN	NN	_	27	compound	_	_
27	pathways	pathway	NNS	NNS	_	22	nmod	_	_
28	.	.	.	.	_	12	punct	_	_

1	Although	although	IN	IN	_	11	mark	_	_
2	removal	removal	NN	NN	_	11	nsubj	_	_
3	of	of	IN	IN	_	8	case	_	_
4	the	the	DT	DT	_	8	det	_	_
5	first	first	JJ	JJ	_	8	amod	_	_
6	67	67	CD	CD	_	8	nummod	_	_
7	amino	amino	NN	NN	_	8	compound	_	_
8	acids	acid	NNS	NNS	_	2	nmod	_	_
9	of	of	IN	IN	_	10	case	_	_
10	p95vav	p95vav	NN	NN	_	8	nmod	_	_
11	activates	activate	VBZ	VBZ	_	22	advcl	_	_
12	its	its	PRP$	PRP$	_	14	nmod:poss	_	_
13	transforming	transforming	NN	NN	_	14	compound	_	_
14	potential	potential	NN	NN	_	11	dobj	_	_
15	in	in	IN	IN	_	18	case	_	_
16	NIH	nih	NN	NN	_	18	compound	_	_
17	3T3	3t3	NN	NN	_	18	compound	_	_
18	cells	cell	NNS	NNS	_	14	nmod	_	_
19	,	,	,	,	_	22	punct	_	_
20	this	this	DT	DT	_	21	det	_	_
21	region	region	NN	NN	_	22	nsubj	_	_
22	appears	appear	VBZ	VBZ	_	0	root	_	_
23	to	to	TO	TO	_	25	mark	_	_
24	be	be	VB	VB	_	25	auxpass	_	_
25	required	require	VBN	VBN	_	22	xcomp	_	_
26	for	for	IN	IN	_	28	case	_	_
27	its	its	PRP$	PRP$	_	28	nmod:poss	_	_
28	function	function	NN	NN	_	25	nmod	_	_
29	in	in	IN	IN	_	31	case	_	_
30	T	t	NN	NN	_	31	compound	_	_
31	cells	cell	NNS	NNS	_	28	nmod	_	_
32	.	.	.	.	_	22	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	further	further	RB	RB	_	3	advmod	_	_
3	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	11	mark	_	_
5	the	the	DT	DT	_	8	det	_	_
6	p95vav-induced	p95vav-induced	JJ	JJ	_	8	amod	_	_
7	NFAT	nfat	NN	NN	_	8	compound	_	_
8	activation	activation	NN	NN	_	11	nsubjpass	_	_
9	is	be	VBZ	VBZ	_	11	auxpass	_	_
10	not	not	RB	RB	_	11	neg	_	_
11	mimicked	mimic	VBN	VBN	_	3	ccomp	_	_
12	by	by	IN	IN	_	14	case	_	_
13	Ras	ras	NN	NN	_	14	compound	_	_
14	activation	activation	NN	NN	_	11	nmod	_	_
15	,	,	,	,	_	11	punct	_	_
16	though	though	IN	IN	_	20	mark	_	_
17	its	its	PRP$	PRP$	_	18	nmod:poss	_	_
18	function	function	NN	NN	_	20	nsubj	_	_
19	is	be	VBZ	VBZ	_	20	cop	_	_
20	dependent	dependent	JJ	JJ	_	11	advcl	_	_
21	upon	upon	IN	IN	_	22	case	_	_
22	Ras	ras	NN	NN	_	20	nmod	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	Raf	raf	NN	NN	_	22	conj	_	_
25	.	.	.	.	_	3	punct	_	_

1	Furthermore	furthermore	RB	RB	_	9	advmod	_	_
2	,	,	,	,	_	9	punct	_	_
3	the	the	DT	DT	_	5	det	_	_
4	activating	activating	NN	NN	_	5	compound	_	_
5	function	function	NN	NN	_	9	nsubjpass	_	_
6	of	of	IN	IN	_	7	case	_	_
7	p95vav	p95vav	NN	NN	_	5	nmod	_	_
8	is	be	VBZ	VBZ	_	9	auxpass	_	_
9	blocked	block	VBN	VBN	_	0	root	_	_
10	by	by	IN	IN	_	11	case	_	_
11	FK506	fk506	NN	NN	_	9	nmod	_	_
12	,	,	,	,	_	9	punct	_	_
13	suggesting	suggest	VBG	VBG	_	9	advcl	_	_
14	that	that	IN	IN	_	18	mark	_	_
15	its	its	PRP$	PRP$	_	16	nmod:poss	_	_
16	activity	activity	NN	NN	_	18	nsubj	_	_
17	also	also	RB	RB	_	18	advmod	_	_
18	depends	depend	VBZ	VBZ	_	13	ccomp	_	_
19	on	on	IN	IN	_	20	case	_	_
20	calcineurin	calcineurin	NN	NN	_	18	nmod	_	_
21	.	.	.	.	_	9	punct	_	_

1	To	to	TO	TO	_	3	mark	_	_
2	further	further	RB	RB	_	3	advmod	_	_
3	dissect	dissect	VB	VB	_	0	root	_	_
4	p95vav	p95vav	NN	NN	_	5	compound	_	_
5	involvement	involvement	NN	NN	_	3	dobj	_	_
6	in	in	IN	IN	_	8	case	_	_
7	TCR	tcr	NN	NN	_	8	compound	_	_
8	signaling	signaling	NN	NN	_	5	nmod	_	_
9	,	,	,	,	_	3	punct	_	_
10	we	we	PRP	PRP	_	11	nsubj	_	_
11	analyzed	analyze	VBD	VBD	_	3	parataxis	_	_
12	various	various	JJ	JJ	_	14	amod	_	_
13	Jurkat	jurkat	NN	NN	_	14	compound	_	_
14	mutants	mutant	NNS	NNS	_	11	dobj	_	_
15	deficient	deficient	JJ	JJ	_	14	amod	_	_
16	in	in	IN	IN	_	19	case	_	_
17	TCR	tcr	NN	NN	_	19	compound	_	_
18	signaling	signaling	NN	NN	_	19	compound	_	_
19	function	function	NN	NN	_	15	nmod	_	_
20	or	or	CC	CC	_	19	cc	_	_
21	TCR	tcr	NN	NN	_	22	compound	_	_
22	expression	expression	NN	NN	_	19	conj	_	_
23	and	and	CC	CC	_	11	cc	_	_
24	showed	show	VBD	VBD	_	11	conj	_	_
25	that	that	IN	IN	_	32	mark	_	_
26	an	a	DT	DT	_	30	det	_	_
27	intact	intact	JJ	JJ	_	30	amod	_	_
28	TCR	tcr	NN	NN	_	30	compound	_	_
29	signaling	signaling	NN	NN	_	30	compound	_	_
30	pathway	pathway	NN	NN	_	32	nsubjpass	_	_
31	is	be	VBZ	VBZ	_	32	auxpass	_	_
32	required	require	VBN	VBN	_	24	ccomp	_	_
33	for	for	IN	IN	_	36	mark	_	_
34	p95vav	p95vav	NN	NN	_	36	nsubj	_	_
35	to	to	TO	TO	_	36	mark	_	_
36	function	function	VB	VB	_	32	advcl	_	_
37	.	.	.	.	_	3	punct	_	_

1	However	however	RB	RB	_	8	advmod	_	_
2	,	,	,	,	_	8	punct	_	_
3	overexpression	overexpression	NN	NN	_	8	nsubj	_	_
4	of	of	IN	IN	_	5	case	_	_
5	p95vav	p95vav	NN	NN	_	3	nmod	_	_
6	does	do	VBZ	VBZ	_	8	aux	_	_
7	not	not	RB	RB	_	8	neg	_	_
8	appear	appear	VB	VB	_	0	root	_	_
9	to	to	TO	TO	_	10	mark	_	_
10	influence	influence	VB	VB	_	8	xcomp	_	_
11	TCR-induced	tcr-induced	JJ	JJ	_	14	amod	_	_
12	protein	protein	NN	NN	_	14	compound	_	_
13	tyrosine	tyrosine	NN	NN	_	14	compound	_	_
14	phosphorylation	phosphorylation	NN	NN	_	10	dobj	_	_
15	or	or	CC	CC	_	14	cc	_	_
16	increases	increase	NNS	NNS	_	14	conj	_	_
17	in	in	IN	IN	_	20	case	_	_
18	cytoplasmic	cytoplasmic	JJ	JJ	_	20	amod	_	_
19	free	free	JJ	JJ	_	20	amod	_	_
20	calcium	calcium	NN	NN	_	16	nmod	_	_
21	.	.	.	.	_	8	punct	_	_

1	Taken	take	VBN	VBN	_	0	root	_	_
2	together	together	RB	RB	_	1	advmod	_	_
3	,	,	,	,	_	1	punct	_	_
4	our	we	PRP$	PRP$	_	5	nmod:poss	_	_
5	data	datum	NNS	NNS	_	6	nsubj	_	_
6	suggest	suggest	VBP	VBP	_	1	parataxis	_	_
7	that	that	IN	IN	_	9	mark	_	_
8	p95vav	p95vav	NN	NN	_	9	nsubj	_	_
9	plays	play	VBZ	VBZ	_	6	ccomp	_	_
10	an	a	DT	DT	_	12	det	_	_
11	important	important	JJ	JJ	_	12	amod	_	_
12	role	role	NN	NN	_	9	dobj	_	_
13	at	at	IN	IN	_	18	case	_	_
14	an	a	DT	DT	_	18	det	_	_
15	yet	yet	RB	RB	_	16	advmod	_	_
16	unidentified	unidentified	JJ	JJ	_	18	amod	_	_
17	proximal	proximal	JJ	JJ	_	18	amod	_	_
18	position	position	NN	NN	_	9	nmod	_	_
19	in	in	IN	IN	_	23	case	_	_
20	the	the	DT	DT	_	23	det	_	_
21	TCR	tcr	NN	NN	_	23	compound	_	_
22	signaling	signaling	NN	NN	_	23	compound	_	_
23	cascade	cascade	NN	NN	_	18	nmod	_	_
24	.	.	.	.	_	1	punct	_	_

1	Activation	activation	NN	NN	_	8	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	NF-kappa	nf-kappa	NN	NN	_	4	compound	_	_
4	B	b	NN	NN	_	1	nmod	_	_
5	by	by	IN	IN	_	7	case	_	_
6	phosphatase	phosphatase	NN	NN	_	7	compound	_	_
7	inhibitors	inhibitor	NNS	NNS	_	1	nmod	_	_
8	involves	involve	VBZ	VBZ	_	0	root	_	_
9	the	the	DT	DT	_	10	det	_	_
10	phosphorylation	phosphorylation	NN	NN	_	8	dobj	_	_
11	of	of	IN	IN	_	15	case	_	_
12	I	i	NN	NN	_	15	compound	_	_
13	kappa	kappa	NN	NN	_	15	compound	_	_
14	B	b	NN	NN	_	15	compound	_	_
15	alpha	alpha	NN	NN	_	10	nmod	_	_
16	at	at	IN	IN	_	19	case	_	_
17	phosphatase	phosphatase	NN	NN	_	19	compound	_	_
18	2A-sensitive	2a-sensitive	JJ	JJ	_	19	amod	_	_
19	sites	site	NNS	NNS	_	10	nmod	_	_
20	.	.	.	.	_	8	punct	_	_

1	Activation	activation	NN	NN	_	9	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	NF-kappa	nf-kappa	NN	NN	_	4	compound	_	_
4	B	b	NN	NN	_	1	nmod	_	_
5	by	by	IN	IN	_	8	case	_	_
6	various	various	JJ	JJ	_	8	amod	_	_
7	cellular	cellular	JJ	JJ	_	8	amod	_	_
8	stimuli	stimulus	NNS	NNS	_	1	nmod	_	_
9	involves	involve	VBZ	VBZ	_	0	root	_	_
10	the	the	DT	DT	_	11	dep	_	_
11	phosphorylation	phosphorylation	NN	NN	_	9	dobj	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	subsequent	subsequent	JJ	JJ	_	14	amod	_	_
14	degradation	degradation	NN	NN	_	11	conj	_	_
15	of	of	IN	IN	_	17	case	_	_
16	its	its	PRP$	PRP$	_	17	nmod:poss	_	_
17	inhibitor	inhibitor	NN	NN	_	11	nmod	_	_
18	,	,	,	,	_	17	punct	_	_
19	I	i	NN	NN	_	22	compound	_	_
20	kappa	kappa	NN	NN	_	22	compound	_	_
21	B	b	NN	NN	_	22	compound	_	_
22	alpha	alpha	NN	NN	_	17	appos	_	_
23	,	,	,	,	_	9	punct	_	_
24	although	although	IN	IN	_	28	mark	_	_
25	the	the	DT	DT	_	27	det	_	_
26	underlying	underlie	VBG	VBG	_	27	amod	_	_
27	mechanism	mechanism	NN	NN	_	28	nsubj	_	_
28	remains	remain	VBZ	VBZ	_	9	advcl	_	_
29	unclear	unclear	JJ	JJ	_	28	xcomp	_	_
30	.	.	.	.	_	9	punct	_	_

1	In	in	IN	IN	_	4	case	_	_
2	the	the	DT	DT	_	4	det	_	_
3	present	present	JJ	JJ	_	4	amod	_	_
4	study	study	NN	NN	_	21	nmod	_	_
5	,	,	,	,	_	21	punct	_	_
6	the	the	DT	DT	_	7	det	_	_
7	role	role	NN	NN	_	21	nsubjpass	_	_
8	of	of	IN	IN	_	10	case	_	_
9	serine/threonine	serine/threonine	NN	NN	_	10	compound	_	_
10	phosphatases	phosphatase	NNS	NNS	_	7	nmod	_	_
11	in	in	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	regulation	regulation	NN	NN	_	7	nmod	_	_
14	of	of	IN	IN	_	19	case	_	_
15	I	i	NN	NN	_	18	compound	_	_
16	kappa	kappa	NN	NN	_	18	compound	_	_
17	B	b	NN	NN	_	18	compound	_	_
18	alpha	alpha	NN	NN	_	19	compound	_	_
19	phosphorylation	phosphorylation	NN	NN	_	13	nmod	_	_
20	was	be	VBD	VBD	_	21	auxpass	_	_
21	investigated	investigate	VBN	VBN	_	0	root	_	_
22	.	.	.	.	_	21	punct	_	_

1	Our	we	PRP$	PRP$	_	2	nmod:poss	_	_
2	studies	study	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	42	mark	_	_
5	incubation	incubation	NN	NN	_	42	nsubj	_	_
6	of	of	IN	IN	_	9	case	_	_
7	human	human	JJ	JJ	_	9	amod	_	_
8	T	t	NN	NN	_	9	compound	_	_
9	cells	cell	NNS	NNS	_	5	nmod	_	_
10	with	with	IN	IN	_	12	case	_	_
11	low	low	JJ	JJ	_	12	amod	_	_
12	concentrations	concentration	NNS	NNS	_	5	nmod	_	_
13	(	(	-LRB-	-LRB-	_	16	punct	_	_
14	approximately	approximately	RB	RB	_	15	advmod	_	_
15	1-5	1-5	CD	CD	_	16	nummod	_	_
16	nM	nm	NN	NN	_	12	appos	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	of	of	IN	IN	_	20	case	_	_
19	calyculin	calyculin	NN	NN	_	20	compound	_	_
20	A	a	NN	NN	_	12	nmod	_	_
21	or	or	CC	CC	_	20	cc	_	_
22	okadaic	okadaic	JJ	JJ	_	23	amod	_	_
23	acid	acid	NN	NN	_	20	conj	_	_
24	,	,	,	,	_	20	punct	_	_
25	potent	potent	JJ	JJ	_	26	amod	_	_
26	inhibitors	inhibitor	NNS	NNS	_	20	appos	_	_
27	of	of	IN	IN	_	30	case	_	_
28	protein	protein	NN	NN	_	29	compound	_	_
29	phosphatase	phosphatase	NN	NN	_	30	compound	_	_
30	type	type	NN	NN	_	26	nmod	_	_
31	1	1	CD	CD	_	30	nummod	_	_
32	(	(	-LRB-	-LRB-	_	33	punct	_	_
33	PP-1	pp-1	NN	NN	_	30	appos	_	_
34	)	)	-RRB-	-RRB-	_	33	punct	_	_
35	and	and	CC	CC	_	30	cc	_	_
36	type	type	NN	NN	_	37	compound	_	_
37	2A	2a	NN	NN	_	30	conj	_	_
38	(	(	-LRB-	-LRB-	_	39	punct	_	_
39	PP-2A	pp-2a	NN	NN	_	37	appos	_	_
40	)	)	-RRB-	-RRB-	_	39	punct	_	_
41	,	,	,	,	_	5	punct	_	_
42	induces	induce	VBZ	VBZ	_	3	ccomp	_	_
43	the	the	DT	DT	_	44	det	_	_
44	phosphorylation	phosphorylation	NN	NN	_	42	dobj	_	_
45	of	of	IN	IN	_	49	case	_	_
46	I	i	NN	NN	_	49	compound	_	_
47	kappa	kappa	NN	NN	_	49	compound	_	_
48	B	b	NN	NN	_	49	compound	_	_
49	alpha	alpha	NN	NN	_	44	nmod	_	_
50	even	even	RB	RB	_	42	advmod	_	_
51	in	in	IN	IN	_	53	case	_	_
52	the	the	DT	DT	_	53	det	_	_
53	absence	absence	NN	NN	_	42	nmod	_	_
54	of	of	IN	IN	_	57	case	_	_
55	any	any	DT	DT	_	57	det	_	_
56	cellular	cellular	JJ	JJ	_	57	amod	_	_
57	stimulus	stimulus	NN	NN	_	53	nmod	_	_
58	.	.	.	.	_	3	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	action	action	NN	NN	_	23	nsubjpass	_	_
3	of	of	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	phosphatase	phosphatase	NN	NN	_	6	compound	_	_
6	inhibitors	inhibitor	NNS	NNS	_	2	nmod	_	_
7	,	,	,	,	_	2	punct	_	_
8	which	which	WDT	WDT	_	10	nsubjpass	_	_
9	is	be	VBZ	VBZ	_	10	auxpass	_	_
10	associated	associate	VBN	VBN	_	2	acl:relcl	_	_
11	with	with	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	activation	activation	NN	NN	_	10	nmod	_	_
14	of	of	IN	IN	_	19	case	_	_
15	the	the	DT	DT	_	19	det	_	_
16	RelA.p50	rela.p50	NN	NN	_	19	compound	_	_
17	NF-kappa	nf-kappa	NN	NN	_	19	compound	_	_
18	B	b	NN	NN	_	19	compound	_	_
19	heterodimer	heterodimer	NN	NN	_	13	nmod	_	_
20	,	,	,	,	_	2	punct	_	_
21	is	be	VBZ	VBZ	_	23	auxpass	_	_
22	not	not	RB	RB	_	23	neg	_	_
23	affected	affect	VBN	VBN	_	0	root	_	_
24	by	by	IN	IN	_	25	case	_	_
25	agents	agent	NNS	NNS	_	23	nmod	_	_
26	that	that	WDT	WDT	_	27	nsubj	_	_
27	block	block	VBP	VBP	_	25	acl:relcl	_	_
28	the	the	DT	DT	_	29	det	_	_
29	induction	induction	NN	NN	_	27	dobj	_	_
30	of	of	IN	IN	_	35	case	_	_
31	I	i	NN	NN	_	34	compound	_	_
32	kappa	kappa	NN	NN	_	34	compound	_	_
33	B	b	NN	NN	_	34	compound	_	_
34	alpha	alpha	NN	NN	_	35	compound	_	_
35	phosphorylation	phosphorylation	NN	NN	_	29	nmod	_	_
36	by	by	IN	IN	_	40	case	_	_
37	tumor	tumor	NN	NN	_	40	compound	_	_
38	necrosis	necrosis	NN	NN	_	40	compound	_	_
39	factor	factor	NN	NN	_	40	compound	_	_
40	alpha	alpha	NN	NN	_	29	nmod	_	_
41	(	(	-LRB-	-LRB-	_	42	punct	_	_
42	TNF-alpha	tnf-alpha	NN	NN	_	40	appos	_	_
43	)	)	-RRB-	-RRB-	_	42	punct	_	_
44	.	.	.	.	_	23	punct	_	_

1	Furthermore	furthermore	RB	RB	_	22	advmod	_	_
2	,	,	,	,	_	22	punct	_	_
3	the	the	DT	DT	_	8	det	_	_
4	phosphorylated	phosphorylate	VBN	VBN	_	8	amod	_	_
5	I	i	NN	NN	_	8	compound	_	_
6	kappa	kappa	NN	NN	_	8	compound	_	_
7	B	b	NN	NN	_	8	compound	_	_
8	alpha	alpha	NN	NN	_	22	nsubj	_	_
9	from	from	IN	IN	_	12	case	_	_
10	calyculin	calyculin	NN	NN	_	12	compound	_	_
11	A-treated	a-treated	JJ	JJ	_	12	amod	_	_
12	cells	cell	NNS	NNS	_	8	nmod	_	_
13	,	,	,	,	_	8	punct	_	_
14	but	but	CC	CC	_	15	cc	_	_
15	not	not	RB	RB	_	8	cc	_	_
16	that	that	DT	DT	_	8	conj	_	_
17	from	from	IN	IN	_	19	case	_	_
18	TNF-alpha-stimulated	tnf-alpha-stimulated	JJ	JJ	_	19	amod	_	_
19	cells	cell	NNS	NNS	_	16	nmod	_	_
20	,	,	,	,	_	8	punct	_	_
21	is	be	VBZ	VBZ	_	22	cop	_	_
22	sensitive	sensitive	JJ	JJ	_	0	root	_	_
23	to	to	TO	TO	_	24	case	_	_
24	PP-2A	pp-2a	NN	NN	_	22	nmod	_	_
25	in	in	FW	FW	_	26	compound	_	_
26	vitro	vitro	FW	FW	_	22	advmod	_	_
27	,	,	,	,	_	22	punct	_	_
28	suggesting	suggest	VBG	VBG	_	22	xcomp	_	_
29	the	the	DT	DT	_	30	det	_	_
30	existence	existence	NN	NN	_	28	dobj	_	_
31	of	of	IN	IN	_	33	case	_	_
32	fundamental	fundamental	JJ	JJ	_	33	amod	_	_
33	differences	difference	NNS	NNS	_	30	nmod	_	_
34	in	in	IN	IN	_	36	case	_	_
35	the	the	DT	DT	_	36	det	_	_
36	phosphorylation	phosphorylation	NN	NN	_	33	nmod	_	_
37	of	of	IN	IN	_	41	case	_	_
38	I	i	NN	NN	_	41	compound	_	_
39	kappa	kappa	NN	NN	_	41	compound	_	_
40	B	b	NN	NN	_	41	compound	_	_
41	alpha	alpha	NN	NN	_	36	nmod	_	_
42	induced	induce	VBN	VBN	_	36	acl	_	_
43	by	by	IN	IN	_	49	case	_	_
44	the	the	DT	DT	_	49	det	_	_
45	two	two	CD	CD	_	49	nummod	_	_
46	different	different	JJ	JJ	_	49	amod	_	_
47	NF-kappa	nf-kappa	NN	NN	_	48	compound	_	_
48	B	b	NN	NN	_	49	compound	_	_
49	inducers	inducer	NNS	NNS	_	42	nmod	_	_
50	.	.	.	.	_	22	punct	_	_

1	However	however	RB	RB	_	18	advmod	_	_
2	,	,	,	,	_	18	punct	_	_
3	induction	induction	NN	NN	_	18	nsubjpass	_	_
4	of	of	IN	IN	_	9	case	_	_
5	I	i	NN	NN	_	8	compound	_	_
6	kappa	kappa	NN	NN	_	8	compound	_	_
7	B	b	NN	NN	_	8	compound	_	_
8	alpha	alpha	NN	NN	_	9	compound	_	_
9	phosphorylation	phosphorylation	NN	NN	_	3	nmod	_	_
10	by	by	IN	IN	_	12	case	_	_
11	both	both	CC	CC	_	12	cc:preconj	_	_
12	TNF-alpha	tnf-alpha	NN	NN	_	3	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	the	the	DT	DT	_	16	det	_	_
15	phosphatase	phosphatase	NN	NN	_	16	compound	_	_
16	inhibitors	inhibitor	NNS	NNS	_	12	conj	_	_
17	is	be	VBZ	VBZ	_	18	auxpass	_	_
18	associated	associate	VBN	VBN	_	0	root	_	_
19	with	with	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	subsequent	subsequent	JJ	JJ	_	22	amod	_	_
22	degradation	degradation	NN	NN	_	18	nmod	_	_
23	of	of	IN	IN	_	27	case	_	_
24	I	i	NN	NN	_	27	compound	_	_
25	kappa	kappa	NN	NN	_	27	compound	_	_
26	B	b	NN	NN	_	27	compound	_	_
27	alpha	alpha	NN	NN	_	22	nmod	_	_
28	.	.	.	.	_	18	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	further	further	RB	RB	_	3	advmod	_	_
3	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	14	mark	_	_
5	TNF-alpha-	tnf-alpha-	NN	NN	_	14	nsubj	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	calyculin	calyculin	NN	NN	_	5	conj	_	_
8	A-induced	a-induced	JJ	JJ	_	7	amod	_	_
9	I	i	NN	NN	_	13	compound	_	_
10	kappa	kappa	NN	NN	_	13	compound	_	_
11	B	b	NN	NN	_	13	compound	_	_
12	alpha	alpha	NN	NN	_	13	compound	_	_
13	degradation	degradation	NN	NN	_	5	dep	_	_
14	exhibits	exhibit	VBZ	VBZ	_	3	ccomp	_	_
15	similar	similar	JJ	JJ	_	19	amod	_	_
16	but	but	CC	CC	_	17	cc	_	_
17	not	not	RB	RB	_	15	cc	_	_
18	identical	identical	JJ	JJ	_	15	conj	_	_
19	sensitivities	sensitivity	NNS	NNS	_	14	dobj	_	_
20	to	to	TO	TO	_	23	case	_	_
21	a	a	DT	DT	_	23	det	_	_
22	proteasome	proteasome	JJ	JJ	_	23	amod	_	_
23	inhibitor	inhibitor	NN	NN	_	19	nmod	_	_
24	.	.	.	.	_	3	punct	_	_

1	Together	together	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	these	these	DT	DT	_	4	det	_	_
4	results	result	NNS	NNS	_	5	nsubj	_	_
5	suggest	suggest	VBP	VBP	_	0	root	_	_
6	that	that	IN	IN	_	25	mark	_	_
7	phosphorylation	phosphorylation	NN	NN	_	25	nsubj	_	_
8	of	of	IN	IN	_	12	case	_	_
9	I	i	NN	NN	_	12	compound	_	_
10	kappa	kappa	NN	NN	_	12	compound	_	_
11	B	b	NN	NN	_	12	compound	_	_
12	alpha	alpha	NN	NN	_	7	nmod	_	_
13	,	,	,	,	_	7	punct	_	_
14	mediated	mediate	VBN	VBN	_	7	acl	_	_
15	through	through	IN	IN	_	18	case	_	_
16	both	both	CC	CC	_	18	dep	_	_
17	the	the	DT	DT	_	18	det	_	_
18	TNF-alpha-inducible	tnf-alpha-inducible	JJ	JJ	_	14	nmod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	the	the	DT	DT	_	22	det	_	_
21	PP-2A-opposing	pp-2a-opposing	JJ	JJ	_	22	amod	_	_
22	kinases	kinase	NNS	NNS	_	18	conj	_	_
23	,	,	,	,	_	7	punct	_	_
24	may	may	MD	MD	_	25	aux	_	_
25	serve	serve	VB	VB	_	5	ccomp	_	_
26	to	to	TO	TO	_	27	mark	_	_
27	target	target	NN	NN	_	25	xcomp	_	_
28	I	i	NN	NN	_	31	compound	_	_
29	kappa	kappa	NN	NN	_	31	compound	_	_
30	B	b	NN	NN	_	31	compound	_	_
31	alpha	alpha	NN	NN	_	27	dobj	_	_
32	for	for	IN	IN	_	34	case	_	_
33	proteasome-mediated	proteasome-mediated	JJ	JJ	_	34	amod	_	_
34	degradation	degradation	NN	NN	_	27	nmod	_	_
35	.	.	.	.	_	5	punct	_	_

1	RB	rb	NN	NN	_	0	root	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	a	a	DT	DT	_	7	det	_	_
4	novel	novel	JJ	JJ	_	7	amod	_	_
5	E2F-1	e2f-1	NN	NN	_	7	compound	_	_
6	binding	binding	NN	NN	_	7	compound	_	_
7	protein	protein	NN	NN	_	1	conj	_	_
8	in	in	IN	IN	_	14	case	_	_
9	MHC	mhc	NN	NN	_	14	compound	_	_
10	class	class	NN	NN	_	14	compound	_	_
11	II	ii	CD	CD	_	14	nummod	_	_
12	deficient	deficient	JJ	JJ	_	14	amod	_	_
13	B-cell	b-cell	NN	NN	_	14	compound	_	_
14	lines	line	NNS	NNS	_	1	nmod	_	_
15	and	and	CC	CC	_	1	cc	_	_
16	normal	normal	JJ	JJ	_	18	amod	_	_
17	IFN-gamma	ifn-gamma	NN	NN	_	18	compound	_	_
18	induction	induction	NN	NN	_	1	conj	_	_
19	of	of	IN	IN	_	23	case	_	_
20	the	the	DT	DT	_	23	det	_	_
21	class	class	NN	NN	_	23	compound	_	_
22	IL	il	NN	NN	_	23	compound	_	_
23	transactivator	transactivator	NN	NN	_	18	nmod	_	_
24	CIITA	ciita	NN	NN	_	23	dep	_	_
25	in	in	IN	IN	_	31	case	_	_
26	class	class	NN	NN	_	31	compound	_	_
27	II	ii	CD	CD	_	31	nummod	_	_
28	non-inducible	non-inducible	JJ	JJ	_	31	amod	_	_
29	RB-defective	rb-defective	JJ	JJ	_	31	amod	_	_
30	tumor	tumor	NN	NN	_	31	compound	_	_
31	lines	line	NNS	NNS	_	18	nmod	_	_
32	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	9	det	_	_
2	major	major	JJ	JJ	_	9	amod	_	_
3	histocompatibility	histocompatibility	NN	NN	_	9	compound	_	_
4	(	(	-LRB-	-LRB-	_	9	punct	_	_
5	MHC	mhc	NN	NN	_	9	compound	_	_
6	)	)	-RRB-	-RRB-	_	9	punct	_	_
7	class	class	NN	NN	_	9	compound	_	_
8	II	ii	CD	CD	_	9	nummod	_	_
9	genes	gene	NNS	NNS	_	10	nsubj	_	_
10	encode	encode	VBP	VBP	_	0	root	_	_
11	cell	cell	NN	NN	_	13	compound	_	_
12	surface	surface	NN	NN	_	13	compound	_	_
13	proteins	protein	NNS	NNS	_	10	dobj	_	_
14	that	that	WDT	WDT	_	15	nsubj	_	_
15	bind	bind	VBP	VBP	_	13	acl:relcl	_	_
16	antigenic	antigenic	JJ	JJ	_	17	amod	_	_
17	peptide	peptide	NN	NN	_	15	dobj	_	_
18	for	for	IN	IN	_	19	case	_	_
19	presentation	presentation	NN	NN	_	15	nmod	_	_
20	to	to	TO	TO	_	21	case	_	_
21	T-cells	t-cell	NNS	NNS	_	19	nmod	_	_
22	.	.	.	.	_	10	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	class	class	NN	NN	_	4	compound	_	_
3	II	ii	CD	CD	_	4	nummod	_	_
4	proteins	protein	NNS	NNS	_	6	nsubjpass	_	_
5	are	be	VBP	VBP	_	6	auxpass	_	_
6	expressed	express	VBN	VBN	_	0	root	_	_
7	constitutively	constitutively	RB	RB	_	6	advmod	_	_
8	on	on	IN	IN	_	9	case	_	_
9	B-cells	b-cell	NNS	NNS	_	6	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	EBV-transformed	ebv-transformed	JJ	JJ	_	12	amod	_	_
12	B-cells	b-cell	NNS	NNS	_	9	conj	_	_
13	,	,	,	,	_	12	punct	_	_
14	and	and	CC	CC	_	6	cc	_	_
15	are	be	VBP	VBP	_	16	cop	_	_
16	inducible	inducible	JJ	JJ	_	6	conj	_	_
17	by	by	IN	IN	_	18	case	_	_
18	IFN-gamma	ifn-gamma	NN	NN	_	16	nmod	_	_
19	on	on	IN	IN	_	22	case	_	_
20	a	a	DT	DT	_	22	det	_	_
21	wide	wide	JJ	JJ	_	22	amod	_	_
22	variety	variety	NN	NN	_	18	nmod	_	_
23	of	of	IN	IN	_	25	case	_	_
24	cell	cell	NN	NN	_	25	compound	_	_
25	types	type	NNS	NNS	_	22	nmod	_	_
26	.	.	.	.	_	6	punct	_	_

1	Retinoblastoma	retinoblastoma	NN	NN	_	2	compound	_	_
2	protein	protein	NN	NN	_	9	nsubj	_	_
3	(	(	-LRB-	-LRB-	_	4	punct	_	_
4	RB	rb	NN	NN	_	2	appos	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	is	be	VBZ	VBZ	_	9	cop	_	_
7	a	a	DT	DT	_	9	det	_	_
8	tumor	tumor	NN	NN	_	9	compound	_	_
9	suppressor	suppressor	NN	NN	_	0	root	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	functions	function	VBZ	VBZ	_	9	conj	_	_
12	as	as	IN	IN	_	15	case	_	_
13	a	a	DT	DT	_	15	det	_	_
14	transcriptional	transcriptional	JJ	JJ	_	15	amod	_	_
15	repressor	repressor	NN	NN	_	11	nmod	_	_
16	by	by	IN	IN	_	17	mark	_	_
17	binding	bind	VBG	VBG	_	11	advcl	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	inactivating	inactivate	VBG	VBG	_	17	conj	_	_
20	the	the	DT	DT	_	22	det	_	_
21	transactivator	transactivator	NN	NN	_	22	compound	_	_
22	E2F-I	e2f-i	NN	NN	_	17	dobj	_	_
23	.	.	.	.	_	9	punct	_	_

1	RB-defective	rb-defective	JJ	JJ	_	3	amod	_	_
2	tumor	tumor	NN	NN	_	3	compound	_	_
3	lines	line	NNS	NNS	_	5	nsubj	_	_
4	are	be	VBP	VBP	_	5	cop	_	_
5	non-inducible	non-inducible	JJ	JJ	_	0	root	_	_
6	for	for	IN	IN	_	8	case	_	_
7	MHC	mhc	NN	NN	_	8	compound	_	_
8	class	class	NN	NN	_	5	nmod	_	_
9	II	ii	CD	CD	_	8	nummod	_	_
10	by	by	IN	IN	_	11	case	_	_
11	IFN-gamma	ifn-gamma	NN	NN	_	5	nmod	_	_
12	,	,	,	,	_	5	punct	_	_
13	or	or	CC	CC	_	5	cc	_	_
14	very	very	RB	RB	_	16	advmod	_	_
15	weakly	weakly	RB	RB	_	16	advmod	_	_
16	inducible	inducible	JJ	JJ	_	5	conj	_	_
17	,	,	,	,	_	5	punct	_	_
18	but	but	CC	CC	_	5	cc	_	_
19	transfection	transfection	NN	NN	_	28	nsubj	_	_
20	of	of	IN	IN	_	23	case	_	_
21	2	2	CD	CD	_	23	nummod	_	_
22	different	different	JJ	JJ	_	23	amod	_	_
23	lines	line	NNS	NNS	_	19	nmod	_	_
24	with	with	IN	IN	_	27	case	_	_
25	RB	rb	NN	NN	_	27	compound	_	_
26	expression	expression	NN	NN	_	27	compound	_	_
27	vectors	vector	NNS	NNS	_	19	nmod	_	_
28	re-establishes	re-establish	VBZ	VBZ	_	5	conj	_	_
29	or	or	CC	CC	_	28	cc	_	_
30	substantially	substantially	RB	RB	_	31	advmod	_	_
31	enhances	enhance	VBZ	VBZ	_	28	conj	_	_
32	class	class	NN	NN	_	34	compound	_	_
33	II	ii	CD	CD	_	34	nummod	_	_
34	inducibility	inducibility	NN	NN	_	28	dobj	_	_
35	.	.	.	.	_	5	punct	_	_

1	Therefore	therefore	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	examined	examine	VBD	VBD	_	0	root	_	_
5	the	the	DT	DT	_	7	det	_	_
6	RB	rb	NN	NN	_	7	compound	_	_
7	status	status	NN	NN	_	4	dobj	_	_
8	of	of	IN	IN	_	10	case	_	_
9	a	a	DT	DT	_	10	det	_	_
10	series	series	NN	NN	_	7	nmod	_	_
11	of	of	IN	IN	_	13	case	_	_
12	B-cell	b-cell	NN	NN	_	13	compound	_	_
13	mutants	mutant	NNS	NNS	_	10	nmod	_	_
14	that	that	WDT	WDT	_	16	nsubj	_	_
15	are	be	VBP	VBP	_	16	cop	_	_
16	defective	defective	JJ	JJ	_	13	acl:relcl	_	_
17	in	in	IN	IN	_	20	case	_	_
18	class	class	NN	NN	_	20	compound	_	_
19	II	ii	CD	CD	_	20	nummod	_	_
20	expression	expression	NN	NN	_	16	nmod	_	_
21	,	,	,	,	_	16	punct	_	_
22	generated	generate	VBN	VBN	_	16	ccomp	_	_
23	either	either	CC	CC	_	22	dep	_	_
24	in	in	FW	FW	_	25	compound	_	_
25	vitro	vitro	FW	FW	_	22	advmod	_	_
26	or	or	CC	CC	_	22	cc	_	_
27	derived	derive	VBN	VBN	_	22	conj	_	_
28	from	from	IN	IN	_	35	case	_	_
29	Bare	bare	NN	NN	_	31	compound	_	_
30	Lymphocyte	lymphocyte	NN	NN	_	31	compound	_	_
31	Syndrome	syndrome	NN	NN	_	35	compound	_	_
32	(	(	-LRB-	-LRB-	_	33	punct	_	_
33	BLS	bls	NN	NN	_	31	appos	_	_
34	)	)	-RRB-	-RRB-	_	33	punct	_	_
35	patients	patient	NNS	NNS	_	27	nmod	_	_
36	.	.	.	.	_	4	punct	_	_

1	Nuclear	nuclear	JJ	JJ	_	2	amod	_	_
2	matrix-bound	matrix-bound	JJ	JJ	_	3	amod	_	_
3	RB	rb	NN	NN	_	5	nsubj	_	_
4	was	be	VBD	VBD	_	5	cop	_	_
5	detectable	detectable	JJ	JJ	_	0	root	_	_
6	in	in	IN	IN	_	8	case	_	_
7	all	all	DT	DT	_	8	det	_	_
8	cases	case	NNS	NNS	_	5	nmod	_	_
9	,	,	,	,	_	5	punct	_	_
10	indicating	indicate	VBG	VBG	_	5	xcomp	_	_
11	that	that	IN	IN	_	17	mark	_	_
12	loss	loss	NN	NN	_	17	nsubj	_	_
13	of	of	IN	IN	_	14	case	_	_
14	RB	rb	NN	NN	_	12	nmod	_	_
15	is	be	VBZ	VBZ	_	17	cop	_	_
16	not	not	RB	RB	_	17	neg	_	_
17	responsible	responsible	JJ	JJ	_	10	ccomp	_	_
18	for	for	IN	IN	_	22	case	_	_
19	decreased	decrease	VBN	VBN	_	22	amod	_	_
20	class	class	NN	NN	_	22	compound	_	_
21	II	ii	CD	CD	_	22	nummod	_	_
22	expression	expression	NN	NN	_	17	nmod	_	_
23	in	in	IN	IN	_	25	case	_	_
24	these	these	DT	DT	_	25	det	_	_
25	lines	line	NNS	NNS	_	22	nmod	_	_
26	.	.	.	.	_	5	punct	_	_

1	A	a	DT	DT	_	5	det	_	_
2	second	second	JJ	JJ	_	5	amod	_	_
3	E2F-I	e2f-i	NN	NN	_	5	compound	_	_
4	binding	binding	NN	NN	_	5	compound	_	_
5	protein	protein	NN	NN	_	14	nsubj	_	_
6	,	,	,	,	_	5	punct	_	_
7	most	most	RBS	RBS	_	8	advmod	_	_
8	likely	likely	RB	RB	_	9	advmod	_	_
9	DP-I	dp-i	NN	NN	_	5	appos	_	_
10	,	,	,	,	_	5	punct	_	_
11	was	be	VBD	VBD	_	14	cop	_	_
12	also	also	RB	RB	_	14	advmod	_	_
13	apparently	apparently	RB	RB	_	14	advmod	_	_
14	normal	normal	JJ	JJ	_	0	root	_	_
15	in	in	IN	IN	_	17	case	_	_
16	both	both	CC	CC	_	17	cc:preconj	_	_
17	class	class	NN	NN	_	14	nmod	_	_
18	II-positive	ii-positive	JJ	JJ	_	17	dep	_	_
19	and	and	CC	CC	_	17	cc	_	_
20	-negative	-negative	JJ	JJ	_	17	conj	_	_
21	B-cell	b-cell	NN	NN	_	22	compound	_	_
22	lines	line	NNS	NNS	_	17	dep	_	_
23	.	.	.	.	_	14	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	examined	examine	VBD	VBD	_	0	root	_	_
4	the	the	DT	DT	_	6	det	_	_
5	IFN-gamma	ifn-gamma	NN	NN	_	6	compound	_	_
6	induction	induction	NN	NN	_	3	dobj	_	_
7	of	of	IN	IN	_	8	case	_	_
8	CIITA	ciita	NN	NN	_	6	nmod	_	_
9	in	in	IN	IN	_	11	case	_	_
10	RB-defective	rb-defective	JJ	JJ	_	11	case	_	_
11	lines	line	NNS	NNS	_	6	acl	_	_
12	.	.	.	.	_	3	punct	_	_

1	CIITA	ciita	NN	NN	_	7	nsubj	_	_
2	is	be	VBZ	VBZ	_	7	cop	_	_
3	a	a	DT	DT	_	7	det	_	_
4	class	class	NN	NN	_	7	compound	_	_
5	II	ii	CD	CD	_	7	nummod	_	_
6	gene	gene	NN	NN	_	7	compound	_	_
7	transactivator	transactivator	NN	NN	_	0	root	_	_
8	known	know	VBN	VBN	_	7	acl	_	_
9	to	to	TO	TO	_	11	mark	_	_
10	be	be	VB	VB	_	11	cop	_	_
11	defective	defective	JJ	JJ	_	8	ccomp	_	_
12	in	in	IN	IN	_	14	case	_	_
13	one	one	CD	CD	_	14	nummod	_	_
14	form	form	NN	NN	_	11	nmod	_	_
15	of	of	IN	IN	_	16	case	_	_
16	BLS	bls	NN	NN	_	14	nmod	_	_
17	and	and	CC	CC	_	11	cc	_	_
18	to	to	TO	TO	_	20	mark	_	_
19	be	be	VB	VB	_	20	auxpass	_	_
20	required	require	VBN	VBN	_	11	conj	_	_
21	for	for	IN	IN	_	23	case	_	_
22	the	the	DT	DT	_	23	det	_	_
23	induction	induction	NN	NN	_	20	nmod	_	_
24	of	of	IN	IN	_	26	case	_	_
25	MHC	mhc	NN	NN	_	26	compound	_	_
26	class	class	NN	NN	_	23	nmod	_	_
27	II	ii	CD	CD	_	26	nummod	_	_
28	by	by	IN	IN	_	29	case	_	_
29	IFN-gamma	ifn-gamma	NN	NN	_	23	nmod	_	_
30	.	.	.	.	_	7	punct	_	_

1	CIITA	ciita	NN	NN	_	2	compound	_	_
2	mRNA	mrna	NN	NN	_	5	nsubj	_	_
3	is	be	VBZ	VBZ	_	5	cop	_	_
4	normally	normally	RB	RB	_	5	advmod	_	_
5	inducible	inducible	JJ	JJ	_	0	root	_	_
6	by	by	IN	IN	_	7	case	_	_
7	IFN-gamma	ifn-gamma	NN	NN	_	5	nmod	_	_
8	in	in	IN	IN	_	14	case	_	_
9	class	class	NN	NN	_	14	compound	_	_
10	II	ii	CD	CD	_	14	nummod	_	_
11	non-inducible	non-inducible	JJ	JJ	_	14	amod	_	_
12	,	,	,	,	_	14	punct	_	_
13	RB-defective	rb-defective	JJ	JJ	_	14	amod	_	_
14	lines	line	NNS	NNS	_	5	nmod	_	_
15	,	,	,	,	_	5	punct	_	_
16	and	and	CC	CC	_	5	cc	_	_
17	in	in	IN	IN	_	19	case	_	_
18	one	one	CD	CD	_	19	nummod	_	_
19	line	line	NN	NN	_	24	nmod	_	_
20	,	,	,	,	_	24	punct	_	_
21	re-expression	re-expression	NN	NN	_	24	nsubj	_	_
22	of	of	IN	IN	_	23	case	_	_
23	RB	rb	NN	NN	_	21	nmod	_	_
24	has	have	VBZ	VBZ	_	5	conj	_	_
25	no	no	DT	DT	_	26	neg	_	_
26	effect	effect	NN	NN	_	24	dobj	_	_
27	on	on	IN	IN	_	31	case	_	_
28	CIITA	ciita	NN	NN	_	29	compound	_	_
29	mRNA	mrna	NN	NN	_	31	compound	_	_
30	induction	induction	NN	NN	_	31	compound	_	_
31	levels	level	NNS	NNS	_	24	nmod	_	_
32	.	.	.	.	_	5	punct	_	_

1	Thus	thus	RB	RB	_	15	advmod	_	_
2	,	,	,	,	_	15	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	block	block	NN	NN	_	15	nsubj	_	_
5	in	in	IN	IN	_	9	case	_	_
6	MHC	mhc	NN	NN	_	9	compound	_	_
7	class	class	NN	NN	_	9	compound	_	_
8	II	ii	CD	CD	_	9	nummod	_	_
9	inducibility	inducibility	NN	NN	_	4	nmod	_	_
10	in	in	IN	IN	_	12	case	_	_
11	RB-defective	rb-defective	JJ	JJ	_	12	amod	_	_
12	cells	cell	NNS	NNS	_	9	nmod	_	_
13	is	be	VBZ	VBZ	_	15	cop	_	_
14	not	not	RB	RB	_	15	neg	_	_
15	due	due	JJ	JJ	_	0	root	_	_
16	to	to	TO	TO	_	18	case	_	_
17	a	a	DT	DT	_	18	det	_	_
18	block	block	NN	NN	_	15	nmod	_	_
19	in	in	IN	IN	_	21	case	_	_
20	CIITA	ciita	NN	NN	_	21	compound	_	_
21	inducibility	inducibility	NN	NN	_	18	nmod	_	_
22	.	.	.	.	_	15	punct	_	_

1	Latent	latent	JJ	JJ	_	3	amod	_	_
2	membrane	membrane	NN	NN	_	3	compound	_	_
3	protein-1	protein-1	NN	NN	_	4	nsubj	_	_
4	induces	induce	VBZ	VBZ	_	0	root	_	_
5	cyclin	cyclin	NN	NN	_	6	compound	_	_
6	D2	d2	NN	NN	_	7	compound	_	_
7	expression	expression	NN	NN	_	4	dobj	_	_
8	,	,	,	,	_	7	punct	_	_
9	pRb	prb	NN	NN	_	10	compound	_	_
10	hyperphosphorylation	hyperphosphorylation	NN	NN	_	7	conj	_	_
11	,	,	,	,	_	7	punct	_	_
12	and	and	CC	CC	_	7	cc	_	_
13	loss	loss	NN	NN	_	7	conj	_	_
14	of	of	IN	IN	_	18	case	_	_
15	TGF-beta	tgf-beta	NN	NN	_	18	compound	_	_
16	1-mediated	1-mediated	JJ	JJ	_	18	amod	_	_
17	growth	growth	NN	NN	_	18	compound	_	_
18	inhibition	inhibition	NN	NN	_	13	nmod	_	_
19	in	in	IN	IN	_	22	case	_	_
20	EBV-positive	ebv-positive	JJ	JJ	_	22	amod	_	_
21	B	b	NN	NN	_	22	compound	_	_
22	cells	cell	NNS	NNS	_	7	nmod	_	_
23	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	normal	normal	JJ	JJ	_	4	amod	_	_
3	cell	cell	NN	NN	_	4	compound	_	_
4	cycle	cycle	NN	NN	_	6	nsubjpass	_	_
5	is	be	VBZ	VBZ	_	6	auxpass	_	_
6	regulated	regulate	VBN	VBN	_	0	root	_	_
7	by	by	IN	IN	_	9	case	_	_
8	several	several	JJ	JJ	_	9	amod	_	_
9	molecules	molecule	NNS	NNS	_	6	nmod	_	_
10	,	,	,	,	_	9	punct	_	_
11	such	such	JJ	JJ	_	16	case	_	_
12	as	as	IN	IN	_	11	mwe	_	_
13	the	the	DT	DT	_	16	det	_	_
14	tumor-suppressor	tumor-suppressor	JJ	JJ	_	16	amod	_	_
15	protein	protein	NN	NN	_	16	compound	_	_
16	pRb	prb	NN	NN	_	9	nmod	_	_
17	,	,	,	,	_	16	punct	_	_
18	the	the	DT	DT	_	20	det	_	_
19	G1	g1	NN	NN	_	20	compound	_	_
20	cyclins	cyclin	NNS	NNS	_	16	conj	_	_
21	,	,	,	,	_	16	punct	_	_
22	the	the	DT	DT	_	24	det	_	_
23	cyclin-dependent	cyclin-dependent	JJ	JJ	_	24	amod	_	_
24	kinases	kinase	NNS	NNS	_	16	conj	_	_
25	,	,	,	,	_	16	punct	_	_
26	and	and	CC	CC	_	16	cc	_	_
27	their	they	PRP$	PRP$	_	28	nmod:poss	_	_
28	inhibitors	inhibitor	NNS	NNS	_	16	conj	_	_
29	.	.	.	.	_	6	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	regulators	regulator	NNS	NNS	_	4	nsubjpass	_	_
3	are	be	VBP	VBP	_	4	auxpass	_	_
4	targeted	target	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	_	9	case	_	_
6	negative	negative	JJ	JJ	_	9	amod	_	_
7	growth	growth	NN	NN	_	9	compound	_	_
8	regulatory	regulatory	JJ	JJ	_	9	amod	_	_
9	signals	signal	NNS	NNS	_	4	nmod	_	_
10	,	,	,	,	_	9	punct	_	_
11	such	such	JJ	JJ	_	13	case	_	_
12	as	as	IN	IN	_	11	mwe	_	_
13	that	that	DT	DT	_	9	nmod	_	_
14	provided	provide	VBN	VBN	_	13	acl	_	_
15	by	by	IN	IN	_	16	case	_	_
16	TGF-beta	tgf-beta	NN	NN	_	14	nmod	_	_
17	.	.	.	.	_	4	punct	_	_

1	Here	here	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	show	show	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	21	mark	_	_
6	the	the	DT	DT	_	7	det	_	_
7	presence	presence	NN	NN	_	21	nsubj	_	_
8	of	of	IN	IN	_	11	case	_	_
9	either	either	CC	CC	_	11	cc:preconj	_	_
10	wild-type	wild-type	JJ	JJ	_	11	amod	_	_
11	EBV	ebv	NN	NN	_	7	nmod	_	_
12	or	or	CC	CC	_	11	cc	_	_
13	its	its	PRP$	PRP$	_	17	nmod:poss	_	_
14	transforming	transform	VBG	VBG	_	17	amod	_	_
15	latent	latent	JJ	JJ	_	17	amod	_	_
16	membrane	membrane	NN	NN	_	17	compound	_	_
17	protein-1	protein-1	NN	NN	_	11	conj	_	_
18	(	(	-LRB-	-LRB-	_	19	punct	_	_
19	LMP-1	lmp-1	NN	NN	_	17	appos	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	results	result	VBZ	VBZ	_	4	ccomp	_	_
22	in	in	IN	IN	_	24	case	_	_
23	the	the	DT	DT	_	24	det	_	_
24	loss	loss	NN	NN	_	21	nmod	_	_
25	of	of	IN	IN	_	29	case	_	_
26	TGF-beta	tgf-beta	NN	NN	_	29	compound	_	_
27	1-mediated	1-mediated	JJ	JJ	_	29	amod	_	_
28	growth	growth	NN	NN	_	29	compound	_	_
29	inhibition	inhibition	NN	NN	_	24	nmod	_	_
30	in	in	IN	IN	_	33	case	_	_
31	human	human	JJ	JJ	_	33	amod	_	_
32	B	b	NN	NN	_	33	compound	_	_
33	cells	cell	NNS	NNS	_	24	nmod	_	_
34	.	.	.	.	_	4	punct	_	_

1	Chemical	chemical	JJ	JJ	_	2	amod	_	_
2	cross-linking	cross-linking	NN	NN	_	7	nsubj	_	_
3	with	with	IN	IN	_	5	case	_	_
4	125I-labeled	125i-labeled	JJ	JJ	_	5	amod	_	_
5	TGF-beta	tgf-beta	NN	NN	_	2	nmod	_	_
6	1	1	CD	CD	_	5	nummod	_	_
7	showed	show	VBD	VBD	_	0	root	_	_
8	an	a	DT	DT	_	13	det	_	_
9	essentially	essentially	RB	RB	_	10	advmod	_	_
10	normal	normal	JJ	JJ	_	13	amod	_	_
11	TGF-beta	tgf-beta	NN	NN	_	12	compound	_	_
12	receptor	receptor	NN	NN	_	13	compound	_	_
13	profile	profile	NN	NN	_	7	dobj	_	_
14	in	in	IN	IN	_	15	case	_	_
15	EBV-positive	ebv-positive	JJ	JJ	_	7	nmod	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	EBV-negative	ebv-negative	JJ	JJ	_	15	conj	_	_
18	Burkitt	burkitt	NN	NN	_	22	nmod:poss	_	_
19	's	's	POS	POS	_	22	case	_	_
20	lymphoma	lymphoma	NN	NN	_	22	compound	_	_
21	cell	cell	NN	NN	_	22	compound	_	_
22	lines	line	NNS	NNS	_	15	dep	_	_
23	,	,	,	,	_	7	punct	_	_
24	and	and	CC	CC	_	7	cc	_	_
25	these	these	DT	DT	_	26	det	_	_
26	receptors	receptor	NNS	NNS	_	28	nsubjpass	_	_
27	were	be	VBD	VBD	_	28	auxpass	_	_
28	shown	show	VBN	VBN	_	7	conj	_	_
29	to	to	TO	TO	_	31	mark	_	_
30	be	be	VB	VB	_	31	cop	_	_
31	functional	functional	JJ	JJ	_	28	xcomp	_	_
32	in	in	IN	IN	_	33	mark	_	_
33	transducing	transduce	VBG	VBG	_	31	advcl	_	_
34	signals	signal	NNS	NNS	_	33	dobj	_	_
35	,	,	,	,	_	28	punct	_	_
36	as	as	IN	IN	_	37	mark	_	_
37	evidenced	evidence	VBN	VBN	_	28	advcl	_	_
38	by	by	IN	IN	_	42	case	_	_
39	the	the	DT	DT	_	42	det	_	_
40	TGF-beta	tgf-beta	NN	NN	_	42	compound	_	_
41	1-mediated	1-mediated	JJ	JJ	_	42	amod	_	_
42	modulation	modulation	NN	NN	_	37	nmod	_	_
43	of	of	IN	IN	_	46	case	_	_
44	junB	junb	NN	NN	_	45	compound	_	_
45	gene	gene	NN	NN	_	46	compound	_	_
46	expression	expression	NN	NN	_	42	nmod	_	_
47	.	.	.	.	_	7	punct	_	_

1	However	however	RB	RB	_	7	advmod	_	_
2	,	,	,	,	_	7	punct	_	_
3	TGF-beta	tgf-beta	NN	NN	_	7	nsubj	_	_
4	1	1	CD	CD	_	3	nummod	_	_
5	did	do	VBD	VBD	_	7	aux	_	_
6	not	not	RB	RB	_	7	neg	_	_
7	induce	induce	VB	VB	_	0	root	_	_
8	dephosphorylation	dephosphorylation	NN	NN	_	7	dobj	_	_
9	of	of	IN	IN	_	10	case	_	_
10	pRb	prb	NN	NN	_	8	nmod	_	_
11	in	in	IN	IN	_	12	case	_	_
12	EBV	ebv	NN	NN	_	7	nmod	_	_
13	(	(	-LRB-	-LRB-	_	12	punct	_	_
14	or	or	CC	CC	_	12	cc	_	_
15	LMP-1	lmp-1	NN	NN	_	18	compound	_	_
16	)	)	-RRB-	-RRB-	_	18	punct	_	_
17	-positive	-positive	JJ	JJ	_	18	amod	_	_
18	cells	cell	NNS	NNS	_	12	conj	_	_
19	as	as	IN	IN	_	20	mark	_	_
20	opposed	oppose	VBN	VBN	_	7	advcl	_	_
21	to	to	TO	TO	_	24	case	_	_
22	EBV	ebv	JJ	JJ	_	24	amod	_	_
23	-negative	-negative	JJ	JJ	_	24	amod	_	_
24	cells	cell	NNS	NNS	_	20	nmod	_	_
25	,	,	,	,	_	20	punct	_	_
26	suggesting	suggest	VBG	VBG	_	20	dep	_	_
27	a	a	DT	DT	_	28	det	_	_
28	dichotomy	dichotomy	NN	NN	_	26	dobj	_	_
29	in	in	IN	IN	_	34	case	_	_
30	the	the	DT	DT	_	34	det	_	_
31	TGF-beta	tgf-beta	NN	NN	_	34	compound	_	_
32	1	1	CD	CD	_	31	nummod	_	_
33	signaling	signaling	NN	NN	_	34	compound	_	_
34	pathway	pathway	NN	NN	_	28	nmod	_	_
35	leading	lead	VBG	VBG	_	28	acl	_	_
36	to	to	TO	TO	_	38	case	_	_
37	separable	separable	JJ	JJ	_	38	amod	_	_
38	gene	gene	NN	NN	_	35	nmod	_	_
39	regulatory	regulatory	JJ	JJ	_	38	dep	_	_
40	and	and	CC	CC	_	38	cc	_	_
41	growth	growth	NN	NN	_	38	conj	_	_
42	inhibitory	inhibitory	JJ	JJ	_	41	amod	_	_
43	responses	response	NNS	NNS	_	38	dep	_	_
44	.	.	.	.	_	7	punct	_	_

1	Furthermore	furthermore	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	LMP-1	lmp-1	NN	NN	_	5	nsubjpass	_	_
4	was	be	VBD	VBD	_	5	auxpass	_	_
5	found	find	VBN	VBN	_	0	root	_	_
6	to	to	TO	TO	_	7	mark	_	_
7	induce	induce	VB	VB	_	5	xcomp	_	_
8	the	the	DT	DT	_	9	det	_	_
9	expression	expression	NN	NN	_	7	dobj	_	_
10	of	of	IN	IN	_	12	case	_	_
11	cyclin	cyclin	NN	NN	_	12	compound	_	_
12	D2	d2	NN	NN	_	9	nmod	_	_
13	;	;	:	:	_	5	punct	_	_
14	normal	normal	JJ	JJ	_	16	amod	_	_
15	B	b	NN	NN	_	16	compound	_	_
16	cells	cell	NNS	NNS	_	25	nsubj	_	_
17	or	or	CC	CC	_	16	cc	_	_
18	EBV-negative	ebv-negative	JJ	JJ	_	22	amod	_	_
19	Burkitt	burkitt	NN	NN	_	22	nmod:poss	_	_
20	's	's	POS	POS	_	22	case	_	_
21	lymphoma	lymphoma	NN	NN	_	22	compound	_	_
22	cells	cell	NNS	NNS	_	16	conj	_	_
23	do	do	VBP	VBP	_	25	aux	_	_
24	not	not	RB	RB	_	25	neg	_	_
25	express	express	VB	VB	_	5	parataxis	_	_
26	D-type	d-type	JJ	JJ	_	27	amod	_	_
27	cyclins	cyclin	NNS	NNS	_	25	dobj	_	_
28	.	.	.	.	_	5	punct	_	_

1	Taken	take	VBN	VBN	_	0	root	_	_
2	together	together	RB	RB	_	1	advmod	_	_
3	,	,	,	,	_	1	punct	_	_
4	these	these	DT	DT	_	5	det	_	_
5	data	datum	NNS	NNS	_	6	nsubj	_	_
6	point	point	VBP	VBP	_	1	parataxis	_	_
7	to	to	TO	TO	_	10	case	_	_
8	a	a	DT	DT	_	10	det	_	_
9	potential	potential	JJ	JJ	_	10	amod	_	_
10	mechanism	mechanism	NN	NN	_	6	nmod	_	_
11	underlying	underlie	VBG	VBG	_	10	acl	_	_
12	EBV-mediated	ebv-mediated	JJ	JJ	_	15	amod	_	_
13	B	b	NN	NN	_	15	compound	_	_
14	cell	cell	NN	NN	_	15	compound	_	_
15	transformation	transformation	NN	NN	_	11	dobj	_	_
16	whereby	whereby	WRB	WRB	_	27	advmod	_	_
17	constitutive	constitutive	JJ	JJ	_	18	amod	_	_
18	induction	induction	NN	NN	_	27	nsubj	_	_
19	of	of	IN	IN	_	23	case	_	_
20	key	key	JJ	JJ	_	23	amod	_	_
21	cell	cell	NN	NN	_	23	compound	_	_
22	cycle	cycle	NN	NN	_	23	compound	_	_
23	regulators	regulator	NNS	NNS	_	18	nmod	_	_
24	by	by	IN	IN	_	25	case	_	_
25	LMP-1	lmp-1	NN	NN	_	18	nmod	_	_
26	can	can	MD	MD	_	27	aux	_	_
27	lead	lead	VB	VB	_	15	acl:relcl	_	_
28	to	to	TO	TO	_	30	case	_	_
29	pRb	prb	NN	NN	_	30	compound	_	_
30	hyperphosphorylation	hyperphosphorylation	NN	NN	_	27	nmod	_	_
31	and	and	CC	CC	_	30	cc	_	_
32	uncontrolled	uncontrolled	JJ	JJ	_	34	amod	_	_
33	cell	cell	NN	NN	_	34	compound	_	_
34	proliferation	proliferation	NN	NN	_	30	conj	_	_
35	.	.	.	.	_	1	punct	_	_

1	C/EBP	c/ebp	NN	NN	_	2	compound	_	_
2	proteins	protein	NNS	NNS	_	3	nsubj	_	_
3	activate	activate	VBP	VBP	_	0	root	_	_
4	transcription	transcription	NN	NN	_	3	dobj	_	_
5	from	from	IN	IN	_	14	case	_	_
6	the	the	DT	DT	_	14	det	_	_
7	human	human	JJ	JJ	_	14	amod	_	_
8	immunodeficiency	immunodeficiency	NN	NN	_	14	compound	_	_
9	virus	virus	NN	NN	_	14	compound	_	_
10	type	type	NN	NN	_	14	compound	_	_
11	1	1	CD	CD	_	14	nummod	_	_
12	long	long	JJ	JJ	_	14	amod	_	_
13	terminal	terminal	JJ	JJ	_	14	amod	_	_
14	repeat	repeat	NN	NN	_	4	nmod	_	_
15	in	in	IN	IN	_	16	case	_	_
16	macrophages/monocytes	macrophages/monocytes	NNS	NNS	_	4	nmod	_	_
17	.	.	.	.	_	3	punct	_	_

1	Three	three	CD	CD	_	3	nummod	_	_
2	binding	bind	VBG	VBG	_	3	amod	_	_
3	sites	site	NNS	NNS	_	8	nsubjpass	_	_
4	for	for	IN	IN	_	6	case	_	_
5	C/EBP	c/ebp	NN	NN	_	6	compound	_	_
6	proteins	protein	NNS	NNS	_	3	nmod	_	_
7	are	be	VBP	VBP	_	8	auxpass	_	_
8	found	find	VBN	VBN	_	0	root	_	_
9	in	in	IN	IN	_	21	case	_	_
10	the	the	DT	DT	_	21	det	_	_
11	human	human	JJ	JJ	_	21	amod	_	_
12	immunodeficiency	immunodeficiency	NN	NN	_	21	compound	_	_
13	virus	virus	NN	NN	_	21	compound	_	_
14	type	type	NN	NN	_	21	compound	_	_
15	1	1	CD	CD	_	21	nummod	_	_
16	(	(	-LRB-	-LRB-	_	21	punct	_	_
17	HIV-1	hiv-1	NN	NN	_	21	compound	_	_
18	)	)	-RRB-	-RRB-	_	21	punct	_	_
19	long	long	JJ	JJ	_	21	amod	_	_
20	terminal	terminal	JJ	JJ	_	21	amod	_	_
21	repeat	repeat	NN	NN	_	8	nmod	_	_
22	(	(	-LRB-	-LRB-	_	23	punct	_	_
23	LTR	ltr	NN	NN	_	21	appos	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	(	(	-LRB-	-LRB-	_	27	punct	_	_
26	V.M.	V.M.	NNP	NNP	_	27	compound	_	_
27	Tesmer	Tesmer	NNP	NNP	_	8	dep	_	_
28	,	,	,	,	_	27	punct	_	_
29	A.Rajadhyaksha	A.Rajadhyaksha	NNP	NNP	_	27	conj	_	_
30	,	,	,	,	_	27	punct	_	_
31	J.Babin	J.Babin	NNP	NNP	_	27	conj	_	_
32	,	,	,	,	_	27	punct	_	_
33	and	and	CC	CC	_	27	cc	_	_
34	M.Bina	M.Bina	NNP	NNP	_	27	conj	_	_
35	,	,	,	,	_	27	punct	_	_
36	Proc.Natl.Acad.Sci.	Proc.Natl.Acad.Sci.	NNP	NNP	_	37	compound	_	_
37	USA	USA	NNP	NNP	_	27	appos	_	_
38	90	90	CD	CD	_	37	nummod	_	_
39	:	:	:	:	_	27	punct	_	_
40	7298-7302	7298-7302	CD	CD	_	27	dep	_	_
41	,	,	,	,	_	27	punct	_	_
42	1993	1993	CD	CD	_	27	amod	_	_
43	)	)	-RRB-	-RRB-	_	27	punct	_	_
44	.	.	.	.	_	8	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	determined	determine	VBN	VBN	_	0	root	_	_
4	the	the	DT	DT	_	6	det	_	_
5	functional	functional	JJ	JJ	_	6	amod	_	_
6	role	role	NN	NN	_	3	dobj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	C/EBP	c/ebp	NN	NN	_	9	compound	_	_
9	proteins	protein	NNS	NNS	_	6	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	C/EBP	c/ebp	NN	NN	_	12	compound	_	_
12	sites	site	NNS	NNS	_	9	conj	_	_
13	in	in	IN	IN	_	14	mark	_	_
14	regulating	regulate	VBG	VBG	_	6	acl	_	_
15	transcription	transcription	NN	NN	_	14	dobj	_	_
16	from	from	IN	IN	_	19	case	_	_
17	the	the	DT	DT	_	19	det	_	_
18	HIV-1	hiv-1	NN	NN	_	19	compound	_	_
19	LTR	ltr	NN	NN	_	15	nmod	_	_
20	in	in	IN	IN	_	21	case	_	_
21	monocytes/macrophages	monocytes/macrophages	NNS	NNS	_	15	nmod	_	_
22	.	.	.	.	_	3	punct	_	_

1	Inhibition	inhibition	NN	NN	_	21	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	endogenous	endogenous	JJ	JJ	_	5	amod	_	_
4	C/EBP	c/ebp	NN	NN	_	5	compound	_	_
5	proteins	protein	NNS	NNS	_	1	nmod	_	_
6	,	,	,	,	_	1	punct	_	_
7	using	use	VBG	VBG	_	1	acl	_	_
8	either	either	CC	CC	_	10	cc:preconj	_	_
9	an	a	DT	DT	_	10	det	_	_
10	excess	excess	NN	NN	_	7	dobj	_	_
11	of	of	IN	IN	_	14	case	_	_
12	C/EBP	c/ebp	NN	NN	_	14	compound	_	_
13	binding	binding	NN	NN	_	14	compound	_	_
14	sites	site	NNS	NNS	_	10	nmod	_	_
15	or	or	CC	CC	_	10	cc	_	_
16	a	a	DT	DT	_	19	det	_	_
17	trans-dominant	trans-dominant	JJ	JJ	_	19	amod	_	_
18	negative	negative	JJ	JJ	_	19	amod	_	_
19	inhibitor	inhibitor	NN	NN	_	10	conj	_	_
20	,	,	,	,	_	1	punct	_	_
21	demonstrated	demonstrate	VBD	VBD	_	0	root	_	_
22	that	that	IN	IN	_	26	mark	_	_
23	C/EBP	c/ebp	NN	NN	_	24	compound	_	_
24	proteins	protein	NNS	NNS	_	26	nsubjpass	_	_
25	are	be	VBP	VBP	_	26	auxpass	_	_
26	required	require	VBN	VBN	_	21	ccomp	_	_
27	for	for	IN	IN	_	28	case	_	_
28	basal	basal	JJ	JJ	_	26	nmod	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	activated	activate	VBN	VBN	_	28	conj	_	_
31	levels	level	NNS	NNS	_	28	dep	_	_
32	of	of	IN	IN	_	35	case	_	_
33	HIV-1	hiv-1	NN	NN	_	34	compound	_	_
34	LTR	ltr	NN	NN	_	35	compound	_	_
35	transcription	transcription	NN	NN	_	28	nmod	_	_
36	in	in	IN	IN	_	41	case	_	_
37	the	the	DT	DT	_	41	det	_	_
38	promonocytic	promonocytic	JJ	JJ	_	41	amod	_	_
39	cell	cell	NN	NN	_	41	compound	_	_
40	line	line	NN	NN	_	41	compound	_	_
41	U937	u937	NN	NN	_	35	nmod	_	_
42	.	.	.	.	_	21	punct	_	_

1	Northern	northern	NN	NN	_	9	nsubj	_	_
2	(	(	-LRB-	-LRB-	_	3	punct	_	_
3	RNA	rna	NN	NN	_	1	appos	_	_
4	)	)	-RRB-	-RRB-	_	3	punct	_	_
5	blots	blot	NNS	NNS	_	1	dep	_	_
6	and	and	CC	CC	_	1	cc	_	_
7	binding	binding	NN	NN	_	1	conj	_	_
8	assays	assay	NNS	NNS	_	1	dep	_	_
9	showed	show	VBD	VBD	_	0	root	_	_
10	that	that	IN	IN	_	18	mark	_	_
11	NF-IL6	nf-il6	NN	NN	_	18	nsubj	_	_
12	is	be	VBZ	VBZ	_	18	cop	_	_
13	the	the	DT	DT	_	18	det	_	_
14	only	only	RB	RB	_	18	advmod	_	_
15	known	known	JJ	JJ	_	18	amod	_	_
16	C/EBP	c/ebp	NN	NN	_	18	compound	_	_
17	family	family	NN	NN	_	18	compound	_	_
18	member	member	NN	NN	_	9	ccomp	_	_
19	which	which	WDT	WDT	_	21	nsubjpass	_	_
20	is	be	VBZ	VBZ	_	21	auxpass	_	_
21	increased	increase	VBN	VBN	_	18	acl:relcl	_	_
22	when	when	WRB	WRB	_	26	advmod	_	_
23	U937	u937	NN	NN	_	24	compound	_	_
24	cells	cell	NNS	NNS	_	26	nsubjpass	_	_
25	are	be	VBP	VBP	_	26	auxpass	_	_
26	activated	activate	VBN	VBN	_	21	advcl	_	_
27	.	.	.	.	_	9	punct	_	_

1	Mutational	mutational	JJ	JJ	_	2	amod	_	_
2	analyses	analysis	NNS	NNS	_	7	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	HIV-1	hiv-1	NN	NN	_	6	compound	_	_
6	LTR	ltr	NN	NN	_	2	nmod	_	_
7	showed	show	VBD	VBD	_	0	root	_	_
8	that	that	IN	IN	_	13	mark	_	_
9	one	one	CD	CD	_	11	nummod	_	_
10	C/EBP	c/ebp	NN	NN	_	11	compound	_	_
11	site	site	NN	NN	_	13	nsubjpass	_	_
12	is	be	VBZ	VBZ	_	13	auxpass	_	_
13	required	require	VBN	VBN	_	7	ccomp	_	_
14	for	for	IN	IN	_	17	case	_	_
15	normal	normal	JJ	JJ	_	17	amod	_	_
16	LTR	ltr	NN	NN	_	17	compound	_	_
17	transcription	transcription	NN	NN	_	13	nmod	_	_
18	both	both	CC	CC	_	23	cc:preconj	_	_
19	before	before	IN	IN	_	23	nmod	_	_
20	and	and	CC	CC	_	23	cc	_	_
21	after	after	IN	IN	_	23	conj	_	_
22	cellular	cellular	JJ	JJ	_	23	amod	_	_
23	activation	activation	NN	NN	_	17	nmod	_	_
24	and	and	CC	CC	_	13	cc	_	_
25	that	that	IN	IN	_	33	mark	_	_
26	the	the	DT	DT	_	30	det	_	_
27	two	two	CD	CD	_	30	nummod	_	_
28	3'	3'	JJ	JJ	_	30	amod	_	_
29	C/EBP	c/ebp	NN	NN	_	30	compound	_	_
30	sites	site	NNS	NNS	_	33	nsubj	_	_
31	are	be	VBP	VBP	_	33	cop	_	_
32	functionally	functionally	RB	RB	_	33	advmod	_	_
33	equivalent	equivalent	JJ	JJ	_	13	conj	_	_
34	.	.	.	.	_	7	punct	_	_

1	However	however	RB	RB	_	14	advmod	_	_
2	,	,	,	,	_	14	punct	_	_
3	transcription	transcription	NN	NN	_	14	nsubjpass	_	_
4	from	from	IN	IN	_	7	case	_	_
5	crippled	cripple	VBN	VBN	_	7	amod	_	_
6	HIV-1	hiv-1	NN	NN	_	7	compound	_	_
7	LTRs	ltr	NNS	NNS	_	3	nmod	_	_
8	lacking	lack	VBG	VBG	_	7	acl	_	_
9	C/EBP	c/ebp	NN	NN	_	10	compound	_	_
10	sites	site	NNS	NNS	_	8	dobj	_	_
11	can	can	MD	MD	_	14	aux	_	_
12	still	still	RB	RB	_	14	advmod	_	_
13	be	be	VB	VB	_	14	auxpass	_	_
14	induced	induce	VBN	VBN	_	0	root	_	_
15	following	follow	VBG	VBG	_	16	case	_	_
16	activation	activation	NN	NN	_	14	nmod	_	_
17	of	of	IN	IN	_	19	case	_	_
18	U937	u937	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	16	nmod	_	_
20	.	.	.	.	_	14	punct	_	_

1	Several	several	JJ	JJ	_	2	amod	_	_
2	models	model	NNS	NNS	_	4	nsubjpass	_	_
3	are	be	VBP	VBP	_	4	auxpass	_	_
4	suggested	suggest	VBN	VBN	_	0	root	_	_
5	for	for	IN	IN	_	10	mark	_	_
6	how	how	WRB	WRB	_	10	advmod	_	_
7	elevated	elevated	JJ	JJ	_	8	amod	_	_
8	NF-IL6	nf-il6	NN	NN	_	10	nsubj	_	_
9	may	may	MD	MD	_	10	aux	_	_
10	participate	participate	VB	VB	_	4	advcl	_	_
11	in	in	IN	IN	_	14	case	_	_
12	an	a	DT	DT	_	14	det	_	_
13	autostimulatory	autostimulatory	JJ	JJ	_	14	amod	_	_
14	loop	loop	NN	NN	_	10	nmod	_	_
15	involving	involve	VBG	VBG	_	14	acl	_	_
16	HIV	hiv	NN	NN	_	17	compound	_	_
17	infection	infection	NN	NN	_	15	dobj	_	_
18	,	,	,	,	_	17	punct	_	_
19	macrophage	macrophage	NN	NN	_	20	compound	_	_
20	activation	activation	NN	NN	_	17	conj	_	_
21	,	,	,	,	_	17	punct	_	_
22	cytokine	cytokine	NN	NN	_	23	compound	_	_
23	expression	expression	NN	NN	_	17	conj	_	_
24	,	,	,	,	_	17	punct	_	_
25	and	and	CC	CC	_	17	cc	_	_
26	HIV	hiv	NN	NN	_	27	compound	_	_
27	replication	replication	NN	NN	_	17	conj	_	_
28	.	.	.	.	_	4	punct	_	_

1	An	a	DT	DT	_	3	det	_	_
2	IRF-1-dependent	irf-1-dependent	JJ	JJ	_	3	amod	_	_
3	pathway	pathway	NN	NN	_	0	root	_	_
4	of	of	IN	IN	_	7	case	_	_
5	DNA	dna	NN	NN	_	7	compound	_	_
6	damage-induced	damage-induced	JJ	JJ	_	7	amod	_	_
7	apoptosis	apoptosis	NN	NN	_	3	nmod	_	_
8	in	in	IN	IN	_	11	case	_	_
9	mitogen-activated	mitogen-activated	JJ	JJ	_	11	amod	_	_
10	T	t	NN	NN	_	11	compound	_	_
11	lymphocytes	lymphocyte	NNS	NNS	_	3	nmod	_	_
12	.	.	.	.	_	3	punct	_	_

1	Lymphocytes	lymphocyte	NNS	NNS	_	4	nsubj	_	_
2	are	be	VBP	VBP	_	4	cop	_	_
3	particularly	particularly	RB	RB	_	4	advmod	_	_
4	susceptible	susceptible	JJ	JJ	_	0	root	_	_
5	to	to	TO	TO	_	8	case	_	_
6	DNA	dna	NN	NN	_	8	compound	_	_
7	damage-induced	damage-induced	JJ	JJ	_	8	amod	_	_
8	apoptosis	apoptosis	NN	NN	_	4	nmod	_	_
9	,	,	,	,	_	8	punct	_	_
10	a	a	DT	DT	_	11	det	_	_
11	response	response	NN	NN	_	8	appos	_	_
12	which	which	WDT	WDT	_	14	nsubj	_	_
13	may	may	MD	MD	_	14	aux	_	_
14	serve	serve	VB	VB	_	11	acl:relcl	_	_
15	as	as	IN	IN	_	17	case	_	_
16	a	a	DT	DT	_	17	det	_	_
17	form	form	NN	NN	_	14	nmod	_	_
18	of	of	IN	IN	_	21	case	_	_
19	'	'	``	``	_	21	punct	_	_
20	altruistic	altruistic	JJ	JJ	_	21	amod	_	_
21	suicide	suicide	NN	NN	_	17	nmod	_	_
22	'	'	''	''	_	21	punct	_	_
23	to	to	TO	TO	_	24	mark	_	_
24	counter	counter	VB	VB	_	14	xcomp	_	_
25	their	they	PRP$	PRP$	_	28	nmod:poss	_	_
26	intrinsic	intrinsic	JJ	JJ	_	27	amod	_	_
27	high	high	JJ	JJ	_	28	amod	_	_
28	potential	potential	NN	NN	_	24	dobj	_	_
29	for	for	IN	IN	_	30	case	_	_
30	mutation	mutation	NN	NN	_	28	nmod	_	_
31	and	and	CC	CC	_	30	cc	_	_
32	clonal	clonal	JJ	JJ	_	33	amod	_	_
33	expansion	expansion	NN	NN	_	30	conj	_	_
34	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	tumour	tumour	NN	NN	_	4	compound	_	_
3	suppressor	suppressor	NN	NN	_	4	compound	_	_
4	p53	p53	NN	NN	_	7	nsubjpass	_	_
5	has	have	VBZ	VBZ	_	7	aux	_	_
6	been	be	VBN	VBN	_	7	auxpass	_	_
7	shown	show	VBN	VBN	_	0	root	_	_
8	to	to	TO	TO	_	9	mark	_	_
9	regulate	regulate	VB	VB	_	7	xcomp	_	_
10	this	this	DT	DT	_	11	det	_	_
11	type	type	NN	NN	_	9	dobj	_	_
12	of	of	IN	IN	_	13	case	_	_
13	apoptosis	apoptosis	NN	NN	_	11	nmod	_	_
14	in	in	IN	IN	_	15	case	_	_
15	thymocytes	thymocyte	NNS	NNS	_	13	nmod	_	_
16	,	,	,	,	_	7	punct	_	_
17	but	but	CC	CC	_	7	cc	_	_
18	an	a	DT	DT	_	26	det	_	_
19	as	as	RB	RB	_	21	advmod	_	_
20	yet	yet	RB	RB	_	21	advmod	_	_
21	unknown	unknown	JJ	JJ	_	26	amod	_	_
22	,	,	,	,	_	26	punct	_	_
23	p53-independent	p53-independent	JJ	JJ	_	26	amod	_	_
24	pathway	pathway	NN	NN	_	26	compound	_	_
25	(	(	-LRB-	-LRB-	_	26	punct	_	_
26	s	s	NNS	NNS	_	28	nsubj	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	appears	appear	VBZ	VBZ	_	7	conj	_	_
29	to	to	TO	TO	_	30	mark	_	_
30	mediate	mediate	VB	VB	_	28	xcomp	_	_
31	the	the	DT	DT	_	33	det	_	_
32	same	same	JJ	JJ	_	33	amod	_	_
33	event	event	NN	NN	_	30	dobj	_	_
34	in	in	IN	IN	_	38	case	_	_
35	mitogen-activated	mitogen-activated	JJ	JJ	_	38	amod	_	_
36	mature	mature	JJ	JJ	_	38	amod	_	_
37	T	t	NN	NN	_	38	compound	_	_
38	lymphocytes	lymphocyte	NNS	NNS	_	30	nmod	_	_
39	.	.	.	.	_	7	punct	_	_

1	Here	here	RB	RB	_	3	advmod	_	_
2	we	we	PRP	PRP	_	3	nsubj	_	_
3	show	show	VBP	VBP	_	0	root	_	_
4	DNA	dna	NN	NN	_	6	compound	_	_
5	damage-induced	damage-induced	JJ	JJ	_	6	amod	_	_
6	apoptosis	apoptosis	NN	NN	_	3	dobj	_	_
7	in	in	IN	IN	_	10	case	_	_
8	these	these	DT	DT	_	10	det	_	_
9	T	t	NN	NN	_	10	compound	_	_
10	lymphocytes	lymphocyte	NNS	NNS	_	6	nmod	_	_
11	is	be	VBZ	VBZ	_	12	cop	_	_
12	dependent	dependent	JJ	JJ	_	3	dep	_	_
13	on	on	IN	IN	_	20	case	_	_
14	the	the	DT	DT	_	20	det	_	_
15	antioncogenic	antioncogenic	JJ	JJ	_	20	amod	_	_
16	transcription	transcription	NN	NN	_	20	compound	_	_
17	factor	factor	NN	NN	_	20	compound	_	_
18	interferon	interferon	NN	NN	_	20	compound	_	_
19	regulatory	regulatory	JJ	JJ	_	20	amod	_	_
20	factor	factor	NN	NN	_	12	nmod	_	_
21	(	(	-LRB-	-LRB-	_	22	punct	_	_
22	IRF	irf	NN	NN	_	20	dep	_	_
23	)	)	-RRB-	-RRB-	_	22	punct	_	_
24	-1	-1	CD	CD	_	22	nummod	_	_
25	.	.	.	.	_	3	punct	_	_

1	Thus	thus	RB	RB	_	13	advmod	_	_
2	two	two	CD	CD	_	6	nummod	_	_
3	different	different	JJ	JJ	_	6	amod	_	_
4	anti-onco-genic	anti-onco-genic	JJ	JJ	_	6	amod	_	_
5	transcription	transcription	NN	NN	_	6	compound	_	_
6	factors	factor	NNS	NNS	_	13	nsubjpass	_	_
7	,	,	,	,	_	6	punct	_	_
8	p53	p53	NN	NN	_	6	appos	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	IRF-1	irf-1	NN	NN	_	8	conj	_	_
11	,	,	,	,	_	6	punct	_	_
12	are	be	VBP	VBP	_	13	auxpass	_	_
13	required	require	VBN	VBN	_	0	root	_	_
14	for	for	IN	IN	_	17	case	_	_
15	distinct	distinct	JJ	JJ	_	17	amod	_	_
16	apoptotic	apoptotic	JJ	JJ	_	17	amod	_	_
17	pathways	pathway	NNS	NNS	_	13	nmod	_	_
18	in	in	IN	IN	_	20	case	_	_
19	T	t	NN	NN	_	20	compound	_	_
20	lymphocytes	lymphocyte	NNS	NNS	_	17	nmod	_	_
21	.	.	.	.	_	13	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	show	show	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	31	mark	_	_
5	mitogen	mitogen	NN	NN	_	6	compound	_	_
6	induction	induction	NN	NN	_	31	nsubj	_	_
7	of	of	IN	IN	_	16	case	_	_
8	the	the	DT	DT	_	16	det	_	_
9	interleukin-1	interleukin-1	NN	NN	_	16	compound	_	_
10	beta	beta	NN	NN	_	16	compound	_	_
11	converting	converting	NN	NN	_	16	compound	_	_
12	enzyme	enzyme	NN	NN	_	16	compound	_	_
13	(	(	-LRB-	-LRB-	_	16	punct	_	_
14	ICE	ice	NN	NN	_	16	compound	_	_
15	)	)	-RRB-	-RRB-	_	16	punct	_	_
16	gene	gene	NN	NN	_	6	nmod	_	_
17	,	,	,	,	_	16	punct	_	_
18	a	a	DT	DT	_	20	det	_	_
19	mammalian	mammalian	JJ	JJ	_	20	amod	_	_
20	homologue	homologue	NN	NN	_	16	appos	_	_
21	of	of	IN	IN	_	27	case	_	_
22	the	the	DT	DT	_	27	det	_	_
23	Caenorhabditis	caenorhabditis	FW	FW	_	27	compound	_	_
24	elegans	elegans	FW	FW	_	27	compound	_	_
25	cell	cell	NN	NN	_	27	compound	_	_
26	death	death	NN	NN	_	27	compound	_	_
27	gene	gene	NN	NN	_	20	nmod	_	_
28	ced-3	ced-3	NN	NN	_	27	dep	_	_
29	,	,	,	,	_	6	punct	_	_
30	is	be	VBZ	VBZ	_	31	cop	_	_
31	IRF-1-dependent	irf-1-dependent	JJ	JJ	_	3	ccomp	_	_
32	.	.	.	.	_	3	punct	_	_

1	Ectopic	ectopic	JJ	JJ	_	2	amod	_	_
2	overexpression	overexpression	NN	NN	_	5	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	IRF-1	irf-1	NN	NN	_	2	nmod	_	_
5	results	result	VBZ	VBZ	_	0	root	_	_
6	in	in	IN	IN	_	8	case	_	_
7	the	the	DT	DT	_	8	det	_	_
8	activation	activation	NN	NN	_	5	nmod	_	_
9	of	of	IN	IN	_	12	case	_	_
10	the	the	DT	DT	_	12	det	_	_
11	endogenous	endogenous	JJ	JJ	_	12	amod	_	_
12	gene	gene	NN	NN	_	8	nmod	_	_
13	for	for	IN	IN	_	14	case	_	_
14	ICE	ice	NN	NN	_	8	nmod	_	_
15	and	and	CC	CC	_	5	cc	_	_
16	enhances	enhance	VBZ	VBZ	_	5	conj	_	_
17	the	the	DT	DT	_	18	det	_	_
18	sensitivity	sensitivity	NN	NN	_	16	dobj	_	_
19	of	of	IN	IN	_	20	case	_	_
20	cells	cell	NNS	NNS	_	18	nmod	_	_
21	to	to	TO	TO	_	23	case	_	_
22	radiation-induced	radiation-induced	JJ	JJ	_	23	amod	_	_
23	apoptosis	apoptosis	NN	NN	_	18	nmod	_	_
24	.	.	.	.	_	5	punct	_	_

1	Sp1	sp1	NN	NN	_	2	nsubj	_	_
2	functions	function	VBZ	VBZ	_	0	root	_	_
3	in	in	IN	IN	_	6	case	_	_
4	a	a	DT	DT	_	6	det	_	_
5	chromatin-dependent	chromatin-dependent	JJ	JJ	_	6	amod	_	_
6	manner	manner	NN	NN	_	2	nmod	_	_
7	to	to	TO	TO	_	8	mark	_	_
8	augment	augment	VB	VB	_	2	xcomp	_	_
9	human	human	JJ	JJ	_	11	amod	_	_
10	alpha-globin	alpha-globin	NN	NN	_	11	compound	_	_
11	promoter	promoter	NN	NN	_	12	compound	_	_
12	activity	activity	NN	NN	_	8	dobj	_	_
13	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	5'	5'	JJ	JJ	_	4	amod	_	_
3	flanking	flanking	JJ	JJ	_	4	amod	_	_
4	region	region	NN	NN	_	13	nsubj	_	_
5	of	of	IN	IN	_	9	case	_	_
6	the	the	DT	DT	_	9	det	_	_
7	human	human	JJ	JJ	_	9	amod	_	_
8	alpha-globin	alpha-globin	NN	NN	_	9	compound	_	_
9	gene	gene	NN	NN	_	4	nmod	_	_
10	is	be	VBZ	VBZ	_	13	cop	_	_
11	highly	highly	RB	RB	_	13	advmod	_	_
12	G+C	g+c	NN	NN	_	13	nmod:npmod	_	_
13	rich	rich	JJ	JJ	_	0	root	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	contains	contain	VBZ	VBZ	_	13	conj	_	_
16	multiple	multiple	JJ	JJ	_	17	amod	_	_
17	copies	copy	NNS	NNS	_	15	dobj	_	_
18	of	of	IN	IN	_	21	case	_	_
19	the	the	DT	DT	_	21	det	_	_
20	consensus	consensus	NN	NN	_	21	compound	_	_
21	sequence	sequence	NN	NN	_	17	nmod	_	_
22	for	for	IN	IN	_	26	case	_	_
23	the	the	DT	DT	_	26	det	_	_
24	Sp1	sp1	NN	NN	_	26	compound	_	_
25	binding	binding	NN	NN	_	26	compound	_	_
26	site	site	NN	NN	_	21	nmod	_	_
27	.	.	.	.	_	13	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	investigated	investigate	VBD	VBD	_	0	root	_	_
3	the	the	DT	DT	_	4	det	_	_
4	role	role	NN	NN	_	2	dobj	_	_
5	of	of	IN	IN	_	8	case	_	_
6	this	this	DT	DT	_	8	det	_	_
7	G+C-rich	g+c-rich	JJ	JJ	_	8	amod	_	_
8	region	region	NN	NN	_	4	nmod	_	_
9	in	in	IN	IN	_	10	mark	_	_
10	augmenting	augment	VBG	VBG	_	2	advcl	_	_
11	alpha-globin	alpha-globin	NN	NN	_	12	compound	_	_
12	promoter	promoter	NN	NN	_	13	compound	_	_
13	activity	activity	NN	NN	_	10	dobj	_	_
14	in	in	IN	IN	_	16	case	_	_
15	the	the	DT	DT	_	16	det	_	_
16	presence	presence	NN	NN	_	10	nmod	_	_
17	of	of	IN	IN	_	21	case	_	_
18	the	the	DT	DT	_	21	det	_	_
19	far-upstream	far-upstream	JJ	JJ	_	21	amod	_	_
20	alpha-globin	alpha-globin	NN	NN	_	21	compound	_	_
21	enhancer	enhancer	NN	NN	_	16	nmod	_	_
22	,	,	,	,	_	21	punct	_	_
23	HS-40	hs-40	NN	NN	_	21	appos	_	_
24	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	show	show	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	18	mark	_	_
4	in	in	IN	IN	_	8	case	_	_
5	transiently	transiently	RB	RB	_	8	advmod	_	_
6	transfected	transfect	VBN	VBN	_	8	amod	_	_
7	erythroid	erythroid	JJ	JJ	_	8	amod	_	_
8	cells	cell	NNS	NNS	_	18	nmod	_	_
9	,	,	,	,	_	18	punct	_	_
10	deletion	deletion	NN	NN	_	18	nsubj	_	_
11	of	of	IN	IN	_	17	case	_	_
12	the	the	DT	DT	_	17	det	_	_
13	alpha-globin	alpha-globin	NN	NN	_	17	compound	_	_
14	G+C-rich	g+c-rich	JJ	JJ	_	17	amod	_	_
15	5'	5'	JJ	JJ	_	17	amod	_	_
16	flanking	flanking	JJ	JJ	_	17	amod	_	_
17	region	region	NN	NN	_	10	nmod	_	_
18	has	have	VBZ	VBZ	_	2	ccomp	_	_
19	no	no	DT	DT	_	20	neg	_	_
20	effect	effect	NN	NN	_	18	dobj	_	_
21	on	on	IN	IN	_	24	case	_	_
22	alpha-globin	alpha-globin	NN	NN	_	23	compound	_	_
23	promoter	promoter	NN	NN	_	24	compound	_	_
24	activity	activity	NN	NN	_	18	nmod	_	_
25	.	.	.	.	_	2	punct	_	_

1	However	however	RB	RB	_	13	advmod	_	_
2	,	,	,	,	_	13	punct	_	_
3	upon	upon	IN	IN	_	5	case	_	_
4	stable	stable	JJ	JJ	_	5	amod	_	_
5	integration	integration	NN	NN	_	13	nmod	_	_
6	into	into	IN	IN	_	7	case	_	_
7	chromatin	chromatin	NN	NN	_	5	nmod	_	_
8	,	,	,	,	_	13	punct	_	_
9	deletion	deletion	NN	NN	_	13	nsubj	_	_
10	of	of	IN	IN	_	12	case	_	_
11	this	this	DT	DT	_	12	det	_	_
12	region	region	NN	NN	_	9	nmod	_	_
13	causes	cause	VBZ	VBZ	_	0	root	_	_
14	a	a	DT	DT	_	18	det	_	_
15	nearly	nearly	RB	RB	_	16	advmod	_	_
16	90	90	CD	CD	_	17	dep	_	_
17	%	%	NN	NN	_	18	dep	_	_
18	decrease	decrease	NN	NN	_	13	dobj	_	_
19	in	in	IN	IN	_	21	case	_	_
20	promoter	promoter	NN	NN	_	21	compound	_	_
21	activity	activity	NN	NN	_	18	nmod	_	_
22	compared	compare	VBN	VBN	_	24	case	_	_
23	with	with	IN	IN	_	24	case	_	_
24	expression	expression	NN	NN	_	13	advcl	_	_
25	from	from	IN	IN	_	28	case	_	_
26	an	a	DT	DT	_	28	det	_	_
27	alpha-globin	alpha-globin	NN	NN	_	28	compound	_	_
28	promoter	promoter	NN	NN	_	24	nmod	_	_
29	retaining	retain	VBG	VBG	_	28	acl	_	_
30	this	this	DT	DT	_	31	det	_	_
31	region	region	NN	NN	_	29	dobj	_	_
32	.	.	.	.	_	13	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	11	mark	_	_
5	the	the	DT	DT	_	10	det	_	_
6	alpha-globin	alpha-globin	NN	NN	_	10	compound	_	_
7	G+C-rich	g+c-rich	JJ	JJ	_	10	amod	_	_
8	5'	5'	JJ	JJ	_	10	amod	_	_
9	flanking	flanking	JJ	JJ	_	10	amod	_	_
10	region	region	NN	NN	_	11	nsubj	_	_
11	augments	augment	VBZ	VBZ	_	3	ccomp	_	_
12	alpha-globin	alpha-globin	NN	NN	_	13	compound	_	_
13	promoter	promoter	NN	NN	_	14	compound	_	_
14	activity	activity	NN	NN	_	11	dobj	_	_
15	in	in	IN	IN	_	18	case	_	_
16	a	a	DT	DT	_	18	det	_	_
17	chromatin-dependent	chromatin-dependent	JJ	JJ	_	18	amod	_	_
18	manner	manner	NN	NN	_	11	nmod	_	_
19	.	.	.	.	_	3	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	further	further	RB	RB	_	3	advmod	_	_
3	show	show	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	9	mark	_	_
5	this	this	DT	DT	_	7	det	_	_
6	G+C-rich	g+c-rich	JJ	JJ	_	7	amod	_	_
7	region	region	NN	NN	_	9	nsubjpass	_	_
8	is	be	VBZ	VBZ	_	9	auxpass	_	_
9	required	require	VBN	VBN	_	3	ccomp	_	_
10	for	for	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	activation	activation	NN	NN	_	9	nmod	_	_
13	of	of	IN	IN	_	16	case	_	_
14	alpha-globin	alpha-globin	NN	NN	_	15	compound	_	_
15	gene	gene	NN	NN	_	16	compound	_	_
16	expression	expression	NN	NN	_	12	nmod	_	_
17	during	during	IN	IN	_	19	case	_	_
18	erythroid	erythroid	JJ	JJ	_	19	amod	_	_
19	differentiation	differentiation	NN	NN	_	9	nmod	_	_
20	.	.	.	.	_	3	punct	_	_

1	Finally	finally	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	show	show	VBP	VBP	_	0	root	_	_
5	by	by	IN	IN	_	8	case	_	_
6	both	both	CC	CC	_	8	cc:preconj	_	_
7	footprint	footprint	NN	NN	_	8	compound	_	_
8	analysis	analysis	NN	NN	_	4	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	functional	functional	JJ	JJ	_	11	amod	_	_
11	assays	assay	NNS	NNS	_	8	conj	_	_
12	that	that	IN	IN	_	31	mark	_	_
13	the	the	DT	DT	_	14	det	_	_
14	ability	ability	NN	NN	_	31	nsubjpass	_	_
15	of	of	IN	IN	_	18	case	_	_
16	the	the	DT	DT	_	18	det	_	_
17	G+C-rich	g+c-rich	JJ	JJ	_	18	amod	_	_
18	region	region	NN	NN	_	14	nmod	_	_
19	to	to	TO	TO	_	20	mark	_	_
20	increase	increase	VB	VB	_	14	acl	_	_
21	alpha-globin	alpha-globin	NN	NN	_	22	compound	_	_
22	promoter	promoter	NN	NN	_	23	compound	_	_
23	activity	activity	NN	NN	_	20	dobj	_	_
24	from	from	IN	IN	_	29	case	_	_
25	a	a	DT	DT	_	29	det	_	_
26	stably	stably	RB	RB	_	27	advmod	_	_
27	integrated	integrate	VBN	VBN	_	29	amod	_	_
28	alpha-globin	alpha-globin	NN	NN	_	29	compound	_	_
29	gene	gene	NN	NN	_	23	nmod	_	_
30	is	be	VBZ	VBZ	_	31	auxpass	_	_
31	mediated	mediate	VBN	VBN	_	4	ccomp	_	_
32	by	by	IN	IN	_	36	case	_	_
33	its	its	PRP$	PRP$	_	36	nmod:poss	_	_
34	multiple	multiple	JJ	JJ	_	36	amod	_	_
35	binding	bind	VBG	VBG	_	36	amod	_	_
36	sites	site	NNS	NNS	_	31	nmod	_	_
37	for	for	IN	IN	_	40	case	_	_
38	the	the	DT	DT	_	40	det	_	_
39	transcription	transcription	NN	NN	_	40	compound	_	_
40	factor	factor	NN	NN	_	36	nmod	_	_
41	Sp1	sp1	NN	NN	_	40	dep	_	_
42	.	.	.	.	_	4	punct	_	_

1	Interleukin	interleukin	NN	NN	_	3	nsubj	_	_
2	12	12	CD	CD	_	1	nummod	_	_
3	induces	induce	VBZ	VBZ	_	0	root	_	_
4	tyrosine	tyrosine	NN	NN	_	5	compound	_	_
5	phosphorylation	phosphorylation	NN	NN	_	3	dobj	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	activation	activation	NN	NN	_	5	conj	_	_
8	of	of	IN	IN	_	9	case	_	_
9	STAT4	stat4	NN	NN	_	7	nmod	_	_
10	in	in	IN	IN	_	12	case	_	_
11	human	human	JJ	JJ	_	12	amod	_	_
12	lymphocytes	lymphocyte	NNS	NNS	_	3	nmod	_	_
13	.	.	.	.	_	3	punct	_	_

1	Interleukin	interleukin	NN	NN	_	10	nsubj	_	_
2	12	12	CD	CD	_	1	nummod	_	_
3	(	(	-LRB-	-LRB-	_	4	punct	_	_
4	IL-12	il-12	NN	NN	_	1	appos	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	is	be	VBZ	VBZ	_	10	cop	_	_
7	an	a	DT	DT	_	10	det	_	_
8	important	important	JJ	JJ	_	10	amod	_	_
9	immunoregulatory	immunoregulatory	JJ	JJ	_	10	amod	_	_
10	cytokine	cytokine	NN	NN	_	0	root	_	_
11	whose	whose	WP$	WP$	_	12	nmod:poss	_	_
12	receptor	receptor	NN	NN	_	15	nsubj	_	_
13	is	be	VBZ	VBZ	_	15	cop	_	_
14	a	a	DT	DT	_	15	det	_	_
15	member	member	NN	NN	_	10	acl:relcl	_	_
16	of	of	IN	IN	_	20	case	_	_
17	the	the	DT	DT	_	20	det	_	_
18	hematopoietin	hematopoietin	NN	NN	_	20	compound	_	_
19	receptor	receptor	NN	NN	_	20	compound	_	_
20	superfamily	superfamily	NN	NN	_	15	nmod	_	_
21	.	.	.	.	_	10	punct	_	_

1	We	we	PRP	PRP	_	4	nsubj	_	_
2	have	have	VBP	VBP	_	4	aux	_	_
3	recently	recently	RB	RB	_	4	advmod	_	_
4	demonstrated	demonstrate	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	16	mark	_	_
6	stimulation	stimulation	NN	NN	_	16	nsubj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	human	human	JJ	JJ	_	9	amod	_	_
9	T	t	NN	NN	_	6	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	natural	natural	JJ	JJ	_	12	amod	_	_
12	killer	killer	NN	NN	_	9	conj	_	_
13	cells	cell	NNS	NNS	_	9	dep	_	_
14	with	with	IN	IN	_	15	case	_	_
15	IL-12	il-12	NN	NN	_	6	nmod	_	_
16	induces	induce	VBZ	VBZ	_	4	ccomp	_	_
17	tyrosine	tyrosine	NN	NN	_	18	compound	_	_
18	phosphorylation	phosphorylation	NN	NN	_	16	dobj	_	_
19	of	of	IN	IN	_	24	case	_	_
20	the	the	DT	DT	_	24	det	_	_
21	Janus	janus	NN	NN	_	24	compound	_	_
22	family	family	NN	NN	_	24	compound	_	_
23	tyrosine	tyrosine	NN	NN	_	24	compound	_	_
24	kinase	kinase	NN	NN	_	18	nmod	_	_
25	JAK2	jak2	NN	NN	_	24	dep	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	Tyk2	tyk2	NN	NN	_	25	conj	_	_
28	,	,	,	,	_	16	punct	_	_
29	implicating	implicate	VBG	VBG	_	16	advcl	_	_
30	these	these	DT	DT	_	31	det	_	_
31	kinases	kinase	NNS	NNS	_	29	dobj	_	_
32	in	in	IN	IN	_	36	case	_	_
33	the	the	DT	DT	_	36	det	_	_
34	immediate	immediate	JJ	JJ	_	36	amod	_	_
35	biochemical	biochemical	JJ	JJ	_	36	amod	_	_
36	response	response	NN	NN	_	29	nmod	_	_
37	to	to	TO	TO	_	38	case	_	_
38	IL-12	il-12	NN	NN	_	36	nmod	_	_
39	.	.	.	.	_	4	punct	_	_

1	Recently	recently	RB	RB	_	18	advmod	_	_
2	,	,	,	,	_	18	punct	_	_
3	transcription	transcription	NN	NN	_	4	compound	_	_
4	factors	factor	NNS	NNS	_	18	nsubjpass	_	_
5	known	know	VBN	VBN	_	4	acl	_	_
6	as	as	IN	IN	_	7	case	_	_
7	STATs	stats	NNS	NNS	_	5	nmod	_	_
8	(	(	-LRB-	-LRB-	_	10	punct	_	_
9	signal	signal	NN	NN	_	10	compound	_	_
10	transducers	transducer	NNS	NNS	_	7	dep	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	activators	activator	NNS	NNS	_	14	compound	_	_
13	of	of	IN	IN	_	14	amod	_	_
14	transcription	transcription	NN	NN	_	10	conj	_	_
15	)	)	-RRB-	-RRB-	_	10	punct	_	_
16	have	have	VBP	VBP	_	18	aux	_	_
17	been	be	VBN	VBN	_	18	auxpass	_	_
18	shown	show	VBN	VBN	_	0	root	_	_
19	to	to	TO	TO	_	22	mark	_	_
20	be	be	VB	VB	_	22	auxpass	_	_
21	tyrosine	tyrosine	NN	NN	_	22	nmod:npmod	_	_
22	phosphorylated	phosphorylated	JJ	JJ	_	18	xcomp	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	activated	activate	VBN	VBN	_	22	conj	_	_
25	in	in	IN	IN	_	26	case	_	_
26	response	response	NN	NN	_	24	nmod	_	_
27	to	to	TO	TO	_	29	case	_	_
28	a	a	DT	DT	_	29	det	_	_
29	number	number	NN	NN	_	26	nmod	_	_
30	of	of	IN	IN	_	31	case	_	_
31	cytokines	cytokine	NNS	NNS	_	29	nmod	_	_
32	that	that	WDT	WDT	_	33	nsubj	_	_
33	bind	bind	VBP	VBP	_	31	acl:relcl	_	_
34	hematopoietin	hematopoietin	NN	NN	_	35	compound	_	_
35	receptors	receptor	NNS	NNS	_	33	dobj	_	_
36	and	and	CC	CC	_	33	cc	_	_
37	activate	activate	VBP	VBP	_	33	conj	_	_
38	JAK	jak	NN	NN	_	39	compound	_	_
39	kinases	kinase	NNS	NNS	_	37	dobj	_	_
40	.	.	.	.	_	18	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	report	report	NN	NN	_	5	nmod	_	_
4	we	we	PRP	PRP	_	5	nsubj	_	_
5	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
6	that	that	IN	IN	_	8	mark	_	_
7	IL-12	il-12	NN	NN	_	8	nsubj	_	_
8	induces	induce	VBZ	VBZ	_	5	ccomp	_	_
9	tyrosine	tyrosine	NN	NN	_	10	compound	_	_
10	phosphorylation	phosphorylation	NN	NN	_	8	dobj	_	_
11	of	of	IN	IN	_	17	case	_	_
12	a	a	DT	DT	_	17	det	_	_
13	recently	recently	RB	RB	_	14	advmod	_	_
14	identified	identify	VBN	VBN	_	17	amod	_	_
15	STAT	stat	NN	NN	_	17	compound	_	_
16	family	family	NN	NN	_	17	compound	_	_
17	member	member	NN	NN	_	10	nmod	_	_
18	,	,	,	,	_	17	punct	_	_
19	STAT4	stat4	NN	NN	_	17	appos	_	_
20	,	,	,	,	_	5	punct	_	_
21	and	and	CC	CC	_	5	cc	_	_
22	show	show	VBP	VBP	_	5	conj	_	_
23	that	that	IN	IN	_	27	mark	_	_
24	STAT4	stat4	NN	NN	_	25	compound	_	_
25	expression	expression	NN	NN	_	27	nsubjpass	_	_
26	is	be	VBZ	VBZ	_	27	auxpass	_	_
27	regulated	regulate	VBN	VBN	_	22	ccomp	_	_
28	by	by	IN	IN	_	30	case	_	_
29	T-cell	t-cell	NN	NN	_	30	compound	_	_
30	activation	activation	NN	NN	_	27	nmod	_	_
31	.	.	.	.	_	5	punct	_	_

1	Furthermore	furthermore	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	show	show	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	7	mark	_	_
6	IL-12	il-12	NN	NN	_	7	nsubj	_	_
7	stimulates	stimulate	VBZ	VBZ	_	4	ccomp	_	_
8	formation	formation	NN	NN	_	7	dobj	_	_
9	of	of	IN	IN	_	12	case	_	_
10	a	a	DT	DT	_	12	det	_	_
11	DNA-binding	dna-binding	JJ	JJ	_	12	amod	_	_
12	complex	complex	NN	NN	_	8	nmod	_	_
13	that	that	WDT	WDT	_	14	nsubj	_	_
14	recognizes	recognize	VBZ	VBZ	_	12	acl:relcl	_	_
15	a	a	DT	DT	_	17	det	_	_
16	DNA	dna	NN	NN	_	17	compound	_	_
17	sequence	sequence	NN	NN	_	14	dobj	_	_
18	previously	previously	RB	RB	_	17	advmod	_	_
19	shown	show	VBN	VBN	_	17	acl	_	_
20	to	to	TO	TO	_	21	mark	_	_
21	bind	bind	VB	VB	_	19	xcomp	_	_
22	STAT	stat	NN	NN	_	23	compound	_	_
23	proteins	protein	NNS	NNS	_	21	dobj	_	_
24	and	and	CC	CC	_	7	cc	_	_
25	that	that	IN	IN	_	28	mark	_	_
26	this	this	DT	DT	_	27	det	_	_
27	complex	complex	NN	NN	_	28	nsubj	_	_
28	contains	contain	VBZ	VBZ	_	7	conj	_	_
29	STAT4	stat4	NN	NN	_	28	dobj	_	_
30	.	.	.	.	_	4	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	14	nsubj	_	_
3	,	,	,	,	_	2	punct	_	_
4	and	and	CC	CC	_	2	cc	_	_
5	the	the	DT	DT	_	7	det	_	_
6	recent	recent	JJ	JJ	_	7	amod	_	_
7	demonstration	demonstration	NN	NN	_	2	conj	_	_
8	of	of	IN	IN	_	10	case	_	_
9	JAK	jak	NN	NN	_	10	compound	_	_
10	phosphorylation	phosphorylation	NN	NN	_	7	nmod	_	_
11	by	by	IN	IN	_	12	case	_	_
12	IL-12	il-12	NN	NN	_	10	nmod	_	_
13	,	,	,	,	_	2	punct	_	_
14	identify	identify	VBP	VBP	_	0	root	_	_
15	a	a	DT	DT	_	18	det	_	_
16	rapid	rapid	JJ	JJ	_	18	amod	_	_
17	signal-transduction	signal-transduction	JJ	JJ	_	18	amod	_	_
18	pathway	pathway	NN	NN	_	14	dobj	_	_
19	likely	likely	JJ	JJ	_	18	amod	_	_
20	to	to	TO	TO	_	21	mark	_	_
21	mediate	mediate	VB	VB	_	19	xcomp	_	_
22	IL-12-induced	il-12-induced	JJ	JJ	_	24	amod	_	_
23	gene	gene	NN	NN	_	24	compound	_	_
24	expression	expression	NN	NN	_	21	dobj	_	_
25	.	.	.	.	_	14	punct	_	_

1	Regulation	regulation	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	5	case	_	_
3	c-jun	c-jun	NN	NN	_	4	compound	_	_
4	mRNA	mrna	NN	NN	_	5	compound	_	_
5	expression	expression	NN	NN	_	1	nmod	_	_
6	by	by	IN	IN	_	7	case	_	_
7	hydroxyurea	hydroxyurea	NN	NN	_	1	nmod	_	_
8	in	in	IN	IN	_	11	case	_	_
9	human	human	JJ	JJ	_	11	amod	_	_
10	K562	k562	NN	NN	_	11	compound	_	_
11	cells	cell	NNS	NNS	_	1	nmod	_	_
12	during	during	IN	IN	_	14	case	_	_
13	erythroid	erythroid	JJ	JJ	_	14	amod	_	_
14	differentiation	differentiation	NN	NN	_	1	nmod	_	_
15	-LSB-	-lsb-	-LRB-	-LRB-	_	18	punct	_	_
16	published	publish	VBN	VBN	_	17	amod	_	_
17	erratum	erratum	NN	NN	_	18	nsubj	_	_
18	appears	appear	VBZ	VBZ	_	1	dep	_	_
19	in	in	IN	IN	_	24	case	_	_
20	Biochim	Biochim	NNP	NNP	_	24	compound	_	_
21	Biophys	Biophys	NNP	NNP	_	24	compound	_	_
22	Acta	Acta	NNP	NNP	_	24	compound	_	_
23	1995	1995	CD	CD	_	24	nummod	_	_
24	Dec	Dec	NNP	NNP	_	18	nmod	_	_
25	27	27	CD	CD	_	24	nummod	_	_
26	;	;	:	:	_	24	punct	_	_
27	1264	1264	CD	CD	_	29	nummod	_	_
28	(	(	-LRB-	-LRB-	_	29	punct	_	_
29	3	3	CD	CD	_	24	dep	_	_
30	)	)	-RRB-	-RRB-	_	29	punct	_	_
31	:	:	:	:	_	24	punct	_	_
32	409	409	CD	CD	_	24	dep	_	_
33	-RSB-	-rsb-	-RRB-	-RRB-	_	18	punct	_	_

1	Hydroxyurea	hydroxyurea	NN	NN	_	8	nsubj	_	_
2	(	(	-LRB-	-LRB-	_	3	punct	_	_
3	HU	hu	NN	NN	_	1	appos	_	_
4	)	)	-RRB-	-RRB-	_	3	punct	_	_
5	is	be	VBZ	VBZ	_	8	cop	_	_
6	an	a	DT	DT	_	8	det	_	_
7	antitumor	antitumor	JJ	JJ	_	8	amod	_	_
8	agent	agent	NN	NN	_	0	root	_	_
9	which	which	WDT	WDT	_	11	nsubj	_	_
10	also	also	RB	RB	_	11	advmod	_	_
11	induces	induce	VBZ	VBZ	_	8	acl:relcl	_	_
12	hemoglobinization	hemoglobinization	NN	NN	_	11	dobj	_	_
13	during	during	IN	IN	_	15	case	_	_
14	erythroid	erythroid	JJ	JJ	_	15	amod	_	_
15	differentiation	differentiation	NN	NN	_	11	nmod	_	_
16	.	.	.	.	_	8	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	addition	addition	NN	NN	_	5	nmod	_	_
3	,	,	,	,	_	5	punct	_	_
4	HU	hu	NN	NN	_	5	nsubj	_	_
5	stimulates	stimulate	VBZ	VBZ	_	0	root	_	_
6	the	the	DT	DT	_	7	det	_	_
7	synthesis	synthesis	NN	NN	_	5	dobj	_	_
8	of	of	IN	IN	_	10	case	_	_
9	fetal	fetal	JJ	JJ	_	10	amod	_	_
10	hemoglobin	hemoglobin	NN	NN	_	7	nmod	_	_
11	in	in	IN	IN	_	15	case	_	_
12	sickle	sickle	NN	NN	_	15	compound	_	_
13	cell	cell	NN	NN	_	15	compound	_	_
14	anemia	anemia	NN	NN	_	15	compound	_	_
15	patients	patient	NNS	NNS	_	7	nmod	_	_
16	.	.	.	.	_	5	punct	_	_

1	To	to	TO	TO	_	3	mark	_	_
2	further	further	RB	RB	_	3	advmod	_	_
3	understand	understand	VB	VB	_	0	root	_	_
4	its	its	PRP$	PRP$	_	5	nmod:poss	_	_
5	mechanism	mechanism	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	7	case	_	_
7	action	action	NN	NN	_	5	nmod	_	_
8	,	,	,	,	_	3	punct	_	_
9	we	we	PRP	PRP	_	10	nsubj	_	_
10	investigated	investigate	VBD	VBD	_	3	parataxis	_	_
11	the	the	DT	DT	_	12	det	_	_
12	effects	effect	NNS	NNS	_	10	dobj	_	_
13	of	of	IN	IN	_	14	case	_	_
14	HU	hu	NN	NN	_	12	nmod	_	_
15	on	on	IN	IN	_	16	case	_	_
16	regulation	regulation	NN	NN	_	12	nmod	_	_
17	of	of	IN	IN	_	19	case	_	_
18	c-jun	c-jun	NN	NN	_	19	compound	_	_
19	expression	expression	NN	NN	_	16	nmod	_	_
20	prior	prior	RB	RB	_	12	advmod	_	_
21	to	to	TO	TO	_	23	case	_	_
22	the	the	DT	DT	_	23	det	_	_
23	onset	onset	NN	NN	_	20	nmod	_	_
24	of	of	IN	IN	_	26	case	_	_
25	erythroid	erythroid	JJ	JJ	_	26	amod	_	_
26	differentiation	differentiation	NN	NN	_	23	nmod	_	_
27	of	of	IN	IN	_	29	case	_	_
28	K562	k562	NN	NN	_	29	compound	_	_
29	cells	cell	NNS	NNS	_	26	nmod	_	_
30	.	.	.	.	_	3	punct	_	_

1	HU	hu	NN	NN	_	2	nsubj	_	_
2	induced	induce	VBD	VBD	_	0	root	_	_
3	a	a	DT	DT	_	5	det	_	_
4	dose-dependent	dose-dependent	JJ	JJ	_	5	amod	_	_
5	stimulation	stimulation	NN	NN	_	2	dobj	_	_
6	of	of	IN	IN	_	8	case	_	_
7	c-jun	c-jun	NN	NN	_	8	compound	_	_
8	synthesis	synthesis	NN	NN	_	5	nmod	_	_
9	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	levels	level	NNS	NNS	_	7	nsubjpass	_	_
3	of	of	IN	IN	_	5	case	_	_
4	c-jun	c-jun	NN	NN	_	5	compound	_	_
5	mRNA	mrna	NN	NN	_	2	nmod	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	elevated	elevate	VBN	VBN	_	0	root	_	_
8	4	4	CD	CD	_	7	dobj	_	_
9	to	to	TO	TO	_	8	dep	_	_
10	7.5-fold	7.5-fold	RB	RB	_	8	advmod	_	_
11	by	by	IN	IN	_	12	case	_	_
12	HU	hu	NN	NN	_	7	nmod	_	_
13	within	within	IN	IN	_	15	case	_	_
14	2	2	CD	CD	_	15	nummod	_	_
15	h	h	NN	NN	_	7	nmod	_	_
16	.	.	.	.	_	7	punct	_	_

1	This	this	DT	DT	_	3	nsubjpass	_	_
2	was	be	VBD	VBD	_	3	auxpass	_	_
3	followed	follow	VBN	VBN	_	0	root	_	_
4	by	by	IN	IN	_	7	case	_	_
5	a	a	DT	DT	_	7	det	_	_
6	gradual	gradual	JJ	JJ	_	7	amod	_	_
7	decline	decline	NN	NN	_	3	nmod	_	_
8	to	to	TO	TO	_	11	case	_	_
9	the	the	DT	DT	_	11	det	_	_
10	basal	basal	JJ	JJ	_	11	amod	_	_
11	level	level	NN	NN	_	7	nmod	_	_
12	by	by	IN	IN	_	14	case	_	_
13	24	24	CD	CD	_	14	nummod	_	_
14	h	h	NN	NN	_	3	nmod	_	_
15	.	.	.	.	_	3	punct	_	_

1	Both	both	CC	CC	_	3	cc:preconj	_	_
2	nuclear	nuclear	JJ	JJ	_	3	amod	_	_
3	run-on	run-on	JJ	JJ	_	10	nsubj	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	actinomycin	actinomycin	NN	NN	_	7	compound	_	_
6	D	d	NN	NN	_	7	compound	_	_
7	pulse	pulse	NN	NN	_	3	conj	_	_
8	experiments	experiment	NNS	NNS	_	3	dep	_	_
9	strongly	strongly	RB	RB	_	10	advmod	_	_
10	indicate	indicate	VBP	VBP	_	0	root	_	_
11	that	that	IN	IN	_	13	mark	_	_
12	HU	hu	NN	NN	_	13	nsubj	_	_
13	regulates	regulate	VBZ	VBZ	_	10	ccomp	_	_
14	c-jun	c-jun	NN	NN	_	15	compound	_	_
15	mRNA	mrna	NN	NN	_	16	compound	_	_
16	expression	expression	NN	NN	_	13	dobj	_	_
17	by	by	IN	IN	_	18	mark	_	_
18	increasing	increase	VBG	VBG	_	13	advcl	_	_
19	the	the	DT	DT	_	20	det	_	_
20	rate	rate	NN	NN	_	18	dobj	_	_
21	of	of	IN	IN	_	22	case	_	_
22	synthesis	synthesis	NN	NN	_	20	nmod	_	_
23	as	as	RB	RB	_	18	cc	_	_
24	well	well	RB	RB	_	23	mwe	_	_
25	as	as	IN	IN	_	23	mwe	_	_
26	stabilizing	stabilize	VBG	VBG	_	18	conj	_	_
27	the	the	DT	DT	_	29	det	_	_
28	c-jun	c-jun	NN	NN	_	29	compound	_	_
29	mRNA	mrna	NN	NN	_	26	dobj	_	_
30	.	.	.	.	_	10	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	addition	addition	NN	NN	_	10	nmod	_	_
3	,	,	,	,	_	10	punct	_	_
4	the	the	DT	DT	_	5	det	_	_
5	level	level	NN	NN	_	10	nsubj	_	_
6	of	of	IN	IN	_	8	case	_	_
7	jun	jun	NN	NN	_	8	compound	_	_
8	protein	protein	NN	NN	_	5	nmod	_	_
9	was	be	VBD	VBD	_	10	cop	_	_
10	elevated	elevated	JJ	JJ	_	0	root	_	_
11	by	by	IN	IN	_	14	case	_	_
12	2	2	CD	CD	_	14	nummod	_	_
13	to	to	TO	TO	_	14	dep	_	_
14	5-fold	5-fold	NN	NN	_	10	nmod	_	_
15	within	within	IN	IN	_	17	case	_	_
16	4	4	CD	CD	_	17	nummod	_	_
17	h	h	NN	NN	_	10	nmod	_	_
18	in	in	IN	IN	_	21	case	_	_
19	HU	hu	NN	NN	_	21	compound	_	_
20	treated	treated	JJ	JJ	_	21	amod	_	_
21	cells	cell	NNS	NNS	_	10	nmod	_	_
22	.	.	.	.	_	10	punct	_	_

1	Furthermore	furthermore	RB	RB	_	10	advmod	_	_
2	,	,	,	,	_	10	punct	_	_
3	concentrations	concentration	NNS	NNS	_	10	nsubj	_	_
4	of	of	IN	IN	_	5	case	_	_
5	HU	hu	NN	NN	_	3	nmod	_	_
6	below	below	IN	IN	_	8	case	_	_
7	250	250	CD	CD	_	8	nummod	_	_
8	microM	microm	NN	NN	_	3	nmod	_	_
9	slightly	slightly	RB	RB	_	10	advmod	_	_
10	increased	increase	VBD	VBD	_	0	root	_	_
11	the	the	DT	DT	_	14	det	_	_
12	5X	5x	NN	NN	_	14	compound	_	_
13	AP-1/CAT	ap-1/cat	NN	NN	_	14	compound	_	_
14	activity	activity	NN	NN	_	10	dobj	_	_
15	.	.	.	.	_	10	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	4	nsubj	_	_
3	strongly	strongly	RB	RB	_	4	advmod	_	_
4	suggest	suggest	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	7	mark	_	_
6	HU	hu	NN	NN	_	7	nsubj	_	_
7	induces	induce	VBZ	VBZ	_	4	ccomp	_	_
8	both	both	CC	CC	_	9	cc:preconj	_	_
9	transcriptional	transcriptional	JJ	JJ	_	7	dobj	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	post-transcription	post-transcription	JJ	JJ	_	9	conj	_	_
12	regulation	regulation	NN	NN	_	9	dep	_	_
13	of	of	IN	IN	_	14	case	_	_
14	c-jun	c-jun	NN	NN	_	9	nmod	_	_
15	during	during	IN	IN	_	17	case	_	_
16	erythroid	erythroid	JJ	JJ	_	17	amod	_	_
17	differentiation	differentiation	NN	NN	_	9	nmod	_	_
18	.	.	.	.	_	4	punct	_	_

1	IL-2	il-2	NN	NN	_	2	compound	_	_
2	gene	gene	NN	NN	_	3	compound	_	_
3	expression	expression	NN	NN	_	10	nsubj	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	NF-kappa	nf-kappa	NN	NN	_	6	compound	_	_
6	B	b	NN	NN	_	7	compound	_	_
7	activation	activation	NN	NN	_	3	conj	_	_
8	through	through	IN	IN	_	9	case	_	_
9	CD28	cd28	NN	NN	_	3	nmod	_	_
10	requires	require	VBZ	VBZ	_	0	root	_	_
11	reactive	reactive	JJ	JJ	_	13	amod	_	_
12	oxygen	oxygen	NN	NN	_	13	compound	_	_
13	production	production	NN	NN	_	10	dobj	_	_
14	by	by	IN	IN	_	15	case	_	_
15	5-lipoxygenase	5-lipoxygenase	NN	NN	_	13	nmod	_	_
16	.	.	.	.	_	10	punct	_	_

1	Activation	activation	NN	NN	_	7	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	CD28	cd28	NN	NN	_	6	compound	_	_
5	surface	surface	NN	NN	_	6	compound	_	_
6	receptor	receptor	NN	NN	_	1	nmod	_	_
7	provides	provide	VBZ	VBZ	_	0	root	_	_
8	a	a	DT	DT	_	11	det	_	_
9	major	major	JJ	JJ	_	11	amod	_	_
10	costimulatory	costimulatory	JJ	JJ	_	11	amod	_	_
11	signal	signal	NN	NN	_	7	dobj	_	_
12	for	for	IN	IN	_	15	case	_	_
13	T	t	NN	NN	_	15	compound	_	_
14	cell	cell	NN	NN	_	15	compound	_	_
15	activation	activation	NN	NN	_	11	nmod	_	_
16	resulting	result	VBG	VBG	_	11	acl	_	_
17	in	in	IN	IN	_	19	case	_	_
18	enhanced	enhance	VBN	VBN	_	19	amod	_	_
19	production	production	NN	NN	_	16	nmod	_	_
20	of	of	IN	IN	_	21	case	_	_
21	interleukin-2	interleukin-2	NN	NN	_	19	nmod	_	_
22	(	(	-LRB-	-LRB-	_	23	punct	_	_
23	IL-2	il-2	NN	NN	_	21	appos	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	and	and	CC	CC	_	19	cc	_	_
26	cell	cell	NN	NN	_	27	compound	_	_
27	proliferation	proliferation	NN	NN	_	19	conj	_	_
28	.	.	.	.	_	7	punct	_	_

1	In	in	IN	IN	_	4	case	_	_
2	primary	primary	JJ	JJ	_	4	amod	_	_
3	T	t	NN	NN	_	4	compound	_	_
4	lymphocytes	lymphocyte	NNS	NNS	_	6	nmod	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	show	show	VBP	VBP	_	0	root	_	_
7	that	that	IN	IN	_	10	mark	_	_
8	CD28	cd28	NN	NN	_	9	compound	_	_
9	ligation	ligation	NN	NN	_	10	nsubj	_	_
10	leads	lead	VBZ	VBZ	_	6	ccomp	_	_
11	to	to	TO	TO	_	15	case	_	_
12	the	the	DT	DT	_	15	det	_	_
13	rapid	rapid	JJ	JJ	_	15	amod	_	_
14	intracellular	intracellular	JJ	JJ	_	15	amod	_	_
15	formation	formation	NN	NN	_	10	nmod	_	_
16	of	of	IN	IN	_	19	case	_	_
17	reactive	reactive	JJ	JJ	_	19	amod	_	_
18	oxygen	oxygen	NN	NN	_	19	compound	_	_
19	intermediates	intermediate	NNS	NNS	_	15	nmod	_	_
20	(	(	-LRB-	-LRB-	_	21	punct	_	_
21	ROIs	roi	NNS	NNS	_	19	appos	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	which	which	WDT	WDT	_	25	nsubjpass	_	_
24	are	be	VBP	VBP	_	25	auxpass	_	_
25	required	require	VBN	VBN	_	19	acl:relcl	_	_
26	for	for	IN	IN	_	28	case	_	_
27	CD28-mediated	cd28-mediated	JJ	JJ	_	28	amod	_	_
28	activation	activation	NN	NN	_	25	nmod	_	_
29	of	of	IN	IN	_	33	case	_	_
30	the	the	DT	DT	_	33	det	_	_
31	NF-kappa	nf-kappa	NN	NN	_	33	compound	_	_
32	B/CD28-responsive	b/cd28-responsive	JJ	JJ	_	33	amod	_	_
33	complex	complex	NN	NN	_	28	nmod	_	_
34	and	and	CC	CC	_	28	cc	_	_
35	IL-2	il-2	NN	NN	_	36	compound	_	_
36	expression	expression	NN	NN	_	28	conj	_	_
37	.	.	.	.	_	6	punct	_	_

1	Delineation	delineation	NN	NN	_	8	nsubjpass	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	CD28	cd28	NN	NN	_	6	compound	_	_
5	signaling	signaling	NN	NN	_	6	compound	_	_
6	cascade	cascade	NN	NN	_	1	nmod	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	found	find	VBN	VBN	_	0	root	_	_
9	to	to	TO	TO	_	8	dep	_	_
10	involve	involve	VB	VB	_	9	ccomp	_	_
11	protein	protein	NN	NN	_	13	compound	_	_
12	tyrosine	tyrosine	NN	NN	_	13	compound	_	_
13	kinase	kinase	NN	NN	_	14	compound	_	_
14	activity	activity	NN	NN	_	10	dobj	_	_
15	,	,	,	,	_	10	punct	_	_
16	followed	follow	VBN	VBN	_	10	advcl	_	_
17	by	by	IN	IN	_	19	case	_	_
18	the	the	DT	DT	_	19	det	_	_
19	activation	activation	NN	NN	_	16	nmod	_	_
20	of	of	IN	IN	_	22	case	_	_
21	phospholipase	phospholipase	NN	NN	_	22	compound	_	_
22	A2	a2	NN	NN	_	19	nmod	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	5-lipoxygenase	5-lipoxygenase	NN	NN	_	22	conj	_	_
25	.	.	.	.	_	8	punct	_	_

1	Our	we	PRP$	PRP$	_	2	nmod:poss	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	7	mark	_	_
5	lipoxygenase	lipoxygenase	NN	NN	_	6	compound	_	_
6	metabolites	metabolite	NNS	NNS	_	7	nsubj	_	_
7	activate	activate	VBP	VBP	_	3	ccomp	_	_
8	ROI	roi	NN	NN	_	9	compound	_	_
9	formation	formation	NN	NN	_	7	dobj	_	_
10	which	which	WDT	WDT	_	12	nsubj	_	_
11	then	then	RB	RB	_	12	advmod	_	_
12	induce	induce	VBP	VBP	_	9	acl:relcl	_	_
13	IL-2	il-2	NN	NN	_	14	compound	_	_
14	expression	expression	NN	NN	_	12	dobj	_	_
15	via	via	IN	IN	_	18	case	_	_
16	NF-kappa	nf-kappa	NN	NN	_	17	compound	_	_
17	B	b	NN	NN	_	18	compound	_	_
18	activation	activation	NN	NN	_	12	nmod	_	_
19	.	.	.	.	_	3	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	findings	finding	NNS	NNS	_	5	nsubj	_	_
3	should	should	MD	MD	_	5	aux	_	_
4	be	be	VB	VB	_	5	cop	_	_
5	useful	useful	JJ	JJ	_	0	root	_	_
6	for	for	IN	IN	_	8	case	_	_
7	therapeutic	therapeutic	JJ	JJ	_	8	amod	_	_
8	strategies	strategy	NNS	NNS	_	5	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	the	the	DT	DT	_	11	det	_	_
11	development	development	NN	NN	_	8	conj	_	_
12	of	of	IN	IN	_	13	case	_	_
13	immunosuppressants	immunosuppressant	NNS	NNS	_	11	nmod	_	_
14	targeting	target	VBG	VBG	_	13	acl	_	_
15	the	the	DT	DT	_	18	det	_	_
16	CD28	cd28	NN	NN	_	18	compound	_	_
17	costimulatory	costimulatory	NN	NN	_	18	compound	_	_
18	pathway	pathway	NN	NN	_	14	dobj	_	_
19	.	.	.	.	_	5	punct	_	_

1	HIV-1	hiv-1	NN	NN	_	3	compound	_	_
2	envelope	envelope	NN	NN	_	3	compound	_	_
3	glycoproteins	glycoprotein	NNS	NNS	_	4	nsubj	_	_
4	induce	induce	VBP	VBP	_	0	root	_	_
5	activation	activation	NN	NN	_	4	dobj	_	_
6	of	of	IN	IN	_	8	case	_	_
7	activated	activate	VBN	VBN	_	8	amod	_	_
8	protein-1	protein-1	NN	NN	_	5	nmod	_	_
9	in	in	IN	IN	_	12	case	_	_
10	CD4+	cd4+	JJ	JJ	_	12	amod	_	_
11	T	t	NN	NN	_	12	compound	_	_
12	cells	cell	NNS	NNS	_	5	nmod	_	_
13	-LSB-	-lsb-	-LRB-	-LRB-	_	16	punct	_	_
14	published	publish	VBN	VBN	_	15	amod	_	_
15	erratum	erratum	NN	NN	_	16	nsubj	_	_
16	appears	appear	VBZ	VBZ	_	4	parataxis	_	_
17	in	in	IN	IN	_	22	case	_	_
18	J	J	NNP	NNP	_	22	compound	_	_
19	Biol	Biol	NNP	NNP	_	22	compound	_	_
20	Chem	Chem	NNP	NNP	_	22	compound	_	_
21	1995	1995	CD	CD	_	22	nummod	_	_
22	Dec	Dec	NNP	NNP	_	16	nmod	_	_
23	1	1	CD	CD	_	22	nummod	_	_
24	;	;	:	:	_	22	punct	_	_
25	270	270	CD	CD	_	30	nummod	_	_
26	(	(	-LRB-	-LRB-	_	30	punct	_	_
27	48	48	CD	CD	_	30	nummod	_	_
28	)	)	-RRB-	-RRB-	_	30	punct	_	_
29	:	:	:	:	_	30	punct	_	_
30	29038	29038	CD	CD	_	22	dep	_	_
31	-RSB-	-rsb-	-RRB-	-RRB-	_	16	punct	_	_

1	Activation	activation	NN	NN	_	10	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	CD4	cd4	NN	NN	_	6	compound	_	_
4	positive	positive	JJ	JJ	_	6	amod	_	_
5	T	t	NN	NN	_	6	compound	_	_
6	cells	cell	NNS	NNS	_	1	nmod	_	_
7	is	be	VBZ	VBZ	_	10	cop	_	_
8	a	a	DT	DT	_	10	det	_	_
9	primary	primary	JJ	JJ	_	10	amod	_	_
10	requirement	requirement	NN	NN	_	0	root	_	_
11	for	for	IN	IN	_	14	case	_	_
12	human	human	JJ	JJ	_	14	amod	_	_
13	immunodeficiency	immunodeficiency	NN	NN	_	14	compound	_	_
14	virus	virus	NN	NN	_	10	nmod	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	HIV	hiv	NN	NN	_	14	appos	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	entry	entry	NN	NN	_	14	dep	_	_
19	,	,	,	,	_	14	punct	_	_
20	efficient	efficient	JJ	JJ	_	22	amod	_	_
21	HIV	hiv	NN	NN	_	22	compound	_	_
22	replication	replication	NN	NN	_	14	conj	_	_
23	,	,	,	,	_	14	punct	_	_
24	and	and	CC	CC	_	14	cc	_	_
25	progression	progression	NN	NN	_	14	conj	_	_
26	to	to	TO	TO	_	27	case	_	_
27	AIDS	aids	NN	NN	_	25	nmod	_	_
28	,	,	,	,	_	10	punct	_	_

1	Utilizing	utilize	VBG	VBG	_	0	root	_	_
2	CD4	cd4	NN	NN	_	6	compound	_	_
3	positive	positive	JJ	JJ	_	6	amod	_	_
4	T	t	NN	NN	_	6	compound	_	_
5	cell	cell	NN	NN	_	6	compound	_	_
6	lines	line	NNS	NNS	_	1	dobj	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	purified	purify	VBN	VBN	_	10	amod	_	_
9	T	t	NN	NN	_	10	compound	_	_
10	cells	cell	NNS	NNS	_	6	conj	_	_
11	from	from	IN	IN	_	13	case	_	_
12	normal	normal	JJ	JJ	_	13	amod	_	_
13	individuals	individual	NNS	NNS	_	6	nmod	_	_
14	,	,	,	,	_	1	punct	_	_
15	we	we	PRP	PRP	_	17	nsubj	_	_
16	have	have	VBP	VBP	_	17	aux	_	_
17	demonstrated	demonstrate	VBN	VBN	_	1	parataxis	_	_
18	that	that	IN	IN	_	29	mark	_	_
19	native	native	JJ	JJ	_	21	amod	_	_
20	envelope	envelope	NN	NN	_	21	compound	_	_
21	glycoproteins	glycoprotein	NNS	NNS	_	29	nsubj	_	_
22	of	of	IN	IN	_	23	case	_	_
23	HIV	hiv	NN	NN	_	21	nmod	_	_
24	,	,	,	,	_	23	punct	_	_
25	gp	gp	NN	NN	_	23	appos	_	_
26	160	160	CD	CD	_	25	nummod	_	_
27	,	,	,	,	_	23	punct	_	_
28	can	can	MD	MD	_	29	aux	_	_
29	induce	induce	VB	VB	_	17	ccomp	_	_
30	activation	activation	NN	NN	_	29	dobj	_	_
31	of	of	IN	IN	_	36	case	_	_
32	transcription	transcription	NN	NN	_	36	compound	_	_
33	factor	factor	NN	NN	_	36	compound	_	_
34	,	,	,	,	_	36	punct	_	_
35	activated	activate	VBN	VBN	_	36	amod	_	_
36	protein-1	protein-1	NN	NN	_	30	nmod	_	_
37	(	(	-LRB-	-LRB-	_	38	punct	_	_
38	AP-1	ap-1	NN	NN	_	36	appos	_	_
39	)	)	-RRB-	-RRB-	_	38	punct	_	_
40	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	stimulatory	stimulatory	JJ	JJ	_	3	amod	_	_
3	effects	effect	NNS	NNS	_	7	nsubjpass	_	_
4	of	of	IN	IN	_	5	case	_	_
5	gp160	gp160	NN	NN	_	3	nmod	_	_
6	are	be	VBP	VBP	_	7	auxpass	_	_
7	mediated	mediate	VBN	VBN	_	0	root	_	_
8	through	through	IN	IN	_	11	case	_	_
9	the	the	DT	DT	_	11	det	_	_
10	CD4	cd4	NN	NN	_	11	compound	_	_
11	molecule	molecule	NN	NN	_	7	nmod	_	_
12	,	,	,	,	_	7	punct	_	_
13	since	since	IN	IN	_	20	mark	_	_
14	treatment	treatment	NN	NN	_	20	nsubj	_	_
15	of	of	IN	IN	_	16	case	_	_
16	gp160	gp160	NN	NN	_	14	nmod	_	_
17	with	with	IN	IN	_	19	case	_	_
18	soluble	soluble	JJ	JJ	_	19	amod	_	_
19	CD4-IgG	cd4-igg	NN	NN	_	14	nmod	_	_
20	abrogates	abrogate	VBZ	VBZ	_	7	advcl	_	_
21	its	its	PRP$	PRP$	_	22	nmod:poss	_	_
22	activity	activity	NN	NN	_	20	dobj	_	_
23	,	,	,	,	_	20	punct	_	_
24	and	and	CC	CC	_	20	cc	_	_
25	CD4	cd4	NN	NN	_	29	compound	_	_
26	negative	negative	JJ	JJ	_	29	amod	_	_
27	T	t	NN	NN	_	29	compound	_	_
28	cell	cell	NN	NN	_	29	compound	_	_
29	lines	line	NNS	NNS	_	30	nsubj	_	_
30	fail	fail	VBP	VBP	_	20	conj	_	_
31	to	to	TO	TO	_	33	mark	_	_
32	be	be	VB	VB	_	33	auxpass	_	_
33	stimulated	stimulate	VBN	VBN	_	30	xcomp	_	_
34	with	with	IN	IN	_	35	case	_	_
35	gp160	gp160	NN	NN	_	33	nmod	_	_
36	.	.	.	.	_	7	punct	_	_

1	Immunoprecipitation	immunoprecipitation	NN	NN	_	16	nsubj	_	_
2	of	of	IN	IN	_	7	case	_	_
3	the	the	DT	DT	_	7	det	_	_
4	gp	gp	NN	NN	_	7	compound	_	_
5	160-induced	160-induced	JJ	JJ	_	7	amod	_	_
6	nuclear	nuclear	JJ	JJ	_	7	amod	_	_
7	extracts	extract	NNS	NNS	_	1	nmod	_	_
8	with	with	IN	IN	_	10	case	_	_
9	polyclonal	polyclonal	JJ	JJ	_	10	amod	_	_
10	antibodies	antibody	NNS	NNS	_	1	nmod	_	_
11	to	to	TO	TO	_	12	case	_	_
12	Fos	fos	NN	NN	_	10	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	Jun	jun	NN	NN	_	15	compound	_	_
15	proteins	protein	NNS	NNS	_	12	conj	_	_
16	indicates	indicate	VBZ	VBZ	_	0	root	_	_
17	that	that	IN	IN	_	21	mark	_	_
18	AP-1	ap-1	NN	NN	_	19	compound	_	_
19	complex	complex	NN	NN	_	21	nsubjpass	_	_
20	is	be	VBZ	VBZ	_	21	auxpass	_	_
21	comprised	comprise	VBN	VBN	_	16	ccomp	_	_
22	of	of	IN	IN	_	23	case	_	_
23	members	member	NNS	NNS	_	21	nmod	_	_
24	of	of	IN	IN	_	26	case	_	_
25	these	these	DT	DT	_	26	det	_	_
26	family	family	NN	NN	_	23	nmod	_	_
27	of	of	IN	IN	_	28	case	_	_
28	proteins	protein	NNS	NNS	_	26	nmod	_	_
29	.	.	.	.	_	16	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	gp160-induced	gp160-induced	JJ	JJ	_	4	amod	_	_
3	AP-1	ap-1	NN	NN	_	4	compound	_	_
4	complex	complex	NN	NN	_	6	nsubj	_	_
5	is	be	VBZ	VBZ	_	6	cop	_	_
6	dependent	dependent	JJ	JJ	_	0	root	_	_
7	upon	upon	IN	IN	_	10	case	_	_
8	protein	protein	NN	NN	_	10	compound	_	_
9	tyrosine	tyrosine	NN	NN	_	10	compound	_	_
10	phosphorylation	phosphorylation	NN	NN	_	6	nmod	_	_
11	and	and	CC	CC	_	6	cc	_	_
12	is	be	VBZ	VBZ	_	14	cop	_	_
13	protein	protein	NN	NN	_	14	nmod:npmod	_	_
14	synthesis-independent	synthesis-independent	JJ	JJ	_	6	conj	_	_
15	.	.	.	.	_	6	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	stimulation	stimulation	NN	NN	_	6	nsubjpass	_	_
3	can	can	MD	MD	_	6	aux	_	_
4	also	also	RB	RB	_	6	advmod	_	_
5	be	be	VB	VB	_	6	auxpass	_	_
6	abolished	abolish	VBN	VBN	_	0	root	_	_
7	by	by	IN	IN	_	8	case	_	_
8	inhibitors	inhibitor	NNS	NNS	_	6	nmod	_	_
9	of	of	IN	IN	_	12	case	_	_
10	protein	protein	NN	NN	_	12	compound	_	_
11	kinase	kinase	NN	NN	_	12	compound	_	_
12	C	c	NN	NN	_	8	nmod	_	_
13	,	,	,	,	_	6	punct	_	_
14	but	but	CC	CC	_	6	cc	_	_
15	it	it	PRP	PRP	_	17	nsubj	_	_
16	is	be	VBZ	VBZ	_	17	cop	_	_
17	unaffected	unaffected	JJ	JJ	_	6	conj	_	_
18	by	by	IN	IN	_	21	case	_	_
19	calcium	calcium	NN	NN	_	21	compound	_	_
20	channel	channel	NN	NN	_	21	compound	_	_
21	blocker	blocker	NN	NN	_	17	nmod	_	_
22	or	or	CC	CC	_	21	cc	_	_
23	cyclosporine	cyclosporine	NN	NN	_	24	compound	_	_
24	A	a	NN	NN	_	21	conj	_	_
25	.	.	.	.	_	6	punct	_	_

1	This	this	DT	DT	_	3	det	_	_
2	gp160	gp160	NN	NN	_	3	compound	_	_
3	treatment	treatment	NN	NN	_	5	nsubj	_	_
4	adversely	adversely	RB	RB	_	5	advmod	_	_
5	affects	affect	VBZ	VBZ	_	0	root	_	_
6	the	the	DT	DT	_	8	det	_	_
7	functional	functional	JJ	JJ	_	8	amod	_	_
8	capabilities	capability	NNS	NNS	_	5	dobj	_	_
9	of	of	IN	IN	_	11	case	_	_
10	T	t	NN	NN	_	11	compound	_	_
11	cells	cell	NNS	NNS	_	8	nmod	_	_
12	:	:	:	:	_	5	punct	_	_
13	pre-treatment	pre-treatment	NN	NN	_	27	nsubj	_	_
14	of	of	IN	IN	_	17	case	_	_
15	CD4+	cd4+	JJ	JJ	_	17	amod	_	_
16	T	t	NN	NN	_	17	compound	_	_
17	cells	cell	NNS	NNS	_	13	nmod	_	_
18	with	with	IN	IN	_	19	case	_	_
19	gp160	gp160	NN	NN	_	13	nmod	_	_
20	for	for	IN	IN	_	22	case	_	_
21	4	4	CD	CD	_	22	nummod	_	_
22	h	h	NN	NN	_	13	nmod	_	_
23	at	at	IN	IN	_	26	case	_	_
24	37	37	CD	CD	_	26	nummod	_	_
25	degrees	degree	NNS	NNS	_	26	compound	_	_
26	C	c	NN	NN	_	13	nmod	_	_
27	inhibited	inhibit	VBD	VBD	_	5	parataxis	_	_
28	anti-CD3-induced	anti-cd3-induced	JJ	JJ	_	30	amod	_	_
29	interleukin-2	interleukin-2	NN	NN	_	30	compound	_	_
30	secretion	secretion	NN	NN	_	27	dobj	_	_
31	.	.	.	.	_	5	punct	_	_

1	Effects	effect	NNS	NNS	_	6	nsubjpass	_	_
2	similar	similar	JJ	JJ	_	1	amod	_	_
3	to	to	TO	TO	_	4	case	_	_
4	gp160	gp160	NN	NN	_	2	nmod	_	_
5	were	be	VBD	VBD	_	6	auxpass	_	_
6	seen	see	VBN	VBN	_	0	root	_	_
7	with	with	IN	IN	_	9	case	_	_
8	anti-CD4	anti-cd4	JJ	JJ	_	9	amod	_	_
9	mAb	mab	NN	NN	_	6	nmod	_	_
10	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	aberrant	aberrant	JJ	JJ	_	3	amod	_	_
3	activation	activation	NN	NN	_	14	nsubj	_	_
4	of	of	IN	IN	_	5	case	_	_
5	AP-1	ap-1	NN	NN	_	3	nmod	_	_
6	by	by	IN	IN	_	7	case	_	_
7	gp160	gp160	NN	NN	_	3	nmod	_	_
8	in	in	IN	IN	_	12	case	_	_
9	CD4	cd4	NN	NN	_	12	compound	_	_
10	positive	positive	JJ	JJ	_	12	amod	_	_
11	T	t	NN	NN	_	12	compound	_	_
12	cells	cell	NNS	NNS	_	3	nmod	_	_
13	could	could	MD	MD	_	14	aux	_	_
14	result	result	VB	VB	_	0	root	_	_
15	in	in	IN	IN	_	16	case	_	_
16	up-regulation	up-regulation	NN	NN	_	14	nmod	_	_
17	of	of	IN	IN	_	18	case	_	_
18	cytokines	cytokine	NNS	NNS	_	16	nmod	_	_
19	containing	contain	VBG	VBG	_	18	acl	_	_
20	AP-1	ap-1	NN	NN	_	21	compound	_	_
21	sites	site	NNS	NNS	_	19	dobj	_	_
22	,	,	,	,	_	21	punct	_	_
23	e.g.	e.g.	FW	FW	_	21	acl	_	_
24	interleukin-3	interleukin-3	NN	NN	_	21	dep	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	granulocyte	granulocyte	NN	NN	_	29	compound	_	_
27	macrophage	macrophage	NN	NN	_	29	compound	_	_
28	colony-stimulating	colony-stimulating	JJ	JJ	_	29	amod	_	_
29	factor	factor	NN	NN	_	24	conj	_	_
30	,	,	,	,	_	14	punct	_	_
31	and	and	CC	CC	_	14	cc	_	_
32	concurrently	concurrently	RB	RB	_	33	advmod	_	_
33	lead	lead	VBP	VBP	_	14	conj	_	_
34	to	to	TO	TO	_	37	case	_	_
35	T	t	NN	NN	_	36	compound	_	_
36	cell	cell	NN	NN	_	37	compound	_	_
37	unresponsiveness	unresponsiveness	NN	NN	_	33	nmod	_	_
38	by	by	IN	IN	_	39	mark	_	_
39	inhibiting	inhibit	VBG	VBG	_	33	advcl	_	_
40	interleukin-2	interleukin-2	NN	NN	_	41	compound	_	_
41	secretion	secretion	NN	NN	_	39	dobj	_	_
42	.	.	.	.	_	14	punct	_	_

1	Infection	infection	NN	NN	_	0	root	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	replication	replication	NN	NN	_	1	conj	_	_
4	of	of	IN	IN	_	8	case	_	_
5	Tat-	tat-	JJ	JJ	_	8	amod	_	_
6	human	human	JJ	JJ	_	8	amod	_	_
7	immunodeficiency	immunodeficiency	NN	NN	_	8	compound	_	_
8	viruses	virus	NNS	NNS	_	1	nmod	_	_
9	:	:	:	:	_	1	punct	_	_
10	genetic	genetic	JJ	JJ	_	11	amod	_	_
11	analyses	analysis	NNS	NNS	_	1	dep	_	_
12	of	of	IN	IN	_	13	case	_	_
13	LTR	ltr	NN	NN	_	11	nmod	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	tat	tat	NN	NN	_	13	conj	_	_
16	mutations	mutation	NNS	NNS	_	13	dep	_	_
17	in	in	IN	IN	_	18	case	_	_
18	primary	primary	JJ	JJ	_	13	nmod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	long-term	long-term	JJ	JJ	_	18	conj	_	_
21	human	human	JJ	JJ	_	23	amod	_	_
22	lymphoid	lymphoid	JJ	JJ	_	23	amod	_	_
23	cells	cell	NNS	NNS	_	18	dep	_	_
24	.	.	.	.	_	1	punct	_	_

1	Tat	tat	NN	NN	_	6	nsubj	_	_
2	is	be	VBZ	VBZ	_	6	cop	_	_
3	an	a	DT	DT	_	6	det	_	_
4	essential	essential	JJ	JJ	_	6	amod	_	_
5	regulatory	regulatory	JJ	JJ	_	6	amod	_	_
6	protein	protein	NN	NN	_	0	root	_	_
7	for	for	IN	IN	_	9	case	_	_
8	the	the	DT	DT	_	9	det	_	_
9	replication	replication	NN	NN	_	6	nmod	_	_
10	of	of	IN	IN	_	13	case	_	_
11	human	human	JJ	JJ	_	13	amod	_	_
12	immunodeficiency	immunodeficiency	NN	NN	_	13	compound	_	_
13	virus	virus	NN	NN	_	9	nmod	_	_
14	(	(	-LRB-	-LRB-	_	15	punct	_	_
15	HIV	hiv	NN	NN	_	13	appos	_	_
16	)	)	-RRB-	-RRB-	_	15	punct	_	_
17	.	.	.	.	_	6	punct	_	_

1	Mutations	mutation	NNS	NNS	_	8	nsubjpass	_	_
2	in	in	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	tat	tat	NN	NN	_	5	compound	_	_
5	gene	gene	NN	NN	_	1	nmod	_	_
6	have	have	VBP	VBP	_	8	aux	_	_
7	been	be	VBN	VBN	_	8	auxpass	_	_
8	shown	show	VBN	VBN	_	0	root	_	_
9	to	to	TO	TO	_	10	mark	_	_
10	block	block	VB	VB	_	8	xcomp	_	_
11	HIV	hiv	NN	NN	_	12	compound	_	_
12	replication	replication	NN	NN	_	10	dobj	_	_
13	in	in	IN	IN	_	16	case	_	_
14	human	human	JJ	JJ	_	16	amod	_	_
15	T	t	NN	NN	_	16	compound	_	_
16	cells	cell	NNS	NNS	_	10	nmod	_	_
17	.	.	.	.	_	8	punct	_	_

1	Several	several	JJ	JJ	_	2	amod	_	_
2	studies	study	NNS	NNS	_	4	nsubj	_	_
3	have	have	VBP	VBP	_	4	aux	_	_
4	established	establish	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	7	mark	_	_
6	Tat	tat	NN	NN	_	7	nsubj	_	_
7	releases	release	VBZ	VBZ	_	4	ccomp	_	_
8	an	a	DT	DT	_	10	det	_	_
9	elongation	elongation	NN	NN	_	10	compound	_	_
10	block	block	NN	NN	_	7	dobj	_	_
11	to	to	TO	TO	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	transcription	transcription	NN	NN	_	10	nmod	_	_
14	of	of	IN	IN	_	18	case	_	_
15	HIV	hiv	NN	NN	_	18	compound	_	_
16	long	long	JJ	JJ	_	18	amod	_	_
17	terminal	terminal	JJ	JJ	_	18	amod	_	_
18	repeat	repeat	NN	NN	_	13	nmod	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	LTR	ltr	NN	NN	_	18	appos	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	;	;	:	:	_	4	punct	_	_
23	however	however	RB	RB	_	4	advmod	_	_
24	,	,	,	,	_	4	punct	_	_
25	it	it	PRP	PRP	_	28	nsubjpass	_	_
26	is	be	VBZ	VBZ	_	28	auxpass	_	_
27	not	not	RB	RB	_	28	neg	_	_
28	known	know	VBN	VBN	_	4	dep	_	_
29	whether	whether	IN	IN	_	34	mark	_	_
30	this	this	DT	DT	_	31	det	_	_
31	mechanism	mechanism	NN	NN	_	34	nsubj	_	_
32	alone	alone	RB	RB	_	31	advmod	_	_
33	is	be	VBZ	VBZ	_	34	cop	_	_
34	sufficient	sufficient	JJ	JJ	_	28	ccomp	_	_
35	to	to	TO	TO	_	36	mark	_	_
36	explain	explain	VB	VB	_	34	xcomp	_	_
37	the	the	DT	DT	_	38	det	_	_
38	block	block	NN	NN	_	36	dobj	_	_
39	to	to	TO	TO	_	41	case	_	_
40	HIV	hiv	NN	NN	_	41	compound	_	_
41	replication	replication	NN	NN	_	38	nmod	_	_
42	in	in	IN	IN	_	45	case	_	_
43	human	human	JJ	JJ	_	45	amod	_	_
44	T	t	NN	NN	_	45	compound	_	_
45	cells	cell	NNS	NNS	_	41	nmod	_	_
46	when	when	WRB	WRB	_	49	advmod	_	_
47	Tat	tat	NN	NN	_	49	nsubj	_	_
48	is	be	VBZ	VBZ	_	49	cop	_	_
49	absent	absent	JJ	JJ	_	36	advcl	_	_
50	.	.	.	.	_	4	punct	_	_

1	It	it	PRP	PRP	_	3	nsubj	_	_
2	is	be	VBZ	VBZ	_	3	cop	_	_
3	possible	possible	JJ	JJ	_	0	root	_	_
4	that	that	IN	IN	_	8	mark	_	_
5	Tat	tat	NN	NN	_	8	nsubjpass	_	_
6	is	be	VBZ	VBZ	_	8	auxpass	_	_
7	also	also	RB	RB	_	8	advmod	_	_
8	needed	need	VBN	VBN	_	3	ccomp	_	_
9	for	for	IN	IN	_	11	case	_	_
10	other	other	JJ	JJ	_	11	amod	_	_
11	functions	function	NNS	NNS	_	8	nmod	_	_
12	during	during	IN	IN	_	14	case	_	_
13	HIV	hiv	NN	NN	_	14	compound	_	_
14	replication	replication	NN	NN	_	8	nmod	_	_
15	.	.	.	.	_	3	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	test	test	VB	VB	_	0	root	_	_
3	these	these	DT	DT	_	4	det	_	_
4	hypotheses	hypothesis	NNS	NNS	_	2	dobj	_	_
5	,	,	,	,	_	2	punct	_	_
6	we	we	PRP	PRP	_	7	nsubj	_	_
7	studied	study	VBD	VBD	_	2	parataxis	_	_
8	several	several	JJ	JJ	_	10	amod	_	_
9	tat	tat	NN	NN	_	10	compound	_	_
10	mutants	mutant	NNS	NNS	_	7	dobj	_	_
11	,	,	,	,	_	10	punct	_	_
12	including	include	VBG	VBG	_	16	case	_	_
13	two	two	CD	CD	_	16	nummod	_	_
14	stop	stop	NN	NN	_	16	compound	_	_
15	codon	codon	NN	NN	_	16	compound	_	_
16	mutants	mutant	NNS	NNS	_	10	nmod	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	one	one	CD	CD	_	20	nummod	_	_
19	deletion	deletion	NN	NN	_	20	compound	_	_
20	mutant	mutant	NN	NN	_	16	conj	_	_
21	using	use	VBG	VBG	_	7	xcomp	_	_
22	replication-competent	replication-competent	JJ	JJ	_	24	amod	_	_
23	HIV-1	hiv-1	NN	NN	_	24	compound	_	_
24	constructs	construct	NNS	NNS	_	21	dobj	_	_
25	carrying	carry	VBG	VBG	_	24	acl	_	_
26	wild-type	wild-type	JJ	JJ	_	25	dobj	_	_
27	or	or	CC	CC	_	26	cc	_	_
28	mutant	mutant	JJ	JJ	_	26	conj	_	_
29	LTRs	ltr	NNS	NNS	_	26	dep	_	_
30	with	with	IN	IN	_	31	case	_	_
31	modifications	modification	NNS	NNS	_	26	nmod	_	_
32	in	in	IN	IN	_	35	case	_	_
33	the	the	DT	DT	_	35	dep	_	_
34	NF-kappa	nf-kappa	NN	NN	_	35	compound	_	_
35	B	b	NN	NN	_	31	nmod	_	_
36	and/or	and/or	CC	CC	_	35	cc	_	_
37	Sp1	sp1	NN	NN	_	35	conj	_	_
38	binding	binding	NN	NN	_	39	compound	_	_
39	sites	site	NNS	NNS	_	35	dep	_	_
40	.	.	.	.	_	2	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	study	study	NN	NN	_	6	nmod	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	show	show	VBP	VBP	_	0	root	_	_
7	that	that	IN	IN	_	14	mark	_	_
8	Tat-	tat-	JJ	JJ	_	9	amod	_	_
9	HIV-1	hiv-1	NN	NN	_	14	nsubj	_	_
10	with	with	IN	IN	_	12	case	_	_
11	wild-type	wild-type	JJ	JJ	_	12	amod	_	_
12	LTRs	ltr	NNS	NNS	_	9	nmod	_	_
13	can	can	MD	MD	_	14	aux	_	_
14	replicate	replicate	VB	VB	_	6	ccomp	_	_
15	in	in	IN	IN	_	17	case	_	_
16	HeLa	hela	NN	NN	_	17	compound	_	_
17	cells	cell	NNS	NNS	_	14	nmod	_	_
18	,	,	,	,	_	14	punct	_	_
19	and	and	CC	CC	_	14	cc	_	_
20	the	the	DT	DT	_	21	det	_	_
21	virus	virus	NN	NN	_	27	nsubj	_	_
22	produced	produce	VBN	VBN	_	21	acl	_	_
23	from	from	IN	IN	_	25	case	_	_
24	HeLa	hela	NN	NN	_	25	compound	_	_
25	cells	cell	NNS	NNS	_	22	nmod	_	_
26	can	can	MD	MD	_	27	aux	_	_
27	infect	infect	VB	VB	_	14	conj	_	_
28	primary	primary	JJ	JJ	_	31	amod	_	_
29	peripheral	peripheral	JJ	JJ	_	31	amod	_	_
30	blood	blood	NN	NN	_	31	compound	_	_
31	lymphocytes	lymphocyte	NNS	NNS	_	27	dobj	_	_
32	and	and	CC	CC	_	31	cc	_	_
33	macrophages	macrophage	NNS	NNS	_	31	conj	_	_
34	.	.	.	.	_	6	punct	_	_

1	It	it	PRP	PRP	_	3	nsubjpass	_	_
2	was	be	VBD	VBD	_	3	auxpass	_	_
3	found	find	VBN	VBN	_	0	root	_	_
4	that	that	IN	IN	_	16	mark	_	_
5	the	the	DT	DT	_	6	det	_	_
6	propagation	propagation	NN	NN	_	16	nsubj	_	_
7	of	of	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	Tat	tat	NN	NN	_	10	compound	_	_
10	mutants	mutant	NNS	NNS	_	6	nmod	_	_
11	containing	contain	VBG	VBG	_	10	acl	_	_
12	wild-type	wild-type	JJ	JJ	_	13	amod	_	_
13	LTRs	ltr	NNS	NNS	_	11	dobj	_	_
14	was	be	VBD	VBD	_	16	cop	_	_
15	less	less	RBR	RBR	_	16	advmod	_	_
16	efficient	efficient	JJ	JJ	_	3	ccomp	_	_
17	than	than	IN	IN	_	18	case	_	_
18	that	that	DT	DT	_	16	nmod	_	_
19	of	of	IN	IN	_	23	case	_	_
20	the	the	DT	DT	_	23	det	_	_
21	LTR-modified	ltr-modified	JJ	JJ	_	23	amod	_	_
22	Tat	tat	NN	NN	_	23	compound	_	_
23	mutants	mutant	NNS	NNS	_	18	nmod	_	_
24	.	.	.	.	_	3	punct	_	_

1	Large	large	JJ	JJ	_	2	amod	_	_
2	amounts	amount	NNS	NNS	_	9	nsubjpass	_	_
3	of	of	IN	IN	_	5	case	_	_
4	viral	viral	JJ	JJ	_	5	amod	_	_
5	RNA	rna	NN	NN	_	2	nmod	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	particles	particle	NNS	NNS	_	5	conj	_	_
8	were	be	VBD	VBD	_	9	auxpass	_	_
9	synthesized	synthesize	VBN	VBN	_	0	root	_	_
10	in	in	IN	IN	_	11	case	_	_
11	infections	infection	NNS	NNS	_	9	nmod	_	_
12	established	establish	VBN	VBN	_	11	acl	_	_
13	using	use	VBG	VBG	_	9	xcomp	_	_
14	the	the	DT	DT	_	16	det	_	_
15	tat	tat	NN	NN	_	16	compound	_	_
16	mutants	mutant	NNS	NNS	_	13	dobj	_	_
17	that	that	WDT	WDT	_	18	nsubj	_	_
18	contain	contain	VBP	VBP	_	16	acl:relcl	_	_
19	modified	modify	VBN	VBN	_	20	amod	_	_
20	LTRs	ltr	NNS	NNS	_	18	dobj	_	_
21	.	.	.	.	_	9	punct	_	_

1	However	however	RB	RB	_	12	advmod	_	_
2	,	,	,	,	_	12	punct	_	_
3	this	this	DT	DT	_	5	det	_	_
4	efficient	efficient	JJ	JJ	_	5	amod	_	_
5	propagation	propagation	NN	NN	_	12	nsubj	_	_
6	of	of	IN	IN	_	10	case	_	_
7	the	the	DT	DT	_	10	det	_	_
8	LTR-modified	ltr-modified	JJ	JJ	_	10	amod	_	_
9	tat	tat	NN	NN	_	10	compound	_	_
10	mutants	mutant	NNS	NNS	_	5	nmod	_	_
11	was	be	VBD	VBD	_	12	cop	_	_
12	restricted	restricted	JJ	JJ	_	0	root	_	_
13	to	to	TO	TO	_	17	case	_	_
14	some	some	DT	DT	_	17	det	_	_
15	lymphoid	lymphoid	JJ	JJ	_	17	amod	_	_
16	cell	cell	NN	NN	_	17	compound	_	_
17	lines	line	NNS	NNS	_	12	nmod	_	_
18	that	that	WDT	WDT	_	21	nsubjpass	_	_
19	have	have	VBP	VBP	_	21	aux	_	_
20	been	be	VBN	VBN	_	21	auxpass	_	_
21	transformed	transform	VBN	VBN	_	17	acl:relcl	_	_
22	with	with	IN	IN	_	24	case	_	_
23	other	other	JJ	JJ	_	24	amod	_	_
24	viruses	virus	NNS	NNS	_	21	nmod	_	_
25	.	.	.	.	_	12	punct	_	_

1	Thus	thus	RB	RB	_	18	advmod	_	_
2	,	,	,	,	_	18	punct	_	_
3	despite	despite	IN	IN	_	6	case	_	_
4	its	its	PRP$	PRP$	_	6	nmod:poss	_	_
5	essential	essential	JJ	JJ	_	6	amod	_	_
6	role	role	NN	NN	_	18	nmod	_	_
7	for	for	IN	IN	_	8	mark	_	_
8	releasing	release	VBG	VBG	_	6	acl	_	_
9	an	a	DT	DT	_	11	det	_	_
10	elongation	elongation	NN	NN	_	11	compound	_	_
11	block	block	NN	NN	_	8	dobj	_	_
12	,	,	,	,	_	18	punct	_	_
13	Tat	tat	NN	NN	_	18	nsubjpass	_	_
14	is	be	VBZ	VBZ	_	18	auxpass	_	_
15	not	not	RB	RB	_	18	neg	_	_
16	otherwise	otherwise	RB	RB	_	18	advmod	_	_
17	absolutely	absolutely	RB	RB	_	18	advmod	_	_
18	required	require	VBN	VBN	_	0	root	_	_
19	for	for	IN	IN	_	20	case	_	_
20	synthesis	synthesis	NN	NN	_	18	nmod	_	_
21	of	of	IN	IN	_	24	case	_	_
22	full-length	full-length	JJ	JJ	_	24	amod	_	_
23	HIV	hiv	NN	NN	_	24	compound	_	_
24	transcripts	transcript	NNS	NNS	_	20	nmod	_	_
25	and	and	CC	CC	_	20	cc	_	_
26	assembly	assembly	NN	NN	_	20	conj	_	_
27	of	of	IN	IN	_	29	case	_	_
28	virus	virus	NN	NN	_	29	compound	_	_
29	particles	particle	NNS	NNS	_	26	nmod	_	_
30	.	.	.	.	_	18	punct	_	_

1	Direct	direct	JJ	JJ	_	2	amod	_	_
2	sequencing	sequencing	NN	NN	_	10	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	viral	viral	JJ	JJ	_	6	amod	_	_
6	genomes	genome	NNS	NNS	_	2	nmod	_	_
7	and	and	CC	CC	_	2	cc	_	_
8	reinfection	reinfection	NN	NN	_	9	compound	_	_
9	kinetics	kinetics	NNS	NNS	_	2	conj	_	_
10	showed	show	VBD	VBD	_	0	root	_	_
11	no	no	DT	DT	_	12	neg	_	_
12	evidence	evidence	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	15	case	_	_
14	wild-type	wild-type	JJ	JJ	_	15	amod	_	_
15	reversion	reversion	NN	NN	_	12	nmod	_	_
16	even	even	RB	RB	_	10	advmod	_	_
17	after	after	IN	IN	_	19	case	_	_
18	prolonged	prolonged	JJ	JJ	_	19	amod	_	_
19	infection	infection	NN	NN	_	10	nmod	_	_
20	with	with	IN	IN	_	23	case	_	_
21	the	the	DT	DT	_	23	det	_	_
22	Tat-	tat-	JJ	JJ	_	23	amod	_	_
23	virus	virus	NN	NN	_	19	nmod	_	_
24	.	.	.	.	_	10	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	implications	implication	NNS	NNS	_	22	nsubjpass	_	_
3	for	for	IN	IN	_	7	case	_	_
4	in	in	FW	FW	_	7	amod	_	_
5	vivo	vivo	FW	FW	_	4	dep	_	_
6	HIV-1	hiv-1	NN	NN	_	7	compound	_	_
7	replication	replication	NN	NN	_	2	nmod	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	potential	potential	JJ	JJ	_	10	amod	_	_
10	application	application	NN	NN	_	7	conj	_	_
11	of	of	IN	IN	_	13	case	_	_
12	this	this	DT	DT	_	13	det	_	_
13	system	system	NN	NN	_	10	nmod	_	_
14	to	to	TO	TO	_	16	case	_	_
15	the	the	DT	DT	_	16	det	_	_
16	study	study	NN	NN	_	10	nmod	_	_
17	of	of	IN	IN	_	20	case	_	_
18	alternative	alternative	JJ	JJ	_	20	amod	_	_
19	Tat	tat	NN	NN	_	20	compound	_	_
20	function	function	NN	NN	_	16	nmod	_	_
21	are	be	VBP	VBP	_	22	auxpass	_	_
22	discussed	discuss	VBN	VBN	_	0	root	_	_
23	.	.	.	.	_	22	punct	_	_

1	Restoration	restoration	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	9	case	_	_
3	the	the	DT	DT	_	9	det	_	_
4	Epstein-Barr	epstein-barr	JJ	JJ	_	7	amod	_	_
5	virus	virus	NN	NN	_	7	compound	_	_
6	ZEBRA	zebra	NN	NN	_	7	compound	_	_
7	protein	protein	NN	NN	_	9	nmod:poss	_	_
8	's	's	POS	POS	_	9	case	_	_
9	capacity	capacity	NN	NN	_	1	nmod	_	_
10	to	to	TO	TO	_	11	mark	_	_
11	disrupt	disrupt	VB	VB	_	9	acl	_	_
12	latency	latency	NN	NN	_	11	dobj	_	_
13	by	by	IN	IN	_	15	case	_	_
14	the	the	DT	DT	_	15	det	_	_
15	addition	addition	NN	NN	_	1	nmod	_	_
16	of	of	IN	IN	_	19	case	_	_
17	heterologous	heterologous	JJ	JJ	_	19	amod	_	_
18	activation	activation	NN	NN	_	19	compound	_	_
19	regions	region	NNS	NNS	_	15	nmod	_	_
20	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	ZEBRA	zebra	NN	NN	_	3	compound	_	_
3	protein	protein	NN	NN	_	4	nsubj	_	_
4	has	have	VBZ	VBZ	_	0	root	_	_
5	a	a	DT	DT	_	8	det	_	_
6	unique	unique	JJ	JJ	_	8	amod	_	_
7	biological	biological	JJ	JJ	_	8	amod	_	_
8	function	function	NN	NN	_	4	dobj	_	_
9	among	among	IN	IN	_	11	case	_	_
10	herpesviral	herpesviral	JJ	JJ	_	11	amod	_	_
11	proteins	protein	NNS	NNS	_	4	nmod	_	_
12	.	.	.	.	_	4	punct	_	_

1	It	it	PRP	PRP	_	3	nsubj	_	_
2	is	be	VBZ	VBZ	_	3	cop	_	_
3	responsible	responsible	JJ	JJ	_	0	root	_	_
4	for	for	IN	IN	_	6	case	_	_
5	the	the	DT	DT	_	6	det	_	_
6	disruption	disruption	NN	NN	_	3	nmod	_	_
7	of	of	IN	IN	_	13	case	_	_
8	Epstein-Barr	epstein-barr	JJ	JJ	_	9	amod	_	_
9	virus	virus	NN	NN	_	13	compound	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	EBV	ebv	NN	NN	_	9	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	latency	latency	NN	NN	_	6	nmod	_	_
14	and	and	CC	CC	_	6	cc	_	_
15	the	the	DT	DT	_	16	det	_	_
16	induction	induction	NN	NN	_	6	conj	_	_
17	of	of	IN	IN	_	20	case	_	_
18	the	the	DT	DT	_	20	det	_	_
19	lytic	lytic	JJ	JJ	_	20	amod	_	_
20	cycle	cycle	NN	NN	_	16	nmod	_	_
21	.	.	.	.	_	3	punct	_	_

1	ZEBRA	zebra	NN	NN	_	6	nsubj	_	_
2	is	be	VBZ	VBZ	_	6	cop	_	_
3	a	a	DT	DT	_	6	det	_	_
4	bZIP	bzip	NN	NN	_	6	compound	_	_
5	transcriptional	transcriptional	JJ	JJ	_	6	amod	_	_
6	activator	activator	NN	NN	_	0	root	_	_
7	which	which	WDT	WDT	_	8	nsubj	_	_
8	binds	bind	VBZ	VBZ	_	6	acl:relcl	_	_
9	as	as	IN	IN	_	11	case	_	_
10	a	a	DT	DT	_	11	det	_	_
11	dimer	dimer	NN	NN	_	8	nmod	_	_
12	to	to	TO	TO	_	15	case	_	_
13	7-bp	7-bp	JJ	JJ	_	15	amod	_	_
14	response	response	NN	NN	_	15	compound	_	_
15	elements	element	NNS	NNS	_	8	nmod	_	_
16	within	within	IN	IN	_	18	case	_	_
17	EBV	ebv	NN	NN	_	18	compound	_	_
18	promoters	promoter	NNS	NNS	_	15	nmod	_	_
19	and	and	CC	CC	_	8	cc	_	_
20	is	be	VBZ	VBZ	_	22	auxpass	_	_
21	directly	directly	RB	RB	_	22	advmod	_	_
22	involved	involve	VBN	VBN	_	8	conj	_	_
23	in	in	IN	IN	_	25	case	_	_
24	the	the	DT	DT	_	25	det	_	_
25	stimulation	stimulation	NN	NN	_	22	nmod	_	_
26	of	of	IN	IN	_	28	case	_	_
27	virus	virus	NN	NN	_	28	compound	_	_
28	replication	replication	NN	NN	_	25	nmod	_	_
29	at	at	IN	IN	_	33	case	_	_
30	the	the	DT	DT	_	33	det	_	_
31	EBV	ebv	NN	NN	_	33	compound	_	_
32	lytic	lytic	JJ	JJ	_	33	amod	_	_
33	origin	origin	NN	NN	_	25	nmod	_	_
34	.	.	.	.	_	6	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	employed	employ	VBN	VBN	_	0	root	_	_
4	the	the	DT	DT	_	7	det	_	_
5	ZEBRA/EBV	zebra/ebv	NN	NN	_	7	compound	_	_
6	biological	biological	JJ	JJ	_	7	amod	_	_
7	system	system	NN	NN	_	3	dobj	_	_
8	to	to	TO	TO	_	9	mark	_	_
9	test	test	VB	VB	_	3	xcomp	_	_
10	whether	whether	IN	IN	_	16	mark	_	_
11	a	a	DT	DT	_	14	det	_	_
12	heterologous	heterologous	JJ	JJ	_	14	amod	_	_
13	activation	activation	NN	NN	_	14	compound	_	_
14	domain	domain	NN	NN	_	16	nsubj	_	_
15	can	can	MD	MD	_	16	aux	_	_
16	substitute	substitute	VB	VB	_	9	ccomp	_	_
17	for	for	IN	IN	_	20	case	_	_
18	another	another	DT	DT	_	20	det	_	_
19	activation	activation	NN	NN	_	20	compound	_	_
20	domain	domain	NN	NN	_	16	nmod	_	_
21	(	(	-LRB-	-LRB-	_	24	punct	_	_
22	the	the	DT	DT	_	24	det	_	_
23	ZEBRA	zebra	NN	NN	_	24	compound	_	_
24	domain	domain	NN	NN	_	20	appos	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	ZEBRA	zebra	NN	NN	_	4	compound	_	_
3	activation	activation	NN	NN	_	4	compound	_	_
4	region	region	NN	NN	_	6	nsubjpass	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	replaced	replace	VBN	VBN	_	0	root	_	_
7	with	with	IN	IN	_	12	case	_	_
8	the	the	DT	DT	_	12	det	_	_
9	potent	potent	JJ	JJ	_	12	amod	_	_
10	acid	acid	NN	NN	_	12	compound	_	_
11	activation	activation	NN	NN	_	12	compound	_	_
12	region	region	NN	NN	_	6	nmod	_	_
13	from	from	IN	IN	_	19	case	_	_
14	the	the	DT	DT	_	19	det	_	_
15	herpes	herpes	NN	NN	_	19	compound	_	_
16	simplex	simplex	JJ	JJ	_	19	amod	_	_
17	virus	virus	NN	NN	_	19	compound	_	_
18	VP16	vp16	NN	NN	_	19	compound	_	_
19	protein	protein	NN	NN	_	12	nmod	_	_
20	or	or	CC	CC	_	12	cc	_	_
21	with	with	IN	IN	_	24	case	_	_
22	the	the	DT	DT	_	24	det	_	_
23	activation	activation	NN	NN	_	24	compound	_	_
24	region	region	NN	NN	_	12	conj	_	_
25	of	of	IN	IN	_	29	case	_	_
26	the	the	DT	DT	_	29	det	_	_
27	EBV	ebv	NN	NN	_	29	compound	_	_
28	R	r	NN	NN	_	29	compound	_	_
29	protein	protein	NN	NN	_	24	nmod	_	_
30	.	.	.	.	_	6	punct	_	_

1	Both	both	DT	DT	_	2	det	_	_
2	chimeras	chimera	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	found	find	VBN	VBN	_	0	root	_	_
5	to	to	TO	TO	_	6	mark	_	_
6	transactivate	transactivate	VB	VB	_	4	xcomp	_	_
7	model	model	NN	NN	_	6	dobj	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	native	native	JJ	JJ	_	7	conj	_	_
10	promoters	promoter	NNS	NNS	_	7	dep	_	_
11	at	at	IN	IN	_	12	case	_	_
12	equivalent	equivalent	JJ	JJ	_	6	nmod	_	_
13	or	or	CC	CC	_	12	cc	_	_
14	better	better	JJR	JJR	_	12	conj	_	_
15	levels	level	NNS	NNS	_	12	dep	_	_
16	than	than	IN	IN	_	17	case	_	_
17	ZEBRA	zebra	NN	NN	_	4	nmod	_	_
18	itself	itself	PRP	PRP	_	17	nmod:npmod	_	_
19	.	.	.	.	_	4	punct	_	_

1	Activation	activation	NN	NN	_	4	nsubj	_	_
2	was	be	VBD	VBD	_	4	cop	_	_
3	not	not	RB	RB	_	4	neg	_	_
4	target-	target-	NN	NN	_	0	root	_	_
5	or	or	CC	CC	_	4	cc	_	_
6	cell-type	cell-type	NN	NN	_	4	conj	_	_
7	dependent	dependent	JJ	JJ	_	4	dep	_	_
8	,	,	,	,	_	4	punct	_	_
9	nor	nor	CC	CC	_	4	cc	_	_
10	was	be	VBD	VBD	_	12	cop	_	_
11	it	it	PRP	PRP	_	12	nsubj	_	_
12	dependent	dependent	JJ	JJ	_	4	conj	_	_
13	on	on	IN	IN	_	15	case	_	_
14	the	the	DT	DT	_	15	det	_	_
15	presence	presence	NN	NN	_	12	nmod	_	_
16	of	of	IN	IN	_	17	case	_	_
17	virus	virus	NN	NN	_	15	nmod	_	_
18	.	.	.	.	_	4	punct	_	_

1	These	these	DT	DT	_	3	det	_	_
2	activation	activation	NN	NN	_	3	compound	_	_
3	domains	domain	NNS	NNS	_	4	nsubj	_	_
4	restored	restore	VBD	VBD	_	0	root	_	_
5	ZEBRA	zebra	NN	NN	_	7	nmod:poss	_	_
6	's	's	POS	POS	_	7	case	_	_
7	ability	ability	NN	NN	_	4	dobj	_	_
8	to	to	TO	TO	_	9	mark	_	_
9	induce	induce	VB	VB	_	7	dep	_	_
10	early	early	JJ	JJ	_	11	amod	_	_
11	antigen	antigen	NN	NN	_	9	dobj	_	_
12	and	and	CC	CC	_	9	cc	_	_
13	to	to	TO	TO	_	14	mark	_	_
14	stimulate	stimulate	VB	VB	_	9	conj	_	_
15	origin	origin	NN	NN	_	16	compound	_	_
16	replication	replication	NN	NN	_	14	dobj	_	_
17	to	to	TO	TO	_	18	case	_	_
18	levels	level	NNS	NNS	_	14	nmod	_	_
19	that	that	WDT	WDT	_	21	nsubj	_	_
20	were	be	VBD	VBD	_	21	cop	_	_
21	equal	equal	JJ	JJ	_	18	acl:relcl	_	_
22	to	to	TO	TO	_	21	nmod	_	_
23	or	or	CC	CC	_	21	cc	_	_
24	greater	greater	JJR	JJR	_	21	conj	_	_
25	than	than	IN	IN	_	24	nmod	_	_
26	those	those	DT	DT	_	21	dep	_	_
27	of	of	IN	IN	_	29	case	_	_
28	wild	wild	JJ	JJ	_	29	amod	_	_
29	type	type	NN	NN	_	26	nmod	_	_
30	.	.	.	.	_	4	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	studies	study	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	18	mark	_	_
5	the	the	DT	DT	_	6	det	_	_
6	specificities	specificity	NNS	NNS	_	18	nsubj	_	_
7	of	of	IN	IN	_	8	case	_	_
8	some	some	DT	DT	_	6	nmod	_	_
9	of	of	IN	IN	_	13	case	_	_
10	the	the	DT	DT	_	13	det	_	_
11	known	known	JJ	JJ	_	13	amod	_	_
12	biological	biological	JJ	JJ	_	13	amod	_	_
13	functions	function	NNS	NNS	_	8	nmod	_	_
14	of	of	IN	IN	_	15	case	_	_
15	ZEBRA	zebra	NN	NN	_	13	nmod	_	_
16	are	be	VBP	VBP	_	18	cop	_	_
17	not	not	RB	RB	_	18	neg	_	_
18	dependent	dependent	JJ	JJ	_	3	ccomp	_	_
19	upon	upon	IN	IN	_	21	case	_	_
20	the	the	DT	DT	_	21	det	_	_
21	nature	nature	NN	NN	_	18	nmod	_	_
22	of	of	IN	IN	_	25	case	_	_
23	the	the	DT	DT	_	25	det	_	_
24	activation	activation	NN	NN	_	25	compound	_	_
25	domain	domain	NN	NN	_	21	nmod	_	_
26	present	present	JJ	JJ	_	25	amod	_	_
27	within	within	IN	IN	_	28	case	_	_
28	ZEBRA	zebra	NN	NN	_	26	nmod	_	_
29	.	.	.	.	_	3	punct	_	_

1	Activation	activation	NN	NN	_	0	root	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	expression	expression	NN	NN	_	1	conj	_	_
4	of	of	IN	IN	_	7	case	_	_
5	the	the	DT	DT	_	7	det	_	_
6	nuclear	nuclear	JJ	JJ	_	7	amod	_	_
7	factors	factor	NNS	NNS	_	1	nmod	_	_
8	of	of	IN	IN	_	11	case	_	_
9	activated	activate	VBN	VBN	_	11	amod	_	_
10	T	t	NN	NN	_	11	compound	_	_
11	cells	cell	NNS	NNS	_	7	nmod	_	_
12	,	,	,	,	_	7	punct	_	_
13	NFATp	nfatp	NN	NN	_	7	appos	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	NFATc	nfatc	NN	NN	_	13	conj	_	_
16	,	,	,	,	_	1	punct	_	_
17	in	in	IN	IN	_	21	case	_	_
18	human	human	JJ	JJ	_	21	amod	_	_
19	natural	natural	JJ	JJ	_	21	amod	_	_
20	killer	killer	NN	NN	_	21	compound	_	_
21	cells	cell	NNS	NNS	_	1	nmod	_	_
22	:	:	:	:	_	1	punct	_	_
23	regulation	regulation	NN	NN	_	1	dep	_	_
24	upon	upon	IN	IN	_	27	case	_	_
25	CD16	cd16	NN	NN	_	27	compound	_	_
26	ligand	ligand	NN	NN	_	27	compound	_	_
27	binding	binding	NN	NN	_	23	nmod	_	_
28	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	putative	putative	JJ	JJ	_	3	amod	_	_
3	factors	factor	NNS	NNS	_	28	nsubjpass	_	_
4	that	that	WDT	WDT	_	5	nsubj	_	_
5	couple	couple	VBP	VBP	_	3	acl:relcl	_	_
6	the	the	DT	DT	_	8	det	_	_
7	signal	signal	NN	NN	_	8	compound	_	_
8	transduction	transduction	NN	NN	_	5	dobj	_	_
9	from	from	IN	IN	_	11	case	_	_
10	surface	surface	NN	NN	_	11	compound	_	_
11	receptors	receptor	NNS	NNS	_	8	nmod	_	_
12	to	to	TO	TO	_	14	case	_	_
13	the	the	DT	DT	_	14	det	_	_
14	activation	activation	NN	NN	_	8	nmod	_	_
15	of	of	IN	IN	_	17	case	_	_
16	cytokine	cytokine	NN	NN	_	17	compound	_	_
17	synthesis	synthesis	NN	NN	_	14	nmod	_	_
18	in	in	IN	IN	_	24	case	_	_
19	natural	natural	JJ	JJ	_	24	amod	_	_
20	killer	killer	NN	NN	_	24	compound	_	_
21	(	(	-LRB-	-LRB-	_	24	punct	_	_
22	NK	nk	NN	NN	_	24	compound	_	_
23	)	)	-RRB-	-RRB-	_	24	punct	_	_
24	cells	cell	NNS	NNS	_	5	nmod	_	_
25	have	have	VBP	VBP	_	28	aux	_	_
26	not	not	RB	RB	_	28	neg	_	_
27	been	be	VBN	VBN	_	28	auxpass	_	_
28	elucidated	elucidate	VBN	VBN	_	0	root	_	_
29	.	.	.	.	_	28	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	report	report	VBP	VBP	_	0	root	_	_
3	here	here	RB	RB	_	2	advmod	_	_
4	that	that	IN	IN	_	32	mark	_	_
5	the	the	DT	DT	_	7	det	_	_
6	nuclear	nuclear	JJ	JJ	_	7	amod	_	_
7	factor	factor	NN	NN	_	32	nsubj	_	_
8	of	of	IN	IN	_	11	case	_	_
9	activated	activate	VBN	VBN	_	11	amod	_	_
10	T	t	NN	NN	_	11	compound	_	_
11	cells	cell	NNS	NNS	_	7	nmod	_	_
12	(	(	-LRB-	-LRB-	_	13	punct	_	_
13	NFATp	nfatp	NN	NN	_	7	appos	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	,	,	,	,	_	7	punct	_	_
16	a	a	DT	DT	_	23	det	_	_
17	cyclosporin	cyclosporin	NN	NN	_	23	compound	_	_
18	A	a	NN	NN	_	23	compound	_	_
19	(	(	-LRB-	-LRB-	_	23	punct	_	_
20	CsA	csa	NN	NN	_	23	compound	_	_
21	)	)	-RRB-	-RRB-	_	23	punct	_	_
22	-sensitive	-sensitive	JJ	JJ	_	23	amod	_	_
23	factor	factor	NN	NN	_	7	appos	_	_
24	that	that	WDT	WDT	_	25	nsubj	_	_
25	regulates	regulate	VBZ	VBZ	_	23	acl:relcl	_	_
26	the	the	DT	DT	_	27	det	_	_
27	transcription	transcription	NN	NN	_	25	dobj	_	_
28	of	of	IN	IN	_	30	case	_	_
29	several	several	JJ	JJ	_	30	amod	_	_
30	cytokines	cytokine	NNS	NNS	_	27	nmod	_	_
31	,	,	,	,	_	7	punct	_	_
32	mediates	mediate	VBZ	VBZ	_	2	ccomp	_	_
33	CD16-induced	cd16-induced	JJ	JJ	_	34	amod	_	_
34	activation	activation	NN	NN	_	32	dobj	_	_
35	of	of	IN	IN	_	37	case	_	_
36	cytokine	cytokine	NN	NN	_	37	compound	_	_
37	genes	gene	NNS	NNS	_	34	nmod	_	_
38	in	in	IN	IN	_	41	case	_	_
39	human	human	JJ	JJ	_	41	amod	_	_
40	NK	nk	NN	NN	_	41	compound	_	_
41	cells	cell	NNS	NNS	_	34	nmod	_	_
42	.	.	.	.	_	2	punct	_	_

1	CD16	cd16	NN	NN	_	8	compound	_	_
2	(	(	-LRB-	-LRB-	_	5	punct	_	_
3	Fc	fc	NN	NN	_	5	compound	_	_
4	gamma	gamma	NN	NN	_	5	compound	_	_
5	RIIIA	riiia	NN	NN	_	1	appos	_	_
6	)	)	-RRB-	-RRB-	_	5	punct	_	_
7	-induced	-induced	JJ	JJ	_	8	amod	_	_
8	expression	expression	NN	NN	_	15	nsubj	_	_
9	of	of	IN	IN	_	11	case	_	_
10	cytokine	cytokine	NN	NN	_	11	compound	_	_
11	mRNA	mrna	NN	NN	_	8	nmod	_	_
12	in	in	IN	IN	_	14	case	_	_
13	NK	nk	NN	NN	_	14	compound	_	_
14	cells	cell	NNS	NNS	_	8	nmod	_	_
15	occurs	occur	VBZ	VBZ	_	0	root	_	_
16	via	via	IN	IN	_	21	case	_	_
17	a	a	DT	DT	_	21	det	_	_
18	CsA-sensitive	csa-sensitive	JJ	JJ	_	21	amod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	Ca(2+)-dependent	ca(2+)-dependent	JJ	JJ	_	18	conj	_	_
21	mechanism	mechanism	NN	NN	_	15	nmod	_	_
22	.	.	.	.	_	15	punct	_	_

1	Stimulation	stimulation	NN	NN	_	8	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	NK	nk	NN	NN	_	4	compound	_	_
4	cells	cell	NNS	NNS	_	1	nmod	_	_
5	with	with	IN	IN	_	7	case	_	_
6	CD16	cd16	NN	NN	_	7	compound	_	_
7	ligands	ligand	NNS	NNS	_	1	nmod	_	_
8	induces	induce	VBZ	VBZ	_	0	root	_	_
9	NFAT-like	nfat-like	JJ	JJ	_	12	amod	_	_
10	DNA	dna	NN	NN	_	12	compound	_	_
11	binding	binding	NN	NN	_	12	compound	_	_
12	activity	activity	NN	NN	_	8	dobj	_	_
13	in	in	IN	IN	_	16	case	_	_
14	the	the	DT	DT	_	16	det	_	_
15	nuclear	nuclear	JJ	JJ	_	16	amod	_	_
16	extracts	extract	NNS	NNS	_	8	nmod	_	_
17	from	from	IN	IN	_	19	case	_	_
18	these	these	DT	DT	_	19	det	_	_
19	cells	cell	NNS	NNS	_	16	nmod	_	_
20	,	,	,	,	_	8	punct	_	_
21	as	as	IN	IN	_	22	mark	_	_
22	detected	detect	VBN	VBN	_	8	advcl	_	_
23	in	in	IN	IN	_	27	case	_	_
24	electrophoretic	electrophoretic	JJ	JJ	_	27	amod	_	_
25	mobility	mobility	NN	NN	_	27	compound	_	_
26	shift	shift	NN	NN	_	27	compound	_	_
27	assays	assay	NNS	NNS	_	22	nmod	_	_
28	.	.	.	.	_	8	punct	_	_

1	This	this	DT	DT	_	2	nsubj	_	_
2	occurs	occur	VBZ	VBZ	_	0	root	_	_
3	with	with	IN	IN	_	5	case	_	_
4	fast	fast	JJ	JJ	_	5	amod	_	_
5	kinetics	kinetics	NNS	NNS	_	2	nmod	_	_
6	after	after	IN	IN	_	7	case	_	_
7	stimulation	stimulation	NN	NN	_	2	nmod	_	_
8	,	,	,	,	_	2	punct	_	_
9	via	via	IN	IN	_	14	case	_	_
10	a	a	DT	DT	_	14	det	_	_
11	CsA-sensitive	csa-sensitive	JJ	JJ	_	14	amod	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	Ca(2+)-dependent	ca(2+)-dependent	JJ	JJ	_	11	conj	_	_
14	mechanism	mechanism	NN	NN	_	2	nmod	_	_
15	that	that	WDT	WDT	_	18	nsubj	_	_
16	does	do	VBZ	VBZ	_	18	aux	_	_
17	not	not	RB	RB	_	18	neg	_	_
18	require	require	VB	VB	_	14	acl:relcl	_	_
19	de	de	FW	FW	_	22	amod	_	_
20	novo	novo	FW	FW	_	19	dep	_	_
21	protein	protein	NN	NN	_	22	compound	_	_
22	synthesis	synthesis	NN	NN	_	18	dobj	_	_
23	.	.	.	.	_	2	punct	_	_

1	NK	nk	NN	NN	_	3	compound	_	_
2	cell	cell	NN	NN	_	3	compound	_	_
3	NFAT	nfat	NN	NN	_	5	nsubj	_	_
4	is	be	VBZ	VBZ	_	5	cop	_	_
5	present	present	JJ	JJ	_	0	root	_	_
6	in	in	IN	IN	_	8	case	_	_
7	the	the	DT	DT	_	8	det	_	_
8	cytosol	cytosol	NN	NN	_	5	nmod	_	_
9	of	of	IN	IN	_	11	case	_	_
10	nonstimulated	nonstimulated	JJ	JJ	_	11	amod	_	_
11	cells	cell	NNS	NNS	_	8	nmod	_	_
12	,	,	,	,	_	5	punct	_	_
13	migrates	migrate	VBZ	VBZ	_	5	conj	_	_
14	to	to	TO	TO	_	16	case	_	_
15	the	the	DT	DT	_	16	det	_	_
16	nucleus	nucleus	NN	NN	_	13	nmod	_	_
17	upon	upon	IN	IN	_	18	case	_	_
18	stimulation	stimulation	NN	NN	_	13	nmod	_	_
19	,	,	,	,	_	5	punct	_	_
20	and	and	CC	CC	_	5	cc	_	_
21	can	can	MD	MD	_	22	aux	_	_
22	associate	associate	VB	VB	_	5	conj	_	_
23	with	with	IN	IN	_	24	case	_	_
24	AP-1	ap-1	NN	NN	_	22	nmod	_	_
25	.	.	.	.	_	5	punct	_	_

1	Two	two	CD	CD	_	3	nummod	_	_
2	distinct	distinct	JJ	JJ	_	3	amod	_	_
3	molecules	molecule	NNS	NNS	_	11	nsubjpass	_	_
4	,	,	,	,	_	3	punct	_	_
5	NFATp	nfatp	NN	NN	_	3	appos	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	NFATc	nfatc	NN	NN	_	5	conj	_	_
8	,	,	,	,	_	3	punct	_	_
9	have	have	VBP	VBP	_	11	aux	_	_
10	been	be	VBN	VBN	_	11	auxpass	_	_
11	reported	report	VBN	VBN	_	0	root	_	_
12	to	to	TO	TO	_	13	mark	_	_
13	mediate	mediate	VB	VB	_	11	xcomp	_	_
14	NFAT	nfat	NN	NN	_	15	compound	_	_
15	activity	activity	NN	NN	_	13	dobj	_	_
16	.	.	.	.	_	11	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	11	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	supershift	supershift	NN	NN	_	5	compound	_	_
5	assays	assay	NNS	NNS	_	2	nmod	_	_
6	using	use	VBG	VBG	_	5	acl	_	_
7	NFATp-	nfatp-	NN	NN	_	6	dobj	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	NFATc-specific	nfatc-specific	JJ	JJ	_	7	conj	_	_
10	antibodies	antibody	NNS	NNS	_	7	dep	_	_
11	indicate	indicate	VBP	VBP	_	0	root	_	_
12	that	that	IN	IN	_	21	mark	_	_
13	NK	nk	NN	NN	_	15	compound	_	_
14	cell	cell	NN	NN	_	15	compound	_	_
15	activation	activation	NN	NN	_	21	nsubj	_	_
16	early	early	RB	RB	_	15	advmod	_	_
17	after	after	IN	IN	_	20	case	_	_
18	CD16	cd16	NN	NN	_	20	compound	_	_
19	ligand	ligand	NN	NN	_	20	compound	_	_
20	binding	binding	NN	NN	_	15	nmod	_	_
21	involves	involve	VBZ	VBZ	_	11	ccomp	_	_
22	primarily	primarily	RB	RB	_	21	advmod	_	_
23	,	,	,	,	_	22	punct	_	_
24	if	if	IN	IN	_	25	dep	_	_
25	not	not	RB	RB	_	22	cc	_	_
26	exclusively	exclusively	RB	RB	_	22	conj	_	_
27	,	,	,	,	_	21	punct	_	_
28	NFATp	nfatp	NN	NN	_	21	dobj	_	_
29	,	,	,	,	_	11	punct	_	_
30	and	and	CC	CC	_	11	cc	_	_
31	Western	western	NN	NN	_	33	compound	_	_
32	blot	blot	NN	NN	_	33	compound	_	_
33	analysis	analysis	NN	NN	_	34	nsubj	_	_
34	shows	show	VBZ	VBZ	_	11	conj	_	_
35	that	that	IN	IN	_	37	mark	_	_
36	this	this	DT	DT	_	37	nsubj	_	_
37	has	have	VBZ	VBZ	_	34	ccomp	_	_
38	the	the	DT	DT	_	41	det	_	_
39	same	same	JJ	JJ	_	41	amod	_	_
40	electrophoretic	electrophoretic	JJ	JJ	_	41	amod	_	_
41	mobility	mobility	NN	NN	_	37	dobj	_	_
42	(	(	-LRB-	-LRB-	_	45	punct	_	_
43	approximately	approximately	RB	RB	_	44	advmod	_	_
44	120	120	CD	CD	_	45	nummod	_	_
45	kD	kd	NN	NN	_	41	appos	_	_
46	)	)	-RRB-	-RRB-	_	45	punct	_	_
47	as	as	IN	IN	_	48	case	_	_
48	that	that	DT	DT	_	41	nmod	_	_
49	of	of	IN	IN	_	51	case	_	_
50	T	t	NN	NN	_	51	compound	_	_
51	lymphocytes	lymphocyte	NNS	NNS	_	48	nmod	_	_
52	.	.	.	.	_	11	punct	_	_

1	NK	nk	NN	NN	_	2	compound	_	_
2	cells	cell	NNS	NNS	_	5	nsubj	_	_
3	do	do	VBP	VBP	_	5	aux	_	_
4	not	not	RB	RB	_	5	neg	_	_
5	express	express	VB	VB	_	0	root	_	_
6	NFATc	nfatc	NN	NN	_	5	dobj	_	_
7	constitutively	constitutively	RB	RB	_	5	advmod	_	_
8	,	,	,	,	_	5	punct	_	_
9	but	but	CC	CC	_	5	cc	_	_
10	NFATc	nfatc	NN	NN	_	11	compound	_	_
11	mRNA	mrna	NN	NN	_	12	compound	_	_
12	accumulation	accumulation	NN	NN	_	14	nsubjpass	_	_
13	is	be	VBZ	VBZ	_	14	auxpass	_	_
14	induced	induce	VBN	VBN	_	5	conj	_	_
15	in	in	IN	IN	_	17	case	_	_
16	these	these	DT	DT	_	17	det	_	_
17	cells	cell	NNS	NNS	_	14	nmod	_	_
18	within	within	IN	IN	_	20	case	_	_
19	2	2	CD	CD	_	20	nummod	_	_
20	h	h	NN	NN	_	14	nmod	_	_
21	of	of	IN	IN	_	22	case	_	_
22	stimulation	stimulation	NN	NN	_	20	nmod	_	_
23	with	with	IN	IN	_	25	case	_	_
24	CD16	cd16	NN	NN	_	25	compound	_	_
25	ligands	ligand	NNS	NNS	_	22	nmod	_	_
26	.	.	.	.	_	5	punct	_	_

1	However	however	RB	RB	_	14	advmod	_	_
2	,	,	,	,	_	14	punct	_	_
3	supershift	supershift	NN	NN	_	4	compound	_	_
4	assays	assay	NNS	NNS	_	14	nsubj	_	_
5	using	use	VBG	VBG	_	4	acl	_	_
6	the	the	DT	DT	_	8	det	_	_
7	available	available	JJ	JJ	_	8	amod	_	_
8	mAb	mab	NN	NN	_	5	dobj	_	_
9	recognizing	recognize	VBG	VBG	_	8	acl	_	_
10	the	the	DT	DT	_	13	det	_	_
11	T	t	NN	NN	_	13	compound	_	_
12	cell	cell	NN	NN	_	13	compound	_	_
13	NFATc	nfatc	NN	NN	_	9	dobj	_	_
14	revealed	reveal	VBD	VBD	_	0	root	_	_
15	no	no	DT	DT	_	18	neg	_	_
16	detectable	detectable	JJ	JJ	_	18	amod	_	_
17	NFATc	nfatc	NN	NN	_	18	compound	_	_
18	protein	protein	NN	NN	_	14	dobj	_	_
19	in	in	IN	IN	_	20	case	_	_
20	nuclear	nuclear	JJ	JJ	_	14	nmod	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	cytoplasmic	cytoplasmic	JJ	JJ	_	20	conj	_	_
23	extracts	extract	NNS	NNS	_	20	dep	_	_
24	from	from	IN	IN	_	25	case	_	_
25	CD16-	cd16-	NN	NN	_	20	nmod	_	_
26	or	or	CC	CC	_	25	cc	_	_
27	phorbol	phorbol	NN	NN	_	29	compound	_	_
28	ester-stimulated	ester-stimulated	JJ	JJ	_	29	amod	_	_
29	cells	cell	NNS	NNS	_	25	conj	_	_
30	at	at	IN	IN	_	32	case	_	_
31	any	any	DT	DT	_	32	det	_	_
32	time	time	NN	NN	_	14	nmod	_	_
33	tested	test	VBN	VBN	_	32	acl	_	_
34	,	,	,	,	_	32	punct	_	_
35	up	up	RB	RB	_	37	advmod	_	_
36	to	to	TO	TO	_	37	dep	_	_
37	4	4	CD	CD	_	38	nummod	_	_
38	h	h	NN	NN	_	32	appos	_	_
39	.	.	.	.	_	14	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	provide	provide	VBP	VBP	_	0	root	_	_
4	the	the	DT	DT	_	7	det	_	_
5	first	first	JJ	JJ	_	7	amod	_	_
6	direct	direct	JJ	JJ	_	7	amod	_	_
7	evidence	evidence	NN	NN	_	3	dobj	_	_
8	that	that	IN	IN	_	19	mark	_	_
9	both	both	DT	DT	_	12	dep	_	_
10	CsA-sensitive	csa-sensitive	JJ	JJ	_	12	amod	_	_
11	transcription	transcription	NN	NN	_	12	compound	_	_
12	factors	factor	NNS	NNS	_	19	nsubjpass	_	_
13	,	,	,	,	_	12	punct	_	_
14	NFATp	nfatp	NN	NN	_	12	appos	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	NFATc	nfatc	NN	NN	_	14	conj	_	_
17	,	,	,	,	_	12	punct	_	_
18	are	be	VBP	VBP	_	19	auxpass	_	_
19	expressed	express	VBN	VBN	_	7	ccomp	_	_
20	in	in	IN	IN	_	23	case	_	_
21	human	human	JJ	JJ	_	23	amod	_	_
22	NK	nk	NN	NN	_	23	compound	_	_
23	cells	cell	NNS	NNS	_	19	nmod	_	_
24	,	,	,	,	_	19	punct	_	_
25	and	and	CC	CC	_	19	cc	_	_
26	that	that	IN	IN	_	33	mark	_	_
27	their	they	PRP$	PRP$	_	28	nmod:poss	_	_
28	activation	activation	NN	NN	_	33	nsubjpass	_	_
29	and/or	and/or	CC	CC	_	28	cc	_	_
30	expression	expression	NN	NN	_	28	conj	_	_
31	can	can	MD	MD	_	33	aux	_	_
32	be	be	VB	VB	_	33	auxpass	_	_
33	regulated	regulate	VBN	VBN	_	19	conj	_	_
34	in	in	IN	IN	_	36	case	_	_
35	primary	primary	JJ	JJ	_	36	amod	_	_
36	cells	cell	NNS	NNS	_	33	nmod	_	_
37	by	by	IN	IN	_	40	case	_	_
38	a	a	DT	DT	_	40	det	_	_
39	single	single	JJ	JJ	_	40	amod	_	_
40	stimulus	stimulus	NN	NN	_	33	nmod	_	_
41	,	,	,	,	_	40	punct	_	_
42	that	that	WDT	WDT	_	53	nsubj	_	_
43	,	,	,	,	_	53	punct	_	_
44	in	in	IN	IN	_	46	case	_	_
45	the	the	DT	DT	_	46	det	_	_
46	case	case	NN	NN	_	53	nmod	_	_
47	of	of	IN	IN	_	48	case	_	_
48	CD16	cd16	NN	NN	_	46	nmod	_	_
49	in	in	IN	IN	_	51	case	_	_
50	NK	nk	NN	NN	_	51	compound	_	_
51	cells	cell	NNS	NNS	_	48	nmod	_	_
52	,	,	,	,	_	53	punct	_	_
53	results	result	VBZ	VBZ	_	40	acl:relcl	_	_
54	in	in	IN	IN	_	56	case	_	_
55	early	early	JJ	JJ	_	56	amod	_	_
56	activation	activation	NN	NN	_	53	nmod	_	_
57	of	of	IN	IN	_	58	case	_	_
58	NFATp	nfatp	NN	NN	_	56	nmod	_	_
59	and	and	CC	CC	_	56	cc	_	_
60	subsequently	subsequently	RB	RB	_	61	advmod	_	_
61	induced	induce	VBN	VBN	_	62	amod	_	_
62	expression	expression	NN	NN	_	56	conj	_	_
63	of	of	IN	IN	_	65	case	_	_
64	NFATc	nfatc	NN	NN	_	65	compound	_	_
65	mRNA	mrna	NN	NN	_	62	nmod	_	_
66	.	.	.	.	_	3	punct	_	_

1	Activation	activation	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	HIV-1	hiv-1	NN	NN	_	5	compound	_	_
5	enhancer	enhancer	NN	NN	_	1	nmod	_	_
6	by	by	IN	IN	_	10	case	_	_
7	the	the	DT	DT	_	10	det	_	_
8	LEF-1	lef-1	NN	NN	_	10	compound	_	_
9	HMG	hmg	NN	NN	_	10	compound	_	_
10	protein	protein	NN	NN	_	1	nmod	_	_
11	on	on	IN	IN	_	13	case	_	_
12	nucleosome-assembled	nucleosome-assembled	JJ	JJ	_	13	amod	_	_
13	DNA	dna	NN	NN	_	10	nmod	_	_
14	in	in	FW	FW	_	15	compound	_	_
15	vitro	vitro	FW	FW	_	13	advmod	_	_
16	.	.	.	.	_	1	punct	_	_

1	Lymphoid	lymphoid	NN	NN	_	3	compound	_	_
2	enhancer-binding	enhancer-binding	JJ	JJ	_	3	amod	_	_
3	factor	factor	NN	NN	_	17	nsubj	_	_
4	1	1	CD	CD	_	3	nummod	_	_
5	(	(	-LRB-	-LRB-	_	6	punct	_	_
6	LEF-1	lef-1	NN	NN	_	3	appos	_	_
7	)	)	-RRB-	-RRB-	_	6	punct	_	_
8	is	be	VBZ	VBZ	_	17	cop	_	_
9	a	a	DT	DT	_	17	det	_	_
10	regulatory	regulatory	JJ	JJ	_	17	amod	_	_
11	high	high	JJ	JJ	_	17	amod	_	_
12	mobility	mobility	NN	NN	_	17	compound	_	_
13	group	group	NN	NN	_	17	compound	_	_
14	(	(	-LRB-	-LRB-	_	17	punct	_	_
15	HMG	hmg	NN	NN	_	17	compound	_	_
16	)	)	-RRB-	-RRB-	_	17	punct	_	_
17	protein	protein	NN	NN	_	0	root	_	_
18	that	that	WDT	WDT	_	19	nsubj	_	_
19	activates	activate	VBZ	VBZ	_	17	acl:relcl	_	_
20	the	the	DT	DT	_	29	det	_	_
21	T	t	NN	NN	_	29	compound	_	_
22	cell	cell	NN	NN	_	29	compound	_	_
23	receptor	receptor	NN	NN	_	29	compound	_	_
24	alpha	alpha	NN	NN	_	29	compound	_	_
25	(	(	-LRB-	-LRB-	_	29	punct	_	_
26	TCR	tcr	NN	NN	_	29	compound	_	_
27	alpha	alpha	NN	NN	_	29	compound	_	_
28	)	)	-RRB-	-RRB-	_	29	punct	_	_
29	enhancer	enhancer	NN	NN	_	19	dobj	_	_
30	in	in	IN	IN	_	33	case	_	_
31	a	a	DT	DT	_	33	det	_	_
32	context-restricted	context-restricted	JJ	JJ	_	33	amod	_	_
33	manner	manner	NN	NN	_	19	nmod	_	_
34	in	in	IN	IN	_	36	case	_	_
35	T	t	NN	NN	_	36	compound	_	_
36	cells	cell	NNS	NNS	_	19	nmod	_	_
37	.	.	.	.	_	17	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	paper	paper	NN	NN	_	5	nmod	_	_
4	we	we	PRP	PRP	_	5	nsubj	_	_
5	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
6	that	that	IN	IN	_	30	mark	_	_
7	the	the	DT	DT	_	9	det	_	_
8	distal	distal	JJ	JJ	_	9	amod	_	_
9	region	region	NN	NN	_	30	nsubj	_	_
10	of	of	IN	IN	_	18	case	_	_
11	the	the	DT	DT	_	18	det	_	_
12	human	human	JJ	JJ	_	18	amod	_	_
13	immunodeficiency	immunodeficiency	NN	NN	_	18	compound	_	_
14	virus-1	virus-1	NN	NN	_	18	compound	_	_
15	(	(	-LRB-	-LRB-	_	18	punct	_	_
16	HIV-1	hiv-1	NN	NN	_	18	compound	_	_
17	)	)	-RRB-	-RRB-	_	18	punct	_	_
18	enhancer	enhancer	NN	NN	_	9	nmod	_	_
19	,	,	,	,	_	9	punct	_	_
20	which	which	WDT	WDT	_	21	nsubj	_	_
21	contains	contain	VBZ	VBZ	_	9	acl:relcl	_	_
22	DNA-binding	dna-binding	JJ	JJ	_	23	amod	_	_
23	sites	site	NNS	NNS	_	21	dobj	_	_
24	for	for	IN	IN	_	25	case	_	_
25	LEF-1	lef-1	NN	NN	_	23	nmod	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	Ets-1	ets-1	NN	NN	_	25	conj	_	_
28	,	,	,	,	_	9	punct	_	_
29	also	also	RB	RB	_	30	advmod	_	_
30	provides	provide	VBZ	VBZ	_	5	ccomp	_	_
31	a	a	DT	DT	_	33	det	_	_
32	functional	functional	JJ	JJ	_	33	amod	_	_
33	context	context	NN	NN	_	30	dobj	_	_
34	for	for	IN	IN	_	35	case	_	_
35	activation	activation	NN	NN	_	33	nmod	_	_
36	by	by	IN	IN	_	37	case	_	_
37	LEF-1	lef-1	NN	NN	_	35	nmod	_	_
38	.	.	.	.	_	5	punct	_	_

1	First	first	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	show	show	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	11	mark	_	_
6	mutations	mutation	NNS	NNS	_	11	nsubj	_	_
7	in	in	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	LEF-1-binding	lef-1-binding	JJ	JJ	_	10	amod	_	_
10	site	site	NN	NN	_	6	nmod	_	_
11	inhibit	inhibit	VBP	VBP	_	4	ccomp	_	_
12	the	the	DT	DT	_	13	det	_	_
13	activity	activity	NN	NN	_	11	dobj	_	_
14	of	of	IN	IN	_	16	case	_	_
15	multimerized	multimerized	JJ	JJ	_	16	amod	_	_
16	copies	copy	NNS	NNS	_	13	nmod	_	_
17	of	of	IN	IN	_	20	case	_	_
18	the	the	DT	DT	_	20	det	_	_
19	HIV-1	hiv-1	NN	NN	_	20	compound	_	_
20	enhancer	enhancer	NN	NN	_	16	nmod	_	_
21	in	in	IN	IN	_	24	case	_	_
22	Jurkat	jurkat	NN	NN	_	24	compound	_	_
23	T	t	NN	NN	_	24	compound	_	_
24	cells	cell	NNS	NNS	_	11	nmod	_	_
25	,	,	,	,	_	11	punct	_	_
26	and	and	CC	CC	_	11	cc	_	_
27	that	that	IN	IN	_	30	mark	_	_
28	LEF-1/GAL4	lef-1/gal4	NN	NN	_	30	nsubj	_	_
29	can	can	MD	MD	_	30	aux	_	_
30	activate	activate	VB	VB	_	11	conj	_	_
31	a	a	DT	DT	_	34	det	_	_
32	GAL4-substituted	gal4-substituted	JJ	JJ	_	34	amod	_	_
33	HIV-1	hiv-1	NN	NN	_	34	compound	_	_
34	enhancer	enhancer	NN	NN	_	30	iobj	_	_
35	80-	80-	CD	CD	_	30	dobj	_	_
36	to	to	TO	TO	_	37	case	_	_
37	100-fold	100-fold	RB	RB	_	35	nmod	_	_
38	in	in	FW	FW	_	39	compound	_	_
39	vivo	vivo	FW	FW	_	30	advmod	_	_
40	.	.	.	.	_	4	punct	_	_

1	Second	second	RB	RB	_	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	recombinant	recombinant	JJ	JJ	_	4	amod	_	_
4	LEF-1	lef-1	NN	NN	_	6	nsubjpass	_	_
5	is	be	VBZ	VBZ	_	6	auxpass	_	_
6	shown	show	VBN	VBN	_	0	root	_	_
7	to	to	TO	TO	_	8	mark	_	_
8	activate	activate	VB	VB	_	6	xcomp	_	_
9	HIV-1	hiv-1	NN	NN	_	10	compound	_	_
10	transcription	transcription	NN	NN	_	8	dobj	_	_
11	on	on	IN	IN	_	13	case	_	_
12	chromatin-assembled	chromatin-assembled	JJ	JJ	_	13	amod	_	_
13	DNA	dna	NN	NN	_	10	nmod	_	_
14	in	in	FW	FW	_	15	compound	_	_
15	vitro	vitro	FW	FW	_	8	advmod	_	_
16	.	.	.	.	_	6	punct	_	_

1	By	by	IN	IN	_	2	mark	_	_
2	using	use	VBG	VBG	_	12	advcl	_	_
3	a	a	DT	DT	_	5	det	_	_
4	nucleosome-assembly	nucleosome-assembly	JJ	JJ	_	5	amod	_	_
5	system	system	NN	NN	_	2	dobj	_	_
6	derived	derive	VBN	VBN	_	5	acl	_	_
7	from	from	IN	IN	_	9	case	_	_
8	Drosophila	drosophila	FW	FW	_	9	compound	_	_
9	embryos	embryo	NNS	NNS	_	6	nmod	_	_
10	,	,	,	,	_	12	punct	_	_
11	we	we	PRP	PRP	_	12	nsubj	_	_
12	find	find	VBP	VBP	_	0	root	_	_
13	that	that	IN	IN	_	23	mark	_	_
14	the	the	DT	DT	_	15	det	_	_
15	packaging	packaging	NN	NN	_	23	nsubj	_	_
16	of	of	IN	IN	_	17	case	_	_
17	DNA	dna	NN	NN	_	15	nmod	_	_
18	into	into	IN	IN	_	19	case	_	_
19	chromatin	chromatin	NN	NN	_	15	nmod	_	_
20	in	in	FW	FW	_	21	compound	_	_
21	vitro	vitro	FW	FW	_	15	advmod	_	_
22	strongly	strongly	RB	RB	_	23	advmod	_	_
23	represses	repress	VBZ	VBZ	_	12	ccomp	_	_
24	HIV-1	hiv-1	NN	NN	_	25	compound	_	_
25	transcription	transcription	NN	NN	_	23	dobj	_	_
26	and	and	CC	CC	_	23	cc	_	_
27	that	that	IN	IN	_	31	mark	_	_
28	repression	repression	NN	NN	_	31	nsubjpass	_	_
29	can	can	MD	MD	_	31	aux	_	_
30	be	be	VB	VB	_	31	auxpass	_	_
31	counteracted	counteract	VBN	VBN	_	23	conj	_	_
32	efficiently	efficiently	RB	RB	_	31	advmod	_	_
33	by	by	IN	IN	_	34	case	_	_
34	preincubation	preincubation	NN	NN	_	31	nmod	_	_
35	of	of	IN	IN	_	37	case	_	_
36	the	the	DT	DT	_	37	det	_	_
37	DNA	dna	NN	NN	_	34	nmod	_	_
38	with	with	IN	IN	_	39	case	_	_
39	LEF-1	lef-1	NN	NN	_	34	nmod	_	_
40	(	(	-LRB-	-LRB-	_	42	punct	_	_
41	or	or	CC	CC	_	42	cc	_	_
42	LEF-1	lef-1	NN	NN	_	39	dep	_	_
43	and	and	CC	CC	_	42	cc	_	_
44	Ets-1	ets-1	NN	NN	_	42	conj	_	_
45	)	)	-RRB-	-RRB-	_	42	punct	_	_
46	supplemented	supplement	VBN	VBN	_	39	acl	_	_
47	with	with	IN	IN	_	48	case	_	_
48	fractions	fraction	NNS	NNS	_	46	nmod	_	_
49	containing	contain	VBG	VBG	_	48	acl	_	_
50	the	the	DT	DT	_	52	det	_	_
51	promoter-binding	promoter-binding	JJ	JJ	_	52	amod	_	_
52	protein	protein	NN	NN	_	49	dobj	_	_
53	,	,	,	,	_	52	punct	_	_
54	Sp1	sp1	NN	NN	_	52	appos	_	_
55	.	.	.	.	_	12	punct	_	_

1	Addition	addition	NN	NN	_	20	nsubj	_	_
2	of	of	IN	IN	_	3	case	_	_
3	TFE-3	tfe-3	NN	NN	_	1	nmod	_	_
4	,	,	,	,	_	3	punct	_	_
5	which	which	WDT	WDT	_	6	nsubj	_	_
6	binds	bind	VBZ	VBZ	_	3	acl:relcl	_	_
7	to	to	TO	TO	_	10	case	_	_
8	an	a	DT	DT	_	10	det	_	_
9	E-box	e-box	NN	NN	_	10	compound	_	_
10	motif	motif	NN	NN	_	6	nmod	_	_
11	upstream	upstream	JJ	JJ	_	10	advmod	_	_
12	of	of	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	dep	_	_
14	LEF-1	lef-1	NN	NN	_	11	nmod	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	Ets-1	ets-1	NN	NN	_	14	conj	_	_
17	sites	site	NNS	NNS	_	14	dep	_	_
18	,	,	,	,	_	1	punct	_	_
19	further	further	RB	RB	_	20	advmod	_	_
20	augments	augment	VBZ	VBZ	_	0	root	_	_
21	transcription	transcription	NN	NN	_	20	dobj	_	_
22	in	in	IN	IN	_	24	case	_	_
23	this	this	DT	DT	_	24	det	_	_
24	system	system	NN	NN	_	21	nmod	_	_
25	.	.	.	.	_	20	punct	_	_

1	Individually	individually	RB	RB	_	2	advmod	_	_
2	or	or	CC	CC	_	20	advmod	_	_
3	collectively	collectively	RB	RB	_	2	advmod	_	_
4	,	,	,	,	_	20	punct	_	_
5	none	none	NN	NN	_	20	nsubj	_	_
6	of	of	IN	IN	_	10	case	_	_
7	the	the	DT	DT	_	10	det	_	_
8	three	three	CD	CD	_	10	nummod	_	_
9	enhancer-binding	enhancer-binding	JJ	JJ	_	10	amod	_	_
10	proteins	protein	NNS	NNS	_	5	nmod	_	_
11	(	(	-LRB-	-LRB-	_	12	punct	_	_
12	LEF-1	lef-1	NN	NN	_	10	dep	_	_
13	,	,	,	,	_	12	punct	_	_
14	Ets-1	ets-1	NN	NN	_	12	conj	_	_
15	,	,	,	,	_	12	punct	_	_
16	and	and	CC	CC	_	12	cc	_	_
17	TFE-3	tfe-3	NN	NN	_	12	conj	_	_
18	)	)	-RRB-	-RRB-	_	12	punct	_	_
19	could	could	MD	MD	_	20	aux	_	_
20	activate	activate	VB	VB	_	0	root	_	_
21	transcription	transcription	NN	NN	_	20	dobj	_	_
22	in	in	IN	IN	_	24	case	_	_
23	the	the	DT	DT	_	24	det	_	_
24	absence	absence	NN	NN	_	20	nmod	_	_
25	of	of	IN	IN	_	26	case	_	_
26	Sp1	sp1	NN	NN	_	24	nmod	_	_
27	.	.	.	.	_	20	punct	_	_

1	A	a	DT	DT	_	3	det	_	_
2	truncation	truncation	NN	NN	_	3	compound	_	_
3	mutant	mutant	NN	NN	_	23	nsubj	_	_
4	of	of	IN	IN	_	5	case	_	_
5	LEF-1	lef-1	NN	NN	_	3	nmod	_	_
6	(	(	-LRB-	-LRB-	_	7	punct	_	_
7	HMG-88	hmg-88	CD	CD	_	3	appos	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	,	,	,	,	_	3	punct	_	_
10	which	which	WDT	WDT	_	11	nsubj	_	_
11	contains	contain	VBZ	VBZ	_	3	acl:relcl	_	_
12	the	the	DT	DT	_	14	det	_	_
13	HMG	hmg	NN	NN	_	14	compound	_	_
14	box	box	NN	NN	_	11	dobj	_	_
15	but	but	CC	CC	_	11	cc	_	_
16	lacks	lack	VBZ	VBZ	_	11	conj	_	_
17	the	the	DT	DT	_	19	det	_	_
18	trans-activation	trans-activation	JJ	JJ	_	19	amod	_	_
19	domain	domain	NN	NN	_	16	dobj	_	_
20	,	,	,	,	_	3	punct	_	_
21	did	do	VBD	VBD	_	23	aux	_	_
22	not	not	RB	RB	_	23	neg	_	_
23	activate	activate	VB	VB	_	0	root	_	_
24	transcription	transcription	NN	NN	_	23	dobj	_	_
25	from	from	IN	IN	_	27	case	_	_
26	nucleosomal	nucleosomal	JJ	JJ	_	27	amod	_	_
27	DNA	dna	NN	NN	_	24	nmod	_	_
28	,	,	,	,	_	23	punct	_	_
29	indicating	indicate	VBG	VBG	_	23	advcl	_	_
30	that	that	IN	IN	_	40	mark	_	_
31	bending	bending	NN	NN	_	40	nsubj	_	_
32	of	of	IN	IN	_	33	case	_	_
33	DNA	dna	NN	NN	_	31	nmod	_	_
34	by	by	IN	IN	_	37	case	_	_
35	the	the	DT	DT	_	37	det	_	_
36	HMG	hmg	NN	NN	_	37	compound	_	_
37	domain	domain	NN	NN	_	31	nmod	_	_
38	is	be	VBZ	VBZ	_	40	cop	_	_
39	not	not	RB	RB	_	40	neg	_	_
40	sufficient	sufficient	JJ	JJ	_	29	ccomp	_	_
41	to	to	TO	TO	_	42	mark	_	_
42	activate	activate	VB	VB	_	40	xcomp	_	_
43	transcription	transcription	NN	NN	_	42	dobj	_	_
44	in	in	FW	FW	_	45	compound	_	_
45	vitro	vitro	FW	FW	_	42	advmod	_	_
46	.	.	.	.	_	23	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	conclude	conclude	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	13	mark	_	_
4	transcription	transcription	NN	NN	_	5	compound	_	_
5	activation	activation	NN	NN	_	13	nsubj	_	_
6	by	by	IN	IN	_	7	case	_	_
7	LEF-1	lef-1	NN	NN	_	5	nmod	_	_
8	in	in	FW	FW	_	9	compound	_	_
9	vitro	vitro	FW	FW	_	5	advmod	_	_
10	is	be	VBZ	VBZ	_	13	cop	_	_
11	a	a	DT	DT	_	13	det	_	_
12	chromatin-dependent	chromatin-dependent	JJ	JJ	_	13	amod	_	_
13	process	process	NN	NN	_	2	ccomp	_	_
14	that	that	WDT	WDT	_	15	nsubj	_	_
15	requires	require	VBZ	VBZ	_	13	acl:relcl	_	_
16	a	a	DT	DT	_	19	det	_	_
17	functional	functional	JJ	JJ	_	19	amod	_	_
18	trans-activation	trans-activation	NN	NN	_	19	compound	_	_
19	domain	domain	NN	NN	_	15	dobj	_	_
20	in	in	IN	IN	_	21	case	_	_
21	addition	addition	NN	NN	_	15	nmod	_	_
22	to	to	TO	TO	_	25	case	_	_
23	the	the	DT	DT	_	25	det	_	_
24	HMG	hmg	NN	NN	_	25	compound	_	_
25	domain	domain	NN	NN	_	21	nmod	_	_
26	.	.	.	.	_	2	punct	_	_

1	TCL1	tcl1	NN	NN	_	3	compound	_	_
2	oncogene	oncogene	NN	NN	_	3	compound	_	_
3	activation	activation	NN	NN	_	0	root	_	_
4	in	in	IN	IN	_	7	case	_	_
5	preleukemic	preleukemic	JJ	JJ	_	7	amod	_	_
6	T	t	NN	NN	_	7	compound	_	_
7	cells	cell	NNS	NNS	_	3	nmod	_	_
8	from	from	IN	IN	_	10	case	_	_
9	a	a	DT	DT	_	10	det	_	_
10	case	case	NN	NN	_	7	nmod	_	_
11	of	of	IN	IN	_	12	case	_	_
12	ataxia-telangiectasia	ataxia-telangiectasia	NN	NN	_	10	nmod	_	_
13	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	TCL1	tcl1	NN	NN	_	3	compound	_	_
3	oncogene	oncogene	NN	NN	_	9	nsubjpass	_	_
4	on	on	IN	IN	_	6	case	_	_
5	human	human	JJ	JJ	_	6	amod	_	_
6	chromosome	chromosome	NN	NN	_	3	nmod	_	_
7	14q32.1	14q32.1	NN	NN	_	6	dep	_	_
8	is	be	VBZ	VBZ	_	9	auxpass	_	_
9	involved	involve	VBN	VBN	_	0	root	_	_
10	in	in	IN	IN	_	11	case	_	_
11	chromosome	chromosome	NN	NN	_	9	nmod	_	_
12	translocations	translocation	NNS	NNS	_	11	dep	_	_
13	-LSB-	-lsb-	-LRB-	-LRB-	_	14	punct	_	_
14	t(14;14)(q11;q32.1)	t(14;14)(q11;q32.1)	NN	NN	_	12	dep	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	t(7;14)(q35;q32.1)	t(7;14)(q35;q32.1)	NN	NN	_	14	conj	_	_
17	-RSB-	-rsb-	-RRB-	-RRB-	_	14	punct	_	_
18	and	and	CC	CC	_	11	cc	_	_
19	inversions	inversion	NNS	NNS	_	11	conj	_	_
20	-LSB-	-lsb-	-LRB-	-LRB-	_	21	punct	_	_
21	inv14(q11;q32.1)	inv14(q11;q32.1)	NN	NN	_	19	appos	_	_
22	-RSB-	-rsb-	-RRB-	-RRB-	_	21	punct	_	_
23	with	with	IN	IN	_	26	case	_	_
24	TCR	tcr	NN	NN	_	26	compound	_	_
25	alpha/beta	alpha/beta	NN	NN	_	26	compound	_	_
26	loci	locus	NNS	NNS	_	19	nmod	_	_
27	in	in	IN	IN	_	29	case	_	_
28	T-cell	t-cell	NN	NN	_	29	compound	_	_
29	leukemias	leukemia	NNS	NNS	_	26	nmod	_	_
30	,	,	,	,	_	29	punct	_	_
31	such	such	JJ	JJ	_	33	case	_	_
32	as	as	IN	IN	_	31	mwe	_	_
33	T-prolymphocytic	t-prolymphocytic	JJ	JJ	_	29	nmod	_	_
34	(	(	-LRB-	-LRB-	_	35	punct	_	_
35	T-PLL	t-pll	NN	NN	_	33	appos	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	.	.	.	.	_	9	punct	_	_

1	It	it	PRP	PRP	_	4	nsubjpass	_	_
2	is	be	VBZ	VBZ	_	4	auxpass	_	_
3	also	also	RB	RB	_	4	advmod	_	_
4	involved	involve	VBN	VBN	_	0	root	_	_
5	in	in	IN	IN	_	6	case	_	_
6	T-acute	t-acute	JJ	JJ	_	4	nmod	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	-chronic	-chronic	JJ	JJ	_	6	conj	_	_
9	leukemias	leukemia	NNS	NNS	_	6	dep	_	_
10	arising	arise	VBG	VBG	_	6	acl	_	_
11	in	in	IN	IN	_	12	case	_	_
12	cases	case	NNS	NNS	_	10	nmod	_	_
13	of	of	IN	IN	_	14	case	_	_
14	ataxia-telangiectasia	ataxia-telangiectasia	NN	NN	_	12	nmod	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	AT	at	NN	NN	_	14	appos	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	,	,	,	,	_	14	punct	_	_
19	an	a	DT	DT	_	21	det	_	_
20	immunodeficiency	immunodeficiency	NN	NN	_	21	compound	_	_
21	syndrome	syndrome	NN	NN	_	14	appos	_	_
22	.	.	.	.	_	4	punct	_	_

1	Similar	similar	JJ	JJ	_	3	amod	_	_
2	chromosomal	chromosomal	JJ	JJ	_	3	amod	_	_
3	rearrangements	rearrangement	NNS	NNS	_	4	nsubj	_	_
4	occur	occur	VBP	VBP	_	0	root	_	_
5	also	also	RB	RB	_	4	advmod	_	_
6	in	in	IN	IN	_	11	case	_	_
7	the	the	DT	DT	_	11	det	_	_
8	clonally	clonally	RB	RB	_	9	advmod	_	_
9	expanded	expand	VBN	VBN	_	11	amod	_	_
10	T	t	NN	NN	_	11	compound	_	_
11	cells	cell	NNS	NNS	_	4	nmod	_	_
12	in	in	IN	IN	_	14	case	_	_
13	AT	at	NN	NN	_	14	compound	_	_
14	patients	patient	NNS	NNS	_	11	nmod	_	_
15	before	before	IN	IN	_	17	case	_	_
16	the	the	DT	DT	_	17	det	_	_
17	appearance	appearance	NN	NN	_	4	nmod	_	_
18	of	of	IN	IN	_	21	case	_	_
19	the	the	DT	DT	_	21	det	_	_
20	overt	overt	JJ	JJ	_	21	amod	_	_
21	leukemia	leukemia	NN	NN	_	17	nmod	_	_
22	.	.	.	.	_	4	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	analyzed	analyze	VBN	VBN	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	expression	expression	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	8	case	_	_
7	TCL1	tcl1	NN	NN	_	8	compound	_	_
8	mRNA	mrna	NN	NN	_	5	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	protein	protein	NN	NN	_	8	conj	_	_
11	in	in	IN	IN	_	14	case	_	_
12	peripheral	peripheral	JJ	JJ	_	14	amod	_	_
13	blood	blood	NN	NN	_	14	compound	_	_
14	lymphocytes	lymphocyte	NNS	NNS	_	3	nmod	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	PBLs	pbl	NNS	NNS	_	14	appos	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	from	from	IN	IN	_	21	case	_	_
19	four	four	CD	CD	_	21	nummod	_	_
20	AT	at	NN	NN	_	21	compound	_	_
21	cases	case	NNS	NNS	_	14	nmod	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	from	from	IN	IN	_	25	case	_	_
24	healthy	healthy	JJ	JJ	_	25	amod	_	_
25	controls	control	NNS	NNS	_	21	conj	_	_
26	.	.	.	.	_	3	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	found	find	VBD	VBD	_	0	root	_	_
3	that	that	IN	IN	_	8	mark	_	_
4	the	the	DT	DT	_	6	det	_	_
5	TCL1	tcl1	NN	NN	_	6	compound	_	_
6	gene	gene	NN	NN	_	8	nsubjpass	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	overexpressed	overexpress	VBN	VBN	_	2	ccomp	_	_
9	in	in	IN	IN	_	11	case	_	_
10	the	the	DT	DT	_	11	det	_	_
11	PBLs	pbl	NNS	NNS	_	8	nmod	_	_
12	of	of	IN	IN	_	15	case	_	_
13	an	a	DT	DT	_	15	det	_	_
14	AT	at	NN	NN	_	15	compound	_	_
15	patient	patient	NN	NN	_	11	nmod	_	_
16	with	with	IN	IN	_	21	case	_	_
17	a	a	DT	DT	_	21	det	_	_
18	large	large	JJ	JJ	_	21	amod	_	_
19	clonal	clonal	JJ	JJ	_	21	amod	_	_
20	T-cell	t-cell	NN	NN	_	21	compound	_	_
21	population	population	NN	NN	_	15	nmod	_	_
22	exhibiting	exhibit	VBG	VBG	_	21	acl	_	_
23	the	the	DT	DT	_	25	det	_	_
24	t(14;14)	t(14;14)	NN	NN	_	25	compound	_	_
25	translocation	translocation	NN	NN	_	22	dobj	_	_
26	but	but	CC	CC	_	11	cc	_	_
27	not	not	RB	RB	_	30	neg	_	_
28	in	in	IN	IN	_	30	case	_	_
29	the	the	DT	DT	_	30	det	_	_
30	lymphocytes	lymphocyte	NNS	NNS	_	11	conj	_	_
31	of	of	IN	IN	_	34	case	_	_
32	the	the	DT	DT	_	34	det	_	_
33	other	other	JJ	JJ	_	34	amod	_	_
34	cases	case	NNS	NNS	_	30	nmod	_	_
35	.	.	.	.	_	2	punct	_	_

1	Fluorescence	fluorescence	NN	NN	_	4	compound	_	_
2	in	in	FW	FW	_	4	amod	_	_
3	situ	situ	FW	FW	_	2	dep	_	_
4	hybridization	hybridization	NN	NN	_	22	nsubj	_	_
5	of	of	IN	IN	_	9	case	_	_
6	the	the	DT	DT	_	9	det	_	_
7	TCL1	tcl1	NN	NN	_	9	compound	_	_
8	genomic	genomic	JJ	JJ	_	9	amod	_	_
9	locus	locus	NN	NN	_	4	nmod	_	_
10	to	to	TO	TO	_	12	case	_	_
11	lymphocyte	lymphocyte	NN	NN	_	12	compound	_	_
12	metaphases	metaphase	NNS	NNS	_	4	nmod	_	_
13	from	from	IN	IN	_	16	case	_	_
14	the	the	DT	DT	_	16	det	_	_
15	AT	at	NN	NN	_	16	compound	_	_
16	patient	patient	NN	NN	_	12	nmod	_	_
17	with	with	IN	IN	_	21	case	_	_
18	the	the	DT	DT	_	21	det	_	_
19	T-cell	t-cell	NN	NN	_	21	compound	_	_
20	clonal	clonal	JJ	JJ	_	21	amod	_	_
21	expansion	expansion	NN	NN	_	16	nmod	_	_
22	showed	show	VBD	VBD	_	0	root	_	_
23	that	that	IN	IN	_	30	mark	_	_
24	the	the	DT	DT	_	25	det	_	_
25	breakpoint	breakpoint	NN	NN	_	30	nsubj	_	_
26	of	of	IN	IN	_	29	case	_	_
27	the	the	DT	DT	_	29	det	_	_
28	t(14;14)	t(14;14)	NN	NN	_	29	compound	_	_
29	translocation	translocation	NN	NN	_	25	nmod	_	_
30	lies	lie	VBZ	VBZ	_	22	ccomp	_	_
31	within	within	IN	IN	_	34	case	_	_
32	the	the	DT	DT	_	34	det	_	_
33	TCL1	tcl1	NN	NN	_	34	compound	_	_
34	locus	locus	NN	NN	_	30	nmod	_	_
35	and	and	CC	CC	_	30	cc	_	_
36	is	be	VBZ	VBZ	_	37	auxpass	_	_
37	accompanied	accompany	VBN	VBN	_	30	conj	_	_
38	by	by	IN	IN	_	41	case	_	_
39	an	a	DT	DT	_	41	det	_	_
40	inverted	invert	VBN	VBN	_	41	amod	_	_
41	duplication	duplication	NN	NN	_	37	nmod	_	_
42	of	of	IN	IN	_	45	case	_	_
43	the	the	DT	DT	_	45	det	_	_
44	distal	distal	JJ	JJ	_	45	amod	_	_
45	part	part	NN	NN	_	41	nmod	_	_
46	of	of	IN	IN	_	47	case	_	_
47	chromosome	chromosome	NN	NN	_	45	nmod	_	_
48	14	14	CD	CD	_	47	nummod	_	_
49	.	.	.	.	_	22	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	7	mark	_	_
5	TCL1	tcl1	NN	NN	_	7	nsubjpass	_	_
6	is	be	VBZ	VBZ	_	7	auxpass	_	_
7	activated	activate	VBN	VBN	_	3	ccomp	_	_
8	in	in	IN	IN	_	11	case	_	_
9	preleukemic	preleukemic	JJ	JJ	_	11	amod	_	_
10	clonal	clonal	JJ	JJ	_	11	amod	_	_
11	cells	cell	NNS	NNS	_	7	nmod	_	_
12	as	as	IN	IN	_	14	case	_	_
13	a	a	DT	DT	_	14	det	_	_
14	consequence	consequence	NN	NN	_	7	nmod	_	_
15	of	of	IN	IN	_	17	case	_	_
16	chromosome	chromosome	NN	NN	_	17	compound	_	_
17	translocation	translocation	NN	NN	_	14	nmod	_	_
18	involving	involving	NN	NN	_	17	dep	_	_
19	sequences	sequence	NNS	NNS	_	18	dobj	_	_
20	from	from	IN	IN	_	23	case	_	_
21	the	the	DT	DT	_	23	det	_	_
22	TCR	tcr	NN	NN	_	23	compound	_	_
23	locus	locus	NN	NN	_	19	nmod	_	_
24	at	at	IN	IN	_	25	case	_	_
25	14q11	14q11	NN	NN	_	23	nmod	_	_
26	.	.	.	.	_	3	punct	_	_

1	Deregulation	deregulation	NN	NN	_	7	nsubj	_	_
2	of	of	IN	IN	_	3	case	_	_
3	TCL1	tcl1	NN	NN	_	1	nmod	_	_
4	is	be	VBZ	VBZ	_	7	cop	_	_
5	the	the	DT	DT	_	7	det	_	_
6	first	first	JJ	JJ	_	7	amod	_	_
7	event	event	NN	NN	_	0	root	_	_
8	in	in	IN	IN	_	10	case	_	_
9	the	the	DT	DT	_	10	det	_	_
10	initiation	initiation	NN	NN	_	7	nmod	_	_
11	of	of	IN	IN	_	12	case	_	_
12	malignancy	malignancy	NN	NN	_	10	nmod	_	_
13	in	in	IN	IN	_	15	case	_	_
14	these	these	DT	DT	_	15	det	_	_
15	types	type	NNS	NNS	_	7	nmod	_	_
16	of	of	IN	IN	_	17	case	_	_
17	leukemias	leukemia	NNS	NNS	_	15	nmod	_	_
18	and	and	CC	CC	_	7	cc	_	_
19	represents	represent	VBZ	VBZ	_	7	conj	_	_
20	a	a	DT	DT	_	22	det	_	_
21	potential	potential	JJ	JJ	_	22	amod	_	_
22	tool	tool	NN	NN	_	19	dobj	_	_
23	for	for	IN	IN	_	25	case	_	_
24	clinical	clinical	JJ	JJ	_	25	amod	_	_
25	evaluation	evaluation	NN	NN	_	22	nmod	_	_
26	.	.	.	.	_	7	punct	_	_

1	Ubiquitin-mediated	ubiquitin-mediated	JJ	JJ	_	2	amod	_	_
2	processing	processing	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	5	case	_	_
4	NF-kappa	nf-kappa	NN	NN	_	5	compound	_	_
5	B	b	NN	NN	_	2	nmod	_	_
6	transcriptional	transcriptional	JJ	JJ	_	8	amod	_	_
7	activator	activator	NN	NN	_	8	compound	_	_
8	precursor	precursor	NN	NN	_	5	dep	_	_
9	p105	p105	NN	NN	_	5	dep	_	_
10	.	.	.	.	_	2	punct	_	_

1	Reconstitution	reconstitution	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	5	case	_	_
3	a	a	DT	DT	_	5	det	_	_
4	cell-free	cell-free	JJ	JJ	_	5	amod	_	_
5	system	system	NN	NN	_	1	nmod	_	_
6	and	and	CC	CC	_	1	cc	_	_
7	identification	identification	NN	NN	_	1	conj	_	_
8	of	of	IN	IN	_	11	case	_	_
9	the	the	DT	DT	_	11	det	_	_
10	ubiquitin-carrier	ubiquitin-carrier	JJ	JJ	_	11	amod	_	_
11	protein	protein	NN	NN	_	7	nmod	_	_
12	,	,	,	,	_	11	punct	_	_
13	E2	e2	NN	NN	_	11	appos	_	_
14	,	,	,	,	_	11	punct	_	_
15	and	and	CC	CC	_	11	cc	_	_
16	a	a	DT	DT	_	19	det	_	_
17	novel	novel	JJ	JJ	_	19	amod	_	_
18	ubiquitin-protein	ubiquitin-protein	JJ	JJ	_	19	amod	_	_
19	ligase	ligase	NN	NN	_	11	conj	_	_
20	,	,	,	,	_	11	punct	_	_
21	E3	e3	NN	NN	_	11	conj	_	_
22	,	,	,	,	_	11	punct	_	_
23	involved	involve	VBN	VBN	_	11	acl	_	_
24	in	in	IN	IN	_	25	case	_	_
25	conjugation	conjugation	NN	NN	_	23	nmod	_	_
26	.	.	.	.	_	1	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	most	most	JJS	JJS	_	3	amod	_	_
3	cases	case	NNS	NNS	_	12	nmod	_	_
4	,	,	,	,	_	12	punct	_	_
5	the	the	DT	DT	_	7	det	_	_
6	transcriptional	transcriptional	JJ	JJ	_	7	amod	_	_
7	factor	factor	NN	NN	_	12	nsubj	_	_
8	NF-kappa	nf-kappa	NN	NN	_	9	compound	_	_
9	B	b	NN	NN	_	7	dep	_	_
10	is	be	VBZ	VBZ	_	12	cop	_	_
11	a	a	DT	DT	_	12	det	_	_
12	heterodimer	heterodimer	NN	NN	_	0	root	_	_
13	consisting	consist	VBG	VBG	_	12	acl	_	_
14	of	of	IN	IN	_	16	case	_	_
15	two	two	CD	CD	_	16	nummod	_	_
16	subunits	subunit	NNS	NNS	_	13	nmod	_	_
17	,	,	,	,	_	16	punct	_	_
18	p50	p50	NN	NN	_	16	appos	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	p65	p65	NN	NN	_	18	conj	_	_
21	,	,	,	,	_	16	punct	_	_
22	which	which	WDT	WDT	_	24	nsubjpass	_	_
23	are	be	VBP	VBP	_	24	auxpass	_	_
24	encoded	encode	VBN	VBN	_	16	acl:relcl	_	_
25	by	by	IN	IN	_	28	case	_	_
26	two	two	CD	CD	_	28	nummod	_	_
27	distinct	distinct	JJ	JJ	_	28	amod	_	_
28	genes	gene	NNS	NNS	_	24	nmod	_	_
29	of	of	IN	IN	_	32	case	_	_
30	the	the	DT	DT	_	32	det	_	_
31	Rel	rel	NN	NN	_	32	compound	_	_
32	family	family	NN	NN	_	28	nmod	_	_
33	.	.	.	.	_	12	punct	_	_

1	p50	p50	NN	NN	_	3	nsubjpass	_	_
2	is	be	VBZ	VBZ	_	3	auxpass	_	_
3	translated	translate	VBN	VBN	_	0	root	_	_
4	as	as	IN	IN	_	6	case	_	_
5	a	a	DT	DT	_	6	det	_	_
6	precursor	precursor	NN	NN	_	3	nmod	_	_
7	of	of	IN	IN	_	9	case	_	_
8	105	105	CD	CD	_	9	nummod	_	_
9	kDa	kda	NN	NN	_	6	nmod	_	_
10	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	C-terminal	c-terminal	JJ	JJ	_	3	amod	_	_
3	domain	domain	NN	NN	_	9	nsubjpass	_	_
4	of	of	IN	IN	_	6	case	_	_
5	the	the	DT	DT	_	6	det	_	_
6	precursor	precursor	NN	NN	_	3	nmod	_	_
7	is	be	VBZ	VBZ	_	9	auxpass	_	_
8	rapidly	rapidly	RB	RB	_	9	advmod	_	_
9	degraded	degrade	VBN	VBN	_	0	root	_	_
10	,	,	,	,	_	9	punct	_	_
11	forming	form	VBG	VBG	_	9	advcl	_	_
12	the	the	DT	DT	_	15	det	_	_
13	mature	mature	JJ	JJ	_	15	amod	_	_
14	p50	p50	NN	NN	_	15	compound	_	_
15	subunit	subunit	NN	NN	_	11	dobj	_	_
16	consisted	consist	VBN	VBN	_	15	acl	_	_
17	of	of	IN	IN	_	20	case	_	_
18	the	the	DT	DT	_	20	det	_	_
19	N-terminal	n-terminal	JJ	JJ	_	20	amod	_	_
20	region	region	NN	NN	_	16	nmod	_	_
21	of	of	IN	IN	_	23	case	_	_
22	the	the	DT	DT	_	23	det	_	_
23	molecule	molecule	NN	NN	_	20	nmod	_	_
24	.	.	.	.	_	9	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	mechanism	mechanism	NN	NN	_	9	nsubjpass	_	_
3	of	of	IN	IN	_	4	case	_	_
4	generation	generation	NN	NN	_	2	nmod	_	_
5	of	of	IN	IN	_	6	case	_	_
6	p50	p50	NN	NN	_	4	nmod	_	_
7	is	be	VBZ	VBZ	_	9	auxpass	_	_
8	not	not	RB	RB	_	9	neg	_	_
9	known	know	VBN	VBN	_	0	root	_	_
10	.	.	.	.	_	9	punct	_	_

1	It	it	PRP	PRP	_	4	nsubjpass	_	_
2	has	have	VBZ	VBZ	_	4	aux	_	_
3	been	be	VBN	VBN	_	4	auxpass	_	_
4	suggested	suggest	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	10	mark	_	_
6	the	the	DT	DT	_	8	det	_	_
7	ubiquitin-proteasome	ubiquitin-proteasome	JJ	JJ	_	8	amod	_	_
8	system	system	NN	NN	_	10	nsubjpass	_	_
9	is	be	VBZ	VBZ	_	10	auxpass	_	_
10	involved	involve	VBN	VBN	_	4	ccomp	_	_
11	in	in	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	process	process	NN	NN	_	10	nmod	_	_
14	;	;	:	:	_	4	punct	_	_
15	however	however	RB	RB	_	39	advmod	_	_
16	,	,	,	,	_	39	punct	_	_
17	the	the	DT	DT	_	19	det	_	_
18	specific	specific	JJ	JJ	_	19	amod	_	_
19	enzymes	enzyme	NNS	NNS	_	39	nsubj	_	_
20	involved	involve	VBN	VBN	_	19	acl	_	_
21	and	and	CC	CC	_	19	cc	_	_
22	the	the	DT	DT	_	23	det	_	_
23	mechanism	mechanism	NN	NN	_	19	conj	_	_
24	of	of	IN	IN	_	26	case	_	_
25	limited	limited	JJ	JJ	_	26	amod	_	_
26	proteolysis	proteolysis	NN	NN	_	23	nmod	_	_
27	,	,	,	,	_	26	punct	_	_
28	in	in	IN	IN	_	29	case	_	_
29	which	which	WDT	WDT	_	35	nmod	_	_
30	half	half	NN	NN	_	35	nsubjpass	_	_
31	of	of	IN	IN	_	33	case	_	_
32	the	the	DT	DT	_	33	det	_	_
33	molecule	molecule	NN	NN	_	30	nmod	_	_
34	is	be	VBZ	VBZ	_	35	auxpass	_	_
35	spared	spare	VBN	VBN	_	26	acl:relcl	_	_
36	,	,	,	,	_	19	punct	_	_
37	have	have	VBP	VBP	_	39	aux	_	_
38	been	be	VBN	VBN	_	39	cop	_	_
39	obscure	obscure	JJ	JJ	_	4	parataxis	_	_
40	.	.	.	.	_	4	punct	_	_

1	Palombella	Palombella	NNP	NNP	_	30	nsubj	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	colleagues	colleague	NNS	NNS	_	1	conj	_	_
4	(	(	-LRB-	-LRB-	_	7	punct	_	_
5	Palombella	Palombella	NNP	NNP	_	7	compound	_	_
6	,	,	,	,	_	7	punct	_	_
7	V.J.	V.J.	NNP	NNP	_	1	dep	_	_
8	,	,	,	,	_	7	punct	_	_
9	Rando	Rando	NNP	NNP	_	11	compound	_	_
10	,	,	,	,	_	11	punct	_	_
11	O.J.	O.J.	NNP	NNP	_	7	conj	_	_
12	,	,	,	,	_	7	punct	_	_
13	Goldberg	Goldberg	NNP	NNP	_	15	compound	_	_
14	,	,	,	,	_	15	punct	_	_
15	A.L.	A.L.	NNP	NNP	_	7	conj	_	_
16	,	,	,	,	_	7	punct	_	_
17	and	and	CC	CC	_	7	cc	_	_
18	Maniatis	Maniatis	NNP	NNP	_	20	compound	_	_
19	,	,	,	,	_	20	punct	_	_
20	T.	T.	NNP	NNP	_	7	conj	_	_
21	(	(	-LRB-	-LRB-	_	22	punct	_	_
22	1994	1994	CD	CD	_	7	appos	_	_
23	)	)	-RRB-	-RRB-	_	22	punct	_	_
24	Cell	Cell	NNP	NNP	_	7	dep	_	_
25	78	78	CD	CD	_	24	nummod	_	_
26	,	,	,	,	_	7	punct	_	_
27	773-785	773-785	CD	CD	_	7	amod	_	_
28	)	)	-RRB-	-RRB-	_	7	punct	_	_
29	have	have	VBP	VBP	_	30	aux	_	_
30	shown	show	VBN	VBN	_	0	root	_	_
31	that	that	IN	IN	_	34	mark	_	_
32	ubiquitin	ubiquitin	NN	NN	_	34	nsubjpass	_	_
33	is	be	VBZ	VBZ	_	34	auxpass	_	_
34	required	require	VBN	VBN	_	30	ccomp	_	_
35	for	for	IN	IN	_	37	case	_	_
36	the	the	DT	DT	_	37	det	_	_
37	processing	processing	NN	NN	_	34	nmod	_	_
38	in	in	IN	IN	_	41	case	_	_
39	a	a	DT	DT	_	41	det	_	_
40	cell-free	cell-free	JJ	JJ	_	41	amod	_	_
41	system	system	NN	NN	_	37	nmod	_	_
42	of	of	IN	IN	_	50	case	_	_
43	a	a	DT	DT	_	50	det	_	_
44	truncated	truncate	VBN	VBN	_	50	amod	_	_
45	,	,	,	,	_	44	punct	_	_
46	artificially	artificially	RB	RB	_	47	advmod	_	_
47	constructed	construct	VBN	VBN	_	44	dep	_	_
48	,	,	,	,	_	50	punct	_	_
49	60-kDa	60-kda	JJ	JJ	_	50	amod	_	_
50	precursor	precursor	NN	NN	_	41	nmod	_	_
51	.	.	.	.	_	30	punct	_	_

1	They	they	PRP	PRP	_	4	nsubj	_	_
2	have	have	VBP	VBP	_	4	aux	_	_
3	also	also	RB	RB	_	4	advmod	_	_
4	shown	show	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	8	mark	_	_
6	proteasome	proteasome	NN	NN	_	7	compound	_	_
7	inhibitors	inhibitor	NNS	NNS	_	8	nsubj	_	_
8	block	block	VBP	VBP	_	4	ccomp	_	_
9	the	the	DT	DT	_	10	det	_	_
10	processing	processing	NN	NN	_	8	dobj	_	_
11	both	both	CC	CC	_	13	cc:preconj	_	_
12	in	in	FW	FW	_	13	compound	_	_
13	vitro	vitro	FW	FW	_	8	advmod	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	in	in	FW	FW	_	13	conj	_	_
16	vivo	vivo	FW	FW	_	15	dep	_	_
17	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	study	study	NN	NN	_	6	nmod	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
7	reconstitution	reconstitution	NN	NN	_	6	dobj	_	_
8	of	of	IN	IN	_	12	case	_	_
9	a	a	DT	DT	_	12	det	_	_
10	cell-free	cell-free	JJ	JJ	_	12	amod	_	_
11	processing	processing	NN	NN	_	12	compound	_	_
12	system	system	NN	NN	_	7	nmod	_	_
13	and	and	CC	CC	_	6	cc	_	_
14	demonstrate	demonstrate	VBP	VBP	_	6	conj	_	_
15	directly	directly	RB	RB	_	14	advmod	_	_
16	that	that	IN	IN	_	25	mark	_	_
17	:	:	:	:	_	25	punct	_	_
18	(	(	-LRB-	-LRB-	_	19	punct	_	_
19	a	a	LS	LS	_	25	dep	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	the	the	DT	DT	_	23	det	_	_
22	ubiquitin-proteasome	ubiquitin-proteasome	JJ	JJ	_	23	amod	_	_
23	system	system	NN	NN	_	25	nsubjpass	_	_
24	is	be	VBZ	VBZ	_	25	auxpass	_	_
25	involved	involve	VBN	VBN	_	14	ccomp	_	_
26	in	in	IN	IN	_	27	case	_	_
27	processing	processing	NN	NN	_	25	nmod	_	_
28	of	of	IN	IN	_	32	case	_	_
29	the	the	DT	DT	_	32	det	_	_
30	intact	intact	JJ	JJ	_	32	amod	_	_
31	p105	p105	NN	NN	_	32	compound	_	_
32	precursor	precursor	NN	NN	_	27	nmod	_	_
33	,	,	,	,	_	25	punct	_	_
34	(	(	-LRB-	-LRB-	_	35	punct	_	_
35	b	b	LS	LS	_	47	dep	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	conjugation	conjugation	NN	NN	_	47	nsubj	_	_
38	of	of	IN	IN	_	39	case	_	_
39	ubiquitin	ubiquitin	NN	NN	_	37	nmod	_	_
40	to	to	TO	TO	_	42	case	_	_
41	the	the	DT	DT	_	42	det	_	_
42	precursor	precursor	NN	NN	_	37	nmod	_	_
43	is	be	VBZ	VBZ	_	47	cop	_	_
44	an	a	DT	DT	_	47	det	_	_
45	essential	essential	JJ	JJ	_	47	amod	_	_
46	intermediate	intermediate	JJ	JJ	_	47	amod	_	_
47	step	step	NN	NN	_	25	ccomp	_	_
48	in	in	IN	IN	_	50	case	_	_
49	the	the	DT	DT	_	50	det	_	_
50	processing	processing	NN	NN	_	47	nmod	_	_
51	,	,	,	,	_	25	punct	_	_
52	(	(	-LRB-	-LRB-	_	53	punct	_	_
53	c	c	LS	LS	_	80	dep	_	_
54	)	)	-RRB-	-RRB-	_	53	punct	_	_
55	the	the	DT	DT	_	59	det	_	_
56	recently	recently	RB	RB	_	58	advmod	_	_
57	discovered	discover	VBN	VBN	_	58	dep	_	_
58	novel	novel	JJ	JJ	_	59	amod	_	_
59	species	species	NNS	NNS	_	80	nsubjpass	_	_
60	of	of	IN	IN	_	63	case	_	_
61	the	the	DT	DT	_	63	det	_	_
62	ubiquitin-carrier	ubiquitin-carrier	JJ	JJ	_	63	amod	_	_
63	protein	protein	NN	NN	_	59	nmod	_	_
64	,	,	,	,	_	59	punct	_	_
65	E2-F1	e2-f1	NN	NN	_	59	appos	_	_
66	,	,	,	,	_	59	punct	_	_
67	that	that	WDT	WDT	_	69	nsubjpass	_	_
68	is	be	VBZ	VBZ	_	69	auxpass	_	_
69	involved	involve	VBN	VBN	_	59	acl:relcl	_	_
70	in	in	IN	IN	_	72	case	_	_
71	the	the	DT	DT	_	72	dep	_	_
72	conjugation	conjugation	NN	NN	_	69	nmod	_	_
73	and	and	CC	CC	_	72	cc	_	_
74	degradation	degradation	NN	NN	_	72	conj	_	_
75	of	of	IN	IN	_	76	case	_	_
76	p53	p53	NN	NN	_	72	nmod	_	_
77	,	,	,	,	_	59	punct	_	_
78	is	be	VBZ	VBZ	_	80	auxpass	_	_
79	also	also	RB	RB	_	80	advmod	_	_
80	required	require	VBN	VBN	_	25	ccomp	_	_
81	for	for	IN	IN	_	84	case	_	_
82	the	the	DT	DT	_	84	det	_	_
83	limited	limited	JJ	JJ	_	84	amod	_	_
84	processing	processing	NN	NN	_	80	nmod	_	_
85	of	of	IN	IN	_	88	case	_	_
86	the	the	DT	DT	_	88	det	_	_
87	p105	p105	NN	NN	_	88	compound	_	_
88	precursor	precursor	NN	NN	_	84	nmod	_	_
89	,	,	,	,	_	25	punct	_	_
90	and	and	CC	CC	_	25	cc	_	_
91	(	(	-LRB-	-LRB-	_	92	punct	_	_
92	d	d	LS	LS	_	105	dep	_	_
93	)	)	-RRB-	-RRB-	_	92	punct	_	_
94	a	a	DT	DT	_	99	det	_	_
95	novel	novel	JJ	JJ	_	99	amod	_	_
96	,	,	,	,	_	99	punct	_	_
97	approximately	approximately	RB	RB	_	99	advmod	_	_
98	320-kDa	320-kda	CD	CD	_	99	nummod	_	_
99	species	species	NNS	NNS	_	105	nsubjpass	_	_
100	of	of	IN	IN	_	102	case	_	_
101	ubiquitin-protein	ubiquitin-protein	JJ	JJ	_	102	amod	_	_
102	ligase	ligase	NN	NN	_	99	nmod	_	_
103	,	,	,	,	_	99	punct	_	_
104	is	be	VBZ	VBZ	_	105	auxpass	_	_
105	involved	involve	VBN	VBN	_	25	conj	_	_
106	in	in	IN	IN	_	108	case	_	_
107	the	the	DT	DT	_	108	det	_	_
108	process	process	NN	NN	_	105	nmod	_	_
109	.	.	.	.	_	6	punct	_	_

1	This	this	DT	DT	_	3	det	_	_
2	novel	novel	JJ	JJ	_	3	amod	_	_
3	enzyme	enzyme	NN	NN	_	5	nsubj	_	_
4	is	be	VBZ	VBZ	_	5	cop	_	_
5	distinct	distinct	JJ	JJ	_	0	root	_	_
6	from	from	IN	IN	_	7	case	_	_
7	E6-AP	e6-ap	NN	NN	_	5	nmod	_	_
8	,	,	,	,	_	7	punct	_	_
9	the	the	DT	DT	_	11	det	_	_
10	p53-conjugating	p53-conjugating	NN	NN	_	11	compound	_	_
11	ligase	ligase	NN	NN	_	7	appos	_	_
12	,	,	,	,	_	7	punct	_	_
13	and	and	CC	CC	_	7	cc	_	_
14	from	from	IN	IN	_	16	case	_	_
15	E3	e3	NN	NN	_	16	compound	_	_
16	alpha	alpha	NN	NN	_	7	conj	_	_
17	,	,	,	,	_	16	punct	_	_
18	the	the	DT	DT	_	22	det	_	_
19	``	``	``	``	_	22	punct	_	_
20	N-end	n-end	JJ	JJ	_	22	amod	_	_
21	rule	rule	NN	NN	_	22	compound	_	_
22	ligase	ligase	NN	NN	_	16	appos	_	_
23	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	hematopoietic	hematopoietic	JJ	JJ	_	4	amod	_	_
3	transcription	transcription	NN	NN	_	4	compound	_	_
4	factor	factor	NN	NN	_	7	nsubjpass	_	_
5	PU.1	pu.1	NN	NN	_	4	dep	_	_
6	is	be	VBZ	VBZ	_	7	auxpass	_	_
7	downregulated	downregulate	VBN	VBN	_	0	root	_	_
8	in	in	IN	IN	_	13	case	_	_
9	human	human	JJ	JJ	_	13	amod	_	_
10	multiple	multiple	JJ	JJ	_	13	amod	_	_
11	myeloma	myeloma	NN	NN	_	13	compound	_	_
12	cell	cell	NN	NN	_	13	compound	_	_
13	lines	line	NNS	NNS	_	7	nmod	_	_
14	.	.	.	.	_	7	punct	_	_

1	PU.1	pu.1	NN	NN	_	6	nsubj	_	_
2	is	be	VBZ	VBZ	_	6	cop	_	_
3	a	a	DT	DT	_	6	det	_	_
4	hematopoietic	hematopoietic	JJ	JJ	_	6	amod	_	_
5	transcription	transcription	NN	NN	_	6	compound	_	_
6	factor	factor	NN	NN	_	0	root	_	_
7	belonging	belong	VBG	VBG	_	6	acl	_	_
8	to	to	TO	TO	_	10	case	_	_
9	the	the	DT	DT	_	10	det	_	_
10	Ets-family	ets-family	NN	NN	_	7	nmod	_	_
11	.	.	.	.	_	6	punct	_	_

1	It	it	PRP	PRP	_	3	nsubj	_	_
2	is	be	VBZ	VBZ	_	3	cop	_	_
3	identical	identical	JJ	JJ	_	0	root	_	_
4	to	to	TO	TO	_	7	case	_	_
5	the	the	DT	DT	_	7	det	_	_
6	Spi-1	spi-1	NN	NN	_	7	compound	_	_
7	oncogene	oncogene	NN	NN	_	3	nmod	_	_
8	,	,	,	,	_	7	punct	_	_
9	which	which	WDT	WDT	_	11	nsubjpass	_	_
10	is	be	VBZ	VBZ	_	11	auxpass	_	_
11	implicated	implicate	VBN	VBN	_	7	acl:relcl	_	_
12	in	in	IN	IN	_	17	case	_	_
13	spleen	spleen	NN	NN	_	14	nmod:npmod	_	_
14	focus-forming	focus-forming	JJ	JJ	_	17	amod	_	_
15	virus-induced	virus-induced	JJ	JJ	_	14	dep	_	_
16	murine	murine	JJ	JJ	_	14	dep	_	_
17	erythroleukemias	erythroleukemia	NNS	NNS	_	11	nmod	_	_
18	.	.	.	.	_	3	punct	_	_

1	PU.1	pu.1	NN	NN	_	2	nsubj	_	_
2	seems	seem	VBZ	VBZ	_	0	root	_	_
3	to	to	TO	TO	_	5	mark	_	_
4	be	be	VB	VB	_	5	auxpass	_	_
5	required	require	VBN	VBN	_	2	xcomp	_	_
6	for	for	IN	IN	_	8	case	_	_
7	early	early	JJ	JJ	_	8	amod	_	_
8	development	development	NN	NN	_	5	nmod	_	_
9	of	of	IN	IN	_	12	case	_	_
10	multiple	multiple	JJ	JJ	_	12	amod	_	_
11	hematopoietic	hematopoietic	JJ	JJ	_	12	amod	_	_
12	lineages	lineage	NNS	NNS	_	8	nmod	_	_
13	,	,	,	,	_	2	punct	_	_
14	but	but	CC	CC	_	2	cc	_	_
15	its	its	PRP$	PRP$	_	16	nmod:poss	_	_
16	expression	expression	NN	NN	_	22	nsubjpass	_	_
17	in	in	IN	IN	_	19	case	_	_
18	mature	mature	JJ	JJ	_	19	amod	_	_
19	cells	cell	NNS	NNS	_	16	nmod	_	_
20	is	be	VBZ	VBZ	_	22	auxpass	_	_
21	preferentially	preferentially	RB	RB	_	22	advmod	_	_
22	observed	observe	VBN	VBN	_	2	conj	_	_
23	in	in	IN	IN	_	24	case	_	_
24	cells	cell	NNS	NNS	_	22	nmod	_	_
25	of	of	IN	IN	_	29	case	_	_
26	the	the	DT	DT	_	29	det	_	_
27	B-cell-and	b-cell-and	NN	NN	_	29	compound	_	_
28	monocyte/macrophage-differentiation	monocyte/macrophage-differentiation	NN	NN	_	29	compound	_	_
29	lineage	lineage	NN	NN	_	24	nmod	_	_
30	.	.	.	.	_	2	punct	_	_

1	It	it	PRP	PRP	_	2	nsubj	_	_
2	binds	bind	VBZ	VBZ	_	0	root	_	_
3	the	the	DT	DT	_	6	det	_	_
4	so-called	so-called	JJ	JJ	_	6	amod	_	_
5	Pu	pu	NN	NN	_	6	compound	_	_
6	box	box	NN	NN	_	2	dobj	_	_
7	,	,	,	,	_	6	punct	_	_
8	an	a	DT	DT	_	13	det	_	_
9	important	important	JJ	JJ	_	13	amod	_	_
10	tissue-specific	tissue-specific	JJ	JJ	_	13	amod	_	_
11	regulatory	regulatory	JJ	JJ	_	13	amod	_	_
12	DNA	dna	NN	NN	_	13	compound	_	_
13	element	element	NN	NN	_	6	appos	_	_
14	present	present	JJ	JJ	_	13	amod	_	_
15	in	in	IN	IN	_	17	case	_	_
16	a	a	DT	DT	_	17	det	_	_
17	number	number	NN	NN	_	14	nmod	_	_
18	of	of	IN	IN	_	19	case	_	_
19	genes	gene	NNS	NNS	_	17	nmod	_	_
20	expressed	express	VBN	VBN	_	17	acl	_	_
21	in	in	IN	IN	_	24	case	_	_
22	these	these	DT	DT	_	24	det	_	_
23	cell	cell	NN	NN	_	24	compound	_	_
24	lineages	lineage	NNS	NNS	_	20	nmod	_	_
25	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	analyzed	analyze	VBN	VBN	_	0	root	_	_
4	the	the	DT	DT	_	5	dep	_	_
5	expression	expression	NN	NN	_	3	dobj	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	activity	activity	NN	NN	_	5	conj	_	_
8	of	of	IN	IN	_	9	case	_	_
9	PU.1	pu.1	NN	NN	_	5	nmod	_	_
10	during	during	IN	IN	_	13	case	_	_
11	human	human	JJ	JJ	_	13	amod	_	_
12	B-cell	b-cell	NN	NN	_	13	compound	_	_
13	development	development	NN	NN	_	5	nmod	_	_
14	using	use	VBG	VBG	_	3	xcomp	_	_
15	a	a	DT	DT	_	16	det	_	_
16	panel	panel	NN	NN	_	14	dobj	_	_
17	of	of	IN	IN	_	19	case	_	_
18	B-cell	b-cell	NN	NN	_	19	compound	_	_
19	lines	line	NNS	NNS	_	16	nmod	_	_
20	representing	represent	VBG	VBG	_	16	acl	_	_
21	different	different	JJ	JJ	_	22	amod	_	_
22	stages	stage	NNS	NNS	_	20	dobj	_	_
23	of	of	IN	IN	_	24	case	_	_
24	maturation	maturation	NN	NN	_	22	nmod	_	_
25	,	,	,	,	_	22	punct	_	_
26	from	from	IN	IN	_	28	case	_	_
27	early	early	JJ	JJ	_	28	amod	_	_
28	precursors	precursor	NNS	NNS	_	22	nmod	_	_
29	to	to	TO	TO	_	32	case	_	_
30	differentiated	differentiate	VBN	VBN	_	32	amod	_	_
31	plasma	plasma	NN	NN	_	32	compound	_	_
32	cells	cell	NNS	NNS	_	22	nmod	_	_
33	.	.	.	.	_	3	punct	_	_

1	PU.1	pu.1	NN	NN	_	2	compound	_	_
2	mRNA	mrna	NN	NN	_	3	compound	_	_
3	expression	expression	NN	NN	_	25	nsubj	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	PU.1	pu.1	NN	NN	_	8	compound	_	_
6	DNA	dna	NN	NN	_	8	compound	_	_
7	binding	binding	NN	NN	_	8	compound	_	_
8	activity	activity	NN	NN	_	3	conj	_	_
9	,	,	,	,	_	3	punct	_	_
10	as	as	IN	IN	_	11	mark	_	_
11	measured	measure	VBN	VBN	_	25	dep	_	_
12	by	by	IN	IN	_	15	case	_	_
13	Northern	northern	NN	NN	_	15	compound	_	_
14	blot	blot	NN	NN	_	15	compound	_	_
15	analysis	analysis	NN	NN	_	11	nmod	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	electrophoretic	electrophoretic	JJ	JJ	_	20	amod	_	_
18	mobility	mobility	NN	NN	_	20	compound	_	_
19	shift	shift	NN	NN	_	20	compound	_	_
20	assay	assay	NN	NN	_	15	conj	_	_
21	,	,	,	,	_	11	punct	_	_
22	respectively	respectively	RB	RB	_	11	advmod	_	_
23	,	,	,	,	_	25	punct	_	_
24	were	be	VBD	VBD	_	25	cop	_	_
25	evident	evident	JJ	JJ	_	0	root	_	_
26	in	in	IN	IN	_	28	case	_	_
27	cell	cell	NN	NN	_	28	compound	_	_
28	lines	line	NNS	NNS	_	25	nmod	_	_
29	representing	represent	VBG	VBG	_	28	acl	_	_
30	pro-B	pro-b	JJ	JJ	_	29	dobj	_	_
31	,	,	,	,	_	30	punct	_	_
32	pre-B	pre-b	JJ	JJ	_	30	conj	_	_
33	,	,	,	,	_	30	punct	_	_
34	and	and	CC	CC	_	30	cc	_	_
35	mature	mature	JJ	JJ	_	36	amod	_	_
36	B	b	NN	NN	_	30	conj	_	_
37	cells	cell	NNS	NNS	_	30	dep	_	_
38	.	.	.	.	_	25	punct	_	_

1	We	we	PRP	PRP	_	4	nsubj	_	_
2	could	could	MD	MD	_	4	aux	_	_
3	also	also	RB	RB	_	4	advmod	_	_
4	show	show	VB	VB	_	0	root	_	_
5	Pu	pu	NN	NN	_	7	compound	_	_
6	box-dependent	box-dependent	JJ	JJ	_	7	amod	_	_
7	transactivation	transactivation	NN	NN	_	4	dobj	_	_
8	of	of	IN	IN	_	11	case	_	_
9	a	a	DT	DT	_	11	det	_	_
10	reporter	reporter	NN	NN	_	11	compound	_	_
11	gene	gene	NN	NN	_	7	nmod	_	_
12	in	in	IN	IN	_	14	case	_	_
13	transient	transient	JJ	JJ	_	14	amod	_	_
14	transfections	transfection	NNS	NNS	_	7	nmod	_	_
15	in	in	IN	IN	_	18	case	_	_
16	these	these	DT	DT	_	18	det	_	_
17	cell	cell	NN	NN	_	18	compound	_	_
18	lines	line	NNS	NNS	_	14	nmod	_	_
19	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	34	nmod	_	_
3	,	,	,	,	_	34	punct	_	_
4	in	in	IN	IN	_	6	case	_	_
5	a	a	DT	DT	_	6	det	_	_
6	number	number	NN	NN	_	34	nmod	_	_
7	of	of	IN	IN	_	11	case	_	_
8	multiple	multiple	JJ	JJ	_	11	amod	_	_
9	myeloma	myeloma	NN	NN	_	11	compound	_	_
10	cell	cell	NN	NN	_	11	compound	_	_
11	lines	line	NNS	NNS	_	6	nmod	_	_
12	,	,	,	,	_	6	punct	_	_
13	representing	represent	VBG	VBG	_	6	acl	_	_
14	differentiated	differentiate	VBN	VBN	_	19	amod	_	_
15	,	,	,	,	_	19	punct	_	_
16	plasma	plasma	NN	NN	_	19	compound	_	_
17	cell-like	cell-like	JJ	JJ	_	19	amod	_	_
18	B	b	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	13	dobj	_	_
20	,	,	,	,	_	34	punct	_	_
21	PU.1	pu.1	NN	NN	_	24	compound	_	_
22	DNA	dna	NN	NN	_	24	compound	_	_
23	binding	binding	NN	NN	_	24	compound	_	_
24	activity	activity	NN	NN	_	34	nsubj	_	_
25	,	,	,	,	_	24	punct	_	_
26	mRNA	mrna	NN	NN	_	27	compound	_	_
27	expression	expression	NN	NN	_	24	conj	_	_
28	,	,	,	,	_	24	punct	_	_
29	and	and	CC	CC	_	24	cc	_	_
30	Pu	pu	NN	NN	_	32	compound	_	_
31	box-dependent	box-dependent	JJ	JJ	_	32	amod	_	_
32	transactivation	transactivation	NN	NN	_	24	conj	_	_
33	were	be	VBD	VBD	_	34	cop	_	_
34	absent	absent	JJ	JJ	_	0	root	_	_
35	or	or	CC	CC	_	34	cc	_	_
36	detectable	detectable	JJ	JJ	_	34	conj	_	_
37	at	at	IN	IN	_	41	case	_	_
38	a	a	DT	DT	_	41	det	_	_
39	very	very	RB	RB	_	40	advmod	_	_
40	low	low	JJ	JJ	_	41	amod	_	_
41	level	level	NN	NN	_	36	nmod	_	_
42	.	.	.	.	_	34	punct	_	_

1	In	in	IN	IN	_	4	case	_	_
2	lymphoblastoid	lymphoblastoid	JJ	JJ	_	4	amod	_	_
3	cell	cell	NN	NN	_	4	compound	_	_
4	lines	line	NNS	NNS	_	21	nmod	_	_
5	,	,	,	,	_	4	punct	_	_
6	which	which	WDT	WDT	_	7	nsubj	_	_
7	exemplify	exemplify	VBP	VBP	_	4	acl:relcl	_	_
8	an	a	DT	DT	_	10	det	_	_
9	intermediate	intermediate	JJ	JJ	_	10	amod	_	_
10	stage	stage	NN	NN	_	7	dobj	_	_
11	of	of	IN	IN	_	13	case	_	_
12	B-cell	b-cell	NN	NN	_	13	compound	_	_
13	differentiation	differentiation	NN	NN	_	10	nmod	_	_
14	,	,	,	,	_	21	punct	_	_
15	a	a	DT	DT	_	17	det	_	_
16	reduced	reduce	VBN	VBN	_	17	amod	_	_
17	expression	expression	NN	NN	_	21	nsubjpass	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	activity	activity	NN	NN	_	17	conj	_	_
20	were	be	VBD	VBD	_	21	auxpass	_	_
21	observed	observe	VBN	VBN	_	0	root	_	_
22	.	.	.	.	_	21	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	findings	finding	NNS	NNS	_	10	nsubj	_	_
3	in	in	IN	IN	_	9	case	_	_
4	the	the	DT	DT	_	9	det	_	_
5	human	human	JJ	JJ	_	9	amod	_	_
6	multiple	multiple	JJ	JJ	_	9	amod	_	_
7	myeloma	myeloma	NN	NN	_	9	compound	_	_
8	cell	cell	NN	NN	_	9	compound	_	_
9	lines	line	NNS	NNS	_	2	nmod	_	_
10	represent	represent	VBP	VBP	_	0	root	_	_
11	the	the	DT	DT	_	13	det	_	_
12	first	first	JJ	JJ	_	13	amod	_	_
13	examples	example	NNS	NNS	_	10	dobj	_	_
14	of	of	IN	IN	_	16	case	_	_
15	B	b	NN	NN	_	16	compound	_	_
16	cells	cell	NNS	NNS	_	13	nmod	_	_
17	with	with	IN	IN	_	20	case	_	_
18	downregulated	downregulate	VBN	VBN	_	20	amod	_	_
19	PU.1	pu.1	NN	NN	_	20	compound	_	_
20	expression	expression	NN	NN	_	16	nmod	_	_
21	and	and	CC	CC	_	10	cc	_	_
22	apparently	apparently	RB	RB	_	23	advmod	_	_
23	contradict	contradict	VBP	VBP	_	10	conj	_	_
24	observations	observation	NNS	NNS	_	23	dobj	_	_
25	in	in	IN	IN	_	28	case	_	_
26	the	the	DT	DT	_	28	det	_	_
27	murine	murine	JJ	JJ	_	28	amod	_	_
28	system	system	NN	NN	_	24	nmod	_	_
29	in	in	IN	IN	_	30	case	_	_
30	which	which	WDT	WDT	_	33	nmod	_	_
31	PU.1	pu.1	NN	NN	_	33	nsubj	_	_
32	is	be	VBZ	VBZ	_	33	cop	_	_
33	expressed	express	VBN	VBN	_	24	acl:relcl	_	_
34	and	and	CC	CC	_	33	cc	_	_
35	active	active	JJ	JJ	_	33	conj	_	_
36	in	in	IN	IN	_	39	case	_	_
37	plasmacytoma	plasmacytoma	NN	NN	_	39	compound	_	_
38	cell	cell	NN	NN	_	39	compound	_	_
39	lines	line	NNS	NNS	_	33	nmod	_	_
40	.	.	.	.	_	10	punct	_	_

1	At	at	IN	IN	_	2	case	_	_
2	present	present	JJ	JJ	_	6	nmod	_	_
3	,	,	,	,	_	6	punct	_	_
4	it	it	PRP	PRP	_	6	nsubj	_	_
5	is	be	VBZ	VBZ	_	6	cop	_	_
6	unclear	unclear	JJ	JJ	_	0	root	_	_
7	whether	whether	IN	IN	_	21	mark	_	_
8	the	the	DT	DT	_	9	det	_	_
9	lack	lack	NN	NN	_	21	nsubj	_	_
10	of	of	IN	IN	_	11	case	_	_
11	PU.1	pu.1	NN	NN	_	9	nmod	_	_
12	expression	expression	NN	NN	_	11	dep	_	_
13	and	and	CC	CC	_	11	cc	_	_
14	activity	activity	NN	NN	_	11	conj	_	_
15	in	in	IN	IN	_	20	case	_	_
16	human	human	JJ	JJ	_	20	amod	_	_
17	multiple	multiple	JJ	JJ	_	20	amod	_	_
18	myeloma	myeloma	NN	NN	_	20	compound	_	_
19	cell	cell	NN	NN	_	20	compound	_	_
20	lines	line	NNS	NNS	_	9	nmod	_	_
21	represents	represent	VBZ	VBZ	_	6	ccomp	_	_
22	a	a	DT	DT	_	24	det	_	_
23	malignancy-associated	malignancy-associated	JJ	JJ	_	24	amod	_	_
24	defect	defect	NN	NN	_	21	dobj	_	_
25	in	in	IN	IN	_	27	case	_	_
26	these	these	DT	DT	_	27	det	_	_
27	cells	cell	NNS	NNS	_	24	nmod	_	_
28	or	or	CC	CC	_	21	cc	_	_
29	exemplifies	exemplify	VBZ	VBZ	_	21	conj	_	_
30	a	a	DT	DT	_	33	det	_	_
31	normal	normal	JJ	JJ	_	33	amod	_	_
32	developmental	developmental	JJ	JJ	_	33	amod	_	_
33	regulation	regulation	NN	NN	_	29	dobj	_	_
34	in	in	IN	IN	_	38	case	_	_
35	terminally	terminally	RB	RB	_	38	advmod	_	_
36	differentiated	differentiate	VBN	VBN	_	38	amod	_	_
37	B	b	NN	NN	_	38	compound	_	_
38	cells	cell	NNS	NNS	_	33	nmod	_	_
39	.	.	.	.	_	6	punct	_	_

1	Microtubules	microtubule	NNS	NNS	_	2	nsubj	_	_
2	mediate	mediate	VBP	VBP	_	0	root	_	_
3	cellular	cellular	JJ	JJ	_	6	amod	_	_
4	25-hydroxyvitamin	25-hydroxyvitamin	NN	NN	_	6	compound	_	_
5	D3	d3	NN	NN	_	6	compound	_	_
6	trafficking	trafficking	NN	NN	_	2	dobj	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	the	the	DT	DT	_	10	det	_	_
9	genomic	genomic	JJ	JJ	_	10	amod	_	_
10	response	response	NN	NN	_	6	conj	_	_
11	to	to	TO	TO	_	13	case	_	_
12	1,25-dihydroxyvitamin	1,25-dihydroxyvitamin	NN	NN	_	13	compound	_	_
13	D3	d3	NN	NN	_	10	nmod	_	_
14	in	in	IN	IN	_	17	case	_	_
15	normal	normal	JJ	JJ	_	17	amod	_	_
16	human	human	JJ	JJ	_	17	amod	_	_
17	monocytes	monocyte	NNS	NNS	_	2	nmod	_	_
18	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	genomic	genomic	JJ	JJ	_	3	amod	_	_
3	actions	action	NNS	NNS	_	11	nsubjpass	_	_
4	of	of	IN	IN	_	6	case	_	_
5	1,25-dihydroxyvitamin	1,25-dihydroxyvitamin	NN	NN	_	6	compound	_	_
6	D3	d3	NN	NN	_	3	nmod	_	_
7	(	(	-LRB-	-LRB-	_	8	punct	_	_
8	1,25(OH)2D3	1,25(oh)2d3	NN	NN	_	6	appos	_	_
9	)	)	-RRB-	-RRB-	_	8	punct	_	_
10	are	be	VBP	VBP	_	11	auxpass	_	_
11	mediated	mediate	VBN	VBN	_	0	root	_	_
12	by	by	IN	IN	_	17	case	_	_
13	the	the	DT	DT	_	17	det	_	_
14	intracellular	intracellular	JJ	JJ	_	17	amod	_	_
15	vitamin	vitamin	NN	NN	_	17	compound	_	_
16	D	d	NN	NN	_	17	compound	_	_
17	receptor	receptor	NN	NN	_	11	nmod	_	_
18	(	(	-LRB-	-LRB-	_	19	punct	_	_
19	VDR	vdr	NN	NN	_	17	appos	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	.	.	.	.	_	11	punct	_	_

1	Although	although	IN	IN	_	4	mark	_	_
2	immunocytochemistry	immunocytochemistry	NN	NN	_	4	nsubj	_	_
3	has	have	VBZ	VBZ	_	4	aux	_	_
4	shown	show	VBN	VBN	_	30	advcl	_	_
5	that	that	IN	IN	_	10	mark	_	_
6	disruption	disruption	NN	NN	_	10	nsubj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	microtubular	microtubular	JJ	JJ	_	9	amod	_	_
9	assembly	assembly	NN	NN	_	6	nmod	_	_
10	prevents	prevent	VBZ	VBZ	_	4	ccomp	_	_
11	nuclear	nuclear	JJ	JJ	_	12	amod	_	_
12	access	access	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	16	case	_	_
14	the	the	DT	DT	_	16	det	_	_
15	sterol-VDR	sterol-vdr	NN	NN	_	16	compound	_	_
16	complex	complex	NN	NN	_	12	nmod	_	_
17	,	,	,	,	_	30	punct	_	_
18	the	the	DT	DT	_	19	det	_	_
19	role	role	NN	NN	_	30	nsubjpass	_	_
20	of	of	IN	IN	_	21	case	_	_
21	microtubules	microtubule	NNS	NNS	_	19	nmod	_	_
22	in	in	IN	IN	_	24	case	_	_
23	the	the	DT	DT	_	24	det	_	_
24	response	response	NN	NN	_	19	nmod	_	_
25	to	to	TO	TO	_	26	case	_	_
26	1,25(OH)2D3	1,25(oh)2d3	NN	NN	_	24	nmod	_	_
27	has	have	VBZ	VBZ	_	30	aux	_	_
28	not	not	RB	RB	_	30	neg	_	_
29	been	be	VBN	VBN	_	30	auxpass	_	_
30	studied	study	VBN	VBN	_	0	root	_	_
31	in	in	IN	IN	_	33	case	_	_
32	viable	viable	JJ	JJ	_	33	amod	_	_
33	cells	cell	NNS	NNS	_	30	nmod	_	_
34	.	.	.	.	_	30	punct	_	_

1	Our	we	PRP$	PRP$	_	2	nmod:poss	_	_
2	studies	study	NNS	NNS	_	3	nsubj	_	_
3	examined	examine	VBD	VBD	_	0	root	_	_
4	this	this	DT	DT	_	5	det	_	_
5	interaction	interaction	NN	NN	_	3	dobj	_	_
6	in	in	IN	IN	_	9	case	_	_
7	normal	normal	JJ	JJ	_	9	amod	_	_
8	human	human	JJ	JJ	_	9	amod	_	_
9	monocytes	monocyte	NNS	NNS	_	5	nmod	_	_
10	.	.	.	.	_	3	punct	_	_

1	Monocytes	monocyte	NNS	NNS	_	2	nsubj	_	_
2	convert	convert	VBP	VBP	_	0	root	_	_
3	25(OH)D3	25(oh)d3	NN	NN	_	2	dobj	_	_
4	to	to	TO	TO	_	5	case	_	_
5	1,25(OH)2D3	1,25(oh)2d3	NN	NN	_	2	nmod	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	to	to	TO	TO	_	9	case	_	_
8	24-hydroxylated	24-hydroxylated	JJ	JJ	_	9	amod	_	_
9	metabolites	metabolite	NNS	NNS	_	5	conj	_	_
10	more	more	RBR	RBR	_	11	advmod	_	_
11	polar	polar	JJ	JJ	_	9	amod	_	_
12	than	than	IN	IN	_	13	case	_	_
13	1,25(OH)2D3	1,25(oh)2d3	NN	NN	_	11	nmod	_	_
14	.	.	.	.	_	2	punct	_	_

1	Microtubule	microtubule	NN	NN	_	2	compound	_	_
2	disruption	disruption	NN	NN	_	4	nsubj	_	_
3	totally	totally	RB	RB	_	4	advmod	_	_
4	abolished	abolish	VBD	VBD	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	ability	ability	NN	NN	_	4	dobj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	exogenous	exogenous	JJ	JJ	_	9	amod	_	_
9	1,25(OH)2D3	1,25(oh)2d3	NN	NN	_	6	nmod	_	_
10	to	to	TO	TO	_	11	mark	_	_
11	suppress	suppress	VB	VB	_	6	dep	_	_
12	its	its	PRP$	PRP$	_	14	nmod:poss	_	_
13	own	own	JJ	JJ	_	14	amod	_	_
14	synthesis	synthesis	NN	NN	_	11	dobj	_	_
15	and	and	CC	CC	_	11	cc	_	_
16	to	to	TO	TO	_	17	mark	_	_
17	induce	induce	VB	VB	_	11	conj	_	_
18	24-hydroxylase	24-hydroxylase	NN	NN	_	19	compound	_	_
19	mRNA	mrna	NN	NN	_	17	dobj	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	activity	activity	NN	NN	_	19	conj	_	_
22	,	,	,	,	_	4	punct	_	_
23	without	without	IN	IN	_	24	mark	_	_
24	affecting	affect	VBG	VBG	_	4	advcl	_	_
25	either	either	CC	CC	_	28	cc:preconj	_	_
26	total	total	JJ	JJ	_	28	amod	_	_
27	1,25(OH)2D3	1,25(oh)2d3	NN	NN	_	28	compound	_	_
28	uptake	uptake	NN	NN	_	24	dobj	_	_
29	or	or	CC	CC	_	28	cc	_	_
30	maximal	maximal	JJ	JJ	_	32	amod	_	_
31	1,25(OH)2D3-VDR	1,25(oh)2d3-vdr	JJ	JJ	_	32	amod	_	_
32	binding	binding	NN	NN	_	28	conj	_	_
33	.	.	.	.	_	4	punct	_	_

1	Thus	thus	RB	RB	_	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	intact	intact	JJ	JJ	_	4	amod	_	_
4	microtubules	microtubule	NNS	NNS	_	6	nsubj	_	_
5	are	be	VBP	VBP	_	6	cop	_	_
6	essential	essential	JJ	JJ	_	0	root	_	_
7	for	for	IN	IN	_	9	case	_	_
8	1,25(OH)2D3-dependent	1,25(oh)2d3-dependent	JJ	JJ	_	9	amod	_	_
9	modulation	modulation	NN	NN	_	6	nmod	_	_
10	of	of	IN	IN	_	12	case	_	_
11	gene	gene	NN	NN	_	12	compound	_	_
12	transcription	transcription	NN	NN	_	9	nmod	_	_
13	.	.	.	.	_	6	punct	_	_

1	Interestingly	interestingly	RB	RB	_	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	microtubule	microtubule	NN	NN	_	4	compound	_	_
4	disruption	disruption	NN	NN	_	6	nsubj	_	_
5	also	also	RB	RB	_	6	advmod	_	_
6	decreased	decrease	VBD	VBD	_	0	root	_	_
7	monocyte	monocyte	NN	NN	_	9	compound	_	_
8	1,25(OH)2D3	1,25(oh)2d3	NN	NN	_	9	compound	_	_
9	synthesis	synthesis	NN	NN	_	6	dobj	_	_
10	,	,	,	,	_	6	punct	_	_
11	not	not	RB	RB	_	13	neg	_	_
12	by	by	IN	IN	_	13	mark	_	_
13	decreasing	decrease	VBG	VBG	_	6	nmod	_	_
14	the	the	DT	DT	_	15	det	_	_
15	Vmax	vmax	NN	NN	_	13	dobj	_	_
16	of	of	IN	IN	_	20	case	_	_
17	monocyte	monocyte	NN	NN	_	20	compound	_	_
18	mitochondrial	mitochondrial	JJ	JJ	_	20	amod	_	_
19	1	1	CD	CD	_	20	nummod	_	_
20	alpha-hydroxylase	alpha-hydroxylase	NN	NN	_	15	nmod	_	_
21	but	but	CC	CC	_	13	cc	_	_
22	through	through	IN	IN	_	24	case	_	_
23	an	a	DT	DT	_	24	det	_	_
24	increase	increase	NN	NN	_	13	conj	_	_
25	in	in	IN	IN	_	27	case	_	_
26	the	the	DT	DT	_	27	det	_	_
27	Km	km	NN	NN	_	24	nmod	_	_
28	for	for	IN	IN	_	29	case	_	_
29	25(OH)2D3	25(oh)2d3	NN	NN	_	27	nmod	_	_
30	.	.	.	.	_	6	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	examined	examine	VBD	VBD	_	0	root	_	_
3	25(OH)D3	25(oh)d3	NN	NN	_	4	compound	_	_
4	transport	transport	NN	NN	_	2	dobj	_	_
5	.	.	.	.	_	2	punct	_	_

1	Microtubule	microtubule	NN	NN	_	2	compound	_	_
2	disruption	disruption	NN	NN	_	5	nsubj	_	_
3	did	do	VBD	VBD	_	5	aux	_	_
4	not	not	RB	RB	_	5	neg	_	_
5	affect	affect	VB	VB	_	0	root	_	_
6	total	total	JJ	JJ	_	9	amod	_	_
7	cellular	cellular	JJ	JJ	_	9	amod	_	_
8	25(OH)D3	25(oh)d3	NN	NN	_	9	compound	_	_
9	uptake	uptake	NN	NN	_	5	dobj	_	_
10	but	but	CC	CC	_	5	cc	_	_
11	reduced	reduce	VBD	VBD	_	5	conj	_	_
12	its	its	PRP$	PRP$	_	14	nmod:poss	_	_
13	intracellular	intracellular	JJ	JJ	_	14	amod	_	_
14	trafficking	trafficking	NN	NN	_	11	dobj	_	_
15	to	to	TO	TO	_	17	case	_	_
16	the	the	DT	DT	_	17	det	_	_
17	mitochondria	mitochondria	NN	NN	_	14	nmod	_	_
18	.	.	.	.	_	5	punct	_	_

1	Thus	thus	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	microtubules	microtubule	NNS	NNS	_	4	nsubj	_	_
4	participate	participate	VBP	VBP	_	0	root	_	_
5	in	in	IN	IN	_	8	case	_	_
6	intracellular	intracellular	JJ	JJ	_	8	amod	_	_
7	25(OH)D3	25(oh)d3	NN	NN	_	8	compound	_	_
8	transport	transport	NN	NN	_	4	nmod	_	_
9	,	,	,	,	_	4	punct	_	_
10	and	and	CC	CC	_	4	cc	_	_
11	their	they	PRP$	PRP$	_	12	nmod:poss	_	_
12	integrity	integrity	NN	NN	_	13	nsubj	_	_
13	determines	determine	VBZ	VBZ	_	4	conj	_	_
14	normal	normal	JJ	JJ	_	16	amod	_	_
15	1,25(OH)2D3	1,25(oh)2d3	NN	NN	_	16	compound	_	_
16	synthesis	synthesis	NN	NN	_	13	dobj	_	_
17	.	.	.	.	_	4	punct	_	_

1	Functional	functional	JJ	JJ	_	2	amod	_	_
2	characterization	characterization	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	7	case	_	_
4	novel	novel	JJ	JJ	_	7	amod	_	_
5	IL-2	il-2	NN	NN	_	7	compound	_	_
6	transcriptional	transcriptional	JJ	JJ	_	7	amod	_	_
7	inhibitors	inhibitor	NNS	NNS	_	2	nmod	_	_
8	.	.	.	.	_	2	punct	_	_

1	IL-2-mediated	il-2-mediated	JJ	JJ	_	4	amod	_	_
2	T	t	NN	NN	_	3	compound	_	_
3	cell	cell	NN	NN	_	4	compound	_	_
4	proliferation	proliferation	NN	NN	_	9	nsubj	_	_
5	is	be	VBZ	VBZ	_	9	cop	_	_
6	a	a	DT	DT	_	9	det	_	_
7	critical	critical	JJ	JJ	_	9	amod	_	_
8	early	early	JJ	JJ	_	7	dep	_	_
9	event	event	NN	NN	_	0	root	_	_
10	in	in	IN	IN	_	13	case	_	_
11	the	the	DT	DT	_	13	det	_	_
12	inflammatory	inflammatory	JJ	JJ	_	13	amod	_	_
13	process	process	NN	NN	_	9	nmod	_	_
14	.	.	.	.	_	9	punct	_	_

1	Formation	formation	NN	NN	_	12	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	NFAT-1	nfat-1	NN	NN	_	6	compound	_	_
5	transcriptional	transcriptional	JJ	JJ	_	6	amod	_	_
6	complex	complex	NN	NN	_	1	nmod	_	_
7	on	on	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	IL-2	il-2	NN	NN	_	10	compound	_	_
10	promoter	promoter	NN	NN	_	1	nmod	_	_
11	is	be	VBZ	VBZ	_	12	cop	_	_
12	essential	essential	JJ	JJ	_	0	root	_	_
13	for	for	IN	IN	_	15	case	_	_
14	IL-2	il-2	NN	NN	_	15	compound	_	_
15	transcription	transcription	NN	NN	_	12	nmod	_	_
16	.	.	.	.	_	12	punct	_	_

1	Using	use	VBG	VBG	_	0	root	_	_
2	a	a	DT	DT	_	4	det	_	_
3	cell	cell	NN	NN	_	4	compound	_	_
4	line	line	NN	NN	_	1	dobj	_	_
5	that	that	WDT	WDT	_	8	nsubjpass	_	_
6	is	be	VBZ	VBZ	_	8	auxpass	_	_
7	stably	stably	RB	RB	_	8	advmod	_	_
8	transfected	transfect	VBN	VBN	_	4	acl:relcl	_	_
9	with	with	IN	IN	_	11	case	_	_
10	a	a	DT	DT	_	11	det	_	_
11	trimer	trimer	NN	NN	_	8	nmod	_	_
12	of	of	IN	IN	_	16	case	_	_
13	the	the	DT	DT	_	16	det	_	_
14	NFAT-1	nfat-1	NN	NN	_	16	compound	_	_
15	regulatory	regulatory	JJ	JJ	_	16	amod	_	_
16	element	element	NN	NN	_	11	nmod	_	_
17	linked	link	VBN	VBN	_	16	acl	_	_
18	to	to	TO	TO	_	22	case	_	_
19	a	a	DT	DT	_	22	det	_	_
20	lac-Z	lac-z	NN	NN	_	22	compound	_	_
21	reporter	reporter	NN	NN	_	22	compound	_	_
22	gene	gene	NN	NN	_	17	nmod	_	_
23	,	,	,	,	_	1	punct	_	_
24	we	we	PRP	PRP	_	25	nsubj	_	_
25	screened	screen	VBD	VBD	_	1	parataxis	_	_
26	for	for	IN	IN	_	27	case	_	_
27	inhibitors	inhibitor	NNS	NNS	_	25	nmod	_	_
28	of	of	IN	IN	_	31	case	_	_
29	NFAT-1-mediated	nfat-1-mediated	JJ	JJ	_	31	amod	_	_
30	beta-galactosidase	beta-galactosidase	NN	NN	_	31	compound	_	_
31	activity	activity	NN	NN	_	27	nmod	_	_
32	.	.	.	.	_	1	punct	_	_

1	WIN	win	NN	NN	_	7	nsubjpass	_	_
2	61058	61058	CD	CD	_	1	nummod	_	_
3	and	and	CC	CC	_	1	cc	_	_
4	WIN	win	NN	NN	_	1	conj	_	_
5	53071	53071	CD	CD	_	4	nummod	_	_
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	identified	identify	VBN	VBN	_	0	root	_	_
8	as	as	IN	IN	_	10	case	_	_
9	microM	microm	NN	NN	_	10	compound	_	_
10	inhibitors	inhibitor	NNS	NNS	_	7	nmod	_	_
11	.	.	.	.	_	7	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	compounds	compound	NNS	NNS	_	4	nsubj	_	_
3	also	also	RB	RB	_	4	advmod	_	_
4	inhibited	inhibit	VBD	VBD	_	0	root	_	_
5	beta-galactosidase	beta-galactosidase	NN	NN	_	6	compound	_	_
6	mRNA	mrna	NN	NN	_	7	compound	_	_
7	levels	level	NNS	NNS	_	4	dobj	_	_
8	.	.	.	.	_	4	punct	_	_

1	Similar	similar	JJ	JJ	_	2	amod	_	_
2	inhibition	inhibition	NN	NN	_	8	nsubjpass	_	_
3	of	of	IN	IN	_	6	case	_	_
4	NFAT-1-mediated	nfat-1-mediated	JJ	JJ	_	6	amod	_	_
5	gene	gene	NN	NN	_	6	compound	_	_
6	expression	expression	NN	NN	_	2	nmod	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	observed	observe	VBN	VBN	_	0	root	_	_
9	in	in	IN	IN	_	13	case	_	_
10	a	a	DT	DT	_	13	det	_	_
11	second	second	JJ	JJ	_	13	amod	_	_
12	cell	cell	NN	NN	_	13	compound	_	_
13	line	line	NN	NN	_	8	nmod	_	_
14	,	,	,	,	_	13	punct	_	_
15	which	which	WDT	WDT	_	18	nsubjpass	_	_
16	is	be	VBZ	VBZ	_	18	auxpass	_	_
17	stably	stably	RB	RB	_	18	advmod	_	_
18	transfected	transfect	VBN	VBN	_	13	acl:relcl	_	_
19	with	with	IN	IN	_	22	case	_	_
20	NFAT-1	nfat-1	NN	NN	_	22	compound	_	_
21	regulatory	regulatory	JJ	JJ	_	22	amod	_	_
22	elements	element	NNS	NNS	_	18	nmod	_	_
23	linked	link	VBN	VBN	_	22	acl	_	_
24	to	to	TO	TO	_	29	case	_	_
25	the	the	DT	DT	_	29	det	_	_
26	reporter	reporter	NN	NN	_	29	compound	_	_
27	gene	gene	NN	NN	_	29	compound	_	_
28	for	for	IN	IN	_	29	amod	_	_
29	sCD8	scd8	NN	NN	_	23	nmod	_	_
30	.	.	.	.	_	8	punct	_	_

1	At	at	IN	IN	_	3	case	_	_
2	10	10	CD	CD	_	3	nummod	_	_
3	microM	microm	NN	NN	_	7	nmod	_	_
4	,	,	,	,	_	7	punct	_	_
5	both	both	DT	DT	_	6	det	_	_
6	compounds	compound	NNS	NNS	_	7	nsubj	_	_
7	inhibited	inhibit	VBD	VBD	_	0	root	_	_
8	IL-2	il-2	NN	NN	_	9	compound	_	_
9	mRNA	mrna	NN	NN	_	7	dobj	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	protein	protein	NN	NN	_	9	conj	_	_
12	levels	level	NNS	NNS	_	9	dep	_	_
13	in	in	IN	IN	_	17	case	_	_
14	the	the	DT	DT	_	17	det	_	_
15	NFAT-1-linked	nfat-1-linked	JJ	JJ	_	17	amod	_	_
16	lac-Z	lac-z	NN	NN	_	17	compound	_	_
17	transfectants	transfectant	NNS	NNS	_	7	nmod	_	_
18	,	,	,	,	_	17	punct	_	_
19	and	and	CC	CC	_	17	cc	_	_
20	in	in	IN	IN	_	22	case	_	_
21	human	human	JJ	JJ	_	22	amod	_	_
22	lymphocytes	lymphocyte	NNS	NNS	_	17	conj	_	_
23	.	.	.	.	_	7	punct	_	_

1	Both	both	DT	DT	_	2	det	_	_
2	compounds	compound	NNS	NNS	_	3	nsubj	_	_
3	inhibited	inhibit	VBD	VBD	_	0	root	_	_
4	the	the	DT	DT	_	7	det	_	_
5	mixed	mixed	JJ	JJ	_	7	amod	_	_
6	lymphocyte	lymphocyte	NN	NN	_	7	compound	_	_
7	reaction	reaction	NN	NN	_	3	dobj	_	_
8	,	,	,	,	_	3	punct	_	_
9	and	and	CC	CC	_	3	cc	_	_
10	this	this	DT	DT	_	11	det	_	_
11	inhibition	inhibition	NN	NN	_	13	nsubjpass	_	_
12	was	be	VBD	VBD	_	13	auxpass	_	_
13	reversed	reverse	VBN	VBN	_	3	conj	_	_
14	by	by	IN	IN	_	16	case	_	_
15	exogenous	exogenous	JJ	JJ	_	16	amod	_	_
16	IL-2	il-2	NN	NN	_	13	nmod	_	_
17	.	.	.	.	_	3	punct	_	_

1	WIN	win	NN	NN	_	3	nsubj	_	_
2	53071	53071	CD	CD	_	1	nummod	_	_
3	inhibited	inhibit	VBD	VBD	_	0	root	_	_
4	IL-2	il-2	NN	NN	_	5	compound	_	_
5	production	production	NN	NN	_	3	dobj	_	_
6	induced	induce	VBN	VBN	_	5	acl	_	_
7	in	in	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	dep	_	_
9	calcium-dependent	calcium-dependent	JJ	JJ	_	10	amod	_	_
10	PMA	pma	NN	NN	_	6	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	ionomycin	ionomycin	NN	NN	_	10	conj	_	_
13	pathway	pathway	NN	NN	_	10	dep	_	_
14	.	.	.	.	_	3	punct	_	_

1	Conversely	conversely	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	calcium-independent	calcium-independent	JJ	JJ	_	5	amod	_	_
4	anti-CD28	anti-cd28	JJ	JJ	_	5	amod	_	_
5	Ab	ab	NN	NN	_	9	compound	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	PMA-induced	pma-induced	JJ	JJ	_	8	amod	_	_
8	IL-2	il-2	NN	NN	_	5	conj	_	_
9	production	production	NN	NN	_	11	nsubj	_	_
10	was	be	VBD	VBD	_	11	cop	_	_
11	resistant	resistant	JJ	JJ	_	0	root	_	_
12	.	.	.	.	_	11	punct	_	_

1	Both	both	DT	DT	_	2	det	_	_
2	compounds	compound	NNS	NNS	_	3	nsubj	_	_
3	altered	alter	VBD	VBD	_	0	root	_	_
4	the	the	DT	DT	_	7	det	_	_
5	NFAT-1	nfat-1	NN	NN	_	7	compound	_	_
6	transcriptional	transcriptional	JJ	JJ	_	7	amod	_	_
7	complex	complex	NN	NN	_	3	dobj	_	_
8	,	,	,	,	_	3	punct	_	_
9	causing	cause	VBG	VBG	_	3	advcl	_	_
10	its	its	PRP$	PRP$	_	12	nmod:poss	_	_
11	retarded	retard	VBN	VBN	_	12	amod	_	_
12	mobility	mobility	NN	NN	_	9	dobj	_	_
13	on	on	IN	IN	_	14	case	_	_
14	gels	gel	NNS	NNS	_	12	nmod	_	_
15	.	.	.	.	_	3	punct	_	_

1	By	by	IN	IN	_	4	case	_	_
2	these	these	DT	DT	_	4	det	_	_
3	functional	functional	JJ	JJ	_	4	amod	_	_
4	criteria	criterion	NNS	NNS	_	7	nmod	_	_
5	,	,	,	,	_	7	punct	_	_
6	we	we	PRP	PRP	_	7	nsubj	_	_
7	believe	believe	VBP	VBP	_	0	root	_	_
8	we	we	PRP	PRP	_	7	dobj	_	_
9	have	have	VBP	VBP	_	10	aux	_	_
10	identified	identify	VBN	VBN	_	7	dep	_	_
11	two	two	CD	CD	_	16	nummod	_	_
12	structurally	structurally	RB	RB	_	13	advmod	_	_
13	distinct	distinct	JJ	JJ	_	16	amod	_	_
14	,	,	,	,	_	13	punct	_	_
15	novel	novel	JJ	JJ	_	13	dep	_	_
16	inhibitors	inhibitor	NNS	NNS	_	10	dobj	_	_
17	of	of	IN	IN	_	19	case	_	_
18	NFAT-1-mediated	nfat-1-mediated	JJ	JJ	_	19	amod	_	_
19	transcription	transcription	NN	NN	_	16	nmod	_	_
20	.	.	.	.	_	7	punct	_	_

1	Platelet-activating	platelet-activating	JJ	JJ	_	2	amod	_	_
2	factor	factor	NN	NN	_	3	nsubj	_	_
3	stimulates	stimulate	VBZ	VBZ	_	0	root	_	_
4	transcription	transcription	NN	NN	_	3	dobj	_	_
5	of	of	IN	IN	_	12	case	_	_
6	the	the	DT	DT	_	12	det	_	_
7	heparin-binding	heparin-binding	JJ	JJ	_	12	amod	_	_
8	epidermal	epidermal	JJ	JJ	_	12	amod	_	_
9	growth	growth	NN	NN	_	12	compound	_	_
10	factor-like	factor-like	JJ	JJ	_	12	amod	_	_
11	growth	growth	NN	NN	_	12	compound	_	_
12	factor	factor	NN	NN	_	4	nmod	_	_
13	in	in	IN	IN	_	14	case	_	_
14	monocytes	monocyte	NNS	NNS	_	4	nmod	_	_
15	.	.	.	.	_	3	punct	_	_

1	Correlation	correlation	NN	NN	_	0	root	_	_
2	with	with	IN	IN	_	8	case	_	_
3	an	a	DT	DT	_	8	det	_	_
4	increased	increase	VBN	VBN	_	8	amod	_	_
5	kappa	kappa	NN	NN	_	8	compound	_	_
6	B	b	NN	NN	_	8	compound	_	_
7	binding	binding	NN	NN	_	8	compound	_	_
8	activity	activity	NN	NN	_	1	nmod	_	_
9	.	.	.	.	_	1	punct	_	_

1	Human	human	JJ	JJ	_	3	amod	_	_
2	peripheral	peripheral	JJ	JJ	_	3	amod	_	_
3	blood	blood	NN	NN	_	5	nsubj	_	_
4	monocytes	monocyte	NNS	NNS	_	3	dep	_	_
5	responded	respond	VBD	VBD	_	0	root	_	_
6	to	to	TO	TO	_	7	case	_	_
7	stimulation	stimulation	NN	NN	_	5	nmod	_	_
8	of	of	IN	IN	_	10	case	_	_
9	platelet-activating	platelet-activating	JJ	JJ	_	10	amod	_	_
10	factor	factor	NN	NN	_	7	nmod	_	_
11	(	(	-LRB-	-LRB-	_	12	punct	_	_
12	PAF	paf	NN	NN	_	10	appos	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	with	with	IN	IN	_	15	case	_	_
15	up-regulation	up-regulation	NN	NN	_	7	nmod	_	_
16	of	of	IN	IN	_	18	case	_	_
17	the	the	DT	DT	_	18	det	_	_
18	transcript	transcript	NN	NN	_	15	nmod	_	_
19	for	for	IN	IN	_	25	case	_	_
20	heparin-binding	heparin-binding	JJ	JJ	_	25	amod	_	_
21	epidermal	epidermal	JJ	JJ	_	25	amod	_	_
22	growth	growth	NN	NN	_	25	compound	_	_
23	factor-like	factor-like	JJ	JJ	_	25	amod	_	_
24	growth	growth	NN	NN	_	25	compound	_	_
25	factor	factor	NN	NN	_	18	nmod	_	_
26	(	(	-LRB-	-LRB-	_	27	punct	_	_
27	HB-EGF	hb-egf	NN	NN	_	25	appos	_	_
28	)	)	-RRB-	-RRB-	_	27	punct	_	_
29	,	,	,	,	_	25	punct	_	_
30	a	a	DT	DT	_	32	det	_	_
31	potent	potent	JJ	JJ	_	32	amod	_	_
32	mitogen	mitogen	NN	NN	_	25	appos	_	_
33	for	for	IN	IN	_	37	case	_	_
34	vascular	vascular	JJ	JJ	_	37	amod	_	_
35	smooth	smooth	JJ	JJ	_	37	amod	_	_
36	muscle	muscle	NN	NN	_	37	compound	_	_
37	cells	cell	NNS	NNS	_	32	nmod	_	_
38	.	.	.	.	_	5	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	function	function	NN	NN	_	6	nsubjpass	_	_
3	of	of	IN	IN	_	4	case	_	_
4	PAF	paf	NN	NN	_	2	nmod	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	observed	observe	VBN	VBN	_	0	root	_	_
7	at	at	IN	IN	_	9	case	_	_
8	nanomolar	nanomolar	JJ	JJ	_	9	amod	_	_
9	concentrations	concentration	NNS	NNS	_	6	nmod	_	_
10	of	of	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	ligand	ligand	NN	NN	_	9	nmod	_	_
13	,	,	,	,	_	6	punct	_	_
14	starting	start	VBG	VBG	_	6	advcl	_	_
15	at	at	IN	IN	_	17	case	_	_
16	30	30	CD	CD	_	17	nummod	_	_
17	min	min	NN	NN	_	14	nmod	_	_
18	after	after	IN	IN	_	19	case	_	_
19	stimulation	stimulation	NN	NN	_	17	nmod	_	_
20	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	PAF-induced	paf-induced	JJ	JJ	_	3	amod	_	_
3	up-regulation	up-regulation	NN	NN	_	8	nsubjpass	_	_
4	of	of	IN	IN	_	6	case	_	_
5	HB-EGF	hb-egf	NN	NN	_	6	compound	_	_
6	mRNA	mrna	NN	NN	_	3	nmod	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	accompanied	accompany	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	_	11	case	_	_
10	an	a	DT	DT	_	11	det	_	_
11	increase	increase	NN	NN	_	8	nmod	_	_
12	in	in	IN	IN	_	16	case	_	_
13	kappa	kappa	NN	NN	_	16	compound	_	_
14	B	b	NN	NN	_	16	compound	_	_
15	binding	binding	NN	NN	_	16	compound	_	_
16	activity	activity	NN	NN	_	11	nmod	_	_
17	.	.	.	.	_	8	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	functions	function	NNS	NNS	_	5	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	PAF	paf	NN	NN	_	2	nmod	_	_
5	appeared	appear	VBD	VBD	_	0	root	_	_
6	to	to	TO	TO	_	8	mark	_	_
7	be	be	VB	VB	_	8	auxpass	_	_
8	mediated	mediate	VBN	VBN	_	5	xcomp	_	_
9	through	through	IN	IN	_	14	case	_	_
10	the	the	DT	DT	_	14	det	_	_
11	cell	cell	NN	NN	_	14	compound	_	_
12	surface	surface	NN	NN	_	14	compound	_	_
13	PAF	paf	NN	NN	_	14	compound	_	_
14	receptors	receptor	NNS	NNS	_	8	nmod	_	_
15	,	,	,	,	_	5	punct	_	_
16	as	as	IN	IN	_	29	mark	_	_
17	two	two	CD	CD	_	20	nummod	_	_
18	PAF	paf	NN	NN	_	20	compound	_	_
19	receptor	receptor	NN	NN	_	20	compound	_	_
20	antagonists	antagonist	NNS	NNS	_	29	nsubj	_	_
21	,	,	,	,	_	20	punct	_	_
22	WEB	web	NN	NN	_	20	appos	_	_
23	2086	2086	CD	CD	_	22	nummod	_	_
24	and	and	CC	CC	_	22	cc	_	_
25	L-659	l-659	NN	NN	_	22	conj	_	_
26	,	,	,	,	_	25	punct	_	_
27	989	989	CD	CD	_	25	nummod	_	_
28	,	,	,	,	_	20	punct	_	_
29	blocked	block	VBD	VBD	_	5	advcl	_	_
30	both	both	CC	CC	_	32	cc:preconj	_	_
31	the	the	DT	DT	_	32	det	_	_
32	up-regulation	up-regulation	NN	NN	_	29	dobj	_	_
33	of	of	IN	IN	_	35	case	_	_
34	HB-EGF	hb-egf	NN	NN	_	35	compound	_	_
35	mRNA	mrna	NN	NN	_	32	nmod	_	_
36	and	and	CC	CC	_	32	cc	_	_
37	kappa	kappa	NN	NN	_	40	compound	_	_
38	B	b	NN	NN	_	40	compound	_	_
39	binding	binding	NN	NN	_	40	compound	_	_
40	activity	activity	NN	NN	_	32	conj	_	_
41	induced	induce	VBN	VBN	_	32	acl	_	_
42	by	by	IN	IN	_	43	case	_	_
43	PAF	paf	NN	NN	_	41	nmod	_	_
44	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	antagonists	antagonist	NNS	NNS	_	6	nsubj	_	_
3	,	,	,	,	_	2	punct	_	_
4	however	however	RB	RB	_	6	advmod	_	_
5	,	,	,	,	_	6	punct	_	_
6	had	have	VBD	VBD	_	0	root	_	_
7	no	no	DT	DT	_	8	neg	_	_
8	effect	effect	NN	NN	_	6	dobj	_	_
9	on	on	IN	IN	_	12	case	_	_
10	phorbol	phorbol	NN	NN	_	12	compound	_	_
11	ester-induced	ester-induced	JJ	JJ	_	12	amod	_	_
12	up-regulation	up-regulation	NN	NN	_	6	nmod	_	_
13	of	of	IN	IN	_	15	case	_	_
14	HB-EGF	hb-egf	NN	NN	_	15	compound	_	_
15	mRNA	mrna	NN	NN	_	12	nmod	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	kappa	kappa	NN	NN	_	20	compound	_	_
18	B	b	NN	NN	_	20	compound	_	_
19	binding	binding	NN	NN	_	20	compound	_	_
20	activity	activity	NN	NN	_	15	conj	_	_
21	.	.	.	.	_	6	punct	_	_

1	Pretreatment	pretreatment	NN	NN	_	7	nsubj	_	_
2	of	of	IN	IN	_	3	case	_	_
3	monocytes	monocyte	NNS	NNS	_	1	nmod	_	_
4	with	with	IN	IN	_	6	case	_	_
5	pertussis	pertussis	NN	NN	_	6	compound	_	_
6	toxin	toxin	NN	NN	_	1	nmod	_	_
7	inhibited	inhibit	VBD	VBD	_	0	root	_	_
8	these	these	DT	DT	_	9	det	_	_
9	functions	function	NNS	NNS	_	7	dobj	_	_
10	of	of	IN	IN	_	11	case	_	_
11	PAF	paf	NN	NN	_	9	nmod	_	_
12	,	,	,	,	_	7	punct	_	_
13	whereas	whereas	IN	IN	_	16	mark	_	_
14	cholera	cholera	NN	NN	_	15	compound	_	_
15	toxin	toxin	NN	NN	_	16	nsubj	_	_
16	had	have	VBD	VBD	_	7	advcl	_	_
17	no	no	DT	DT	_	19	neg	_	_
18	inhibitory	inhibitory	JJ	JJ	_	19	amod	_	_
19	effect	effect	NN	NN	_	16	dobj	_	_
20	.	.	.	.	_	7	punct	_	_

1	Pyrrolidine	pyrrolidine	NN	NN	_	2	compound	_	_
2	dithiocarbamate	dithiocarbamate	NN	NN	_	12	nsubj	_	_
3	,	,	,	,	_	2	punct	_	_
4	an	a	DT	DT	_	5	det	_	_
5	inhibitor	inhibitor	NN	NN	_	2	appos	_	_
6	for	for	IN	IN	_	9	case	_	_
7	NF-kappa	nf-kappa	NN	NN	_	8	compound	_	_
8	B	b	NN	NN	_	9	compound	_	_
9	activation	activation	NN	NN	_	5	nmod	_	_
10	,	,	,	,	_	2	punct	_	_
11	markedly	markedly	RB	RB	_	12	advmod	_	_
12	reduced	reduce	VBD	VBD	_	0	root	_	_
13	PAF-stimulated	paf-stimulated	JJ	JJ	_	17	amod	_	_
14	kappa	kappa	NN	NN	_	17	compound	_	_
15	B	b	NN	NN	_	17	compound	_	_
16	binding	binding	NN	NN	_	17	compound	_	_
17	activity	activity	NN	NN	_	12	dobj	_	_
18	as	as	RB	RB	_	17	cc	_	_
19	well	well	RB	RB	_	18	mwe	_	_
20	as	as	IN	IN	_	18	mwe	_	_
21	up-regulation	up-regulation	NN	NN	_	17	conj	_	_
22	of	of	IN	IN	_	24	case	_	_
23	HB-EGF	hb-egf	NN	NN	_	24	compound	_	_
24	mRNA	mrna	NN	NN	_	21	nmod	_	_
25	.	.	.	.	_	12	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	a	a	DT	DT	_	6	det	_	_
5	potential	potential	JJ	JJ	_	6	amod	_	_
6	role	role	NN	NN	_	3	dobj	_	_
7	of	of	IN	IN	_	8	case	_	_
8	PAF	paf	NN	NN	_	6	nmod	_	_
9	in	in	IN	IN	_	11	case	_	_
10	HB-EGF	hb-egf	NN	NN	_	11	compound	_	_
11	expression	expression	NN	NN	_	6	nmod	_	_
12	and	and	CC	CC	_	3	cc	_	_
13	provide	provide	VBP	VBP	_	3	conj	_	_
14	evidence	evidence	NN	NN	_	13	dobj	_	_
15	that	that	IN	IN	_	19	mark	_	_
16	this	this	DT	DT	_	17	det	_	_
17	stimulation	stimulation	NN	NN	_	19	nsubj	_	_
18	may	may	MD	MD	_	19	aux	_	_
19	occur	occur	VB	VB	_	14	ccomp	_	_
20	through	through	IN	IN	_	25	case	_	_
21	increased	increase	VBN	VBN	_	25	amod	_	_
22	kappa	kappa	NN	NN	_	25	compound	_	_
23	B	b	NN	NN	_	25	compound	_	_
24	binding	binding	NN	NN	_	25	compound	_	_
25	activity	activity	NN	NN	_	19	nmod	_	_
26	.	.	.	.	_	3	punct	_	_

1	IL-1	il-1	NN	NN	_	2	compound	_	_
2	receptor	receptor	NN	NN	_	6	nsubj	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	TCR	tcr	NN	NN	_	2	conj	_	_
5	signals	signal	NNS	NNS	_	2	dep	_	_
6	synergize	synergize	VBP	VBP	_	0	root	_	_
7	to	to	TO	TO	_	8	mark	_	_
8	activate	activate	VB	VB	_	6	xcomp	_	_
9	NF-kappa	nf-kappa	NN	NN	_	12	compound	_	_
10	B-mediated	b-mediated	JJ	JJ	_	12	amod	_	_
11	gene	gene	NN	NN	_	12	compound	_	_
12	transcription	transcription	NN	NN	_	8	dobj	_	_
13	.	.	.	.	_	6	punct	_	_

1	Previous	previous	JJ	JJ	_	2	amod	_	_
2	studies	study	NNS	NNS	_	4	nsubj	_	_
3	have	have	VBP	VBP	_	4	aux	_	_
4	demonstrated	demonstrate	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	16	mark	_	_
6	IL-1	il-1	NN	NN	_	7	compound	_	_
7	receptor	receptor	NN	NN	_	16	nsubj	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	IL-1R	il-1r	NN	NN	_	7	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	-	-	:	:	_	7	punct	_	_
12	and	and	CC	CC	_	7	cc	_	_
13	TCR-initiated	tcr-initiated	JJ	JJ	_	14	amod	_	_
14	signals	signal	NNS	NNS	_	7	conj	_	_
15	can	can	MD	MD	_	16	aux	_	_
16	interact	interact	VB	VB	_	4	ccomp	_	_
17	synergistically	synergistically	RB	RB	_	16	advmod	_	_
18	to	to	TO	TO	_	19	mark	_	_
19	increase	increase	VB	VB	_	16	xcomp	_	_
20	the	the	DT	DT	_	21	det	_	_
21	rate	rate	NN	NN	_	19	dobj	_	_
22	of	of	IN	IN	_	23	case	_	_
23	transcription	transcription	NN	NN	_	21	nmod	_	_
24	of	of	IN	IN	_	26	case	_	_
25	several	several	JJ	JJ	_	26	amod	_	_
26	lymphokine	lymphokine	NN	NN	_	23	nmod	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	lymphokine	lymphokine	NN	NN	_	29	compound	_	_
29	receptor	receptor	NN	NN	_	26	conj	_	_
30	genes	gene	NNS	NNS	_	26	dep	_	_
31	during	during	IN	IN	_	34	case	_	_
32	the	the	DT	DT	_	34	det	_	_
33	competence	competence	NN	NN	_	34	compound	_	_
34	phase	phase	NN	NN	_	19	nmod	_	_
35	of	of	IN	IN	_	38	case	_	_
36	the	the	DT	DT	_	38	det	_	_
37	activation	activation	NN	NN	_	38	compound	_	_
38	program	program	NN	NN	_	34	nmod	_	_
39	in	in	IN	IN	_	42	case	_	_
40	T	t	NN	NN	_	42	compound	_	_
41	helper	helper	NN	NN	_	42	compound	_	_
42	lymphocytes	lymphocyte	NNS	NNS	_	34	nmod	_	_
43	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	report	report	NN	NN	_	5	nmod	_	_
4	we	we	PRP	PRP	_	5	nsubj	_	_
5	describe	describe	VBP	VBP	_	0	root	_	_
6	how	how	WRB	WRB	_	14	advmod	_	_
7	signals	signal	NNS	NNS	_	14	nsubj	_	_
8	initiated	initiate	VBN	VBN	_	7	acl	_	_
9	through	through	IN	IN	_	13	case	_	_
10	the	the	DT	DT	_	13	det	_	_
11	type	type	NN	NN	_	13	compound	_	_
12	I	i	CD	CD	_	13	nummod	_	_
13	IL-1R	il-1r	NN	NN	_	8	nmod	_	_
14	interact	interact	VBP	VBP	_	5	ccomp	_	_
15	with	with	IN	IN	_	16	case	_	_
16	signals	signal	NNS	NNS	_	14	nmod	_	_
17	from	from	IN	IN	_	20	case	_	_
18	the	the	DT	DT	_	20	det	_	_
19	antigen	antigen	NN	NN	_	20	compound	_	_
20	receptor	receptor	NN	NN	_	16	nmod	_	_
21	to	to	TO	TO	_	23	mark	_	_
22	synergistically	synergistically	RB	RB	_	23	advmod	_	_
23	augment	augment	VB	VB	_	14	xcomp	_	_
24	the	the	DT	DT	_	26	det	_	_
25	transactivating	transactivating	NN	NN	_	26	compound	_	_
26	properties	property	NNS	NNS	_	23	dobj	_	_
27	of	of	IN	IN	_	29	case	_	_
28	NF-kappa	nf-kappa	NN	NN	_	29	compound	_	_
29	B	b	NN	NN	_	26	nmod	_	_
30	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	6	det	_	_
2	synergistic	synergistic	JJ	JJ	_	6	amod	_	_
3	antigen	antigen	NN	NN	_	4	compound	_	_
4	receptor	receptor	NN	NN	_	6	compound	_	_
5	initiated	initiated	JJ	JJ	_	6	amod	_	_
6	signals	signal	NNS	NNS	_	8	nsubjpass	_	_
7	are	be	VBP	VBP	_	8	auxpass	_	_
8	mediated	mediate	VBN	VBN	_	0	root	_	_
9	through	through	IN	IN	_	12	case	_	_
10	protein	protein	NN	NN	_	12	compound	_	_
11	kinase	kinase	NN	NN	_	12	compound	_	_
12	C	c	NN	NN	_	8	nmod	_	_
13	because	because	IN	IN	_	17	mark	_	_
14	they	they	PRP	PRP	_	17	nsubjpass	_	_
15	can	can	MD	MD	_	17	aux	_	_
16	be	be	VB	VB	_	17	auxpass	_	_
17	mimicked	mimic	VBN	VBN	_	8	advcl	_	_
18	by	by	IN	IN	_	21	case	_	_
19	the	the	DT	DT	_	21	det	_	_
20	phorbol	phorbol	NN	NN	_	21	compound	_	_
21	ester	ester	NN	NN	_	17	nmod	_	_
22	,	,	,	,	_	21	punct	_	_
23	12-O-tetradecanoylphorbol-13-acetate	12-o-tetradecanoylphorbol-13-acetate	NN	NN	_	21	appos	_	_
24	,	,	,	,	_	21	punct	_	_
25	but	but	CC	CC	_	21	cc	_	_
26	not	not	RB	RB	_	29	neg	_	_
27	with	with	IN	IN	_	29	case	_	_
28	calcium	calcium	NN	NN	_	29	compound	_	_
29	ionophores	ionophore	NNS	NNS	_	21	conj	_	_
30	;	;	:	:	_	8	punct	_	_
31	and	and	CC	CC	_	8	cc	_	_
32	are	be	VBP	VBP	_	34	cop	_	_
33	staurosporine	staurosporine	NN	NN	_	34	nmod:npmod	_	_
34	sensitive	sensitive	JJ	JJ	_	8	conj	_	_
35	but	but	CC	CC	_	34	cc	_	_
36	cyclosporine	cyclosporine	NN	NN	_	37	nmod:npmod	_	_
37	resistant	resistant	JJ	JJ	_	34	conj	_	_
38	.	.	.	.	_	8	punct	_	_

1	Gel	gel	NN	NN	_	3	compound	_	_
2	shift	shift	NN	NN	_	3	compound	_	_
3	analyses	analysis	NNS	NNS	_	4	nsubj	_	_
4	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	11	mark	_	_
6	NF-kappa	nf-kappa	NN	NN	_	7	compound	_	_
7	B	b	NN	NN	_	9	compound	_	_
8	nuclear	nuclear	JJ	JJ	_	9	amod	_	_
9	translocation	translocation	NN	NN	_	11	nsubjpass	_	_
10	is	be	VBZ	VBZ	_	11	auxpass	_	_
11	stimulated	stimulate	VBN	VBN	_	4	ccomp	_	_
12	primarily	primarily	RB	RB	_	11	advmod	_	_
13	by	by	IN	IN	_	14	case	_	_
14	IL-1	il-1	NN	NN	_	11	nmod	_	_
15	rather	rather	RB	RB	_	14	cc	_	_
16	than	than	IN	IN	_	15	mwe	_	_
17	by	by	IN	IN	_	20	case	_	_
18	antigen	antigen	NN	NN	_	19	compound	_	_
19	receptor	receptor	NN	NN	_	20	compound	_	_
20	signals	signal	NNS	NNS	_	14	conj	_	_
21	.	.	.	.	_	4	punct	_	_

1	Western	western	NN	NN	_	2	compound	_	_
2	blot	blot	NN	NN	_	6	nsubj	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	phosphorylation	phosphorylation	NN	NN	_	2	conj	_	_
5	analyses	analysis	NNS	NNS	_	2	dep	_	_
6	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
7	that	that	IN	IN	_	17	mark	_	_
8	the	the	DT	DT	_	10	det	_	_
9	synergistic	synergistic	JJ	JJ	_	10	amod	_	_
10	effect	effect	NN	NN	_	17	nsubj	_	_
11	on	on	IN	IN	_	15	case	_	_
12	NF-kappa	nf-kappa	NN	NN	_	13	compound	_	_
13	B	b	NN	NN	_	15	compound	_	_
14	functional	functional	JJ	JJ	_	15	amod	_	_
15	activity	activity	NN	NN	_	10	nmod	_	_
16	is	be	VBZ	VBZ	_	17	cop	_	_
17	independent	independent	JJ	JJ	_	6	ccomp	_	_
18	of	of	IN	IN	_	28	case	_	_
19	I	i	NN	NN	_	22	compound	_	_
20	kappa	kappa	NN	NN	_	22	compound	_	_
21	B	b	NN	NN	_	22	compound	_	_
22	alpha	alpha	NN	NN	_	28	compound	_	_
23	(	(	-LRB-	-LRB-	_	24	punct	_	_
24	MAD3	mad3	NN	NN	_	22	appos	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	-NF-kappa	-nf-kappa	NN	NN	_	28	compound	_	_
27	B	b	NN	NN	_	28	compound	_	_
28	dissociation	dissociation	NN	NN	_	17	nmod	_	_
29	in	in	IN	IN	_	31	case	_	_
30	the	the	DT	DT	_	31	det	_	_
31	cytosol	cytosol	NN	NN	_	28	nmod	_	_
32	and	and	CC	CC	_	17	cc	_	_
33	is	be	VBZ	VBZ	_	35	auxpass	_	_
34	not	not	RB	RB	_	35	neg	_	_
35	associated	associate	VBN	VBN	_	17	conj	_	_
36	with	with	IN	IN	_	41	case	_	_
37	I	i	NN	NN	_	39	compound	_	_
38	kappa	kappa	NN	NN	_	39	compound	_	_
39	B	b	NN	NN	_	41	compound	_	_
40	nuclear	nuclear	JJ	JJ	_	41	amod	_	_
41	translocation	translocation	NN	NN	_	35	nmod	_	_
42	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	7	det	_	_
2	IL-1-induced	il-1-induced	JJ	JJ	_	7	amod	_	_
3	NF-kappa	nf-kappa	NN	NN	_	4	compound	_	_
4	B	b	NN	NN	_	7	compound	_	_
5	DNA	dna	NN	NN	_	7	compound	_	_
6	nuclear	nuclear	JJ	JJ	_	7	amod	_	_
7	localization	localization	NN	NN	_	9	nsubj	_	_
8	is	be	VBZ	VBZ	_	9	cop	_	_
9	transient	transient	JJ	JJ	_	0	root	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	can	can	MD	MD	_	13	aux	_	_
12	be	be	VB	VB	_	13	cop	_	_
13	prolonged	prolonged	JJ	JJ	_	9	conj	_	_
14	either	either	CC	CC	_	19	cc:preconj	_	_
15	by	by	IN	IN	_	19	case	_	_
16	an	a	DT	DT	_	19	det	_	_
17	antigen	antigen	NN	NN	_	19	compound	_	_
18	receptor-initiated	receptor-initiated	JJ	JJ	_	19	amod	_	_
19	signal	signal	NN	NN	_	13	nmod	_	_
20	or	or	CC	CC	_	19	cc	_	_
21	by	by	IN	IN	_	22	mark	_	_
22	inhibiting	inhibit	VBG	VBG	_	19	conj	_	_
23	protein	protein	NN	NN	_	24	compound	_	_
24	synthesis	synthesis	NN	NN	_	22	dobj	_	_
25	.	.	.	.	_	9	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	6	mark	_	_
5	IL-1	il-1	NN	NN	_	6	nsubj	_	_
6	induces	induce	VBZ	VBZ	_	3	ccomp	_	_
7	both	both	CC	CC	_	11	cc:preconj	_	_
8	NF-kappa	nf-kappa	NN	NN	_	9	compound	_	_
9	B	b	NN	NN	_	11	compound	_	_
10	nuclear	nuclear	JJ	JJ	_	11	amod	_	_
11	translocation	translocation	NN	NN	_	6	dobj	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	the	the	DT	DT	_	14	det	_	_
14	synthesis	synthesis	NN	NN	_	11	conj	_	_
15	of	of	IN	IN	_	19	case	_	_
16	a	a	DT	DT	_	19	det	_	_
17	protein	protein	NN	NN	_	19	compound	_	_
18	(	(	-LRB-	-LRB-	_	19	punct	_	_
19	s	s	NNS	NNS	_	14	nmod	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	responsible	responsible	JJ	JJ	_	19	amod	_	_
22	for	for	IN	IN	_	23	mark	_	_
23	terminating	terminate	VBG	VBG	_	21	advcl	_	_
24	NF-kappa	nf-kappa	NN	NN	_	26	compound	_	_
25	B-DNA	b-dna	NN	NN	_	26	compound	_	_
26	interaction	interaction	NN	NN	_	23	dobj	_	_
27	in	in	IN	IN	_	29	case	_	_
28	the	the	DT	DT	_	29	det	_	_
29	nucleus	nucleus	NN	NN	_	26	nmod	_	_
30	.	.	.	.	_	3	punct	_	_

1	Antigen	antigen	NN	NN	_	3	compound	_	_
2	receptor	receptor	NN	NN	_	3	compound	_	_
3	signals	signal	NNS	NNS	_	4	nsubj	_	_
4	prolong	prolong	VBP	VBP	_	0	root	_	_
5	NF-kappa	nf-kappa	NN	NN	_	7	compound	_	_
6	B-DNA	b-dna	NN	NN	_	7	compound	_	_
7	interaction	interaction	NN	NN	_	4	dobj	_	_
8	,	,	,	,	_	4	punct	_	_
9	probably	probably	RB	RB	_	12	advmod	_	_
10	by	by	IN	IN	_	12	mark	_	_
11	functionally	functionally	RB	RB	_	12	advmod	_	_
12	antagonizing	antagonize	VBG	VBG	_	4	advcl	_	_
13	the	the	DT	DT	_	15	det	_	_
14	IL-1-induced	il-1-induced	JJ	JJ	_	15	amod	_	_
15	synthesis	synthesis	NN	NN	_	12	dobj	_	_
16	of	of	IN	IN	_	20	case	_	_
17	a	a	DT	DT	_	20	det	_	_
18	protein	protein	NN	NN	_	20	compound	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	s	s	NNS	NNS	_	15	nmod	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	responsible	responsible	JJ	JJ	_	20	amod	_	_
23	for	for	IN	IN	_	28	case	_	_
24	the	the	DT	DT	_	28	det	_	_
25	transient	transient	JJ	JJ	_	28	amod	_	_
26	NF-kappa	nf-kappa	NN	NN	_	28	compound	_	_
27	B-DNA	b-dna	NN	NN	_	28	compound	_	_
28	interaction	interaction	NN	NN	_	22	nmod	_	_
29	and	and	CC	CC	_	4	cc	_	_
30	consequently	consequently	RB	RB	_	4	advmod	_	_
31	synergistically	synergistically	RB	RB	_	4	advmod	_	_
32	enhance	enhance	VBP	VBP	_	4	dep	_	_
33	IL-1-induced	il-1-induced	JJ	JJ	_	37	amod	_	_
34	NF-kappa	nf-kappa	NN	NN	_	37	compound	_	_
35	B-dependent	b-dependent	JJ	JJ	_	37	amod	_	_
36	gene	gene	NN	NN	_	37	compound	_	_
37	transcription	transcription	NN	NN	_	32	dobj	_	_
38	.	.	.	.	_	4	punct	_	_

1	Identification	identification	NN	NN	_	0	root	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	purification	purification	NN	NN	_	1	conj	_	_
4	of	of	IN	IN	_	7	case	_	_
5	human	human	JJ	JJ	_	7	amod	_	_
6	Stat	stat	NN	NN	_	7	compound	_	_
7	proteins	protein	NNS	NNS	_	1	nmod	_	_
8	activated	activate	VBN	VBN	_	7	acl	_	_
9	in	in	IN	IN	_	10	case	_	_
10	response	response	NN	NN	_	8	nmod	_	_
11	to	to	TO	TO	_	12	case	_	_
12	interleukin-2	interleukin-2	NN	NN	_	10	nmod	_	_
13	.	.	.	.	_	1	punct	_	_

1	A	a	DT	DT	_	3	det	_	_
2	key	key	JJ	JJ	_	3	amod	_	_
3	cytokine	cytokine	NN	NN	_	10	nsubj	_	_
4	induced	induce	VBN	VBN	_	3	acl	_	_
5	during	during	IN	IN	_	8	case	_	_
6	the	the	DT	DT	_	8	det	_	_
7	immune	immune	JJ	JJ	_	8	amod	_	_
8	response	response	NN	NN	_	4	nmod	_	_
9	is	be	VBZ	VBZ	_	10	cop	_	_
10	IL-2	il-2	NN	NN	_	0	root	_	_
11	.	.	.	.	_	10	punct	_	_

1	Following	follow	VBG	VBG	_	4	case	_	_
2	T	t	NN	NN	_	4	compound	_	_
3	cell	cell	NN	NN	_	4	compound	_	_
4	activation	activation	NN	NN	_	19	nmod	_	_
5	,	,	,	,	_	19	punct	_	_
6	the	the	DT	DT	_	7	det	_	_
7	genes	gene	NNS	NNS	_	19	nsubjpass	_	_
8	encoding	encode	VBG	VBG	_	7	acl	_	_
9	IL-2	il-2	NN	NN	_	8	dobj	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	the	the	DT	DT	_	13	det	_	_
12	various	various	JJ	JJ	_	13	amod	_	_
13	chains	chain	NNS	NNS	_	9	conj	_	_
14	of	of	IN	IN	_	16	case	_	_
15	its	its	PRP$	PRP$	_	16	nmod:poss	_	_
16	receptor	receptor	NN	NN	_	13	nmod	_	_
17	are	be	VBP	VBP	_	19	auxpass	_	_
18	transcriptionally	transcriptionally	RB	RB	_	19	advmod	_	_
19	induced	induce	VBN	VBN	_	0	root	_	_
20	.	.	.	.	_	19	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	turn	turn	NN	NN	_	6	nmod	_	_
3	,	,	,	,	_	6	punct	_	_
4	secreted	secrete	VBN	VBN	_	5	amod	_	_
5	IL-2	il-2	NN	NN	_	6	nsubj	_	_
6	serves	serve	VBZ	VBZ	_	0	root	_	_
7	to	to	TO	TO	_	8	mark	_	_
8	stimulate	stimulate	VB	VB	_	6	xcomp	_	_
9	the	the	DT	DT	_	10	dep	_	_
10	proliferation	proliferation	NN	NN	_	8	dobj	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	differentiation	differentiation	NN	NN	_	10	conj	_	_
13	of	of	IN	IN	_	15	case	_	_
14	T	t	NN	NN	_	15	compound	_	_
15	lymphocytes	lymphocyte	NNS	NNS	_	10	nmod	_	_
16	.	.	.	.	_	6	punct	_	_

1	Several	several	JJ	JJ	_	3	amod	_	_
2	recent	recent	JJ	JJ	_	3	amod	_	_
3	studies	study	NNS	NNS	_	5	nsubj	_	_
4	have	have	VBP	VBP	_	5	aux	_	_
5	implicated	implicate	VBN	VBN	_	0	root	_	_
6	Jak	jak	NN	NN	_	7	compound	_	_
7	kinases	kinase	NNS	NNS	_	5	dobj	_	_
8	in	in	IN	IN	_	11	case	_	_
9	the	the	DT	DT	_	11	det	_	_
10	signaling	signaling	NN	NN	_	11	compound	_	_
11	pathway	pathway	NN	NN	_	7	nmod	_	_
12	induced	induce	VBN	VBN	_	11	acl	_	_
13	by	by	IN	IN	_	14	case	_	_
14	IL-2	il-2	NN	NN	_	12	nmod	_	_
15	.	.	.	.	_	5	punct	_	_

1	Following	follow	VBG	VBG	_	0	root	_	_
2	this	this	DT	DT	_	3	det	_	_
3	lead	lead	NN	NN	_	1	dobj	_	_
4	,	,	,	,	_	1	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	set	set	VBD	VBD	_	1	parataxis	_	_
7	out	out	RP	RP	_	6	compound:prt	_	_
8	to	to	TO	TO	_	9	mark	_	_
9	identify	identify	VB	VB	_	6	xcomp	_	_
10	transcription	transcription	NN	NN	_	11	compound	_	_
11	factors	factor	NNS	NNS	_	9	dobj	_	_
12	induced	induce	VBN	VBN	_	11	acl	_	_
13	in	in	IN	IN	_	14	case	_	_
14	response	response	NN	NN	_	12	nmod	_	_
15	to	to	TO	TO	_	16	case	_	_
16	IL-2	il-2	NN	NN	_	14	nmod	_	_
17	.	.	.	.	_	1	punct	_	_

1	Human	human	JJ	JJ	_	4	amod	_	_
2	peripheral	peripheral	JJ	JJ	_	4	amod	_	_
3	blood	blood	NN	NN	_	4	compound	_	_
4	lymphocytes	lymphocyte	NNS	NNS	_	6	nsubjpass	_	_
5	were	be	VBD	VBD	_	6	auxpass	_	_
6	observed	observe	VBN	VBN	_	0	root	_	_
7	to	to	TO	TO	_	8	mark	_	_
8	contain	contain	VB	VB	_	6	xcomp	_	_
9	several	several	JJ	JJ	_	13	amod	_	_
10	IL-2-inducible	il-2-inducible	JJ	JJ	_	13	amod	_	_
11	DNA	dna	NN	NN	_	13	compound	_	_
12	binding	binding	NN	NN	_	13	compound	_	_
13	activities	activity	NNS	NNS	_	8	dobj	_	_
14	.	.	.	.	_	6	punct	_	_

1	Similar	similar	JJ	JJ	_	2	amod	_	_
2	activities	activity	NNS	NNS	_	5	nsubjpass	_	_
3	were	be	VBD	VBD	_	5	auxpass	_	_
4	also	also	RB	RB	_	5	advmod	_	_
5	observed	observe	VBN	VBN	_	0	root	_	_
6	in	in	IN	IN	_	11	case	_	_
7	a	a	DT	DT	_	11	det	_	_
8	transformed	transform	VBN	VBN	_	11	amod	_	_
9	human	human	JJ	JJ	_	11	amod	_	_
10	lymphocyte	lymphocyte	NN	NN	_	11	compound	_	_
11	line	line	NN	NN	_	5	nmod	_	_
12	,	,	,	,	_	11	punct	_	_
13	termed	term	VBN	VBN	_	11	acl	_	_
14	YT	yt	NN	NN	_	13	xcomp	_	_
15	.	.	.	.	_	5	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	purified	purify	VBN	VBN	_	0	root	_	_
4	these	these	DT	DT	_	5	det	_	_
5	activities	activity	NNS	NNS	_	3	dobj	_	_
6	and	and	CC	CC	_	3	cc	_	_
7	found	find	VBD	VBD	_	3	conj	_	_
8	that	that	IN	IN	_	13	mark	_	_
9	the	the	DT	DT	_	12	det	_	_
10	principal	principal	JJ	JJ	_	12	amod	_	_
11	IL-2-inducible	il-2-inducible	JJ	JJ	_	12	amod	_	_
12	component	component	NN	NN	_	13	nsubj	_	_
13	bears	bear	VBZ	VBZ	_	7	ccomp	_	_
14	significant	significant	JJ	JJ	_	15	amod	_	_
15	relatedness	relatedness	NN	NN	_	13	dobj	_	_
16	to	to	TO	TO	_	20	case	_	_
17	a	a	DT	DT	_	20	det	_	_
18	prolactin-induced	prolactin-induced	JJ	JJ	_	20	amod	_	_
19	transcription	transcription	NN	NN	_	20	compound	_	_
20	factor	factor	NN	NN	_	15	nmod	_	_
21	first	first	RB	RB	_	22	advmod	_	_
22	identified	identify	VBN	VBN	_	20	acl	_	_
23	in	in	IN	IN	_	27	case	_	_
24	sheep	sheep	NN	NN	_	27	compound	_	_
25	mammary	mammary	JJ	JJ	_	27	amod	_	_
26	gland	gland	NN	NN	_	27	compound	_	_
27	tissue	tissue	NN	NN	_	22	nmod	_	_
28	.	.	.	.	_	3	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	hypothesize	hypothesize	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	12	mark	_	_
4	activation	activation	NN	NN	_	12	nsubj	_	_
5	of	of	IN	IN	_	7	case	_	_
6	this	this	DT	DT	_	7	det	_	_
7	protein	protein	NN	NN	_	4	nmod	_	_
8	,	,	,	,	_	7	punct	_	_
9	designated	designate	VBN	VBN	_	7	acl	_	_
10	hStat5	hstat5	NN	NN	_	9	xcomp	_	_
11	,	,	,	,	_	4	punct	_	_
12	helps	help	VBZ	VBZ	_	2	ccomp	_	_
13	govern	govern	VB	VB	_	12	ccomp	_	_
14	the	the	DT	DT	_	16	det	_	_
15	biological	biological	JJ	JJ	_	16	amod	_	_
16	effects	effect	NNS	NNS	_	13	dobj	_	_
17	of	of	IN	IN	_	18	case	_	_
18	IL-2	il-2	NN	NN	_	16	nmod	_	_
19	during	during	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	immune	immune	JJ	JJ	_	22	amod	_	_
22	response	response	NN	NN	_	13	nmod	_	_
23	.	.	.	.	_	2	punct	_	_

1	Induction	induction	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	4	case	_	_
3	transcription	transcription	NN	NN	_	4	compound	_	_
4	factors	factor	NNS	NNS	_	1	nmod	_	_
5	in	in	IN	IN	_	8	case	_	_
6	human	human	JJ	JJ	_	8	amod	_	_
7	T	t	NN	NN	_	8	compound	_	_
8	lymphocytes	lymphocyte	NNS	NNS	_	1	nmod	_	_
9	by	by	IN	IN	_	11	case	_	_
10	aspirin-like	aspirin-like	JJ	JJ	_	11	amod	_	_
11	drugs	drug	NNS	NNS	_	1	nmod	_	_
12	.	.	.	.	_	1	punct	_	_

1	Aspirin-like	aspirin-like	JJ	JJ	_	2	amod	_	_
2	drugs	drug	NNS	NNS	_	6	nsubj	_	_
3	(	(	-LRB-	-LRB-	_	4	punct	_	_
4	ALD	ald	NN	NN	_	2	appos	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	induce	induce	VBP	VBP	_	0	root	_	_
7	calcium	calcium	NN	NN	_	8	compound	_	_
8	mobilization	mobilization	NN	NN	_	6	dobj	_	_
9	,	,	,	,	_	8	punct	_	_
10	an	a	DT	DT	_	12	det	_	_
11	essential	essential	JJ	JJ	_	12	amod	_	_
12	component	component	NN	NN	_	8	appos	_	_
13	of	of	IN	IN	_	16	case	_	_
14	T	t	NN	NN	_	16	compound	_	_
15	cell	cell	NN	NN	_	16	compound	_	_
16	activation	activation	NN	NN	_	12	nmod	_	_
17	,	,	,	,	_	6	punct	_	_
18	but	but	CC	CC	_	6	cc	_	_
19	do	do	VBP	VBP	_	21	aux	_	_
20	not	not	RB	RB	_	21	neg	_	_
21	induce	induce	VB	VB	_	6	conj	_	_
22	the	the	DT	DT	_	23	det	_	_
23	biosynthesis	biosynthesis	NN	NN	_	21	dobj	_	_
24	of	of	IN	IN	_	25	case	_	_
25	IL-2	il-2	NN	NN	_	23	nmod	_	_
26	.	.	.	.	_	6	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	understand	understand	VB	VB	_	0	root	_	_
3	the	the	DT	DT	_	4	det	_	_
4	extent	extent	NN	NN	_	2	dobj	_	_
5	to	to	TO	TO	_	6	case	_	_
6	which	which	WDT	WDT	_	9	nmod	_	_
7	ALD	ald	NN	NN	_	9	nsubj	_	_
8	may	may	MD	MD	_	9	aux	_	_
9	mimic	mimic	VB	VB	_	4	acl:relcl	_	_
10	mitogenic	mitogenic	JJ	JJ	_	11	amod	_	_
11	stimulation	stimulation	NN	NN	_	9	dobj	_	_
12	,	,	,	,	_	2	punct	_	_
13	we	we	PRP	PRP	_	14	nsubj	_	_
14	studied	study	VBD	VBD	_	2	parataxis	_	_
15	cytoplasmic	cytoplasmic	JJ	JJ	_	14	dobj	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	nuclear	nuclear	JJ	JJ	_	15	conj	_	_
18	signaling	signaling	NN	NN	_	19	compound	_	_
19	steps	step	NNS	NNS	_	15	dep	_	_
20	in	in	IN	IN	_	23	case	_	_
21	ALD-treated	ald-treated	JJ	JJ	_	23	amod	_	_
22	T	t	NN	NN	_	23	compound	_	_
23	cells	cell	NNS	NNS	_	15	nmod	_	_
24	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	found	find	VBD	VBD	_	0	root	_	_
3	that	that	IN	IN	_	5	mark	_	_
4	ALD	ald	NN	NN	_	5	nsubj	_	_
5	induce	induce	VBP	VBP	_	2	ccomp	_	_
6	a	a	DT	DT	_	8	det	_	_
7	transient	transient	JJ	JJ	_	8	amod	_	_
8	activation	activation	NN	NN	_	5	dobj	_	_
9	of	of	IN	IN	_	11	case	_	_
10	protein	protein	NN	NN	_	11	compound	_	_
11	kinase	kinase	NN	NN	_	8	nmod	_	_
12	(	(	-LRB-	-LRB-	_	13	punct	_	_
13	PKC	pkc	NN	NN	_	11	appos	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	but	but	CC	CC	_	5	cc	_	_
16	have	have	VBP	VBP	_	5	conj	_	_
17	no	no	DT	DT	_	18	neg	_	_
18	effect	effect	NN	NN	_	16	dobj	_	_
19	(	(	-LRB-	-LRB-	_	21	punct	_	_
20	in	in	IN	IN	_	21	case	_	_
21	comparison	comparison	NN	NN	_	16	dep	_	_
22	to	to	TO	TO	_	24	case	_	_
23	anti-CD3	anti-cd3	JJ	JJ	_	24	amod	_	_
24	antibodies	antibody	NNS	NNS	_	21	nmod	_	_
25	)	)	-RRB-	-RRB-	_	21	punct	_	_
26	on	on	IN	IN	_	29	case	_	_
27	protein	protein	NN	NN	_	29	compound	_	_
28	tyrosine	tyrosine	NN	NN	_	29	compound	_	_
29	phosphorylation	phosphorylation	NN	NN	_	16	nmod	_	_
30	nor	nor	CC	CC	_	29	cc	_	_
31	on	on	IN	IN	_	36	case	_	_
32	PCL	pcl	NN	NN	_	36	compound	_	_
33	gamma	gamma	NN	NN	_	36	compound	_	_
34	1	1	CD	CD	_	36	nummod	_	_
35	tyrosine	tyrosine	NN	NN	_	36	compound	_	_
36	phosphorylation	phosphorylation	NN	NN	_	29	conj	_	_
37	.	.	.	.	_	2	punct	_	_

1	ALD-induced	ald-induced	JJ	JJ	_	3	amod	_	_
2	calcium	calcium	NN	NN	_	3	compound	_	_
3	mobilization	mobilization	NN	NN	_	8	nsubj	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	PKC	pkc	NN	NN	_	6	compound	_	_
6	activation	activation	NN	NN	_	3	conj	_	_
7	are	be	VBP	VBP	_	8	cop	_	_
8	independent	independent	JJ	JJ	_	0	root	_	_
9	of	of	IN	IN	_	13	case	_	_
10	tyrosine	tyrosine	NN	NN	_	12	compound	_	_
11	protein	protein	NN	NN	_	12	compound	_	_
12	kinase	kinase	NN	NN	_	13	compound	_	_
13	activity	activity	NN	NN	_	8	nmod	_	_
14	as	as	IN	IN	_	15	mark	_	_
15	shown	show	VBN	VBN	_	8	advcl	_	_
16	by	by	IN	IN	_	18	case	_	_
17	the	the	DT	DT	_	18	det	_	_
18	lack	lack	NN	NN	_	15	nmod	_	_
19	of	of	IN	IN	_	20	case	_	_
20	effect	effect	NN	NN	_	18	nmod	_	_
21	of	of	IN	IN	_	22	case	_	_
22	herbimycin	herbimycin	NN	NN	_	20	nmod	_	_
23	,	,	,	,	_	22	punct	_	_
24	a	a	DT	DT	_	27	det	_	_
25	tyrosine-protein	tyrosine-protein	JJ	JJ	_	27	amod	_	_
26	kinase-specific	kinase-specific	JJ	JJ	_	27	amod	_	_
27	inhibitor	inhibitor	NN	NN	_	22	appos	_	_
28	.	.	.	.	_	8	punct	_	_

1	Although	although	IN	IN	_	3	mark	_	_
2	we	we	PRP	PRP	_	3	nsubj	_	_
3	detected	detect	VBD	VBD	_	16	advcl	_	_
4	no	no	DT	DT	_	6	neg	_	_
5	IL-2	il-2	NN	NN	_	6	compound	_	_
6	mRNA	mrna	NN	NN	_	3	dobj	_	_
7	in	in	IN	IN	_	9	case	_	_
8	ALD-treated	ald-treated	JJ	JJ	_	9	amod	_	_
9	cells	cell	NNS	NNS	_	3	nmod	_	_
10	,	,	,	,	_	16	punct	_	_
11	the	the	DT	DT	_	12	det	_	_
12	nuclei	nucleus	NNS	NNS	_	16	nsubj	_	_
13	of	of	IN	IN	_	15	case	_	_
14	these	these	DT	DT	_	15	det	_	_
15	cells	cell	NNS	NNS	_	12	nmod	_	_
16	contain	contain	VBP	VBP	_	0	root	_	_
17	proteins	protein	NNS	NNS	_	16	dobj	_	_
18	capable	capable	JJ	JJ	_	17	amod	_	_
19	of	of	IN	IN	_	20	mark	_	_
20	binding	bind	VBG	VBG	_	18	advcl	_	_
21	to	to	TO	TO	_	24	case	_	_
22	three	three	CD	CD	_	24	nummod	_	_
23	regulatory	regulatory	JJ	JJ	_	24	amod	_	_
24	sequences	sequence	NNS	NNS	_	20	nmod	_	_
25	in	in	IN	IN	_	29	case	_	_
26	the	the	DT	DT	_	29	det	_	_
27	IL-2	il-2	NN	NN	_	29	compound	_	_
28	promoter	promoter	NN	NN	_	29	compound	_	_
29	region	region	NN	NN	_	24	nmod	_	_
30	:	:	:	:	_	16	punct	_	_
31	NFAT	nfat	NN	NN	_	16	dep	_	_
32	,	,	,	,	_	31	punct	_	_
33	NF	nf	NN	NN	_	35	compound	_	_
34	kappa	kappa	NN	NN	_	35	compound	_	_
35	B	b	NN	NN	_	31	conj	_	_
36	,	,	,	,	_	31	punct	_	_
37	and	and	CC	CC	_	31	cc	_	_
38	AP-1	ap-1	NN	NN	_	31	conj	_	_
39	.	.	.	.	_	16	punct	_	_

1	These	these	DT	DT	_	3	det	_	_
2	binding	binding	NN	NN	_	3	compound	_	_
3	activities	activity	NNS	NNS	_	5	nsubjpass	_	_
4	are	be	VBP	VBP	_	5	auxpass	_	_
5	expressed	express	VBN	VBN	_	0	root	_	_
6	only	only	RB	RB	_	5	advmod	_	_
7	in	in	IN	IN	_	10	case	_	_
8	activated	activate	VBN	VBN	_	10	amod	_	_
9	T	t	NN	NN	_	10	compound	_	_
10	cells	cell	NNS	NNS	_	5	nmod	_	_
11	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	expression	expression	NN	NN	_	5	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	AP-1	ap-1	NN	NN	_	2	nmod	_	_
5	depended	depend	VBD	VBD	_	0	root	_	_
6	on	on	IN	IN	_	8	case	_	_
7	calcium	calcium	NN	NN	_	8	compound	_	_
8	mobilization	mobilization	NN	NN	_	5	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	PKC	pkc	NN	NN	_	11	compound	_	_
11	activation	activation	NN	NN	_	8	conj	_	_
12	.	.	.	.	_	5	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	6	mark	_	_
5	ALD	ald	NN	NN	_	6	nsubj	_	_
6	cause	cause	VBP	VBP	_	3	ccomp	_	_
7	transient	transient	JJ	JJ	_	10	amod	_	_
8	but	but	CC	CC	_	7	cc	_	_
9	significant	significant	JJ	JJ	_	7	conj	_	_
10	changes	change	NNS	NNS	_	6	dobj	_	_
11	in	in	IN	IN	_	15	case	_	_
12	T	t	NN	NN	_	15	compound	_	_
13	cell	cell	NN	NN	_	15	compound	_	_
14	transmembrane	transmembrane	NN	NN	_	15	compound	_	_
15	signaling	signaling	NN	NN	_	6	nmod	_	_
16	,	,	,	,	_	6	punct	_	_
17	although	although	IN	IN	_	28	mark	_	_
18	some	some	DT	DT	_	19	det	_	_
19	events	event	NNS	NNS	_	28	nsubjpass	_	_
20	induced	induce	VBN	VBN	_	19	acl	_	_
21	by	by	IN	IN	_	22	case	_	_
22	stimulation	stimulation	NN	NN	_	20	nmod	_	_
23	with	with	IN	IN	_	25	case	_	_
24	anti-CD3	anti-cd3	JJ	JJ	_	25	amod	_	_
25	antibodies	antibody	NNS	NNS	_	22	nmod	_	_
26	are	be	VBP	VBP	_	28	auxpass	_	_
27	not	not	RB	RB	_	28	neg	_	_
28	induced	induce	VBN	VBN	_	6	advcl	_	_
29	by	by	IN	IN	_	30	case	_	_
30	ALD	ald	NN	NN	_	28	nmod	_	_
31	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	signal	signal	NN	NN	_	4	nsubjpass	_	_
3	is	be	VBZ	VBZ	_	4	auxpass	_	_
4	transmitted	transmit	VBN	VBN	_	0	root	_	_
5	to	to	TO	TO	_	7	case	_	_
6	the	the	DT	DT	_	7	det	_	_
7	nucleus	nucleus	NN	NN	_	4	nmod	_	_
8	and	and	CC	CC	_	4	cc	_	_
9	induces	induce	VBZ	VBZ	_	4	conj	_	_
10	DNA-binding	dna-binding	JJ	JJ	_	11	amod	_	_
11	activity	activity	NN	NN	_	9	dobj	_	_
12	by	by	IN	IN	_	15	case	_	_
13	several	several	JJ	JJ	_	15	amod	_	_
14	transcription	transcription	NN	NN	_	15	compound	_	_
15	factors	factor	NNS	NNS	_	9	nmod	_	_
16	.	.	.	.	_	4	punct	_	_

1	However	however	RB	RB	_	8	advmod	_	_
2	,	,	,	,	_	8	punct	_	_
3	the	the	DT	DT	_	5	det	_	_
4	ALD	ald	NN	NN	_	5	compound	_	_
5	stimulus	stimulus	NN	NN	_	8	nsubj	_	_
6	is	be	VBZ	VBZ	_	8	cop	_	_
7	not	not	RB	RB	_	8	neg	_	_
8	capable	capable	JJ	JJ	_	0	root	_	_
9	of	of	IN	IN	_	10	mark	_	_
10	causing	cause	VBG	VBG	_	8	advcl	_	_
11	complete	complete	JJ	JJ	_	14	amod	_	_
12	T	t	NN	NN	_	14	compound	_	_
13	cell	cell	NN	NN	_	14	compound	_	_
14	activation	activation	NN	NN	_	10	dobj	_	_
15	.	.	.	.	_	8	punct	_	_

1	Interleukin	interleukin	NN	NN	_	3	compound	_	_
2	(	(	-LRB-	-LRB-	_	3	punct	_	_
3	IL	il	NN	NN	_	6	nsubj	_	_
4	)	)	-RRB-	-RRB-	_	3	punct	_	_
5	-10	-10	CD	CD	_	3	nummod	_	_
6	inhibits	inhibit	VBZ	VBZ	_	0	root	_	_
7	nuclear	nuclear	JJ	JJ	_	10	amod	_	_
8	factor	factor	NN	NN	_	10	compound	_	_
9	kappa	kappa	NN	NN	_	10	compound	_	_
10	B	b	NN	NN	_	16	compound	_	_
11	(	(	-LRB-	-LRB-	_	14	punct	_	_
12	NF	nf	NN	NN	_	14	compound	_	_
13	kappa	kappa	NN	NN	_	14	compound	_	_
14	B	b	NN	NN	_	10	appos	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	activation	activation	NN	NN	_	6	dobj	_	_
17	in	in	IN	IN	_	19	case	_	_
18	human	human	JJ	JJ	_	19	amod	_	_
19	monocytes	monocyte	NNS	NNS	_	16	nmod	_	_
20	.	.	.	.	_	6	punct	_	_

1	IL-10	il-10	NN	NN	_	4	nsubj	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	IL-4	il-4	NN	NN	_	1	conj	_	_
4	suppress	suppress	VBP	VBP	_	0	root	_	_
5	cytokine	cytokine	NN	NN	_	6	compound	_	_
6	synthesis	synthesis	NN	NN	_	4	dobj	_	_
7	by	by	IN	IN	_	9	case	_	_
8	different	different	JJ	JJ	_	9	amod	_	_
9	mechanisms	mechanism	NNS	NNS	_	4	nmod	_	_
10	.	.	.	.	_	4	punct	_	_

1	Our	we	PRP$	PRP$	_	3	nmod:poss	_	_
2	previous	previous	JJ	JJ	_	3	amod	_	_
3	studies	study	NNS	NNS	_	8	nsubj	_	_
4	in	in	IN	IN	_	6	case	_	_
5	human	human	JJ	JJ	_	6	amod	_	_
6	monocytes	monocyte	NNS	NNS	_	3	nmod	_	_
7	have	have	VBP	VBP	_	8	aux	_	_
8	demonstrated	demonstrate	VBN	VBN	_	0	root	_	_
9	that	that	IN	IN	_	15	mark	_	_
10	interleukin	interleukin	NN	NN	_	12	compound	_	_
11	(	(	-LRB-	-LRB-	_	12	punct	_	_
12	IL	il	NN	NN	_	15	nsubj	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	-10	-10	CD	CD	_	12	nummod	_	_
15	inhibits	inhibit	VBZ	VBZ	_	8	ccomp	_	_
16	lipopolysaccharide	lipopolysaccharide	NN	NN	_	21	compound	_	_
17	(	(	-LRB-	-LRB-	_	21	punct	_	_
18	LPS	lps	NN	NN	_	21	compound	_	_
19	)	)	-RRB-	-RRB-	_	21	punct	_	_
20	-stimulated	-stimulated	JJ	JJ	_	21	amod	_	_
21	production	production	NN	NN	_	15	dobj	_	_
22	of	of	IN	IN	_	24	case	_	_
23	inflammatory	inflammatory	JJ	JJ	_	24	amod	_	_
24	cytokines	cytokine	NNS	NNS	_	21	nmod	_	_
25	,	,	,	,	_	24	punct	_	_
26	IL-1	il-1	NN	NN	_	27	compound	_	_
27	beta	beta	NN	NN	_	24	appos	_	_
28	,	,	,	,	_	27	punct	_	_
29	IL-6	il-6	NN	NN	_	27	conj	_	_
30	,	,	,	,	_	27	punct	_	_
31	IL-8	il-8	NN	NN	_	27	conj	_	_
32	,	,	,	,	_	27	punct	_	_
33	and	and	CC	CC	_	27	cc	_	_
34	tumor	tumor	NN	NN	_	40	compound	_	_
35	necrosis	necrosis	NN	NN	_	40	compound	_	_
36	factor	factor	NN	NN	_	40	compound	_	_
37	(	(	-LRB-	-LRB-	_	40	punct	_	_
38	TNF	tnf	NN	NN	_	40	compound	_	_
39	)	)	-RRB-	-RRB-	_	40	punct	_	_
40	-alpha	-alpha	NN	NN	_	27	conj	_	_
41	by	by	IN	IN	_	42	mark	_	_
42	blocking	block	VBG	VBG	_	15	advcl	_	_
43	gene	gene	NN	NN	_	44	compound	_	_
44	transcription	transcription	NN	NN	_	42	dobj	_	_
45	.	.	.	.	_	8	punct	_	_

1	Using	use	VBG	VBG	_	0	root	_	_
2	electrophoretic	electrophoretic	JJ	JJ	_	5	amod	_	_
3	mobility	mobility	NN	NN	_	5	compound	_	_
4	shift	shift	NN	NN	_	5	compound	_	_
5	assays	assay	NNS	NNS	_	1	dobj	_	_
6	(	(	-LRB-	-LRB-	_	7	punct	_	_
7	EMSA	emsa	NN	NN	_	5	appos	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	,	,	,	,	_	1	punct	_	_
10	we	we	PRP	PRP	_	12	nsubj	_	_
11	now	now	RB	RB	_	12	advmod	_	_
12	show	show	VBP	VBP	_	1	parataxis	_	_
13	that	that	IN	IN	_	25	mark	_	_
14	,	,	,	,	_	25	punct	_	_
15	in	in	IN	IN	_	16	case	_	_
16	monocytes	monocyte	NNS	NNS	_	25	nmod	_	_
17	stimulated	stimulate	VBN	VBN	_	16	acl	_	_
18	with	with	IN	IN	_	19	case	_	_
19	LPS	lps	NN	NN	_	17	nmod	_	_
20	or	or	CC	CC	_	19	cc	_	_
21	TNF	tnf	NN	NN	_	22	compound	_	_
22	alpha	alpha	NN	NN	_	19	conj	_	_
23	,	,	,	,	_	25	punct	_	_
24	IL-10	il-10	NN	NN	_	25	nsubj	_	_
25	inhibits	inhibit	VBZ	VBZ	_	12	ccomp	_	_
26	nuclear	nuclear	JJ	JJ	_	27	amod	_	_
27	stimulation	stimulation	NN	NN	_	25	dobj	_	_
28	of	of	IN	IN	_	32	case	_	_
29	nuclear	nuclear	JJ	JJ	_	32	amod	_	_
30	factor	factor	NN	NN	_	32	compound	_	_
31	kappa	kappa	NN	NN	_	32	compound	_	_
32	B	b	NN	NN	_	27	nmod	_	_
33	(	(	-LRB-	-LRB-	_	36	punct	_	_
34	NF	nf	NN	NN	_	36	compound	_	_
35	kappa	kappa	NN	NN	_	36	compound	_	_
36	B	b	NN	NN	_	32	appos	_	_
37	)	)	-RRB-	-RRB-	_	36	punct	_	_
38	,	,	,	,	_	32	punct	_	_
39	a	a	DT	DT	_	41	det	_	_
40	transcription	transcription	NN	NN	_	41	compound	_	_
41	factor	factor	NN	NN	_	32	appos	_	_
42	involved	involve	VBN	VBN	_	41	acl	_	_
43	in	in	IN	IN	_	45	case	_	_
44	the	the	DT	DT	_	45	det	_	_
45	expression	expression	NN	NN	_	42	nmod	_	_
46	of	of	IN	IN	_	49	case	_	_
47	inflammatory	inflammatory	JJ	JJ	_	49	amod	_	_
48	cytokine	cytokine	NN	NN	_	49	compound	_	_
49	genes	gene	NNS	NNS	_	45	nmod	_	_
50	.	.	.	.	_	1	punct	_	_

1	Several	several	JJ	JJ	_	2	amod	_	_
2	other	other	JJ	JJ	_	4	amod	_	_
3	transcription	transcription	NN	NN	_	4	compound	_	_
4	factors	factor	NNS	NNS	_	22	nsubjpass	_	_
5	including	include	VBG	VBG	_	6	case	_	_
6	NF-IL-6	nf-il-6	NN	NN	_	4	nmod	_	_
7	,	,	,	,	_	6	punct	_	_
8	AP-1	ap-1	NN	NN	_	6	conj	_	_
9	,	,	,	,	_	6	punct	_	_
10	AP-2	ap-2	NN	NN	_	6	conj	_	_
11	,	,	,	,	_	6	punct	_	_
12	GR	gr	NN	NN	_	6	conj	_	_
13	,	,	,	,	_	6	punct	_	_
14	CREB	creb	NN	NN	_	6	conj	_	_
15	,	,	,	,	_	6	punct	_	_
16	Oct-1	oct-1	NN	NN	_	6	conj	_	_
17	,	,	,	,	_	6	punct	_	_
18	and	and	CC	CC	_	6	cc	_	_
19	Sp-1	sp-1	NN	NN	_	6	conj	_	_
20	are	be	VBP	VBP	_	22	auxpass	_	_
21	not	not	RB	RB	_	22	neg	_	_
22	affected	affect	VBN	VBN	_	0	root	_	_
23	by	by	IN	IN	_	24	case	_	_
24	IL-10	il-10	NN	NN	_	22	nmod	_	_
25	.	.	.	.	_	22	punct	_	_

1	This	this	DT	DT	_	3	det	_	_
2	selective	selective	JJ	JJ	_	3	amod	_	_
3	inhibition	inhibition	NN	NN	_	11	nsubj	_	_
4	by	by	IN	IN	_	5	case	_	_
5	IL-10	il-10	NN	NN	_	3	nmod	_	_
6	of	of	IN	IN	_	10	case	_	_
7	NF	nf	NN	NN	_	9	compound	_	_
8	kappa	kappa	NN	NN	_	9	compound	_	_
9	B	b	NN	NN	_	10	compound	_	_
10	activation	activation	NN	NN	_	3	nmod	_	_
11	occurs	occur	VBZ	VBZ	_	0	root	_	_
12	rapidly	rapidly	RB	RB	_	13	advmod	_	_
13	and	and	CC	CC	_	11	advmod	_	_
14	in	in	IN	IN	_	17	case	_	_
15	a	a	DT	DT	_	17	det	_	_
16	dose-dependent	dose-dependent	JJ	JJ	_	17	amod	_	_
17	manner	manner	NN	NN	_	13	conj	_	_
18	and	and	CC	CC	_	11	cc	_	_
19	correlates	correlate	VBZ	VBZ	_	11	conj	_	_
20	well	well	RB	RB	_	19	advmod	_	_
21	with	with	IN	IN	_	27	case	_	_
22	IL-10	il-10	NN	NN	_	27	nmod:poss	_	_
23	's	's	POS	POS	_	27	case	_	_
24	cytokine	cytokine	NN	NN	_	27	compound	_	_
25	synthesis	synthesis	NN	NN	_	27	compound	_	_
26	inhibitory	inhibitory	JJ	JJ	_	27	amod	_	_
27	activity	activity	NN	NN	_	19	nmod	_	_
28	in	in	IN	IN	_	29	case	_	_
29	terms	term	NNS	NNS	_	19	nmod	_	_
30	of	of	IN	IN	_	32	case	_	_
31	both	both	CC	CC	_	32	cc:preconj	_	_
32	kinetics	kinetics	NNS	NNS	_	29	nmod	_	_
33	and	and	CC	CC	_	32	cc	_	_
34	dose	dose	NN	NN	_	35	compound	_	_
35	responsiveness	responsiveness	NN	NN	_	32	conj	_	_
36	.	.	.	.	_	11	punct	_	_

1	Furthermore	furthermore	RB	RB	_	21	advmod	_	_
2	,	,	,	,	_	21	punct	_	_
3	compounds	compound	NNS	NNS	_	21	nsubj	_	_
4	such	such	JJ	JJ	_	8	case	_	_
5	as	as	IN	IN	_	4	mwe	_	_
6	tosylphenylalanyl	tosylphenylalanyl	NN	NN	_	8	compound	_	_
7	chloromethyl	chloromethyl	NN	NN	_	8	compound	_	_
8	ketone	ketone	NN	NN	_	3	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	pyrrolidinedithiocarbamate	pyrrolidinedithiocarbamate	NN	NN	_	8	conj	_	_
11	that	that	WDT	WDT	_	13	nsubjpass	_	_
12	are	be	VBP	VBP	_	13	auxpass	_	_
13	known	know	VBN	VBN	_	8	acl:relcl	_	_
14	to	to	TO	TO	_	16	mark	_	_
15	selectively	selectively	RB	RB	_	16	advmod	_	_
16	inhibit	inhibit	VB	VB	_	13	xcomp	_	_
17	NF	nf	NN	NN	_	19	compound	_	_
18	kappa	kappa	NN	NN	_	19	compound	_	_
19	B	b	NN	NN	_	20	compound	_	_
20	activation	activation	NN	NN	_	16	dobj	_	_
21	block	block	VBP	VBP	_	0	root	_	_
22	cytokine	cytokine	NN	NN	_	24	compound	_	_
23	gene	gene	NN	NN	_	24	compound	_	_
24	transcription	transcription	NN	NN	_	21	dobj	_	_
25	in	in	IN	IN	_	27	case	_	_
26	LPS-stimulated	lps-stimulated	JJ	JJ	_	27	amod	_	_
27	monocytes	monocyte	NNS	NNS	_	24	nmod	_	_
28	.	.	.	.	_	21	punct	_	_

1	Taken	take	VBN	VBN	_	0	root	_	_
2	together	together	RB	RB	_	1	advmod	_	_
3	,	,	,	,	_	1	punct	_	_
4	these	these	DT	DT	_	5	det	_	_
5	results	result	NNS	NNS	_	6	nsubj	_	_
6	suggest	suggest	VBP	VBP	_	1	parataxis	_	_
7	that	that	IN	IN	_	18	mark	_	_
8	inhibition	inhibition	NN	NN	_	18	nsubj	_	_
9	of	of	IN	IN	_	13	case	_	_
10	NF	nf	NN	NN	_	12	compound	_	_
11	kappa	kappa	NN	NN	_	12	compound	_	_
12	B	b	NN	NN	_	13	compound	_	_
13	activation	activation	NN	NN	_	8	nmod	_	_
14	may	may	MD	MD	_	18	aux	_	_
15	be	be	VB	VB	_	18	cop	_	_
16	an	a	DT	DT	_	18	det	_	_
17	important	important	JJ	JJ	_	18	amod	_	_
18	mechanism	mechanism	NN	NN	_	6	ccomp	_	_
19	for	for	IN	IN	_	21	case	_	_
20	IL-10	il-10	NN	NN	_	21	compound	_	_
21	suppression	suppression	NN	NN	_	18	nmod	_	_
22	of	of	IN	IN	_	25	case	_	_
23	cytokine	cytokine	NN	NN	_	25	compound	_	_
24	gene	gene	NN	NN	_	25	compound	_	_
25	transcription	transcription	NN	NN	_	21	nmod	_	_
26	in	in	IN	IN	_	28	case	_	_
27	human	human	JJ	JJ	_	28	amod	_	_
28	monocytes	monocyte	NNS	NNS	_	25	nmod	_	_
29	.	.	.	.	_	1	punct	_	_

1	IL-4	il-4	NN	NN	_	13	nsubj	_	_
2	,	,	,	,	_	1	punct	_	_
3	another	another	DT	DT	_	4	det	_	_
4	cytokine	cytokine	NN	NN	_	1	appos	_	_
5	that	that	WDT	WDT	_	6	nsubj	_	_
6	inhibits	inhibit	VBZ	VBZ	_	4	acl:relcl	_	_
7	cytokine	cytokine	NN	NN	_	8	compound	_	_
8	mRNA	mrna	NN	NN	_	9	compound	_	_
9	accumulation	accumulation	NN	NN	_	6	dobj	_	_
10	in	in	IN	IN	_	11	case	_	_
11	monocytes	monocyte	NNS	NNS	_	9	nmod	_	_
12	,	,	,	,	_	1	punct	_	_
13	shows	show	VBZ	VBZ	_	0	root	_	_
14	little	little	JJ	JJ	_	16	amod	_	_
15	inhibitory	inhibitory	JJ	JJ	_	16	amod	_	_
16	effect	effect	NN	NN	_	13	dobj	_	_
17	on	on	IN	IN	_	22	case	_	_
18	LPS-induced	lps-induced	JJ	JJ	_	22	amod	_	_
19	NF	nf	NN	NN	_	21	compound	_	_
20	kappa	kappa	NN	NN	_	21	compound	_	_
21	B	b	NN	NN	_	22	compound	_	_
22	activation	activation	NN	NN	_	13	nmod	_	_
23	.	.	.	.	_	13	punct	_	_

1	Further	further	RB	RB	_	2	advmod	_	_
2	examination	examination	NN	NN	_	3	nsubj	_	_
3	reveals	reveal	VBZ	VBZ	_	0	root	_	_
4	that	that	IN	IN	_	10	mark	_	_
5	,	,	,	,	_	10	punct	_	_
6	unlike	unlike	IN	IN	_	7	case	_	_
7	IL-10	il-10	NN	NN	_	10	nmod	_	_
8	,	,	,	,	_	10	punct	_	_
9	IL-4	il-4	NN	NN	_	10	nsubj	_	_
10	enhances	enhance	VBZ	VBZ	_	3	ccomp	_	_
11	mRNA	mrna	NN	NN	_	12	compound	_	_
12	degradation	degradation	NN	NN	_	10	dobj	_	_
13	and	and	CC	CC	_	10	cc	_	_
14	does	do	VBZ	VBZ	_	16	aux	_	_
15	not	not	RB	RB	_	16	neg	_	_
16	suppress	suppress	VB	VB	_	10	conj	_	_
17	cytokine	cytokine	NN	NN	_	19	compound	_	_
18	gene	gene	NN	NN	_	19	compound	_	_
19	transcription	transcription	NN	NN	_	16	dobj	_	_
20	.	.	.	.	_	3	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	8	mark	_	_
5	IL-10	il-10	NN	NN	_	8	nsubj	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	IL-4	il-4	NN	NN	_	5	conj	_	_
8	inhibit	inhibit	VBP	VBP	_	3	ccomp	_	_
9	cytokine	cytokine	NN	NN	_	10	compound	_	_
10	production	production	NN	NN	_	8	dobj	_	_
11	by	by	IN	IN	_	13	case	_	_
12	different	different	JJ	JJ	_	13	amod	_	_
13	mechanisms	mechanism	NNS	NNS	_	10	nmod	_	_
14	.	.	.	.	_	3	punct	_	_

1	Coupling	coupling	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	6	case	_	_
3	a	a	DT	DT	_	6	det	_	_
4	signal	signal	NN	NN	_	6	compound	_	_
5	response	response	NN	NN	_	6	compound	_	_
6	domain	domain	NN	NN	_	1	nmod	_	_
7	in	in	IN	IN	_	11	case	_	_
8	I	i	NN	NN	_	11	compound	_	_
9	kappa	kappa	NN	NN	_	11	compound	_	_
10	B	b	NN	NN	_	11	compound	_	_
11	alpha	alpha	NN	NN	_	6	nmod	_	_
12	to	to	TO	TO	_	14	case	_	_
13	multiple	multiple	JJ	JJ	_	14	amod	_	_
14	pathways	pathway	NNS	NNS	_	1	nmod	_	_
15	for	for	IN	IN	_	18	case	_	_
16	NF-kappa	nf-kappa	NN	NN	_	17	compound	_	_
17	B	b	NN	NN	_	18	compound	_	_
18	activation	activation	NN	NN	_	14	nmod	_	_
19	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	eukaryotic	eukaryotic	JJ	JJ	_	4	amod	_	_
3	transcription	transcription	NN	NN	_	4	compound	_	_
4	factor	factor	NN	NN	_	7	nsubj	_	_
5	NF-kappa	nf-kappa	NN	NN	_	6	compound	_	_
6	B	b	NN	NN	_	4	dep	_	_
7	plays	play	VBZ	VBZ	_	0	root	_	_
8	a	a	DT	DT	_	10	det	_	_
9	central	central	JJ	JJ	_	10	amod	_	_
10	role	role	NN	NN	_	7	dobj	_	_
11	in	in	IN	IN	_	14	case	_	_
12	the	the	DT	DT	_	14	det	_	_
13	induced	induce	VBN	VBN	_	14	amod	_	_
14	expression	expression	NN	NN	_	7	nmod	_	_
15	of	of	IN	IN	_	19	case	_	_
16	human	human	JJ	JJ	_	19	amod	_	_
17	immunodeficiency	immunodeficiency	NN	NN	_	19	compound	_	_
18	virus	virus	NN	NN	_	19	compound	_	_
19	type	type	NN	NN	_	14	nmod	_	_
20	1	1	CD	CD	_	19	nummod	_	_
21	and	and	CC	CC	_	14	cc	_	_
22	in	in	IN	IN	_	24	case	_	_
23	many	many	JJ	JJ	_	24	amod	_	_
24	aspects	aspect	NNS	NNS	_	14	conj	_	_
25	of	of	IN	IN	_	28	case	_	_
26	the	the	DT	DT	_	28	det	_	_
27	genetic	genetic	JJ	JJ	_	28	amod	_	_
28	program	program	NN	NN	_	24	nmod	_	_
29	mediating	mediate	VBG	VBG	_	28	acl	_	_
30	normal	normal	JJ	JJ	_	31	amod	_	_
31	T-cell	t-cell	NN	NN	_	29	dobj	_	_
32	activation	activation	NN	NN	_	31	dep	_	_
33	and	and	CC	CC	_	31	cc	_	_
34	growth	growth	NN	NN	_	31	conj	_	_
35	.	.	.	.	_	7	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	nuclear	nuclear	JJ	JJ	_	3	amod	_	_
3	activity	activity	NN	NN	_	9	nsubjpass	_	_
4	of	of	IN	IN	_	6	case	_	_
5	NF-kappa	nf-kappa	NN	NN	_	6	compound	_	_
6	B	b	NN	NN	_	3	nmod	_	_
7	is	be	VBZ	VBZ	_	9	auxpass	_	_
8	tightly	tightly	RB	RB	_	9	advmod	_	_
9	regulated	regulate	VBN	VBN	_	0	root	_	_
10	from	from	IN	IN	_	13	case	_	_
11	the	the	DT	DT	_	13	det	_	_
12	cytoplasmic	cytoplasmic	JJ	JJ	_	13	amod	_	_
13	compartment	compartment	NN	NN	_	9	nmod	_	_
14	by	by	IN	IN	_	17	case	_	_
15	an	a	DT	DT	_	17	det	_	_
16	inhibitory	inhibitory	JJ	JJ	_	17	amod	_	_
17	subunit	subunit	NN	NN	_	9	nmod	_	_
18	called	call	VBN	VBN	_	17	acl	_	_
19	I	i	NN	NN	_	22	compound	_	_
20	kappa	kappa	NN	NN	_	22	compound	_	_
21	B	b	NN	NN	_	22	compound	_	_
22	alpha	alpha	NN	NN	_	18	xcomp	_	_
23	.	.	.	.	_	9	punct	_	_

1	This	this	DT	DT	_	3	det	_	_
2	cytoplasmic	cytoplasmic	JJ	JJ	_	3	amod	_	_
3	inhibitor	inhibitor	NN	NN	_	6	nsubjpass	_	_
4	is	be	VBZ	VBZ	_	6	auxpass	_	_
5	rapidly	rapidly	RB	RB	_	6	advmod	_	_
6	phosphorylated	phosphorylate	VBN	VBN	_	0	root	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	degraded	degrade	VBN	VBN	_	6	conj	_	_
9	in	in	IN	IN	_	10	case	_	_
10	response	response	NN	NN	_	6	nmod	_	_
11	to	to	TO	TO	_	14	case	_	_
12	a	a	DT	DT	_	14	det	_	_
13	diverse	diverse	JJ	JJ	_	14	amod	_	_
14	set	set	NN	NN	_	10	nmod	_	_
15	of	of	IN	IN	_	18	case	_	_
16	NF-kappa	nf-kappa	NN	NN	_	18	compound	_	_
17	B-inducing	b-inducing	JJ	JJ	_	18	amod	_	_
18	agents	agent	NNS	NNS	_	14	nmod	_	_
19	,	,	,	,	_	14	punct	_	_
20	including	include	VBG	VBG	_	22	case	_	_
21	T-cell	t-cell	NN	NN	_	22	compound	_	_
22	mitogens	mitogen	NNS	NNS	_	14	nmod	_	_
23	,	,	,	,	_	22	punct	_	_
24	proinflammatory	proinflammatory	JJ	JJ	_	25	amod	_	_
25	cytokines	cytokine	NNS	NNS	_	22	dep	_	_
26	,	,	,	,	_	22	punct	_	_
27	and	and	CC	CC	_	22	cc	_	_
28	viral	viral	JJ	JJ	_	29	amod	_	_
29	transactivators	transactivator	NNS	NNS	_	22	conj	_	_
30	such	such	JJ	JJ	_	34	case	_	_
31	as	as	IN	IN	_	30	mwe	_	_
32	the	the	DT	DT	_	34	det	_	_
33	Tax	tax	NN	NN	_	34	compound	_	_
34	protein	protein	NN	NN	_	29	nmod	_	_
35	of	of	IN	IN	_	40	case	_	_
36	human	human	JJ	JJ	_	40	amod	_	_
37	T-cell	t-cell	NN	NN	_	40	compound	_	_
38	leukemia	leukemia	NN	NN	_	40	compound	_	_
39	virus	virus	NN	NN	_	40	compound	_	_
40	type	type	NN	NN	_	34	nmod	_	_
41	1	1	CD	CD	_	40	nummod	_	_
42	.	.	.	.	_	6	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	explore	explore	VB	VB	_	0	root	_	_
3	these	these	DT	DT	_	8	det	_	_
4	I	i	NN	NN	_	8	compound	_	_
5	kappa	kappa	NN	NN	_	8	compound	_	_
6	B	b	NN	NN	_	8	compound	_	_
7	alpha-dependent	alpha-dependent	JJ	JJ	_	8	amod	_	_
8	mechanisms	mechanism	NNS	NNS	_	2	dobj	_	_
9	for	for	IN	IN	_	12	case	_	_
10	NF-kappa	nf-kappa	NN	NN	_	11	compound	_	_
11	B	b	NN	NN	_	12	compound	_	_
12	induction	induction	NN	NN	_	8	nmod	_	_
13	,	,	,	,	_	2	punct	_	_
14	we	we	PRP	PRP	_	15	nsubj	_	_
15	identified	identify	VBD	VBD	_	2	parataxis	_	_
16	novel	novel	JJ	JJ	_	17	amod	_	_
17	mutants	mutant	NNS	NNS	_	15	dobj	_	_
18	of	of	IN	IN	_	22	case	_	_
19	I	i	NN	NN	_	22	compound	_	_
20	kappa	kappa	NN	NN	_	22	compound	_	_
21	B	b	NN	NN	_	22	compound	_	_
22	alpha	alpha	NN	NN	_	17	nmod	_	_
23	that	that	WDT	WDT	_	24	nsubj	_	_
24	uncouple	uncouple	VBP	VBP	_	17	acl:relcl	_	_
25	its	its	PRP$	PRP$	_	29	nmod:poss	_	_
26	inhibitory	inhibitory	JJ	JJ	_	29	amod	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	signal-transducing	signal-transducing	JJ	JJ	_	26	conj	_	_
29	functions	function	NNS	NNS	_	24	dobj	_	_
30	in	in	IN	IN	_	33	case	_	_
31	human	human	JJ	JJ	_	33	amod	_	_
32	T	t	NN	NN	_	33	compound	_	_
33	lymphocytes	lymphocyte	NNS	NNS	_	24	nmod	_	_
34	.	.	.	.	_	2	punct	_	_

1	Specifically	specifically	RB	RB	_	15	advmod	_	_
2	,	,	,	,	_	15	punct	_	_
3	removal	removal	NN	NN	_	15	nsubj	_	_
4	of	of	IN	IN	_	9	case	_	_
5	the	the	DT	DT	_	9	det	_	_
6	N-terminal	n-terminal	JJ	JJ	_	9	amod	_	_
7	36	36	CD	CD	_	9	nummod	_	_
8	amino	amino	NN	NN	_	9	compound	_	_
9	acids	acid	NNS	NNS	_	3	nmod	_	_
10	of	of	IN	IN	_	14	case	_	_
11	I	i	NN	NN	_	14	compound	_	_
12	kappa	kappa	NN	NN	_	14	compound	_	_
13	B	b	NN	NN	_	14	compound	_	_
14	alpha	alpha	NN	NN	_	9	nmod	_	_
15	failed	fail	VBD	VBD	_	0	root	_	_
16	to	to	TO	TO	_	17	mark	_	_
17	disrupt	disrupt	VB	VB	_	15	xcomp	_	_
18	its	its	PRP$	PRP$	_	19	nmod:poss	_	_
19	ability	ability	NN	NN	_	17	dobj	_	_
20	to	to	TO	TO	_	21	mark	_	_
21	form	form	VB	VB	_	19	acl	_	_
22	latent	latent	JJ	JJ	_	23	amod	_	_
23	complexes	complex	NNS	NNS	_	21	dobj	_	_
24	with	with	IN	IN	_	26	case	_	_
25	NF-kappa	nf-kappa	NN	NN	_	26	compound	_	_
26	B	b	NN	NN	_	23	nmod	_	_
27	in	in	IN	IN	_	29	case	_	_
28	the	the	DT	DT	_	29	det	_	_
29	cytoplasm	cytoplasm	NN	NN	_	23	nmod	_	_
30	.	.	.	.	_	15	punct	_	_

1	However	however	RB	RB	_	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	this	this	DT	DT	_	5	det	_	_
4	deletion	deletion	NN	NN	_	5	compound	_	_
5	mutation	mutation	NN	NN	_	6	nsubj	_	_
6	prevented	prevent	VBD	VBD	_	0	root	_	_
7	the	the	DT	DT	_	9	det	_	_
8	induced	induce	VBN	VBN	_	9	amod	_	_
9	phosphorylation	phosphorylation	NN	NN	_	6	dobj	_	_
10	,	,	,	,	_	9	punct	_	_
11	degradative	degradative	JJ	JJ	_	12	amod	_	_
12	loss	loss	NN	NN	_	9	conj	_	_
13	,	,	,	,	_	9	punct	_	_
14	and	and	CC	CC	_	9	cc	_	_
15	functional	functional	JJ	JJ	_	16	amod	_	_
16	release	release	NN	NN	_	9	conj	_	_
17	of	of	IN	IN	_	21	case	_	_
18	I	i	NN	NN	_	21	compound	_	_
19	kappa	kappa	NN	NN	_	21	compound	_	_
20	B	b	NN	NN	_	21	compound	_	_
21	alpha	alpha	NN	NN	_	16	nmod	_	_
22	from	from	IN	IN	_	24	case	_	_
23	NF-kappa	nf-kappa	NN	NN	_	24	compound	_	_
24	B	b	NN	NN	_	16	nmod	_	_
25	in	in	IN	IN	_	27	case	_	_
26	Tax-expressing	tax-expressing	JJ	JJ	_	27	amod	_	_
27	cells	cell	NNS	NNS	_	9	nmod	_	_
28	.	.	.	.	_	6	punct	_	_

1	Alanine	alanine	NN	NN	_	2	compound	_	_
2	substitutions	substitution	NNS	NNS	_	20	nsubj	_	_
3	introduced	introduce	VBN	VBN	_	2	acl	_	_
4	at	at	IN	IN	_	7	case	_	_
5	two	two	CD	CD	_	7	nummod	_	_
6	serine	serine	NN	NN	_	7	compound	_	_
7	residues	residue	NNS	NNS	_	3	nmod	_	_
8	positioned	positioned	JJ	JJ	_	7	amod	_	_
9	within	within	IN	IN	_	13	case	_	_
10	this	this	DT	DT	_	13	det	_	_
11	N-terminal	n-terminal	JJ	JJ	_	13	amod	_	_
12	regulatory	regulatory	JJ	JJ	_	13	amod	_	_
13	region	region	NN	NN	_	8	nmod	_	_
14	of	of	IN	IN	_	18	case	_	_
15	I	i	NN	NN	_	18	compound	_	_
16	kappa	kappa	NN	NN	_	18	compound	_	_
17	B	b	NN	NN	_	18	compound	_	_
18	alpha	alpha	NN	NN	_	13	nmod	_	_
19	also	also	RB	RB	_	20	advmod	_	_
20	yielded	yield	VBD	VBD	_	0	root	_	_
21	constitutive	constitutive	JJ	JJ	_	22	amod	_	_
22	repressors	repressor	NNS	NNS	_	20	dobj	_	_
23	that	that	WDT	WDT	_	24	nsubj	_	_
24	escaped	escape	VBD	VBD	_	22	acl:relcl	_	_
25	from	from	IN	IN	_	27	case	_	_
26	Tax-induced	tax-induced	JJ	JJ	_	27	amod	_	_
27	turnover	turnover	NN	NN	_	24	nmod	_	_
28	and	and	CC	CC	_	24	cc	_	_
29	that	that	WDT	WDT	_	31	nsubj	_	_
30	potently	potently	RB	RB	_	31	advmod	_	_
31	inhibited	inhibit	VBD	VBD	_	24	conj	_	_
32	immune	immune	JJ	JJ	_	34	amod	_	_
33	activation	activation	NN	NN	_	34	compound	_	_
34	pathways	pathway	NNS	NNS	_	31	dobj	_	_
35	for	for	IN	IN	_	38	case	_	_
36	NF-kappa	nf-kappa	NN	NN	_	37	compound	_	_
37	B	b	NN	NN	_	38	compound	_	_
38	induction	induction	NN	NN	_	34	nmod	_	_
39	,	,	,	,	_	34	punct	_	_
40	including	include	VBG	VBG	_	41	case	_	_
41	those	those	DT	DT	_	34	nmod	_	_
42	initiated	initiate	VBN	VBN	_	41	acl	_	_
43	from	from	IN	IN	_	44	case	_	_
44	antigen	antigen	NN	NN	_	42	nmod	_	_
45	and	and	CC	CC	_	44	cc	_	_
46	cytokine	cytokine	NN	NN	_	44	conj	_	_
47	receptors	receptor	NNS	NNS	_	44	dep	_	_
48	.	.	.	.	_	20	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	12	nmod	_	_
3	,	,	,	,	_	12	punct	_	_
4	introduction	introduction	NN	NN	_	12	nsubj	_	_
5	of	of	IN	IN	_	7	case	_	_
6	a	a	DT	DT	_	7	det	_	_
7	phosphoserine	phosphoserine	NN	NN	_	4	nmod	_	_
8	mimetic	mimetic	JJ	JJ	_	7	amod	_	_
9	at	at	IN	IN	_	11	case	_	_
10	these	these	DT	DT	_	11	det	_	_
11	sites	site	NNS	NNS	_	8	nmod	_	_
12	rectified	rectify	VBD	VBD	_	0	root	_	_
13	this	this	DT	DT	_	15	det	_	_
14	functional	functional	JJ	JJ	_	15	amod	_	_
15	defect	defect	NN	NN	_	12	dobj	_	_
16	,	,	,	,	_	12	punct	_	_
17	a	a	DT	DT	_	18	det	_	_
18	finding	finding	NN	NN	_	12	dep	_	_
19	consistent	consistent	JJ	JJ	_	18	amod	_	_
20	with	with	IN	IN	_	23	case	_	_
21	a	a	DT	DT	_	23	det	_	_
22	causal	causal	JJ	JJ	_	23	amod	_	_
23	linkage	linkage	NN	NN	_	19	nmod	_	_
24	between	between	IN	IN	_	27	case	_	_
25	the	the	DT	DT	_	27	det	_	_
26	phosphorylation	phosphorylation	NN	NN	_	27	compound	_	_
27	status	status	NN	NN	_	23	nmod	_	_
28	and	and	CC	CC	_	27	cc	_	_
29	proteolytic	proteolytic	JJ	JJ	_	30	amod	_	_
30	stability	stability	NN	NN	_	27	conj	_	_
31	of	of	IN	IN	_	34	case	_	_
32	this	this	DT	DT	_	34	det	_	_
33	cytoplasmic	cytoplasmic	JJ	JJ	_	34	amod	_	_
34	inhibitor	inhibitor	NN	NN	_	27	nmod	_	_
35	.	.	.	.	_	12	punct	_	_

1	Together	together	RB	RB	_	7	advmod	_	_
2	,	,	,	,	_	7	punct	_	_
3	these	these	DT	DT	_	6	det	_	_
4	in	in	FW	FW	_	6	amod	_	_
5	vivo	vivo	FW	FW	_	4	dep	_	_
6	studies	study	NNS	NNS	_	7	nsubj	_	_
7	define	define	VBP	VBP	_	0	root	_	_
8	a	a	DT	DT	_	12	det	_	_
9	critical	critical	JJ	JJ	_	12	amod	_	_
10	signal	signal	NN	NN	_	12	compound	_	_
11	response	response	NN	NN	_	12	compound	_	_
12	domain	domain	NN	NN	_	7	dobj	_	_
13	in	in	IN	IN	_	17	case	_	_
14	I	i	NN	NN	_	17	compound	_	_
15	kappa	kappa	NN	NN	_	17	compound	_	_
16	B	b	NN	NN	_	17	compound	_	_
17	alpha	alpha	NN	NN	_	12	nmod	_	_
18	that	that	WDT	WDT	_	20	nsubj	_	_
19	coordinately	coordinately	RB	RB	_	20	advmod	_	_
20	controls	control	VBZ	VBZ	_	12	acl:relcl	_	_
21	the	the	DT	DT	_	23	det	_	_
22	biologic	biologic	JJ	JJ	_	23	amod	_	_
23	activities	activity	NNS	NNS	_	20	dobj	_	_
24	of	of	IN	IN	_	28	case	_	_
25	I	i	NN	NN	_	28	compound	_	_
26	kappa	kappa	NN	NN	_	28	compound	_	_
27	B	b	NN	NN	_	28	compound	_	_
28	alpha	alpha	NN	NN	_	23	nmod	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	NF-kappa	nf-kappa	NN	NN	_	31	compound	_	_
31	B	b	NN	NN	_	28	conj	_	_
32	in	in	IN	IN	_	33	case	_	_
33	response	response	NN	NN	_	20	nmod	_	_
34	to	to	TO	TO	_	35	case	_	_
35	viral	viral	JJ	JJ	_	33	nmod	_	_
36	and	and	CC	CC	_	35	cc	_	_
37	immune	immune	JJ	JJ	_	35	conj	_	_
38	stimuli	stimulus	NNS	NNS	_	35	dep	_	_
39	.	.	.	.	_	7	punct	_	_

1	HIV	hiv	NN	NN	_	5	compound	_	_
2	type	type	NN	NN	_	5	compound	_	_
3	1	1	CD	CD	_	5	nummod	_	_
4	protease	protease	NN	NN	_	5	compound	_	_
5	activation	activation	NN	NN	_	0	root	_	_
6	of	of	IN	IN	_	8	case	_	_
7	NF-kappa	nf-kappa	NN	NN	_	8	compound	_	_
8	B	b	NN	NN	_	5	nmod	_	_
9	within	within	IN	IN	_	12	case	_	_
10	T	t	NN	NN	_	12	compound	_	_
11	lymphoid	lymphoid	JJ	JJ	_	12	amod	_	_
12	cells	cell	NNS	NNS	_	5	nmod	_	_
13	.	.	.	.	_	5	punct	_	_

1	NF-kappa	nf-kappa	NN	NN	_	2	compound	_	_
2	B	b	NN	NN	_	6	nsubj	_	_
3	is	be	VBZ	VBZ	_	6	cop	_	_
4	a	a	DT	DT	_	6	det	_	_
5	nuclear	nuclear	JJ	JJ	_	6	amod	_	_
6	protein	protein	NN	NN	_	0	root	_	_
7	of	of	IN	IN	_	11	case	_	_
8	the	the	DT	DT	_	11	det	_	_
9	rel	rel	NN	NN	_	11	compound	_	_
10	oncogene	oncogene	NN	NN	_	11	compound	_	_
11	family	family	NN	NN	_	6	nmod	_	_
12	capable	capable	JJ	JJ	_	11	amod	_	_
13	of	of	IN	IN	_	14	mark	_	_
14	enhancing	enhance	VBG	VBG	_	12	advcl	_	_
15	transcription	transcription	NN	NN	_	14	dobj	_	_
16	of	of	IN	IN	_	19	case	_	_
17	several	several	JJ	JJ	_	19	amod	_	_
18	cellular	cellular	JJ	JJ	_	19	amod	_	_
19	genes	gene	NNS	NNS	_	15	nmod	_	_
20	,	,	,	,	_	19	punct	_	_
21	including	include	VBG	VBG	_	22	case	_	_
22	IL-2	il-2	NN	NN	_	19	nmod	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	the	the	DT	DT	_	26	det	_	_
25	IL-2	il-2	NN	NN	_	26	compound	_	_
26	receptor	receptor	NN	NN	_	22	conj	_	_
27	,	,	,	,	_	22	punct	_	_
28	and	and	CC	CC	_	22	cc	_	_
29	viral	viral	JJ	JJ	_	30	amod	_	_
30	genes	gene	NNS	NNS	_	22	conj	_	_
31	transcribed	transcribe	VBN	VBN	_	30	acl	_	_
32	from	from	IN	IN	_	35	case	_	_
33	the	the	DT	DT	_	35	det	_	_
34	HIV-1	hiv-1	NN	NN	_	35	compound	_	_
35	LTR	ltr	NN	NN	_	31	nmod	_	_
36	.	.	.	.	_	6	punct	_	_

1	It	it	PRP	PRP	_	4	nsubjpass	_	_
2	has	have	VBZ	VBZ	_	4	aux	_	_
3	been	be	VBN	VBN	_	4	auxpass	_	_
4	reported	report	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	9	mark	_	_
6	HIV-1	hiv-1	NN	NN	_	7	compound	_	_
7	protease	protease	NN	NN	_	9	nsubj	_	_
8	may	may	MD	MD	_	9	aux	_	_
9	cleave	cleave	VB	VB	_	4	ccomp	_	_
10	the	the	DT	DT	_	13	det	_	_
11	NF-kappa	nf-kappa	NN	NN	_	12	compound	_	_
12	B	b	NN	NN	_	13	compound	_	_
13	precursor	precursor	NN	NN	_	9	dobj	_	_
14	to	to	TO	TO	_	17	case	_	_
15	its	its	PRP$	PRP$	_	17	nmod:poss	_	_
16	active	active	JJ	JJ	_	17	amod	_	_
17	form	form	NN	NN	_	9	nmod	_	_
18	in	in	FW	FW	_	19	compound	_	_
19	vitro	vitro	FW	FW	_	9	advmod	_	_
20	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	study	study	NN	NN	_	15	nmod	_	_
4	the	the	DT	DT	_	5	det	_	_
5	effects	effect	NNS	NNS	_	15	nsubjpass	_	_
6	of	of	IN	IN	_	8	case	_	_
7	HIV	hiv	NN	NN	_	8	compound	_	_
8	protease	protease	NN	NN	_	5	nmod	_	_
9	on	on	IN	IN	_	13	case	_	_
10	NF-kappa	nf-kappa	NN	NN	_	11	compound	_	_
11	B	b	NN	NN	_	13	compound	_	_
12	precursor	precursor	NN	NN	_	13	compound	_	_
13	activation	activation	NN	NN	_	5	nmod	_	_
14	were	be	VBD	VBD	_	15	auxpass	_	_
15	examined	examine	VBN	VBN	_	0	root	_	_
16	in	in	IN	IN	_	17	case	_	_
17	Jurkat	jurkat	NN	NN	_	15	nmod	_	_
18	T	t	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	17	dep	_	_
20	by	by	IN	IN	_	21	mark	_	_
21	introducing	introduce	VBG	VBG	_	15	advcl	_	_
22	a	a	DT	DT	_	25	det	_	_
23	protease	protease	NN	NN	_	25	compound	_	_
24	expression	expression	NN	NN	_	25	compound	_	_
25	vector	vector	NN	NN	_	21	dobj	_	_
26	into	into	IN	IN	_	28	case	_	_
27	the	the	DT	DT	_	28	det	_	_
28	cells	cell	NNS	NNS	_	21	nmod	_	_
29	.	.	.	.	_	15	punct	_	_

1	Increased	increase	VBN	VBN	_	4	amod	_	_
2	NF-kappa	nf-kappa	NN	NN	_	3	compound	_	_
3	B	b	NN	NN	_	4	compound	_	_
4	activity	activity	NN	NN	_	6	nsubjpass	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	observed	observe	VBN	VBN	_	0	root	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	this	this	DT	DT	_	10	det	_	_
9	increased	increase	VBN	VBN	_	10	amod	_	_
10	activity	activity	NN	NN	_	12	nsubjpass	_	_
11	was	be	VBD	VBD	_	12	auxpass	_	_
12	blocked	block	VBN	VBN	_	6	conj	_	_
13	by	by	IN	IN	_	16	case	_	_
14	a	a	DT	DT	_	16	det	_	_
15	specific	specific	JJ	JJ	_	16	amod	_	_
16	inhibitor	inhibitor	NN	NN	_	12	nmod	_	_
17	of	of	IN	IN	_	20	case	_	_
18	the	the	DT	DT	_	20	det	_	_
19	viral	viral	JJ	JJ	_	20	amod	_	_
20	protease	protease	NN	NN	_	16	nmod	_	_
21	.	.	.	.	_	6	punct	_	_

1	Viral	viral	JJ	JJ	_	2	amod	_	_
2	transcription	transcription	NN	NN	_	13	nsubjpass	_	_
3	,	,	,	,	_	2	punct	_	_
4	as	as	IN	IN	_	5	mark	_	_
5	measured	measure	VBN	VBN	_	13	dep	_	_
6	using	use	VBG	VBG	_	5	xcomp	_	_
7	LTR-CAT	ltr-cat	JJ	JJ	_	8	amod	_	_
8	assays	assay	NNS	NNS	_	6	dobj	_	_
9	,	,	,	,	_	13	punct	_	_
10	was	be	VBD	VBD	_	13	auxpass	_	_
11	only	only	RB	RB	_	12	advmod	_	_
12	slightly	slightly	RB	RB	_	13	advmod	_	_
13	enhanced	enhance	VBN	VBN	_	0	root	_	_
14	in	in	IN	IN	_	18	case	_	_
15	the	the	DT	DT	_	18	det	_	_
16	HIV-protease	hiv-protease	NN	NN	_	18	compound	_	_
17	expressing	expressing	JJ	JJ	_	18	amod	_	_
18	cells	cell	NNS	NNS	_	13	nmod	_	_
19	,	,	,	,	_	13	punct	_	_
20	while	while	IN	IN	_	32	mark	_	_
21	secretion	secretion	NN	NN	_	32	nsubjpass	_	_
22	of	of	IN	IN	_	23	case	_	_
23	IL-2	il-2	NN	NN	_	21	nmod	_	_
24	and	and	CC	CC	_	21	cc	_	_
25	expression	expression	NN	NN	_	21	conj	_	_
26	of	of	IN	IN	_	29	case	_	_
27	the	the	DT	DT	_	29	det	_	_
28	IL-2	il-2	NN	NN	_	29	compound	_	_
29	receptor	receptor	NN	NN	_	25	nmod	_	_
30	were	be	VBD	VBD	_	32	auxpass	_	_
31	not	not	RB	RB	_	32	neg	_	_
32	affected	affect	VBN	VBN	_	13	advcl	_	_
33	.	.	.	.	_	13	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	limited	limited	JJ	JJ	_	3	amod	_	_
3	activation	activation	NN	NN	_	10	nsubj	_	_
4	of	of	IN	IN	_	6	case	_	_
5	NF-kappa	nf-kappa	NN	NN	_	6	compound	_	_
6	B	b	NN	NN	_	3	nmod	_	_
7	by	by	IN	IN	_	9	case	_	_
8	HIV	hiv	NN	NN	_	9	compound	_	_
9	protease	protease	NN	NN	_	3	nmod	_	_
10	appears	appear	VBZ	VBZ	_	0	root	_	_
11	unlikely	unlikely	JJ	JJ	_	10	xcomp	_	_
12	to	to	TO	TO	_	13	mark	_	_
13	have	have	VB	VB	_	11	xcomp	_	_
14	a	a	DT	DT	_	16	det	_	_
15	significant	significant	JJ	JJ	_	16	amod	_	_
16	effect	effect	NN	NN	_	13	dobj	_	_
17	on	on	IN	IN	_	19	case	_	_
18	virus	virus	NN	NN	_	19	compound	_	_
19	expression	expression	NN	NN	_	13	nmod	_	_
20	or	or	CC	CC	_	19	cc	_	_
21	T	t	NN	NN	_	23	compound	_	_
22	cell	cell	NN	NN	_	23	compound	_	_
23	function	function	NN	NN	_	19	conj	_	_
24	.	.	.	.	_	10	punct	_	_

1	Erythropoietin	erythropoietin	NN	NN	_	2	nsubj	_	_
2	stimulates	stimulate	VBZ	VBZ	_	0	root	_	_
3	transcription	transcription	NN	NN	_	2	dobj	_	_
4	of	of	IN	IN	_	7	case	_	_
5	the	the	DT	DT	_	7	det	_	_
6	TAL1/SCL	tal1/scl	NN	NN	_	7	compound	_	_
7	gene	gene	NN	NN	_	3	nmod	_	_
8	and	and	CC	CC	_	3	cc	_	_
9	phosphorylation	phosphorylation	NN	NN	_	3	conj	_	_
10	of	of	IN	IN	_	13	case	_	_
11	its	its	PRP$	PRP$	_	13	nmod:poss	_	_
12	protein	protein	NN	NN	_	13	compound	_	_
13	products	product	NNS	NNS	_	9	nmod	_	_
14	.	.	.	.	_	2	punct	_	_

1	Activation	activation	NN	NN	_	27	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	the	the	DT	DT	_	4	det	_	_
4	TAL1	tal1	NN	NN	_	1	nmod	_	_
5	(	(	-LRB-	-LRB-	_	4	punct	_	_
6	or	or	CC	CC	_	4	cc	_	_
7	SCL	scl	NN	NN	_	9	compound	_	_
8	)	)	-RRB-	-RRB-	_	9	punct	_	_
9	gene	gene	NN	NN	_	4	conj	_	_
10	,	,	,	,	_	4	punct	_	_
11	originally	originally	RB	RB	_	12	advmod	_	_
12	identified	identify	VBN	VBN	_	4	acl	_	_
13	through	through	IN	IN	_	15	case	_	_
14	its	its	PRP$	PRP$	_	15	nmod:poss	_	_
15	involvement	involvement	NN	NN	_	12	nmod	_	_
16	by	by	IN	IN	_	20	case	_	_
17	a	a	DT	DT	_	20	det	_	_
18	recurrent	recurrent	JJ	JJ	_	20	amod	_	_
19	chromosomal	chromosomal	JJ	JJ	_	20	amod	_	_
20	translocation	translocation	NN	NN	_	15	nmod	_	_
21	,	,	,	,	_	1	punct	_	_
22	is	be	VBZ	VBZ	_	27	cop	_	_
23	the	the	DT	DT	_	27	det	_	_
24	most	most	RBS	RBS	_	26	advmod	_	_
25	frequent	frequent	JJ	JJ	_	26	amod	_	_
26	molecular	molecular	JJ	JJ	_	27	amod	_	_
27	lesion	lesion	NN	NN	_	0	root	_	_
28	recognized	recognize	VBN	VBN	_	27	acl	_	_
29	in	in	IN	IN	_	33	case	_	_
30	T-cell	t-cell	NN	NN	_	33	compound	_	_
31	acute	acute	JJ	JJ	_	33	amod	_	_
32	lymphoblastic	lymphoblastic	JJ	JJ	_	33	amod	_	_
33	leukemia	leukemia	NN	NN	_	28	nmod	_	_
34	.	.	.	.	_	27	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	protein	protein	NN	NN	_	3	compound	_	_
3	products	product	NNS	NNS	_	7	nsubj	_	_
4	of	of	IN	IN	_	6	case	_	_
5	this	this	DT	DT	_	6	det	_	_
6	gene	gene	NN	NN	_	3	nmod	_	_
7	contain	contain	VBP	VBP	_	0	root	_	_
8	the	the	DT	DT	_	10	det	_	_
9	basic-helix-loop-helix	basic-helix-loop-helix	JJ	JJ	_	10	amod	_	_
10	motif	motif	NN	NN	_	7	dobj	_	_
11	characteristic	characteristic	JJ	JJ	_	10	amod	_	_
12	of	of	IN	IN	_	15	case	_	_
13	a	a	DT	DT	_	15	det	_	_
14	large	large	JJ	JJ	_	15	amod	_	_
15	family	family	NN	NN	_	11	nmod	_	_
16	of	of	IN	IN	_	18	case	_	_
17	transcription	transcription	NN	NN	_	18	compound	_	_
18	factors	factor	NNS	NNS	_	15	nmod	_	_
19	that	that	WDT	WDT	_	20	nsubj	_	_
20	bind	bind	VBP	VBP	_	18	acl:relcl	_	_
21	to	to	TO	TO	_	26	case	_	_
22	the	the	DT	DT	_	26	det	_	_
23	canonical	canonical	JJ	JJ	_	26	amod	_	_
24	DNA	dna	NN	NN	_	26	compound	_	_
25	sequence	sequence	NN	NN	_	26	compound	_	_
26	CANNTG	canntg	NN	NN	_	20	nmod	_	_
27	as	as	IN	IN	_	29	case	_	_
28	protein	protein	NN	NN	_	29	compound	_	_
29	heterodimers	heterodimer	NNS	NNS	_	20	nmod	_	_
30	.	.	.	.	_	7	punct	_	_

1	TAL1	tal1	NN	NN	_	2	compound	_	_
2	expression	expression	NN	NN	_	16	nsubj	_	_
3	by	by	IN	IN	_	5	case	_	_
4	erythroid	erythroid	JJ	JJ	_	5	amod	_	_
5	cells	cell	NNS	NNS	_	2	nmod	_	_
6	in	in	FW	FW	_	5	amod	_	_
7	vivo	vivo	FW	FW	_	6	dep	_	_
8	and	and	CC	CC	_	5	cc	_	_
9	in	in	IN	IN	_	13	case	_	_
10	chemical-induced	chemical-induced	JJ	JJ	_	13	amod	_	_
11	erythroleukemia	erythroleukemia	NN	NN	_	13	compound	_	_
12	cell	cell	NN	NN	_	13	compound	_	_
13	lines	line	NNS	NNS	_	5	conj	_	_
14	in	in	FW	FW	_	13	amod	_	_
15	vivo	vivo	FW	FW	_	14	dep	_	_
16	suggested	suggest	VBD	VBD	_	0	root	_	_
17	the	the	DT	DT	_	18	det	_	_
18	gene	gene	NN	NN	_	16	dobj	_	_
19	might	might	MD	MD	_	20	aux	_	_
20	regulate	regulate	VB	VB	_	16	dep	_	_
21	aspects	aspect	NNS	NNS	_	20	dobj	_	_
22	of	of	IN	IN	_	24	case	_	_
23	erythroid	erythroid	JJ	JJ	_	24	amod	_	_
24	differentiation	differentiation	NN	NN	_	21	nmod	_	_
25	.	.	.	.	_	16	punct	_	_

1	Since	since	IN	IN	_	8	mark	_	_
2	the	the	DT	DT	_	4	det	_	_
3	terminal	terminal	JJ	JJ	_	4	amod	_	_
4	events	event	NNS	NNS	_	8	nsubjpass	_	_
5	of	of	IN	IN	_	6	case	_	_
6	erythropoiesis	erythropoiesis	NN	NN	_	4	nmod	_	_
7	are	be	VBP	VBP	_	8	auxpass	_	_
8	controlled	control	VBN	VBN	_	19	advcl	_	_
9	by	by	IN	IN	_	13	case	_	_
10	the	the	DT	DT	_	13	det	_	_
11	glycoprotein	glycoprotein	NN	NN	_	13	compound	_	_
12	hormone	hormone	NN	NN	_	13	compound	_	_
13	erythropoietin	erythropoietin	NN	NN	_	8	nmod	_	_
14	(	(	-LRB-	-LRB-	_	15	punct	_	_
15	Epo	epo	NN	NN	_	13	appos	_	_
16	)	)	-RRB-	-RRB-	_	15	punct	_	_
17	,	,	,	,	_	19	punct	_	_
18	we	we	PRP	PRP	_	19	nsubj	_	_
19	investigated	investigate	VBD	VBD	_	0	root	_	_
20	whether	whether	IN	IN	_	34	mark	_	_
21	the	the	DT	DT	_	22	dep	_	_
22	expression	expression	NN	NN	_	34	nsubjpass	_	_
23	or	or	CC	CC	_	22	cc	_	_
24	activity	activity	NN	NN	_	22	conj	_	_
25	of	of	IN	IN	_	28	case	_	_
26	the	the	DT	DT	_	28	det	_	_
27	TAL1	tal1	NN	NN	_	28	compound	_	_
28	gene	gene	NN	NN	_	22	nmod	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	its	its	PRP$	PRP$	_	32	nmod:poss	_	_
31	protein	protein	NN	NN	_	32	compound	_	_
32	products	product	NNS	NNS	_	28	conj	_	_
33	were	be	VBD	VBD	_	34	auxpass	_	_
34	affected	affect	VBN	VBN	_	19	ccomp	_	_
35	by	by	IN	IN	_	36	case	_	_
36	Epo	epo	NN	NN	_	34	nmod	_	_
37	in	in	IN	IN	_	39	case	_	_
38	splenic	splenic	JJ	JJ	_	39	amod	_	_
39	erythroblasts	erythroblast	NNS	NNS	_	36	nmod	_	_
40	from	from	IN	IN	_	41	case	_	_
41	mice	mouse	NNS	NNS	_	39	nmod	_	_
42	infected	infect	VBN	VBN	_	41	acl	_	_
43	with	with	IN	IN	_	46	case	_	_
44	an	a	DT	DT	_	46	det	_	_
45	anemia-inducing	anemia-inducing	JJ	JJ	_	46	amod	_	_
46	strain	strain	NN	NN	_	42	nmod	_	_
47	of	of	IN	IN	_	49	case	_	_
48	Friend	friend	NN	NN	_	49	compound	_	_
49	virus	virus	NN	NN	_	46	nmod	_	_
50	(	(	-LRB-	-LRB-	_	52	punct	_	_
51	FVA	fva	NN	NN	_	52	compound	_	_
52	cells	cell	NNS	NNS	_	49	appos	_	_
53	)	)	-RRB-	-RRB-	_	52	punct	_	_
54	.	.	.	.	_	19	punct	_	_

1	Epo	epo	NN	NN	_	2	nsubj	_	_
2	elicited	elicit	VBD	VBD	_	0	root	_	_
3	a	a	DT	DT	_	7	det	_	_
4	rapid	rapid	JJ	JJ	_	7	amod	_	_
5	,	,	,	,	_	4	punct	_	_
6	dose-related	dose-related	JJ	JJ	_	4	dep	_	_
7	increase	increase	NN	NN	_	2	dobj	_	_
8	in	in	IN	IN	_	10	case	_	_
9	TAL1	tal1	NN	NN	_	10	compound	_	_
10	mRNA	mrna	NN	NN	_	7	nmod	_	_
11	by	by	IN	IN	_	12	mark	_	_
12	increasing	increase	VBG	VBG	_	2	advcl	_	_
13	transcription	transcription	NN	NN	_	12	dobj	_	_
14	of	of	IN	IN	_	16	case	_	_
15	the	the	DT	DT	_	16	det	_	_
16	gene	gene	NN	NN	_	13	nmod	_	_
17	and	and	CC	CC	_	12	cc	_	_
18	stabilizing	stabilize	VBG	VBG	_	12	conj	_	_
19	one	one	CD	CD	_	18	dobj	_	_
20	of	of	IN	IN	_	22	case	_	_
21	its	its	PRP$	PRP$	_	22	nmod:poss	_	_
22	mRNAs	mrna	NNS	NNS	_	19	nmod	_	_
23	.	.	.	.	_	2	punct	_	_

1	An	a	DT	DT	_	6	det	_	_
2	Epo-inducible	epo-inducible	JJ	JJ	_	6	amod	_	_
3	TAL1	tal1	NN	NN	_	6	compound	_	_
4	DNA	dna	NN	NN	_	6	compound	_	_
5	binding	binding	NN	NN	_	6	compound	_	_
6	activity	activity	NN	NN	_	8	nsubjpass	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	identified	identify	VBN	VBN	_	0	root	_	_
9	in	in	IN	IN	_	13	case	_	_
10	FVA	fva	NN	NN	_	13	compound	_	_
11	cell	cell	NN	NN	_	13	compound	_	_
12	nuclear	nuclear	JJ	JJ	_	13	amod	_	_
13	extracts	extract	NNS	NNS	_	8	nmod	_	_
14	that	that	WDT	WDT	_	16	nsubj	_	_
15	subsequently	subsequently	RB	RB	_	16	advmod	_	_
16	decayed	decay	VBD	VBD	_	13	acl:relcl	_	_
17	despite	despite	IN	IN	_	18	mark	_	_
18	accumulating	accumulate	VBG	VBG	_	16	advcl	_	_
19	mRNA	mrna	NN	NN	_	18	dobj	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	protein	protein	NN	NN	_	19	conj	_	_
22	.	.	.	.	_	8	punct	_	_

1	Induction	induction	NN	NN	_	7	nsubjpass	_	_
2	of	of	IN	IN	_	5	case	_	_
3	DNA	dna	NN	NN	_	5	compound	_	_
4	binding	binding	NN	NN	_	5	compound	_	_
5	activity	activity	NN	NN	_	1	nmod	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	associated	associate	VBN	VBN	_	0	root	_	_
8	temporally	temporally	RB	RB	_	7	advmod	_	_
9	with	with	IN	IN	_	11	case	_	_
10	Epo-induced	epo-induced	JJ	JJ	_	11	amod	_	_
11	phosphorylation	phosphorylation	NN	NN	_	7	nmod	_	_
12	of	of	IN	IN	_	15	case	_	_
13	nuclear	nuclear	JJ	JJ	_	15	amod	_	_
14	TAL1	tal1	NN	NN	_	15	compound	_	_
15	protein	protein	NN	NN	_	11	nmod	_	_
16	.	.	.	.	_	7	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	6	mark	_	_
5	Epo	epo	NN	NN	_	6	nsubj	_	_
6	acts	act	VBZ	VBZ	_	3	ccomp	_	_
7	at	at	IN	IN	_	9	case	_	_
8	both	both	CC	CC	_	9	cc:preconj	_	_
9	transcriptional	transcriptional	JJ	JJ	_	6	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	posttranscriptional	posttranscriptional	JJ	JJ	_	9	conj	_	_
12	levels	level	NNS	NNS	_	9	dep	_	_
13	on	on	IN	IN	_	16	case	_	_
14	the	the	DT	DT	_	16	det	_	_
15	TAL1	tal1	NN	NN	_	16	compound	_	_
16	locus	locus	NN	NN	_	9	nmod	_	_
17	in	in	IN	IN	_	20	case	_	_
18	Friend	friend	NN	NN	_	20	compound	_	_
19	virus-induced	virus-induced	JJ	JJ	_	20	amod	_	_
20	erythroblasts	erythroblast	NNS	NNS	_	6	nmod	_	_
21	and	and	CC	CC	_	3	cc	_	_
22	establish	establish	VBP	VBP	_	3	conj	_	_
23	a	a	DT	DT	_	24	det	_	_
24	link	link	NN	NN	_	22	dobj	_	_
25	between	between	IN	IN	_	28	case	_	_
26	Epo	epo	NN	NN	_	28	compound	_	_
27	signaling	signaling	NN	NN	_	28	compound	_	_
28	mechanisms	mechanism	NNS	NNS	_	24	nmod	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	a	a	DT	DT	_	31	det	_	_
31	member	member	NN	NN	_	28	conj	_	_
32	of	of	IN	IN	_	34	case	_	_
33	a	a	DT	DT	_	34	det	_	_
34	family	family	NN	NN	_	31	nmod	_	_
35	of	of	IN	IN	_	37	case	_	_
36	transcription	transcription	NN	NN	_	37	compound	_	_
37	factors	factor	NNS	NNS	_	34	nmod	_	_
38	involved	involve	VBN	VBN	_	37	acl	_	_
39	in	in	IN	IN	_	41	case	_	_
40	the	the	DT	DT	_	41	det	_	_
41	differentiation	differentiation	NN	NN	_	38	nmod	_	_
42	of	of	IN	IN	_	45	case	_	_
43	diverse	diverse	JJ	JJ	_	45	amod	_	_
44	cell	cell	NN	NN	_	45	compound	_	_
45	lineages	lineage	NNS	NNS	_	41	nmod	_	_
46	.	.	.	.	_	3	punct	_	_

1	Abnormal	abnormal	JJ	JJ	_	2	amod	_	_
2	regulation	regulation	NN	NN	_	12	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	IL-2	il-2	NN	NN	_	6	compound	_	_
6	promoter	promoter	NN	NN	_	2	nmod	_	_
7	in	in	IN	IN	_	8	case	_	_
8	lpr	lpr	NN	NN	_	2	nmod	_	_
9	CD4-CD8-	cd4-cd8-	JJ	JJ	_	11	amod	_	_
10	T	t	NN	NN	_	11	compound	_	_
11	lymphocytes	lymphocyte	NNS	NNS	_	8	dep	_	_
12	results	result	VBZ	VBZ	_	0	root	_	_
13	in	in	IN	IN	_	15	case	_	_
14	constitutive	constitutive	JJ	JJ	_	15	amod	_	_
15	expression	expression	NN	NN	_	12	nmod	_	_
16	of	of	IN	IN	_	25	case	_	_
17	a	a	DT	DT	_	25	det	_	_
18	novel	novel	JJ	JJ	_	25	amod	_	_
19	nuclear	nuclear	JJ	JJ	_	25	amod	_	_
20	factor	factor	NN	NN	_	25	compound	_	_
21	of	of	IN	IN	_	25	amod	_	_
22	activated	activate	VBN	VBN	_	25	amod	_	_
23	T	t	NN	NN	_	25	compound	_	_
24	cells-binding	cells-binding	JJ	JJ	_	25	amod	_	_
25	factor	factor	NN	NN	_	15	nmod	_	_
26	.	.	.	.	_	12	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	inert	inert	JJ	JJ	_	3	amod	_	_
3	quality	quality	NN	NN	_	16	nsubj	_	_
4	of	of	IN	IN	_	15	case	_	_
5	MRL-Ipr/Ipr	mrl-ipr/ipr	NN	NN	_	15	compound	_	_
6	(	(	-LRB-	-LRB-	_	15	punct	_	_
7	Ipr	ipr	NN	NN	_	15	compound	_	_
8	)	)	-RRB-	-RRB-	_	15	punct	_	_
9	peripheral	peripheral	JJ	JJ	_	15	amod	_	_
10	CD4-CD8-	cd4-cd8-	JJ	JJ	_	15	amod	_	_
11	(	(	-LRB-	-LRB-	_	15	punct	_	_
12	CD4-8-	cd4-8-	JJ	JJ	_	15	amod	_	_
13	)	)	-RRB-	-RRB-	_	15	punct	_	_
14	T	t	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	3	nmod	_	_
16	manifests	manifest	VBZ	VBZ	_	0	root	_	_
17	primarily	primarily	RB	RB	_	16	advmod	_	_
18	as	as	IN	IN	_	20	case	_	_
19	an	a	DT	DT	_	20	det	_	_
20	inability	inability	NN	NN	_	16	nmod	_	_
21	to	to	TO	TO	_	22	mark	_	_
22	proliferate	proliferate	VB	VB	_	20	acl	_	_
23	or	or	CC	CC	_	22	cc	_	_
24	produce	produce	VB	VB	_	22	conj	_	_
25	IL-2	il-2	NN	NN	_	22	dobj	_	_
26	in	in	IN	IN	_	27	case	_	_
27	response	response	NN	NN	_	22	nmod	_	_
28	to	to	TO	TO	_	29	case	_	_
29	TCR	tcr	NN	NN	_	27	nmod	_	_
30	or	or	CC	CC	_	29	cc	_	_
31	mitogenic	mitogenic	JJ	JJ	_	29	conj	_	_
32	stimulation	stimulation	NN	NN	_	29	dep	_	_
33	.	.	.	.	_	16	punct	_	_

1	Yet	yet	RB	RB	_	6	advmod	_	_
2	these	these	DT	DT	_	4	det	_	_
3	same	same	JJ	JJ	_	4	amod	_	_
4	cells	cell	NNS	NNS	_	6	nsubj	_	_
5	do	do	VBP	VBP	_	6	aux	_	_
6	initiate	initiate	VB	VB	_	0	root	_	_
7	early	early	JJ	JJ	_	10	amod	_	_
8	TCR-mediated	tcr-mediated	JJ	JJ	_	10	amod	_	_
9	signaling	signaling	NN	NN	_	10	compound	_	_
10	events	event	NNS	NNS	_	6	dobj	_	_
11	,	,	,	,	_	10	punct	_	_
12	such	such	JJ	JJ	_	14	case	_	_
13	as	as	IN	IN	_	12	mwe	_	_
14	generation	generation	NN	NN	_	10	nmod	_	_
15	of	of	IN	IN	_	17	case	_	_
16	inositol	inositol	JJ	JJ	_	17	amod	_	_
17	phosphates	phosphate	NNS	NNS	_	14	nmod	_	_
18	and	and	CC	CC	_	14	cc	_	_
19	increased	increase	VBN	VBN	_	21	amod	_	_
20	intracellular	intracellular	JJ	JJ	_	21	amod	_	_
21	calcium	calcium	NN	NN	_	14	conj	_	_
22	.	.	.	.	_	6	punct	_	_

1	They	they	PRP	PRP	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	display	display	VBP	VBP	_	0	root	_	_
4	constitutively	constitutively	RB	RB	_	3	advmod	_	_
5	high	high	JJ	JJ	_	6	amod	_	_
6	levels	level	NNS	NNS	_	3	dobj	_	_
7	of	of	IN	IN	_	8	case	_	_
8	p59fyn	p59fyn	NN	NN	_	6	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	CD3	cd3	NN	NN	_	11	compound	_	_
11	zeta	zeta	NN	NN	_	12	compound	_	_
12	tyrosine	tyrosine	NN	NN	_	8	conj	_	_
13	phosphorylation	phosphorylation	NN	NN	_	8	dep	_	_
14	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	generation	generation	NN	NN	_	10	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	second	second	JJ	JJ	_	5	amod	_	_
5	messengers	messenger	NNS	NNS	_	2	nmod	_	_
6	in	in	IN	IN	_	8	case	_	_
7	T	t	NN	NN	_	8	compound	_	_
8	cells	cell	NNS	NNS	_	2	nmod	_	_
9	normally	normally	RB	RB	_	10	advmod	_	_
10	leads	lead	VBZ	VBZ	_	0	root	_	_
11	to	to	TO	TO	_	13	case	_	_
12	downstream	downstream	JJ	JJ	_	13	amod	_	_
13	signaling	signaling	NN	NN	_	10	nmod	_	_
14	that	that	WDT	WDT	_	15	nsubj	_	_
15	results	result	VBZ	VBZ	_	13	acl:relcl	_	_
16	in	in	IN	IN	_	18	case	_	_
17	transcriptional	transcriptional	JJ	JJ	_	18	amod	_	_
18	activation	activation	NN	NN	_	15	nmod	_	_
19	of	of	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	IL-2	il-2	NN	NN	_	22	compound	_	_
22	gene	gene	NN	NN	_	18	nmod	_	_
23	.	.	.	.	_	10	punct	_	_

1	We	we	PRP	PRP	_	5	nsubj	_	_
2	,	,	,	,	_	1	punct	_	_
3	therefore	therefore	RB	RB	_	5	advmod	_	_
4	,	,	,	,	_	5	punct	_	_
5	compared	compare	VBD	VBD	_	0	root	_	_
6	the	the	DT	DT	_	8	det	_	_
7	activation	activation	NN	NN	_	8	compound	_	_
8	state	state	NN	NN	_	5	dobj	_	_
9	of	of	IN	IN	_	14	case	_	_
10	the	the	DT	DT	_	14	det	_	_
11	IL-2	il-2	NN	NN	_	14	compound	_	_
12	gene	gene	NN	NN	_	14	compound	_	_
13	promoter	promoter	NN	NN	_	14	compound	_	_
14	region	region	NN	NN	_	8	nmod	_	_
15	in	in	IN	IN	_	17	case	_	_
16	freshly	freshly	RB	RB	_	17	advmod	_	_
17	isolated	isolate	VBN	VBN	_	8	nmod	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	stimulated	stimulate	VBN	VBN	_	17	conj	_	_
20	Ipr	ipr	NN	NN	_	23	compound	_	_
21	CD4-8-	cd4-8-	JJ	JJ	_	23	amod	_	_
22	T	t	NN	NN	_	23	compound	_	_
23	cells	cell	NNS	NNS	_	17	dep	_	_
24	with	with	IN	IN	_	25	case	_	_
25	that	that	DT	DT	_	5	nmod	_	_
26	of	of	IN	IN	_	29	case	_	_
27	normal	normal	JJ	JJ	_	29	amod	_	_
28	T	t	NN	NN	_	29	compound	_	_
29	lymphocytes	lymphocyte	NNS	NNS	_	25	nmod	_	_
30	.	.	.	.	_	5	punct	_	_

1	Levels	level	NNS	NNS	_	19	nsubjpass	_	_
2	of	of	IN	IN	_	4	case	_	_
3	the	the	DT	DT	_	4	det	_	_
4	octamer	octamer	NN	NN	_	1	nmod	_	_
5	,	,	,	,	_	4	punct	_	_
6	NF-kappa	nf-kappa	NN	NN	_	7	compound	_	_
7	B	b	NN	NN	_	4	conj	_	_
8	(	(	-LRB-	-LRB-	_	10	punct	_	_
9	p50-p65	p50-p65	NN	NN	_	10	compound	_	_
10	heterodimer	heterodimer	NN	NN	_	4	appos	_	_
11	)	)	-RRB-	-RRB-	_	10	punct	_	_
12	,	,	,	,	_	4	punct	_	_
13	and	and	CC	CC	_	4	cc	_	_
14	AP-1	ap-1	NN	NN	_	16	compound	_	_
15	transcriptional	transcriptional	JJ	JJ	_	16	amod	_	_
16	factors	factor	NNS	NNS	_	4	conj	_	_
17	are	be	VBP	VBP	_	19	auxpass	_	_
18	constitutively	constitutively	RB	RB	_	19	advmod	_	_
19	elevated	elevate	VBN	VBN	_	0	root	_	_
20	in	in	IN	IN	_	26	case	_	_
21	freshly	freshly	RB	RB	_	22	advmod	_	_
22	isolated	isolate	VBN	VBN	_	26	amod	_	_
23	Ipr	ipr	NN	NN	_	26	compound	_	_
24	CD4-8-	cd4-8-	JJ	JJ	_	26	amod	_	_
25	T	t	NN	NN	_	26	compound	_	_
26	cells	cell	NNS	NNS	_	19	nmod	_	_
27	,	,	,	,	_	19	punct	_	_
28	consistent	consistent	JJ	JJ	_	19	xcomp	_	_
29	with	with	IN	IN	_	32	case	_	_
30	the	the	DT	DT	_	32	det	_	_
31	activated	activate	VBN	VBN	_	32	amod	_	_
32	phenotype	phenotype	NN	NN	_	28	nmod	_	_
33	of	of	IN	IN	_	35	case	_	_
34	these	these	DT	DT	_	35	det	_	_
35	cells	cell	NNS	NNS	_	32	nmod	_	_
36	.	.	.	.	_	19	punct	_	_

1	Upon	upon	IN	IN	_	2	case	_	_
2	stimulation	stimulation	NN	NN	_	22	nmod	_	_
3	with	with	IN	IN	_	4	case	_	_
4	mitogens	mitogen	NNS	NNS	_	2	nmod	_	_
5	,	,	,	,	_	22	punct	_	_
6	formation	formation	NN	NN	_	22	nsubj	_	_
7	of	of	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	transactivating	transactivate	VBG	VBG	_	10	amod	_	_
10	complex	complex	NN	NN	_	6	nmod	_	_
11	,	,	,	,	_	10	punct	_	_
12	nuclear	nuclear	JJ	JJ	_	17	amod	_	_
13	factor	factor	NN	NN	_	17	compound	_	_
14	of	of	IN	IN	_	17	amod	_	_
15	activated	activate	VBN	VBN	_	17	amod	_	_
16	T	t	NN	NN	_	17	compound	_	_
17	cells	cell	NNS	NNS	_	10	appos	_	_
18	(	(	-LRB-	-LRB-	_	19	punct	_	_
19	NF-AT	nf-at	NN	NN	_	17	appos	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	,	,	,	,	_	6	punct	_	_
22	occurs	occur	VBZ	VBZ	_	0	root	_	_
23	with	with	IN	IN	_	25	case	_	_
24	normal	normal	JJ	JJ	_	25	amod	_	_
25	kinetics	kinetics	NNS	NNS	_	22	nmod	_	_
26	in	in	IN	IN	_	30	case	_	_
27	Ipr	ipr	NN	NN	_	30	compound	_	_
28	CD4-8-	cd4-8-	JJ	JJ	_	30	amod	_	_
29	T	t	NN	NN	_	30	compound	_	_
30	cells	cell	NNS	NNS	_	22	nmod	_	_
31	.	.	.	.	_	22	punct	_	_

1	Yet	yet	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	levels	level	NNS	NNS	_	11	nsubj	_	_
5	of	of	IN	IN	_	9	case	_	_
6	the	the	DT	DT	_	9	det	_	_
7	activating	activate	VBG	VBG	_	9	amod	_	_
8	NF-AT	nf-at	NN	NN	_	9	compound	_	_
9	complex	complex	NN	NN	_	4	nmod	_	_
10	never	never	RB	RB	_	11	neg	_	_
11	reach	reach	VBP	VBP	_	0	root	_	_
12	those	those	DT	DT	_	11	dobj	_	_
13	observed	observe	VBN	VBN	_	12	acl	_	_
14	in	in	IN	IN	_	19	case	_	_
15	similarly	similarly	RB	RB	_	16	advmod	_	_
16	stimulated	stimulate	VBN	VBN	_	19	amod	_	_
17	normal	normal	JJ	JJ	_	19	amod	_	_
18	T	t	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	13	nmod	_	_
20	.	.	.	.	_	11	punct	_	_

1	Furthermore	furthermore	RB	RB	_	10	advmod	_	_
2	,	,	,	,	_	10	punct	_	_
3	nuclear	nuclear	JJ	JJ	_	4	amod	_	_
4	extracts	extract	NNS	NNS	_	10	nsubj	_	_
5	from	from	IN	IN	_	9	case	_	_
6	Ipr	ipr	NN	NN	_	9	compound	_	_
7	CD4-8-	cd4-8-	JJ	JJ	_	9	amod	_	_
8	T	t	NN	NN	_	9	compound	_	_
9	cells	cell	NNS	NNS	_	4	nmod	_	_
10	display	display	VBP	VBP	_	0	root	_	_
11	high	high	JJ	JJ	_	12	amod	_	_
12	levels	level	NNS	NNS	_	10	dobj	_	_
13	of	of	IN	IN	_	18	case	_	_
14	a	a	DT	DT	_	18	det	_	_
15	novel	novel	JJ	JJ	_	18	amod	_	_
16	specific	specific	JJ	JJ	_	15	dep	_	_
17	binding	binding	NN	NN	_	18	compound	_	_
18	activity	activity	NN	NN	_	12	nmod	_	_
19	at	at	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	NF-AT	nf-at	NN	NN	_	22	compound	_	_
22	site	site	NN	NN	_	10	nmod	_	_
23	,	,	,	,	_	22	punct	_	_
24	which	which	WDT	WDT	_	26	nsubj	_	_
25	is	be	VBZ	VBZ	_	26	cop	_	_
26	present	present	JJ	JJ	_	22	acl:relcl	_	_
27	at	at	IN	IN	_	30	case	_	_
28	much	much	JJ	JJ	_	30	amod	_	_
29	lower	lower	JJR	JJR	_	28	dep	_	_
30	levels	level	NNS	NNS	_	26	nmod	_	_
31	in	in	IN	IN	_	36	case	_	_
32	freshly	freshly	RB	RB	_	33	advmod	_	_
33	isolated	isolate	VBN	VBN	_	36	amod	_	_
34	normal	normal	JJ	JJ	_	36	amod	_	_
35	T	t	NN	NN	_	36	compound	_	_
36	lymphocytes	lymphocyte	NNS	NNS	_	30	nmod	_	_
37	.	.	.	.	_	10	punct	_	_

1	Upon	upon	IN	IN	_	3	case	_	_
2	mitogenic	mitogenic	JJ	JJ	_	3	amod	_	_
3	stimulation	stimulation	NN	NN	_	15	nmod	_	_
4	,	,	,	,	_	15	punct	_	_
5	the	the	DT	DT	_	7	det	_	_
6	binding	binding	NN	NN	_	7	compound	_	_
7	activity	activity	NN	NN	_	15	nsubjpass	_	_
8	of	of	IN	IN	_	12	case	_	_
9	the	the	DT	DT	_	12	det	_	_
10	novel	novel	JJ	JJ	_	12	amod	_	_
11	NF-AT-binding	nf-at-binding	JJ	JJ	_	12	amod	_	_
12	factor	factor	NN	NN	_	7	nmod	_	_
13	is	be	VBZ	VBZ	_	15	auxpass	_	_
14	rapidly	rapidly	RB	RB	_	15	advmod	_	_
15	down-regulated	down-regulate	VBN	VBN	_	0	root	_	_
16	in	in	IN	IN	_	19	case	_	_
17	normal	normal	JJ	JJ	_	19	amod	_	_
18	T	t	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	15	nmod	_	_
20	,	,	,	,	_	15	punct	_	_
21	but	but	CC	CC	_	15	cc	_	_
22	persists	persist	VBZ	VBZ	_	15	conj	_	_
23	at	at	IN	IN	_	25	case	_	_
24	high	high	JJ	JJ	_	25	amod	_	_
25	levels	level	NNS	NNS	_	22	nmod	_	_
26	in	in	IN	IN	_	30	case	_	_
27	Ipr	ipr	NN	NN	_	30	compound	_	_
28	CD4-8-	cd4-8-	JJ	JJ	_	30	amod	_	_
29	T	t	NN	NN	_	30	compound	_	_
30	cells	cell	NNS	NNS	_	22	nmod	_	_
31	.	.	.	.	_	15	punct	_	_

1	These	these	DT	DT	_	3	det	_	_
2	two	two	CD	CD	_	3	nummod	_	_
3	abnormalities	abnormality	NNS	NNS	_	8	nsubj	_	_
4	at	at	IN	IN	_	7	case	_	_
5	the	the	DT	DT	_	7	det	_	_
6	NF-AT	nf-at	NN	NN	_	7	compound	_	_
7	site	site	NN	NN	_	3	nmod	_	_
8	provide	provide	VBP	VBP	_	0	root	_	_
9	a	a	DT	DT	_	11	det	_	_
10	potential	potential	JJ	JJ	_	11	amod	_	_
11	mechanism	mechanism	NN	NN	_	8	dobj	_	_
12	to	to	TO	TO	_	13	mark	_	_
13	account	account	VB	VB	_	11	acl	_	_
14	for	for	IN	IN	_	16	case	_	_
15	the	the	DT	DT	_	16	det	_	_
16	defect	defect	NN	NN	_	13	nmod	_	_
17	in	in	IN	IN	_	19	case	_	_
18	IL-2	il-2	NN	NN	_	19	compound	_	_
19	production	production	NN	NN	_	16	nmod	_	_
20	from	from	IN	IN	_	24	case	_	_
21	Ipr	ipr	NN	NN	_	24	compound	_	_
22	CD4-8-	cd4-8-	JJ	JJ	_	24	amod	_	_
23	T	t	NN	NN	_	24	compound	_	_
24	cells	cell	NNS	NNS	_	19	nmod	_	_
25	.	.	.	.	_	8	punct	_	_

1	GM-CSF	gm-csf	NN	NN	_	4	nsubj	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	IL-2	il-2	NN	NN	_	1	conj	_	_
4	share	share	VBP	VBP	_	0	root	_	_
5	common	common	JJ	JJ	_	7	amod	_	_
6	control	control	NN	NN	_	7	compound	_	_
7	mechanisms	mechanism	NNS	NNS	_	4	dobj	_	_
8	in	in	IN	IN	_	9	case	_	_
9	response	response	NN	NN	_	4	nmod	_	_
10	to	to	TO	TO	_	12	case	_	_
11	costimulatory	costimulatory	JJ	JJ	_	12	amod	_	_
12	signals	signal	NNS	NNS	_	9	nmod	_	_
13	in	in	IN	IN	_	15	case	_	_
14	T	t	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	12	nmod	_	_
16	.	.	.	.	_	4	punct	_	_

1	Antigen	antigen	NN	NN	_	19	nsubj	_	_
2	complexed	complex	VBN	VBN	_	1	acl	_	_
3	with	with	IN	IN	_	7	case	_	_
4	major	major	JJ	JJ	_	7	amod	_	_
5	histocompatibility	histocompatibility	NN	NN	_	7	compound	_	_
6	complex	complex	NN	NN	_	7	compound	_	_
7	class	class	NN	NN	_	2	nmod	_	_
8	I	i	CD	CD	_	7	dep	_	_
9	or	or	CC	CC	_	7	cc	_	_
10	II	ii	CD	CD	_	7	conj	_	_
11	molecules	molecule	NNS	NNS	_	7	dep	_	_
12	on	on	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	det	_	_
14	surface	surface	NN	NN	_	2	nmod	_	_
15	of	of	IN	IN	_	18	case	_	_
16	antigen	antigen	NN	NN	_	18	compound	_	_
17	presenting	presenting	NN	NN	_	18	compound	_	_
18	cells	cell	NNS	NNS	_	14	nmod	_	_
19	interacts	interact	VBZ	VBZ	_	0	root	_	_
20	with	with	IN	IN	_	24	case	_	_
21	the	the	DT	DT	_	24	det	_	_
22	T	t	NN	NN	_	24	compound	_	_
23	cell	cell	NN	NN	_	24	compound	_	_
24	receptor	receptor	NN	NN	_	19	nmod	_	_
25	(	(	-LRB-	-LRB-	_	26	punct	_	_
26	TCR	tcr	NN	NN	_	24	appos	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	on	on	IN	IN	_	30	case	_	_
29	the	the	DT	DT	_	30	det	_	_
30	surface	surface	NN	NN	_	19	nmod	_	_
31	of	of	IN	IN	_	33	case	_	_
32	T	t	NN	NN	_	33	compound	_	_
33	cells	cell	NNS	NNS	_	30	nmod	_	_
34	and	and	CC	CC	_	19	cc	_	_
35	initiates	initiate	VBZ	VBZ	_	19	conj	_	_
36	an	a	DT	DT	_	38	det	_	_
37	activation	activation	NN	NN	_	38	compound	_	_
38	cascade	cascade	NN	NN	_	35	dobj	_	_
39	.	.	.	.	_	19	punct	_	_

1	So	so	RB	RB	_	2	advmod	_	_
2	called	call	VBN	VBN	_	4	amod	_	_
3	costimulatory	costimulatory	JJ	JJ	_	4	amod	_	_
4	signals	signal	NNS	NNS	_	23	nsubjpass	_	_
5	,	,	,	,	_	4	punct	_	_
6	mediated	mediate	VBN	VBN	_	4	acl	_	_
7	by	by	IN	IN	_	11	case	_	_
8	other	other	JJ	JJ	_	11	amod	_	_
9	cell	cell	NN	NN	_	11	compound	_	_
10	surface	surface	NN	NN	_	11	compound	_	_
11	interactions	interaction	NNS	NNS	_	6	nmod	_	_
12	or	or	CC	CC	_	11	cc	_	_
13	soluble	soluble	JJ	JJ	_	14	amod	_	_
14	cytokines	cytokine	NNS	NNS	_	11	conj	_	_
15	produced	produce	VBN	VBN	_	14	acl	_	_
16	by	by	IN	IN	_	19	case	_	_
17	antigen	antigen	NN	NN	_	19	compound	_	_
18	presenting	presenting	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	15	nmod	_	_
20	,	,	,	,	_	4	punct	_	_
21	are	be	VBP	VBP	_	23	auxpass	_	_
22	also	also	RB	RB	_	23	advmod	_	_
23	required	require	VBN	VBN	_	0	root	_	_
24	for	for	IN	IN	_	28	case	_	_
25	complete	complete	JJ	JJ	_	28	amod	_	_
26	T	t	NN	NN	_	28	compound	_	_
27	cell	cell	NN	NN	_	28	compound	_	_
28	activation	activation	NN	NN	_	23	nmod	_	_
29	.	.	.	.	_	23	punct	_	_

1	High	high	JJ	JJ	_	2	amod	_	_
2	levels	level	NNS	NNS	_	11	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	cytokine	cytokine	NN	NN	_	6	compound	_	_
5	gene	gene	NN	NN	_	6	compound	_	_
6	expression	expression	NN	NN	_	2	nmod	_	_
7	in	in	IN	IN	_	9	case	_	_
8	T	t	NN	NN	_	9	compound	_	_
9	cells	cell	NNS	NNS	_	2	nmod	_	_
10	also	also	RB	RB	_	11	advmod	_	_
11	required	require	VBD	VBD	_	0	root	_	_
12	both	both	CC	CC	_	13	cc:preconj	_	_
13	TCR	tcr	NN	NN	_	11	dobj	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	costimulatory	costimulatory	JJ	JJ	_	13	conj	_	_
16	signals	signal	NNS	NNS	_	13	dep	_	_
17	.	.	.	.	_	11	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	granulocyte-macrophage	granulocyte-macrophage	JJ	JJ	_	4	amod	_	_
3	colony-stimulating	colony-stimulating	JJ	JJ	_	4	amod	_	_
4	factor	factor	NN	NN	_	5	nsubj	_	_
5	requires	require	VBZ	VBZ	_	0	root	_	_
6	sequences	sequence	NNS	NNS	_	5	dobj	_	_
7	in	in	IN	IN	_	9	case	_	_
8	the	the	DT	DT	_	9	det	_	_
9	promoter	promoter	NN	NN	_	6	nmod	_	_
10	as	as	RB	RB	_	6	cc	_	_
11	well	well	RB	RB	_	10	mwe	_	_
12	as	as	IN	IN	_	10	mwe	_	_
13	a	a	DT	DT	_	15	det	_	_
14	powerful	powerful	JJ	JJ	_	15	amod	_	_
15	enhancer	enhancer	NN	NN	_	6	conj	_	_
16	located	located	JJ	JJ	_	15	amod	_	_
17	3kb	3kb	RB	RB	_	18	nmod:npmod	_	_
18	upstream	upstream	RB	RB	_	16	advmod	_	_
19	to	to	TO	TO	_	20	mark	_	_
20	respond	respond	VB	VB	_	5	xcomp	_	_
21	to	to	TO	TO	_	23	case	_	_
22	TCR-like	tcr-like	JJ	JJ	_	23	case	_	_
23	signals	signal	NNS	NNS	_	20	advcl	_	_
24	.	.	.	.	_	5	punct	_	_

1	These	these	DT	DT	_	5	det	_	_
2	promoter	promoter	NN	NN	_	5	compound	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	enhancer	enhancer	NN	NN	_	2	conj	_	_
5	regions	region	NNS	NNS	_	8	nsubjpass	_	_
6	are	be	VBP	VBP	_	8	auxpass	_	_
7	mainly	mainly	RB	RB	_	8	advmod	_	_
8	activated	activate	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	_	18	case	_	_
10	the	the	DT	DT	_	18	det	_	_
11	transcription	transcription	NN	NN	_	18	compound	_	_
12	factor	factor	NN	NN	_	18	compound	_	_
13	nuclear	nuclear	JJ	JJ	_	18	amod	_	_
14	factor	factor	NN	NN	_	18	compound	_	_
15	of	of	IN	IN	_	18	amod	_	_
16	activated	activate	VBN	VBN	_	18	amod	_	_
17	T	t	NN	NN	_	18	compound	_	_
18	cells	cell	NNS	NNS	_	8	nmod	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	NFAT	nfat	NN	NN	_	18	appos	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	.	.	.	.	_	8	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	activation	activation	NN	NN	_	11	nsubjpass	_	_
3	of	of	IN	IN	_	4	case	_	_
4	NFAT	nfat	NN	NN	_	2	nmod	_	_
5	by	by	IN	IN	_	7	case	_	_
6	TCR	tcr	NN	NN	_	7	compound	_	_
7	signals	signal	NNS	NNS	_	2	nmod	_	_
8	has	have	VBZ	VBZ	_	11	aux	_	_
9	been	be	VBN	VBN	_	11	auxpass	_	_
10	well	well	RB	RB	_	11	advmod	_	_
11	described	describe	VBN	VBN	_	0	root	_	_
12	for	for	IN	IN	_	13	case	_	_
13	interleukin-2	interleukin-2	NN	NN	_	11	nmod	_	_
14	(	(	-LRB-	-LRB-	_	15	punct	_	_
15	IL-2	il-2	NN	NN	_	13	appos	_	_
16	)	)	-RRB-	-RRB-	_	15	punct	_	_
17	and	and	CC	CC	_	13	cc	_	_
18	IL-4	il-4	NN	NN	_	13	conj	_	_
19	gene	gene	NN	NN	_	20	compound	_	_
20	transcription	transcription	NN	NN	_	13	dep	_	_
21	in	in	IN	IN	_	23	case	_	_
22	T	t	NN	NN	_	23	compound	_	_
23	cells	cell	NNS	NNS	_	13	nmod	_	_
24	.	.	.	.	_	11	punct	_	_

1	Costimulatory	costimulatory	JJ	JJ	_	2	amod	_	_
2	signals	signal	NNS	NNS	_	17	nsubj	_	_
3	,	,	,	,	_	2	punct	_	_
4	such	such	JJ	JJ	_	6	case	_	_
5	as	as	IN	IN	_	4	mwe	_	_
6	activation	activation	NN	NN	_	2	nmod	_	_
7	of	of	IN	IN	_	12	case	_	_
8	the	the	DT	DT	_	12	det	_	_
9	CD28	cd28	NN	NN	_	12	compound	_	_
10	cell	cell	NN	NN	_	12	compound	_	_
11	surface	surface	NN	NN	_	12	compound	_	_
12	molecule	molecule	NN	NN	_	6	nmod	_	_
13	on	on	IN	IN	_	15	case	_	_
14	T	t	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	6	nmod	_	_
16	,	,	,	,	_	2	punct	_	_
17	lead	lead	VBP	VBP	_	0	root	_	_
18	to	to	TO	TO	_	19	case	_	_
19	activation	activation	NN	NN	_	17	nmod	_	_
20	through	through	IN	IN	_	23	case	_	_
21	a	a	DT	DT	_	23	det	_	_
22	distinct	distinct	JJ	JJ	_	23	amod	_	_
23	region	region	NN	NN	_	17	nmod	_	_
24	of	of	IN	IN	_	32	case	_	_
25	the	the	DT	DT	_	32	det	_	_
26	granulocyte-macrophage	granulocyte-macrophage	JJ	JJ	_	32	amod	_	_
27	colony-stimulating	colony-stimulating	JJ	JJ	_	32	amod	_	_
28	factor	factor	NN	NN	_	32	compound	_	_
29	(	(	-LRB-	-LRB-	_	32	punct	_	_
30	GM-CSF	gm-csf	NN	NN	_	32	compound	_	_
31	)	)	-RRB-	-RRB-	_	32	punct	_	_
32	promoter	promoter	NN	NN	_	23	nmod	_	_
33	.	.	.	.	_	17	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	region	region	NN	NN	_	4	nsubjpass	_	_
3	is	be	VBZ	VBZ	_	4	auxpass	_	_
4	termed	term	VBN	VBN	_	0	root	_	_
5	the	the	DT	DT	_	6	dep	_	_
6	CK-1	ck-1	NN	NN	_	4	xcomp	_	_
7	or	or	CC	CC	_	6	cc	_	_
8	CD28RE	cd28re	NN	NN	_	6	conj	_	_
9	and	and	CC	CC	_	4	cc	_	_
10	appears	appear	VBZ	VBZ	_	4	conj	_	_
11	to	to	TO	TO	_	12	mark	_	_
12	bind	bind	VB	VB	_	10	xcomp	_	_
13	specific	specific	JJ	JJ	_	14	amod	_	_
14	members	member	NNS	NNS	_	12	dobj	_	_
15	of	of	IN	IN	_	19	case	_	_
16	the	the	DT	DT	_	19	det	_	_
17	NF-kappa	nf-kappa	NN	NN	_	19	compound	_	_
18	B	b	NN	NN	_	19	compound	_	_
19	family	family	NN	NN	_	14	nmod	_	_
20	of	of	IN	IN	_	22	case	_	_
21	transcription	transcription	NN	NN	_	22	compound	_	_
22	factors	factor	NNS	NNS	_	19	nmod	_	_
23	.	.	.	.	_	4	punct	_	_

1	Human	human	JJ	JJ	_	5	amod	_	_
2	T	t	NN	NN	_	5	compound	_	_
3	leukemia	leukemia	NN	NN	_	5	compound	_	_
4	virus	virus	NN	NN	_	5	compound	_	_
5	type	type	NN	NN	_	10	nsubj	_	_
6	1	1	CD	CD	_	5	nummod	_	_
7	(	(	-LRB-	-LRB-	_	8	punct	_	_
8	HTLV-1	htlv-1	NN	NN	_	5	appos	_	_
9	)	)	-RRB-	-RRB-	_	8	punct	_	_
10	infects	infect	VBZ	VBZ	_	0	root	_	_
11	T	t	NN	NN	_	12	compound	_	_
12	cells	cell	NNS	NNS	_	10	dobj	_	_
13	and	and	CC	CC	_	10	cc	_	_
14	can	can	MD	MD	_	15	aux	_	_
15	lead	lead	VB	VB	_	10	conj	_	_
16	to	to	TO	TO	_	17	mark	_	_
17	increase	increase	VB	VB	_	15	xcomp	_	_
18	GM-CSF	gm-csf	NN	NN	_	19	compound	_	_
19	expression	expression	NN	NN	_	17	dobj	_	_
20	.	.	.	.	_	10	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	found	find	VBN	VBN	_	0	root	_	_
4	that	that	IN	IN	_	12	mark	_	_
5	the	the	DT	DT	_	8	det	_	_
6	HTLV-1	htlv-1	NN	NN	_	8	compound	_	_
7	transactivator	transactivator	NN	NN	_	8	compound	_	_
8	protein	protein	NN	NN	_	12	nsubj	_	_
9	,	,	,	,	_	8	punct	_	_
10	tax	tax	NN	NN	_	8	appos	_	_
11	,	,	,	,	_	8	punct	_	_
12	acts	act	VBZ	VBZ	_	3	ccomp	_	_
13	as	as	IN	IN	_	16	case	_	_
14	a	a	DT	DT	_	16	det	_	_
15	costimulatory	costimulatory	JJ	JJ	_	16	amod	_	_
16	signal	signal	NN	NN	_	12	nmod	_	_
17	for	for	IN	IN	_	18	case	_	_
18	GM-CSF	gm-csf	NN	NN	_	16	nmod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	IL-2	il-2	NN	NN	_	18	conj	_	_
21	gene	gene	NN	NN	_	22	compound	_	_
22	transcription	transcription	NN	NN	_	18	dep	_	_
23	,	,	,	,	_	12	punct	_	_
24	in	in	IN	IN	_	28	mark	_	_
25	that	that	IN	IN	_	28	mark	_	_
26	it	it	PRP	PRP	_	28	nsubj	_	_
27	can	can	MD	MD	_	28	aux	_	_
28	cooperate	cooperate	VB	VB	_	12	advcl	_	_
29	with	with	IN	IN	_	31	case	_	_
30	TCR	tcr	NN	NN	_	31	compound	_	_
31	signals	signal	NNS	NNS	_	28	nmod	_	_
32	to	to	TO	TO	_	33	mark	_	_
33	mediate	mediate	VB	VB	_	28	xcomp	_	_
34	high	high	JJ	JJ	_	37	amod	_	_
35	level	level	NN	NN	_	37	compound	_	_
36	gene	gene	NN	NN	_	37	compound	_	_
37	expression	expression	NN	NN	_	33	dobj	_	_
38	.	.	.	.	_	3	punct	_	_

1	Tax	tax	NN	NN	_	2	nsubj	_	_
2	activates	activate	VBZ	VBZ	_	0	root	_	_
3	the	the	DT	DT	_	5	det	_	_
4	GM-CSF	gm-csf	NN	NN	_	5	compound	_	_
5	promoter	promoter	NN	NN	_	2	dobj	_	_
6	through	through	IN	IN	_	9	case	_	_
7	the	the	DT	DT	_	9	det	_	_
8	CK-1/CD28RE	ck-1/cd28re	NN	NN	_	9	compound	_	_
9	region	region	NN	NN	_	2	nmod	_	_
10	and	and	CC	CC	_	2	cc	_	_
11	also	also	RB	RB	_	12	advmod	_	_
12	activates	activate	VBZ	VBZ	_	2	conj	_	_
13	nuclear	nuclear	JJ	JJ	_	15	amod	_	_
14	factor-kappa	factor-kappa	NN	NN	_	15	compound	_	_
15	B	b	NN	NN	_	12	dobj	_	_
16	binding	bind	VBG	VBG	_	15	acl	_	_
17	to	to	TO	TO	_	19	case	_	_
18	this	this	DT	DT	_	19	det	_	_
19	region	region	NN	NN	_	16	nmod	_	_
20	.	.	.	.	_	2	punct	_	_

1	However	however	RB	RB	_	12	advmod	_	_
2	,	,	,	,	_	12	punct	_	_
3	other	other	JJ	JJ	_	5	amod	_	_
4	transcription	transcription	NN	NN	_	5	compound	_	_
5	factors	factor	NNS	NNS	_	12	nsubjpass	_	_
6	or	or	CC	CC	_	5	cc	_	_
7	coactivators	coactivator	NNS	NNS	_	5	conj	_	_
8	of	of	IN	IN	_	10	case	_	_
9	NF-kappa	nf-kappa	NN	NN	_	10	compound	_	_
10	B	b	NN	NN	_	5	nmod	_	_
11	are	be	VBP	VBP	_	12	auxpass	_	_
12	required	require	VBN	VBN	_	0	root	_	_
13	for	for	IN	IN	_	15	case	_	_
14	tax	tax	NN	NN	_	15	compound	_	_
15	activation	activation	NN	NN	_	12	nmod	_	_
16	but	but	CC	CC	_	12	cc	_	_
17	these	these	DT	DT	_	18	nsubj	_	_
18	remain	remain	VBP	VBP	_	12	conj	_	_
19	to	to	TO	TO	_	21	mark	_	_
20	be	be	VB	VB	_	21	auxpass	_	_
21	identified	identify	VBN	VBN	_	18	xcomp	_	_
22	.	.	.	.	_	12	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	CK-1/CD28RE	ck-1/cd28re	NN	NN	_	5	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	GM-CSF	gm-csf	NN	NN	_	2	nmod	_	_
5	shows	show	VBZ	VBZ	_	0	root	_	_
6	a	a	DT	DT	_	8	det	_	_
7	high	high	JJ	JJ	_	8	amod	_	_
8	degree	degree	NN	NN	_	5	dobj	_	_
9	of	of	IN	IN	_	10	case	_	_
10	similarity	similarity	NN	NN	_	8	nmod	_	_
11	to	to	TO	TO	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	IL-2	il-2	NN	NN	_	10	nmod	_	_
14	CD28RE	cd28re	NN	NN	_	13	dep	_	_
15	and	and	CC	CC	_	5	cc	_	_
16	the	the	DT	DT	_	18	det	_	_
17	IL-3	il-3	NN	NN	_	18	compound	_	_
18	gene	gene	NN	NN	_	20	nsubj	_	_
19	also	also	RB	RB	_	20	advmod	_	_
20	contains	contain	VBZ	VBZ	_	5	conj	_	_
21	a	a	DT	DT	_	23	det	_	_
22	related	related	JJ	JJ	_	23	amod	_	_
23	region	region	NN	NN	_	20	dobj	_	_
24	.	.	.	.	_	5	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	observation	observation	NN	NN	_	20	nsubj	_	_
3	,	,	,	,	_	2	punct	_	_
4	together	together	RB	RB	_	20	advmod	_	_
5	with	with	IN	IN	_	7	case	_	_
6	the	the	DT	DT	_	7	det	_	_
7	fact	fact	NN	NN	_	20	nmod	_	_
8	that	that	IN	IN	_	13	mark	_	_
9	both	both	CC	CC	_	10	cc:preconj	_	_
10	GM-CSF	gm-csf	NN	NN	_	13	nsubj	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	IL-2	il-2	NN	NN	_	10	conj	_	_
13	respond	respond	VBP	VBP	_	7	ccomp	_	_
14	to	to	TO	TO	_	16	case	_	_
15	TCR	tcr	NN	NN	_	16	compound	_	_
16	signals	signal	NNS	NNS	_	13	nmod	_	_
17	via	via	IN	IN	_	18	case	_	_
18	NFAT	nfat	NN	NN	_	13	nmod	_	_
19	,	,	,	,	_	20	punct	_	_
20	implies	imply	VBZ	VBZ	_	0	root	_	_
21	a	a	DT	DT	_	23	det	_	_
22	high	high	JJ	JJ	_	23	amod	_	_
23	degree	degree	NN	NN	_	20	dobj	_	_
24	of	of	IN	IN	_	25	case	_	_
25	conservation	conservation	NN	NN	_	23	nmod	_	_
26	in	in	IN	IN	_	28	case	_	_
27	the	the	DT	DT	_	28	det	_	_
28	regulation	regulation	NN	NN	_	20	nmod	_	_
29	of	of	IN	IN	_	32	case	_	_
30	cytokine	cytokine	NN	NN	_	32	compound	_	_
31	gene	gene	NN	NN	_	32	compound	_	_
32	expression	expression	NN	NN	_	28	nmod	_	_
33	in	in	IN	IN	_	35	case	_	_
34	T	t	NN	NN	_	35	compound	_	_
35	cells	cell	NNS	NNS	_	28	nmod	_	_
36	.	.	.	.	_	20	punct	_	_

1	MIP1	mip1	NN	NN	_	4	compound	_	_
2	alpha	alpha	NN	NN	_	4	compound	_	_
3	nuclear	nuclear	JJ	JJ	_	4	amod	_	_
4	protein	protein	NN	NN	_	0	root	_	_
5	(	(	-LRB-	-LRB-	_	6	punct	_	_
6	MNP	mnp	NN	NN	_	4	appos	_	_
7	)	)	-RRB-	-RRB-	_	6	punct	_	_
8	,	,	,	,	_	4	punct	_	_
9	a	a	DT	DT	_	12	det	_	_
10	novel	novel	JJ	JJ	_	12	amod	_	_
11	transcription	transcription	NN	NN	_	12	compound	_	_
12	factor	factor	NN	NN	_	4	appos	_	_
13	expressed	express	VBN	VBN	_	12	acl	_	_
14	in	in	IN	IN	_	16	case	_	_
15	hematopoietic	hematopoietic	JJ	JJ	_	16	amod	_	_
16	cells	cell	NNS	NNS	_	13	nmod	_	_
17	that	that	WDT	WDT	_	19	nsubj	_	_
18	is	be	VBZ	VBZ	_	19	cop	_	_
19	crucial	crucial	JJ	JJ	_	12	acl:relcl	_	_
20	for	for	IN	IN	_	21	case	_	_
21	transcription	transcription	NN	NN	_	19	nmod	_	_
22	of	of	IN	IN	_	27	case	_	_
23	the	the	DT	DT	_	27	det	_	_
24	human	human	JJ	JJ	_	27	amod	_	_
25	MIP-1	mip-1	NN	NN	_	27	compound	_	_
26	alpha	alpha	NN	NN	_	27	compound	_	_
27	gene	gene	NN	NN	_	21	nmod	_	_
28	.	.	.	.	_	4	punct	_	_

1	Murine	murine	JJ	JJ	_	6	amod	_	_
2	macrophage	macrophage	NN	NN	_	6	compound	_	_
3	inflammatory	inflammatory	JJ	JJ	_	6	amod	_	_
4	protein	protein	NN	NN	_	6	compound	_	_
5	1	1	CD	CD	_	6	nummod	_	_
6	alpha	alpha	NN	NN	_	24	nsubj	_	_
7	(	(	-LRB-	-LRB-	_	9	punct	_	_
8	MIP-1	mip-1	NN	NN	_	9	compound	_	_
9	alpha	alpha	NN	NN	_	6	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	and	and	CC	CC	_	6	cc	_	_
12	its	its	PRP$	PRP$	_	14	nmod:poss	_	_
13	human	human	JJ	JJ	_	14	amod	_	_
14	equivalent	equivalent	NN	NN	_	6	conj	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	GOS19	gos19	NN	NN	_	14	dep	_	_
17	,	,	,	,	_	16	punct	_	_
18	LD78	ld78	NN	NN	_	16	conj	_	_
19	,	,	,	,	_	16	punct	_	_
20	or	or	CC	CC	_	16	cc	_	_
21	AT464	at464	NN	NN	_	16	conj	_	_
22	)	)	-RRB-	-RRB-	_	16	punct	_	_
23	are	be	VBP	VBP	_	24	cop	_	_
24	members	member	NNS	NNS	_	0	root	_	_
25	of	of	IN	IN	_	28	case	_	_
26	the	the	DT	DT	_	28	det	_	_
27	-C-C	-c-c	NN	NN	_	28	compound	_	_
28	family	family	NN	NN	_	24	nmod	_	_
29	of	of	IN	IN	_	31	case	_	_
30	low-molecular-weight	low-molecular-weight	JJ	JJ	_	31	amod	_	_
31	chemokines	chemokine	NNS	NNS	_	28	nmod	_	_
32	.	.	.	.	_	24	punct	_	_

1	Secreted	secrete	VBN	VBN	_	0	root	_	_
2	from	from	IN	IN	_	5	case	_	_
3	activated	activate	VBN	VBN	_	5	amod	_	_
4	T	t	NN	NN	_	5	compound	_	_
5	cells	cell	NNS	NNS	_	1	nmod	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	macrophages	macrophage	NNS	NNS	_	5	conj	_	_
8	,	,	,	,	_	1	punct	_	_
9	bone	bone	NN	NN	_	13	nsubj	_	_
10	marrow-derived	marrow-derived	JJ	JJ	_	12	amod	_	_
11	MIP-1	mip-1	NN	NN	_	12	compound	_	_
12	alpha/GOS19	alpha/gos19	NN	NN	_	9	dep	_	_
13	inhibits	inhibit	VBZ	VBZ	_	1	parataxis	_	_
14	primitive	primitive	JJ	JJ	_	17	amod	_	_
15	hematopoietic	hematopoietic	JJ	JJ	_	17	amod	_	_
16	stem	stem	NN	NN	_	17	compound	_	_
17	cells	cell	NNS	NNS	_	13	dobj	_	_
18	and	and	CC	CC	_	13	cc	_	_
19	appears	appear	VBZ	VBZ	_	13	conj	_	_
20	to	to	TO	TO	_	22	mark	_	_
21	be	be	VB	VB	_	22	auxpass	_	_
22	involved	involve	VBN	VBN	_	19	xcomp	_	_
23	in	in	IN	IN	_	26	case	_	_
24	the	the	DT	DT	_	26	det	_	_
25	homeostatic	homeostatic	JJ	JJ	_	26	amod	_	_
26	control	control	NN	NN	_	22	nmod	_	_
27	of	of	IN	IN	_	30	case	_	_
28	stem	stem	NN	NN	_	29	compound	_	_
29	cell	cell	NN	NN	_	30	compound	_	_
30	proliferation	proliferation	NN	NN	_	26	nmod	_	_
31	.	.	.	.	_	1	punct	_	_

1	It	it	PRP	PRP	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	induces	induce	VBZ	VBZ	_	0	root	_	_
4	chemotaxis	chemotaxis	NN	NN	_	3	dobj	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	inflammatory	inflammatory	JJ	JJ	_	7	amod	_	_
7	responses	response	NNS	NNS	_	4	conj	_	_
8	in	in	IN	IN	_	11	case	_	_
9	mature	mature	JJ	JJ	_	11	amod	_	_
10	cell	cell	NN	NN	_	11	compound	_	_
11	types	type	NNS	NNS	_	3	nmod	_	_
12	.	.	.	.	_	3	punct	_	_

1	Therefore	therefore	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	it	it	PRP	PRP	_	5	nsubj	_	_
4	is	be	VBZ	VBZ	_	5	cop	_	_
5	important	important	JJ	JJ	_	0	root	_	_
6	to	to	TO	TO	_	7	mark	_	_
7	understand	understand	VB	VB	_	5	xcomp	_	_
8	the	the	DT	DT	_	9	det	_	_
9	mechanisms	mechanism	NNS	NNS	_	7	dobj	_	_
10	which	which	WDT	WDT	_	11	nsubj	_	_
11	control	control	VBP	VBP	_	9	acl:relcl	_	_
12	the	the	DT	DT	_	13	det	_	_
13	expression	expression	NN	NN	_	11	dobj	_	_
14	of	of	IN	IN	_	16	case	_	_
15	MIP-1	mip-1	NN	NN	_	16	compound	_	_
16	alpha/GOS19	alpha/gos19	NN	NN	_	13	nmod	_	_
17	.	.	.	.	_	5	punct	_	_

1	Previous	previous	JJ	JJ	_	2	amod	_	_
2	work	work	NN	NN	_	4	nsubj	_	_
3	has	have	VBZ	VBZ	_	4	aux	_	_
4	shown	show	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	23	mark	_	_
6	in	in	IN	IN	_	9	case	_	_
7	Jurkat	jurkat	NN	NN	_	9	compound	_	_
8	T	t	NN	NN	_	9	compound	_	_
9	cells	cell	NNS	NNS	_	23	nmod	_	_
10	,	,	,	,	_	23	punct	_	_
11	a	a	DT	DT	_	12	det	_	_
12	set	set	NN	NN	_	23	nsubj	_	_
13	of	of	IN	IN	_	17	case	_	_
14	widely	widely	RB	RB	_	15	advmod	_	_
15	expressed	express	VBN	VBN	_	17	amod	_	_
16	transcription	transcription	NN	NN	_	17	compound	_	_
17	factors	factor	NNS	NNS	_	12	nmod	_	_
18	(	(	-LRB-	-LRB-	_	21	punct	_	_
19	the	the	DT	DT	_	21	det	_	_
20	ICK-1	ick-1	NN	NN	_	21	compound	_	_
21	family	family	NN	NN	_	12	appos	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	affect	affect	VBP	VBP	_	4	ccomp	_	_
24	the	the	DT	DT	_	26	det	_	_
25	GOS19	gos19	NN	NN	_	26	compound	_	_
26	promoter	promoter	NN	NN	_	23	dobj	_	_
27	.	.	.	.	_	4	punct	_	_

1	One	one	CD	CD	_	2	nummod	_	_
2	member	member	NN	NN	_	6	nsubj	_	_
3	,	,	,	,	_	2	punct	_	_
4	ICK-1A	ick-1a	NN	NN	_	2	appos	_	_
5	,	,	,	,	_	2	punct	_	_
6	behaves	behave	VBZ	VBZ	_	0	root	_	_
7	as	as	IN	IN	_	11	case	_	_
8	a	a	DT	DT	_	11	det	_	_
9	strong	strong	JJ	JJ	_	11	amod	_	_
10	negative	negative	JJ	JJ	_	11	amod	_	_
11	regulator	regulator	NN	NN	_	6	nmod	_	_
12	.	.	.	.	_	6	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	communication	communication	NN	NN	_	6	nmod	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	provide	provide	VBP	VBP	_	0	root	_	_
7	evidence	evidence	NN	NN	_	6	dobj	_	_
8	that	that	IN	IN	_	20	mark	_	_
9	the	the	DT	DT	_	10	det	_	_
10	pathway	pathway	NN	NN	_	20	nsubj	_	_
11	of	of	IN	IN	_	12	case	_	_
12	induction	induction	NN	NN	_	10	nmod	_	_
13	in	in	IN	IN	_	17	case	_	_
14	the	the	DT	DT	_	17	det	_	_
15	macrophage	macrophage	NN	NN	_	17	compound	_	_
16	cell	cell	NN	NN	_	17	compound	_	_
17	line	line	NN	NN	_	10	nmod	_	_
18	U937	u937	NN	NN	_	17	dep	_	_
19	is	be	VBZ	VBZ	_	20	cop	_	_
20	different	different	JJ	JJ	_	7	ccomp	_	_
21	from	from	IN	IN	_	22	case	_	_
22	that	that	DT	DT	_	20	nmod	_	_
23	in	in	IN	IN	_	25	case	_	_
24	Jurkat	jurkat	NN	NN	_	25	compound	_	_
25	cells	cell	NNS	NNS	_	22	nmod	_	_
26	.	.	.	.	_	6	punct	_	_

1	Furthermore	furthermore	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	show	show	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	12	mark	_	_
6	the	the	DT	DT	_	9	det	_	_
7	ICK-1	ick-1	NN	NN	_	9	compound	_	_
8	binding	binding	NN	NN	_	9	compound	_	_
9	site	site	NN	NN	_	12	nsubj	_	_
10	does	do	VBZ	VBZ	_	12	aux	_	_
11	not	not	RB	RB	_	12	neg	_	_
12	confer	confer	VB	VB	_	4	ccomp	_	_
13	negative	negative	JJ	JJ	_	14	amod	_	_
14	regulation	regulation	NN	NN	_	12	dobj	_	_
15	in	in	IN	IN	_	17	case	_	_
16	U937	u937	NN	NN	_	17	compound	_	_
17	cells	cell	NNS	NNS	_	14	nmod	_	_
18	.	.	.	.	_	4	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	provide	provide	VBP	VBP	_	0	root	_	_
3	evidence	evidence	NN	NN	_	2	dobj	_	_
4	for	for	IN	IN	_	8	case	_	_
5	an	a	DT	DT	_	8	det	_	_
6	additional	additional	JJ	JJ	_	8	amod	_	_
7	binding	bind	VBG	VBG	_	8	amod	_	_
8	site	site	NN	NN	_	3	nmod	_	_
9	,	,	,	,	_	8	punct	_	_
10	the	the	DT	DT	_	18	det	_	_
11	MIP-1	mip-1	NN	NN	_	18	compound	_	_
12	alpha	alpha	NN	NN	_	18	compound	_	_
13	nuclear	nuclear	JJ	JJ	_	18	amod	_	_
14	protein	protein	NN	NN	_	18	compound	_	_
15	(	(	-LRB-	-LRB-	_	18	punct	_	_
16	MNP	mnp	NN	NN	_	18	compound	_	_
17	)	)	-RRB-	-RRB-	_	18	punct	_	_
18	site	site	NN	NN	_	8	appos	_	_
19	,	,	,	,	_	18	punct	_	_
20	which	which	WDT	WDT	_	21	nsubj	_	_
21	overlaps	overlap	VBZ	VBZ	_	18	acl:relcl	_	_
22	the	the	DT	DT	_	24	det	_	_
23	ICK-1	ick-1	NN	NN	_	24	compound	_	_
24	site	site	NN	NN	_	21	dobj	_	_
25	.	.	.	.	_	2	punct	_	_

1	Interaction	interaction	NN	NN	_	15	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	nuclear	nuclear	JJ	JJ	_	4	amod	_	_
4	extracts	extract	NNS	NNS	_	1	nmod	_	_
5	from	from	IN	IN	_	8	case	_	_
6	various	various	JJ	JJ	_	8	amod	_	_
7	cell	cell	NN	NN	_	8	compound	_	_
8	lines	line	NNS	NNS	_	4	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	tissue	tissue	NN	NN	_	8	conj	_	_
11	with	with	IN	IN	_	14	case	_	_
12	the	the	DT	DT	_	14	det	_	_
13	MNP	mnp	NN	NN	_	14	compound	_	_
14	site	site	NN	NN	_	1	nmod	_	_
15	leads	lead	VBZ	VBZ	_	0	root	_	_
16	to	to	TO	TO	_	18	case	_	_
17	the	the	DT	DT	_	18	det	_	_
18	formation	formation	NN	NN	_	15	nmod	_	_
19	of	of	IN	IN	_	22	case	_	_
20	fast-migrating	fast-migrating	JJ	JJ	_	22	amod	_	_
21	protein-DNA	protein-dna	JJ	JJ	_	22	amod	_	_
22	complexes	complex	NNS	NNS	_	18	nmod	_	_
23	with	with	IN	IN	_	28	case	_	_
24	similar	similar	JJ	JJ	_	28	amod	_	_
25	but	but	CC	CC	_	24	cc	_	_
26	distinct	distinct	JJ	JJ	_	24	conj	_	_
27	electrophoretic	electrophoretic	JJ	JJ	_	28	amod	_	_
28	mobilities	mobility	NNS	NNS	_	18	nmod	_	_
29	.	.	.	.	_	15	punct	_	_

1	A	a	DT	DT	_	2	det	_	_
2	mutation	mutation	NN	NN	_	13	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	MNP	mnp	NN	NN	_	6	compound	_	_
6	site	site	NN	NN	_	2	nmod	_	_
7	which	which	WDT	WDT	_	10	nsubj	_	_
8	does	do	VBZ	VBZ	_	10	aux	_	_
9	not	not	RB	RB	_	10	neg	_	_
10	abrogate	abrogate	VB	VB	_	6	acl:relcl	_	_
11	ICK-1	ick-1	NN	NN	_	12	compound	_	_
12	binding	binding	NN	NN	_	10	dobj	_	_
13	inactivates	inactivate	VBZ	VBZ	_	0	root	_	_
14	the	the	DT	DT	_	16	det	_	_
15	GOS19.1	gos19.1	NN	NN	_	16	compound	_	_
16	promoter	promoter	NN	NN	_	13	dobj	_	_
17	in	in	IN	IN	_	19	case	_	_
18	U937	u937	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	16	nmod	_	_
20	and	and	CC	CC	_	13	cc	_	_
21	reduces	reduce	VBZ	VBZ	_	13	conj	_	_
22	its	its	PRP$	PRP$	_	23	nmod:poss	_	_
23	activity	activity	NN	NN	_	21	dobj	_	_
24	by	by	IN	IN	_	25	case	_	_
25	fourfold	fourfold	RB	RB	_	21	nmod	_	_
26	in	in	IN	IN	_	28	case	_	_
27	Jurkat	jurkat	NN	NN	_	28	compound	_	_
28	cells	cell	NNS	NNS	_	21	nmod	_	_
29	.	.	.	.	_	13	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	propose	propose	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	15	mark	_	_
4	the	the	DT	DT	_	8	det	_	_
5	MNP	mnp	NN	NN	_	6	compound	_	_
6	protein	protein	NN	NN	_	8	compound	_	_
7	(	(	-LRB-	-LRB-	_	8	punct	_	_
8	s	s	NNS	NNS	_	15	nsubj	_	_
9	)	)	-RRB-	-RRB-	_	8	punct	_	_
10	binding	bind	VBG	VBG	_	8	acl	_	_
11	at	at	IN	IN	_	14	case	_	_
12	the	the	DT	DT	_	14	det	_	_
13	MNP	mnp	NN	NN	_	14	compound	_	_
14	site	site	NN	NN	_	10	nmod	_	_
15	constitutes	constitute	VBZ	VBZ	_	2	ccomp	_	_
16	a	a	DT	DT	_	21	det	_	_
17	novel	novel	JJ	JJ	_	21	amod	_	_
18	transcription	transcription	NN	NN	_	19	compound	_	_
19	factor	factor	NN	NN	_	21	compound	_	_
20	(	(	-LRB-	-LRB-	_	21	punct	_	_
21	s	s	NNS	NNS	_	15	dobj	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	expressed	express	VBN	VBN	_	21	acl	_	_
24	in	in	IN	IN	_	26	case	_	_
25	hematopoietic	hematopoietic	JJ	JJ	_	26	amod	_	_
26	cells	cell	NNS	NNS	_	23	nmod	_	_
27	.	.	.	.	_	2	punct	_	_

1	Ligand-dependent	ligand-dependent	JJ	JJ	_	2	amod	_	_
2	repression	repression	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	7	case	_	_
4	the	the	DT	DT	_	7	det	_	_
5	erythroid	erythroid	JJ	JJ	_	7	amod	_	_
6	transcription	transcription	NN	NN	_	7	compound	_	_
7	factor	factor	NN	NN	_	2	nmod	_	_
8	GATA-1	gata-1	NN	NN	_	7	dep	_	_
9	by	by	IN	IN	_	12	case	_	_
10	the	the	DT	DT	_	12	det	_	_
11	estrogen	estrogen	NN	NN	_	12	compound	_	_
12	receptor	receptor	NN	NN	_	2	nmod	_	_
13	.	.	.	.	_	2	punct	_	_

1	High-dose	high-dose	JJ	JJ	_	3	amod	_	_
2	estrogen	estrogen	NN	NN	_	3	compound	_	_
3	administration	administration	NN	NN	_	4	nsubj	_	_
4	induces	induce	VBZ	VBZ	_	0	root	_	_
5	anemia	anemia	NN	NN	_	4	dobj	_	_
6	in	in	IN	IN	_	7	case	_	_
7	mammals	mammal	NNS	NNS	_	4	nmod	_	_
8	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	chickens	chicken	NNS	NNS	_	5	nmod	_	_
3	,	,	,	,	_	5	punct	_	_
4	estrogens	estrogen	NNS	NNS	_	5	nsubj	_	_
5	stimulate	stimulate	VBP	VBP	_	0	root	_	_
6	outgrowth	outgrowth	NN	NN	_	5	dobj	_	_
7	of	of	IN	IN	_	12	case	_	_
8	bone	bone	NN	NN	_	12	compound	_	_
9	marrow-derived	marrow-derived	JJ	JJ	_	12	amod	_	_
10	erythroid	erythroid	JJ	JJ	_	12	amod	_	_
11	progenitor	progenitor	NN	NN	_	12	compound	_	_
12	cells	cell	NNS	NNS	_	6	nmod	_	_
13	and	and	CC	CC	_	5	cc	_	_
14	delay	delay	VBP	VBP	_	5	conj	_	_
15	their	they	PRP$	PRP$	_	16	nmod:poss	_	_
16	maturation	maturation	NN	NN	_	14	dobj	_	_
17	.	.	.	.	_	5	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	delay	delay	NN	NN	_	4	nsubjpass	_	_
3	is	be	VBZ	VBZ	_	4	auxpass	_	_
4	associated	associate	VBN	VBN	_	0	root	_	_
5	with	with	IN	IN	_	6	case	_	_
6	down-regulation	down-regulation	NN	NN	_	4	nmod	_	_
7	of	of	IN	IN	_	11	case	_	_
8	many	many	JJ	JJ	_	11	amod	_	_
9	erythroid	erythroid	JJ	JJ	_	11	amod	_	_
10	cell-specific	cell-specific	JJ	JJ	_	11	amod	_	_
11	genes	gene	NNS	NNS	_	6	nmod	_	_
12	,	,	,	,	_	11	punct	_	_
13	including	include	VBG	VBG	_	14	case	_	_
14	alpha-	alpha-	NN	NN	_	11	nmod	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	beta-globin	beta-globin	NN	NN	_	14	conj	_	_
17	,	,	,	,	_	14	punct	_	_
18	band	band	NN	NN	_	14	conj	_	_
19	3	3	CD	CD	_	18	nummod	_	_
20	,	,	,	,	_	14	punct	_	_
21	band	band	NN	NN	_	14	conj	_	_
22	4.1	4.1	CD	CD	_	21	nummod	_	_
23	,	,	,	,	_	14	punct	_	_
24	and	and	CC	CC	_	14	cc	_	_
25	the	the	DT	DT	_	28	det	_	_
26	erythroid	erythroid	JJ	JJ	_	28	amod	_	_
27	cell-specific	cell-specific	JJ	JJ	_	28	amod	_	_
28	histone	histone	NN	NN	_	14	conj	_	_
29	H5	h5	NN	NN	_	28	dep	_	_
30	.	.	.	.	_	4	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	show	show	VBP	VBP	_	0	root	_	_
3	here	here	RB	RB	_	2	advmod	_	_
4	that	that	IN	IN	_	7	mark	_	_
5	estrogens	estrogen	NNS	NNS	_	7	nsubj	_	_
6	also	also	RB	RB	_	7	advmod	_	_
7	reduce	reduce	VBP	VBP	_	2	ccomp	_	_
8	the	the	DT	DT	_	9	det	_	_
9	number	number	NN	NN	_	7	dobj	_	_
10	of	of	IN	IN	_	13	case	_	_
11	erythroid	erythroid	JJ	JJ	_	13	amod	_	_
12	progenitor	progenitor	NN	NN	_	13	compound	_	_
13	cells	cell	NNS	NNS	_	9	nmod	_	_
14	in	in	IN	IN	_	19	case	_	_
15	primary	primary	JJ	JJ	_	19	amod	_	_
16	human	human	JJ	JJ	_	19	amod	_	_
17	bone	bone	NN	NN	_	19	compound	_	_
18	marrow	marrow	NN	NN	_	19	compound	_	_
19	cultures	culture	NNS	NNS	_	7	nmod	_	_
20	.	.	.	.	_	2	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	address	address	VB	VB	_	0	root	_	_
3	potential	potential	JJ	JJ	_	4	amod	_	_
4	mechanisms	mechanism	NNS	NNS	_	2	dobj	_	_
5	by	by	IN	IN	_	6	case	_	_
6	which	which	WDT	WDT	_	8	nmod	_	_
7	estrogens	estrogen	NNS	NNS	_	8	nsubj	_	_
8	suppress	suppress	VBP	VBP	_	4	acl:relcl	_	_
9	erythropoiesis	erythropoiesis	NN	NN	_	8	dobj	_	_
10	,	,	,	,	_	2	punct	_	_
11	we	we	PRP	PRP	_	13	nsubj	_	_
12	have	have	VBP	VBP	_	13	aux	_	_
13	examined	examine	VBN	VBN	_	2	parataxis	_	_
14	their	they	PRP$	PRP$	_	15	nmod:poss	_	_
15	effects	effect	NNS	NNS	_	13	dobj	_	_
16	on	on	IN	IN	_	17	case	_	_
17	GATA-1	gata-1	NN	NN	_	15	nmod	_	_
18	,	,	,	,	_	17	punct	_	_
19	an	a	DT	DT	_	22	det	_	_
20	erythroid	erythroid	JJ	JJ	_	22	amod	_	_
21	transcription	transcription	NN	NN	_	22	compound	_	_
22	factor	factor	NN	NN	_	17	appos	_	_
23	that	that	WDT	WDT	_	24	nsubj	_	_
24	participates	participate	VBZ	VBZ	_	22	acl:relcl	_	_
25	in	in	IN	IN	_	27	case	_	_
26	the	the	DT	DT	_	27	det	_	_
27	regulation	regulation	NN	NN	_	24	nmod	_	_
28	of	of	IN	IN	_	30	case	_	_
29	the	the	DT	DT	_	30	det	_	_
30	majority	majority	NN	NN	_	27	nmod	_	_
31	of	of	IN	IN	_	34	case	_	_
32	erythroid	erythroid	JJ	JJ	_	34	amod	_	_
33	cell-specific	cell-specific	JJ	JJ	_	34	amod	_	_
34	genes	gene	NNS	NNS	_	30	nmod	_	_
35	and	and	CC	CC	_	24	cc	_	_
36	is	be	VBZ	VBZ	_	37	cop	_	_
37	necessary	necessary	JJ	JJ	_	24	conj	_	_
38	for	for	IN	IN	_	40	case	_	_
39	full	full	JJ	JJ	_	40	amod	_	_
40	maturation	maturation	NN	NN	_	37	nmod	_	_
41	of	of	IN	IN	_	42	case	_	_
42	erythrocytes	erythrocyte	NNS	NNS	_	40	nmod	_	_
43	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	11	mark	_	_
4	the	the	DT	DT	_	6	det	_	_
5	transcriptional	transcriptional	JJ	JJ	_	6	amod	_	_
6	activity	activity	NN	NN	_	11	nsubjpass	_	_
7	of	of	IN	IN	_	8	case	_	_
8	GATA-1	gata-1	NN	NN	_	6	nmod	_	_
9	is	be	VBZ	VBZ	_	11	auxpass	_	_
10	strongly	strongly	RB	RB	_	11	advmod	_	_
11	repressed	repress	VBN	VBN	_	2	ccomp	_	_
12	by	by	IN	IN	_	15	case	_	_
13	the	the	DT	DT	_	15	det	_	_
14	estrogen	estrogen	NN	NN	_	15	compound	_	_
15	receptor	receptor	NN	NN	_	11	nmod	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	ER	er	NN	NN	_	15	appos	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	in	in	IN	IN	_	22	case	_	_
20	a	a	DT	DT	_	22	det	_	_
21	ligand-dependent	ligand-dependent	JJ	JJ	_	22	amod	_	_
22	manner	manner	NN	NN	_	11	nmod	_	_
23	and	and	CC	CC	_	11	cc	_	_
24	that	that	IN	IN	_	28	mark	_	_
25	this	this	DT	DT	_	26	det	_	_
26	repression	repression	NN	NN	_	28	nsubj	_	_
27	is	be	VBZ	VBZ	_	28	cop	_	_
28	reversible	reversible	JJ	JJ	_	11	conj	_	_
29	in	in	IN	IN	_	31	case	_	_
30	the	the	DT	DT	_	31	det	_	_
31	presence	presence	NN	NN	_	28	nmod	_	_
32	of	of	IN	IN	_	33	case	_	_
33	4-hydroxytamoxifen	4-hydroxytamoxifen	NN	NN	_	31	nmod	_	_
34	.	.	.	.	_	2	punct	_	_

1	ER-mediated	er-mediated	JJ	JJ	_	2	amod	_	_
2	repression	repression	NN	NN	_	6	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	GATA-1	gata-1	NN	NN	_	5	compound	_	_
5	activity	activity	NN	NN	_	2	nmod	_	_
6	occurs	occur	VBZ	VBZ	_	0	root	_	_
7	on	on	IN	IN	_	10	case	_	_
8	an	a	DT	DT	_	10	det	_	_
9	artificial	artificial	JJ	JJ	_	10	amod	_	_
10	promoter	promoter	NN	NN	_	6	nmod	_	_
11	containing	contain	VBG	VBG	_	10	acl	_	_
12	a	a	DT	DT	_	15	det	_	_
13	single	single	JJ	JJ	_	15	amod	_	_
14	GATA-binding	gata-binding	JJ	JJ	_	15	amod	_	_
15	site	site	NN	NN	_	11	dobj	_	_
16	,	,	,	,	_	10	punct	_	_
17	as	as	RB	RB	_	10	cc	_	_
18	well	well	RB	RB	_	17	mwe	_	_
19	as	as	IN	IN	_	17	mwe	_	_
20	in	in	IN	IN	_	22	case	_	_
21	the	the	DT	DT	_	22	det	_	_
22	context	context	NN	NN	_	10	conj	_	_
23	of	of	IN	IN	_	26	case	_	_
24	an	a	DT	DT	_	26	det	_	_
25	intact	intact	JJ	JJ	_	26	amod	_	_
26	promoter	promoter	NN	NN	_	22	nmod	_	_
27	which	which	WDT	WDT	_	30	nsubjpass	_	_
28	is	be	VBZ	VBZ	_	30	auxpass	_	_
29	normally	normally	RB	RB	_	30	advmod	_	_
30	regulated	regulate	VBN	VBN	_	26	acl:relcl	_	_
31	by	by	IN	IN	_	32	case	_	_
32	GATA-1	gata-1	NN	NN	_	30	nmod	_	_
33	.	.	.	.	_	6	punct	_	_

1	GATA-1	gata-1	NN	NN	_	4	nsubj	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	ER	er	NN	NN	_	1	conj	_	_
4	bind	bind	VBP	VBP	_	0	root	_	_
5	to	to	TO	TO	_	7	case	_	_
6	each	each	DT	DT	_	7	det	_	_
7	other	other	JJ	JJ	_	4	nmod	_	_
8	in	in	FW	FW	_	9	compound	_	_
9	vitro	vitro	FW	FW	_	4	advmod	_	_
10	in	in	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	absence	absence	NN	NN	_	4	nmod	_	_
13	of	of	IN	IN	_	14	case	_	_
14	DNA	dna	NN	NN	_	12	nmod	_	_
15	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	coimmunoprecipitation	coimmunoprecipitation	NN	NN	_	3	compound	_	_
3	experiments	experiment	NNS	NNS	_	12	nmod	_	_
4	using	use	VBG	VBG	_	3	acl	_	_
5	transfected	transfect	VBN	VBN	_	7	amod	_	_
6	COS	cos	NN	NN	_	7	compound	_	_
7	cells	cell	NNS	NNS	_	4	dobj	_	_
8	,	,	,	,	_	12	punct	_	_
9	GATA-1	gata-1	NN	NN	_	12	nsubj	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	ER	er	NN	NN	_	9	conj	_	_
12	associate	associate	VBP	VBP	_	0	root	_	_
13	in	in	IN	IN	_	16	case	_	_
14	a	a	DT	DT	_	16	det	_	_
15	ligand-dependent	ligand-dependent	JJ	JJ	_	16	amod	_	_
16	manner	manner	NN	NN	_	12	nmod	_	_
17	.	.	.	.	_	12	punct	_	_

1	Mapping	mapping	NN	NN	_	2	compound	_	_
2	experiments	experiment	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	9	mark	_	_
5	GATA-1	gata-1	NN	NN	_	9	nsubj	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	the	the	DT	DT	_	8	det	_	_
8	ER	er	NN	NN	_	5	conj	_	_
9	form	form	VBP	VBP	_	3	ccomp	_	_
10	at	at	IN	IN	_	11	case	_	_
11	least	least	JJS	JJS	_	12	nmod:npmod	_	_
12	two	two	CD	CD	_	13	nummod	_	_
13	contacts	contact	NNS	NNS	_	9	dobj	_	_
14	,	,	,	,	_	13	punct	_	_
15	which	which	WDT	WDT	_	16	nsubj	_	_
16	involve	involve	VBP	VBP	_	13	acl:relcl	_	_
17	the	the	DT	DT	_	19	det	_	_
18	finger	finger	NN	NN	_	19	compound	_	_
19	region	region	NN	NN	_	16	dobj	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	the	the	DT	DT	_	24	det	_	_
22	N-terminal	n-terminal	JJ	JJ	_	24	amod	_	_
23	activation	activation	NN	NN	_	24	compound	_	_
24	domain	domain	NN	NN	_	19	conj	_	_
25	of	of	IN	IN	_	26	case	_	_
26	GATA-1	gata-1	NN	NN	_	19	nmod	_	_
27	.	.	.	.	_	3	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	speculate	speculate	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	5	mark	_	_
4	estrogens	estrogen	NNS	NNS	_	5	nsubj	_	_
5	exert	exert	VBP	VBP	_	2	ccomp	_	_
6	effects	effect	NNS	NNS	_	5	dobj	_	_
7	on	on	IN	IN	_	8	case	_	_
8	erythropoiesis	erythropoiesis	NN	NN	_	5	nmod	_	_
9	by	by	IN	IN	_	10	mark	_	_
10	modulating	modulate	VBG	VBG	_	5	advcl	_	_
11	GATA-1	gata-1	NN	NN	_	12	compound	_	_
12	activity	activity	NN	NN	_	10	dobj	_	_
13	through	through	IN	IN	_	15	case	_	_
14	protein-protein	protein-protein	JJ	JJ	_	15	amod	_	_
15	interaction	interaction	NN	NN	_	10	nmod	_	_
16	with	with	IN	IN	_	18	case	_	_
17	the	the	DT	DT	_	18	det	_	_
18	ER	er	NN	NN	_	15	nmod	_	_
19	.	.	.	.	_	2	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	ABSTRACT	abstract	NN	NN	_	0	root	_	_
3	TRUNCATED	truncate	VBN	VBN	_	2	acl	_	_
4	AT	at	IN	IN	_	6	case	_	_
5	250	250	CD	CD	_	6	nummod	_	_
6	WORDS	word	NNS	NNS	_	3	nmod	_	_
7	)	)	-RRB-	-RRB-	_	2	punct	_	_

1	Reduced	reduce	VBN	VBN	_	3	amod	_	_
2	mitogenic	mitogenic	JJ	JJ	_	3	amod	_	_
3	stimulation	stimulation	NN	NN	_	0	root	_	_
4	of	of	IN	IN	_	8	case	_	_
5	peripheral	peripheral	JJ	JJ	_	8	amod	_	_
6	blood	blood	NN	NN	_	8	compound	_	_
7	mononuclear	mononuclear	JJ	JJ	_	8	amod	_	_
8	cells	cell	NNS	NNS	_	3	nmod	_	_
9	as	as	IN	IN	_	12	case	_	_
10	a	a	DT	DT	_	12	det	_	_
11	prognostic	prognostic	JJ	JJ	_	12	amod	_	_
12	parameter	parameter	NN	NN	_	3	nmod	_	_
13	for	for	IN	IN	_	15	case	_	_
14	the	the	DT	DT	_	15	det	_	_
15	course	course	NN	NN	_	12	nmod	_	_
16	of	of	IN	IN	_	18	case	_	_
17	breast	breast	NN	NN	_	18	compound	_	_
18	cancer	cancer	NN	NN	_	15	nmod	_	_
19	:	:	:	:	_	3	punct	_	_
20	a	a	DT	DT	_	23	det	_	_
21	prospective	prospective	JJ	JJ	_	23	amod	_	_
22	longitudinal	longitudinal	JJ	JJ	_	21	dep	_	_
23	study	study	NN	NN	_	3	dep	_	_
24	.	.	.	.	_	3	punct	_	_

1	Immunosuppression	immunosuppression	NN	NN	_	5	nsubjpass	_	_
2	has	have	VBZ	VBZ	_	5	aux	_	_
3	been	be	VBN	VBN	_	5	auxpass	_	_
4	often	often	RB	RB	_	5	advmod	_	_
5	associated	associate	VBN	VBN	_	0	root	_	_
6	with	with	IN	IN	_	8	case	_	_
7	the	the	DT	DT	_	8	det	_	_
8	course	course	NN	NN	_	5	nmod	_	_
9	of	of	IN	IN	_	11	case	_	_
10	malignant	malignant	JJ	JJ	_	11	amod	_	_
11	diseases	disease	NNS	NNS	_	8	nmod	_	_
12	.	.	.	.	_	5	punct	_	_

1	In	in	IN	IN	_	4	case	_	_
2	the	the	DT	DT	_	4	det	_	_
3	present	present	JJ	JJ	_	4	amod	_	_
4	study	study	NN	NN	_	27	nmod	_	_
5	,	,	,	,	_	27	punct	_	_
6	the	the	DT	DT	_	7	det	_	_
7	proliferation	proliferation	NN	NN	_	27	nsubjpass	_	_
8	of	of	IN	IN	_	12	case	_	_
9	peripheral	peripheral	JJ	JJ	_	12	amod	_	_
10	blood	blood	NN	NN	_	12	compound	_	_
11	mononuclear	mononuclear	JJ	JJ	_	12	amod	_	_
12	cells	cell	NNS	NNS	_	7	nmod	_	_
13	(	(	-LRB-	-LRB-	_	14	punct	_	_
14	PBMCs	pbmc	NNS	NNS	_	12	appos	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	in	in	IN	IN	_	17	case	_	_
17	response	response	NN	NN	_	7	nmod	_	_
18	to	to	TO	TO	_	20	case	_	_
19	mitogenic	mitogenic	JJ	JJ	_	20	amod	_	_
20	stimulation	stimulation	NN	NN	_	17	nmod	_	_
21	with	with	IN	IN	_	22	case	_	_
22	phytohaemagglutinin	phytohaemagglutinin	NN	NN	_	20	nmod	_	_
23	(	(	-LRB-	-LRB-	_	24	punct	_	_
24	PHA	pha	NN	NN	_	22	appos	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	was	be	VBD	VBD	_	27	auxpass	_	_
27	assessed	assess	VBN	VBN	_	0	root	_	_
28	prospectively	prospectively	RB	RB	_	27	advmod	_	_
29	in	in	IN	IN	_	31	case	_	_
30	90	90	CD	CD	_	31	nummod	_	_
31	patients	patient	NNS	NNS	_	27	nmod	_	_
32	with	with	IN	IN	_	36	case	_	_
33	stage	stage	NN	NN	_	36	compound	_	_
34	I-III	i-iii	CD	CD	_	36	nummod	_	_
35	breast	breast	NN	NN	_	36	compound	_	_
36	cancer	cancer	NN	NN	_	31	nmod	_	_
37	.	.	.	.	_	27	punct	_	_

1	Whereas	whereas	IN	IN	_	15	mark	_	_
2	PHA-induced	pha-induced	JJ	JJ	_	3	amod	_	_
3	proliferation	proliferation	NN	NN	_	15	nsubjpass	_	_
4	of	of	IN	IN	_	5	case	_	_
5	PBMCs	pbmc	NNS	NNS	_	3	nmod	_	_
6	derived	derive	VBN	VBN	_	5	acl	_	_
7	from	from	IN	IN	_	8	case	_	_
8	patients	patient	NNS	NNS	_	6	nmod	_	_
9	with	with	IN	IN	_	11	case	_	_
10	breast	breast	NN	NN	_	11	compound	_	_
11	cancer	cancer	NN	NN	_	8	nmod	_	_
12	preoperatively	preoperatively	RB	RB	_	6	advmod	_	_
13	was	be	VBD	VBD	_	15	auxpass	_	_
14	significantly	significantly	RB	RB	_	15	advmod	_	_
15	decreased	decrease	VBN	VBN	_	41	advcl	_	_
16	when	when	WRB	WRB	_	17	advmod	_	_
17	compared	compare	VBN	VBN	_	15	advcl	_	_
18	with	with	IN	IN	_	19	case	_	_
19	data	datum	NNS	NNS	_	17	nmod	_	_
20	obtained	obtain	VBN	VBN	_	19	acl	_	_
21	in	in	IN	IN	_	24	case	_	_
22	healthy	healthy	JJ	JJ	_	24	amod	_	_
23	control	control	JJ	JJ	_	24	amod	_	_
24	individuals	individual	NNS	NNS	_	20	nmod	_	_
25	(	(	-LRB-	-LRB-	_	26	punct	_	_
26	P	p	NN	NN	_	24	dep	_	_
27	&lt;	&lt;	JJR	JJR	_	26	amod	_	_
28	0.001	0.001	CD	CD	_	27	dep	_	_
29	)	)	-RRB-	-RRB-	_	26	punct	_	_
30	,	,	,	,	_	41	punct	_	_
31	the	the	DT	DT	_	32	det	_	_
32	degree	degree	NN	NN	_	41	nsubj	_	_
33	of	of	IN	IN	_	35	case	_	_
34	the	the	DT	DT	_	35	det	_	_
35	defect	defect	NN	NN	_	32	nmod	_	_
36	in	in	IN	IN	_	38	case	_	_
37	PHA-induced	pha-induced	JJ	JJ	_	38	amod	_	_
38	proliferation	proliferation	NN	NN	_	35	nmod	_	_
39	of	of	IN	IN	_	40	case	_	_
40	PBMCs	pbmc	NNS	NNS	_	38	nmod	_	_
41	depended	depend	VBD	VBD	_	0	root	_	_
42	upon	upon	IN	IN	_	45	case	_	_
43	the	the	DT	DT	_	45	det	_	_
44	tumour	tumour	NN	NN	_	45	compound	_	_
45	burden	burden	NN	NN	_	41	nmod	_	_
46	as	as	IN	IN	_	47	mark	_	_
47	manifested	manifest	VBN	VBN	_	41	advcl	_	_
48	by	by	IN	IN	_	50	case	_	_
49	tumour	tumour	NN	NN	_	50	compound	_	_
50	size	size	NN	NN	_	47	nmod	_	_
51	and	and	CC	CC	_	50	cc	_	_
52	axillary	axillary	NN	NN	_	55	compound	_	_
53	lymph	lymph	NN	NN	_	55	compound	_	_
54	node	node	NN	NN	_	55	compound	_	_
55	involvement	involvement	NN	NN	_	50	conj	_	_
56	(	(	-LRB-	-LRB-	_	57	punct	_	_
57	P	p	NN	NN	_	50	dep	_	_
58	&lt;	&lt;	JJR	JJR	_	57	amod	_	_
59	0.003	0.003	CD	CD	_	58	dep	_	_
60	in	in	IN	IN	_	62	case	_	_
61	each	each	DT	DT	_	62	det	_	_
62	case	case	NN	NN	_	57	nmod	_	_
63	)	)	-RRB-	-RRB-	_	57	punct	_	_
64	.	.	.	.	_	41	punct	_	_

1	PHA-induced	pha-induced	JJ	JJ	_	2	amod	_	_
2	proliferation	proliferation	NN	NN	_	5	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	PBMCs	pbmc	NNS	NNS	_	2	nmod	_	_
5	dropped	drop	VBD	VBD	_	0	root	_	_
6	significantly	significantly	RB	RB	_	5	advmod	_	_
7	in	in	IN	IN	_	8	case	_	_
8	patients	patient	NNS	NNS	_	5	nmod	_	_
9	who	who	WP	WP	_	10	nsubj	_	_
10	received	receive	VBD	VBD	_	8	acl:relcl	_	_
11	adjuvant	adjuvant	JJ	JJ	_	12	amod	_	_
12	chemotherapy	chemotherapy	NN	NN	_	10	dobj	_	_
13	consisting	consist	VBG	VBG	_	12	acl	_	_
14	of	of	IN	IN	_	15	case	_	_
15	cyclophosphamide	cyclophosphamide	NN	NN	_	13	nmod	_	_
16	,	,	,	,	_	15	punct	_	_
17	methotrexate	methotrexate	NN	NN	_	15	conj	_	_
18	and	and	CC	CC	_	15	cc	_	_
19	fluorouracil	fluorouracil	NN	NN	_	15	conj	_	_
20	(	(	-LRB-	-LRB-	_	21	punct	_	_
21	CMF	cmf	NN	NN	_	15	appos	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	after	after	IN	IN	_	26	case	_	_
24	an	a	DT	DT	_	26	det	_	_
25	observation	observation	NN	NN	_	26	compound	_	_
26	period	period	NN	NN	_	10	nmod	_	_
27	of	of	IN	IN	_	29	case	_	_
28	6	6	CD	CD	_	29	nummod	_	_
29	months	month	NNS	NNS	_	26	nmod	_	_
30	(	(	-LRB-	-LRB-	_	31	punct	_	_
31	P	p	NN	NN	_	8	dep	_	_
32	&lt;	&lt;	JJR	JJR	_	31	amod	_	_
33	0.01	0.01	CD	CD	_	32	dep	_	_
34	)	)	-RRB-	-RRB-	_	31	punct	_	_
35	,	,	,	,	_	8	punct	_	_
36	but	but	CC	CC	_	8	cc	_	_
37	not	not	RB	RB	_	39	neg	_	_
38	in	in	IN	IN	_	39	case	_	_
39	patients	patient	NNS	NNS	_	8	conj	_	_
40	under	under	IN	IN	_	42	case	_	_
41	adjuvant	adjuvant	JJ	JJ	_	42	amod	_	_
42	treatment	treatment	NN	NN	_	39	nmod	_	_
43	with	with	IN	IN	_	44	case	_	_
44	tamoxifen	tamoxifen	NN	NN	_	42	nmod	_	_
45	only	only	RB	RB	_	44	advmod	_	_
46	.	.	.	.	_	5	punct	_	_

1	After	after	IN	IN	_	5	case	_	_
2	an	a	DT	DT	_	5	det	_	_
3	additional	additional	JJ	JJ	_	5	amod	_	_
4	6	6	CD	CD	_	5	nummod	_	_
5	months	month	NNS	NNS	_	19	advcl	_	_
6	(	(	-LRB-	-LRB-	_	7	punct	_	_
7	i.e.	i.e.	FW	FW	_	5	dep	_	_
8	12	12	CD	CD	_	9	nummod	_	_
9	months	month	NNS	NNS	_	7	nmod	_	_
10	after	after	IN	IN	_	9	case	_	_
11	surgery	surgery	NN	NN	_	9	dep	_	_
12	)	)	-RRB-	-RRB-	_	7	punct	_	_
13	,	,	,	,	_	19	punct	_	_
14	PHA-induced	pha-induced	JJ	JJ	_	15	amod	_	_
15	proliferation	proliferation	NN	NN	_	19	nsubj	_	_
16	of	of	IN	IN	_	17	case	_	_
17	PBMCs	pbmc	NNS	NNS	_	15	nmod	_	_
18	was	be	VBD	VBD	_	19	cop	_	_
19	similar	similar	JJ	JJ	_	0	root	_	_
20	in	in	IN	IN	_	21	case	_	_
21	patients	patient	NNS	NNS	_	19	nmod	_	_
22	after	after	IN	IN	_	24	case	_	_
23	adjuvant	adjuvant	JJ	JJ	_	24	amod	_	_
24	chemotherapy	chemotherapy	NN	NN	_	21	nmod	_	_
25	with	with	IN	IN	_	26	case	_	_
26	CMF	cmf	NN	NN	_	24	nmod	_	_
27	and	and	CC	CC	_	21	cc	_	_
28	in	in	IN	IN	_	29	case	_	_
29	those	those	DT	DT	_	21	conj	_	_
30	receiving	receive	VBG	VBG	_	29	acl	_	_
31	continued	continued	JJ	JJ	_	34	amod	_	_
32	adjuvant	adjuvant	JJ	JJ	_	34	amod	_	_
33	tamoxifen	tamoxifen	NN	NN	_	34	compound	_	_
34	treatment	treatment	NN	NN	_	30	dobj	_	_
35	(	(	-LRB-	-LRB-	_	36	punct	_	_
36	P	p	NN	NN	_	29	dep	_	_
37	&gt;	&gt;	JJR	JJR	_	36	amod	_	_
38	0.1	0.1	CD	CD	_	37	dep	_	_
39	)	)	-RRB-	-RRB-	_	36	punct	_	_
40	,	,	,	,	_	19	punct	_	_
41	but	but	CC	CC	_	19	cc	_	_
42	in	in	IN	IN	_	44	case	_	_
43	all	all	DT	DT	_	44	det	_	_
44	patients	patient	NNS	NNS	_	19	conj	_	_
45	still	still	RB	RB	_	46	advmod	_	_
46	significantly	significantly	RB	RB	_	19	advmod	_	_
47	decreased	decrease	VBD	VBD	_	19	dep	_	_
48	as	as	IN	IN	_	49	mark	_	_
49	compared	compare	VBN	VBN	_	47	advcl	_	_
50	with	with	IN	IN	_	52	case	_	_
51	healthy	healthy	JJ	JJ	_	52	amod	_	_
52	controls	control	NNS	NNS	_	49	nmod	_	_
53	(	(	-LRB-	-LRB-	_	54	punct	_	_
54	P	p	NN	NN	_	52	dep	_	_
55	&lt;	&lt;	JJR	JJR	_	54	amod	_	_
56	0.001	0.001	CD	CD	_	55	dep	_	_
57	)	)	-RRB-	-RRB-	_	54	punct	_	_
58	.	.	.	.	_	19	punct	_	_

1	When	when	WRB	WRB	_	10	advmod	_	_
2	data	datum	NNS	NNS	_	10	nsubjpass	_	_
3	obtained	obtain	VBN	VBN	_	2	acl	_	_
4	preoperatively	preoperatively	RB	RB	_	5	advmod	_	_
5	and	and	CC	CC	_	3	advmod	_	_
6	after	after	IN	IN	_	8	case	_	_
7	12	12	CD	CD	_	8	nummod	_	_
8	months	month	NNS	NNS	_	5	conj	_	_
9	were	be	VBD	VBD	_	10	auxpass	_	_
10	compared	compare	VBN	VBN	_	14	advcl	_	_
11	,	,	,	,	_	14	punct	_	_
12	it	it	PRP	PRP	_	14	nsubjpass	_	_
13	was	be	VBD	VBD	_	14	auxpass	_	_
14	found	find	VBN	VBN	_	0	root	_	_
15	that	that	IN	IN	_	37	mark	_	_
16	out	out	RB	RB	_	19	advmod	_	_
17	of	of	IN	IN	_	19	case	_	_
18	23	23	CD	CD	_	19	nummod	_	_
19	patients	patient	NNS	NNS	_	37	advcl	_	_
20	whose	whose	WP$	WP$	_	21	nmod:poss	_	_
21	PBMCs	pbmc	NNS	NNS	_	23	nsubj	_	_
22	had	have	VBD	VBD	_	23	aux	_	_
23	experienced	experience	VBN	VBN	_	19	acl:relcl	_	_
24	a	a	DT	DT	_	25	det	_	_
25	drop	drop	NN	NN	_	23	dobj	_	_
26	in	in	IN	IN	_	29	case	_	_
27	their	they	PRP$	PRP$	_	29	nmod:poss	_	_
28	PHA-induced	pha-induced	JJ	JJ	_	29	amod	_	_
29	proliferation	proliferation	NN	NN	_	23	nmod	_	_
30	,	,	,	,	_	37	punct	_	_
31	14	14	CD	CD	_	37	nsubj	_	_
32	(	(	-LRB-	-LRB-	_	34	punct	_	_
33	61	61	CD	CD	_	34	nummod	_	_
34	%	%	NN	NN	_	31	appos	_	_
35	)	)	-RRB-	-RRB-	_	34	punct	_	_
36	had	have	VBD	VBD	_	37	aux	_	_
37	developed	develop	VBN	VBN	_	14	ccomp	_	_
38	metastatic	metastatic	JJ	JJ	_	39	amod	_	_
39	disease	disease	NN	NN	_	37	dobj	_	_
40	within	within	IN	IN	_	44	case	_	_
41	the	the	DT	DT	_	44	det	_	_
42	subsequent	subsequent	JJ	JJ	_	44	amod	_	_
43	24	24	CD	CD	_	44	nummod	_	_
44	months	month	NNS	NNS	_	37	advcl	_	_
45	(	(	-LRB-	-LRB-	_	48	punct	_	_
46	i.e.	i.e.	FW	FW	_	48	dep	_	_
47	36	36	CD	CD	_	48	nummod	_	_
48	months	month	NNS	NNS	_	44	dep	_	_
49	after	after	IN	IN	_	50	case	_	_
50	surgery	surgery	NN	NN	_	48	nmod	_	_
51	)	)	-RRB-	-RRB-	_	48	punct	_	_
52	.	.	.	.	_	14	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	31	nmod	_	_
3	,	,	,	,	_	31	punct	_	_
4	out	out	RB	RB	_	7	advmod	_	_
5	of	of	IN	IN	_	7	case	_	_
6	59	59	CD	CD	_	7	nummod	_	_
7	patients	patient	NNS	NNS	_	31	advcl	_	_
8	whose	whose	WP$	WP$	_	9	nmod:poss	_	_
9	PBMCs	pbmc	NNS	NNS	_	10	nsubj	_	_
10	showed	show	VBD	VBD	_	7	acl:relcl	_	_
11	an	a	DT	DT	_	12	det	_	_
12	increase	increase	NN	NN	_	10	dobj	_	_
13	in	in	IN	IN	_	16	case	_	_
14	their	they	PRP$	PRP$	_	16	nmod:poss	_	_
15	PHA-induced	pha-induced	JJ	JJ	_	16	amod	_	_
16	proliferation	proliferation	NN	NN	_	10	nmod	_	_
17	within	within	IN	IN	_	21	case	_	_
18	the	the	DT	DT	_	21	det	_	_
19	first	first	JJ	JJ	_	21	amod	_	_
20	12	12	CD	CD	_	21	nummod	_	_
21	months	month	NNS	NNS	_	10	nmod	_	_
22	after	after	IN	IN	_	23	case	_	_
23	surgery	surgery	NN	NN	_	21	nmod	_	_
24	,	,	,	,	_	31	punct	_	_
25	only	only	RB	RB	_	26	advmod	_	_
26	one	one	CD	CD	_	31	nsubj	_	_
27	(	(	-LRB-	-LRB-	_	29	punct	_	_
28	2	2	CD	CD	_	29	nummod	_	_
29	%	%	NN	NN	_	26	appos	_	_
30	)	)	-RRB-	-RRB-	_	29	punct	_	_
31	presented	present	VBD	VBD	_	0	root	_	_
32	with	with	IN	IN	_	34	case	_	_
33	disease	disease	NN	NN	_	34	compound	_	_
34	progression	progression	NN	NN	_	31	nmod	_	_
35	.	.	.	.	_	31	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	thus	thus	RB	RB	_	3	advmod	_	_
3	conclude	conclude	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	15	mark	_	_
5	PHA-induced	pha-induced	JJ	JJ	_	6	amod	_	_
6	proliferation	proliferation	NN	NN	_	15	nsubj	_	_
7	of	of	IN	IN	_	8	case	_	_
8	PBMCs	pbmc	NNS	NNS	_	6	nmod	_	_
9	derived	derive	VBN	VBN	_	8	acl	_	_
10	from	from	IN	IN	_	11	case	_	_
11	patients	patient	NNS	NNS	_	9	nmod	_	_
12	with	with	IN	IN	_	14	case	_	_
13	breast	breast	NN	NN	_	14	compound	_	_
14	cancer	cancer	NN	NN	_	11	nmod	_	_
15	depends	depend	VBZ	VBZ	_	3	ccomp	_	_
16	upon	upon	IN	IN	_	19	case	_	_
17	the	the	DT	DT	_	19	det	_	_
18	tumour	tumour	NN	NN	_	19	compound	_	_
19	load	load	NN	NN	_	15	nmod	_	_
20	and	and	CC	CC	_	15	cc	_	_
21	is	be	VBZ	VBZ	_	25	cop	_	_
22	a	a	DT	DT	_	25	det	_	_
23	good	good	JJ	JJ	_	25	amod	_	_
24	clinical	clinical	JJ	JJ	_	23	dep	_	_
25	predictor	predictor	NN	NN	_	15	conj	_	_
26	for	for	IN	IN	_	29	case	_	_
27	the	the	DT	DT	_	29	det	_	_
28	further	further	JJ	JJ	_	29	amod	_	_
29	course	course	NN	NN	_	25	nmod	_	_
30	of	of	IN	IN	_	32	case	_	_
31	the	the	DT	DT	_	32	det	_	_
32	disease	disease	NN	NN	_	29	nmod	_	_
33	.	.	.	.	_	3	punct	_	_

1	Characterization	characterization	NN	NN	_	6	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	CD48	cd48	NN	NN	_	5	compound	_	_
5	gene	gene	NN	NN	_	1	nmod	_	_
6	demonstrates	demonstrate	VBZ	VBZ	_	0	root	_	_
7	a	a	DT	DT	_	9	det	_	_
8	positive	positive	JJ	JJ	_	9	amod	_	_
9	element	element	NN	NN	_	6	dobj	_	_
10	that	that	WDT	WDT	_	12	nsubj	_	_
11	is	be	VBZ	VBZ	_	12	cop	_	_
12	specific	specific	JJ	JJ	_	9	acl:relcl	_	_
13	to	to	TO	TO	_	17	case	_	_
14	Epstein-Barr	epstein-barr	JJ	JJ	_	17	amod	_	_
15	virus-immortalized	virus-immortalized	JJ	JJ	_	17	amod	_	_
16	B-cell	b-cell	NN	NN	_	17	compound	_	_
17	lines	line	NNS	NNS	_	12	nmod	_	_
18	and	and	CC	CC	_	12	cc	_	_
19	contains	contain	VBZ	VBZ	_	12	conj	_	_
20	an	a	DT	DT	_	24	det	_	_
21	essential	essential	JJ	JJ	_	24	amod	_	_
22	NF-kappa	nf-kappa	NN	NN	_	24	compound	_	_
23	B	b	NN	NN	_	24	compound	_	_
24	site	site	NN	NN	_	19	dobj	_	_
25	.	.	.	.	_	6	punct	_	_

1	Epstein-Barr	epstein-barr	JJ	JJ	_	2	amod	_	_
2	virus	virus	NN	NN	_	6	compound	_	_
3	(	(	-LRB-	-LRB-	_	4	punct	_	_
4	EBV	ebv	NN	NN	_	2	appos	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	infection	infection	NN	NN	_	13	nsubj	_	_
7	of	of	IN	IN	_	12	case	_	_
8	mature	mature	JJ	JJ	_	12	amod	_	_
9	,	,	,	,	_	12	punct	_	_
10	resting	rest	VBG	VBG	_	12	amod	_	_
11	B	b	NN	NN	_	12	compound	_	_
12	cells	cell	NNS	NNS	_	6	nmod	_	_
13	drives	drive	VBZ	VBZ	_	0	root	_	_
14	them	they	PRP	PRP	_	13	dobj	_	_
15	to	to	TO	TO	_	16	mark	_	_
16	become	become	VB	VB	_	13	advcl	_	_
17	lymphoblasts	lymphoblast	NNS	NNS	_	16	xcomp	_	_
18	expressing	express	VBG	VBG	_	17	acl	_	_
19	high	high	JJ	JJ	_	20	amod	_	_
20	levels	level	NNS	NNS	_	18	dobj	_	_
21	of	of	IN	IN	_	24	case	_	_
22	cell	cell	NN	NN	_	24	compound	_	_
23	surface	surface	NN	NN	_	24	compound	_	_
24	molecules	molecule	NNS	NNS	_	20	nmod	_	_
25	,	,	,	,	_	24	punct	_	_
26	such	such	JJ	JJ	_	28	case	_	_
27	as	as	IN	IN	_	26	mwe	_	_
28	CD48	cd48	NN	NN	_	24	nmod	_	_
29	,	,	,	,	_	28	punct	_	_
30	characteristically	characteristically	RB	RB	_	31	advmod	_	_
31	expressed	express	VBN	VBN	_	28	acl	_	_
32	on	on	IN	IN	_	36	case	_	_
33	normal	normal	JJ	JJ	_	36	amod	_	_
34	activated	activate	VBN	VBN	_	36	amod	_	_
35	B	b	NN	NN	_	36	compound	_	_
36	cells	cell	NNS	NNS	_	31	nmod	_	_
37	.	.	.	.	_	13	punct	_	_

1	Here	here	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	report	report	VBP	VBP	_	0	root	_	_
5	on	on	IN	IN	_	7	case	_	_
6	the	the	DT	DT	_	7	det	_	_
7	identification	identification	NN	NN	_	4	nmod	_	_
8	of	of	IN	IN	_	11	case	_	_
9	an	a	DT	DT	_	11	det	_	_
10	enhancer	enhancer	NN	NN	_	11	compound	_	_
11	element	element	NN	NN	_	7	nmod	_	_
12	in	in	IN	IN	_	15	case	_	_
13	the	the	DT	DT	_	15	det	_	_
14	CD48	cd48	NN	NN	_	15	compound	_	_
15	gene	gene	NN	NN	_	11	nmod	_	_
16	which	which	WDT	WDT	_	18	nsubj	_	_
17	reproducibly	reproducibly	RB	RB	_	18	advmod	_	_
18	confers	confer	VBZ	VBZ	_	11	acl:relcl	_	_
19	strong	strong	JJ	JJ	_	21	amod	_	_
20	transcriptional	transcriptional	JJ	JJ	_	21	amod	_	_
21	activity	activity	NN	NN	_	18	dobj	_	_
22	only	only	RB	RB	_	27	advmod	_	_
23	in	in	IN	IN	_	27	case	_	_
24	EBV-positive	ebv-positive	JJ	JJ	_	27	amod	_	_
25	B-lymphoblastoid	b-lymphoblastoid	JJ	JJ	_	27	amod	_	_
26	cell	cell	NN	NN	_	27	compound	_	_
27	lines	line	NNS	NNS	_	18	nmod	_	_
28	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	element	element	NN	NN	_	5	nsubjpass	_	_
3	is	be	VBZ	VBZ	_	5	auxpass	_	_
4	not	not	RB	RB	_	5	neg	_	_
5	activated	activate	VBN	VBN	_	0	root	_	_
6	upon	upon	IN	IN	_	7	case	_	_
7	infection	infection	NN	NN	_	5	nmod	_	_
8	of	of	IN	IN	_	12	case	_	_
9	established	established	JJ	JJ	_	12	amod	_	_
10	EBV-negative	ebv-negative	JJ	JJ	_	12	amod	_	_
11	B-cell	b-cell	NN	NN	_	12	compound	_	_
12	lines	line	NNS	NNS	_	7	nmod	_	_
13	,	,	,	,	_	5	punct	_	_
14	indicating	indicate	VBG	VBG	_	5	advcl	_	_
15	that	that	IN	IN	_	17	mark	_	_
16	EBV	ebv	NN	NN	_	17	nsubj	_	_
17	fails	fail	VBZ	VBZ	_	14	ccomp	_	_
18	to	to	TO	TO	_	19	mark	_	_
19	drive	drive	VB	VB	_	17	xcomp	_	_
20	these	these	DT	DT	_	21	det	_	_
21	cells	cell	NNS	NNS	_	19	dobj	_	_
22	to	to	TO	TO	_	26	case	_	_
23	a	a	DT	DT	_	26	det	_	_
24	fully	fully	RB	RB	_	26	advmod	_	_
25	lymphoblastoid	lymphoblastoid	JJ	JJ	_	26	amod	_	_
26	phenotype	phenotype	NN	NN	_	19	nmod	_	_
27	.	.	.	.	_	5	punct	_	_

1	An	a	DT	DT	_	5	det	_	_
2	NF-kappa	nf-kappa	NN	NN	_	3	compound	_	_
3	B	b	NN	NN	_	5	compound	_	_
4	binding	binding	NN	NN	_	5	compound	_	_
5	site	site	NN	NN	_	9	nsubj	_	_
6	is	be	VBZ	VBZ	_	9	cop	_	_
7	an	a	DT	DT	_	9	det	_	_
8	essential	essential	JJ	JJ	_	9	amod	_	_
9	component	component	NN	NN	_	0	root	_	_
10	of	of	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	element	element	NN	NN	_	9	nmod	_	_
13	but	but	CC	CC	_	9	cc	_	_
14	alone	alone	RB	RB	_	17	advmod	_	_
15	is	be	VBZ	VBZ	_	17	cop	_	_
16	not	not	RB	RB	_	17	neg	_	_
17	sufficient	sufficient	JJ	JJ	_	9	conj	_	_
18	to	to	TO	TO	_	19	mark	_	_
19	account	account	VB	VB	_	17	xcomp	_	_
20	for	for	IN	IN	_	22	case	_	_
21	the	the	DT	DT	_	22	det	_	_
22	activity	activity	NN	NN	_	19	nmod	_	_
23	or	or	CC	CC	_	22	cc	_	_
24	the	the	DT	DT	_	25	det	_	_
25	specificity	specificity	NN	NN	_	22	conj	_	_
26	of	of	IN	IN	_	28	case	_	_
27	the	the	DT	DT	_	28	det	_	_
28	element	element	NN	NN	_	25	nmod	_	_
29	.	.	.	.	_	9	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	detected	detect	VBN	VBN	_	0	root	_	_
4	a	a	DT	DT	_	8	det	_	_
5	specific	specific	JJ	JJ	_	8	amod	_	_
6	nuclear	nuclear	JJ	JJ	_	8	amod	_	_
7	protein	protein	NN	NN	_	8	compound	_	_
8	complex	complex	NN	NN	_	3	dobj	_	_
9	that	that	WDT	WDT	_	10	nsubj	_	_
10	binds	bind	VBZ	VBZ	_	8	acl:relcl	_	_
11	to	to	TO	TO	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	element	element	NN	NN	_	10	nmod	_	_
14	and	and	CC	CC	_	3	cc	_	_
15	show	show	VBP	VBP	_	3	conj	_	_
16	that	that	IN	IN	_	24	mark	_	_
17	NF-kappa	nf-kappa	NN	NN	_	18	compound	_	_
18	B1	b1	NN	NN	_	24	nsubj	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	p50	p50	NN	NN	_	18	appos	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	is	be	VBZ	VBZ	_	24	cop	_	_
23	a	a	DT	DT	_	24	det	_	_
24	part	part	NN	NN	_	15	ccomp	_	_
25	of	of	IN	IN	_	27	case	_	_
26	this	this	DT	DT	_	27	det	_	_
27	complex	complex	NN	NN	_	24	nmod	_	_
28	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	5	det	_	_
2	EBV-encoded	ebv-encoded	JJ	JJ	_	5	amod	_	_
3	latent	latent	JJ	JJ	_	5	amod	_	_
4	membrane	membrane	NN	NN	_	5	compound	_	_
5	protein	protein	NN	NN	_	8	nsubj	_	_
6	1	1	CD	CD	_	5	nummod	_	_
7	is	be	VBZ	VBZ	_	8	cop	_	_
8	capable	capable	JJ	JJ	_	0	root	_	_
9	of	of	IN	IN	_	10	mark	_	_
10	transactivating	transactivate	VBG	VBG	_	8	advcl	_	_
11	the	the	DT	DT	_	13	det	_	_
12	isolated	isolate	VBN	VBN	_	13	amod	_	_
13	CD48	cd48	NN	NN	_	10	dobj	_	_
14	NF-kappa	nf-kappa	NN	NN	_	16	compound	_	_
15	B	b	NN	NN	_	16	compound	_	_
16	site	site	NN	NN	_	13	dep	_	_
17	but	but	CC	CC	_	18	cc	_	_
18	not	not	RB	RB	_	13	cc	_	_
19	the	the	DT	DT	_	21	det	_	_
20	intact	intact	JJ	JJ	_	21	amod	_	_
21	element	element	NN	NN	_	13	conj	_	_
22	,	,	,	,	_	8	punct	_	_
23	suggesting	suggest	VBG	VBG	_	8	xcomp	_	_
24	that	that	IN	IN	_	35	mark	_	_
25	the	the	DT	DT	_	30	det	_	_
26	latent	latent	JJ	JJ	_	30	amod	_	_
27	membrane	membrane	NN	NN	_	30	compound	_	_
28	protein	protein	NN	NN	_	30	compound	_	_
29	1-driven	1-driven	JJ	JJ	_	30	amod	_	_
30	activation	activation	NN	NN	_	35	nsubj	_	_
31	of	of	IN	IN	_	33	case	_	_
32	NF-kappa	nf-kappa	NN	NN	_	33	compound	_	_
33	B/Rel	b/rel	NN	NN	_	30	nmod	_	_
34	must	must	MD	MD	_	35	aux	_	_
35	interact	interact	VB	VB	_	23	ccomp	_	_
36	with	with	IN	IN	_	39	case	_	_
37	other	other	JJ	JJ	_	39	amod	_	_
38	regulatory	regulatory	JJ	JJ	_	39	amod	_	_
39	pathways	pathway	NNS	NNS	_	35	nmod	_	_
40	to	to	TO	TO	_	41	mark	_	_
41	control	control	VB	VB	_	35	xcomp	_	_
42	expression	expression	NN	NN	_	41	dobj	_	_
43	of	of	IN	IN	_	45	case	_	_
44	cellular	cellular	JJ	JJ	_	45	amod	_	_
45	genes	gene	NNS	NNS	_	42	nmod	_	_
46	as	as	IN	IN	_	48	mark	_	_
47	EBV	ebv	NN	NN	_	48	nsubj	_	_
48	drives	drive	VBZ	VBZ	_	35	advcl	_	_
49	resting	rest	VBG	VBG	_	51	amod	_	_
50	B	b	NN	NN	_	51	compound	_	_
51	cells	cell	NNS	NNS	_	48	dobj	_	_
52	into	into	IN	IN	_	55	case	_	_
53	the	the	DT	DT	_	55	det	_	_
54	cell	cell	NN	NN	_	55	compound	_	_
55	cycle	cycle	NN	NN	_	48	nmod	_	_
56	.	.	.	.	_	8	punct	_	_

1	Distinct	distinct	JJ	JJ	_	2	amod	_	_
2	roles	role	NNS	NNS	_	0	root	_	_
3	of	of	IN	IN	_	7	case	_	_
4	the	the	DT	DT	_	7	det	_	_
5	molecular	molecular	JJ	JJ	_	7	amod	_	_
6	chaperone	chaperone	NN	NN	_	7	compound	_	_
7	hsp90	hsp90	NN	NN	_	2	nmod	_	_
8	in	in	IN	IN	_	9	mark	_	_
9	modulating	modulate	VBG	VBG	_	2	acl	_	_
10	dioxin	dioxin	NN	NN	_	12	compound	_	_
11	receptor	receptor	NN	NN	_	12	compound	_	_
12	function	function	NN	NN	_	9	dobj	_	_
13	via	via	IN	IN	_	16	case	_	_
14	the	the	DT	DT	_	16	det	_	_
15	basic	basic	JJ	JJ	_	16	amod	_	_
16	helix-loop-helix	helix-loop-helix	JJ	JJ	_	9	nmod	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	PAS	pas	NN	NN	_	19	compound	_	_
19	domains	domain	NNS	NNS	_	16	conj	_	_
20	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	intracellular	intracellular	JJ	JJ	_	4	amod	_	_
3	dioxin	dioxin	NN	NN	_	4	compound	_	_
4	receptor	receptor	NN	NN	_	5	nsubj	_	_
5	mediates	mediate	VBZ	VBZ	_	0	root	_	_
6	signal	signal	NN	NN	_	7	compound	_	_
7	transduction	transduction	NN	NN	_	5	dobj	_	_
8	by	by	IN	IN	_	9	case	_	_
9	dioxin	dioxin	NN	NN	_	5	nmod	_	_
10	and	and	CC	CC	_	5	cc	_	_
11	functions	function	VBZ	VBZ	_	5	conj	_	_
12	as	as	IN	IN	_	16	case	_	_
13	a	a	DT	DT	_	16	det	_	_
14	ligand-activated	ligand-activated	JJ	JJ	_	16	amod	_	_
15	transcription	transcription	NN	NN	_	16	compound	_	_
16	factor	factor	NN	NN	_	11	nmod	_	_
17	.	.	.	.	_	5	punct	_	_

1	It	it	PRP	PRP	_	2	nsubj	_	_
2	contains	contain	VBZ	VBZ	_	0	root	_	_
3	a	a	DT	DT	_	9	det	_	_
4	basic	basic	JJ	JJ	_	9	amod	_	_
5	helix-loop-helix	helix-loop-helix	JJ	JJ	_	9	amod	_	_
6	(	(	-LRB-	-LRB-	_	9	punct	_	_
7	bHLH	bhlh	JJ	JJ	_	9	amod	_	_
8	)	)	-RRB-	-RRB-	_	9	punct	_	_
9	motif	motif	NN	NN	_	2	dobj	_	_
10	contiguous	contiguous	JJ	JJ	_	9	amod	_	_
11	with	with	IN	IN	_	18	case	_	_
12	a	a	DT	DT	_	18	det	_	_
13	Per-Arnt-Sim	per-arnt-sim	NN	NN	_	18	compound	_	_
14	(	(	-LRB-	-LRB-	_	18	punct	_	_
15	PAS	pas	NN	NN	_	18	compound	_	_
16	)	)	-RRB-	-RRB-	_	18	punct	_	_
17	homology	homology	NN	NN	_	18	compound	_	_
18	region	region	NN	NN	_	10	nmod	_	_
19	.	.	.	.	_	2	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	extracts	extract	NNS	NNS	_	9	nmod	_	_
3	from	from	IN	IN	_	5	case	_	_
4	nonstimulated	nonstimulated	JJ	JJ	_	5	amod	_	_
5	cells	cell	NNS	NNS	_	2	nmod	_	_
6	the	the	DT	DT	_	7	det	_	_
7	receptor	receptor	NN	NN	_	9	nsubjpass	_	_
8	is	be	VBZ	VBZ	_	9	auxpass	_	_
9	recovered	recover	VBN	VBN	_	0	root	_	_
10	in	in	IN	IN	_	14	case	_	_
11	an	a	DT	DT	_	14	det	_	_
12	inducible	inducible	JJ	JJ	_	14	amod	_	_
13	cytoplasmic	cytoplasmic	JJ	JJ	_	12	dep	_	_
14	form	form	NN	NN	_	9	nmod	_	_
15	associated	associate	VBN	VBN	_	14	acl	_	_
16	with	with	IN	IN	_	21	case	_	_
17	the	the	DT	DT	_	21	det	_	_
18	90-kDa	90-kda	JJ	JJ	_	21	amod	_	_
19	heat	heat	NN	NN	_	21	compound	_	_
20	shock	shock	NN	NN	_	21	compound	_	_
21	protein	protein	NN	NN	_	15	nmod	_	_
22	(	(	-LRB-	-LRB-	_	23	punct	_	_
23	hsp90	hsp90	NN	NN	_	21	appos	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	,	,	,	,	_	21	punct	_	_
26	a	a	DT	DT	_	28	det	_	_
27	molecular	molecular	JJ	JJ	_	28	amod	_	_
28	chaperone	chaperone	NN	NN	_	21	appos	_	_
29	.	.	.	.	_	9	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	reconstituted	reconstitute	VBN	VBN	_	0	root	_	_
4	ligand-dependent	ligand-dependent	JJ	JJ	_	5	amod	_	_
5	activation	activation	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	8	case	_	_
7	the	the	DT	DT	_	8	det	_	_
8	receptor	receptor	NN	NN	_	5	nmod	_	_
9	to	to	TO	TO	_	12	case	_	_
10	a	a	DT	DT	_	12	det	_	_
11	DNA-binding	dna-binding	JJ	JJ	_	12	amod	_	_
12	form	form	NN	NN	_	3	nmod	_	_
13	by	by	IN	IN	_	14	mark	_	_
14	using	use	VBG	VBG	_	3	advcl	_	_
15	the	the	DT	DT	_	17	det	_	_
16	dioxin	dioxin	NN	NN	_	17	compound	_	_
17	receptor	receptor	NN	NN	_	14	dobj	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	its	its	PRP$	PRP$	_	22	nmod:poss	_	_
20	bHLH-PAS	bhlh-pas	JJ	JJ	_	22	amod	_	_
21	partner	partner	NN	NN	_	22	compound	_	_
22	factor	factor	NN	NN	_	17	conj	_	_
23	Arnt	arnt	NN	NN	_	22	dep	_	_
24	expressed	express	VBN	VBN	_	22	acl	_	_
25	by	by	IN	IN	_	28	case	_	_
26	in	in	FW	FW	_	28	amod	_	_
27	vitro	vitro	FW	FW	_	26	dep	_	_
28	translation	translation	NN	NN	_	24	nmod	_	_
29	in	in	IN	IN	_	31	case	_	_
30	reticulocyte	reticulocyte	JJ	JJ	_	31	amod	_	_
31	lysate	lysate	NN	NN	_	28	nmod	_	_
32	.	.	.	.	_	3	punct	_	_

1	Deletion	deletion	NN	NN	_	9	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	PAS	pas	NN	NN	_	5	compound	_	_
5	domain	domain	NN	NN	_	1	nmod	_	_
6	of	of	IN	IN	_	8	case	_	_
7	the	the	DT	DT	_	8	det	_	_
8	receptor	receptor	NN	NN	_	5	nmod	_	_
9	resulted	result	VBD	VBD	_	0	root	_	_
10	in	in	IN	IN	_	12	case	_	_
11	constitutive	constitutive	JJ	JJ	_	12	amod	_	_
12	dimerization	dimerization	NN	NN	_	9	nmod	_	_
13	with	with	IN	IN	_	14	case	_	_
14	Arnt	arnt	NN	NN	_	12	nmod	_	_
15	.	.	.	.	_	9	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	7	nmod	_	_
3	,	,	,	,	_	7	punct	_	_
4	this	this	DT	DT	_	6	det	_	_
5	receptor	receptor	NN	NN	_	6	compound	_	_
6	mutant	mutant	NN	NN	_	7	nsubj	_	_
7	showed	show	VBD	VBD	_	0	root	_	_
8	low	low	JJ	JJ	_	9	amod	_	_
9	levels	level	NNS	NNS	_	7	dobj	_	_
10	of	of	IN	IN	_	14	case	_	_
11	xenobiotic	xenobiotic	JJ	JJ	_	14	amod	_	_
12	response	response	NN	NN	_	14	compound	_	_
13	element-binding	element-binding	JJ	JJ	_	14	amod	_	_
14	activity	activity	NN	NN	_	9	nmod	_	_
15	,	,	,	,	_	7	punct	_	_
16	indicating	indicate	VBG	VBG	_	7	advcl	_	_
17	that	that	IN	IN	_	23	mark	_	_
18	the	the	DT	DT	_	20	det	_	_
19	PAS	pas	NN	NN	_	20	compound	_	_
20	domain	domain	NN	NN	_	23	nsubj	_	_
21	may	may	MD	MD	_	23	aux	_	_
22	be	be	VB	VB	_	23	cop	_	_
23	important	important	JJ	JJ	_	16	ccomp	_	_
24	for	for	IN	IN	_	26	case	_	_
25	DNA-binding	dna-binding	JJ	JJ	_	26	amod	_	_
26	affinity	affinity	NN	NN	_	23	nmod	_	_
27	and/or	and/or	CC	CC	_	26	cc	_	_
28	specificity	specificity	NN	NN	_	26	conj	_	_
29	of	of	IN	IN	_	31	case	_	_
30	the	the	DT	DT	_	31	det	_	_
31	receptor	receptor	NN	NN	_	26	nmod	_	_
32	.	.	.	.	_	7	punct	_	_

1	It	it	PRP	PRP	_	4	nsubj	_	_
2	was	be	VBD	VBD	_	4	cop	_	_
3	not	not	RB	RB	_	4	neg	_	_
4	possible	possible	JJ	JJ	_	0	root	_	_
5	to	to	TO	TO	_	6	mark	_	_
6	reconstitute	reconstitute	VB	VB	_	4	xcomp	_	_
7	dioxin	dioxin	NN	NN	_	8	compound	_	_
8	receptor	receptor	NN	NN	_	9	compound	_	_
9	function	function	NN	NN	_	6	dobj	_	_
10	with	with	IN	IN	_	11	case	_	_
11	proteins	protein	NNS	NNS	_	6	nmod	_	_
12	expressed	express	VBN	VBN	_	11	acl	_	_
13	in	in	IN	IN	_	16	case	_	_
14	wheat	wheat	NN	NN	_	16	compound	_	_
15	germ	germ	NN	NN	_	16	compound	_	_
16	lysate	lysate	NN	NN	_	12	nmod	_	_
17	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	line	line	NN	NN	_	14	nmod	_	_
3	with	with	IN	IN	_	5	case	_	_
4	these	these	DT	DT	_	5	det	_	_
5	observations	observation	NNS	NNS	_	2	nmod	_	_
6	,	,	,	,	_	14	punct	_	_
7	reticulocyte	reticulocyte	NN	NN	_	8	compound	_	_
8	lysate	lysate	NN	NN	_	14	nsubj	_	_
9	but	but	CC	CC	_	10	cc	_	_
10	not	not	RB	RB	_	8	cc	_	_
11	wheat	wheat	NN	NN	_	13	compound	_	_
12	germ	germ	NN	NN	_	13	compound	_	_
13	lysate	lysate	NN	NN	_	8	conj	_	_
14	promoted	promote	VBD	VBD	_	0	root	_	_
15	the	the	DT	DT	_	16	det	_	_
16	association	association	NN	NN	_	14	dobj	_	_
17	of	of	IN	IN	_	22	case	_	_
18	de	de	FW	FW	_	22	amod	_	_
19	novo	novo	FW	FW	_	18	dep	_	_
20	synthesized	synthesize	VBN	VBN	_	22	amod	_	_
21	dioxin	dioxin	NN	NN	_	22	compound	_	_
22	receptor	receptor	NN	NN	_	16	nmod	_	_
23	with	with	IN	IN	_	24	case	_	_
24	hsp90	hsp90	NN	NN	_	16	nmod	_	_
25	.	.	.	.	_	14	punct	_	_

1	At	at	IN	IN	_	2	case	_	_
2	least	least	JJS	JJS	_	3	nmod:npmod	_	_
3	two	two	CD	CD	_	5	nummod	_	_
4	distinct	distinct	JJ	JJ	_	5	amod	_	_
5	domains	domain	NNS	NNS	_	9	nsubj	_	_
6	of	of	IN	IN	_	8	case	_	_
7	the	the	DT	DT	_	8	det	_	_
8	receptor	receptor	NN	NN	_	5	nmod	_	_
9	mediated	mediate	VBD	VBD	_	0	root	_	_
10	interaction	interaction	NN	NN	_	9	dobj	_	_
11	with	with	IN	IN	_	12	case	_	_
12	hsp90	hsp90	NN	NN	_	10	nmod	_	_
13	:	:	:	:	_	9	punct	_	_
14	the	the	DT	DT	_	16	det	_	_
15	ligand-binding	ligand-binding	JJ	JJ	_	16	amod	_	_
16	domain	domain	NN	NN	_	9	dep	_	_
17	located	located	JJ	JJ	_	16	amod	_	_
18	within	within	IN	IN	_	21	case	_	_
19	the	the	DT	DT	_	21	det	_	_
20	PAS	pas	NN	NN	_	21	compound	_	_
21	region	region	NN	NN	_	17	nmod	_	_
22	and	and	CC	CC	_	16	cc	_	_
23	,	,	,	,	_	16	punct	_	_
24	surprisingly	surprisingly	RB	RB	_	16	advmod	_	_
25	,	,	,	,	_	16	punct	_	_
26	the	the	DT	DT	_	28	det	_	_
27	bHLH	bhlh	JJ	JJ	_	28	amod	_	_
28	domain	domain	NN	NN	_	16	conj	_	_
29	.	.	.	.	_	9	punct	_	_

1	Whereas	whereas	IN	IN	_	4	mark	_	_
2	ligand-binding	ligand-binding	JJ	JJ	_	3	amod	_	_
3	activity	activity	NN	NN	_	4	nsubj	_	_
4	correlated	correlate	VBD	VBD	_	12	advcl	_	_
5	with	with	IN	IN	_	6	case	_	_
6	association	association	NN	NN	_	4	nmod	_	_
7	with	with	IN	IN	_	8	case	_	_
8	hsp90	hsp90	NN	NN	_	6	nmod	_	_
9	,	,	,	,	_	12	punct	_	_
10	bHLH-hsp90	bhlh-hsp90	JJ	JJ	_	11	amod	_	_
11	interaction	interaction	NN	NN	_	12	nsubj	_	_
12	appeared	appear	VBD	VBD	_	0	root	_	_
13	to	to	TO	TO	_	15	mark	_	_
14	be	be	VB	VB	_	15	cop	_	_
15	important	important	JJ	JJ	_	12	xcomp	_	_
16	for	for	IN	IN	_	18	case	_	_
17	DNA-binding	dna-binding	JJ	JJ	_	18	amod	_	_
18	activity	activity	NN	NN	_	15	nmod	_	_
19	but	but	CC	CC	_	18	cc	_	_
20	not	not	RB	RB	_	22	neg	_	_
21	for	for	IN	IN	_	22	case	_	_
22	dimerization	dimerization	NN	NN	_	18	conj	_	_
23	of	of	IN	IN	_	25	case	_	_
24	the	the	DT	DT	_	25	det	_	_
25	receptor	receptor	NN	NN	_	22	nmod	_	_
26	.	.	.	.	_	12	punct	_	_

1	Several	several	JJ	JJ	_	2	amod	_	_
2	distinct	distinct	JJ	JJ	_	3	amod	_	_
3	roles	role	NNS	NNS	_	13	nsubj	_	_
4	for	for	IN	IN	_	5	case	_	_
5	hsp90	hsp90	NN	NN	_	3	nmod	_	_
6	in	in	IN	IN	_	7	mark	_	_
7	modulating	modulate	VBG	VBG	_	3	acl	_	_
8	dioxin	dioxin	NN	NN	_	9	compound	_	_
9	receptor	receptor	NN	NN	_	10	compound	_	_
10	function	function	NN	NN	_	7	dobj	_	_
11	are	be	VBP	VBP	_	13	cop	_	_
12	therefore	therefore	RB	RB	_	13	advmod	_	_
13	likely	likely	JJ	JJ	_	0	root	_	_
14	:	:	:	:	_	13	punct	_	_
15	correct	correct	JJ	JJ	_	16	amod	_	_
16	folding	folding	NN	NN	_	13	dep	_	_
17	of	of	IN	IN	_	20	case	_	_
18	the	the	DT	DT	_	20	det	_	_
19	ligand-binding	ligand-binding	JJ	JJ	_	20	amod	_	_
20	domain	domain	NN	NN	_	16	nmod	_	_
21	,	,	,	,	_	16	punct	_	_
22	interference	interference	NN	NN	_	16	conj	_	_
23	with	with	IN	IN	_	25	case	_	_
24	Arnt	arnt	NN	NN	_	25	compound	_	_
25	heterodimerization	heterodimerization	NN	NN	_	22	nmod	_	_
26	,	,	,	,	_	16	punct	_	_
27	and	and	CC	CC	_	16	cc	_	_
28	folding	folding	NN	NN	_	16	conj	_	_
29	of	of	IN	IN	_	32	case	_	_
30	a	a	DT	DT	_	32	det	_	_
31	DNA-binding	dna-binding	JJ	JJ	_	32	amod	_	_
32	conformation	conformation	NN	NN	_	28	nmod	_	_
33	of	of	IN	IN	_	36	case	_	_
34	the	the	DT	DT	_	36	det	_	_
35	bHLH	bhlh	JJ	JJ	_	36	amod	_	_
36	domain	domain	NN	NN	_	32	nmod	_	_
37	.	.	.	.	_	13	punct	_	_

1	Thus	thus	RB	RB	_	7	advmod	_	_
2	,	,	,	,	_	7	punct	_	_
3	the	the	DT	DT	_	6	det	_	_
4	dioxin	dioxin	NN	NN	_	5	compound	_	_
5	receptor	receptor	NN	NN	_	6	compound	_	_
6	system	system	NN	NN	_	7	nsubj	_	_
7	provides	provide	VBZ	VBZ	_	0	root	_	_
8	a	a	DT	DT	_	12	det	_	_
9	complex	complex	JJ	JJ	_	12	amod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	interesting	interesting	JJ	JJ	_	9	conj	_	_
12	model	model	NN	NN	_	7	dobj	_	_
13	of	of	IN	IN	_	15	case	_	_
14	the	the	DT	DT	_	15	det	_	_
15	regulation	regulation	NN	NN	_	12	nmod	_	_
16	of	of	IN	IN	_	18	case	_	_
17	transcription	transcription	NN	NN	_	18	compound	_	_
18	factors	factor	NNS	NNS	_	15	nmod	_	_
19	by	by	IN	IN	_	20	case	_	_
20	hsp90	hsp90	NN	NN	_	15	nmod	_	_
21	.	.	.	.	_	7	punct	_	_

1	T-cell	t-cell	NN	NN	_	3	compound	_	_
2	functional	functional	JJ	JJ	_	3	amod	_	_
3	regions	region	NNS	NNS	_	0	root	_	_
4	of	of	IN	IN	_	9	case	_	_
5	the	the	DT	DT	_	9	det	_	_
6	human	human	JJ	JJ	_	9	amod	_	_
7	IL-3	il-3	NN	NN	_	9	compound	_	_
8	proximal	proximal	JJ	JJ	_	9	amod	_	_
9	promoter	promoter	NN	NN	_	3	nmod	_	_
10	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	7	det	_	_
2	human	human	JJ	JJ	_	7	amod	_	_
3	interleukin-3	interleukin-3	NN	NN	_	7	compound	_	_
4	(	(	-LRB-	-LRB-	_	7	punct	_	_
5	IL-3	il-3	NN	NN	_	7	compound	_	_
6	)	)	-RRB-	-RRB-	_	7	punct	_	_
7	gene	gene	NN	NN	_	9	nsubjpass	_	_
8	is	be	VBZ	VBZ	_	9	auxpass	_	_
9	expressed	express	VBN	VBN	_	0	root	_	_
10	almost	almost	RB	RB	_	11	advmod	_	_
11	exclusively	exclusively	RB	RB	_	9	advmod	_	_
12	in	in	IN	IN	_	15	case	_	_
13	activated	activate	VBN	VBN	_	15	amod	_	_
14	T	t	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	9	nmod	_	_
16	.	.	.	.	_	9	punct	_	_

1	Its	its	PRP$	PRP$	_	2	nmod:poss	_	_
2	expression	expression	NN	NN	_	4	nsubjpass	_	_
3	is	be	VBZ	VBZ	_	4	auxpass	_	_
4	regulated	regulate	VBN	VBN	_	0	root	_	_
5	at	at	IN	IN	_	8	case	_	_
6	both	both	CC	CC	_	8	cc:preconj	_	_
7	the	the	DT	DT	_	8	dep	_	_
8	transcriptional	transcriptional	JJ	JJ	_	4	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	post-transcriptional	post-transcriptional	JJ	JJ	_	8	conj	_	_
11	level	level	NN	NN	_	8	dep	_	_
12	.	.	.	.	_	4	punct	_	_

1	We	we	PRP	PRP	_	4	nsubj	_	_
2	have	have	VBP	VBP	_	4	aux	_	_
3	previously	previously	RB	RB	_	4	advmod	_	_
4	shown	show	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	23	mark	_	_
6	treatment	treatment	NN	NN	_	23	nsubj	_	_
7	of	of	IN	IN	_	10	case	_	_
8	Jurkat	jurkat	NN	NN	_	10	compound	_	_
9	T	t	NN	NN	_	10	compound	_	_
10	cells	cell	NNS	NNS	_	6	nmod	_	_
11	with	with	IN	IN	_	12	case	_	_
12	phytohemaglutinin	phytohemaglutinin	NN	NN	_	6	nmod	_	_
13	(	(	-LRB-	-LRB-	_	14	punct	_	_
14	PHA	pha	NN	NN	_	12	appos	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	and	and	CC	CC	_	12	cc	_	_
17	the	the	DT	DT	_	19	det	_	_
18	phorbol	phorbol	NN	NN	_	19	compound	_	_
19	ester	ester	NN	NN	_	12	conj	_	_
20	,	,	,	,	_	19	punct	_	_
21	PMA	pma	NN	NN	_	19	appos	_	_
22	,	,	,	,	_	19	punct	_	_
23	activated	activate	VBD	VBD	_	4	ccomp	_	_
24	transcription	transcription	NN	NN	_	25	compound	_	_
25	initiation	initiation	NN	NN	_	23	dobj	_	_
26	from	from	IN	IN	_	29	case	_	_
27	the	the	DT	DT	_	29	det	_	_
28	IL-3	il-3	NN	NN	_	29	compound	_	_
29	gene	gene	NN	NN	_	25	nmod	_	_
30	.	.	.	.	_	4	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	define	define	VB	VB	_	0	root	_	_
3	the	the	DT	DT	_	4	det	_	_
4	regions	region	NNS	NNS	_	2	dobj	_	_
5	of	of	IN	IN	_	7	case	_	_
6	the	the	DT	DT	_	7	det	_	_
7	gene	gene	NN	NN	_	4	nmod	_	_
8	required	require	VBN	VBN	_	7	acl	_	_
9	for	for	IN	IN	_	11	case	_	_
10	transcription	transcription	NN	NN	_	11	compound	_	_
11	activation	activation	NN	NN	_	8	nmod	_	_
12	,	,	,	,	_	2	punct	_	_
13	we	we	PRP	PRP	_	14	nsubj	_	_
14	generated	generate	VBD	VBD	_	2	parataxis	_	_
15	a	a	DT	DT	_	16	det	_	_
16	series	series	NN	NN	_	14	dobj	_	_
17	of	of	IN	IN	_	19	case	_	_
18	reporter	reporter	NN	NN	_	19	compound	_	_
19	constructs	construct	NNS	NNS	_	16	nmod	_	_
20	containing	contain	VBG	VBG	_	19	acl	_	_
21	different	different	JJ	JJ	_	22	amod	_	_
22	regions	region	NNS	NNS	_	20	dobj	_	_
23	of	of	IN	IN	_	27	case	_	_
24	the	the	DT	DT	_	27	det	_	_
25	IL-3	il-3	NN	NN	_	27	nmod:npmod	_	_
26	gene	gene	NN	NN	_	27	nmod:npmod	_	_
27	5'	5'	JJ	JJ	_	22	nmod	_	_
28	and	and	CC	CC	_	27	cc	_	_
29	3'	3'	JJ	JJ	_	31	amod	_	_
30	flanking	flanking	JJ	JJ	_	31	amod	_	_
31	sequences	sequence	NNS	NNS	_	27	conj	_	_
32	.	.	.	.	_	2	punct	_	_

1	Both	both	CC	CC	_	2	cc:preconj	_	_
2	positive	positive	JJ	JJ	_	8	nsubjpass	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	negative	negative	JJ	JJ	_	2	conj	_	_
5	regulatory	regulatory	JJ	JJ	_	6	amod	_	_
6	elements	element	NNS	NNS	_	2	dep	_	_
7	were	be	VBD	VBD	_	8	auxpass	_	_
8	identified	identify	VBN	VBN	_	0	root	_	_
9	in	in	IN	IN	_	14	case	_	_
10	the	the	DT	DT	_	14	det	_	_
11	proximal	proximal	JJ	JJ	_	14	amod	_	_
12	5'	5'	JJ	JJ	_	14	amod	_	_
13	flanking	flanking	JJ	JJ	_	14	amod	_	_
14	region	region	NN	NN	_	8	nmod	_	_
15	of	of	IN	IN	_	18	case	_	_
16	the	the	DT	DT	_	18	det	_	_
17	IL-3	il-3	NN	NN	_	18	compound	_	_
18	gene	gene	NN	NN	_	14	nmod	_	_
19	.	.	.	.	_	8	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	promoter	promoter	NN	NN	_	3	compound	_	_
3	region	region	NN	NN	_	8	nsubj	_	_
4	between	between	IN	IN	_	5	case	_	_
5	-173	-173	CD	CD	_	3	nmod	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	-60	-60	CD	CD	_	5	conj	_	_
8	contained	contain	VBD	VBD	_	0	root	_	_
9	the	the	DT	DT	_	12	det	_	_
10	strongest	strongest	JJS	JJS	_	12	amod	_	_
11	activating	activate	VBG	VBG	_	12	amod	_	_
12	elements	element	NNS	NNS	_	8	dobj	_	_
13	.	.	.	.	_	8	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	transcription	transcription	NN	NN	_	3	compound	_	_
3	factor	factor	NN	NN	_	6	nsubj	_	_
4	AP-1	ap-1	NN	NN	_	3	dep	_	_
5	could	could	MD	MD	_	6	aux	_	_
6	bind	bind	VB	VB	_	0	root	_	_
7	to	to	TO	TO	_	11	case	_	_
8	this	this	DT	DT	_	11	det	_	_
9	positive	positive	JJ	JJ	_	11	amod	_	_
10	activator	activator	NN	NN	_	11	compound	_	_
11	region	region	NN	NN	_	6	nmod	_	_
12	of	of	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	det	_	_
14	promoter	promoter	NN	NN	_	11	nmod	_	_
15	.	.	.	.	_	6	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	examined	examine	VBD	VBD	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	function	function	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	10	case	_	_
7	the	the	DT	DT	_	10	det	_	_
8	IL-3	il-3	NN	NN	_	10	compound	_	_
9	CK-1/CK-2	ck-1/ck-2	NN	NN	_	10	compound	_	_
10	elements	element	NNS	NNS	_	5	nmod	_	_
11	that	that	WDT	WDT	_	13	nsubj	_	_
12	are	be	VBP	VBP	_	13	cop	_	_
13	present	present	JJ	JJ	_	10	acl:relcl	_	_
14	in	in	IN	IN	_	17	case	_	_
15	many	many	JJ	JJ	_	17	amod	_	_
16	cytokine	cytokine	NN	NN	_	17	compound	_	_
17	genes	gene	NNS	NNS	_	13	nmod	_	_
18	and	and	CC	CC	_	3	cc	_	_
19	found	find	VBD	VBD	_	3	conj	_	_
20	that	that	IN	IN	_	22	mark	_	_
21	they	they	PRP	PRP	_	22	nsubj	_	_
22	acted	act	VBD	VBD	_	19	ccomp	_	_
23	as	as	IN	IN	_	25	case	_	_
24	a	a	DT	DT	_	25	det	_	_
25	repressor	repressor	NN	NN	_	22	nmod	_	_
26	of	of	IN	IN	_	29	case	_	_
27	basal	basal	JJ	JJ	_	29	amod	_	_
28	level	level	NN	NN	_	29	compound	_	_
29	expression	expression	NN	NN	_	25	nmod	_	_
30	when	when	WRB	WRB	_	31	advmod	_	_
31	cloned	clone	VBN	VBN	_	22	advcl	_	_
32	upstream	upstream	RB	RB	_	31	advmod	_	_
33	of	of	IN	IN	_	36	case	_	_
34	a	a	DT	DT	_	36	det	_	_
35	heterologous	heterologous	JJ	JJ	_	36	amod	_	_
36	promoter	promoter	NN	NN	_	32	nmod	_	_
37	but	but	CC	CC	_	22	cc	_	_
38	were	be	VBD	VBD	_	40	cop	_	_
39	also	also	RB	RB	_	40	advmod	_	_
40	inducible	inducible	JJ	JJ	_	22	conj	_	_
41	by	by	IN	IN	_	42	case	_	_
42	PMA/PHA	pma/pha	NN	NN	_	40	nmod	_	_
43	.	.	.	.	_	3	punct	_	_

1	Two	two	CD	CD	_	4	nummod	_	_
2	distinct	distinct	JJ	JJ	_	4	amod	_	_
3	signalling	signalling	NN	NN	_	4	compound	_	_
4	pathways	pathway	NNS	NNS	_	6	nsubjpass	_	_
5	are	be	VBP	VBP	_	6	auxpass	_	_
6	involved	involve	VBN	VBN	_	0	root	_	_
7	in	in	IN	IN	_	9	case	_	_
8	the	the	DT	DT	_	9	det	_	_
9	control	control	NN	NN	_	6	nmod	_	_
10	of	of	IN	IN	_	14	case	_	_
11	the	the	DT	DT	_	14	det	_	_
12	biphasic	biphasic	JJ	JJ	_	14	amod	_	_
13	junB	junb	NN	NN	_	14	compound	_	_
14	transcription	transcription	NN	NN	_	9	nmod	_	_
15	induced	induce	VBN	VBN	_	14	acl	_	_
16	by	by	IN	IN	_	17	case	_	_
17	interleukin-6	interleukin-6	NN	NN	_	15	nmod	_	_
18	in	in	IN	IN	_	23	case	_	_
19	the	the	DT	DT	_	23	det	_	_
20	B	b	NN	NN	_	23	compound	_	_
21	cell	cell	NN	NN	_	23	compound	_	_
22	hybridoma	hybridoma	NN	NN	_	23	compound	_	_
23	7TD1	7td1	NN	NN	_	15	nmod	_	_
24	.	.	.	.	_	6	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	measured	measure	VBN	VBN	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	level	level	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	8	case	_	_
7	junB	junb	NN	NN	_	8	compound	_	_
8	mRNA	mrna	NN	NN	_	5	nmod	_	_
9	in	in	IN	IN	_	15	case	_	_
10	the	the	DT	DT	_	15	det	_	_
11	B	b	NN	NN	_	15	compound	_	_
12	hybridoma	hybridoma	NN	NN	_	15	compound	_	_
13	cell	cell	NN	NN	_	15	compound	_	_
14	line	line	NN	NN	_	15	compound	_	_
15	7TD1	7td1	NN	NN	_	8	nmod	_	_
16	,	,	,	,	_	3	punct	_	_
17	under	under	IN	IN	_	22	case	_	_
18	interleukin-6	interleukin-6	NN	NN	_	22	compound	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	IL-6	il-6	NN	NN	_	18	appos	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	stimulation	stimulation	NN	NN	_	3	nmod	_	_
23	.	.	.	.	_	3	punct	_	_

1	IL-6	il-6	NN	NN	_	2	nsubj	_	_
2	increases	increase	VBZ	VBZ	_	0	root	_	_
3	junB	junb	NN	NN	_	4	compound	_	_
4	mRNA	mrna	NN	NN	_	2	dobj	_	_
5	in	in	IN	IN	_	8	case	_	_
6	a	a	DT	DT	_	8	det	_	_
7	biphasic	biphasic	JJ	JJ	_	8	amod	_	_
8	fashion	fashion	NN	NN	_	2	nmod	_	_
9	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	first	first	JJ	JJ	_	4	amod	_	_
3	early-induced	early-induced	JJ	JJ	_	2	dep	_	_
4	peak	peak	NN	NN	_	6	nsubj	_	_
5	was	be	VBD	VBD	_	6	cop	_	_
6	transient	transient	JJ	JJ	_	0	root	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	likely	likely	RB	RB	_	9	advmod	_	_
9	corresponds	correspond	VBZ	VBZ	_	6	conj	_	_
10	to	to	TO	TO	_	16	case	_	_
11	the	the	DT	DT	_	16	det	_	_
12	well	well	RB	RB	_	13	advmod	_	_
13	documented	document	VBN	VBN	_	16	amod	_	_
14	typical	typical	JJ	JJ	_	13	dep	_	_
15	junB	junb	NN	NN	_	16	compound	_	_
16	mRNA	mrna	NN	NN	_	9	nmod	_	_
17	,	,	,	,	_	16	punct	_	_
18	stimulated	stimulate	VBN	VBN	_	16	acl	_	_
19	in	in	IN	IN	_	20	case	_	_
20	response	response	NN	NN	_	18	nmod	_	_
21	to	to	TO	TO	_	24	case	_	_
22	numerous	numerous	JJ	JJ	_	24	amod	_	_
23	growth	growth	NN	NN	_	24	compound	_	_
24	factors	factor	NNS	NNS	_	20	nmod	_	_
25	,	,	,	,	_	24	punct	_	_
26	including	include	VBG	VBG	_	27	case	_	_
27	IL-6	il-6	NN	NN	_	24	nmod	_	_
28	.	.	.	.	_	6	punct	_	_

1	At	at	IN	IN	_	2	case	_	_
2	variance	variance	NN	NN	_	14	nmod	_	_
3	,	,	,	,	_	14	punct	_	_
4	the	the	DT	DT	_	6	det	_	_
5	second	second	JJ	JJ	_	6	amod	_	_
6	peak	peak	NN	NN	_	14	nsubj	_	_
7	which	which	WDT	WDT	_	11	nsubjpass	_	_
8	has	have	VBZ	VBZ	_	11	aux	_	_
9	never	never	RB	RB	_	11	neg	_	_
10	been	be	VBN	VBN	_	11	auxpass	_	_
11	reported	report	VBN	VBN	_	6	acl:relcl	_	_
12	previously	previously	RB	RB	_	11	advmod	_	_
13	,	,	,	,	_	6	punct	_	_
14	lasted	last	VBD	VBD	_	0	root	_	_
15	several	several	JJ	JJ	_	16	amod	_	_
16	hours	hour	NNS	NNS	_	14	dobj	_	_
17	.	.	.	.	_	14	punct	_	_

1	As	as	IN	IN	_	3	case	_	_
2	a	a	DT	DT	_	3	det	_	_
3	consequence	consequence	NN	NN	_	12	nmod	_	_
4	of	of	IN	IN	_	6	case	_	_
5	its	its	PRP$	PRP$	_	6	nmod:poss	_	_
6	effect	effect	NN	NN	_	3	nmod	_	_
7	on	on	IN	IN	_	9	case	_	_
8	junB	junb	NN	NN	_	9	compound	_	_
9	mRNA	mrna	NN	NN	_	6	nmod	_	_
10	,	,	,	,	_	12	punct	_	_
11	IL-6	il-6	NN	NN	_	12	nsubj	_	_
12	stimulated	stimulate	VBD	VBD	_	0	root	_	_
13	,	,	,	,	_	12	punct	_	_
14	in	in	IN	IN	_	17	case	_	_
15	a	a	DT	DT	_	17	det	_	_
16	biphasic	biphasic	JJ	JJ	_	17	amod	_	_
17	fashion	fashion	NN	NN	_	12	nmod	_	_
18	,	,	,	,	_	12	punct	_	_
19	the	the	DT	DT	_	21	det	_	_
20	nuclear	nuclear	JJ	JJ	_	21	amod	_	_
21	accumulation	accumulation	NN	NN	_	12	dobj	_	_
22	of	of	IN	IN	_	25	case	_	_
23	the	the	DT	DT	_	25	det	_	_
24	JunB	junb	NN	NN	_	25	compound	_	_
25	protein	protein	NN	NN	_	21	nmod	_	_
26	.	.	.	.	_	12	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	study	study	NN	NN	_	6	nmod	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	demonstrated	demonstrate	VBD	VBD	_	0	root	_	_
7	that	that	IN	IN	_	10	mark	_	_
8	IL-6	il-6	NN	NN	_	9	compound	_	_
9	regulation	regulation	NN	NN	_	10	nsubj	_	_
10	occurred	occur	VBD	VBD	_	6	ccomp	_	_
11	exclusively	exclusively	RB	RB	_	10	advmod	_	_
12	at	at	IN	IN	_	15	case	_	_
13	the	the	DT	DT	_	15	det	_	_
14	transcriptional	transcriptional	JJ	JJ	_	15	amod	_	_
15	level	level	NN	NN	_	10	nmod	_	_
16	and	and	CC	CC	_	10	cc	_	_
17	that	that	IN	IN	_	29	mark	_	_
18	the	the	DT	DT	_	20	det	_	_
19	bimodal	bimodal	JJ	JJ	_	20	amod	_	_
20	increase	increase	NN	NN	_	29	nsubjpass	_	_
21	of	of	IN	IN	_	23	case	_	_
22	junB	junb	NN	NN	_	23	compound	_	_
23	mRNA	mrna	NN	NN	_	20	nmod	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	JunB	junb	NN	NN	_	26	compound	_	_
26	protein	protein	NN	NN	_	23	conj	_	_
27	can	can	MD	MD	_	29	aux	_	_
28	be	be	VB	VB	_	29	auxpass	_	_
29	accounted	account	VBN	VBN	_	10	conj	_	_
30	for	for	IN	IN	_	34	case	_	_
31	by	by	IN	IN	_	34	case	_	_
32	a	a	DT	DT	_	34	det	_	_
33	biphasic	biphasic	JJ	JJ	_	34	amod	_	_
34	stimulation	stimulation	NN	NN	_	29	nmod	_	_
35	of	of	IN	IN	_	37	case	_	_
36	junB	junb	NN	NN	_	37	compound	_	_
37	transcription	transcription	NN	NN	_	34	nmod	_	_
38	.	.	.	.	_	6	punct	_	_

1	Furthermore	furthermore	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	our	we	PRP$	PRP$	_	4	nmod:poss	_	_
4	data	datum	NNS	NNS	_	5	nsubj	_	_
5	point	point	VBP	VBP	_	0	root	_	_
6	to	to	TO	TO	_	9	case	_	_
7	two	two	CD	CD	_	9	nummod	_	_
8	major	major	JJ	JJ	_	9	amod	_	_
9	differences	difference	NNS	NNS	_	5	nmod	_	_
10	between	between	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	mechanism	mechanism	NN	NN	_	9	nmod	_	_
13	of	of	IN	IN	_	14	case	_	_
14	control	control	NN	NN	_	12	nmod	_	_
15	of	of	IN	IN	_	17	case	_	_
16	the	the	DT	DT	_	17	det	_	_
17	early	early	JJ	JJ	_	14	nmod	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	the	the	DT	DT	_	20	det	_	_
20	late	late	JJ	JJ	_	17	conj	_	_
21	IL-6-induced	il-6-induced	JJ	JJ	_	24	amod	_	_
22	junB	junb	NN	NN	_	24	compound	_	_
23	transcription	transcription	NN	NN	_	24	compound	_	_
24	waves	wave	NNS	NNS	_	17	dep	_	_
25	.	.	.	.	_	5	punct	_	_

1	First	first	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	cycloheximide	cycloheximide	NN	NN	_	5	nsubj	_	_
4	strongly	strongly	RB	RB	_	5	advmod	_	_
5	potentiated	potentiate	VBD	VBD	_	0	root	_	_
6	the	the	DT	DT	_	7	det	_	_
7	transcription	transcription	NN	NN	_	5	dobj	_	_
8	of	of	IN	IN	_	11	case	_	_
9	the	the	DT	DT	_	11	det	_	_
10	second	second	JJ	JJ	_	11	amod	_	_
11	wave	wave	NN	NN	_	7	nmod	_	_
12	,	,	,	,	_	5	punct	_	_
13	whereas	whereas	IN	IN	_	15	mark	_	_
14	it	it	PRP	PRP	_	15	nsubj	_	_
15	failed	fail	VBD	VBD	_	5	advcl	_	_
16	to	to	TO	TO	_	17	mark	_	_
17	affect	affect	VB	VB	_	15	xcomp	_	_
18	the	the	DT	DT	_	20	det	_	_
19	early-induced	early-induced	JJ	JJ	_	20	amod	_	_
20	burst	burst	NN	NN	_	17	dobj	_	_
21	.	.	.	.	_	5	punct	_	_

1	Second	second	RB	RB	_	10	advmod	_	_
2	,	,	,	,	_	10	punct	_	_
3	tyrphostin	tyrphostin	NN	NN	_	10	nsubj	_	_
4	,	,	,	,	_	3	punct	_	_
5	a	a	DT	DT	_	8	det	_	_
6	tyrosine	tyrosine	NN	NN	_	8	compound	_	_
7	kinase	kinase	NN	NN	_	8	compound	_	_
8	inhibitor	inhibitor	NN	NN	_	3	appos	_	_
9	,	,	,	,	_	3	punct	_	_
10	impaired	impair	VBD	VBD	_	0	root	_	_
11	the	the	DT	DT	_	12	det	_	_
12	expression	expression	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	15	case	_	_
14	the	the	DT	DT	_	15	det	_	_
15	first	first	JJ	JJ	_	12	nmod	_	_
16	but	but	CC	CC	_	17	cc	_	_
17	not	not	RB	RB	_	15	cc	_	_
18	the	the	DT	DT	_	19	det	_	_
19	second	second	JJ	JJ	_	15	conj	_	_
20	junB	junb	NN	NN	_	21	compound	_	_
21	mRNA	mrna	NN	NN	_	22	compound	_	_
22	peak	peak	NN	NN	_	15	dep	_	_
23	.	.	.	.	_	10	punct	_	_

1	Conversely	conversely	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	genistein	genistein	NN	NN	_	11	nsubj	_	_
4	,	,	,	,	_	3	punct	_	_
5	another	another	DT	DT	_	8	det	_	_
6	tyrosine	tyrosine	NN	NN	_	8	compound	_	_
7	kinase	kinase	NN	NN	_	8	compound	_	_
8	inhibitor	inhibitor	NN	NN	_	3	appos	_	_
9	,	,	,	,	_	3	punct	_	_
10	totally	totally	RB	RB	_	11	advmod	_	_
11	abolished	abolish	VBD	VBD	_	0	root	_	_
12	the	the	DT	DT	_	13	det	_	_
13	expression	expression	NN	NN	_	11	dobj	_	_
14	of	of	IN	IN	_	17	case	_	_
15	the	the	DT	DT	_	17	det	_	_
16	second	second	JJ	JJ	_	17	amod	_	_
17	peak	peak	NN	NN	_	13	nmod	_	_
18	of	of	IN	IN	_	20	case	_	_
19	junB	junb	NN	NN	_	20	compound	_	_
20	mRNA	mrna	NN	NN	_	17	nmod	_	_
21	whereas	whereas	IN	IN	_	25	mark	_	_
22	it	it	PRP	PRP	_	25	nsubj	_	_
23	did	do	VBD	VBD	_	25	aux	_	_
24	not	not	RB	RB	_	25	neg	_	_
25	affect	affect	VB	VB	_	11	advcl	_	_
26	the	the	DT	DT	_	27	det	_	_
27	expression	expression	NN	NN	_	25	dobj	_	_
28	of	of	IN	IN	_	31	case	_	_
29	the	the	DT	DT	_	31	det	_	_
30	first	first	JJ	JJ	_	31	amod	_	_
31	peak	peak	NN	NN	_	27	nmod	_	_
32	.	.	.	.	_	11	punct	_	_

1	Altogether	altogether	RB	RB	_	4	advmod	_	_
2	these	these	DT	DT	_	3	det	_	_
3	data	datum	NNS	NNS	_	4	nsubj	_	_
4	indicate	indicate	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	12	mark	_	_
6	,	,	,	,	_	12	punct	_	_
7	in	in	IN	IN	_	9	case	_	_
8	7TD1	7td1	NN	NN	_	9	compound	_	_
9	cells	cell	NNS	NNS	_	12	nmod	_	_
10	,	,	,	,	_	12	punct	_	_
11	IL-6	il-6	NN	NN	_	12	nsubj	_	_
12	controls	control	VBZ	VBZ	_	4	ccomp	_	_
13	junB	junb	NN	NN	_	14	compound	_	_
14	transcription	transcription	NN	NN	_	12	dobj	_	_
15	in	in	IN	IN	_	18	case	_	_
16	a	a	DT	DT	_	18	det	_	_
17	biphasic	biphasic	JJ	JJ	_	18	amod	_	_
18	fashion	fashion	NN	NN	_	12	nmod	_	_
19	by	by	IN	IN	_	20	case	_	_
20	means	means	NNS	NNS	_	12	nmod	_	_
21	of	of	IN	IN	_	25	case	_	_
22	two	two	CD	CD	_	25	nummod	_	_
23	separate	separate	JJ	JJ	_	25	amod	_	_
24	transduction	transduction	NN	NN	_	25	compound	_	_
25	pathways	pathway	NNS	NNS	_	20	nmod	_	_
26	.	.	.	.	_	4	punct	_	_

1	Posttranscriptional	posttranscriptional	JJ	JJ	_	2	amod	_	_
2	regulation	regulation	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	7	case	_	_
4	macrophage	macrophage	NN	NN	_	7	compound	_	_
5	tissue	tissue	NN	NN	_	6	compound	_	_
6	factor	factor	NN	NN	_	7	compound	_	_
7	expression	expression	NN	NN	_	2	nmod	_	_
8	by	by	IN	IN	_	9	case	_	_
9	antioxidants	antioxidant	NNS	NNS	_	2	nmod	_	_
10	.	.	.	.	_	2	punct	_	_

1	Tissue	tissue	NN	NN	_	2	compound	_	_
2	factor	factor	NN	NN	_	6	compound	_	_
3	(	(	-LRB-	-LRB-	_	4	punct	_	_
4	TF	tf	NN	NN	_	2	appos	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	expression	expression	NN	NN	_	12	nsubj	_	_
7	by	by	IN	IN	_	8	case	_	_
8	cells	cell	NNS	NNS	_	6	nmod	_	_
9	of	of	IN	IN	_	11	case	_	_
10	monocyte/macrophage	monocyte/macrophage	NN	NN	_	11	compound	_	_
11	lineage	lineage	NN	NN	_	8	nmod	_	_
12	represents	represent	VBZ	VBZ	_	0	root	_	_
13	an	a	DT	DT	_	15	det	_	_
14	important	important	JJ	JJ	_	15	amod	_	_
15	mechanism	mechanism	NN	NN	_	12	dobj	_	_
16	underlying	underlie	VBG	VBG	_	15	acl	_	_
17	the	the	DT	DT	_	18	det	_	_
18	initiation	initiation	NN	NN	_	16	dobj	_	_
19	of	of	IN	IN	_	21	case	_	_
20	fibrin	fibrin	NN	NN	_	21	compound	_	_
21	deposition	deposition	NN	NN	_	18	nmod	_	_
22	at	at	IN	IN	_	23	case	_	_
23	sites	site	NNS	NNS	_	18	nmod	_	_
24	of	of	IN	IN	_	26	case	_	_
25	extravascular	extravascular	JJ	JJ	_	26	amod	_	_
26	inflammation	inflammation	NN	NN	_	23	nmod	_	_
27	.	.	.	.	_	12	punct	_	_

1	Recent	recent	JJ	JJ	_	2	amod	_	_
2	evidence	evidence	NN	NN	_	3	nsubj	_	_
3	suggests	suggest	VBZ	VBZ	_	0	root	_	_
4	a	a	DT	DT	_	5	det	_	_
5	role	role	NN	NN	_	3	dobj	_	_
6	for	for	IN	IN	_	8	case	_	_
7	oxidant	oxidant	JJ	JJ	_	8	amod	_	_
8	stress	stress	NN	NN	_	5	nmod	_	_
9	in	in	IN	IN	_	12	case	_	_
10	the	the	DT	DT	_	12	det	_	_
11	signalling	signalling	NN	NN	_	12	compound	_	_
12	pathway	pathway	NN	NN	_	8	nmod	_	_
13	of	of	IN	IN	_	16	case	_	_
14	various	various	JJ	JJ	_	16	amod	_	_
15	cell	cell	NN	NN	_	16	compound	_	_
16	types	type	NNS	NNS	_	12	nmod	_	_
17	by	by	IN	IN	_	18	case	_	_
18	virtue	virtue	NN	NN	_	3	nmod	_	_
19	of	of	IN	IN	_	21	case	_	_
20	its	its	PRP$	PRP$	_	21	nmod:poss	_	_
21	ability	ability	NN	NN	_	18	nmod	_	_
22	to	to	TO	TO	_	23	mark	_	_
23	induce	induce	VB	VB	_	21	acl	_	_
24	DNA	dna	NN	NN	_	25	compound	_	_
25	binding	binding	NN	NN	_	23	dobj	_	_
26	of	of	IN	IN	_	29	case	_	_
27	various	various	JJ	JJ	_	29	amod	_	_
28	transcription	transcription	NN	NN	_	29	compound	_	_
29	factors	factor	NNS	NNS	_	25	nmod	_	_
30	,	,	,	,	_	29	punct	_	_
31	including	include	VBG	VBG	_	35	case	_	_
32	nuclear	nuclear	JJ	JJ	_	35	amod	_	_
33	factor	factor	NN	NN	_	35	compound	_	_
34	kappa	kappa	NN	NN	_	35	compound	_	_
35	B	b	NN	NN	_	29	nmod	_	_
36	and	and	CC	CC	_	35	cc	_	_
37	AP-1	ap-1	NN	NN	_	35	conj	_	_
38	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	effect	effect	NN	NN	_	15	nsubjpass	_	_
3	of	of	IN	IN	_	5	case	_	_
4	antioxidant	antioxidant	JJ	JJ	_	5	amod	_	_
5	treatment	treatment	NN	NN	_	2	nmod	_	_
6	on	on	IN	IN	_	13	case	_	_
7	lipopolysaccharide	lipopolysaccharide	NN	NN	_	13	compound	_	_
8	(	(	-LRB-	-LRB-	_	13	punct	_	_
9	LPS	lps	NN	NN	_	13	compound	_	_
10	)	)	-RRB-	-RRB-	_	13	punct	_	_
11	-induced	-induced	JJ	JJ	_	13	amod	_	_
12	TF	tf	NN	NN	_	13	compound	_	_
13	expression	expression	NN	NN	_	2	nmod	_	_
14	was	be	VBD	VBD	_	15	auxpass	_	_
15	examined	examine	VBN	VBN	_	0	root	_	_
16	in	in	IN	IN	_	19	case	_	_
17	murine	murine	NN	NN	_	19	compound	_	_
18	peritoneal	peritoneal	JJ	JJ	_	19	amod	_	_
19	macrophages	macrophage	NNS	NNS	_	15	nmod	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	human	human	JJ	JJ	_	22	amod	_	_
22	monocytes	monocyte	NNS	NNS	_	19	conj	_	_
23	.	.	.	.	_	15	punct	_	_

1	Both	both	CC	CC	_	3	cc:preconj	_	_
2	pyrrolidine	pyrrolidine	NN	NN	_	3	compound	_	_
3	dithiocarbamate	dithiocarbamate	NN	NN	_	20	nsubj	_	_
4	,	,	,	,	_	3	punct	_	_
5	an	a	DT	DT	_	7	det	_	_
6	oxidant	oxidant	JJ	JJ	_	7	amod	_	_
7	scavenger	scavenger	NN	NN	_	3	appos	_	_
8	,	,	,	,	_	3	punct	_	_
9	and	and	CC	CC	_	3	cc	_	_
10	N-acetyl-cysteine	n-acetyl-cysteine	NN	NN	_	3	conj	_	_
11	,	,	,	,	_	10	punct	_	_
12	a	a	DT	DT	_	13	det	_	_
13	precursor	precursor	NN	NN	_	10	appos	_	_
14	of	of	IN	IN	_	17	case	_	_
15	the	the	DT	DT	_	17	det	_	_
16	endogenous	endogenous	JJ	JJ	_	17	amod	_	_
17	antioxidant	antioxidant	JJ	JJ	_	13	nmod	_	_
18	glutathione	glutathione	NN	NN	_	17	dep	_	_
19	,	,	,	,	_	3	punct	_	_
20	inhibited	inhibit	VBD	VBD	_	0	root	_	_
21	stimulation	stimulation	NN	NN	_	20	dobj	_	_
22	of	of	IN	IN	_	25	case	_	_
23	macrophage	macrophage	NN	NN	_	25	compound	_	_
24	procoagulant	procoagulant	NN	NN	_	25	compound	_	_
25	activity	activity	NN	NN	_	21	nmod	_	_
26	by	by	IN	IN	_	27	case	_	_
27	LPS	lps	NN	NN	_	21	nmod	_	_
28	.	.	.	.	_	20	punct	_	_

1	Northern	northern	NN	NN	_	3	compound	_	_
2	blot	blot	NN	NN	_	3	compound	_	_
3	analysis	analysis	NN	NN	_	4	nsubj	_	_
4	showed	show	VBD	VBD	_	0	root	_	_
5	that	that	IN	IN	_	10	mark	_	_
6	neither	neither	DT	DT	_	10	nsubj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	these	these	DT	DT	_	9	det	_	_
9	agents	agent	NNS	NNS	_	6	nmod	_	_
10	reduced	reduce	VBD	VBD	_	4	ccomp	_	_
11	LPS-stimulated	lps-stimulated	JJ	JJ	_	14	amod	_	_
12	TF	tf	NN	NN	_	14	compound	_	_
13	mRNA	mrna	NN	NN	_	14	compound	_	_
14	accumulation	accumulation	NN	NN	_	10	dobj	_	_
15	,	,	,	,	_	4	punct	_	_
16	thereby	thereby	RB	RB	_	17	advmod	_	_
17	suggesting	suggest	VBG	VBG	_	4	xcomp	_	_
18	a	a	DT	DT	_	20	det	_	_
19	posttranscriptional	posttranscriptional	JJ	JJ	_	20	amod	_	_
20	mechanism	mechanism	NN	NN	_	17	dobj	_	_
21	for	for	IN	IN	_	23	case	_	_
22	the	the	DT	DT	_	23	det	_	_
23	effect	effect	NN	NN	_	20	nmod	_	_
24	.	.	.	.	_	4	punct	_	_

1	Immunofluorescence	immunofluorescence	NN	NN	_	2	compound	_	_
2	studies	study	NNS	NNS	_	10	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	human	human	JJ	JJ	_	5	amod	_	_
5	monocytes	monocyte	NNS	NNS	_	2	nmod	_	_
6	using	use	VBG	VBG	_	2	acl	_	_
7	polyclonal	polyclonal	JJ	JJ	_	9	amod	_	_
8	anti-TF	anti-tf	JJ	JJ	_	9	amod	_	_
9	antibody	antibody	NN	NN	_	6	dobj	_	_
10	showed	show	VBD	VBD	_	0	root	_	_
11	that	that	IN	IN	_	14	mark	_	_
12	N-acetyl-cysteine	n-acetyl-cysteine	NN	NN	_	13	compound	_	_
13	treatment	treatment	NN	NN	_	14	nsubj	_	_
14	prevented	prevent	VBD	VBD	_	10	ccomp	_	_
15	the	the	DT	DT	_	18	det	_	_
16	characteristic	characteristic	JJ	JJ	_	18	amod	_	_
17	plasmalemmal	plasmalemmal	JJ	JJ	_	18	amod	_	_
18	localization	localization	NN	NN	_	14	dobj	_	_
19	of	of	IN	IN	_	21	case	_	_
20	TF	tf	NN	NN	_	21	compound	_	_
21	antigen	antigen	NN	NN	_	18	nmod	_	_
22	that	that	WDT	WDT	_	23	nsubj	_	_
23	occurs	occur	VBZ	VBZ	_	18	acl:relcl	_	_
24	in	in	IN	IN	_	25	case	_	_
25	response	response	NN	NN	_	23	nmod	_	_
26	to	to	TO	TO	_	27	case	_	_
27	LPS	lps	NN	NN	_	25	nmod	_	_
28	.	.	.	.	_	10	punct	_	_

1	Western	western	NN	NN	_	3	compound	_	_
2	blot	blot	NN	NN	_	3	compound	_	_
3	analysis	analysis	NN	NN	_	4	nsubj	_	_
4	showed	show	VBD	VBD	_	0	root	_	_
5	that	that	IN	IN	_	7	mark	_	_
6	N-acetyl-cysteine	n-acetyl-cysteine	NN	NN	_	7	nsubj	_	_
7	reduced	reduce	VBD	VBD	_	4	ccomp	_	_
8	the	the	DT	DT	_	9	det	_	_
9	accumulation	accumulation	NN	NN	_	7	dobj	_	_
10	of	of	IN	IN	_	14	case	_	_
11	the	the	DT	DT	_	14	det	_	_
12	47-kD	47-kd	JJ	JJ	_	14	amod	_	_
13	mature	mature	JJ	JJ	_	14	amod	_	_
14	glycoprotein	glycoprotein	NN	NN	_	9	nmod	_	_
15	in	in	IN	IN	_	17	case	_	_
16	LPS-treated	lps-treated	JJ	JJ	_	17	amod	_	_
17	cells	cell	NNS	NNS	_	9	nmod	_	_
18	,	,	,	,	_	4	punct	_	_
19	a	a	DT	DT	_	20	det	_	_
20	finding	finding	NN	NN	_	4	dep	_	_
21	consistent	consistent	JJ	JJ	_	20	amod	_	_
22	with	with	IN	IN	_	24	case	_	_
23	the	the	DT	DT	_	24	det	_	_
24	results	result	NNS	NNS	_	21	nmod	_	_
25	of	of	IN	IN	_	28	case	_	_
26	the	the	DT	DT	_	28	det	_	_
27	immunofluorescence	immunofluorescence	NN	NN	_	28	compound	_	_
28	studies	study	NNS	NNS	_	24	nmod	_	_
29	.	.	.	.	_	4	punct	_	_

1	Furthermore	furthermore	RB	RB	_	7	advmod	_	_
2	,	,	,	,	_	7	punct	_	_
3	these	these	DT	DT	_	4	det	_	_
4	conditions	condition	NNS	NNS	_	7	nsubj	_	_
5	did	do	VBD	VBD	_	7	aux	_	_
6	not	not	RB	RB	_	7	neg	_	_
7	result	result	VB	VB	_	0	root	_	_
8	in	in	IN	IN	_	10	case	_	_
9	an	a	DT	DT	_	10	det	_	_
10	accumulation	accumulation	NN	NN	_	7	nmod	_	_
11	of	of	IN	IN	_	15	case	_	_
12	the	the	DT	DT	_	15	det	_	_
13	less	less	RBR	RBR	_	14	advmod	_	_
14	mature	mature	JJ	JJ	_	15	amod	_	_
15	forms	form	NNS	NNS	_	10	nmod	_	_
16	of	of	IN	IN	_	17	case	_	_
17	TF	tf	NN	NN	_	15	nmod	_	_
18	.	.	.	.	_	7	punct	_	_

1	When	when	WRB	WRB	_	2	advmod	_	_
2	considered	consider	VBN	VBN	_	7	advcl	_	_
3	together	together	RB	RB	_	2	advmod	_	_
4	,	,	,	,	_	7	punct	_	_
5	these	these	DT	DT	_	6	det	_	_
6	data	datum	NNS	NNS	_	7	nsubj	_	_
7	suggest	suggest	VBP	VBP	_	0	root	_	_
8	that	that	IN	IN	_	10	mark	_	_
9	antioxidants	antioxidant	NNS	NNS	_	10	nsubj	_	_
10	exert	exert	VBP	VBP	_	7	ccomp	_	_
11	their	they	PRP$	PRP$	_	12	nmod:poss	_	_
12	effects	effect	NNS	NNS	_	10	dobj	_	_
13	by	by	IN	IN	_	14	mark	_	_
14	impairing	impair	VBG	VBG	_	10	dep	_	_
15	translation	translation	NN	NN	_	14	dobj	_	_
16	and/or	and/or	CC	CC	_	14	cc	_	_
17	by	by	IN	IN	_	18	mark	_	_
18	causing	cause	VBG	VBG	_	14	conj	_	_
19	degradation	degradation	NN	NN	_	18	dobj	_	_
20	of	of	IN	IN	_	23	case	_	_
21	newly	newly	RB	RB	_	23	advmod	_	_
22	translated	translate	VBN	VBN	_	23	amod	_	_
23	protein	protein	NN	NN	_	19	nmod	_	_
24	.	.	.	.	_	7	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	effect	effect	NN	NN	_	9	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	antioxidants	antioxidant	NNS	NNS	_	2	nmod	_	_
5	on	on	IN	IN	_	8	case	_	_
6	tumor	tumor	NN	NN	_	8	compound	_	_
7	necrosis	necrosis	NN	NN	_	8	compound	_	_
8	factor	factor	NN	NN	_	2	nmod	_	_
9	appeared	appear	VBD	VBD	_	0	root	_	_
10	to	to	TO	TO	_	13	mark	_	_
11	be	be	VB	VB	_	13	cop	_	_
12	species	species	NNS	NNS	_	13	dep	_	_
13	specific	specific	JJ	JJ	_	9	xcomp	_	_
14	,	,	,	,	_	13	punct	_	_
15	with	with	IN	IN	_	17	case	_	_
16	no	no	DT	DT	_	17	neg	_	_
17	effect	effect	NN	NN	_	13	nmod	_	_
18	on	on	IN	IN	_	22	case	_	_
19	LPS-induced	lps-induced	JJ	JJ	_	22	amod	_	_
20	tumor	tumor	NN	NN	_	22	compound	_	_
21	necrosis	necrosis	NN	NN	_	22	compound	_	_
22	factor	factor	NN	NN	_	17	nmod	_	_
23	in	in	IN	IN	_	25	case	_	_
24	murine	murine	NN	NN	_	25	compound	_	_
25	cells	cell	NNS	NNS	_	22	nmod	_	_
26	,	,	,	,	_	17	punct	_	_
27	but	but	CC	CC	_	17	cc	_	_
28	with	with	IN	IN	_	29	case	_	_
29	inhibition	inhibition	NN	NN	_	17	conj	_	_
30	in	in	IN	IN	_	32	case	_	_
31	human	human	JJ	JJ	_	32	amod	_	_
32	monocytes	monocyte	NNS	NNS	_	29	nmod	_	_
33	.	.	.	.	_	9	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	posttranscriptional	posttranscriptional	JJ	JJ	_	3	amod	_	_
3	effect	effect	NN	NN	_	10	nsubj	_	_
4	of	of	IN	IN	_	5	case	_	_
5	antioxidants	antioxidant	NNS	NNS	_	3	nmod	_	_
6	on	on	IN	IN	_	9	case	_	_
7	TF	tf	NN	NN	_	9	compound	_	_
8	expression	expression	NN	NN	_	9	compound	_	_
9	data	datum	NNS	NNS	_	3	nmod	_	_
10	suggests	suggest	VBZ	VBZ	_	0	root	_	_
11	a	a	DT	DT	_	13	det	_	_
12	novel	novel	JJ	JJ	_	13	amod	_	_
13	mechanism	mechanism	NN	NN	_	10	dobj	_	_
14	whereby	whereby	WRB	WRB	_	18	advmod	_	_
15	these	these	DT	DT	_	16	det	_	_
16	agents	agent	NNS	NNS	_	18	nsubj	_	_
17	might	might	MD	MD	_	18	aux	_	_
18	modulate	modulate	VB	VB	_	13	acl:relcl	_	_
19	monocyte/macrophage	monocyte/macrophage	NN	NN	_	20	compound	_	_
20	activation	activation	NN	NN	_	18	dobj	_	_
21	.	.	.	.	_	10	punct	_	_

1	1,25-Dihydroxyvitamin	1,25-dihydroxyvitamin	NN	NN	_	3	compound	_	_
2	D3	d3	NN	NN	_	3	compound	_	_
3	receptors	receptor	NNS	NNS	_	0	root	_	_
4	in	in	IN	IN	_	8	case	_	_
5	peripheral	peripheral	JJ	JJ	_	8	amod	_	_
6	blood	blood	NN	NN	_	8	compound	_	_
7	mononuclear	mononuclear	JJ	JJ	_	8	amod	_	_
8	cells	cell	NNS	NNS	_	3	nmod	_	_
9	from	from	IN	IN	_	10	case	_	_
10	patients	patient	NNS	NNS	_	8	nmod	_	_
11	with	with	IN	IN	_	12	case	_	_
12	primary	primary	JJ	JJ	_	10	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	secondary	secondary	JJ	JJ	_	12	conj	_	_
15	hyperparathyroidism	hyperparathyroidism	NN	NN	_	12	dep	_	_
16	.	.	.	.	_	3	punct	_	_

1	A	a	DT	DT	_	3	det	_	_
2	decreased	decrease	VBN	VBN	_	3	amod	_	_
3	number	number	NN	NN	_	12	nsubjpass	_	_
4	of	of	IN	IN	_	9	case	_	_
5	calcitriol	calcitriol	NN	NN	_	9	compound	_	_
6	(	(	-LRB-	-LRB-	_	9	punct	_	_
7	1,25(OH)2D3	1,25(oh)2d3	NN	NN	_	9	compound	_	_
8	)	)	-RRB-	-RRB-	_	9	punct	_	_
9	receptors	receptor	NNS	NNS	_	3	nmod	_	_
10	has	have	VBZ	VBZ	_	12	aux	_	_
11	been	be	VBN	VBN	_	12	auxpass	_	_
12	observed	observe	VBN	VBN	_	0	root	_	_
13	in	in	IN	IN	_	15	case	_	_
14	parathyroid	parathyroid	JJ	JJ	_	15	amod	_	_
15	glands	gland	NNS	NNS	_	12	nmod	_	_
16	of	of	IN	IN	_	18	case	_	_
17	uremic	uremic	JJ	JJ	_	18	amod	_	_
18	animals	animal	NNS	NNS	_	15	nmod	_	_
19	.	.	.	.	_	12	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	humans	human	NNS	NNS	_	13	nmod	_	_
3	,	,	,	,	_	13	punct	_	_
4	studies	study	NNS	NNS	_	13	nsubj	_	_
5	carried	carry	VBN	VBN	_	4	acl	_	_
6	out	out	RP	RP	_	5	compound:prt	_	_
7	in	in	IN	IN	_	11	case	_	_
8	surgically	surgically	RB	RB	_	9	advmod	_	_
9	removed	remove	VBN	VBN	_	11	amod	_	_
10	parathyroid	parathyroid	JJ	JJ	_	11	amod	_	_
11	glands	gland	NNS	NNS	_	5	nmod	_	_
12	have	have	VBP	VBP	_	13	aux	_	_
13	shown	show	VBN	VBN	_	0	root	_	_
14	that	that	IN	IN	_	18	mark	_	_
15	calcitriol	calcitriol	NN	NN	_	16	compound	_	_
16	binding	binding	NN	NN	_	18	nsubj	_	_
17	is	be	VBZ	VBZ	_	18	cop	_	_
18	higher	higher	JJR	JJR	_	13	ccomp	_	_
19	in	in	IN	IN	_	20	case	_	_
20	primary	primary	JJ	JJ	_	18	nmod	_	_
21	than	than	IN	IN	_	24	case	_	_
22	in	in	IN	IN	_	24	case	_	_
23	secondary	secondary	JJ	JJ	_	24	amod	_	_
24	hyperparathyroidism	hyperparathyroidism	NN	NN	_	18	nmod	_	_
25	.	.	.	.	_	13	punct	_	_

1	Since	since	IN	IN	_	8	mark	_	_
2	specific	specific	JJ	JJ	_	3	amod	_	_
3	receptors	receptor	NNS	NNS	_	8	nsubjpass	_	_
4	for	for	IN	IN	_	5	case	_	_
5	calcitriol	calcitriol	NN	NN	_	3	nmod	_	_
6	have	have	VBP	VBP	_	8	aux	_	_
7	been	be	VBN	VBN	_	8	auxpass	_	_
8	described	describe	VBN	VBN	_	20	advcl	_	_
9	in	in	IN	IN	_	13	case	_	_
10	peripheral	peripheral	JJ	JJ	_	13	amod	_	_
11	blood	blood	NN	NN	_	13	compound	_	_
12	mononuclear	mononuclear	JJ	JJ	_	13	amod	_	_
13	cells	cell	NNS	NNS	_	8	nmod	_	_
14	(	(	-LRB-	-LRB-	_	15	punct	_	_
15	PBMC	pbmc	NN	NN	_	13	appos	_	_
16	)	)	-RRB-	-RRB-	_	15	punct	_	_
17	,	,	,	,	_	20	punct	_	_
18	we	we	PRP	PRP	_	20	nsubj	_	_
19	have	have	VBP	VBP	_	20	aux	_	_
20	investigated	investigate	VBN	VBN	_	0	root	_	_
21	the	the	DT	DT	_	23	det	_	_
22	specific	specific	JJ	JJ	_	23	amod	_	_
23	uptake	uptake	NN	NN	_	20	dobj	_	_
24	of	of	IN	IN	_	26	case	_	_
25	3H-labelled	3h-labelled	JJ	JJ	_	26	amod	_	_
26	1,25(OH)2D3	1,25(oh)2d3	NN	NN	_	23	nmod	_	_
27	in	in	IN	IN	_	28	case	_	_
28	PBMC	pbmc	NN	NN	_	23	nmod	_	_
29	of	of	IN	IN	_	31	case	_	_
30	12	12	CD	CD	_	31	nummod	_	_
31	women	woman	NNS	NNS	_	28	nmod	_	_
32	with	with	IN	IN	_	34	case	_	_
33	primary	primary	JJ	JJ	_	34	amod	_	_
34	hyperparathyroidism	hyperparathyroidism	NN	NN	_	31	nmod	_	_
35	(	(	-LRB-	-LRB-	_	36	punct	_	_
36	PHP	php	NN	NN	_	34	appos	_	_
37	)	)	-RRB-	-RRB-	_	36	punct	_	_
38	,	,	,	,	_	31	punct	_	_
39	8	8	CD	CD	_	40	nummod	_	_
40	women	woman	NNS	NNS	_	31	conj	_	_
41	with	with	IN	IN	_	42	case	_	_
42	hyperparathyroidism	hyperparathyroidism	NN	NN	_	40	nmod	_	_
43	secondary	secondary	JJ	JJ	_	42	amod	_	_
44	to	to	TO	TO	_	47	case	_	_
45	chronic	chronic	JJ	JJ	_	46	amod	_	_
46	renal	renal	JJ	JJ	_	47	amod	_	_
47	failure	failure	NN	NN	_	43	nmod	_	_
48	(	(	-LRB-	-LRB-	_	49	punct	_	_
49	SH	sh	NN	NN	_	42	appos	_	_
50	)	)	-RRB-	-RRB-	_	49	punct	_	_
51	,	,	,	,	_	31	punct	_	_
52	9	9	CD	CD	_	53	nummod	_	_
53	women	woman	NNS	NNS	_	31	conj	_	_
54	with	with	IN	IN	_	56	case	_	_
55	renal	renal	JJ	JJ	_	56	amod	_	_
56	transplant	transplant	NN	NN	_	53	nmod	_	_
57	(	(	-LRB-	-LRB-	_	58	punct	_	_
58	RT	rt	NN	NN	_	56	appos	_	_
59	)	)	-RRB-	-RRB-	_	58	punct	_	_
60	,	,	,	,	_	31	punct	_	_
61	and	and	CC	CC	_	31	cc	_	_
62	23	23	CD	CD	_	64	nummod	_	_
63	healthy	healthy	JJ	JJ	_	64	amod	_	_
64	women	woman	NNS	NNS	_	31	conj	_	_
65	.	.	.	.	_	20	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	median	median	JJ	JJ	_	4	amod	_	_
3	dissociation	dissociation	NN	NN	_	4	compound	_	_
4	constant	constant	NN	NN	_	9	nsubj	_	_
5	(	(	-LRB-	-LRB-	_	6	punct	_	_
6	Kd	kd	NN	NN	_	4	appos	_	_
7	)	)	-RRB-	-RRB-	_	6	punct	_	_
8	was	be	VBD	VBD	_	9	cop	_	_
9	similar	similar	JJ	JJ	_	0	root	_	_
10	in	in	IN	IN	_	13	case	_	_
11	all	all	DT	DT	_	13	det	_	_
12	three	three	CD	CD	_	13	nummod	_	_
13	groups	group	NNS	NNS	_	9	nmod	_	_
14	of	of	IN	IN	_	15	case	_	_
15	patients	patient	NNS	NNS	_	13	nmod	_	_
16	and	and	CC	CC	_	13	cc	_	_
17	in	in	IN	IN	_	19	case	_	_
18	healthy	healthy	JJ	JJ	_	19	amod	_	_
19	women	woman	NNS	NNS	_	13	conj	_	_
20	(	(	-LRB-	-LRB-	_	21	punct	_	_
21	mean	mean	NN	NN	_	9	dep	_	_
22	+/-	+/-	CC	CC	_	21	cc	_	_
23	S.D.	s.d.	NN	NN	_	21	conj	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	range	range	NN	NN	_	21	appos	_	_
26	)	)	-RRB-	-RRB-	_	25	punct	_	_
27	:	:	:	:	_	21	punct	_	_
28	PHP	php	NN	NN	_	21	dep	_	_
29	,	,	,	,	_	28	punct	_	_
30	1.2	1.2	CD	CD	_	28	appos	_	_
31	+/-	+/-	CC	CC	_	30	cc	_	_
32	1.0	1.0	CD	CD	_	30	conj	_	_
33	(	(	-LRB-	-LRB-	_	34	punct	_	_
34	0.2-4	0.2-4	CD	CD	_	30	appos	_	_
35	)	)	-RRB-	-RRB-	_	34	punct	_	_
36	x	x	CC	CC	_	30	cc	_	_
37	10(-10)	10(-10)	CD	CD	_	38	nummod	_	_
38	M	m	NN	NN	_	30	conj	_	_
39	;	;	:	:	_	28	punct	_	_
40	SH	sh	NN	NN	_	28	dep	_	_
41	,	,	,	,	_	40	punct	_	_
42	0.6	0.6	CD	CD	_	40	appos	_	_
43	+/-	+/-	CC	CC	_	42	cc	_	_
44	0.4	0.4	CD	CD	_	42	conj	_	_
45	(	(	-LRB-	-LRB-	_	46	punct	_	_
46	0.2-1.2	0.2-1.2	CD	CD	_	42	appos	_	_
47	)	)	-RRB-	-RRB-	_	46	punct	_	_
48	x	x	CC	CC	_	42	cc	_	_
49	10(-10)	10(-10)	CD	CD	_	50	nummod	_	_
50	M	m	NN	NN	_	42	conj	_	_
51	;	;	:	:	_	28	punct	_	_
52	RT	rt	NN	NN	_	28	dep	_	_
53	,	,	,	,	_	52	punct	_	_
54	1.1	1.1	CD	CD	_	52	appos	_	_
55	+/-	+/-	CC	CC	_	54	cc	_	_
56	0.5	0.5	CD	CD	_	54	conj	_	_
57	(	(	-LRB-	-LRB-	_	58	punct	_	_
58	0.4-1.9	0.4-1.9	CD	CD	_	54	appos	_	_
59	)	)	-RRB-	-RRB-	_	58	punct	_	_
60	x	x	CC	CC	_	54	cc	_	_
61	10(-10)	10(-10)	CD	CD	_	62	nummod	_	_
62	M	m	NN	NN	_	54	conj	_	_
63	;	;	:	:	_	21	punct	_	_
64	controls	control	NNS	NNS	_	21	dep	_	_
65	,	,	,	,	_	64	punct	_	_
66	1.0	1.0	CD	CD	_	64	appos	_	_
67	+/-	+/-	CC	CC	_	66	cc	_	_
68	0.6	0.6	CD	CD	_	66	conj	_	_
69	(	(	-LRB-	-LRB-	_	70	punct	_	_
70	0.3-2.6	0.3-2.6	CD	CD	_	66	appos	_	_
71	)	)	-RRB-	-RRB-	_	70	punct	_	_
72	x	x	CC	CC	_	66	cc	_	_
73	10(-10)	10(-10)	CD	CD	_	74	nummod	_	_
74	M	m	NN	NN	_	66	conj	_	_
75	)	)	-RRB-	-RRB-	_	21	punct	_	_
76	.	.	.	.	_	9	punct	_	_

1	However	however	RB	RB	_	12	advmod	_	_
2	,	,	,	,	_	12	punct	_	_
3	the	the	DT	DT	_	6	det	_	_
4	maximal	maximal	JJ	JJ	_	6	amod	_	_
5	binding	binding	NN	NN	_	6	compound	_	_
6	capacity	capacity	NN	NN	_	12	nsubjpass	_	_
7	(	(	-LRB-	-LRB-	_	8	punct	_	_
8	Nmax	nmax	NN	NN	_	6	appos	_	_
9	)	)	-RRB-	-RRB-	_	8	punct	_	_
10	was	be	VBD	VBD	_	12	auxpass	_	_
11	significantly	significantly	RB	RB	_	12	advmod	_	_
12	enhanced	enhance	VBN	VBN	_	0	root	_	_
13	in	in	IN	IN	_	14	case	_	_
14	PHP	php	NN	NN	_	12	nmod	_	_
15	(	(	-LRB-	-LRB-	_	23	punct	_	_
16	3.9	3.9	CD	CD	_	23	compound	_	_
17	+/-	+/-	CC	CC	_	16	cc	_	_
18	1.9	1.9	CD	CD	_	16	conj	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	1.3-7.6	1.3-7.6	CD	CD	_	16	appos	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	fmol/10(7)	fmol/10(7)	NN	NN	_	23	compound	_	_
23	cells	cell	NNS	NNS	_	12	dep	_	_
24	vs.	vs.	CC	CC	_	23	cc	_	_
25	2.3	2.3	CD	CD	_	32	compound	_	_
26	+/-	+/-	CC	CC	_	25	cc	_	_
27	0.9	0.9	CD	CD	_	25	conj	_	_
28	(	(	-LRB-	-LRB-	_	29	punct	_	_
29	1.1-4.4	1.1-4.4	CD	CD	_	25	appos	_	_
30	)	)	-RRB-	-RRB-	_	29	punct	_	_
31	fmol/10(7)	fmol/10(7)	NN	NN	_	32	compound	_	_
32	cells	cell	NNS	NNS	_	23	conj	_	_
33	in	in	IN	IN	_	34	case	_	_
34	controls	control	NNS	NNS	_	23	nmod	_	_
35	;	;	:	:	_	23	punct	_	_
36	P	p	NN	NN	_	23	dep	_	_
37	=	=	JJ	JJ	_	36	amod	_	_
38	0.0006	0.0006	CD	CD	_	37	dep	_	_
39	)	)	-RRB-	-RRB-	_	23	punct	_	_
40	and	and	CC	CC	_	12	cc	_	_
41	decreased	decrease	VBN	VBN	_	12	conj	_	_
42	in	in	IN	IN	_	43	case	_	_
43	SH	sh	NN	NN	_	41	nmod	_	_
44	(	(	-LRB-	-LRB-	_	52	punct	_	_
45	0.8	0.8	CD	CD	_	52	compound	_	_
46	+/-	+/-	CC	CC	_	45	cc	_	_
47	0.5	0.5	CD	CD	_	45	conj	_	_
48	(	(	-LRB-	-LRB-	_	49	punct	_	_
49	0.2-1.6	0.2-1.6	CD	CD	_	45	appos	_	_
50	)	)	-RRB-	-RRB-	_	49	punct	_	_
51	fmol/10(7)	fmol/10(7)	NN	NN	_	52	compound	_	_
52	cells	cell	NNS	NNS	_	41	dep	_	_
53	vs.	vs.	CC	CC	_	52	cc	_	_
54	2.3	2.3	CD	CD	_	61	compound	_	_
55	+/-	+/-	CC	CC	_	54	cc	_	_
56	0.9	0.9	CD	CD	_	54	conj	_	_
57	(	(	-LRB-	-LRB-	_	58	punct	_	_
58	1.1-4.4	1.1-4.4	CD	CD	_	54	appos	_	_
59	)	)	-RRB-	-RRB-	_	58	punct	_	_
60	fmol/10(7)	fmol/10(7)	NN	NN	_	61	compound	_	_
61	cells	cell	NNS	NNS	_	52	conj	_	_
62	in	in	IN	IN	_	63	case	_	_
63	controls	control	NNS	NNS	_	52	nmod	_	_
64	;	;	:	:	_	52	punct	_	_
65	P	p	NN	NN	_	52	dep	_	_
66	=	=	JJ	JJ	_	65	amod	_	_
67	0.0001	0.0001	CD	CD	_	66	dep	_	_
68	)	)	-RRB-	-RRB-	_	52	punct	_	_
69	,	,	,	,	_	12	punct	_	_
70	whereas	whereas	IN	IN	_	74	mark	_	_
71	no	no	DT	DT	_	72	neg	_	_
72	changes	change	NNS	NNS	_	74	nsubjpass	_	_
73	were	be	VBD	VBD	_	74	auxpass	_	_
74	seen	see	VBN	VBN	_	12	advcl	_	_
75	in	in	IN	IN	_	76	case	_	_
76	RT	rt	NN	NN	_	74	nmod	_	_
77	(	(	-LRB-	-LRB-	_	85	punct	_	_
78	2.3	2.3	CD	CD	_	85	compound	_	_
79	+/-	+/-	CC	CC	_	78	cc	_	_
80	0.7	0.7	CD	CD	_	78	conj	_	_
81	(	(	-LRB-	-LRB-	_	82	punct	_	_
82	1.2-3.3	1.2-3.3	CD	CD	_	78	appos	_	_
83	)	)	-RRB-	-RRB-	_	82	punct	_	_
84	fmol/10(7)	fmol/10(7)	NN	NN	_	85	compound	_	_
85	cells	cell	NNS	NNS	_	76	dep	_	_
86	vs.	vs.	CC	CC	_	85	cc	_	_
87	2.3	2.3	CD	CD	_	94	compound	_	_
88	+/-	+/-	CC	CC	_	87	cc	_	_
89	0.9	0.9	CD	CD	_	87	conj	_	_
90	(	(	-LRB-	-LRB-	_	91	punct	_	_
91	1.1-4.4	1.1-4.4	CD	CD	_	87	appos	_	_
92	)	)	-RRB-	-RRB-	_	91	punct	_	_
93	fmol/10(7)	fmol/10(7)	NN	NN	_	94	compound	_	_
94	cells	cell	NNS	NNS	_	85	conj	_	_
95	in	in	IN	IN	_	96	case	_	_
96	controls	control	NNS	NNS	_	85	nmod	_	_
97	)	)	-RRB-	-RRB-	_	85	punct	_	_
98	.	.	.	.	_	12	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	three	three	CD	CD	_	3	nummod	_	_
3	patients	patient	NNS	NNS	_	15	nmod	_	_
4	with	with	IN	IN	_	5	case	_	_
5	PHP	php	NN	NN	_	3	nmod	_	_
6	who	who	WP	WP	_	8	nsubjpass	_	_
7	were	be	VBD	VBD	_	8	auxpass	_	_
8	subjected	subject	VBN	VBN	_	3	acl:relcl	_	_
9	to	to	TO	TO	_	10	case	_	_
10	parathyroidectomy	parathyroidectomy	NN	NN	_	8	nmod	_	_
11	,	,	,	,	_	15	punct	_	_
12	the	the	DT	DT	_	14	det	_	_
13	calcitriol	calcitriol	NN	NN	_	14	compound	_	_
14	number	number	NN	NN	_	15	nsubj	_	_
15	came	come	VBD	VBD	_	0	root	_	_
16	down	down	RB	RB	_	15	compound:prt	_	_
17	to	to	TO	TO	_	18	case	_	_
18	normal	normal	JJ	JJ	_	15	advcl	_	_
19	.	.	.	.	_	15	punct	_	_

1	Changes	change	NNS	NNS	_	11	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	calcitriol	calcitriol	NN	NN	_	4	compound	_	_
4	receptors	receptor	NNS	NNS	_	1	nmod	_	_
5	in	in	IN	IN	_	6	case	_	_
6	primary	primary	JJ	JJ	_	1	nmod	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	secondary	secondary	JJ	JJ	_	6	conj	_	_
9	hyperparathyroidism	hyperparathyroidism	NN	NN	_	6	dep	_	_
10	could	could	MD	MD	_	11	aux	_	_
11	magnify	magnify	VB	VB	_	0	root	_	_
12	the	the	DT	DT	_	13	det	_	_
13	consequences	consequence	NNS	NNS	_	11	dobj	_	_
14	of	of	IN	IN	_	15	case	_	_
15	disturbances	disturbance	NNS	NNS	_	13	nmod	_	_
16	in	in	IN	IN	_	18	case	_	_
17	serum	serum	NN	NN	_	18	compound	_	_
18	concentration	concentration	NN	NN	_	15	nmod	_	_
19	of	of	IN	IN	_	20	case	_	_
20	calcitriol	calcitriol	NN	NN	_	18	nmod	_	_
21	itself	itself	PRP	PRP	_	20	nmod:npmod	_	_
22	and	and	CC	CC	_	11	cc	_	_
23	might	might	MD	MD	_	24	aux	_	_
24	play	play	VB	VB	_	11	conj	_	_
25	an	a	DT	DT	_	27	det	_	_
26	important	important	JJ	JJ	_	27	amod	_	_
27	role	role	NN	NN	_	24	dobj	_	_
28	in	in	IN	IN	_	30	case	_	_
29	the	the	DT	DT	_	30	det	_	_
30	development	development	NN	NN	_	24	nmod	_	_
31	of	of	IN	IN	_	33	case	_	_
32	secondary	secondary	JJ	JJ	_	33	amod	_	_
33	hyperparathyroidism	hyperparathyroidism	NN	NN	_	30	nmod	_	_
34	in	in	IN	IN	_	35	case	_	_
35	uremia	uremia	NN	NN	_	33	nmod	_	_
36	.	.	.	.	_	11	punct	_	_

1	Effects	effect	NNS	NNS	_	0	root	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	antisense	antisense	JJ	JJ	_	6	amod	_	_
5	myb	myb	NN	NN	_	6	compound	_	_
6	expression	expression	NN	NN	_	1	nmod	_	_
7	on	on	IN	IN	_	8	case	_	_
8	hemin-	hemin-	NN	NN	_	1	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	erythropoietin-induced	erythropoietin-induced	JJ	JJ	_	12	amod	_	_
11	erythroid	erythroid	JJ	JJ	_	12	amod	_	_
12	differentiation	differentiation	NN	NN	_	8	conj	_	_
13	of	of	IN	IN	_	15	case	_	_
14	K562	k562	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	8	nmod	_	_
16	.	.	.	.	_	1	punct	_	_

1	In	in	IN	IN	_	4	mark	_	_
2	order	order	NN	NN	_	1	mwe	_	_
3	to	to	TO	TO	_	4	mark	_	_
4	elucidate	elucidate	VB	VB	_	29	advcl	_	_
5	the	the	DT	DT	_	6	det	_	_
6	role	role	NN	NN	_	4	dobj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	c-myb	c-myb	NN	NN	_	9	compound	_	_
9	gene	gene	NN	NN	_	6	nmod	_	_
10	in	in	IN	IN	_	12	case	_	_
11	erythroid	erythroid	JJ	JJ	_	12	amod	_	_
12	differentiation	differentiation	NN	NN	_	6	nmod	_	_
13	of	of	IN	IN	_	15	case	_	_
14	K562	k562	NN	NN	_	15	compound	_	_
15	cell	cell	NN	NN	_	12	nmod	_	_
16	induced	induce	VBN	VBN	_	12	acl	_	_
17	by	by	IN	IN	_	18	case	_	_
18	hemin	hemin	NN	NN	_	16	nmod	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	Hm	hm	NN	NN	_	18	appos	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	and	and	CC	CC	_	18	cc	_	_
23	erythropoietin	erythropoietin	NN	NN	_	18	conj	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	Epo	epo	NN	NN	_	23	appos	_	_
26	)	)	-RRB-	-RRB-	_	25	punct	_	_
27	,	,	,	,	_	29	punct	_	_
28	we	we	PRP	PRP	_	29	nsubj	_	_
29	constructed	construct	VBD	VBD	_	0	root	_	_
30	recombinant	recombinant	JJ	JJ	_	31	amod	_	_
31	plasmid	plasmid	NN	NN	_	29	dobj	_	_
32	that	that	WDT	WDT	_	34	nsubj	_	_
33	could	could	MD	MD	_	34	aux	_	_
34	produce	produce	VB	VB	_	31	acl:relcl	_	_
35	antisense	antisense	JJ	JJ	_	37	amod	_	_
36	myb	myb	NN	NN	_	37	compound	_	_
37	RNA	rna	NN	NN	_	34	dobj	_	_
38	after	after	IN	IN	_	39	case	_	_
39	induction	induction	NN	NN	_	34	nmod	_	_
40	with	with	IN	IN	_	41	case	_	_
41	dexamethasone	dexamethasone	NN	NN	_	39	nmod	_	_
42	.	.	.	.	_	29	punct	_	_

1	During	during	IN	IN	_	2	case	_	_
2	treatment	treatment	NN	NN	_	9	nmod	_	_
3	with	with	IN	IN	_	4	case	_	_
4	Hm	hm	NN	NN	_	2	nmod	_	_
5	,	,	,	,	_	9	punct	_	_
6	K562	k562	NN	NN	_	7	compound	_	_
7	cells	cell	NNS	NNS	_	9	nsubj	_	_
8	constitutively	constitutively	RB	RB	_	9	advmod	_	_
9	expressed	express	VBD	VBD	_	0	root	_	_
10	c-myb	c-myb	NN	NN	_	11	compound	_	_
11	mRNA	mrna	NN	NN	_	9	dobj	_	_
12	,	,	,	,	_	9	punct	_	_
13	and	and	CC	CC	_	9	cc	_	_
14	50	50	CD	CD	_	15	nummod	_	_
15	%	%	NN	NN	_	18	nsubj	_	_
16	of	of	IN	IN	_	17	case	_	_
17	them	they	PRP	PRP	_	15	nmod	_	_
18	began	begin	VBD	VBD	_	9	conj	_	_
19	to	to	TO	TO	_	20	mark	_	_
20	synthesize	synthesize	VB	VB	_	18	xcomp	_	_
21	hemoglobin	hemoglobin	NN	NN	_	20	dobj	_	_
22	(	(	-LRB-	-LRB-	_	23	punct	_	_
23	Hb	hb	NN	NN	_	21	appos	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	.	.	.	.	_	9	punct	_	_

1	Expression	expression	NN	NN	_	6	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	antisense	antisense	JJ	JJ	_	5	amod	_	_
4	myb	myb	NN	NN	_	5	compound	_	_
5	RNA	rna	NN	NN	_	1	nmod	_	_
6	reduced	reduce	VBD	VBD	_	0	root	_	_
7	the	the	DT	DT	_	8	det	_	_
8	amount	amount	NN	NN	_	6	dobj	_	_
9	of	of	IN	IN	_	11	case	_	_
10	c-myb	c-myb	NN	NN	_	11	compound	_	_
11	mRNA	mrna	NN	NN	_	8	nmod	_	_
12	,	,	,	,	_	6	punct	_	_
13	and	and	CC	CC	_	6	cc	_	_
14	the	the	DT	DT	_	15	det	_	_
15	percentage	percentage	NN	NN	_	20	nsubjpass	_	_
16	of	of	IN	IN	_	18	case	_	_
17	Hb-synthesizing	hb-synthesizing	JJ	JJ	_	18	amod	_	_
18	cells	cell	NNS	NNS	_	15	nmod	_	_
19	was	be	VBD	VBD	_	20	auxpass	_	_
20	decreased	decrease	VBN	VBN	_	6	conj	_	_
21	to	to	TO	TO	_	23	case	_	_
22	20	20	CD	CD	_	23	nummod	_	_
23	%	%	NN	NN	_	20	nmod	_	_
24	.	.	.	.	_	6	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	the	the	DT	DT	_	3	det	_	_
3	presence	presence	NN	NN	_	9	nmod	_	_
4	of	of	IN	IN	_	5	case	_	_
5	Epo	epo	NN	NN	_	3	nmod	_	_
6	,	,	,	,	_	9	punct	_	_
7	c-myb	c-myb	NN	NN	_	8	compound	_	_
8	mRNA	mrna	NN	NN	_	9	nsubj	_	_
9	declined	decline	VBD	VBD	_	0	root	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	20	20	CD	CD	_	12	nummod	_	_
12	%	%	NN	NN	_	16	nsubj	_	_
13	of	of	IN	IN	_	15	case	_	_
14	K562	k562	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	12	nmod	_	_
16	synthesized	synthesize	VBD	VBD	_	9	conj	_	_
17	Hb	hb	NN	NN	_	16	dobj	_	_
18	regardless	regardless	JJ	JJ	_	16	advmod	_	_
19	of	of	IN	IN	_	23	case	_	_
20	antisense	antisense	JJ	JJ	_	22	amod	_	_
21	myb	myb	NN	NN	_	22	compound	_	_
22	RNA	rna	NN	NN	_	23	compound	_	_
23	expression	expression	NN	NN	_	18	nmod	_	_
24	.	.	.	.	_	9	punct	_	_

1	It	it	PRP	PRP	_	3	nsubjpass	_	_
2	is	be	VBZ	VBZ	_	3	auxpass	_	_
3	suggested	suggest	VBN	VBN	_	0	root	_	_
4	that	that	IN	IN	_	11	mark	_	_
5	constitutive	constitutive	JJ	JJ	_	6	amod	_	_
6	expression	expression	NN	NN	_	11	nsubj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	c-myb	c-myb	NN	NN	_	9	compound	_	_
9	mRNA	mrna	NN	NN	_	6	nmod	_	_
10	is	be	VBZ	VBZ	_	11	cop	_	_
11	necessary	necessary	JJ	JJ	_	3	ccomp	_	_
12	for	for	IN	IN	_	14	case	_	_
13	Hm-induced	hm-induced	JJ	JJ	_	14	case	_	_
14	differentiation	differentiation	NN	NN	_	11	advcl	_	_
15	,	,	,	,	_	11	punct	_	_
16	and	and	CC	CC	_	11	cc	_	_
17	that	that	IN	IN	_	32	mark	_	_
18	a	a	DT	DT	_	19	det	_	_
19	decrease	decrease	NN	NN	_	32	nsubj	_	_
20	in	in	IN	IN	_	22	case	_	_
21	the	the	DT	DT	_	22	det	_	_
22	amount	amount	NN	NN	_	19	nmod	_	_
23	of	of	IN	IN	_	25	case	_	_
24	c-myb	c-myb	NN	NN	_	25	compound	_	_
25	mRNA	mrna	NN	NN	_	22	nmod	_	_
26	induced	induce	VBN	VBN	_	25	acl	_	_
27	by	by	IN	IN	_	31	case	_	_
28	antisense	antisense	JJ	JJ	_	30	amod	_	_
29	myb	myb	NN	NN	_	30	compound	_	_
30	RNA	rna	NN	NN	_	31	compound	_	_
31	expression	expression	NN	NN	_	26	nmod	_	_
32	suppresses	suppress	VBZ	VBZ	_	11	conj	_	_
33	Hm-induced	hm-induced	JJ	JJ	_	34	amod	_	_
34	differentiation	differentiation	NN	NN	_	32	dobj	_	_
35	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	amount	amount	NN	NN	_	10	nsubjpass	_	_
3	of	of	IN	IN	_	5	case	_	_
4	c-myb	c-myb	NN	NN	_	5	compound	_	_
5	mRNA	mrna	NN	NN	_	2	nmod	_	_
6	in	in	IN	IN	_	8	case	_	_
7	K562	k562	NN	NN	_	8	compound	_	_
8	cells	cell	NNS	NNS	_	5	nmod	_	_
9	was	be	VBD	VBD	_	10	auxpass	_	_
10	reduced	reduce	VBN	VBN	_	0	root	_	_
11	during	during	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	differentiation	differentiation	NN	NN	_	10	nmod	_	_
14	induced	induce	VBN	VBN	_	13	acl	_	_
15	by	by	IN	IN	_	16	case	_	_
16	Epo	epo	NN	NN	_	14	nmod	_	_
17	.	.	.	.	_	10	punct	_	_

1	Expression	expression	NN	NN	_	7	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	GATA-1	gata-1	NN	NN	_	4	compound	_	_
4	mRNA	mrna	NN	NN	_	1	nmod	_	_
5	was	be	VBD	VBD	_	7	cop	_	_
6	almost	almost	RB	RB	_	7	advmod	_	_
7	constant	constant	JJ	JJ	_	0	root	_	_
8	during	during	IN	IN	_	10	case	_	_
9	Hm-induced	hm-induced	JJ	JJ	_	10	amod	_	_
10	differentiation	differentiation	NN	NN	_	7	nmod	_	_
11	,	,	,	,	_	7	punct	_	_
12	but	but	CC	CC	_	7	cc	_	_
13	increased	increase	VBD	VBD	_	7	conj	_	_
14	during	during	IN	IN	_	16	case	_	_
15	Epo	epo	NN	NN	_	16	compound	_	_
16	treatment	treatment	NN	NN	_	13	nmod	_	_
17	.	.	.	.	_	7	punct	_	_

1	It	it	PRP	PRP	_	3	nsubjpass	_	_
2	is	be	VBZ	VBZ	_	3	auxpass	_	_
3	supposed	suppose	VBN	VBN	_	0	root	_	_
4	that	that	IN	IN	_	11	mark	_	_
5	the	the	DT	DT	_	6	det	_	_
6	mechanism	mechanism	NN	NN	_	11	nsubjpass	_	_
7	of	of	IN	IN	_	9	case	_	_
8	Hm-induced	hm-induced	JJ	JJ	_	9	amod	_	_
9	differentiation	differentiation	NN	NN	_	6	nmod	_	_
10	is	be	VBZ	VBZ	_	11	auxpass	_	_
11	distinguished	distinguish	VBN	VBN	_	3	ccomp	_	_
12	from	from	IN	IN	_	13	case	_	_
13	that	that	DT	DT	_	11	nmod	_	_
14	of	of	IN	IN	_	16	case	_	_
15	Epo-induced	epo-induced	JJ	JJ	_	16	amod	_	_
16	differentiation	differentiation	NN	NN	_	13	nmod	_	_
17	in	in	IN	IN	_	19	case	_	_
18	K562	k562	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	16	nmod	_	_
20	.	.	.	.	_	3	punct	_	_

1	Regulation	regulation	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	6	case	_	_
3	I	i	NN	NN	_	6	compound	_	_
4	kappa	kappa	NN	NN	_	6	compound	_	_
5	B	b	NN	NN	_	6	compound	_	_
6	alpha	alpha	NN	NN	_	1	nmod	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	p105	p105	NN	NN	_	6	conj	_	_
9	in	in	IN	IN	_	10	case	_	_
10	monocytes	monocyte	NNS	NNS	_	6	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	macrophages	macrophage	NNS	NNS	_	10	conj	_	_
13	persistently	persistently	RB	RB	_	14	advmod	_	_
14	infected	infect	VBN	VBN	_	10	acl	_	_
15	with	with	IN	IN	_	18	case	_	_
16	human	human	JJ	JJ	_	18	amod	_	_
17	immunodeficiency	immunodeficiency	NN	NN	_	18	compound	_	_
18	virus	virus	NN	NN	_	14	nmod	_	_
19	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	mechanisms	mechanism	NNS	NNS	_	16	nsubjpass	_	_
3	regulating	regulate	VBG	VBG	_	2	acl	_	_
4	human	human	JJ	JJ	_	6	amod	_	_
5	immunodeficiency	immunodeficiency	NN	NN	_	6	compound	_	_
6	virus	virus	NN	NN	_	10	compound	_	_
7	(	(	-LRB-	-LRB-	_	8	punct	_	_
8	HIV	hiv	NN	NN	_	6	appos	_	_
9	)	)	-RRB-	-RRB-	_	8	punct	_	_
10	persistence	persistence	NN	NN	_	3	dobj	_	_
11	in	in	IN	IN	_	13	case	_	_
12	human	human	JJ	JJ	_	13	amod	_	_
13	monocytes/macrophages	monocytes/macrophages	NNS	NNS	_	10	nmod	_	_
14	are	be	VBP	VBP	_	16	auxpass	_	_
15	partially	partially	RB	RB	_	16	advmod	_	_
16	understood	understand	VBN	VBN	_	0	root	_	_
17	.	.	.	.	_	16	punct	_	_

1	Persistent	persistent	JJ	JJ	_	3	amod	_	_
2	HIV	hiv	NN	NN	_	3	compound	_	_
3	infection	infection	NN	NN	_	8	nsubj	_	_
4	of	of	IN	IN	_	7	case	_	_
5	U937	u937	NN	NN	_	7	compound	_	_
6	monocytic	monocytic	JJ	JJ	_	7	amod	_	_
7	cells	cell	NNS	NNS	_	3	nmod	_	_
8	results	result	VBZ	VBZ	_	0	root	_	_
9	in	in	IN	IN	_	12	case	_	_
10	NF-kappa	nf-kappa	NN	NN	_	11	compound	_	_
11	B	b	NN	NN	_	12	compound	_	_
12	activation	activation	NN	NN	_	8	nmod	_	_
13	.	.	.	.	_	8	punct	_	_

1	Whether	whether	IN	IN	_	8	mark	_	_
2	virus-induced	virus-induced	JJ	JJ	_	5	amod	_	_
3	NF-kappa	nf-kappa	NN	NN	_	4	compound	_	_
4	B	b	NN	NN	_	5	compound	_	_
5	activation	activation	NN	NN	_	8	nsubj	_	_
6	is	be	VBZ	VBZ	_	8	cop	_	_
7	a	a	DT	DT	_	8	det	_	_
8	mechanism	mechanism	NN	NN	_	16	csubj	_	_
9	that	that	WDT	WDT	_	10	nsubj	_	_
10	favors	favor	VBZ	VBZ	_	8	acl:relcl	_	_
11	continuous	continuous	JJ	JJ	_	13	amod	_	_
12	viral	viral	JJ	JJ	_	13	amod	_	_
13	replication	replication	NN	NN	_	10	dobj	_	_
14	in	in	IN	IN	_	15	case	_	_
15	macrophages	macrophage	NNS	NNS	_	13	nmod	_	_
16	remains	remain	VBZ	VBZ	_	0	root	_	_
17	unknown	unknown	JJ	JJ	_	16	xcomp	_	_
18	.	.	.	.	_	16	punct	_	_

1	To	to	TO	TO	_	3	mark	_	_
2	further	further	RB	RB	_	3	advmod	_	_
3	delineate	delineate	VB	VB	_	0	root	_	_
4	the	the	DT	DT	_	6	det	_	_
5	molecular	molecular	JJ	JJ	_	6	amod	_	_
6	mechanisms	mechanism	NNS	NNS	_	3	dobj	_	_
7	involved	involve	VBN	VBN	_	6	acl	_	_
8	in	in	IN	IN	_	10	case	_	_
9	the	the	DT	DT	_	10	det	_	_
10	activation	activation	NN	NN	_	7	nmod	_	_
11	of	of	IN	IN	_	13	case	_	_
12	NF-kappa	nf-kappa	NN	NN	_	13	compound	_	_
13	B	b	NN	NN	_	10	nmod	_	_
14	in	in	IN	IN	_	16	case	_	_
15	HIV-infected	hiv-infected	JJ	JJ	_	16	amod	_	_
16	monocytes	monocyte	NNS	NNS	_	10	nmod	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	macrophages	macrophage	NNS	NNS	_	16	conj	_	_
19	,	,	,	,	_	3	punct	_	_
20	we	we	PRP	PRP	_	22	nsubj	_	_
21	have	have	VBP	VBP	_	22	aux	_	_
22	focused	focus	VBN	VBN	_	3	parataxis	_	_
23	on	on	IN	IN	_	25	case	_	_
24	the	the	DT	DT	_	25	det	_	_
25	regulation	regulation	NN	NN	_	22	nmod	_	_
26	of	of	IN	IN	_	31	case	_	_
27	the	the	DT	DT	_	31	det	_	_
28	I	i	NN	NN	_	31	compound	_	_
29	kappa	kappa	NN	NN	_	31	compound	_	_
30	B	b	NN	NN	_	31	compound	_	_
31	molecules	molecule	NNS	NNS	_	25	nmod	_	_
32	.	.	.	.	_	3	punct	_	_

1	First	first	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	show	show	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	9	mark	_	_
6	persistent	persistent	JJ	JJ	_	8	amod	_	_
7	HIV	hiv	NN	NN	_	8	compound	_	_
8	infection	infection	NN	NN	_	9	nsubj	_	_
9	results	result	VBZ	VBZ	_	4	ccomp	_	_
10	in	in	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	activation	activation	NN	NN	_	9	nmod	_	_
13	of	of	IN	IN	_	15	case	_	_
14	NF-kappa	nf-kappa	NN	NN	_	15	compound	_	_
15	B	b	NN	NN	_	12	nmod	_	_
16	not	not	RB	RB	_	17	neg	_	_
17	only	only	RB	RB	_	20	cc:preconj	_	_
18	in	in	IN	IN	_	20	case	_	_
19	monocytic	monocytic	JJ	JJ	_	20	amod	_	_
20	cells	cell	NNS	NNS	_	12	nmod	_	_
21	but	but	CC	CC	_	20	cc	_	_
22	also	also	RB	RB	_	24	advmod	_	_
23	in	in	IN	IN	_	24	case	_	_
24	macrophages	macrophage	NNS	NNS	_	20	conj	_	_
25	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	HIV-infected	hiv-infected	JJ	JJ	_	3	amod	_	_
3	cells	cell	NNS	NNS	_	12	nmod	_	_
4	,	,	,	,	_	12	punct	_	_
5	I	i	NN	NN	_	8	compound	_	_
6	kappa	kappa	NN	NN	_	8	compound	_	_
7	B	b	NN	NN	_	8	compound	_	_
8	alpha	alpha	NN	NN	_	10	compound	_	_
9	protein	protein	NN	NN	_	10	compound	_	_
10	levels	level	NNS	NNS	_	12	nsubjpass	_	_
11	are	be	VBP	VBP	_	12	auxpass	_	_
12	decreased	decrease	VBN	VBN	_	0	root	_	_
13	secondary	secondary	JJ	JJ	_	12	xcomp	_	_
14	to	to	TO	TO	_	17	case	_	_
15	enhanced	enhance	VBN	VBN	_	17	amod	_	_
16	protein	protein	NN	NN	_	17	compound	_	_
17	degradation	degradation	NN	NN	_	13	nmod	_	_
18	.	.	.	.	_	12	punct	_	_

1	This	this	DT	DT	_	2	nsubj	_	_
2	parallels	parallel	VBZ	VBZ	_	0	root	_	_
3	the	the	DT	DT	_	9	det	_	_
4	increased	increase	VBN	VBN	_	9	amod	_	_
5	I	i	NN	NN	_	8	compound	_	_
6	kappa	kappa	NN	NN	_	8	compound	_	_
7	B	b	NN	NN	_	8	compound	_	_
8	alpha	alpha	NN	NN	_	9	compound	_	_
9	synthesis	synthesis	NN	NN	_	2	dobj	_	_
10	secondary	secondary	JJ	JJ	_	9	amod	_	_
11	to	to	TO	TO	_	18	case	_	_
12	increased	increase	VBN	VBN	_	18	amod	_	_
13	I	i	NN	NN	_	16	compound	_	_
14	kappa	kappa	NN	NN	_	16	compound	_	_
15	B	b	NN	NN	_	16	compound	_	_
16	alpha	alpha	NN	NN	_	18	compound	_	_
17	gene	gene	NN	NN	_	18	compound	_	_
18	transcription	transcription	NN	NN	_	10	nmod	_	_
19	,	,	,	,	_	18	punct	_	_
20	i.e.	i.e.	FW	FW	_	18	acl	_	_
21	,	,	,	,	_	18	punct	_	_
22	increased	increase	VBN	VBN	_	23	amod	_	_
23	RNA	rna	NN	NN	_	18	appos	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	transcriptional	transcriptional	JJ	JJ	_	23	conj	_	_
26	activity	activity	NN	NN	_	23	dep	_	_
27	of	of	IN	IN	_	29	case	_	_
28	its	its	PRP$	PRP$	_	29	nmod:poss	_	_
29	promoter-enhancer	promoter-enhancer	NN	NN	_	23	nmod	_	_
30	.	.	.	.	_	2	punct	_	_

1	Another	another	DT	DT	_	2	det	_	_
2	protein	protein	NN	NN	_	13	nsubjpass	_	_
3	with	with	IN	IN	_	7	case	_	_
4	I	i	NN	NN	_	7	compound	_	_
5	kappa	kappa	NN	NN	_	7	compound	_	_
6	B	b	NN	NN	_	7	compound	_	_
7	function	function	NN	NN	_	2	nmod	_	_
8	,	,	,	,	_	2	punct	_	_
9	p105	p105	NN	NN	_	2	appos	_	_
10	,	,	,	,	_	2	punct	_	_
11	is	be	VBZ	VBZ	_	13	auxpass	_	_
12	also	also	RB	RB	_	13	advmod	_	_
13	modified	modify	VBN	VBN	_	0	root	_	_
14	in	in	IN	IN	_	16	case	_	_
15	HIV-infected	hiv-infected	JJ	JJ	_	16	amod	_	_
16	cells	cell	NNS	NNS	_	13	nmod	_	_
17	:	:	:	:	_	13	punct	_	_
18	p105	p105	NN	NN	_	25	nsubjpass	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	p50	p50	NN	NN	_	18	conj	_	_
21	steady-state	steady-state	JJ	JJ	_	23	amod	_	_
22	protein	protein	NN	NN	_	23	compound	_	_
23	levels	level	NNS	NNS	_	18	dep	_	_
24	are	be	VBP	VBP	_	25	auxpass	_	_
25	increased	increase	VBN	VBN	_	13	parataxis	_	_
26	as	as	IN	IN	_	28	case	_	_
27	a	a	DT	DT	_	28	det	_	_
28	result	result	NN	NN	_	25	nmod	_	_
29	of	of	IN	IN	_	31	case	_	_
30	increased	increase	VBN	VBN	_	31	amod	_	_
31	synthesis	synthesis	NN	NN	_	28	nmod	_	_
32	and	and	CC	CC	_	31	cc	_	_
33	proteolytic	proteolytic	JJ	JJ	_	34	amod	_	_
34	processing	processing	NN	NN	_	31	conj	_	_
35	of	of	IN	IN	_	36	case	_	_
36	p105	p105	NN	NN	_	31	nmod	_	_
37	.	.	.	.	_	13	punct	_	_

1	Transcriptional	transcriptional	JJ	JJ	_	2	amod	_	_
2	activity	activity	NN	NN	_	7	nsubjpass	_	_
3	of	of	IN	IN	_	4	case	_	_
4	p105	p105	NN	NN	_	2	nmod	_	_
5	is	be	VBZ	VBZ	_	7	auxpass	_	_
6	also	also	RB	RB	_	7	advmod	_	_
7	increased	increase	VBN	VBN	_	0	root	_	_
8	in	in	IN	IN	_	10	case	_	_
9	infected	infected	JJ	JJ	_	10	amod	_	_
10	cells	cell	NNS	NNS	_	7	nmod	_	_
11	and	and	CC	CC	_	7	cc	_	_
12	is	be	VBZ	VBZ	_	14	auxpass	_	_
13	also	also	RB	RB	_	14	advmod	_	_
14	mediated	mediate	VBN	VBN	_	7	conj	_	_
15	by	by	IN	IN	_	17	case	_	_
16	NF-kappa	nf-kappa	NN	NN	_	17	compound	_	_
17	B	b	NN	NN	_	14	nmod	_	_
18	through	through	IN	IN	_	23	case	_	_
19	a	a	DT	DT	_	23	det	_	_
20	specific	specific	JJ	JJ	_	23	amod	_	_
21	kappa	kappa	NN	NN	_	23	compound	_	_
22	B	b	NN	NN	_	23	compound	_	_
23	motif	motif	NN	NN	_	14	nmod	_	_
24	.	.	.	.	_	7	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	existence	existence	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	10	case	_	_
7	a	a	DT	DT	_	10	det	_	_
8	triple	triple	JJ	JJ	_	10	amod	_	_
9	autoregulatory	autoregulatory	JJ	JJ	_	10	amod	_	_
10	loop	loop	NN	NN	_	5	nmod	_	_
11	in	in	IN	IN	_	12	case	_	_
12	monocytes	monocyte	NNS	NNS	_	10	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	macrophages	macrophage	NNS	NNS	_	12	conj	_	_
15	involving	involve	VBG	VBG	_	10	acl	_	_
16	HIV	hiv	NN	NN	_	15	dobj	_	_
17	,	,	,	,	_	16	punct	_	_
18	p105	p105	NN	NN	_	16	conj	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	p50	p50	NN	NN	_	18	conj	_	_
21	,	,	,	,	_	16	punct	_	_
22	and	and	CC	CC	_	16	cc	_	_
23	MAD3	mad3	NN	NN	_	16	conj	_	_
24	,	,	,	,	_	5	punct	_	_
25	with	with	IN	IN	_	28	case	_	_
26	the	the	DT	DT	_	28	det	_	_
27	end	end	NN	NN	_	28	compound	_	_
28	result	result	NN	NN	_	5	nmod	_	_
29	of	of	IN	IN	_	33	case	_	_
30	persistent	persistent	JJ	JJ	_	33	amod	_	_
31	NF-kappa	nf-kappa	NN	NN	_	33	compound	_	_
32	B	b	NN	NN	_	33	compound	_	_
33	activation	activation	NN	NN	_	28	nmod	_	_
34	and	and	CC	CC	_	33	cc	_	_
35	viral	viral	JJ	JJ	_	36	amod	_	_
36	persistence	persistence	NN	NN	_	33	conj	_	_
37	.	.	.	.	_	3	punct	_	_

1	Furthermore	furthermore	RB	RB	_	10	advmod	_	_
2	,	,	,	,	_	10	punct	_	_
3	persistent	persistent	JJ	JJ	_	5	amod	_	_
4	HIV	hiv	NN	NN	_	5	compound	_	_
5	infection	infection	NN	NN	_	10	nsubj	_	_
6	of	of	IN	IN	_	7	case	_	_
7	monocytes	monocyte	NNS	NNS	_	5	nmod	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	macrophages	macrophage	NNS	NNS	_	7	conj	_	_
10	provides	provide	VBZ	VBZ	_	0	root	_	_
11	a	a	DT	DT	_	13	det	_	_
12	useful	useful	JJ	JJ	_	13	amod	_	_
13	model	model	NN	NN	_	10	dobj	_	_
14	with	with	IN	IN	_	15	case	_	_
15	which	which	WDT	WDT	_	17	nmod	_	_
16	to	to	TO	TO	_	17	mark	_	_
17	study	study	VB	VB	_	13	acl:relcl	_	_
18	concomitant	concomitant	JJ	JJ	_	19	amod	_	_
19	modifications	modification	NNS	NNS	_	17	dobj	_	_
20	of	of	IN	IN	_	25	case	_	_
21	different	different	JJ	JJ	_	25	amod	_	_
22	I	i	NN	NN	_	25	compound	_	_
23	kappa	kappa	NN	NN	_	25	compound	_	_
24	B	b	NN	NN	_	25	compound	_	_
25	molecules	molecule	NNS	NNS	_	19	nmod	_	_
26	.	.	.	.	_	10	punct	_	_

1	Detection	detection	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	9	case	_	_
3	the	the	DT	DT	_	9	det	_	_
4	chromosome	chromosome	NN	NN	_	9	compound	_	_
5	16	16	CD	CD	_	9	nummod	_	_
6	CBF	cbf	NN	NN	_	9	compound	_	_
7	beta-MYH11	beta-myh11	NN	NN	_	9	compound	_	_
8	fusion	fusion	NN	NN	_	9	compound	_	_
9	transcript	transcript	NN	NN	_	1	nmod	_	_
10	in	in	IN	IN	_	12	case	_	_
11	myelomonocytic	myelomonocytic	JJ	JJ	_	12	amod	_	_
12	leukemias	leukemia	NNS	NNS	_	1	nmod	_	_
13	.	.	.	.	_	1	punct	_	_

1	Karyotypic	karyotypic	JJ	JJ	_	2	amod	_	_
2	detection	detection	NN	NN	_	14	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	chromosomal	chromosomal	JJ	JJ	_	6	amod	_	_
5	16	16	CD	CD	_	6	nummod	_	_
6	abnormalities	abnormality	NNS	NNS	_	2	nmod	_	_
7	classically	classically	RB	RB	_	8	advmod	_	_
8	associated	associate	VBN	VBN	_	6	acl	_	_
9	with	with	IN	IN	_	11	case	_	_
10	AML	aml	NN	NN	_	11	compound	_	_
11	M4Eo	m4eo	NN	NN	_	8	nmod	_	_
12	can	can	MD	MD	_	14	aux	_	_
13	be	be	VB	VB	_	14	cop	_	_
14	difficult	difficult	JJ	JJ	_	0	root	_	_
15	.	.	.	.	_	14	punct	_	_

1	Characterization	characterization	NN	NN	_	17	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	two	two	CD	CD	_	5	nummod	_	_
5	genes	gene	NNS	NNS	_	1	nmod	_	_
6	involved	involve	VBN	VBN	_	5	acl	_	_
7	in	in	IN	IN	_	9	case	_	_
8	the	the	DT	DT	_	9	det	_	_
9	inv(16)(p13q22)	inv(16)(p13q22)	NN	NN	_	6	nmod	_	_
10	,	,	,	,	_	5	punct	_	_
11	CBF	cbf	NN	NN	_	12	compound	_	_
12	beta	beta	NN	NN	_	5	appos	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	MYH11	myh11	NN	NN	_	12	conj	_	_
15	,	,	,	,	_	1	punct	_	_
16	has	have	VBZ	VBZ	_	17	aux	_	_
17	allowed	allow	VBN	VBN	_	0	root	_	_
18	the	the	DT	DT	_	19	det	_	_
19	detection	detection	NN	NN	_	17	dobj	_	_
20	of	of	IN	IN	_	22	case	_	_
21	fusion	fusion	NN	NN	_	22	compound	_	_
22	transcripts	transcript	NNS	NNS	_	19	nmod	_	_
23	by	by	IN	IN	_	27	case	_	_
24	reverse-transcriptase	reverse-transcriptase	NN	NN	_	27	compound	_	_
25	polymerase	polymerase	NN	NN	_	27	compound	_	_
26	chain	chain	NN	NN	_	27	compound	_	_
27	reaction	reaction	NN	NN	_	19	nmod	_	_
28	(	(	-LRB-	-LRB-	_	29	punct	_	_
29	RT-PCR	rt-pcr	NN	NN	_	27	appos	_	_
30	)	)	-RRB-	-RRB-	_	29	punct	_	_
31	.	.	.	.	_	17	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	analyzed	analyze	VBN	VBN	_	0	root	_	_
4	CBF	cbf	NN	NN	_	7	compound	_	_
5	beta-MYH11	beta-myh11	NN	NN	_	7	compound	_	_
6	fusion	fusion	NN	NN	_	7	compound	_	_
7	transcripts	transcript	NNS	NNS	_	3	dobj	_	_
8	by	by	IN	IN	_	9	case	_	_
9	RT-PCR	rt-pcr	NN	NN	_	3	nmod	_	_
10	in	in	IN	IN	_	12	case	_	_
11	myelomonocytic	myelomonocytic	JJ	JJ	_	12	amod	_	_
12	leukemias	leukemia	NNS	NNS	_	3	nmod	_	_
13	,	,	,	,	_	3	punct	_	_
14	with	with	IN	IN	_	17	nmod	_	_
15	or	or	CC	CC	_	17	cc	_	_
16	without	without	IN	IN	_	17	conj	_	_
17	eosinophilia	eosinophilia	NN	NN	_	3	nmod	_	_
18	,	,	,	,	_	3	punct	_	_
19	to	to	TO	TO	_	20	mark	_	_
20	determine	determine	VB	VB	_	3	xcomp	_	_
21	whether	whether	IN	IN	_	24	mark	_	_
22	their	they	PRP$	PRP$	_	23	nmod:poss	_	_
23	presence	presence	NN	NN	_	24	nsubj	_	_
24	correlates	correlate	VBZ	VBZ	_	20	ccomp	_	_
25	with	with	IN	IN	_	26	case	_	_
26	morphology	morphology	NN	NN	_	24	nmod	_	_
27	.	.	.	.	_	3	punct	_	_

1	Fifty-three	fifty-three	CD	CD	_	2	nummod	_	_
2	cases	case	NNS	NNS	_	41	nsubjpass	_	_
3	(	(	-LRB-	-LRB-	_	4	punct	_	_
4	11	11	CD	CD	_	2	dep	_	_
5	AML	aml	NN	NN	_	6	compound	_	_
6	M4Eo	m4eo	NN	NN	_	4	dep	_	_
7	;	;	:	:	_	4	punct	_	_
8	1	1	CD	CD	_	10	nummod	_	_
9	AML	aml	NN	NN	_	10	compound	_	_
10	M4	m4	NN	NN	_	4	conj	_	_
11	with	with	IN	IN	_	14	case	_	_
12	atypical	atypical	JJ	JJ	_	14	amod	_	_
13	abnormal	abnormal	JJ	JJ	_	14	amod	_	_
14	eosinophils	eosinophil	NNS	NNS	_	10	nmod	_	_
15	(	(	-LRB-	-LRB-	_	19	punct	_	_
16	AML	aml	NN	NN	_	19	compound	_	_
17	M4	m4	NN	NN	_	19	compound	_	_
18	``	``	``	``	_	19	punct	_	_
19	Eo	eo	NN	NN	_	10	appos	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	;	;	:	:	_	4	punct	_	_
22	29	29	CD	CD	_	4	conj	_	_
23	AML	aml	NN	NN	_	24	compound	_	_
24	M4	m4	NN	NN	_	22	dep	_	_
25	;	;	:	:	_	4	punct	_	_
26	8	8	CD	CD	_	4	conj	_	_
27	AML	aml	NN	NN	_	28	compound	_	_
28	M5	m5	NN	NN	_	26	dep	_	_
29	;	;	:	:	_	4	punct	_	_
30	3	3	CD	CD	_	4	conj	_	_
31	CMML	cmml	NN	NN	_	30	dep	_	_
32	;	;	:	:	_	4	punct	_	_
33	and	and	CC	CC	_	4	cc	_	_
34	1	1	CD	CD	_	4	conj	_	_
35	AML	aml	NN	NN	_	36	compound	_	_
36	M2	m2	NN	NN	_	34	dep	_	_
37	with	with	IN	IN	_	38	case	_	_
38	eosinophilia	eosinophilia	NN	NN	_	36	nmod	_	_
39	)	)	-RRB-	-RRB-	_	4	punct	_	_
40	were	be	VBD	VBD	_	41	auxpass	_	_
41	analyzed	analyze	VBN	VBN	_	0	root	_	_
42	.	.	.	.	_	41	punct	_	_

1	All	all	DT	DT	_	5	det	_	_
2	11	11	CD	CD	_	5	nummod	_	_
3	typical	typical	JJ	JJ	_	5	amod	_	_
4	AML	aml	NN	NN	_	5	compound	_	_
5	M4Eo	m4eo	NN	NN	_	9	nsubj	_	_
6	were	be	VBD	VBD	_	9	cop	_	_
7	CBF	cbf	NN	NN	_	9	nmod:npmod	_	_
8	beta-MYH11	beta-myh11	NN	NN	_	9	nmod:npmod	_	_
9	positive	positive	JJ	JJ	_	0	root	_	_
10	.	.	.	.	_	9	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	single	single	JJ	JJ	_	3	amod	_	_
3	case	case	NN	NN	_	12	nsubj	_	_
4	of	of	IN	IN	_	6	case	_	_
5	AML	aml	NN	NN	_	6	compound	_	_
6	M4	m4	NN	NN	_	3	nmod	_	_
7	with	with	IN	IN	_	10	case	_	_
8	distinctive	distinctive	JJ	JJ	_	10	amod	_	_
9	eosinophil	eosinophil	NN	NN	_	10	compound	_	_
10	abnormalities	abnormality	NNS	NNS	_	6	nmod	_	_
11	was	be	VBD	VBD	_	12	cop	_	_
12	negative	negative	JJ	JJ	_	0	root	_	_
13	by	by	IN	IN	_	14	case	_	_
14	karyotype	karyotype	NN	NN	_	12	nmod	_	_
15	,	,	,	,	_	14	punct	_	_
16	RT-PCR	rt-pcr	NN	NN	_	14	conj	_	_
17	and	and	CC	CC	_	14	cc	_	_
18	fluorescent	fluorescent	JJ	JJ	_	21	amod	_	_
19	in	in	FW	FW	_	21	amod	_	_
20	situ	situ	FW	FW	_	19	dep	_	_
21	hybridization	hybridization	NN	NN	_	14	conj	_	_
22	(	(	-LRB-	-LRB-	_	23	punct	_	_
23	FISH	fish	NN	NN	_	21	appos	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	.	.	.	.	_	12	punct	_	_

1	Three	three	CD	CD	_	16	nsubj	_	_
2	of	of	IN	IN	_	3	case	_	_
3	29	29	CD	CD	_	1	nmod	_	_
4	(	(	-LRB-	-LRB-	_	6	punct	_	_
5	10	10	CD	CD	_	6	nummod	_	_
6	%	%	NN	NN	_	3	appos	_	_
7	)	)	-RRB-	-RRB-	_	6	punct	_	_
8	AML	aml	NN	NN	_	9	compound	_	_
9	M4	m4	NN	NN	_	3	dep	_	_
10	without	without	IN	IN	_	12	case	_	_
11	abnormal	abnormal	JJ	JJ	_	12	amod	_	_
12	eosinophils	eosinophil	NNS	NNS	_	9	nmod	_	_
13	were	be	VBD	VBD	_	16	cop	_	_
14	CBF	cbf	NN	NN	_	16	nmod:npmod	_	_
15	beta-MYH11	beta-myh11	NN	NN	_	16	nmod:npmod	_	_
16	positive	positive	JJ	JJ	_	0	root	_	_
17	,	,	,	,	_	16	punct	_	_
18	1	1	CD	CD	_	23	nsubj	_	_
19	of	of	IN	IN	_	18	acl	_	_
20	which	which	WDT	WDT	_	18	dep	_	_
21	did	do	VBD	VBD	_	23	aux	_	_
22	not	not	RB	RB	_	23	neg	_	_
23	show	show	VB	VB	_	16	dep	_	_
24	any	any	DT	DT	_	28	det	_	_
25	apparent	apparent	JJ	JJ	_	28	amod	_	_
26	chromosome	chromosome	NN	NN	_	28	compound	_	_
27	16	16	CD	CD	_	26	nummod	_	_
28	abnormalities	abnormality	NNS	NNS	_	23	dobj	_	_
29	by	by	IN	IN	_	32	case	_	_
30	classical	classical	JJ	JJ	_	32	amod	_	_
31	metaphase	metaphase	NN	NN	_	32	compound	_	_
32	analysis	analysis	NN	NN	_	23	nmod	_	_
33	(	(	-LRB-	-LRB-	_	34	punct	_	_
34	2	2	CD	CD	_	16	dep	_	_
35	not	not	RB	RB	_	36	neg	_	_
36	tested	test	VBN	VBN	_	34	acl	_	_
37	)	)	-RRB-	-RRB-	_	34	punct	_	_
38	.	.	.	.	_	16	punct	_	_

1	Both	both	DT	DT	_	2	det	_	_
2	cases	case	NNS	NNS	_	5	nsubj	_	_
3	tested	test	VBN	VBN	_	2	acl	_	_
4	also	also	RB	RB	_	5	advmod	_	_
5	showed	show	VBD	VBD	_	0	root	_	_
6	MYH11	myh11	NN	NN	_	8	compound	_	_
7	genomic	genomic	JJ	JJ	_	8	amod	_	_
8	rearrangement	rearrangement	NN	NN	_	5	dobj	_	_
9	.	.	.	.	_	5	punct	_	_

1	None	none	NN	NN	_	8	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	other	other	JJ	JJ	_	5	amod	_	_
5	leukemias	leukemia	NNS	NNS	_	1	nmod	_	_
6	were	be	VBD	VBD	_	8	cop	_	_
7	RT-PCR	rt-pcr	NN	NN	_	8	nmod:npmod	_	_
8	positive	positive	JJ	JJ	_	0	root	_	_
9	.	.	.	.	_	8	punct	_	_

1	Follow-up	follow-up	NN	NN	_	5	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	three	three	CD	CD	_	4	nummod	_	_
4	patient	patient	NN	NN	_	1	nmod	_	_
5	showed	show	VBD	VBD	_	0	root	_	_
6	residual	residual	JJ	JJ	_	7	amod	_	_
7	positivity	positivity	NN	NN	_	5	dobj	_	_
8	in	in	IN	IN	_	11	case	_	_
9	apparent	apparent	JJ	JJ	_	11	amod	_	_
10	complete	complete	JJ	JJ	_	9	dep	_	_
11	remission	remission	NN	NN	_	7	nmod	_	_
12	.	.	.	.	_	5	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	show	show	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	9	mark	_	_
5	CBF	cbf	NN	NN	_	8	compound	_	_
6	beta-MYH11	beta-myh11	NN	NN	_	8	compound	_	_
7	fusion	fusion	NN	NN	_	8	compound	_	_
8	transcripts	transcript	NNS	NNS	_	9	nsubj	_	_
9	occur	occur	VBP	VBP	_	3	ccomp	_	_
10	not	not	RB	RB	_	11	neg	_	_
11	only	only	RB	RB	_	15	cc:preconj	_	_
12	in	in	IN	IN	_	15	case	_	_
13	the	the	DT	DT	_	15	det	_	_
14	vast	vast	JJ	JJ	_	15	amod	_	_
15	majority	majority	NN	NN	_	9	nmod	_	_
16	of	of	IN	IN	_	19	case	_	_
17	typical	typical	JJ	JJ	_	19	amod	_	_
18	AML	aml	NN	NN	_	19	compound	_	_
19	M4Eo	m4eo	NN	NN	_	15	nmod	_	_
20	,	,	,	,	_	15	punct	_	_
21	but	but	CC	CC	_	15	cc	_	_
22	also	also	RB	RB	_	26	advmod	_	_
23	in	in	IN	IN	_	26	case	_	_
24	approximately	approximately	RB	RB	_	25	advmod	_	_
25	10	10	CD	CD	_	26	nummod	_	_
26	%	%	NN	NN	_	15	conj	_	_
27	of	of	IN	IN	_	29	case	_	_
28	AML	aml	NN	NN	_	29	compound	_	_
29	M4	m4	NN	NN	_	26	nmod	_	_
30	without	without	IN	IN	_	32	case	_	_
31	eosinophilic	eosinophilic	JJ	JJ	_	32	amod	_	_
32	abnormalities	abnormality	NNS	NNS	_	29	nmod	_	_
33	,	,	,	,	_	26	punct	_	_
34	a	a	DT	DT	_	37	det	_	_
35	much	much	RB	RB	_	36	advmod	_	_
36	higher	higher	JJR	JJR	_	37	amod	_	_
37	incidence	incidence	NN	NN	_	26	appos	_	_
38	than	than	IN	IN	_	50	mark	_	_
39	the	the	DT	DT	_	41	det	_	_
40	sporadic	sporadic	JJ	JJ	_	41	amod	_	_
41	reports	report	NNS	NNS	_	50	nsubj	_	_
42	of	of	IN	IN	_	45	case	_	_
43	chromosome	chromosome	NN	NN	_	45	compound	_	_
44	16	16	CD	CD	_	43	nummod	_	_
45	abnormalities	abnormality	NNS	NNS	_	41	nmod	_	_
46	in	in	IN	IN	_	48	case	_	_
47	AML	aml	NN	NN	_	48	compound	_	_
48	M4	m4	NN	NN	_	45	nmod	_	_
49	would	would	MD	MD	_	50	aux	_	_
50	suggest	suggest	VB	VB	_	37	advcl	_	_
51	.	.	.	.	_	3	punct	_	_

1	Taken	take	VBN	VBN	_	0	root	_	_
2	together	together	RB	RB	_	1	advmod	_	_
3	with	with	IN	IN	_	5	case	_	_
4	the	the	DT	DT	_	5	det	_	_
5	detection	detection	NN	NN	_	1	nmod	_	_
6	of	of	IN	IN	_	9	case	_	_
7	CBF	cbf	NN	NN	_	9	compound	_	_
8	beta-MYH11	beta-myh11	NN	NN	_	9	compound	_	_
9	transcripts	transcript	NNS	NNS	_	5	nmod	_	_
10	in	in	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	absence	absence	NN	NN	_	5	nmod	_	_
13	of	of	IN	IN	_	17	case	_	_
14	apparent	apparent	JJ	JJ	_	17	amod	_	_
15	chromosome	chromosome	NN	NN	_	17	compound	_	_
16	16	16	CD	CD	_	15	nummod	_	_
17	abnormalities	abnormality	NNS	NNS	_	12	nmod	_	_
18	by	by	IN	IN	_	21	case	_	_
19	classical	classical	JJ	JJ	_	21	amod	_	_
20	banding	banding	NN	NN	_	21	compound	_	_
21	techniques	technique	NNS	NNS	_	5	nmod	_	_
22	,	,	,	,	_	1	punct	_	_
23	these	these	DT	DT	_	24	det	_	_
24	data	datum	NNS	NNS	_	25	nsubj	_	_
25	show	show	VBP	VBP	_	1	parataxis	_	_
26	that	that	IN	IN	_	36	mark	_	_
27	additional	additional	JJ	JJ	_	28	amod	_	_
28	screening	screening	NN	NN	_	36	nsubjpass	_	_
29	by	by	IN	IN	_	31	case	_	_
30	either	either	CC	CC	_	31	cc:preconj	_	_
31	RT-PCR	rt-pcr	NN	NN	_	28	nmod	_	_
32	or	or	CC	CC	_	31	cc	_	_
33	FISH	fish	NN	NN	_	31	conj	_	_
34	should	should	MD	MD	_	36	aux	_	_
35	be	be	VB	VB	_	36	auxpass	_	_
36	performed	perform	VBN	VBN	_	25	ccomp	_	_
37	in	in	IN	IN	_	40	case	_	_
38	all	all	DT	DT	_	40	det	_	_
39	AML	aml	NN	NN	_	40	compound	_	_
40	M4	m4	NN	NN	_	36	nmod	_	_
41	,	,	,	,	_	36	punct	_	_
42	regardless	regardless	RB	RB	_	36	advmod	_	_
43	of	of	IN	IN	_	45	case	_	_
44	morphologic	morphologic	JJ	JJ	_	45	amod	_	_
45	features	feature	NNS	NNS	_	42	nmod	_	_
46	,	,	,	,	_	36	punct	_	_
47	to	to	TO	TO	_	48	mark	_	_
48	allow	allow	VB	VB	_	36	xcomp	_	_
49	accurate	accurate	JJ	JJ	_	50	amod	_	_
50	evaluation	evaluation	NN	NN	_	48	dobj	_	_
51	of	of	IN	IN	_	54	case	_	_
52	the	the	DT	DT	_	54	det	_	_
53	prognostic	prognostic	JJ	JJ	_	54	amod	_	_
54	importance	importance	NN	NN	_	50	nmod	_	_
55	of	of	IN	IN	_	58	case	_	_
56	this	this	DT	DT	_	58	det	_	_
57	fusion	fusion	NN	NN	_	58	compound	_	_
58	transcript	transcript	NN	NN	_	54	nmod	_	_
59	.	.	.	.	_	1	punct	_	_

1	OBF-1	obf-1	NN	NN	_	0	root	_	_
2	,	,	,	,	_	1	punct	_	_
3	a	a	DT	DT	_	7	det	_	_
4	novel	novel	JJ	JJ	_	7	amod	_	_
5	B	b	NN	NN	_	7	compound	_	_
6	cell-specific	cell-specific	JJ	JJ	_	7	amod	_	_
7	coactivator	coactivator	NN	NN	_	1	appos	_	_
8	that	that	WDT	WDT	_	9	nsubj	_	_
9	stimulates	stimulate	VBZ	VBZ	_	7	acl:relcl	_	_
10	immunoglobulin	immunoglobulin	NN	NN	_	11	compound	_	_
11	promoter	promoter	NN	NN	_	12	compound	_	_
12	activity	activity	NN	NN	_	9	dobj	_	_
13	through	through	IN	IN	_	14	case	_	_
14	association	association	NN	NN	_	9	nmod	_	_
15	with	with	IN	IN	_	17	case	_	_
16	octamer-binding	octamer-binding	JJ	JJ	_	17	amod	_	_
17	proteins	protein	NNS	NNS	_	14	nmod	_	_
18	.	.	.	.	_	1	punct	_	_

1	Recent	recent	JJ	JJ	_	2	amod	_	_
2	biochemical	biochemical	JJ	JJ	_	6	nsubj	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	genetic	genetic	JJ	JJ	_	2	conj	_	_
5	studies	study	NNS	NNS	_	2	dep	_	_
6	indicate	indicate	VBP	VBP	_	0	root	_	_
7	that	that	IN	IN	_	23	mark	_	_
8	in	in	IN	IN	_	9	case	_	_
9	addition	addition	NN	NN	_	23	nmod	_	_
10	to	to	TO	TO	_	13	case	_	_
11	the	the	DT	DT	_	13	det	_	_
12	octamer-binding	octamer-binding	JJ	JJ	_	13	amod	_	_
13	proteins	protein	NNS	NNS	_	9	nmod	_	_
14	Oct-1	oct-1	NN	NN	_	13	dep	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	Oct-2	oct-2	NN	NN	_	14	conj	_	_
17	,	,	,	,	_	23	punct	_	_
18	other	other	JJ	JJ	_	21	amod	_	_
19	B	b	NN	NN	_	21	compound	_	_
20	cell	cell	NN	NN	_	21	compound	_	_
21	components	component	NNS	NNS	_	23	nsubjpass	_	_
22	are	be	VBP	VBP	_	23	auxpass	_	_
23	required	require	VBN	VBN	_	6	ccomp	_	_
24	for	for	IN	IN	_	32	case	_	_
25	lymphoid-restricted	lymphoid-restricted	JJ	JJ	_	32	amod	_	_
26	,	,	,	,	_	25	punct	_	_
27	octamer	octamer	NN	NN	_	28	nmod:npmod	_	_
28	site-mediated	site-mediated	JJ	JJ	_	25	dep	_	_
29	immunoglobulin	immunoglobulin	NN	NN	_	31	compound	_	_
30	gene	gene	NN	NN	_	31	compound	_	_
31	promoter	promoter	NN	NN	_	32	compound	_	_
32	activity	activity	NN	NN	_	23	nmod	_	_
33	.	.	.	.	_	6	punct	_	_

1	Using	use	VBG	VBG	_	0	root	_	_
2	a	a	DT	DT	_	4	det	_	_
3	genetic	genetic	JJ	JJ	_	4	amod	_	_
4	screen	screen	NN	NN	_	1	dobj	_	_
5	in	in	IN	IN	_	6	case	_	_
6	yeast	yeast	NN	NN	_	4	nmod	_	_
7	,	,	,	,	_	1	punct	_	_
8	we	we	PRP	PRP	_	10	nsubj	_	_
9	have	have	VBP	VBP	_	10	aux	_	_
10	isolated	isolate	VBN	VBN	_	1	parataxis	_	_
11	B	b	NN	NN	_	13	compound	_	_
12	cell-derived	cell-derived	JJ	JJ	_	13	amod	_	_
13	cDNAs	cdna	NNS	NNS	_	10	dobj	_	_
14	encoding	encoding	JJ	JJ	_	13	dep	_	_
15	Oct-binding	oct-binding	JJ	JJ	_	16	amod	_	_
16	factor	factor	NN	NN	_	14	dobj	_	_
17	1	1	CD	CD	_	16	nummod	_	_
18	(	(	-LRB-	-LRB-	_	19	punct	_	_
19	OBF-1	obf-1	NN	NN	_	16	appos	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	,	,	,	,	_	16	punct	_	_
22	a	a	DT	DT	_	24	det	_	_
23	novel	novel	JJ	JJ	_	24	amod	_	_
24	protein	protein	NN	NN	_	16	appos	_	_
25	that	that	WDT	WDT	_	27	nsubj	_	_
26	specifically	specifically	RB	RB	_	27	advmod	_	_
27	associates	associate	VBZ	VBZ	_	24	acl:relcl	_	_
28	with	with	IN	IN	_	29	case	_	_
29	Oct-1	oct-1	NN	NN	_	27	nmod	_	_
30	and	and	CC	CC	_	29	cc	_	_
31	Oct-2	oct-2	NN	NN	_	29	conj	_	_
32	.	.	.	.	_	1	punct	_	_

1	Biochemical	biochemical	JJ	JJ	_	2	amod	_	_
2	studies	study	NNS	NNS	_	3	nsubj	_	_
3	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	6	mark	_	_
5	OBF-1	obf-1	NN	NN	_	6	nsubj	_	_
6	has	have	VBZ	VBZ	_	3	ccomp	_	_
7	no	no	DT	DT	_	10	neg	_	_
8	intrinsic	intrinsic	JJ	JJ	_	10	amod	_	_
9	DNA-binding	dna-binding	JJ	JJ	_	10	amod	_	_
10	activity	activity	NN	NN	_	6	dobj	_	_
11	and	and	CC	CC	_	6	cc	_	_
12	recognizes	recognize	VBZ	VBZ	_	6	conj	_	_
13	the	the	DT	DT	_	15	det	_	_
14	POU	pou	NN	NN	_	15	compound	_	_
15	domains	domain	NNS	NNS	_	12	dobj	_	_
16	of	of	IN	IN	_	17	case	_	_
17	Oct-1	oct-1	NN	NN	_	15	nmod	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	Oct-2	oct-2	NN	NN	_	17	conj	_	_
20	,	,	,	,	_	15	punct	_	_
21	but	but	CC	CC	_	22	cc	_	_
22	not	not	RB	RB	_	15	cc	_	_
23	those	those	DT	DT	_	15	conj	_	_
24	of	of	IN	IN	_	25	case	_	_
25	Oct-4	oct-4	NN	NN	_	23	nmod	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	Oct-6	oct-6	NN	NN	_	25	conj	_	_
28	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	OBF-1	obf-1	NN	NN	_	3	compound	_	_
3	mRNA	mrna	NN	NN	_	5	nsubjpass	_	_
4	is	be	VBZ	VBZ	_	5	auxpass	_	_
5	expressed	express	VBN	VBN	_	0	root	_	_
6	in	in	IN	IN	_	10	case	_	_
7	a	a	DT	DT	_	10	det	_	_
8	highly	highly	RB	RB	_	9	advmod	_	_
9	cell-specific	cell-specific	JJ	JJ	_	10	amod	_	_
10	manner	manner	NN	NN	_	5	nmod	_	_
11	,	,	,	,	_	5	punct	_	_
12	being	be	VBG	VBG	_	14	cop	_	_
13	most	most	RBS	RBS	_	14	advmod	_	_
14	abundant	abundant	JJ	JJ	_	5	advcl	_	_
15	in	in	IN	IN	_	17	case	_	_
16	B	b	NN	NN	_	17	compound	_	_
17	cells	cell	NNS	NNS	_	14	nmod	_	_
18	and	and	CC	CC	_	14	cc	_	_
19	essentially	essentially	RB	RB	_	14	advmod	_	_
20	absent	absent	JJ	JJ	_	14	conj	_	_
21	in	in	IN	IN	_	22	case	_	_
22	most	most	JJS	JJS	_	20	nmod	_	_
23	of	of	IN	IN	_	26	case	_	_
24	the	the	DT	DT	_	26	dep	_	_
25	other	other	JJ	JJ	_	26	amod	_	_
26	cells	cell	NNS	NNS	_	22	nmod	_	_
27	or	or	CC	CC	_	26	cc	_	_
28	tissues	tissue	NNS	NNS	_	26	conj	_	_
29	tested	test	VBN	VBN	_	26	acl	_	_
30	.	.	.	.	_	5	punct	_	_

1	Furthermore	furthermore	RB	RB	_	10	advmod	_	_
2	,	,	,	,	_	10	punct	_	_
3	expression	expression	NN	NN	_	10	nsubj	_	_
4	of	of	IN	IN	_	5	case	_	_
5	OBF-1	obf-1	NN	NN	_	3	nmod	_	_
6	in	in	IN	IN	_	8	case	_	_
7	HeLa	hela	NN	NN	_	8	compound	_	_
8	cells	cell	NNS	NNS	_	3	nmod	_	_
9	selectively	selectively	RB	RB	_	10	advmod	_	_
10	stimulates	stimulate	VBZ	VBZ	_	0	root	_	_
11	the	the	DT	DT	_	12	det	_	_
12	activity	activity	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	17	case	_	_
14	a	a	DT	DT	_	17	det	_	_
15	natural	natural	JJ	JJ	_	17	amod	_	_
16	immunoglobulin	immunoglobulin	NN	NN	_	17	compound	_	_
17	promoter	promoter	NN	NN	_	12	nmod	_	_
18	in	in	IN	IN	_	22	case	_	_
19	an	a	DT	DT	_	22	det	_	_
20	octamer	octamer	NN	NN	_	22	compound	_	_
21	site-dependent	site-dependent	JJ	JJ	_	22	amod	_	_
22	manner	manner	NN	NN	_	10	nmod	_	_
23	.	.	.	.	_	10	punct	_	_

1	Thus	thus	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	OBF-1	obf-1	NN	NN	_	4	nsubj	_	_
4	has	have	VBZ	VBZ	_	0	root	_	_
5	all	all	PDT	PDT	_	7	det:predet	_	_
6	the	the	DT	DT	_	7	det	_	_
7	properties	property	NNS	NNS	_	4	dobj	_	_
8	expected	expect	VBN	VBN	_	7	acl	_	_
9	for	for	IN	IN	_	15	case	_	_
10	a	a	DT	DT	_	15	det	_	_
11	B	b	NN	NN	_	15	compound	_	_
12	cell-specific	cell-specific	JJ	JJ	_	15	amod	_	_
13	transcriptional	transcriptional	JJ	JJ	_	15	amod	_	_
14	coactivator	coactivator	NN	NN	_	15	compound	_	_
15	protein	protein	NN	NN	_	8	nmod	_	_
16	.	.	.	.	_	4	punct	_	_

1	HIV-1	hiv-1	NN	NN	_	2	compound	_	_
2	Tat	tat	NN	NN	_	3	nsubj	_	_
3	potentiates	potentiate	VBZ	VBZ	_	0	root	_	_
4	TNF-induced	tnf-induced	JJ	JJ	_	7	amod	_	_
5	NF-kappa	nf-kappa	NN	NN	_	6	compound	_	_
6	B	b	NN	NN	_	7	compound	_	_
7	activation	activation	NN	NN	_	3	dobj	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	cytotoxicity	cytotoxicity	NN	NN	_	7	conj	_	_
10	by	by	IN	IN	_	11	mark	_	_
11	altering	alter	VBG	VBG	_	3	advcl	_	_
12	the	the	DT	DT	_	15	det	_	_
13	cellular	cellular	JJ	JJ	_	15	amod	_	_
14	redox	redox	NN	NN	_	15	compound	_	_
15	state	state	NN	NN	_	11	dobj	_	_
16	.	.	.	.	_	3	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	study	study	NN	NN	_	3	nsubj	_	_
3	demonstrates	demonstrate	VBZ	VBZ	_	0	root	_	_
4	that	that	IN	IN	_	15	mark	_	_
5	human	human	JJ	JJ	_	14	amod	_	_
6	immunodeficiency	immunodeficiency	NN	NN	_	14	compound	_	_
7	virus	virus	NN	NN	_	14	compound	_	_
8	type	type	NN	NN	_	14	compound	_	_
9	1	1	CD	CD	_	14	nummod	_	_
10	(	(	-LRB-	-LRB-	_	14	punct	_	_
11	HIV-1	hiv-1	NN	NN	_	14	compound	_	_
12	)	)	-RRB-	-RRB-	_	14	punct	_	_
13	Tat	tat	NN	NN	_	14	compound	_	_
14	protein	protein	NN	NN	_	15	nsubj	_	_
15	amplifies	amplify	VBZ	VBZ	_	3	ccomp	_	_
16	the	the	DT	DT	_	17	det	_	_
17	activity	activity	NN	NN	_	15	dobj	_	_
18	of	of	IN	IN	_	21	case	_	_
19	tumor	tumor	NN	NN	_	21	compound	_	_
20	necrosis	necrosis	NN	NN	_	21	compound	_	_
21	factor	factor	NN	NN	_	17	nmod	_	_
22	(	(	-LRB-	-LRB-	_	23	punct	_	_
23	TNF	tnf	NN	NN	_	21	appos	_	_
24	)	)	-RRB-	-RRB-	_	23	punct	_	_
25	,	,	,	,	_	21	punct	_	_
26	a	a	DT	DT	_	27	det	_	_
27	cytokine	cytokine	NN	NN	_	21	appos	_	_
28	that	that	WDT	WDT	_	29	nsubj	_	_
29	stimulates	stimulate	VBZ	VBZ	_	27	acl:relcl	_	_
30	HIV-1	hiv-1	NN	NN	_	31	compound	_	_
31	replication	replication	NN	NN	_	29	dobj	_	_
32	through	through	IN	IN	_	33	case	_	_
33	activation	activation	NN	NN	_	29	nmod	_	_
34	of	of	IN	IN	_	36	case	_	_
35	NF-kappa	nf-kappa	NN	NN	_	36	compound	_	_
36	B	b	NN	NN	_	33	nmod	_	_
37	.	.	.	.	_	3	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	HeLa	hela	NN	NN	_	3	compound	_	_
3	cells	cell	NNS	NNS	_	21	nmod	_	_
4	stably	stably	RB	RB	_	5	advmod	_	_
5	transfected	transfect	VBN	VBN	_	3	acl	_	_
6	with	with	IN	IN	_	10	case	_	_
7	the	the	DT	DT	_	10	det	_	_
8	HIV-1	hiv-1	NN	NN	_	10	compound	_	_
9	tat	tat	NN	NN	_	10	compound	_	_
10	gene	gene	NN	NN	_	5	nmod	_	_
11	(	(	-LRB-	-LRB-	_	13	punct	_	_
12	HeLa-tat	hela-tat	JJ	JJ	_	13	amod	_	_
13	cells	cell	NNS	NNS	_	3	appos	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	,	,	,	,	_	21	punct	_	_
16	expression	expression	NN	NN	_	21	nsubj	_	_
17	of	of	IN	IN	_	20	case	_	_
18	the	the	DT	DT	_	20	det	_	_
19	Tat	tat	NN	NN	_	20	compound	_	_
20	protein	protein	NN	NN	_	16	nmod	_	_
21	enhanced	enhance	VBD	VBD	_	0	root	_	_
22	both	both	CC	CC	_	24	cc:preconj	_	_
23	TNF-induced	tnf-induced	JJ	JJ	_	24	amod	_	_
24	activation	activation	NN	NN	_	21	dobj	_	_
25	of	of	IN	IN	_	27	case	_	_
26	NF-kappa	nf-kappa	NN	NN	_	27	compound	_	_
27	B	b	NN	NN	_	24	nmod	_	_
28	and	and	CC	CC	_	24	cc	_	_
29	TNF-mediated	tnf-mediated	JJ	JJ	_	30	amod	_	_
30	cytotoxicity	cytotoxicity	NN	NN	_	24	conj	_	_
31	.	.	.	.	_	21	punct	_	_

1	A	a	DT	DT	_	3	det	_	_
2	similar	similar	JJ	JJ	_	3	amod	_	_
3	potentiation	potentiation	NN	NN	_	8	nsubjpass	_	_
4	of	of	IN	IN	_	6	case	_	_
5	TNF	tnf	NN	NN	_	6	compound	_	_
6	effects	effect	NNS	NNS	_	3	nmod	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	observed	observe	VBN	VBN	_	0	root	_	_
9	in	in	IN	IN	_	12	case	_	_
10	Jurkat	jurkat	NN	NN	_	12	compound	_	_
11	T	t	NN	NN	_	12	compound	_	_
12	cells	cell	NNS	NNS	_	8	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	HeLa	hela	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	12	conj	_	_
16	treated	treat	VBN	VBN	_	12	acl	_	_
17	with	with	IN	IN	_	20	case	_	_
18	soluble	soluble	JJ	JJ	_	20	amod	_	_
19	Tat	tat	NN	NN	_	20	compound	_	_
20	protein	protein	NN	NN	_	16	nmod	_	_
21	.	.	.	.	_	8	punct	_	_

1	TNF-mediated	tnf-mediated	JJ	JJ	_	2	amod	_	_
2	activation	activation	NN	NN	_	8	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	NF-kappa	nf-kappa	NN	NN	_	5	compound	_	_
5	B	b	NN	NN	_	2	nmod	_	_
6	and	and	CC	CC	_	2	cc	_	_
7	cytotoxicity	cytotoxicity	NN	NN	_	2	conj	_	_
8	involves	involve	VBZ	VBZ	_	0	root	_	_
9	the	the	DT	DT	_	11	det	_	_
10	intracellular	intracellular	JJ	JJ	_	11	amod	_	_
11	formation	formation	NN	NN	_	8	dobj	_	_
12	of	of	IN	IN	_	15	case	_	_
13	reactive	reactive	JJ	JJ	_	15	amod	_	_
14	oxygen	oxygen	NN	NN	_	15	compound	_	_
15	intermediates	intermediate	NNS	NNS	_	11	nmod	_	_
16	.	.	.	.	_	8	punct	_	_

1	Therefore	therefore	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	Tat-mediated	tat-mediated	JJ	JJ	_	4	amod	_	_
4	effects	effect	NNS	NNS	_	11	nsubjpass	_	_
5	on	on	IN	IN	_	9	case	_	_
6	the	the	DT	DT	_	9	det	_	_
7	cellular	cellular	JJ	JJ	_	9	amod	_	_
8	redox	redox	NN	NN	_	9	compound	_	_
9	state	state	NN	NN	_	4	nmod	_	_
10	were	be	VBD	VBD	_	11	auxpass	_	_
11	analyzed	analyze	VBN	VBN	_	0	root	_	_
12	.	.	.	.	_	11	punct	_	_

1	In	in	IN	IN	_	4	case	_	_
2	both	both	CC	CC	_	4	cc:preconj	_	_
3	T	t	NN	NN	_	4	compound	_	_
4	cells	cell	NNS	NNS	_	10	nmod	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	HeLa	hela	NN	NN	_	7	compound	_	_
7	cells	cell	NNS	NNS	_	4	conj	_	_
8	HIV-1	hiv-1	NN	NN	_	9	compound	_	_
9	Tat	tat	NN	NN	_	10	nsubj	_	_
10	suppressed	suppress	VBD	VBD	_	0	root	_	_
11	the	the	DT	DT	_	12	det	_	_
12	expression	expression	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	16	case	_	_
14	Mn-dependent	mn-dependent	JJ	JJ	_	16	amod	_	_
15	superoxide	superoxide	NN	NN	_	16	compound	_	_
16	dismutase	dismutase	NN	NN	_	12	nmod	_	_
17	(	(	-LRB-	-LRB-	_	18	punct	_	_
18	Mn-SOD	mn-sod	NN	NN	_	16	appos	_	_
19	)	)	-RRB-	-RRB-	_	18	punct	_	_
20	,	,	,	,	_	16	punct	_	_
21	a	a	DT	DT	_	23	det	_	_
22	mitochondrial	mitochondrial	JJ	JJ	_	23	amod	_	_
23	enzyme	enzyme	NN	NN	_	16	appos	_	_
24	that	that	WDT	WDT	_	26	nsubj	_	_
25	is	be	VBZ	VBZ	_	26	cop	_	_
26	part	part	NN	NN	_	23	acl:relcl	_	_
27	of	of	IN	IN	_	31	case	_	_
28	the	the	DT	DT	_	31	det	_	_
29	cellular	cellular	JJ	JJ	_	31	amod	_	_
30	defense	defense	NN	NN	_	31	compound	_	_
31	system	system	NN	NN	_	26	nmod	_	_
32	against	against	IN	IN	_	34	case	_	_
33	oxidative	oxidative	JJ	JJ	_	34	amod	_	_
34	stress	stress	NN	NN	_	31	nmod	_	_
35	.	.	.	.	_	10	punct	_	_

1	Thus	thus	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	Mn-SOD	mn-sod	NN	NN	_	5	compound	_	_
4	RNA	rna	NN	NN	_	5	compound	_	_
5	protein	protein	NN	NN	_	11	nsubjpass	_	_
6	levels	level	NNS	NNS	_	5	dep	_	_
7	and	and	CC	CC	_	5	cc	_	_
8	activity	activity	NN	NN	_	5	conj	_	_
9	were	be	VBD	VBD	_	11	auxpass	_	_
10	markedly	markedly	RB	RB	_	11	advmod	_	_
11	reduced	reduce	VBN	VBN	_	0	root	_	_
12	in	in	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	det	_	_
14	presence	presence	NN	NN	_	11	nmod	_	_
15	of	of	IN	IN	_	16	case	_	_
16	Tat	tat	NN	NN	_	14	nmod	_	_
17	.	.	.	.	_	11	punct	_	_

1	Decreased	decrease	VBN	VBN	_	3	amod	_	_
2	Mn-SOD	mn-sod	NN	NN	_	3	compound	_	_
3	expression	expression	NN	NN	_	5	nsubjpass	_	_
4	was	be	VBD	VBD	_	5	auxpass	_	_
5	associated	associate	VBN	VBN	_	0	root	_	_
6	with	with	IN	IN	_	8	case	_	_
7	decreased	decrease	VBN	VBN	_	8	amod	_	_
8	levels	level	NNS	NNS	_	5	nmod	_	_
9	of	of	IN	IN	_	10	case	_	_
10	glutathione	glutathione	NN	NN	_	8	nmod	_	_
11	and	and	CC	CC	_	8	cc	_	_
12	a	a	DT	DT	_	14	det	_	_
13	lower	lower	JJR	JJR	_	14	amod	_	_
14	ratio	ratio	NN	NN	_	8	conj	_	_
15	of	of	IN	IN	_	19	case	_	_
16	reduced	reduce	VBN	VBN	_	19	amod	_	_
17	:	:	:	:	_	16	punct	_	_
18	oxidized	oxidize	VBN	VBN	_	16	dep	_	_
19	glutathione	glutathione	NN	NN	_	14	nmod	_	_
20	.	.	.	.	_	5	punct	_	_

1	A	a	DT	DT	_	4	det	_	_
2	truncated	truncate	VBN	VBN	_	4	amod	_	_
3	Tat	tat	NN	NN	_	4	compound	_	_
4	protein	protein	NN	NN	_	23	nsubj	_	_
5	(	(	-LRB-	-LRB-	_	6	punct	_	_
6	Tat1-72	tat1-72	CD	CD	_	4	appos	_	_
7	)	)	-RRB-	-RRB-	_	6	punct	_	_
8	,	,	,	,	_	4	punct	_	_
9	known	know	VBN	VBN	_	4	acl	_	_
10	to	to	TO	TO	_	11	mark	_	_
11	transactivate	transactivate	VB	VB	_	9	xcomp	_	_
12	the	the	DT	DT	_	16	det	_	_
13	HIV-1	hiv-1	NN	NN	_	16	compound	_	_
14	long	long	JJ	JJ	_	16	amod	_	_
15	terminal	terminal	JJ	JJ	_	16	amod	_	_
16	repeat	repeat	NN	NN	_	11	dobj	_	_
17	(	(	-LRB-	-LRB-	_	18	punct	_	_
18	LTR	ltr	NN	NN	_	16	appos	_	_
19	)	)	-RRB-	-RRB-	_	18	punct	_	_
20	,	,	,	,	_	4	punct	_	_
21	no	no	RB	RB	_	22	neg	_	_
22	longer	longer	RBR	RBR	_	23	advmod	_	_
23	affected	affect	VBD	VBD	_	0	root	_	_
24	Mn-SOD	mn-sod	NN	NN	_	25	compound	_	_
25	expression	expression	NN	NN	_	23	dobj	_	_
26	,	,	,	,	_	25	punct	_	_
27	the	the	DT	DT	_	30	det	_	_
28	cellular	cellular	JJ	JJ	_	30	amod	_	_
29	redox	redox	NN	NN	_	30	compound	_	_
30	state	state	NN	NN	_	25	conj	_	_
31	or	or	CC	CC	_	25	cc	_	_
32	TNF-mediated	tnf-mediated	JJ	JJ	_	33	amod	_	_
33	cytotoxicity	cytotoxicity	NN	NN	_	25	conj	_	_
34	.	.	.	.	_	23	punct	_	_

1	Thus	thus	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	our	we	PRP$	PRP$	_	4	nmod:poss	_	_
4	experiments	experiment	NNS	NNS	_	5	nsubj	_	_
5	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
6	that	that	IN	IN	_	14	mark	_	_
7	the	the	DT	DT	_	9	det	_	_
8	C-terminal	c-terminal	JJ	JJ	_	9	amod	_	_
9	region	region	NN	NN	_	14	nsubjpass	_	_
10	of	of	IN	IN	_	12	case	_	_
11	HIV-1	hiv-1	NN	NN	_	12	compound	_	_
12	Tat	tat	NN	NN	_	9	nmod	_	_
13	is	be	VBZ	VBZ	_	14	auxpass	_	_
14	required	require	VBN	VBN	_	5	ccomp	_	_
15	to	to	TO	TO	_	16	mark	_	_
16	suppress	suppress	VB	VB	_	14	ccomp	_	_
17	Mn-SOD	mn-sod	NN	NN	_	18	compound	_	_
18	expression	expression	NN	NN	_	16	dobj	_	_
19	and	and	CC	CC	_	16	cc	_	_
20	to	to	TO	TO	_	21	mark	_	_
21	induce	induce	VB	VB	_	16	conj	_	_
22	pro-oxidative	pro-oxidative	JJ	JJ	_	23	amod	_	_
23	conditions	condition	NNS	NNS	_	21	dobj	_	_
24	reflected	reflect	VBN	VBN	_	23	acl	_	_
25	by	by	IN	IN	_	27	case	_	_
26	a	a	DT	DT	_	27	det	_	_
27	drop	drop	NN	NN	_	24	nmod	_	_
28	in	in	IN	IN	_	30	case	_	_
29	reduced	reduce	VBN	VBN	_	30	amod	_	_
30	glutathione	glutathione	NN	NN	_	27	nmod	_	_
31	(	(	-LRB-	-LRB-	_	32	punct	_	_
32	GSH	gsh	NN	NN	_	30	appos	_	_
33	)	)	-RRB-	-RRB-	_	32	punct	_	_
34	and	and	CC	CC	_	30	cc	_	_
35	the	the	DT	DT	_	43	det	_	_
36	GSH	gsh	NN	NN	_	43	compound	_	_
37	:	:	:	:	_	36	punct	_	_
38	oxidized	oxidize	VBN	VBN	_	39	amod	_	_
39	GSH	gsh	NN	NN	_	36	dep	_	_
40	(	(	-LRB-	-LRB-	_	41	punct	_	_
41	GSSG	gssg	NN	NN	_	39	appos	_	_
42	)	)	-RRB-	-RRB-	_	41	punct	_	_
43	ratio	ratio	NN	NN	_	30	conj	_	_
44	.	.	.	.	_	5	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	ABSTRACT	abstract	NN	NN	_	0	root	_	_
3	TRUNCATED	truncate	VBN	VBN	_	2	acl	_	_
4	AT	at	IN	IN	_	6	case	_	_
5	250	250	CD	CD	_	6	nummod	_	_
6	WORDS	word	NNS	NNS	_	3	nmod	_	_
7	)	)	-RRB-	-RRB-	_	2	punct	_	_

1	Calcium/calmodulin-dependent	calcium/calmodulin-dependent	JJ	JJ	_	3	amod	_	_
2	protein	protein	NN	NN	_	3	compound	_	_
3	kinase	kinase	NN	NN	_	5	nsubj	_	_
4	II	ii	CD	CD	_	3	nummod	_	_
5	downregulates	downregulate	VBZ	VBZ	_	0	root	_	_
6	both	both	CC	CC	_	7	cc:preconj	_	_
7	calcineurin	calcineurin	NN	NN	_	5	dobj	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	protein	protein	NN	NN	_	10	compound	_	_
10	kinase	kinase	NN	NN	_	7	conj	_	_
11	C-mediated	c-mediated	JJ	JJ	_	10	amod	_	_
12	pathways	pathway	NNS	NNS	_	7	dep	_	_
13	for	for	IN	IN	_	16	case	_	_
14	cytokine	cytokine	NN	NN	_	15	compound	_	_
15	gene	gene	NN	NN	_	16	compound	_	_
16	transcription	transcription	NN	NN	_	7	nmod	_	_
17	in	in	IN	IN	_	20	case	_	_
18	human	human	JJ	JJ	_	20	amod	_	_
19	T	t	NN	NN	_	20	compound	_	_
20	cells	cell	NNS	NNS	_	16	nmod	_	_
21	.	.	.	.	_	5	punct	_	_

1	Engagement	engagement	NN	NN	_	9	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	T	t	NN	NN	_	6	compound	_	_
5	cell	cell	NN	NN	_	6	compound	_	_
6	receptor	receptor	NN	NN	_	1	nmod	_	_
7	for	for	IN	IN	_	8	case	_	_
8	antigen	antigen	NN	NN	_	6	nmod	_	_
9	activates	activate	VBZ	VBZ	_	0	root	_	_
10	phospholipase	phospholipase	NN	NN	_	11	compound	_	_
11	C	c	NN	NN	_	9	dobj	_	_
12	resulting	result	VBG	VBG	_	9	xcomp	_	_
13	in	in	IN	IN	_	15	case	_	_
14	an	a	DT	DT	_	15	det	_	_
15	increase	increase	NN	NN	_	12	nmod	_	_
16	in	in	IN	IN	_	20	case	_	_
17	intracellular	intracellular	JJ	JJ	_	20	amod	_	_
18	free	free	JJ	JJ	_	20	amod	_	_
19	calcium	calcium	NN	NN	_	20	compound	_	_
20	concentration	concentration	NN	NN	_	15	nmod	_	_
21	(	(	-LRB-	-LRB-	_	22	punct	_	_
22	-LSB-Ca2+-RSB-i	-lsb-ca2+-rsb-i	NN	NN	_	20	appos	_	_
23	)	)	-RRB-	-RRB-	_	22	punct	_	_
24	and	and	CC	CC	_	15	cc	_	_
25	activation	activation	NN	NN	_	15	conj	_	_
26	of	of	IN	IN	_	29	case	_	_
27	protein	protein	NN	NN	_	29	compound	_	_
28	kinase	kinase	NN	NN	_	29	compound	_	_
29	C	c	NN	NN	_	25	nmod	_	_
30	(	(	-LRB-	-LRB-	_	31	punct	_	_
31	PKC	pkc	NN	NN	_	29	appos	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	.	.	.	.	_	9	punct	_	_

1	Increased	increase	VBN	VBN	_	2	amod	_	_
2	-LSB-Ca2+-RSB-i	-lsb-ca2+-rsb-i	NN	NN	_	3	nsubj	_	_
3	activates	activate	VBZ	VBZ	_	0	root	_	_
4	Ca2+/calmodulin-dependent	ca2+/calmodulin-dependent	JJ	JJ	_	5	amod	_	_
5	kinases	kinase	NNS	NNS	_	3	dobj	_	_
6	including	include	VBG	VBG	_	11	case	_	_
7	the	the	DT	DT	_	11	det	_	_
8	multifunctional	multifunctional	JJ	JJ	_	11	amod	_	_
9	Ca2+/calmodulin-dependent	ca2+/calmodulin-dependent	JJ	JJ	_	11	amod	_	_
10	protein	protein	NN	NN	_	11	compound	_	_
11	kinase	kinase	NN	NN	_	5	nmod	_	_
12	II	ii	CD	CD	_	11	nummod	_	_
13	(	(	-LRB-	-LRB-	_	14	punct	_	_
14	CaM-K	cam-k	NN	NN	_	11	appos	_	_
15	II	ii	CD	CD	_	14	nummod	_	_
16	)	)	-RRB-	-RRB-	_	14	punct	_	_
17	,	,	,	,	_	11	punct	_	_
18	as	as	RB	RB	_	11	cc	_	_
19	well	well	RB	RB	_	18	mwe	_	_
20	as	as	IN	IN	_	18	mwe	_	_
21	calcineurin	calcineurin	NN	NN	_	11	conj	_	_
22	,	,	,	,	_	21	punct	_	_
23	a	a	DT	DT	_	27	det	_	_
24	type	type	NN	NN	_	27	compound	_	_
25	2B	2b	NN	NN	_	27	compound	_	_
26	protein	protein	NN	NN	_	27	compound	_	_
27	phosphatase	phosphatase	NN	NN	_	21	appos	_	_
28	.	.	.	.	_	3	punct	_	_

1	Recent	recent	JJ	JJ	_	2	amod	_	_
2	studies	study	NNS	NNS	_	4	nsubj	_	_
3	have	have	VBP	VBP	_	4	aux	_	_
4	identified	identify	VBN	VBN	_	0	root	_	_
5	calcineurin	calcineurin	NN	NN	_	4	dobj	_	_
6	as	as	IN	IN	_	9	case	_	_
7	a	a	DT	DT	_	9	det	_	_
8	key	key	JJ	JJ	_	9	amod	_	_
9	enzyme	enzyme	NN	NN	_	4	nmod	_	_
10	for	for	IN	IN	_	11	case	_	_
11	interleukin	interleukin	NN	NN	_	9	nmod	_	_
12	(	(	-LRB-	-LRB-	_	13	punct	_	_
13	IL	il	NN	NN	_	11	appos	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	-2	-2	CD	CD	_	11	nummod	_	_
16	and	and	CC	CC	_	11	cc	_	_
17	IL-4	il-4	NN	NN	_	11	conj	_	_
18	promoter	promoter	NN	NN	_	19	compound	_	_
19	activation	activation	NN	NN	_	11	dep	_	_
20	.	.	.	.	_	4	punct	_	_

1	However	however	RB	RB	_	8	advmod	_	_
2	,	,	,	,	_	8	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	role	role	NN	NN	_	8	nsubj	_	_
5	of	of	IN	IN	_	6	case	_	_
6	CaM-K	cam-k	NN	NN	_	4	nmod	_	_
7	II	ii	CD	CD	_	6	nummod	_	_
8	remains	remain	VBZ	VBZ	_	0	root	_	_
9	unknown	unknown	JJ	JJ	_	8	xcomp	_	_
10	.	.	.	.	_	8	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	used	use	VBN	VBN	_	0	root	_	_
4	mutants	mutant	NNS	NNS	_	3	dobj	_	_
5	of	of	IN	IN	_	7	case	_	_
6	these	these	DT	DT	_	7	dep	_	_
7	kinases	kinase	NNS	NNS	_	4	nmod	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	phosphatases	phosphatase	NNS	NNS	_	7	conj	_	_
10	(	(	-LRB-	-LRB-	_	12	punct	_	_
11	gamma	gamma	NN	NN	_	12	compound	_	_
12	B*CaM-K	b*cam-k	NN	NN	_	7	dep	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	delta	delta	NN	NN	_	15	compound	_	_
15	CaM-AI	cam-ai	NN	NN	_	12	conj	_	_
16	,	,	,	,	_	12	punct	_	_
17	respectively	respectively	RB	RB	_	12	advmod	_	_
18	)	)	-RRB-	-RRB-	_	12	punct	_	_
19	to	to	TO	TO	_	20	mark	_	_
20	explore	explore	VB	VB	_	3	xcomp	_	_
21	their	they	PRP$	PRP$	_	23	nmod:poss	_	_
22	relative	relative	JJ	JJ	_	23	amod	_	_
23	role	role	NN	NN	_	20	dobj	_	_
24	in	in	IN	IN	_	27	case	_	_
25	cytokine	cytokine	NN	NN	_	26	compound	_	_
26	gene	gene	NN	NN	_	27	compound	_	_
27	transcription	transcription	NN	NN	_	23	nmod	_	_
28	and	and	CC	CC	_	27	cc	_	_
29	their	they	PRP$	PRP$	_	30	nmod:poss	_	_
30	interactions	interaction	NNS	NNS	_	27	conj	_	_
31	with	with	IN	IN	_	34	case	_	_
32	PKC-dependent	pkc-dependent	JJ	JJ	_	34	amod	_	_
33	signaling	signaling	NN	NN	_	34	compound	_	_
34	systems	system	NNS	NNS	_	30	nmod	_	_
35	.	.	.	.	_	3	punct	_	_

1	gamma	gamma	NN	NN	_	2	compound	_	_
2	B*CaM-K	b*cam-k	NN	NN	_	15	nsubjpass	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	delta	delta	NN	NN	_	5	compound	_	_
5	CaM-AI	cam-ai	NN	NN	_	2	conj	_	_
6	,	,	,	,	_	2	punct	_	_
7	known	know	VBN	VBN	_	2	acl	_	_
8	to	to	TO	TO	_	9	mark	_	_
9	exhibit	exhibit	VB	VB	_	7	xcomp	_	_
10	constitutive	constitutive	JJ	JJ	_	11	amod	_	_
11	Ca(2+)-independent	ca(2+)-independent	JJ	JJ	_	12	amod	_	_
12	activity	activity	NN	NN	_	9	dobj	_	_
13	,	,	,	,	_	2	punct	_	_
14	were	be	VBD	VBD	_	15	auxpass	_	_
15	cotransfected	cotransfect	VBN	VBN	_	0	root	_	_
16	(	(	-LRB-	-LRB-	_	18	punct	_	_
17	alone	alone	RB	RB	_	18	advmod	_	_
18	or	or	CC	CC	_	15	dep	_	_
19	in	in	IN	IN	_	20	case	_	_
20	combination	combination	NN	NN	_	18	conj	_	_
21	)	)	-RRB-	-RRB-	_	18	punct	_	_
22	in	in	IN	IN	_	25	case	_	_
23	Jurkat	jurkat	NN	NN	_	25	compound	_	_
24	T	t	NN	NN	_	25	compound	_	_
25	cells	cell	NNS	NNS	_	15	nmod	_	_
26	with	with	IN	IN	_	28	case	_	_
27	a	a	DT	DT	_	28	det	_	_
28	plasmid	plasmid	NN	NN	_	15	nmod	_	_
29	containing	contain	VBG	VBG	_	28	acl	_	_
30	the	the	DT	DT	_	33	det	_	_
31	intact	intact	JJ	JJ	_	33	amod	_	_
32	IL-2	il-2	NN	NN	_	33	compound	_	_
33	promoter	promoter	NN	NN	_	29	dobj	_	_
34	driving	drive	VBG	VBG	_	33	acl	_	_
35	the	the	DT	DT	_	36	det	_	_
36	expression	expression	NN	NN	_	34	dobj	_	_
37	of	of	IN	IN	_	42	case	_	_
38	the	the	DT	DT	_	42	det	_	_
39	chloramphenicol	chloramphenicol	NN	NN	_	42	compound	_	_
40	acetyltransferase	acetyltransferase	NN	NN	_	42	compound	_	_
41	reporter	reporter	NN	NN	_	42	compound	_	_
42	gene	gene	NN	NN	_	36	nmod	_	_
43	.	.	.	.	_	15	punct	_	_

1	Cotransfection	cotransfection	NN	NN	_	10	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	gamma	gamma	NN	NN	_	4	compound	_	_
4	B*CaM-K	b*cam-k	NN	NN	_	1	nmod	_	_
5	with	with	IN	IN	_	9	case	_	_
6	the	the	DT	DT	_	9	det	_	_
7	IL-2	il-2	NN	NN	_	9	compound	_	_
8	promoter	promoter	NN	NN	_	9	compound	_	_
9	construct	construct	NN	NN	_	1	nmod	_	_
10	downregulated	downregulate	VBD	VBD	_	0	root	_	_
11	its	its	PRP$	PRP$	_	12	nmod:poss	_	_
12	transcription	transcription	NN	NN	_	10	dobj	_	_
13	in	in	IN	IN	_	14	case	_	_
14	response	response	NN	NN	_	10	nmod	_	_
15	to	to	TO	TO	_	16	case	_	_
16	stimulation	stimulation	NN	NN	_	14	nmod	_	_
17	with	with	IN	IN	_	18	case	_	_
18	ionomycin	ionomycin	NN	NN	_	16	nmod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	phorbol	phorbol	NN	NN	_	22	compound	_	_
21	myristate	myristate	NN	NN	_	22	compound	_	_
22	acetate	acetate	NN	NN	_	18	conj	_	_
23	(	(	-LRB-	-LRB-	_	24	punct	_	_
24	PMA	pma	NN	NN	_	22	appos	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	.	.	.	.	_	10	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	inhibitory	inhibitory	JJ	JJ	_	3	amod	_	_
3	effect	effect	NN	NN	_	11	nsubjpass	_	_
4	of	of	IN	IN	_	5	case	_	_
5	CaM-K	cam-k	NN	NN	_	3	nmod	_	_
6	II	ii	CD	CD	_	5	nummod	_	_
7	on	on	IN	IN	_	9	case	_	_
8	IL-2	il-2	NN	NN	_	9	compound	_	_
9	promoter	promoter	NN	NN	_	3	nmod	_	_
10	was	be	VBD	VBD	_	11	auxpass	_	_
11	associated	associate	VBN	VBN	_	0	root	_	_
12	with	with	IN	IN	_	14	case	_	_
13	decreased	decrease	VBN	VBN	_	14	amod	_	_
14	transcription	transcription	NN	NN	_	11	nmod	_	_
15	of	of	IN	IN	_	17	case	_	_
16	its	its	PRP$	PRP$	_	17	nmod:poss	_	_
17	AP-1	ap-1	NN	NN	_	14	nmod	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	NF-AT	nf-at	NN	NN	_	17	conj	_	_
20	transactivating	transactivating	NN	NN	_	21	compound	_	_
21	pathways	pathway	NNS	NNS	_	17	dep	_	_
22	.	.	.	.	_	11	punct	_	_

1	Under	under	IN	IN	_	4	case	_	_
2	the	the	DT	DT	_	4	det	_	_
3	same	same	JJ	JJ	_	4	amod	_	_
4	conditions	condition	NNS	NNS	_	8	nmod	_	_
5	,	,	,	,	_	8	punct	_	_
6	delta	delta	NN	NN	_	7	compound	_	_
7	CaM-AI	cam-ai	NN	NN	_	8	nsubj	_	_
8	superinduced	superinduce	VBD	VBD	_	0	root	_	_
9	IL-2	il-2	NN	NN	_	10	compound	_	_
10	promoter	promoter	NN	NN	_	11	compound	_	_
11	activity	activity	NN	NN	_	8	dobj	_	_
12	(	(	-LRB-	-LRB-	_	15	punct	_	_
13	approximately	approximately	RB	RB	_	14	advmod	_	_
14	twofold	twofold	JJ	JJ	_	15	amod	_	_
15	increase	increase	NN	NN	_	11	appos	_	_
16	)	)	-RRB-	-RRB-	_	15	punct	_	_
17	.	.	.	.	_	8	punct	_	_

1	When	when	WRB	WRB	_	5	advmod	_	_
2	both	both	DT	DT	_	3	det	_	_
3	mutants	mutant	NNS	NNS	_	5	nsubjpass	_	_
4	were	be	VBD	VBD	_	5	auxpass	_	_
5	used	use	VBN	VBN	_	11	advcl	_	_
6	in	in	IN	IN	_	7	case	_	_
7	combination	combination	NN	NN	_	5	nmod	_	_
8	,	,	,	,	_	11	punct	_	_
9	gamma	gamma	NN	NN	_	10	compound	_	_
10	B*CaM-K	b*cam-k	NN	NN	_	11	nsubj	_	_
11	inhibited	inhibit	VBD	VBD	_	0	root	_	_
12	the	the	DT	DT	_	13	det	_	_
13	induction	induction	NN	NN	_	11	dobj	_	_
14	of	of	IN	IN	_	17	case	_	_
15	the	the	DT	DT	_	17	det	_	_
16	IL-2	il-2	NN	NN	_	17	compound	_	_
17	promoter	promoter	NN	NN	_	13	nmod	_	_
18	by	by	IN	IN	_	20	case	_	_
19	delta	delta	NN	NN	_	20	compound	_	_
20	CaM-AI	cam-ai	NN	NN	_	13	nmod	_	_
21	.	.	.	.	_	11	punct	_	_

1	Similar	similar	JJ	JJ	_	2	amod	_	_
2	results	result	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	obtained	obtain	VBN	VBN	_	0	root	_	_
5	when	when	WRB	WRB	_	14	advmod	_	_
6	a	a	DT	DT	_	7	det	_	_
7	construct	construct	NN	NN	_	14	nsubjpass	_	_
8	containing	contain	VBG	VBG	_	7	acl	_	_
9	the	the	DT	DT	_	11	det	_	_
10	IL-4	il-4	NN	NN	_	11	compound	_	_
11	promoter	promoter	NN	NN	_	8	dobj	_	_
12	also	also	RB	RB	_	14	advmod	_	_
13	was	be	VBD	VBD	_	14	auxpass	_	_
14	used	use	VBN	VBN	_	4	advcl	_	_
15	.	.	.	.	_	4	punct	_	_

1	gamma	gamma	NN	NN	_	2	compound	_	_
2	B*CaM-K	b*cam-k	NN	NN	_	4	nsubj	_	_
3	also	also	RB	RB	_	4	advmod	_	_
4	downregulated	downregulate	VBD	VBD	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	activation	activation	NN	NN	_	4	dobj	_	_
7	of	of	IN	IN	_	8	case	_	_
8	AP-1	ap-1	NN	NN	_	6	nmod	_	_
9	in	in	IN	IN	_	10	case	_	_
10	response	response	NN	NN	_	4	nmod	_	_
11	to	to	TO	TO	_	12	case	_	_
12	transfection	transfection	NN	NN	_	10	nmod	_	_
13	with	with	IN	IN	_	17	case	_	_
14	a	a	DT	DT	_	17	det	_	_
15	constitutively	constitutively	RB	RB	_	16	advmod	_	_
16	active	active	JJ	JJ	_	17	amod	_	_
17	mutant	mutant	NN	NN	_	12	nmod	_	_
18	of	of	IN	IN	_	19	case	_	_
19	PKC	pkc	NN	NN	_	17	nmod	_	_
20	or	or	CC	CC	_	12	cc	_	_
21	stimulation	stimulation	NN	NN	_	12	conj	_	_
22	with	with	IN	IN	_	23	case	_	_
23	PMA	pma	NN	NN	_	21	nmod	_	_
24	.	.	.	.	_	4	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	8	mark	_	_
5	CaM-K	cam-k	NN	NN	_	8	nsubj	_	_
6	II	ii	CD	CD	_	5	nummod	_	_
7	may	may	MD	MD	_	8	aux	_	_
8	exert	exert	VB	VB	_	3	ccomp	_	_
9	negative	negative	JJ	JJ	_	10	amod	_	_
10	influences	influence	NNS	NNS	_	8	dobj	_	_
11	on	on	IN	IN	_	14	case	_	_
12	cytokine	cytokine	NN	NN	_	13	compound	_	_
13	gene	gene	NN	NN	_	14	compound	_	_
14	transcription	transcription	NN	NN	_	8	nmod	_	_
15	in	in	IN	IN	_	18	case	_	_
16	human	human	JJ	JJ	_	18	amod	_	_
17	T	t	NN	NN	_	18	compound	_	_
18	cells	cell	NNS	NNS	_	14	nmod	_	_
19	,	,	,	,	_	3	punct	_	_
20	and	and	CC	CC	_	3	cc	_	_
21	provide	provide	VBP	VBP	_	3	conj	_	_
22	preliminary	preliminary	JJ	JJ	_	23	amod	_	_
23	evidence	evidence	NN	NN	_	21	dobj	_	_
24	for	for	IN	IN	_	26	case	_	_
25	negative	negative	JJ	JJ	_	26	amod	_	_
26	cross-talk	cross-talk	NN	NN	_	23	nmod	_	_
27	with	with	IN	IN	_	29	case	_	_
28	the	the	DT	DT	_	29	dep	_	_
29	calcineurin-	calcineurin-	NN	NN	_	26	nmod	_	_
30	and	and	CC	CC	_	29	cc	_	_
31	PKC-	pkc-	NN	NN	_	29	conj	_	_
32	dependent	dependent	JJ	JJ	_	34	amod	_	_
33	signaling	signaling	NN	NN	_	34	compound	_	_
34	systems	system	NNS	NNS	_	29	dep	_	_
35	.	.	.	.	_	3	punct	_	_

1	Regulation	regulation	NN	NN	_	0	root	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	specificity	specificity	NN	NN	_	1	conj	_	_
4	of	of	IN	IN	_	6	case	_	_
5	MNDA	mnda	NN	NN	_	6	compound	_	_
6	expression	expression	NN	NN	_	1	nmod	_	_
7	in	in	IN	IN	_	8	case	_	_
8	monocytes	monocyte	NNS	NNS	_	6	nmod	_	_
9	,	,	,	,	_	8	punct	_	_
10	macrophages	macrophage	NNS	NNS	_	8	conj	_	_
11	,	,	,	,	_	8	punct	_	_
12	and	and	CC	CC	_	8	cc	_	_
13	leukemia/B	leukemia/b	NN	NN	_	16	compound	_	_
14	lymphoma	lymphoma	NN	NN	_	16	compound	_	_
15	cell	cell	NN	NN	_	16	compound	_	_
16	lines	line	NNS	NNS	_	8	conj	_	_
17	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	expression	expression	NN	NN	_	15	nsubjpass	_	_
3	of	of	IN	IN	_	10	case	_	_
4	the	the	DT	DT	_	10	det	_	_
5	human	human	JJ	JJ	_	10	amod	_	_
6	myeloid	myeloid	JJ	JJ	_	10	amod	_	_
7	cell	cell	NN	NN	_	10	compound	_	_
8	nuclear	nuclear	JJ	JJ	_	10	amod	_	_
9	differentiation	differentiation	NN	NN	_	10	compound	_	_
10	antigen	antigen	NN	NN	_	2	nmod	_	_
11	(	(	-LRB-	-LRB-	_	12	punct	_	_
12	MNDA	mnda	NN	NN	_	10	appos	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	was	be	VBD	VBD	_	15	auxpass	_	_
15	observed	observe	VBN	VBN	_	0	root	_	_
16	specifically	specifically	RB	RB	_	15	advmod	_	_
17	in	in	IN	IN	_	18	case	_	_
18	cells	cell	NNS	NNS	_	15	nmod	_	_
19	of	of	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	granulocyte-macrophage	granulocyte-macrophage	JJ	JJ	_	22	amod	_	_
22	lineage	lineage	NN	NN	_	18	nmod	_	_
23	in	in	IN	IN	_	26	case	_	_
24	our	we	PRP$	PRP$	_	26	nmod:poss	_	_
25	earlier	earlier	JJR	JJR	_	26	amod	_	_
26	reports	report	NNS	NNS	_	15	nmod	_	_
27	.	.	.	.	_	15	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	specificity	specificity	NN	NN	_	13	nsubjpass	_	_
3	of	of	IN	IN	_	5	case	_	_
4	MNDA	mnda	NN	NN	_	5	compound	_	_
5	expression	expression	NN	NN	_	2	nmod	_	_
6	for	for	IN	IN	_	7	case	_	_
7	cells	cell	NNS	NNS	_	5	nmod	_	_
8	in	in	IN	IN	_	11	case	_	_
9	the	the	DT	DT	_	11	det	_	_
10	granulocyte-macrophage	granulocyte-macrophage	NN	NN	_	11	compound	_	_
11	lineage	lineage	NN	NN	_	7	nmod	_	_
12	was	be	VBD	VBD	_	13	auxpass	_	_
13	reexamined	reexamine	VBN	VBN	_	0	root	_	_
14	in	in	IN	IN	_	16	case	_	_
15	cell	cell	NN	NN	_	16	compound	_	_
16	lines	line	NNS	NNS	_	13	nmod	_	_
17	established	establish	VBN	VBN	_	16	acl	_	_
18	from	from	IN	IN	_	19	case	_	_
19	patients	patient	NNS	NNS	_	17	nmod	_	_
20	with	with	IN	IN	_	25	case	_	_
21	Philadelphia	philadelphia	NN	NN	_	25	compound	_	_
22	chromosome-positive	chromosome-positive	JJ	JJ	_	25	amod	_	_
23	chronic	chronic	JJ	JJ	_	25	amod	_	_
24	myeloid	myeloid	JJ	JJ	_	25	amod	_	_
25	leukemia	leukemia	NN	NN	_	19	nmod	_	_
26	.	.	.	.	_	13	punct	_	_

1	Cell	cell	NN	NN	_	2	compound	_	_
2	lines	line	NNS	NNS	_	6	nsubj	_	_
3	that	that	WDT	WDT	_	4	nsubj	_	_
4	expressed	express	VBD	VBD	_	2	acl:relcl	_	_
5	MNDA	mnda	NN	NN	_	4	dobj	_	_
6	exhibited	exhibit	VBD	VBD	_	0	root	_	_
7	myeloid	myeloid	JJ	JJ	_	9	amod	_	_
8	cell	cell	NN	NN	_	9	compound	_	_
9	features	feature	NNS	NNS	_	6	dobj	_	_
10	and	and	CC	CC	_	6	cc	_	_
11	granulocyte	granulocyte	NN	NN	_	17	nsubjpass	_	_
12	or	or	CC	CC	_	11	cc	_	_
13	monocyte	monocyte	NN	NN	_	11	conj	_	_
14	differentiation	differentiation	NN	NN	_	11	dep	_	_
15	could	could	MD	MD	_	17	aux	_	_
16	be	be	VB	VB	_	17	auxpass	_	_
17	induced	induce	VBN	VBN	_	6	conj	_	_
18	in	in	FW	FW	_	19	compound	_	_
19	vitro	vitro	FW	FW	_	17	advmod	_	_
20	,	,	,	,	_	6	punct	_	_
21	while	while	IN	IN	_	36	mark	_	_
22	cell	cell	NN	NN	_	23	compound	_	_
23	lines	line	NNS	NNS	_	36	nsubj	_	_
24	exhibiting	exhibit	VBG	VBG	_	23	acl	_	_
25	properties	property	NNS	NNS	_	24	dobj	_	_
26	of	of	IN	IN	_	30	case	_	_
27	very	very	RB	RB	_	30	advmod	_	_
28	early	early	JJ	JJ	_	30	amod	_	_
29	stage	stage	NN	NN	_	30	compound	_	_
30	cells	cell	NNS	NNS	_	25	nmod	_	_
31	or	or	CC	CC	_	30	cc	_	_
32	multipotential	multipotential	JJ	JJ	_	33	amod	_	_
33	cells	cell	NNS	NNS	_	30	conj	_	_
34	did	do	VBD	VBD	_	36	aux	_	_
35	not	not	RB	RB	_	36	neg	_	_
36	express	express	VB	VB	_	6	dep	_	_
37	MNDA	mnda	NN	NN	_	36	dobj	_	_
38	.	.	.	.	_	6	punct	_	_

1	Cells	cell	NNS	NNS	_	10	nsubj	_	_
2	originating	originate	VBG	VBG	_	1	acl	_	_
3	from	from	IN	IN	_	4	case	_	_
4	cases	case	NNS	NNS	_	2	nmod	_	_
5	of	of	IN	IN	_	8	case	_	_
6	Burkitt	burkitt	NN	NN	_	8	nmod:poss	_	_
7	's	's	POS	POS	_	8	case	_	_
8	lymphoma	lymphoma	NN	NN	_	4	nmod	_	_
9	were	be	VBD	VBD	_	10	cop	_	_
10	negative	negative	JJ	JJ	_	0	root	_	_
11	.	.	.	.	_	10	punct	_	_

1	By	by	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	18	nmod	_	_
3	,	,	,	,	_	18	punct	_	_
4	three	three	CD	CD	_	7	nummod	_	_
5	lymphoblastoid	lymphoblastoid	JJ	JJ	_	7	amod	_	_
6	cell	cell	NN	NN	_	7	compound	_	_
7	lines	line	NNS	NNS	_	18	nsubj	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	immortalized	immortalize	VBN	VBN	_	7	dep	_	_
10	in	in	FW	FW	_	11	compound	_	_
11	vitro	vitro	FW	FW	_	9	advmod	_	_
12	with	with	IN	IN	_	14	case	_	_
13	Epstein-Barr	epstein-barr	JJ	JJ	_	14	amod	_	_
14	virus	virus	NN	NN	_	9	nmod	_	_
15	)	)	-RRB-	-RRB-	_	9	punct	_	_
16	were	be	VBD	VBD	_	18	cop	_	_
17	weakly	weakly	RB	RB	_	18	advmod	_	_
18	positive	positive	JJ	JJ	_	0	root	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	MNDA	mnda	NN	NN	_	22	nsubjpass	_	_
21	was	be	VBD	VBD	_	22	auxpass	_	_
22	up-regulated	up-regulate	VBN	VBN	_	18	conj	_	_
23	by	by	IN	IN	_	28	case	_	_
24	interferon-alpha	interferon-alpha	NN	NN	_	28	compound	_	_
25	(	(	-LRB-	-LRB-	_	26	punct	_	_
26	IFN-alpha	ifn-alpha	NN	NN	_	24	appos	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	treatment	treatment	NN	NN	_	22	nmod	_	_
29	.	.	.	.	_	18	punct	_	_

1	As	as	IN	IN	_	3	mark	_	_
2	we	we	PRP	PRP	_	3	nsubj	_	_
3	reported	report	VBD	VBD	_	13	advcl	_	_
4	previously	previously	RB	RB	_	3	advmod	_	_
5	,	,	,	,	_	13	punct	_	_
6	MNDA	mnda	NN	NN	_	7	compound	_	_
7	mRNA	mrna	NN	NN	_	8	compound	_	_
8	level	level	NN	NN	_	13	nsubjpass	_	_
9	in	in	IN	IN	_	11	case	_	_
10	adherent	adherent	JJ	JJ	_	11	amod	_	_
11	monocytes	monocyte	NNS	NNS	_	8	nmod	_	_
12	is	be	VBZ	VBZ	_	13	auxpass	_	_
13	elevated	elevate	VBN	VBN	_	0	root	_	_
14	by	by	IN	IN	_	15	case	_	_
15	IFN-alpha	ifn-alpha	NN	NN	_	13	nmod	_	_
16	;	;	:	:	_	13	punct	_	_
17	in	in	IN	IN	_	19	case	_	_
18	this	this	DT	DT	_	19	det	_	_
19	study	study	NN	NN	_	23	nmod	_	_
20	,	,	,	,	_	23	punct	_	_
21	we	we	PRP	PRP	_	23	nsubj	_	_
22	further	further	RB	RB	_	23	advmod	_	_
23	assessed	assess	VBD	VBD	_	13	parataxis	_	_
24	MNDA	mnda	NN	NN	_	25	compound	_	_
25	expression	expression	NN	NN	_	23	dobj	_	_
26	in	in	IN	IN	_	30	case	_	_
27	in	in	FW	FW	_	30	amod	_	_
28	vitro	vitro	FW	FW	_	27	dep	_	_
29	monocyte-derived	monocyte-derived	JJ	JJ	_	30	amod	_	_
30	macrophages	macrophage	NNS	NNS	_	25	nmod	_	_
31	.	.	.	.	_	13	punct	_	_

1	Three	three	CD	CD	_	3	nummod	_	_
2	additional	additional	JJ	JJ	_	3	amod	_	_
3	agents	agent	NNS	NNS	_	30	nsubjpass	_	_
4	(	(	-LRB-	-LRB-	_	5	punct	_	_
5	endotoxin	endotoxin	NN	NN	_	3	dep	_	_
6	,	,	,	,	_	5	punct	_	_
7	phytohemagglutinin	phytohemagglutinin	NN	NN	_	5	conj	_	_
8	,	,	,	,	_	5	punct	_	_
9	and	and	CC	CC	_	5	cc	_	_
10	phorbol	phorbol	NN	NN	_	11	compound	_	_
11	ester	ester	NN	NN	_	5	conj	_	_
12	)	)	-RRB-	-RRB-	_	5	punct	_	_
13	and	and	CC	CC	_	3	cc	_	_
14	other	other	JJ	JJ	_	15	amod	_	_
15	conditions	condition	NNS	NNS	_	3	conj	_	_
16	that	that	WDT	WDT	_	17	nsubj	_	_
17	affect	affect	VBP	VBP	_	15	acl:relcl	_	_
18	function	function	NN	NN	_	17	dobj	_	_
19	,	,	,	,	_	18	punct	_	_
20	cytokine	cytokine	NN	NN	_	18	appos	_	_
21	production	production	NN	NN	_	20	dep	_	_
22	,	,	,	,	_	20	punct	_	_
23	differentiation	differentiation	NN	NN	_	20	appos	_	_
24	,	,	,	,	_	20	punct	_	_
25	and/or	and/or	CC	CC	_	20	cc	_	_
26	growth	growth	NN	NN	_	20	conj	_	_
27	of	of	IN	IN	_	28	case	_	_
28	monocytes	monocyte	NNS	NNS	_	26	nmod	_	_
29	were	be	VBD	VBD	_	30	auxpass	_	_
30	examined	examine	VBN	VBN	_	0	root	_	_
31	for	for	IN	IN	_	33	case	_	_
32	their	they	PRP$	PRP$	_	33	nmod:poss	_	_
33	ability	ability	NN	NN	_	30	nmod	_	_
34	to	to	TO	TO	_	35	mark	_	_
35	alter	alter	VB	VB	_	33	acl	_	_
36	MNDA	mnda	NN	NN	_	37	compound	_	_
37	expression	expression	NN	NN	_	35	dobj	_	_
38	.	.	.	.	_	30	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	varied	vary	VBD	VBD	_	0	root	_	_
4	with	with	IN	IN	_	6	case	_	_
5	the	the	DT	DT	_	6	det	_	_
6	agent	agent	NN	NN	_	3	nmod	_	_
7	,	,	,	,	_	6	punct	_	_
8	cell	cell	NN	NN	_	9	compound	_	_
9	type	type	NN	NN	_	6	conj	_	_
10	,	,	,	,	_	6	punct	_	_
11	and	and	CC	CC	_	6	cc	_	_
12	stage	stage	NN	NN	_	6	conj	_	_
13	of	of	IN	IN	_	14	case	_	_
14	differentiation	differentiation	NN	NN	_	12	nmod	_	_
15	.	.	.	.	_	3	punct	_	_

1	Changes	change	NNS	NNS	_	5	nsubj	_	_
2	in	in	IN	IN	_	4	case	_	_
3	MNDA	mnda	NN	NN	_	4	compound	_	_
4	expression	expression	NN	NN	_	1	nmod	_	_
5	occurred	occur	VBD	VBD	_	0	root	_	_
6	slowly	slowly	RB	RB	_	5	advmod	_	_
7	(	(	-LRB-	-LRB-	_	8	punct	_	_
8	hours	hour	NNS	NNS	_	6	dep	_	_
9	to	to	TO	TO	_	10	case	_	_
10	days	day	NNS	NNS	_	8	nmod	_	_
11	)	)	-RRB-	-RRB-	_	8	punct	_	_
12	,	,	,	,	_	5	punct	_	_
13	suggesting	suggest	VBG	VBG	_	5	xcomp	_	_
14	that	that	IN	IN	_	17	mark	_	_
15	MNDA	mnda	NN	NN	_	17	nsubj	_	_
16	could	could	MD	MD	_	17	aux	_	_
17	mediate	mediate	VB	VB	_	13	ccomp	_	_
18	changes	change	NNS	NNS	_	17	dobj	_	_
19	realized	realize	VBN	VBN	_	18	acl	_	_
20	over	over	IN	IN	_	23	case	_	_
21	a	a	DT	DT	_	23	det	_	_
22	long	long	JJ	JJ	_	23	amod	_	_
23	period	period	NN	NN	_	19	nmod	_	_
24	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	4	nsubj	_	_
3	also	also	RB	RB	_	4	advmod	_	_
4	reveal	reveal	VBP	VBP	_	0	root	_	_
5	a	a	DT	DT	_	6	det	_	_
6	discordance	discordance	NN	NN	_	4	dobj	_	_
7	in	in	IN	IN	_	11	case	_	_
8	certain	certain	JJ	JJ	_	11	amod	_	_
9	MNDA	mnda	NN	NN	_	11	compound	_	_
10	positive	positive	JJ	JJ	_	11	amod	_	_
11	cells	cell	NNS	NNS	_	6	nmod	_	_
12	between	between	IN	IN	_	14	case	_	_
13	steady-state	steady-state	JJ	JJ	_	14	amod	_	_
14	levels	level	NNS	NNS	_	6	nmod	_	_
15	or	or	CC	CC	_	14	cc	_	_
16	changes	change	NNS	NNS	_	14	conj	_	_
17	in	in	IN	IN	_	18	case	_	_
18	levels	level	NNS	NNS	_	16	nmod	_	_
19	of	of	IN	IN	_	20	case	_	_
20	protein	protein	NN	NN	_	16	nmod	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	mRNA	mrna	NN	NN	_	20	conj	_	_
23	indicating	indicate	VBG	VBG	_	16	acl	_	_
24	that	that	IN	IN	_	30	mark	_	_
25	the	the	DT	DT	_	26	det	_	_
26	regulation	regulation	NN	NN	_	30	nsubj	_	_
27	of	of	IN	IN	_	29	case	_	_
28	MNDA	mnda	NN	NN	_	29	compound	_	_
29	expression	expression	NN	NN	_	26	nmod	_	_
30	occurs	occur	VBZ	VBZ	_	23	ccomp	_	_
31	at	at	IN	IN	_	35	case	_	_
32	more	more	JJR	JJR	_	34	advmod	_	_
33	than	than	IN	IN	_	32	mwe	_	_
34	one	one	CD	CD	_	35	nummod	_	_
35	point	point	NN	NN	_	30	nmod	_	_
36	.	.	.	.	_	4	punct	_	_

1	Changes	change	NNS	NNS	_	6	nsubj	_	_
2	in	in	IN	IN	_	4	case	_	_
3	MNDA	mnda	NN	NN	_	4	compound	_	_
4	expression	expression	NN	NN	_	1	nmod	_	_
5	are	be	VBP	VBP	_	6	cop	_	_
6	consistent	consistent	JJ	JJ	_	0	root	_	_
7	with	with	IN	IN	_	9	case	_	_
8	a	a	DT	DT	_	9	det	_	_
9	role	role	NN	NN	_	6	nmod	_	_
10	in	in	IN	IN	_	11	mark	_	_
11	opposing	oppose	VBG	VBG	_	9	acl	_	_
12	macrophage	macrophage	NN	NN	_	13	compound	_	_
13	differentiation	differentiation	NN	NN	_	11	dobj	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	activation	activation	NN	NN	_	13	conj	_	_
16	of	of	IN	IN	_	17	case	_	_
17	monocytes/macrophages	monocytes/macrophages	NNS	NNS	_	15	nmod	_	_
18	.	.	.	.	_	6	punct	_	_

1	Differences	difference	NNS	NNS	_	0	root	_	_
2	in	in	IN	IN	_	3	case	_	_
3	binding	binding	NN	NN	_	1	nmod	_	_
4	of	of	IN	IN	_	6	case	_	_
5	glucocorticoid	glucocorticoid	NN	NN	_	6	compound	_	_
6	receptor	receptor	NN	NN	_	3	nmod	_	_
7	to	to	TO	TO	_	8	case	_	_
8	DNA	dna	NN	NN	_	3	nmod	_	_
9	in	in	IN	IN	_	11	case	_	_
10	steroid-resistant	steroid-resistant	JJ	JJ	_	11	amod	_	_
11	asthma	asthma	NN	NN	_	1	nmod	_	_
12	.	.	.	.	_	1	punct	_	_

1	Although	although	IN	IN	_	7	mark	_	_
2	glucocorticosteroids	glucocorticosteroid	NNS	NNS	_	7	nsubj	_	_
3	are	be	VBP	VBP	_	7	cop	_	_
4	a	a	DT	DT	_	7	det	_	_
5	very	very	RB	RB	_	6	advmod	_	_
6	effective	effective	JJ	JJ	_	7	amod	_	_
7	treatment	treatment	NN	NN	_	22	advcl	_	_
8	for	for	IN	IN	_	9	case	_	_
9	asthma	asthma	NN	NN	_	7	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	other	other	JJ	JJ	_	14	amod	_	_
12	chronic	chronic	JJ	JJ	_	14	amod	_	_
13	inflammatory	inflammatory	JJ	JJ	_	12	dep	_	_
14	diseases	disease	NNS	NNS	_	9	conj	_	_
15	,	,	,	,	_	22	punct	_	_
16	a	a	DT	DT	_	18	det	_	_
17	small	small	JJ	JJ	_	18	amod	_	_
18	proportion	proportion	NN	NN	_	22	nsubj	_	_
19	of	of	IN	IN	_	20	case	_	_
20	patients	patient	NNS	NNS	_	18	nmod	_	_
21	are	be	VBP	VBP	_	22	cop	_	_
22	resistant	resistant	JJ	JJ	_	0	root	_	_
23	to	to	TO	TO	_	26	case	_	_
24	their	they	PRP$	PRP$	_	26	nmod:poss	_	_
25	therapeutic	therapeutic	JJ	JJ	_	26	amod	_	_
26	effects	effect	NNS	NNS	_	22	nmod	_	_
27	.	.	.	.	_	22	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	molecular	molecular	JJ	JJ	_	3	amod	_	_
3	mechanism	mechanism	NN	NN	_	9	nsubj	_	_
4	for	for	IN	IN	_	7	case	_	_
5	this	this	DT	DT	_	7	det	_	_
6	steroid	steroid	NN	NN	_	7	compound	_	_
7	resistance	resistance	NN	NN	_	3	nmod	_	_
8	is	be	VBZ	VBZ	_	9	cop	_	_
9	unclear	unclear	JJ	JJ	_	0	root	_	_
10	.	.	.	.	_	9	punct	_	_

1	Steroid	steroid	NN	NN	_	2	compound	_	_
2	resistance	resistance	NN	NN	_	6	nsubjpass	_	_
3	can	can	MD	MD	_	6	aux	_	_
4	not	not	RB	RB	_	6	neg	_	_
5	be	be	VB	VB	_	6	auxpass	_	_
6	explained	explain	VBN	VBN	_	0	root	_	_
7	by	by	IN	IN	_	9	case	_	_
8	pharmacokinetic	pharmacokinetic	JJ	JJ	_	9	amod	_	_
9	mechanisms	mechanism	NNS	NNS	_	6	nmod	_	_
10	,	,	,	,	_	9	punct	_	_
11	by	by	IN	IN	_	13	case	_	_
12	a	a	DT	DT	_	13	det	_	_
13	defect	defect	NN	NN	_	9	conj	_	_
14	in	in	IN	IN	_	16	case	_	_
15	the	the	DT	DT	_	16	det	_	_
16	binding	binding	NN	NN	_	13	nmod	_	_
17	of	of	IN	IN	_	18	case	_	_
18	steroids	steroid	NNS	NNS	_	16	nmod	_	_
19	to	to	TO	TO	_	21	case	_	_
20	glucocorticoid	glucocorticoid	NN	NN	_	21	compound	_	_
21	receptors	receptor	NNS	NNS	_	16	nmod	_	_
22	,	,	,	,	_	9	punct	_	_
23	nor	nor	CC	CC	_	9	cc	_	_
24	by	by	IN	IN	_	27	case	_	_
25	defective	defective	JJ	JJ	_	27	amod	_	_
26	nuclear	nuclear	JJ	JJ	_	27	amod	_	_
27	translocation	translocation	NN	NN	_	9	conj	_	_
28	of	of	IN	IN	_	30	case	_	_
29	this	this	DT	DT	_	30	det	_	_
30	receptor	receptor	NN	NN	_	27	nmod	_	_
31	,	,	,	,	_	6	punct	_	_
32	thereby	thereby	RB	RB	_	33	advmod	_	_
33	suggesting	suggest	VBG	VBG	_	6	advcl	_	_
34	that	that	IN	IN	_	38	mark	_	_
35	the	the	DT	DT	_	37	det	_	_
36	molecular	molecular	JJ	JJ	_	37	amod	_	_
37	abnormality	abnormality	NN	NN	_	38	nsubj	_	_
38	lies	lie	VBZ	VBZ	_	33	ccomp	_	_
39	distal	distal	JJ	JJ	_	38	xcomp	_	_
40	to	to	TO	TO	_	42	case	_	_
41	nuclear	nuclear	JJ	JJ	_	42	amod	_	_
42	translocation	translocation	NN	NN	_	39	nmod	_	_
43	.	.	.	.	_	6	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	examined	examine	VBD	VBD	_	0	root	_	_
3	the	the	DT	DT	_	4	det	_	_
4	ability	ability	NN	NN	_	2	dobj	_	_
5	of	of	IN	IN	_	9	case	_	_
6	nuclear	nuclear	JJ	JJ	_	9	amod	_	_
7	translocated	translocate	VBN	VBN	_	9	amod	_	_
8	glucocorticoid	glucocorticoid	NN	NN	_	9	compound	_	_
9	receptors	receptor	NNS	NNS	_	4	nmod	_	_
10	to	to	TO	TO	_	11	mark	_	_
11	bind	bind	VB	VB	_	4	acl	_	_
12	to	to	TO	TO	_	16	case	_	_
13	their	they	PRP$	PRP$	_	16	nmod:poss	_	_
14	DNA	dna	NN	NN	_	16	compound	_	_
15	binding	binding	NN	NN	_	16	compound	_	_
16	sites	site	NNS	NNS	_	11	nmod	_	_
17	(	(	-LRB-	-LRB-	_	18	punct	_	_
18	GRE	gre	NN	NN	_	16	appos	_	_
19	)	)	-RRB-	-RRB-	_	18	punct	_	_
20	using	use	VBG	VBG	_	2	xcomp	_	_
21	electrophoretic	electrophoretic	JJ	JJ	_	24	amod	_	_
22	mobility	mobility	NN	NN	_	24	compound	_	_
23	shift	shift	NN	NN	_	24	compound	_	_
24	assays	assay	NNS	NNS	_	20	dobj	_	_
25	in	in	IN	IN	_	26	case	_	_
26	PBMC	pbmc	NN	NN	_	24	nmod	_	_
27	from	from	IN	IN	_	28	case	_	_
28	patients	patient	NNS	NNS	_	26	nmod	_	_
29	with	with	IN	IN	_	30	case	_	_
30	steroid-sensitive	steroid-sensitive	JJ	JJ	_	28	nmod	_	_
31	and	and	CC	CC	_	30	cc	_	_
32	steroid-resistant	steroid-resistant	JJ	JJ	_	30	conj	_	_
33	asthma	asthma	NN	NN	_	30	dep	_	_
34	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	binding	binding	NN	NN	_	14	nsubjpass	_	_
3	of	of	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	glucocorticoid	glucocorticoid	NN	NN	_	6	compound	_	_
6	receptor	receptor	NN	NN	_	2	nmod	_	_
7	to	to	TO	TO	_	8	case	_	_
8	DNA	dna	NN	NN	_	2	nmod	_	_
9	in	in	IN	IN	_	11	case	_	_
10	these	these	DT	DT	_	11	det	_	_
11	patients	patient	NNS	NNS	_	8	nmod	_	_
12	was	be	VBD	VBD	_	14	auxpass	_	_
13	also	also	RB	RB	_	14	advmod	_	_
14	studied	study	VBN	VBN	_	0	root	_	_
15	using	use	VBG	VBG	_	14	xcomp	_	_
16	Scatchard	scatchard	NN	NN	_	17	compound	_	_
17	analysis	analysis	NN	NN	_	15	dobj	_	_
18	.	.	.	.	_	14	punct	_	_

1	Dexamethasone	dexamethasone	NN	NN	_	2	nsubj	_	_
2	induced	induce	VBD	VBD	_	0	root	_	_
3	a	a	DT	DT	_	9	det	_	_
4	significant	significant	JJ	JJ	_	8	dep	_	_
5	rapid	rapid	JJ	JJ	_	8	dep	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	sustained	sustained	JJ	JJ	_	5	conj	_	_
8	twofold	twofold	JJ	JJ	_	9	amod	_	_
9	increase	increase	NN	NN	_	2	dobj	_	_
10	in	in	IN	IN	_	12	case	_	_
11	GRE	gre	NN	NN	_	12	compound	_	_
12	binding	binding	NN	NN	_	9	nmod	_	_
13	in	in	IN	IN	_	14	case	_	_
14	PBMCs	pbmc	NNS	NNS	_	12	nmod	_	_
15	from	from	IN	IN	_	18	case	_	_
16	steroid-sensitive	steroid-sensitive	JJ	JJ	_	18	amod	_	_
17	asthmatic	asthmatic	JJ	JJ	_	18	amod	_	_
18	patients	patient	NNS	NNS	_	14	nmod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	nonasthmatic	nonasthmatic	JJ	JJ	_	21	amod	_	_
21	individuals	individual	NNS	NNS	_	18	conj	_	_
22	,	,	,	,	_	2	punct	_	_
23	but	but	CC	CC	_	2	cc	_	_
24	this	this	DT	DT	_	27	nsubjpass	_	_
25	was	be	VBD	VBD	_	27	auxpass	_	_
26	markedly	markedly	RB	RB	_	27	advmod	_	_
27	reduced	reduce	VBN	VBN	_	2	conj	_	_
28	in	in	IN	IN	_	31	case	_	_
29	steroid-resistant	steroid-resistant	JJ	JJ	_	31	amod	_	_
30	asthmatic	asthmatic	JJ	JJ	_	31	amod	_	_
31	patients	patient	NNS	NNS	_	27	nmod	_	_
32	.	.	.	.	_	2	punct	_	_

1	Scatchard	scatchard	NN	NN	_	2	compound	_	_
2	analysis	analysis	NN	NN	_	7	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	glucocorticoid	glucocorticoid	NN	NN	_	6	compound	_	_
5	receptor-GRE	receptor-gre	NN	NN	_	6	compound	_	_
6	binding	binding	NN	NN	_	2	nmod	_	_
7	showed	show	VBD	VBD	_	0	root	_	_
8	no	no	DT	DT	_	9	neg	_	_
9	change	change	NN	NN	_	7	dobj	_	_
10	in	in	IN	IN	_	12	case	_	_
11	binding	binding	NN	NN	_	12	compound	_	_
12	affinity	affinity	NN	NN	_	7	nmod	_	_
13	but	but	CC	CC	_	7	cc	_	_
14	did	do	VBD	VBD	_	15	aux	_	_
15	show	show	VB	VB	_	7	conj	_	_
16	a	a	DT	DT	_	18	det	_	_
17	reduced	reduce	VBN	VBN	_	18	amod	_	_
18	number	number	NN	NN	_	15	dobj	_	_
19	of	of	IN	IN	_	20	case	_	_
20	receptors	receptor	NNS	NNS	_	18	nmod	_	_
21	available	available	JJ	JJ	_	20	amod	_	_
22	for	for	IN	IN	_	24	case	_	_
23	DNA	dna	NN	NN	_	24	compound	_	_
24	binding	binding	NN	NN	_	21	nmod	_	_
25	in	in	IN	IN	_	28	case	_	_
26	the	the	DT	DT	_	28	det	_	_
27	steroid-resistant	steroid-resistant	JJ	JJ	_	28	amod	_	_
28	patients	patient	NNS	NNS	_	24	nmod	_	_
29	.	.	.	.	_	7	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	16	mark	_	_
5	the	the	DT	DT	_	6	det	_	_
6	ability	ability	NN	NN	_	16	nsubj	_	_
7	of	of	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	glucocorticoid	glucocorticoid	NN	NN	_	10	compound	_	_
10	receptor	receptor	NN	NN	_	6	nmod	_	_
11	to	to	TO	TO	_	12	mark	_	_
12	bind	bind	VB	VB	_	6	acl	_	_
13	to	to	TO	TO	_	14	case	_	_
14	GRE	gre	NN	NN	_	12	nmod	_	_
15	is	be	VBZ	VBZ	_	16	cop	_	_
16	impaired	impaired	JJ	JJ	_	3	ccomp	_	_
17	in	in	IN	IN	_	19	case	_	_
18	steroid-resistant	steroid-resistant	JJ	JJ	_	19	amod	_	_
19	patients	patient	NNS	NNS	_	16	nmod	_	_
20	because	because	IN	IN	_	24	case	_	_
21	of	of	IN	IN	_	24	case	_	_
22	a	a	DT	DT	_	24	det	_	_
23	reduced	reduce	VBN	VBN	_	24	amod	_	_
24	number	number	NN	NN	_	16	nmod	_	_
25	of	of	IN	IN	_	26	case	_	_
26	receptors	receptor	NNS	NNS	_	24	nmod	_	_
27	available	available	JJ	JJ	_	26	amod	_	_
28	for	for	IN	IN	_	29	mark	_	_
29	binding	bind	VBG	VBG	_	27	advcl	_	_
30	to	to	TO	TO	_	31	case	_	_
31	DNA	dna	NN	NN	_	29	nmod	_	_
32	.	.	.	.	_	3	punct	_	_

1	A	a	DT	DT	_	2	det	_	_
2	family	family	NN	NN	_	12	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	serine	serine	NN	NN	_	5	compound	_	_
5	proteases	protease	NNS	NNS	_	2	nmod	_	_
6	expressed	express	VBN	VBN	_	5	acl	_	_
7	exclusively	exclusively	RB	RB	_	6	advmod	_	_
8	in	in	IN	IN	_	10	case	_	_
9	myelo-monocytic	myelo-monocytic	JJ	JJ	_	10	amod	_	_
10	cells	cell	NNS	NNS	_	6	nmod	_	_
11	specifically	specifically	RB	RB	_	12	advmod	_	_
12	processes	process	VBZ	VBZ	_	0	root	_	_
13	the	the	DT	DT	_	18	det	_	_
14	nuclear	nuclear	JJ	JJ	_	18	amod	_	_
15	factor-kappa	factor-kappa	NN	NN	_	18	compound	_	_
16	B	b	NN	NN	_	18	compound	_	_
17	subunit	subunit	NN	NN	_	18	compound	_	_
18	p65	p65	NN	NN	_	12	dobj	_	_
19	in	in	FW	FW	_	20	compound	_	_
20	vitro	vitro	FW	FW	_	12	advmod	_	_
21	and	and	CC	CC	_	12	cc	_	_
22	may	may	MD	MD	_	23	aux	_	_
23	impair	impair	VB	VB	_	12	conj	_	_
24	human	human	JJ	JJ	_	27	amod	_	_
25	immunodeficiency	immunodeficiency	NN	NN	_	27	compound	_	_
26	virus	virus	NN	NN	_	27	compound	_	_
27	replication	replication	NN	NN	_	23	dobj	_	_
28	in	in	IN	IN	_	30	case	_	_
29	these	these	DT	DT	_	30	det	_	_
30	cells	cell	NNS	NNS	_	27	nmod	_	_
31	.	.	.	.	_	12	punct	_	_

1	Two	two	CD	CD	_	2	nummod	_	_
2	groups	group	NNS	NNS	_	8	nsubjpass	_	_
3	of	of	IN	IN	_	6	case	_	_
4	U937	u937	NN	NN	_	6	compound	_	_
5	promonocytic	promonocytic	JJ	JJ	_	6	amod	_	_
6	cells	cell	NNS	NNS	_	2	nmod	_	_
7	were	be	VBD	VBD	_	8	auxpass	_	_
8	obtained	obtain	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	_	10	mark	_	_
10	limiting	limit	VBG	VBG	_	8	advcl	_	_
11	dilution	dilution	NN	NN	_	12	compound	_	_
12	cloning	cloning	NN	NN	_	10	dobj	_	_
13	which	which	WDT	WDT	_	14	nsubj	_	_
14	differed	differ	VBD	VBD	_	12	acl:relcl	_	_
15	strikingly	strikingly	RB	RB	_	14	advmod	_	_
16	in	in	IN	IN	_	18	case	_	_
17	their	they	PRP$	PRP$	_	18	nmod:poss	_	_
18	ability	ability	NN	NN	_	14	nmod	_	_
19	to	to	TO	TO	_	20	mark	_	_
20	support	support	VB	VB	_	18	acl	_	_
21	human	human	JJ	JJ	_	23	amod	_	_
22	immunodeficiency	immunodeficiency	NN	NN	_	23	compound	_	_
23	virus	virus	NN	NN	_	28	compound	_	_
24	1	1	CD	CD	_	23	nummod	_	_
25	(	(	-LRB-	-LRB-	_	26	punct	_	_
26	HIV-1	hiv-1	NN	NN	_	23	appos	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	replication	replication	NN	NN	_	20	dobj	_	_
29	.	.	.	.	_	8	punct	_	_

1	``	``	``	``	_	3	punct	_	_
2	Plus	plus	JJ	JJ	_	3	amod	_	_
3	clones	clone	NNS	NNS	_	4	nsubj	_	_
4	replicated	replicate	VBD	VBD	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	virus	virus	NN	NN	_	4	dobj	_	_
7	efficiently	efficiently	RB	RB	_	4	advmod	_	_
8	,	,	,	,	_	4	punct	_	_
9	whereas	whereas	IN	IN	_	13	mark	_	_
10	``	``	``	``	_	12	punct	_	_
11	minus	minus	JJ	JJ	_	12	amod	_	_
12	clones	clone	NNS	NNS	_	13	nsubj	_	_
13	did	do	VBD	VBD	_	4	advcl	_	_
14	not	not	RB	RB	_	13	neg	_	_
15	.	.	.	.	_	4	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	examined	examine	VBD	VBD	_	0	root	_	_
3	these	these	DT	DT	_	4	det	_	_
4	clones	clone	NNS	NNS	_	2	dobj	_	_
5	for	for	IN	IN	_	6	case	_	_
6	differences	difference	NNS	NNS	_	2	nmod	_	_
7	in	in	IN	IN	_	15	case	_	_
8	nuclear	nuclear	JJ	JJ	_	14	amod	_	_
9	factor	factor	NN	NN	_	14	compound	_	_
10	(	(	-LRB-	-LRB-	_	14	punct	_	_
11	NF	nf	NN	NN	_	14	compound	_	_
12	)	)	-RRB-	-RRB-	_	14	punct	_	_
13	-kappa	-kappa	NN	NN	_	14	compound	_	_
14	B	b	NN	NN	_	15	compound	_	_
15	activity	activity	NN	NN	_	6	nmod	_	_
16	which	which	WDT	WDT	_	18	nsubj	_	_
17	might	might	MD	MD	_	18	aux	_	_
18	account	account	VB	VB	_	15	acl:relcl	_	_
19	for	for	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	observed	observe	VBN	VBN	_	22	amod	_	_
22	phenomenon	phenomenon	NN	NN	_	18	nmod	_	_
23	.	.	.	.	_	2	punct	_	_

1	Stimulation	stimulation	NN	NN	_	5	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	plus	plus	CC	CC	_	4	cc	_	_
4	clones	clone	NNS	NNS	_	1	nmod	_	_
5	liberated	liberate	VBD	VBD	_	0	root	_	_
6	the	the	DT	DT	_	9	det	_	_
7	classical	classical	JJ	JJ	_	9	amod	_	_
8	p50-p65	p50-p65	NN	NN	_	9	compound	_	_
9	complex	complex	NN	NN	_	5	dobj	_	_
10	from	from	IN	IN	_	12	case	_	_
11	cytoplasmic	cytoplasmic	JJ	JJ	_	12	amod	_	_
12	pools	pool	NNS	NNS	_	5	nmod	_	_
13	,	,	,	,	_	5	punct	_	_
14	whereas	whereas	IN	IN	_	17	mark	_	_
15	minus	minus	JJ	JJ	_	16	amod	_	_
16	clones	clone	NNS	NNS	_	17	nsubj	_	_
17	produced	produce	VBD	VBD	_	5	advcl	_	_
18	an	a	DT	DT	_	23	det	_	_
19	apparently	apparently	RB	RB	_	20	advmod	_	_
20	novel	novel	JJ	JJ	_	23	amod	_	_
21	,	,	,	,	_	23	punct	_	_
22	faster-migrating	faster-migrating	JJ	JJ	_	23	amod	_	_
23	complex	complex	NN	NN	_	17	dobj	_	_
24	,	,	,	,	_	5	punct	_	_
25	as	as	IN	IN	_	26	mark	_	_
26	judged	judge	VBN	VBN	_	5	advcl	_	_
27	by	by	IN	IN	_	31	case	_	_
28	electrophoretic	electrophoretic	JJ	JJ	_	31	amod	_	_
29	mobility	mobility	NN	NN	_	31	compound	_	_
30	shift	shift	NN	NN	_	31	compound	_	_
31	assays	assay	NNS	NNS	_	26	nmod	_	_
32	.	.	.	.	_	5	punct	_	_

1	It	it	PRP	PRP	_	3	nsubj	_	_
2	is	be	VBZ	VBZ	_	3	cop	_	_
3	surprising	surprising	JJ	JJ	_	0	root	_	_
4	that	that	IN	IN	_	9	mark	_	_
5	the	the	DT	DT	_	7	det	_	_
6	faster-migrating	faster-migrating	JJ	JJ	_	7	amod	_	_
7	complex	complex	NN	NN	_	9	nsubjpass	_	_
8	was	be	VBD	VBD	_	9	auxpass	_	_
9	composed	compose	VBN	VBN	_	3	ccomp	_	_
10	also	also	RB	RB	_	9	advmod	_	_
11	of	of	IN	IN	_	12	case	_	_
12	p50	p50	NN	NN	_	9	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	p65	p65	NN	NN	_	12	conj	_	_
15	.	.	.	.	_	3	punct	_	_

1	However	however	RB	RB	_	8	advmod	_	_
2	,	,	,	,	_	8	punct	_	_
3	the	the	DT	DT	_	5	det	_	_
4	p65	p65	NN	NN	_	5	compound	_	_
5	subunit	subunit	NN	NN	_	8	nsubjpass	_	_
6	was	be	VBD	VBD	_	8	auxpass	_	_
7	COOH-terminally	cooh-terminally	RB	RB	_	8	advmod	_	_
8	truncated	truncate	VBN	VBN	_	0	root	_	_
9	,	,	,	,	_	8	punct	_	_
10	as	as	IN	IN	_	11	mark	_	_
11	shown	show	VBN	VBN	_	8	advcl	_	_
12	by	by	IN	IN	_	13	case	_	_
13	immunoprecipitation	immunoprecipitation	NN	NN	_	11	nmod	_	_
14	.	.	.	.	_	8	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	truncation	truncation	NN	NN	_	3	nsubj	_	_
3	resulted	result	VBD	VBD	_	0	root	_	_
4	from	from	IN	IN	_	6	case	_	_
5	limited	limited	JJ	JJ	_	6	amod	_	_
6	proteolysis	proteolysis	NN	NN	_	3	nmod	_	_
7	of	of	IN	IN	_	8	case	_	_
8	p65	p65	NN	NN	_	6	nmod	_	_
9	during	during	IN	IN	_	11	case	_	_
10	cellular	cellular	JJ	JJ	_	11	amod	_	_
11	extraction	extraction	NN	NN	_	3	nmod	_	_
12	which	which	WDT	WDT	_	13	nsubj	_	_
13	released	release	VBD	VBD	_	11	acl:relcl	_	_
14	particular	particular	JJ	JJ	_	17	amod	_	_
15	lysosomal	lysosomal	JJ	JJ	_	17	amod	_	_
16	serine	serine	NN	NN	_	17	compound	_	_
17	proteases	protease	NNS	NNS	_	13	dobj	_	_
18	,	,	,	,	_	17	punct	_	_
19	such	such	JJ	JJ	_	21	case	_	_
20	as	as	IN	IN	_	19	mwe	_	_
21	elastase	elastase	NN	NN	_	17	nmod	_	_
22	,	,	,	,	_	21	punct	_	_
23	cathepsin	cathepsin	NN	NN	_	24	compound	_	_
24	G	g	NN	NN	_	21	conj	_	_
25	,	,	,	,	_	21	punct	_	_
26	and	and	CC	CC	_	21	cc	_	_
27	proteinase	proteinase	NN	NN	_	21	conj	_	_
28	3	3	CD	CD	_	27	nummod	_	_
29	.	.	.	.	_	3	punct	_	_

1	These	these	DT	DT	_	3	det	_	_
2	specific	specific	JJ	JJ	_	3	amod	_	_
3	proteases	protease	NNS	NNS	_	6	nsubjpass	_	_
4	are	be	VBP	VBP	_	6	auxpass	_	_
5	coordinately	coordinately	RB	RB	_	6	advmod	_	_
6	expressed	express	VBN	VBN	_	0	root	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	were	be	VBD	VBD	_	9	cop	_	_
9	present	present	JJ	JJ	_	6	conj	_	_
10	exclusively	exclusively	RB	RB	_	9	nmod	_	_
11	in	in	IN	IN	_	15	case	_	_
12	the	the	DT	DT	_	15	det	_	_
13	minus	minus	JJ	JJ	_	15	amod	_	_
14	U937	u937	NN	NN	_	15	compound	_	_
15	clones	clone	NNS	NNS	_	10	nmod	_	_
16	,	,	,	,	_	10	punct	_	_
17	but	but	CC	CC	_	10	cc	_	_
18	not	not	RB	RB	_	22	neg	_	_
19	in	in	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	plus	plus	JJ	JJ	_	22	amod	_	_
22	clones	clone	NNS	NNS	_	10	conj	_	_
23	,	,	,	,	_	9	punct	_	_
24	as	as	IN	IN	_	25	mark	_	_
25	demonstrated	demonstrate	VBN	VBN	_	9	advcl	_	_
26	in	in	IN	IN	_	28	case	_	_
27	the	the	DT	DT	_	28	det	_	_
28	case	case	NN	NN	_	25	nmod	_	_
29	of	of	IN	IN	_	31	case	_	_
30	cathepsin	cathepsin	NN	NN	_	31	compound	_	_
31	G	g	NN	NN	_	28	nmod	_	_
32	.	.	.	.	_	6	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	addition	addition	NN	NN	_	7	nmod	_	_
3	,	,	,	,	_	7	punct	_	_
4	these	these	DT	DT	_	5	det	_	_
5	proteases	protease	NNS	NNS	_	7	nsubjpass	_	_
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	detected	detect	VBN	VBN	_	0	root	_	_
8	in	in	IN	IN	_	10	case	_	_
9	certain	certain	JJ	JJ	_	10	amod	_	_
10	subclones	subclone	NNS	NNS	_	7	nmod	_	_
11	of	of	IN	IN	_	12	case	_	_
12	THP-1	thp-1	NN	NN	_	10	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	HL-60	hl-60	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	12	conj	_	_
16	and	and	CC	CC	_	10	cc	_	_
17	in	in	IN	IN	_	19	case	_	_
18	primary	primary	JJ	JJ	_	19	amod	_	_
19	monocytes	monocyte	NNS	NNS	_	10	conj	_	_
20	,	,	,	,	_	7	punct	_	_
21	in	in	IN	IN	_	23	case	_	_
22	each	each	DT	DT	_	23	det	_	_
23	case	case	NN	NN	_	24	nmod	_	_
24	correlating	correlate	VBG	VBG	_	7	advcl	_	_
25	with	with	IN	IN	_	26	case	_	_
26	the	the	DT	DT	_	24	nmod	_	_
27	truncated	truncate	VBN	VBN	_	26	amod	_	_
28	from	from	IN	IN	_	26	amod	_	_
29	of	of	IN	IN	_	30	case	_	_
30	p65	p65	NN	NN	_	26	nmod	_	_
31	.	.	.	.	_	7	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
3	in	in	FW	FW	_	5	amod	_	_
4	vitro	vitro	FW	FW	_	3	dep	_	_
5	cleavage	cleavage	NN	NN	_	2	dobj	_	_
6	of	of	IN	IN	_	7	case	_	_
7	p65	p65	NN	NN	_	5	nmod	_	_
8	by	by	IN	IN	_	10	case	_	_
9	purified	purify	VBN	VBN	_	10	amod	_	_
10	elastase	elastase	NN	NN	_	2	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	cathepsin	cathepsin	NN	NN	_	13	compound	_	_
13	G	g	NN	NN	_	10	conj	_	_
14	.	.	.	.	_	2	punct	_	_

1	It	it	PRP	PRP	_	3	nsubj	_	_
2	is	be	VBZ	VBZ	_	3	cop	_	_
3	possible	possible	JJ	JJ	_	0	root	_	_
4	that	that	IN	IN	_	9	mark	_	_
5	particular	particular	JJ	JJ	_	7	amod	_	_
6	serine	serine	NN	NN	_	7	compound	_	_
7	proteases	protease	NNS	NNS	_	9	nsubj	_	_
8	may	may	MD	MD	_	9	aux	_	_
9	have	have	VB	VB	_	3	ccomp	_	_
10	inhibiting	inhibiting	NN	NN	_	11	compound	_	_
11	effects	effect	NNS	NNS	_	9	dobj	_	_
12	on	on	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	det	_	_
14	replication	replication	NN	NN	_	9	nmod	_	_
15	of	of	IN	IN	_	16	case	_	_
16	HIV-1	hiv-1	NN	NN	_	14	nmod	_	_
17	in	in	IN	IN	_	19	case	_	_
18	myelo-monocytic	myelo-monocytic	JJ	JJ	_	19	amod	_	_
19	cells	cell	NNS	NNS	_	14	nmod	_	_
20	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	4	nsubj	_	_
3	also	also	RB	RB	_	4	advmod	_	_
4	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	10	mark	_	_
6	special	special	JJ	JJ	_	7	amod	_	_
7	precautions	precaution	NNS	NNS	_	10	nsubjpass	_	_
8	must	must	MD	MD	_	10	aux	_	_
9	be	be	VB	VB	_	10	auxpass	_	_
10	taken	take	VBN	VBN	_	4	ccomp	_	_
11	when	when	WRB	WRB	_	12	advmod	_	_
12	making	make	VBG	VBG	_	10	advcl	_	_
13	extracts	extract	NNS	NNS	_	12	dobj	_	_
14	from	from	IN	IN	_	16	case	_	_
15	myelo-monocytic	myelo-monocytic	JJ	JJ	_	16	amod	_	_
16	cells	cell	NNS	NNS	_	12	nmod	_	_
17	.	.	.	.	_	4	punct	_	_

1	Positive	positive	JJ	JJ	_	0	root	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	negative	negative	JJ	JJ	_	1	conj	_	_
4	regulation	regulation	NN	NN	_	1	dep	_	_
5	of	of	IN	IN	_	9	case	_	_
6	the	the	DT	DT	_	9	det	_	_
7	composite	composite	JJ	JJ	_	9	amod	_	_
8	octamer	octamer	NN	NN	_	9	compound	_	_
9	motif	motif	NN	NN	_	1	nmod	_	_
10	of	of	IN	IN	_	14	case	_	_
11	the	the	DT	DT	_	14	det	_	_
12	interleukin	interleukin	NN	NN	_	14	compound	_	_
13	2	2	CD	CD	_	14	nummod	_	_
14	enhancer	enhancer	NN	NN	_	9	nmod	_	_
15	by	by	IN	IN	_	16	case	_	_
16	AP-1	ap-1	NN	NN	_	1	nmod	_	_
17	,	,	,	,	_	16	punct	_	_
18	Oct-2	oct-2	NN	NN	_	16	conj	_	_
19	,	,	,	,	_	16	punct	_	_
20	and	and	CC	CC	_	16	cc	_	_
21	retinoic	retinoic	JJ	JJ	_	23	amod	_	_
22	acid	acid	NN	NN	_	23	compound	_	_
23	receptor	receptor	NN	NN	_	16	conj	_	_
24	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	5	det	_	_
2	differentiating	differentiate	VBG	VBG	_	5	amod	_	_
3	agent	agent	NN	NN	_	5	compound	_	_
4	retinoic	retinoic	JJ	JJ	_	5	amod	_	_
5	acid	acid	NN	NN	_	12	nsubjpass	_	_
6	(	(	-LRB-	-LRB-	_	7	punct	_	_
7	RA	ra	NN	NN	_	5	appos	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	has	have	VBZ	VBZ	_	12	aux	_	_
10	been	be	VBN	VBN	_	12	auxpass	_	_
11	previously	previously	RB	RB	_	12	advmod	_	_
12	reported	report	VBN	VBN	_	0	root	_	_
13	to	to	TO	TO	_	14	mark	_	_
14	interfere	interfere	VB	VB	_	12	xcomp	_	_
15	with	with	IN	IN	_	21	case	_	_
16	12-O-tetradecanoyl-phorbol-13-acetate	12-o-tetradecanoyl-phorbol-13-acetate	NN	NN	_	21	compound	_	_
17	(	(	-LRB-	-LRB-	_	18	punct	_	_
18	TPA	tpa	NN	NN	_	16	appos	_	_
19	)	)	-RRB-	-RRB-	_	18	punct	_	_
20	/Ca(2+)-induced	/ca(2+)-induced	JJ	JJ	_	21	amod	_	_
21	signals	signal	NNS	NNS	_	14	nmod	_	_
22	for	for	IN	IN	_	24	case	_	_
23	the	the	DT	DT	_	24	det	_	_
24	regulation	regulation	NN	NN	_	14	nmod	_	_
25	of	of	IN	IN	_	31	case	_	_
26	the	the	DT	DT	_	31	det	_	_
27	-96	-96	CD	CD	_	31	nummod	_	_
28	to	to	TO	TO	_	31	dep	_	_
29	-66-bp	-66-bp	JJ	JJ	_	31	amod	_	_
30	octamer	octamer	NN	NN	_	31	compound	_	_
31	motif	motif	NN	NN	_	24	nmod	_	_
32	found	find	VBN	VBN	_	31	acl	_	_
33	in	in	IN	IN	_	35	case	_	_
34	the	the	DT	DT	_	35	det	_	_
35	enhancer	enhancer	NN	NN	_	32	nmod	_	_
36	for	for	IN	IN	_	43	case	_	_
37	the	the	DT	DT	_	43	det	_	_
38	interleukin	interleukin	NN	NN	_	43	compound	_	_
39	(	(	-LRB-	-LRB-	_	43	punct	_	_
40	IL	il	NN	NN	_	43	compound	_	_
41	)	)	-RRB-	-RRB-	_	43	punct	_	_
42	-2	-2	CD	CD	_	43	nummod	_	_
43	gene	gene	NN	NN	_	35	nmod	_	_
44	,	,	,	,	_	43	punct	_	_
45	which	which	WDT	WDT	_	46	nsubj	_	_
46	encodes	encode	VBZ	VBZ	_	43	acl:relcl	_	_
47	a	a	DT	DT	_	52	det	_	_
48	major	major	JJ	JJ	_	52	amod	_	_
49	T	t	NN	NN	_	52	compound	_	_
50	lymphocyte	lymphocyte	NN	NN	_	52	compound	_	_
51	growth	growth	NN	NN	_	52	compound	_	_
52	factor	factor	NN	NN	_	46	dobj	_	_
53	.	.	.	.	_	12	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	IL-2	il-2	NN	NN	_	4	compound	_	_
3	octamer	octamer	NN	NN	_	4	compound	_	_
4	motif	motif	NN	NN	_	8	nsubj	_	_
5	is	be	VBZ	VBZ	_	8	cop	_	_
6	a	a	DT	DT	_	8	det	_	_
7	composite	composite	JJ	JJ	_	8	amod	_	_
8	cis-element	cis-element	NN	NN	_	0	root	_	_
9	which	which	WDT	WDT	_	10	nsubj	_	_
10	binds	bind	VBZ	VBZ	_	8	acl:relcl	_	_
11	Oct-1	oct-1	NN	NN	_	10	dobj	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	Oct-2	oct-2	NN	NN	_	11	conj	_	_
14	as	as	RB	RB	_	11	cc	_	_
15	well	well	RB	RB	_	14	mwe	_	_
16	as	as	IN	IN	_	14	mwe	_	_
17	a	a	DT	DT	_	20	det	_	_
18	TPA/Ca(2+)-inducible	tpa/ca(2+)-inducible	JJ	JJ	_	20	amod	_	_
19	nuclear	nuclear	JJ	JJ	_	20	amod	_	_
20	factor	factor	NN	NN	_	11	conj	_	_
21	,	,	,	,	_	20	punct	_	_
22	previously	previously	RB	RB	_	23	advmod	_	_
23	termed	term	VBN	VBN	_	20	acl	_	_
24	octamer-associated	octamer-associated	JJ	JJ	_	25	amod	_	_
25	protein	protein	NN	NN	_	23	xcomp	_	_
26	(	(	-LRB-	-LRB-	_	27	punct	_	_
27	OAP40	oap40	CD	CD	_	25	appos	_	_
28	)	)	-RRB-	-RRB-	_	27	punct	_	_
29	.	.	.	.	_	8	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	show	show	VBP	VBP	_	0	root	_	_
3	here	here	RB	RB	_	2	advmod	_	_
4	that	that	IN	IN	_	17	mark	_	_
5	Oct-2	oct-2	NN	NN	_	17	nsubj	_	_
6	,	,	,	,	_	5	punct	_	_
7	despite	despite	IN	IN	_	9	case	_	_
8	the	the	DT	DT	_	9	det	_	_
9	presence	presence	NN	NN	_	17	nmod	_	_
10	of	of	IN	IN	_	15	case	_	_
11	an	a	DT	DT	_	15	det	_	_
12	active	active	JJ	JJ	_	15	amod	_	_
13	transcriptional	transcriptional	JJ	JJ	_	12	dep	_	_
14	activation	activation	NN	NN	_	15	compound	_	_
15	domain	domain	NN	NN	_	9	nmod	_	_
16	,	,	,	,	_	17	punct	_	_
17	requires	require	VBZ	VBZ	_	2	ccomp	_	_
18	TPA/Ca(2+)-induced	tpa/ca(2+)-induced	JJ	JJ	_	19	amod	_	_
19	signals	signal	NNS	NNS	_	17	dobj	_	_
20	to	to	TO	TO	_	22	mark	_	_
21	strongly	strongly	RB	RB	_	22	advmod	_	_
22	transactivate	transactivate	VB	VB	_	17	xcomp	_	_
23	the	the	DT	DT	_	26	det	_	_
24	IL-2	il-2	NN	NN	_	26	compound	_	_
25	octamer	octamer	NN	NN	_	26	compound	_	_
26	motif	motif	NN	NN	_	22	dobj	_	_
27	in	in	IN	IN	_	30	case	_	_
28	Jurkat	jurkat	NN	NN	_	30	compound	_	_
29	T	t	NN	NN	_	30	compound	_	_
30	cells	cell	NNS	NNS	_	22	nmod	_	_
31	.	.	.	.	_	2	punct	_	_

1	This	this	DT	DT	_	3	det	_	_
2	Oct-2-dependent	oct-2-dependent	JJ	JJ	_	3	amod	_	_
3	transactivation	transactivation	NN	NN	_	5	nsubjpass	_	_
4	is	be	VBZ	VBZ	_	5	auxpass	_	_
5	inhibited	inhibit	VBN	VBN	_	0	root	_	_
6	by	by	IN	IN	_	7	case	_	_
7	RA	ra	NN	NN	_	5	nmod	_	_
8	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	presence	presence	NN	NN	_	10	nsubj	_	_
3	of	of	IN	IN	_	7	case	_	_
4	an	a	DT	DT	_	7	det	_	_
5	intact	intact	JJ	JJ	_	7	amod	_	_
6	COOH-terminal	cooh-terminal	JJ	JJ	_	7	amod	_	_
7	domain	domain	NN	NN	_	2	nmod	_	_
8	of	of	IN	IN	_	9	case	_	_
9	Oct-2	oct-2	NN	NN	_	7	nmod	_	_
10	contributes	contribute	VBZ	VBZ	_	0	root	_	_
11	to	to	TO	TO	_	14	case	_	_
12	both	both	CC	CC	_	14	cc:preconj	_	_
13	TPA/Ca(2+)-induced	tpa/ca(2+)-induced	JJ	JJ	_	14	amod	_	_
14	transactivation	transactivation	NN	NN	_	10	nmod	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	the	the	DT	DT	_	18	det	_	_
17	RA-mediated	ra-mediated	JJ	JJ	_	18	amod	_	_
18	repression	repression	NN	NN	_	14	conj	_	_
19	.	.	.	.	_	10	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	show	show	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	14	mark	_	_
5	both	both	CC	CC	_	6	cc:preconj	_	_
6	Fos	fos	NN	NN	_	14	nsubj	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	Jun	jun	NN	NN	_	6	conj	_	_
9	components	component	NNS	NNS	_	6	dep	_	_
10	of	of	IN	IN	_	13	case	_	_
11	the	the	DT	DT	_	13	det	_	_
12	AP-1	ap-1	NN	NN	_	13	compound	_	_
13	factors	factor	NNS	NNS	_	6	nmod	_	_
14	participate	participate	VBP	VBP	_	3	ccomp	_	_
15	in	in	IN	IN	_	18	case	_	_
16	the	the	DT	DT	_	18	det	_	_
17	OAP40	oap40	NN	NN	_	18	compound	_	_
18	complex	complex	NN	NN	_	14	nmod	_	_
19	.	.	.	.	_	3	punct	_	_

1	Furthermore	furthermore	RB	RB	_	17	advmod	_	_
2	,	,	,	,	_	17	punct	_	_
3	transfected	transfect	VBN	VBN	_	4	amod	_	_
4	c-jun	c-jun	NN	NN	_	17	nsubj	_	_
5	,	,	,	,	_	4	punct	_	_
6	jun-B	jun-b	NN	NN	_	4	conj	_	_
7	,	,	,	,	_	4	punct	_	_
8	jun-D	jun-d	NN	NN	_	4	conj	_	_
9	,	,	,	,	_	4	punct	_	_
10	c-fos	c-fos	NN	NN	_	4	conj	_	_
11	,	,	,	,	_	4	punct	_	_
12	or	or	CC	CC	_	4	cc	_	_
13	Fos-B	fos-b	NN	NN	_	4	conj	_	_
14	expression	expression	NN	NN	_	15	compound	_	_
15	vectors	vector	NNS	NNS	_	4	dep	_	_
16	partially	partially	RB	RB	_	17	advmod	_	_
17	substitute	substitute	VBP	VBP	_	0	root	_	_
18	for	for	IN	IN	_	19	case	_	_
19	TPA	tpa	NN	NN	_	17	nmod	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	Ca2+	ca2+	NN	NN	_	19	conj	_	_
22	and	and	CC	CC	_	17	cc	_	_
23	cooperate	cooperate	VBP	VBP	_	17	conj	_	_
24	with	with	IN	IN	_	25	case	_	_
25	Oct-2	oct-2	NN	NN	_	23	nmod	_	_
26	for	for	IN	IN	_	28	case	_	_
27	the	the	DT	DT	_	28	det	_	_
28	transactivation	transactivation	NN	NN	_	23	nmod	_	_
29	of	of	IN	IN	_	33	case	_	_
30	the	the	DT	DT	_	33	det	_	_
31	combined	combined	JJ	JJ	_	33	amod	_	_
32	OAP/octamer	oap/octamer	NN	NN	_	33	compound	_	_
33	cis-element	cis-element	NN	NN	_	28	nmod	_	_
34	.	.	.	.	_	17	punct	_	_

1	Mutations	mutation	NNS	NNS	_	7	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	genuine	genuine	JJ	JJ	_	6	amod	_	_
5	octamer-binding	octamer-binding	JJ	JJ	_	6	amod	_	_
6	site	site	NN	NN	_	1	nmod	_	_
7	abrogate	abrogate	VBP	VBP	_	0	root	_	_
8	both	both	CC	CC	_	10	cc:preconj	_	_
9	the	the	DT	DT	_	10	det	_	_
10	binding	binding	NN	NN	_	7	dobj	_	_
11	of	of	IN	IN	_	12	case	_	_
12	Oct-1	oct-1	NN	NN	_	10	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	Oct-2	oct-2	NN	NN	_	12	conj	_	_
15	and	and	CC	CC	_	10	cc	_	_
16	the	the	DT	DT	_	18	det	_	_
17	TPA/Ca(2+)-induced	tpa/ca(2+)-induced	JJ	JJ	_	18	amod	_	_
18	transactivation	transactivation	NN	NN	_	10	conj	_	_
19	of	of	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	OAP/octamer	oap/octamer	NN	NN	_	22	compound	_	_
22	motif	motif	NN	NN	_	18	nmod	_	_
23	.	.	.	.	_	7	punct	_	_

1	OAP	oap	NN	NN	_	2	nsubj	_	_
2	confers	confer	VBZ	VBZ	_	0	root	_	_
3	to	to	TO	TO	_	5	case	_	_
4	Oct-2	oct-2	NN	NN	_	5	compound	_	_
5	responsivity	responsivity	NN	NN	_	2	nmod	_	_
6	to	to	TO	TO	_	8	case	_	_
7	both	both	CC	CC	_	8	cc:preconj	_	_
8	TPA/Ca2+	tpa/ca2+	NN	NN	_	5	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	RA	ra	NN	NN	_	8	conj	_	_
11	,	,	,	,	_	2	punct	_	_
12	since	since	IN	IN	_	20	mark	_	_
13	specific	specific	JJ	JJ	_	14	amod	_	_
14	mutations	mutation	NNS	NNS	_	20	nsubj	_	_
15	of	of	IN	IN	_	18	case	_	_
16	the	the	DT	DT	_	18	det	_	_
17	AP-1/OAP-binding	ap-1/oap-binding	JJ	JJ	_	18	amod	_	_
18	site	site	NN	NN	_	14	nmod	_	_
19	significantly	significantly	RB	RB	_	20	advmod	_	_
20	reduce	reduce	VBP	VBP	_	2	advcl	_	_
21	the	the	DT	DT	_	22	det	_	_
22	transactivation	transactivation	NN	NN	_	20	dobj	_	_
23	by	by	IN	IN	_	24	case	_	_
24	Oct-2	oct-2	NN	NN	_	22	nmod	_	_
25	in	in	IN	IN	_	26	case	_	_
26	response	response	NN	NN	_	20	nmod	_	_
27	to	to	TO	TO	_	28	case	_	_
28	TPA	tpa	NN	NN	_	26	nmod	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	Ca2+	ca2+	NN	NN	_	28	conj	_	_
31	and	and	CC	CC	_	20	cc	_	_
32	abolish	abolish	VBP	VBP	_	20	conj	_	_
33	the	the	DT	DT	_	34	det	_	_
34	inhibition	inhibition	NN	NN	_	32	dobj	_	_
35	by	by	IN	IN	_	36	case	_	_
36	RA	ra	NN	NN	_	34	nmod	_	_
37	.	.	.	.	_	2	punct	_	_

1	Furthermore	furthermore	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	retinoic	retinoic	JJ	JJ	_	5	amod	_	_
4	acid	acid	NN	NN	_	5	compound	_	_
5	receptor	receptor	NN	NN	_	9	compound	_	_
6	(	(	-LRB-	-LRB-	_	7	punct	_	_
7	RAR	rar	NN	NN	_	5	appos	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	alpha	alpha	NN	NN	_	11	nsubj	_	_
10	is	be	VBZ	VBZ	_	11	cop	_	_
11	able	able	JJ	JJ	_	0	root	_	_
12	to	to	TO	TO	_	13	mark	_	_
13	inhibit	inhibit	VB	VB	_	11	xcomp	_	_
14	in	in	FW	FW	_	15	compound	_	_
15	vitro	vitro	FW	FW	_	13	advmod	_	_
16	the	the	DT	DT	_	17	det	_	_
17	formation	formation	NN	NN	_	13	dobj	_	_
18	of	of	IN	IN	_	20	case	_	_
19	the	the	DT	DT	_	20	det	_	_
20	complex	complex	NN	NN	_	17	nmod	_	_
21	between	between	IN	IN	_	24	case	_	_
22	the	the	DT	DT	_	24	det	_	_
23	nuclear	nuclear	JJ	JJ	_	24	amod	_	_
24	AP-1/OAP	ap-1/oap	NN	NN	_	20	nmod	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	its	its	PRP$	PRP$	_	29	nmod:poss	_	_
27	specific	specific	JJ	JJ	_	29	amod	_	_
28	binding	bind	VBG	VBG	_	29	amod	_	_
29	site	site	NN	NN	_	24	conj	_	_
30	,	,	,	,	_	11	punct	_	_
31	resulting	result	VBG	VBG	_	11	xcomp	_	_
32	in	in	IN	IN	_	34	case	_	_
33	the	the	DT	DT	_	34	det	_	_
34	interference	interference	NN	NN	_	31	nmod	_	_
35	with	with	IN	IN	_	38	case	_	_
36	Oct-2-dependent	oct-2-dependent	JJ	JJ	_	38	amod	_	_
37	cis-regulatory	cis-regulatory	JJ	JJ	_	38	amod	_	_
38	function	function	NN	NN	_	34	nmod	_	_
39	of	of	IN	IN	_	42	case	_	_
40	this	this	DT	DT	_	42	det	_	_
41	AP-1	ap-1	NN	NN	_	42	compound	_	_
42	element	element	NN	NN	_	38	nmod	_	_
43	.	.	.	.	_	11	punct	_	_

1	Therefore	therefore	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	propose	propose	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	13	mark	_	_
6	the	the	DT	DT	_	9	det	_	_
7	TPA/calcium-activated	tpa/calcium-activated	JJ	JJ	_	9	amod	_	_
8	AP-1/OAP	ap-1/oap	NN	NN	_	9	compound	_	_
9	element	element	NN	NN	_	13	nsubj	_	_
10	is	be	VBZ	VBZ	_	13	cop	_	_
11	the	the	DT	DT	_	13	det	_	_
12	main	main	JJ	JJ	_	13	amod	_	_
13	target	target	NN	NN	_	4	ccomp	_	_
14	of	of	IN	IN	_	15	case	_	_
15	positive	positive	JJ	JJ	_	13	nmod	_	_
16	or	or	CC	CC	_	15	cc	_	_
17	negative	negative	JJ	JJ	_	15	conj	_	_
18	regulatory	regulatory	JJ	JJ	_	19	amod	_	_
19	signals	signal	NNS	NNS	_	15	dep	_	_
20	influencing	influence	VBG	VBG	_	15	acl	_	_
21	the	the	DT	DT	_	24	det	_	_
22	IL-2	il-2	NN	NN	_	24	compound	_	_
23	octamer	octamer	NN	NN	_	24	compound	_	_
24	motif	motif	NN	NN	_	20	dobj	_	_
25	,	,	,	,	_	20	punct	_	_
26	through	through	IN	IN	_	27	case	_	_
27	synergism	synergism	NN	NN	_	20	nmod	_	_
28	with	with	IN	IN	_	29	case	_	_
29	Oct-2	oct-2	NN	NN	_	27	nmod	_	_
30	and	and	CC	CC	_	27	cc	_	_
31	antagonism	antagonism	NN	NN	_	27	conj	_	_
32	by	by	IN	IN	_	33	case	_	_
33	RAR	rar	NN	NN	_	31	nmod	_	_
34	.	.	.	.	_	4	punct	_	_

1	Human	human	JJ	JJ	_	8	amod	_	_
2	T-cell	t-cell	NN	NN	_	8	compound	_	_
3	leukemia	leukemia	NN	NN	_	8	compound	_	_
4	virus	virus	NN	NN	_	8	compound	_	_
5	type	type	NN	NN	_	8	compound	_	_
6	I	i	CD	CD	_	8	nummod	_	_
7	Tax	tax	NN	NN	_	8	compound	_	_
8	activation	activation	NN	NN	_	12	nsubj	_	_
9	of	of	IN	IN	_	11	case	_	_
10	NF-kappa	nf-kappa	NN	NN	_	11	compound	_	_
11	B/Rel	b/rel	NN	NN	_	8	nmod	_	_
12	involves	involve	VBZ	VBZ	_	0	root	_	_
13	phosphorylation	phosphorylation	NN	NN	_	12	dobj	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	degradation	degradation	NN	NN	_	13	conj	_	_
16	of	of	IN	IN	_	20	case	_	_
17	I	i	NN	NN	_	20	compound	_	_
18	kappa	kappa	NN	NN	_	20	compound	_	_
19	B	b	NN	NN	_	20	compound	_	_
20	alpha	alpha	NN	NN	_	13	nmod	_	_
21	and	and	CC	CC	_	13	cc	_	_
22	RelA	rela	NN	NN	_	27	compound	_	_
23	(	(	-LRB-	-LRB-	_	24	punct	_	_
24	p65	p65	NN	NN	_	22	appos	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	-mediated	-mediated	JJ	JJ	_	27	amod	_	_
27	induction	induction	NN	NN	_	13	conj	_	_
28	of	of	IN	IN	_	31	case	_	_
29	the	the	DT	DT	_	31	det	_	_
30	c-rel	c-rel	JJ	JJ	_	31	amod	_	_
31	gene	gene	NN	NN	_	27	nmod	_	_
32	.	.	.	.	_	12	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	tax	tax	NN	NN	_	4	compound	_	_
3	gene	gene	NN	NN	_	4	compound	_	_
4	product	product	NN	NN	_	19	nsubj	_	_
5	of	of	IN	IN	_	10	case	_	_
6	human	human	JJ	JJ	_	10	amod	_	_
7	T-cell	t-cell	NN	NN	_	10	compound	_	_
8	leukemia	leukemia	NN	NN	_	10	compound	_	_
9	virus	virus	NN	NN	_	10	compound	_	_
10	type	type	NN	NN	_	4	nmod	_	_
11	I	i	CD	CD	_	10	nummod	_	_
12	(	(	-LRB-	-LRB-	_	13	punct	_	_
13	HTLV-I	htlv-i	NN	NN	_	10	appos	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	is	be	VBZ	VBZ	_	19	cop	_	_
16	a	a	DT	DT	_	19	det	_	_
17	potent	potent	JJ	JJ	_	19	amod	_	_
18	transcriptional	transcriptional	JJ	JJ	_	19	amod	_	_
19	activator	activator	NN	NN	_	0	root	_	_
20	that	that	WDT	WDT	_	22	nsubj	_	_
21	both	both	CC	CC	_	22	cc:preconj	_	_
22	stimulates	stimulate	VBZ	VBZ	_	19	acl:relcl	_	_
23	viral	viral	JJ	JJ	_	25	amod	_	_
24	gene	gene	NN	NN	_	25	compound	_	_
25	expression	expression	NN	NN	_	22	dobj	_	_
26	and	and	CC	CC	_	22	cc	_	_
27	activates	activate	VBZ	VBZ	_	22	conj	_	_
28	an	a	DT	DT	_	29	det	_	_
29	array	array	NN	NN	_	27	dobj	_	_
30	of	of	IN	IN	_	32	case	_	_
31	cellular	cellular	JJ	JJ	_	32	amod	_	_
32	genes	gene	NNS	NNS	_	29	nmod	_	_
33	involved	involve	VBN	VBN	_	32	acl	_	_
34	in	in	IN	IN	_	36	case	_	_
35	T-cell	t-cell	NN	NN	_	36	compound	_	_
36	growth	growth	NN	NN	_	33	nmod	_	_
37	.	.	.	.	_	19	punct	_	_

1	Tax	tax	NN	NN	_	2	nsubj	_	_
2	acts	act	VBZ	VBZ	_	0	root	_	_
3	indirectly	indirectly	RB	RB	_	2	advmod	_	_
4	by	by	IN	IN	_	5	mark	_	_
5	inducing	induce	VBG	VBG	_	2	advcl	_	_
6	or	or	CC	CC	_	5	cc	_	_
7	modifying	modify	VBG	VBG	_	5	conj	_	_
8	the	the	DT	DT	_	9	det	_	_
9	action	action	NN	NN	_	5	dobj	_	_
10	of	of	IN	IN	_	12	case	_	_
11	various	various	JJ	JJ	_	12	amod	_	_
12	host	host	NN	NN	_	9	nmod	_	_
13	transcription	transcription	NN	NN	_	14	compound	_	_
14	factors	factor	NNS	NNS	_	12	dep	_	_
15	,	,	,	,	_	12	punct	_	_
16	including	include	VBG	VBG	_	17	case	_	_
17	members	member	NNS	NNS	_	12	nmod	_	_
18	of	of	IN	IN	_	22	case	_	_
19	the	the	DT	DT	_	22	det	_	_
20	NF-kappa	nf-kappa	NN	NN	_	22	compound	_	_
21	B/Rel	b/rel	NN	NN	_	22	compound	_	_
22	family	family	NN	NN	_	17	nmod	_	_
23	of	of	IN	IN	_	25	case	_	_
24	enhancer-binding	enhancer-binding	JJ	JJ	_	25	amod	_	_
25	proteins	protein	NNS	NNS	_	22	nmod	_	_
26	.	.	.	.	_	2	punct	_	_

1	In	in	IN	IN	_	4	case	_	_
2	resting	rest	VBG	VBG	_	4	amod	_	_
3	T	t	NN	NN	_	4	compound	_	_
4	cells	cell	NNS	NNS	_	13	nmod	_	_
5	,	,	,	,	_	13	punct	_	_
6	many	many	JJ	JJ	_	13	nsubjpass	_	_
7	of	of	IN	IN	_	11	case	_	_
8	these	these	DT	DT	_	11	det	_	_
9	NF-kappa	nf-kappa	NN	NN	_	11	compound	_	_
10	B/Rel	b/rel	NN	NN	_	11	compound	_	_
11	factors	factor	NNS	NNS	_	6	nmod	_	_
12	are	be	VBP	VBP	_	13	auxpass	_	_
13	sequestered	sequester	VBN	VBN	_	0	root	_	_
14	in	in	IN	IN	_	16	case	_	_
15	the	the	DT	DT	_	16	det	_	_
16	cytoplasm	cytoplasm	NN	NN	_	13	nmod	_	_
17	by	by	IN	IN	_	21	case	_	_
18	various	various	JJ	JJ	_	21	amod	_	_
19	ankyrin-rich	ankyrin-rich	JJ	JJ	_	21	amod	_	_
20	inhibitory	inhibitory	JJ	JJ	_	21	amod	_	_
21	proteins	protein	NNS	NNS	_	13	nmod	_	_
22	,	,	,	,	_	21	punct	_	_
23	including	include	VBG	VBG	_	27	case	_	_
24	I	i	NN	NN	_	27	compound	_	_
25	kappa	kappa	NN	NN	_	27	compound	_	_
26	B	b	NN	NN	_	27	compound	_	_
27	alpha	alpha	NN	NN	_	21	nmod	_	_
28	.	.	.	.	_	13	punct	_	_

1	HTLV-I	htlv-i	NN	NN	_	2	compound	_	_
2	Tax	tax	NN	NN	_	3	compound	_	_
3	expression	expression	NN	NN	_	4	nsubj	_	_
4	leads	lead	VBZ	VBZ	_	0	root	_	_
5	to	to	TO	TO	_	9	case	_	_
6	the	the	DT	DT	_	9	det	_	_
7	constitutive	constitutive	JJ	JJ	_	9	amod	_	_
8	nuclear	nuclear	JJ	JJ	_	9	amod	_	_
9	expression	expression	NN	NN	_	4	nmod	_	_
10	of	of	IN	IN	_	14	case	_	_
11	biologically	biologically	RB	RB	_	12	advmod	_	_
12	active	active	JJ	JJ	_	14	amod	_	_
13	NF-kappa	nf-kappa	NN	NN	_	14	compound	_	_
14	B	b	NN	NN	_	9	nmod	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	c-Rel	c-rel	NN	NN	_	17	compound	_	_
17	complexes	complex	NNS	NNS	_	14	conj	_	_
18	;	;	:	:	_	4	punct	_	_
19	however	however	RB	RB	_	30	advmod	_	_
20	,	,	,	,	_	30	punct	_	_
21	the	the	DT	DT	_	25	det	_	_
22	biochemical	biochemical	JJ	JJ	_	25	amod	_	_
23	mechanism	mechanism	NN	NN	_	25	compound	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	s	s	NNS	NNS	_	30	nsubj	_	_
26	)	)	-RRB-	-RRB-	_	25	punct	_	_
27	underlying	underlie	VBG	VBG	_	25	acl	_	_
28	this	this	DT	DT	_	29	det	_	_
29	response	response	NN	NN	_	27	dobj	_	_
30	remains	remain	VBZ	VBZ	_	4	parataxis	_	_
31	poorly	poorly	RB	RB	_	32	advmod	_	_
32	understood	understand	VBN	VBN	_	30	xcomp	_	_
33	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	study	study	NN	NN	_	6	nmod	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
7	that	that	IN	IN	_	23	mark	_	_
8	Tax-stimulated	tax-stimulated	JJ	JJ	_	10	amod	_	_
9	nuclear	nuclear	JJ	JJ	_	10	amod	_	_
10	expression	expression	NN	NN	_	23	nsubjpass	_	_
11	of	of	IN	IN	_	13	case	_	_
12	NF-kappa	nf-kappa	NN	NN	_	13	compound	_	_
13	B	b	NN	NN	_	10	nmod	_	_
14	in	in	IN	IN	_	21	case	_	_
15	both	both	CC	CC	_	21	dep	_	_
16	HTLV-I-infected	htlv-i-infected	JJ	JJ	_	21	amod	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	Tax-transfected	tax-transfected	JJ	JJ	_	16	conj	_	_
19	human	human	JJ	JJ	_	21	amod	_	_
20	T	t	NN	NN	_	21	compound	_	_
21	cells	cell	NNS	NNS	_	10	nmod	_	_
22	is	be	VBZ	VBZ	_	23	auxpass	_	_
23	associated	associate	VBN	VBN	_	6	ccomp	_	_
24	with	with	IN	IN	_	26	case	_	_
25	the	the	DT	DT	_	26	dep	_	_
26	phosphorylation	phosphorylation	NN	NN	_	23	nmod	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	rapid	rapid	JJ	JJ	_	30	amod	_	_
29	proteolytic	proteolytic	JJ	JJ	_	28	dep	_	_
30	degradation	degradation	NN	NN	_	26	conj	_	_
31	of	of	IN	IN	_	35	case	_	_
32	I	i	NN	NN	_	35	compound	_	_
33	kappa	kappa	NN	NN	_	35	compound	_	_
34	B	b	NN	NN	_	35	compound	_	_
35	alpha	alpha	NN	NN	_	26	nmod	_	_
36	.	.	.	.	_	6	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	22	nmod	_	_
3	to	to	TO	TO	_	7	case	_	_
4	prior	prior	JJ	JJ	_	7	amod	_	_
5	in	in	FW	FW	_	4	dep	_	_
6	vitro	vitro	FW	FW	_	5	dep	_	_
7	studies	study	NNS	NNS	_	2	nmod	_	_
8	,	,	,	,	_	22	punct	_	_
9	at	at	IN	IN	_	10	case	_	_
10	least	least	JJS	JJS	_	12	advmod	_	_
11	a	a	DT	DT	_	12	det	_	_
12	fraction	fraction	NN	NN	_	22	nsubj	_	_
13	of	of	IN	IN	_	16	case	_	_
14	the	the	DT	DT	_	16	det	_	_
15	phosphorylated	phosphorylated	JJ	JJ	_	16	amod	_	_
16	form	form	NN	NN	_	12	nmod	_	_
17	of	of	IN	IN	_	21	case	_	_
18	I	i	NN	NN	_	21	compound	_	_
19	kappa	kappa	NN	NN	_	21	compound	_	_
20	B	b	NN	NN	_	21	compound	_	_
21	alpha	alpha	NN	NN	_	16	nmod	_	_
22	remains	remain	VBZ	VBZ	_	0	root	_	_
23	physically	physically	RB	RB	_	22	advmod	_	_
24	associated	associate	VBN	VBN	_	22	xcomp	_	_
25	with	with	IN	IN	_	29	case	_	_
26	the	the	DT	DT	_	29	det	_	_
27	NF-kappa	nf-kappa	NN	NN	_	29	compound	_	_
28	B	b	NN	NN	_	29	compound	_	_
29	complex	complex	NN	NN	_	24	nmod	_	_
30	in	in	FW	FW	_	31	compound	_	_
31	vivo	vivo	FW	FW	_	24	advmod	_	_
32	but	but	CC	CC	_	22	cc	_	_
33	is	be	VBZ	VBZ	_	34	cop	_	_
34	subject	subject	JJ	JJ	_	22	conj	_	_
35	to	to	TO	TO	_	37	case	_	_
36	rapid	rapid	JJ	JJ	_	37	amod	_	_
37	degradation	degradation	NN	NN	_	34	nmod	_	_
38	,	,	,	,	_	34	punct	_	_
39	thereby	thereby	RB	RB	_	40	advmod	_	_
40	promoting	promote	VBG	VBG	_	34	xcomp	_	_
41	the	the	DT	DT	_	43	det	_	_
42	nuclear	nuclear	JJ	JJ	_	43	amod	_	_
43	translocation	translocation	NN	NN	_	40	dobj	_	_
44	of	of	IN	IN	_	49	case	_	_
45	the	the	DT	DT	_	49	det	_	_
46	active	active	JJ	JJ	_	49	amod	_	_
47	NF-kappa	nf-kappa	NN	NN	_	49	compound	_	_
48	B	b	NN	NN	_	49	compound	_	_
49	complex	complex	NN	NN	_	43	nmod	_	_
50	.	.	.	.	_	22	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	further	further	RB	RB	_	3	advmod	_	_
3	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	12	mark	_	_
5	Tax	tax	NN	NN	_	6	compound	_	_
6	induction	induction	NN	NN	_	12	nsubjpass	_	_
7	of	of	IN	IN	_	10	case	_	_
8	nuclear	nuclear	JJ	JJ	_	10	amod	_	_
9	c-Rel	c-rel	NN	NN	_	10	compound	_	_
10	expression	expression	NN	NN	_	6	nmod	_	_
11	is	be	VBZ	VBZ	_	12	auxpass	_	_
12	activated	activate	VBN	VBN	_	3	ccomp	_	_
13	by	by	IN	IN	_	19	case	_	_
14	the	the	DT	DT	_	15	det	_	_
15	RelA	rela	NN	NN	_	19	compound	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	p65	p65	NN	NN	_	15	appos	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	subunit	subunit	NN	NN	_	12	nmod	_	_
20	of	of	IN	IN	_	22	case	_	_
21	NF-kappa	nf-kappa	NN	NN	_	22	compound	_	_
22	B	b	NN	NN	_	19	nmod	_	_
23	,	,	,	,	_	19	punct	_	_
24	which	which	WDT	WDT	_	25	nsubj	_	_
25	activates	activate	VBZ	VBZ	_	19	acl:relcl	_	_
26	transcription	transcription	NN	NN	_	25	dobj	_	_
27	of	of	IN	IN	_	30	case	_	_
28	the	the	DT	DT	_	30	det	_	_
29	c-rel	c-rel	JJ	JJ	_	30	amod	_	_
30	gene	gene	NN	NN	_	26	nmod	_	_
31	through	through	IN	IN	_	37	case	_	_
32	an	a	DT	DT	_	37	det	_	_
33	intrinsic	intrinsic	JJ	JJ	_	37	amod	_	_
34	kappa	kappa	NN	NN	_	37	compound	_	_
35	B	b	NN	NN	_	37	compound	_	_
36	enhancer	enhancer	NN	NN	_	37	compound	_	_
37	element	element	NN	NN	_	25	nmod	_	_
38	.	.	.	.	_	3	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	normal	normal	JJ	JJ	_	3	amod	_	_
3	cells	cell	NNS	NNS	_	11	nmod	_	_
4	,	,	,	,	_	11	punct	_	_
5	the	the	DT	DT	_	7	det	_	_
6	subsequent	subsequent	JJ	JJ	_	7	amod	_	_
7	accumulation	accumulation	NN	NN	_	11	nsubj	_	_
8	of	of	IN	IN	_	10	case	_	_
9	nuclear	nuclear	JJ	JJ	_	10	amod	_	_
10	c-Rel	c-rel	NN	NN	_	7	nmod	_	_
11	acts	act	VBZ	VBZ	_	0	root	_	_
12	to	to	TO	TO	_	13	mark	_	_
13	inhibit	inhibit	VB	VB	_	11	xcomp	_	_
14	its	its	PRP$	PRP$	_	17	nmod:poss	_	_
15	own	own	JJ	JJ	_	17	amod	_	_
16	continued	continued	JJ	JJ	_	17	amod	_	_
17	production	production	NN	NN	_	13	dobj	_	_
18	,	,	,	,	_	11	punct	_	_
19	indicating	indicate	VBG	VBG	_	11	xcomp	_	_
20	the	the	DT	DT	_	21	det	_	_
21	presence	presence	NN	NN	_	19	dobj	_	_
22	of	of	IN	IN	_	25	case	_	_
23	an	a	DT	DT	_	25	det	_	_
24	autoregulatory	autoregulatory	JJ	JJ	_	25	amod	_	_
25	loop	loop	NN	NN	_	21	nmod	_	_
26	.	.	.	.	_	11	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	ABSTRACT	abstract	NN	NN	_	0	root	_	_
3	TRUNCATED	truncate	VBN	VBN	_	2	acl	_	_
4	AT	at	IN	IN	_	6	case	_	_
5	250	250	CD	CD	_	6	nummod	_	_
6	WORDS	word	NNS	NNS	_	3	nmod	_	_
7	)	)	-RRB-	-RRB-	_	2	punct	_	_

1	Distinct	distinct	JJ	JJ	_	4	amod	_	_
2	DNase-I	dnase-i	NN	NN	_	4	compound	_	_
3	hypersensitive	hypersensitive	JJ	JJ	_	4	amod	_	_
4	sites	site	NNS	NNS	_	6	nsubjpass	_	_
5	are	be	VBP	VBP	_	6	auxpass	_	_
6	associated	associate	VBN	VBN	_	0	root	_	_
7	with	with	IN	IN	_	9	case	_	_
8	TAL-1	tal-1	NN	NN	_	9	compound	_	_
9	transcription	transcription	NN	NN	_	6	nmod	_	_
10	in	in	IN	IN	_	11	case	_	_
11	erythroid	erythroid	JJ	JJ	_	9	nmod	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	T-cell	t-cell	NN	NN	_	11	conj	_	_
14	lines	line	NNS	NNS	_	11	dep	_	_
15	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	tal-1	tal-1	NN	NN	_	3	compound	_	_
3	gene	gene	NN	NN	_	18	nsubjpass	_	_
4	,	,	,	,	_	3	punct	_	_
5	frequently	frequently	RB	RB	_	6	advmod	_	_
6	activated	activate	VBN	VBN	_	3	acl	_	_
7	in	in	IN	IN	_	12	case	_	_
8	human	human	JJ	JJ	_	12	amod	_	_
9	T-cell	t-cell	NN	NN	_	12	compound	_	_
10	acute	acute	JJ	JJ	_	12	amod	_	_
11	lymphoblastic	lymphoblastic	JJ	JJ	_	12	amod	_	_
12	leukemia	leukemia	NN	NN	_	6	nmod	_	_
13	(	(	-LRB-	-LRB-	_	14	punct	_	_
14	T-ALL	t-all	NN	NN	_	12	appos	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	,	,	,	,	_	3	punct	_	_
17	is	be	VBZ	VBZ	_	18	auxpass	_	_
18	expressed	express	VBN	VBN	_	0	root	_	_
19	in	in	IN	IN	_	21	case	_	_
20	the	the	DT	DT	_	21	dep	_	_
21	erythroid	erythroid	JJ	JJ	_	18	nmod	_	_
22	,	,	,	,	_	21	punct	_	_
23	megakaryocytic	megakaryocytic	JJ	JJ	_	21	conj	_	_
24	,	,	,	,	_	21	punct	_	_
25	and	and	CC	CC	_	21	cc	_	_
26	mast	mast	NN	NN	_	21	conj	_	_
27	cell	cell	NN	NN	_	28	compound	_	_
28	lineages	lineage	NNS	NNS	_	21	dep	_	_
29	during	during	IN	IN	_	31	case	_	_
30	normal	normal	JJ	JJ	_	31	amod	_	_
31	hematopoiesis	hematopoiesis	NN	NN	_	18	nmod	_	_
32	.	.	.	.	_	18	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	gain	gain	VB	VB	_	0	root	_	_
3	further	further	JJ	JJ	_	4	amod	_	_
4	insight	insight	NN	NN	_	2	dobj	_	_
5	into	into	IN	IN	_	8	case	_	_
6	the	the	DT	DT	_	8	det	_	_
7	molecular	molecular	JJ	JJ	_	8	amod	_	_
8	mechanisms	mechanism	NNS	NNS	_	4	nmod	_	_
9	that	that	WDT	WDT	_	10	nsubj	_	_
10	control	control	VBP	VBP	_	8	acl:relcl	_	_
11	tal-1	tal-1	NN	NN	_	12	compound	_	_
12	expression	expression	NN	NN	_	10	dobj	_	_
13	,	,	,	,	_	2	punct	_	_
14	we	we	PRP	PRP	_	15	nsubj	_	_
15	investigated	investigate	VBD	VBD	_	2	parataxis	_	_
16	tal-1	tal-1	NN	NN	_	18	compound	_	_
17	chromatin	chromatin	NN	NN	_	18	compound	_	_
18	structure	structure	NN	NN	_	15	dobj	_	_
19	in	in	IN	IN	_	22	case	_	_
20	erythroid/megakaryocytic	erythroid/megakaryocytic	JJ	JJ	_	22	amod	_	_
21	cell	cell	NN	NN	_	22	compound	_	_
22	lines	line	NNS	NNS	_	18	nmod	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	in	in	IN	IN	_	26	case	_	_
25	T-cell	t-cell	NN	NN	_	26	compound	_	_
26	lines	line	NNS	NNS	_	22	conj	_	_
27	either	either	CC	CC	_	32	cc:preconj	_	_
28	with	with	IN	IN	_	32	nmod	_	_
29	or	or	CC	CC	_	32	cc	_	_
30	without	without	IN	IN	_	32	conj	_	_
31	tal-1	tal-1	NN	NN	_	32	compound	_	_
32	rearrangements	rearrangement	NNS	NNS	_	26	nmod	_	_
33	.	.	.	.	_	2	punct	_	_

1	Tal-1	tal-1	NN	NN	_	2	compound	_	_
2	transcription	transcription	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	shown	show	VBN	VBN	_	0	root	_	_
5	to	to	TO	TO	_	7	mark	_	_
6	be	be	VB	VB	_	7	cop	_	_
7	monoallelic	monoallelic	JJ	JJ	_	4	xcomp	_	_
8	in	in	IN	IN	_	9	case	_	_
9	Jurkat	jurkat	NN	NN	_	7	nmod	_	_
10	,	,	,	,	_	9	punct	_	_
11	a	a	DT	DT	_	13	det	_	_
12	T-cell	t-cell	NN	NN	_	13	compound	_	_
13	line	line	NN	NN	_	9	appos	_	_
14	that	that	WDT	WDT	_	15	nsubj	_	_
15	expresses	express	VBZ	VBZ	_	13	acl:relcl	_	_
16	tal-1	tal-1	NN	NN	_	15	dobj	_	_
17	in	in	IN	IN	_	19	case	_	_
18	the	the	DT	DT	_	19	det	_	_
19	absence	absence	NN	NN	_	15	nmod	_	_
20	of	of	IN	IN	_	23	case	_	_
21	apparent	apparent	JJ	JJ	_	23	dep	_	_
22	genomic	genomic	JJ	JJ	_	23	dep	_	_
23	alteration	alteration	NN	NN	_	19	nmod	_	_
24	of	of	IN	IN	_	26	case	_	_
25	the	the	DT	DT	_	26	det	_	_
26	locus	locus	NN	NN	_	23	nmod	_	_
27	.	.	.	.	_	4	punct	_	_

1	Methylation	methylation	NN	NN	_	2	compound	_	_
2	studies	study	NNS	NNS	_	3	nsubj	_	_
3	indicated	indicate	VBD	VBD	_	0	root	_	_
4	that	that	IN	IN	_	10	mark	_	_
5	the	the	DT	DT	_	9	det	_	_
6	tal-15	tal-15	NN	NN	_	9	nmod:poss	_	_
7	'	'	POS	POS	_	9	case	_	_
8	GC-rich	gc-rich	JJ	JJ	_	9	amod	_	_
9	region	region	NN	NN	_	10	nsubj	_	_
10	behaves	behave	VBZ	VBZ	_	3	ccomp	_	_
11	like	like	IN	IN	_	14	case	_	_
12	a	a	DT	DT	_	14	det	_	_
13	CpG	cpg	NN	NN	_	14	compound	_	_
14	island	island	NN	NN	_	10	nmod	_	_
15	,	,	,	,	_	14	punct	_	_
16	hypomethylated	hypomethylate	VBN	VBN	_	14	dep	_	_
17	in	in	IN	IN	_	19	case	_	_
18	normal	normal	JJ	JJ	_	19	amod	_	_
19	cells	cell	NNS	NNS	_	16	nmod	_	_
20	,	,	,	,	_	16	punct	_	_
21	and	and	CC	CC	_	16	cc	_	_
22	methylated	methylate	VBN	VBN	_	16	conj	_	_
23	de	de	FW	FW	_	24	compound	_	_
24	novo	novo	FW	FW	_	22	advmod	_	_
25	on	on	IN	IN	_	28	case	_	_
26	transcriptionally	transcriptionally	RB	RB	_	28	advmod	_	_
27	inactive	inactive	JJ	JJ	_	28	amod	_	_
28	alleles	allele	NNS	NNS	_	22	nmod	_	_
29	in	in	IN	IN	_	32	case	_	_
30	established	established	JJ	JJ	_	32	amod	_	_
31	cell	cell	NN	NN	_	32	compound	_	_
32	lines	line	NNS	NNS	_	28	nmod	_	_
33	.	.	.	.	_	3	punct	_	_

1	Five	five	CD	CD	_	5	nummod	_	_
2	major	major	JJ	JJ	_	5	amod	_	_
3	DNase-I	dnase-i	NN	NN	_	5	compound	_	_
4	hypersensitive	hypersensitive	JJ	JJ	_	5	amod	_	_
5	sites	site	NNS	NNS	_	10	nsubjpass	_	_
6	(	(	-LRB-	-LRB-	_	7	punct	_	_
7	HS	hs	NN	NN	_	5	appos	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	were	be	VBD	VBD	_	10	auxpass	_	_
10	mapped	map	VBN	VBN	_	0	root	_	_
11	in	in	IN	IN	_	14	case	_	_
12	the	the	DT	DT	_	14	det	_	_
13	tal-1	tal-1	NN	NN	_	14	compound	_	_
14	locus	locus	NN	NN	_	10	nmod	_	_
15	.	.	.	.	_	10	punct	_	_

1	HS	hs	NN	NN	_	10	nsubjpass	_	_
2	I	i	CD	CD	_	1	dep	_	_
3	,	,	,	,	_	1	punct	_	_
4	IV	iv	CD	CD	_	1	conj	_	_
5	,	,	,	,	_	1	punct	_	_
6	and	and	CC	CC	_	1	cc	_	_
7	V	v	CD	CD	_	1	conj	_	_
8	were	be	VBD	VBD	_	10	auxpass	_	_
9	exclusively	exclusively	RB	RB	_	10	advmod	_	_
10	observed	observe	VBN	VBN	_	0	root	_	_
11	in	in	IN	IN	_	15	case	_	_
12	the	the	DT	DT	_	15	det	_	_
13	erythroid/megakaryocytic	erythroid/megakaryocytic	JJ	JJ	_	15	amod	_	_
14	cell	cell	NN	NN	_	15	compound	_	_
15	lines	line	NNS	NNS	_	10	nmod	_	_
16	that	that	WDT	WDT	_	17	nsubj	_	_
17	express	express	VBP	VBP	_	15	acl:relcl	_	_
18	tal-1	tal-1	NN	NN	_	17	dobj	_	_
19	from	from	IN	IN	_	21	case	_	_
20	the	the	DT	DT	_	21	det	_	_
21	promoters	promoter	NNS	NNS	_	17	nmod	_	_
22	1a	1a	NN	NN	_	21	dep	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	1b	1b	NN	NN	_	22	conj	_	_
25	.	.	.	.	_	10	punct	_	_

1	HS	hs	NN	NN	_	4	nsubjpass	_	_
2	II	ii	CD	CD	_	1	nummod	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	weak	weak	JJ	JJ	_	0	root	_	_
5	in	in	IN	IN	_	8	case	_	_
6	hematopoietic	hematopoietic	JJ	JJ	_	8	amod	_	_
7	cell	cell	NN	NN	_	8	compound	_	_
8	lines	line	NNS	NNS	_	4	nmod	_	_
9	,	,	,	,	_	4	punct	_	_
10	absent	absent	JJ	JJ	_	4	conj	_	_
11	in	in	IN	IN	_	12	case	_	_
12	Hela	hela	NN	NN	_	10	nmod	_	_
13	,	,	,	,	_	4	punct	_	_
14	and	and	CC	CC	_	4	cc	_	_
15	greatly	greatly	RB	RB	_	4	advmod	_	_
16	enhanced	enhance	VBN	VBN	_	4	conj	_	_
17	in	in	IN	IN	_	18	case	_	_
18	Jurkat	jurkat	NN	NN	_	16	nmod	_	_
19	,	,	,	,	_	4	punct	_	_
20	suggesting	suggest	VBG	VBG	_	4	xcomp	_	_
21	that	that	IN	IN	_	26	mark	_	_
22	this	this	DT	DT	_	23	det	_	_
23	region	region	NN	NN	_	26	nsubjpass	_	_
24	might	might	MD	MD	_	26	aux	_	_
25	be	be	VB	VB	_	26	auxpass	_	_
26	implicated	implicate	VBN	VBN	_	20	ccomp	_	_
27	in	in	IN	IN	_	29	case	_	_
28	the	the	DT	DT	_	29	det	_	_
29	cis-activation	cis-activation	NN	NN	_	26	nmod	_	_
30	of	of	IN	IN	_	33	case	_	_
31	tal-1	tal-1	NN	NN	_	33	compound	_	_
32	promoter	promoter	NN	NN	_	33	compound	_	_
33	1b	1b	NN	NN	_	29	nmod	_	_
34	in	in	IN	IN	_	37	case	_	_
35	this	this	DT	DT	_	37	det	_	_
36	cell	cell	NN	NN	_	37	compound	_	_
37	line	line	NN	NN	_	33	nmod	_	_
38	.	.	.	.	_	4	punct	_	_

1	HS	hs	NN	NN	_	4	nsubjpass	_	_
2	III	iii	CD	CD	_	1	nummod	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	weak	weak	JJ	JJ	_	0	root	_	_
5	in	in	IN	IN	_	6	case	_	_
6	HEL	hel	NN	NN	_	4	nmod	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	Jurkat	jurkat	NN	NN	_	6	conj	_	_
9	,	,	,	,	_	4	punct	_	_
10	and	and	CC	CC	_	4	cc	_	_
11	greatly	greatly	RB	RB	_	4	advmod	_	_
12	enhanced	enhance	VBN	VBN	_	4	conj	_	_
13	in	in	IN	IN	_	14	case	_	_
14	DU528	du528	NN	NN	_	12	nmod	_	_
15	,	,	,	,	_	14	punct	_	_
16	a	a	DT	DT	_	18	det	_	_
17	T-cell	t-cell	NN	NN	_	18	compound	_	_
18	line	line	NN	NN	_	14	appos	_	_
19	that	that	WDT	WDT	_	20	nsubj	_	_
20	bears	bear	VBZ	VBZ	_	18	acl:relcl	_	_
21	a	a	DT	DT	_	22	det	_	_
22	t(1;14)	t(1;14)	NN	NN	_	20	dobj	_	_
23	and	and	CC	CC	_	20	cc	_	_
24	initiates	initiate	VBZ	VBZ	_	20	conj	_	_
25	tal-1	tal-1	NN	NN	_	26	compound	_	_
26	transcription	transcription	NN	NN	_	24	dobj	_	_
27	within	within	IN	IN	_	28	case	_	_
28	exon	exon	NN	NN	_	24	nmod	_	_
29	4	4	CD	CD	_	28	nummod	_	_
30	.	.	.	.	_	4	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	9	mark	_	_
5	distinct	distinct	JJ	JJ	_	7	amod	_	_
6	regulatory	regulatory	JJ	JJ	_	7	amod	_	_
7	elements	element	NNS	NNS	_	9	nsubjpass	_	_
8	are	be	VBP	VBP	_	9	auxpass	_	_
9	associated	associate	VBN	VBN	_	3	ccomp	_	_
10	with	with	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	use	use	NN	NN	_	9	nmod	_	_
13	of	of	IN	IN	_	17	case	_	_
14	the	the	DT	DT	_	17	det	_	_
15	different	different	JJ	JJ	_	17	amod	_	_
16	tal-1	tal-1	NN	NN	_	17	compound	_	_
17	promoters	promoter	NNS	NNS	_	12	nmod	_	_
18	.	.	.	.	_	3	punct	_	_

1	Functions	function	NNS	NNS	_	0	root	_	_
2	of	of	IN	IN	_	3	case	_	_
3	glutathione	glutathione	NN	NN	_	1	nmod	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	glutathione	glutathione	NN	NN	_	6	compound	_	_
6	disulfide	disulfide	NN	NN	_	3	conj	_	_
7	in	in	IN	IN	_	8	case	_	_
8	immunology	immunology	NN	NN	_	1	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	immunopathology	immunopathology	NN	NN	_	8	conj	_	_
11	.	.	.	.	_	1	punct	_	_

1	Even	even	RB	RB	_	4	advmod	_	_
2	a	a	DT	DT	_	4	det	_	_
3	moderate	moderate	JJ	JJ	_	4	amod	_	_
4	increase	increase	NN	NN	_	10	nsubj	_	_
5	in	in	IN	IN	_	9	case	_	_
6	the	the	DT	DT	_	9	det	_	_
7	cellular	cellular	JJ	JJ	_	9	amod	_	_
8	cysteine	cysteine	NN	NN	_	9	compound	_	_
9	supply	supply	NN	NN	_	4	nmod	_	_
10	elevates	elevate	VBZ	VBZ	_	0	root	_	_
11	the	the	DT	DT	_	13	dep	_	_
12	intracellular	intracellular	JJ	JJ	_	13	amod	_	_
13	glutathione	glutathione	NN	NN	_	10	dobj	_	_
14	(	(	-LRB-	-LRB-	_	15	punct	_	_
15	GSH	gsh	NN	NN	_	13	appos	_	_
16	)	)	-RRB-	-RRB-	_	15	punct	_	_
17	and	and	CC	CC	_	13	cc	_	_
18	glutathione	glutathione	NN	NN	_	19	compound	_	_
19	disulfide	disulfide	NN	NN	_	13	conj	_	_
20	(	(	-LRB-	-LRB-	_	21	punct	_	_
21	GSSG	gssg	NN	NN	_	19	appos	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	levels	level	NNS	NNS	_	13	dep	_	_
24	and	and	CC	CC	_	10	cc	_	_
25	potentiates	potentiate	VBZ	VBZ	_	10	conj	_	_
26	immunological	immunological	JJ	JJ	_	27	amod	_	_
27	functions	function	NNS	NNS	_	25	dobj	_	_
28	of	of	IN	IN	_	29	case	_	_
29	lymphocytes	lymphocyte	NNS	NNS	_	27	nmod	_	_
30	in	in	FW	FW	_	31	compound	_	_
31	vitro	vitro	FW	FW	_	25	advmod	_	_
32	.	.	.	.	_	10	punct	_	_

1	At	at	IN	IN	_	4	case	_	_
2	low	low	JJ	JJ	_	4	amod	_	_
3	GSSG	gssg	NN	NN	_	4	compound	_	_
4	levels	level	NNS	NNS	_	11	nmod	_	_
5	,	,	,	,	_	11	punct	_	_
6	T	t	NN	NN	_	7	compound	_	_
7	cells	cell	NNS	NNS	_	11	nsubj	_	_
8	can	can	MD	MD	_	11	aux	_	_
9	not	not	RB	RB	_	11	neg	_	_
10	optimally	optimally	RB	RB	_	11	advmod	_	_
11	activate	activate	VB	VB	_	0	root	_	_
12	the	the	DT	DT	_	16	det	_	_
13	immunologically	immunologically	RB	RB	_	14	advmod	_	_
14	important	important	JJ	JJ	_	16	amod	_	_
15	transcription	transcription	NN	NN	_	16	compound	_	_
16	factor	factor	NN	NN	_	11	dobj	_	_
17	NF	nf	NN	NN	_	19	compound	_	_
18	kappa	kappa	NN	NN	_	19	compound	_	_
19	B	b	NN	NN	_	16	dep	_	_
20	,	,	,	,	_	11	punct	_	_
21	whereas	whereas	IN	IN	_	25	mark	_	_
22	high	high	JJ	JJ	_	24	amod	_	_
23	GSSG	gssg	NN	NN	_	24	compound	_	_
24	levels	level	NNS	NNS	_	25	nsubj	_	_
25	inhibit	inhibit	VBP	VBP	_	11	advcl	_	_
26	the	the	DT	DT	_	29	det	_	_
27	DNA	dna	NN	NN	_	29	compound	_	_
28	binding	binding	NN	NN	_	29	compound	_	_
29	activity	activity	NN	NN	_	25	dobj	_	_
30	of	of	IN	IN	_	33	case	_	_
31	NF	nf	NN	NN	_	33	compound	_	_
32	kappa	kappa	NN	NN	_	33	compound	_	_
33	B	b	NN	NN	_	29	nmod	_	_
34	.	.	.	.	_	11	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	effects	effect	NNS	NNS	_	6	nsubjpass	_	_
3	of	of	IN	IN	_	4	case	_	_
4	GSSG	gssg	NN	NN	_	2	nmod	_	_
5	are	be	VBP	VBP	_	6	auxpass	_	_
6	antagonized	antagonize	VBN	VBN	_	0	root	_	_
7	by	by	IN	IN	_	9	case	_	_
8	reduced	reduce	VBN	VBN	_	9	amod	_	_
9	thioredoxin	thioredoxin	NN	NN	_	6	nmod	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	TRX	trx	NN	NN	_	9	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	.	.	.	.	_	6	punct	_	_

1	As	as	IN	IN	_	11	mark	_	_
2	the	the	DT	DT	_	6	det	_	_
3	protein	protein	NN	NN	_	5	compound	_	_
4	tyrosine	tyrosine	NN	NN	_	5	compound	_	_
5	kinase	kinase	NN	NN	_	6	compound	_	_
6	activities	activity	NNS	NNS	_	11	nsubjpass	_	_
7	p56lck	p56lck	NN	NN	_	6	dep	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	p59fyn	p59fyn	NN	NN	_	7	conj	_	_
10	are	be	VBP	VBP	_	11	auxpass	_	_
11	activated	activate	VBN	VBN	_	22	advcl	_	_
12	in	in	IN	IN	_	14	case	_	_
13	intact	intact	JJ	JJ	_	14	amod	_	_
14	cells	cell	NNS	NNS	_	11	nmod	_	_
15	by	by	IN	IN	_	17	case	_	_
16	hydrogen	hydrogen	NN	NN	_	17	compound	_	_
17	peroxide	peroxide	NN	NN	_	11	nmod	_	_
18	,	,	,	,	_	22	punct	_	_
19	they	they	PRP	PRP	_	22	nsubj	_	_
20	are	be	VBP	VBP	_	22	cop	_	_
21	likely	likely	JJ	JJ	_	22	amod	_	_
22	targets	target	NNS	NNS	_	0	root	_	_
23	for	for	IN	IN	_	25	case	_	_
24	GSSG	gssg	NN	NN	_	25	compound	_	_
25	action	action	NN	NN	_	22	nmod	_	_
26	.	.	.	.	_	22	punct	_	_

1	These	these	DT	DT	_	3	det	_	_
2	redox-regulated	redox-regulated	JJ	JJ	_	3	amod	_	_
3	enzymes	enzyme	NNS	NNS	_	4	nsubj	_	_
4	trigger	trigger	VBP	VBP	_	0	root	_	_
5	signal	signal	NN	NN	_	6	compound	_	_
6	cascades	cascade	NNS	NNS	_	4	dobj	_	_
7	for	for	IN	IN	_	11	case	_	_
8	NF	nf	NN	NN	_	10	compound	_	_
9	kappa	kappa	NN	NN	_	10	compound	_	_
10	B	b	NN	NN	_	11	compound	_	_
11	activation	activation	NN	NN	_	4	nmod	_	_
12	and	and	CC	CC	_	4	cc	_	_
13	transduce	transduce	VBP	VBP	_	4	conj	_	_
14	signals	signal	NNS	NNS	_	13	dobj	_	_
15	from	from	IN	IN	_	20	case	_	_
16	the	the	DT	DT	_	20	det	_	_
17	T	t	NN	NN	_	20	compound	_	_
18	cell	cell	NN	NN	_	20	compound	_	_
19	antigen	antigen	NN	NN	_	20	compound	_	_
20	receptor	receptor	NN	NN	_	13	nmod	_	_
21	,	,	,	,	_	20	punct	_	_
22	from	from	IN	IN	_	23	case	_	_
23	CD4	cd4	NN	NN	_	20	conj	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	CD8	cd8	NN	NN	_	26	compound	_	_
26	molecules	molecule	NNS	NNS	_	23	conj	_	_
27	,	,	,	,	_	20	punct	_	_
28	and	and	CC	CC	_	20	cc	_	_
29	from	from	IN	IN	_	33	case	_	_
30	the	the	DT	DT	_	33	det	_	_
31	IL-2	il-2	NN	NN	_	33	compound	_	_
32	receptor	receptor	NN	NN	_	33	compound	_	_
33	beta-chain	beta-chain	NN	NN	_	20	conj	_	_
34	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	effector	effector	NN	NN	_	3	compound	_	_
3	phase	phase	NN	NN	_	13	nsubjpass	_	_
4	of	of	IN	IN	_	8	case	_	_
5	cytotoxic	cytotoxic	JJ	JJ	_	7	amod	_	_
6	T	t	NN	NN	_	7	compound	_	_
7	cell	cell	NN	NN	_	8	compound	_	_
8	responses	response	NNS	NNS	_	3	nmod	_	_
9	and	and	CC	CC	_	3	cc	_	_
10	IL-2-dependent	il-2-dependent	JJ	JJ	_	11	amod	_	_
11	functions	function	NNS	NNS	_	3	conj	_	_
12	are	be	VBP	VBP	_	13	auxpass	_	_
13	inhibited	inhibit	VBN	VBN	_	0	root	_	_
14	even	even	RB	RB	_	18	advmod	_	_
15	by	by	IN	IN	_	18	case	_	_
16	a	a	DT	DT	_	18	det	_	_
17	partial	partial	JJ	JJ	_	18	amod	_	_
18	depletion	depletion	NN	NN	_	13	nmod	_	_
19	of	of	IN	IN	_	23	case	_	_
20	the	the	DT	DT	_	23	det	_	_
21	intracellular	intracellular	JJ	JJ	_	23	amod	_	_
22	GSH	gsh	NN	NN	_	23	compound	_	_
23	pool	pool	NN	NN	_	18	nmod	_	_
24	.	.	.	.	_	13	punct	_	_

1	As	as	IN	IN	_	5	mark	_	_
2	signal	signal	NN	NN	_	3	compound	_	_
3	transduction	transduction	NN	NN	_	5	nsubjpass	_	_
4	is	be	VBZ	VBZ	_	5	auxpass	_	_
5	facilitated	facilitate	VBN	VBN	_	11	advcl	_	_
6	by	by	IN	IN	_	8	case	_	_
7	prooxidant	prooxidant	JJ	JJ	_	8	amod	_	_
8	conditions	condition	NNS	NNS	_	5	nmod	_	_
9	,	,	,	,	_	11	punct	_	_
10	we	we	PRP	PRP	_	11	nsubj	_	_
11	propose	propose	VBP	VBP	_	0	root	_	_
12	that	that	IN	IN	_	23	mark	_	_
13	the	the	DT	DT	_	16	det	_	_
14	well-known	well-known	JJ	JJ	_	16	amod	_	_
15	immunological	immunological	JJ	JJ	_	14	dep	_	_
16	consequences	consequence	NNS	NNS	_	23	nsubj	_	_
17	of	of	IN	IN	_	19	case	_	_
18	GSH	gsh	NN	NN	_	19	compound	_	_
19	depletion	depletion	NN	NN	_	16	nmod	_	_
20	ultimately	ultimately	RB	RB	_	23	advmod	_	_
21	may	may	MD	MD	_	23	aux	_	_
22	be	be	VB	VB	_	23	cop	_	_
23	results	result	NNS	NNS	_	11	ccomp	_	_
24	of	of	IN	IN	_	28	case	_	_
25	the	the	DT	DT	_	28	det	_	_
26	accompanying	accompany	VBG	VBG	_	28	amod	_	_
27	GSSG	gssg	NN	NN	_	28	compound	_	_
28	deficiency	deficiency	NN	NN	_	23	nmod	_	_
29	.	.	.	.	_	11	punct	_	_

1	As	as	IN	IN	_	8	mark	_	_
2	HIV-infected	hiv-infected	JJ	JJ	_	3	amod	_	_
3	patients	patient	NNS	NNS	_	8	nsubj	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	SIV-infected	siv-infected	JJ	JJ	_	7	amod	_	_
6	rhesus	rhesus	NN	NN	_	7	compound	_	_
7	macaques	macaque	NNS	NNS	_	3	conj	_	_
8	have	have	VBP	VBP	_	29	advcl	_	_
9	,	,	,	,	_	8	punct	_	_
10	on	on	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	average	average	NN	NN	_	8	nmod	_	_
13	,	,	,	,	_	8	punct	_	_
14	significantly	significantly	RB	RB	_	21	advmod	_	_
15	decreased	decrease	VBN	VBN	_	21	amod	_	_
16	plasma	plasma	NN	NN	_	21	compound	_	_
17	cyst	cyst	NN	NN	_	21	compound	_	_
18	(	(	-LRB-	-LRB-	_	21	punct	_	_
19	e	e	NN	NN	_	21	compound	_	_
20	)	)	-RRB-	-RRB-	_	21	punct	_	_
21	ine	ine	NN	NN	_	8	dobj	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	intracellular	intracellular	JJ	JJ	_	24	amod	_	_
24	GSH	gsh	NN	NN	_	21	conj	_	_
25	levels	level	NNS	NNS	_	21	dep	_	_
26	,	,	,	,	_	29	punct	_	_
27	we	we	PRP	PRP	_	29	nsubj	_	_
28	also	also	RB	RB	_	29	advmod	_	_
29	hypothesize	hypothesize	VBP	VBP	_	0	root	_	_
30	that	that	IN	IN	_	35	mark	_	_
31	AIDS	aids	NN	NN	_	35	nsubj	_	_
32	may	may	MD	MD	_	35	aux	_	_
33	be	be	VB	VB	_	35	cop	_	_
34	the	the	DT	DT	_	35	det	_	_
35	consequence	consequence	NN	NN	_	29	ccomp	_	_
36	of	of	IN	IN	_	39	case	_	_
37	a	a	DT	DT	_	39	det	_	_
38	GSSG	gssg	NN	NN	_	39	compound	_	_
39	deficiency	deficiency	NN	NN	_	35	nmod	_	_
40	as	as	RB	RB	_	35	advmod	_	_
41	well	well	RB	RB	_	40	mwe	_	_
42	.	.	.	.	_	29	punct	_	_

1	Erythropoietin-dependent	erythropoietin-dependent	JJ	JJ	_	2	amod	_	_
2	induction	induction	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	5	case	_	_
4	hemoglobin	hemoglobin	NN	NN	_	5	compound	_	_
5	synthesis	synthesis	NN	NN	_	2	nmod	_	_
6	in	in	IN	IN	_	10	case	_	_
7	a	a	DT	DT	_	10	det	_	_
8	cytokine-dependent	cytokine-dependent	JJ	JJ	_	10	amod	_	_
9	cell	cell	NN	NN	_	10	compound	_	_
10	line	line	NN	NN	_	2	nmod	_	_
11	M-TAT	m-tat	NN	NN	_	10	dep	_	_
12	.	.	.	.	_	2	punct	_	_

1	M-TAT	m-tat	NN	NN	_	6	nsubj	_	_
2	is	be	VBZ	VBZ	_	6	cop	_	_
3	a	a	DT	DT	_	6	det	_	_
4	cytokine-dependent	cytokine-dependent	JJ	JJ	_	6	amod	_	_
5	cell	cell	NN	NN	_	6	compound	_	_
6	line	line	NN	NN	_	0	root	_	_
7	with	with	IN	IN	_	9	case	_	_
8	the	the	DT	DT	_	9	det	_	_
9	potential	potential	NN	NN	_	6	nmod	_	_
10	to	to	TO	TO	_	11	mark	_	_
11	differentiate	differentiate	VB	VB	_	9	acl	_	_
12	along	along	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	dep	_	_
14	erythroid	erythroid	JJ	JJ	_	11	nmod	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	megakaryocytic	megakaryocytic	JJ	JJ	_	14	conj	_	_
17	lineages	lineage	NNS	NNS	_	14	dep	_	_
18	.	.	.	.	_	6	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	cultured	culture	VBD	VBD	_	0	root	_	_
3	M-TAT	m-tat	NN	NN	_	4	compound	_	_
4	cells	cell	NNS	NNS	_	2	iobj	_	_
5	long	long	JJ	JJ	_	6	amod	_	_
6	term	term	NN	NN	_	2	dobj	_	_
7	(	(	-LRB-	-LRB-	_	8	punct	_	_
8	&gt;	&gt;	JJR	JJR	_	6	dep	_	_
9	1	1	CD	CD	_	10	nummod	_	_
10	year	year	NN	NN	_	8	nmod:tmod	_	_
11	)	)	-RRB-	-RRB-	_	8	punct	_	_
12	in	in	IN	IN	_	15	case	_	_
13	the	the	DT	DT	_	15	det	_	_
14	continuous	continuous	JJ	JJ	_	15	amod	_	_
15	presence	presence	NN	NN	_	2	nmod	_	_
16	of	of	IN	IN	_	17	case	_	_
17	erythropoietin	erythropoietin	NN	NN	_	15	nmod	_	_
18	(	(	-LRB-	-LRB-	_	19	punct	_	_
19	EPO	epo	NN	NN	_	17	appos	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	,	,	,	,	_	17	punct	_	_
22	granulocyte-macrophage	granulocyte-macrophage	JJ	JJ	_	24	amod	_	_
23	colony-stimulating	colony-stimulating	JJ	JJ	_	24	amod	_	_
24	factor	factor	NN	NN	_	17	conj	_	_
25	(	(	-LRB-	-LRB-	_	26	punct	_	_
26	GM-CSF	gm-csf	NN	NN	_	24	appos	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	,	,	,	,	_	17	punct	_	_
29	or	or	CC	CC	_	17	cc	_	_
30	stem	stem	NN	NN	_	32	compound	_	_
31	cell	cell	NN	NN	_	32	compound	_	_
32	factor	factor	NN	NN	_	17	conj	_	_
33	(	(	-LRB-	-LRB-	_	34	punct	_	_
34	SCF	scf	NN	NN	_	32	appos	_	_
35	)	)	-RRB-	-RRB-	_	34	punct	_	_
36	.	.	.	.	_	2	punct	_	_

1	These	these	DT	DT	_	4	det	_	_
2	long	long	JJ	JJ	_	4	amod	_	_
3	term	term	NN	NN	_	4	compound	_	_
4	cultures	culture	NNS	NNS	_	6	nsubjpass	_	_
5	are	be	VBP	VBP	_	6	auxpass	_	_
6	referred	refer	VBN	VBN	_	0	root	_	_
7	to	to	TO	TO	_	6	nmod	_	_
8	as	as	IN	IN	_	9	case	_	_
9	M-TAT/EPO	m-tat/epo	NN	NN	_	6	nmod	_	_
10	,	,	,	,	_	9	punct	_	_
11	M-TAT/GM-CSF	m-tat/gm-csf	NN	NN	_	9	conj	_	_
12	,	,	,	,	_	9	punct	_	_
13	and	and	CC	CC	_	9	cc	_	_
14	M-TAT/SCF	m-tat/scf	NN	NN	_	9	conj	_	_
15	cells	cell	NNS	NNS	_	9	dep	_	_
16	,	,	,	,	_	6	punct	_	_
17	respectively	respectively	RB	RB	_	6	advmod	_	_
18	.	.	.	.	_	6	punct	_	_

1	Hemoglobin	hemoglobin	NN	NN	_	2	compound	_	_
2	concentration	concentration	NN	NN	_	13	nsubj	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	gamma-globin	gamma-globin	NN	NN	_	2	conj	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	erythroid	erythroid	JJ	JJ	_	9	amod	_	_
7	delta-aminolevulinate	delta-aminolevulinate	JJ	JJ	_	9	amod	_	_
8	synthase	synthase	NN	NN	_	9	compound	_	_
9	mRNA	mrna	NN	NN	_	4	conj	_	_
10	levels	level	NNS	NNS	_	4	dep	_	_
11	were	be	VBD	VBD	_	13	cop	_	_
12	significantly	significantly	RB	RB	_	13	advmod	_	_
13	higher	higher	JJR	JJR	_	0	root	_	_
14	in	in	IN	IN	_	16	case	_	_
15	M-TAT/EPO	m-tat/epo	NN	NN	_	16	compound	_	_
16	cells	cell	NNS	NNS	_	13	nmod	_	_
17	than	than	IN	IN	_	20	case	_	_
18	in	in	IN	IN	_	20	case	_	_
19	M-TAT/GM-CSF	m-tat/gm-csf	NN	NN	_	20	compound	_	_
20	cells	cell	NNS	NNS	_	13	nmod	_	_
21	.	.	.	.	_	13	punct	_	_

1	When	when	WRB	WRB	_	6	advmod	_	_
2	the	the	DT	DT	_	4	det	_	_
3	supplemented	supplement	VBN	VBN	_	4	amod	_	_
4	cytokine	cytokine	NN	NN	_	6	nsubjpass	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	switched	switch	VBN	VBN	_	17	advcl	_	_
7	from	from	IN	IN	_	8	case	_	_
8	GM-CSF	gm-csf	NN	NN	_	6	nmod	_	_
9	to	to	TO	TO	_	10	case	_	_
10	EPO	epo	NN	NN	_	6	nmod	_	_
11	,	,	,	,	_	17	punct	_	_
12	hemoglobin	hemoglobin	NN	NN	_	13	compound	_	_
13	synthesis	synthesis	NN	NN	_	17	nsubj	_	_
14	in	in	IN	IN	_	16	case	_	_
15	M-TAT/GM-CSF	m-tat/gm-csf	NN	NN	_	16	compound	_	_
16	cells	cell	NNS	NNS	_	13	nmod	_	_
17	increased	increase	VBD	VBD	_	0	root	_	_
18	rapidly	rapidly	RB	RB	_	17	advmod	_	_
19	(	(	-LRB-	-LRB-	_	22	punct	_	_
20	within	within	IN	IN	_	22	case	_	_
21	5	5	CD	CD	_	22	nummod	_	_
22	h	h	NN	NN	_	18	dep	_	_
23	)	)	-RRB-	-RRB-	_	22	punct	_	_
24	,	,	,	,	_	17	punct	_	_
25	and	and	CC	CC	_	17	cc	_	_
26	the	the	DT	DT	_	27	det	_	_
27	level	level	NN	NN	_	31	nsubj	_	_
28	of	of	IN	IN	_	30	case	_	_
29	GATA-1	gata-1	NN	NN	_	30	compound	_	_
30	mRNA	mrna	NN	NN	_	27	nmod	_	_
31	increased	increase	VBD	VBD	_	17	conj	_	_
32	.	.	.	.	_	17	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	13	nmod	_	_
3	,	,	,	,	_	13	punct	_	_
4	the	the	DT	DT	_	5	det	_	_
5	addition	addition	NN	NN	_	13	nsubj	_	_
6	of	of	IN	IN	_	7	case	_	_
7	GM-CSF	gm-csf	NN	NN	_	5	nmod	_	_
8	to	to	TO	TO	_	12	case	_	_
9	the	the	DT	DT	_	12	det	_	_
10	M-TAT/EPO	m-tat/epo	NN	NN	_	12	compound	_	_
11	cell	cell	NN	NN	_	12	compound	_	_
12	culture	culture	NN	NN	_	5	nmod	_	_
13	decreased	decrease	VBD	VBD	_	0	root	_	_
14	the	the	DT	DT	_	15	det	_	_
15	amount	amount	NN	NN	_	13	dobj	_	_
16	of	of	IN	IN	_	17	case	_	_
17	hemoglobin	hemoglobin	NN	NN	_	15	nmod	_	_
18	,	,	,	,	_	13	punct	_	_
19	even	even	RB	RB	_	22	advmod	_	_
20	in	in	IN	IN	_	22	case	_	_
21	the	the	DT	DT	_	22	det	_	_
22	presence	presence	NN	NN	_	13	nmod	_	_
23	of	of	IN	IN	_	24	case	_	_
24	EPO	epo	NN	NN	_	22	nmod	_	_
25	,	,	,	,	_	13	punct	_	_
26	indicating	indicate	VBG	VBG	_	13	advcl	_	_
27	that	that	IN	IN	_	35	mark	_	_
28	the	the	DT	DT	_	30	det	_	_
29	EPO	epo	NN	NN	_	30	compound	_	_
30	signal	signal	NN	NN	_	35	nsubjpass	_	_
31	for	for	IN	IN	_	33	case	_	_
32	erythroid	erythroid	JJ	JJ	_	33	amod	_	_
33	differentiation	differentiation	NN	NN	_	30	nmod	_	_
34	is	be	VBZ	VBZ	_	35	auxpass	_	_
35	suppressed	suppress	VBN	VBN	_	26	ccomp	_	_
36	by	by	IN	IN	_	37	case	_	_
37	GM-CSF	gm-csf	NN	NN	_	35	nmod	_	_
38	.	.	.	.	_	13	punct	_	_

1	Thus	thus	RB	RB	_	9	advmod	_	_
2	,	,	,	,	_	9	punct	_	_
3	erythroid	erythroid	JJ	JJ	_	4	amod	_	_
4	development	development	NN	NN	_	9	nsubjpass	_	_
5	of	of	IN	IN	_	7	case	_	_
6	M-TAT	m-tat	NN	NN	_	7	compound	_	_
7	cells	cell	NNS	NNS	_	4	nmod	_	_
8	is	be	VBZ	VBZ	_	9	auxpass	_	_
9	promoted	promote	VBN	VBN	_	0	root	_	_
10	by	by	IN	IN	_	11	case	_	_
11	EPO	epo	NN	NN	_	9	nmod	_	_
12	and	and	CC	CC	_	9	cc	_	_
13	suppressed	suppress	VBN	VBN	_	9	conj	_	_
14	by	by	IN	IN	_	15	case	_	_
15	GM-CSF	gm-csf	NN	NN	_	13	nmod	_	_
16	.	.	.	.	_	9	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	support	support	VBP	VBP	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	hypothesis	hypothesis	NN	NN	_	3	dobj	_	_
6	that	that	IN	IN	_	9	mark	_	_
7	EPO	epo	NN	NN	_	9	nsubj	_	_
8	actively	actively	RB	RB	_	9	advmod	_	_
9	influences	influence	VBZ	VBZ	_	5	ccomp	_	_
10	the	the	DT	DT	_	11	det	_	_
11	programming	programming	NN	NN	_	9	dobj	_	_
12	of	of	IN	IN	_	14	case	_	_
13	gene	gene	NN	NN	_	14	compound	_	_
14	expression	expression	NN	NN	_	11	nmod	_	_
15	required	require	VBN	VBN	_	14	acl	_	_
16	for	for	IN	IN	_	20	case	_	_
17	erythroid	erythroid	JJ	JJ	_	19	amod	_	_
18	progenitor	progenitor	NN	NN	_	19	compound	_	_
19	cell	cell	NN	NN	_	20	compound	_	_
20	differentiation	differentiation	NN	NN	_	15	nmod	_	_
21	.	.	.	.	_	3	punct	_	_

1	DNA-binding	dna-binding	JJ	JJ	_	2	amod	_	_
2	studies	study	NNS	NNS	_	0	root	_	_
3	of	of	IN	IN	_	8	case	_	_
4	the	the	DT	DT	_	8	det	_	_
5	Epstein-Barr	epstein-barr	JJ	JJ	_	8	amod	_	_
6	virus	virus	NN	NN	_	8	compound	_	_
7	nuclear	nuclear	JJ	JJ	_	8	amod	_	_
8	antigen	antigen	NN	NN	_	2	nmod	_	_
9	2	2	CD	CD	_	8	nummod	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	EBNA-2	ebna-2	NN	NN	_	8	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	:	:	:	:	_	2	punct	_	_
14	evidence	evidence	NN	NN	_	2	dep	_	_
15	for	for	IN	IN	_	17	case	_	_
16	complex	complex	JJ	JJ	_	17	amod	_	_
17	formation	formation	NN	NN	_	14	nmod	_	_
18	by	by	IN	IN	_	24	case	_	_
19	latent	latent	JJ	JJ	_	24	amod	_	_
20	membrane	membrane	NN	NN	_	24	compound	_	_
21	protein	protein	NN	NN	_	24	compound	_	_
22	gene	gene	NN	NN	_	24	compound	_	_
23	promoter-binding	promoter-binding	JJ	JJ	_	24	amod	_	_
24	proteins	protein	NNS	NNS	_	17	nmod	_	_
25	in	in	IN	IN	_	28	case	_	_
26	EBNA-2-positive	ebna-2-positive	JJ	JJ	_	28	amod	_	_
27	cell	cell	NN	NN	_	28	compound	_	_
28	lines	line	NNS	NNS	_	24	nmod	_	_
29	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	13	det	_	_
2	Epstein-Barr	epstein-barr	JJ	JJ	_	8	amod	_	_
3	virus	virus	NN	NN	_	8	compound	_	_
4	(	(	-LRB-	-LRB-	_	8	punct	_	_
5	EBV	ebv	NN	NN	_	8	compound	_	_
6	)	)	-RRB-	-RRB-	_	8	punct	_	_
7	nuclear	nuclear	JJ	JJ	_	8	amod	_	_
8	antigen	antigen	NN	NN	_	13	compound	_	_
9	2	2	CD	CD	_	8	nummod	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	EBNA-2	ebna-2	NN	NN	_	8	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	protein	protein	NN	NN	_	15	nsubj	_	_
14	is	be	VBZ	VBZ	_	15	cop	_	_
15	essential	essential	JJ	JJ	_	0	root	_	_
16	for	for	IN	IN	_	18	case	_	_
17	the	the	DT	DT	_	18	det	_	_
18	immortalization	immortalization	NN	NN	_	15	nmod	_	_
19	of	of	IN	IN	_	23	case	_	_
20	human	human	JJ	JJ	_	23	amod	_	_
21	primary	primary	JJ	JJ	_	23	amod	_	_
22	B	b	NN	NN	_	23	compound	_	_
23	cells	cell	NNS	NNS	_	18	acl	_	_
24	by	by	IN	IN	_	25	case	_	_
25	EBV	ebv	NN	NN	_	18	nmod	_	_
26	.	.	.	.	_	15	punct	_	_

1	EBNA-2	ebna-2	NN	NN	_	2	nsubj	_	_
2	trans-activates	trans-activate	VBZ	VBZ	_	0	root	_	_
3	cellular	cellular	JJ	JJ	_	2	dobj	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	viral	viral	JJ	JJ	_	3	conj	_	_
6	genes	gene	NNS	NNS	_	3	dep	_	_
7	like	like	IN	IN	_	8	case	_	_
8	CD23	cd23	NN	NN	_	3	nmod	_	_
9	,	,	,	,	_	8	punct	_	_
10	c-fgr	c-fgr	NN	NN	_	8	conj	_	_
11	,	,	,	,	_	8	punct	_	_
12	latent	latent	JJ	JJ	_	14	amod	_	_
13	membrane	membrane	NN	NN	_	14	compound	_	_
14	protein	protein	NN	NN	_	8	conj	_	_
15	1	1	CD	CD	_	14	nummod	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	LMP1	lmp1	NN	NN	_	14	appos	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	and	and	CC	CC	_	8	cc	_	_
20	terminal	terminal	JJ	JJ	_	21	amod	_	_
21	protein	protein	NN	NN	_	8	conj	_	_
22	1	1	CD	CD	_	21	nummod	_	_
23	(	(	-LRB-	-LRB-	_	24	punct	_	_
24	TP1	tp1	NN	NN	_	21	appos	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	.	.	.	.	_	2	punct	_	_

1	Trans-activation	trans-activation	NN	NN	_	15	nsubjpass	_	_
2	of	of	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	TP1	tp1	NN	NN	_	5	compound	_	_
5	promoter	promoter	NN	NN	_	1	nmod	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	of	of	IN	IN	_	11	case	_	_
8	the	the	DT	DT	_	11	det	_	_
9	BamHI	bamhi	NN	NN	_	11	compound	_	_
10	C	c	NN	NN	_	11	compound	_	_
11	promoter	promoter	NN	NN	_	5	conj	_	_
12	has	have	VBZ	VBZ	_	15	aux	_	_
13	already	already	RB	RB	_	15	advmod	_	_
14	been	be	VBN	VBN	_	15	auxpass	_	_
15	investigated	investigate	VBN	VBN	_	0	root	_	_
16	in	in	IN	IN	_	17	case	_	_
17	detail	detail	NN	NN	_	15	nmod	_	_
18	and	and	CC	CC	_	15	cc	_	_
19	appears	appear	VBZ	VBZ	_	15	conj	_	_
20	to	to	TO	TO	_	22	mark	_	_
21	be	be	VB	VB	_	22	auxpass	_	_
22	mediated	mediate	VBN	VBN	_	19	xcomp	_	_
23	via	via	IN	IN	_	25	case	_	_
24	protein-protein	protein-protein	JJ	JJ	_	25	amod	_	_
25	interactions	interaction	NNS	NNS	_	22	nmod	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	not	not	RB	RB	_	30	neg	_	_
28	by	by	IN	IN	_	30	case	_	_
29	direct	direct	JJ	JJ	_	30	amod	_	_
30	binding	binding	NN	NN	_	25	conj	_	_
31	of	of	IN	IN	_	34	case	_	_
32	EBNA-2	ebna-2	NN	NN	_	34	compound	_	_
33	type	type	NN	NN	_	34	compound	_	_
34	A	a	NN	NN	_	30	nmod	_	_
35	(	(	-LRB-	-LRB-	_	38	punct	_	_
36	of	of	IN	IN	_	38	case	_	_
37	EBV	ebv	NN	NN	_	38	compound	_	_
38	type	type	NN	NN	_	34	nmod	_	_
39	1	1	CD	CD	_	38	nummod	_	_
40	)	)	-RRB-	-RRB-	_	38	punct	_	_
41	to	to	TO	TO	_	43	case	_	_
42	the	the	DT	DT	_	43	det	_	_
43	DNA	dna	NN	NN	_	30	nmod	_	_
44	.	.	.	.	_	15	punct	_	_

1	EBNA-2	ebna-2	NN	NN	_	3	nsubj	_	_
2	is	be	VBZ	VBZ	_	3	cop	_	_
3	able	able	JJ	JJ	_	0	root	_	_
4	to	to	TO	TO	_	5	mark	_	_
5	trans-activate	trans-activate	VB	VB	_	3	xcomp	_	_
6	the	the	DT	DT	_	7	det	_	_
7	expression	expression	NN	NN	_	5	dobj	_	_
8	of	of	IN	IN	_	11	case	_	_
9	the	the	DT	DT	_	11	det	_	_
10	LMP	lmp	NN	NN	_	11	compound	_	_
11	gene	gene	NN	NN	_	7	nmod	_	_
12	in	in	IN	IN	_	15	case	_	_
13	several	several	JJ	JJ	_	15	amod	_	_
14	cell	cell	NN	NN	_	15	compound	_	_
15	lines	line	NNS	NNS	_	7	nmod	_	_
16	.	.	.	.	_	3	punct	_	_

1	Various	various	JJ	JJ	_	2	amod	_	_
2	reports	report	NNS	NNS	_	4	nsubj	_	_
3	have	have	VBP	VBP	_	4	aux	_	_
4	delineated	delineate	VBN	VBN	_	0	root	_	_
5	the	the	DT	DT	_	7	det	_	_
6	cis-acting	cis-acting	JJ	JJ	_	7	amod	_	_
7	elements	element	NNS	NNS	_	4	dobj	_	_
8	of	of	IN	IN	_	11	case	_	_
9	the	the	DT	DT	_	11	det	_	_
10	LMP	lmp	NN	NN	_	11	compound	_	_
11	promoter	promoter	NN	NN	_	7	nmod	_	_
12	through	through	IN	IN	_	13	case	_	_
13	which	which	WDT	WDT	_	15	nmod	_	_
14	EBNA-2	ebna-2	NN	NN	_	15	nsubj	_	_
15	mediates	mediate	VBZ	VBZ	_	7	acl:relcl	_	_
16	trans-activation	trans-activation	NN	NN	_	15	dobj	_	_
17	.	.	.	.	_	4	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	determine	determine	VB	VB	_	0	root	_	_
3	whether	whether	IN	IN	_	6	mark	_	_
4	EBNA-2	ebna-2	NN	NN	_	6	nsubj	_	_
5	also	also	RB	RB	_	6	advmod	_	_
6	trans-activates	trans-activate	VBZ	VBZ	_	2	ccomp	_	_
7	the	the	DT	DT	_	9	det	_	_
8	LMP	lmp	NN	NN	_	9	compound	_	_
9	promoter	promoter	NN	NN	_	6	dobj	_	_
10	by	by	IN	IN	_	12	case	_	_
11	protein-protein	protein-protein	JJ	JJ	_	12	amod	_	_
12	interactions	interaction	NNS	NNS	_	6	nmod	_	_
13	,	,	,	,	_	2	punct	_	_
14	we	we	PRP	PRP	_	15	nsubj	_	_
15	performed	perform	VBD	VBD	_	2	parataxis	_	_
16	a	a	DT	DT	_	17	det	_	_
17	series	series	NN	NN	_	15	dobj	_	_
18	of	of	IN	IN	_	21	case	_	_
19	gel	gel	NN	NN	_	21	compound	_	_
20	retardation	retardation	NN	NN	_	21	compound	_	_
21	assays	assay	NNS	NNS	_	17	nmod	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	competition	competition	NN	NN	_	24	compound	_	_
24	experiments	experiment	NNS	NNS	_	21	conj	_	_
25	with	with	IN	IN	_	28	case	_	_
26	LMP	lmp	NN	NN	_	28	compound	_	_
27	promoter	promoter	NN	NN	_	28	compound	_	_
28	fragments	fragment	NNS	NNS	_	21	nmod	_	_
29	of	of	IN	IN	_	31	case	_	_
30	different	different	JJ	JJ	_	31	amod	_	_
31	sizes	size	NNS	NNS	_	28	nmod	_	_
32	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	determined	determine	VBD	VBD	_	0	root	_	_
3	that	that	IN	IN	_	16	mark	_	_
4	the	the	DT	DT	_	6	det	_	_
5	protein-binding	protein-binding	JJ	JJ	_	6	amod	_	_
6	region	region	NN	NN	_	16	nsubj	_	_
7	on	on	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	LMP	lmp	NN	NN	_	10	compound	_	_
10	promoter	promoter	NN	NN	_	6	nmod	_	_
11	was	be	VBD	VBD	_	16	cop	_	_
12	within	within	IN	IN	_	16	case	_	_
13	a	a	DT	DT	_	16	det	_	_
14	42	42	CD	CD	_	16	nummod	_	_
15	bp	bp	NN	NN	_	16	compound	_	_
16	fragment	fragment	NN	NN	_	2	ccomp	_	_
17	encompassing	encompass	VBG	VBG	_	16	acl	_	_
18	nucleotides	nucleotide	NNS	NNS	_	17	dobj	_	_
19	-135	-135	CD	CD	_	18	nummod	_	_
20	to	to	TO	TO	_	18	dep	_	_
21	-176	-176	CD	CD	_	18	nummod	_	_
22	relative	relative	JJ	JJ	_	18	amod	_	_
23	to	to	TO	TO	_	28	case	_	_
24	the	the	DT	DT	_	28	det	_	_
25	LMP	lmp	NN	NN	_	28	compound	_	_
26	transcriptional	transcriptional	JJ	JJ	_	28	amod	_	_
27	start	start	NN	NN	_	28	compound	_	_
28	site	site	NN	NN	_	22	nmod	_	_
29	.	.	.	.	_	2	punct	_	_

1	None	none	NN	NN	_	7	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	DNA	dna	NN	NN	_	5	compound	_	_
5	fragments	fragment	NNS	NNS	_	1	nmod	_	_
6	investigated	investigate	VBN	VBN	_	5	acl	_	_
7	indicated	indicate	VBD	VBD	_	0	root	_	_
8	interaction	interaction	NN	NN	_	7	dobj	_	_
9	of	of	IN	IN	_	10	case	_	_
10	EBNA-2	ebna-2	NN	NN	_	8	nmod	_	_
11	with	with	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	DNA	dna	NN	NN	_	8	nmod	_	_
14	via	via	IN	IN	_	16	case	_	_
15	protein-protein	protein-protein	JJ	JJ	_	16	amod	_	_
16	interactions	interaction	NNS	NNS	_	8	nmod	_	_
17	.	.	.	.	_	7	punct	_	_

1	No	no	DT	DT	_	3	neg	_	_
2	significant	significant	JJ	JJ	_	3	amod	_	_
3	differences	difference	NNS	NNS	_	12	nsubjpass	_	_
4	between	between	IN	IN	_	5	case	_	_
5	EBNA-2-positive	ebna-2-positive	JJ	JJ	_	3	nmod	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	EBNA-2-negative	ebna-2-negative	JJ	JJ	_	5	conj	_	_
8	nuclear	nuclear	JJ	JJ	_	9	amod	_	_
9	extracts	extract	NNS	NNS	_	5	dep	_	_
10	could	could	MD	MD	_	12	aux	_	_
11	be	be	VB	VB	_	12	auxpass	_	_
12	seen	see	VBN	VBN	_	0	root	_	_
13	in	in	IN	IN	_	17	case	_	_
14	the	the	DT	DT	_	17	det	_	_
15	gel	gel	NN	NN	_	17	compound	_	_
16	retardation	retardation	NN	NN	_	17	compound	_	_
17	assay	assay	NN	NN	_	12	nmod	_	_
18	under	under	IN	IN	_	19	case	_	_
19	conditions	condition	NNS	NNS	_	12	nmod	_	_
20	that	that	WDT	WDT	_	22	nsubj	_	_
21	clearly	clearly	RB	RB	_	22	advmod	_	_
22	showed	show	VBD	VBD	_	19	acl:relcl	_	_
23	binding	binding	NN	NN	_	22	dobj	_	_
24	of	of	IN	IN	_	25	case	_	_
25	EBNA-2A	ebna-2a	NN	NN	_	23	nmod	_	_
26	to	to	TO	TO	_	29	case	_	_
27	the	the	DT	DT	_	29	det	_	_
28	TP1	tp1	NN	NN	_	29	compound	_	_
29	promoter	promoter	NN	NN	_	23	nmod	_	_
30	.	.	.	.	_	12	punct	_	_

1	However	however	RB	RB	_	13	advmod	_	_
2	,	,	,	,	_	13	punct	_	_
3	analysis	analysis	NN	NN	_	13	nsubj	_	_
4	of	of	IN	IN	_	7	case	_	_
5	sucrose	sucrose	NN	NN	_	7	compound	_	_
6	gradient	gradient	NN	NN	_	7	compound	_	_
7	fractions	fraction	NNS	NNS	_	3	nmod	_	_
8	in	in	IN	IN	_	12	case	_	_
9	the	the	DT	DT	_	12	det	_	_
10	gel	gel	NN	NN	_	12	compound	_	_
11	retardation	retardation	NN	NN	_	12	compound	_	_
12	assay	assay	NN	NN	_	7	nmod	_	_
13	provided	provide	VBD	VBD	_	0	root	_	_
14	evidence	evidence	NN	NN	_	13	dobj	_	_
15	that	that	IN	IN	_	20	mark	_	_
16	the	the	DT	DT	_	19	det	_	_
17	LMP	lmp	NN	NN	_	19	compound	_	_
18	promoter-binding	promoter-binding	JJ	JJ	_	19	amod	_	_
19	proteins	protein	NNS	NNS	_	20	nsubj	_	_
20	form	form	VBP	VBP	_	14	ccomp	_	_
21	a	a	DT	DT	_	22	det	_	_
22	complex	complex	NN	NN	_	20	dobj	_	_
23	of	of	IN	IN	_	25	case	_	_
24	higher	higher	JJR	JJR	_	25	amod	_	_
25	M(r)	m(r)	NN	NN	_	22	nmod	_	_
26	in	in	IN	IN	_	29	case	_	_
27	EBNA-2-positive	ebna-2-positive	JJ	JJ	_	28	amod	_	_
28	cell	cell	NN	NN	_	29	compound	_	_
29	extracts	extract	NNS	NNS	_	20	nmod	_	_
30	.	.	.	.	_	13	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	complexes	complex	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	destroyed	destroy	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	_	6	case	_	_
6	detergent	detergent	NN	NN	_	4	nmod	_	_
7	.	.	.	.	_	4	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	deduce	deduce	VBP	VBP	_	0	root	_	_
3	from	from	IN	IN	_	5	case	_	_
4	these	these	DT	DT	_	5	det	_	_
5	results	result	NNS	NNS	_	2	nmod	_	_
6	that	that	IN	IN	_	11	mark	_	_
7	EBNA-2-positive	ebna-2-positive	JJ	JJ	_	8	amod	_	_
8	cells	cell	NNS	NNS	_	11	nsubj	_	_
9	might	might	MD	MD	_	11	aux	_	_
10	indeed	indeed	RB	RB	_	11	advmod	_	_
11	contain	contain	VB	VB	_	2	ccomp	_	_
12	specific	specific	JJ	JJ	_	13	amod	_	_
13	complexes	complex	NNS	NNS	_	11	dobj	_	_
14	bound	bind	VBN	VBN	_	13	acl	_	_
15	to	to	TO	TO	_	18	case	_	_
16	the	the	DT	DT	_	18	det	_	_
17	LMP	lmp	NN	NN	_	18	compound	_	_
18	promoter	promoter	NN	NN	_	14	nmod	_	_
19	which	which	WDT	WDT	_	25	nsubj	_	_
20	are	be	VBP	VBP	_	25	cop	_	_
21	,	,	,	,	_	25	punct	_	_
22	however	however	RB	RB	_	25	advmod	_	_
23	,	,	,	,	_	25	punct	_	_
24	too	too	RB	RB	_	25	advmod	_	_
25	labile	labile	JJ	JJ	_	13	acl:relcl	_	_
26	to	to	TO	TO	_	28	mark	_	_
27	be	be	VB	VB	_	28	auxpass	_	_
28	detected	detect	VBN	VBN	_	25	ccomp	_	_
29	in	in	IN	IN	_	34	case	_	_
30	a	a	DT	DT	_	34	det	_	_
31	standard	standard	JJ	JJ	_	34	amod	_	_
32	gel	gel	NN	NN	_	34	compound	_	_
33	retardation	retardation	NN	NN	_	34	compound	_	_
34	assay	assay	NN	NN	_	28	nmod	_	_
35	.	.	.	.	_	2	punct	_	_

1	Enhanced	enhance	VBN	VBN	_	2	amod	_	_
2	responsiveness	responsiveness	NN	NN	_	8	nsubj	_	_
3	to	to	TO	TO	_	7	case	_	_
4	nuclear	nuclear	JJ	JJ	_	7	amod	_	_
5	factor	factor	NN	NN	_	7	compound	_	_
6	kappa	kappa	NN	NN	_	7	compound	_	_
7	B	b	NN	NN	_	2	nmod	_	_
8	contributes	contribute	VBZ	VBZ	_	0	root	_	_
9	to	to	TO	TO	_	12	case	_	_
10	the	the	DT	DT	_	12	det	_	_
11	unique	unique	JJ	JJ	_	12	amod	_	_
12	phenotype	phenotype	NN	NN	_	8	nmod	_	_
13	of	of	IN	IN	_	17	case	_	_
14	simian	simian	JJ	JJ	_	17	amod	_	_
15	immunodeficiency	immunodeficiency	NN	NN	_	17	compound	_	_
16	virus	virus	NN	NN	_	17	compound	_	_
17	variant	variant	NN	NN	_	12	nmod	_	_
18	SIVsmmPBj14	sivsmmpbj14	NN	NN	_	17	dep	_	_
19	.	.	.	.	_	8	punct	_	_

1	Infection	infection	NN	NN	_	12	nsubj	_	_
2	with	with	IN	IN	_	4	case	_	_
3	a	a	DT	DT	_	4	det	_	_
4	variant	variant	NN	NN	_	1	nmod	_	_
5	of	of	IN	IN	_	8	case	_	_
6	simian	simian	JJ	JJ	_	8	amod	_	_
7	immunodeficiency	immunodeficiency	NN	NN	_	8	compound	_	_
8	virus	virus	NN	NN	_	4	nmod	_	_
9	,	,	,	,	_	4	punct	_	_
10	SIVsmmPBj14	sivsmmpbj14	NN	NN	_	4	appos	_	_
11	,	,	,	,	_	1	punct	_	_
12	leads	lead	VBZ	VBZ	_	0	root	_	_
13	to	to	TO	TO	_	16	case	_	_
14	severe	severe	JJ	JJ	_	16	amod	_	_
15	acute	acute	JJ	JJ	_	14	dep	_	_
16	disease	disease	NN	NN	_	12	nmod	_	_
17	in	in	IN	IN	_	18	case	_	_
18	macaques	macaque	NNS	NNS	_	16	nmod	_	_
19	.	.	.	.	_	12	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	study	study	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	designed	design	VBN	VBN	_	0	root	_	_
5	to	to	TO	TO	_	6	mark	_	_
6	investigate	investigate	VB	VB	_	4	ccomp	_	_
7	the	the	DT	DT	_	9	det	_	_
8	functional	functional	JJ	JJ	_	9	amod	_	_
9	significance	significance	NN	NN	_	6	dobj	_	_
10	of	of	IN	IN	_	13	case	_	_
11	previously	previously	RB	RB	_	12	advmod	_	_
12	described	describe	VBN	VBN	_	13	amod	_	_
13	mutations	mutation	NNS	NNS	_	9	nmod	_	_
14	in	in	IN	IN	_	19	case	_	_
15	the	the	DT	DT	_	19	det	_	_
16	viral	viral	JJ	JJ	_	19	amod	_	_
17	long	long	JJ	JJ	_	19	amod	_	_
18	terminal	terminal	JJ	JJ	_	19	amod	_	_
19	repeat	repeat	NN	NN	_	13	nmod	_	_
20	(	(	-LRB-	-LRB-	_	21	punct	_	_
21	LTR	ltr	NN	NN	_	19	appos	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	and	and	CC	CC	_	6	cc	_	_
24	to	to	TO	TO	_	25	mark	_	_
25	elucidate	elucidate	VB	VB	_	6	conj	_	_
26	their	they	PRP$	PRP$	_	27	nmod:poss	_	_
27	contribution	contribution	NN	NN	_	25	dobj	_	_
28	to	to	TO	TO	_	31	case	_	_
29	the	the	DT	DT	_	31	det	_	_
30	unique	unique	JJ	JJ	_	31	amod	_	_
31	phenotype	phenotype	NN	NN	_	27	nmod	_	_
32	of	of	IN	IN	_	33	case	_	_
33	SIVsmmPBj14	sivsmmpbj14	NN	NN	_	31	nmod	_	_
34	.	.	.	.	_	4	punct	_	_

1	LTR-directed	ltr-directed	JJ	JJ	_	2	amod	_	_
2	transcription	transcription	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	measured	measure	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	_	6	mark	_	_
6	using	use	VBG	VBG	_	4	advcl	_	_
7	luciferase	luciferase	NN	NN	_	9	compound	_	_
8	reporter	reporter	NN	NN	_	9	compound	_	_
9	constructs	construct	NNS	NNS	_	6	dobj	_	_
10	that	that	WDT	WDT	_	13	nsubjpass	_	_
11	were	be	VBD	VBD	_	13	auxpass	_	_
12	transiently	transiently	RB	RB	_	13	advmod	_	_
13	transfected	transfect	VBN	VBN	_	9	acl:relcl	_	_
14	into	into	IN	IN	_	16	case	_	_
15	cultured	culture	VBN	VBN	_	16	amod	_	_
16	cells	cell	NNS	NNS	_	13	nmod	_	_
17	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	4	case	_	_
2	a	a	DT	DT	_	4	det	_	_
3	wide	wide	JJ	JJ	_	4	amod	_	_
4	range	range	NN	NN	_	19	nmod	_	_
5	of	of	IN	IN	_	7	case	_	_
6	cell	cell	NN	NN	_	7	compound	_	_
7	types	type	NNS	NNS	_	4	nmod	_	_
8	,	,	,	,	_	19	punct	_	_
9	the	the	DT	DT	_	12	det	_	_
10	basal	basal	JJ	JJ	_	12	amod	_	_
11	transcriptional	transcriptional	JJ	JJ	_	10	dep	_	_
12	activity	activity	NN	NN	_	19	nsubjpass	_	_
13	of	of	IN	IN	_	15	case	_	_
14	the	the	DT	DT	_	15	det	_	_
15	LTR	ltr	NN	NN	_	12	nmod	_	_
16	from	from	IN	IN	_	17	case	_	_
17	SIVsmmPBj14	sivsmmpbj14	NN	NN	_	15	nmod	_	_
18	was	be	VBD	VBD	_	19	auxpass	_	_
19	found	find	VBN	VBN	_	0	root	_	_
20	to	to	TO	TO	_	25	mark	_	_
21	be	be	VB	VB	_	25	cop	_	_
22	2-	2-	CD	CD	_	25	nmod:npmod	_	_
23	to	to	TO	TO	_	22	dep	_	_
24	4.5-fold	4.5-fold	RB	RB	_	22	advmod	_	_
25	higher	higher	JJR	JJR	_	19	xcomp	_	_
26	than	than	IN	IN	_	27	case	_	_
27	that	that	DT	DT	_	25	nmod	_	_
28	of	of	IN	IN	_	30	case	_	_
29	an	a	DT	DT	_	30	det	_	_
30	LTR	ltr	NN	NN	_	27	nmod	_	_
31	from	from	IN	IN	_	35	case	_	_
32	a	a	DT	DT	_	35	det	_	_
33	non-acutely	non-acutely	RB	RB	_	34	advmod	_	_
34	pathogenic	pathogenic	JJ	JJ	_	35	amod	_	_
35	strain	strain	NN	NN	_	30	nmod	_	_
36	.	.	.	.	_	19	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	LTRs	ltr	NNS	NNS	_	3	nsubj	_	_
3	differ	differ	VBP	VBP	_	0	root	_	_
4	by	by	IN	IN	_	7	case	_	_
5	five	five	CD	CD	_	7	nummod	_	_
6	point	point	NN	NN	_	7	compound	_	_
7	mutations	mutation	NNS	NNS	_	3	nmod	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	a	a	DT	DT	_	11	det	_	_
10	22-bp	22-bp	JJ	JJ	_	11	amod	_	_
11	duplication	duplication	NN	NN	_	7	conj	_	_
12	in	in	IN	IN	_	13	case	_	_
13	SIVsmmPBj14	sivsmmpbj14	NN	NN	_	11	nmod	_	_
14	,	,	,	,	_	11	punct	_	_
15	which	which	WDT	WDT	_	16	nsubj	_	_
16	includes	include	VBZ	VBZ	_	11	acl:relcl	_	_
17	a	a	DT	DT	_	27	det	_	_
18	nuclear	nuclear	JJ	JJ	_	27	amod	_	_
19	factor	factor	NN	NN	_	27	compound	_	_
20	kappa	kappa	NN	NN	_	27	compound	_	_
21	B	b	NN	NN	_	27	compound	_	_
22	(	(	-LRB-	-LRB-	_	27	punct	_	_
23	NF	nf	NN	NN	_	27	compound	_	_
24	kappa	kappa	NN	NN	_	27	compound	_	_
25	B	b	NN	NN	_	27	compound	_	_
26	)	)	-RRB-	-RRB-	_	27	punct	_	_
27	site	site	NN	NN	_	16	dobj	_	_
28	.	.	.	.	_	3	punct	_	_

1	Transcriptional	transcriptional	JJ	JJ	_	2	amod	_	_
2	differences	difference	NNS	NNS	_	8	nsubjpass	_	_
3	between	between	IN	IN	_	5	case	_	_
4	these	these	DT	DT	_	5	det	_	_
5	LTRs	ltr	NNS	NNS	_	2	nmod	_	_
6	were	be	VBD	VBD	_	8	auxpass	_	_
7	further	further	RB	RB	_	8	advmod	_	_
8	enhanced	enhance	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	_	10	case	_	_
10	two-	two-	CD	CD	_	8	nmod	_	_
11	to	to	TO	TO	_	10	dep	_	_
12	threefold	threefold	RB	RB	_	10	advmod	_	_
13	upon	upon	IN	IN	_	14	case	_	_
14	treatment	treatment	NN	NN	_	8	nmod	_	_
15	of	of	IN	IN	_	16	case	_	_
16	cells	cell	NNS	NNS	_	14	nmod	_	_
17	with	with	IN	IN	_	19	case	_	_
18	phorbol	phorbol	NN	NN	_	19	compound	_	_
19	ester	ester	NN	NN	_	14	nmod	_	_
20	or	or	CC	CC	_	19	cc	_	_
21	tumor	tumor	NN	NN	_	24	compound	_	_
22	necrosis	necrosis	NN	NN	_	24	compound	_	_
23	factor	factor	NN	NN	_	24	compound	_	_
24	alpha	alpha	NN	NN	_	19	conj	_	_
25	or	or	CC	CC	_	14	cc	_	_
26	by	by	IN	IN	_	27	case	_	_
27	cotransfection	cotransfection	NN	NN	_	14	conj	_	_
28	with	with	IN	IN	_	29	case	_	_
29	plasmids	plasmid	NNS	NNS	_	27	nmod	_	_
30	expressing	express	VBG	VBG	_	29	acl	_	_
31	NF	nf	NN	NN	_	33	compound	_	_
32	kappa	kappa	NN	NN	_	33	compound	_	_
33	B	b	NN	NN	_	34	compound	_	_
34	subunits	subunit	NNS	NNS	_	30	dobj	_	_
35	.	.	.	.	_	8	punct	_	_

1	Mutagenesis	mutagenesis	NN	NN	_	2	compound	_	_
2	studies	study	NNS	NNS	_	16	nsubj	_	_
3	,	,	,	,	_	2	punct	_	_
4	and	and	CC	CC	_	2	cc	_	_
5	the	the	DT	DT	_	6	det	_	_
6	use	use	NN	NN	_	2	conj	_	_
7	of	of	IN	IN	_	10	case	_	_
8	a	a	DT	DT	_	10	det	_	_
9	reporter	reporter	NN	NN	_	10	compound	_	_
10	construct	construct	NN	NN	_	6	nmod	_	_
11	containing	contain	VBG	VBG	_	10	acl	_	_
12	an	a	DT	DT	_	14	det	_	_
13	enhancerless	enhancerless	JJ	JJ	_	14	amod	_	_
14	promoter	promoter	NN	NN	_	11	dobj	_	_
15	,	,	,	,	_	2	punct	_	_
16	indicate	indicate	VBP	VBP	_	0	root	_	_
17	that	that	IN	IN	_	22	mark	_	_
18	these	these	DT	DT	_	20	det	_	_
19	transcriptional	transcriptional	JJ	JJ	_	20	amod	_	_
20	effects	effect	NNS	NNS	_	22	nsubj	_	_
21	are	be	VBP	VBP	_	22	cop	_	_
22	due	due	JJ	JJ	_	16	ccomp	_	_
23	principally	principally	RB	RB	_	28	advmod	_	_
24	to	to	TO	TO	_	28	case	_	_
25	the	the	DT	DT	_	28	det	_	_
26	22-bp	22-bp	JJ	JJ	_	28	amod	_	_
27	sequence	sequence	NN	NN	_	28	compound	_	_
28	duplication	duplication	NN	NN	_	22	nmod	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	the	the	DT	DT	_	34	det	_	_
31	NF	nf	NN	NN	_	34	compound	_	_
32	kappa	kappa	NN	NN	_	34	compound	_	_
33	B	b	NN	NN	_	34	compound	_	_
34	site	site	NN	NN	_	28	conj	_	_
35	contained	contain	VBN	VBN	_	34	acl	_	_
36	within	within	IN	IN	_	37	case	_	_
37	it	it	PRP	PRP	_	35	nmod	_	_
38	.	.	.	.	_	16	punct	_	_

1	Finally	finally	RB	RB	_	14	advmod	_	_
2	,	,	,	,	_	14	punct	_	_
3	infectious	infectious	JJ	JJ	_	5	amod	_	_
4	virus	virus	NN	NN	_	5	compound	_	_
5	stocks	stock	NNS	NNS	_	14	nsubjpass	_	_
6	that	that	WDT	WDT	_	8	nsubj	_	_
7	were	be	VBD	VBD	_	8	cop	_	_
8	isogenic	isogenic	JJ	JJ	_	5	acl:relcl	_	_
9	except	except	IN	IN	_	12	case	_	_
10	for	for	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	LTR	ltr	NN	NN	_	8	nmod	_	_
13	were	be	VBD	VBD	_	14	auxpass	_	_
14	generated	generate	VBN	VBN	_	0	root	_	_
15	.	.	.	.	_	14	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	LTR	ltr	NN	NN	_	6	nsubjpass	_	_
3	from	from	IN	IN	_	4	case	_	_
4	SIVsmmPBj14	sivsmmpbj14	NN	NN	_	2	nmod	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	found	find	VBN	VBN	_	0	root	_	_
7	to	to	TO	TO	_	8	mark	_	_
8	confer	confer	VB	VB	_	6	xcomp	_	_
9	an	a	DT	DT	_	10	det	_	_
10	increase	increase	NN	NN	_	8	dobj	_	_
11	in	in	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	kinetics	kinetics	NNS	NNS	_	10	nmod	_	_
14	of	of	IN	IN	_	16	case	_	_
15	virus	virus	NN	NN	_	16	compound	_	_
16	replication	replication	NN	NN	_	13	nmod	_	_
17	in	in	IN	IN	_	19	case	_	_
18	cultured	culture	VBN	VBN	_	19	amod	_	_
19	cells	cell	NNS	NNS	_	8	nmod	_	_
20	.	.	.	.	_	6	punct	_	_

1	Inclusion	inclusion	NN	NN	_	9	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	this	this	DT	DT	_	4	det	_	_
4	LTR	ltr	NN	NN	_	1	nmod	_	_
5	in	in	IN	IN	_	7	case	_	_
6	recombinant	recombinant	JJ	JJ	_	7	amod	_	_
7	SIVs	siv	NNS	NNS	_	1	nmod	_	_
8	also	also	RB	RB	_	9	advmod	_	_
9	resulted	result	VBD	VBD	_	0	root	_	_
10	in	in	IN	IN	_	15	case	_	_
11	a	a	DT	DT	_	15	det	_	_
12	two-	two-	CD	CD	_	14	compound	_	_
13	to	to	TO	TO	_	14	dep	_	_
14	threefold	threefold	JJ	JJ	_	15	amod	_	_
15	rise	rise	NN	NN	_	9	nmod	_	_
16	in	in	IN	IN	_	18	case	_	_
17	the	the	DT	DT	_	18	det	_	_
18	extent	extent	NN	NN	_	15	nmod	_	_
19	of	of	IN	IN	_	21	case	_	_
20	cellular	cellular	JJ	JJ	_	21	amod	_	_
21	proliferation	proliferation	NN	NN	_	18	nmod	_	_
22	that	that	WDT	WDT	_	24	nsubjpass	_	_
23	was	be	VBD	VBD	_	24	auxpass	_	_
24	induced	induce	VBN	VBN	_	21	acl:relcl	_	_
25	in	in	IN	IN	_	31	case	_	_
26	quiescent	quiescent	JJ	JJ	_	31	amod	_	_
27	simian	simian	JJ	JJ	_	31	amod	_	_
28	peripheral	peripheral	JJ	JJ	_	31	amod	_	_
29	blood	blood	NN	NN	_	31	compound	_	_
30	mononuclear	mononuclear	JJ	JJ	_	31	amod	_	_
31	cells	cell	NNS	NNS	_	24	nmod	_	_
32	.	.	.	.	_	9	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	studies	study	NNS	NNS	_	4	nsubj	_	_
3	are	be	VBP	VBP	_	4	cop	_	_
4	consistent	consistent	JJ	JJ	_	0	root	_	_
5	with	with	IN	IN	_	7	case	_	_
6	the	the	DT	DT	_	7	det	_	_
7	hypothesis	hypothesis	NN	NN	_	4	nmod	_	_
8	that	that	IN	IN	_	11	mark	_	_
9	LTR	ltr	NN	NN	_	10	compound	_	_
10	mutations	mutation	NNS	NNS	_	11	nsubj	_	_
11	assist	assist	VBP	VBP	_	7	ccomp	_	_
12	SIVsmmPBj14	sivsmmpbj14	NN	NN	_	11	dobj	_	_
13	in	in	IN	IN	_	14	mark	_	_
14	responding	respond	VBG	VBG	_	11	advcl	_	_
15	efficiently	efficiently	RB	RB	_	14	advmod	_	_
16	to	to	TO	TO	_	18	case	_	_
17	cellular	cellular	JJ	JJ	_	18	amod	_	_
18	stimulation	stimulation	NN	NN	_	14	nmod	_	_
19	and	and	CC	CC	_	11	cc	_	_
20	allow	allow	VBP	VBP	_	11	conj	_	_
21	it	it	PRP	PRP	_	20	dobj	_	_
22	to	to	TO	TO	_	23	mark	_	_
23	replicate	replicate	VB	VB	_	20	xcomp	_	_
24	to	to	TO	TO	_	26	case	_	_
25	high	high	JJ	JJ	_	26	amod	_	_
26	titers	titer	NNS	NNS	_	23	nmod	_	_
27	during	during	IN	IN	_	30	case	_	_
28	the	the	DT	DT	_	30	det	_	_
29	acute	acute	JJ	JJ	_	30	amod	_	_
30	phase	phase	NN	NN	_	23	nmod	_	_
31	of	of	IN	IN	_	33	case	_	_
32	viral	viral	JJ	JJ	_	33	amod	_	_
33	infection	infection	NN	NN	_	30	nmod	_	_
34	.	.	.	.	_	4	punct	_	_

1	Identification	identification	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	4	case	_	_
3	a	a	DT	DT	_	4	det	_	_
4	region	region	NN	NN	_	1	nmod	_	_
5	which	which	WDT	WDT	_	6	nsubj	_	_
6	directs	direct	VBZ	VBZ	_	4	acl:relcl	_	_
7	the	the	DT	DT	_	9	det	_	_
8	monocytic	monocytic	JJ	JJ	_	9	amod	_	_
9	activity	activity	NN	NN	_	6	dobj	_	_
10	of	of	IN	IN	_	21	case	_	_
11	the	the	DT	DT	_	21	det	_	_
12	colony-stimulating	colony-stimulating	JJ	JJ	_	21	amod	_	_
13	factor	factor	NN	NN	_	21	compound	_	_
14	1	1	CD	CD	_	21	nummod	_	_
15	(	(	-LRB-	-LRB-	_	21	punct	_	_
16	macrophage	macrophage	NN	NN	_	21	compound	_	_
17	colony-stimulating	colony-stimulating	JJ	JJ	_	21	amod	_	_
18	factor	factor	NN	NN	_	21	compound	_	_
19	)	)	-RRB-	-RRB-	_	21	punct	_	_
20	receptor	receptor	NN	NN	_	21	compound	_	_
21	promoter	promoter	NN	NN	_	9	nmod	_	_
22	and	and	CC	CC	_	6	cc	_	_
23	binds	bind	VBZ	VBZ	_	6	conj	_	_
24	PEBP2/CBF	pebp2/cbf	NN	NN	_	23	dobj	_	_
25	(	(	-LRB-	-LRB-	_	26	punct	_	_
26	AML1	aml1	NN	NN	_	24	appos	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	receptor	receptor	NN	NN	_	18	nsubjpass	_	_
3	for	for	IN	IN	_	7	case	_	_
4	the	the	DT	DT	_	7	det	_	_
5	macrophage	macrophage	NN	NN	_	7	compound	_	_
6	colony-stimulating	colony-stimulating	JJ	JJ	_	7	amod	_	_
7	factor	factor	NN	NN	_	2	nmod	_	_
8	(	(	-LRB-	-LRB-	_	11	punct	_	_
9	or	or	CC	CC	_	11	cc	_	_
10	colony-stimulating	colony-stimulating	JJ	JJ	_	11	amod	_	_
11	factor	factor	NN	NN	_	7	dep	_	_
12	1	1	CD	CD	_	11	nummod	_	_
13	-LSB-	-lsb-	-LRB-	-LRB-	_	14	punct	_	_
14	CSF-1	csf-1	NN	NN	_	11	appos	_	_
15	-RSB-	-rsb-	-RRB-	-RRB-	_	14	punct	_	_
16	)	)	-RRB-	-RRB-	_	11	punct	_	_
17	is	be	VBZ	VBZ	_	18	auxpass	_	_
18	expressed	express	VBN	VBN	_	0	root	_	_
19	from	from	IN	IN	_	21	case	_	_
20	different	different	JJ	JJ	_	21	amod	_	_
21	promoters	promoter	NNS	NNS	_	18	nmod	_	_
22	in	in	IN	IN	_	24	case	_	_
23	monocytic	monocytic	JJ	JJ	_	24	amod	_	_
24	cells	cell	NNS	NNS	_	21	nmod	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	placental	placental	JJ	JJ	_	27	amod	_	_
27	trophoblasts	trophoblast	NNS	NNS	_	24	conj	_	_
28	.	.	.	.	_	18	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	demonstrated	demonstrate	VBN	VBN	_	0	root	_	_
4	that	that	IN	IN	_	13	mark	_	_
5	the	the	DT	DT	_	7	det	_	_
6	monocyte-specific	monocyte-specific	JJ	JJ	_	7	amod	_	_
7	expression	expression	NN	NN	_	13	nsubjpass	_	_
8	of	of	IN	IN	_	11	case	_	_
9	the	the	DT	DT	_	11	det	_	_
10	CSF-1	csf-1	NN	NN	_	11	compound	_	_
11	receptor	receptor	NN	NN	_	7	nmod	_	_
12	is	be	VBZ	VBZ	_	13	auxpass	_	_
13	regulated	regulate	VBN	VBN	_	3	ccomp	_	_
14	at	at	IN	IN	_	16	case	_	_
15	the	the	DT	DT	_	16	det	_	_
16	level	level	NN	NN	_	13	nmod	_	_
17	of	of	IN	IN	_	18	case	_	_
18	transcription	transcription	NN	NN	_	16	nmod	_	_
19	by	by	IN	IN	_	22	case	_	_
20	a	a	DT	DT	_	22	det	_	_
21	tissue-specific	tissue-specific	JJ	JJ	_	22	amod	_	_
22	promoter	promoter	NN	NN	_	13	nmod	_	_
23	whose	whose	WP$	WP$	_	24	nmod:poss	_	_
24	activity	activity	NN	NN	_	26	nsubjpass	_	_
25	is	be	VBZ	VBZ	_	26	auxpass	_	_
26	stimulated	stimulate	VBN	VBN	_	22	acl:relcl	_	_
27	by	by	IN	IN	_	31	case	_	_
28	the	the	DT	DT	_	31	det	_	_
29	monocyte/B-cell-specific	monocyte/b-cell-specific	JJ	JJ	_	31	amod	_	_
30	transcription	transcription	NN	NN	_	31	compound	_	_
31	factor	factor	NN	NN	_	26	nmod	_	_
32	PU.1	pu.1	NN	NN	_	31	dep	_	_
33	(	(	-LRB-	-LRB-	_	34	punct	_	_
34	D.-E.Zhang	D.-E.Zhang	NNP	NNP	_	3	dep	_	_
35	,	,	,	,	_	34	punct	_	_
36	C.J.Hetherington	C.J.Hetherington	NNP	NNP	_	34	conj	_	_
37	,	,	,	,	_	34	punct	_	_
38	H.-M.Chen	H.-M.Chen	NNP	NNP	_	34	conj	_	_
39	,	,	,	,	_	34	punct	_	_
40	and	and	CC	CC	_	34	cc	_	_
41	D.G.Tenen	D.G.Tenen	NNP	NNP	_	34	conj	_	_
42	,	,	,	,	_	34	punct	_	_
43	Mol	Mol	NNP	NNP	_	45	compound	_	_
44	.Cell.	.Cell.	NNP	NNP	_	45	compound	_	_
45	Biol.	Biol.	NNP	NNP	_	34	appos	_	_
46	14	14	CD	CD	_	45	nummod	_	_
47	:	:	:	:	_	34	punct	_	_
48	373-381	373-381	CD	CD	_	34	dep	_	_
49	,	,	,	,	_	34	punct	_	_
50	1994	1994	CD	CD	_	34	amod	_	_
51	)	)	-RRB-	-RRB-	_	34	punct	_	_
52	.	.	.	.	_	3	punct	_	_

1	Here	here	RB	RB	_	3	advmod	_	_
2	we	we	PRP	PRP	_	3	nsubj	_	_
3	report	report	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	13	mark	_	_
5	the	the	DT	DT	_	7	det	_	_
6	tissue	tissue	NN	NN	_	7	compound	_	_
7	specificity	specificity	NN	NN	_	13	nsubjpass	_	_
8	of	of	IN	IN	_	10	case	_	_
9	this	this	DT	DT	_	10	det	_	_
10	promoter	promoter	NN	NN	_	7	nmod	_	_
11	is	be	VBZ	VBZ	_	13	auxpass	_	_
12	also	also	RB	RB	_	13	advmod	_	_
13	mediated	mediate	VBN	VBN	_	3	ccomp	_	_
14	by	by	IN	IN	_	15	case	_	_
15	sequences	sequence	NNS	NNS	_	13	nmod	_	_
16	in	in	IN	IN	_	18	case	_	_
17	a	a	DT	DT	_	18	det	_	_
18	region	region	NN	NN	_	15	nmod	_	_
19	II	ii	CD	CD	_	18	nummod	_	_
20	(	(	-LRB-	-LRB-	_	21	punct	_	_
21	bp	bp	NN	NN	_	18	appos	_	_
22	-88	-88	CD	CD	_	24	compound	_	_
23	to	to	TO	TO	_	24	dep	_	_
24	-59	-59	CD	CD	_	21	nummod	_	_
25	)	)	-RRB-	-RRB-	_	21	punct	_	_
26	,	,	,	,	_	18	punct	_	_
27	which	which	WDT	WDT	_	28	nsubj	_	_
28	lies	lie	VBZ	VBZ	_	18	acl:relcl	_	_
29	10	10	CD	CD	_	30	nummod	_	_
30	bp	bp	NN	NN	_	28	dobj	_	_
31	upstream	upstream	RB	RB	_	30	advmod	_	_
32	from	from	IN	IN	_	35	case	_	_
33	the	the	DT	DT	_	35	det	_	_
34	PU.1-binding	pu.1-binding	JJ	JJ	_	35	amod	_	_
35	site	site	NN	NN	_	30	nmod	_	_
36	.	.	.	.	_	3	punct	_	_

1	When	when	WRB	WRB	_	2	advmod	_	_
2	analyzed	analyze	VBN	VBN	_	10	advcl	_	_
3	by	by	IN	IN	_	5	case	_	_
4	DNase	dnase	NN	NN	_	5	compound	_	_
5	footprinting	footprinting	NN	NN	_	2	nmod	_	_
6	,	,	,	,	_	10	punct	_	_
7	region	region	NN	NN	_	10	nsubjpass	_	_
8	II	ii	CD	CD	_	7	nummod	_	_
9	was	be	VBD	VBD	_	10	auxpass	_	_
10	protected	protect	VBN	VBN	_	0	root	_	_
11	preferentially	preferentially	RB	RB	_	10	advmod	_	_
12	in	in	IN	IN	_	14	case	_	_
13	monocytic	monocytic	JJ	JJ	_	14	amod	_	_
14	cells	cell	NNS	NNS	_	10	nmod	_	_
15	.	.	.	.	_	10	punct	_	_

1	Electrophoretic	electrophoretic	JJ	JJ	_	4	amod	_	_
2	mobility	mobility	NN	NN	_	4	compound	_	_
3	shift	shift	NN	NN	_	4	compound	_	_
4	assays	assay	NNS	NNS	_	5	nsubj	_	_
5	confirmed	confirm	VBD	VBD	_	0	root	_	_
6	that	that	IN	IN	_	9	mark	_	_
7	region	region	NN	NN	_	9	nsubj	_	_
8	II	ii	CD	CD	_	7	nummod	_	_
9	interacts	interact	VBZ	VBZ	_	5	ccomp	_	_
10	specifically	specifically	RB	RB	_	9	advmod	_	_
11	with	with	IN	IN	_	13	case	_	_
12	nuclear	nuclear	JJ	JJ	_	13	amod	_	_
13	proteins	protein	NNS	NNS	_	9	nmod	_	_
14	from	from	IN	IN	_	16	case	_	_
15	monocytic	monocytic	JJ	JJ	_	16	amod	_	_
16	cells	cell	NNS	NNS	_	13	nmod	_	_
17	.	.	.	.	_	5	punct	_	_

1	Two	two	CD	CD	_	4	nummod	_	_
2	gel	gel	NN	NN	_	4	compound	_	_
3	shift	shift	NN	NN	_	4	compound	_	_
4	complexes	complex	NNS	NNS	_	13	nsubjpass	_	_
5	(	(	-LRB-	-LRB-	_	7	punct	_	_
6	Mono	mono	NN	NN	_	7	compound	_	_
7	A	a	NN	NN	_	4	dep	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	Mono	mono	NN	NN	_	10	compound	_	_
10	B	b	NN	NN	_	7	conj	_	_
11	)	)	-RRB-	-RRB-	_	7	punct	_	_
12	were	be	VBD	VBD	_	13	auxpass	_	_
13	formed	form	VBN	VBN	_	0	root	_	_
14	with	with	IN	IN	_	17	case	_	_
15	separate	separate	JJ	JJ	_	17	amod	_	_
16	sequence	sequence	NN	NN	_	17	compound	_	_
17	elements	element	NNS	NNS	_	13	nmod	_	_
18	within	within	IN	IN	_	20	case	_	_
19	this	this	DT	DT	_	20	det	_	_
20	region	region	NN	NN	_	17	nmod	_	_
21	.	.	.	.	_	13	punct	_	_

1	Competition	competition	NN	NN	_	5	nsubj	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	supershift	supershift	NN	NN	_	1	conj	_	_
4	experiments	experiment	NNS	NNS	_	1	dep	_	_
5	indicate	indicate	VBP	VBP	_	0	root	_	_
6	that	that	IN	IN	_	9	mark	_	_
7	Mono	mono	NN	NN	_	8	compound	_	_
8	B	b	NN	NN	_	9	nsubj	_	_
9	contains	contain	VBZ	VBZ	_	5	ccomp	_	_
10	a	a	DT	DT	_	11	det	_	_
11	member	member	NN	NN	_	9	dobj	_	_
12	of	of	IN	IN	_	22	case	_	_
13	the	the	DT	DT	_	22	det	_	_
14	polyomavirus	polyomavirus	NN	NN	_	22	compound	_	_
15	enhancer-binding	enhancer-binding	JJ	JJ	_	22	amod	_	_
16	protein	protein	NN	NN	_	22	compound	_	_
17	2/core-binding	2/core-binding	JJ	JJ	_	22	amod	_	_
18	factor	factor	NN	NN	_	22	compound	_	_
19	(	(	-LRB-	-LRB-	_	22	punct	_	_
20	PEBP2/CBF	pebp2/cbf	NN	NN	_	22	compound	_	_
21	)	)	-RRB-	-RRB-	_	22	punct	_	_
22	family	family	NN	NN	_	11	nmod	_	_
23	,	,	,	,	_	22	punct	_	_
24	which	which	WDT	WDT	_	25	nsubj	_	_
25	includes	include	VBZ	VBZ	_	11	acl:relcl	_	_
26	the	the	DT	DT	_	29	det	_	_
27	AML1	aml1	NN	NN	_	29	compound	_	_
28	gene	gene	NN	NN	_	29	compound	_	_
29	product	product	NN	NN	_	25	dobj	_	_
30	,	,	,	,	_	9	punct	_	_
31	while	while	IN	IN	_	37	mark	_	_
32	Mono	mono	NN	NN	_	33	compound	_	_
33	A	a	NN	NN	_	37	nsubj	_	_
34	is	be	VBZ	VBZ	_	37	cop	_	_
35	a	a	DT	DT	_	37	det	_	_
36	distinct	distinct	JJ	JJ	_	37	amod	_	_
37	complex	complex	NN	NN	_	9	advcl	_	_
38	preferentially	preferentially	RB	RB	_	39	advmod	_	_
39	expressed	express	VBN	VBN	_	37	acl	_	_
40	in	in	IN	IN	_	42	case	_	_
41	monocytic	monocytic	JJ	JJ	_	42	amod	_	_
42	cells	cell	NNS	NNS	_	39	nmod	_	_
43	.	.	.	.	_	5	punct	_	_

1	Promoter	promoter	NN	NN	_	2	compound	_	_
2	constructs	construct	NNS	NNS	_	12	nsubjpass	_	_
3	with	with	IN	IN	_	4	case	_	_
4	mutations	mutation	NNS	NNS	_	2	nmod	_	_
5	in	in	IN	IN	_	8	case	_	_
6	these	these	DT	DT	_	8	det	_	_
7	sequence	sequence	NN	NN	_	8	compound	_	_
8	elements	element	NNS	NNS	_	4	nmod	_	_
9	were	be	VBD	VBD	_	12	auxpass	_	_
10	no	no	RB	RB	_	11	neg	_	_
11	longer	longer	RBR	RBR	_	12	advmod	_	_
12	expressed	express	VBN	VBN	_	0	root	_	_
13	specifically	specifically	RB	RB	_	12	advmod	_	_
14	in	in	IN	IN	_	15	case	_	_
15	monocytes	monocyte	NNS	NNS	_	12	nmod	_	_
16	.	.	.	.	_	12	punct	_	_

1	Furthermore	furthermore	RB	RB	_	8	advmod	_	_
2	,	,	,	,	_	8	punct	_	_
3	multimerized	multimerized	JJ	JJ	_	7	amod	_	_
4	region	region	NN	NN	_	7	compound	_	_
5	II	ii	CD	CD	_	7	nummod	_	_
6	sequence	sequence	NN	NN	_	7	compound	_	_
7	elements	element	NNS	NNS	_	8	nsubj	_	_
8	enhanced	enhance	VBD	VBD	_	0	root	_	_
9	the	the	DT	DT	_	10	det	_	_
10	activity	activity	NN	NN	_	8	dobj	_	_
11	of	of	IN	IN	_	16	case	_	_
12	a	a	DT	DT	_	16	det	_	_
13	heterologous	heterologous	JJ	JJ	_	16	amod	_	_
14	thymidine	thymidine	NN	NN	_	16	compound	_	_
15	kinase	kinase	NN	NN	_	16	compound	_	_
16	promoter	promoter	NN	NN	_	10	nmod	_	_
17	in	in	IN	IN	_	19	case	_	_
18	monocytic	monocytic	JJ	JJ	_	19	amod	_	_
19	cells	cell	NNS	NNS	_	10	nmod	_	_
20	but	but	CC	CC	_	21	cc	_	_
21	not	not	RB	RB	_	19	cc	_	_
22	other	other	JJ	JJ	_	24	amod	_	_
23	cell	cell	NN	NN	_	24	compound	_	_
24	types	type	NNS	NNS	_	19	conj	_	_
25	tested	test	VBN	VBN	_	24	acl	_	_
26	.	.	.	.	_	8	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	19	mark	_	_
5	the	the	DT	DT	_	8	det	_	_
6	monocyte/B-cell-specific	monocyte/b-cell-specific	JJ	JJ	_	8	amod	_	_
7	transcription	transcription	NN	NN	_	8	compound	_	_
8	factor	factor	NN	NN	_	19	nsubj	_	_
9	PU.1	pu.1	NN	NN	_	8	dep	_	_
10	and	and	CC	CC	_	8	cc	_	_
11	the	the	DT	DT	_	13	dep	_	_
12	Mono	mono	NN	NN	_	13	compound	_	_
13	A	a	NN	NN	_	8	conj	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	Mono	mono	NN	NN	_	16	compound	_	_
16	B	b	NN	NN	_	13	conj	_	_
17	protein	protein	NN	NN	_	18	compound	_	_
18	complexes	complex	NNS	NNS	_	13	dep	_	_
19	act	act	VBP	VBP	_	3	ccomp	_	_
20	in	in	IN	IN	_	21	case	_	_
21	concert	concert	NN	NN	_	19	nmod	_	_
22	to	to	TO	TO	_	23	mark	_	_
23	regulate	regulate	VB	VB	_	19	xcomp	_	_
24	monocyte-specific	monocyte-specific	JJ	JJ	_	25	amod	_	_
25	transcription	transcription	NN	NN	_	23	dobj	_	_
26	of	of	IN	IN	_	29	case	_	_
27	the	the	DT	DT	_	29	det	_	_
28	CSF-1	csf-1	NN	NN	_	29	compound	_	_
29	receptor	receptor	NN	NN	_	25	nmod	_	_
30	.	.	.	.	_	3	punct	_	_

1	Epstein-Barr	epstein-barr	JJ	JJ	_	4	amod	_	_
2	virus	virus	NN	NN	_	4	compound	_	_
3	SM	sm	NN	NN	_	4	compound	_	_
4	protein	protein	NN	NN	_	0	root	_	_
5	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	protein	protein	NN	NN	_	3	compound	_	_
3	products	product	NNS	NNS	_	17	nsubjpass	_	_
4	of	of	IN	IN	_	14	case	_	_
5	the	the	DT	DT	_	14	det	_	_
6	Epstein-Barr	epstein-barr	JJ	JJ	_	7	amod	_	_
7	virus	virus	NN	NN	_	14	compound	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	EBV	ebv	NN	NN	_	7	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	BMLF1	bmlf1	NN	NN	_	14	compound	_	_
12	open	open	JJ	JJ	_	14	amod	_	_
13	reading	reading	NN	NN	_	14	compound	_	_
14	frame	frame	NN	NN	_	3	nmod	_	_
15	have	have	VBP	VBP	_	17	aux	_	_
16	been	be	VBN	VBN	_	17	auxpass	_	_
17	characterized	characterize	VBN	VBN	_	0	root	_	_
18	in	in	IN	IN	_	22	case	_	_
19	the	the	DT	DT	_	22	det	_	_
20	early	early	JJ	JJ	_	22	amod	_	_
21	productive	productive	JJ	JJ	_	20	dep	_	_
22	cycle	cycle	NN	NN	_	17	nmod	_	_
23	in	in	IN	IN	_	24	case	_	_
24	B95-8	b95-8	NN	NN	_	22	nmod	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	Akata	akata	NN	NN	_	27	compound	_	_
27	cells	cell	NNS	NNS	_	24	conj	_	_
28	.	.	.	.	_	17	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	SM	sm	NN	NN	_	3	compound	_	_
3	protein	protein	NN	NN	_	18	nsubj	_	_
4	derived	derive	VBN	VBN	_	3	acl	_	_
5	from	from	IN	IN	_	8	case	_	_
6	the	the	DT	DT	_	8	det	_	_
7	spliced	splice	VBN	VBN	_	8	amod	_	_
8	RNA	rna	NN	NN	_	4	nmod	_	_
9	joining	join	VBG	VBG	_	8	acl	_	_
10	BSLF2	bslf2	NN	NN	_	9	dobj	_	_
11	to	to	TO	TO	_	12	case	_	_
12	BMLF1	bmlf1	NN	NN	_	9	nmod	_	_
13	is	be	VBZ	VBZ	_	18	cop	_	_
14	much	much	RB	RB	_	17	advmod	_	_
15	the	the	DT	DT	_	17	det	_	_
16	most	most	RBS	RBS	_	17	advmod	_	_
17	abundant	abundant	JJ	JJ	_	18	amod	_	_
18	protein	protein	NN	NN	_	0	root	_	_
19	.	.	.	.	_	18	punct	_	_

1	SM	sm	NN	NN	_	4	nsubj	_	_
2	is	be	VBZ	VBZ	_	4	cop	_	_
3	a	a	DT	DT	_	4	det	_	_
4	phosphoprotein	phosphoprotein	NN	NN	_	0	root	_	_
5	in	in	IN	IN	_	7	case	_	_
6	EBV-infected	ebv-infected	JJ	JJ	_	7	amod	_	_
7	cells	cell	NNS	NNS	_	4	nmod	_	_
8	and	and	CC	CC	_	4	cc	_	_
9	can	can	MD	MD	_	11	aux	_	_
10	be	be	VB	VB	_	11	auxpass	_	_
11	phosphorylated	phosphorylate	VBN	VBN	_	4	conj	_	_
12	in	in	FW	FW	_	13	compound	_	_
13	vitro	vitro	FW	FW	_	11	advmod	_	_
14	with	with	IN	IN	_	16	case	_	_
15	casein	casein	NN	NN	_	16	compound	_	_
16	kinase	kinase	NN	NN	_	11	nmod	_	_
17	II	ii	CD	CD	_	16	nummod	_	_
18	(	(	-LRB-	-LRB-	_	19	punct	_	_
19	CKII	ckii	NN	NN	_	16	appos	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	.	.	.	.	_	4	punct	_	_

1	Computer	computer	NN	NN	_	2	compound	_	_
2	analysis	analysis	NN	NN	_	8	nsubj	_	_
3	of	of	IN	IN	_	7	case	_	_
4	the	the	DT	DT	_	7	det	_	_
5	SM	sm	NN	NN	_	6	compound	_	_
6	protein	protein	NN	NN	_	7	compound	_	_
7	sequence	sequence	NN	NN	_	2	nmod	_	_
8	showed	show	VBD	VBD	_	0	root	_	_
9	a	a	DT	DT	_	12	det	_	_
10	C	c	NN	NN	_	12	compound	_	_
11	terminal	terminal	JJ	JJ	_	12	amod	_	_
12	section	section	NN	NN	_	8	dobj	_	_
13	of	of	IN	IN	_	14	case	_	_
14	SM	sm	NN	NN	_	12	nmod	_	_
15	to	to	TO	TO	_	17	mark	_	_
16	be	be	VB	VB	_	17	cop	_	_
17	related	related	JJ	JJ	_	8	xcomp	_	_
18	to	to	TO	TO	_	21	case	_	_
19	genome	genome	NN	NN	_	21	compound	_	_
20	positional	positional	JJ	JJ	_	21	amod	_	_
21	homologues	homologue	NNS	NNS	_	17	nmod	_	_
22	of	of	IN	IN	_	25	case	_	_
23	four	four	CD	CD	_	25	nummod	_	_
24	other	other	JJ	JJ	_	25	amod	_	_
25	herpesviruses	herpesvirus	NNS	NNS	_	21	nmod	_	_
26	and	and	CC	CC	_	8	cc	_	_
27	revealed	reveal	VBD	VBD	_	8	conj	_	_
28	consensus	consensus	NN	NN	_	30	compound	_	_
29	CKII	ckii	NN	NN	_	30	compound	_	_
30	sites	site	NNS	NNS	_	27	dobj	_	_
31	near	near	JJ	JJ	_	34	case	_	_
32	the	the	DT	DT	_	34	det	_	_
33	N	n	NN	NN	_	34	compound	_	_
34	termini	terminus	NNS	NNS	_	30	nmod	_	_
35	of	of	IN	IN	_	39	case	_	_
36	the	the	DT	DT	_	39	det	_	_
37	EBV	ebv	NN	NN	_	39	compound	_	_
38	SM	sm	NN	NN	_	39	compound	_	_
39	protein	protein	NN	NN	_	34	nmod	_	_
40	,	,	,	,	_	39	punct	_	_
41	the	the	DT	DT	_	49	det	_	_
42	herpes	herpes	NN	NN	_	49	compound	_	_
43	simplex	simplex	JJ	JJ	_	49	amod	_	_
44	virus	virus	NN	NN	_	49	compound	_	_
45	(	(	-LRB-	-LRB-	_	49	punct	_	_
46	HSV	hsv	NN	NN	_	49	compound	_	_
47	)	)	-RRB-	-RRB-	_	49	punct	_	_
48	ICP27	icp27	NN	NN	_	49	compound	_	_
49	protein	protein	NN	NN	_	39	conj	_	_
50	and	and	CC	CC	_	39	cc	_	_
51	the	the	DT	DT	_	61	det	_	_
52	herpesvirus	herpesvirus	NN	NN	_	61	compound	_	_
53	saimiri	saimirus	NNS	NNS	_	61	compound	_	_
54	(	(	-LRB-	-LRB-	_	61	punct	_	_
55	HVS	hv	NNS	NNS	_	61	compound	_	_
56	)	)	-RRB-	-RRB-	_	61	punct	_	_
57	open	open	JJ	JJ	_	61	amod	_	_
58	reading	reading	NN	NN	_	61	compound	_	_
59	frame	frame	NN	NN	_	61	compound	_	_
60	57	57	CD	CD	_	61	nummod	_	_
61	protein	protein	NN	NN	_	39	conj	_	_
62	.	.	.	.	_	8	punct	_	_

1	Site-directed	site-directed	JJ	JJ	_	2	amod	_	_
2	mutagenesis	mutagenesis	NN	NN	_	12	nsubj	_	_
3	of	of	IN	IN	_	7	case	_	_
4	the	the	DT	DT	_	7	det	_	_
5	consensus	consensus	NN	NN	_	7	compound	_	_
6	CKII	ckii	NN	NN	_	7	compound	_	_
7	site	site	NN	NN	_	2	nmod	_	_
8	in	in	IN	IN	_	9	case	_	_
9	EBV	ebv	NN	NN	_	7	nmod	_	_
10	SM	sm	NN	NN	_	9	dep	_	_
11	greatly	greatly	RB	RB	_	12	advmod	_	_
12	reduced	reduce	VBD	VBD	_	0	root	_	_
13	the	the	DT	DT	_	16	det	_	_
14	in	in	FW	FW	_	16	amod	_	_
15	vitro	vitro	FW	FW	_	14	dep	_	_
16	phosphorylation	phosphorylation	NN	NN	_	12	dobj	_	_
17	of	of	IN	IN	_	18	case	_	_
18	SM	sm	NN	NN	_	16	nmod	_	_
19	by	by	IN	IN	_	20	case	_	_
20	CKII	ckii	NN	NN	_	16	nmod	_	_
21	.	.	.	.	_	12	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	mechanism	mechanism	NN	NN	_	10	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	transactivation	transactivation	NN	NN	_	2	nmod	_	_
5	by	by	IN	IN	_	7	case	_	_
6	BMLF1	bmlf1	NN	NN	_	7	compound	_	_
7	proteins	protein	NNS	NNS	_	4	nmod	_	_
8	has	have	VBZ	VBZ	_	10	aux	_	_
9	been	be	VBN	VBN	_	10	cop	_	_
10	controversial	controversial	JJ	JJ	_	0	root	_	_
11	but	but	CC	CC	_	10	cc	_	_
12	SM	sm	NN	NN	_	14	nsubjpass	_	_
13	was	be	VBD	VBD	_	14	auxpass	_	_
14	shown	show	VBN	VBN	_	10	conj	_	_
15	to	to	TO	TO	_	16	mark	_	_
16	transactivate	transactivate	VB	VB	_	14	xcomp	_	_
17	gene	gene	NN	NN	_	18	compound	_	_
18	expression	expression	NN	NN	_	16	dobj	_	_
19	from	from	IN	IN	_	23	case	_	_
20	a	a	DT	DT	_	23	det	_	_
21	CAT	cat	NN	NN	_	23	compound	_	_
22	reporter	reporter	NN	NN	_	23	compound	_	_
23	construct	construct	NN	NN	_	18	nmod	_	_
24	by	by	IN	IN	_	25	mark	_	_
25	increasing	increase	VBG	VBG	_	16	advcl	_	_
26	the	the	DT	DT	_	27	det	_	_
27	amount	amount	NN	NN	_	25	dobj	_	_
28	of	of	IN	IN	_	31	case	_	_
29	cytoplasmic	cytoplasmic	JJ	JJ	_	31	amod	_	_
30	CAT	cat	NN	NN	_	31	compound	_	_
31	mRNA	mrna	NN	NN	_	27	nmod	_	_
32	.	.	.	.	_	10	punct	_	_

1	Mutagenesis	mutagenesis	NN	NN	_	8	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	CKII	ckii	NN	NN	_	5	compound	_	_
5	site	site	NN	NN	_	1	nmod	_	_
6	in	in	IN	IN	_	7	case	_	_
7	SM	sm	NN	NN	_	5	nmod	_	_
8	made	make	VBD	VBD	_	0	root	_	_
9	no	no	DT	DT	_	10	neg	_	_
10	difference	difference	NN	NN	_	8	dobj	_	_
11	to	to	TO	TO	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	transactivation	transactivation	NN	NN	_	8	nmod	_	_
14	in	in	IN	IN	_	18	case	_	_
15	this	this	DT	DT	_	18	det	_	_
16	transient	transient	JJ	JJ	_	18	amod	_	_
17	transfection	transfection	NN	NN	_	18	compound	_	_
18	assay	assay	NN	NN	_	8	nmod	_	_
19	.	.	.	.	_	8	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	role	role	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	4	case	_	_
4	NFATp	nfatp	NN	NN	_	2	nmod	_	_
5	in	in	IN	IN	_	12	case	_	_
6	cyclosporin	cyclosporin	NN	NN	_	11	compound	_	_
7	A-sensitive	a-sensitive	JJ	JJ	_	11	amod	_	_
8	tumor	tumor	NN	NN	_	11	compound	_	_
9	necrosis	necrosis	NN	NN	_	11	compound	_	_
10	factor-alpha	factor-alpha	NN	NN	_	11	compound	_	_
11	gene	gene	NN	NN	_	12	compound	_	_
12	transcription	transcription	NN	NN	_	2	nmod	_	_
13	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	9	det	_	_
2	tumor	tumor	NN	NN	_	9	compound	_	_
3	necrosis	necrosis	NN	NN	_	9	compound	_	_
4	factor-alpha	factor-alpha	NN	NN	_	9	compound	_	_
5	(	(	-LRB-	-LRB-	_	9	punct	_	_
6	TNF	tnf	NN	NN	_	9	compound	_	_
7	alpha	alpha	NN	NN	_	9	compound	_	_
8	)	)	-RRB-	-RRB-	_	9	punct	_	_
9	gene	gene	NN	NN	_	14	nsubj	_	_
10	is	be	VBZ	VBZ	_	14	cop	_	_
11	an	a	DT	DT	_	14	det	_	_
12	immediate	immediate	JJ	JJ	_	14	amod	_	_
13	early	early	JJ	JJ	_	14	amod	_	_
14	gene	gene	NN	NN	_	0	root	_	_
15	in	in	IN	IN	_	18	case	_	_
16	activated	activate	VBN	VBN	_	18	amod	_	_
17	T	t	NN	NN	_	18	compound	_	_
18	cells	cell	NNS	NNS	_	14	nmod	_	_
19	,	,	,	,	_	14	punct	_	_
20	in	in	IN	IN	_	25	mark	_	_
21	that	that	IN	IN	_	25	mark	_	_
22	it	it	PRP	PRP	_	25	nsubjpass	_	_
23	is	be	VBZ	VBZ	_	25	auxpass	_	_
24	rapidly	rapidly	RB	RB	_	25	advmod	_	_
25	induced	induce	VBN	VBN	_	14	advcl	_	_
26	without	without	IN	IN	_	28	case	_	_
27	a	a	DT	DT	_	28	det	_	_
28	requirement	requirement	NN	NN	_	25	nmod	_	_
29	for	for	IN	IN	_	31	case	_	_
30	protein	protein	NN	NN	_	31	compound	_	_
31	synthesis	synthesis	NN	NN	_	28	nmod	_	_
32	.	.	.	.	_	14	punct	_	_

1	Maximal	maximal	JJ	JJ	_	2	amod	_	_
2	induction	induction	NN	NN	_	9	nsubjpass	_	_
3	of	of	IN	IN	_	6	case	_	_
4	TNF	tnf	NN	NN	_	6	compound	_	_
5	alpha	alpha	NN	NN	_	6	compound	_	_
6	mRNA	mrna	NN	NN	_	2	nmod	_	_
7	can	can	MD	MD	_	9	aux	_	_
8	be	be	VB	VB	_	9	auxpass	_	_
9	induced	induce	VBN	VBN	_	0	root	_	_
10	by	by	IN	IN	_	11	case	_	_
11	treatment	treatment	NN	NN	_	9	nmod	_	_
12	of	of	IN	IN	_	14	case	_	_
13	T	t	NN	NN	_	14	compound	_	_
14	cells	cell	NNS	NNS	_	11	nmod	_	_
15	with	with	IN	IN	_	17	case	_	_
16	calcium	calcium	NN	NN	_	17	compound	_	_
17	ionophores	ionophore	NNS	NNS	_	11	nmod	_	_
18	alone	alone	RB	RB	_	17	advmod	_	_
19	,	,	,	,	_	9	punct	_	_
20	via	via	IN	IN	_	23	case	_	_
21	a	a	DT	DT	_	23	det	_	_
22	calcineurin-dependent	calcineurin-dependent	JJ	JJ	_	23	amod	_	_
23	process	process	NN	NN	_	9	nmod	_	_
24	that	that	WDT	WDT	_	26	nsubjpass	_	_
25	is	be	VBZ	VBZ	_	26	auxpass	_	_
26	blocked	block	VBN	VBN	_	23	acl:relcl	_	_
27	by	by	IN	IN	_	29	case	_	_
28	cyclosporin	cyclosporin	NN	NN	_	29	compound	_	_
29	A	a	NN	NN	_	26	nmod	_	_
30	.	.	.	.	_	9	punct	_	_

1	We	we	PRP	PRP	_	4	nsubj	_	_
2	have	have	VBP	VBP	_	4	aux	_	_
3	previously	previously	RB	RB	_	4	advmod	_	_
4	identified	identify	VBN	VBN	_	0	root	_	_
5	a	a	DT	DT	_	7	det	_	_
6	promoter	promoter	NN	NN	_	7	compound	_	_
7	element	element	NN	NN	_	4	dobj	_	_
8	,	,	,	,	_	7	punct	_	_
9	kappa	kappa	NN	NN	_	7	appos	_	_
10	3	3	CD	CD	_	9	nummod	_	_
11	,	,	,	,	_	7	punct	_	_
12	that	that	WDT	WDT	_	14	nsubjpass	_	_
13	is	be	VBZ	VBZ	_	14	auxpass	_	_
14	required	require	VBN	VBN	_	7	acl:relcl	_	_
15	for	for	IN	IN	_	20	case	_	_
16	calcium-stimulated	calcium-stimulated	JJ	JJ	_	20	amod	_	_
17	,	,	,	,	_	16	punct	_	_
18	cyclosporin	cyclosporin	NN	NN	_	19	nmod:npmod	_	_
19	A-sensitive	a-sensitive	JJ	JJ	_	16	dep	_	_
20	induction	induction	NN	NN	_	14	nmod	_	_
21	of	of	IN	IN	_	25	case	_	_
22	the	the	DT	DT	_	25	det	_	_
23	TNF	tnf	NN	NN	_	25	compound	_	_
24	alpha	alpha	NN	NN	_	25	compound	_	_
25	gene	gene	NN	NN	_	20	nmod	_	_
26	in	in	IN	IN	_	29	case	_	_
27	activated	activate	VBN	VBN	_	29	amod	_	_
28	T	t	NN	NN	_	29	compound	_	_
29	cells	cell	NNS	NNS	_	20	nmod	_	_
30	.	.	.	.	_	4	punct	_	_

1	Here	here	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	11	mark	_	_
6	the	the	DT	DT	_	10	det	_	_
7	kappa	kappa	NN	NN	_	10	compound	_	_
8	3	3	CD	CD	_	10	nummod	_	_
9	binding	binding	NN	NN	_	10	compound	_	_
10	factor	factor	NN	NN	_	11	nsubj	_	_
11	contains	contain	VBZ	VBZ	_	4	ccomp	_	_
12	NFATp	nfatp	NN	NN	_	11	dobj	_	_
13	,	,	,	,	_	12	punct	_	_
14	a	a	DT	DT	_	17	det	_	_
15	cyclosporin-sensitive	cyclosporin-sensitive	JJ	JJ	_	17	amod	_	_
16	DNA-binding	dna-binding	JJ	JJ	_	17	amod	_	_
17	protein	protein	NN	NN	_	12	appos	_	_
18	required	require	VBN	VBN	_	17	acl	_	_
19	for	for	IN	IN	_	22	case	_	_
20	interleukin-2	interleukin-2	NN	NN	_	21	compound	_	_
21	gene	gene	NN	NN	_	22	compound	_	_
22	transcription	transcription	NN	NN	_	18	nmod	_	_
23	.	.	.	.	_	4	punct	_	_

1	NFATp	nfatp	NN	NN	_	2	nsubj	_	_
2	binds	bind	VBZ	VBZ	_	0	root	_	_
3	to	to	TO	TO	_	5	case	_	_
4	two	two	CD	CD	_	5	nummod	_	_
5	sites	site	NNS	NNS	_	2	nmod	_	_
6	within	within	IN	IN	_	10	case	_	_
7	the	the	DT	DT	_	10	det	_	_
8	kappa	kappa	NN	NN	_	10	compound	_	_
9	3	3	CD	CD	_	10	nummod	_	_
10	element	element	NN	NN	_	5	nmod	_	_
11	,	,	,	,	_	2	punct	_	_
12	and	and	CC	CC	_	2	cc	_	_
13	occupancy	occupancy	NN	NN	_	18	nsubjpass	_	_
14	of	of	IN	IN	_	16	case	_	_
15	both	both	DT	DT	_	16	det	_	_
16	sites	site	NNS	NNS	_	13	nmod	_	_
17	is	be	VBZ	VBZ	_	18	auxpass	_	_
18	required	require	VBN	VBN	_	2	conj	_	_
19	for	for	IN	IN	_	23	case	_	_
20	TNF	tnf	NN	NN	_	23	compound	_	_
21	alpha	alpha	NN	NN	_	23	compound	_	_
22	gene	gene	NN	NN	_	23	compound	_	_
23	induction	induction	NN	NN	_	18	nmod	_	_
24	.	.	.	.	_	2	punct	_	_

1	Thus	thus	RB	RB	_	18	advmod	_	_
2	,	,	,	,	_	18	punct	_	_
3	although	although	IN	IN	_	8	mark	_	_
4	the	the	DT	DT	_	7	det	_	_
5	kappa	kappa	NN	NN	_	7	compound	_	_
6	3	3	CD	CD	_	7	nummod	_	_
7	element	element	NN	NN	_	8	nsubj	_	_
8	has	have	VBZ	VBZ	_	18	dep	_	_
9	little	little	JJ	JJ	_	11	amod	_	_
10	sequence	sequence	NN	NN	_	11	compound	_	_
11	similarity	similarity	NN	NN	_	8	dobj	_	_
12	to	to	TO	TO	_	15	case	_	_
13	other	other	JJ	JJ	_	15	amod	_	_
14	NFATp-binding	nfatp-binding	JJ	JJ	_	15	amod	_	_
15	sites	site	NNS	NNS	_	11	nmod	_	_
16	,	,	,	,	_	18	punct	_	_
17	it	it	PRP	PRP	_	18	nsubj	_	_
18	appears	appear	VBZ	VBZ	_	0	root	_	_
19	to	to	TO	TO	_	20	mark	_	_
20	function	function	VB	VB	_	18	xcomp	_	_
21	as	as	IN	IN	_	25	case	_	_
22	a	a	DT	DT	_	25	det	_	_
23	cyclosporin-sensitive	cyclosporin-sensitive	JJ	JJ	_	25	amod	_	_
24	promoter	promoter	NN	NN	_	25	compound	_	_
25	element	element	NN	NN	_	20	nmod	_	_
26	in	in	IN	IN	_	28	case	_	_
27	T	t	NN	NN	_	28	compound	_	_
28	cells	cell	NNS	NNS	_	25	nmod	_	_
29	by	by	IN	IN	_	30	case	_	_
30	virtue	virtue	NN	NN	_	25	nmod	_	_
31	of	of	IN	IN	_	33	case	_	_
32	its	its	PRP$	PRP$	_	33	nmod:poss	_	_
33	ability	ability	NN	NN	_	30	nmod	_	_
34	to	to	TO	TO	_	35	mark	_	_
35	bind	bind	VB	VB	_	33	acl	_	_
36	NFATp	nfatp	NN	NN	_	35	dobj	_	_
37	.	.	.	.	_	18	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	involvement	involvement	NN	NN	_	16	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	NFATp	nfatp	NN	NN	_	2	nmod	_	_
5	in	in	IN	IN	_	7	case	_	_
6	transcriptional	transcriptional	JJ	JJ	_	7	amod	_	_
7	activation	activation	NN	NN	_	2	nmod	_	_
8	of	of	IN	IN	_	11	case	_	_
9	both	both	DT	DT	_	11	dep	_	_
10	the	the	DT	DT	_	11	det	_	_
11	interleukin-2	interleukin-2	NN	NN	_	7	nmod	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	TNF	tnf	NN	NN	_	15	compound	_	_
14	alpha	alpha	NN	NN	_	15	compound	_	_
15	genes	gene	NNS	NNS	_	11	conj	_	_
16	suggests	suggest	VBZ	VBZ	_	0	root	_	_
17	that	that	IN	IN	_	20	mark	_	_
18	this	this	DT	DT	_	19	det	_	_
19	factor	factor	NN	NN	_	20	nsubj	_	_
20	plays	play	VBZ	VBZ	_	16	ccomp	_	_
21	an	a	DT	DT	_	23	det	_	_
22	important	important	JJ	JJ	_	23	amod	_	_
23	role	role	NN	NN	_	20	dobj	_	_
24	in	in	IN	IN	_	27	case	_	_
25	the	the	DT	DT	_	27	det	_	_
26	coordinate	coordinate	JJ	JJ	_	27	amod	_	_
27	induction	induction	NN	NN	_	20	nmod	_	_
28	of	of	IN	IN	_	31	case	_	_
29	multiple	multiple	JJ	JJ	_	31	amod	_	_
30	cytokine	cytokine	NN	NN	_	31	compound	_	_
31	genes	gene	NNS	NNS	_	27	nmod	_	_
32	,	,	,	,	_	20	punct	_	_
33	starting	start	VBG	VBG	_	20	advcl	_	_
34	at	at	IN	IN	_	37	case	_	_
35	the	the	DT	DT	_	37	det	_	_
36	earliest	earliest	JJS	JJS	_	37	amod	_	_
37	stages	stage	NNS	NNS	_	33	nmod	_	_
38	of	of	IN	IN	_	41	case	_	_
39	T	t	NN	NN	_	41	compound	_	_
40	cell	cell	NN	NN	_	41	compound	_	_
41	activation	activation	NN	NN	_	37	nmod	_	_
42	.	.	.	.	_	16	punct	_	_

1	Inhibition	inhibition	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	8	case	_	_
3	human	human	JJ	JJ	_	8	amod	_	_
4	immunodeficiency	immunodeficiency	NN	NN	_	8	compound	_	_
5	virus	virus	NN	NN	_	8	compound	_	_
6	type	type	NN	NN	_	8	compound	_	_
7	1	1	CD	CD	_	8	nummod	_	_
8	replication	replication	NN	NN	_	1	nmod	_	_
9	by	by	IN	IN	_	15	case	_	_
10	a	a	DT	DT	_	15	det	_	_
11	Tat-activated	tat-activated	JJ	JJ	_	15	amod	_	_
12	,	,	,	,	_	15	punct	_	_
13	transduced	transduce	VBN	VBN	_	15	amod	_	_
14	interferon	interferon	NN	NN	_	15	compound	_	_
15	gene	gene	NN	NN	_	1	nmod	_	_
16	:	:	:	:	_	1	punct	_	_
17	targeted	target	VBN	VBN	_	18	amod	_	_
18	expression	expression	NN	NN	_	1	dep	_	_
19	to	to	TO	TO	_	25	case	_	_
20	human	human	JJ	JJ	_	25	amod	_	_
21	immunodeficiency	immunodeficiency	NN	NN	_	25	compound	_	_
22	virus	virus	NN	NN	_	25	compound	_	_
23	type	type	NN	NN	_	25	compound	_	_
24	1-infected	1-infected	JJ	JJ	_	25	amod	_	_
25	cells	cell	NNS	NNS	_	18	nmod	_	_
26	.	.	.	.	_	1	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	have	have	VBP	VBP	_	3	aux	_	_
3	examined	examine	VBN	VBN	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	feasibility	feasibility	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	7	mark	_	_
7	using	use	VBG	VBG	_	5	acl	_	_
8	interferon	interferon	NN	NN	_	13	compound	_	_
9	(	(	-LRB-	-LRB-	_	10	punct	_	_
10	IFN	ifn	NN	NN	_	8	appos	_	_
11	)	)	-RRB-	-RRB-	_	10	punct	_	_
12	gene	gene	NN	NN	_	13	compound	_	_
13	transfer	transfer	NN	NN	_	7	dobj	_	_
14	as	as	IN	IN	_	17	case	_	_
15	a	a	DT	DT	_	17	det	_	_
16	novel	novel	JJ	JJ	_	17	amod	_	_
17	approach	approach	NN	NN	_	7	nmod	_	_
18	to	to	TO	TO	_	27	case	_	_
19	anti-human	anti-human	JJ	JJ	_	22	amod	_	_
20	immunodeficiency	immunodeficiency	NN	NN	_	22	compound	_	_
21	virus	virus	NN	NN	_	22	compound	_	_
22	type	type	NN	NN	_	27	compound	_	_
23	1	1	CD	CD	_	22	nummod	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	HIV-1	hiv-1	NN	NN	_	22	appos	_	_
26	)	)	-RRB-	-RRB-	_	25	punct	_	_
27	therapy	therapy	NN	NN	_	17	nmod	_	_
28	in	in	IN	IN	_	30	case	_	_
29	this	this	DT	DT	_	30	det	_	_
30	study	study	NN	NN	_	3	nmod	_	_
31	.	.	.	.	_	3	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	limit	limit	VB	VB	_	0	root	_	_
3	expression	expression	NN	NN	_	2	dobj	_	_
4	of	of	IN	IN	_	14	case	_	_
5	a	a	DT	DT	_	14	det	_	_
6	transduced	transduce	VBN	VBN	_	14	amod	_	_
7	HIV-1	hiv-1	NN	NN	_	14	compound	_	_
8	long	long	JJ	JJ	_	14	amod	_	_
9	terminal	terminal	JJ	JJ	_	14	amod	_	_
10	repeat	repeat	NN	NN	_	14	compound	_	_
11	(	(	-LRB-	-LRB-	_	14	punct	_	_
12	LTR	ltr	NN	NN	_	14	compound	_	_
13	)	)	-RRB-	-RRB-	_	14	punct	_	_
14	-IFNA2	-ifna2	NN	NN	_	3	nmod	_	_
15	(	(	-LRB-	-LRB-	_	24	punct	_	_
16	the	the	DT	DT	_	19	det	_	_
17	new	new	JJ	JJ	_	18	amod	_	_
18	approved	approved	JJ	JJ	_	19	amod	_	_
19	nomenclature	nomenclature	NN	NN	_	24	nsubjpass	_	_
20	for	for	IN	IN	_	22	case	_	_
21	IFN	ifn	NN	NN	_	22	compound	_	_
22	genes	gene	NNS	NNS	_	19	nmod	_	_
23	is	be	VBZ	VBZ	_	24	auxpass	_	_
24	used	use	VBN	VBN	_	14	dep	_	_
25	throughout	throughout	IN	IN	_	27	case	_	_
26	this	this	DT	DT	_	27	det	_	_
27	article	article	NN	NN	_	24	nmod	_	_
28	)	)	-RRB-	-RRB-	_	24	punct	_	_
29	hybrid	hybrid	NN	NN	_	30	compound	_	_
30	gene	gene	NN	NN	_	39	nsubjpass	_	_
31	to	to	TO	TO	_	34	case	_	_
32	the	the	DT	DT	_	34	det	_	_
33	HIV-1-infected	hiv-1-infected	JJ	JJ	_	34	amod	_	_
34	cells	cell	NNS	NNS	_	30	nmod	_	_
35	,	,	,	,	_	30	punct	_	_
36	HIV-1	hiv-1	NN	NN	_	37	compound	_	_
37	LTR	ltr	NN	NN	_	30	appos	_	_
38	was	be	VBD	VBD	_	39	auxpass	_	_
39	modified	modify	VBN	VBN	_	2	parataxis	_	_
40	.	.	.	.	_	2	punct	_	_

1	Deletion	deletion	NN	NN	_	12	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	NF-kappa	nf-kappa	NN	NN	_	6	compound	_	_
5	B	b	NN	NN	_	6	compound	_	_
6	elements	element	NNS	NNS	_	1	nmod	_	_
7	of	of	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	HIV-1	hiv-1	NN	NN	_	10	compound	_	_
10	LTR	ltr	NN	NN	_	6	nmod	_	_
11	significantly	significantly	RB	RB	_	12	advmod	_	_
12	inhibited	inhibit	VBD	VBD	_	0	root	_	_
13	Tat-mediated	tat-mediated	JJ	JJ	_	14	amod	_	_
14	transactivation	transactivation	NN	NN	_	12	dobj	_	_
15	in	in	IN	IN	_	17	case	_	_
16	T-cell	t-cell	NN	NN	_	17	compound	_	_
17	lines	line	NNS	NNS	_	12	nmod	_	_
18	,	,	,	,	_	17	punct	_	_
19	as	as	RB	RB	_	17	cc	_	_
20	well	well	RB	RB	_	19	mwe	_	_
21	as	as	IN	IN	_	19	mwe	_	_
22	in	in	IN	IN	_	25	case	_	_
23	a	a	DT	DT	_	25	det	_	_
24	monocyte	monocyte	NN	NN	_	25	compound	_	_
25	line	line	NN	NN	_	17	conj	_	_
26	,	,	,	,	_	25	punct	_	_
27	U937	u937	NN	NN	_	25	appos	_	_
28	.	.	.	.	_	12	punct	_	_

1	Replacement	replacement	NN	NN	_	35	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	NF-kappa	nf-kappa	NN	NN	_	6	compound	_	_
5	B	b	NN	NN	_	6	compound	_	_
6	elements	element	NNS	NNS	_	1	nmod	_	_
7	in	in	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	HIV-1	hiv-1	NN	NN	_	10	compound	_	_
10	LTR	ltr	NN	NN	_	6	nmod	_	_
11	by	by	IN	IN	_	14	case	_	_
12	a	a	DT	DT	_	14	det	_	_
13	DNA	dna	NN	NN	_	14	compound	_	_
14	fragment	fragment	NN	NN	_	1	nmod	_	_
15	derived	derive	VBN	VBN	_	14	acl	_	_
16	from	from	IN	IN	_	19	case	_	_
17	the	the	DT	DT	_	19	det	_	_
18	5'-flanking	5'-flanking	JJ	JJ	_	19	amod	_	_
19	region	region	NN	NN	_	15	nmod	_	_
20	of	of	IN	IN	_	22	case	_	_
21	IFN-stimulated	ifn-stimulated	JJ	JJ	_	22	amod	_	_
22	gene	gene	NN	NN	_	19	nmod	_	_
23	15	15	CD	CD	_	22	nummod	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	ISG15	isg15	NN	NN	_	22	appos	_	_
26	)	)	-RRB-	-RRB-	_	25	punct	_	_
27	,	,	,	,	_	22	punct	_	_
28	containing	contain	VBG	VBG	_	22	acl	_	_
29	the	the	DT	DT	_	32	det	_	_
30	IFN-stimulated	ifn-stimulated	JJ	JJ	_	32	amod	_	_
31	response	response	NN	NN	_	32	compound	_	_
32	element	element	NN	NN	_	28	dobj	_	_
33	,	,	,	,	_	1	punct	_	_
34	partially	partially	RB	RB	_	35	advmod	_	_
35	restored	restore	VBD	VBD	_	0	root	_	_
36	Tat-mediated	tat-mediated	JJ	JJ	_	37	amod	_	_
37	activation	activation	NN	NN	_	35	dobj	_	_
38	of	of	IN	IN	_	39	case	_	_
39	LTR	ltr	NN	NN	_	37	nmod	_	_
40	in	in	IN	IN	_	42	case	_	_
41	T	t	NN	NN	_	42	compound	_	_
42	cells	cell	NNS	NNS	_	37	nmod	_	_
43	as	as	RB	RB	_	42	cc	_	_
44	well	well	RB	RB	_	43	mwe	_	_
45	as	as	IN	IN	_	43	mwe	_	_
46	in	in	IN	IN	_	47	case	_	_
47	monocytes	monocyte	NNS	NNS	_	42	conj	_	_
48	.	.	.	.	_	35	punct	_	_

1	Insertion	insertion	NN	NN	_	16	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	this	this	DT	DT	_	5	det	_	_
4	chimeric	chimeric	JJ	JJ	_	5	amod	_	_
5	promoter	promoter	NN	NN	_	1	nmod	_	_
6	(	(	-LRB-	-LRB-	_	8	punct	_	_
7	ISG15	isg15	NN	NN	_	8	compound	_	_
8	LTR	ltr	NN	NN	_	5	appos	_	_
9	)	)	-RRB-	-RRB-	_	8	punct	_	_
10	upstream	upstream	JJ	JJ	_	1	advmod	_	_
11	of	of	IN	IN	_	15	case	_	_
12	the	the	DT	DT	_	15	det	_	_
13	human	human	JJ	JJ	_	15	amod	_	_
14	IFNA2	ifna2	NN	NN	_	15	compound	_	_
15	gene	gene	NN	NN	_	10	nmod	_	_
16	directed	direct	VBD	VBD	_	0	root	_	_
17	high	high	JJ	JJ	_	18	amod	_	_
18	levels	level	NNS	NNS	_	16	dobj	_	_
19	of	of	IN	IN	_	21	case	_	_
20	IFN	ifn	NN	NN	_	21	compound	_	_
21	synthesis	synthesis	NN	NN	_	18	nmod	_	_
22	in	in	IN	IN	_	24	case	_	_
23	Tat-expressing	tat-expressing	JJ	JJ	_	24	amod	_	_
24	cells	cell	NNS	NNS	_	16	nmod	_	_
25	,	,	,	,	_	16	punct	_	_
26	while	while	IN	IN	_	31	mark	_	_
27	this	this	DT	DT	_	28	det	_	_
28	promoter	promoter	NN	NN	_	31	nsubj	_	_
29	was	be	VBD	VBD	_	31	cop	_	_
30	not	not	RB	RB	_	31	neg	_	_
31	responsive	responsive	JJ	JJ	_	16	advcl	_	_
32	to	to	TO	TO	_	37	case	_	_
33	tumor	tumor	NN	NN	_	37	compound	_	_
34	necrosis	necrosis	NN	NN	_	37	compound	_	_
35	factor	factor	NN	NN	_	37	compound	_	_
36	alpha-mediated	alpha-mediated	JJ	JJ	_	37	amod	_	_
37	activation	activation	NN	NN	_	31	nmod	_	_
38	.	.	.	.	_	16	punct	_	_

1	ISG15-LTR-IFN	isg15-ltr-ifn	JJ	JJ	_	3	amod	_	_
2	hybrid	hybrid	NN	NN	_	3	compound	_	_
3	gene	gene	NN	NN	_	10	nsubjpass	_	_
4	inserted	insert	VBN	VBN	_	3	acl	_	_
5	into	into	IN	IN	_	8	case	_	_
6	the	the	DT	DT	_	8	det	_	_
7	retrovirus	retrovirus	NN	NN	_	8	compound	_	_
8	vector	vector	NN	NN	_	4	nmod	_	_
9	was	be	VBD	VBD	_	10	auxpass	_	_
10	transduced	transduce	VBN	VBN	_	0	root	_	_
11	into	into	IN	IN	_	12	case	_	_
12	Jurkat	jurkat	NN	NN	_	10	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	U937	u937	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	12	conj	_	_
16	.	.	.	.	_	10	punct	_	_

1	Selected	select	VBN	VBN	_	3	amod	_	_
2	transfected	transfect	VBN	VBN	_	3	amod	_	_
3	clones	clone	NNS	NNS	_	4	nsubj	_	_
4	produced	produce	VBD	VBD	_	0	root	_	_
5	low	low	JJ	JJ	_	6	amod	_	_
6	levels	level	NNS	NNS	_	4	dobj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	IFN	ifn	NN	NN	_	9	compound	_	_
9	A	a	NN	NN	_	6	nmod	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	IFNA	ifna	NN	NN	_	9	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	constitutively	constitutively	RB	RB	_	4	advmod	_	_
14	,	,	,	,	_	4	punct	_	_
15	and	and	CC	CC	_	4	cc	_	_
16	their	they	PRP$	PRP$	_	17	nmod:poss	_	_
17	abilities	ability	NNS	NNS	_	33	nsubjpass	_	_
18	to	to	TO	TO	_	19	mark	_	_
19	express	express	VB	VB	_	17	acl	_	_
20	interleukin-2	interleukin-2	NN	NN	_	19	dobj	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	interleukin-2	interleukin-2	NN	NN	_	23	compound	_	_
23	receptor	receptor	NN	NN	_	20	conj	_	_
24	upon	upon	IN	IN	_	25	case	_	_
25	stimulation	stimulation	NN	NN	_	19	nmod	_	_
26	with	with	IN	IN	_	27	case	_	_
27	phytohemagglutinin	phytohemagglutinin	NN	NN	_	25	nmod	_	_
28	and	and	CC	CC	_	27	cc	_	_
29	phorbol	phorbol	NN	NN	_	31	compound	_	_
30	myristate	myristate	NN	NN	_	31	compound	_	_
31	acetate	acetate	NN	NN	_	27	conj	_	_
32	were	be	VBD	VBD	_	33	auxpass	_	_
33	retained	retain	VBN	VBN	_	4	conj	_	_
34	.	.	.	.	_	4	punct	_	_

1	Enhancement	enhancement	NN	NN	_	9	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	IFNA	ifna	NN	NN	_	4	compound	_	_
4	synthesis	synthesis	NN	NN	_	1	nmod	_	_
5	observed	observe	VBN	VBN	_	1	acl	_	_
6	upon	upon	IN	IN	_	8	case	_	_
7	HIV-1	hiv-1	NN	NN	_	8	compound	_	_
8	infection	infection	NN	NN	_	5	nmod	_	_
9	resulted	result	VBD	VBD	_	0	root	_	_
10	in	in	IN	IN	_	12	case	_	_
11	significant	significant	JJ	JJ	_	12	amod	_	_
12	inhibition	inhibition	NN	NN	_	9	nmod	_	_
13	of	of	IN	IN	_	15	case	_	_
14	HIV-1	hiv-1	NN	NN	_	15	compound	_	_
15	replication	replication	NN	NN	_	12	nmod	_	_
16	for	for	IN	IN	_	18	case	_	_
17	a	a	DT	DT	_	18	det	_	_
18	period	period	NN	NN	_	9	nmod	_	_
19	of	of	IN	IN	_	23	case	_	_
20	at	at	IN	IN	_	21	case	_	_
21	least	least	JJS	JJS	_	22	nmod:npmod	_	_
22	30	30	CD	CD	_	23	nummod	_	_
23	days	day	NNS	NNS	_	18	nmod	_	_
24	.	.	.	.	_	9	punct	_	_

1	Virus	virus	NN	NN	_	7	nsubj	_	_
2	isolated	isolate	VBN	VBN	_	1	acl	_	_
3	from	from	IN	IN	_	5	case	_	_
4	IFNA-producing	ifna-producing	JJ	JJ	_	5	amod	_	_
5	cells	cell	NNS	NNS	_	2	nmod	_	_
6	was	be	VBD	VBD	_	7	cop	_	_
7	able	able	JJ	JJ	_	0	root	_	_
8	to	to	TO	TO	_	9	mark	_	_
9	replicate	replicate	VB	VB	_	7	xcomp	_	_
10	in	in	IN	IN	_	13	case	_	_
11	the	the	DT	DT	_	13	det	_	_
12	U937	u937	NN	NN	_	13	compound	_	_
13	cells	cell	NNS	NNS	_	9	nmod	_	_
14	but	but	CC	CC	_	7	cc	_	_
15	did	do	VBD	VBD	_	17	aux	_	_
16	not	not	RB	RB	_	17	neg	_	_
17	replicate	replicate	VB	VB	_	7	conj	_	_
18	efficiently	efficiently	RB	RB	_	17	advmod	_	_
19	in	in	IN	IN	_	21	case	_	_
20	U937	u937	NN	NN	_	21	compound	_	_
21	cells	cell	NNS	NNS	_	17	nmod	_	_
22	transduced	transduce	VBN	VBN	_	21	acl	_	_
23	with	with	IN	IN	_	26	case	_	_
24	the	the	DT	DT	_	26	det	_	_
25	IFNA	ifna	NN	NN	_	26	compound	_	_
26	gene	gene	NN	NN	_	22	nmod	_	_
27	.	.	.	.	_	7	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	14	mark	_	_
5	targeting	target	VBG	VBG	_	14	csubj	_	_
6	IFN	ifn	NN	NN	_	7	compound	_	_
7	synthesis	synthesis	NN	NN	_	5	dobj	_	_
8	to	to	TO	TO	_	10	case	_	_
9	HIV-1-infected	hiv-1-infected	JJ	JJ	_	10	amod	_	_
10	cells	cell	NNS	NNS	_	5	nmod	_	_
11	is	be	VBZ	VBZ	_	14	cop	_	_
12	an	a	DT	DT	_	14	det	_	_
13	attainable	attainable	JJ	JJ	_	14	amod	_	_
14	goal	goal	NN	NN	_	3	ccomp	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	that	that	IN	IN	_	20	mark	_	_
17	autocrine	autocrine	NN	NN	_	19	compound	_	_
18	IFN	ifn	NN	NN	_	19	compound	_	_
19	synthesis	synthesis	NN	NN	_	20	nsubj	_	_
20	results	result	VBZ	VBZ	_	14	conj	_	_
21	in	in	IN	IN	_	26	case	_	_
22	a	a	DT	DT	_	26	det	_	_
23	long-lasting	long-lasting	JJ	JJ	_	26	amod	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	permanent	permanent	JJ	JJ	_	23	conj	_	_
26	suppression	suppression	NN	NN	_	20	nmod	_	_
27	of	of	IN	IN	_	29	case	_	_
28	HIV-1	hiv-1	NN	NN	_	29	compound	_	_
29	replication	replication	NN	NN	_	26	nmod	_	_
30	.	.	.	.	_	3	punct	_	_

1	Epstein-Barr	epstein-barr	JJ	JJ	_	4	amod	_	_
2	virus	virus	NN	NN	_	4	compound	_	_
3	nuclear	nuclear	JJ	JJ	_	4	amod	_	_
4	protein	protein	NN	NN	_	6	compound	_	_
5	2	2	CD	CD	_	4	nummod	_	_
6	transactivation	transactivation	NN	NN	_	15	nsubjpass	_	_
7	of	of	IN	IN	_	13	case	_	_
8	the	the	DT	DT	_	13	det	_	_
9	latent	latent	JJ	JJ	_	13	amod	_	_
10	membrane	membrane	NN	NN	_	13	compound	_	_
11	protein	protein	NN	NN	_	13	compound	_	_
12	1	1	CD	CD	_	13	nummod	_	_
13	promoter	promoter	NN	NN	_	6	nmod	_	_
14	is	be	VBZ	VBZ	_	15	auxpass	_	_
15	mediated	mediate	VBN	VBN	_	0	root	_	_
16	by	by	IN	IN	_	18	case	_	_
17	J	j	NN	NN	_	18	compound	_	_
18	kappa	kappa	NN	NN	_	15	nmod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	PU.1	pu.1	NN	NN	_	18	conj	_	_
21	.	.	.	.	_	15	punct	_	_

1	Expression	expression	NN	NN	_	18	nsubjpass	_	_
2	of	of	IN	IN	_	16	case	_	_
3	the	the	DT	DT	_	16	det	_	_
4	Epstein-Barr	epstein-barr	JJ	JJ	_	16	amod	_	_
5	virus	virus	NN	NN	_	16	compound	_	_
6	(	(	-LRB-	-LRB-	_	16	punct	_	_
7	EBV	ebv	NN	NN	_	16	compound	_	_
8	)	)	-RRB-	-RRB-	_	16	punct	_	_
9	latent	latent	JJ	JJ	_	16	amod	_	_
10	membrane	membrane	NN	NN	_	16	compound	_	_
11	protein	protein	NN	NN	_	16	compound	_	_
12	1	1	CD	CD	_	16	nummod	_	_
13	(	(	-LRB-	-LRB-	_	16	punct	_	_
14	LMP-1	lmp-1	NN	NN	_	16	compound	_	_
15	)	)	-RRB-	-RRB-	_	16	punct	_	_
16	oncogene	oncogene	NN	NN	_	1	nmod	_	_
17	is	be	VBZ	VBZ	_	18	auxpass	_	_
18	regulated	regulate	VBN	VBN	_	0	root	_	_
19	by	by	IN	IN	_	28	case	_	_
20	the	the	DT	DT	_	28	det	_	_
21	EBV	ebv	NN	NN	_	28	compound	_	_
22	nuclear	nuclear	JJ	JJ	_	28	amod	_	_
23	protein	protein	NN	NN	_	28	compound	_	_
24	2	2	CD	CD	_	28	nummod	_	_
25	(	(	-LRB-	-LRB-	_	28	punct	_	_
26	EBNA-2	ebna-2	NN	NN	_	28	compound	_	_
27	)	)	-RRB-	-RRB-	_	28	punct	_	_
28	transactivator	transactivator	NN	NN	_	18	nmod	_	_
29	.	.	.	.	_	18	punct	_	_

1	EBNA-2	ebna-2	NN	NN	_	3	nsubjpass	_	_
2	is	be	VBZ	VBZ	_	3	auxpass	_	_
3	known	know	VBN	VBN	_	0	root	_	_
4	to	to	TO	TO	_	5	mark	_	_
5	interact	interact	VB	VB	_	3	xcomp	_	_
6	with	with	IN	IN	_	10	case	_	_
7	the	the	DT	DT	_	10	det	_	_
8	cellular	cellular	JJ	JJ	_	10	amod	_	_
9	DNA-binding	dna-binding	JJ	JJ	_	10	amod	_	_
10	protein	protein	NN	NN	_	5	nmod	_	_
11	J	j	NN	NN	_	12	compound	_	_
12	kappa	kappa	NN	NN	_	10	dep	_	_
13	and	and	CC	CC	_	3	cc	_	_
14	is	be	VBZ	VBZ	_	15	auxpass	_	_
15	recruited	recruit	VBN	VBN	_	3	conj	_	_
16	to	to	TO	TO	_	17	case	_	_
17	promoters	promoter	NNS	NNS	_	15	nmod	_	_
18	containing	contain	VBG	VBG	_	17	acl	_	_
19	the	the	DT	DT	_	20	det	_	_
20	GTGGGAA	gtgggaa	NN	NN	_	18	dobj	_	_
21	J	j	NN	NN	_	24	compound	_	_
22	kappa	kappa	NN	NN	_	24	compound	_	_
23	recognition	recognition	NN	NN	_	24	compound	_	_
24	sequence	sequence	NN	NN	_	20	dep	_	_
25	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	5	det	_	_
2	minimal	minimal	JJ	JJ	_	5	amod	_	_
3	EBNA-2-responsive	ebna-2-responsive	JJ	JJ	_	5	amod	_	_
4	LMP-1	lmp-1	NN	NN	_	5	compound	_	_
5	promoter	promoter	NN	NN	_	6	nsubj	_	_
6	includes	include	VBZ	VBZ	_	0	root	_	_
7	one	one	CD	CD	_	10	nummod	_	_
8	J	j	NN	NN	_	10	compound	_	_
9	kappa-binding	kappa-binding	JJ	JJ	_	10	amod	_	_
10	site	site	NN	NN	_	6	dobj	_	_
11	,	,	,	,	_	6	punct	_	_
12	and	and	CC	CC	_	6	cc	_	_
13	we	we	PRP	PRP	_	15	nsubj	_	_
14	now	now	RB	RB	_	15	advmod	_	_
15	show	show	VBP	VBP	_	6	conj	_	_
16	that	that	IN	IN	_	30	mark	_	_
17	mutation	mutation	NN	NN	_	30	nsubj	_	_
18	of	of	IN	IN	_	20	case	_	_
19	that	that	DT	DT	_	20	det	_	_
20	site	site	NN	NN	_	17	nmod	_	_
21	,	,	,	,	_	17	punct	_	_
22	such	such	JJ	JJ	_	17	appos	_	_
23	that	that	IN	IN	_	28	dobj	_	_
24	J	j	NN	NN	_	25	compound	_	_
25	kappa	kappa	NN	NN	_	28	nsubj	_	_
26	can	can	MD	MD	_	28	aux	_	_
27	not	not	RB	RB	_	28	neg	_	_
28	bind	bind	VB	VB	_	22	acl:relcl	_	_
29	,	,	,	,	_	17	punct	_	_
30	reduces	reduce	VBZ	VBZ	_	15	ccomp	_	_
31	EBNA-2	ebna-2	NN	NN	_	32	compound	_	_
32	responsiveness	responsiveness	NN	NN	_	30	dobj	_	_
33	by	by	IN	IN	_	35	case	_	_
34	60	60	CD	CD	_	35	nummod	_	_
35	%	%	NN	NN	_	30	nmod	_	_
36	.	.	.	.	_	6	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	identify	identify	VB	VB	_	0	root	_	_
3	other	other	JJ	JJ	_	4	amod	_	_
4	factors	factor	NNS	NNS	_	2	dobj	_	_
5	which	which	WDT	WDT	_	6	nsubj	_	_
6	interact	interact	VBP	VBP	_	4	acl:relcl	_	_
7	with	with	IN	IN	_	12	case	_	_
8	the	the	DT	DT	_	12	det	_	_
9	LMP-1	lmp-1	NN	NN	_	12	compound	_	_
10	EBNA-2	ebna-2	NN	NN	_	12	compound	_	_
11	response	response	NN	NN	_	12	compound	_	_
12	element	element	NN	NN	_	6	nmod	_	_
13	(	(	-LRB-	-LRB-	_	14	punct	_	_
14	E2RE	e2re	NN	NN	_	12	appos	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	,	,	,	,	_	2	punct	_	_
17	a	a	DT	DT	_	20	det	_	_
18	-236/-145	-236/-145	JJ	JJ	_	20	amod	_	_
19	minimal	minimal	JJ	JJ	_	20	amod	_	_
20	E2RE	e2re	NN	NN	_	22	nsubjpass	_	_
21	was	be	VBD	VBD	_	22	auxpass	_	_
22	used	use	VBN	VBN	_	2	parataxis	_	_
23	as	as	IN	IN	_	25	case	_	_
24	a	a	DT	DT	_	25	det	_	_
25	probe	probe	NN	NN	_	22	nmod	_	_
26	in	in	IN	IN	_	31	case	_	_
27	an	a	DT	DT	_	31	det	_	_
28	electrophoretic	electrophoretic	JJ	JJ	_	31	amod	_	_
29	mobility	mobility	NN	NN	_	31	compound	_	_
30	shift	shift	NN	NN	_	31	compound	_	_
31	assay	assay	NN	NN	_	22	nmod	_	_
32	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	previously	previously	RB	RB	_	3	advmod	_	_
3	characterized	characterize	VBN	VBN	_	4	amod	_	_
4	factors	factor	NNS	NNS	_	12	nsubj	_	_
5	J	j	NN	NN	_	6	compound	_	_
6	kappa	kappa	NN	NN	_	4	dep	_	_
7	,	,	,	,	_	6	punct	_	_
8	PU.1	pu.1	NN	NN	_	6	conj	_	_
9	,	,	,	,	_	6	punct	_	_
10	and	and	CC	CC	_	6	cc	_	_
11	AML1	aml1	NN	NN	_	6	conj	_	_
12	bind	bind	VBP	VBP	_	0	root	_	_
13	to	to	TO	TO	_	16	case	_	_
14	the	the	DT	DT	_	16	det	_	_
15	LMP-1	lmp-1	NN	NN	_	16	compound	_	_
16	E2RE	e2re	NN	NN	_	12	nmod	_	_
17	,	,	,	,	_	12	punct	_	_
18	along	along	IN	IN	_	23	case	_	_
19	with	with	IN	IN	_	23	case	_	_
20	six	six	CD	CD	_	23	nummod	_	_
21	other	other	JJ	JJ	_	22	amod	_	_
22	unidentified	unidentified	JJ	JJ	_	23	amod	_	_
23	factors	factor	NNS	NNS	_	12	nmod	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	LBF2	lbf2	NN	NN	_	23	appos	_	_
26	to	to	TO	TO	_	27	case	_	_
27	LBF7	lbf7	NN	NN	_	25	nmod	_	_
28	)	)	-RRB-	-RRB-	_	25	punct	_	_
29	.	.	.	.	_	12	punct	_	_

1	Binding	bind	VBG	VBG	_	2	amod	_	_
2	sites	site	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	mapped	map	VBN	VBN	_	0	root	_	_
5	for	for	IN	IN	_	7	case	_	_
6	each	each	DT	DT	_	7	det	_	_
7	factor	factor	NN	NN	_	4	nmod	_	_
8	.	.	.	.	_	4	punct	_	_

1	LBF4	lbf4	NN	NN	_	6	nsubj	_	_
2	is	be	VBZ	VBZ	_	6	cop	_	_
3	B-	b-	NN	NN	_	6	dep	_	_
4	and	and	CC	CC	_	6	cc	_	_
5	T-cell	t-cell	NN	NN	_	6	conj	_	_
6	specific	specific	JJ	JJ	_	0	root	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	recognizes	recognize	VBZ	VBZ	_	6	conj	_	_
9	the	the	DT	DT	_	13	det	_	_
10	PU.1	pu.1	NN	NN	_	13	compound	_	_
11	GGAA	ggaa	NN	NN	_	13	compound	_	_
12	core	core	NN	NN	_	13	compound	_	_
13	sequence	sequence	NN	NN	_	8	dobj	_	_
14	as	as	IN	IN	_	15	mark	_	_
15	shown	show	VBN	VBN	_	8	advcl	_	_
16	by	by	IN	IN	_	18	case	_	_
17	methylation	methylation	NN	NN	_	18	compound	_	_
18	interference	interference	NN	NN	_	15	nmod	_	_
19	.	.	.	.	_	6	punct	_	_

1	LBF4	lbf4	NN	NN	_	2	nsubj	_	_
2	has	have	VBZ	VBZ	_	0	root	_	_
3	a	a	DT	DT	_	5	det	_	_
4	molecular	molecular	JJ	JJ	_	5	amod	_	_
5	mass	mass	NN	NN	_	2	dobj	_	_
6	of	of	IN	IN	_	8	case	_	_
7	105	105	CD	CD	_	8	nummod	_	_
8	kDa	kda	NN	NN	_	5	nmod	_	_
9	and	and	CC	CC	_	2	cc	_	_
10	is	be	VBZ	VBZ	_	12	cop	_	_
11	probably	probably	RB	RB	_	12	advmod	_	_
12	unrelated	unrelated	JJ	JJ	_	2	conj	_	_
13	to	to	TO	TO	_	14	case	_	_
14	PU.1	pu.1	NN	NN	_	12	nmod	_	_
15	.	.	.	.	_	2	punct	_	_

1	LBF2	lbf2	NN	NN	_	3	nsubjpass	_	_
2	was	be	VBD	VBD	_	3	auxpass	_	_
3	found	find	VBN	VBN	_	0	root	_	_
4	only	only	RB	RB	_	8	advmod	_	_
5	in	in	IN	IN	_	8	case	_	_
6	epithelial	epithelial	JJ	JJ	_	8	amod	_	_
7	cell	cell	NN	NN	_	8	compound	_	_
8	lines	line	NNS	NNS	_	3	nmod	_	_
9	,	,	,	,	_	3	punct	_	_
10	whereas	whereas	IN	IN	_	23	mark	_	_
11	LBF3	lbf3	NN	NN	_	23	nsubj	_	_
12	,	,	,	,	_	11	punct	_	_
13	LBF5	lbf5	NN	NN	_	11	conj	_	_
14	,	,	,	,	_	11	punct	_	_
15	LBF6	lbf6	NN	NN	_	11	conj	_	_
16	,	,	,	,	_	11	punct	_	_
17	and	and	CC	CC	_	11	cc	_	_
18	LBF7	lbf7	NN	NN	_	11	conj	_	_
19	were	be	VBD	VBD	_	23	cop	_	_
20	not	not	RB	RB	_	23	neg	_	_
21	cell	cell	NN	NN	_	23	nmod:npmod	_	_
22	type	type	NN	NN	_	23	nmod:npmod	_	_
23	specific	specific	JJ	JJ	_	3	advcl	_	_
24	.	.	.	.	_	3	punct	_	_

1	Mutations	mutation	NNS	NNS	_	8	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	the	the	DT	DT	_	4	dep	_	_
4	AML1-	aml1-	NN	NN	_	1	nmod	_	_
5	or	or	CC	CC	_	4	cc	_	_
6	LBF4-binding	lbf4-binding	JJ	JJ	_	4	conj	_	_
7	sites	site	NNS	NNS	_	4	dep	_	_
8	had	have	VBD	VBD	_	0	root	_	_
9	no	no	DT	DT	_	10	neg	_	_
10	effect	effect	NN	NN	_	8	dobj	_	_
11	on	on	IN	IN	_	13	case	_	_
12	EBNA-2	ebna-2	NN	NN	_	13	compound	_	_
13	transactivation	transactivation	NN	NN	_	8	nmod	_	_
14	,	,	,	,	_	8	punct	_	_
15	whereas	whereas	IN	IN	_	22	mark	_	_
16	mutation	mutation	NN	NN	_	22	nsubj	_	_
17	of	of	IN	IN	_	20	case	_	_
18	the	the	DT	DT	_	20	det	_	_
19	PU.1-binding	pu.1-binding	JJ	JJ	_	20	amod	_	_
20	site	site	NN	NN	_	16	nmod	_	_
21	completely	completely	RB	RB	_	22	advmod	_	_
22	eliminated	eliminate	VBD	VBD	_	8	advcl	_	_
23	EBNA-2	ebna-2	NN	NN	_	24	compound	_	_
24	responses	response	NNS	NNS	_	22	dobj	_	_
25	.	.	.	.	_	8	punct	_	_

1	A	a	DT	DT	_	4	det	_	_
2	gst-EBNA-2	gst-ebna-2	NN	NN	_	4	compound	_	_
3	fusion	fusion	NN	NN	_	4	compound	_	_
4	protein	protein	NN	NN	_	6	nsubj	_	_
5	specifically	specifically	RB	RB	_	6	advmod	_	_
6	depleted	deplete	VBD	VBD	_	0	root	_	_
7	PU.1	pu.1	NN	NN	_	6	dobj	_	_
8	from	from	IN	IN	_	10	case	_	_
9	nuclear	nuclear	JJ	JJ	_	10	amod	_	_
10	extracts	extract	NNS	NNS	_	6	nmod	_	_
11	and	and	CC	CC	_	6	cc	_	_
12	bound	bind	VBD	VBD	_	6	conj	_	_
13	in	in	FW	FW	_	14	compound	_	_
14	vitro	vitro	FW	FW	_	12	advmod	_	_
15	translated	translate	VBN	VBN	_	16	amod	_	_
16	PU.1	pu.1	NN	NN	_	12	dobj	_	_
17	,	,	,	,	_	6	punct	_	_
18	providing	provide	VBG	VBG	_	6	advcl	_	_
19	biochemical	biochemical	JJ	JJ	_	20	amod	_	_
20	evidence	evidence	NN	NN	_	18	dobj	_	_
21	for	for	IN	IN	_	25	case	_	_
22	a	a	DT	DT	_	25	det	_	_
23	direct	direct	JJ	JJ	_	25	amod	_	_
24	EBNA-2-PU.1	ebna-2-pu.1	JJ	JJ	_	25	amod	_	_
25	interaction	interaction	NN	NN	_	20	nmod	_	_
26	.	.	.	.	_	6	punct	_	_

1	Thus	thus	RB	RB	_	10	advmod	_	_
2	,	,	,	,	_	10	punct	_	_
3	EBNA-2	ebna-2	NN	NN	_	4	compound	_	_
4	transactivation	transactivation	NN	NN	_	10	nsubj	_	_
5	of	of	IN	IN	_	8	case	_	_
6	the	the	DT	DT	_	8	det	_	_
7	LMP-1	lmp-1	NN	NN	_	8	compound	_	_
8	promoter	promoter	NN	NN	_	4	nmod	_	_
9	is	be	VBZ	VBZ	_	10	cop	_	_
10	dependent	dependent	JJ	JJ	_	0	root	_	_
11	on	on	IN	IN	_	12	case	_	_
12	interaction	interaction	NN	NN	_	10	nmod	_	_
13	with	with	IN	IN	_	20	case	_	_
14	at	at	IN	IN	_	15	case	_	_
15	least	least	JJS	JJS	_	16	nmod:npmod	_	_
16	two	two	CD	CD	_	20	nummod	_	_
17	distinct	distinct	JJ	JJ	_	20	amod	_	_
18	sequence-specific	sequence-specific	JJ	JJ	_	17	dep	_	_
19	DNA-binding	dna-binding	JJ	JJ	_	20	amod	_	_
20	proteins	protein	NNS	NNS	_	12	nmod	_	_
21	,	,	,	,	_	20	punct	_	_
22	J	j	NN	NN	_	23	compound	_	_
23	kappa	kappa	NN	NN	_	20	appos	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	PU.1	pu.1	NN	NN	_	23	conj	_	_
26	.	.	.	.	_	10	punct	_	_

1	LBF3	lbf3	NN	NN	_	12	nsubjpass	_	_
2	,	,	,	,	_	1	punct	_	_
3	LBF5	lbf5	NN	NN	_	1	conj	_	_
4	,	,	,	,	_	1	punct	_	_
5	LBF6	lbf6	NN	NN	_	1	conj	_	_
6	,	,	,	,	_	1	punct	_	_
7	or	or	CC	CC	_	1	cc	_	_
8	LBF7	lbf7	NN	NN	_	1	conj	_	_
9	may	may	MD	MD	_	12	aux	_	_
10	also	also	RB	RB	_	12	advmod	_	_
11	be	be	VB	VB	_	12	auxpass	_	_
12	involved	involve	VBN	VBN	_	0	root	_	_
13	,	,	,	,	_	12	punct	_	_
14	since	since	IN	IN	_	19	mark	_	_
15	their	they	PRP$	PRP$	_	17	nmod:poss	_	_
16	binding	bind	VBG	VBG	_	17	amod	_	_
17	sites	site	NNS	NNS	_	19	nsubj	_	_
18	also	also	RB	RB	_	19	advmod	_	_
19	contribute	contribute	VBP	VBP	_	12	advcl	_	_
20	to	to	TO	TO	_	22	case	_	_
21	EBNA-2	ebna-2	NN	NN	_	22	compound	_	_
22	responsiveness	responsiveness	NN	NN	_	19	nmod	_	_
23	.	.	.	.	_	12	punct	_	_

1	Pyrrolidine	pyrrolidine	NN	NN	_	2	compound	_	_
2	dithiocarbamate	dithiocarbamate	NN	NN	_	18	nsubj	_	_
3	,	,	,	,	_	2	punct	_	_
4	a	a	DT	DT	_	6	det	_	_
5	potent	potent	JJ	JJ	_	6	amod	_	_
6	inhibitor	inhibitor	NN	NN	_	2	appos	_	_
7	of	of	IN	IN	_	16	case	_	_
8	nuclear	nuclear	JJ	JJ	_	11	amod	_	_
9	factor	factor	NN	NN	_	11	compound	_	_
10	kappa	kappa	NN	NN	_	11	compound	_	_
11	B	b	NN	NN	_	16	compound	_	_
12	(	(	-LRB-	-LRB-	_	14	punct	_	_
13	NF-kappa	nf-kappa	NN	NN	_	14	compound	_	_
14	B	b	NN	NN	_	11	appos	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	activation	activation	NN	NN	_	6	nmod	_	_
17	,	,	,	,	_	2	punct	_	_
18	prevents	prevent	VBZ	VBZ	_	0	root	_	_
19	apoptosis	apoptosis	NN	NN	_	18	dobj	_	_
20	in	in	IN	IN	_	25	case	_	_
21	human	human	JJ	JJ	_	25	amod	_	_
22	promyelocytic	promyelocytic	JJ	JJ	_	25	amod	_	_
23	leukemia	leukemia	NN	NN	_	25	compound	_	_
24	HL-60	hl-60	NN	NN	_	25	compound	_	_
25	cells	cell	NNS	NNS	_	19	nmod	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	thymocytes	thymocyte	NNS	NNS	_	25	conj	_	_
28	.	.	.	.	_	18	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	examined	examine	VBD	VBD	_	0	root	_	_
3	the	the	DT	DT	_	4	det	_	_
4	effect	effect	NN	NN	_	2	dobj	_	_
5	of	of	IN	IN	_	7	case	_	_
6	pyrrolidine	pyrrolidine	NN	NN	_	7	compound	_	_
7	dithiocarbamate	dithiocarbamate	NN	NN	_	4	nmod	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	PDTC	pdtc	NN	NN	_	7	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	,	,	,	,	_	7	punct	_	_
12	which	which	WDT	WDT	_	14	nsubj	_	_
13	potently	potently	RB	RB	_	14	advmod	_	_
14	blocks	block	VBZ	VBZ	_	7	acl:relcl	_	_
15	the	the	DT	DT	_	16	det	_	_
16	activation	activation	NN	NN	_	14	dobj	_	_
17	of	of	IN	IN	_	21	case	_	_
18	nuclear	nuclear	JJ	JJ	_	21	amod	_	_
19	factor	factor	NN	NN	_	21	compound	_	_
20	kappa	kappa	NN	NN	_	21	compound	_	_
21	B	b	NN	NN	_	16	nmod	_	_
22	(	(	-LRB-	-LRB-	_	24	punct	_	_
23	NF-kappa	nf-kappa	NN	NN	_	24	compound	_	_
24	B	b	NN	NN	_	21	appos	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	,	,	,	,	_	4	punct	_	_
27	on	on	IN	IN	_	29	case	_	_
28	the	the	DT	DT	_	29	det	_	_
29	induction	induction	NN	NN	_	4	nmod	_	_
30	of	of	IN	IN	_	31	case	_	_
31	apoptosis	apoptosis	NN	NN	_	29	nmod	_	_
32	by	by	IN	IN	_	34	case	_	_
33	a	a	DT	DT	_	34	det	_	_
34	variety	variety	NN	NN	_	31	nmod	_	_
35	of	of	IN	IN	_	36	case	_	_
36	agents	agent	NNS	NNS	_	34	nmod	_	_
37	.	.	.	.	_	2	punct	_	_

1	Treatment	treatment	NN	NN	_	20	nsubj	_	_
2	of	of	IN	IN	_	8	case	_	_
3	a	a	DT	DT	_	8	det	_	_
4	human	human	JJ	JJ	_	8	amod	_	_
5	promyelocytic	promyelocytic	JJ	JJ	_	8	amod	_	_
6	leukemia	leukemia	NN	NN	_	8	compound	_	_
7	cell	cell	NN	NN	_	8	compound	_	_
8	line	line	NN	NN	_	1	nmod	_	_
9	,	,	,	,	_	8	punct	_	_
10	HL-60	hl-60	NN	NN	_	8	appos	_	_
11	,	,	,	,	_	1	punct	_	_
12	with	with	IN	IN	_	15	case	_	_
13	10	10	CD	CD	_	15	nummod	_	_
14	micrograms/mL	micrograms/ml	NNS	NNS	_	15	compound	_	_
15	etoposide	etoposide	NN	NN	_	1	nmod	_	_
16	or	or	CC	CC	_	15	cc	_	_
17	2	2	CD	CD	_	19	nummod	_	_
18	microM	microm	NN	NN	_	19	compound	_	_
19	1-beta-D-arabinofuranosylcytosine	1-beta-d-arabinofuranosylcytosine	NN	NN	_	15	conj	_	_
20	induced	induce	VBD	VBD	_	0	root	_	_
21	NF-kappa	nf-kappa	NN	NN	_	22	compound	_	_
22	B	b	NN	NN	_	23	compound	_	_
23	activation	activation	NN	NN	_	20	dobj	_	_
24	within	within	IN	IN	_	26	case	_	_
25	1	1	CD	CD	_	26	nummod	_	_
26	hr	hr	NN	NN	_	20	nmod	_	_
27	and	and	CC	CC	_	20	cc	_	_
28	subsequently	subsequently	RB	RB	_	29	advmod	_	_
29	caused	cause	VBD	VBD	_	20	conj	_	_
30	apoptosis	apoptosis	NN	NN	_	29	dobj	_	_
31	within	within	IN	IN	_	33	case	_	_
32	3-4	3-4	JJ	JJ	_	33	nummod	_	_
33	hr	hr	NN	NN	_	29	nmod	_	_
34	.	.	.	.	_	20	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	simultaneous	simultaneous	JJ	JJ	_	3	amod	_	_
3	addition	addition	NN	NN	_	11	nsubj	_	_
4	of	of	IN	IN	_	7	case	_	_
5	50-500	50-500	CD	CD	_	6	dep	_	_
6	microM	microm	NN	NN	_	7	dep	_	_
7	PDTC	pdtc	NN	NN	_	3	nmod	_	_
8	with	with	IN	IN	_	10	case	_	_
9	these	these	DT	DT	_	10	det	_	_
10	agents	agent	NNS	NNS	_	3	nmod	_	_
11	blocked	block	VBD	VBD	_	0	root	_	_
12	NF-kappa	nf-kappa	NN	NN	_	13	compound	_	_
13	B	b	NN	NN	_	14	compound	_	_
14	activation	activation	NN	NN	_	11	dobj	_	_
15	and	and	CC	CC	_	11	cc	_	_
16	completely	completely	RB	RB	_	17	advmod	_	_
17	abrogated	abrogate	VBD	VBD	_	11	conj	_	_
18	both	both	CC	CC	_	21	cc:preconj	_	_
19	morphologically	morphologically	RB	RB	_	21	advmod	_	_
20	apoptotic	apoptotic	JJ	JJ	_	21	amod	_	_
21	changes	change	NNS	NNS	_	17	dobj	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	internucleosomal	internucleosomal	JJ	JJ	_	25	amod	_	_
24	DNA	dna	NN	NN	_	25	compound	_	_
25	fragmentation	fragmentation	NN	NN	_	21	conj	_	_
26	for	for	IN	IN	_	30	case	_	_
27	up	up	RB	RB	_	29	advmod	_	_
28	to	to	TO	TO	_	29	dep	_	_
29	6	6	CD	CD	_	30	nummod	_	_
30	hr	hr	NN	NN	_	17	nmod	_	_
31	.	.	.	.	_	11	punct	_	_

1	However	however	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	PDTC	pdtc	NN	NN	_	4	nsubj	_	_
4	failed	fail	VBD	VBD	_	0	root	_	_
5	to	to	TO	TO	_	6	mark	_	_
6	inhibit	inhibit	VB	VB	_	4	xcomp	_	_
7	the	the	DT	DT	_	9	det	_	_
8	endonuclease	endonuclease	NN	NN	_	9	compound	_	_
9	activity	activity	NN	NN	_	6	dobj	_	_
10	contained	contain	VBN	VBN	_	9	acl	_	_
11	in	in	IN	IN	_	15	case	_	_
12	the	the	DT	DT	_	15	det	_	_
13	whole	whole	JJ	JJ	_	15	amod	_	_
14	cell	cell	NN	NN	_	15	compound	_	_
15	lysates	lysate	NNS	NNS	_	10	nmod	_	_
16	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	inhibitory	inhibitory	JJ	JJ	_	3	amod	_	_
3	effect	effect	NN	NN	_	8	nsubjpass	_	_
4	of	of	IN	IN	_	5	case	_	_
5	PDTC	pdtc	NN	NN	_	3	nmod	_	_
6	was	be	VBD	VBD	_	8	auxpass	_	_
7	also	also	RB	RB	_	8	advmod	_	_
8	observed	observe	VBN	VBN	_	0	root	_	_
9	in	in	IN	IN	_	10	case	_	_
10	etoposide-	etoposide-	NN	NN	_	8	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	dexamethasone-induced	dexamethasone-induced	JJ	JJ	_	10	conj	_	_
13	apoptosis	apoptosis	NN	NN	_	10	dep	_	_
14	in	in	IN	IN	_	16	case	_	_
15	human	human	JJ	JJ	_	16	amod	_	_
16	thymocytes	thymocyte	NNS	NNS	_	10	nmod	_	_
17	at	at	IN	IN	_	19	case	_	_
18	a	a	DT	DT	_	19	det	_	_
19	concentration	concentration	NN	NN	_	10	nmod	_	_
20	of	of	IN	IN	_	22	case	_	_
21	1-10	1-10	CD	CD	_	22	nummod	_	_
22	microM	microm	NN	NN	_	19	nmod	_	_
23	.	.	.	.	_	8	punct	_	_

1	Since	since	IN	IN	_	3	mark	_	_
2	PDTC	pdtc	NN	NN	_	3	nsubj	_	_
3	has	have	VBZ	VBZ	_	12	advcl	_	_
4	both	both	CC	CC	_	5	cc:preconj	_	_
5	antioxidant	antioxidant	NN	NN	_	3	dobj	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	metal-ion	metal-ion	JJ	JJ	_	5	conj	_	_
8	chelating	chelating	NN	NN	_	9	compound	_	_
9	activities	activity	NNS	NNS	_	5	dep	_	_
10	,	,	,	,	_	12	punct	_	_
11	we	we	PRP	PRP	_	12	nsubj	_	_
12	tested	test	VBD	VBD	_	0	root	_	_
13	the	the	DT	DT	_	14	det	_	_
14	effects	effect	NNS	NNS	_	12	dobj	_	_
15	of	of	IN	IN	_	16	case	_	_
16	N-acetyl-L-cysteine	n-acetyl-l-cysteine	NN	NN	_	14	nmod	_	_
17	(	(	-LRB-	-LRB-	_	18	punct	_	_
18	NAC	nac	NN	NN	_	16	appos	_	_
19	)	)	-RRB-	-RRB-	_	18	punct	_	_
20	(	(	-LRB-	-LRB-	_	21	punct	_	_
21	antioxidant	antioxidant	JJ	JJ	_	16	dep	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	or	or	CC	CC	_	16	cc	_	_
24	o-phenanthroline	o-phenanthroline	NN	NN	_	16	conj	_	_
25	(	(	-LRB-	-LRB-	_	26	punct	_	_
26	OP	op	NN	NN	_	24	appos	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	(	(	-LRB-	-LRB-	_	30	punct	_	_
29	metal-ion	metal-ion	JJ	JJ	_	30	amod	_	_
30	chelator	chelator	NN	NN	_	24	appos	_	_
31	)	)	-RRB-	-RRB-	_	30	punct	_	_
32	on	on	IN	IN	_	34	case	_	_
33	the	the	DT	DT	_	34	det	_	_
34	induction	induction	NN	NN	_	14	nmod	_	_
35	of	of	IN	IN	_	36	case	_	_
36	apoptosis	apoptosis	NN	NN	_	34	nmod	_	_
37	.	.	.	.	_	12	punct	_	_

1	Pretreatment	pretreatment	NN	NN	_	21	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	HL-60	hl-60	NN	NN	_	4	compound	_	_
4	cells	cell	NNS	NNS	_	1	nmod	_	_
5	or	or	CC	CC	_	4	cc	_	_
6	thymocytes	thymocyte	NNS	NNS	_	4	conj	_	_
7	with	with	IN	IN	_	10	case	_	_
8	100-500	100-500	CD	CD	_	9	dep	_	_
9	microM	microm	NN	NN	_	10	dep	_	_
10	OP	op	NN	NN	_	1	nmod	_	_
11	for	for	IN	IN	_	13	case	_	_
12	2	2	CD	CD	_	13	nummod	_	_
13	hr	hr	NN	NN	_	10	nmod	_	_
14	,	,	,	,	_	10	punct	_	_
15	but	but	CC	CC	_	16	cc	_	_
16	not	not	RB	RB	_	10	cc	_	_
17	10-60	10-60	CD	CD	_	18	dep	_	_
18	mM	mm	NN	NN	_	19	dep	_	_
19	NAC	nac	NN	NN	_	10	conj	_	_
20	,	,	,	,	_	1	punct	_	_
21	suppressed	suppress	VBD	VBD	_	0	root	_	_
22	subsequent	subsequent	JJ	JJ	_	23	amod	_	_
23	occurrence	occurrence	NN	NN	_	21	dobj	_	_
24	of	of	IN	IN	_	25	case	_	_
25	apoptosis	apoptosis	NN	NN	_	23	nmod	_	_
26	induced	induce	VBN	VBN	_	25	acl	_	_
27	by	by	IN	IN	_	28	case	_	_
28	etoposide	etoposide	NN	NN	_	26	nmod	_	_
29	.	.	.	.	_	21	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	10	mark	_	_
5	the	the	DT	DT	_	6	det	_	_
6	activation	activation	NN	NN	_	10	nsubj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	NF-kappa	nf-kappa	NN	NN	_	9	compound	_	_
9	B	b	NN	NN	_	6	nmod	_	_
10	plays	play	VBZ	VBZ	_	3	ccomp	_	_
11	an	a	DT	DT	_	13	det	_	_
12	important	important	JJ	JJ	_	13	amod	_	_
13	role	role	NN	NN	_	10	dobj	_	_
14	in	in	IN	IN	_	17	case	_	_
15	the	the	DT	DT	_	17	det	_	_
16	apoptotic	apoptotic	JJ	JJ	_	17	amod	_	_
17	process	process	NN	NN	_	10	nmod	_	_
18	of	of	IN	IN	_	21	case	_	_
19	human	human	JJ	JJ	_	21	amod	_	_
20	hematopoietic	hematopoietic	JJ	JJ	_	21	amod	_	_
21	cells	cell	NNS	NNS	_	17	nmod	_	_
22	.	.	.	.	_	3	punct	_	_

1	Differential	differential	JJ	JJ	_	2	amod	_	_
2	regulation	regulation	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	4	case	_	_
4	proto-oncogenes	proto-oncogene	NNS	NNS	_	2	nmod	_	_
5	c-jun	c-jun	NN	NN	_	4	dep	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	c-fos	c-fos	NN	NN	_	5	conj	_	_
8	in	in	IN	IN	_	10	case	_	_
9	T	t	NN	NN	_	10	compound	_	_
10	lymphocytes	lymphocyte	NNS	NNS	_	2	nmod	_	_
11	activated	activate	VBN	VBN	_	10	acl	_	_
12	through	through	IN	IN	_	13	case	_	_
13	CD28	cd28	NN	NN	_	11	nmod	_	_
14	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	5	det	_	_
2	T	t	NN	NN	_	5	compound	_	_
3	cell	cell	NN	NN	_	5	compound	_	_
4	surface	surface	NN	NN	_	5	compound	_	_
5	molecule	molecule	NN	NN	_	7	nsubj	_	_
6	CD28	cd28	NN	NN	_	5	dep	_	_
7	binds	bind	VBZ	VBZ	_	0	root	_	_
8	to	to	TO	TO	_	9	case	_	_
9	ligands	ligand	NNS	NNS	_	7	nmod	_	_
10	on	on	IN	IN	_	12	case	_	_
11	accessory	accessory	JJ	JJ	_	12	amod	_	_
12	cells	cell	NNS	NNS	_	9	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	APCs	apc	NNS	NNS	_	12	conj	_	_
15	,	,	,	,	_	7	punct	_	_
16	playing	play	VBG	VBG	_	7	xcomp	_	_
17	an	a	DT	DT	_	20	det	_	_
18	important	important	JJ	JJ	_	20	amod	_	_
19	costimulatory	costimulatory	JJ	JJ	_	18	dep	_	_
20	role	role	NN	NN	_	16	dobj	_	_
21	in	in	IN	IN	_	23	case	_	_
22	the	the	DT	DT	_	23	det	_	_
23	response	response	NN	NN	_	16	nmod	_	_
24	of	of	IN	IN	_	26	case	_	_
25	T	t	NN	NN	_	26	compound	_	_
26	cells	cell	NNS	NNS	_	23	nmod	_	_
27	to	to	TO	TO	_	28	case	_	_
28	Ags	ags	NN	NN	_	23	nmod	_	_
29	.	.	.	.	_	7	punct	_	_

1	Our	we	PRP$	PRP$	_	2	nmod:poss	_	_
2	knowledge	knowledge	NN	NN	_	13	nsubj	_	_
3	of	of	IN	IN	_	7	case	_	_
4	the	the	DT	DT	_	7	det	_	_
5	intracellular	intracellular	JJ	JJ	_	7	amod	_	_
6	signaling	signaling	NN	NN	_	7	compound	_	_
7	pathways	pathway	NNS	NNS	_	2	nmod	_	_
8	coupled	couple	VBN	VBN	_	7	acl	_	_
9	to	to	TO	TO	_	11	case	_	_
10	this	this	DT	DT	_	11	det	_	_
11	receptor	receptor	NN	NN	_	8	nmod	_	_
12	is	be	VBZ	VBZ	_	13	cop	_	_
13	incomplete	incomplete	JJ	JJ	_	0	root	_	_
14	.	.	.	.	_	13	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	addition	addition	NN	NN	_	16	nmod	_	_
3	to	to	TO	TO	_	4	case	_	_
4	activation	activation	NN	NN	_	2	nmod	_	_
5	of	of	IN	IN	_	8	case	_	_
6	phospholipase	phospholipase	NN	NN	_	8	compound	_	_
7	C	c	NN	NN	_	8	compound	_	_
8	gamma	gamma	NN	NN	_	4	nmod	_	_
9	1	1	CD	CD	_	8	nummod	_	_
10	,	,	,	,	_	16	punct	_	_
11	ligation	ligation	NN	NN	_	16	nsubj	_	_
12	of	of	IN	IN	_	14	case	_	_
13	this	this	DT	DT	_	14	det	_	_
14	receptor	receptor	NN	NN	_	11	nmod	_	_
15	also	also	RB	RB	_	16	advmod	_	_
16	seems	seem	VBZ	VBZ	_	0	root	_	_
17	to	to	TO	TO	_	18	mark	_	_
18	activate	activate	VB	VB	_	16	xcomp	_	_
19	a	a	DT	DT	_	23	det	_	_
20	calcium-independent	calcium-independent	JJ	JJ	_	23	amod	_	_
21	,	,	,	,	_	20	punct	_	_
22	CD28-specific	cd28-specific	JJ	JJ	_	20	dep	_	_
23	pathway	pathway	NN	NN	_	18	dobj	_	_
24	.	.	.	.	_	16	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	paper	paper	NN	NN	_	6	nmod	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	report	report	VBP	VBP	_	0	root	_	_
7	that	that	IN	IN	_	23	mark	_	_
8	cross-linking	cross-linking	NN	NN	_	23	nsubj	_	_
9	of	of	IN	IN	_	10	case	_	_
10	CD28	cd28	NN	NN	_	8	nmod	_	_
11	(	(	-LRB-	-LRB-	_	14	punct	_	_
12	but	but	CC	CC	_	13	cc	_	_
13	not	not	RB	RB	_	14	cc	_	_
14	CD2	cd2	NN	NN	_	10	dep	_	_
15	,	,	,	,	_	14	punct	_	_
16	CD5	cd5	NN	NN	_	14	conj	_	_
17	,	,	,	,	_	14	punct	_	_
18	LFA-1	lfa-1	NN	NN	_	14	conj	_	_
19	,	,	,	,	_	14	punct	_	_
20	or	or	CC	CC	_	14	cc	_	_
21	CD7	cd7	NN	NN	_	14	conj	_	_
22	)	)	-RRB-	-RRB-	_	14	punct	_	_
23	leads	lead	VBZ	VBZ	_	6	ccomp	_	_
24	to	to	TO	TO	_	26	case	_	_
25	an	a	DT	DT	_	26	det	_	_
26	elevation	elevation	NN	NN	_	23	nmod	_	_
27	of	of	IN	IN	_	29	case	_	_
28	c-jun	c-jun	NN	NN	_	29	compound	_	_
29	mRNA	mrna	NN	NN	_	26	nmod	_	_
30	,	,	,	,	_	23	punct	_	_
31	with	with	IN	IN	_	34	case	_	_
32	only	only	RB	RB	_	34	advmod	_	_
33	minimal	minimal	JJ	JJ	_	34	amod	_	_
34	activation	activation	NN	NN	_	23	nmod	_	_
35	of	of	IN	IN	_	37	case	_	_
36	c-fos	c-fos	NN	NN	_	37	compound	_	_
37	expression	expression	NN	NN	_	34	nmod	_	_
38	.	.	.	.	_	6	punct	_	_

1	CD28-dependent	cd28-dependent	JJ	JJ	_	2	amod	_	_
2	induction	induction	NN	NN	_	6	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	c-jun	c-jun	NN	NN	_	5	compound	_	_
5	expression	expression	NN	NN	_	2	nmod	_	_
6	requires	require	VBZ	VBZ	_	0	root	_	_
7	protein	protein	NN	NN	_	9	compound	_	_
8	tyrosine	tyrosine	NN	NN	_	9	compound	_	_
9	kinase	kinase	NN	NN	_	10	compound	_	_
10	activity	activity	NN	NN	_	6	dobj	_	_
11	,	,	,	,	_	6	punct	_	_
12	but	but	CC	CC	_	6	cc	_	_
13	does	do	VBZ	VBZ	_	15	aux	_	_
14	not	not	RB	RB	_	15	neg	_	_
15	depend	depend	VB	VB	_	6	conj	_	_
16	on	on	IN	IN	_	17	case	_	_
17	activation	activation	NN	NN	_	15	nmod	_	_
18	of	of	IN	IN	_	24	case	_	_
19	a	a	DT	DT	_	24	det	_	_
20	phorbol	phorbol	NN	NN	_	24	compound	_	_
21	ester-responsive	ester-responsive	JJ	JJ	_	24	amod	_	_
22	protein	protein	NN	NN	_	24	compound	_	_
23	kinase	kinase	NN	NN	_	24	compound	_	_
24	C	c	NN	NN	_	17	nmod	_	_
25	or	or	CC	CC	_	17	cc	_	_
26	elevation	elevation	NN	NN	_	17	conj	_	_
27	of	of	IN	IN	_	29	case	_	_
28	cytosolic	cytosolic	JJ	JJ	_	29	amod	_	_
29	calcium	calcium	NN	NN	_	26	nmod	_	_
30	.	.	.	.	_	6	punct	_	_

1	Furthermore	furthermore	RB	RB	_	10	advmod	_	_
2	,	,	,	,	_	10	punct	_	_
3	CD28-dependent	cd28-dependent	JJ	JJ	_	4	amod	_	_
4	elevation	elevation	NN	NN	_	10	nsubj	_	_
5	of	of	IN	IN	_	7	case	_	_
6	c-jun	c-jun	NN	NN	_	7	compound	_	_
7	mRNA	mrna	NN	NN	_	4	nmod	_	_
8	does	do	VBZ	VBZ	_	10	aux	_	_
9	not	not	RB	RB	_	10	neg	_	_
10	appear	appear	VB	VB	_	0	root	_	_
11	to	to	TO	TO	_	13	mark	_	_
12	be	be	VB	VB	_	13	auxpass	_	_
13	mediated	mediate	VBN	VBN	_	10	xcomp	_	_
14	at	at	IN	IN	_	16	case	_	_
15	the	the	DT	DT	_	16	det	_	_
16	level	level	NN	NN	_	13	nmod	_	_
17	of	of	IN	IN	_	19	case	_	_
18	mRNA	mrna	NN	NN	_	19	compound	_	_
19	stability	stability	NN	NN	_	16	nmod	_	_
20	.	.	.	.	_	10	punct	_	_

1	A	a	DT	DT	_	2	det	_	_
2	mechanism	mechanism	NN	NN	_	4	nsubjpass	_	_
3	is	be	VBZ	VBZ	_	4	auxpass	_	_
4	suggested	suggest	VBN	VBN	_	0	root	_	_
5	whereby	whereby	WRB	WRB	_	4	advmod	_	_
6	expression	expression	NN	NN	_	23	nsubj	_	_
7	of	of	IN	IN	_	8	case	_	_
8	c-jun	c-jun	NN	NN	_	6	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	junB	junb	NN	NN	_	8	conj	_	_
11	,	,	,	,	_	6	punct	_	_
12	in	in	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	det	_	_
14	absence	absence	NN	NN	_	23	nmod	_	_
15	of	of	IN	IN	_	16	case	_	_
16	members	member	NNS	NNS	_	14	nmod	_	_
17	of	of	IN	IN	_	20	case	_	_
18	the	the	DT	DT	_	20	det	_	_
19	fos	fos	NN	NN	_	20	compound	_	_
20	family	family	NN	NN	_	16	nmod	_	_
21	,	,	,	,	_	23	punct	_	_
22	can	can	MD	MD	_	23	aux	_	_
23	prevent	prevent	VB	VB	_	4	ccomp	_	_
24	inappropriate	inappropriate	JJ	JJ	_	25	amod	_	_
25	activation	activation	NN	NN	_	23	dobj	_	_
26	of	of	IN	IN	_	28	case	_	_
27	T	t	NN	NN	_	28	compound	_	_
28	cells	cell	NNS	NNS	_	25	nmod	_	_
29	caused	cause	VBN	VBN	_	25	acl	_	_
30	by	by	IN	IN	_	31	case	_	_
31	ligation	ligation	NN	NN	_	29	nmod	_	_
32	of	of	IN	IN	_	33	case	_	_
33	CD28	cd28	NN	NN	_	31	nmod	_	_
34	in	in	IN	IN	_	36	case	_	_
35	the	the	DT	DT	_	36	det	_	_
36	absence	absence	NN	NN	_	29	nmod	_	_
37	of	of	IN	IN	_	41	case	_	_
38	a	a	DT	DT	_	41	det	_	_
39	specific	specific	JJ	JJ	_	41	amod	_	_
40	antigenic	antigenic	JJ	JJ	_	39	dep	_	_
41	stimulus	stimulus	NN	NN	_	36	nmod	_	_
42	.	.	.	.	_	4	punct	_	_

1	Constitutive	constitutive	JJ	JJ	_	4	amod	_	_
2	nuclear	nuclear	JJ	JJ	_	4	amod	_	_
3	NF-kappa	nf-kappa	NN	NN	_	4	compound	_	_
4	B	b	NN	NN	_	0	root	_	_
5	in	in	IN	IN	_	6	case	_	_
6	cells	cell	NNS	NNS	_	4	nmod	_	_
7	of	of	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	monocyte	monocyte	NN	NN	_	10	compound	_	_
10	lineage	lineage	NN	NN	_	6	nmod	_	_
11	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	monocytes	monocyte	NNS	NNS	_	11	nmod	_	_
3	,	,	,	,	_	11	punct	_	_
4	the	the	DT	DT	_	8	det	_	_
5	nuclear	nuclear	JJ	JJ	_	8	amod	_	_
6	factor	factor	NN	NN	_	8	compound	_	_
7	NF-kappa	nf-kappa	NN	NN	_	8	compound	_	_
8	B	b	NN	NN	_	11	nsubjpass	_	_
9	has	have	VBZ	VBZ	_	11	aux	_	_
10	been	be	VBN	VBN	_	11	auxpass	_	_
11	invoked	invoke	VBN	VBN	_	0	root	_	_
12	as	as	IN	IN	_	16	case	_	_
13	an	a	DT	DT	_	16	det	_	_
14	important	important	JJ	JJ	_	16	amod	_	_
15	transcription	transcription	NN	NN	_	16	compound	_	_
16	factor	factor	NN	NN	_	11	nmod	_	_
17	in	in	IN	IN	_	19	case	_	_
18	the	the	DT	DT	_	19	det	_	_
19	expression	expression	NN	NN	_	16	nmod	_	_
20	of	of	IN	IN	_	22	case	_	_
21	cytokine	cytokine	NN	NN	_	22	compound	_	_
22	genes	gene	NNS	NNS	_	19	nmod	_	_
23	,	,	,	,	_	22	punct	_	_
24	of	of	IN	IN	_	26	case	_	_
25	cell-surface	cell-surface	JJ	JJ	_	26	amod	_	_
26	receptors	receptor	NNS	NNS	_	22	nmod	_	_
27	and	and	CC	CC	_	19	cc	_	_
28	in	in	IN	IN	_	30	case	_	_
29	the	the	DT	DT	_	30	det	_	_
30	expression	expression	NN	NN	_	19	conj	_	_
31	of	of	IN	IN	_	34	case	_	_
32	human	human	JJ	JJ	_	34	amod	_	_
33	immunodeficiency	immunodeficiency	NN	NN	_	34	compound	_	_
34	virus	virus	NN	NN	_	30	nmod	_	_
35	.	.	.	.	_	11	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	such	such	JJ	JJ	_	3	amod	_	_
3	cells	cell	NNS	NNS	_	13	nmod	_	_
4	,	,	,	,	_	13	punct	_	_
5	DNA	dna	NN	NN	_	7	compound	_	_
6	binding	binding	NN	NN	_	7	compound	_	_
7	activity	activity	NN	NN	_	13	nsubjpass	_	_
8	of	of	IN	IN	_	10	case	_	_
9	NF-kappa	nf-kappa	NN	NN	_	10	compound	_	_
10	B	b	NN	NN	_	7	nmod	_	_
11	can	can	MD	MD	_	13	aux	_	_
12	be	be	VB	VB	_	13	auxpass	_	_
13	detected	detect	VBN	VBN	_	0	root	_	_
14	without	without	IN	IN	_	16	case	_	_
15	intentional	intentional	JJ	JJ	_	16	amod	_	_
16	stimulation	stimulation	NN	NN	_	13	nmod	_	_
17	.	.	.	.	_	13	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	our	we	PRP$	PRP$	_	3	nmod:poss	_	_
3	studies	study	NNS	NNS	_	31	nmod	_	_
4	,	,	,	,	_	31	punct	_	_
5	cells	cell	NNS	NNS	_	31	nsubj	_	_
6	of	of	IN	IN	_	10	case	_	_
7	the	the	DT	DT	_	10	det	_	_
8	human	human	JJ	JJ	_	10	amod	_	_
9	monocytic	monocytic	JJ	JJ	_	10	amod	_	_
10	line	line	NN	NN	_	5	nmod	_	_
11	Mono	mono	NN	NN	_	12	compound	_	_
12	Mac	mac	NN	NN	_	10	dep	_	_
13	6	6	CD	CD	_	12	nummod	_	_
14	,	,	,	,	_	5	punct	_	_
15	cultured	culture	VBN	VBN	_	5	acl	_	_
16	in	in	IN	IN	_	17	case	_	_
17	medium	medium	NN	NN	_	15	nmod	_	_
18	containing	contain	VBG	VBG	_	17	acl	_	_
19	fetal-calf	fetal-calf	JJ	JJ	_	20	amod	_	_
20	serum	serum	NN	NN	_	18	dobj	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	low	low	JJ	JJ	_	23	amod	_	_
23	levels	level	NNS	NNS	_	20	conj	_	_
24	of	of	IN	IN	_	25	case	_	_
25	lipopolysaccharide	lipopolysaccharide	NN	NN	_	23	nmod	_	_
26	(	(	-LRB-	-LRB-	_	27	punct	_	_
27	LPS	lps	NN	NN	_	25	appos	_	_
28	)	)	-RRB-	-RRB-	_	27	punct	_	_
29	,	,	,	,	_	5	punct	_	_
30	also	also	RB	RB	_	31	advmod	_	_
31	exhibit	exhibit	VBP	VBP	_	0	root	_	_
32	such	such	JJ	JJ	_	34	amod	_	_
33	'	'	``	``	_	34	punct	_	_
34	constitutive	constitutive	JJ	JJ	_	37	amod	_	_
35	'	'	''	''	_	34	punct	_	_
36	NF-kappa	nf-kappa	NN	NN	_	37	compound	_	_
37	B	b	NN	NN	_	31	dobj	_	_
38	,	,	,	,	_	31	punct	_	_
39	as	as	IN	IN	_	40	mark	_	_
40	demonstrated	demonstrate	VBN	VBN	_	31	advcl	_	_
41	by	by	IN	IN	_	43	case	_	_
42	mobility-shift	mobility-shift	JJ	JJ	_	43	amod	_	_
43	analysis	analysis	NN	NN	_	40	nmod	_	_
44	of	of	IN	IN	_	46	case	_	_
45	nuclear	nuclear	JJ	JJ	_	46	amod	_	_
46	extracts	extract	NNS	NNS	_	43	nmod	_	_
47	.	.	.	.	_	31	punct	_	_

1	This	this	DT	DT	_	4	det	_	_
2	nuclear	nuclear	JJ	JJ	_	4	amod	_	_
3	NF-kappa	nf-kappa	NN	NN	_	4	compound	_	_
4	B	b	NN	NN	_	7	nsubj	_	_
5	was	be	VBD	VBD	_	7	cop	_	_
6	still	still	RB	RB	_	7	advmod	_	_
7	present	present	JJ	JJ	_	0	root	_	_
8	when	when	WRB	WRB	_	12	advmod	_	_
9	contaminant	contaminant	JJ	JJ	_	10	amod	_	_
10	LPS	lps	NN	NN	_	12	nsubjpass	_	_
11	was	be	VBD	VBD	_	12	auxpass	_	_
12	removed	remove	VBN	VBN	_	7	advcl	_	_
13	by	by	IN	IN	_	14	case	_	_
14	ultrafiltration	ultrafiltration	NN	NN	_	12	nmod	_	_
15	and	and	CC	CC	_	12	cc	_	_
16	when	when	WRB	WRB	_	19	advmod	_	_
17	serum	serum	NN	NN	_	19	nsubjpass	_	_
18	was	be	VBD	VBD	_	19	auxpass	_	_
19	omitted	omit	VBN	VBN	_	12	conj	_	_
20	.	.	.	.	_	7	punct	_	_

1	Protein-DNA	protein-dna	JJ	JJ	_	2	amod	_	_
2	complexes	complex	NNS	NNS	_	8	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	constitutive	constitutive	JJ	JJ	_	6	amod	_	_
5	NF-kappa	nf-kappa	NN	NN	_	6	compound	_	_
6	B	b	NN	NN	_	2	nmod	_	_
7	are	be	VBP	VBP	_	8	cop	_	_
8	similar	similar	JJ	JJ	_	0	root	_	_
9	in	in	IN	IN	_	10	case	_	_
10	mobility	mobility	NN	NN	_	8	nmod	_	_
11	to	to	TO	TO	_	15	case	_	_
12	the	the	DT	DT	_	15	det	_	_
13	LPS-induced	lps-induced	JJ	JJ	_	15	amod	_	_
14	NF-kappa	nf-kappa	NN	NN	_	15	compound	_	_
15	B	b	NN	NN	_	8	nmod	_	_
16	and	and	CC	CC	_	8	cc	_	_
17	both	both	DT	DT	_	19	nsubjpass	_	_
18	are	be	VBP	VBP	_	19	auxpass	_	_
19	recognized	recognize	VBN	VBN	_	8	conj	_	_
20	by	by	IN	IN	_	22	case	_	_
21	an	a	DT	DT	_	22	det	_	_
22	antibody	antibody	NN	NN	_	19	nmod	_	_
23	specific	specific	JJ	JJ	_	22	amod	_	_
24	to	to	TO	TO	_	27	case	_	_
25	the	the	DT	DT	_	27	det	_	_
26	p50	p50	NN	NN	_	27	compound	_	_
27	subunit	subunit	NN	NN	_	23	nmod	_	_
28	of	of	IN	IN	_	30	case	_	_
29	NF-kappa	nf-kappa	NN	NN	_	30	compound	_	_
30	B	b	NN	NN	_	27	nmod	_	_
31	.	.	.	.	_	8	punct	_	_

1	By	by	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	15	nmod	_	_
3	,	,	,	,	_	15	punct	_	_
4	treatment	treatment	NN	NN	_	15	nsubj	_	_
5	of	of	IN	IN	_	6	case	_	_
6	cells	cell	NNS	NNS	_	4	nmod	_	_
7	with	with	IN	IN	_	9	case	_	_
8	pyrrolidine	pyrrolidine	NN	NN	_	9	compound	_	_
9	dithiocarbamate	dithiocarbamate	NN	NN	_	4	nmod	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	PDTC	pdtc	NN	NN	_	9	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	will	will	MD	MD	_	15	aux	_	_
14	only	only	RB	RB	_	15	advmod	_	_
15	block	block	VB	VB	_	0	root	_	_
16	LPS-induced	lps-induced	JJ	JJ	_	18	amod	_	_
17	NF-kappa	nf-kappa	NN	NN	_	18	compound	_	_
18	B	b	NN	NN	_	15	dobj	_	_
19	,	,	,	,	_	18	punct	_	_
20	but	but	CC	CC	_	21	cc	_	_
21	not	not	RB	RB	_	18	cc	_	_
22	the	the	DT	DT	_	25	det	_	_
23	constitutive	constitutive	JJ	JJ	_	25	amod	_	_
24	binding	bind	VBG	VBG	_	25	amod	_	_
25	protein	protein	NN	NN	_	18	conj	_	_
26	.	.	.	.	_	15	punct	_	_

1	Using	use	VBG	VBG	_	0	root	_	_
2	LPS-free	lps-free	JJ	JJ	_	1	dobj	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	serum-free	serum-free	JJ	JJ	_	2	conj	_	_
5	conditions	condition	NNS	NNS	_	2	dep	_	_
6	,	,	,	,	_	1	punct	_	_
7	constitutive	constitutive	JJ	JJ	_	9	amod	_	_
8	NF-kappa	nf-kappa	NN	NN	_	9	compound	_	_
9	B	b	NN	NN	_	12	nsubjpass	_	_
10	can	can	MD	MD	_	12	aux	_	_
11	be	be	VB	VB	_	12	auxpass	_	_
12	detected	detect	VBN	VBN	_	1	parataxis	_	_
13	in	in	IN	IN	_	16	case	_	_
14	different	different	JJ	JJ	_	16	amod	_	_
15	cell	cell	NN	NN	_	16	compound	_	_
16	lines	line	NNS	NNS	_	12	nmod	_	_
17	of	of	IN	IN	_	20	case	_	_
18	the	the	DT	DT	_	20	det	_	_
19	monocytic	monocytic	JJ	JJ	_	20	amod	_	_
20	lineage	lineage	NN	NN	_	16	nmod	_	_
21	(	(	-LRB-	-LRB-	_	22	punct	_	_
22	HL60	hl60	NN	NN	_	16	dep	_	_
23	,	,	,	,	_	22	punct	_	_
24	U937	u937	NN	NN	_	22	conj	_	_
25	,	,	,	,	_	22	punct	_	_
26	THP-1	thp-1	NN	NN	_	22	conj	_	_
27	,	,	,	,	_	22	punct	_	_
28	Mono	mono	NN	NN	_	29	compound	_	_
29	Mac	mac	NN	NN	_	22	conj	_	_
30	1	1	CD	CD	_	29	nummod	_	_
31	and	and	CC	CC	_	22	cc	_	_
32	Mono	mono	NN	NN	_	33	compound	_	_
33	Mac	mac	NN	NN	_	22	conj	_	_
34	6	6	CD	CD	_	33	nummod	_	_
35	)	)	-RRB-	-RRB-	_	22	punct	_	_
36	,	,	,	,	_	16	punct	_	_
37	but	but	CC	CC	_	16	cc	_	_
38	not	not	RB	RB	_	43	neg	_	_
39	in	in	IN	IN	_	43	case	_	_
40	Molt	molt	NN	NN	_	43	compound	_	_
41	4	4	CD	CD	_	43	nummod	_	_
42	T	t	NN	NN	_	43	compound	_	_
43	cells	cell	NNS	NNS	_	16	conj	_	_
44	or	or	CC	CC	_	43	cc	_	_
45	K562	k562	NN	NN	_	47	compound	_	_
46	stem	stem	NN	NN	_	47	compound	_	_
47	cells	cell	NNS	NNS	_	43	conj	_	_
48	.	.	.	.	_	1	punct	_	_

1	When	when	WRB	WRB	_	2	advmod	_	_
2	ordered	order	VBN	VBN	_	17	advcl	_	_
3	according	accord	VBG	VBG	_	5	case	_	_
4	to	to	TO	TO	_	3	mwe	_	_
5	stage	stage	NN	NN	_	2	nmod	_	_
6	of	of	IN	IN	_	7	case	_	_
7	maturation	maturation	NN	NN	_	5	nmod	_	_
8	,	,	,	,	_	17	punct	_	_
9	the	the	DT	DT	_	10	det	_	_
10	amount	amount	NN	NN	_	17	nsubjpass	_	_
11	of	of	IN	IN	_	14	case	_	_
12	constitutive	constitutive	JJ	JJ	_	14	amod	_	_
13	NF-kappa	nf-kappa	NN	NN	_	14	compound	_	_
14	B	b	NN	NN	_	10	nmod	_	_
15	was	be	VBD	VBD	_	17	auxpass	_	_
16	not	not	RB	RB	_	17	neg	_	_
17	increased	increase	VBN	VBN	_	0	root	_	_
18	in	in	IN	IN	_	22	case	_	_
19	more	more	RBR	RBR	_	22	advmod	_	_
20	mature	mature	JJ	JJ	_	22	amod	_	_
21	cell	cell	NN	NN	_	22	compound	_	_
22	lines	line	NNS	NNS	_	17	nmod	_	_
23	.	.	.	.	_	17	punct	_	_

1	Furthermore	furthermore	RB	RB	_	26	advmod	_	_
2	,	,	,	,	_	26	punct	_	_
3	when	when	WRB	WRB	_	4	advmod	_	_
4	inducing	induce	VBG	VBG	_	26	advcl	_	_
5	differentiation	differentiation	NN	NN	_	4	dobj	_	_
6	in	in	IN	IN	_	10	case	_	_
7	Mono	mono	NN	NN	_	10	compound	_	_
8	Mac	mac	NN	NN	_	10	compound	_	_
9	6	6	CD	CD	_	10	nummod	_	_
10	cells	cell	NNS	NNS	_	5	nmod	_	_
11	,	,	,	,	_	4	punct	_	_
12	with	with	IN	IN	_	14	case	_	_
13	vitamin	vitamin	NN	NN	_	14	compound	_	_
14	D3	d3	NN	NN	_	4	nmod	_	_
15	,	,	,	,	_	26	punct	_	_
16	no	no	DT	DT	_	17	neg	_	_
17	change	change	NN	NN	_	26	nsubjpass	_	_
18	in	in	IN	IN	_	19	case	_	_
19	constitutive	constitutive	JJ	JJ	_	17	nmod	_	_
20	or	or	CC	CC	_	19	cc	_	_
21	inducible	inducible	JJ	JJ	_	19	conj	_	_
22	NF-kappa	nf-kappa	NN	NN	_	23	compound	_	_
23	B	b	NN	NN	_	19	dep	_	_
24	can	can	MD	MD	_	26	aux	_	_
25	be	be	VB	VB	_	26	auxpass	_	_
26	detected	detect	VBN	VBN	_	0	root	_	_
27	.	.	.	.	_	26	punct	_	_

1	Analysis	analysis	NN	NN	_	5	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	primary	primary	JJ	JJ	_	4	amod	_	_
4	cells	cell	NNS	NNS	_	1	nmod	_	_
5	revealed	reveal	VBD	VBD	_	0	root	_	_
6	substantial	substantial	JJ	JJ	_	10	amod	_	_
7	constitutive	constitutive	JJ	JJ	_	6	dep	_	_
8	NF-kappa	nf-kappa	NN	NN	_	10	compound	_	_
9	B-binding	b-binding	JJ	JJ	_	10	amod	_	_
10	activity	activity	NN	NN	_	5	dobj	_	_
11	in	in	IN	IN	_	13	case	_	_
12	blood	blood	NN	NN	_	13	compound	_	_
13	monocytes	monocyte	NNS	NNS	_	10	nmod	_	_
14	,	,	,	,	_	13	punct	_	_
15	pleural	pleural	JJ	JJ	_	16	amod	_	_
16	macrophages	macrophage	NNS	NNS	_	13	conj	_	_
17	and	and	CC	CC	_	13	cc	_	_
18	alveolar	alveolar	JJ	JJ	_	19	amod	_	_
19	macrophages	macrophage	NNS	NNS	_	13	conj	_	_
20	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	constitutive	constitutive	JJ	JJ	_	4	amod	_	_
3	NF-kappa	nf-kappa	NN	NN	_	4	compound	_	_
4	B	b	NN	NN	_	5	nsubj	_	_
5	appears	appear	VBZ	VBZ	_	0	root	_	_
6	to	to	TO	TO	_	9	mark	_	_
7	be	be	VB	VB	_	9	cop	_	_
8	functionally	functionally	RB	RB	_	9	advmod	_	_
9	active	active	JJ	JJ	_	5	xcomp	_	_
10	,	,	,	,	_	5	punct	_	_
11	since	since	IN	IN	_	24	mark	_	_
12	a	a	DT	DT	_	14	det	_	_
13	low	low	JJ	JJ	_	14	amod	_	_
14	level	level	NN	NN	_	24	nsubj	_	_
15	of	of	IN	IN	_	22	case	_	_
16	tumour	tumour	NN	NN	_	22	compound	_	_
17	necrosis	necrosis	NN	NN	_	22	compound	_	_
18	factor	factor	NN	NN	_	22	compound	_	_
19	(	(	-LRB-	-LRB-	_	22	punct	_	_
20	TNF	tnf	NN	NN	_	22	compound	_	_
21	)	)	-RRB-	-RRB-	_	22	punct	_	_
22	transcript	transcript	NN	NN	_	14	nmod	_	_
23	is	be	VBZ	VBZ	_	24	cop	_	_
24	detectable	detectable	JJ	JJ	_	5	advcl	_	_
25	in	in	IN	IN	_	26	case	_	_
26	monocytes	monocyte	NNS	NNS	_	24	nmod	_	_
27	,	,	,	,	_	5	punct	_	_
28	and	and	CC	CC	_	5	cc	_	_
29	this	this	DT	DT	_	30	det	_	_
30	level	level	NN	NN	_	33	nsubjpass	_	_
31	can	can	MD	MD	_	33	aux	_	_
32	be	be	VB	VB	_	33	auxpass	_	_
33	increased	increase	VBN	VBN	_	5	conj	_	_
34	by	by	IN	IN	_	35	mark	_	_
35	blocking	block	VBG	VBG	_	33	advcl	_	_
36	transcript	transcript	NN	NN	_	37	compound	_	_
37	degradation	degradation	NN	NN	_	35	dobj	_	_
38	using	use	VBG	VBG	_	35	advcl	_	_
39	cycloheximide	cycloheximide	NN	NN	_	38	dobj	_	_
40	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	level	level	NN	NN	_	11	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	constitutive	constitutive	JJ	JJ	_	6	amod	_	_
5	NF-kappa	nf-kappa	NN	NN	_	6	compound	_	_
6	B	b	NN	NN	_	2	nmod	_	_
7	in	in	IN	IN	_	9	case	_	_
8	these	these	DT	DT	_	9	det	_	_
9	cells	cell	NNS	NNS	_	2	nmod	_	_
10	is	be	VBZ	VBZ	_	11	cop	_	_
11	variable	variable	JJ	JJ	_	0	root	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	is	be	VBZ	VBZ	_	15	auxpass	_	_
14	frequently	frequently	RB	RB	_	15	advmod	_	_
15	found	find	VBN	VBN	_	11	conj	_	_
16	to	to	TO	TO	_	18	mark	_	_
17	be	be	VB	VB	_	18	cop	_	_
18	lower	lower	JJR	JJR	_	15	xcomp	_	_
19	in	in	IN	IN	_	23	case	_	_
20	the	the	DT	DT	_	23	det	_	_
21	more	more	RBR	RBR	_	23	advmod	_	_
22	mature	mature	JJ	JJ	_	23	amod	_	_
23	macrophages	macrophage	NNS	NNS	_	18	nmod	_	_
24	.	.	.	.	_	11	punct	_	_

1	Constitutive	constitutive	JJ	JJ	_	3	amod	_	_
2	NF-kappa	nf-kappa	NN	NN	_	3	compound	_	_
3	B	b	NN	NN	_	6	nsubjpass	_	_
4	was	be	VBD	VBD	_	6	auxpass	_	_
5	not	not	RB	RB	_	6	neg	_	_
6	maintained	maintain	VBN	VBN	_	0	root	_	_
7	by	by	IN	IN	_	9	case	_	_
8	autocrine	autocrine	JJ	JJ	_	9	amod	_	_
9	action	action	NN	NN	_	6	nmod	_	_
10	of	of	IN	IN	_	11	case	_	_
11	cytokines	cytokine	NNS	NNS	_	9	nmod	_	_
12	TNF	tnf	NN	NN	_	11	dep	_	_
13	,	,	,	,	_	12	punct	_	_
14	interleukin	interleukin	NN	NN	_	12	conj	_	_
15	6	6	CD	CD	_	14	nummod	_	_
16	,	,	,	,	_	12	punct	_	_
17	interleukin	interleukin	NN	NN	_	12	conj	_	_
18	10	10	CD	CD	_	17	nummod	_	_
19	,	,	,	,	_	12	punct	_	_
20	granulocyte-macrophage	granulocyte-macrophage	JJ	JJ	_	22	amod	_	_
21	colony-stimulating	colony-stimulating	JJ	JJ	_	22	amod	_	_
22	factor	factor	NN	NN	_	12	conj	_	_
23	or	or	CC	CC	_	12	cc	_	_
24	macrophage	macrophage	NN	NN	_	26	compound	_	_
25	colony-stimulating	colony-stimulating	JJ	JJ	_	26	amod	_	_
26	factor	factor	NN	NN	_	12	conj	_	_
27	,	,	,	,	_	6	punct	_	_
28	since	since	IN	IN	_	33	mark	_	_
29	neutralizing	neutralize	VBG	VBG	_	30	amod	_	_
30	antibodies	antibody	NNS	NNS	_	33	nsubj	_	_
31	did	do	VBD	VBD	_	33	aux	_	_
32	not	not	RB	RB	_	33	neg	_	_
33	reduce	reduce	VB	VB	_	6	advcl	_	_
34	constitutive	constitutive	JJ	JJ	_	36	amod	_	_
35	DNA-binding	dna-binding	JJ	JJ	_	34	dep	_	_
36	activity	activity	NN	NN	_	33	dobj	_	_
37	.	.	.	.	_	6	punct	_	_

1	Furthermore	furthermore	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	blockade	blockade	NN	NN	_	11	nsubj	_	_
4	of	of	IN	IN	_	5	case	_	_
5	prostaglandin	prostaglandin	NN	NN	_	3	nmod	_	_
6	or	or	CC	CC	_	3	cc	_	_
7	leukotriene	leukotriene	NN	NN	_	8	compound	_	_
8	biosynthesis	biosynthesis	NN	NN	_	3	conj	_	_
9	did	do	VBD	VBD	_	11	aux	_	_
10	not	not	RB	RB	_	11	neg	_	_
11	affect	affect	VB	VB	_	0	root	_	_
12	constitutive	constitutive	JJ	JJ	_	14	amod	_	_
13	NF-kappa	nf-kappa	NN	NN	_	14	compound	_	_
14	B	b	NN	NN	_	11	dobj	_	_
15	.	.	.	.	_	11	punct	_	_

1	(	(	-LRB-	-LRB-	_	2	punct	_	_
2	ABSTRACT	abstract	NN	NN	_	0	root	_	_
3	TRUNCATED	truncate	VBN	VBN	_	2	acl	_	_
4	AT	at	IN	IN	_	6	case	_	_
5	400	400	CD	CD	_	6	nummod	_	_
6	WORDS	word	NNS	NNS	_	3	nmod	_	_
7	)	)	-RRB-	-RRB-	_	2	punct	_	_

1	Protein	protein	NN	NN	_	3	compound	_	_
2	kinase	kinase	NN	NN	_	3	compound	_	_
3	C-zeta	c-zeta	NN	NN	_	4	nsubj	_	_
4	mediates	mediate	VBZ	VBZ	_	0	root	_	_
5	NF-kappa	nf-kappa	NN	NN	_	6	compound	_	_
6	B	b	NN	NN	_	7	compound	_	_
7	activation	activation	NN	NN	_	4	dobj	_	_
8	in	in	IN	IN	_	12	case	_	_
9	human	human	JJ	JJ	_	12	amod	_	_
10	immunodeficiency	immunodeficiency	NN	NN	_	12	compound	_	_
11	virus-infected	virus-infected	JJ	JJ	_	12	amod	_	_
12	monocytes	monocyte	NNS	NNS	_	7	nmod	_	_
13	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	molecular	molecular	NN	NN	_	3	compound	_	_
3	mechanisms	mechanism	NNS	NNS	_	21	nsubj	_	_
4	regulating	regulate	VBG	VBG	_	3	acl	_	_
5	human	human	JJ	JJ	_	7	amod	_	_
6	immunodeficiency	immunodeficiency	NN	NN	_	7	compound	_	_
7	virus	virus	NN	NN	_	11	compound	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	HIV	hiv	NN	NN	_	7	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	persistence	persistence	NN	NN	_	4	dobj	_	_
12	in	in	IN	IN	_	16	case	_	_
13	a	a	DT	DT	_	16	det	_	_
14	major	major	JJ	JJ	_	16	amod	_	_
15	cell	cell	NN	NN	_	16	compound	_	_
16	reservoir	reservoir	NN	NN	_	11	nmod	_	_
17	such	such	JJ	JJ	_	20	case	_	_
18	as	as	IN	IN	_	17	mwe	_	_
19	the	the	DT	DT	_	20	det	_	_
20	macrophage	macrophage	NN	NN	_	16	nmod	_	_
21	remain	remain	VBP	VBP	_	0	root	_	_
22	unknown	unknown	JJ	JJ	_	21	xcomp	_	_
23	.	.	.	.	_	21	punct	_	_

1	NF-kappa	nf-kappa	NN	NN	_	2	compound	_	_
2	B	b	NN	NN	_	6	nsubj	_	_
3	is	be	VBZ	VBZ	_	6	cop	_	_
4	a	a	DT	DT	_	6	det	_	_
5	transcription	transcription	NN	NN	_	6	compound	_	_
6	factor	factor	NN	NN	_	0	root	_	_
7	involved	involve	VBN	VBN	_	6	acl	_	_
8	in	in	IN	IN	_	10	case	_	_
9	the	the	DT	DT	_	10	det	_	_
10	regulation	regulation	NN	NN	_	7	nmod	_	_
11	of	of	IN	IN	_	16	case	_	_
12	the	the	DT	DT	_	16	det	_	_
13	HIV	hiv	NN	NN	_	16	compound	_	_
14	long	long	JJ	JJ	_	16	amod	_	_
15	terminal	terminal	JJ	JJ	_	16	amod	_	_
16	repeat	repeat	NN	NN	_	10	nmod	_	_
17	and	and	CC	CC	_	6	cc	_	_
18	is	be	VBZ	VBZ	_	20	auxpass	_	_
19	selectively	selectively	RB	RB	_	20	advmod	_	_
20	activated	activate	VBN	VBN	_	6	conj	_	_
21	following	follow	VBG	VBG	_	23	case	_	_
22	HIV	hiv	NN	NN	_	23	compound	_	_
23	infection	infection	NN	NN	_	20	nmod	_	_
24	of	of	IN	IN	_	26	case	_	_
25	human	human	JJ	JJ	_	26	amod	_	_
26	macrophages	macrophage	NNS	NNS	_	23	nmod	_	_
27	.	.	.	.	_	6	punct	_	_

1	Although	although	IN	IN	_	17	mark	_	_
2	little	little	JJ	JJ	_	3	amod	_	_
3	information	information	NN	NN	_	17	nsubj	_	_
4	as	as	IN	IN	_	10	case	_	_
5	to	to	TO	TO	_	10	mark	_	_
6	what	what	WP	WP	_	9	det	_	_
7	signal	signal	NN	NN	_	9	compound	_	_
8	transduction	transduction	NN	NN	_	9	compound	_	_
9	pathways	pathway	NNS	NNS	_	10	nsubj	_	_
10	mediate	mediate	VBP	VBP	_	3	acl	_	_
11	NF-kappa	nf-kappa	NN	NN	_	12	compound	_	_
12	B	b	NN	NN	_	13	compound	_	_
13	activation	activation	NN	NN	_	10	dobj	_	_
14	in	in	IN	IN	_	15	case	_	_
15	monocytes-macrophages	monocytes-macrophage	NNS	NNS	_	13	nmod	_	_
16	is	be	VBZ	VBZ	_	17	cop	_	_
17	available	available	JJ	JJ	_	22	advcl	_	_
18	,	,	,	,	_	22	punct	_	_
19	our	we	PRP$	PRP$	_	21	nmod:poss	_	_
20	previous	previous	JJ	JJ	_	21	amod	_	_
21	work	work	NN	NN	_	22	nsubj	_	_
22	indicated	indicate	VBD	VBD	_	0	root	_	_
23	that	that	IN	IN	_	34	mark	_	_
24	classical	classical	JJ	JJ	_	31	amod	_	_
25	protein	protein	NN	NN	_	31	compound	_	_
26	kinase	kinase	NN	NN	_	31	compound	_	_
27	C	c	NN	NN	_	31	compound	_	_
28	(	(	-LRB-	-LRB-	_	31	punct	_	_
29	PKC	pkc	NN	NN	_	31	compound	_	_
30	)	)	-RRB-	-RRB-	_	31	punct	_	_
31	isoenzymes	isoenzyme	NNS	NNS	_	34	nsubjpass	_	_
32	were	be	VBD	VBD	_	34	auxpass	_	_
33	not	not	RB	RB	_	34	neg	_	_
34	involved	involve	VBN	VBN	_	22	ccomp	_	_
35	in	in	IN	IN	_	40	case	_	_
36	the	the	DT	DT	_	40	det	_	_
37	HIV-mediated	hiv-mediated	JJ	JJ	_	40	amod	_	_
38	NF-kappa	nf-kappa	NN	NN	_	39	compound	_	_
39	B	b	NN	NN	_	40	compound	_	_
40	activation	activation	NN	NN	_	34	nmod	_	_
41	.	.	.	.	_	22	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	study	study	NN	NN	_	7	nmod	_	_
4	,	,	,	,	_	7	punct	_	_
5	we	we	PRP	PRP	_	7	nsubj	_	_
6	have	have	VBP	VBP	_	7	aux	_	_
7	focused	focus	VBN	VBN	_	0	root	_	_
8	on	on	IN	IN	_	11	case	_	_
9	atypical	atypical	JJ	JJ	_	11	amod	_	_
10	PKC	pkc	NN	NN	_	11	compound	_	_
11	isoenzymes	isoenzyme	NNS	NNS	_	7	nmod	_	_
12	.	.	.	.	_	7	punct	_	_

1	PKC-zeta	pkc-zeta	NN	NN	_	2	nsubj	_	_
2	belongs	belong	VBZ	VBZ	_	0	root	_	_
3	to	to	TO	TO	_	5	case	_	_
4	this	this	DT	DT	_	5	det	_	_
5	family	family	NN	NN	_	2	nmod	_	_
6	and	and	CC	CC	_	2	cc	_	_
7	is	be	VBZ	VBZ	_	8	auxpass	_	_
8	known	know	VBN	VBN	_	2	conj	_	_
9	to	to	TO	TO	_	13	mark	_	_
10	be	be	VB	VB	_	13	cop	_	_
11	an	a	DT	DT	_	13	det	_	_
12	important	important	JJ	JJ	_	13	amod	_	_
13	step	step	NN	NN	_	8	xcomp	_	_
14	in	in	IN	IN	_	17	case	_	_
15	NF-kappa	nf-kappa	NN	NN	_	16	compound	_	_
16	B	b	NN	NN	_	17	compound	_	_
17	activation	activation	NN	NN	_	13	nmod	_	_
18	in	in	IN	IN	_	21	case	_	_
19	other	other	JJ	JJ	_	21	amod	_	_
20	cell	cell	NN	NN	_	21	compound	_	_
21	systems	system	NNS	NNS	_	17	nmod	_	_
22	.	.	.	.	_	2	punct	_	_

1	Immunoblotting	immunoblotting	NN	NN	_	2	compound	_	_
2	experiments	experiment	NNS	NNS	_	6	nsubj	_	_
3	with	with	IN	IN	_	5	case	_	_
4	U937	u937	NN	NN	_	5	compound	_	_
5	cells	cell	NNS	NNS	_	2	nmod	_	_
6	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
7	that	that	IN	IN	_	10	mark	_	_
8	PKC-zeta	pkc-zeta	NN	NN	_	10	nsubj	_	_
9	is	be	VBZ	VBZ	_	10	cop	_	_
10	present	present	JJ	JJ	_	6	dep	_	_
11	in	in	IN	IN	_	13	case	_	_
12	these	these	DT	DT	_	13	det	_	_
13	cells	cell	NNS	NNS	_	10	nmod	_	_
14	,	,	,	,	_	10	punct	_	_
15	and	and	CC	CC	_	10	cc	_	_
16	its	its	PRP$	PRP$	_	17	nmod:poss	_	_
17	expression	expression	NN	NN	_	10	conj	_	_
18	can	can	MD	MD	_	20	aux	_	_
19	be	be	VB	VB	_	20	auxpass	_	_
20	downmodulated	downmodulate	VBN	VBN	_	10	dep	_	_
21	by	by	IN	IN	_	23	case	_	_
22	antisense	antisense	JJ	JJ	_	23	amod	_	_
23	oligonucleotides	oligonucleotide	NNS	NNS	_	20	nmod	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	AO	ao	NN	NN	_	23	appos	_	_
26	)	)	-RRB-	-RRB-	_	25	punct	_	_
27	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	5	det	_	_
2	HIV-mediated	hiv-mediated	JJ	JJ	_	5	amod	_	_
3	NF-kappa	nf-kappa	NN	NN	_	4	compound	_	_
4	B	b	NN	NN	_	5	compound	_	_
5	activation	activation	NN	NN	_	8	nsubjpass	_	_
6	is	be	VBZ	VBZ	_	8	auxpass	_	_
7	selectively	selectively	RB	RB	_	8	advmod	_	_
8	reduced	reduce	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	_	10	case	_	_
10	AO	ao	NN	NN	_	8	nmod	_	_
11	to	to	TO	TO	_	12	case	_	_
12	PKC-zeta	pkc-zeta	NN	NN	_	8	nmod	_	_
13	.	.	.	.	_	8	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	addition	addition	NN	NN	_	22	nmod	_	_
3	,	,	,	,	_	22	punct	_	_
4	cotransfection	cotransfection	NN	NN	_	22	nsubj	_	_
5	of	of	IN	IN	_	9	case	_	_
6	a	a	DT	DT	_	9	det	_	_
7	negative	negative	JJ	JJ	_	9	amod	_	_
8	dominant	dominant	JJ	JJ	_	9	amod	_	_
9	molecule	molecule	NN	NN	_	4	nmod	_	_
10	of	of	IN	IN	_	11	case	_	_
11	PKC-zeta	pkc-zeta	NN	NN	_	9	nmod	_	_
12	(	(	-LRB-	-LRB-	_	14	punct	_	_
13	PKC-zeta	pkc-zeta	NN	NN	_	14	compound	_	_
14	mut	mut	NN	NN	_	9	appos	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	with	with	IN	IN	_	20	case	_	_
17	NF-kappa	nf-kappa	NN	NN	_	20	compound	_	_
18	B-dependent	b-dependent	JJ	JJ	_	20	amod	_	_
19	reporter	reporter	NN	NN	_	20	compound	_	_
20	genes	gene	NNS	NNS	_	4	nmod	_	_
21	selectively	selectively	RB	RB	_	22	advmod	_	_
22	inhibits	inhibit	VBZ	VBZ	_	0	root	_	_
23	the	the	DT	DT	_	24	dep	_	_
24	HIV-	hiv-	NN	NN	_	22	dobj	_	_
25	but	but	CC	CC	_	24	cc	_	_
26	not	not	RB	RB	_	29	neg	_	_
27	phorbol	phorbol	NN	NN	_	29	compound	_	_
28	myristate	myristate	NN	NN	_	29	compound	_	_
29	acetate-	acetate-	NN	NN	_	24	conj	_	_
30	or	or	CC	CC	_	29	cc	_	_
31	lipopolysaccharide-mediated	lipopolysaccharide-mediated	JJ	JJ	_	29	conj	_	_
32	activation	activation	NN	NN	_	29	dep	_	_
33	of	of	IN	IN	_	35	case	_	_
34	NF-kappa	nf-kappa	NN	NN	_	35	compound	_	_
35	B	b	NN	NN	_	24	nmod	_	_
36	.	.	.	.	_	22	punct	_	_

1	That	that	IN	IN	_	4	mark	_	_
2	PKC-zeta	pkc-zeta	NN	NN	_	4	nsubj	_	_
3	is	be	VBZ	VBZ	_	4	cop	_	_
4	specific	specific	JJ	JJ	_	10	csubjpass	_	_
5	in	in	IN	IN	_	6	mark	_	_
6	regulating	regulate	VBG	VBG	_	4	advcl	_	_
7	NF-kappa	nf-kappa	NN	NN	_	8	compound	_	_
8	B	b	NN	NN	_	6	dobj	_	_
9	is	be	VBZ	VBZ	_	10	auxpass	_	_
10	concluded	conclude	VBN	VBN	_	0	root	_	_
11	from	from	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	inability	inability	NN	NN	_	10	nmod	_	_
14	of	of	IN	IN	_	17	case	_	_
15	PKC-zeta	pkc-zeta	NN	NN	_	17	compound	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	mut	mut	NN	NN	_	13	nmod	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	to	to	TO	TO	_	20	mark	_	_
20	interfere	interfere	VB	VB	_	13	acl	_	_
21	with	with	IN	IN	_	23	case	_	_
22	the	the	DT	DT	_	23	dep	_	_
23	basal	basal	JJ	JJ	_	20	nmod	_	_
24	or	or	CC	CC	_	23	cc	_	_
25	phorbol	phorbol	NN	NN	_	26	compound	_	_
26	myristate	myristate	NN	NN	_	23	conj	_	_
27	acetate-inducible	acetate-inducible	JJ	JJ	_	26	amod	_	_
28	CREB-	creb-	NN	NN	_	23	dep	_	_
29	or	or	CC	CC	_	28	cc	_	_
30	AP1-dependent	ap1-dependent	JJ	JJ	_	28	conj	_	_
31	transcriptional	transcriptional	JJ	JJ	_	32	amod	_	_
32	activity	activity	NN	NN	_	28	dep	_	_
33	.	.	.	.	_	10	punct	_	_

1	Lastly	lastly	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
5	a	a	DT	DT	_	7	det	_	_
6	selective	selective	JJ	JJ	_	7	amod	_	_
7	inhibition	inhibition	NN	NN	_	4	dobj	_	_
8	of	of	IN	IN	_	10	case	_	_
9	p24	p24	NN	NN	_	10	compound	_	_
10	production	production	NN	NN	_	7	nmod	_	_
11	by	by	IN	IN	_	14	case	_	_
12	HIV-infected	hiv-infected	JJ	JJ	_	14	amod	_	_
13	human	human	JJ	JJ	_	14	amod	_	_
14	macrophages	macrophage	NNS	NNS	_	7	nmod	_	_
15	when	when	WRB	WRB	_	16	advmod	_	_
16	treated	treat	VBN	VBN	_	7	acl:relcl	_	_
17	with	with	IN	IN	_	18	case	_	_
18	AO	ao	NN	NN	_	16	nmod	_	_
19	to	to	TO	TO	_	20	case	_	_
20	PKC-zeta	pkc-zeta	NN	NN	_	16	nmod	_	_
21	.	.	.	.	_	4	punct	_	_

1	Altogether	altogether	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	these	these	DT	DT	_	4	det	_	_
4	results	result	NNS	NNS	_	5	nsubj	_	_
5	suggest	suggest	VBP	VBP	_	0	root	_	_
6	that	that	IN	IN	_	14	mark	_	_
7	atypical	atypical	JJ	JJ	_	9	amod	_	_
8	PKC	pkc	NN	NN	_	9	compound	_	_
9	isoenzymes	isoenzyme	NNS	NNS	_	14	nsubj	_	_
10	,	,	,	,	_	9	punct	_	_
11	including	include	VBG	VBG	_	12	case	_	_
12	PKC-zeta	pkc-zeta	NN	NN	_	9	nmod	_	_
13	,	,	,	,	_	9	punct	_	_
14	participate	participate	VBP	VBP	_	5	ccomp	_	_
15	in	in	IN	IN	_	19	case	_	_
16	the	the	DT	DT	_	19	det	_	_
17	signal	signal	NN	NN	_	19	compound	_	_
18	transduction	transduction	NN	NN	_	19	compound	_	_
19	pathways	pathway	NNS	NNS	_	14	nmod	_	_
20	by	by	IN	IN	_	21	case	_	_
21	which	which	WDT	WDT	_	24	nmod	_	_
22	HIV	hiv	NN	NN	_	23	compound	_	_
23	infection	infection	NN	NN	_	24	nsubj	_	_
24	results	result	VBZ	VBZ	_	19	acl:relcl	_	_
25	in	in	IN	IN	_	27	case	_	_
26	the	the	DT	DT	_	27	det	_	_
27	activation	activation	NN	NN	_	24	nmod	_	_
28	of	of	IN	IN	_	30	case	_	_
29	NF-kappa	nf-kappa	NN	NN	_	30	compound	_	_
30	B	b	NN	NN	_	27	nmod	_	_
31	in	in	IN	IN	_	34	case	_	_
32	human	human	JJ	JJ	_	34	amod	_	_
33	monocytic	monocytic	JJ	JJ	_	34	amod	_	_
34	cells	cell	NNS	NNS	_	27	nmod	_	_
35	and	and	CC	CC	_	34	cc	_	_
36	macrophages	macrophage	NNS	NNS	_	34	conj	_	_
37	.	.	.	.	_	5	punct	_	_

1	Inhibition	inhibition	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	4	case	_	_
3	NF-AT-dependent	nf-at-dependent	JJ	JJ	_	4	amod	_	_
4	transcription	transcription	NN	NN	_	1	nmod	_	_
5	by	by	IN	IN	_	7	case	_	_
6	NF-kappa	nf-kappa	NN	NN	_	7	compound	_	_
7	B	b	NN	NN	_	1	nmod	_	_
8	:	:	:	:	_	1	punct	_	_
9	implications	implication	NNS	NNS	_	1	dep	_	_
10	for	for	IN	IN	_	13	case	_	_
11	differential	differential	JJ	JJ	_	13	amod	_	_
12	gene	gene	NN	NN	_	13	compound	_	_
13	expression	expression	NN	NN	_	9	nmod	_	_
14	in	in	IN	IN	_	18	case	_	_
15	T	t	NN	NN	_	18	compound	_	_
16	helper	helper	NN	NN	_	18	compound	_	_
17	cell	cell	NN	NN	_	18	compound	_	_
18	subsets	subset	NNS	NNS	_	13	nmod	_	_
19	.	.	.	.	_	1	punct	_	_

1	Activation	activation	NN	NN	_	7	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	individual	individual	JJ	JJ	_	6	amod	_	_
4	CD4+	cd4+	JJ	JJ	_	6	amod	_	_
5	T	t	NN	NN	_	6	compound	_	_
6	cells	cell	NNS	NNS	_	1	nmod	_	_
7	results	result	VBZ	VBZ	_	0	root	_	_
8	in	in	IN	IN	_	11	case	_	_
9	differential	differential	JJ	JJ	_	11	amod	_	_
10	lymphokine	lymphokine	NN	NN	_	11	compound	_	_
11	expression	expression	NN	NN	_	7	nmod	_	_
12	:	:	:	:	_	7	punct	_	_
13	interleukin	interleukin	NN	NN	_	20	nsubjpass	_	_
14	2	2	CD	CD	_	13	nummod	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	IL-2	il-2	NN	NN	_	13	appos	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	is	be	VBZ	VBZ	_	20	auxpass	_	_
19	preferentially	preferentially	RB	RB	_	20	advmod	_	_
20	produced	produce	VBN	VBN	_	7	parataxis	_	_
21	by	by	IN	IN	_	29	case	_	_
22	T	t	NN	NN	_	29	compound	_	_
23	helper	helper	NN	NN	_	29	compound	_	_
24	type	type	NN	NN	_	29	compound	_	_
25	1	1	CD	CD	_	29	nummod	_	_
26	(	(	-LRB-	-LRB-	_	29	punct	_	_
27	TH1	th1	NN	NN	_	29	compound	_	_
28	)	)	-RRB-	-RRB-	_	29	punct	_	_
29	cells	cell	NNS	NNS	_	20	nmod	_	_
30	,	,	,	,	_	29	punct	_	_
31	which	which	WDT	WDT	_	33	nsubjpass	_	_
32	are	be	VBP	VBP	_	33	auxpass	_	_
33	involved	involve	VBN	VBN	_	29	acl:relcl	_	_
34	in	in	IN	IN	_	37	case	_	_
35	cell-mediated	cell-mediated	JJ	JJ	_	37	amod	_	_
36	immune	immune	JJ	JJ	_	37	amod	_	_
37	responses	response	NNS	NNS	_	33	nmod	_	_
38	,	,	,	,	_	20	punct	_	_
39	whereas	whereas	IN	IN	_	42	mark	_	_
40	IL-4	il-4	NN	NN	_	42	nsubjpass	_	_
41	is	be	VBZ	VBZ	_	42	auxpass	_	_
42	synthesized	synthesize	VBN	VBN	_	20	advcl	_	_
43	by	by	IN	IN	_	45	case	_	_
44	TH2	th2	NN	NN	_	45	compound	_	_
45	cells	cell	NNS	NNS	_	42	nmod	_	_
46	,	,	,	,	_	45	punct	_	_
47	which	which	WDT	WDT	_	49	nsubj	_	_
48	are	be	VBP	VBP	_	49	cop	_	_
49	essential	essential	JJ	JJ	_	45	acl:relcl	_	_
50	for	for	IN	IN	_	52	case	_	_
51	humoral	humoral	JJ	JJ	_	52	amod	_	_
52	immunity	immunity	NN	NN	_	49	nmod	_	_
53	.	.	.	.	_	7	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	Ca(2+)-dependent	ca(2+)-dependent	JJ	JJ	_	3	amod	_	_
3	factor	factor	NN	NN	_	5	nsubj	_	_
4	NF-ATp	nf-atp	NN	NN	_	3	dep	_	_
5	plays	play	VBZ	VBZ	_	0	root	_	_
6	a	a	DT	DT	_	8	det	_	_
7	key	key	JJ	JJ	_	8	amod	_	_
8	role	role	NN	NN	_	5	dobj	_	_
9	in	in	IN	IN	_	12	case	_	_
10	the	the	DT	DT	_	12	det	_	_
11	inducible	inducible	JJ	JJ	_	12	amod	_	_
12	transcription	transcription	NN	NN	_	5	nmod	_	_
13	of	of	IN	IN	_	17	case	_	_
14	both	both	DT	DT	_	17	dep	_	_
15	these	these	DT	DT	_	17	det	_	_
16	lymphokine	lymphokine	NN	NN	_	17	compound	_	_
17	genes	gene	NNS	NNS	_	12	nmod	_	_
18	.	.	.	.	_	5	punct	_	_

1	However	however	RB	RB	_	18	advmod	_	_
2	,	,	,	,	_	18	punct	_	_
3	while	while	IN	IN	_	6	mark	_	_
4	IL2	il2	NN	NN	_	5	compound	_	_
5	expression	expression	NN	NN	_	6	nsubj	_	_
6	requires	require	VBZ	VBZ	_	18	dep	_	_
7	the	the	DT	DT	_	8	det	_	_
8	contribution	contribution	NN	NN	_	6	dobj	_	_
9	of	of	IN	IN	_	10	case	_	_
10	Ca(2+)-	ca(2+)-	NN	NN	_	8	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	protein	protein	NN	NN	_	15	compound	_	_
13	kinase	kinase	NN	NN	_	15	compound	_	_
14	C-dependent	c-dependent	JJ	JJ	_	15	amod	_	_
15	signals	signal	NNS	NNS	_	10	conj	_	_
16	,	,	,	,	_	18	punct	_	_
17	we	we	PRP	PRP	_	18	nsubj	_	_
18	report	report	VBP	VBP	_	0	root	_	_
19	that	that	IN	IN	_	30	mark	_	_
20	activation	activation	NN	NN	_	30	nsubjpass	_	_
21	of	of	IN	IN	_	24	case	_	_
22	human	human	JJ	JJ	_	23	amod	_	_
23	IL4	il4	NN	NN	_	24	compound	_	_
24	transcription	transcription	NN	NN	_	20	nmod	_	_
25	through	through	IN	IN	_	28	case	_	_
26	the	the	DT	DT	_	28	det	_	_
27	Ca(2+)-dependent	ca(2+)-dependent	JJ	JJ	_	28	amod	_	_
28	pathway	pathway	NN	NN	_	20	nmod	_	_
29	is	be	VBZ	VBZ	_	30	auxpass	_	_
30	diminished	diminish	VBN	VBN	_	18	ccomp	_	_
31	by	by	IN	IN	_	35	case	_	_
32	protein	protein	NN	NN	_	34	compound	_	_
33	kinase	kinase	NN	NN	_	34	compound	_	_
34	C	c	NN	NN	_	35	compound	_	_
35	stimulation	stimulation	NN	NN	_	30	nmod	_	_
36	in	in	IN	IN	_	39	case	_	_
37	Jurkat	jurkat	NN	NN	_	39	compound	_	_
38	T	t	NN	NN	_	39	compound	_	_
39	cells	cell	NNS	NNS	_	35	nmod	_	_
40	.	.	.	.	_	18	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	phenomenon	phenomenon	NN	NN	_	4	nsubj	_	_
3	is	be	VBZ	VBZ	_	4	cop	_	_
4	due	due	JJ	JJ	_	0	root	_	_
5	to	to	TO	TO	_	8	case	_	_
6	mutually	mutually	RB	RB	_	7	advmod	_	_
7	exclusive	exclusive	JJ	JJ	_	8	amod	_	_
8	binding	binding	NN	NN	_	4	nmod	_	_
9	of	of	IN	IN	_	10	case	_	_
10	NF-ATp	nf-atp	NN	NN	_	8	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	NF-kappa	nf-kappa	NN	NN	_	13	compound	_	_
13	B	b	NN	NN	_	10	conj	_	_
14	to	to	TO	TO	_	17	case	_	_
15	the	the	DT	DT	_	17	det	_	_
16	P	p	NN	NN	_	17	compound	_	_
17	sequence	sequence	NN	NN	_	8	nmod	_	_
18	,	,	,	,	_	17	punct	_	_
19	an	a	DT	DT	_	20	det	_	_
20	element	element	NN	NN	_	17	appos	_	_
21	located	located	JJ	JJ	_	20	amod	_	_
22	69	69	CD	CD	_	23	nummod	_	_
23	bp	bp	NN	NN	_	21	nmod	_	_
24	upstream	upstream	RB	RB	_	23	advmod	_	_
25	of	of	IN	IN	_	23	case	_	_
26	the	the	DT	DT	_	30	det	_	_
27	IL4	il4	NN	NN	_	30	compound	_	_
28	transcription	transcription	NN	NN	_	30	compound	_	_
29	initiation	initiation	NN	NN	_	30	compound	_	_
30	site	site	NN	NN	_	23	dep	_	_
31	.	.	.	.	_	4	punct	_	_

1	Human	human	JJ	JJ	_	4	amod	_	_
2	IL4	il4	NN	NN	_	4	compound	_	_
3	promoter-mediated	promoter-mediated	JJ	JJ	_	4	amod	_	_
4	transcription	transcription	NN	NN	_	6	nsubjpass	_	_
5	is	be	VBZ	VBZ	_	6	auxpass	_	_
6	downregulated	downregulate	VBN	VBN	_	0	root	_	_
7	in	in	IN	IN	_	9	case	_	_
8	Jurkat	jurkat	NN	NN	_	9	compound	_	_
9	cells	cell	NNS	NNS	_	6	nmod	_	_
10	stimulated	stimulate	VBN	VBN	_	9	acl	_	_
11	with	with	IN	IN	_	15	case	_	_
12	the	the	DT	DT	_	15	det	_	_
13	NF-kappa	nf-kappa	NN	NN	_	15	compound	_	_
14	B-activating	b-activating	JJ	JJ	_	15	amod	_	_
15	cytokine	cytokine	NN	NN	_	10	nmod	_	_
16	tumor	tumor	NN	NN	_	19	compound	_	_
17	necrosis	necrosis	NN	NN	_	19	compound	_	_
18	factor	factor	NN	NN	_	19	compound	_	_
19	alpha	alpha	NN	NN	_	15	dep	_	_
20	and	and	CC	CC	_	6	cc	_	_
21	suppressed	suppress	VBN	VBN	_	6	conj	_	_
22	in	in	IN	IN	_	24	case	_	_
23	RelA-overexpressing	rela-overexpressing	JJ	JJ	_	24	amod	_	_
24	cells	cell	NNS	NNS	_	21	nmod	_	_
25	.	.	.	.	_	6	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	13	nmod	_	_
3	,	,	,	,	_	13	punct	_	_
4	protein	protein	NN	NN	_	6	compound	_	_
5	kinase	kinase	NN	NN	_	6	compound	_	_
6	C	c	NN	NN	_	7	compound	_	_
7	stimulation	stimulation	NN	NN	_	13	nsubj	_	_
8	or	or	CC	CC	_	7	cc	_	_
9	RelA	rela	NN	NN	_	10	compound	_	_
10	overexpression	overexpression	NN	NN	_	7	conj	_	_
11	does	do	VBZ	VBZ	_	13	aux	_	_
12	not	not	RB	RB	_	13	neg	_	_
13	affect	affect	VB	VB	_	0	root	_	_
14	the	the	DT	DT	_	15	det	_	_
15	activity	activity	NN	NN	_	13	dobj	_	_
16	of	of	IN	IN	_	20	case	_	_
17	a	a	DT	DT	_	20	det	_	_
18	human	human	JJ	JJ	_	20	amod	_	_
19	IL4	il4	NN	NN	_	20	compound	_	_
20	promoter	promoter	NN	NN	_	15	nmod	_	_
21	containing	contain	VBG	VBG	_	20	acl	_	_
22	a	a	DT	DT	_	25	det	_	_
23	mouse	mouse	NN	NN	_	25	compound	_	_
24	P	p	NN	NN	_	25	compound	_	_
25	sequence	sequence	NN	NN	_	21	dobj	_	_
26	,	,	,	,	_	25	punct	_	_
27	which	which	WDT	WDT	_	31	nsubj	_	_
28	is	be	VBZ	VBZ	_	31	cop	_	_
29	a	a	DT	DT	_	31	det	_	_
30	higher-affinity	higher-affinity	JJ	JJ	_	31	amod	_	_
31	site	site	NN	NN	_	25	acl:relcl	_	_
32	for	for	IN	IN	_	33	case	_	_
33	NF-ATp	nf-atp	NN	NN	_	31	nmod	_	_
34	and	and	CC	CC	_	31	cc	_	_
35	a	a	DT	DT	_	37	det	_	_
36	lower-affinity	lower-affinity	JJ	JJ	_	37	amod	_	_
37	site	site	NN	NN	_	31	conj	_	_
38	for	for	IN	IN	_	39	case	_	_
39	RelA	rela	NN	NN	_	37	nmod	_	_
40	.	.	.	.	_	13	punct	_	_

1	Thus	thus	RB	RB	_	14	advmod	_	_
2	,	,	,	,	_	14	punct	_	_
3	competition	competition	NN	NN	_	14	nsubj	_	_
4	between	between	IN	IN	_	8	case	_	_
5	two	two	CD	CD	_	8	nummod	_	_
6	general	general	JJ	JJ	_	8	amod	_	_
7	transcriptional	transcriptional	JJ	JJ	_	8	amod	_	_
8	activators	activator	NNS	NNS	_	3	nmod	_	_
9	,	,	,	,	_	8	punct	_	_
10	RelA	rela	NN	NN	_	8	appos	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	NF-ATp	nf-atp	NN	NN	_	10	conj	_	_
13	,	,	,	,	_	3	punct	_	_
14	mediates	mediate	VBZ	VBZ	_	0	root	_	_
15	the	the	DT	DT	_	17	det	_	_
16	inhibitory	inhibitory	JJ	JJ	_	17	amod	_	_
17	effect	effect	NN	NN	_	14	dobj	_	_
18	of	of	IN	IN	_	22	case	_	_
19	protein	protein	NN	NN	_	21	compound	_	_
20	kinase	kinase	NN	NN	_	21	compound	_	_
21	C	c	NN	NN	_	22	compound	_	_
22	stimulation	stimulation	NN	NN	_	17	nmod	_	_
23	on	on	IN	IN	_	25	case	_	_
24	IL4	il4	NN	NN	_	25	compound	_	_
25	expression	expression	NN	NN	_	17	nmod	_	_
26	and	and	CC	CC	_	14	cc	_	_
27	may	may	MD	MD	_	28	aux	_	_
28	contribute	contribute	VB	VB	_	14	conj	_	_
29	to	to	TO	TO	_	32	case	_	_
30	differential	differential	JJ	JJ	_	32	amod	_	_
31	gene	gene	NN	NN	_	32	compound	_	_
32	expression	expression	NN	NN	_	28	nmod	_	_
33	in	in	IN	IN	_	35	case	_	_
34	TH	th	NN	NN	_	35	compound	_	_
35	cells	cell	NNS	NNS	_	32	nmod	_	_
36	.	.	.	.	_	14	punct	_	_

1	Functional	functional	JJ	JJ	_	2	amod	_	_
2	characterization	characterization	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	murine	murine	JJ	JJ	_	6	amod	_	_
6	homolog	homolog	NN	NN	_	2	nmod	_	_
7	of	of	IN	IN	_	11	case	_	_
8	the	the	DT	DT	_	11	det	_	_
9	B	b	NN	NN	_	11	compound	_	_
10	cell-specific	cell-specific	JJ	JJ	_	11	amod	_	_
11	coactivator	coactivator	NN	NN	_	6	nmod	_	_
12	BOB.1/OBF.1	bob.1/obf.1	NN	NN	_	11	dep	_	_
13	.	.	.	.	_	2	punct	_	_

1	B	b	NN	NN	_	5	compound	_	_
2	cell-specific	cell-specific	JJ	JJ	_	5	amod	_	_
3	transcriptional	transcriptional	JJ	JJ	_	5	amod	_	_
4	promoter	promoter	NN	NN	_	5	compound	_	_
5	activity	activity	NN	NN	_	11	nsubj	_	_
6	mediated	mediate	VBN	VBN	_	5	acl	_	_
7	by	by	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	octamer	octamer	NN	NN	_	10	compound	_	_
10	motif	motif	NN	NN	_	6	nmod	_	_
11	requires	require	VBZ	VBZ	_	0	root	_	_
12	the	the	DT	DT	_	13	dep	_	_
13	Oct1	oct1	NN	NN	_	11	dobj	_	_
14	or	or	CC	CC	_	13	cc	_	_
15	Oct2	oct2	NN	NN	_	16	compound	_	_
16	protein	protein	NN	NN	_	13	conj	_	_
17	and	and	CC	CC	_	13	cc	_	_
18	additional	additional	JJ	JJ	_	21	amod	_	_
19	B	b	NN	NN	_	21	compound	_	_
20	cell-restricted	cell-restricted	JJ	JJ	_	21	amod	_	_
21	cofactors	cofactor	NNS	NNS	_	13	conj	_	_
22	.	.	.	.	_	11	punct	_	_

1	One	one	CD	CD	_	3	nummod	_	_
2	such	such	JJ	JJ	_	3	amod	_	_
3	cofactor	cofactor	NN	NN	_	9	nsubjpass	_	_
4	,	,	,	,	_	3	punct	_	_
5	BOB.1/OBF.1	bob.1/obf.1	NN	NN	_	3	appos	_	_
6	,	,	,	,	_	3	punct	_	_
7	was	be	VBD	VBD	_	9	auxpass	_	_
8	recently	recently	RB	RB	_	9	advmod	_	_
9	isolated	isolate	VBN	VBN	_	0	root	_	_
10	from	from	IN	IN	_	13	case	_	_
11	human	human	JJ	JJ	_	13	amod	_	_
12	B	b	NN	NN	_	13	compound	_	_
13	cells	cell	NNS	NNS	_	9	nmod	_	_
14	.	.	.	.	_	9	punct	_	_

1	Here	here	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	describe	describe	VBP	VBP	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	isolation	isolation	NN	NN	_	4	dobj	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	detailed	detailed	JJ	JJ	_	9	amod	_	_
9	characterization	characterization	NN	NN	_	6	conj	_	_
10	of	of	IN	IN	_	13	case	_	_
11	the	the	DT	DT	_	13	det	_	_
12	murine	murine	JJ	JJ	_	13	amod	_	_
13	homolog	homolog	NN	NN	_	6	nmod	_	_
14	.	.	.	.	_	4	punct	_	_

1	Full-length	full-length	JJ	JJ	_	2	amod	_	_
2	cDNAs	cdna	NNS	NNS	_	7	nsubjpass	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	genomic	genomic	JJ	JJ	_	5	amod	_	_
5	clones	clone	NNS	NNS	_	2	conj	_	_
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	isolated	isolate	VBN	VBN	_	0	root	_	_
8	,	,	,	,	_	7	punct	_	_
9	and	and	CC	CC	_	7	cc	_	_
10	the	the	DT	DT	_	12	det	_	_
11	gene	gene	NN	NN	_	12	compound	_	_
12	structure	structure	NN	NN	_	14	nsubjpass	_	_
13	was	be	VBD	VBD	_	14	auxpass	_	_
14	determined	determine	VBN	VBN	_	7	conj	_	_
15	.	.	.	.	_	7	punct	_	_

1	Comparison	comparison	NN	NN	_	7	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	deduced	deduce	VBN	VBN	_	6	amod	_	_
5	amino	amino	NN	NN	_	6	compound	_	_
6	acids	acid	NNS	NNS	_	1	nmod	_	_
7	shows	show	VBZ	VBZ	_	0	root	_	_
8	88	88	CD	CD	_	9	compound	_	_
9	%	%	NN	NN	_	11	amod	_	_
10	sequence	sequence	NN	NN	_	11	compound	_	_
11	identity	identity	NN	NN	_	7	dobj	_	_
12	between	between	IN	IN	_	13	case	_	_
13	mouse	mouse	NN	NN	_	11	nmod	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	human	human	JJ	JJ	_	13	conj	_	_
16	BOB.1/OBF.1	bob.1/obf.1	NN	NN	_	13	dep	_	_
17	.	.	.	.	_	7	punct	_	_

1	The	the	DT	DT	_	5	det	_	_
2	NH2-terminal	nh2-terminal	JJ	JJ	_	5	amod	_	_
3	126	126	CD	CD	_	5	nummod	_	_
4	amino	amino	NN	NN	_	5	compound	_	_
5	acids	acid	NNS	NNS	_	10	nsubj	_	_
6	of	of	IN	IN	_	7	case	_	_
7	BOB.1/OBF.1	bob.1/obf.1	NN	NN	_	5	nmod	_	_
8	are	be	VBP	VBP	_	10	cop	_	_
9	both	both	CC	CC	_	10	cc:preconj	_	_
10	essential	essential	JJ	JJ	_	0	root	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	sufficient	sufficient	JJ	JJ	_	10	conj	_	_
13	for	for	IN	IN	_	14	case	_	_
14	interaction	interaction	NN	NN	_	10	nmod	_	_
15	with	with	IN	IN	_	18	case	_	_
16	the	the	DT	DT	_	18	det	_	_
17	POU	pou	NN	NN	_	18	compound	_	_
18	domains	domain	NNS	NNS	_	14	nmod	_	_
19	of	of	IN	IN	_	21	case	_	_
20	either	either	CC	CC	_	21	cc:preconj	_	_
21	Oct1	oct1	NN	NN	_	18	nmod	_	_
22	or	or	CC	CC	_	21	cc	_	_
23	Oct2	oct2	NN	NN	_	21	conj	_	_
24	.	.	.	.	_	10	punct	_	_

1	This	this	DT	DT	_	3	det	_	_
2	protein-protein	protein-protein	JJ	JJ	_	3	amod	_	_
3	interaction	interaction	NN	NN	_	6	nsubj	_	_
4	does	do	VBZ	VBZ	_	6	aux	_	_
5	not	not	RB	RB	_	6	neg	_	_
6	require	require	VB	VB	_	0	root	_	_
7	the	the	DT	DT	_	9	det	_	_
8	simultaneous	simultaneous	JJ	JJ	_	9	amod	_	_
9	binding	binding	NN	NN	_	6	dobj	_	_
10	of	of	IN	IN	_	12	case	_	_
11	Oct	oct	NN	NN	_	12	compound	_	_
12	proteins	protein	NNS	NNS	_	9	nmod	_	_
13	to	to	TO	TO	_	14	case	_	_
14	DNA	dna	NN	NN	_	9	nmod	_	_
15	,	,	,	,	_	6	punct	_	_
16	and	and	CC	CC	_	6	cc	_	_
17	high	high	JJ	JJ	_	19	amod	_	_
18	resolution	resolution	NN	NN	_	19	compound	_	_
19	footprinting	footprinting	NN	NN	_	24	nsubj	_	_
20	of	of	IN	IN	_	23	case	_	_
21	the	the	DT	DT	_	23	det	_	_
22	Oct-DNA	oct-dna	NN	NN	_	23	compound	_	_
23	interaction	interaction	NN	NN	_	19	nmod	_	_
24	reveals	reveal	VBZ	VBZ	_	6	conj	_	_
25	that	that	IN	IN	_	35	mark	_	_
26	binding	binding	NN	NN	_	35	nsubj	_	_
27	of	of	IN	IN	_	28	case	_	_
28	BOB.1/OBF.1	bob.1/obf.1	NN	NN	_	26	nmod	_	_
29	to	to	TO	TO	_	30	case	_	_
30	Oct1	oct1	NN	NN	_	26	nmod	_	_
31	or	or	CC	CC	_	30	cc	_	_
32	Oct2	oct2	NN	NN	_	30	conj	_	_
33	does	do	VBZ	VBZ	_	35	aux	_	_
34	not	not	RB	RB	_	35	neg	_	_
35	alter	alter	VB	VB	_	24	ccomp	_	_
36	the	the	DT	DT	_	37	det	_	_
37	interaction	interaction	NN	NN	_	35	dobj	_	_
38	with	with	IN	IN	_	39	case	_	_
39	DNA	dna	NN	NN	_	37	nmod	_	_
40	.	.	.	.	_	6	punct	_	_

1	BOB.1/OBF.1	bob.1/obf.1	NN	NN	_	4	nsubj	_	_
2	can	can	MD	MD	_	4	aux	_	_
3	efficiently	efficiently	RB	RB	_	4	advmod	_	_
4	activate	activate	VB	VB	_	0	root	_	_
5	octamer-dependent	octamer-dependent	JJ	JJ	_	6	amod	_	_
6	promoters	promoter	NNS	NNS	_	4	dobj	_	_
7	in	in	IN	IN	_	8	case	_	_
8	fibroblasts	fibroblast	NNS	NNS	_	6	nmod	_	_
9	;	;	:	:	_	4	punct	_	_
10	however	however	RB	RB	_	13	advmod	_	_
11	,	,	,	,	_	13	punct	_	_
12	it	it	PRP	PRP	_	13	nsubj	_	_
13	fails	fail	VBZ	VBZ	_	4	parataxis	_	_
14	to	to	TO	TO	_	15	mark	_	_
15	stimulate	stimulate	VB	VB	_	13	xcomp	_	_
16	octamer-dependent	octamer-dependent	JJ	JJ	_	17	amod	_	_
17	enhancer	enhancer	NN	NN	_	18	compound	_	_
18	activity	activity	NN	NN	_	15	dobj	_	_
19	.	.	.	.	_	4	punct	_	_

1	Fusion	fusion	NN	NN	_	12	nsubj	_	_
2	of	of	IN	IN	_	3	case	_	_
3	subdomains	subdomain	NNS	NNS	_	1	nmod	_	_
4	of	of	IN	IN	_	5	case	_	_
5	BOB.1/OBF.1	bob.1/obf.1	NN	NN	_	3	nmod	_	_
6	with	with	IN	IN	_	11	case	_	_
7	the	the	DT	DT	_	11	det	_	_
8	GAL4	gal4	NN	NN	_	11	compound	_	_
9	DNA	dna	NN	NN	_	11	compound	_	_
10	binding	binding	NN	NN	_	11	compound	_	_
11	domain	domain	NN	NN	_	1	nmod	_	_
12	reveals	reveal	VBZ	VBZ	_	0	root	_	_
13	that	that	IN	IN	_	21	mark	_	_
14	both	both	CC	CC	_	15	cc:preconj	_	_
15	NH2-	nh2-	NN	NN	_	21	nsubj	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	COOH-terminal	cooh-terminal	JJ	JJ	_	18	amod	_	_
18	domains	domain	NNS	NNS	_	15	conj	_	_
19	of	of	IN	IN	_	20	case	_	_
20	BOB.1/OBF.1	bob.1/obf.1	NN	NN	_	15	nmod	_	_
21	contribute	contribute	VBP	VBP	_	12	dep	_	_
22	to	to	TO	TO	_	25	case	_	_
23	full	full	JJ	JJ	_	25	amod	_	_
24	transactivation	transactivation	NN	NN	_	25	compound	_	_
25	function	function	NN	NN	_	21	nmod	_	_
26	,	,	,	,	_	21	punct	_	_
27	the	the	DT	DT	_	29	det	_	_
28	COOH-terminal	cooh-terminal	JJ	JJ	_	29	amod	_	_
29	domain	domain	NN	NN	_	21	dep	_	_
30	is	be	VBZ	VBZ	_	32	cop	_	_
31	more	more	RBR	RBR	_	32	advmod	_	_
32	efficient	efficient	JJ	JJ	_	21	dep	_	_
33	in	in	IN	IN	_	36	case	_	_
34	this	this	DT	DT	_	36	det	_	_
35	transactivation	transactivation	NN	NN	_	36	compound	_	_
36	assay	assay	NN	NN	_	32	nmod	_	_
37	.	.	.	.	_	12	punct	_	_

1	Consistent	consistent	JJ	JJ	_	23	advmod	_	_
2	with	with	IN	IN	_	4	case	_	_
3	the	the	DT	DT	_	4	det	_	_
4	failure	failure	NN	NN	_	1	nmod	_	_
5	of	of	IN	IN	_	7	case	_	_
6	full-length	full-length	JJ	JJ	_	7	amod	_	_
7	BOB.1/OBF.1	bob.1/obf.1	NN	NN	_	4	nmod	_	_
8	to	to	TO	TO	_	9	mark	_	_
9	stimulate	stimulate	VB	VB	_	4	acl	_	_
10	octamer-dependent	octamer-dependent	JJ	JJ	_	12	amod	_	_
11	enhancer	enhancer	NN	NN	_	12	compound	_	_
12	elements	element	NNS	NNS	_	9	dobj	_	_
13	in	in	IN	IN	_	16	case	_	_
14	non	non	JJ	JJ	_	16	amod	_	_
15	B	b	NN	NN	_	16	compound	_	_
16	cells	cell	NNS	NNS	_	12	nmod	_	_
17	,	,	,	,	_	23	punct	_	_
18	the	the	DT	DT	_	20	det	_	_
19	GAL4	gal4	NN	NN	_	20	compound	_	_
20	fusions	fusion	NNS	NNS	_	23	nsubj	_	_
21	likewise	likewise	RB	RB	_	23	advmod	_	_
22	only	only	RB	RB	_	23	advmod	_	_
23	stimulate	stimulate	VBP	VBP	_	0	root	_	_
24	from	from	IN	IN	_	27	case	_	_
25	a	a	DT	DT	_	27	det	_	_
26	promoter-proximal	promoter-proximal	JJ	JJ	_	27	amod	_	_
27	position	position	NN	NN	_	23	nmod	_	_
28	.	.	.	.	_	23	punct	_	_

1	IL-10	il-10	NN	NN	_	2	nsubj	_	_
2	cooperates	cooperate	VBZ	VBZ	_	0	root	_	_
3	with	with	IN	IN	_	4	case	_	_
4	TNF-alpha	tnf-alpha	NN	NN	_	2	nmod	_	_
5	to	to	TO	TO	_	6	mark	_	_
6	activate	activate	VB	VB	_	2	xcomp	_	_
7	HIV-1	hiv-1	NN	NN	_	6	dobj	_	_
8	from	from	IN	IN	_	9	case	_	_
9	latently	latently	RB	RB	_	6	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	acutely	acutely	RB	RB	_	9	conj	_	_
12	infected	infected	JJ	JJ	_	13	amod	_	_
13	cells	cell	NNS	NNS	_	9	dep	_	_
14	of	of	IN	IN	_	16	case	_	_
15	monocyte/macrophage	monocyte/macrophage	NN	NN	_	16	compound	_	_
16	lineage	lineage	NN	NN	_	9	nmod	_	_
17	.	.	.	.	_	2	punct	_	_

1	IL-10	il-10	NN	NN	_	3	nsubj	_	_
2	is	be	VBZ	VBZ	_	3	cop	_	_
3	elevated	elevated	JJ	JJ	_	0	root	_	_
4	in	in	IN	IN	_	6	case	_	_
5	HIV-1-infected	hiv-1-infected	JJ	JJ	_	6	amod	_	_
6	individuals	individual	NNS	NNS	_	3	nmod	_	_
7	and	and	CC	CC	_	3	cc	_	_
8	has	have	VBZ	VBZ	_	10	aux	_	_
9	been	be	VBN	VBN	_	10	auxpass	_	_
10	implicated	implicate	VBN	VBN	_	3	conj	_	_
11	in	in	IN	IN	_	13	case	_	_
12	disease	disease	NN	NN	_	13	compound	_	_
13	progression	progression	NN	NN	_	10	nmod	_	_
14	.	.	.	.	_	3	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	study	study	NN	NN	_	6	nmod	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	investigated	investigate	VBD	VBD	_	0	root	_	_
7	the	the	DT	DT	_	8	det	_	_
8	effects	effect	NNS	NNS	_	6	dobj	_	_
9	of	of	IN	IN	_	10	case	_	_
10	IL-10	il-10	NN	NN	_	8	nmod	_	_
11	on	on	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	activation	activation	NN	NN	_	8	nmod	_	_
14	of	of	IN	IN	_	15	case	_	_
15	HIV-1	hiv-1	NN	NN	_	13	nmod	_	_
16	from	from	IN	IN	_	18	case	_	_
17	infected	infected	JJ	JJ	_	18	amod	_	_
18	monocytes	monocyte	NNS	NNS	_	15	nmod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	macrophages	macrophage	NNS	NNS	_	18	conj	_	_
21	.	.	.	.	_	6	punct	_	_

1	Although	although	IN	IN	_	6	mark	_	_
2	IL-10	il-10	NN	NN	_	6	nsubj	_	_
3	alone	alone	RB	RB	_	2	advmod	_	_
4	did	do	VBD	VBD	_	6	aux	_	_
5	not	not	RB	RB	_	6	neg	_	_
6	induce	induce	VB	VB	_	18	advcl	_	_
7	HIV-1	hiv-1	NN	NN	_	8	compound	_	_
8	replication	replication	NN	NN	_	6	dobj	_	_
9	,	,	,	,	_	18	punct	_	_
10	in	in	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	presence	presence	NN	NN	_	18	nmod	_	_
13	of	of	IN	IN	_	14	case	_	_
14	TNF-alpha	tnf-alpha	NN	NN	_	12	nmod	_	_
15	,	,	,	,	_	18	punct	_	_
16	IL-10	il-10	NN	NN	_	18	nsubj	_	_
17	markedly	markedly	RB	RB	_	18	advmod	_	_
18	enhanced	enhance	VBD	VBD	_	0	root	_	_
19	virion	virion	NN	NN	_	20	compound	_	_
20	production	production	NN	NN	_	18	dobj	_	_
21	from	from	IN	IN	_	27	case	_	_
22	a	a	DT	DT	_	27	det	_	_
23	chronically	chronically	RB	RB	_	24	advmod	_	_
24	infected	infected	JJ	JJ	_	27	amod	_	_
25	promonocytic	promonocytic	JJ	JJ	_	27	amod	_	_
26	cell	cell	NN	NN	_	27	compound	_	_
27	line	line	NN	NN	_	20	nmod	_	_
28	(	(	-LRB-	-LRB-	_	29	punct	_	_
29	U1	u1	NN	NN	_	27	appos	_	_
30	)	)	-RRB-	-RRB-	_	29	punct	_	_
31	and	and	CC	CC	_	27	cc	_	_
32	in	in	IN	IN	_	36	case	_	_
33	acutely	acutely	RB	RB	_	34	advmod	_	_
34	infected	infected	JJ	JJ	_	36	amod	_	_
35	monocyte-derived	monocyte-derived	JJ	JJ	_	36	amod	_	_
36	macrophages	macrophage	NNS	NNS	_	27	conj	_	_
37	.	.	.	.	_	18	punct	_	_

1	Neutralizing	neutralize	VBG	VBG	_	7	csubj	_	_
2	mAbs	mab	NNS	NNS	_	1	dobj	_	_
3	to	to	TO	TO	_	4	case	_	_
4	IL-10	il-10	NN	NN	_	1	nmod	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	TNF-alpha	tnf-alpha	NN	NN	_	4	conj	_	_
7	indicated	indicate	VBD	VBD	_	0	root	_	_
8	that	that	IN	IN	_	12	mark	_	_
9	both	both	DT	DT	_	10	dep	_	_
10	cytokines	cytokine	NNS	NNS	_	12	nsubj	_	_
11	were	be	VBD	VBD	_	12	cop	_	_
12	essential	essential	JJ	JJ	_	7	ccomp	_	_
13	for	for	IN	IN	_	15	case	_	_
14	the	the	DT	DT	_	15	det	_	_
15	induction	induction	NN	NN	_	12	nmod	_	_
16	and	and	CC	CC	_	12	cc	_	_
17	were	be	VBD	VBD	_	18	auxpass	_	_
18	required	require	VBN	VBN	_	12	conj	_	_
19	to	to	TO	TO	_	20	mark	_	_
20	generate	generate	VB	VB	_	18	xcomp	_	_
21	a	a	DT	DT	_	23	det	_	_
22	synergistic	synergistic	JJ	JJ	_	23	amod	_	_
23	increase	increase	NN	NN	_	20	dobj	_	_
24	in	in	IN	IN	_	26	case	_	_
25	virus	virus	NN	NN	_	26	compound	_	_
26	expression	expression	NN	NN	_	23	nmod	_	_
27	.	.	.	.	_	7	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	effects	effect	NNS	NNS	_	8	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	two	two	CD	CD	_	6	nummod	_	_
6	cytokines	cytokine	NNS	NNS	_	2	nmod	_	_
7	were	be	VBD	VBD	_	8	cop	_	_
8	distinguishable	distinguishable	JJ	JJ	_	0	root	_	_
9	functionally	functionally	RB	RB	_	8	advmod	_	_
10	since	since	IN	IN	_	14	mark	_	_
11	pretreatment	pretreatment	NN	NN	_	14	nsubj	_	_
12	with	with	IN	IN	_	13	case	_	_
13	TNF-alpha	tnf-alpha	NN	NN	_	11	nmod	_	_
14	attenuated	attenuate	VBD	VBD	_	8	advcl	_	_
15	the	the	DT	DT	_	17	det	_	_
16	cytokine	cytokine	NN	NN	_	17	compound	_	_
17	cooperativity	cooperativity	NN	NN	_	14	dobj	_	_
18	,	,	,	,	_	14	punct	_	_
19	while	while	IN	IN	_	23	mark	_	_
20	pretreatment	pretreatment	NN	NN	_	23	nsubj	_	_
21	with	with	IN	IN	_	22	case	_	_
22	IL-10	il-10	NN	NN	_	20	nmod	_	_
23	potentiated	potentiate	VBD	VBD	_	14	advcl	_	_
24	their	they	PRP$	PRP$	_	25	nmod:poss	_	_
25	cooperativity	cooperativity	NN	NN	_	23	dobj	_	_
26	,	,	,	,	_	14	punct	_	_
27	suggesting	suggest	VBG	VBG	_	14	xcomp	_	_
28	that	that	IN	IN	_	32	mark	_	_
29	IL-10	il-10	NN	NN	_	32	nsubj	_	_
30	and	and	CC	CC	_	29	cc	_	_
31	TNF-alpha	tnf-alpha	NN	NN	_	29	conj	_	_
32	play	play	VBP	VBP	_	27	ccomp	_	_
33	different	different	JJ	JJ	_	34	amod	_	_
34	roles	role	NNS	NNS	_	32	dobj	_	_
35	in	in	IN	IN	_	37	case	_	_
36	the	the	DT	DT	_	37	det	_	_
37	activation	activation	NN	NN	_	32	nmod	_	_
38	of	of	IN	IN	_	39	case	_	_
39	virus	virus	NN	NN	_	37	nmod	_	_
40	.	.	.	.	_	8	punct	_	_

1	Northern	northern	JJ	JJ	_	3	amod	_	_
2	blot	blot	NN	NN	_	3	compound	_	_
3	analysis	analysis	NN	NN	_	13	nsubj	_	_
4	as	as	RB	RB	_	3	cc	_	_
5	well	well	RB	RB	_	4	mwe	_	_
6	as	as	IN	IN	_	4	mwe	_	_
7	Ab	ab	NN	NN	_	8	compound	_	_
8	blocking	blocking	NN	NN	_	3	conj	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	cytokine	cytokine	NN	NN	_	11	compound	_	_
11	secretion	secretion	NN	NN	_	8	conj	_	_
12	studies	study	NNS	NNS	_	8	dep	_	_
13	indicated	indicate	VBD	VBD	_	0	root	_	_
14	that	that	IN	IN	_	25	mark	_	_
15	the	the	DT	DT	_	16	det	_	_
16	induction	induction	NN	NN	_	25	nsubjpass	_	_
17	of	of	IN	IN	_	20	case	_	_
18	either	either	CC	CC	_	20	cc:preconj	_	_
19	endogenous	endogenous	JJ	JJ	_	20	amod	_	_
20	TNF-alpha	tnf-alpha	NN	NN	_	16	nmod	_	_
21	or	or	CC	CC	_	20	cc	_	_
22	IL-10	il-10	NN	NN	_	20	conj	_	_
23	was	be	VBD	VBD	_	25	auxpass	_	_
24	not	not	RB	RB	_	25	neg	_	_
25	involved	involve	VBN	VBN	_	13	ccomp	_	_
26	in	in	IN	IN	_	28	case	_	_
27	the	the	DT	DT	_	28	det	_	_
28	cooperativity	cooperativity	NN	NN	_	25	nmod	_	_
29	,	,	,	,	_	25	punct	_	_
30	nor	nor	CC	CC	_	25	cc	_	_
31	was	be	VBD	VBD	_	33	dep	_	_
32	an	a	DT	DT	_	33	det	_	_
33	up-regulation	up-regulation	NN	NN	_	25	conj	_	_
34	of	of	IN	IN	_	36	case	_	_
35	TNF-alpha	tnf-alpha	NN	NN	_	36	compound	_	_
36	receptors	receptor	NNS	NNS	_	33	nmod	_	_
37	.	.	.	.	_	13	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	combination	combination	NN	NN	_	7	nmod	_	_
3	with	with	IN	IN	_	4	case	_	_
4	TNF-alpha	tnf-alpha	NN	NN	_	2	nmod	_	_
5	,	,	,	,	_	7	punct	_	_
6	IL-10	il-10	NN	NN	_	7	nsubj	_	_
7	stimulated	stimulate	VBD	VBD	_	0	root	_	_
8	activating	activate	VBG	VBG	_	9	amod	_	_
9	protein-1	protein-1	NN	NN	_	7	dobj	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	AP-1	ap-1	NN	NN	_	9	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	and	and	CC	CC	_	9	cc	_	_
14	nuclear	nuclear	JJ	JJ	_	20	amod	_	_
15	factor	factor	NN	NN	_	20	compound	_	_
16	(	(	-LRB-	-LRB-	_	20	punct	_	_
17	NF	nf	NN	NN	_	20	compound	_	_
18	)	)	-RRB-	-RRB-	_	20	punct	_	_
19	-kappa	-kappa	NN	NN	_	20	compound	_	_
20	B	b	NN	NN	_	22	compound	_	_
21	binding	binding	NN	NN	_	22	compound	_	_
22	activities	activity	NNS	NNS	_	9	conj	_	_
23	and	and	CC	CC	_	7	cc	_	_
24	cooperated	cooperate	VBD	VBD	_	7	conj	_	_
25	to	to	TO	TO	_	26	mark	_	_
26	increase	increase	VB	VB	_	24	xcomp	_	_
27	HIV-1	hiv-1	NN	NN	_	30	compound	_	_
28	steady-state	steady-state	JJ	JJ	_	30	amod	_	_
29	mRNA	mrna	NN	NN	_	30	compound	_	_
30	levels	level	NNS	NNS	_	26	dobj	_	_
31	and	and	CC	CC	_	26	cc	_	_
32	enhance	enhance	VB	VB	_	26	conj	_	_
33	long	long	JJ	JJ	_	36	amod	_	_
34	terminal	terminal	JJ	JJ	_	36	amod	_	_
35	repeat-directed	repeat-directed	JJ	JJ	_	36	amod	_	_
36	transcription	transcription	NN	NN	_	32	dobj	_	_
37	through	through	IN	IN	_	38	case	_	_
38	activation	activation	NN	NN	_	32	nmod	_	_
39	of	of	IN	IN	_	44	case	_	_
40	the	the	DT	DT	_	44	det	_	_
41	NF-kappa	nf-kappa	NN	NN	_	44	compound	_	_
42	B	b	NN	NN	_	44	compound	_	_
43	binding	binding	NN	NN	_	44	compound	_	_
44	sites	site	NNS	NNS	_	38	nmod	_	_
45	,	,	,	,	_	7	punct	_	_
46	suggesting	suggest	VBG	VBG	_	7	advcl	_	_
47	the	the	DT	DT	_	49	det	_	_
48	IL-10	il-10	NN	NN	_	49	compound	_	_
49	effect	effect	NN	NN	_	46	dobj	_	_
50	occurs	occur	VBZ	VBZ	_	46	dep	_	_
51	at	at	IN	IN	_	54	advmod	_	_
52	least	least	JJS	JJS	_	51	mwe	_	_
53	in	in	IN	IN	_	54	case	_	_
54	part	part	NN	NN	_	50	nmod	_	_
55	at	at	IN	IN	_	58	case	_	_
56	the	the	DT	DT	_	58	det	_	_
57	transcriptional	transcriptional	JJ	JJ	_	58	amod	_	_
58	level	level	NN	NN	_	50	nmod	_	_
59	.	.	.	.	_	7	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	20	mark	_	_
5	IL-10	il-10	NN	NN	_	20	nsubj	_	_
6	,	,	,	,	_	5	punct	_	_
7	in	in	IN	IN	_	8	case	_	_
8	addition	addition	NN	NN	_	20	nmod	_	_
9	to	to	TO	TO	_	10	mark	_	_
10	down-regulating	down-regulate	VBG	VBG	_	8	acl	_	_
11	the	the	DT	DT	_	14	det	_	_
12	cellular	cellular	JJ	JJ	_	14	amod	_	_
13	immune	immune	JJ	JJ	_	14	amod	_	_
14	response	response	NN	NN	_	10	dobj	_	_
15	to	to	TO	TO	_	16	case	_	_
16	HIV-1	hiv-1	NN	NN	_	14	nmod	_	_
17	,	,	,	,	_	20	punct	_	_
18	may	may	MD	MD	_	20	aux	_	_
19	also	also	RB	RB	_	20	advmod	_	_
20	play	play	VB	VB	_	3	ccomp	_	_
21	a	a	DT	DT	_	22	det	_	_
22	role	role	NN	NN	_	20	dobj	_	_
23	in	in	IN	IN	_	25	case	_	_
24	TNF-alpha-mediated	tnf-alpha-mediated	JJ	JJ	_	25	amod	_	_
25	activation	activation	NN	NN	_	20	nmod	_	_
26	of	of	IN	IN	_	28	case	_	_
27	HIV-1	hiv-1	NN	NN	_	28	compound	_	_
28	replication	replication	NN	NN	_	25	nmod	_	_
29	in	in	IN	IN	_	32	case	_	_
30	the	the	DT	DT	_	32	det	_	_
31	monocyte/macrophage	monocyte/macrophage	JJ	JJ	_	32	amod	_	_
32	lineage	lineage	NN	NN	_	28	nmod	_	_
33	.	.	.	.	_	3	punct	_	_

1	Inhibition	inhibition	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	8	case	_	_
3	lipopolysaccharide-induced	lipopolysaccharide-induced	JJ	JJ	_	8	amod	_	_
4	monocyte	monocyte	NN	NN	_	6	compound	_	_
5	interleukin-1	interleukin-1	NN	NN	_	6	compound	_	_
6	receptor	receptor	NN	NN	_	8	compound	_	_
7	antagonist	antagonist	NN	NN	_	8	compound	_	_
8	synthesis	synthesis	NN	NN	_	1	nmod	_	_
9	by	by	IN	IN	_	10	case	_	_
10	cortisol	cortisol	NN	NN	_	1	nmod	_	_
11	:	:	:	:	_	1	punct	_	_
12	involvement	involvement	NN	NN	_	1	dep	_	_
13	of	of	IN	IN	_	16	case	_	_
14	the	the	DT	DT	_	16	det	_	_
15	mineralocorticoid	mineralocorticoid	NN	NN	_	16	compound	_	_
16	receptor	receptor	NN	NN	_	12	nmod	_	_
17	.	.	.	.	_	1	punct	_	_

1	Glucocorticoids	glucocorticoid	NNS	NNS	_	19	nsubj	_	_
2	,	,	,	,	_	1	punct	_	_
3	as	as	IN	IN	_	5	case	_	_
4	a	a	DT	DT	_	5	det	_	_
5	part	part	NN	NN	_	19	nmod	_	_
6	of	of	IN	IN	_	9	case	_	_
7	their	they	PRP$	PRP$	_	9	nmod:poss	_	_
8	physiological	physiological	JJ	JJ	_	9	amod	_	_
9	role	role	NN	NN	_	5	nmod	_	_
10	in	in	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	control	control	NN	NN	_	9	nmod	_	_
13	of	of	IN	IN	_	14	case	_	_
14	inflammatory	inflammatory	JJ	JJ	_	12	nmod	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	immune	immune	JJ	JJ	_	14	conj	_	_
17	processes	process	NNS	NNS	_	14	dep	_	_
18	,	,	,	,	_	19	punct	_	_
19	suppress	suppress	VBP	VBP	_	0	root	_	_
20	the	the	DT	DT	_	21	det	_	_
21	expression	expression	NN	NN	_	19	dobj	_	_
22	of	of	IN	IN	_	23	case	_	_
23	interleukin-1	interleukin-1	NN	NN	_	21	nmod	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	IL-1	il-1	NN	NN	_	23	appos	_	_
26	)	)	-RRB-	-RRB-	_	25	punct	_	_
27	and	and	CC	CC	_	23	cc	_	_
28	other	other	JJ	JJ	_	29	amod	_	_
29	cytokines	cytokine	NNS	NNS	_	23	conj	_	_
30	.	.	.	.	_	19	punct	_	_

1	Human	human	JJ	JJ	_	11	amod	_	_
2	monocyte	monocyte	NN	NN	_	11	compound	_	_
3	IL-1	il-1	NN	NN	_	11	compound	_	_
4	receptor	receptor	NN	NN	_	11	compound	_	_
5	antagonist	antagonist	NN	NN	_	11	compound	_	_
6	(	(	-LRB-	-LRB-	_	11	punct	_	_
7	IL-1ra	il-1ra	NN	NN	_	11	compound	_	_
8	)	)	-RRB-	-RRB-	_	11	punct	_	_
9	messenger	messenger	NN	NN	_	11	compound	_	_
10	ribonucleic	ribonucleic	NN	NN	_	11	compound	_	_
11	acid	acid	NN	NN	_	15	compound	_	_
12	(	(	-LRB-	-LRB-	_	13	punct	_	_
13	mRNA	mrna	NN	NN	_	11	appos	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	expression	expression	NN	NN	_	20	nsubjpass	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	protein	protein	NN	NN	_	18	compound	_	_
18	secretion	secretion	NN	NN	_	15	conj	_	_
19	are	be	VBP	VBP	_	20	auxpass	_	_
20	inhibited	inhibit	VBN	VBN	_	0	root	_	_
21	by	by	IN	IN	_	22	case	_	_
22	dexamethasone	dexamethasone	NN	NN	_	20	nmod	_	_
23	.	.	.	.	_	20	punct	_	_

1	We	we	PRP	PRP	_	5	nsubj	_	_
2	have	have	VBP	VBP	_	5	aux	_	_
3	now	now	RB	RB	_	5	advmod	_	_
4	further	further	RB	RB	_	5	advmod	_	_
5	studied	study	VBN	VBN	_	0	root	_	_
6	the	the	DT	DT	_	7	det	_	_
7	regulation	regulation	NN	NN	_	5	dobj	_	_
8	of	of	IN	IN	_	9	case	_	_
9	IL-1ra	il-1ra	NN	NN	_	7	nmod	_	_
10	by	by	IN	IN	_	15	case	_	_
11	the	the	DT	DT	_	15	det	_	_
12	major	major	JJ	JJ	_	15	amod	_	_
13	physiological	physiological	JJ	JJ	_	12	dep	_	_
14	human	human	JJ	JJ	_	15	amod	_	_
15	glucocorticoid	glucocorticoid	NN	NN	_	7	nmod	_	_
16	,	,	,	,	_	15	punct	_	_
17	cortisol	cortisol	NN	NN	_	15	appos	_	_
18	.	.	.	.	_	5	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	found	find	VBD	VBD	_	0	root	_	_
3	that	that	IN	IN	_	6	mark	_	_
4	cortisol	cortisol	NN	NN	_	5	compound	_	_
5	incubation	incubation	NN	NN	_	6	nsubj	_	_
6	induced	induce	VBD	VBD	_	2	ccomp	_	_
7	a	a	DT	DT	_	8	det	_	_
8	decrease	decrease	NN	NN	_	6	dobj	_	_
9	in	in	IN	IN	_	12	case	_	_
10	IL-1ra	il-1ra	NN	NN	_	11	compound	_	_
11	mRNA	mrna	NN	NN	_	12	compound	_	_
12	expression	expression	NN	NN	_	8	nmod	_	_
13	and	and	CC	CC	_	8	cc	_	_
14	a	a	DT	DT	_	16	det	_	_
15	significant	significant	JJ	JJ	_	16	amod	_	_
16	inhibition	inhibition	NN	NN	_	8	conj	_	_
17	of	of	IN	IN	_	20	case	_	_
18	IL-1ra	il-1ra	NN	NN	_	19	compound	_	_
19	protein	protein	NN	NN	_	20	compound	_	_
20	secretion	secretion	NN	NN	_	16	nmod	_	_
21	in	in	IN	IN	_	23	case	_	_
22	cell	cell	NN	NN	_	23	compound	_	_
23	cultures	culture	NNS	NNS	_	6	nmod	_	_
24	of	of	IN	IN	_	27	case	_	_
25	human	human	JJ	JJ	_	27	amod	_	_
26	peripheral	peripheral	JJ	JJ	_	27	amod	_	_
27	monocytes	monocyte	NNS	NNS	_	23	nmod	_	_
28	stimulated	stimulate	VBN	VBN	_	27	acl	_	_
29	with	with	IN	IN	_	32	case	_	_
30	the	the	DT	DT	_	32	det	_	_
31	bacterial	bacterial	JJ	JJ	_	32	amod	_	_
32	endotoxin	endotoxin	NN	NN	_	28	nmod	_	_
33	lipopolysaccharide	lipopolysaccharide	NN	NN	_	32	dep	_	_
34	(	(	-LRB-	-LRB-	_	35	punct	_	_
35	LPS	lps	NN	NN	_	33	appos	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	.	.	.	.	_	2	punct	_	_

1	Oral	oral	JJ	JJ	_	2	amod	_	_
2	administration	administration	NN	NN	_	11	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	276	276	CD	CD	_	5	compound	_	_
5	mumol	mumol	NN	NN	_	6	amod	_	_
6	cortisol	cortisol	NN	NN	_	2	nmod	_	_
7	to	to	TO	TO	_	9	case	_	_
8	normal	normal	JJ	JJ	_	9	amod	_	_
9	subjects	subject	NNS	NNS	_	2	nmod	_	_
10	also	also	RB	RB	_	11	advmod	_	_
11	decreased	decrease	VBD	VBD	_	0	root	_	_
12	LPS-induced	lps-induced	JJ	JJ	_	14	amod	_	_
13	IL-1ra	il-1ra	NN	NN	_	14	compound	_	_
14	synthesis	synthesis	NN	NN	_	11	dobj	_	_
15	in	in	IN	IN	_	17	case	_	_
16	cultured	culture	VBN	VBN	_	17	amod	_	_
17	monocytes	monocyte	NNS	NNS	_	14	nmod	_	_
18	.	.	.	.	_	11	punct	_	_

1	By	by	IN	IN	_	2	mark	_	_
2	coincubating	coincubate	VBG	VBG	_	30	advcl	_	_
3	the	the	DT	DT	_	4	det	_	_
4	monocytes	monocyte	NNS	NNS	_	2	dobj	_	_
5	with	with	IN	IN	_	10	case	_	_
6	either	either	CC	CC	_	10	cc:preconj	_	_
7	the	the	DT	DT	_	10	det	_	_
8	mineralocorticoid	mineralocorticoid	NN	NN	_	10	compound	_	_
9	antagonist	antagonist	NN	NN	_	10	compound	_	_
10	spironolactone	spironolactone	NN	NN	_	2	nmod	_	_
11	or	or	CC	CC	_	10	cc	_	_
12	the	the	DT	DT	_	16	det	_	_
13	glucocorticoid	glucocorticoid	NN	NN	_	14	compound	_	_
14	receptor	receptor	NN	NN	_	16	compound	_	_
15	antagonist	antagonist	NN	NN	_	16	compound	_	_
16	RU	ru	NN	NN	_	10	conj	_	_
17	38486	38486	CD	CD	_	16	nummod	_	_
18	,	,	,	,	_	30	punct	_	_
19	the	the	DT	DT	_	23	det	_	_
20	in	in	FW	FW	_	23	amod	_	_
21	vitro	vitro	FW	FW	_	20	dep	_	_
22	cortisol-induced	cortisol-induced	JJ	JJ	_	20	dep	_	_
23	inhibition	inhibition	NN	NN	_	30	nsubjpass	_	_
24	of	of	IN	IN	_	27	case	_	_
25	LPS-stimulated	lps-stimulated	JJ	JJ	_	27	amod	_	_
26	IL-1ra	il-1ra	NN	NN	_	27	compound	_	_
27	secretion	secretion	NN	NN	_	23	nmod	_	_
28	was	be	VBD	VBD	_	30	auxpass	_	_
29	partially	partially	RB	RB	_	30	advmod	_	_
30	reversed	reverse	VBN	VBN	_	0	root	_	_
31	.	.	.	.	_	30	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	mineralocorticoid	mineralocorticoid	NN	NN	_	3	compound	_	_
3	aldosterone	aldosterone	NN	NN	_	4	nsubj	_	_
4	exerted	exert	VBD	VBD	_	0	root	_	_
5	a	a	DT	DT	_	7	det	_	_
6	significant	significant	JJ	JJ	_	7	amod	_	_
7	decrease	decrease	NN	NN	_	4	dobj	_	_
8	in	in	IN	IN	_	12	case	_	_
9	LPS-induced	lps-induced	JJ	JJ	_	12	amod	_	_
10	monocyte	monocyte	NN	NN	_	12	compound	_	_
11	IL-1ra	il-1ra	NN	NN	_	12	compound	_	_
12	secretion	secretion	NN	NN	_	7	nmod	_	_
13	in	in	FW	FW	_	14	compound	_	_
14	vitro	vitro	FW	FW	_	4	advmod	_	_
15	,	,	,	,	_	4	punct	_	_
16	which	which	WDT	WDT	_	18	nsubjpass	_	_
17	was	be	VBD	VBD	_	18	auxpass	_	_
18	blocked	block	VBN	VBN	_	4	dep	_	_
19	by	by	IN	IN	_	20	case	_	_
20	coincubation	coincubation	NN	NN	_	18	nmod	_	_
21	with	with	IN	IN	_	22	case	_	_
22	spironolactone	spironolactone	NN	NN	_	20	nmod	_	_
23	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	addition	addition	NN	NN	_	14	nmod	_	_
3	,	,	,	,	_	14	punct	_	_
4	the	the	DT	DT	_	5	det	_	_
5	expression	expression	NN	NN	_	14	nsubjpass	_	_
6	of	of	IN	IN	_	9	case	_	_
7	mineralocorticoid	mineralocorticoid	NN	NN	_	9	compound	_	_
8	receptor	receptor	NN	NN	_	9	compound	_	_
9	mRNA	mrna	NN	NN	_	5	nmod	_	_
10	in	in	IN	IN	_	12	case	_	_
11	human	human	JJ	JJ	_	12	amod	_	_
12	monocytes	monocyte	NNS	NNS	_	5	nmod	_	_
13	was	be	VBD	VBD	_	14	auxpass	_	_
14	observed	observe	VBN	VBN	_	0	root	_	_
15	by	by	IN	IN	_	16	case	_	_
16	PCR	pcr	NN	NN	_	14	nmod	_	_
17	of	of	IN	IN	_	20	case	_	_
18	reversed	reverse	VBN	VBN	_	20	amod	_	_
19	transcribed	transcribe	VBN	VBN	_	20	amod	_	_
20	RNA	rna	NN	NN	_	16	nmod	_	_
21	.	.	.	.	_	14	punct	_	_

1	Our	we	PRP$	PRP$	_	2	nmod:poss	_	_
2	results	result	NNS	NNS	_	4	nsubj	_	_
3	further	further	RB	RB	_	4	advmod	_	_
4	indicate	indicate	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	8	mark	_	_
6	corticosteroids	corticosteroid	NNS	NNS	_	8	nsubj	_	_
7	physiologically	physiologically	RB	RB	_	8	advmod	_	_
8	control	control	VBP	VBP	_	4	ccomp	_	_
9	the	the	DT	DT	_	11	det	_	_
10	IL-1/IL-1ra	il-1/il-1ra	JJ	JJ	_	11	amod	_	_
11	system	system	NN	NN	_	8	dobj	_	_
12	during	during	IN	IN	_	13	case	_	_
13	inflammatory	inflammatory	JJ	JJ	_	8	nmod	_	_
14	or	or	CC	CC	_	13	cc	_	_
15	immune	immune	JJ	JJ	_	13	conj	_	_
16	processes	process	NNS	NNS	_	13	dep	_	_
17	.	.	.	.	_	4	punct	_	_

1	Moreover	moreover	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	provide	provide	VBP	VBP	_	0	root	_	_
5	evidence	evidence	NN	NN	_	4	dobj	_	_
6	that	that	IN	IN	_	20	mark	_	_
7	,	,	,	,	_	20	punct	_	_
8	in	in	IN	IN	_	9	case	_	_
9	addition	addition	NN	NN	_	20	nmod	_	_
10	to	to	TO	TO	_	14	case	_	_
11	a	a	DT	DT	_	14	det	_	_
12	glucocorticoid	glucocorticoid	NN	NN	_	14	compound	_	_
13	receptor-mediated	receptor-mediated	JJ	JJ	_	14	amod	_	_
14	effect	effect	NN	NN	_	9	nmod	_	_
15	,	,	,	,	_	20	punct	_	_
16	the	the	DT	DT	_	18	det	_	_
17	mineralocorticoid	mineralocorticoid	NN	NN	_	18	compound	_	_
18	receptor	receptor	NN	NN	_	20	nsubjpass	_	_
19	is	be	VBZ	VBZ	_	20	auxpass	_	_
20	involved	involve	VBN	VBN	_	5	ccomp	_	_
21	in	in	IN	IN	_	23	case	_	_
22	the	the	DT	DT	_	23	det	_	_
23	inhibition	inhibition	NN	NN	_	20	nmod	_	_
24	of	of	IN	IN	_	27	case	_	_
25	monocyte	monocyte	NN	NN	_	27	compound	_	_
26	IL-1ra	il-1ra	NN	NN	_	27	compound	_	_
27	secretion	secretion	NN	NN	_	23	nmod	_	_
28	by	by	IN	IN	_	29	case	_	_
29	cortisol	cortisol	NN	NN	_	23	nmod	_	_
30	.	.	.	.	_	4	punct	_	_

1	Distinctive	distinctive	JJ	JJ	_	3	amod	_	_
2	expression	expression	NN	NN	_	3	compound	_	_
3	pattern	pattern	NN	NN	_	0	root	_	_
4	of	of	IN	IN	_	7	case	_	_
5	the	the	DT	DT	_	7	det	_	_
6	BCL-6	bcl-6	NN	NN	_	7	compound	_	_
7	protein	protein	NN	NN	_	3	nmod	_	_
8	in	in	IN	IN	_	14	case	_	_
9	nodular	nodular	JJ	JJ	_	14	amod	_	_
10	lymphocyte	lymphocyte	NN	NN	_	14	compound	_	_
11	predominance	predominance	NN	NN	_	14	compound	_	_
12	Hodgkin	hodgkin	NN	NN	_	14	nmod:poss	_	_
13	's	's	POS	POS	_	14	case	_	_
14	disease	disease	NN	NN	_	3	nmod	_	_
15	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	BCL-6	bcl-6	NN	NN	_	3	compound	_	_
3	gene	gene	NN	NN	_	12	nsubjpass	_	_
4	encoding	encode	VBG	VBG	_	3	acl	_	_
5	a	a	DT	DT	_	10	det	_	_
6	nuclear-located	nuclear-located	JJ	JJ	_	10	amod	_	_
7	Kruppel-type	kruppel-type	JJ	JJ	_	10	amod	_	_
8	zinc	zinc	NN	NN	_	10	compound	_	_
9	finger	finger	NN	NN	_	10	compound	_	_
10	protein	protein	NN	NN	_	4	dobj	_	_
11	is	be	VBZ	VBZ	_	12	auxpass	_	_
12	rearranged	rearrange	VBN	VBN	_	0	root	_	_
13	in	in	IN	IN	_	20	case	_	_
14	about	about	RB	RB	_	15	advmod	_	_
15	30	30	CD	CD	_	16	dep	_	_
16	%	%	NN	NN	_	20	dep	_	_
17	diffuse	diffuse	JJ	JJ	_	20	amod	_	_
18	large	large	JJ	JJ	_	20	amod	_	_
19	B-cell	b-cell	NN	NN	_	20	compound	_	_
20	lymphomas	lymphoma	NNS	NNS	_	12	nmod	_	_
21	and	and	CC	CC	_	12	cc	_	_
22	is	be	VBZ	VBZ	_	23	auxpass	_	_
23	expressed	express	VBN	VBN	_	12	conj	_	_
24	predominantly	predominantly	RB	RB	_	23	advmod	_	_
25	in	in	IN	IN	_	30	case	_	_
26	normal	normal	JJ	JJ	_	30	amod	_	_
27	germinal	germinal	JJ	JJ	_	30	amod	_	_
28	center	center	NN	NN	_	30	compound	_	_
29	B	b	NN	NN	_	30	compound	_	_
30	cells	cell	NNS	NNS	_	23	nmod	_	_
31	and	and	CC	CC	_	30	cc	_	_
32	related	related	JJ	JJ	_	33	amod	_	_
33	lymphomas	lymphoma	NNS	NNS	_	30	conj	_	_
34	.	.	.	.	_	12	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	findings	finding	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	7	mark	_	_
5	BCL-6	bcl-6	NN	NN	_	7	nsubj	_	_
6	may	may	MD	MD	_	7	aux	_	_
7	play	play	VB	VB	_	3	ccomp	_	_
8	a	a	DT	DT	_	9	det	_	_
9	role	role	NN	NN	_	7	dobj	_	_
10	in	in	IN	IN	_	11	mark	_	_
11	regulating	regulate	VBG	VBG	_	7	advcl	_	_
12	differentiation	differentiation	NN	NN	_	11	dobj	_	_
13	of	of	IN	IN	_	18	case	_	_
14	normal	normal	JJ	JJ	_	18	amod	_	_
15	germinal	germinal	JJ	JJ	_	18	amod	_	_
16	center	center	NN	NN	_	18	compound	_	_
17	B	b	NN	NN	_	18	compound	_	_
18	cells	cell	NNS	NNS	_	12	nmod	_	_
19	and	and	CC	CC	_	7	cc	_	_
20	that	that	IN	IN	_	28	mark	_	_
21	its	its	PRP$	PRP$	_	23	nmod:poss	_	_
22	deregulated	deregulate	VBN	VBN	_	23	amod	_	_
23	expression	expression	NN	NN	_	28	nsubj	_	_
24	caused	cause	VBN	VBN	_	23	acl	_	_
25	by	by	IN	IN	_	26	case	_	_
26	rearrangements	rearrangement	NNS	NNS	_	24	nmod	_	_
27	may	may	MD	MD	_	28	aux	_	_
28	contribute	contribute	VB	VB	_	7	conj	_	_
29	to	to	TO	TO	_	30	case	_	_
30	lymphomagenesis	lymphomagenesis	NN	NN	_	28	nmod	_	_
31	.	.	.	.	_	3	punct	_	_

1	This	this	DT	DT	_	2	nsubj	_	_
2	prompted	prompt	VBD	VBD	_	0	root	_	_
3	us	we	PRP	PRP	_	2	dobj	_	_
4	to	to	TO	TO	_	5	mark	_	_
5	investigate	investigate	VB	VB	_	2	xcomp	_	_
6	the	the	DT	DT	_	7	det	_	_
7	expression	expression	NN	NN	_	5	dobj	_	_
8	of	of	IN	IN	_	11	case	_	_
9	the	the	DT	DT	_	11	det	_	_
10	BCL-6	bcl-6	NN	NN	_	11	compound	_	_
11	protein	protein	NN	NN	_	7	nmod	_	_
12	in	in	IN	IN	_	15	case	_	_
13	Hodgkin	hodgkin	NN	NN	_	15	nmod:poss	_	_
14	's	's	POS	POS	_	15	case	_	_
15	disease	disease	NN	NN	_	11	nmod	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	HD	hd	NN	NN	_	15	appos	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	,	,	,	,	_	5	punct	_	_
20	focusing	focus	VBG	VBG	_	5	advcl	_	_
21	on	on	IN	IN	_	26	case	_	_
22	the	the	DT	DT	_	26	det	_	_
23	nodular	nodular	JJ	JJ	_	26	amod	_	_
24	lymphocyte	lymphocyte	NN	NN	_	26	compound	_	_
25	predominance	predominance	NN	NN	_	26	compound	_	_
26	subtype	subtype	NN	NN	_	20	nmod	_	_
27	(	(	-LRB-	-LRB-	_	28	punct	_	_
28	NLPHD	nlphd	NN	NN	_	26	appos	_	_
29	)	)	-RRB-	-RRB-	_	28	punct	_	_
30	,	,	,	,	_	26	punct	_	_
31	which	which	WDT	WDT	_	32	nsubj	_	_
32	differs	differ	VBZ	VBZ	_	26	acl:relcl	_	_
33	from	from	IN	IN	_	35	case	_	_
34	classical	classical	JJ	JJ	_	35	amod	_	_
35	HD	hd	NN	NN	_	32	nmod	_	_
36	by	by	IN	IN	_	37	case	_	_
37	virtue	virtue	NN	NN	_	32	nmod	_	_
38	of	of	IN	IN	_	41	case	_	_
39	the	the	DT	DT	_	41	det	_	_
40	B-cell	b-cell	NN	NN	_	41	compound	_	_
41	nature	nature	NN	NN	_	37	nmod	_	_
42	of	of	IN	IN	_	46	case	_	_
43	the	the	DT	DT	_	46	det	_	_
44	malignant	malignant	JJ	JJ	_	46	amod	_	_
45	cell	cell	NN	NN	_	46	compound	_	_
46	population	population	NN	NN	_	41	nmod	_	_
47	(	(	-LRB-	-LRB-	_	52	punct	_	_
48	so-called	so-called	JJ	JJ	_	52	amod	_	_
49	L	l	NN	NN	_	52	compound	_	_
50	&amp;	&amp;	CC	CC	_	49	cc	_	_
51	H	h	NN	NN	_	49	conj	_	_
52	cells	cell	NNS	NNS	_	46	dep	_	_
53	)	)	-RRB-	-RRB-	_	52	punct	_	_
54	and	and	CC	CC	_	41	cc	_	_
55	its	its	PRP$	PRP$	_	56	nmod:poss	_	_
56	relationship	relationship	NN	NN	_	41	conj	_	_
57	with	with	IN	IN	_	59	case	_	_
58	germinal	germinal	JJ	JJ	_	59	amod	_	_
59	centers	center	NNS	NNS	_	56	nmod	_	_
60	.	.	.	.	_	2	punct	_	_

1	Forty-one	forty-one	CD	CD	_	3	nummod	_	_
2	HD	hd	NN	NN	_	3	compound	_	_
3	samples	sample	NNS	NNS	_	18	nsubjpass	_	_
4	(	(	-LRB-	-LRB-	_	6	punct	_	_
5	19	19	CD	CD	_	6	nummod	_	_
6	NLPHD	nlphd	NN	NN	_	3	dep	_	_
7	,	,	,	,	_	6	punct	_	_
8	12	12	CD	CD	_	10	nummod	_	_
9	nodular	nodular	JJ	JJ	_	10	amod	_	_
10	sclerosis	sclerosis	NN	NN	_	6	conj	_	_
11	,	,	,	,	_	6	punct	_	_
12	and	and	CC	CC	_	6	cc	_	_
13	10	10	CD	CD	_	15	nummod	_	_
14	mixed	mixed	JJ	JJ	_	15	amod	_	_
15	cellularity	cellularity	NN	NN	_	6	conj	_	_
16	)	)	-RRB-	-RRB-	_	6	punct	_	_
17	were	be	VBD	VBD	_	18	auxpass	_	_
18	immunostained	immunostain	VBN	VBN	_	0	root	_	_
19	with	with	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	monoclonal	monoclonal	JJ	JJ	_	22	amod	_	_
22	antibodies	antibody	NNS	NNS	_	18	nmod	_	_
23	PG-B6	pg-b6	NN	NN	_	22	dep	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	PG-B6p	pg-b6p	NN	NN	_	23	conj	_	_
26	that	that	WDT	WDT	_	27	nsubj	_	_
27	react	react	VBP	VBP	_	22	acl:relcl	_	_
28	with	with	IN	IN	_	30	case	_	_
29	a	a	DT	DT	_	30	det	_	_
30	fixative-sensitive	fixative-sensitive	JJ	JJ	_	27	nmod	_	_
31	and	and	CC	CC	_	30	cc	_	_
32	a	a	DT	DT	_	34	det	_	_
33	formalin-resistant	formalin-resistant	JJ	JJ	_	34	amod	_	_
34	epitope	epitope	NN	NN	_	30	conj	_	_
35	on	on	IN	IN	_	38	case	_	_
36	the	the	DT	DT	_	38	det	_	_
37	aminoterminal	aminoterminal	JJ	JJ	_	38	amod	_	_
38	region	region	NN	NN	_	30	nmod	_	_
39	of	of	IN	IN	_	43	case	_	_
40	the	the	DT	DT	_	43	det	_	_
41	BCL-6	bcl-6	NN	NN	_	43	compound	_	_
42	gene	gene	NN	NN	_	43	compound	_	_
43	product	product	NN	NN	_	38	nmod	_	_
44	,	,	,	,	_	27	punct	_	_
45	respectively	respectively	RB	RB	_	27	advmod	_	_
46	.	.	.	.	_	18	punct	_	_

1	Strong	strong	JJ	JJ	_	3	amod	_	_
2	nuclear	nuclear	JJ	JJ	_	3	amod	_	_
3	positivity	positivity	NN	NN	_	9	nsubjpass	_	_
4	for	for	IN	IN	_	7	case	_	_
5	the	the	DT	DT	_	7	det	_	_
6	BCL-6	bcl-6	NN	NN	_	7	compound	_	_
7	protein	protein	NN	NN	_	3	nmod	_	_
8	was	be	VBD	VBD	_	9	auxpass	_	_
9	detected	detect	VBN	VBN	_	0	root	_	_
10	in	in	IN	IN	_	13	case	_	_
11	tumor	tumor	NN	NN	_	13	compound	_	_
12	(	(	-LRB-	-LRB-	_	13	punct	_	_
13	L	l	NN	NN	_	9	nmod	_	_
14	&amp;	&amp;	CC	CC	_	13	cc	_	_
15	H	h	NN	NN	_	17	compound	_	_
16	)	)	-RRB-	-RRB-	_	17	punct	_	_
17	cells	cell	NNS	NNS	_	13	conj	_	_
18	in	in	IN	IN	_	20	case	_	_
19	all	all	DT	DT	_	20	det	_	_
20	cases	case	NNS	NNS	_	13	nmod	_	_
21	of	of	IN	IN	_	22	case	_	_
22	NLPHD	nlphd	NN	NN	_	20	nmod	_	_
23	.	.	.	.	_	9	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	6	nmod	_	_
3	,	,	,	,	_	6	punct	_	_
4	BCL-6	bcl-6	NN	NN	_	6	nsubjpass	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	expressed	express	VBN	VBN	_	0	root	_	_
7	only	only	RB	RB	_	11	advmod	_	_
8	in	in	IN	IN	_	11	case	_	_
9	a	a	DT	DT	_	11	det	_	_
10	small	small	JJ	JJ	_	11	amod	_	_
11	percentage	percentage	NN	NN	_	6	nmod	_	_
12	of	of	IN	IN	_	16	case	_	_
13	Hodgkin	hodgkin	NN	NN	_	16	compound	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	Reed-Sternberg	reed-sternberg	NN	NN	_	13	conj	_	_
16	cells	cell	NNS	NNS	_	11	nmod	_	_
17	in	in	IN	IN	_	20	case	_	_
18	about	about	RB	RB	_	19	advmod	_	_
19	30	30	CD	CD	_	20	nummod	_	_
20	%	%	NN	NN	_	16	nmod	_	_
21	of	of	IN	IN	_	24	case	_	_
22	classical	classical	JJ	JJ	_	24	amod	_	_
23	HD	hd	NN	NN	_	24	compound	_	_
24	cases	case	NNS	NNS	_	20	nmod	_	_
25	.	.	.	.	_	6	punct	_	_

1	Notably	notably	RB	RB	_	24	advmod	_	_
2	,	,	,	,	_	24	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	nuclei	nucleus	NNS	NNS	_	24	nsubj	_	_
5	of	of	IN	IN	_	9	case	_	_
6	reactive	reactive	JJ	JJ	_	9	amod	_	_
7	CD3+/CD4+	cd3+/cd4+	JJ	JJ	_	9	amod	_	_
8	T	t	NN	NN	_	9	compound	_	_
9	cells	cell	NNS	NNS	_	4	nmod	_	_
10	nearby	nearby	JJ	JJ	_	9	amod	_	_
11	to	to	TO	TO	_	10	nmod	_	_
12	and	and	CC	CC	_	10	cc	_	_
13	rosetting	roset	VBG	VBG	_	10	conj	_	_
14	around	around	IN	IN	_	13	nmod	_	_
15	L	l	NN	NN	_	18	compound	_	_
16	&amp;	&amp;	CC	CC	_	15	cc	_	_
17	H	h	NN	NN	_	15	conj	_	_
18	cells	cell	NNS	NNS	_	10	dep	_	_
19	in	in	IN	IN	_	20	case	_	_
20	NLPHD	nlphd	NN	NN	_	18	nmod	_	_
21	were	be	VBD	VBD	_	24	cop	_	_
22	also	also	RB	RB	_	24	advmod	_	_
23	strongly	strongly	RB	RB	_	24	advmod	_	_
24	BCL-6+	bcl-6+	JJ	JJ	_	0	root	_	_
25	,	,	,	,	_	24	punct	_	_
26	but	but	CC	CC	_	24	cc	_	_
27	lacked	lack	VBD	VBD	_	24	conj	_	_
28	CD40	cd40	NN	NN	_	29	compound	_	_
29	ligand	ligand	NN	NN	_	33	compound	_	_
30	(	(	-LRB-	-LRB-	_	31	punct	_	_
31	CD40L	cd40l	NN	NN	_	29	appos	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	expression	expression	NN	NN	_	27	dobj	_	_
34	.	.	.	.	_	24	punct	_	_

1	This	this	DT	DT	_	3	det	_	_
2	staining	staining	NN	NN	_	3	compound	_	_
3	pattern	pattern	NN	NN	_	5	nsubj	_	_
4	clearly	clearly	RB	RB	_	5	advmod	_	_
5	differed	differ	VBD	VBD	_	0	root	_	_
6	from	from	IN	IN	_	7	case	_	_
7	that	that	DT	DT	_	5	nmod	_	_
8	of	of	IN	IN	_	10	case	_	_
9	classical	classical	JJ	JJ	_	10	amod	_	_
10	HD	hd	NN	NN	_	7	nmod	_	_
11	,	,	,	,	_	10	punct	_	_
12	whose	whose	WP$	WP$	_	14	nmod:poss	_	_
13	cellular	cellular	JJ	JJ	_	14	amod	_	_
14	background	background	NN	NN	_	16	nsubjpass	_	_
15	was	be	VBD	VBD	_	16	auxpass	_	_
16	made	make	VBN	VBN	_	10	acl:relcl	_	_
17	up	up	IN	IN	_	16	compound:prt	_	_
18	of	of	IN	IN	_	21	case	_	_
19	CD3+/CD4+	cd3+/cd4+	JJ	JJ	_	21	amod	_	_
20	T	t	NN	NN	_	21	compound	_	_
21	cells	cell	NNS	NNS	_	16	nmod	_	_
22	showing	show	VBG	VBG	_	21	acl	_	_
23	the	the	DT	DT	_	25	det	_	_
24	BCL-6-/CD40L+	bcl-6-/cd40l+	JJ	JJ	_	25	amod	_	_
25	phenotype	phenotype	NN	NN	_	22	dobj	_	_
26	.	.	.	.	_	5	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	4	nsubj	_	_
3	further	further	RBR	RBR	_	4	advmod	_	_
4	support	support	VBP	VBP	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	concept	concept	NN	NN	_	4	dobj	_	_
7	that	that	IN	IN	_	15	mark	_	_
8	NLPHD	nlphd	NN	NN	_	15	nsubj	_	_
9	is	be	VBZ	VBZ	_	15	cop	_	_
10	an	a	DT	DT	_	15	det	_	_
11	histogenetically	histogenetically	RB	RB	_	12	advmod	_	_
12	distinct	distinct	JJ	JJ	_	15	amod	_	_
13	,	,	,	,	_	12	punct	_	_
14	B-cell-derived	b-cell-derived	JJ	JJ	_	12	dep	_	_
15	subtype	subtype	NN	NN	_	6	ccomp	_	_
16	of	of	IN	IN	_	17	case	_	_
17	HD	hd	NN	NN	_	15	nmod	_	_
18	and	and	CC	CC	_	4	cc	_	_
19	suggest	suggest	VBP	VBP	_	4	conj	_	_
20	a	a	DT	DT	_	21	det	_	_
21	role	role	NN	NN	_	19	dobj	_	_
22	for	for	IN	IN	_	23	case	_	_
23	BCL-6	bcl-6	NN	NN	_	21	nmod	_	_
24	in	in	IN	IN	_	26	case	_	_
25	its	its	PRP$	PRP$	_	26	nmod:poss	_	_
26	development	development	NN	NN	_	21	nmod	_	_
27	.	.	.	.	_	4	punct	_	_

1	MEK1	mek1	NN	NN	_	8	nsubjpass	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	the	the	DT	DT	_	6	det	_	_
4	extracellular	extracellular	JJ	JJ	_	6	amod	_	_
5	signal-regulated	signal-regulated	JJ	JJ	_	6	amod	_	_
6	kinases	kinase	NNS	NNS	_	1	conj	_	_
7	are	be	VBP	VBP	_	8	auxpass	_	_
8	required	require	VBN	VBN	_	0	root	_	_
9	for	for	IN	IN	_	11	case	_	_
10	the	the	DT	DT	_	11	det	_	_
11	stimulation	stimulation	NN	NN	_	8	nmod	_	_
12	of	of	IN	IN	_	15	case	_	_
13	IL-2	il-2	NN	NN	_	14	compound	_	_
14	gene	gene	NN	NN	_	15	compound	_	_
15	transcription	transcription	NN	NN	_	11	nmod	_	_
16	in	in	IN	IN	_	18	case	_	_
17	T	t	NN	NN	_	18	compound	_	_
18	cells	cell	NNS	NNS	_	15	nmod	_	_
19	.	.	.	.	_	8	punct	_	_

1	TCR	tcr	NN	NN	_	2	compound	_	_
2	engagement	engagement	NN	NN	_	3	nsubj	_	_
3	stimulates	stimulate	VBZ	VBZ	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	activation	activation	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	9	case	_	_
7	the	the	DT	DT	_	9	det	_	_
8	protein	protein	NN	NN	_	9	compound	_	_
9	kinase	kinase	NN	NN	_	5	nmod	_	_
10	Raf-1	raf-1	NN	NN	_	9	dep	_	_
11	.	.	.	.	_	3	punct	_	_

1	Active	active	JJ	JJ	_	2	amod	_	_
2	Raf-1	raf-1	NN	NN	_	3	nsubj	_	_
3	phosphorylates	phosphorylate	VBZ	VBZ	_	0	root	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	activates	activate	VBZ	VBZ	_	3	conj	_	_
6	the	the	DT	DT	_	15	det	_	_
7	mitogen-activated	mitogen-activated	JJ	JJ	_	15	amod	_	_
8	protein	protein	NN	NN	_	15	compound	_	_
9	(	(	-LRB-	-LRB-	_	15	punct	_	_
10	MAP	map	NN	NN	_	15	compound	_	_
11	)	)	-RRB-	-RRB-	_	15	punct	_	_
12	kinase/extracellular	kinase/extracellular	JJ	JJ	_	15	amod	_	_
13	signal-regulated	signal-regulated	JJ	JJ	_	15	amod	_	_
14	kinase	kinase	NN	NN	_	15	compound	_	_
15	kinase	kinase	NN	NN	_	3	dobj	_	_
16	1	1	CD	CD	_	15	nummod	_	_
17	(	(	-LRB-	-LRB-	_	18	punct	_	_
18	MEK1	mek1	NN	NN	_	15	appos	_	_
19	)	)	-RRB-	-RRB-	_	18	punct	_	_
20	,	,	,	,	_	3	punct	_	_
21	which	which	WDT	WDT	_	24	nsubj	_	_
22	in	in	IN	IN	_	23	case	_	_
23	turn	turn	NN	NN	_	24	nmod	_	_
24	phosphorylates	phosphorylate	VBZ	VBZ	_	3	dep	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	activates	activate	VBZ	VBZ	_	24	conj	_	_
27	the	the	DT	DT	_	32	det	_	_
28	MAP	map	NN	NN	_	32	compound	_	_
29	kinases/extracellular	kinases/extracellular	JJ	JJ	_	32	amod	_	_
30	signal	signal	NN	NN	_	32	compound	_	_
31	regulated	regulated	JJ	JJ	_	32	amod	_	_
32	kinases	kinase	NNS	NNS	_	24	dobj	_	_
33	,	,	,	,	_	32	punct	_	_
34	ERK1	erk1	NN	NN	_	32	appos	_	_
35	and	and	CC	CC	_	34	cc	_	_
36	ERK2	erk2	NN	NN	_	34	conj	_	_
37	.	.	.	.	_	3	punct	_	_

1	Raf-1	raf-1	NN	NN	_	2	compound	_	_
2	activity	activity	NN	NN	_	3	nsubj	_	_
3	promotes	promote	VBZ	VBZ	_	0	root	_	_
4	IL-2	il-2	NN	NN	_	5	compound	_	_
5	production	production	NN	NN	_	3	dobj	_	_
6	in	in	IN	IN	_	9	case	_	_
7	activated	activate	VBN	VBN	_	9	amod	_	_
8	T	t	NN	NN	_	9	compound	_	_
9	lymphocytes	lymphocyte	NNS	NNS	_	5	nmod	_	_
10	.	.	.	.	_	3	punct	_	_

1	Therefore	therefore	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	we	we	PRP	PRP	_	4	nsubj	_	_
4	sought	seek	VBD	VBD	_	0	root	_	_
5	to	to	TO	TO	_	6	mark	_	_
6	determine	determine	VB	VB	_	4	xcomp	_	_
7	whether	whether	IN	IN	_	13	mark	_	_
8	MEK1	mek1	NN	NN	_	13	nsubj	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	ERK	erk	NN	NN	_	8	conj	_	_
11	activities	activity	NNS	NNS	_	8	dep	_	_
12	also	also	RB	RB	_	13	advmod	_	_
13	stimulate	stimulate	VBP	VBP	_	6	ccomp	_	_
14	IL-2	il-2	NN	NN	_	15	compound	_	_
15	gene	gene	NN	NN	_	16	compound	_	_
16	transcription	transcription	NN	NN	_	13	dobj	_	_
17	.	.	.	.	_	4	punct	_	_

1	Expression	expression	NN	NN	_	12	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	constitutively	constitutively	RB	RB	_	4	advmod	_	_
4	active	active	JJ	JJ	_	5	amod	_	_
5	Raf-1	raf-1	NN	NN	_	1	nmod	_	_
6	or	or	CC	CC	_	5	cc	_	_
7	MEK1	mek1	NN	NN	_	5	conj	_	_
8	in	in	IN	IN	_	11	case	_	_
9	Jurkat	jurkat	NN	NN	_	11	compound	_	_
10	T	t	NN	NN	_	11	compound	_	_
11	cells	cell	NNS	NNS	_	1	nmod	_	_
12	enhanced	enhance	VBD	VBD	_	0	root	_	_
13	the	the	DT	DT	_	14	det	_	_
14	stimulation	stimulation	NN	NN	_	12	dobj	_	_
15	of	of	IN	IN	_	18	case	_	_
16	IL-2	il-2	NN	NN	_	18	compound	_	_
17	promoter-driven	promoter-driven	JJ	JJ	_	18	amod	_	_
18	transcription	transcription	NN	NN	_	14	nmod	_	_
19	stimulated	stimulate	VBN	VBN	_	18	acl	_	_
20	by	by	IN	IN	_	23	case	_	_
21	a	a	DT	DT	_	23	det	_	_
22	calcium	calcium	NN	NN	_	23	compound	_	_
23	ionophore	ionophore	NN	NN	_	19	nmod	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	PMA	pma	NN	NN	_	23	conj	_	_
26	,	,	,	,	_	12	punct	_	_
27	and	and	CC	CC	_	12	cc	_	_
28	together	together	RB	RB	_	32	advmod	_	_
29	with	with	IN	IN	_	32	case	_	_
30	a	a	DT	DT	_	32	det	_	_
31	calcium	calcium	NN	NN	_	32	compound	_	_
32	ionophore	ionophore	NN	NN	_	39	nmod	_	_
33	the	the	DT	DT	_	34	det	_	_
34	expression	expression	NN	NN	_	39	nsubj	_	_
35	of	of	IN	IN	_	37	case	_	_
36	each	each	DT	DT	_	37	det	_	_
37	protein	protein	NN	NN	_	34	nmod	_	_
38	was	be	VBD	VBD	_	39	cop	_	_
39	sufficient	sufficient	JJ	JJ	_	12	conj	_	_
40	to	to	TO	TO	_	41	mark	_	_
41	stimulate	stimulate	VB	VB	_	39	xcomp	_	_
42	NF-AT	nf-at	NN	NN	_	43	compound	_	_
43	activity	activity	NN	NN	_	41	dobj	_	_
44	.	.	.	.	_	12	punct	_	_

1	Expression	expression	NN	NN	_	5	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	MEK1-interfering	mek1-interfering	JJ	JJ	_	4	amod	_	_
4	mutants	mutant	NNS	NNS	_	1	nmod	_	_
5	inhibited	inhibit	VBD	VBD	_	0	root	_	_
6	the	the	DT	DT	_	7	det	_	_
7	stimulation	stimulation	NN	NN	_	5	dobj	_	_
8	of	of	IN	IN	_	11	case	_	_
9	IL-2	il-2	NN	NN	_	11	compound	_	_
10	promoter-driven	promoter-driven	JJ	JJ	_	11	amod	_	_
11	transcription	transcription	NN	NN	_	7	nmod	_	_
12	and	and	CC	CC	_	5	cc	_	_
13	blocked	block	VBD	VBD	_	5	conj	_	_
14	the	the	DT	DT	_	15	det	_	_
15	ability	ability	NN	NN	_	13	dobj	_	_
16	of	of	IN	IN	_	19	case	_	_
17	constitutively	constitutively	RB	RB	_	18	advmod	_	_
18	active	active	JJ	JJ	_	19	amod	_	_
19	Ras	ras	NN	NN	_	15	nmod	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	Raf-1	raf-1	NN	NN	_	19	conj	_	_
22	to	to	TO	TO	_	23	mark	_	_
23	costimulate	costimulate	VB	VB	_	15	acl	_	_
24	NF-AT	nf-at	NN	NN	_	25	compound	_	_
25	activity	activity	NN	NN	_	23	dobj	_	_
26	with	with	IN	IN	_	29	case	_	_
27	a	a	DT	DT	_	29	det	_	_
28	calcium	calcium	NN	NN	_	29	compound	_	_
29	ionophore	ionophore	NN	NN	_	23	nmod	_	_
30	.	.	.	.	_	5	punct	_	_

1	Expression	expression	NN	NN	_	15	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	MAP	map	NN	NN	_	6	compound	_	_
5	kinase-specific	kinase-specific	JJ	JJ	_	6	amod	_	_
6	phosphatase	phosphatase	NN	NN	_	1	nmod	_	_
7	,	,	,	,	_	6	punct	_	_
8	MKP-1	mkp-1	NN	NN	_	6	appos	_	_
9	,	,	,	,	_	6	punct	_	_
10	which	which	WDT	WDT	_	11	nsubj	_	_
11	blocks	block	VBZ	VBZ	_	6	acl:relcl	_	_
12	ERK	erk	NN	NN	_	13	compound	_	_
13	activation	activation	NN	NN	_	11	dobj	_	_
14	,	,	,	,	_	1	punct	_	_
15	inhibited	inhibit	VBD	VBD	_	0	root	_	_
16	IL-2	il-2	NN	NN	_	17	compound	_	_
17	promoter	promoter	NN	NN	_	15	dobj	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	NF-AT-driven	nf-at-driven	JJ	JJ	_	20	amod	_	_
20	transcription	transcription	NN	NN	_	17	conj	_	_
21	stimulated	stimulate	VBN	VBN	_	17	acl	_	_
22	by	by	IN	IN	_	25	case	_	_
23	a	a	DT	DT	_	25	det	_	_
24	calcium	calcium	NN	NN	_	25	compound	_	_
25	ionophore	ionophore	NN	NN	_	21	nmod	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	PMA	pma	NN	NN	_	25	conj	_	_
28	,	,	,	,	_	15	punct	_	_
29	and	and	CC	CC	_	15	cc	_	_
30	in	in	IN	IN	_	31	case	_	_
31	addition	addition	NN	NN	_	34	nmod	_	_
32	,	,	,	,	_	34	punct	_	_
33	MKP-1	mkp-1	NN	NN	_	34	nsubj	_	_
34	neutralized	neutralize	VBD	VBD	_	15	conj	_	_
35	the	the	DT	DT	_	37	det	_	_
36	transcriptional	transcriptional	JJ	JJ	_	37	amod	_	_
37	enhancement	enhancement	NN	NN	_	34	dobj	_	_
38	caused	cause	VBN	VBN	_	37	acl	_	_
39	by	by	IN	IN	_	41	case	_	_
40	active	active	JJ	JJ	_	41	amod	_	_
41	Raf-1	raf-1	NN	NN	_	38	nmod	_	_
42	and	and	CC	CC	_	41	cc	_	_
43	MEK1	mek1	NN	NN	_	41	conj	_	_
44	expression	expression	NN	NN	_	41	dep	_	_
45	.	.	.	.	_	15	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	conclude	conclude	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	20	mark	_	_
4	the	the	DT	DT	_	9	det	_	_
5	MAP	map	NN	NN	_	6	compound	_	_
6	kinase	kinase	NN	NN	_	9	compound	_	_
7	signal	signal	NN	NN	_	9	compound	_	_
8	transduction	transduction	NN	NN	_	9	compound	_	_
9	pathway	pathway	NN	NN	_	20	nsubj	_	_
10	consisting	consist	VBG	VBG	_	9	acl	_	_
11	of	of	IN	IN	_	12	case	_	_
12	Raf-1	raf-1	NN	NN	_	10	nmod	_	_
13	,	,	,	,	_	12	punct	_	_
14	MEK1	mek1	NN	NN	_	12	appos	_	_
15	,	,	,	,	_	12	punct	_	_
16	and	and	CC	CC	_	12	cc	_	_
17	ERK1	erk1	NN	NN	_	12	conj	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	ERK2	erk2	NN	NN	_	17	conj	_	_
20	functions	function	VBZ	VBZ	_	2	ccomp	_	_
21	in	in	IN	IN	_	26	case	_	_
22	the	the	DT	DT	_	26	det	_	_
23	stimulation	stimulation	NN	NN	_	26	compound	_	_
24	IL-2	il-2	NN	NN	_	25	compound	_	_
25	gene	gene	NN	NN	_	26	compound	_	_
26	transcription	transcription	NN	NN	_	20	nmod	_	_
27	in	in	IN	IN	_	30	case	_	_
28	activated	activate	VBN	VBN	_	30	amod	_	_
29	T	t	NN	NN	_	30	compound	_	_
30	lymphocytes	lymphocyte	NNS	NNS	_	26	nmod	_	_
31	.	.	.	.	_	2	punct	_	_

1	HIV	hiv	NN	NN	_	2	compound	_	_
2	glycoprotein	glycoprotein	NN	NN	_	4	nsubj	_	_
3	120	120	CD	CD	_	2	nummod	_	_
4	enhances	enhance	VBZ	VBZ	_	0	root	_	_
5	intercellular	intercellular	JJ	JJ	_	7	amod	_	_
6	adhesion	adhesion	NN	NN	_	7	compound	_	_
7	molecule-1	molecule-1	NN	NN	_	9	compound	_	_
8	gene	gene	NN	NN	_	9	compound	_	_
9	expression	expression	NN	NN	_	4	dobj	_	_
10	in	in	IN	IN	_	12	case	_	_
11	glial	glial	JJ	JJ	_	12	amod	_	_
12	cells	cell	NNS	NNS	_	9	nmod	_	_
13	.	.	.	.	_	4	punct	_	_

1	Involvement	involvement	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	5	case	_	_
3	Janus	janus	NN	NN	_	5	compound	_	_
4	kinase/signal	kinase/signal	JJ	JJ	_	5	amod	_	_
5	transducer	transducer	NN	NN	_	1	nmod	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	activator	activator	NN	NN	_	9	compound	_	_
8	of	of	IN	IN	_	9	amod	_	_
9	transcription	transcription	NN	NN	_	5	conj	_	_
10	and	and	CC	CC	_	1	cc	_	_
11	protein	protein	NN	NN	_	13	compound	_	_
12	kinase	kinase	NN	NN	_	13	compound	_	_
13	C	c	NN	NN	_	15	compound	_	_
14	signaling	signaling	NN	NN	_	15	compound	_	_
15	pathways	pathway	NNS	NNS	_	1	conj	_	_
16	.	.	.	.	_	1	punct	_	_

1	It	it	PRP	PRP	_	4	nsubjpass	_	_
2	is	be	VBZ	VBZ	_	4	auxpass	_	_
3	well	well	RB	RB	_	4	advmod	_	_
4	established	establish	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	26	mark	_	_
6	the	the	DT	DT	_	10	det	_	_
7	two	two	CD	CD	_	10	nummod	_	_
8	major	major	JJ	JJ	_	10	amod	_	_
9	glial	glial	JJ	JJ	_	10	amod	_	_
10	cells	cell	NNS	NNS	_	26	nsubj	_	_
11	in	in	IN	IN	_	15	case	_	_
12	the	the	DT	DT	_	15	det	_	_
13	central	central	JJ	JJ	_	15	amod	_	_
14	nervous	nervous	JJ	JJ	_	15	amod	_	_
15	system	system	NN	NN	_	10	nmod	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	CNS	cns	NN	NN	_	15	appos	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	,	,	,	,	_	10	punct	_	_
20	astrocytes	astrocyte	NNS	NNS	_	10	appos	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	microglia	microglia	NN	NN	_	20	conj	_	_
23	,	,	,	,	_	10	punct	_	_
24	are	be	VBP	VBP	_	26	cop	_	_
25	key	key	JJ	JJ	_	26	amod	_	_
26	participants	participant	NNS	NNS	_	4	ccomp	_	_
27	in	in	IN	IN	_	28	mark	_	_
28	mediating	mediate	VBG	VBG	_	26	acl	_	_
29	the	the	DT	DT	_	31	det	_	_
30	neurologic	neurologic	JJ	JJ	_	31	amod	_	_
31	dysfunction	dysfunction	NN	NN	_	28	dobj	_	_
32	associated	associate	VBN	VBN	_	31	acl	_	_
33	with	with	IN	IN	_	35	case	_	_
34	HIV	hiv	NN	NN	_	35	compound	_	_
35	infection	infection	NN	NN	_	32	nmod	_	_
36	of	of	IN	IN	_	38	case	_	_
37	the	the	DT	DT	_	38	det	_	_
38	CNS	cns	NN	NN	_	35	nmod	_	_
39	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	study	study	NN	NN	_	6	nmod	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	investigated	investigate	VBD	VBD	_	0	root	_	_
7	the	the	DT	DT	_	8	det	_	_
8	ability	ability	NN	NN	_	6	dobj	_	_
9	of	of	IN	IN	_	13	case	_	_
10	the	the	DT	DT	_	13	det	_	_
11	major	major	JJ	JJ	_	13	amod	_	_
12	envelope	envelope	NN	NN	_	13	compound	_	_
13	glycoprotein	glycoprotein	NN	NN	_	8	nmod	_	_
14	of	of	IN	IN	_	15	case	_	_
15	HIV	hiv	NN	NN	_	13	nmod	_	_
16	,	,	,	,	_	13	punct	_	_
17	glycoprotein	glycoprotein	NN	NN	_	13	dep	_	_
18	120	120	CD	CD	_	17	nummod	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	gp120	gp120	NN	NN	_	17	appos	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	,	,	,	,	_	8	punct	_	_
23	to	to	TO	TO	_	24	mark	_	_
24	regulate	regulate	VB	VB	_	8	acl	_	_
25	intercellular	intercellular	JJ	JJ	_	27	amod	_	_
26	adhesion	adhesion	NN	NN	_	27	compound	_	_
27	molecule-1	molecule-1	NN	NN	_	31	compound	_	_
28	(	(	-LRB-	-LRB-	_	29	punct	_	_
29	ICAM-1	icam-1	NN	NN	_	27	appos	_	_
30	)	)	-RRB-	-RRB-	_	29	punct	_	_
31	expression	expression	NN	NN	_	24	dobj	_	_
32	in	in	IN	IN	_	34	case	_	_
33	glial	glial	JJ	JJ	_	34	amod	_	_
34	cells	cell	NNS	NNS	_	31	nmod	_	_
35	,	,	,	,	_	6	punct	_	_
36	because	because	IN	IN	_	39	mark	_	_
37	ICAM-1	icam-1	NN	NN	_	39	nsubj	_	_
38	is	be	VBZ	VBZ	_	39	cop	_	_
39	important	important	JJ	JJ	_	6	advcl	_	_
40	in	in	IN	IN	_	41	mark	_	_
41	mediating	mediate	VBG	VBG	_	39	advcl	_	_
42	immune	immune	JJ	JJ	_	43	amod	_	_
43	responsiveness	responsiveness	NN	NN	_	41	dobj	_	_
44	in	in	IN	IN	_	46	case	_	_
45	the	the	DT	DT	_	46	det	_	_
46	CNS	cns	NN	NN	_	43	nmod	_	_
47	,	,	,	,	_	41	punct	_	_
48	facilitating	facilitate	VBG	VBG	_	41	conj	_	_
49	entry	entry	NN	NN	_	48	dobj	_	_
50	of	of	IN	IN	_	52	case	_	_
51	HIV-infected	hiv-infected	JJ	JJ	_	52	amod	_	_
52	cells	cell	NNS	NNS	_	49	nmod	_	_
53	into	into	IN	IN	_	55	case	_	_
54	the	the	DT	DT	_	55	det	_	_
55	CNS	cns	NN	NN	_	49	nmod	_	_
56	,	,	,	,	_	41	punct	_	_
57	and	and	CC	CC	_	41	cc	_	_
58	promoting	promote	VBG	VBG	_	41	conj	_	_
59	syncytia	syncytia	NN	NN	_	60	compound	_	_
60	formation	formation	NN	NN	_	58	dobj	_	_
61	.	.	.	.	_	6	punct	_	_

1	Our	we	PRP$	PRP$	_	2	nmod:poss	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	6	mark	_	_
5	gp120	gp120	NN	NN	_	6	nsubj	_	_
6	enhances	enhance	VBZ	VBZ	_	3	ccomp	_	_
7	ICAM-1	icam-1	NN	NN	_	9	compound	_	_
8	gene	gene	NN	NN	_	9	compound	_	_
9	expression	expression	NN	NN	_	6	dobj	_	_
10	in	in	IN	IN	_	13	case	_	_
11	primary	primary	JJ	JJ	_	13	amod	_	_
12	rat	rat	NN	NN	_	13	compound	_	_
13	astrocytes	astrocyte	NNS	NNS	_	9	nmod	_	_
14	,	,	,	,	_	13	punct	_	_
15	primary	primary	JJ	JJ	_	17	amod	_	_
16	human	human	JJ	JJ	_	17	amod	_	_
17	astrocytes	astrocyte	NNS	NNS	_	13	conj	_	_
18	,	,	,	,	_	13	punct	_	_
19	a	a	DT	DT	_	24	det	_	_
20	human	human	JJ	JJ	_	24	amod	_	_
21	astroglioma	astroglioma	NN	NN	_	24	compound	_	_
22	cell	cell	NN	NN	_	24	compound	_	_
23	line	line	NN	NN	_	24	compound	_	_
24	CRT	crt	NN	NN	_	13	conj	_	_
25	,	,	,	,	_	13	punct	_	_
26	and	and	CC	CC	_	13	cc	_	_
27	primary	primary	JJ	JJ	_	29	amod	_	_
28	rat	rat	NN	NN	_	29	compound	_	_
29	microglia	microglium	NNS	NNS	_	13	conj	_	_
30	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	signal	signal	NN	NN	_	4	compound	_	_
3	transduction	transduction	NN	NN	_	4	compound	_	_
4	events	event	NNS	NNS	_	11	nsubj	_	_
5	involved	involve	VBN	VBN	_	4	acl	_	_
6	in	in	IN	IN	_	8	case	_	_
7	gp120-mediated	gp120-mediated	JJ	JJ	_	8	amod	_	_
8	enhancement	enhancement	NN	NN	_	5	nmod	_	_
9	of	of	IN	IN	_	10	case	_	_
10	ICAM-1	icam-1	NN	NN	_	8	nmod	_	_
11	appear	appear	VBP	VBP	_	0	root	_	_
12	to	to	TO	TO	_	13	mark	_	_
13	involve	involve	VB	VB	_	11	xcomp	_	_
14	activation	activation	NN	NN	_	13	dobj	_	_
15	of	of	IN	IN	_	19	case	_	_
16	both	both	CC	CC	_	19	cc:preconj	_	_
17	protein	protein	NN	NN	_	19	compound	_	_
18	kinase	kinase	NN	NN	_	19	compound	_	_
19	C	c	NN	NN	_	14	nmod	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	tyrosine	tyrosine	NN	NN	_	22	compound	_	_
22	kinase	kinase	NN	NN	_	19	conj	_	_
23	,	,	,	,	_	11	punct	_	_
24	because	because	IN	IN	_	33	mark	_	_
25	inhibitors	inhibitor	NNS	NNS	_	33	nsubj	_	_
26	of	of	IN	IN	_	29	case	_	_
27	protein	protein	NN	NN	_	29	compound	_	_
28	kinase	kinase	NN	NN	_	29	compound	_	_
29	C	c	NN	NN	_	25	nmod	_	_
30	and	and	CC	CC	_	29	cc	_	_
31	tyrosine	tyrosine	NN	NN	_	32	compound	_	_
32	kinase	kinase	NN	NN	_	29	conj	_	_
33	abrogate	abrogate	VBP	VBP	_	11	advcl	_	_
34	gp120-mediated	gp120-mediated	JJ	JJ	_	36	amod	_	_
35	ICAM-1	icam-1	NN	NN	_	36	compound	_	_
36	expression	expression	NN	NN	_	33	dobj	_	_
37	in	in	IN	IN	_	39	case	_	_
38	both	both	CC	CC	_	39	cc:preconj	_	_
39	astrocytes	astrocyte	NNS	NNS	_	36	nmod	_	_
40	and	and	CC	CC	_	39	cc	_	_
41	microglia	microglium	NNS	NNS	_	39	conj	_	_
42	.	.	.	.	_	11	punct	_	_

1	Moreover	moreover	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	gp120	gp120	NN	NN	_	4	nsubj	_	_
4	induces	induce	VBZ	VBZ	_	0	root	_	_
5	tyrosine	tyrosine	NN	NN	_	6	compound	_	_
6	phosphorylation	phosphorylation	NN	NN	_	4	dobj	_	_
7	of	of	IN	IN	_	9	case	_	_
8	signal	signal	NN	NN	_	9	compound	_	_
9	transducer	transducer	NN	NN	_	6	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	activator	activator	NN	NN	_	13	compound	_	_
12	of	of	IN	IN	_	13	amod	_	_
13	transcription	transcription	NN	NN	_	9	conj	_	_
14	(	(	-LRB-	-LRB-	_	16	punct	_	_
15	STAT-1	stat-1	NN	NN	_	16	compound	_	_
16	alpha	alpha	NN	NN	_	9	appos	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	as	as	RB	RB	_	9	cc	_	_
19	well	well	RB	RB	_	18	mwe	_	_
20	as	as	IN	IN	_	18	mwe	_	_
21	the	the	DT	DT	_	23	det	_	_
22	Janus	janus	NN	NN	_	23	compound	_	_
23	kinase	kinase	NN	NN	_	9	conj	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	JAK2	jak2	NN	NN	_	23	appos	_	_
26	)	)	-RRB-	-RRB-	_	25	punct	_	_
27	in	in	IN	IN	_	29	case	_	_
28	glial	glial	JJ	JJ	_	29	amod	_	_
29	cells	cell	NNS	NNS	_	23	nmod	_	_
30	.	.	.	.	_	4	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	8	mark	_	_
5	gp120-mediated	gp120-mediated	JJ	JJ	_	7	amod	_	_
6	ICAM-1	icam-1	NN	NN	_	7	compound	_	_
7	expression	expression	NN	NN	_	8	nsubj	_	_
8	has	have	VBZ	VBZ	_	3	ccomp	_	_
9	functional	functional	JJ	JJ	_	10	amod	_	_
10	significance	significance	NN	NN	_	8	dobj	_	_
11	,	,	,	,	_	8	punct	_	_
12	as	as	IN	IN	_	14	dep	_	_
13	it	it	PRP	PRP	_	14	dep	_	_
14	enhances	enhance	VBZ	VBZ	_	8	advcl	_	_
15	the	the	DT	DT	_	16	det	_	_
16	ability	ability	NN	NN	_	14	dobj	_	_
17	of	of	IN	IN	_	19	case	_	_
18	monocytic	monocytic	JJ	JJ	_	19	amod	_	_
19	cells	cell	NNS	NNS	_	16	nmod	_	_
20	to	to	TO	TO	_	21	mark	_	_
21	bind	bind	VB	VB	_	16	acl	_	_
22	to	to	TO	TO	_	25	case	_	_
23	gp120-stimulated	gp120-stimulated	JJ	JJ	_	25	amod	_	_
24	human	human	JJ	JJ	_	25	amod	_	_
25	astrocytes	astrocyte	NNS	NNS	_	21	nmod	_	_
26	in	in	IN	IN	_	31	case	_	_
27	an	a	DT	DT	_	31	det	_	_
28	ICAM-1/beta	icam-1/beta	NN	NN	_	31	compound	_	_
29	2	2	CD	CD	_	31	nummod	_	_
30	integrin-dependent	integrin-dependent	JJ	JJ	_	31	amod	_	_
31	fashion	fashion	NN	NN	_	21	nmod	_	_
32	.	.	.	.	_	3	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	provide	provide	VBP	VBP	_	0	root	_	_
4	new	new	JJ	JJ	_	5	amod	_	_
5	insights	insight	NNS	NNS	_	3	dobj	_	_
6	into	into	IN	IN	_	10	mark	_	_
7	how	how	WRB	WRB	_	10	advmod	_	_
8	gp120	gp120	NN	NN	_	10	nsubj	_	_
9	can	can	MD	MD	_	10	aux	_	_
10	influence	influence	VB	VB	_	5	acl	_	_
11	the	the	DT	DT	_	12	det	_	_
12	involvement	involvement	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	15	case	_	_
14	glial	glial	JJ	JJ	_	15	amod	_	_
15	cells	cell	NNS	NNS	_	12	nmod	_	_
16	in	in	IN	IN	_	18	case	_	_
17	the	the	DT	DT	_	18	det	_	_
18	pathogenesis	pathogenesis	NN	NN	_	12	nmod	_	_
19	of	of	IN	IN	_	22	case	_	_
20	AIDS	aids	NN	NN	_	22	compound	_	_
21	dementia	dementia	JJ	JJ	_	22	amod	_	_
22	complex	complex	NN	NN	_	18	nmod	_	_
23	.	.	.	.	_	3	punct	_	_

1	Inhibition	inhibition	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	6	case	_	_
3	NF-AT	nf-at	NN	NN	_	6	compound	_	_
4	signal	signal	NN	NN	_	6	compound	_	_
5	transduction	transduction	NN	NN	_	6	compound	_	_
6	events	event	NNS	NNS	_	1	nmod	_	_
7	by	by	IN	IN	_	10	case	_	_
8	a	a	DT	DT	_	10	det	_	_
9	dominant-negative	dominant-negative	JJ	JJ	_	10	amod	_	_
10	form	form	NN	NN	_	1	nmod	_	_
11	of	of	IN	IN	_	12	case	_	_
12	calcineurin	calcineurin	NN	NN	_	10	nmod	_	_
13	.	.	.	.	_	1	punct	_	_

1	An	a	DT	DT	_	7	det	_	_
2	inhibitory	inhibitory	JJ	JJ	_	7	amod	_	_
3	,	,	,	,	_	2	punct	_	_
4	``	``	``	``	_	2	punct	_	_
5	dominant-negative	dominant-negative	JJ	JJ	_	2	dep	_	_
6	,	,	,	,	_	2	punct	_	_
7	form	form	NN	NN	_	17	nsubjpass	_	_
8	of	of	IN	IN	_	15	case	_	_
9	the	the	DT	DT	_	15	det	_	_
10	calcineurin	calcineurin	NN	NN	_	15	compound	_	_
11	catalytic	catalytic	JJ	JJ	_	15	amod	_	_
12	(	(	-LRB-	-LRB-	_	15	punct	_	_
13	A	a	NN	NN	_	15	compound	_	_
14	)	)	-RRB-	-RRB-	_	15	punct	_	_
15	subunit	subunit	NN	NN	_	7	nmod	_	_
16	was	be	VBD	VBD	_	17	auxpass	_	_
17	prepared	prepare	VBN	VBN	_	0	root	_	_
18	,	,	,	,	_	17	punct	_	_
19	which	which	WDT	WDT	_	20	nsubj	_	_
20	lacks	lack	VBZ	VBZ	_	17	dep	_	_
21	the	the	DT	DT	_	23	det	_	_
22	calmodulin-binding	calmodulin-binding	JJ	JJ	_	23	amod	_	_
23	domain	domain	NN	NN	_	20	dobj	_	_
24	,	,	,	,	_	23	punct	_	_
25	autoinhibitory	autoinhibitory	JJ	JJ	_	26	amod	_	_
26	domain	domain	NN	NN	_	23	conj	_	_
27	and	and	CC	CC	_	23	cc	_	_
28	most	most	JJS	JJS	_	23	conj	_	_
29	of	of	IN	IN	_	32	case	_	_
30	its	its	PRP$	PRP$	_	32	nmod:poss	_	_
31	catalytic	catalytic	JJ	JJ	_	32	amod	_	_
32	core	core	NN	NN	_	28	nmod	_	_
33	but	but	CC	CC	_	20	cc	_	_
34	possesses	possess	VBZ	VBZ	_	20	conj	_	_
35	the	the	DT	DT	_	42	det	_	_
36	regulatory	regulatory	JJ	JJ	_	40	amod	_	_
37	(	(	-LRB-	-LRB-	_	40	punct	_	_
38	B	b	NN	NN	_	40	compound	_	_
39	)	)	-RRB-	-RRB-	_	40	punct	_	_
40	subunit	subunit	NN	NN	_	42	compound	_	_
41	binding	binding	NN	NN	_	42	compound	_	_
42	domain	domain	NN	NN	_	34	dobj	_	_
43	.	.	.	.	_	17	punct	_	_

1	When	when	WRB	WRB	_	2	advmod	_	_
2	tested	test	VBN	VBN	_	24	advcl	_	_
3	for	for	IN	IN	_	5	case	_	_
4	its	its	PRP$	PRP$	_	5	nmod:poss	_	_
5	ability	ability	NN	NN	_	2	nmod	_	_
6	to	to	TO	TO	_	7	mark	_	_
7	block	block	VB	VB	_	5	acl	_	_
8	calcineurin-dependent	calcineurin-dependent	JJ	JJ	_	9	amod	_	_
9	signaling	signaling	NN	NN	_	7	dobj	_	_
10	in	in	IN	IN	_	12	case	_	_
11	Jurkat	jurkat	NN	NN	_	12	compound	_	_
12	cells	cell	NNS	NNS	_	9	nmod	_	_
13	,	,	,	,	_	24	punct	_	_
14	expression	expression	NN	NN	_	24	nsubj	_	_
15	of	of	IN	IN	_	23	case	_	_
16	this	this	DT	DT	_	23	det	_	_
17	``	``	``	``	_	23	punct	_	_
18	B-subunit	b-subunit	JJ	JJ	_	23	amod	_	_
19	knock-out	knock-out	JJ	JJ	_	23	amod	_	_
20	(	(	-LRB-	-LRB-	_	23	punct	_	_
21	BKO	bko	NN	NN	_	23	compound	_	_
22	)	)	-RRB-	-RRB-	_	23	punct	_	_
23	construct	construct	NN	NN	_	14	nmod	_	_
24	suppressed	suppress	VBD	VBD	_	0	root	_	_
25	reporter	reporter	NN	NN	_	26	compound	_	_
26	gene	gene	NN	NN	_	27	compound	_	_
27	activity	activity	NN	NN	_	24	dobj	_	_
28	driven	drive	VBN	VBN	_	27	acl	_	_
29	by	by	IN	IN	_	30	case	_	_
30	NF-AT	nf-at	NN	NN	_	28	nmod	_	_
31	,	,	,	,	_	30	punct	_	_
32	the	the	DT	DT	_	35	det	_	_
33	pivotal	pivotal	JJ	JJ	_	35	amod	_	_
34	promoter	promoter	NN	NN	_	35	compound	_	_
35	element	element	NN	NN	_	30	appos	_	_
36	for	for	IN	IN	_	43	case	_	_
37	interleukin	interleukin	NN	NN	_	42	compound	_	_
38	(	(	-LRB-	-LRB-	_	42	punct	_	_
39	IL	il	NN	NN	_	42	compound	_	_
40	)	)	-RRB-	-RRB-	_	42	punct	_	_
41	-2	-2	CD	CD	_	42	nummod	_	_
42	gene	gene	NN	NN	_	43	compound	_	_
43	induction	induction	NN	NN	_	35	nmod	_	_
44	.	.	.	.	_	24	punct	_	_

1	Immunoprecipitation	immunoprecipitation	NN	NN	_	5	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	epitope-labeled	epitope-labeled	JJ	JJ	_	4	amod	_	_
4	BKO	bko	NN	NN	_	1	nmod	_	_
5	demonstrated	demonstrate	VBD	VBD	_	0	root	_	_
6	for	for	IN	IN	_	8	case	_	_
7	the	the	DT	DT	_	8	det	_	_
8	formation	formation	NN	NN	_	5	nmod	_	_
9	of	of	IN	IN	_	12	case	_	_
10	a	a	DT	DT	_	12	det	_	_
11	tight	tight	JJ	JJ	_	12	amod	_	_
12	complex	complex	NN	NN	_	8	nmod	_	_
13	with	with	IN	IN	_	16	case	_	_
14	endogenous	endogenous	JJ	JJ	_	16	amod	_	_
15	B	b	NN	NN	_	16	compound	_	_
16	subunit	subunit	NN	NN	_	12	nmod	_	_
17	in	in	IN	IN	_	19	case	_	_
18	Jurkat	jurkat	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	16	nmod	_	_
20	,	,	,	,	_	5	punct	_	_
21	consistent	consistent	JJ	JJ	_	5	advmod	_	_
22	with	with	IN	IN	_	25	case	_	_
23	an	a	DT	DT	_	25	det	_	_
24	inhibitory	inhibitory	JJ	JJ	_	25	amod	_	_
25	mechanism	mechanism	NN	NN	_	21	nmod	_	_
26	that	that	WDT	WDT	_	27	nsubj	_	_
27	involves	involve	VBZ	VBZ	_	25	acl:relcl	_	_
28	the	the	DT	DT	_	29	det	_	_
29	sequestration	sequestration	NN	NN	_	27	dobj	_	_
30	of	of	IN	IN	_	33	case	_	_
31	the	the	DT	DT	_	33	det	_	_
32	B	b	NN	NN	_	33	compound	_	_
33	subunit	subunit	NN	NN	_	29	nmod	_	_
34	.	.	.	.	_	5	punct	_	_

1	Furthermore	furthermore	RB	RB	_	15	advmod	_	_
2	,	,	,	,	_	15	punct	_	_
3	the	the	DT	DT	_	7	det	_	_
4	sharply	sharply	RB	RB	_	5	advmod	_	_
5	reduced	reduce	VBN	VBN	_	7	amod	_	_
6	NF-AT	nf-at	NN	NN	_	7	compound	_	_
7	activity	activity	NN	NN	_	15	nsubjpass	_	_
8	produced	produce	VBN	VBN	_	7	acl	_	_
9	by	by	IN	IN	_	11	case	_	_
10	co-transfecting	co-transfect	VBG	VBG	_	11	amod	_	_
11	BKO	bko	NN	NN	_	8	nmod	_	_
12	could	could	MD	MD	_	15	aux	_	_
13	be	be	VB	VB	_	15	auxpass	_	_
14	``	``	``	``	_	15	punct	_	_
15	rescued	rescue	VBN	VBN	_	0	root	_	_
16	by	by	IN	IN	_	17	case	_	_
17	overexpression	overexpression	NN	NN	_	15	nmod	_	_
18	of	of	IN	IN	_	21	case	_	_
19	transfected	transfect	VBN	VBN	_	21	amod	_	_
20	B	b	NN	NN	_	21	compound	_	_
21	subunit	subunit	NN	NN	_	17	nmod	_	_
22	,	,	,	,	_	15	punct	_	_
23	suggesting	suggest	VBG	VBG	_	15	advcl	_	_
24	that	that	IN	IN	_	30	mark	_	_
25	depletion	depletion	NN	NN	_	30	nsubj	_	_
26	of	of	IN	IN	_	28	case	_	_
27	this	this	DT	DT	_	28	det	_	_
28	subunit	subunit	NN	NN	_	25	nmod	_	_
29	was	be	VBD	VBD	_	30	cop	_	_
30	responsible	responsible	JJ	JJ	_	23	ccomp	_	_
31	for	for	IN	IN	_	33	case	_	_
32	the	the	DT	DT	_	33	det	_	_
33	inhibition	inhibition	NN	NN	_	30	nmod	_	_
34	.	.	.	.	_	15	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	the	the	DT	DT	_	6	det	_	_
5	potential	potential	JJ	JJ	_	6	amod	_	_
6	utility	utility	NN	NN	_	3	dobj	_	_
7	of	of	IN	IN	_	8	case	_	_
8	agents	agent	NNS	NNS	_	6	nmod	_	_
9	that	that	WDT	WDT	_	10	nsubj	_	_
10	disrupt	disrupt	VBP	VBP	_	8	acl:relcl	_	_
11	calcineurin-mediated	calcineurin-mediated	JJ	JJ	_	14	amod	_	_
12	signal	signal	NN	NN	_	14	compound	_	_
13	transduction	transduction	NN	NN	_	14	compound	_	_
14	pathways	pathway	NNS	NNS	_	10	dobj	_	_
15	by	by	IN	IN	_	16	mark	_	_
16	blocking	block	VBG	VBG	_	10	advcl	_	_
17	formation	formation	NN	NN	_	16	dobj	_	_
18	of	of	IN	IN	_	22	case	_	_
19	the	the	DT	DT	_	22	det	_	_
20	catalytically	catalytically	RB	RB	_	22	advmod	_	_
21	active	active	JJ	JJ	_	22	amod	_	_
22	dimer	dimer	NN	NN	_	17	nmod	_	_
23	of	of	IN	IN	_	24	case	_	_
24	calcineurin	calcineurin	NN	NN	_	22	nmod	_	_
25	A	a	NN	NN	_	24	dep	_	_
26	and	and	CC	CC	_	24	cc	_	_
27	B	b	NN	NN	_	24	conj	_	_
28	subunits	subunit	NNS	NNS	_	24	dep	_	_
29	.	.	.	.	_	3	punct	_	_

1	Cross-linking	cross-linking	NN	NN	_	6	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	Fc	fc	NN	NN	_	5	compound	_	_
4	gamma	gamma	NN	NN	_	5	compound	_	_
5	receptors	receptor	NNS	NNS	_	1	nmod	_	_
6	activates	activate	VBZ	VBZ	_	0	root	_	_
7	HIV-1	hiv-1	NN	NN	_	11	compound	_	_
8	long	long	JJ	JJ	_	11	amod	_	_
9	terminal	terminal	JJ	JJ	_	11	amod	_	_
10	repeat-driven	repeat-driven	JJ	JJ	_	11	amod	_	_
11	transcription	transcription	NN	NN	_	6	dobj	_	_
12	in	in	IN	IN	_	14	case	_	_
13	human	human	JJ	JJ	_	14	amod	_	_
14	monocytes	monocyte	NNS	NNS	_	11	nmod	_	_
15	.	.	.	.	_	6	punct	_	_

1	Elevation	elevation	NN	NN	_	10	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	the	the	DT	DT	_	4	det	_	_
4	levels	level	NNS	NNS	_	1	nmod	_	_
5	of	of	IN	IN	_	8	case	_	_
6	circulating	circulate	VBG	VBG	_	8	amod	_	_
7	immune	immune	JJ	JJ	_	8	amod	_	_
8	complexes	complex	NNS	NNS	_	4	nmod	_	_
9	frequently	frequently	RB	RB	_	10	advmod	_	_
10	accompanies	accompany	VBZ	VBZ	_	0	root	_	_
11	HIV-1	hiv-1	NN	NN	_	12	compound	_	_
12	infection	infection	NN	NN	_	10	dobj	_	_
13	and	and	CC	CC	_	10	cc	_	_
14	is	be	VBZ	VBZ	_	17	cop	_	_
15	a	a	DT	DT	_	17	det	_	_
16	prognostic	prognostic	JJ	JJ	_	17	amod	_	_
17	indicator	indicator	NN	NN	_	10	conj	_	_
18	of	of	IN	IN	_	20	case	_	_
19	clinical	clinical	JJ	JJ	_	20	amod	_	_
20	progression	progression	NN	NN	_	17	nmod	_	_
21	from	from	IN	IN	_	23	case	_	_
22	asymptomatic	asymptomatic	JJ	JJ	_	23	amod	_	_
23	infection	infection	NN	NN	_	20	nmod	_	_
24	to	to	TO	TO	_	25	case	_	_
25	AIDS	aids	NN	NN	_	20	nmod	_	_
26	.	.	.	.	_	10	punct	_	_

1	Here	here	RB	RB	_	3	advmod	_	_
2	we	we	PRP	PRP	_	3	nsubj	_	_
3	report	report	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	25	mark	_	_
5	cross-linking	cross-linking	NN	NN	_	25	nsubj	_	_
6	of	of	IN	IN	_	9	case	_	_
7	Fc	fc	NN	NN	_	9	compound	_	_
8	gamma	gamma	NN	NN	_	9	compound	_	_
9	RI	ri	NN	NN	_	5	nmod	_	_
10	or	or	CC	CC	_	9	cc	_	_
11	Fc	fc	NN	NN	_	13	compound	_	_
12	gamma	gamma	NN	NN	_	13	compound	_	_
13	RII	rii	NN	NN	_	9	conj	_	_
14	by	by	IN	IN	_	17	case	_	_
15	adherent	adherent	JJ	JJ	_	17	amod	_	_
16	human	human	JJ	JJ	_	17	amod	_	_
17	IgG	igg	NN	NN	_	5	nmod	_	_
18	or	or	CC	CC	_	17	cc	_	_
19	by	by	IN	IN	_	24	case	_	_
20	specific	specific	JJ	JJ	_	24	amod	_	_
21	anti-Fc	anti-fc	JJ	JJ	_	24	amod	_	_
22	gamma	gamma	NN	NN	_	24	compound	_	_
23	R	r	NN	NN	_	24	compound	_	_
24	mAb	mab	NN	NN	_	17	conj	_	_
25	activates	activate	VBZ	VBZ	_	3	ccomp	_	_
26	HIV-1	hiv-1	NN	NN	_	28	compound	_	_
27	gene	gene	NN	NN	_	28	compound	_	_
28	expression	expression	NN	NN	_	25	dobj	_	_
29	in	in	IN	IN	_	34	case	_	_
30	the	the	DT	DT	_	34	det	_	_
31	human	human	JJ	JJ	_	34	amod	_	_
32	monocytic	monocytic	JJ	JJ	_	34	amod	_	_
33	cell	cell	NN	NN	_	34	compound	_	_
34	line	line	NN	NN	_	28	nmod	_	_
35	BF24	bf24	NN	NN	_	34	dep	_	_
36	and	and	CC	CC	_	25	cc	_	_
37	increased	increase	VBN	VBN	_	25	conj	_	_
38	HIV	hiv	NN	NN	_	39	compound	_	_
39	RNA	rna	NN	NN	_	40	compound	_	_
40	expression	expression	NN	NN	_	37	dobj	_	_
41	in	in	IN	IN	_	42	case	_	_
42	monocytes	monocyte	NNS	NNS	_	40	nmod	_	_
43	from	from	IN	IN	_	46	case	_	_
44	HIV	hiv	NN	NN	_	46	compound	_	_
45	infected	infected	JJ	JJ	_	46	amod	_	_
46	patients	patient	NNS	NNS	_	42	nmod	_	_
47	as	as	IN	IN	_	48	mark	_	_
48	assayed	assay	VBN	VBN	_	25	advcl	_	_
49	by	by	IN	IN	_	51	case	_	_
50	reverse	reverse	JJ	JJ	_	51	amod	_	_
51	transcription-PCR	transcription-pcr	NN	NN	_	48	nmod	_	_
52	.	.	.	.	_	3	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	THP-1	thp-1	NN	NN	_	3	compound	_	_
3	cells	cell	NNS	NNS	_	9	nmod	_	_
4	,	,	,	,	_	9	punct	_	_
5	Fc	fc	NN	NN	_	7	compound	_	_
6	gamma	gamma	NN	NN	_	7	compound	_	_
7	R	r	NN	NN	_	8	compound	_	_
8	cross-linking	cross-linking	NN	NN	_	9	nsubj	_	_
9	induced	induce	VBD	VBD	_	0	root	_	_
10	NF-kappa	nf-kappa	NN	NN	_	11	compound	_	_
11	B	b	NN	NN	_	9	dobj	_	_
12	,	,	,	,	_	11	punct	_	_
13	which	which	WDT	WDT	_	15	nsubjpass	_	_
14	is	be	VBZ	VBZ	_	15	auxpass	_	_
15	known	know	VBN	VBN	_	11	acl:relcl	_	_
16	to	to	TO	TO	_	17	mark	_	_
17	bind	bind	VB	VB	_	15	ccomp	_	_
18	to	to	TO	TO	_	21	case	_	_
19	the	the	DT	DT	_	21	det	_	_
20	regulatory	regulatory	JJ	JJ	_	21	amod	_	_
21	region	region	NN	NN	_	17	nmod	_	_
22	of	of	IN	IN	_	26	case	_	_
23	the	the	DT	DT	_	26	det	_	_
24	long	long	JJ	JJ	_	26	amod	_	_
25	terminal	terminal	JJ	JJ	_	26	amod	_	_
26	repeat	repeat	NN	NN	_	21	nmod	_	_
27	(	(	-LRB-	-LRB-	_	28	punct	_	_
28	LTR	ltr	NN	NN	_	26	appos	_	_
29	)	)	-RRB-	-RRB-	_	28	punct	_	_
30	of	of	IN	IN	_	31	case	_	_
31	HIV-1	hiv-1	NN	NN	_	26	nmod	_	_
32	and	and	CC	CC	_	17	cc	_	_
33	to	to	TO	TO	_	34	mark	_	_
34	activate	activate	VB	VB	_	17	conj	_	_
35	HIV-1	hiv-1	NN	NN	_	36	compound	_	_
36	transcription	transcription	NN	NN	_	34	dobj	_	_
37	.	.	.	.	_	9	punct	_	_

1	Anti-TNF-alpha	anti-tnf-alpha	JJ	JJ	_	2	amod	_	_
2	antibody	antibody	NN	NN	_	9	nsubj	_	_
3	but	but	CC	CC	_	4	cc	_	_
4	not	not	RB	RB	_	2	cc	_	_
5	anti-IL-1	anti-il-1	JJ	JJ	_	7	amod	_	_
6	beta	beta	NN	NN	_	7	compound	_	_
7	antibody	antibody	NN	NN	_	2	conj	_	_
8	strongly	strongly	RB	RB	_	9	advmod	_	_
9	inhibited	inhibit	VBD	VBD	_	0	root	_	_
10	both	both	CC	CC	_	12	cc:preconj	_	_
11	the	the	DT	DT	_	12	det	_	_
12	induction	induction	NN	NN	_	9	dobj	_	_
13	of	of	IN	IN	_	15	case	_	_
14	HIV-1-LTR-driven	hiv-1-ltr-driven	JJ	JJ	_	15	amod	_	_
15	transcription	transcription	NN	NN	_	12	nmod	_	_
16	and	and	CC	CC	_	12	cc	_	_
17	the	the	DT	DT	_	18	det	_	_
18	induction	induction	NN	NN	_	12	conj	_	_
19	of	of	IN	IN	_	21	case	_	_
20	NF-kappa	nf-kappa	NN	NN	_	21	compound	_	_
21	B	b	NN	NN	_	18	nmod	_	_
22	by	by	IN	IN	_	26	case	_	_
23	Fc	fc	NN	NN	_	25	compound	_	_
24	gamma	gamma	NN	NN	_	25	compound	_	_
25	R	r	NN	NN	_	26	compound	_	_
26	cross-linking	cross-linking	NN	NN	_	12	nmod	_	_
27	.	.	.	.	_	9	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	9	mark	_	_
5	Fc	fc	NN	NN	_	7	compound	_	_
6	gamma	gamma	NN	NN	_	7	compound	_	_
7	R	r	NN	NN	_	9	nsubj	_	_
8	can	can	MD	MD	_	9	aux	_	_
9	mediate	mediate	VB	VB	_	3	ccomp	_	_
10	a	a	DT	DT	_	12	det	_	_
11	TNF-alpha-dependent	tnf-alpha-dependent	JJ	JJ	_	12	amod	_	_
12	induction	induction	NN	NN	_	9	dobj	_	_
13	of	of	IN	IN	_	16	case	_	_
14	HIV-1	hiv-1	NN	NN	_	15	compound	_	_
15	gene	gene	NN	NN	_	16	compound	_	_
16	transcription	transcription	NN	NN	_	12	nmod	_	_
17	and	and	CC	CC	_	3	cc	_	_
18	suggest	suggest	VBP	VBP	_	3	conj	_	_
19	that	that	IN	IN	_	23	mark	_	_
20	immune	immune	JJ	JJ	_	21	amod	_	_
21	complexes	complex	NNS	NNS	_	23	nsubj	_	_
22	may	may	MD	MD	_	23	aux	_	_
23	contribute	contribute	VB	VB	_	18	ccomp	_	_
24	to	to	TO	TO	_	26	case	_	_
25	the	the	DT	DT	_	26	det	_	_
26	pathophysiology	pathophysiology	NN	NN	_	23	nmod	_	_
27	of	of	IN	IN	_	29	case	_	_
28	HIV-1	hiv-1	NN	NN	_	29	compound	_	_
29	infection	infection	NN	NN	_	26	nmod	_	_
30	by	by	IN	IN	_	31	mark	_	_
31	augmenting	augment	VBG	VBG	_	23	advcl	_	_
32	viral	viral	JJ	JJ	_	33	amod	_	_
33	replication	replication	NN	NN	_	31	dobj	_	_
34	in	in	IN	IN	_	35	case	_	_
35	monocytes	monocyte	NNS	NNS	_	33	nmod	_	_
36	.	.	.	.	_	3	punct	_	_

1	Identification	identification	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	6	case	_	_
3	an	a	DT	DT	_	6	det	_	_
4	ionomycin/cyclosporin	ionomycin/cyclosporin	NN	NN	_	6	compound	_	_
5	A-responsive	a-responsive	JJ	JJ	_	6	amod	_	_
6	element	element	NN	NN	_	1	nmod	_	_
7	within	within	IN	IN	_	14	case	_	_
8	the	the	DT	DT	_	14	det	_	_
9	human	human	JJ	JJ	_	14	amod	_	_
10	T	t	NN	NN	_	14	compound	_	_
11	cell	cell	NN	NN	_	14	compound	_	_
12	receptor	receptor	NN	NN	_	14	compound	_	_
13	gamma	gamma	NN	NN	_	14	compound	_	_
14	enhancer	enhancer	NN	NN	_	6	nmod	_	_
15	.	.	.	.	_	1	punct	_	_

1	Activation	activation	NN	NN	_	7	nsubj	_	_
2	through	through	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	Ca2+/calcineurin	ca2+/calcineurin	NN	NN	_	5	compound	_	_
5	pathway	pathway	NN	NN	_	1	nmod	_	_
6	is	be	VBZ	VBZ	_	7	cop	_	_
7	essential	essential	JJ	JJ	_	0	root	_	_
8	to	to	TO	TO	_	10	case	_	_
9	the	the	DT	DT	_	10	det	_	_
10	transcription	transcription	NN	NN	_	7	nmod	_	_
11	of	of	IN	IN	_	14	case	_	_
12	many	many	JJ	JJ	_	14	amod	_	_
13	cytokine	cytokine	NN	NN	_	14	compound	_	_
14	genes	gene	NNS	NNS	_	10	nmod	_	_
15	.	.	.	.	_	7	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	conserved	conserve	VBN	VBN	_	4	amod	_	_
3	cis-acting	cis-acting	NN	NN	_	4	compound	_	_
4	sequence	sequence	NN	NN	_	16	nsubjpass	_	_
5	,	,	,	,	_	4	punct	_	_
6	GGAAAA	ggaaaa	NN	NN	_	4	appos	_	_
7	,	,	,	,	_	4	punct	_	_
8	and	and	CC	CC	_	4	cc	_	_
9	transcription	transcription	NN	NN	_	10	compound	_	_
10	factors	factor	NNS	NNS	_	4	conj	_	_
11	binding	bind	VBG	VBG	_	10	acl	_	_
12	to	to	TO	TO	_	14	case	_	_
13	this	this	DT	DT	_	14	det	_	_
14	sequence	sequence	NN	NN	_	11	nmod	_	_
15	are	be	VBP	VBP	_	16	auxpass	_	_
16	involved	involve	VBN	VBN	_	0	root	_	_
17	in	in	IN	IN	_	19	case	_	_
18	the	the	DT	DT	_	19	det	_	_
19	response	response	NN	NN	_	16	nmod	_	_
20	to	to	TO	TO	_	24	case	_	_
21	increased	increase	VBN	VBN	_	24	amod	_	_
22	intracellular	intracellular	JJ	JJ	_	24	amod	_	_
23	Ca2+	ca2+	NN	NN	_	24	compound	_	_
24	concentrations	concentration	NNS	NNS	_	19	nmod	_	_
25	.	.	.	.	_	16	punct	_	_

1	Here	here	RB	RB	_	3	advmod	_	_
2	we	we	PRP	PRP	_	3	nsubj	_	_
3	report	report	VBP	VBP	_	0	root	_	_
4	the	the	DT	DT	_	5	dep	_	_
5	identification	identification	NN	NN	_	3	dobj	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	importance	importance	NN	NN	_	5	conj	_	_
8	of	of	IN	IN	_	11	case	_	_
9	the	the	DT	DT	_	11	det	_	_
10	same	same	JJ	JJ	_	11	amod	_	_
11	sequence	sequence	NN	NN	_	5	nmod	_	_
12	in	in	IN	IN	_	15	case	_	_
13	a	a	DT	DT	_	15	det	_	_
14	non-cytokine	non-cytokine	JJ	JJ	_	15	amod	_	_
15	gene	gene	NN	NN	_	11	nmod	_	_
16	,	,	,	,	_	11	punct	_	_
17	the	the	DT	DT	_	26	det	_	_
18	human	human	JJ	JJ	_	26	amod	_	_
19	T	t	NN	NN	_	26	compound	_	_
20	cell	cell	NN	NN	_	26	compound	_	_
21	receptor	receptor	NN	NN	_	26	compound	_	_
22	gamma	gamma	NN	NN	_	26	compound	_	_
23	(	(	-LRB-	-LRB-	_	26	punct	_	_
24	TCRG	tcrg	NN	NN	_	26	compound	_	_
25	)	)	-RRB-	-RRB-	_	26	punct	_	_
26	enhancer	enhancer	NN	NN	_	11	appos	_	_
27	.	.	.	.	_	3	punct	_	_

1	Results	result	NNS	NNS	_	11	nsubj	_	_
2	from	from	IN	IN	_	4	case	_	_
3	site-directed	site-directed	JJ	JJ	_	4	amod	_	_
4	mutations	mutation	NNS	NNS	_	1	nmod	_	_
5	and	and	CC	CC	_	1	cc	_	_
6	electrophoretic	electrophoretic	JJ	JJ	_	9	amod	_	_
7	mobility	mobility	NN	NN	_	9	compound	_	_
8	shift	shift	NN	NN	_	9	compound	_	_
9	assays	assay	NNS	NNS	_	1	conj	_	_
10	strongly	strongly	RB	RB	_	11	advmod	_	_
11	suggest	suggest	VBP	VBP	_	0	root	_	_
12	that	that	IN	IN	_	15	mark	_	_
13	this	this	DT	DT	_	14	det	_	_
14	sequence	sequence	NN	NN	_	15	nsubj	_	_
15	mediates	mediate	VBZ	VBZ	_	11	ccomp	_	_
16	the	the	DT	DT	_	18	det	_	_
17	ionomycin-induced	ionomycin-induced	JJ	JJ	_	18	amod	_	_
18	activation	activation	NN	NN	_	15	dobj	_	_
19	of	of	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	TCRG	tcrg	NN	NN	_	22	compound	_	_
22	enhancer	enhancer	NN	NN	_	18	nmod	_	_
23	.	.	.	.	_	11	punct	_	_

1	Our	we	PRP$	PRP$	_	2	nmod:poss	_	_
2	studies	study	NNS	NNS	_	3	nsubj	_	_
3	provide	provide	VBP	VBP	_	0	root	_	_
4	an	a	DT	DT	_	5	det	_	_
5	explanation	explanation	NN	NN	_	3	dobj	_	_
6	for	for	IN	IN	_	9	case	_	_
7	a	a	DT	DT	_	9	det	_	_
8	previous	previous	JJ	JJ	_	9	amod	_	_
9	observation	observation	NN	NN	_	5	nmod	_	_
10	that	that	IN	IN	_	28	mark	_	_
11	TCRG	tcrg	NN	NN	_	12	compound	_	_
12	mRNA	mrna	NN	NN	_	13	compound	_	_
13	levels	level	NNS	NNS	_	28	nsubjpass	_	_
14	,	,	,	,	_	13	punct	_	_
15	but	but	CC	CC	_	16	cc	_	_
16	not	not	RB	RB	_	13	cc	_	_
17	mRNA	mrna	NN	NN	_	18	compound	_	_
18	levels	level	NNS	NNS	_	13	conj	_	_
19	for	for	IN	IN	_	22	case	_	_
20	T	t	NN	NN	_	22	compound	_	_
21	cell	cell	NN	NN	_	22	compound	_	_
22	receptor	receptor	NN	NN	_	13	nmod	_	_
23	alpha	alpha	NN	NN	_	22	dep	_	_
24	and	and	CC	CC	_	22	cc	_	_
25	-beta	-beta	NN	NN	_	22	conj	_	_
26	,	,	,	,	_	13	punct	_	_
27	are	be	VBP	VBP	_	28	auxpass	_	_
28	increased	increase	VBN	VBN	_	9	ccomp	_	_
29	by	by	IN	IN	_	31	case	_	_
30	ionomycin	ionomycin	NN	NN	_	31	compound	_	_
31	treatment	treatment	NN	NN	_	28	nmod	_	_
32	.	.	.	.	_	3	punct	_	_

1	Aspirin-like	aspirin-like	JJ	JJ	_	2	amod	_	_
2	drugs	drug	NNS	NNS	_	4	nsubj	_	_
3	can	can	MD	MD	_	4	aux	_	_
4	protect	protect	VB	VB	_	0	root	_	_
5	human	human	JJ	JJ	_	7	amod	_	_
6	T	t	NN	NN	_	7	compound	_	_
7	lymphocytes	lymphocyte	NNS	NNS	_	4	dobj	_	_
8	against	against	IN	IN	_	10	case	_	_
9	benzoquinone	benzoquinone	NN	NN	_	10	compound	_	_
10	cytotoxicity	cytotoxicity	NN	NN	_	4	nmod	_	_
11	:	:	:	:	_	4	punct	_	_
12	evidence	evidence	NN	NN	_	4	dep	_	_
13	for	for	IN	IN	_	17	case	_	_
14	a	a	DT	DT	_	17	det	_	_
15	NAD(P)H:quinone	nad(p)h:quinone	NN	NN	_	17	compound	_	_
16	reductase-dependent	reductase-dependent	JJ	JJ	_	17	amod	_	_
17	mechanism	mechanism	NN	NN	_	12	nmod	_	_
18	.	.	.	.	_	4	punct	_	_

1	Benzene	benzene	NN	NN	_	2	compound	_	_
2	toxicity	toxicity	NN	NN	_	6	nsubjpass	_	_
3	towards	towards	IN	IN	_	4	case	_	_
4	lymphocytes	lymphocyte	NNS	NNS	_	2	nmod	_	_
5	is	be	VBZ	VBZ	_	6	auxpass	_	_
6	thought	think	VBN	VBN	_	0	root	_	_
7	to	to	TO	TO	_	9	mark	_	_
8	be	be	VB	VB	_	9	auxpass	_	_
9	mediated	mediate	VBN	VBN	_	6	xcomp	_	_
10	by	by	IN	IN	_	11	case	_	_
11	metabolites	metabolite	NNS	NNS	_	9	nmod	_	_
12	of	of	IN	IN	_	13	case	_	_
13	benzene	benzene	NN	NN	_	11	nmod	_	_
14	including	include	VBG	VBG	_	15	case	_	_
15	benzoquinone	benzoquinone	NN	NN	_	11	nmod	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	BQ	bq	NN	NN	_	15	appos	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	.	.	.	.	_	6	punct	_	_

1	NAD(P)H:quinone	nad(p)h:quinone	NN	NN	_	2	compound	_	_
2	reductase	reductase	NN	NN	_	7	nsubjpass	_	_
3	(	(	-LRB-	-LRB-	_	4	punct	_	_
4	QR	qr	NN	NN	_	2	appos	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	is	be	VBZ	VBZ	_	7	auxpass	_	_
7	known	know	VBN	VBN	_	0	root	_	_
8	to	to	TO	TO	_	9	mark	_	_
9	protect	protect	VB	VB	_	7	xcomp	_	_
10	against	against	IN	IN	_	12	case	_	_
11	BQ	bq	NN	NN	_	12	compound	_	_
12	toxicity	toxicity	NN	NN	_	9	nmod	_	_
13	.	.	.	.	_	7	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	expression	expression	NN	NN	_	8	nsubjpass	_	_
3	of	of	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	QR	qr	NN	NN	_	6	compound	_	_
6	gene	gene	NN	NN	_	2	nmod	_	_
7	is	be	VBZ	VBZ	_	8	auxpass	_	_
8	regulated	regulate	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	_	12	case	_	_
10	the	the	DT	DT	_	12	det	_	_
11	transcription	transcription	NN	NN	_	12	compound	_	_
12	factor	factor	NN	NN	_	8	nmod	_	_
13	AP-1	ap-1	NN	NN	_	12	dep	_	_
14	.	.	.	.	_	8	punct	_	_

1	We	we	PRP	PRP	_	4	nsubj	_	_
2	had	have	VBD	VBD	_	4	aux	_	_
3	previously	previously	RB	RB	_	4	advmod	_	_
4	found	find	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	11	mark	_	_
6	aspirin-like	aspirin-like	JJ	JJ	_	7	amod	_	_
7	drugs	drug	NNS	NNS	_	11	nsubj	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	ALD	ald	NN	NN	_	7	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	induce	induce	VBP	VBP	_	4	ccomp	_	_
12	AP-1	ap-1	NN	NN	_	11	dobj	_	_
13	in	in	IN	IN	_	16	case	_	_
14	human	human	JJ	JJ	_	16	amod	_	_
15	T	t	NN	NN	_	16	compound	_	_
16	lymphocytes	lymphocyte	NNS	NNS	_	11	nmod	_	_
17	.	.	.	.	_	4	punct	_	_

1	It	it	PRP	PRP	_	4	nsubjpass	_	_
2	was	be	VBD	VBD	_	4	auxpass	_	_
3	therefore	therefore	RB	RB	_	4	advmod	_	_
4	hypothesized	hypothesize	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	8	mark	_	_
6	ALD	ald	NN	NN	_	8	nsubj	_	_
7	would	would	MD	MD	_	8	aux	_	_
8	protect	protect	VB	VB	_	4	ccomp	_	_
9	lymphocytes	lymphocyte	NNS	NNS	_	8	dobj	_	_
10	against	against	IN	IN	_	12	case	_	_
11	BQ	bq	NN	NN	_	12	compound	_	_
12	toxicity	toxicity	NN	NN	_	8	nmod	_	_
13	by	by	IN	IN	_	14	mark	_	_
14	inducing	induce	VBG	VBG	_	8	advcl	_	_
15	QR	qr	NN	NN	_	14	dobj	_	_
16	.	.	.	.	_	4	punct	_	_

1	Molt-4	molt-4	NN	NN	_	2	compound	_	_
2	cells	cell	NNS	NNS	_	15	nsubjpass	_	_
3	(	(	-LRB-	-LRB-	_	4	punct	_	_
4	M4	m4	NN	NN	_	2	appos	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	,	,	,	,	_	2	punct	_	_
7	a	a	DT	DT	_	12	det	_	_
8	human	human	JJ	JJ	_	12	amod	_	_
9	T	t	NN	NN	_	12	compound	_	_
10	lymphocyte	lymphocyte	NN	NN	_	12	compound	_	_
11	cell	cell	NN	NN	_	12	compound	_	_
12	line	line	NN	NN	_	2	appos	_	_
13	,	,	,	,	_	2	punct	_	_
14	were	be	VBD	VBD	_	15	auxpass	_	_
15	incubated	incubate	VBN	VBN	_	0	root	_	_
16	with	with	IN	IN	_	18	case	_	_
17	different	different	JJ	JJ	_	18	amod	_	_
18	concentrations	concentration	NNS	NNS	_	15	nmod	_	_
19	of	of	IN	IN	_	21	case	_	_
20	two	two	CD	CD	_	21	nummod	_	_
21	ALD	ald	NN	NN	_	18	nmod	_	_
22	,	,	,	,	_	21	punct	_	_
23	flurbiprofen	flurbiprofen	NN	NN	_	21	appos	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	sodium	sodium	NN	NN	_	26	compound	_	_
26	diclofenac	diclofenac	NN	NN	_	23	conj	_	_
27	,	,	,	,	_	15	punct	_	_
28	and	and	CC	CC	_	15	cc	_	_
29	then	then	RB	RB	_	30	advmod	_	_
30	exposed	expose	VBN	VBN	_	15	conj	_	_
31	to	to	TO	TO	_	32	case	_	_
32	BQ	bq	NN	NN	_	30	nmod	_	_
33	.	.	.	.	_	15	punct	_	_

1	Toxicity	toxicity	NN	NN	_	3	nsubjpass	_	_
2	was	be	VBD	VBD	_	3	auxpass	_	_
3	measured	measure	VBN	VBN	_	0	root	_	_
4	by	by	IN	IN	_	5	case	_	_
5	viability	viability	NN	NN	_	3	nmod	_	_
6	(	(	-LRB-	-LRB-	_	9	punct	_	_
7	trypan	trypan	NN	NN	_	9	compound	_	_
8	blue	blue	JJ	JJ	_	9	amod	_	_
9	exclusion	exclusion	NN	NN	_	5	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	.	.	.	.	_	3	punct	_	_

1	Both	both	DT	DT	_	2	det	_	_
2	drugs	drug	NNS	NNS	_	3	nsubj	_	_
3	protected	protect	VBD	VBD	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	cells	cell	NNS	NNS	_	3	dobj	_	_
6	against	against	IN	IN	_	8	case	_	_
7	BQ	bq	NN	NN	_	8	compound	_	_
8	cytotoxicity	cytotoxicity	NN	NN	_	3	nmod	_	_
9	in	in	IN	IN	_	12	case	_	_
10	a	a	DT	DT	_	12	det	_	_
11	dose-dependent	dose-dependent	JJ	JJ	_	12	amod	_	_
12	manner	manner	NN	NN	_	3	nmod	_	_
13	,	,	,	,	_	3	punct	_	_
14	e.g.	e.g.	FW	FW	_	3	advcl	_	_
15	,	,	,	,	_	3	punct	_	_
16	sodium	sodium	NN	NN	_	17	compound	_	_
17	diclofenac	diclofenac	NN	NN	_	21	nsubj	_	_
18	at	at	IN	IN	_	20	case	_	_
19	15	15	CD	CD	_	20	nummod	_	_
20	microM	microm	NN	NN	_	17	nmod	_	_
21	reduced	reduce	VBD	VBD	_	3	parataxis	_	_
22	the	the	DT	DT	_	23	det	_	_
23	fraction	fraction	NN	NN	_	21	dobj	_	_
24	of	of	IN	IN	_	27	case	_	_
25	BQ-treated	bq-treated	JJ	JJ	_	27	amod	_	_
26	dead	dead	JJ	JJ	_	27	amod	_	_
27	cells	cell	NNS	NNS	_	23	nmod	_	_
28	by	by	IN	IN	_	30	case	_	_
29	70	70	CD	CD	_	30	nummod	_	_
30	%	%	NN	NN	_	21	nmod	_	_
31	.	.	.	.	_	3	punct	_	_

1	ALDs	ald	NNS	NNS	_	2	nsubj	_	_
2	induced	induce	VBD	VBD	_	0	root	_	_
3	QR	qr	NN	NN	_	4	compound	_	_
4	activity	activity	NN	NN	_	2	dobj	_	_
5	in	in	IN	IN	_	8	case	_	_
6	the	the	DT	DT	_	8	det	_	_
7	M4	m4	NN	NN	_	8	compound	_	_
8	cells	cell	NNS	NNS	_	4	nmod	_	_
9	in	in	IN	IN	_	12	case	_	_
10	the	the	DT	DT	_	12	det	_	_
11	same	same	JJ	JJ	_	12	amod	_	_
12	range	range	NN	NN	_	2	nmod	_	_
13	of	of	IN	IN	_	14	case	_	_
14	concentrations	concentration	NNS	NNS	_	12	nmod	_	_
15	that	that	WDT	WDT	_	16	nsubj	_	_
16	protected	protect	VBD	VBD	_	12	acl:relcl	_	_
17	the	the	DT	DT	_	18	det	_	_
18	cells	cell	NNS	NNS	_	16	dobj	_	_
19	against	against	IN	IN	_	21	case	_	_
20	BQ	bq	NN	NN	_	21	compound	_	_
21	toxicity	toxicity	NN	NN	_	16	nmod	_	_
22	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	protective	protective	JJ	JJ	_	3	amod	_	_
3	effect	effect	NN	NN	_	8	nsubjpass	_	_
4	of	of	IN	IN	_	5	case	_	_
5	ALD	ald	NN	NN	_	3	nmod	_	_
6	was	be	VBD	VBD	_	8	auxpass	_	_
7	significantly	significantly	RB	RB	_	8	advmod	_	_
8	reduced	reduce	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	_	10	case	_	_
10	dicoumarol	dicoumarol	NN	NN	_	8	nmod	_	_
11	,	,	,	,	_	10	punct	_	_
12	a	a	DT	DT	_	14	det	_	_
13	QR-specific	qr-specific	JJ	JJ	_	14	amod	_	_
14	inhibitor	inhibitor	NN	NN	_	10	appos	_	_
15	.	.	.	.	_	8	punct	_	_

1	Since	since	IN	IN	_	11	mark	_	_
2	human	human	JJ	JJ	_	4	amod	_	_
3	T	t	NN	NN	_	4	compound	_	_
4	cells	cell	NNS	NNS	_	11	nsubj	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	T	t	NN	NN	_	8	compound	_	_
7	cell	cell	NN	NN	_	8	compound	_	_
8	lines	line	NNS	NNS	_	4	conj	_	_
9	do	do	VBP	VBP	_	11	aux	_	_
10	not	not	RB	RB	_	11	neg	_	_
11	metabolize	metabolize	VB	VB	_	17	advcl	_	_
12	arachidonic	arachidonic	JJ	JJ	_	13	amod	_	_
13	acid	acid	NN	NN	_	11	dobj	_	_
14	,	,	,	,	_	17	punct	_	_
15	our	we	PRP$	PRP$	_	16	nmod:poss	_	_
16	data	datum	NNS	NNS	_	17	nsubj	_	_
17	suggest	suggest	VBP	VBP	_	0	root	_	_
18	that	that	IN	IN	_	21	mark	_	_
19	ALD	ald	NN	NN	_	21	nsubj	_	_
20	can	can	MD	MD	_	21	aux	_	_
21	protect	protect	VB	VB	_	17	ccomp	_	_
22	human	human	JJ	JJ	_	24	amod	_	_
23	T	t	NN	NN	_	24	compound	_	_
24	lymphocytes	lymphocyte	NNS	NNS	_	21	dobj	_	_
25	against	against	IN	IN	_	27	case	_	_
26	a	a	DT	DT	_	27	det	_	_
27	metabolite	metabolite	NN	NN	_	21	nmod	_	_
28	of	of	IN	IN	_	29	case	_	_
29	benzene	benzene	NN	NN	_	27	nmod	_	_
30	by	by	IN	IN	_	31	case	_	_
31	induction	induction	NN	NN	_	21	nmod	_	_
32	of	of	IN	IN	_	34	case	_	_
33	QR	qr	NN	NN	_	34	compound	_	_
34	activity	activity	NN	NN	_	31	nmod	_	_
35	.	.	.	.	_	17	punct	_	_

1	Human	human	JJ	JJ	_	2	amod	_	_
2	herpesvirus	herpesvirus	NN	NN	_	12	nsubj	_	_
3	6	6	CD	CD	_	2	nummod	_	_
4	variant	variant	NN	NN	_	5	compound	_	_
5	A	a	NN	NN	_	2	dep	_	_
6	,	,	,	,	_	2	punct	_	_
7	but	but	CC	CC	_	8	cc	_	_
8	not	not	RB	RB	_	2	cc	_	_
9	variant	variant	NN	NN	_	10	compound	_	_
10	B	b	NN	NN	_	2	conj	_	_
11	,	,	,	,	_	2	punct	_	_
12	infects	infect	VBZ	VBZ	_	0	root	_	_
13	EBV-positive	ebv-positive	JJ	JJ	_	16	amod	_	_
14	B	b	NN	NN	_	16	compound	_	_
15	lymphoid	lymphoid	JJ	JJ	_	16	amod	_	_
16	cells	cell	NNS	NNS	_	12	dobj	_	_
17	,	,	,	,	_	12	punct	_	_
18	activating	activate	VBG	VBG	_	12	advcl	_	_
19	the	the	DT	DT	_	22	det	_	_
20	latent	latent	JJ	JJ	_	22	amod	_	_
21	EBV	ebv	NN	NN	_	22	compound	_	_
22	genome	genome	NN	NN	_	18	dobj	_	_
23	through	through	IN	IN	_	26	case	_	_
24	a	a	DT	DT	_	26	det	_	_
25	BZLF-1-dependent	bzlf-1-dependent	JJ	JJ	_	26	amod	_	_
26	mechanism	mechanism	NN	NN	_	18	nmod	_	_
27	.	.	.	.	_	12	punct	_	_

1	Human	human	JJ	JJ	_	2	amod	_	_
2	herpesvirus	herpesvirus	NN	NN	_	14	nsubjpass	_	_
3	6	6	CD	CD	_	2	nummod	_	_
4	,	,	,	,	_	2	punct	_	_
5	a	a	DT	DT	_	9	det	_	_
6	predominantly	predominantly	RB	RB	_	8	advmod	_	_
7	T	t	NN	NN	_	8	nmod:npmod	_	_
8	lymphotropic	lymphotropic	JJ	JJ	_	9	amod	_	_
9	virus	virus	NN	NN	_	2	appos	_	_
10	,	,	,	,	_	2	punct	_	_
11	has	have	VBZ	VBZ	_	14	aux	_	_
12	been	be	VBN	VBN	_	14	auxpass	_	_
13	recently	recently	RB	RB	_	14	advmod	_	_
14	shown	show	VBN	VBN	_	0	root	_	_
15	to	to	TO	TO	_	16	mark	_	_
16	infect	infect	VB	VB	_	14	ccomp	_	_
17	some	some	DT	DT	_	22	det	_	_
18	EBV	ebv	JJ	JJ	_	22	amod	_	_
19	-positive	-positive	JJ	JJ	_	22	amod	_	_
20	B	b	NN	NN	_	22	compound	_	_
21	cell	cell	NN	NN	_	22	compound	_	_
22	lines	line	NNS	NNS	_	16	dobj	_	_
23	,	,	,	,	_	16	punct	_	_
24	and	and	CC	CC	_	16	cc	_	_
25	to	to	TO	TO	_	26	mark	_	_
26	induce	induce	VB	VB	_	16	conj	_	_
27	in	in	IN	IN	_	28	case	_	_
28	them	they	PRP	PRP	_	26	nmod	_	_
29	the	the	DT	DT	_	30	det	_	_
30	activation	activation	NN	NN	_	26	dobj	_	_
31	of	of	IN	IN	_	35	case	_	_
32	the	the	DT	DT	_	35	det	_	_
33	EBV	ebv	NN	NN	_	35	compound	_	_
34	lytic	lytic	JJ	JJ	_	35	amod	_	_
35	cycle	cycle	NN	NN	_	30	nmod	_	_
36	.	.	.	.	_	14	punct	_	_

1	Here	here	RB	RB	_	4	advmod	_	_
2	we	we	PRP	PRP	_	4	nsubj	_	_
3	have	have	VBP	VBP	_	4	aux	_	_
4	confirmed	confirm	VBN	VBN	_	0	root	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	extended	extend	VBN	VBN	_	4	conj	_	_
7	such	such	JJ	JJ	_	8	amod	_	_
8	observations	observation	NNS	NNS	_	4	dobj	_	_
9	,	,	,	,	_	4	punct	_	_
10	showing	show	VBG	VBG	_	4	advcl	_	_
11	that	that	IN	IN	_	18	mark	_	_
12	(	(	-LRB-	-LRB-	_	13	punct	_	_
13	1	1	LS	LS	_	18	dep	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	this	this	DT	DT	_	16	det	_	_
16	phenomenon	phenomenon	NN	NN	_	18	nsubj	_	_
17	is	be	VBZ	VBZ	_	18	cop	_	_
18	restricted	restricted	JJ	JJ	_	10	ccomp	_	_
19	to	to	TO	TO	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	variant	variant	NN	NN	_	22	compound	_	_
22	A	a	NN	NN	_	18	nmod	_	_
23	of	of	IN	IN	_	24	case	_	_
24	HHV-6	hhv-6	NN	NN	_	22	nmod	_	_
25	:	:	:	:	_	4	punct	_	_
26	in	in	IN	IN	_	27	case	_	_
27	fact	fact	NN	NN	_	41	nmod	_	_
28	two	two	CD	CD	_	29	nummod	_	_
29	isolates	isolate	NNS	NNS	_	41	nsubj	_	_
30	belonging	belong	VBG	VBG	_	29	acl	_	_
31	to	to	TO	TO	_	35	case	_	_
32	the	the	DT	DT	_	35	det	_	_
33	HHV-6	hhv-6	NN	NN	_	35	compound	_	_
34	variant	variant	NN	NN	_	35	compound	_	_
35	B	b	NN	NN	_	30	nmod	_	_
36	(	(	-LRB-	-LRB-	_	37	punct	_	_
37	BA92	ba92	NN	NN	_	35	dep	_	_
38	and	and	CC	CC	_	37	cc	_	_
39	Z29	z29	NN	NN	_	37	conj	_	_
40	)	)	-RRB-	-RRB-	_	37	punct	_	_
41	were	be	VBD	VBD	_	4	parataxis	_	_
42	neither	neither	CC	CC	_	41	dep	_	_
43	able	able	JJ	JJ	_	41	conj	_	_
44	to	to	TO	TO	_	43	dep	_	_
45	infect	infect	VB	VB	_	44	ccomp	_	_
46	any	any	DT	DT	_	49	det	_	_
47	B	b	NN	NN	_	49	compound	_	_
48	cell	cell	NN	NN	_	49	compound	_	_
49	line	line	NN	NN	_	45	dobj	_	_
50	,	,	,	,	_	45	punct	_	_
51	independently	independently	RB	RB	_	45	advmod	_	_
52	of	of	IN	IN	_	55	case	_	_
53	the	the	DT	DT	_	55	det	_	_
54	EBV	ebv	NN	NN	_	55	compound	_	_
55	status	status	NN	NN	_	51	nmod	_	_
56	,	,	,	,	_	44	punct	_	_
57	nor	nor	CC	CC	_	44	cc	_	_
58	to	to	TO	TO	_	44	conj	_	_
59	induce	induce	VB	VB	_	58	ccomp	_	_
60	the	the	DT	DT	_	63	det	_	_
61	EBV	ebv	NN	NN	_	63	compound	_	_
62	genome	genome	NN	NN	_	63	compound	_	_
63	expression	expression	NN	NN	_	59	dobj	_	_
64	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	only	only	JJ	JJ	_	3	amod	_	_
3	exception	exception	NN	NN	_	5	nsubjpass	_	_
4	is	be	VBZ	VBZ	_	5	auxpass	_	_
5	represented	represent	VBN	VBN	_	0	root	_	_
6	by	by	IN	IN	_	9	case	_	_
7	the	the	DT	DT	_	9	det	_	_
8	P3HR1	p3hr1	NN	NN	_	9	compound	_	_
9	cells	cell	NNS	NNS	_	5	nmod	_	_
10	,	,	,	,	_	9	punct	_	_
11	in	in	IN	IN	_	12	case	_	_
12	which	which	WDT	WDT	_	24	nmod	_	_
13	,	,	,	,	_	24	punct	_	_
14	however	however	RB	RB	_	24	advmod	_	_
15	,	,	,	,	_	24	punct	_	_
16	the	the	DT	DT	_	17	det	_	_
17	infection	infection	NN	NN	_	24	nsubj	_	_
18	by	by	IN	IN	_	21	case	_	_
19	the	the	DT	DT	_	21	det	_	_
20	variant	variant	NN	NN	_	21	compound	_	_
21	B	b	NN	NN	_	17	nmod	_	_
22	does	do	VBZ	VBZ	_	24	aux	_	_
23	not	not	RB	RB	_	24	neg	_	_
24	determine	determine	VB	VB	_	9	acl:relcl	_	_
25	induction	induction	NN	NN	_	24	dobj	_	_
26	of	of	IN	IN	_	28	case	_	_
27	EBV	ebv	NN	NN	_	28	compound	_	_
28	antigens	antigen	NNS	NNS	_	25	nmod	_	_
29	;	;	:	:	_	5	punct	_	_
30	(	(	-LRB-	-LRB-	_	31	punct	_	_
31	2	2	LS	LS	_	39	dep	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	the	the	DT	DT	_	34	det	_	_
34	presence	presence	NN	NN	_	39	nsubj	_	_
35	of	of	IN	IN	_	38	case	_	_
36	the	the	DT	DT	_	38	det	_	_
37	EBV	ebv	NN	NN	_	38	compound	_	_
38	genome	genome	NN	NN	_	34	nmod	_	_
39	contributes	contribute	VBZ	VBZ	_	5	conj	_	_
40	to	to	TO	TO	_	42	case	_	_
41	the	the	DT	DT	_	42	det	_	_
42	susceptibility	susceptibility	NN	NN	_	39	nmod	_	_
43	of	of	IN	IN	_	47	case	_	_
44	the	the	DT	DT	_	47	det	_	_
45	B	b	NN	NN	_	47	compound	_	_
46	cell	cell	NN	NN	_	47	compound	_	_
47	lines	line	NNS	NNS	_	42	nmod	_	_
48	to	to	TO	TO	_	50	case	_	_
49	HHV-6	hhv-6	NN	NN	_	50	compound	_	_
50	infection	infection	NN	NN	_	42	nmod	_	_
51	,	,	,	,	_	39	punct	_	_
52	increasing	increase	VBG	VBG	_	39	xcomp	_	_
53	the	the	DT	DT	_	55	det	_	_
54	binding	bind	VBG	VBG	_	55	amod	_	_
55	sites	site	NNS	NNS	_	52	dobj	_	_
56	and	and	CC	CC	_	55	cc	_	_
57	the	the	DT	DT	_	58	det	_	_
58	percentage	percentage	NN	NN	_	55	conj	_	_
59	of	of	IN	IN	_	61	case	_	_
60	infectable	infectable	JJ	JJ	_	61	amod	_	_
61	cells	cell	NNS	NNS	_	58	nmod	_	_
62	,	,	,	,	_	52	punct	_	_
63	as	as	IN	IN	_	64	dep	_	_
64	detected	detect	VBN	VBN	_	52	advcl	_	_
65	by	by	IN	IN	_	67	case	_	_
66	immunoelectron	immunoelectron	NN	NN	_	67	compound	_	_
67	microscopy	microscopy	NN	NN	_	64	nmod	_	_
68	;	;	:	:	_	5	punct	_	_
69	and	and	CC	CC	_	5	cc	_	_
70	(	(	-LRB-	-LRB-	_	71	punct	_	_
71	3	3	LS	LS	_	94	dep	_	_
72	)	)	-RRB-	-RRB-	_	71	punct	_	_
73	HHV-6	hhv-6	NN	NN	_	76	compound	_	_
74	infected	infected	JJ	JJ	_	76	amod	_	_
75	T	t	NN	NN	_	76	compound	_	_
76	cells	cell	NNS	NNS	_	94	nsubj	_	_
77	,	,	,	,	_	76	punct	_	_
78	transfected	transfect	VBN	VBN	_	76	acl	_	_
79	with	with	IN	IN	_	80	case	_	_
80	plasmids	plasmid	NNS	NNS	_	78	nmod	_	_
81	bearing	bear	VBG	VBG	_	80	acl	_	_
82	the	the	DT	DT	_	84	det	_	_
83	promoter	promoter	NN	NN	_	84	compound	_	_
84	regions	region	NNS	NNS	_	81	dobj	_	_
85	of	of	IN	IN	_	89	case	_	_
86	the	the	DT	DT	_	89	det	_	_
87	EBV	ebv	NN	NN	_	89	compound	_	_
88	early	early	RB	RB	_	89	advmod	_	_
89	genes	gene	NNS	NNS	_	84	nmod	_	_
90	BZLF1	bzlf1	NN	NN	_	89	dep	_	_
91	and	and	CC	CC	_	90	cc	_	_
92	BMRF1	bmrf1	NN	NN	_	90	conj	_	_
93	,	,	,	,	_	76	punct	_	_
94	show	show	VBP	VBP	_	5	conj	_	_
95	a	a	DT	DT	_	97	det	_	_
96	strong	strong	JJ	JJ	_	97	amod	_	_
97	transactivation	transactivation	NN	NN	_	94	dobj	_	_
98	of	of	IN	IN	_	100	case	_	_
99	these	these	DT	DT	_	100	det	_	_
100	promoters	promoter	NNS	NNS	_	97	nmod	_	_
101	.	.	.	.	_	5	punct	_	_

1	Activation	activation	NN	NN	_	10	nsubj	_	_
2	of	of	IN	IN	_	3	case	_	_
3	JAK3	jak3	NN	NN	_	1	nmod	_	_
4	,	,	,	,	_	3	punct	_	_
5	but	but	CC	CC	_	6	cc	_	_
6	not	not	RB	RB	_	3	cc	_	_
7	JAK1	jak1	NN	NN	_	3	conj	_	_
8	,	,	,	,	_	1	punct	_	_
9	is	be	VBZ	VBZ	_	10	cop	_	_
10	critical	critical	JJ	JJ	_	0	root	_	_
11	for	for	IN	IN	_	13	case	_	_
12	IL-2-induced	il-2-induced	JJ	JJ	_	13	amod	_	_
13	proliferation	proliferation	NN	NN	_	10	nmod	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	STAT5	stat5	NN	NN	_	16	compound	_	_
16	recruitment	recruitment	NN	NN	_	13	conj	_	_
17	by	by	IN	IN	_	20	case	_	_
18	a	a	DT	DT	_	20	det	_	_
19	COOH-terminal	cooh-terminal	JJ	JJ	_	20	amod	_	_
20	region	region	NN	NN	_	16	nmod	_	_
21	of	of	IN	IN	_	25	case	_	_
22	the	the	DT	DT	_	25	det	_	_
23	IL-2	il-2	NN	NN	_	25	compound	_	_
24	receptor	receptor	NN	NN	_	25	compound	_	_
25	beta-chain	beta-chain	NN	NN	_	20	nmod	_	_
26	.	.	.	.	_	10	punct	_	_

1	A	a	DT	DT	_	2	det	_	_
2	number	number	NN	NN	_	8	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	cytokines	cytokine	NNS	NNS	_	2	nmod	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	growth	growth	NN	NN	_	7	compound	_	_
7	factors	factor	NNS	NNS	_	4	conj	_	_
8	use	use	VBP	VBP	_	0	root	_	_
9	the	the	DT	DT	_	11	det	_	_
10	JAK-STAT	jak-stat	NN	NN	_	11	compound	_	_
11	pathway	pathway	NN	NN	_	8	dobj	_	_
12	to	to	TO	TO	_	13	mark	_	_
13	signal	signal	VB	VB	_	8	advcl	_	_
14	from	from	IN	IN	_	17	case	_	_
15	the	the	DT	DT	_	17	det	_	_
16	cell	cell	NN	NN	_	17	compound	_	_
17	membrane	membrane	NN	NN	_	13	nmod	_	_
18	to	to	TO	TO	_	20	case	_	_
19	the	the	DT	DT	_	20	det	_	_
20	nucleus	nucleus	NN	NN	_	13	nmod	_	_
21	.	.	.	.	_	8	punct	_	_

1	While	while	IN	IN	_	6	mark	_	_
2	homodimerizing	homodimerize	VBG	VBG	_	4	amod	_	_
3	cytokine	cytokine	NN	NN	_	4	compound	_	_
4	receptors	receptor	NNS	NNS	_	6	nsubj	_	_
5	may	may	MD	MD	_	6	aux	_	_
6	transmit	transmit	VB	VB	_	27	advcl	_	_
7	signal	signal	NN	NN	_	6	dobj	_	_
8	via	via	IN	IN	_	11	case	_	_
9	a	a	DT	DT	_	11	det	_	_
10	single	single	JJ	JJ	_	11	amod	_	_
11	form	form	NN	NN	_	6	nmod	_	_
12	of	of	IN	IN	_	13	case	_	_
13	JAK	jak	NN	NN	_	11	nmod	_	_
14	(	(	-LRB-	-LRB-	_	18	punct	_	_
15	i.e.	i.e.	FW	FW	_	18	dep	_	_
16	growth	growth	NN	NN	_	18	compound	_	_
17	hormone	hormone	NN	NN	_	18	compound	_	_
18	receptors	receptor	NNS	NNS	_	13	appos	_	_
19	)	)	-RRB-	-RRB-	_	18	punct	_	_
20	,	,	,	,	_	27	punct	_	_
21	several	several	JJ	JJ	_	24	amod	_	_
22	multicomponent	multicomponent	JJ	JJ	_	24	amod	_	_
23	cytokine	cytokine	NN	NN	_	24	compound	_	_
24	receptors	receptor	NNS	NNS	_	27	nsubjpass	_	_
25	have	have	VBP	VBP	_	27	aux	_	_
26	been	be	VBN	VBN	_	27	auxpass	_	_
27	shown	show	VBN	VBN	_	0	root	_	_
28	to	to	TO	TO	_	29	mark	_	_
29	require	require	VB	VB	_	27	xcomp	_	_
30	simultaneous	simultaneous	JJ	JJ	_	31	amod	_	_
31	activation	activation	NN	NN	_	29	dobj	_	_
32	of	of	IN	IN	_	33	case	_	_
33	pairs	pair	NNS	NNS	_	31	nmod	_	_
34	of	of	IN	IN	_	37	case	_	_
35	different	different	JJ	JJ	_	37	amod	_	_
36	JAK	jak	NN	NN	_	37	compound	_	_
37	kinases	kinase	NNS	NNS	_	33	nmod	_	_
38	(	(	-LRB-	-LRB-	_	41	punct	_	_
39	i.e.	i.e.	FW	FW	_	41	dep	_	_
40	interferon	interferon	NN	NN	_	41	compound	_	_
41	receptors	receptor	NNS	NNS	_	37	appos	_	_
42	)	)	-RRB-	-RRB-	_	41	punct	_	_
43	.	.	.	.	_	27	punct	_	_

1	Recent	recent	JJ	JJ	_	2	amod	_	_
2	evidence	evidence	NN	NN	_	21	nsubj	_	_
3	for	for	IN	IN	_	6	case	_	_
4	a	a	DT	DT	_	6	det	_	_
5	preferential	preferential	JJ	JJ	_	6	amod	_	_
6	coupling	coupling	NN	NN	_	2	nmod	_	_
7	of	of	IN	IN	_	8	case	_	_
8	JAK3	jak3	NN	NN	_	6	nmod	_	_
9	to	to	TO	TO	_	11	case	_	_
10	interleukin-2	interleukin-2	NN	NN	_	11	compound	_	_
11	receptor-gamma	receptor-gamma	NN	NN	_	8	nmod	_	_
12	(	(	-LRB-	-LRB-	_	14	punct	_	_
13	IL-2R	il-2r	NN	NN	_	14	compound	_	_
14	gamma	gamma	NN	NN	_	11	appos	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	and	and	CC	CC	_	8	cc	_	_
17	JAK1	jak1	NN	NN	_	8	conj	_	_
18	to	to	TO	TO	_	20	case	_	_
19	IL-2R	il-2r	NN	NN	_	20	compound	_	_
20	beta	beta	NN	NN	_	17	nmod	_	_
21	supports	support	VBZ	VBZ	_	0	root	_	_
22	the	the	DT	DT	_	23	det	_	_
23	concept	concept	NN	NN	_	21	dobj	_	_
24	of	of	IN	IN	_	25	case	_	_
25	heterotrans-activation	heterotrans-activation	NN	NN	_	23	nmod	_	_
26	of	of	IN	IN	_	27	case	_	_
27	JAK1	jak1	NN	NN	_	25	nmod	_	_
28	and	and	CC	CC	_	27	cc	_	_
29	JAK3	jak3	NN	NN	_	27	conj	_	_
30	caused	cause	VBN	VBN	_	25	acl	_	_
31	by	by	IN	IN	_	33	case	_	_
32	IL-2-induced	il-2-induced	JJ	JJ	_	33	amod	_	_
33	heterodimerization	heterodimerization	NN	NN	_	30	nmod	_	_
34	of	of	IN	IN	_	37	case	_	_
35	their	they	PRP$	PRP$	_	37	nmod:poss	_	_
36	receptor	receptor	NN	NN	_	37	compound	_	_
37	partners	partner	NNS	NNS	_	33	nmod	_	_
38	.	.	.	.	_	21	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	present	present	JJ	JJ	_	3	amod	_	_
3	study	study	NN	NN	_	4	nsubj	_	_
4	verified	verify	VBD	VBD	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	ability	ability	NN	NN	_	4	dobj	_	_
7	of	of	IN	IN	_	8	case	_	_
8	IL-2	il-2	NN	NN	_	6	nmod	_	_
9	to	to	TO	TO	_	10	mark	_	_
10	cause	cause	VB	VB	_	6	acl	_	_
11	tyrosine	tyrosine	NN	NN	_	12	compound	_	_
12	phosphorylation	phosphorylation	NN	NN	_	10	dobj	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	activation	activation	NN	NN	_	12	conj	_	_
15	of	of	IN	IN	_	16	case	_	_
16	JAK1	jak1	NN	NN	_	14	nmod	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	JAK3	jak3	NN	NN	_	16	conj	_	_
19	,	,	,	,	_	4	punct	_	_
20	but	but	CC	CC	_	4	cc	_	_
21	demonstrated	demonstrate	VBD	VBD	_	4	conj	_	_
22	that	that	IN	IN	_	24	mark	_	_
23	IL-2	il-2	NN	NN	_	24	nsubj	_	_
24	stimulated	stimulate	VBD	VBD	_	21	ccomp	_	_
25	JAK3	jak3	NN	NN	_	24	dobj	_	_
26	to	to	TO	TO	_	30	case	_	_
27	a	a	DT	DT	_	30	det	_	_
28	significantly	significantly	RB	RB	_	29	advmod	_	_
29	larger	larger	JJR	JJR	_	30	amod	_	_
30	extent	extent	NN	NN	_	24	nmod	_	_
31	than	than	IN	IN	_	32	mark	_	_
32	JAK1	jak1	NN	NN	_	30	dep	_	_
33	in	in	IN	IN	_	36	case	_	_
34	human	human	JJ	JJ	_	36	amod	_	_
35	T	t	NN	NN	_	36	compound	_	_
36	lymphocytes	lymphocyte	NNS	NNS	_	32	nmod	_	_
37	and	and	CC	CC	_	36	cc	_	_
38	the	the	DT	DT	_	41	det	_	_
39	YT	yt	NN	NN	_	41	compound	_	_
40	cell	cell	NN	NN	_	41	compound	_	_
41	line	line	NN	NN	_	36	conj	_	_
42	.	.	.	.	_	4	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	conclusion	conclusion	NN	NN	_	4	nsubjpass	_	_
3	was	be	VBD	VBD	_	4	auxpass	_	_
4	based	base	VBN	VBN	_	0	root	_	_
5	upon	upon	IN	IN	_	8	case	_	_
6	several	several	JJ	JJ	_	8	amod	_	_
7	independent	independent	JJ	JJ	_	8	amod	_	_
8	criteria	criterion	NNS	NNS	_	4	nmod	_	_
9	,	,	,	,	_	8	punct	_	_
10	including	include	VBG	VBG	_	14	case	_	_
11	more	more	RBR	RBR	_	12	advmod	_	_
12	vigorous	vigorous	JJ	JJ	_	14	amod	_	_
13	tyrosine	tyrosine	NN	NN	_	14	compound	_	_
14	phosphorylation	phosphorylation	NN	NN	_	8	nmod	_	_
15	of	of	IN	IN	_	16	case	_	_
16	JAK3	jak3	NN	NN	_	14	nmod	_	_
17	,	,	,	,	_	14	punct	_	_
18	more	more	RBR	RBR	_	20	advmod	_	_
19	marked	marked	JJ	JJ	_	20	amod	_	_
20	enzymatic	enzymatic	JJ	JJ	_	21	amod	_	_
21	activation	activation	NN	NN	_	14	conj	_	_
22	of	of	IN	IN	_	23	case	_	_
23	JAK3	jak3	NN	NN	_	21	nmod	_	_
24	as	as	RB	RB	_	14	cc	_	_
25	well	well	RB	RB	_	24	mwe	_	_
26	as	as	IN	IN	_	24	mwe	_	_
27	higher	higher	JJR	JJR	_	28	amod	_	_
28	abundance	abundance	NN	NN	_	14	conj	_	_
29	of	of	IN	IN	_	30	case	_	_
30	JAK3	jak3	NN	NN	_	28	nmod	_	_
31	in	in	IN	IN	_	35	case	_	_
32	activated	activate	VBN	VBN	_	35	amod	_	_
33	IL-2	il-2	NN	NN	_	35	compound	_	_
34	receptor	receptor	NN	NN	_	35	compound	_	_
35	complexes	complex	NNS	NNS	_	14	nmod	_	_
36	.	.	.	.	_	4	punct	_	_

1	Furthermore	furthermore	RB	RB	_	21	advmod	_	_
2	,	,	,	,	_	21	punct	_	_
3	when	when	WRB	WRB	_	9	advmod	_	_
4	human	human	JJ	JJ	_	6	amod	_	_
5	IL-2R	il-2r	NN	NN	_	6	compound	_	_
6	beta	beta	NN	NN	_	9	nsubjpass	_	_
7	was	be	VBD	VBD	_	9	auxpass	_	_
8	stably	stably	RB	RB	_	9	advmod	_	_
9	expressed	express	VBN	VBN	_	21	advcl	_	_
10	in	in	IN	IN	_	13	case	_	_
11	murine	murine	JJ	JJ	_	13	amod	_	_
12	BA/F3	ba/f3	NN	NN	_	13	compound	_	_
13	cells	cell	NNS	NNS	_	9	nmod	_	_
14	,	,	,	,	_	21	punct	_	_
15	robust	robust	JJ	JJ	_	17	amod	_	_
16	IL-2-induced	il-2-induced	JJ	JJ	_	17	amod	_	_
17	proliferation	proliferation	NN	NN	_	21	nsubj	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	JAK3	jak3	NN	NN	_	20	compound	_	_
20	activation	activation	NN	NN	_	17	conj	_	_
21	occurred	occur	VBD	VBD	_	0	root	_	_
22	without	without	IN	IN	_	24	case	_	_
23	detectable	detectable	JJ	JJ	_	24	amod	_	_
24	involvement	involvement	NN	NN	_	21	nmod	_	_
25	of	of	IN	IN	_	27	case	_	_
26	either	either	CC	CC	_	27	cc:preconj	_	_
27	JAK1	jak1	NN	NN	_	24	nmod	_	_
28	,	,	,	,	_	27	punct	_	_
29	JAK2	jak2	NN	NN	_	27	conj	_	_
30	or	or	CC	CC	_	27	cc	_	_
31	TYK2	tyk2	NN	NN	_	27	conj	_	_
32	.	.	.	.	_	21	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	therefore	therefore	RB	RB	_	3	advmod	_	_
3	propose	propose	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	11	mark	_	_
5	IL-2	il-2	NN	NN	_	6	compound	_	_
6	receptor	receptor	NN	NN	_	8	compound	_	_
7	signal	signal	NN	NN	_	8	compound	_	_
8	transduction	transduction	NN	NN	_	11	nsubj	_	_
9	does	do	VBZ	VBZ	_	11	aux	_	_
10	not	not	RB	RB	_	11	neg	_	_
11	depend	depend	VB	VB	_	3	ccomp	_	_
12	on	on	IN	IN	_	14	case	_	_
13	equimolar	equimolar	JJ	JJ	_	14	amod	_	_
14	heterodimerization	heterodimerization	NN	NN	_	11	nmod	_	_
15	of	of	IN	IN	_	16	case	_	_
16	JAK1	jak1	NN	NN	_	14	nmod	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	JAK3	jak3	NN	NN	_	16	conj	_	_
19	following	follow	VBG	VBG	_	21	case	_	_
20	IL-2-induced	il-2-induced	JJ	JJ	_	21	amod	_	_
21	heterodimerization	heterodimerization	NN	NN	_	11	nmod	_	_
22	of	of	IN	IN	_	24	case	_	_
23	IL-2R	il-2r	NN	NN	_	24	compound	_	_
24	beta	beta	NN	NN	_	21	nmod	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	IL-2R	il-2r	NN	NN	_	27	compound	_	_
27	gamma	gamma	NN	NN	_	24	conj	_	_
28	.	.	.	.	_	3	punct	_	_

1	Nonetheless	nonetheless	RB	RB	_	14	advmod	_	_
2	,	,	,	,	_	14	punct	_	_
3	a	a	DT	DT	_	5	det	_	_
4	membrane-proximal	membrane-proximal	JJ	JJ	_	5	amod	_	_
5	region	region	NN	NN	_	14	nsubj	_	_
6	of	of	IN	IN	_	9	case	_	_
7	human	human	JJ	JJ	_	9	amod	_	_
8	IL-2R	il-2r	NN	NN	_	9	compound	_	_
9	beta	beta	NN	NN	_	5	nmod	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	Asn240-Leu335	asn240-leu335	NN	NN	_	5	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	was	be	VBD	VBD	_	14	cop	_	_
14	critical	critical	JJ	JJ	_	0	root	_	_
15	for	for	IN	IN	_	17	case	_	_
16	JAK3	jak3	NN	NN	_	17	compound	_	_
17	activation	activation	NN	NN	_	14	nmod	_	_
18	,	,	,	,	_	14	punct	_	_
19	and	and	CC	CC	_	14	cc	_	_
20	the	the	DT	DT	_	21	det	_	_
21	amount	amount	NN	NN	_	30	nsubj	_	_
22	of	of	IN	IN	_	23	case	_	_
23	JAK3	jak3	NN	NN	_	21	nmod	_	_
24	present	present	JJ	JJ	_	23	amod	_	_
25	in	in	IN	IN	_	29	case	_	_
26	activated	activate	VBN	VBN	_	29	amod	_	_
27	IL-2	il-2	NN	NN	_	29	compound	_	_
28	receptor	receptor	NN	NN	_	29	compound	_	_
29	complexes	complex	NNS	NNS	_	24	nmod	_	_
30	increased	increase	VBD	VBD	_	14	conj	_	_
31	with	with	IN	IN	_	32	case	_	_
32	time	time	NN	NN	_	30	nmod	_	_
33	,	,	,	,	_	14	punct	_	_
34	suggesting	suggest	VBG	VBG	_	14	conj	_	_
35	that	that	IN	IN	_	44	mark	_	_
36	stabilization	stabilization	NN	NN	_	44	nsubj	_	_
37	of	of	IN	IN	_	39	case	_	_
38	JAK3	jak3	NN	NN	_	39	compound	_	_
39	binding	binding	NN	NN	_	36	nmod	_	_
40	to	to	TO	TO	_	43	case	_	_
41	the	the	DT	DT	_	43	det	_	_
42	receptor	receptor	NN	NN	_	43	compound	_	_
43	complex	complex	NN	NN	_	39	nmod	_	_
44	relies	rely	VBZ	VBZ	_	34	ccomp	_	_
45	on	on	IN	IN	_	48	case	_	_
46	both	both	CC	CC	_	48	cc:preconj	_	_
47	IL-2R	il-2r	NN	NN	_	48	compound	_	_
48	beta	beta	NN	NN	_	44	nmod	_	_
49	and	and	CC	CC	_	48	cc	_	_
50	IL-2R	il-2r	NN	NN	_	51	compound	_	_
51	gamma	gamma	NN	NN	_	48	conj	_	_
52	.	.	.	.	_	14	punct	_	_

1	Moreover	moreover	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	STAT5	stat5	NN	NN	_	5	nsubjpass	_	_
4	was	be	VBD	VBD	_	5	auxpass	_	_
5	found	find	VBN	VBN	_	0	root	_	_
6	to	to	TO	TO	_	12	mark	_	_
7	be	be	VB	VB	_	12	cop	_	_
8	the	the	DT	DT	_	12	det	_	_
9	predominant	predominant	JJ	JJ	_	12	amod	_	_
10	STAT	stat	NN	NN	_	12	compound	_	_
11	transcription	transcription	NN	NN	_	12	compound	_	_
12	factor	factor	NN	NN	_	5	xcomp	_	_
13	used	use	VBN	VBN	_	12	acl	_	_
14	by	by	IN	IN	_	15	case	_	_
15	IL-2	il-2	NN	NN	_	13	nmod	_	_
16	in	in	IN	IN	_	19	case	_	_
17	human	human	JJ	JJ	_	19	amod	_	_
18	T	t	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	15	nmod	_	_
20	,	,	,	,	_	5	punct	_	_
21	and	and	CC	CC	_	5	cc	_	_
22	specifically	specifically	RB	RB	_	23	advmod	_	_
23	required	require	VBD	VBD	_	5	conj	_	_
24	a	a	DT	DT	_	26	det	_	_
25	COOH-terminal	cooh-terminal	JJ	JJ	_	26	amod	_	_
26	region	region	NN	NN	_	23	dobj	_	_
27	of	of	IN	IN	_	29	case	_	_
28	IL-2R	il-2r	NN	NN	_	29	compound	_	_
29	beta	beta	NN	NN	_	26	nmod	_	_
30	(	(	-LRB-	-LRB-	_	31	punct	_	_
31	Ser386-Val525	ser386-val525	NN	NN	_	26	appos	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	,	,	,	,	_	23	punct	_	_
34	while	while	IN	IN	_	39	mark	_	_
35	STAT5	stat5	NN	NN	_	36	compound	_	_
36	recruitment	recruitment	NN	NN	_	39	nsubjpass	_	_
37	was	be	VBD	VBD	_	39	auxpass	_	_
38	not	not	RB	RB	_	39	neg	_	_
39	correlated	correlate	VBN	VBN	_	23	advcl	_	_
40	to	to	TO	TO	_	41	case	_	_
41	activation	activation	NN	NN	_	39	nmod	_	_
42	of	of	IN	IN	_	44	case	_	_
43	IL-2R	il-2r	NN	NN	_	44	compound	_	_
44	gamma	gamma	NN	NN	_	41	nmod	_	_
45	or	or	CC	CC	_	44	cc	_	_
46	JAK3	jak3	NN	NN	_	44	conj	_	_
47	.	.	.	.	_	5	punct	_	_

1	Transactivation	transactivation	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	interleukin-1alpha	interleukin-1alpha	NN	NN	_	5	compound	_	_
5	promoter	promoter	NN	NN	_	1	nmod	_	_
6	by	by	IN	IN	_	10	case	_	_
7	human	human	JJ	JJ	_	10	amod	_	_
8	T-cell	t-cell	NN	NN	_	10	compound	_	_
9	leukemia	leukemia	NN	NN	_	10	compound	_	_
10	virus	virus	NN	NN	_	1	nmod	_	_
11	type	type	NN	NN	_	10	dep	_	_
12	I	i	CD	CD	_	11	nummod	_	_
13	and	and	CC	CC	_	10	cc	_	_
14	type	type	NN	NN	_	10	conj	_	_
15	II	ii	CD	CD	_	14	nummod	_	_
16	Tax	tax	NN	NN	_	17	compound	_	_
17	proteins	protein	NNS	NNS	_	10	dep	_	_
18	.	.	.	.	_	1	punct	_	_

1	Human	human	JJ	JJ	_	12	amod	_	_
2	T-cell	t-cell	NN	NN	_	12	compound	_	_
3	leukemia	leukemia	NN	NN	_	12	compound	_	_
4	virus	virus	NN	NN	_	12	compound	_	_
5	type	type	NN	NN	_	12	compound	_	_
6	I	i	CD	CD	_	12	nummod	_	_
7	(	(	-LRB-	-LRB-	_	12	punct	_	_
8	HTLV-I	htlv-i	NN	NN	_	12	compound	_	_
9	)	)	-RRB-	-RRB-	_	12	punct	_	_
10	-infected	-infected	JJ	JJ	_	12	amod	_	_
11	T-cell	t-cell	NN	NN	_	12	compound	_	_
12	lines	line	NNS	NNS	_	14	nsubj	_	_
13	constitutively	constitutively	RB	RB	_	14	advmod	_	_
14	produce	produce	VBP	VBP	_	0	root	_	_
15	high	high	JJ	JJ	_	16	amod	_	_
16	levels	level	NNS	NNS	_	14	dobj	_	_
17	of	of	IN	IN	_	18	case	_	_
18	interleukin-1alpha	interleukin-1alpha	NN	NN	_	16	nmod	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	IL-1alpha	il-1alpha	NN	NN	_	18	appos	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	.	.	.	.	_	14	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	analyze	analyze	VB	VB	_	0	root	_	_
3	the	the	DT	DT	_	4	det	_	_
4	mechanisms	mechanism	NNS	NNS	_	2	dobj	_	_
5	that	that	WDT	WDT	_	6	nsubj	_	_
6	lead	lead	VBP	VBP	_	4	acl:relcl	_	_
7	to	to	TO	TO	_	9	case	_	_
8	the	the	DT	DT	_	9	det	_	_
9	expression	expression	NN	NN	_	6	nmod	_	_
10	of	of	IN	IN	_	11	case	_	_
11	IL-1alpha	il-1alpha	NN	NN	_	9	nmod	_	_
12	in	in	IN	IN	_	15	case	_	_
13	HTLV-I-infected	htlv-i-infected	JJ	JJ	_	15	amod	_	_
14	cell	cell	NN	NN	_	15	compound	_	_
15	lines	line	NNS	NNS	_	9	nmod	_	_
16	,	,	,	,	_	2	punct	_	_
17	we	we	PRP	PRP	_	18	nsubj	_	_
18	studied	study	VBD	VBD	_	2	parataxis	_	_
19	regulatory	regulatory	JJ	JJ	_	20	amod	_	_
20	regions	region	NNS	NNS	_	18	dobj	_	_
21	of	of	IN	IN	_	25	case	_	_
22	the	the	DT	DT	_	25	det	_	_
23	human	human	JJ	JJ	_	25	amod	_	_
24	IL-1alpha	il-1alpha	NN	NN	_	25	compound	_	_
25	promoter	promoter	NN	NN	_	20	nmod	_	_
26	involved	involve	VBN	VBN	_	25	acl	_	_
27	in	in	IN	IN	_	28	case	_	_
28	activation	activation	NN	NN	_	26	nmod	_	_
29	of	of	IN	IN	_	32	case	_	_
30	the	the	DT	DT	_	32	det	_	_
31	IL-1alpha	il-1alpha	NN	NN	_	32	compound	_	_
32	gene	gene	NN	NN	_	28	nmod	_	_
33	.	.	.	.	_	2	punct	_	_

1	IL-1alpha	il-1alpha	NN	NN	_	3	compound	_	_
2	promoter	promoter	NN	NN	_	3	compound	_	_
3	constructs	construct	NNS	NNS	_	4	nsubj	_	_
4	drive	drive	VBP	VBP	_	0	root	_	_
5	transcription	transcription	NN	NN	_	4	dobj	_	_
6	of	of	IN	IN	_	14	case	_	_
7	the	the	DT	DT	_	14	det	_	_
8	chloramphenicol	chloramphenicol	NN	NN	_	14	compound	_	_
9	acetyltransferase	acetyltransferase	NN	NN	_	14	compound	_	_
10	(	(	-LRB-	-LRB-	_	14	punct	_	_
11	CAT	cat	NN	NN	_	14	compound	_	_
12	)	)	-RRB-	-RRB-	_	14	punct	_	_
13	reporter	reporter	NN	NN	_	14	compound	_	_
14	gene	gene	NN	NN	_	5	nmod	_	_
15	in	in	IN	IN	_	18	case	_	_
16	HTLV-I-positive	htlv-i-positive	JJ	JJ	_	18	amod	_	_
17	MT-2	mt-2	NN	NN	_	18	compound	_	_
18	cells	cell	NNS	NNS	_	5	nmod	_	_
19	,	,	,	,	_	18	punct	_	_
20	which	which	WDT	WDT	_	22	nsubj	_	_
21	constitutively	constitutively	RB	RB	_	22	advmod	_	_
22	produce	produce	VBP	VBP	_	18	acl:relcl	_	_
23	IL-1alpha	il-1alpha	NN	NN	_	22	dobj	_	_
24	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	4	case	_	_
2	a	a	DT	DT	_	4	det	_	_
3	cotransfection	cotransfection	NN	NN	_	4	compound	_	_
4	assay	assay	NN	NN	_	15	nmod	_	_
5	,	,	,	,	_	15	punct	_	_
6	the	the	DT	DT	_	8	det	_	_
7	Tax	tax	NN	NN	_	8	compound	_	_
8	protein	protein	NN	NN	_	15	nsubj	_	_
9	of	of	IN	IN	_	11	case	_	_
10	both	both	CC	CC	_	11	cc:preconj	_	_
11	HTLV-I	htlv-i	NN	NN	_	8	nmod	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	HTLV-II	htlv-ii	NN	NN	_	11	conj	_	_
14	specifically	specifically	RB	RB	_	15	advmod	_	_
15	activated	activate	VBD	VBD	_	0	root	_	_
16	transcription	transcription	NN	NN	_	15	dobj	_	_
17	from	from	IN	IN	_	20	case	_	_
18	the	the	DT	DT	_	20	det	_	_
19	IL-1alpha	il-1alpha	NN	NN	_	20	compound	_	_
20	promoter	promoter	NN	NN	_	16	nmod	_	_
21	in	in	IN	IN	_	26	case	_	_
22	an	a	DT	DT	_	26	det	_	_
23	uninfected	uninfected	JJ	JJ	_	26	amod	_	_
24	Jurkat	jurkat	NN	NN	_	26	compound	_	_
25	cell	cell	NN	NN	_	26	compound	_	_
26	line	line	NN	NN	_	20	nmod	_	_
27	.	.	.	.	_	15	punct	_	_

1	A	a	DT	DT	_	4	det	_	_
2	mutant	mutant	JJ	JJ	_	4	amod	_	_
3	Tax	tax	NN	NN	_	4	compound	_	_
4	protein	protein	NN	NN	_	20	nsubj	_	_
5	deficient	deficient	JJ	JJ	_	4	amod	_	_
6	in	in	IN	IN	_	7	case	_	_
7	transactivation	transactivation	NN	NN	_	5	nmod	_	_
8	of	of	IN	IN	_	9	case	_	_
9	genes	gene	NNS	NNS	_	7	nmod	_	_
10	by	by	IN	IN	_	18	case	_	_
11	the	the	DT	DT	_	18	det	_	_
12	nuclear	nuclear	JJ	JJ	_	17	amod	_	_
13	factor	factor	NN	NN	_	17	compound	_	_
14	(	(	-LRB-	-LRB-	_	17	punct	_	_
15	NF	nf	NN	NN	_	17	compound	_	_
16	)	)	-RRB-	-RRB-	_	17	punct	_	_
17	-kappaB	-kappab	NN	NN	_	18	compound	_	_
18	pathway	pathway	NN	NN	_	7	nmod	_	_
19	was	be	VBD	VBD	_	20	cop	_	_
20	unable	unable	JJ	JJ	_	0	root	_	_
21	to	to	TO	TO	_	22	mark	_	_
22	induce	induce	VB	VB	_	20	xcomp	_	_
23	transcriptional	transcriptional	JJ	JJ	_	24	amod	_	_
24	activity	activity	NN	NN	_	22	dobj	_	_
25	of	of	IN	IN	_	28	case	_	_
26	IL-1alpha	il-1alpha	NN	NN	_	28	compound	_	_
27	promoter-CAT	promoter-cat	JJ	JJ	_	28	amod	_	_
28	constructs	construct	NNS	NNS	_	24	nmod	_	_
29	,	,	,	,	_	20	punct	_	_
30	but	but	CC	CC	_	20	cc	_	_
31	was	be	VBD	VBD	_	32	auxpass	_	_
32	rescued	rescue	VBN	VBN	_	20	conj	_	_
33	by	by	IN	IN	_	35	case	_	_
34	exogenous	exogenous	JJ	JJ	_	35	amod	_	_
35	provision	provision	NN	NN	_	32	nmod	_	_
36	of	of	IN	IN	_	37	case	_	_
37	p65/p50	p65/p50	NN	NN	_	35	nmod	_	_
38	NF-kappaB	nf-kappab	NN	NN	_	37	dep	_	_
39	.	.	.	.	_	20	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	found	find	VBD	VBD	_	0	root	_	_
3	that	that	IN	IN	_	19	mark	_	_
4	two	two	CD	CD	_	7	nummod	_	_
5	IL-1alpha	il-1alpha	NN	NN	_	7	compound	_	_
6	kappaB-like	kappab-like	JJ	JJ	_	7	amod	_	_
7	sites	site	NNS	NNS	_	19	nsubj	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	positions	position	NNS	NNS	_	7	appos	_	_
10	-1,065	-1,065	CD	CD	_	12	nummod	_	_
11	to	to	TO	TO	_	12	dep	_	_
12	-1,056	-1,056	CD	CD	_	9	dep	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	+646	+646	CD	CD	_	16	nummod	_	_
15	to	to	TO	TO	_	16	dep	_	_
16	+655	+655	CD	CD	_	12	conj	_	_
17	)	)	-RRB-	-RRB-	_	9	punct	_	_
18	specifically	specifically	RB	RB	_	19	advmod	_	_
19	formed	form	VBD	VBD	_	2	ccomp	_	_
20	a	a	DT	DT	_	21	det	_	_
21	complex	complex	JJ	JJ	_	19	dobj	_	_
22	with	with	IN	IN	_	25	case	_	_
23	NF-kappaB-containing	nf-kappab-containing	JJ	JJ	_	25	amod	_	_
24	nuclear	nuclear	JJ	JJ	_	25	amod	_	_
25	extract	extract	NN	NN	_	19	nmod	_	_
26	from	from	IN	IN	_	28	case	_	_
27	MT-2	mt-2	NN	NN	_	28	compound	_	_
28	cells	cell	NNS	NNS	_	25	nmod	_	_
29	and	and	CC	CC	_	19	cc	_	_
30	that	that	IN	IN	_	32	mark	_	_
31	NF-kappaB	nf-kappab	NN	NN	_	32	nsubj	_	_
32	bound	bind	VBD	VBD	_	19	conj	_	_
33	with	with	IN	IN	_	35	case	_	_
34	higher	higher	JJR	JJR	_	35	amod	_	_
35	affinity	affinity	NN	NN	_	32	nmod	_	_
36	to	to	TO	TO	_	41	case	_	_
37	the	the	DT	DT	_	41	det	_	_
38	3'	3'	JJ	JJ	_	41	amod	_	_
39	NF-kappaB	nf-kappab	NN	NN	_	41	compound	_	_
40	binding	binding	NN	NN	_	41	compound	_	_
41	site	site	NN	NN	_	35	nmod	_	_
42	than	than	IN	IN	_	47	case	_	_
43	to	to	TO	TO	_	47	case	_	_
44	the	the	DT	DT	_	47	det	_	_
45	5'	5'	JJ	JJ	_	47	amod	_	_
46	NF-kappaB	nf-kappab	NN	NN	_	47	compound	_	_
47	site	site	NN	NN	_	35	acl	_	_
48	.	.	.	.	_	2	punct	_	_

1	Moreover	moreover	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	deletion	deletion	NN	NN	_	11	nsubj	_	_
4	of	of	IN	IN	_	6	case	_	_
5	either	either	CC	CC	_	6	cc:preconj	_	_
6	5'	5'	JJ	JJ	_	3	nmod	_	_
7	or	or	CC	CC	_	6	cc	_	_
8	3'	3'	JJ	JJ	_	6	conj	_	_
9	NF-kappaB	nf-kappab	NN	NN	_	10	compound	_	_
10	sites	site	NNS	NNS	_	6	dep	_	_
11	reduced	reduce	VBD	VBD	_	0	root	_	_
12	IL-1alpha	il-1alpha	NN	NN	_	13	compound	_	_
13	promoter	promoter	NN	NN	_	14	compound	_	_
14	activity	activity	NN	NN	_	11	dobj	_	_
15	in	in	IN	IN	_	17	case	_	_
16	MT-2	mt-2	NN	NN	_	17	compound	_	_
17	cells	cell	NNS	NNS	_	14	nmod	_	_
18	and	and	CC	CC	_	14	cc	_	_
19	transactivation	transactivation	NN	NN	_	14	conj	_	_
20	of	of	IN	IN	_	23	case	_	_
21	the	the	DT	DT	_	23	det	_	_
22	IL-1alpha	il-1alpha	NN	NN	_	23	compound	_	_
23	promoter	promoter	NN	NN	_	19	nmod	_	_
24	by	by	IN	IN	_	26	case	_	_
25	exogenous	exogenous	JJ	JJ	_	26	amod	_	_
26	NF-kappaB	nf-kappab	NN	NN	_	19	nmod	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	Tax	tax	NN	NN	_	26	conj	_	_
29	in	in	IN	IN	_	31	case	_	_
30	Jurkat	jurkat	NN	NN	_	31	compound	_	_
31	cells	cell	NNS	NNS	_	26	nmod	_	_
32	.	.	.	.	_	11	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	a	a	DT	DT	_	6	det	_	_
5	general	general	JJ	JJ	_	6	amod	_	_
6	role	role	NN	NN	_	3	dobj	_	_
7	for	for	IN	IN	_	9	case	_	_
8	Tax	tax	NN	NN	_	9	compound	_	_
9	induction	induction	NN	NN	_	6	nmod	_	_
10	of	of	IN	IN	_	13	case	_	_
11	IL-1alpha	il-1alpha	NN	NN	_	12	compound	_	_
12	gene	gene	NN	NN	_	13	compound	_	_
13	transcription	transcription	NN	NN	_	9	nmod	_	_
14	by	by	IN	IN	_	17	case	_	_
15	the	the	DT	DT	_	17	det	_	_
16	NF-kappaB	nf-kappab	NN	NN	_	17	compound	_	_
17	pathway	pathway	NN	NN	_	9	nmod	_	_
18	.	.	.	.	_	3	punct	_	_

1	Expression	expression	NN	NN	_	11	nsubj	_	_
2	of	of	IN	IN	_	3	case	_	_
3	IL-1alpha	il-1alpha	NN	NN	_	1	nmod	_	_
4	by	by	IN	IN	_	5	case	_	_
5	HTLV-I	htlv-i	NN	NN	_	1	nmod	_	_
6	productively	productively	RB	RB	_	5	advmod	_	_
7	infected	infected	JJ	JJ	_	8	amod	_	_
8	cells	cell	NNS	NNS	_	5	dep	_	_
9	may	may	MD	MD	_	11	aux	_	_
10	be	be	VB	VB	_	11	cop	_	_
11	important	important	JJ	JJ	_	0	root	_	_
12	in	in	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	det	_	_
14	hypercalcemia	hypercalcemia	NN	NN	_	11	nmod	_	_
15	,	,	,	,	_	14	punct	_	_
16	osteolytic	osteolytic	JJ	JJ	_	18	amod	_	_
17	bone	bone	NN	NN	_	18	compound	_	_
18	lesions	lesion	NNS	NNS	_	14	conj	_	_
19	,	,	,	,	_	14	punct	_	_
20	neutrophilia	neutrophilia	NN	NN	_	14	conj	_	_
21	,	,	,	,	_	14	punct	_	_
22	elevation	elevation	NN	NN	_	14	conj	_	_
23	of	of	IN	IN	_	25	case	_	_
24	C-reactive	c-reactive	JJ	JJ	_	25	amod	_	_
25	protein	protein	NN	NN	_	22	nmod	_	_
26	,	,	,	,	_	14	punct	_	_
27	and	and	CC	CC	_	14	cc	_	_
28	fever	fever	NN	NN	_	14	conj	_	_
29	frequently	frequently	RB	RB	_	30	advmod	_	_
30	seen	see	VBN	VBN	_	14	acl	_	_
31	in	in	IN	IN	_	32	case	_	_
32	patients	patient	NNS	NNS	_	30	nmod	_	_
33	with	with	IN	IN	_	37	case	_	_
34	HTLV-I-induced	htlv-i-induced	JJ	JJ	_	37	amod	_	_
35	adult	adult	JJ	JJ	_	37	amod	_	_
36	T-cell	t-cell	NN	NN	_	37	compound	_	_
37	leukemia/lymphoma	leukemia/lymphoma	NN	NN	_	32	nmod	_	_
38	.	.	.	.	_	11	punct	_	_

1	Activation	activation	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	5	case	_	_
3	c-Jun	c-jun	NN	NN	_	5	compound	_	_
4	N-terminal	n-terminal	JJ	JJ	_	5	amod	_	_
5	kinase	kinase	NN	NN	_	1	nmod	_	_
6	in	in	IN	IN	_	9	case	_	_
7	bacterial	bacterial	JJ	JJ	_	9	amod	_	_
8	lipopolysaccharide-stimulated	lipopolysaccharide-stimulated	JJ	JJ	_	9	amod	_	_
9	macrophages	macrophage	NNS	NNS	_	1	nmod	_	_
10	.	.	.	.	_	1	punct	_	_

1	Activation	activation	NN	NN	_	10	nsubj	_	_
2	of	of	IN	IN	_	3	case	_	_
3	macrophages	macrophage	NNS	NNS	_	1	nmod	_	_
4	by	by	IN	IN	_	6	case	_	_
5	bacterial	bacterial	JJ	JJ	_	6	amod	_	_
6	lipopolysaccharide	lipopolysaccharide	NN	NN	_	1	nmod	_	_
7	(	(	-LRB-	-LRB-	_	8	punct	_	_
8	LPS	lps	NN	NN	_	6	appos	_	_
9	)	)	-RRB-	-RRB-	_	8	punct	_	_
10	induces	induce	VBZ	VBZ	_	0	root	_	_
11	transcription	transcription	NN	NN	_	10	dobj	_	_
12	of	of	IN	IN	_	13	case	_	_
13	genes	gene	NNS	NNS	_	11	nmod	_	_
14	that	that	WDT	WDT	_	15	nsubj	_	_
15	encode	encode	VBP	VBP	_	13	acl:relcl	_	_
16	for	for	IN	IN	_	18	case	_	_
17	proinflammatory	proinflammatory	JJ	JJ	_	18	amod	_	_
18	regulators	regulator	NNS	NNS	_	15	nmod	_	_
19	of	of	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	immune	immune	JJ	JJ	_	22	amod	_	_
22	response	response	NN	NN	_	18	nmod	_	_
23	.	.	.	.	_	10	punct	_	_

1	Previous	previous	JJ	JJ	_	2	amod	_	_
2	work	work	NN	NN	_	4	nsubj	_	_
3	has	have	VBZ	VBZ	_	4	aux	_	_
4	suggested	suggest	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	20	mark	_	_
6	activation	activation	NN	NN	_	20	nsubj	_	_
7	of	of	IN	IN	_	12	case	_	_
8	the	the	DT	DT	_	12	det	_	_
9	transcription	transcription	NN	NN	_	12	compound	_	_
10	factor	factor	NN	NN	_	12	compound	_	_
11	activator	activator	NN	NN	_	12	compound	_	_
12	protein	protein	NN	NN	_	6	nmod	_	_
13	1	1	CD	CD	_	12	nummod	_	_
14	(	(	-LRB-	-LRB-	_	15	punct	_	_
15	AP-1	ap-1	NN	NN	_	12	appos	_	_
16	)	)	-RRB-	-RRB-	_	15	punct	_	_
17	is	be	VBZ	VBZ	_	20	cop	_	_
18	one	one	CD	CD	_	20	nummod	_	_
19	LPS-induced	lps-induced	JJ	JJ	_	20	amod	_	_
20	event	event	NN	NN	_	4	ccomp	_	_
21	that	that	WDT	WDT	_	22	nsubj	_	_
22	mediates	mediate	VBZ	VBZ	_	20	acl:relcl	_	_
23	this	this	DT	DT	_	24	det	_	_
24	response	response	NN	NN	_	22	dobj	_	_
25	.	.	.	.	_	4	punct	_	_

1	Consistent	consistent	JJ	JJ	_	7	advmod	_	_
2	with	with	IN	IN	_	4	case	_	_
3	this	this	DT	DT	_	4	det	_	_
4	notion	notion	NN	NN	_	1	nmod	_	_
5	,	,	,	,	_	7	punct	_	_
6	we	we	PRP	PRP	_	7	nsubj	_	_
7	found	find	VBD	VBD	_	0	root	_	_
8	that	that	IN	IN	_	10	mark	_	_
9	LPS	lps	NN	NN	_	10	nsubj	_	_
10	stimulated	stimulate	VBD	VBD	_	7	ccomp	_	_
11	AP-1-mediated	ap-1-mediated	JJ	JJ	_	12	amod	_	_
12	transcription	transcription	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	17	case	_	_
14	a	a	DT	DT	_	17	det	_	_
15	transfected	transfect	VBN	VBN	_	17	amod	_	_
16	reporter	reporter	NN	NN	_	17	compound	_	_
17	gene	gene	NN	NN	_	12	nmod	_	_
18	in	in	IN	IN	_	24	case	_	_
19	the	the	DT	DT	_	24	det	_	_
20	murine	murine	JJ	JJ	_	24	amod	_	_
21	macrophage	macrophage	NN	NN	_	24	compound	_	_
22	cell	cell	NN	NN	_	24	compound	_	_
23	line	line	NN	NN	_	24	compound	_	_
24	RAW	raw	NN	NN	_	12	nmod	_	_
25	264.7	264.7	CD	CD	_	24	nummod	_	_
26	.	.	.	.	_	7	punct	_	_

1	As	as	IN	IN	_	5	mark	_	_
2	AP-1	ap-1	NN	NN	_	3	compound	_	_
3	activity	activity	NN	NN	_	5	nsubjpass	_	_
4	is	be	VBZ	VBZ	_	5	auxpass	_	_
5	regulated	regulate	VBN	VBN	_	31	advcl	_	_
6	in	in	IN	IN	_	7	case	_	_
7	part	part	NN	NN	_	5	nmod	_	_
8	by	by	IN	IN	_	9	case	_	_
9	activation	activation	NN	NN	_	5	nmod	_	_
10	of	of	IN	IN	_	14	case	_	_
11	the	the	DT	DT	_	14	det	_	_
12	c-Jun	c-jun	NN	NN	_	14	compound	_	_
13	N-terminal	n-terminal	JJ	JJ	_	14	amod	_	_
14	kinase	kinase	NN	NN	_	9	nmod	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	JNK	jnk	NN	NN	_	14	appos	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	,	,	,	,	_	14	punct	_	_
19	which	which	WDT	WDT	_	20	nsubj	_	_
20	phosphorylates	phosphorylate	VBZ	VBZ	_	14	acl:relcl	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	subsequently	subsequently	RB	RB	_	23	advmod	_	_
23	increases	increase	VBZ	VBZ	_	20	conj	_	_
24	the	the	DT	DT	_	26	det	_	_
25	transcriptional	transcriptional	JJ	JJ	_	26	amod	_	_
26	activity	activity	NN	NN	_	23	dobj	_	_
27	of	of	IN	IN	_	28	case	_	_
28	c-Jun	c-jun	NN	NN	_	26	nmod	_	_
29	,	,	,	,	_	31	punct	_	_
30	we	we	PRP	PRP	_	31	nsubj	_	_
31	examined	examine	VBD	VBD	_	0	root	_	_
32	whether	whether	IN	IN	_	37	mark	_	_
33	LPS	lps	NN	NN	_	34	compound	_	_
34	treatment	treatment	NN	NN	_	37	nsubj	_	_
35	of	of	IN	IN	_	36	case	_	_
36	macrophages	macrophage	NNS	NNS	_	34	nmod	_	_
37	resulted	result	VBD	VBD	_	31	ccomp	_	_
38	in	in	IN	IN	_	39	case	_	_
39	activation	activation	NN	NN	_	37	nmod	_	_
40	of	of	IN	IN	_	42	case	_	_
41	this	this	DT	DT	_	42	det	_	_
42	kinase	kinase	NN	NN	_	39	nmod	_	_
43	.	.	.	.	_	31	punct	_	_

1	LPS	lps	NN	NN	_	2	compound	_	_
2	treatment	treatment	NN	NN	_	20	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	RAW	raw	NN	NN	_	6	compound	_	_
5	264.7	264.7	CD	CD	_	6	nummod	_	_
6	cells	cell	NNS	NNS	_	2	nmod	_	_
7	,	,	,	,	_	6	punct	_	_
8	murine	murine	JJ	JJ	_	11	amod	_	_
9	bone	bone	NN	NN	_	11	compound	_	_
10	marrow-derived	marrow-derived	JJ	JJ	_	11	amod	_	_
11	macrophages	macrophage	NNS	NNS	_	6	appos	_	_
12	,	,	,	,	_	6	punct	_	_
13	and	and	CC	CC	_	6	cc	_	_
14	the	the	DT	DT	_	19	det	_	_
15	human	human	JJ	JJ	_	19	amod	_	_
16	monocyte	monocyte	NN	NN	_	19	compound	_	_
17	cell	cell	NN	NN	_	19	compound	_	_
18	line	line	NN	NN	_	19	compound	_	_
19	THP-1	thp-1	NN	NN	_	6	conj	_	_
20	resulted	result	VBD	VBD	_	0	root	_	_
21	in	in	IN	IN	_	23	case	_	_
22	rapid	rapid	JJ	JJ	_	23	amod	_	_
23	activation	activation	NN	NN	_	20	nmod	_	_
24	of	of	IN	IN	_	26	case	_	_
25	the	the	DT	DT	_	26	dep	_	_
26	p46	p46	NN	NN	_	23	nmod	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	p54	p54	NN	NN	_	26	conj	_	_
29	isoforms	isoform	NNS	NNS	_	26	dep	_	_
30	of	of	IN	IN	_	31	case	_	_
31	JNK	jnk	NN	NN	_	26	nmod	_	_
32	.	.	.	.	_	20	punct	_	_

1	Treatment	treatment	NN	NN	_	14	nsubj	_	_
2	with	with	IN	IN	_	3	case	_	_
3	wild-type	wild-type	JJ	JJ	_	1	nmod	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	rough	rough	JJ	JJ	_	3	conj	_	_
6	mutant	mutant	JJ	JJ	_	7	amod	_	_
7	forms	form	NNS	NNS	_	3	dep	_	_
8	of	of	IN	IN	_	9	case	_	_
9	LPS	lps	NN	NN	_	3	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	synthetic	synthetic	JJ	JJ	_	13	amod	_	_
12	lipid	lipid	NN	NN	_	13	compound	_	_
13	A	a	NN	NN	_	9	conj	_	_
14	resulted	result	VBD	VBD	_	0	root	_	_
15	in	in	IN	IN	_	17	case	_	_
16	JNK	jnk	NN	NN	_	17	compound	_	_
17	activation	activation	NN	NN	_	14	nmod	_	_
18	,	,	,	,	_	14	punct	_	_
19	while	while	IN	IN	_	28	mark	_	_
20	pretreatment	pretreatment	NN	NN	_	28	nsubj	_	_
21	with	with	IN	IN	_	27	case	_	_
22	the	the	DT	DT	_	27	det	_	_
23	tyrosine	tyrosine	NN	NN	_	24	compound	_	_
24	kinase	kinase	NN	NN	_	27	compound	_	_
25	inhibitor	inhibitor	NN	NN	_	27	compound	_	_
26	herbimycin	herbimycin	NN	NN	_	27	compound	_	_
27	A	a	NN	NN	_	20	nmod	_	_
28	inhibited	inhibit	VBD	VBD	_	14	advcl	_	_
29	this	this	DT	DT	_	30	det	_	_
30	response	response	NN	NN	_	28	dobj	_	_
31	.	.	.	.	_	14	punct	_	_

1	Binding	binding	NN	NN	_	23	nsubjpass	_	_
2	of	of	IN	IN	_	9	case	_	_
3	LPS-LPS	lps-lps	NN	NN	_	9	compound	_	_
4	binding	binding	NN	NN	_	9	compound	_	_
5	protein	protein	NN	NN	_	9	compound	_	_
6	(	(	-LRB-	-LRB-	_	9	punct	_	_
7	LBP	lbp	NN	NN	_	9	compound	_	_
8	)	)	-RRB-	-RRB-	_	9	punct	_	_
9	complexes	complex	NNS	NNS	_	1	nmod	_	_
10	to	to	TO	TO	_	11	case	_	_
11	CD14	cd14	NN	NN	_	1	nmod	_	_
12	,	,	,	,	_	11	punct	_	_
13	a	a	DT	DT	_	15	det	_	_
14	surface	surface	NN	NN	_	15	compound	_	_
15	receptor	receptor	NN	NN	_	11	appos	_	_
16	that	that	WDT	WDT	_	17	nsubj	_	_
17	mediates	mediate	VBZ	VBZ	_	15	acl:relcl	_	_
18	many	many	JJ	JJ	_	20	amod	_	_
19	LPS	lps	NN	NN	_	20	compound	_	_
20	responses	response	NNS	NNS	_	17	dobj	_	_
21	,	,	,	,	_	1	punct	_	_
22	was	be	VBD	VBD	_	23	auxpass	_	_
23	found	find	VBN	VBN	_	0	root	_	_
24	to	to	TO	TO	_	26	mark	_	_
25	be	be	VB	VB	_	26	cop	_	_
26	crucial	crucial	JJ	JJ	_	23	xcomp	_	_
27	,	,	,	,	_	23	punct	_	_
28	as	as	IN	IN	_	44	mark	_	_
29	pretreatment	pretreatment	NN	NN	_	44	nsubj	_	_
30	of	of	IN	IN	_	32	case	_	_
31	THP-1	thp-1	NN	NN	_	32	compound	_	_
32	cells	cell	NNS	NNS	_	29	nmod	_	_
33	with	with	IN	IN	_	37	case	_	_
34	the	the	DT	DT	_	37	det	_	_
35	monoclonal	monoclonal	JJ	JJ	_	37	amod	_	_
36	antibody	antibody	NN	NN	_	37	compound	_	_
37	60b	60b	NN	NN	_	29	nmod	_	_
38	,	,	,	,	_	37	punct	_	_
39	which	which	WDT	WDT	_	40	nsubj	_	_
40	blocks	block	VBZ	VBZ	_	37	acl:relcl	_	_
41	this	this	DT	DT	_	42	det	_	_
42	binding	binding	NN	NN	_	40	dobj	_	_
43	,	,	,	,	_	29	punct	_	_
44	inhibited	inhibit	VBD	VBD	_	23	advcl	_	_
45	JNK	jnk	NN	NN	_	46	compound	_	_
46	activation	activation	NN	NN	_	44	dobj	_	_
47	.	.	.	.	_	23	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	19	mark	_	_
5	LPS	lps	NN	NN	_	6	compound	_	_
6	activation	activation	NN	NN	_	19	nsubj	_	_
7	of	of	IN	IN	_	8	case	_	_
8	JNK	jnk	NN	NN	_	6	nmod	_	_
9	in	in	IN	IN	_	11	case	_	_
10	monocyte/macrophage	monocyte/macrophage	JJ	JJ	_	11	amod	_	_
11	cells	cell	NNS	NNS	_	6	nmod	_	_
12	is	be	VBZ	VBZ	_	19	cop	_	_
13	a	a	DT	DT	_	19	det	_	_
14	CD14-	cd14-	NN	NN	_	19	amod	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	protein	protein	NN	NN	_	18	nmod:npmod	_	_
17	tyrosine	tyrosine	NN	NN	_	18	nmod:npmod	_	_
18	phosphorylation-dependent	phosphorylation-dependent	JJ	JJ	_	14	conj	_	_
19	event	event	NN	NN	_	3	ccomp	_	_
20	that	that	WDT	WDT	_	22	nsubj	_	_
21	may	may	MD	MD	_	22	aux	_	_
22	mediate	mediate	VB	VB	_	19	acl:relcl	_	_
23	the	the	DT	DT	_	25	det	_	_
24	early	early	JJ	JJ	_	25	amod	_	_
25	activation	activation	NN	NN	_	22	dobj	_	_
26	of	of	IN	IN	_	27	case	_	_
27	AP-1	ap-1	NN	NN	_	25	nmod	_	_
28	in	in	IN	IN	_	29	mark	_	_
29	regulating	regulate	VBG	VBG	_	22	advcl	_	_
30	LPS-triggered	lps-triggered	JJ	JJ	_	32	amod	_	_
31	gene	gene	NN	NN	_	32	compound	_	_
32	induction	induction	NN	NN	_	29	dobj	_	_
33	.	.	.	.	_	3	punct	_	_

1	Transcriptional	transcriptional	JJ	JJ	_	2	amod	_	_
2	basis	basis	NN	NN	_	0	root	_	_
3	for	for	IN	IN	_	4	case	_	_
4	hyporesponsiveness	hyporesponsiveness	NN	NN	_	2	nmod	_	_
5	of	of	IN	IN	_	12	case	_	_
6	the	the	DT	DT	_	12	det	_	_
7	human	human	JJ	JJ	_	12	amod	_	_
8	inducible	inducible	JJ	JJ	_	12	amod	_	_
9	nitric	nitric	JJ	JJ	_	12	amod	_	_
10	oxide	oxide	NN	NN	_	12	compound	_	_
11	synthase	synthase	NN	NN	_	12	compound	_	_
12	gene	gene	NN	NN	_	4	nmod	_	_
13	to	to	TO	TO	_	14	case	_	_
14	lipopolysaccharide/interferon-gamma	lipopolysaccharide/interferon-gamma	NN	NN	_	4	nmod	_	_
15	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	work	work	NN	NN	_	5	nsubj	_	_
3	reported	report	VBN	VBN	_	2	acl	_	_
4	here	here	RB	RB	_	3	advmod	_	_
5	resolves	resolve	VBZ	VBZ	_	0	root	_	_
6	,	,	,	,	_	5	punct	_	_
7	at	at	IN	IN	_	9	case	_	_
8	the	the	DT	DT	_	9	det	_	_
9	level	level	NN	NN	_	5	nmod	_	_
10	of	of	IN	IN	_	12	case	_	_
11	gene	gene	NN	NN	_	12	compound	_	_
12	regulation	regulation	NN	NN	_	9	nmod	_	_
13	,	,	,	,	_	5	punct	_	_
14	the	the	DT	DT	_	15	det	_	_
15	controversy	controversy	NN	NN	_	5	dobj	_	_
16	as	as	IN	IN	_	24	case	_	_
17	to	to	TO	TO	_	24	mark	_	_
18	whether	whether	IN	IN	_	24	mark	_	_
19	or	or	CC	CC	_	18	cc	_	_
20	not	not	RB	RB	_	18	mwe	_	_
21	human	human	JJ	JJ	_	22	amod	_	_
22	monocytes/macrophages	monocytes/macrophages	NNS	NNS	_	24	nsubj	_	_
23	can	can	MD	MD	_	24	aux	_	_
24	produce	produce	VB	VB	_	15	acl	_	_
25	nitric	nitric	JJ	JJ	_	26	amod	_	_
26	oxide	oxide	NN	NN	_	24	dobj	_	_
27	(	(	-LRB-	-LRB-	_	28	punct	_	_
28	NO	no	NN	NN	_	26	appos	_	_
29	)	)	-RRB-	-RRB-	_	28	punct	_	_
30	when	when	WRB	WRB	_	31	advmod	_	_
31	stimulated	stimulate	VBN	VBN	_	24	advcl	_	_
32	with	with	IN	IN	_	33	case	_	_
33	lipopolysaccharide	lipopolysaccharide	NN	NN	_	31	nmod	_	_
34	(	(	-LRB-	-LRB-	_	35	punct	_	_
35	LPS	lps	NN	NN	_	33	appos	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	,	,	,	,	_	31	punct	_	_
38	with	with	IN	IN	_	41	nmod	_	_
39	or	or	CC	CC	_	41	cc	_	_
40	without	without	IN	IN	_	41	conj	_	_
41	co-stimulation	co-stimulation	NN	NN	_	31	nmod	_	_
42	by	by	IN	IN	_	43	case	_	_
43	interferon-gamma	interferon-gamma	NN	NN	_	41	nmod	_	_
44	(	(	-LRB-	-LRB-	_	45	punct	_	_
45	IFN-gamma	ifn-gamma	NN	NN	_	43	appos	_	_
46	)	)	-RRB-	-RRB-	_	45	punct	_	_
47	.	.	.	.	_	5	punct	_	_

1	Studies	study	NNS	NNS	_	2	nsubj	_	_
2	included	include	VBD	VBD	_	0	root	_	_
3	structural	structural	JJ	JJ	_	4	amod	_	_
4	comparison	comparison	NN	NN	_	2	dobj	_	_
5	of	of	IN	IN	_	7	case	_	_
6	the	the	DT	DT	_	7	det	_	_
7	promoters	promoter	NNS	NNS	_	4	nmod	_	_
8	for	for	IN	IN	_	9	case	_	_
9	human	human	JJ	JJ	_	7	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	mouse	mouse	NN	NN	_	9	conj	_	_
12	inducible	inducible	JJ	JJ	_	18	amod	_	_
13	NO	no	NN	NN	_	18	compound	_	_
14	synthase	synthase	NN	NN	_	18	compound	_	_
15	(	(	-LRB-	-LRB-	_	18	punct	_	_
16	iNOS	inos	NN	NN	_	18	compound	_	_
17	)	)	-RRB-	-RRB-	_	18	punct	_	_
18	genes	gene	NNS	NNS	_	9	dep	_	_
19	,	,	,	,	_	4	punct	_	_
20	transfection	transfection	NN	NN	_	4	conj	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	assay	assay	NN	NN	_	20	conj	_	_
23	of	of	IN	IN	_	24	case	_	_
24	human	human	JJ	JJ	_	20	nmod	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	mouse	mouse	NN	NN	_	24	conj	_	_
27	iNOS	inos	NN	NN	_	29	compound	_	_
28	promoter	promoter	NN	NN	_	29	compound	_	_
29	regions	region	NNS	NNS	_	24	dep	_	_
30	in	in	IN	IN	_	31	case	_	_
31	response	response	NN	NN	_	20	nmod	_	_
32	to	to	TO	TO	_	33	case	_	_
33	LPS	lps	NN	NN	_	31	nmod	_	_
34	+/-	+/-	CC	CC	_	33	cc	_	_
35	IFN-gamma	ifn-gamma	NN	NN	_	33	conj	_	_
36	,	,	,	,	_	4	punct	_	_
37	and	and	CC	CC	_	4	cc	_	_
38	electrophoretic	electrophoretic	JJ	JJ	_	41	amod	_	_
39	mobility	mobility	NN	NN	_	41	compound	_	_
40	shift	shift	NN	NN	_	41	compound	_	_
41	assays	assay	NNS	NNS	_	4	conj	_	_
42	of	of	IN	IN	_	46	case	_	_
43	kappa	kappa	NN	NN	_	46	compound	_	_
44	B	b	NN	NN	_	46	compound	_	_
45	response	response	NN	NN	_	46	compound	_	_
46	elements	element	NNS	NNS	_	41	nmod	_	_
47	.	.	.	.	_	2	punct	_	_

1	Two	two	CD	CD	_	2	nummod	_	_
2	explanations	explanation	NNS	NNS	_	15	nsubjpass	_	_
3	for	for	IN	IN	_	4	case	_	_
4	hyporesponsiveness	hyporesponsiveness	NN	NN	_	2	nmod	_	_
5	of	of	IN	IN	_	9	case	_	_
6	the	the	DT	DT	_	9	det	_	_
7	human	human	JJ	JJ	_	9	amod	_	_
8	iNOS	inos	NN	NN	_	9	compound	_	_
9	promoter	promoter	NN	NN	_	4	nmod	_	_
10	to	to	TO	TO	_	11	case	_	_
11	LPS	lps	NN	NN	_	4	nmod	_	_
12	+/-	+/-	CC	CC	_	11	cc	_	_
13	IFN-gamma	ifn-gamma	NN	NN	_	11	conj	_	_
14	were	be	VBD	VBD	_	15	auxpass	_	_
15	found	find	VBN	VBN	_	0	root	_	_
16	:	:	:	:	_	15	punct	_	_
17	(	(	-LRB-	-LRB-	_	18	punct	_	_
18	1	1	LS	LS	_	23	dep	_	_
19	)	)	-RRB-	-RRB-	_	18	punct	_	_
20	multiple	multiple	JJ	JJ	_	23	amod	_	_
21	inactivating	inactivate	VBG	VBG	_	20	dep	_	_
22	nucleotide	nucleotide	JJ	JJ	_	23	amod	_	_
23	substitutions	substitution	NNS	NNS	_	15	dep	_	_
24	in	in	IN	IN	_	27	case	_	_
25	the	the	DT	DT	_	27	det	_	_
26	human	human	JJ	JJ	_	27	amod	_	_
27	counterpart	counterpart	NN	NN	_	23	nmod	_	_
28	of	of	IN	IN	_	31	case	_	_
29	the	the	DT	DT	_	31	det	_	_
30	enhancer	enhancer	NN	NN	_	31	compound	_	_
31	element	element	NN	NN	_	27	nmod	_	_
32	that	that	WDT	WDT	_	35	nsubjpass	_	_
33	has	have	VBZ	VBZ	_	35	aux	_	_
34	been	be	VBN	VBN	_	35	auxpass	_	_
35	shown	show	VBN	VBN	_	27	acl:relcl	_	_
36	to	to	TO	TO	_	37	mark	_	_
37	regulate	regulate	VB	VB	_	35	xcomp	_	_
38	LPS/IFN-gamma	lps/ifn-gamma	NN	NN	_	40	compound	_	_
39	induced	induced	JJ	JJ	_	40	amod	_	_
40	expression	expression	NN	NN	_	37	dobj	_	_
41	of	of	IN	IN	_	45	case	_	_
42	the	the	DT	DT	_	45	det	_	_
43	mouse	mouse	NN	NN	_	45	compound	_	_
44	iNOS	inos	NN	NN	_	45	compound	_	_
45	gene	gene	NN	NN	_	40	nmod	_	_
46	;	;	:	:	_	23	punct	_	_
47	and	and	CC	CC	_	23	cc	_	_
48	(	(	-LRB-	-LRB-	_	49	punct	_	_
49	2	2	LS	LS	_	52	dep	_	_
50	)	)	-RRB-	-RRB-	_	49	punct	_	_
51	and	and	CC	CC	_	52	cc	_	_
52	absence	absence	NN	NN	_	23	conj	_	_
53	of	of	IN	IN	_	58	case	_	_
54	one	one	CD	CD	_	58	nummod	_	_
55	or	or	CC	CC	_	54	cc	_	_
56	more	more	JJR	JJR	_	54	conj	_	_
57	nuclear	nuclear	JJ	JJ	_	58	amod	_	_
58	factors	factor	NNS	NNS	_	52	nmod	_	_
59	in	in	IN	IN	_	61	case	_	_
60	human	human	JJ	JJ	_	61	amod	_	_
61	macrophages	macrophage	NNS	NNS	_	58	nmod	_	_
62	(	(	-LRB-	-LRB-	_	70	punct	_	_
63	e.g.	e.g.	FW	FW	_	70	dep	_	_
64	,	,	,	,	_	70	punct	_	_
65	an	a	DT	DT	_	70	det	_	_
66	LPS-inducible	lps-inducible	JJ	JJ	_	70	amod	_	_
67	nuclear	nuclear	JJ	JJ	_	70	amod	_	_
68	factor-kappa	factor-kappa	NN	NN	_	70	compound	_	_
69	B/Rel	b/rel	NN	NN	_	70	compound	_	_
70	complex	complex	NN	NN	_	58	dep	_	_
71	)	)	-RRB-	-RRB-	_	70	punct	_	_
72	,	,	,	,	_	58	punct	_	_
73	that	that	WDT	WDT	_	74	nsubj	_	_
74	is	be	VBZ	VBZ	_	58	acl:relcl	_	_
75	(	(	-LRB-	-LRB-	_	76	punct	_	_
76	are	be	VBP	VBP	_	74	dep	_	_
77	)	)	-RRB-	-RRB-	_	76	punct	_	_
78	required	require	VBN	VBN	_	74	dep	_	_
79	for	for	IN	IN	_	81	case	_	_
80	maximal	maximal	JJ	JJ	_	81	amod	_	_
81	expression	expression	NN	NN	_	78	nmod	_	_
82	of	of	IN	IN	_	84	case	_	_
83	the	the	DT	DT	_	84	det	_	_
84	gene	gene	NN	NN	_	81	nmod	_	_
85	.	.	.	.	_	15	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	importance	importance	NN	NN	_	8	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	resolution	resolution	NN	NN	_	2	nmod	_	_
5	of	of	IN	IN	_	7	case	_	_
6	this	this	DT	DT	_	7	det	_	_
7	controversy	controversy	NN	NN	_	4	nmod	_	_
8	is	be	VBZ	VBZ	_	0	root	_	_
9	that	that	IN	IN	_	17	mark	_	_
10	future	future	JJ	JJ	_	11	amod	_	_
11	research	research	NN	NN	_	17	nsubjpass	_	_
12	in	in	IN	IN	_	14	case	_	_
13	this	this	DT	DT	_	14	det	_	_
14	area	area	NN	NN	_	11	nmod	_	_
15	should	should	MD	MD	_	17	aux	_	_
16	be	be	VB	VB	_	17	auxpass	_	_
17	directed	direct	VBN	VBN	_	8	ccomp	_	_
18	toward	toward	IN	IN	_	20	case	_	_
19	the	the	DT	DT	_	20	det	_	_
20	understanding	understanding	NN	NN	_	17	nmod	_	_
21	of	of	IN	IN	_	23	case	_	_
22	alternative	alternative	JJ	JJ	_	23	amod	_	_
23	mechanisms	mechanism	NNS	NNS	_	20	nmod	_	_
24	that	that	WDT	WDT	_	26	nsubj	_	_
25	can	can	MD	MD	_	26	aux	_	_
26	result	result	VB	VB	_	23	acl:relcl	_	_
27	in	in	IN	IN	_	30	case	_	_
28	the	the	DT	DT	_	30	det	_	_
29	successful	successful	JJ	JJ	_	30	amod	_	_
30	production	production	NN	NN	_	26	nmod	_	_
31	of	of	IN	IN	_	32	case	_	_
32	NO	no	NN	NN	_	30	nmod	_	_
33	.	.	.	.	_	8	punct	_	_

1	Ubiquitinylation	ubiquitinylation	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	4	case	_	_
3	transcription	transcription	NN	NN	_	4	compound	_	_
4	factors	factor	NNS	NNS	_	1	nmod	_	_
5	c-Jun	c-jun	NN	NN	_	4	dep	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	c-Fos	c-fos	NN	NN	_	5	conj	_	_
8	using	use	VBG	VBG	_	1	dep	_	_
9	reconstituted	reconstitute	VBN	VBN	_	11	amod	_	_
10	ubiquitinylating	ubiquitinylate	VBG	VBG	_	11	amod	_	_
11	enzymes	enzyme	NNS	NNS	_	8	dobj	_	_
12	.	.	.	.	_	1	punct	_	_

1	Recombinant	recombinant	JJ	JJ	_	2	amod	_	_
2	c-Jun	c-jun	NN	NN	_	6	nsubjpass	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	c-Fos	c-fos	NN	NN	_	2	conj	_	_
5	were	be	VBD	VBD	_	6	auxpass	_	_
6	ubiquitinylated	ubiquitinylate	VBN	VBN	_	0	root	_	_
7	by	by	IN	IN	_	11	case	_	_
8	the	the	DT	DT	_	11	det	_	_
9	ubiquitin	ubiquitin	NN	NN	_	11	compound	_	_
10	carrier	carrier	NN	NN	_	11	compound	_	_
11	enzymes	enzyme	NNS	NNS	_	6	nmod	_	_
12	E214K	e214k	NN	NN	_	11	dep	_	_
13	,	,	,	,	_	12	punct	_	_
14	E220K	e220k	NN	NN	_	12	conj	_	_
15	,	,	,	,	_	12	punct	_	_
16	or	or	CC	CC	_	12	cc	_	_
17	E232K	e232k	NN	NN	_	12	conj	_	_
18	in	in	IN	IN	_	20	case	_	_
19	the	the	DT	DT	_	20	det	_	_
20	presence	presence	NN	NN	_	6	nmod	_	_
21	of	of	IN	IN	_	24	case	_	_
22	the	the	DT	DT	_	24	det	_	_
23	ubiquitin-activating	ubiquitin-activating	JJ	JJ	_	24	amod	_	_
24	enzyme	enzyme	NN	NN	_	20	nmod	_	_
25	,	,	,	,	_	24	punct	_	_
26	E1	e1	NN	NN	_	24	appos	_	_
27	.	.	.	.	_	6	punct	_	_

1	Addition	addition	NN	NN	_	8	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	ubiquitin	ubiquitin	NN	NN	_	6	compound	_	_
4	protein	protein	NN	NN	_	6	compound	_	_
5	ligase	ligase	NN	NN	_	6	compound	_	_
6	E3	e3	NN	NN	_	1	nmod	_	_
7	substantially	substantially	RB	RB	_	8	advmod	_	_
8	enhanced	enhance	VBD	VBD	_	0	root	_	_
9	the	the	DT	DT	_	11	det	_	_
10	E214K-mediated	e214k-mediated	JJ	JJ	_	11	amod	_	_
11	ubiquitinylation	ubiquitinylation	NN	NN	_	8	dobj	_	_
12	of	of	IN	IN	_	13	case	_	_
13	c-Jun	c-jun	NN	NN	_	11	nmod	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	c-Fos	c-fos	NN	NN	_	13	conj	_	_
16	.	.	.	.	_	8	punct	_	_

1	Truncated	truncate	VBN	VBN	_	2	amod	_	_
2	c-Jun	c-jun	NN	NN	_	13	nsubjpass	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	c-Fos	c-fos	NN	NN	_	2	conj	_	_
5	mutant	mutant	JJ	JJ	_	6	amod	_	_
6	proteins	protein	NNS	NNS	_	2	dep	_	_
7	including	include	VBG	VBG	_	8	case	_	_
8	wbJun	wbjun	NN	NN	_	2	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	wbFos	wbfos	NN	NN	_	8	conj	_	_
11	were	be	VBD	VBD	_	13	auxpass	_	_
12	also	also	RB	RB	_	13	advmod	_	_
13	ubiquitinylated	ubiquitinylate	VBN	VBN	_	0	root	_	_
14	under	under	IN	IN	_	17	case	_	_
15	the	the	DT	DT	_	17	det	_	_
16	same	same	JJ	JJ	_	17	amod	_	_
17	conditions	condition	NNS	NNS	_	13	nmod	_	_
18	,	,	,	,	_	13	punct	_	_
19	suggesting	suggest	VBG	VBG	_	13	advcl	_	_
20	the	the	DT	DT	_	21	det	_	_
21	sites	site	NNS	NNS	_	25	nsubj	_	_
22	of	of	IN	IN	_	23	case	_	_
23	ubiquitinylation	ubiquitinylation	NN	NN	_	21	nmod	_	_
24	are	be	VBP	VBP	_	25	cop	_	_
25	located	located	JJ	JJ	_	19	ccomp	_	_
26	within	within	IN	IN	_	28	case	_	_
27	the	the	DT	DT	_	28	dep	_	_
28	dimerization	dimerization	NN	NN	_	25	nmod	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	DNA	dna	NN	NN	_	31	compound	_	_
31	binding	binding	NN	NN	_	28	conj	_	_
32	domains	domain	NNS	NNS	_	28	dep	_	_
33	of	of	IN	IN	_	34	case	_	_
34	c-Jun	c-jun	NN	NN	_	28	nmod	_	_
35	and	and	CC	CC	_	34	cc	_	_
36	c-Fos	c-fos	NN	NN	_	34	conj	_	_
37	.	.	.	.	_	13	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	E3-dependent	e3-dependent	JJ	JJ	_	3	amod	_	_
3	ubiquitinylation	ubiquitinylation	NN	NN	_	7	nsubjpass	_	_
4	of	of	IN	IN	_	5	case	_	_
5	c-Jun	c-jun	NN	NN	_	3	nmod	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	inhibited	inhibit	VBN	VBN	_	0	root	_	_
8	upon	upon	IN	IN	_	10	case	_	_
9	the	the	DT	DT	_	10	det	_	_
10	heterodimerization	heterodimerization	NN	NN	_	7	nmod	_	_
11	of	of	IN	IN	_	12	case	_	_
12	c-Jun	c-jun	NN	NN	_	10	nmod	_	_
13	with	with	IN	IN	_	14	case	_	_
14	c-Fos	c-fos	NN	NN	_	10	nmod	_	_
15	.	.	.	.	_	7	punct	_	_

1	Further	further	IN	IN	_	2	amod	_	_
2	addition	addition	NN	NN	_	6	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	E220K	e220k	NN	NN	_	2	nmod	_	_
5	significantly	significantly	RB	RB	_	6	advmod	_	_
6	enhanced	enhance	VBD	VBD	_	0	root	_	_
7	ubiquitinylation	ubiquitinylation	NN	NN	_	6	dobj	_	_
8	of	of	IN	IN	_	9	case	_	_
9	c-Jun	c-jun	NN	NN	_	7	nmod	_	_
10	in	in	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	heterodimer	heterodimer	NN	NN	_	7	nmod	_	_
13	suggesting	suggest	VBG	VBG	_	6	xcomp	_	_
14	a	a	DT	DT	_	16	det	_	_
15	regulatory	regulatory	JJ	JJ	_	16	amod	_	_
16	role	role	NN	NN	_	13	dobj	_	_
17	of	of	IN	IN	_	18	case	_	_
18	E220K	e220k	NN	NN	_	16	nmod	_	_
19	.	.	.	.	_	6	punct	_	_

1	Polyubiquitinylated	polyubiquitinylate	VBN	VBN	_	2	amod	_	_
2	c-Jun	c-jun	NN	NN	_	16	nsubjpass	_	_
3	,	,	,	,	_	2	punct	_	_
4	wbFos	wbfos	NN	NN	_	2	conj	_	_
5	,	,	,	,	_	2	punct	_	_
6	and	and	CC	CC	_	2	cc	_	_
7	wbJun	wbjun	NN	NN	_	2	conj	_	_
8	,	,	,	,	_	2	punct	_	_
9	but	but	CC	CC	_	10	cc	_	_
10	not	not	RB	RB	_	2	cc	_	_
11	E220K-ubiquitinylated	e220k-ubiquitinylated	JJ	JJ	_	12	amod	_	_
12	c-Jun	c-jun	NN	NN	_	2	conj	_	_
13	,	,	,	,	_	2	punct	_	_
14	were	be	VBD	VBD	_	16	auxpass	_	_
15	readily	readily	RB	RB	_	16	advmod	_	_
16	degraded	degrade	VBN	VBN	_	0	root	_	_
17	by	by	IN	IN	_	23	case	_	_
18	the	the	DT	DT	_	23	det	_	_
19	ATP-dependent	atp-dependent	JJ	JJ	_	23	amod	_	_
20	26	26	CD	CD	_	23	nummod	_	_
21	S	s	NN	NN	_	23	compound	_	_
22	multicatalytic	multicatalytic	JJ	JJ	_	23	amod	_	_
23	proteases	protease	NNS	NNS	_	16	nmod	_	_
24	.	.	.	.	_	16	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	14	mark	_	_
5	the	the	DT	DT	_	7	det	_	_
6	temporal	temporal	JJ	JJ	_	7	amod	_	_
7	control	control	NN	NN	_	14	nsubjpass	_	_
8	of	of	IN	IN	_	9	case	_	_
9	c-Jun	c-jun	NN	NN	_	7	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	c-Fos	c-fos	NN	NN	_	9	conj	_	_
12	may	may	MD	MD	_	14	aux	_	_
13	be	be	VB	VB	_	14	auxpass	_	_
14	regulated	regulate	VBN	VBN	_	3	dep	_	_
15	through	through	IN	IN	_	18	case	_	_
16	the	the	DT	DT	_	18	det	_	_
17	ubiquitinylation	ubiquitinylation	NN	NN	_	18	compound	_	_
18	pathways	pathway	NNS	NNS	_	14	nmod	_	_
19	,	,	,	,	_	14	punct	_	_
20	and	and	CC	CC	_	14	cc	_	_
21	the	the	DT	DT	_	22	det	_	_
22	ubiquitinylation	ubiquitinylation	NN	NN	_	14	conj	_	_
23	of	of	IN	IN	_	24	case	_	_
24	c-Jun	c-jun	NN	NN	_	22	nmod	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	c-Fos	c-fos	NN	NN	_	24	conj	_	_
27	may	may	MD	MD	_	31	aux	_	_
28	in	in	IN	IN	_	29	case	_	_
29	turn	turn	NN	NN	_	31	nmod	_	_
30	be	be	VB	VB	_	31	auxpass	_	_
31	regulated	regulate	VBN	VBN	_	14	dep	_	_
32	in	in	IN	IN	_	33	case	_	_
33	response	response	NN	NN	_	31	nmod	_	_
34	to	to	TO	TO	_	36	case	_	_
35	the	the	DT	DT	_	36	det	_	_
36	heterodimerization	heterodimerization	NN	NN	_	33	nmod	_	_
37	between	between	IN	IN	_	38	case	_	_
38	them	they	PRP	PRP	_	36	nmod	_	_
39	and	and	CC	CC	_	36	cc	_	_
40	the	the	DT	DT	_	41	det	_	_
41	cooperation	cooperation	NN	NN	_	36	conj	_	_
42	between	between	IN	IN	_	43	case	_	_
43	E220K	e220k	NN	NN	_	41	nmod	_	_
44	and	and	CC	CC	_	43	cc	_	_
45	E3	e3	NN	NN	_	43	conj	_	_
46	mediated	mediated	JJ	JJ	_	47	amod	_	_
47	polyubiquitinylation	polyubiquitinylation	NN	NN	_	43	dep	_	_
48	.	.	.	.	_	3	punct	_	_

1	Modulation	modulation	NN	NN	_	10	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	endogenous	endogenous	JJ	JJ	_	5	amod	_	_
4	IL-1	il-1	NN	NN	_	5	compound	_	_
5	beta	beta	NN	NN	_	1	nmod	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	IL-1	il-1	NN	NN	_	8	compound	_	_
8	receptor	receptor	NN	NN	_	9	compound	_	_
9	antagonist	antagonist	NN	NN	_	5	conj	_	_
10	results	result	VBZ	VBZ	_	0	root	_	_
11	in	in	IN	IN	_	13	case	_	_
12	opposing	opposing	JJ	JJ	_	13	amod	_	_
13	effects	effect	NNS	NNS	_	10	nmod	_	_
14	on	on	IN	IN	_	16	case	_	_
15	HIV	hiv	NN	NN	_	16	compound	_	_
16	expression	expression	NN	NN	_	13	nmod	_	_
17	in	in	IN	IN	_	21	case	_	_
18	chronically	chronically	RB	RB	_	21	advmod	_	_
19	infected	infected	JJ	JJ	_	21	amod	_	_
20	monocytic	monocytic	JJ	JJ	_	21	amod	_	_
21	cells	cell	NNS	NNS	_	16	nmod	_	_
22	.	.	.	.	_	10	punct	_	_

1	A	a	DT	DT	_	2	det	_	_
2	proportion	proportion	NN	NN	_	6	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	HIV-infected	hiv-infected	JJ	JJ	_	5	amod	_	_
5	individuals	individual	NNS	NNS	_	2	nmod	_	_
6	experience	experience	VBP	VBP	_	0	root	_	_
7	episodes	episode	NNS	NNS	_	6	dobj	_	_
8	of	of	IN	IN	_	9	case	_	_
9	localized	localized	JJ	JJ	_	7	nmod	_	_
10	or	or	CC	CC	_	9	cc	_	_
11	systemic	systemic	JJ	JJ	_	9	conj	_	_
12	bacterial	bacterial	JJ	JJ	_	13	amod	_	_
13	infections	infection	NNS	NNS	_	9	dep	_	_
14	caused	cause	VBN	VBN	_	9	acl	_	_
15	by	by	IN	IN	_	17	case	_	_
16	Gram-negative	gram-negative	JJ	JJ	_	17	amod	_	_
17	bacteria	bacterium	NNS	NNS	_	14	nmod	_	_
18	.	.	.	.	_	6	punct	_	_

1	Many	many	JJ	JJ	_	11	nsubjpass	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	clinical	clinical	JJ	JJ	_	6	amod	_	_
5	side	side	JJ	JJ	_	6	amod	_	_
6	effects	effect	NNS	NNS	_	1	nmod	_	_
7	of	of	IN	IN	_	9	case	_	_
8	these	these	DT	DT	_	9	det	_	_
9	infections	infection	NNS	NNS	_	6	nmod	_	_
10	are	be	VBP	VBP	_	11	auxpass	_	_
11	associated	associate	VBN	VBN	_	0	root	_	_
12	with	with	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	det	_	_
14	production	production	NN	NN	_	11	nmod	_	_
15	of	of	IN	IN	_	17	case	_	_
16	proinflammatory	proinflammatory	JJ	JJ	_	17	amod	_	_
17	cytokines	cytokine	NNS	NNS	_	14	nmod	_	_
18	,	,	,	,	_	17	punct	_	_
19	which	which	WDT	WDT	_	21	nsubjpass	_	_
20	are	be	VBP	VBP	_	21	auxpass	_	_
21	induced	induce	VBN	VBN	_	17	acl:relcl	_	_
22	primarily	primarily	RB	RB	_	24	advmod	_	_
23	by	by	IN	IN	_	24	case	_	_
24	LPS	lps	NN	NN	_	21	nmod	_	_
25	,	,	,	,	_	24	punct	_	_
26	a	a	DT	DT	_	27	det	_	_
27	constituent	constituent	NN	NN	_	24	appos	_	_
28	of	of	IN	IN	_	32	case	_	_
29	the	the	DT	DT	_	32	det	_	_
30	bacterial	bacterial	JJ	JJ	_	32	amod	_	_
31	cell	cell	NN	NN	_	32	compound	_	_
32	wall	wall	NN	NN	_	27	nmod	_	_
33	of	of	IN	IN	_	35	case	_	_
34	Gram-negative	gram-negative	JJ	JJ	_	35	amod	_	_
35	bacteria	bacterium	NNS	NNS	_	32	nmod	_	_
36	.	.	.	.	_	11	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	present	present	JJ	JJ	_	3	amod	_	_
3	study	study	NN	NN	_	4	nsubj	_	_
4	examines	examine	VBZ	VBZ	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	mechanisms	mechanism	NNS	NNS	_	4	dobj	_	_
7	involved	involve	VBN	VBN	_	6	acl	_	_
8	in	in	IN	IN	_	10	case	_	_
9	LPS-mediated	lps-mediated	JJ	JJ	_	10	amod	_	_
10	induction	induction	NN	NN	_	7	nmod	_	_
11	of	of	IN	IN	_	13	case	_	_
12	HIV	hiv	NN	NN	_	13	compound	_	_
13	expression	expression	NN	NN	_	10	nmod	_	_
14	in	in	IN	IN	_	16	case	_	_
15	U1	u1	NN	NN	_	16	compound	_	_
16	cells	cell	NNS	NNS	_	13	nmod	_	_
17	,	,	,	,	_	16	punct	_	_
18	a	a	DT	DT	_	21	det	_	_
19	promonocytic	promonocytic	JJ	JJ	_	21	amod	_	_
20	cell	cell	NN	NN	_	21	compound	_	_
21	line	line	NN	NN	_	16	appos	_	_
22	chronically	chronically	RB	RB	_	23	advmod	_	_
23	infected	infect	VBN	VBN	_	21	acl	_	_
24	with	with	IN	IN	_	25	case	_	_
25	HIV	hiv	NN	NN	_	23	nmod	_	_
26	.	.	.	.	_	4	punct	_	_

1	Stimulation	stimulation	NN	NN	_	8	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	U1	u1	NN	NN	_	4	compound	_	_
4	cells	cell	NNS	NNS	_	1	nmod	_	_
5	by	by	IN	IN	_	6	case	_	_
6	LPS	lps	NN	NN	_	1	nmod	_	_
7	alone	alone	RB	RB	_	6	advmod	_	_
8	induced	induce	VBD	VBD	_	0	root	_	_
9	minimal	minimal	JJ	JJ	_	10	amod	_	_
10	levels	level	NNS	NNS	_	8	dobj	_	_
11	of	of	IN	IN	_	13	case	_	_
12	HIV	hiv	NN	NN	_	13	compound	_	_
13	expression	expression	NN	NN	_	10	nmod	_	_
14	,	,	,	,	_	13	punct	_	_
15	which	which	WDT	WDT	_	18	nsubjpass	_	_
16	was	be	VBD	VBD	_	18	auxpass	_	_
17	significantly	significantly	RB	RB	_	18	advmod	_	_
18	enhanced	enhance	VBN	VBN	_	13	acl:relcl	_	_
19	by	by	IN	IN	_	22	case	_	_
20	granulocyte-macrophage	granulocyte-macrophage	JJ	JJ	_	22	amod	_	_
21	colony-stimulating	colony-stimulating	JJ	JJ	_	22	amod	_	_
22	factor	factor	NN	NN	_	18	nmod	_	_
23	(	(	-LRB-	-LRB-	_	24	punct	_	_
24	GM-CSF	gm-csf	NN	NN	_	22	appos	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	.	.	.	.	_	8	punct	_	_

1	Costimulation	costimulation	NN	NN	_	9	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	U1	u1	NN	NN	_	4	compound	_	_
4	cells	cell	NNS	NNS	_	1	nmod	_	_
5	with	with	IN	IN	_	6	case	_	_
6	LPS	lps	NN	NN	_	1	nmod	_	_
7	plus	plus	CC	CC	_	6	cc	_	_
8	GM-CSF	gm-csf	NN	NN	_	6	conj	_	_
9	resulted	result	VBD	VBD	_	0	root	_	_
10	in	in	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	accumulation	accumulation	NN	NN	_	9	nmod	_	_
13	of	of	IN	IN	_	15	case	_	_
14	steady-state	steady-state	JJ	JJ	_	15	amod	_	_
15	levels	level	NNS	NNS	_	12	nmod	_	_
16	of	of	IN	IN	_	18	case	_	_
17	HIV	hiv	NN	NN	_	18	compound	_	_
18	RNA	rna	NN	NN	_	15	nmod	_	_
19	;	;	:	:	_	9	punct	_	_
20	however	however	RB	RB	_	50	advmod	_	_
21	,	,	,	,	_	50	punct	_	_
22	only	only	RB	RB	_	23	advmod	_	_
23	a	a	DT	DT	_	24	dep	_	_
24	weak	weak	JJ	JJ	_	25	dep	_	_
25	induction	induction	NN	NN	_	50	nsubjpass	_	_
26	of	of	IN	IN	_	31	case	_	_
27	HIV	hiv	NN	NN	_	31	compound	_	_
28	long	long	JJ	JJ	_	31	amod	_	_
29	terminal	terminal	JJ	JJ	_	31	amod	_	_
30	repeat-driven	repeat-driven	JJ	JJ	_	31	amod	_	_
31	transcription	transcription	NN	NN	_	25	nmod	_	_
32	,	,	,	,	_	31	punct	_	_
33	which	which	WDT	WDT	_	36	nsubjpass	_	_
34	was	be	VBD	VBD	_	36	auxpass	_	_
35	not	not	RB	RB	_	36	neg	_	_
36	associated	associate	VBN	VBN	_	31	acl:relcl	_	_
37	with	with	IN	IN	_	39	case	_	_
38	the	the	DT	DT	_	39	det	_	_
39	activation	activation	NN	NN	_	36	nmod	_	_
40	of	of	IN	IN	_	44	case	_	_
41	the	the	DT	DT	_	44	det	_	_
42	cellular	cellular	JJ	JJ	_	44	amod	_	_
43	transcription	transcription	NN	NN	_	44	compound	_	_
44	factor	factor	NN	NN	_	39	nmod	_	_
45	nuclear	nuclear	JJ	JJ	_	47	amod	_	_
46	factor-kappa	factor-kappa	NN	NN	_	47	compound	_	_
47	B	b	NN	NN	_	44	dep	_	_
48	,	,	,	,	_	25	punct	_	_
49	was	be	VBD	VBD	_	50	auxpass	_	_
50	noted	note	VBN	VBN	_	9	parataxis	_	_
51	.	.	.	.	_	9	punct	_	_

1	Costimulation	costimulation	NN	NN	_	8	nsubj	_	_
2	of	of	IN	IN	_	3	case	_	_
3	cells	cell	NNS	NNS	_	1	nmod	_	_
4	with	with	IN	IN	_	5	case	_	_
5	LPS	lps	NN	NN	_	1	nmod	_	_
6	plus	plus	CC	CC	_	5	cc	_	_
7	GM-CSF	gm-csf	NN	NN	_	5	conj	_	_
8	induced	induce	VBD	VBD	_	0	root	_	_
9	the	the	DT	DT	_	10	det	_	_
10	production	production	NN	NN	_	8	dobj	_	_
11	of	of	IN	IN	_	13	case	_	_
12	proinflammatory	proinflammatory	JJ	JJ	_	13	amod	_	_
13	cytokines	cytokine	NNS	NNS	_	10	nmod	_	_
14	,	,	,	,	_	13	punct	_	_
15	IL-8	il-8	NN	NN	_	13	conj	_	_
16	,	,	,	,	_	13	punct	_	_
17	IL-1	il-1	NN	NN	_	18	compound	_	_
18	beta	beta	NN	NN	_	13	conj	_	_
19	and	and	CC	CC	_	13	cc	_	_
20	IL-6	il-6	NN	NN	_	13	conj	_	_
21	,	,	,	,	_	13	punct	_	_
22	but	but	CC	CC	_	23	cc	_	_
23	not	not	RB	RB	_	13	cc	_	_
24	TNF-alpha	tnf-alpha	NN	NN	_	13	conj	_	_
25	.	.	.	.	_	8	punct	_	_

1	IL-1	il-1	NN	NN	_	2	compound	_	_
2	receptor	receptor	NN	NN	_	3	compound	_	_
3	antagonist	antagonist	NN	NN	_	7	nsubj	_	_
4	(	(	-LRB-	-LRB-	_	5	punct	_	_
5	ra	ra	NN	NN	_	3	appos	_	_
6	)	)	-RRB-	-RRB-	_	5	punct	_	_
7	inhibited	inhibit	VBD	VBD	_	0	root	_	_
8	LPS	lps	NN	NN	_	9	compound	_	_
9	enhancement	enhancement	NN	NN	_	7	dobj	_	_
10	of	of	IN	IN	_	12	case	_	_
11	HIV	hiv	NN	NN	_	12	compound	_	_
12	expression	expression	NN	NN	_	9	nmod	_	_
13	in	in	IN	IN	_	15	case	_	_
14	GM-CSF-stimulated	gm-csf-stimulated	JJ	JJ	_	15	amod	_	_
15	cells	cell	NNS	NNS	_	12	nmod	_	_
16	,	,	,	,	_	7	punct	_	_
17	suggesting	suggest	VBG	VBG	_	7	advcl	_	_
18	that	that	IN	IN	_	22	mark	_	_
19	endogenous	endogenous	JJ	JJ	_	20	amod	_	_
20	IL-1	il-1	NN	NN	_	22	nsubjpass	_	_
21	was	be	VBD	VBD	_	22	auxpass	_	_
22	involved	involve	VBN	VBN	_	17	ccomp	_	_
23	in	in	IN	IN	_	26	case	_	_
24	LPS-mediated	lps-mediated	JJ	JJ	_	26	amod	_	_
25	viral	viral	JJ	JJ	_	26	amod	_	_
26	production	production	NN	NN	_	22	nmod	_	_
27	.	.	.	.	_	7	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	regard	regard	NN	NN	_	7	nmod	_	_
4	,	,	,	,	_	7	punct	_	_
5	anti-inflammatory	anti-inflammatory	JJ	JJ	_	6	amod	_	_
6	cytokines	cytokine	NNS	NNS	_	7	nsubj	_	_
7	inhibited	inhibit	VBD	VBD	_	0	root	_	_
8	LPS	lps	NN	NN	_	12	amod	_	_
9	plus	plus	CC	CC	_	8	cc	_	_
10	GM-CSF-stimulated	gm-csf-stimulated	JJ	JJ	_	8	conj	_	_
11	HIV	hiv	NN	NN	_	12	compound	_	_
12	expression	expression	NN	NN	_	7	dobj	_	_
13	,	,	,	,	_	7	punct	_	_
14	and	and	CC	CC	_	7	cc	_	_
15	this	this	DT	DT	_	16	det	_	_
16	effect	effect	NN	NN	_	18	nsubj	_	_
17	closely	closely	RB	RB	_	18	advmod	_	_
18	correlated	correlate	VBD	VBD	_	7	conj	_	_
19	with	with	IN	IN	_	20	case	_	_
20	inhibition	inhibition	NN	NN	_	18	nmod	_	_
21	of	of	IN	IN	_	24	case	_	_
22	IL-1	il-1	NN	NN	_	23	compound	_	_
23	beta	beta	NN	NN	_	24	compound	_	_
24	release	release	NN	NN	_	20	nmod	_	_
25	and	and	CC	CC	_	20	cc	_	_
26	,	,	,	,	_	20	punct	_	_
27	in	in	IN	IN	_	28	case	_	_
28	particular	particular	JJ	JJ	_	20	conj	_	_
29	,	,	,	,	_	20	punct	_	_
30	with	with	IN	IN	_	31	case	_	_
31	up-regulation	up-regulation	NN	NN	_	20	conj	_	_
32	of	of	IN	IN	_	35	case	_	_
33	endogenous	endogenous	JJ	JJ	_	35	amod	_	_
34	IL-1ra	il-1ra	NN	NN	_	35	compound	_	_
35	production	production	NN	NN	_	31	nmod	_	_
36	.	.	.	.	_	7	punct	_	_

1	Thus	thus	RB	RB	_	22	advmod	_	_
2	,	,	,	,	_	22	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	balance	balance	NN	NN	_	22	nsubj	_	_
5	between	between	IN	IN	_	10	case	_	_
6	an	a	DT	DT	_	10	det	_	_
7	endogenously	endogenously	RB	RB	_	10	advmod	_	_
8	produced	produce	VBN	VBN	_	10	amod	_	_
9	viral	viral	JJ	JJ	_	10	amod	_	_
10	inducer	inducer	NN	NN	_	4	nmod	_	_
11	(	(	-LRB-	-LRB-	_	13	punct	_	_
12	IL-1	il-1	NN	NN	_	13	compound	_	_
13	beta	beta	NN	NN	_	10	appos	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	and	and	CC	CC	_	10	cc	_	_
16	an	a	DT	DT	_	17	det	_	_
17	inhibitor	inhibitor	NN	NN	_	10	conj	_	_
18	(	(	-LRB-	-LRB-	_	19	punct	_	_
19	IL-1ra	il-1ra	NN	NN	_	17	appos	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	may	may	MD	MD	_	22	aux	_	_
22	represent	represent	VB	VB	_	0	root	_	_
23	an	a	DT	DT	_	25	det	_	_
24	important	important	JJ	JJ	_	25	amod	_	_
25	pathway	pathway	NN	NN	_	22	dobj	_	_
26	leading	lead	VBG	VBG	_	25	acl	_	_
27	to	to	TO	TO	_	28	case	_	_
28	modulation	modulation	NN	NN	_	26	nmod	_	_
29	of	of	IN	IN	_	31	case	_	_
30	HIV	hiv	NN	NN	_	31	compound	_	_
31	expression	expression	NN	NN	_	28	nmod	_	_
32	from	from	IN	IN	_	34	case	_	_
33	monocytic	monocytic	JJ	JJ	_	34	amod	_	_
34	cells	cell	NNS	NNS	_	31	nmod	_	_
35	.	.	.	.	_	22	punct	_	_

1	Transcriptional	transcriptional	JJ	JJ	_	2	amod	_	_
2	regulation	regulation	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	interleukin-2	interleukin-2	NN	NN	_	6	compound	_	_
6	gene	gene	NN	NN	_	2	nmod	_	_
7	in	in	IN	IN	_	13	case	_	_
8	normal	normal	JJ	JJ	_	13	amod	_	_
9	human	human	JJ	JJ	_	13	amod	_	_
10	peripheral	peripheral	JJ	JJ	_	13	amod	_	_
11	blood	blood	NN	NN	_	13	compound	_	_
12	T	t	NN	NN	_	13	compound	_	_
13	cells	cell	NNS	NNS	_	2	nmod	_	_
14	.	.	.	.	_	2	punct	_	_

1	Convergence	convergence	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	4	case	_	_
3	costimulatory	costimulatory	JJ	JJ	_	4	amod	_	_
4	signals	signal	NNS	NNS	_	1	nmod	_	_
5	and	and	CC	CC	_	1	cc	_	_
6	differences	difference	NNS	NNS	_	1	conj	_	_
7	from	from	IN	IN	_	10	case	_	_
8	transformed	transform	VBN	VBN	_	10	amod	_	_
9	T	t	NN	NN	_	10	compound	_	_
10	cells	cell	NNS	NNS	_	6	nmod	_	_
11	.	.	.	.	_	1	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	study	study	VB	VB	_	0	root	_	_
3	transcriptional	transcriptional	JJ	JJ	_	4	amod	_	_
4	regulation	regulation	NN	NN	_	2	dobj	_	_
5	in	in	IN	IN	_	9	case	_	_
6	normal	normal	JJ	JJ	_	9	amod	_	_
7	human	human	JJ	JJ	_	9	amod	_	_
8	T	t	NN	NN	_	9	compound	_	_
9	cells	cell	NNS	NNS	_	4	nmod	_	_
10	,	,	,	,	_	2	punct	_	_
11	we	we	PRP	PRP	_	13	nsubj	_	_
12	have	have	VBP	VBP	_	13	aux	_	_
13	optimized	optimize	VBN	VBN	_	2	parataxis	_	_
14	conditions	condition	NNS	NNS	_	13	dobj	_	_
15	for	for	IN	IN	_	17	case	_	_
16	transient	transient	JJ	JJ	_	17	amod	_	_
17	transfection	transfection	NN	NN	_	14	nmod	_	_
18	.	.	.	.	_	2	punct	_	_

1	Interleukin-2	interleukin-2	NN	NN	_	7	compound	_	_
2	(	(	-LRB-	-LRB-	_	7	punct	_	_
3	IL-2	il-2	NN	NN	_	7	compound	_	_
4	)	)	-RRB-	-RRB-	_	7	punct	_	_
5	promoter-reporter	promoter-reporter	JJ	JJ	_	7	amod	_	_
6	gene	gene	NN	NN	_	7	compound	_	_
7	behavior	behavior	NN	NN	_	9	nsubj	_	_
8	closely	closely	RB	RB	_	9	advmod	_	_
9	parallels	parallel	VBZ	VBZ	_	0	root	_	_
10	the	the	DT	DT	_	12	det	_	_
11	endogenous	endogenous	JJ	JJ	_	12	amod	_	_
12	gene	gene	NN	NN	_	9	dobj	_	_
13	in	in	IN	IN	_	14	case	_	_
14	response	response	NN	NN	_	9	nmod	_	_
15	to	to	TO	TO	_	18	case	_	_
16	T	t	NN	NN	_	18	compound	_	_
17	cell	cell	NN	NN	_	18	compound	_	_
18	receptor	receptor	NN	NN	_	14	nmod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	costimulatory	costimulatory	JJ	JJ	_	21	amod	_	_
21	signals	signal	NNS	NNS	_	18	conj	_	_
22	.	.	.	.	_	9	punct	_	_

1	As	as	IN	IN	_	2	mark	_	_
2	assessed	assess	VBN	VBN	_	21	advcl	_	_
3	with	with	IN	IN	_	5	case	_	_
4	mutagenized	mutagenize	VBN	VBN	_	5	amod	_	_
5	promoters	promoter	NNS	NNS	_	2	nmod	_	_
6	,	,	,	,	_	21	punct	_	_
7	the	the	DT	DT	_	12	det	_	_
8	most	most	RBS	RBS	_	9	advmod	_	_
9	important	important	JJ	JJ	_	12	amod	_	_
10	IL-2	il-2	NN	NN	_	12	compound	_	_
11	cis-regulatory	cis-regulatory	JJ	JJ	_	12	amod	_	_
12	elements	element	NNS	NNS	_	21	nsubj	_	_
13	in	in	IN	IN	_	16	case	_	_
14	normal	normal	JJ	JJ	_	16	amod	_	_
15	T	t	NN	NN	_	16	compound	_	_
16	cells	cell	NNS	NNS	_	12	nmod	_	_
17	are	be	VBP	VBP	_	21	cop	_	_
18	the	the	DT	DT	_	21	det	_	_
19	proximal	proximal	JJ	JJ	_	21	amod	_	_
20	AP-1	ap-1	NN	NN	_	21	compound	_	_
21	site	site	NN	NN	_	0	root	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	the	the	DT	DT	_	25	det	_	_
24	NF-kappaB	nf-kappab	NN	NN	_	25	compound	_	_
25	site	site	NN	NN	_	21	conj	_	_
26	.	.	.	.	_	21	punct	_	_

1	Both	both	CC	CC	_	3	cc:preconj	_	_
2	primary	primary	JJ	JJ	_	3	amod	_	_
3	activation	activation	NN	NN	_	36	nsubjpass	_	_
4	,	,	,	,	_	3	punct	_	_
5	with	with	IN	IN	_	6	case	_	_
6	phytohemagglutinin	phytohemagglutinin	NN	NN	_	3	nmod	_	_
7	or	or	CC	CC	_	6	cc	_	_
8	antibodies	antibody	NNS	NNS	_	10	compound	_	_
9	to	to	TO	TO	_	10	dep	_	_
10	CD3	cd3	NN	NN	_	6	conj	_	_
11	,	,	,	,	_	3	punct	_	_
12	and	and	CC	CC	_	3	cc	_	_
13	costimulation	costimulation	NN	NN	_	3	conj	_	_
14	,	,	,	,	_	13	punct	_	_
15	provided	provide	VBN	VBN	_	13	acl	_	_
16	by	by	IN	IN	_	17	case	_	_
17	pairs	pair	NNS	NNS	_	15	nmod	_	_
18	of	of	IN	IN	_	20	case	_	_
19	CD2	cd2	NN	NN	_	20	compound	_	_
20	antibodies	antibody	NNS	NNS	_	17	nmod	_	_
21	or	or	CC	CC	_	17	cc	_	_
22	B7-positive	b7-positive	JJ	JJ	_	25	amod	_	_
23	(	(	-LRB-	-LRB-	_	25	punct	_	_
24	B	b	NN	NN	_	25	compound	_	_
25	cells	cell	NNS	NNS	_	17	conj	_	_
26	)	)	-RRB-	-RRB-	_	25	punct	_	_
27	or	or	CC	CC	_	25	cc	_	_
28	B7-negative	b7-negative	JJ	JJ	_	33	amod	_	_
29	(	(	-LRB-	-LRB-	_	33	punct	_	_
30	endothelial	endothelial	NN	NN	_	33	compound	_	_
31	)	)	-RRB-	-RRB-	_	33	punct	_	_
32	accessory	accessory	JJ	JJ	_	33	amod	_	_
33	cells	cell	NNS	NNS	_	25	conj	_	_
34	,	,	,	,	_	33	punct	_	_
35	are	be	VBP	VBP	_	36	auxpass	_	_
36	mediated	mediate	VBN	VBN	_	0	root	_	_
37	through	through	IN	IN	_	40	case	_	_
38	the	the	DT	DT	_	40	det	_	_
39	same	same	JJ	JJ	_	40	amod	_	_
40	cis-elements	cis-element	NNS	NNS	_	36	nmod	_	_
41	.	.	.	.	_	36	punct	_	_

1	Interestingly	interestingly	RB	RB	_	14	advmod	_	_
2	,	,	,	,	_	14	punct	_	_
3	the	the	DT	DT	_	10	det	_	_
4	nuclear	nuclear	JJ	JJ	_	10	amod	_	_
5	factor	factor	NN	NN	_	10	compound	_	_
6	of	of	IN	IN	_	10	amod	_	_
7	activated	activate	VBN	VBN	_	10	amod	_	_
8	T	t	NN	NN	_	10	compound	_	_
9	cell	cell	NN	NN	_	10	compound	_	_
10	sites	site	NNS	NNS	_	14	nsubj	_	_
11	are	be	VBP	VBP	_	14	cop	_	_
12	much	much	RB	RB	_	13	advmod	_	_
13	less	less	RBR	RBR	_	14	advmod	_	_
14	important	important	JJ	JJ	_	0	root	_	_
15	in	in	IN	IN	_	18	case	_	_
16	normal	normal	JJ	JJ	_	18	amod	_	_
17	T	t	NN	NN	_	18	compound	_	_
18	cells	cell	NNS	NNS	_	14	nmod	_	_
19	than	than	IN	IN	_	23	case	_	_
20	in	in	IN	IN	_	23	case	_	_
21	Jurkat	jurkat	NN	NN	_	23	compound	_	_
22	T	t	NN	NN	_	23	compound	_	_
23	cells	cell	NNS	NNS	_	14	nmod	_	_
24	.	.	.	.	_	14	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	conclude	conclude	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	7	mark	_	_
4	IL-2	il-2	NN	NN	_	6	compound	_	_
5	transcriptional	transcriptional	JJ	JJ	_	6	amod	_	_
6	regulation	regulation	NN	NN	_	7	nsubj	_	_
7	differs	differ	VBZ	VBZ	_	2	ccomp	_	_
8	in	in	IN	IN	_	11	case	_	_
9	tumor	tumor	NN	NN	_	11	compound	_	_
10	cell	cell	NN	NN	_	11	compound	_	_
11	lines	line	NNS	NNS	_	7	nmod	_	_
12	compared	compare	VBN	VBN	_	16	case	_	_
13	with	with	IN	IN	_	16	case	_	_
14	normal	normal	JJ	JJ	_	16	amod	_	_
15	T	t	NN	NN	_	16	compound	_	_
16	cells	cell	NNS	NNS	_	7	advcl	_	_
17	and	and	CC	CC	_	7	cc	_	_
18	that	that	IN	IN	_	22	mark	_	_
19	different	different	JJ	JJ	_	21	amod	_	_
20	costimulatory	costimulatory	JJ	JJ	_	21	amod	_	_
21	signals	signal	NNS	NNS	_	22	nsubj	_	_
22	converge	converge	VBP	VBP	_	7	conj	_	_
23	on	on	IN	IN	_	26	case	_	_
24	the	the	DT	DT	_	26	det	_	_
25	same	same	JJ	JJ	_	26	amod	_	_
26	cis-elements	cis-element	NNS	NNS	_	22	nmod	_	_
27	in	in	IN	IN	_	30	case	_	_
28	the	the	DT	DT	_	30	det	_	_
29	IL-2	il-2	NN	NN	_	30	compound	_	_
30	promoter	promoter	NN	NN	_	26	nmod	_	_
31	.	.	.	.	_	2	punct	_	_

1	Monocytic	monocytic	JJ	JJ	_	5	amod	_	_
2	cell	cell	NN	NN	_	5	compound	_	_
3	type-specific	type-specific	JJ	JJ	_	5	amod	_	_
4	transcriptional	transcriptional	JJ	JJ	_	5	amod	_	_
5	induction	induction	NN	NN	_	0	root	_	_
6	of	of	IN	IN	_	7	case	_	_
7	collagenase	collagenase	NN	NN	_	5	nmod	_	_
8	.	.	.	.	_	5	punct	_	_

1	Interstitial	interstitial	JJ	JJ	_	2	amod	_	_
2	collagenase	collagenase	NN	NN	_	20	nsubj	_	_
3	(	(	-LRB-	-LRB-	_	4	punct	_	_
4	MMP-1	mmp-1	NN	NN	_	2	appos	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	,	,	,	,	_	2	punct	_	_
7	a	a	DT	DT	_	8	det	_	_
8	metalloproteinase	metalloproteinase	NN	NN	_	2	appos	_	_
9	produced	produce	VBN	VBN	_	8	acl	_	_
10	by	by	IN	IN	_	11	case	_	_
11	resident	resident	JJ	JJ	_	9	nmod	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	inflammatory	inflammatory	JJ	JJ	_	11	conj	_	_
14	cells	cell	NNS	NNS	_	11	dep	_	_
15	during	during	IN	IN	_	18	case	_	_
16	connective	connective	JJ	JJ	_	18	amod	_	_
17	tissue	tissue	NN	NN	_	18	compound	_	_
18	turnover	turnover	NN	NN	_	9	nmod	_	_
19	,	,	,	,	_	2	punct	_	_
20	cleaves	cleave	VBZ	VBZ	_	0	root	_	_
21	type	type	NN	NN	_	24	compound	_	_
22	I	i	CD	CD	_	24	nummod	_	_
23	collagen	collagen	NN	NN	_	24	compound	_	_
24	fibrils	fibril	NNS	NNS	_	20	dobj	_	_
25	.	.	.	.	_	20	punct	_	_

1	This	this	DT	DT	_	3	det	_	_
2	catalytic	catalytic	JJ	JJ	_	3	amod	_	_
3	event	event	NN	NN	_	6	nsubj	_	_
4	is	be	VBZ	VBZ	_	6	cop	_	_
5	rate	rate	NN	NN	_	6	dep	_	_
6	limiting	limit	VBG	VBG	_	0	root	_	_
7	in	in	IN	IN	_	8	case	_	_
8	remodeling	remodeling	NN	NN	_	6	nmod	_	_
9	of	of	IN	IN	_	10	case	_	_
10	tissues	tissue	NNS	NNS	_	8	nmod	_	_
11	rich	rich	JJ	JJ	_	10	amod	_	_
12	in	in	IN	IN	_	14	case	_	_
13	fibrillar	fibrillar	JJ	JJ	_	14	amod	_	_
14	collagen	collagen	NN	NN	_	11	nmod	_	_
15	such	such	JJ	JJ	_	18	case	_	_
16	as	as	IN	IN	_	15	mwe	_	_
17	the	the	DT	DT	_	18	det	_	_
18	skin	skin	NN	NN	_	14	nmod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	lungs	lung	NNS	NNS	_	18	conj	_	_
21	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	regulation	regulation	NN	NN	_	8	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	collagenase	collagenase	NN	NN	_	5	compound	_	_
5	expression	expression	NN	NN	_	2	nmod	_	_
6	is	be	VBZ	VBZ	_	8	cop	_	_
7	cell-type	cell-type	NN	NN	_	8	nmod:npmod	_	_
8	specific	specific	JJ	JJ	_	0	root	_	_
9	;	;	:	:	_	8	punct	_	_
10	bacterial	bacterial	JJ	JJ	_	11	amod	_	_
11	LPS	lps	NN	NN	_	23	nsubj	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	zymosan	zymosan	NN	NN	_	11	conj	_	_
14	,	,	,	,	_	13	punct	_	_
15	a	a	DT	DT	_	19	det	_	_
16	yeast	yeast	NN	NN	_	19	compound	_	_
17	cell	cell	NN	NN	_	19	compound	_	_
18	wall	wall	NN	NN	_	19	compound	_	_
19	derivative	derivative	NN	NN	_	13	appos	_	_
20	,	,	,	,	_	11	punct	_	_
21	are	be	VBP	VBP	_	23	cop	_	_
22	potent	potent	JJ	JJ	_	23	amod	_	_
23	inducers	inducer	NNS	NNS	_	8	parataxis	_	_
24	of	of	IN	IN	_	26	case	_	_
25	collagenase	collagenase	NN	NN	_	26	compound	_	_
26	expression	expression	NN	NN	_	23	nmod	_	_
27	in	in	IN	IN	_	28	case	_	_
28	macrophages	macrophage	NNS	NNS	_	26	nmod	_	_
29	,	,	,	,	_	23	punct	_	_
30	but	but	CC	CC	_	23	cc	_	_
31	do	do	VBP	VBP	_	33	aux	_	_
32	not	not	RB	RB	_	33	neg	_	_
33	alter	alter	VB	VB	_	23	conj	_	_
34	fibroblast	fibroblast	NN	NN	_	36	compound	_	_
35	collagenase	collagenase	NN	NN	_	36	compound	_	_
36	expression	expression	NN	NN	_	33	dobj	_	_
37	.	.	.	.	_	8	punct	_	_

1	Since	since	IN	IN	_	14	mark	_	_
2	promoter	promoter	NN	NN	_	3	compound	_	_
3	elements	element	NNS	NNS	_	14	nsubjpass	_	_
4	controlling	control	VBG	VBG	_	3	acl	_	_
5	collagenase	collagenase	NN	NN	_	6	compound	_	_
6	transcription	transcription	NN	NN	_	4	dobj	_	_
7	in	in	IN	IN	_	9	case	_	_
8	monocytic	monocytic	JJ	JJ	_	9	amod	_	_
9	cells	cell	NNS	NNS	_	6	nmod	_	_
10	have	have	VBP	VBP	_	14	aux	_	_
11	not	not	RB	RB	_	14	neg	_	_
12	been	be	VBN	VBN	_	14	auxpass	_	_
13	previously	previously	RB	RB	_	14	advmod	_	_
14	defined	define	VBN	VBN	_	17	advcl	_	_
15	,	,	,	,	_	17	punct	_	_
16	we	we	PRP	PRP	_	17	nsubj	_	_
17	sought	seek	VBD	VBD	_	0	root	_	_
18	to	to	TO	TO	_	19	mark	_	_
19	delineate	delineate	VB	VB	_	17	xcomp	_	_
20	responsive	responsive	JJ	JJ	_	22	amod	_	_
21	cis-acting	cis-acting	JJ	JJ	_	22	amod	_	_
22	elements	element	NNS	NNS	_	19	dobj	_	_
23	of	of	IN	IN	_	26	case	_	_
24	the	the	DT	DT	_	26	det	_	_
25	collagenase	collagenase	NN	NN	_	26	compound	_	_
26	promoter	promoter	NN	NN	_	22	nmod	_	_
27	in	in	IN	IN	_	30	case	_	_
28	transiently	transiently	RB	RB	_	29	advmod	_	_
29	transfected	transfect	VBN	VBN	_	30	amod	_	_
30	human	human	JJ	JJ	_	26	nmod	_	_
31	(	(	-LRB-	-LRB-	_	32	punct	_	_
32	U937	u937	NN	NN	_	30	appos	_	_
33	)	)	-RRB-	-RRB-	_	32	punct	_	_
34	and	and	CC	CC	_	30	cc	_	_
35	murine	murine	JJ	JJ	_	30	conj	_	_
36	(	(	-LRB-	-LRB-	_	37	punct	_	_
37	J774	j774	NN	NN	_	35	appos	_	_
38	)	)	-RRB-	-RRB-	_	37	punct	_	_
39	monocytic	monocytic	JJ	JJ	_	41	amod	_	_
40	cell	cell	NN	NN	_	41	compound	_	_
41	lines	line	NNS	NNS	_	30	dep	_	_
42	.	.	.	.	_	17	punct	_	_

1	Deletion	deletion	NN	NN	_	2	compound	_	_
2	constructs	construct	NNS	NNS	_	17	nsubj	_	_
3	containing	contain	VBG	VBG	_	2	acl	_	_
4	as	as	RB	RB	_	7	advmod	_	_
5	little	little	JJ	JJ	_	7	advmod	_	_
6	as	as	IN	IN	_	7	advmod	_	_
7	72	72	CD	CD	_	8	nummod	_	_
8	bp	bp	NN	NN	_	3	dobj	_	_
9	of	of	IN	IN	_	11	case	_	_
10	5'-flanking	5'-flanking	JJ	JJ	_	11	amod	_	_
11	sequence	sequence	NN	NN	_	8	nmod	_	_
12	of	of	IN	IN	_	15	case	_	_
13	the	the	DT	DT	_	15	det	_	_
14	collagenase	collagenase	NN	NN	_	15	compound	_	_
15	promoter	promoter	NN	NN	_	11	nmod	_	_
16	were	be	VBD	VBD	_	17	cop	_	_
17	sufficient	sufficient	JJ	JJ	_	0	root	_	_
18	for	for	IN	IN	_	19	case	_	_
19	LPS-	lps-	NN	NN	_	17	nmod	_	_
20	or	or	CC	CC	_	19	cc	_	_
21	zymosan-mediated	zymosan-mediated	JJ	JJ	_	19	conj	_	_
22	transcriptional	transcriptional	JJ	JJ	_	23	amod	_	_
23	induction	induction	NN	NN	_	19	dep	_	_
24	,	,	,	,	_	17	punct	_	_
25	whereas	whereas	IN	IN	_	28	mark	_	_
26	phorbol	phorbol	NN	NN	_	27	compound	_	_
27	inducibility	inducibility	NN	NN	_	28	nsubj	_	_
28	exhibited	exhibit	VBD	VBD	_	17	advcl	_	_
29	an	a	DT	DT	_	31	det	_	_
30	absolute	absolute	JJ	JJ	_	31	amod	_	_
31	requirement	requirement	NN	NN	_	28	dobj	_	_
32	for	for	IN	IN	_	34	case	_	_
33	upstream	upstream	JJ	JJ	_	34	amod	_	_
34	elements	element	NNS	NNS	_	31	nmod	_	_
35	including	include	VBG	VBG	_	41	case	_	_
36	the	the	DT	DT	_	41	det	_	_
37	polyoma	polyoma	NN	NN	_	41	compound	_	_
38	enhancer	enhancer	NN	NN	_	41	compound	_	_
39	A-binding	a-binding	JJ	JJ	_	41	amod	_	_
40	protein-3	protein-3	NN	NN	_	41	compound	_	_
41	site	site	NN	NN	_	34	nmod	_	_
42	(	(	-LRB-	-LRB-	_	45	punct	_	_
43	-83	-83	CD	CD	_	45	nummod	_	_
44	to	to	TO	TO	_	45	dep	_	_
45	-91	-91	CD	CD	_	41	appos	_	_
46	)	)	-RRB-	-RRB-	_	45	punct	_	_
47	and	and	CC	CC	_	41	cc	_	_
48	TTCA	ttca	NN	NN	_	49	compound	_	_
49	sequence	sequence	NN	NN	_	41	conj	_	_
50	(	(	-LRB-	-LRB-	_	53	punct	_	_
51	-102	-102	CD	CD	_	53	nummod	_	_
52	to	to	TO	TO	_	53	dep	_	_
53	-105	-105	CD	CD	_	49	appos	_	_
54	)	)	-RRB-	-RRB-	_	53	punct	_	_
55	in	in	IN	IN	_	58	case	_	_
56	both	both	CC	CC	_	58	cc:preconj	_	_
57	monocytic	monocytic	JJ	JJ	_	58	amod	_	_
58	cells	cell	NNS	NNS	_	28	nmod	_	_
59	and	and	CC	CC	_	58	cc	_	_
60	fibroblasts	fibroblast	NNS	NNS	_	58	conj	_	_
61	.	.	.	.	_	17	punct	_	_

1	Mutagenesis	mutagenesis	NN	NN	_	12	nsubj	_	_
2	of	of	IN	IN	_	9	case	_	_
3	the	the	DT	DT	_	9	det	_	_
4	activator	activator	NN	NN	_	9	compound	_	_
5	protein-1	protein-1	NN	NN	_	9	compound	_	_
6	-LSB-	-lsb-	-LRB-	-LRB-	_	9	punct	_	_
7	AP-1	ap-1	NN	NN	_	9	compound	_	_
8	-RSB-	-rsb-	-RRB-	-RRB-	_	9	punct	_	_
9	site	site	NN	NN	_	1	nmod	_	_
10	at	at	IN	IN	_	11	case	_	_
11	-72	-72	CD	CD	_	9	nmod	_	_
12	abolished	abolish	VBD	VBD	_	0	root	_	_
13	basal	basal	JJ	JJ	_	14	amod	_	_
14	promoter	promoter	NN	NN	_	15	compound	_	_
15	activity	activity	NN	NN	_	12	dobj	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	LPS/zymosan	lps/zymosan	NN	NN	_	18	compound	_	_
18	inducibility	inducibility	NN	NN	_	15	conj	_	_
19	,	,	,	,	_	12	punct	_	_
20	while	while	IN	IN	_	30	mark	_	_
21	mutagenesis	mutagenesis	NN	NN	_	30	nsubj	_	_
22	of	of	IN	IN	_	25	case	_	_
23	an	a	DT	DT	_	25	det	_	_
24	NF-kappaB-like	nf-kappab-like	JJ	JJ	_	25	amod	_	_
25	site	site	NN	NN	_	21	nmod	_	_
26	at	at	IN	IN	_	29	case	_	_
27	-20	-20	CD	CD	_	29	compound	_	_
28	to	to	TO	TO	_	29	dep	_	_
29	-10	-10	CD	CD	_	25	nmod	_	_
30	had	have	VBD	VBD	_	12	advcl	_	_
31	no	no	DT	DT	_	32	neg	_	_
32	effect	effect	NN	NN	_	30	dobj	_	_
33	.	.	.	.	_	12	punct	_	_

1	Nuclear	nuclear	JJ	JJ	_	2	amod	_	_
2	extracts	extract	NNS	NNS	_	8	nsubj	_	_
3	from	from	IN	IN	_	4	case	_	_
4	LPS-	lps-	NN	NN	_	2	nmod	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	zymosan-treated	zymosan-treated	JJ	JJ	_	7	amod	_	_
7	cells	cell	NNS	NNS	_	4	conj	_	_
8	showed	show	VBD	VBD	_	0	root	_	_
9	strong	strong	JJ	JJ	_	11	amod	_	_
10	AP-1	ap-1	NN	NN	_	11	compound	_	_
11	activity	activity	NN	NN	_	8	dobj	_	_
12	by	by	IN	IN	_	14	case	_	_
13	gel-shift	gel-shift	JJ	JJ	_	14	amod	_	_
14	analysis	analysis	NN	NN	_	8	nmod	_	_
15	,	,	,	,	_	8	punct	_	_
16	and	and	CC	CC	_	8	cc	_	_
17	supershift	supershift	NN	NN	_	18	compound	_	_
18	analysis	analysis	NN	NN	_	19	nsubj	_	_
19	showed	show	VBD	VBD	_	8	conj	_	_
20	the	the	DT	DT	_	22	det	_	_
21	AP-1	ap-1	NN	NN	_	22	compound	_	_
22	complexes	complex	NNS	NNS	_	19	dobj	_	_
23	contained	contain	VBD	VBD	_	19	dep	_	_
24	specific	specific	JJ	JJ	_	25	amod	_	_
25	members	member	NNS	NNS	_	23	dobj	_	_
26	of	of	IN	IN	_	29	case	_	_
27	both	both	CC	CC	_	29	cc:preconj	_	_
28	the	the	DT	DT	_	29	dep	_	_
29	jun	jun	NN	NN	_	25	nmod	_	_
30	and	and	CC	CC	_	29	cc	_	_
31	fos	fos	NN	NN	_	29	conj	_	_
32	gene	gene	NN	NN	_	33	compound	_	_
33	families	family	NNS	NNS	_	29	dep	_	_
34	.	.	.	.	_	8	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	20	mark	_	_
5	,	,	,	,	_	20	punct	_	_
6	in	in	IN	IN	_	7	case	_	_
7	contrast	contrast	NN	NN	_	20	nmod	_	_
8	to	to	TO	TO	_	11	case	_	_
9	most	most	JJS	JJS	_	11	amod	_	_
10	LPS	lps	NN	NN	_	11	compound	_	_
11	effects	effect	NNS	NNS	_	7	nmod	_	_
12	,	,	,	,	_	20	punct	_	_
13	AP-1	ap-1	NN	NN	_	20	nsubj	_	_
14	,	,	,	,	_	13	punct	_	_
15	but	but	CC	CC	_	16	cc	_	_
16	not	not	RB	RB	_	13	cc	_	_
17	nuclear	nuclear	JJ	JJ	_	18	amod	_	_
18	factor-kappaB	factor-kappab	NN	NN	_	13	conj	_	_
19	,	,	,	,	_	13	punct	_	_
20	mediates	mediate	VBZ	VBZ	_	3	ccomp	_	_
21	LPS	lps	NN	NN	_	22	compound	_	_
22	induction	induction	NN	NN	_	20	dobj	_	_
23	of	of	IN	IN	_	25	case	_	_
24	collagenase	collagenase	NN	NN	_	25	compound	_	_
25	transcription	transcription	NN	NN	_	22	nmod	_	_
26	in	in	IN	IN	_	28	case	_	_
27	macrophagelike	macrophagelike	JJ	JJ	_	28	amod	_	_
28	cells	cell	NNS	NNS	_	25	nmod	_	_
29	.	.	.	.	_	3	punct	_	_

1	Furthermore	furthermore	RB	RB	_	26	advmod	_	_
2	,	,	,	,	_	26	punct	_	_
3	as	as	IN	IN	_	4	dep	_	_
4	compared	compare	VBN	VBN	_	26	dep	_	_
5	to	to	TO	TO	_	6	case	_	_
6	regulation	regulation	NN	NN	_	4	nmod	_	_
7	by	by	IN	IN	_	9	case	_	_
8	phorbol	phorbol	NN	NN	_	9	compound	_	_
9	ester	ester	NN	NN	_	6	nmod	_	_
10	,	,	,	,	_	26	punct	_	_
11	collagenase	collagenase	NN	NN	_	12	compound	_	_
12	induction	induction	NN	NN	_	26	nsubj	_	_
13	in	in	IN	IN	_	15	case	_	_
14	monocytic	monocytic	JJ	JJ	_	15	amod	_	_
15	cells	cell	NNS	NNS	_	12	nmod	_	_
16	by	by	IN	IN	_	19	case	_	_
17	cell	cell	NN	NN	_	19	compound	_	_
18	wall	wall	NN	NN	_	19	compound	_	_
19	derivatives	derivative	NNS	NNS	_	12	nmod	_	_
20	of	of	IN	IN	_	21	case	_	_
21	bacteria	bacterium	NNS	NNS	_	19	nmod	_	_
22	or	or	CC	CC	_	21	cc	_	_
23	yeast	yeast	NN	NN	_	21	conj	_	_
24	is	be	VBZ	VBZ	_	26	cop	_	_
25	largely	largely	RB	RB	_	26	advmod	_	_
26	independent	independent	JJ	JJ	_	0	root	_	_
27	of	of	IN	IN	_	30	case	_	_
28	upstream	upstream	JJ	JJ	_	30	amod	_	_
29	promoter	promoter	NN	NN	_	30	compound	_	_
30	sequences	sequence	NNS	NNS	_	26	nmod	_	_
31	.	.	.	.	_	26	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	role	role	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	4	case	_	_
4	p16	p16	NN	NN	_	2	nmod	_	_
5	in	in	IN	IN	_	10	case	_	_
6	the	the	DT	DT	_	10	det	_	_
7	E2F-dependent	e2f-dependent	JJ	JJ	_	9	amod	_	_
8	thymidine	thymidine	NN	NN	_	9	compound	_	_
9	kinase	kinase	NN	NN	_	10	compound	_	_
10	regulation	regulation	NN	NN	_	2	nmod	_	_
11	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	role	role	NN	NN	_	31	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	alterations	alteration	NNS	NNS	_	2	nmod	_	_
5	of	of	IN	IN	_	10	case	_	_
6	the	the	DT	DT	_	10	det	_	_
7	MTS1	mts1	NN	NN	_	10	compound	_	_
8	tumor	tumor	NN	NN	_	10	compound	_	_
9	suppressor	suppressor	NN	NN	_	10	compound	_	_
10	gene	gene	NN	NN	_	4	nmod	_	_
11	on	on	IN	IN	_	13	case	_	_
12	chromosome	chromosome	NN	NN	_	13	compound	_	_
13	9p21	9p21	NN	NN	_	10	nmod	_	_
14	,	,	,	,	_	10	punct	_	_
15	which	which	WDT	WDT	_	16	nsubj	_	_
16	encodes	encode	VBZ	VBZ	_	10	acl:relcl	_	_
17	p16	p16	NN	NN	_	16	dobj	_	_
18	,	,	,	,	_	17	punct	_	_
19	the	the	DT	DT	_	20	det	_	_
20	inhibitor	inhibitor	NN	NN	_	17	appos	_	_
21	of	of	IN	IN	_	22	case	_	_
22	cyclin-dependent-kinase-4	cyclin-dependent-kinase-4	NN	NN	_	20	nmod	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	6	6	CD	CD	_	22	conj	_	_
25	,	,	,	,	_	4	punct	_	_
26	in	in	IN	IN	_	27	case	_	_
27	tumorigenesis	tumorigenesis	NN	NN	_	4	nmod	_	_
28	is	be	VBZ	VBZ	_	31	cop	_	_
29	not	not	RB	RB	_	30	dep	_	_
30	yet	yet	RB	RB	_	31	advmod	_	_
31	clear	clear	JJ	JJ	_	0	root	_	_
32	.	.	.	.	_	31	punct	_	_

1	Phosphorylation	phosphorylation	NN	NN	_	12	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	retinoblastoma	retinoblastoma	NN	NN	_	5	compound	_	_
5	protein	protein	NN	NN	_	1	nmod	_	_
6	by	by	IN	IN	_	8	case	_	_
7	cyclin-dependent	cyclin-dependent	JJ	JJ	_	8	amod	_	_
8	kinases	kinase	NNS	NNS	_	1	nmod	_	_
9	4	4	CD	CD	_	8	dep	_	_
10	and	and	CC	CC	_	8	cc	_	_
11	6	6	CD	CD	_	8	conj	_	_
12	prevents	prevent	VBZ	VBZ	_	0	root	_	_
13	its	its	PRP$	PRP$	_	14	nmod:poss	_	_
14	interaction	interaction	NN	NN	_	12	dobj	_	_
15	with	with	IN	IN	_	18	case	_	_
16	the	the	DT	DT	_	18	det	_	_
17	transcription	transcription	NN	NN	_	18	compound	_	_
18	factor	factor	NN	NN	_	14	nmod	_	_
19	E2F	e2f	NN	NN	_	18	dep	_	_
20	,	,	,	,	_	18	punct	_	_
21	which	which	WDT	WDT	_	23	nsubj	_	_
22	subsequently	subsequently	RB	RB	_	23	advmod	_	_
23	promotes	promote	VBZ	VBZ	_	18	acl:relcl	_	_
24	the	the	DT	DT	_	25	det	_	_
25	expression	expression	NN	NN	_	23	dobj	_	_
26	of	of	IN	IN	_	30	case	_	_
27	S	s	NN	NN	_	30	compound	_	_
28	phase	phase	NN	NN	_	30	compound	_	_
29	regulated	regulated	JJ	JJ	_	30	amod	_	_
30	genes	gene	NNS	NNS	_	25	nmod	_	_
31	,	,	,	,	_	30	punct	_	_
32	such	such	JJ	JJ	_	35	case	_	_
33	as	as	IN	IN	_	32	mwe	_	_
34	thymidine	thymidine	NN	NN	_	35	compound	_	_
35	kinase	kinase	NN	NN	_	30	nmod	_	_
36	.	.	.	.	_	12	punct	_	_

1	Although	although	IN	IN	_	11	mark	_	_
2	a	a	DT	DT	_	3	det	_	_
3	role	role	NN	NN	_	11	nsubjpass	_	_
4	of	of	IN	IN	_	5	case	_	_
5	p16	p16	NN	NN	_	3	nmod	_	_
6	in	in	IN	IN	_	8	case	_	_
7	this	this	DT	DT	_	8	det	_	_
8	regulation	regulation	NN	NN	_	3	nmod	_	_
9	has	have	VBZ	VBZ	_	11	aux	_	_
10	been	be	VBN	VBN	_	11	auxpass	_	_
11	presumed	presume	VBN	VBN	_	14	advcl	_	_
12	,	,	,	,	_	14	punct	_	_
13	there	there	EX	EX	_	14	expl	_	_
14	is	be	VBZ	VBZ	_	0	root	_	_
15	no	no	DT	DT	_	16	neg	_	_
16	proof	proof	NN	NN	_	14	nsubj	_	_
17	so	so	RB	RB	_	18	advmod	_	_
18	far	far	RB	RB	_	16	advmod	_	_
19	that	that	IN	IN	_	27	mark	_	_
20	loss	loss	NN	NN	_	27	nsubj	_	_
21	of	of	IN	IN	_	25	case	_	_
22	this	this	DT	DT	_	25	det	_	_
23	tumor	tumor	NN	NN	_	25	compound	_	_
24	suppressor	suppressor	NN	NN	_	25	compound	_	_
25	gene	gene	NN	NN	_	20	nmod	_	_
26	really	really	RB	RB	_	27	advmod	_	_
27	affects	affect	VBZ	VBZ	_	16	dep	_	_
28	E2F-mediated	e2f-mediated	JJ	JJ	_	29	amod	_	_
29	regulations	regulation	NNS	NNS	_	27	dobj	_	_
30	.	.	.	.	_	14	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	investigated	investigate	VBD	VBD	_	0	root	_	_
3	the	the	DT	DT	_	4	det	_	_
4	regulation	regulation	NN	NN	_	2	dobj	_	_
5	of	of	IN	IN	_	7	case	_	_
6	thymidine	thymidine	NN	NN	_	7	compound	_	_
7	kinase	kinase	NN	NN	_	4	nmod	_	_
8	in	in	IN	IN	_	12	case	_	_
9	phytohemagglutinin-stimulated	phytohemagglutinin-stimulated	JJ	JJ	_	12	amod	_	_
10	normal	normal	JJ	JJ	_	12	amod	_	_
11	human	human	JJ	JJ	_	12	amod	_	_
12	lymphocytes	lymphocyte	NNS	NNS	_	4	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	in	in	IN	IN	_	22	case	_	_
15	the	the	DT	DT	_	22	det	_	_
16	p16-negative	p16-negative	JJ	JJ	_	22	amod	_	_
17	human	human	JJ	JJ	_	22	amod	_	_
18	acute	acute	JJ	JJ	_	22	amod	_	_
19	lymphoblastic	lymphoblastic	JJ	JJ	_	22	amod	_	_
20	leukemia	leukemia	NN	NN	_	22	compound	_	_
21	cell	cell	NN	NN	_	22	compound	_	_
22	lines	line	NNS	NNS	_	12	conj	_	_
23	,	,	,	,	_	22	punct	_	_
24	MOLT-4	molt-4	NN	NN	_	22	appos	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	CEM	cem	NN	NN	_	24	conj	_	_
27	.	.	.	.	_	2	punct	_	_

1	Compared	compare	VBN	VBN	_	4	case	_	_
2	to	to	TO	TO	_	4	case	_	_
3	normal	normal	JJ	JJ	_	4	amod	_	_
4	lymphocytes	lymphocyte	NNS	NNS	_	10	advcl	_	_
5	,	,	,	,	_	10	punct	_	_
6	MOLT-4	molt-4	NN	NN	_	10	nsubj	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	CEM	cem	NN	NN	_	6	conj	_	_
9	cells	cell	NNS	NNS	_	6	dep	_	_
10	exhibited	exhibit	VBD	VBD	_	0	root	_	_
11	an	a	DT	DT	_	15	det	_	_
12	altered	altered	JJ	JJ	_	15	amod	_	_
13	cell	cell	NN	NN	_	15	compound	_	_
14	cycle	cycle	NN	NN	_	15	compound	_	_
15	regulation	regulation	NN	NN	_	10	dobj	_	_
16	of	of	IN	IN	_	18	case	_	_
17	thymidine	thymidine	NN	NN	_	18	compound	_	_
18	kinase	kinase	NN	NN	_	15	nmod	_	_
19	,	,	,	,	_	15	punct	_	_
20	a	a	DT	DT	_	24	det	_	_
21	much	much	RB	RB	_	23	advmod	_	_
22	higher	higher	JJR	JJR	_	23	dep	_	_
23	intracellular	intracellular	JJ	JJ	_	24	amod	_	_
24	activity	activity	NN	NN	_	15	conj	_	_
25	of	of	IN	IN	_	27	case	_	_
26	this	this	DT	DT	_	27	det	_	_
27	enzyme	enzyme	NN	NN	_	24	nmod	_	_
28	,	,	,	,	_	15	punct	_	_
29	and	and	CC	CC	_	15	cc	_	_
30	higher	higher	JJR	JJR	_	34	amod	_	_
31	thymidine	thymidine	NN	NN	_	33	compound	_	_
32	kinase	kinase	NN	NN	_	33	compound	_	_
33	mRNA	mrna	NN	NN	_	34	compound	_	_
34	expression	expression	NN	NN	_	15	conj	_	_
35	.	.	.	.	_	10	punct	_	_

1	Transient	transient	JJ	JJ	_	2	amod	_	_
2	expression	expression	NN	NN	_	9	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	p16	p16	NN	NN	_	2	nmod	_	_
5	in	in	IN	IN	_	8	case	_	_
6	normal	normal	JJ	JJ	_	8	amod	_	_
7	human	human	JJ	JJ	_	8	amod	_	_
8	lymphocytes	lymphocyte	NNS	NNS	_	2	nmod	_	_
9	caused	cause	VBD	VBD	_	0	root	_	_
10	arrest	arrest	NN	NN	_	9	dobj	_	_
11	in	in	IN	IN	_	12	case	_	_
12	G1	g1	NN	NN	_	10	nmod	_	_
13	,	,	,	,	_	9	punct	_	_
14	but	but	CC	CC	_	9	cc	_	_
15	was	be	VBD	VBD	_	17	cop	_	_
16	without	without	IN	IN	_	17	case	_	_
17	effect	effect	NN	NN	_	9	conj	_	_
18	on	on	IN	IN	_	21	case	_	_
19	the	the	DT	DT	_	21	det	_	_
20	cell	cell	NN	NN	_	21	compound	_	_
21	growth	growth	NN	NN	_	17	nmod	_	_
22	of	of	IN	IN	_	23	case	_	_
23	MOLT-4	molt-4	NN	NN	_	21	nmod	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	CEM	cem	NN	NN	_	23	conj	_	_
26	cells	cell	NNS	NNS	_	23	dep	_	_
27	,	,	,	,	_	9	punct	_	_
28	although	although	IN	IN	_	32	mark	_	_
29	all	all	DT	DT	_	32	nsubj	_	_
30	of	of	IN	IN	_	31	case	_	_
31	them	they	PRP	PRP	_	29	nmod	_	_
32	express	express	VBP	VBP	_	9	advcl	_	_
33	functional	functional	JJ	JJ	_	35	amod	_	_
34	retinoblastoma	retinoblastoma	NN	NN	_	35	compound	_	_
35	protein	protein	NN	NN	_	32	dobj	_	_
36	.	.	.	.	_	9	punct	_	_

1	Nevertheless	nevertheless	RB	RB	_	13	advmod	_	_
2	,	,	,	,	_	13	punct	_	_
3	in	in	IN	IN	_	8	case	_	_
4	the	the	DT	DT	_	8	det	_	_
5	two	two	CD	CD	_	8	nummod	_	_
6	leukemia	leukemia	NN	NN	_	8	compound	_	_
7	cell	cell	NN	NN	_	8	compound	_	_
8	lines	line	NNS	NNS	_	13	nmod	_	_
9	transient	transient	JJ	JJ	_	10	amod	_	_
10	overexpression	overexpression	NN	NN	_	13	nsubj	_	_
11	of	of	IN	IN	_	12	case	_	_
12	p16	p16	NN	NN	_	10	nmod	_	_
13	reestablished	reestablish	VBD	VBD	_	0	root	_	_
14	the	the	DT	DT	_	16	det	_	_
15	normal	normal	JJ	JJ	_	16	amod	_	_
16	regulation	regulation	NN	NN	_	13	dobj	_	_
17	of	of	IN	IN	_	19	case	_	_
18	thymidine	thymidine	NN	NN	_	19	compound	_	_
19	kinase	kinase	NN	NN	_	16	nmod	_	_
20	,	,	,	,	_	16	punct	_	_
21	paralleled	parallel	VBN	VBN	_	16	acl	_	_
22	by	by	IN	IN	_	24	case	_	_
23	an	a	DT	DT	_	24	det	_	_
24	increase	increase	NN	NN	_	21	nmod	_	_
25	of	of	IN	IN	_	28	case	_	_
26	the	the	DT	DT	_	28	det	_	_
27	underphosphorylated	underphosphorylated	JJ	JJ	_	28	amod	_	_
28	form	form	NN	NN	_	24	nmod	_	_
29	of	of	IN	IN	_	31	case	_	_
30	retinoblastoma	retinoblastoma	NN	NN	_	31	compound	_	_
31	protein	protein	NN	NN	_	28	nmod	_	_
32	and	and	CC	CC	_	24	cc	_	_
33	decrease	decrease	NN	NN	_	24	conj	_	_
34	of	of	IN	IN	_	36	case	_	_
35	free	free	JJ	JJ	_	36	amod	_	_
36	E2F	e2f	NN	NN	_	33	nmod	_	_
37	bound	bind	VBD	VBD	_	36	acl	_	_
38	to	to	TO	TO	_	40	case	_	_
39	its	its	PRP$	PRP$	_	40	nmod:poss	_	_
40	motif	motif	NN	NN	_	37	nmod	_	_
41	in	in	IN	IN	_	45	case	_	_
42	the	the	DT	DT	_	45	det	_	_
43	thymidine	thymidine	NN	NN	_	45	compound	_	_
44	kinase	kinase	NN	NN	_	45	compound	_	_
45	promoter	promoter	NN	NN	_	40	nmod	_	_
46	.	.	.	.	_	13	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	7	mark	_	_
4	loss	loss	NN	NN	_	7	nsubj	_	_
5	of	of	IN	IN	_	6	case	_	_
6	p16	p16	NN	NN	_	4	nmod	_	_
7	causes	cause	VBZ	VBZ	_	2	ccomp	_	_
8	upregulation	upregulation	NN	NN	_	7	dobj	_	_
9	of	of	IN	IN	_	13	case	_	_
10	this	this	DT	DT	_	13	det	_	_
11	DNA	dna	NN	NN	_	13	compound	_	_
12	precursor	precursor	NN	NN	_	13	compound	_	_
13	pathway	pathway	NN	NN	_	8	nmod	_	_
14	enzyme	enzyme	NN	NN	_	13	dep	_	_
15	via	via	IN	IN	_	16	case	_	_
16	activation	activation	NN	NN	_	8	nmod	_	_
17	of	of	IN	IN	_	18	case	_	_
18	E2F	e2f	NN	NN	_	16	nmod	_	_
19	by	by	IN	IN	_	21	case	_	_
20	a	a	DT	DT	_	21	det	_	_
21	mechanism	mechanism	NN	NN	_	16	nmod	_	_
22	involving	involve	VBG	VBG	_	21	acl	_	_
23	retinoblastoma	retinoblastoma	NN	NN	_	24	compound	_	_
24	protein	protein	NN	NN	_	22	dobj	_	_
25	.	.	.	.	_	2	punct	_	_

1	cAMP	camp	NN	NN	_	2	compound	_	_
2	inducibility	inducibility	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	5	case	_	_
4	transcriptional	transcriptional	JJ	JJ	_	5	amod	_	_
5	repressor	repressor	NN	NN	_	2	nmod	_	_
6	ICER	icer	NN	NN	_	5	dep	_	_
7	in	in	IN	IN	_	8	case	_	_
8	developing	develop	VBG	VBG	_	2	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	mature	mature	JJ	JJ	_	13	amod	_	_
11	human	human	JJ	JJ	_	13	amod	_	_
12	T	t	NN	NN	_	13	compound	_	_
13	lymphocytes	lymphocyte	NNS	NNS	_	8	conj	_	_
14	-LSB-	-lsb-	-LRB-	-LRB-	_	17	punct	_	_
15	published	publish	VBN	VBN	_	16	amod	_	_
16	erratum	erratum	NN	NN	_	17	nsubj	_	_
17	appears	appear	VBZ	VBZ	_	2	dep	_	_
18	in	in	IN	IN	_	25	case	_	_
19	Proc	Proc	NNP	NNP	_	25	compound	_	_
20	Natl	Natl	NNP	NNP	_	25	compound	_	_
21	Acad	Acad	NNP	NNP	_	25	compound	_	_
22	Sci	Sci	NNP	NNP	_	25	compound	_	_
23	U	U	NNP	NNP	_	25	compound	_	_
24	S	S	NNP	NNP	_	25	compound	_	_
25	A	A	NNP	NNP	_	17	nmod	_	_
26	1996	1996	CD	CD	_	27	nummod	_	_
27	Jul	Jul	NNP	NNP	_	25	dep	_	_
28	23	23	CD	CD	_	27	nummod	_	_
29	;	;	:	:	_	25	punct	_	_
30	93	93	CD	CD	_	32	nummod	_	_
31	(	(	-LRB-	-LRB-	_	32	punct	_	_
32	15	15	CD	CD	_	25	dep	_	_
33	)	)	-RRB-	-RRB-	_	32	punct	_	_
34	:	:	:	:	_	25	punct	_	_
35	8154	8154	CD	CD	_	25	dep	_	_
36	-RSB-	-rsb-	-RRB-	-RRB-	_	17	punct	_	_

1	Stimulation	stimulation	NN	NN	_	7	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	cAMP-dependent	camp-dependent	JJ	JJ	_	6	amod	_	_
5	signaling	signaling	NN	NN	_	6	compound	_	_
6	pathway	pathway	NN	NN	_	1	nmod	_	_
7	exerts	exert	VBZ	VBZ	_	0	root	_	_
8	an	a	DT	DT	_	10	det	_	_
9	inhibitory	inhibitory	JJ	JJ	_	10	amod	_	_
10	effect	effect	NN	NN	_	7	dobj	_	_
11	on	on	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	dep	_	_
13	proliferation	proliferation	NN	NN	_	7	nmod	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	effector	effector	NN	NN	_	16	compound	_	_
16	functions	function	NNS	NNS	_	13	conj	_	_
17	of	of	IN	IN	_	19	case	_	_
18	T	t	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	13	nmod	_	_
20	.	.	.	.	_	7	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	ability	ability	NN	NN	_	14	nsubjpass	_	_
3	of	of	IN	IN	_	5	case	_	_
4	T	t	NN	NN	_	5	compound	_	_
5	cells	cell	NNS	NNS	_	2	nmod	_	_
6	to	to	TO	TO	_	7	mark	_	_
7	form	form	VB	VB	_	2	acl	_	_
8	high	high	JJ	JJ	_	10	amod	_	_
9	intracellular	intracellular	JJ	JJ	_	10	amod	_	_
10	levels	level	NNS	NNS	_	7	dobj	_	_
11	of	of	IN	IN	_	12	case	_	_
12	cAMP	camp	NN	NN	_	10	nmod	_	_
13	is	be	VBZ	VBZ	_	14	auxpass	_	_
14	acquired	acquire	VBN	VBN	_	0	root	_	_
15	during	during	IN	IN	_	16	case	_	_
16	development	development	NN	NN	_	14	nmod	_	_
17	in	in	IN	IN	_	20	case	_	_
18	the	the	DT	DT	_	20	det	_	_
19	human	human	JJ	JJ	_	20	amod	_	_
20	thymus	thymus	NN	NN	_	16	nmod	_	_
21	and	and	CC	CC	_	14	cc	_	_
22	is	be	VBZ	VBZ	_	23	auxpass	_	_
23	retained	retain	VBN	VBN	_	14	conj	_	_
24	by	by	IN	IN	_	26	case	_	_
25	the	the	DT	DT	_	26	det	_	_
26	majority	majority	NN	NN	_	23	nmod	_	_
27	of	of	IN	IN	_	31	case	_	_
28	mature	mature	JJ	JJ	_	31	amod	_	_
29	peripheral	peripheral	JJ	JJ	_	31	amod	_	_
30	T	t	NN	NN	_	31	compound	_	_
31	lymphocytes	lymphocyte	NNS	NNS	_	26	nmod	_	_
32	.	.	.	.	_	14	punct	_	_

1	Here	here	RB	RB	_	3	advmod	_	_
2	we	we	PRP	PRP	_	3	nsubj	_	_
3	show	show	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	11	mark	_	_
5	elevated	elevated	JJ	JJ	_	7	amod	_	_
6	cAMP	camp	NN	NN	_	7	compound	_	_
7	levels	level	NNS	NNS	_	11	nsubj	_	_
8	in	in	IN	IN	_	10	case	_	_
9	T	t	NN	NN	_	10	compound	_	_
10	cells	cell	NNS	NNS	_	7	nmod	_	_
11	correlate	correlate	VBP	VBP	_	3	ccomp	_	_
12	with	with	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	det	_	_
14	expression	expression	NN	NN	_	11	nmod	_	_
15	of	of	IN	IN	_	19	case	_	_
16	the	the	DT	DT	_	19	det	_	_
17	potent	potent	JJ	JJ	_	19	amod	_	_
18	transcriptional	transcriptional	JJ	JJ	_	19	amod	_	_
19	repressor	repressor	NN	NN	_	14	nmod	_	_
20	ICER	icer	NN	NN	_	19	dep	_	_
21	(	(	-LRB-	-LRB-	_	25	punct	_	_
22	inducible	inducible	JJ	JJ	_	25	amod	_	_
23	cAMP	camp	NN	NN	_	25	compound	_	_
24	early	early	JJ	JJ	_	25	amod	_	_
25	repressor	repressor	NN	NN	_	20	appos	_	_
26	)	)	-RRB-	-RRB-	_	25	punct	_	_
27	previously	previously	RB	RB	_	14	advmod	_	_
28	described	describe	VBN	VBN	_	14	acl	_	_
29	in	in	IN	IN	_	32	case	_	_
30	the	the	DT	DT	_	32	det	_	_
31	hypothalamic-pituitary-gonadal	hypothalamic-pituitary-gonadal	JJ	JJ	_	32	amod	_	_
32	axis	axis	NN	NN	_	28	nmod	_	_
33	.	.	.	.	_	3	punct	_	_

1	Further	further	RB	RB	_	10	advmod	_	_
2	,	,	,	,	_	10	punct	_	_
3	in	in	IN	IN	_	5	case	_	_
4	transcriptional	transcriptional	JJ	JJ	_	5	amod	_	_
5	assays	assay	NNS	NNS	_	10	nmod	_	_
6	in	in	FW	FW	_	5	amod	_	_
7	vivo	vivo	FW	FW	_	6	dep	_	_
8	,	,	,	,	_	10	punct	_	_
9	ICER	icer	NN	NN	_	10	nsubj	_	_
10	inhibits	inhibit	VBZ	VBZ	_	0	root	_	_
11	calcineurin-mediated	calcineurin-mediated	JJ	JJ	_	12	amod	_	_
12	expression	expression	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	17	case	_	_
14	the	the	DT	DT	_	17	det	_	_
15	interleukin	interleukin	NN	NN	_	17	compound	_	_
16	2	2	CD	CD	_	17	nummod	_	_
17	promoter	promoter	NN	NN	_	12	nmod	_	_
18	as	as	RB	RB	_	12	cc	_	_
19	well	well	RB	RB	_	18	mwe	_	_
20	as	as	IN	IN	_	18	mwe	_	_
21	Tax-mediated	tax-mediated	JJ	JJ	_	22	amod	_	_
22	transactivation	transactivation	NN	NN	_	12	conj	_	_
23	of	of	IN	IN	_	33	case	_	_
24	the	the	DT	DT	_	33	det	_	_
25	human	human	JJ	JJ	_	33	amod	_	_
26	T-lymphotropic	t-lymphotropic	JJ	JJ	_	33	amod	_	_
27	virus	virus	NN	NN	_	33	compound	_	_
28	type	type	NN	NN	_	33	compound	_	_
29	I	i	CD	CD	_	33	nummod	_	_
30	(	(	-LRB-	-LRB-	_	33	punct	_	_
31	HTLV-I	htlv-i	NN	NN	_	33	compound	_	_
32	)	)	-RRB-	-RRB-	_	33	punct	_	_
33	promoter	promoter	NN	NN	_	22	nmod	_	_
34	.	.	.	.	_	10	punct	_	_

1	Thus	thus	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	induction	induction	NN	NN	_	11	nsubj	_	_
5	of	of	IN	IN	_	6	case	_	_
6	ICER	icer	NN	NN	_	4	nmod	_	_
7	in	in	IN	IN	_	9	case	_	_
8	T	t	NN	NN	_	9	compound	_	_
9	cells	cell	NNS	NNS	_	4	nmod	_	_
10	may	may	MD	MD	_	11	aux	_	_
11	play	play	VB	VB	_	0	root	_	_
12	an	a	DT	DT	_	14	det	_	_
13	important	important	JJ	JJ	_	14	amod	_	_
14	role	role	NN	NN	_	11	dobj	_	_
15	in	in	IN	IN	_	18	case	_	_
16	the	the	DT	DT	_	18	det	_	_
17	cAMP-induced	camp-induced	JJ	JJ	_	18	amod	_	_
18	quiescence	quiescence	NN	NN	_	11	nmod	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	the	the	DT	DT	_	22	det	_	_
21	persistent	persistent	JJ	JJ	_	22	amod	_	_
22	latency	latency	NN	NN	_	18	conj	_	_
23	of	of	IN	IN	_	24	case	_	_
24	HTLV-I	htlv-i	NN	NN	_	22	nmod	_	_
25	.	.	.	.	_	11	punct	_	_

1	Preassociation	preassociation	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	3	case	_	_
3	STAT1	stat1	NN	NN	_	1	nmod	_	_
4	with	with	IN	IN	_	5	case	_	_
5	STAT2	stat2	NN	NN	_	1	nmod	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	STAT3	stat3	NN	NN	_	5	conj	_	_
8	in	in	IN	IN	_	11	case	_	_
9	separate	separate	JJ	JJ	_	11	amod	_	_
10	signalling	signalling	NN	NN	_	11	compound	_	_
11	complexes	complex	NNS	NNS	_	1	nmod	_	_
12	prior	prior	RB	RB	_	1	advmod	_	_
13	to	to	TO	TO	_	15	case	_	_
14	cytokine	cytokine	NN	NN	_	15	compound	_	_
15	stimulation	stimulation	NN	NN	_	12	nmod	_	_
16	.	.	.	.	_	1	punct	_	_

1	A	a	DT	DT	_	2	det	_	_
2	variety	variety	NN	NN	_	8	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	cytokines	cytokine	NNS	NNS	_	2	nmod	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	growth	growth	NN	NN	_	7	compound	_	_
7	factors	factor	NNS	NNS	_	4	conj	_	_
8	act	act	VBP	VBP	_	0	root	_	_
9	through	through	IN	IN	_	11	case	_	_
10	an	a	DT	DT	_	11	det	_	_
11	induction	induction	NN	NN	_	8	nmod	_	_
12	of	of	IN	IN	_	14	case	_	_
13	gene	gene	NN	NN	_	14	compound	_	_
14	expression	expression	NN	NN	_	11	nmod	_	_
15	mediated	mediate	VBN	VBN	_	14	acl	_	_
16	by	by	IN	IN	_	18	case	_	_
17	a	a	DT	DT	_	18	det	_	_
18	family	family	NN	NN	_	15	nmod	_	_
19	of	of	IN	IN	_	22	case	_	_
20	latent	latent	JJ	JJ	_	22	amod	_	_
21	transcription	transcription	NN	NN	_	22	compound	_	_
22	factors	factor	NNS	NNS	_	18	nmod	_	_
23	called	call	VBN	VBN	_	22	acl	_	_
24	STAT	stat	NN	NN	_	27	compound	_	_
25	(	(	-LRB-	-LRB-	_	27	punct	_	_
26	signal	signal	NN	NN	_	27	compound	_	_
27	transducers	transducer	NNS	NNS	_	23	xcomp	_	_
28	and	and	CC	CC	_	27	cc	_	_
29	activators	activator	NNS	NNS	_	33	compound	_	_
30	of	of	IN	IN	_	33	amod	_	_
31	transcription	transcription	NN	NN	_	33	compound	_	_
32	)	)	-RRB-	-RRB-	_	33	punct	_	_
33	proteins	protein	NNS	NNS	_	27	conj	_	_
34	.	.	.	.	_	8	punct	_	_

1	Ligand-induced	ligand-induced	JJ	JJ	_	3	amod	_	_
2	tyrosine	tyrosine	NN	NN	_	3	compound	_	_
3	phosphorylation	phosphorylation	NN	NN	_	7	nsubj	_	_
4	of	of	IN	IN	_	6	case	_	_
5	the	the	DT	DT	_	6	det	_	_
6	STATs	stats	NNS	NNS	_	3	nmod	_	_
7	promotes	promote	VBZ	VBZ	_	0	root	_	_
8	their	they	PRP$	PRP$	_	9	nmod:poss	_	_
9	homodimer	homodimer	NN	NN	_	7	dobj	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	heterodimer	heterodimer	NN	NN	_	9	conj	_	_
12	formation	formation	NN	NN	_	9	dep	_	_
13	and	and	CC	CC	_	9	cc	_	_
14	subsequent	subsequent	JJ	JJ	_	16	amod	_	_
15	nuclear	nuclear	JJ	JJ	_	16	amod	_	_
16	translocation	translocation	NN	NN	_	9	conj	_	_
17	.	.	.	.	_	7	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
3	here	here	RB	RB	_	2	advmod	_	_
4	that	that	IN	IN	_	8	mark	_	_
5	STAT	stat	NN	NN	_	7	compound	_	_
6	protein	protein	NN	NN	_	7	compound	_	_
7	heterocomplexes	heterocomplex	NNS	NNS	_	8	nsubj	_	_
8	exist	exist	VBP	VBP	_	2	ccomp	_	_
9	prior	prior	RB	RB	_	8	advmod	_	_
10	to	to	TO	TO	_	12	case	_	_
11	cytokine	cytokine	NN	NN	_	12	compound	_	_
12	treatment	treatment	NN	NN	_	9	nmod	_	_
13	.	.	.	.	_	2	punct	_	_

1	When	when	WRB	WRB	_	6	advmod	_	_
2	unstimulated	unstimulated	JJ	JJ	_	4	amod	_	_
3	HeLa	hela	NN	NN	_	4	compound	_	_
4	cells	cell	NNS	NNS	_	6	nsubjpass	_	_
5	are	be	VBP	VBP	_	6	auxpass	_	_
6	ruptured	rupture	VBN	VBN	_	25	advcl	_	_
7	in	in	IN	IN	_	9	case	_	_
8	hypotonic	hypotonic	JJ	JJ	_	9	amod	_	_
9	buffer	buffer	NN	NN	_	6	nmod	_	_
10	without	without	IN	IN	_	11	case	_	_
11	salt	salt	NN	NN	_	6	nmod	_	_
12	or	or	CC	CC	_	11	cc	_	_
13	detergent	detergent	NN	NN	_	11	conj	_	_
14	,	,	,	,	_	25	punct	_	_
15	immunoadsorption	immunoadsorption	NN	NN	_	25	nsubj	_	_
16	of	of	IN	IN	_	18	case	_	_
17	either	either	CC	CC	_	18	cc:preconj	_	_
18	STAT1	stat1	NN	NN	_	15	nmod	_	_
19	or	or	CC	CC	_	18	cc	_	_
20	STAT2	stat2	NN	NN	_	18	conj	_	_
21	from	from	IN	IN	_	24	case	_	_
22	the	the	DT	DT	_	24	det	_	_
23	resulting	result	VBG	VBG	_	24	amod	_	_
24	cytosol	cytosol	NN	NN	_	15	nmod	_	_
25	yields	yield	VBZ	VBZ	_	0	root	_	_
26	coimmunoadsorption	coimmunoadsorption	NN	NN	_	25	dobj	_	_
27	of	of	IN	IN	_	31	case	_	_
28	the	the	DT	DT	_	31	det	_	_
29	other	other	JJ	JJ	_	31	amod	_	_
30	STAT	stat	NN	NN	_	31	compound	_	_
31	protein	protein	NN	NN	_	26	nmod	_	_
32	.	.	.	.	_	25	punct	_	_

1	Similarly	similarly	RB	RB	_	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	STAT1-STAT3	stat1-stat3	NN	NN	_	4	compound	_	_
4	heterocomplexes	heterocomplex	NNS	NNS	_	6	nsubjpass	_	_
5	are	be	VBP	VBP	_	6	auxpass	_	_
6	coimmunoadsorbed	coimmunoadsorb	VBN	VBN	_	0	root	_	_
7	from	from	IN	IN	_	9	case	_	_
8	hypotonic	hypotonic	JJ	JJ	_	9	amod	_	_
9	cytosol	cytosol	NN	NN	_	6	nmod	_	_
10	.	.	.	.	_	6	punct	_	_

1	STAT1	stat1	NN	NN	_	13	nsubj	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	STAT2	stat2	NN	NN	_	1	conj	_	_
4	or	or	CC	CC	_	1	cc	_	_
5	STAT1	stat1	NN	NN	_	1	conj	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	STAT3	stat3	NN	NN	_	5	conj	_	_
8	translated	translate	VBN	VBN	_	1	acl	_	_
9	in	in	IN	IN	_	11	case	_	_
10	reticulocyte	reticulocyte	NN	NN	_	11	compound	_	_
11	lysate	lysate	NN	NN	_	8	nmod	_	_
12	spontaneously	spontaneously	RB	RB	_	8	advmod	_	_
13	form	form	VBP	VBP	_	0	root	_	_
14	heterocomplexes	heterocomplex	NNS	NNS	_	13	dobj	_	_
15	when	when	WRB	WRB	_	20	advmod	_	_
16	the	the	DT	DT	_	18	det	_	_
17	translation	translation	NN	NN	_	18	compound	_	_
18	lysates	lysate	NNS	NNS	_	20	nsubjpass	_	_
19	are	be	VBP	VBP	_	20	auxpass	_	_
20	mixed	mix	VBN	VBN	_	13	advcl	_	_
21	at	at	IN	IN	_	24	case	_	_
22	0	0	CD	CD	_	24	nummod	_	_
23	degrees	degree	NNS	NNS	_	24	compound	_	_
24	C	c	NN	NN	_	20	nmod	_	_
25	.	.	.	.	_	13	punct	_	_

1	Our	we	PRP$	PRP$	_	2	nmod:poss	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	9	mark	_	_
5	interferon-alpha	interferon-alpha	NN	NN	_	8	compound	_	_
6	/beta-induced	/beta-induced	JJ	JJ	_	8	amod	_	_
7	tyrosine	tyrosine	NN	NN	_	8	compound	_	_
8	phosphorylation	phosphorylation	NN	NN	_	9	nsubj	_	_
9	increases	increase	VBZ	VBZ	_	3	ccomp	_	_
10	the	the	DT	DT	_	11	det	_	_
11	stability	stability	NN	NN	_	9	dobj	_	_
12	of	of	IN	IN	_	20	case	_	_
13	a	a	DT	DT	_	20	det	_	_
14	preexisting	preexisting	JJ	JJ	_	20	amod	_	_
15	,	,	,	,	_	14	punct	_	_
16	latent	latent	JJ	JJ	_	14	dep	_	_
17	,	,	,	,	_	20	punct	_	_
18	STAT1-STAT2	stat1-stat2	JJ	JJ	_	20	amod	_	_
19	signaling	signaling	NN	NN	_	20	compound	_	_
20	complex	complex	NN	NN	_	11	nmod	_	_
21	.	.	.	.	_	3	punct	_	_

1	Newly	newly	RB	RB	_	2	advmod	_	_
2	translated	translate	VBN	VBN	_	3	amod	_	_
3	STAT1	stat1	NN	NN	_	4	nsubj	_	_
4	binds	bind	VBZ	VBZ	_	0	root	_	_
5	in	in	IN	IN	_	7	case	_	_
6	equilibrium	equilibrium	NN	NN	_	7	compound	_	_
7	fashion	fashion	NN	NN	_	4	nmod	_	_
8	to	to	TO	TO	_	9	case	_	_
9	STAT2	stat2	NN	NN	_	4	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	STAT3	stat3	NN	NN	_	9	conj	_	_
12	,	,	,	,	_	4	punct	_	_
13	but	but	CC	CC	_	4	cc	_	_
14	we	we	PRP	PRP	_	15	nsubj	_	_
15	show	show	VBP	VBP	_	4	conj	_	_
16	that	that	IN	IN	_	20	mark	_	_
17	STAT2	stat2	NN	NN	_	20	nsubj	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	STAT3	stat3	NN	NN	_	17	conj	_	_
20	exist	exist	VBP	VBP	_	15	ccomp	_	_
21	in	in	IN	IN	_	23	case	_	_
22	separate	separate	JJ	JJ	_	23	amod	_	_
23	heterocomplexes	heterocomplex	NNS	NNS	_	20	nmod	_	_
24	with	with	IN	IN	_	25	case	_	_
25	STAT1	stat1	NN	NN	_	23	nmod	_	_
26	,	,	,	,	_	20	punct	_	_
27	consistent	consistent	JJ	JJ	_	20	advmod	_	_
28	with	with	IN	IN	_	30	case	_	_
29	a	a	DT	DT	_	30	det	_	_
30	model	model	NN	NN	_	27	nmod	_	_
31	in	in	IN	IN	_	32	case	_	_
32	which	which	WDT	WDT	_	34	nmod	_	_
33	STAT1	stat1	NN	NN	_	34	nsubj	_	_
34	contains	contain	VBZ	VBZ	_	30	acl:relcl	_	_
35	a	a	DT	DT	_	38	det	_	_
36	common	common	JJ	JJ	_	38	amod	_	_
37	binding	bind	VBG	VBG	_	38	amod	_	_
38	site	site	NN	NN	_	34	dobj	_	_
39	for	for	IN	IN	_	42	case	_	_
40	other	other	JJ	JJ	_	42	amod	_	_
41	STAT	stat	NN	NN	_	42	compound	_	_
42	proteins	protein	NNS	NNS	_	38	nmod	_	_
43	.	.	.	.	_	4	punct	_	_

1	Epstein-Barr	epstein-barr	JJ	JJ	_	12	amod	_	_
2	virus	virus	NN	NN	_	12	compound	_	_
3	nuclear	nuclear	JJ	JJ	_	12	amod	_	_
4	antigen	antigen	NN	NN	_	12	compound	_	_
5	2	2	CD	CD	_	12	nummod	_	_
6	(	(	-LRB-	-LRB-	_	12	punct	_	_
7	EBNA2	ebna2	NN	NN	_	12	compound	_	_
8	)	)	-RRB-	-RRB-	_	12	punct	_	_
9	-oestrogen	-oestrogen	NN	NN	_	12	compound	_	_
10	receptor	receptor	NN	NN	_	12	compound	_	_
11	fusion	fusion	NN	NN	_	12	compound	_	_
12	proteins	protein	NNS	NNS	_	13	nsubj	_	_
13	complement	complement	VBP	VBP	_	0	root	_	_
14	the	the	DT	DT	_	19	det	_	_
15	EBNA2-deficient	ebna2-deficient	JJ	JJ	_	19	amod	_	_
16	Epstein-Barr	epstein-barr	JJ	JJ	_	19	amod	_	_
17	virus	virus	NN	NN	_	19	compound	_	_
18	strain	strain	NN	NN	_	19	compound	_	_
19	P3HR1	p3hr1	NN	NN	_	13	dobj	_	_
20	in	in	IN	IN	_	21	case	_	_
21	transformation	transformation	NN	NN	_	13	nmod	_	_
22	of	of	IN	IN	_	25	case	_	_
23	primary	primary	JJ	JJ	_	25	amod	_	_
24	B	b	NN	NN	_	25	compound	_	_
25	cells	cell	NNS	NNS	_	21	nmod	_	_
26	but	but	CC	CC	_	13	cc	_	_
27	suppress	suppress	VBP	VBP	_	13	conj	_	_
28	growth	growth	NN	NN	_	27	dobj	_	_
29	of	of	IN	IN	_	34	case	_	_
30	human	human	JJ	JJ	_	34	amod	_	_
31	B	b	NN	NN	_	34	compound	_	_
32	cell	cell	NN	NN	_	34	compound	_	_
33	lymphoma	lymphoma	NN	NN	_	34	compound	_	_
34	lines	line	NNS	NNS	_	28	nmod	_	_
35	.	.	.	.	_	13	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	develop	develop	VB	VB	_	0	root	_	_
3	a	a	DT	DT	_	5	det	_	_
4	transformation	transformation	NN	NN	_	5	compound	_	_
5	system	system	NN	NN	_	2	dobj	_	_
6	with	with	IN	IN	_	17	case	_	_
7	a	a	DT	DT	_	17	det	_	_
8	conditional	conditional	JJ	JJ	_	17	amod	_	_
9	Epstein-Barr	epstein-barr	JJ	JJ	_	17	amod	_	_
10	virus	virus	NN	NN	_	17	compound	_	_
11	nuclear	nuclear	JJ	JJ	_	17	amod	_	_
12	antigen	antigen	NN	NN	_	17	compound	_	_
13	2	2	CD	CD	_	17	nummod	_	_
14	(	(	-LRB-	-LRB-	_	17	punct	_	_
15	EBNA2	ebna2	NN	NN	_	17	compound	_	_
16	)	)	-RRB-	-RRB-	_	17	punct	_	_
17	gene	gene	NN	NN	_	5	nmod	_	_
18	,	,	,	,	_	2	punct	_	_
19	we	we	PRP	PRP	_	20	nsubj	_	_
20	fused	fuse	VBD	VBD	_	2	parataxis	_	_
21	the	the	DT	DT	_	24	det	_	_
22	hormone	hormone	NN	NN	_	24	compound	_	_
23	binding	binding	NN	NN	_	24	compound	_	_
24	domain	domain	NN	NN	_	20	dobj	_	_
25	of	of	IN	IN	_	28	case	_	_
26	the	the	DT	DT	_	28	det	_	_
27	oestrogen	oestrogen	NN	NN	_	28	compound	_	_
28	receptor	receptor	NN	NN	_	24	nmod	_	_
29	to	to	TO	TO	_	31	case	_	_
30	the	the	DT	DT	_	31	dep	_	_
31	N	n	NN	NN	_	20	nmod	_	_
32	or	or	CC	CC	_	31	cc	_	_
33	C	c	NN	NN	_	31	conj	_	_
34	terminus	terminus	NN	NN	_	31	dep	_	_
35	of	of	IN	IN	_	36	case	_	_
36	EBNA2	ebna2	NN	NN	_	31	nmod	_	_
37	.	.	.	.	_	2	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	promoter	promoter	NN	NN	_	3	compound	_	_
3	transactivation	transactivation	NN	NN	_	17	nmod	_	_
4	as	as	RB	RB	_	3	cc	_	_
5	well	well	RB	RB	_	4	mwe	_	_
6	as	as	IN	IN	_	4	mwe	_	_
7	primary	primary	JJ	JJ	_	10	amod	_	_
8	B	b	NN	NN	_	10	compound	_	_
9	cell	cell	NN	NN	_	10	compound	_	_
10	transformation	transformation	NN	NN	_	3	conj	_	_
11	assays	assay	NNS	NNS	_	3	dep	_	_
12	these	these	DT	DT	_	15	det	_	_
13	chimeric	chimeric	JJ	JJ	_	15	amod	_	_
14	EBNA2	ebna2	NN	NN	_	15	compound	_	_
15	proteins	protein	NNS	NNS	_	17	nsubj	_	_
16	are	be	VBP	VBP	_	17	cop	_	_
17	able	able	JJ	JJ	_	0	root	_	_
18	to	to	TO	TO	_	19	mark	_	_
19	substitute	substitute	VB	VB	_	17	xcomp	_	_
20	for	for	IN	IN	_	22	case	_	_
21	wild-type	wild-type	JJ	JJ	_	22	amod	_	_
22	EBNA2	ebna2	NN	NN	_	19	nmod	_	_
23	in	in	IN	IN	_	25	case	_	_
24	the	the	DT	DT	_	25	det	_	_
25	presence	presence	NN	NN	_	19	nmod	_	_
26	of	of	IN	IN	_	27	case	_	_
27	oestrogen	oestrogen	NN	NN	_	25	nmod	_	_
28	.	.	.	.	_	17	punct	_	_

1	Here	here	RB	RB	_	3	advmod	_	_
2	we	we	PRP	PRP	_	3	nsubj	_	_
3	provide	provide	VBP	VBP	_	0	root	_	_
4	evidence	evidence	NN	NN	_	3	dobj	_	_
5	that	that	IN	IN	_	10	mark	_	_
6	this	this	DT	DT	_	7	det	_	_
7	transformation	transformation	NN	NN	_	10	nsubj	_	_
8	is	be	VBZ	VBZ	_	10	cop	_	_
9	the	the	DT	DT	_	10	det	_	_
10	result	result	NN	NN	_	4	ccomp	_	_
11	of	of	IN	IN	_	13	case	_	_
12	double	double	JJ	JJ	_	13	amod	_	_
13	infection	infection	NN	NN	_	10	nmod	_	_
14	of	of	IN	IN	_	16	case	_	_
15	a	a	DT	DT	_	16	det	_	_
16	cell	cell	NN	NN	_	13	nmod	_	_
17	with	with	IN	IN	_	19	case	_	_
18	two	two	CD	CD	_	19	nummod	_	_
19	virions	virion	NNS	NNS	_	16	nmod	_	_
20	,	,	,	,	_	19	punct	_	_
21	the	the	DT	DT	_	24	det	_	_
22	P3HR1	p3hr1	NN	NN	_	24	compound	_	_
23	virus	virus	NN	NN	_	24	compound	_	_
24	genome	genome	NN	NN	_	19	appos	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	a	a	DT	DT	_	28	det	_	_
27	mini-EBV	mini-ebv	NN	NN	_	28	compound	_	_
28	plasmid	plasmid	NN	NN	_	24	conj	_	_
29	carrying	carry	VBG	VBG	_	28	acl	_	_
30	the	the	DT	DT	_	33	det	_	_
31	chimeric	chimeric	JJ	JJ	_	33	amod	_	_
32	EBNA2	ebna2	NN	NN	_	33	compound	_	_
33	gene	gene	NN	NN	_	29	dobj	_	_
34	.	.	.	.	_	3	punct	_	_

1	Unexpectedly	unexpectedly	RB	RB	_	18	advmod	_	_
2	,	,	,	,	_	18	punct	_	_
3	expression	expression	NN	NN	_	18	nsubj	_	_
4	of	of	IN	IN	_	10	case	_	_
5	the	the	DT	DT	_	10	det	_	_
6	same	same	JJ	JJ	_	10	amod	_	_
7	EBNA2-oestrogen	ebna2-oestrogen	NN	NN	_	10	compound	_	_
8	receptor	receptor	NN	NN	_	10	compound	_	_
9	fusion	fusion	NN	NN	_	10	compound	_	_
10	protein	protein	NN	NN	_	3	nmod	_	_
11	in	in	IN	IN	_	17	case	_	_
12	established	established	JJ	JJ	_	17	amod	_	_
13	human	human	JJ	JJ	_	17	amod	_	_
14	B	b	NN	NN	_	17	compound	_	_
15	cell	cell	NN	NN	_	17	compound	_	_
16	lymphoma	lymphoma	NN	NN	_	17	compound	_	_
17	lines	line	NNS	NNS	_	3	nmod	_	_
18	resulted	result	VBD	VBD	_	0	root	_	_
19	in	in	IN	IN	_	21	case	_	_
20	growth	growth	NN	NN	_	21	compound	_	_
21	retardation	retardation	NN	NN	_	18	nmod	_	_
22	or	or	CC	CC	_	21	cc	_	_
23	growth	growth	NN	NN	_	24	compound	_	_
24	arrest	arrest	NN	NN	_	21	conj	_	_
25	upon	upon	IN	IN	_	27	case	_	_
26	the	the	DT	DT	_	27	det	_	_
27	addition	addition	NN	NN	_	21	nmod	_	_
28	of	of	IN	IN	_	29	case	_	_
29	oestrogen	oestrogen	NN	NN	_	27	nmod	_	_
30	.	.	.	.	_	18	punct	_	_

1	By	by	IN	IN	_	2	mark	_	_
2	titrating	titrate	VBG	VBG	_	26	advcl	_	_
3	the	the	DT	DT	_	5	det	_	_
4	oestrogen	oestrogen	NN	NN	_	5	compound	_	_
5	concentration	concentration	NN	NN	_	2	dobj	_	_
6	in	in	IN	IN	_	10	case	_	_
7	these	these	DT	DT	_	10	det	_	_
8	stably	stably	RB	RB	_	10	advmod	_	_
9	transfected	transfect	VBN	VBN	_	10	amod	_	_
10	cells	cell	NNS	NNS	_	5	nmod	_	_
11	,	,	,	,	_	26	punct	_	_
12	the	the	DT	DT	_	14	det	_	_
13	growth	growth	NN	NN	_	14	compound	_	_
14	retarding	retarding	NN	NN	_	26	nsubjpass	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	the	the	DT	DT	_	18	det	_	_
17	transactivating	transactivate	VBG	VBG	_	18	amod	_	_
18	function	function	NN	NN	_	14	conj	_	_
19	of	of	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	chimeric	chimeric	JJ	JJ	_	22	amod	_	_
22	proteins	protein	NNS	NNS	_	18	nmod	_	_
23	could	could	MD	MD	_	26	aux	_	_
24	not	not	RB	RB	_	26	neg	_	_
25	be	be	VB	VB	_	26	auxpass	_	_
26	dissociated	dissociate	VBN	VBN	_	0	root	_	_
27	.	.	.	.	_	26	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	propose	propose	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	15	mark	_	_
4	growth	growth	NN	NN	_	5	compound	_	_
5	inhibition	inhibition	NN	NN	_	15	nsubj	_	_
6	of	of	IN	IN	_	11	case	_	_
7	established	established	JJ	JJ	_	11	amod	_	_
8	B	b	NN	NN	_	11	compound	_	_
9	cell	cell	NN	NN	_	11	compound	_	_
10	lymphoma	lymphoma	NN	NN	_	11	compound	_	_
11	lines	line	NNS	NNS	_	5	nmod	_	_
12	is	be	VBZ	VBZ	_	15	cop	_	_
13	a	a	DT	DT	_	15	det	_	_
14	novel	novel	JJ	JJ	_	15	amod	_	_
15	function	function	NN	NN	_	2	ccomp	_	_
16	of	of	IN	IN	_	17	case	_	_
17	EBNA2	ebna2	NN	NN	_	15	nmod	_	_
18	which	which	WDT	WDT	_	22	nsubjpass	_	_
19	has	have	VBZ	VBZ	_	22	aux	_	_
20	not	not	RB	RB	_	22	neg	_	_
21	been	be	VBN	VBN	_	22	auxpass	_	_
22	detected	detect	VBN	VBN	_	15	acl:relcl	_	_
23	in	in	IN	IN	_	25	case	_	_
24	the	the	DT	DT	_	25	det	_	_
25	absence	absence	NN	NN	_	22	nmod	_	_
26	of	of	IN	IN	_	29	case	_	_
27	an	a	DT	DT	_	29	det	_	_
28	inducible	inducible	JJ	JJ	_	29	amod	_	_
29	system	system	NN	NN	_	25	nmod	_	_
30	.	.	.	.	_	2	punct	_	_

1	It	it	PRP	PRP	_	2	nsubj	_	_
2	remains	remain	VBZ	VBZ	_	0	root	_	_
3	open	open	JJ	JJ	_	2	xcomp	_	_
4	whether	whether	IN	IN	_	21	mark	_	_
5	the	the	DT	DT	_	8	det	_	_
6	growth	growth	NN	NN	_	8	compound	_	_
7	retarding	retarding	NN	NN	_	8	compound	_	_
8	property	property	NN	NN	_	21	nsubj	_	_
9	of	of	IN	IN	_	14	case	_	_
10	the	the	DT	DT	_	14	det	_	_
11	EBNA2-oestrogen	ebna2-oestrogen	JJ	JJ	_	14	amod	_	_
12	receptor	receptor	NN	NN	_	14	compound	_	_
13	fusion	fusion	NN	NN	_	14	compound	_	_
14	protein	protein	NN	NN	_	8	nmod	_	_
15	in	in	IN	IN	_	19	case	_	_
16	B	b	NN	NN	_	19	compound	_	_
17	cell	cell	NN	NN	_	19	compound	_	_
18	lymphoma	lymphoma	NN	NN	_	19	compound	_	_
19	lines	line	NNS	NNS	_	14	nmod	_	_
20	is	be	VBZ	VBZ	_	21	cop	_	_
21	due	due	JJ	JJ	_	2	ccomp	_	_
22	to	to	TO	TO	_	25	case	_	_
23	unphysiologically	unphysiologically	RB	RB	_	24	advmod	_	_
24	high	high	JJ	JJ	_	25	amod	_	_
25	expression	expression	NN	NN	_	21	nmod	_	_
26	of	of	IN	IN	_	29	case	_	_
27	the	the	DT	DT	_	29	det	_	_
28	chimeric	chimeric	JJ	JJ	_	29	amod	_	_
29	protein	protein	NN	NN	_	25	nmod	_	_
30	or	or	CC	CC	_	25	cc	_	_
31	to	to	TO	TO	_	32	case	_	_
32	interference	interference	NN	NN	_	25	conj	_	_
33	with	with	IN	IN	_	36	case	_	_
34	a	a	DT	DT	_	36	det	_	_
35	cellular	cellular	JJ	JJ	_	36	amod	_	_
36	programme	programme	NN	NN	_	32	nmod	_	_
37	driving	drive	VBG	VBG	_	36	acl	_	_
38	proliferation	proliferation	NN	NN	_	37	dobj	_	_
39	in	in	IN	IN	_	42	case	_	_
40	these	these	DT	DT	_	42	det	_	_
41	cell	cell	NN	NN	_	42	compound	_	_
42	lines	line	NNS	NNS	_	38	nmod	_	_
43	.	.	.	.	_	2	punct	_	_

1	Cyclic	cyclic	JJ	JJ	_	4	amod	_	_
2	AMP-responsive	amp-responsive	JJ	JJ	_	4	amod	_	_
3	element-dependent	element-dependent	JJ	JJ	_	4	amod	_	_
4	activation	activation	NN	NN	_	0	root	_	_
5	of	of	IN	IN	_	7	case	_	_
6	Epstein-Barr	epstein-barr	JJ	JJ	_	7	amod	_	_
7	virus	virus	NN	NN	_	4	nmod	_	_
8	zebra	zebra	NN	NN	_	9	compound	_	_
9	promoter	promoter	NN	NN	_	7	dep	_	_
10	by	by	IN	IN	_	12	case	_	_
11	human	human	JJ	JJ	_	12	amod	_	_
12	herpesvirus	herpesvirus	NN	NN	_	4	nmod	_	_
13	6	6	CD	CD	_	12	nummod	_	_
14	.	.	.	.	_	4	punct	_	_

1	We	we	PRP	PRP	_	4	nsubj	_	_
2	have	have	VBP	VBP	_	4	aux	_	_
3	recently	recently	RB	RB	_	4	advmod	_	_
4	shown	show	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	23	mark	_	_
6	infection	infection	NN	NN	_	23	nsubj	_	_
7	of	of	IN	IN	_	15	case	_	_
8	Epstein-Barr	epstein-barr	JJ	JJ	_	15	amod	_	_
9	virus	virus	NN	NN	_	15	compound	_	_
10	(	(	-LRB-	-LRB-	_	15	punct	_	_
11	EBV	ebv	NN	NN	_	15	compound	_	_
12	)	)	-RRB-	-RRB-	_	15	punct	_	_
13	genome-positive	genome-positive	JJ	JJ	_	15	amod	_	_
14	B	b	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	6	nmod	_	_
16	by	by	IN	IN	_	18	case	_	_
17	human	human	JJ	JJ	_	18	amod	_	_
18	herpesvirus	herpesvirus	NN	NN	_	6	nmod	_	_
19	6	6	CD	CD	_	18	nummod	_	_
20	(	(	-LRB-	-LRB-	_	21	punct	_	_
21	HHV-6	hhv-6	NN	NN	_	18	appos	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	results	result	VBZ	VBZ	_	4	ccomp	_	_
24	in	in	IN	IN	_	26	case	_	_
25	the	the	DT	DT	_	26	det	_	_
26	expression	expression	NN	NN	_	23	nmod	_	_
27	of	of	IN	IN	_	32	case	_	_
28	the	the	DT	DT	_	32	det	_	_
29	immediate-early	immediate-early	JJ	JJ	_	32	amod	_	_
30	EBV	ebv	NN	NN	_	32	compound	_	_
31	Zebra	zebra	NN	NN	_	32	compound	_	_
32	gene	gene	NN	NN	_	26	nmod	_	_
33	,	,	,	,	_	23	punct	_	_
34	followed	follow	VBN	VBN	_	23	dep	_	_
35	by	by	IN	IN	_	37	case	_	_
36	virus	virus	NN	NN	_	37	compound	_	_
37	replication	replication	NN	NN	_	34	nmod	_	_
38	(	(	-LRB-	-LRB-	_	39	punct	_	_
39	L.Flamand	L.Flamand	NNP	NNP	_	4	dep	_	_
40	,	,	,	,	_	39	punct	_	_
41	I.Stefanescu	I.Stefanescu	NNP	NNP	_	39	conj	_	_
42	,	,	,	,	_	39	punct	_	_
43	D.V.Ablashi	D.V.Ablashi	NNP	NNP	_	39	conj	_	_
44	,	,	,	,	_	39	punct	_	_
45	and	and	CC	CC	_	39	cc	_	_
46	J.Menezes	J.Menezes	NNP	NNP	_	39	conj	_	_
47	,	,	,	,	_	39	punct	_	_
48	J.Virol.67	J.Virol.67	NNP	NNP	_	39	appos	_	_
49	:	:	:	:	_	39	punct	_	_
50	6768-6777	6768-6777	CD	CD	_	39	dep	_	_
51	,	,	,	,	_	39	punct	_	_
52	1993	1993	CD	CD	_	39	amod	_	_
53	)	)	-RRB-	-RRB-	_	39	punct	_	_
54	.	.	.	.	_	4	punct	_	_

1	Here	here	RB	RB	_	3	advmod	_	_
2	we	we	PRP	PRP	_	3	nsubj	_	_
3	show	show	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	6	mark	_	_
5	HHV-6	hhv-6	NN	NN	_	6	nsubj	_	_
6	upregulates	upregulate	VBZ	VBZ	_	3	ccomp	_	_
7	Zebra	zebra	NN	NN	_	8	compound	_	_
8	gene	gene	NN	NN	_	9	compound	_	_
9	transcription	transcription	NN	NN	_	6	dobj	_	_
10	through	through	IN	IN	_	14	case	_	_
11	a	a	DT	DT	_	14	det	_	_
12	cyclic	cyclic	JJ	JJ	_	14	amod	_	_
13	AMP-responsive	amp-responsive	JJ	JJ	_	14	amod	_	_
14	element	element	NN	NN	_	6	nmod	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	CRE	cre	NN	NN	_	14	appos	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	located	located	JJ	JJ	_	14	amod	_	_
19	within	within	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	Zebra	zebra	NN	NN	_	22	compound	_	_
22	promoter	promoter	NN	NN	_	18	nmod	_	_
23	(	(	-LRB-	-LRB-	_	24	punct	_	_
24	Zp	zp	NN	NN	_	22	appos	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	.	.	.	.	_	3	punct	_	_

1	Using	use	VBG	VBG	_	0	root	_	_
2	human	human	JJ	JJ	_	3	amod	_	_
3	B-	b-	NN	NN	_	1	dobj	_	_
4	or	or	CC	CC	_	3	cc	_	_
5	T-cell	t-cell	NN	NN	_	3	conj	_	_
6	lines	line	NNS	NNS	_	3	dep	_	_
7	transfected	transfect	VBN	VBN	_	3	acl	_	_
8	with	with	IN	IN	_	12	case	_	_
9	ZpCat	zpcat	NN	NN	_	12	compound	_	_
10	reporter	reporter	NN	NN	_	12	compound	_	_
11	gene	gene	NN	NN	_	12	compound	_	_
12	constructs	construct	NNS	NNS	_	7	nmod	_	_
13	,	,	,	,	_	1	punct	_	_
14	we	we	PRP	PRP	_	15	nsubj	_	_
15	demonstrate	demonstrate	VBP	VBP	_	1	parataxis	_	_
16	that	that	IN	IN	_	27	mark	_	_
17	a	a	DT	DT	_	18	det	_	_
18	region	region	NN	NN	_	27	nsubj	_	_
19	designated	designate	VBN	VBN	_	18	acl	_	_
20	the	the	DT	DT	_	22	det	_	_
21	ZII	zii	NN	NN	_	22	compound	_	_
22	domain	domain	NN	NN	_	19	xcomp	_	_
23	of	of	IN	IN	_	24	case	_	_
24	Zp	zp	NN	NN	_	22	nmod	_	_
25	is	be	VBZ	VBZ	_	27	cop	_	_
26	the	the	DT	DT	_	27	det	_	_
27	target	target	NN	NN	_	15	ccomp	_	_
28	of	of	IN	IN	_	30	case	_	_
29	HHV-6	hhv-6	NN	NN	_	30	compound	_	_
30	transactivation	transactivation	NN	NN	_	27	nmod	_	_
31	.	.	.	.	_	1	punct	_	_

1	Mutation	mutation	NN	NN	_	9	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	consensus	consensus	NN	NN	_	6	compound	_	_
5	AP-1/CRE	ap-1/cre	NN	NN	_	6	compound	_	_
6	site	site	NN	NN	_	1	nmod	_	_
7	within	within	IN	IN	_	8	case	_	_
8	ZII	zii	NN	NN	_	6	nmod	_	_
9	abolished	abolish	VBD	VBD	_	0	root	_	_
10	the	the	DT	DT	_	11	det	_	_
11	inducibility	inducibility	NN	NN	_	9	dobj	_	_
12	of	of	IN	IN	_	13	case	_	_
13	Zp	zp	NN	NN	_	11	nmod	_	_
14	by	by	IN	IN	_	15	case	_	_
15	HHV-6	hhv-6	NN	NN	_	11	nmod	_	_
16	,	,	,	,	_	9	punct	_	_
17	whereas	whereas	IN	IN	_	29	mark	_	_
18	positioning	positioning	NN	NN	_	29	nsubj	_	_
19	of	of	IN	IN	_	21	case	_	_
20	the	the	DT	DT	_	21	det	_	_
21	ZII	zii	NN	NN	_	18	nmod	_	_
22	domain	domain	JJ	JJ	_	21	amod	_	_
23	upstream	upstream	JJ	JJ	_	18	advmod	_	_
24	of	of	IN	IN	_	28	case	_	_
25	the	the	DT	DT	_	28	det	_	_
26	beta-globin	beta-globin	NN	NN	_	28	compound	_	_
27	minimal	minimal	JJ	JJ	_	28	amod	_	_
28	promoter	promoter	NN	NN	_	23	nmod	_	_
29	conferred	confer	VBD	VBD	_	9	advcl	_	_
30	responsiveness	responsiveness	NN	NN	_	29	dobj	_	_
31	following	follow	VBG	VBG	_	33	case	_	_
32	HHV-6	hhv-6	NN	NN	_	33	compound	_	_
33	infection	infection	NN	NN	_	30	nmod	_	_
34	.	.	.	.	_	9	punct	_	_

1	Binding	binding	NN	NN	_	8	nsubjpass	_	_
2	of	of	IN	IN	_	4	case	_	_
3	these	these	DT	DT	_	4	det	_	_
4	factors	factor	NNS	NNS	_	1	nmod	_	_
5	to	to	TO	TO	_	6	case	_	_
6	ZII	zii	NN	NN	_	1	nmod	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	prevented	prevent	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	_	10	case	_	_
10	oligonucleotides	oligonucleotide	NNS	NNS	_	8	nmod	_	_
11	containing	contain	VBG	VBG	_	10	acl	_	_
12	CRE	cre	NN	NN	_	11	dobj	_	_
13	but	but	CC	CC	_	10	cc	_	_
14	not	not	RB	RB	_	18	neg	_	_
15	by	by	IN	IN	_	18	case	_	_
16	AP-1	ap-1	NN	NN	_	18	compound	_	_
17	consensus	consensus	NN	NN	_	18	compound	_	_
18	sequences	sequence	NNS	NNS	_	10	conj	_	_
19	.	.	.	.	_	8	punct	_	_

1	Antibodies	antibody	NNS	NNS	_	15	nsubj	_	_
2	against	against	IN	IN	_	7	case	_	_
3	CRE-binding	cre-binding	JJ	JJ	_	7	amod	_	_
4	(	(	-LRB-	-LRB-	_	7	punct	_	_
5	CREB	creb	NN	NN	_	7	compound	_	_
6	)	)	-RRB-	-RRB-	_	7	punct	_	_
7	protein	protein	NN	NN	_	1	nmod	_	_
8	but	but	CC	CC	_	7	cc	_	_
9	not	not	RB	RB	_	11	neg	_	_
10	against	against	IN	IN	_	11	case	_	_
11	c-Fos	c-fos	NN	NN	_	7	conj	_	_
12	or	or	CC	CC	_	11	cc	_	_
13	c-Jun	c-jun	NN	NN	_	11	conj	_	_
14	were	be	VBD	VBD	_	15	cop	_	_
15	able	able	JJ	JJ	_	0	root	_	_
16	to	to	TO	TO	_	17	mark	_	_
17	supershift	supershift	VB	VB	_	15	xcomp	_	_
18	the	the	DT	DT	_	20	det	_	_
19	DNA-protein	dna-protein	JJ	JJ	_	20	amod	_	_
20	complex	complex	NN	NN	_	17	dobj	_	_
21	,	,	,	,	_	15	punct	_	_
22	identifying	identify	VBG	VBG	_	15	xcomp	_	_
23	the	the	DT	DT	_	24	det	_	_
24	nature	nature	NN	NN	_	22	dobj	_	_
25	of	of	IN	IN	_	28	case	_	_
26	the	the	DT	DT	_	28	det	_	_
27	transcription	transcription	NN	NN	_	28	compound	_	_
28	factor	factor	NN	NN	_	24	nmod	_	_
29	which	which	WDT	WDT	_	30	nsubj	_	_
30	binds	bind	VBZ	VBZ	_	28	acl:relcl	_	_
31	to	to	TO	TO	_	32	case	_	_
32	ZII	zii	NN	NN	_	30	nmod	_	_
33	as	as	IN	IN	_	35	case	_	_
34	a	a	DT	DT	_	35	det	_	_
35	member	member	NN	NN	_	30	nmod	_	_
36	of	of	IN	IN	_	41	case	_	_
37	the	the	DT	DT	_	41	det	_	_
38	CREB	creb	NN	NN	_	41	compound	_	_
39	family	family	NN	NN	_	41	compound	_	_
40	of	of	IN	IN	_	41	amod	_	_
41	proteins	protein	NNS	NNS	_	35	nmod	_	_
42	.	.	.	.	_	15	punct	_	_

1	Finally	finally	RB	RB	_	14	advmod	_	_
2	,	,	,	,	_	14	punct	_	_
3	transfection	transfection	NN	NN	_	14	nsubjpass	_	_
4	of	of	IN	IN	_	6	case	_	_
5	CREB	creb	NN	NN	_	6	compound	_	_
6	protein	protein	NN	NN	_	3	nmod	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	protein	protein	NN	NN	_	12	compound	_	_
9	kinase	kinase	NN	NN	_	12	compound	_	_
10	A	a	NN	NN	_	12	compound	_	_
11	expression	expression	NN	NN	_	12	compound	_	_
12	vectors	vector	NNS	NNS	_	6	conj	_	_
13	were	be	VBD	VBD	_	14	auxpass	_	_
14	found	find	VBN	VBN	_	0	root	_	_
15	to	to	TO	TO	_	16	mark	_	_
16	activate	activate	VB	VB	_	14	xcomp	_	_
17	Zp	zp	NN	NN	_	16	dobj	_	_
18	in	in	IN	IN	_	20	case	_	_
19	Jurkat	jurkat	NN	NN	_	20	compound	_	_
20	cells	cell	NNS	NNS	_	16	nmod	_	_
21	,	,	,	,	_	14	punct	_	_
22	suggesting	suggest	VBG	VBG	_	14	advcl	_	_
23	that	that	IN	IN	_	30	mark	_	_
24	phosphorylated	phosphorylated	JJ	JJ	_	25	amod	_	_
25	form	form	NN	NN	_	30	nsubj	_	_
26	of	of	IN	IN	_	28	case	_	_
27	CREB	creb	NN	NN	_	28	compound	_	_
28	protein	protein	NN	NN	_	25	nmod	_	_
29	can	can	MD	MD	_	30	aux	_	_
30	play	play	VB	VB	_	22	ccomp	_	_
31	a	a	DT	DT	_	33	det	_	_
32	determining	determining	JJ	JJ	_	33	amod	_	_
33	role	role	NN	NN	_	30	dobj	_	_
34	in	in	IN	IN	_	38	case	_	_
35	the	the	DT	DT	_	38	det	_	_
36	EBV	ebv	NN	NN	_	38	compound	_	_
37	reactivation	reactivation	NN	NN	_	38	compound	_	_
38	process	process	NN	NN	_	30	nmod	_	_
39	.	.	.	.	_	14	punct	_	_

1	Permanent	permanent	JJ	JJ	_	2	amod	_	_
2	occupancy	occupancy	NN	NN	_	15	nsubjpass	_	_
3	of	of	IN	IN	_	10	case	_	_
4	the	the	DT	DT	_	10	det	_	_
5	human	human	JJ	JJ	_	10	amod	_	_
6	immunodeficiency	immunodeficiency	NN	NN	_	10	compound	_	_
7	virus	virus	NN	NN	_	10	compound	_	_
8	type	type	NN	NN	_	10	compound	_	_
9	1	1	CD	CD	_	10	nummod	_	_
10	enhancer	enhancer	NN	NN	_	2	nmod	_	_
11	by	by	IN	IN	_	13	case	_	_
12	NF-kappa	nf-kappa	NN	NN	_	13	compound	_	_
13	B	b	NN	NN	_	2	nmod	_	_
14	is	be	VBZ	VBZ	_	15	auxpass	_	_
15	needed	need	VBN	VBN	_	0	root	_	_
16	for	for	IN	IN	_	19	case	_	_
17	persistent	persistent	JJ	JJ	_	19	amod	_	_
18	viral	viral	JJ	JJ	_	19	amod	_	_
19	replication	replication	NN	NN	_	15	nmod	_	_
20	in	in	IN	IN	_	21	case	_	_
21	monocytes	monocyte	NNS	NNS	_	19	nmod	_	_
22	.	.	.	.	_	15	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	work	work	NN	NN	_	3	nsubj	_	_
3	aimed	aim	VBD	VBD	_	0	root	_	_
4	to	to	TO	TO	_	5	mark	_	_
5	ascertain	ascertain	VB	VB	_	3	xcomp	_	_
6	the	the	DT	DT	_	7	det	_	_
7	role	role	NN	NN	_	5	dobj	_	_
8	of	of	IN	IN	_	10	case	_	_
9	kappaB-responsive	kappab-responsive	JJ	JJ	_	10	amod	_	_
10	elements	element	NNS	NNS	_	7	nmod	_	_
11	of	of	IN	IN	_	21	case	_	_
12	the	the	DT	DT	_	21	det	_	_
13	human	human	JJ	JJ	_	21	amod	_	_
14	immunodeficiency	immunodeficiency	NN	NN	_	21	compound	_	_
15	virus	virus	NN	NN	_	21	compound	_	_
16	type	type	NN	NN	_	21	compound	_	_
17	1	1	CD	CD	_	21	nummod	_	_
18	(	(	-LRB-	-LRB-	_	21	punct	_	_
19	HIV-1	hiv-1	NN	NN	_	21	compound	_	_
20	)	)	-RRB-	-RRB-	_	21	punct	_	_
21	enhancer	enhancer	NN	NN	_	10	nmod	_	_
22	not	not	RB	RB	_	23	neg	_	_
23	only	only	RB	RB	_	26	cc:preconj	_	_
24	in	in	IN	IN	_	26	case	_	_
25	early	early	JJ	JJ	_	26	amod	_	_
26	initiation	initiation	NN	NN	_	7	nmod	_	_
27	but	but	CC	CC	_	26	cc	_	_
28	also	also	RB	RB	_	31	advmod	_	_
29	in	in	IN	IN	_	31	case	_	_
30	long-term	long-term	JJ	JJ	_	31	amod	_	_
31	maintenance	maintenance	NN	NN	_	26	conj	_	_
32	of	of	IN	IN	_	34	case	_	_
33	proviral	proviral	JJ	JJ	_	34	amod	_	_
34	transcription	transcription	NN	NN	_	26	nmod	_	_
35	in	in	IN	IN	_	36	case	_	_
36	cells	cell	NNS	NNS	_	34	nmod	_	_
37	of	of	IN	IN	_	40	case	_	_
38	the	the	DT	DT	_	40	det	_	_
39	monocytic	monocytic	JJ	JJ	_	40	amod	_	_
40	lineage	lineage	NN	NN	_	36	nmod	_	_
41	.	.	.	.	_	3	punct	_	_

1	For	for	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	purpose	purpose	NN	NN	_	6	nmod	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	used	use	VBD	VBD	_	0	root	_	_
7	three	three	CD	CD	_	9	nummod	_	_
8	main	main	JJ	JJ	_	9	amod	_	_
9	approaches	approach	NNS	NNS	_	6	dobj	_	_
10	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	first	first	JJ	JJ	_	3	nsubj	_	_
3	was	be	VBD	VBD	_	0	root	_	_
4	to	to	TO	TO	_	21	case	_	_
5	abruptly	abruptly	RB	RB	_	21	advmod	_	_
6	terminate	terminate	VB	VB	_	21	dep	_	_
7	tumor	tumor	NN	NN	_	8	compound	_	_
8	necrosis	necrosis	NN	NN	_	6	dobj	_	_
9	factor-induced	factor-induced	JJ	JJ	_	8	amod	_	_
10	NF-kappaB	nf-kappab	NN	NN	_	8	dep	_	_
11	binding	bind	VBG	VBG	_	8	acl	_	_
12	to	to	TO	TO	_	15	case	_	_
13	the	the	DT	DT	_	15	det	_	_
14	enhancer	enhancer	NN	NN	_	15	compound	_	_
15	sequences	sequence	NNS	NNS	_	11	nmod	_	_
16	in	in	IN	IN	_	19	case	_	_
17	U1	u1	NN	NN	_	19	compound	_	_
18	monocytic	monocytic	JJ	JJ	_	19	amod	_	_
19	cells	cell	NNS	NNS	_	15	nmod	_	_
20	,	,	,	,	_	21	punct	_	_
21	using	use	VBG	VBG	_	3	nmod	_	_
22	a	a	DT	DT	_	24	det	_	_
23	short	short	JJ	JJ	_	24	amod	_	_
24	pulse	pulse	NN	NN	_	21	dobj	_	_
25	of	of	IN	IN	_	29	case	_	_
26	exogenous	exogenous	JJ	JJ	_	29	amod	_	_
27	tumor	tumor	NN	NN	_	29	compound	_	_
28	necrosis	necrosis	NN	NN	_	29	compound	_	_
29	factor	factor	NN	NN	_	24	nmod	_	_
30	.	.	.	.	_	3	punct	_	_

1	This	this	DT	DT	_	2	nsubj	_	_
2	resulted	result	VBD	VBD	_	0	root	_	_
3	in	in	IN	IN	_	5	case	_	_
4	concomitant	concomitant	JJ	JJ	_	5	amod	_	_
5	decrease	decrease	NN	NN	_	2	nmod	_	_
6	in	in	IN	IN	_	10	case	_	_
7	nuclear	nuclear	JJ	JJ	_	10	amod	_	_
8	NF-kappaB	nf-kappab	NN	NN	_	10	compound	_	_
9	DNA-binding	dna-binding	JJ	JJ	_	10	amod	_	_
10	activity	activity	NN	NN	_	5	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	endogenous	endogenous	JJ	JJ	_	15	amod	_	_
13	long	long	JJ	JJ	_	15	amod	_	_
14	terminal	terminal	JJ	JJ	_	15	amod	_	_
15	repeat	repeat	NN	NN	_	17	compound	_	_
16	transcriptional	transcriptional	JJ	JJ	_	17	amod	_	_
17	activity	activity	NN	NN	_	10	conj	_	_
18	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	second	second	JJ	JJ	_	3	nsubj	_	_
3	was	be	VBD	VBD	_	0	root	_	_
4	to	to	TO	TO	_	5	mark	_	_
5	suppress	suppress	VB	VB	_	3	xcomp	_	_
6	the	the	DT	DT	_	9	det	_	_
7	permanent	permanent	JJ	JJ	_	9	amod	_	_
8	NF-kappaB	nf-kappab	NN	NN	_	9	compound	_	_
9	translocation	translocation	NN	NN	_	5	dobj	_	_
10	induced	induce	VBN	VBN	_	9	acl	_	_
11	by	by	IN	IN	_	13	case	_	_
12	HIV-1	hiv-1	NN	NN	_	13	compound	_	_
13	replication	replication	NN	NN	_	10	nmod	_	_
14	itself	itself	PRP	PRP	_	13	nmod:npmod	_	_
15	in	in	IN	IN	_	19	case	_	_
16	chronically	chronically	RB	RB	_	19	advmod	_	_
17	infected	infected	JJ	JJ	_	19	amod	_	_
18	U937	u937	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	5	nmod	_	_
20	,	,	,	,	_	5	punct	_	_
21	using	use	VBG	VBG	_	5	advcl	_	_
22	a	a	DT	DT	_	25	det	_	_
23	specific	specific	JJ	JJ	_	25	amod	_	_
24	proteasome	proteasome	NN	NN	_	25	compound	_	_
25	inhibitor	inhibitor	NN	NN	_	21	dobj	_	_
26	(	(	-LRB-	-LRB-	_	27	punct	_	_
27	Z-LLL-H	z-lll-h	NN	NN	_	25	appos	_	_
28	)	)	-RRB-	-RRB-	_	27	punct	_	_
29	.	.	.	.	_	3	punct	_	_

1	As	as	RB	RB	_	4	advmod	_	_
2	early	early	RB	RB	_	4	advmod	_	_
3	as	as	IN	IN	_	4	advmod	_	_
4	2	2	CD	CD	_	5	nummod	_	_
5	h	h	NN	NN	_	17	nmod	_	_
6	after	after	IN	IN	_	5	case	_	_
7	addition	addition	NN	NN	_	5	dep	_	_
8	of	of	IN	IN	_	10	case	_	_
9	the	the	DT	DT	_	10	det	_	_
10	inhibitor	inhibitor	NN	NN	_	7	nmod	_	_
11	to	to	TO	TO	_	14	case	_	_
12	the	the	DT	DT	_	14	det	_	_
13	culture	culture	NN	NN	_	14	compound	_	_
14	medium	medium	NN	NN	_	7	nmod	_	_
15	,	,	,	,	_	17	punct	_	_
16	there	there	EX	EX	_	17	expl	_	_
17	was	be	VBD	VBD	_	0	root	_	_
18	an	a	DT	DT	_	19	det	_	_
19	inhibition	inhibition	NN	NN	_	17	nsubj	_	_
20	of	of	IN	IN	_	23	case	_	_
21	both	both	CC	CC	_	23	cc:preconj	_	_
22	constitutive	constitutive	JJ	JJ	_	23	amod	_	_
23	activation	activation	NN	NN	_	19	nmod	_	_
24	of	of	IN	IN	_	25	case	_	_
25	NF-kappaB	nf-kappab	NN	NN	_	23	nmod	_	_
26	and	and	CC	CC	_	23	cc	_	_
27	HIV-1	hiv-1	NN	NN	_	29	compound	_	_
28	genome	genome	NN	NN	_	29	compound	_	_
29	expression	expression	NN	NN	_	23	conj	_	_
30	.	.	.	.	_	17	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	third	third	JJ	JJ	_	3	amod	_	_
3	approach	approach	NN	NN	_	4	nsubj	_	_
4	was	be	VBD	VBD	_	0	root	_	_
5	to	to	TO	TO	_	6	mark	_	_
6	monitor	monitor	VB	VB	_	4	xcomp	_	_
7	the	the	DT	DT	_	9	det	_	_
8	replication	replication	NN	NN	_	9	compound	_	_
9	competence	competence	NN	NN	_	6	dobj	_	_
10	in	in	IN	IN	_	12	case	_	_
11	U937	u937	NN	NN	_	12	compound	_	_
12	cells	cell	NNS	NNS	_	9	nmod	_	_
13	of	of	IN	IN	_	17	case	_	_
14	an	a	DT	DT	_	17	det	_	_
15	infectious	infectious	JJ	JJ	_	17	amod	_	_
16	HIV-1	hiv-1	NN	NN	_	17	compound	_	_
17	provirus	provirus	NN	NN	_	12	nmod	_	_
18	carrying	carry	VBG	VBG	_	17	acl	_	_
19	point	point	NN	NN	_	20	compound	_	_
20	mutations	mutation	NNS	NNS	_	18	dobj	_	_
21	in	in	IN	IN	_	24	case	_	_
22	the	the	DT	DT	_	24	det	_	_
23	kappaB-responsive	kappab-responsive	JJ	JJ	_	24	amod	_	_
24	elements	element	NNS	NNS	_	18	nmod	_	_
25	of	of	IN	IN	_	29	case	_	_
26	both	both	DT	DT	_	29	dep	_	_
27	long	long	JJ	JJ	_	29	amod	_	_
28	terminal	terminal	JJ	JJ	_	29	amod	_	_
29	repeats	repeat	NNS	NNS	_	24	nmod	_	_
30	.	.	.	.	_	4	punct	_	_

1	Compared	compare	VBN	VBN	_	5	case	_	_
2	with	with	IN	IN	_	5	case	_	_
3	its	its	PRP$	PRP$	_	5	nmod:poss	_	_
4	wild-type	wild-type	JJ	JJ	_	5	amod	_	_
5	counterpart	counterpart	NN	NN	_	10	advcl	_	_
6	,	,	,	,	_	10	punct	_	_
7	this	this	DT	DT	_	9	det	_	_
8	mutated	mutate	VBN	VBN	_	9	amod	_	_
9	provirus	provirus	NN	NN	_	10	nsubj	_	_
10	showed	show	VBD	VBD	_	0	root	_	_
11	a	a	DT	DT	_	19	det	_	_
12	profoundly	profoundly	RB	RB	_	13	advmod	_	_
13	decreased	decrease	VBN	VBN	_	19	amod	_	_
14	,	,	,	,	_	13	punct	_	_
15	Z-LLL-H-insensitive	z-lll-h-insensitive	JJ	JJ	_	13	dep	_	_
16	transcriptional	transcriptional	JJ	JJ	_	13	dep	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	replicative	replicative	JJ	JJ	_	16	conj	_	_
19	activity	activity	NN	NN	_	10	dobj	_	_
20	in	in	IN	IN	_	22	case	_	_
21	U937	u937	NN	NN	_	22	compound	_	_
22	monocytes	monocyte	NNS	NNS	_	19	nmod	_	_
23	.	.	.	.	_	10	punct	_	_

1	Together	together	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	our	we	PRP$	PRP$	_	4	nmod:poss	_	_
4	results	result	NNS	NNS	_	5	nsubj	_	_
5	indicate	indicate	VBP	VBP	_	0	root	_	_
6	that	that	IN	IN	_	19	mark	_	_
7	occupancy	occupancy	NN	NN	_	19	nsubjpass	_	_
8	of	of	IN	IN	_	11	case	_	_
9	the	the	DT	DT	_	11	det	_	_
10	viral	viral	JJ	JJ	_	11	amod	_	_
11	enhancer	enhancer	NN	NN	_	7	nmod	_	_
12	by	by	IN	IN	_	17	case	_	_
13	NF-kappaB	nf-kappab	NN	NN	_	17	compound	_	_
14	(	(	-LRB-	-LRB-	_	17	punct	_	_
15	p50/p65	p50/p65	NN	NN	_	17	compound	_	_
16	)	)	-RRB-	-RRB-	_	17	punct	_	_
17	heterodimers	heterodimer	NNS	NNS	_	7	nmod	_	_
18	is	be	VBZ	VBZ	_	19	auxpass	_	_
19	required	require	VBN	VBN	_	5	ccomp	_	_
20	for	for	IN	IN	_	22	case	_	_
21	ongoing	ongoing	JJ	JJ	_	22	amod	_	_
22	transcription	transcription	NN	NN	_	19	nmod	_	_
23	of	of	IN	IN	_	26	case	_	_
24	integrated	integrate	VBN	VBN	_	26	amod	_	_
25	HIV	hiv	NN	NN	_	26	compound	_	_
26	provirus	provirus	NN	NN	_	22	nmod	_	_
27	in	in	IN	IN	_	28	case	_	_
28	monocytes	monocyte	NNS	NNS	_	22	nmod	_	_
29	,	,	,	,	_	28	punct	_	_
30	even	even	RB	RB	_	32	advmod	_	_
31	in	in	IN	IN	_	32	case	_	_
32	cells	cell	NNS	NNS	_	28	nmod	_	_
33	chronically	chronically	RB	RB	_	34	advmod	_	_
34	infected	infect	VBN	VBN	_	32	dep	_	_
35	and	and	CC	CC	_	34	cc	_	_
36	permanently	permanently	RB	RB	_	37	advmod	_	_
37	producing	produce	VBG	VBG	_	34	conj	_	_
38	functional	functional	JJ	JJ	_	41	amod	_	_
39	HIV	hiv	NN	NN	_	41	compound	_	_
40	Tat	tat	NN	NN	_	41	compound	_	_
41	protein	protein	NN	NN	_	37	dobj	_	_
42	.	.	.	.	_	5	punct	_	_

1	Thus	thus	RB	RB	_	12	advmod	_	_
2	,	,	,	,	_	12	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	ability	ability	NN	NN	_	12	nsubj	_	_
5	of	of	IN	IN	_	7	case	_	_
6	HIV-1	hiv-1	NN	NN	_	7	compound	_	_
7	replication	replication	NN	NN	_	4	nmod	_	_
8	to	to	TO	TO	_	9	mark	_	_
9	activate	activate	VB	VB	_	4	acl	_	_
10	NF-kappaB	nf-kappab	NN	NN	_	9	dobj	_	_
11	is	be	VBZ	VBZ	_	12	cop	_	_
12	crucial	crucial	JJ	JJ	_	0	root	_	_
13	to	to	TO	TO	_	18	case	_	_
14	the	the	DT	DT	_	18	det	_	_
15	intense	intense	JJ	JJ	_	18	amod	_	_
16	self-perpetuated	self-perpetuated	JJ	JJ	_	15	dep	_	_
17	viral	viral	JJ	JJ	_	15	dep	_	_
18	transcription	transcription	NN	NN	_	12	nmod	_	_
19	observed	observe	VBN	VBN	_	18	acl	_	_
20	in	in	IN	IN	_	21	case	_	_
21	cells	cell	NNS	NNS	_	19	nmod	_	_
22	of	of	IN	IN	_	25	case	_	_
23	the	the	DT	DT	_	25	det	_	_
24	monocytic	monocytic	JJ	JJ	_	25	amod	_	_
25	lineage	lineage	NN	NN	_	21	nmod	_	_
26	.	.	.	.	_	12	punct	_	_

1	Efficient	efficient	JJ	JJ	_	2	amod	_	_
2	transcription	transcription	NN	NN	_	0	root	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	replication	replication	NN	NN	_	2	conj	_	_
5	of	of	IN	IN	_	8	case	_	_
6	simian	simian	JJ	JJ	_	8	amod	_	_
7	immunodeficiency	immunodeficiency	NN	NN	_	8	compound	_	_
8	virus	virus	NN	NN	_	2	nmod	_	_
9	in	in	IN	IN	_	11	case	_	_
10	the	the	DT	DT	_	11	det	_	_
11	absence	absence	NN	NN	_	2	nmod	_	_
12	of	of	IN	IN	_	13	case	_	_
13	NF-kappaB	nf-kappab	NN	NN	_	11	nmod	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	Sp1	sp1	NN	NN	_	13	conj	_	_
16	binding	binding	NN	NN	_	17	compound	_	_
17	elements	element	NNS	NNS	_	13	dep	_	_
18	.	.	.	.	_	2	punct	_	_

1	Ten	ten	CD	CD	_	2	nummod	_	_
2	mutants	mutant	NNS	NNS	_	30	nsubjpass	_	_
3	of	of	IN	IN	_	7	case	_	_
4	the	the	DT	DT	_	7	det	_	_
5	simian	simian	JJ	JJ	_	7	amod	_	_
6	immunodeficiency	immunodeficiency	NN	NN	_	7	compound	_	_
7	virus	virus	NN	NN	_	2	nmod	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	SIV	siv	NN	NN	_	7	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	SIVmac239	sivmac239	NN	NN	_	7	dep	_	_
12	bearing	bear	VBG	VBG	_	2	acl	_	_
13	deletions	deletion	NNS	NNS	_	12	dobj	_	_
14	(	(	-LRB-	-LRB-	_	15	punct	_	_
15	delta	delta	JJ	JJ	_	13	dep	_	_
16	)	)	-RRB-	-RRB-	_	15	punct	_	_
17	or	or	CC	CC	_	13	cc	_	_
18	substitutions	substitution	NNS	NNS	_	13	conj	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	subst	subst	JJ	JJ	_	18	dep	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	in	in	IN	IN	_	24	case	_	_
23	the	the	DT	DT	_	24	det	_	_
24	NF-kappaB	nf-kappab	NN	NN	_	12	nmod	_	_
25	and/or	and/or	CC	CC	_	24	cc	_	_
26	Sp1	sp1	NN	NN	_	28	compound	_	_
27	binding	binding	NN	NN	_	28	compound	_	_
28	elements	element	NNS	NNS	_	24	conj	_	_
29	were	be	VBD	VBD	_	30	auxpass	_	_
30	created	create	VBN	VBN	_	0	root	_	_
31	,	,	,	,	_	30	punct	_	_
32	and	and	CC	CC	_	30	cc	_	_
33	the	the	DT	DT	_	35	det	_	_
34	replicative	replicative	JJ	JJ	_	35	amod	_	_
35	capacities	capacity	NNS	NNS	_	40	nsubjpass	_	_
36	of	of	IN	IN	_	38	case	_	_
37	the	the	DT	DT	_	38	det	_	_
38	mutants	mutant	NNS	NNS	_	35	nmod	_	_
39	were	be	VBD	VBD	_	40	auxpass	_	_
40	analyzed	analyze	VBN	VBN	_	30	conj	_	_
41	.	.	.	.	_	30	punct	_	_

1	All	all	DT	DT	_	2	det	_	_
2	mutants	mutant	NNS	NNS	_	19	nsubj	_	_
3	,	,	,	,	_	2	punct	_	_
4	including	include	VBG	VBG	_	8	case	_	_
5	one	one	CD	CD	_	8	nummod	_	_
6	extensively	extensively	RB	RB	_	7	advmod	_	_
7	mutagenized	mutagenize	VBN	VBN	_	8	amod	_	_
8	strain	strain	NN	NN	_	2	nmod	_	_
9	entirely	entirely	RB	RB	_	10	advmod	_	_
10	missing	miss	VBG	VBG	_	8	acl	_	_
11	the	the	DT	DT	_	12	det	_	_
12	NF-kappaB	nf-kappab	NN	NN	_	10	dobj	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	four	four	CD	CD	_	15	nummod	_	_
15	Spl	spl	NN	NN	_	12	conj	_	_
16	binding	binding	NN	NN	_	17	compound	_	_
17	elements	element	NNS	NNS	_	12	dep	_	_
18	,	,	,	,	_	2	punct	_	_
19	replicated	replicate	VBN	VBN	_	0	root	_	_
20	with	with	IN	IN	_	22	case	_	_
21	wild-type	wild-type	JJ	JJ	_	22	amod	_	_
22	kinetics	kinetics	NNS	NNS	_	19	nmod	_	_
23	and	and	CC	CC	_	19	cc	_	_
24	to	to	TO	TO	_	27	case	_	_
25	a	a	DT	DT	_	27	det	_	_
26	wild-type	wild-type	JJ	JJ	_	27	amod	_	_
27	level	level	NN	NN	_	19	conj	_	_
28	in	in	IN	IN	_	33	case	_	_
29	peripheral	peripheral	JJ	JJ	_	33	amod	_	_
30	blood	blood	NN	NN	_	33	compound	_	_
31	mononuclear	mononuclear	JJ	JJ	_	33	amod	_	_
32	cell	cell	NN	NN	_	33	compound	_	_
33	cultures	culture	NNS	NNS	_	27	nmod	_	_
34	in	in	IN	IN	_	38	case	_	_
35	50	50	CD	CD	_	37	compound	_	_
36	to	to	TO	TO	_	37	dep	_	_
37	100	100	CD	CD	_	38	nummod	_	_
38	%	%	NN	NN	_	19	nmod	_	_
39	of	of	IN	IN	_	41	case	_	_
40	the	the	DT	DT	_	41	det	_	_
41	experiments	experiment	NNS	NNS	_	38	nmod	_	_
42	.	.	.	.	_	19	punct	_	_

1	One	one	CD	CD	_	2	nummod	_	_
2	group	group	NN	NN	_	5	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	mutants	mutant	NNS	NNS	_	2	nmod	_	_
5	replicated	replicate	VBN	VBN	_	0	root	_	_
6	very	very	RB	RB	_	7	advmod	_	_
7	similarly	similarly	RB	RB	_	5	advmod	_	_
8	to	to	TO	TO	_	9	case	_	_
9	SIVmac239	sivmac239	NN	NN	_	7	nmod	_	_
10	in	in	IN	IN	_	11	case	_	_
11	kinetics	kinetics	NN	NN	_	7	nmod	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	yield	yield	NN	NN	_	11	conj	_	_
14	in	in	IN	IN	_	16	case	_	_
15	CEMxl74	cemxl74	NN	NN	_	16	compound	_	_
16	cells	cell	NNS	NNS	_	11	nmod	_	_
17	(	(	-LRB-	-LRB-	_	18	punct	_	_
18	2	2	CD	CD	_	7	dep	_	_
19	x	x	CC	CC	_	18	cc	_	_
20	NFKappaB	nfkappab	NN	NN	_	18	conj	_	_
21	&gt;	&gt;	JJ	JJ	_	18	amod	_	_
22	or	or	CC	CC	_	21	cc	_	_
23	=	=	JJ	JJ	_	21	conj	_	_
24	SlVmac239	slvmac239	NN	NN	_	21	dep	_	_
25	approximately	approximately	RB	RB	_	24	advmod	_	_
26	deltaNFkappaB	deltanfkappab	NN	NN	_	24	dep	_	_
27	approximately	approximately	RB	RB	_	24	advmod	_	_
28	deltaSpl234	deltaspl234	NN	NN	_	24	dep	_	_
29	approximately	approximately	RB	RB	_	24	advmod	_	_
30	substNFkappaB	substnfkappab	NN	NN	_	24	dep	_	_
31	approximately	approximately	RB	RB	_	24	advmod	_	_
32	substSpl2	substspl2	NN	NN	_	24	dep	_	_
33	approximately	approximately	RB	RB	_	24	advmod	_	_
34	substSp23	substsp23	NN	NN	_	24	dep	_	_
35	)	)	-RRB-	-RRB-	_	18	punct	_	_
36	,	,	,	,	_	5	punct	_	_
37	while	while	IN	IN	_	41	mark	_	_
38	a	a	DT	DT	_	40	det	_	_
39	second	second	JJ	JJ	_	40	amod	_	_
40	group	group	NN	NN	_	41	nsubj	_	_
41	replicated	replicate	VBD	VBD	_	5	advcl	_	_
42	with	with	IN	IN	_	43	case	_	_
43	delayed	delay	VBN	VBN	_	41	advcl	_	_
44	or	or	CC	CC	_	43	cc	_	_
45	slightly	slightly	RB	RB	_	46	advmod	_	_
46	delayed	delay	VBN	VBN	_	43	conj	_	_
47	kinetics	kinetics	NN	NN	_	43	dep	_	_
48	in	in	IN	IN	_	50	case	_	_
49	CEMxl74	cemxl74	NN	NN	_	50	compound	_	_
50	cells	cell	NNS	NNS	_	43	nmod	_	_
51	(	(	-LRB-	-LRB-	_	52	punct	_	_
52	SIVmac239	sivmac239	NN	NN	_	43	dep	_	_
53	&gt;	&gt;	JJ	JJ	_	52	amod	_	_
54	substSp34	substsp34	NN	NN	_	53	dep	_	_
55	&gt;	&gt;	JJ	JJ	_	54	amod	_	_
56	deltaNFkappaBdeltaSpl234	deltanfkappabdeltaspl234	NN	NN	_	55	dep	_	_
57	approximately	approximately	RB	RB	_	56	advmod	_	_
58	deltaNFkappaBdeltaSp1	deltanfkappabdeltasp1	NN	NN	_	56	dep	_	_
59	&gt;	&gt;	JJ	JJ	_	56	amod	_	_
60	substSpl234	substspl234	NN	NN	_	59	dep	_	_
61	)	)	-RRB-	-RRB-	_	52	punct	_	_
62	.	.	.	.	_	5	punct	_	_

1	Reversions	reversion	NNS	NNS	_	7	nsubjpass	_	_
2	or	or	CC	CC	_	1	cc	_	_
3	additional	additional	JJ	JJ	_	4	amod	_	_
4	mutations	mutation	NNS	NNS	_	1	conj	_	_
5	were	be	VBD	VBD	_	7	auxpass	_	_
6	not	not	RB	RB	_	7	neg	_	_
7	detected	detect	VBN	VBN	_	0	root	_	_
8	in	in	IN	IN	_	10	case	_	_
9	the	the	DT	DT	_	10	dep	_	_
10	U3	u3	NN	NN	_	7	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	R	r	NN	NN	_	10	conj	_	_
13	regions	region	NNS	NNS	_	10	dep	_	_
14	of	of	IN	IN	_	16	case	_	_
15	proviral	proviral	JJ	JJ	_	16	amod	_	_
16	DNA	dna	NN	NN	_	10	nmod	_	_
17	from	from	IN	IN	_	19	case	_	_
18	CEMxl74	cemxl74	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	16	nmod	_	_
20	infected	infect	VBN	VBN	_	19	acl	_	_
21	with	with	IN	IN	_	24	case	_	_
22	the	the	DT	DT	_	24	det	_	_
23	SIVmac239	sivmac239	NN	NN	_	24	compound	_	_
24	mutants	mutant	NNS	NNS	_	20	nmod	_	_
25	.	.	.	.	_	7	punct	_	_

1	Similar	similar	JJ	JJ	_	2	amod	_	_
2	results	result	NNS	NNS	_	4	nsubjpass	_	_
3	were	be	VBD	VBD	_	4	auxpass	_	_
4	obtained	obtain	VBN	VBN	_	0	root	_	_
5	when	when	WRB	WRB	_	17	advmod	_	_
6	mutants	mutant	NNS	NNS	_	17	nsubjpass	_	_
7	of	of	IN	IN	_	8	case	_	_
8	SIVmacMER	sivmacmer	NN	NN	_	6	nmod	_	_
9	(	(	-LRB-	-LRB-	_	12	punct	_	_
10	a	a	DT	DT	_	12	det	_	_
11	macrophage-competent	macrophage-competent	JJ	JJ	_	12	amod	_	_
12	derivative	derivative	NN	NN	_	6	dep	_	_
13	of	of	IN	IN	_	14	case	_	_
14	SIVmac239	sivmac239	NN	NN	_	12	nmod	_	_
15	)	)	-RRB-	-RRB-	_	12	punct	_	_
16	were	be	VBD	VBD	_	17	auxpass	_	_
17	tested	test	VBN	VBN	_	4	advcl	_	_
18	in	in	IN	IN	_	22	case	_	_
19	peripheral	peripheral	JJ	JJ	_	22	amod	_	_
20	blood	blood	NN	NN	_	22	compound	_	_
21	mononuclear	mononuclear	JJ	JJ	_	22	amod	_	_
22	cell	cell	NN	NN	_	17	nmod	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	CEMx174	cemx174	NN	NN	_	25	compound	_	_
25	cultures	culture	NNS	NNS	_	22	conj	_	_
26	.	.	.	.	_	4	punct	_	_

1	However	however	RB	RB	_	10	advmod	_	_
2	,	,	,	,	_	10	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	growth	growth	NN	NN	_	10	nsubjpass	_	_
5	of	of	IN	IN	_	8	case	_	_
6	most	most	JJ	JJ	_	8	amod	_	_
7	mutated	mutate	VBN	VBN	_	8	amod	_	_
8	viruses	virus	NNS	NNS	_	4	nmod	_	_
9	was	be	VBD	VBD	_	10	auxpass	_	_
10	suppressed	suppress	VBN	VBN	_	0	root	_	_
11	in	in	IN	IN	_	16	case	_	_
12	primary	primary	JJ	JJ	_	16	amod	_	_
13	rhesus	rhesus	NN	NN	_	16	compound	_	_
14	monkey	monkey	NN	NN	_	16	compound	_	_
15	alveolar	alveolar	JJ	JJ	_	16	amod	_	_
16	macrophages	macrophage	NNS	NNS	_	10	nmod	_	_
17	(	(	-LRB-	-LRB-	_	18	punct	_	_
18	SIVmacMER	sivmacmer	NN	NN	_	10	dep	_	_
19	approximately	approximately	RB	RB	_	18	advmod	_	_
20	2xNFkappaB	2xnfkappab	NN	NN	_	18	dep	_	_
21	approximately	approximately	RB	RB	_	18	advmod	_	_
22	substNFkappaB	substnfkappab	NN	NN	_	18	dep	_	_
23	&gt;	&gt;	JJ	JJ	_	18	amod	_	_
24	deltaNFkappaB	deltanfkappab	NN	NN	_	23	dep	_	_
25	&gt;	&gt;	JJ	JJ	_	24	amod	_	_
26	deltaNFkappaBdeltaSpl234	deltanfkappabdeltaspl234	NN	NN	_	25	dep	_	_
27	approximately	approximately	RB	RB	_	26	advmod	_	_
28	deltaNFkappaBdeltaSpl	deltanfkappabdeltaspl	NN	NN	_	26	dep	_	_
29	&gt;	&gt;	JJ	JJ	_	25	dep	_	_
30	deltaSpl234	deltaspl234	NN	NN	_	29	dep	_	_
31	approximately	approximately	RB	RB	_	30	advmod	_	_
32	substSpl2	substspl2	NN	NN	_	30	dep	_	_
33	&gt;	&gt;	JJ	JJ	_	29	dep	_	_
34	substSp23	substsp23	NN	NN	_	33	dep	_	_
35	approximately	approximately	RB	RB	_	34	advmod	_	_
36	substSp34	substsp34	NN	NN	_	34	dep	_	_
37	approximately	approximately	RB	RB	_	34	advmod	_	_
38	substSpl234	substspl234	NN	NN	_	34	dep	_	_
39	&gt;	&gt;	JJ	JJ	_	33	dep	_	_
40	or	or	CC	CC	_	39	cc	_	_
41	=	=	JJ	JJ	_	39	conj	_	_
42	SIVmac239	sivmac239	NN	NN	_	39	dep	_	_
43	)	)	-RRB-	-RRB-	_	18	punct	_	_
44	.	.	.	.	_	10	punct	_	_

1	Thus	thus	RB	RB	_	9	advmod	_	_
2	,	,	,	,	_	9	punct	_	_
3	changes	change	NNS	NNS	_	9	nsubj	_	_
4	in	in	IN	IN	_	8	case	_	_
5	the	the	DT	DT	_	8	det	_	_
6	Sp1	sp1	NN	NN	_	8	compound	_	_
7	binding	binding	NN	NN	_	8	compound	_	_
8	sites	site	NNS	NNS	_	3	nmod	_	_
9	had	have	VBD	VBD	_	0	root	_	_
10	the	the	DT	DT	_	13	det	_	_
11	most	most	RBS	RBS	_	12	advmod	_	_
12	dramatic	dramatic	JJ	JJ	_	13	amod	_	_
13	effects	effect	NNS	NNS	_	9	dobj	_	_
14	on	on	IN	IN	_	16	case	_	_
15	SIVmac	sivmac	NN	NN	_	16	compound	_	_
16	replication	replication	NN	NN	_	9	nmod	_	_
17	in	in	IN	IN	_	20	case	_	_
18	primary	primary	JJ	JJ	_	20	amod	_	_
19	macrophage	macrophage	NN	NN	_	20	compound	_	_
20	cultures	culture	NNS	NNS	_	16	nmod	_	_
21	.	.	.	.	_	9	punct	_	_

1	Analysis	analysis	NN	NN	_	13	nsubj	_	_
2	of	of	IN	IN	_	9	case	_	_
3	long	long	JJ	JJ	_	6	amod	_	_
4	terminal	terminal	JJ	JJ	_	6	amod	_	_
5	repeat-driven	repeat-driven	JJ	JJ	_	6	amod	_	_
6	secreted	secrete	VBN	VBN	_	9	amod	_	_
7	alkaline	alkaline	NN	NN	_	8	compound	_	_
8	phosphatase	phosphatase	NN	NN	_	9	compound	_	_
9	activity	activity	NN	NN	_	1	nmod	_	_
10	in	in	IN	IN	_	12	case	_	_
11	transient	transient	JJ	JJ	_	12	amod	_	_
12	assays	assay	NNS	NNS	_	9	nmod	_	_
13	showed	show	VBD	VBD	_	0	root	_	_
14	that	that	IN	IN	_	28	mark	_	_
15	,	,	,	,	_	28	punct	_	_
16	unlike	unlike	IN	IN	_	20	case	_	_
17	human	human	JJ	JJ	_	20	amod	_	_
18	immunodeficiency	immunodeficiency	NN	NN	_	20	compound	_	_
19	virus	virus	NN	NN	_	20	compound	_	_
20	type	type	NN	NN	_	28	nmod	_	_
21	1	1	CD	CD	_	20	nummod	_	_
22	,	,	,	,	_	28	punct	_	_
23	the	the	DT	DT	_	27	det	_	_
24	SIV	siv	NN	NN	_	27	compound	_	_
25	long	long	JJ	JJ	_	27	amod	_	_
26	terminal	terminal	JJ	JJ	_	27	amod	_	_
27	repeat	repeat	NN	NN	_	28	nsubj	_	_
28	possesses	possess	VBZ	VBZ	_	13	ccomp	_	_
29	an	a	DT	DT	_	31	det	_	_
30	enhancer	enhancer	NN	NN	_	31	compound	_	_
31	region	region	NN	NN	_	28	dobj	_	_
32	just	just	RB	RB	_	33	advmod	_	_
33	upstream	upstream	RB	RB	_	31	advmod	_	_
34	of	of	IN	IN	_	37	case	_	_
35	the	the	DT	DT	_	37	det	_	_
36	NF-kappaB	nf-kappab	NN	NN	_	37	compound	_	_
37	element	element	NN	NN	_	33	nmod	_	_
38	which	which	WDT	WDT	_	39	nsubj	_	_
39	maintains	maintain	VBZ	VBZ	_	37	acl:relcl	_	_
40	significant	significant	JJ	JJ	_	41	amod	_	_
41	levels	level	NNS	NNS	_	39	dobj	_	_
42	of	of	IN	IN	_	44	case	_	_
43	basal	basal	JJ	JJ	_	44	amod	_	_
44	transcription	transcription	NN	NN	_	41	nmod	_	_
45	in	in	IN	IN	_	47	case	_	_
46	the	the	DT	DT	_	47	det	_	_
47	absence	absence	NN	NN	_	39	nmod	_	_
48	of	of	IN	IN	_	49	case	_	_
49	NF-kappaB	nf-kappab	NN	NN	_	47	nmod	_	_
50	and	and	CC	CC	_	49	cc	_	_
51	Sp1	sp1	NN	NN	_	49	conj	_	_
52	sites	site	NNS	NNS	_	49	dep	_	_
53	.	.	.	.	_	13	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	region	region	NN	NN	_	4	nsubj	_	_
3	is	be	VBZ	VBZ	_	4	cop	_	_
4	responsive	responsive	JJ	JJ	_	0	root	_	_
5	to	to	TO	TO	_	6	case	_	_
6	transactivation	transactivation	NN	NN	_	4	nmod	_	_
7	by	by	IN	IN	_	8	case	_	_
8	Tat	tat	NN	NN	_	6	nmod	_	_
9	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	addition	addition	NN	NN	_	9	nmod	_	_
3	,	,	,	,	_	9	punct	_	_
4	the	the	DT	DT	_	7	det	_	_
5	SIV	siv	NN	NN	_	7	compound	_	_
6	TATA	tata	NN	NN	_	7	compound	_	_
7	box	box	NN	NN	_	9	nsubjpass	_	_
8	was	be	VBD	VBD	_	9	auxpass	_	_
9	shown	show	VBN	VBN	_	0	root	_	_
10	to	to	TO	TO	_	12	mark	_	_
11	be	be	VB	VB	_	12	cop	_	_
12	stronger	stronger	JJR	JJR	_	9	xcomp	_	_
13	than	than	IN	IN	_	14	case	_	_
14	that	that	DT	DT	_	12	nmod	_	_
15	of	of	IN	IN	_	19	case	_	_
16	human	human	JJ	JJ	_	19	amod	_	_
17	immunodeficiency	immunodeficiency	NN	NN	_	19	compound	_	_
18	virus	virus	NN	NN	_	19	compound	_	_
19	type	type	NN	NN	_	14	nmod	_	_
20	1	1	CD	CD	_	19	nummod	_	_
21	.	.	.	.	_	9	punct	_	_

1	Therefore	therefore	RB	RB	_	18	advmod	_	_
2	,	,	,	,	_	18	punct	_	_
3	the	the	DT	DT	_	7	det	_	_
4	surprisingly	surprisingly	RB	RB	_	6	advmod	_	_
5	high	high	JJ	JJ	_	6	amod	_	_
6	replicative	replicative	JJ	JJ	_	7	amod	_	_
7	capacity	capacity	NN	NN	_	18	nsubj	_	_
8	of	of	IN	IN	_	9	case	_	_
9	NF-kappaB	nf-kappab	NN	NN	_	7	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	Sp1	sp1	NN	NN	_	9	conj	_	_
12	binding	binding	NN	NN	_	14	compound	_	_
13	site	site	NN	NN	_	14	compound	_	_
14	mutants	mutant	NNS	NNS	_	9	dep	_	_
15	of	of	IN	IN	_	16	case	_	_
16	SIVmac	sivmac	NN	NN	_	9	nmod	_	_
17	is	be	VBZ	VBZ	_	18	cop	_	_
18	due	due	JJ	JJ	_	0	root	_	_
19	to	to	TO	TO	_	21	case	_	_
20	unique	unique	JJ	JJ	_	21	amod	_	_
21	features	feature	NNS	NNS	_	18	nmod	_	_
22	or	or	CC	CC	_	21	cc	_	_
23	the	the	DT	DT	_	25	det	_	_
24	enhancer/promoter	enhancer/promoter	NN	NN	_	25	compound	_	_
25	region	region	NN	NN	_	21	conj	_	_
26	.	.	.	.	_	18	punct	_	_

1	Inactivation	inactivation	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	3	case	_	_
3	IkappaBbeta	ikappabbeta	NN	NN	_	1	nmod	_	_
4	by	by	IN	IN	_	7	case	_	_
5	the	the	DT	DT	_	7	det	_	_
6	tax	tax	NN	NN	_	7	compound	_	_
7	protein	protein	NN	NN	_	1	nmod	_	_
8	of	of	IN	IN	_	13	case	_	_
9	human	human	JJ	JJ	_	13	amod	_	_
10	T-cell	t-cell	NN	NN	_	13	compound	_	_
11	leukemia	leukemia	NN	NN	_	13	compound	_	_
12	virus	virus	NN	NN	_	13	compound	_	_
13	type	type	NN	NN	_	7	nmod	_	_
14	1	1	CD	CD	_	13	nummod	_	_
15	:	:	:	:	_	1	punct	_	_
16	a	a	DT	DT	_	18	det	_	_
17	potential	potential	JJ	JJ	_	18	amod	_	_
18	mechanism	mechanism	NN	NN	_	1	dep	_	_
19	for	for	IN	IN	_	21	case	_	_
20	constitutive	constitutive	JJ	JJ	_	21	amod	_	_
21	induction	induction	NN	NN	_	18	nmod	_	_
22	of	of	IN	IN	_	23	case	_	_
23	NF-kappaB	nf-kappab	NN	NN	_	21	nmod	_	_
24	.	.	.	.	_	1	punct	_	_

1	In	in	IN	IN	_	4	case	_	_
2	resting	rest	VBG	VBG	_	4	amod	_	_
3	T	t	NN	NN	_	4	compound	_	_
4	lymphocytes	lymphocyte	NNS	NNS	_	11	nmod	_	_
5	,	,	,	,	_	11	punct	_	_
6	the	the	DT	DT	_	8	det	_	_
7	transcription	transcription	NN	NN	_	8	compound	_	_
8	factor	factor	NN	NN	_	11	nsubjpass	_	_
9	NF-kappaB	nf-kappab	NN	NN	_	8	dep	_	_
10	is	be	VBZ	VBZ	_	11	auxpass	_	_
11	sequestered	sequester	VBN	VBN	_	0	root	_	_
12	in	in	IN	IN	_	14	case	_	_
13	the	the	DT	DT	_	14	det	_	_
14	cytoplasm	cytoplasm	NN	NN	_	11	nmod	_	_
15	via	via	IN	IN	_	16	case	_	_
16	interactions	interaction	NNS	NNS	_	11	nmod	_	_
17	with	with	IN	IN	_	18	case	_	_
18	members	member	NNS	NNS	_	16	nmod	_	_
19	of	of	IN	IN	_	24	case	_	_
20	the	the	DT	DT	_	24	det	_	_
21	I	i	NN	NN	_	24	compound	_	_
22	kappa	kappa	NN	NN	_	24	compound	_	_
23	B	b	NN	NN	_	24	compound	_	_
24	family	family	NN	NN	_	18	nmod	_	_
25	of	of	IN	IN	_	26	case	_	_
26	inhibitors	inhibitor	NNS	NNS	_	24	nmod	_	_
27	,	,	,	,	_	18	punct	_	_
28	including	include	VBG	VBG	_	29	case	_	_
29	IkappaBalpha	ikappabalpha	NN	NN	_	18	nmod	_	_
30	and	and	CC	CC	_	29	cc	_	_
31	IkappaBbeta	ikappabbeta	NN	NN	_	29	conj	_	_
32	.	.	.	.	_	11	punct	_	_

1	During	during	IN	IN	_	4	case	_	_
2	normal	normal	JJ	JJ	_	4	amod	_	_
3	T-cell	t-cell	NN	NN	_	4	compound	_	_
4	activation	activation	NN	NN	_	9	nmod	_	_
5	,	,	,	,	_	9	punct	_	_
6	IkappaBalpha	ikappabalpha	NN	NN	_	9	nsubjpass	_	_
7	is	be	VBZ	VBZ	_	9	auxpass	_	_
8	rapidly	rapidly	RB	RB	_	9	advmod	_	_
9	phosphorylated	phosphorylate	VBN	VBN	_	0	root	_	_
10	,	,	,	,	_	9	punct	_	_
11	ubiquitinated	ubiquitinate	VBN	VBN	_	9	conj	_	_
12	,	,	,	,	_	9	punct	_	_
13	and	and	CC	CC	_	9	cc	_	_
14	degraded	degrade	VBN	VBN	_	9	conj	_	_
15	by	by	IN	IN	_	18	case	_	_
16	the	the	DT	DT	_	18	det	_	_
17	26S	26s	NN	NN	_	18	compound	_	_
18	proteasome	proteasome	NN	NN	_	9	nmod	_	_
19	,	,	,	,	_	9	punct	_	_
20	thus	thus	RB	RB	_	21	advmod	_	_
21	permitting	permit	VBG	VBG	_	9	advcl	_	_
22	the	the	DT	DT	_	23	det	_	_
23	release	release	NN	NN	_	21	dobj	_	_
24	of	of	IN	IN	_	26	case	_	_
25	functional	functional	JJ	JJ	_	26	amod	_	_
26	NF-kappaB	nf-kappab	NN	NN	_	23	nmod	_	_
27	.	.	.	.	_	9	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	contrast	contrast	NN	NN	_	18	nmod	_	_
3	to	to	TO	TO	_	6	case	_	_
4	its	its	PRP$	PRP$	_	6	nmod:poss	_	_
5	transient	transient	JJ	JJ	_	6	amod	_	_
6	pattern	pattern	NN	NN	_	2	nmod	_	_
7	of	of	IN	IN	_	9	case	_	_
8	nuclear	nuclear	JJ	JJ	_	9	amod	_	_
9	induction	induction	NN	NN	_	6	nmod	_	_
10	during	during	IN	IN	_	13	case	_	_
11	an	a	DT	DT	_	13	det	_	_
12	immune	immune	JJ	JJ	_	13	amod	_	_
13	response	response	NN	NN	_	6	nmod	_	_
14	,	,	,	,	_	18	punct	_	_
15	NF-kappaB	nf-kappab	NN	NN	_	18	nsubjpass	_	_
16	is	be	VBZ	VBZ	_	18	auxpass	_	_
17	constitutively	constitutively	RB	RB	_	18	advmod	_	_
18	activated	activate	VBN	VBN	_	0	root	_	_
19	in	in	IN	IN	_	20	case	_	_
20	cells	cell	NNS	NNS	_	18	nmod	_	_
21	expressing	express	VBG	VBG	_	20	acl	_	_
22	the	the	DT	DT	_	25	det	_	_
23	Tax	tax	NN	NN	_	25	compound	_	_
24	transforming	transforming	NN	NN	_	25	compound	_	_
25	protein	protein	NN	NN	_	21	dobj	_	_
26	of	of	IN	IN	_	31	case	_	_
27	human	human	JJ	JJ	_	31	amod	_	_
28	T-cell	t-cell	NN	NN	_	31	compound	_	_
29	leukemia	leukemia	NN	NN	_	31	compound	_	_
30	virus	virus	NN	NN	_	31	compound	_	_
31	type	type	NN	NN	_	25	nmod	_	_
32	I	i	CD	CD	_	31	nummod	_	_
33	(	(	-LRB-	-LRB-	_	34	punct	_	_
34	HTLV-1	htlv-1	NN	NN	_	31	appos	_	_
35	)	)	-RRB-	-RRB-	_	34	punct	_	_
36	.	.	.	.	_	18	punct	_	_

1	Recent	recent	JJ	JJ	_	2	amod	_	_
2	studies	study	NNS	NNS	_	3	nsubj	_	_
3	indicate	indicate	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	7	mark	_	_
5	HTLV-1	htlv-1	NN	NN	_	7	nsubj	_	_
6	Tax	tax	NN	NN	_	5	dep	_	_
7	targets	target	VBZ	VBZ	_	3	ccomp	_	_
8	IkappaBalpha	ikappabalpha	NN	NN	_	7	dobj	_	_
9	to	to	TO	TO	_	12	case	_	_
10	the	the	DT	DT	_	12	det	_	_
11	ubiquitin-proteasome	ubiquitin-proteasome	JJ	JJ	_	12	amod	_	_
12	pathway	pathway	NN	NN	_	7	nmod	_	_
13	.	.	.	.	_	3	punct	_	_

1	However	however	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	it	it	PRP	PRP	_	4	nsubj	_	_
4	remains	remain	VBZ	VBZ	_	0	root	_	_
5	unclear	unclear	JJ	JJ	_	4	xcomp	_	_
6	how	how	WRB	WRB	_	10	advmod	_	_
7	this	this	DT	DT	_	9	det	_	_
8	viral	viral	JJ	JJ	_	9	amod	_	_
9	protein	protein	NN	NN	_	10	nsubj	_	_
10	induces	induce	VBZ	VBZ	_	4	ccomp	_	_
11	a	a	DT	DT	_	17	det	_	_
12	persistent	persistent	JJ	JJ	_	17	amod	_	_
13	rather	rather	RB	RB	_	12	cc	_	_
14	than	than	IN	IN	_	13	mwe	_	_
15	transient	transient	JJ	JJ	_	12	conj	_	_
16	NF-kappaB	nf-kappab	NN	NN	_	17	compound	_	_
17	response	response	NN	NN	_	10	dobj	_	_
18	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	report	report	NN	NN	_	6	nmod	_	_
4	,	,	,	,	_	6	punct	_	_
5	we	we	PRP	PRP	_	6	nsubj	_	_
6	provide	provide	VBP	VBP	_	0	root	_	_
7	evidence	evidence	NN	NN	_	6	dobj	_	_
8	that	that	IN	IN	_	17	mark	_	_
9	in	in	IN	IN	_	10	case	_	_
10	addition	addition	NN	NN	_	17	nmod	_	_
11	to	to	TO	TO	_	12	mark	_	_
12	acting	act	VBG	VBG	_	10	acl	_	_
13	on	on	IN	IN	_	14	case	_	_
14	IkappaBalpha	ikappabalpha	NN	NN	_	12	nmod	_	_
15	,	,	,	,	_	17	punct	_	_
16	Tax	tax	NN	NN	_	17	nsubj	_	_
17	stimulates	stimulate	VBZ	VBZ	_	7	ccomp	_	_
18	the	the	DT	DT	_	19	det	_	_
19	turnover	turnover	NN	NN	_	17	dobj	_	_
20	Of	of	IN	IN	_	21	case	_	_
21	IkappaBbeta	ikappabbeta	NN	NN	_	19	nmod	_	_
22	via	via	IN	IN	_	26	case	_	_
23	a	a	DT	DT	_	26	det	_	_
24	related	related	JJ	JJ	_	26	amod	_	_
25	targeting	targeting	NN	NN	_	26	compound	_	_
26	mechanism	mechanism	NN	NN	_	17	nmod	_	_
27	.	.	.	.	_	6	punct	_	_

1	Like	like	IN	IN	_	2	case	_	_
2	IkappaBalpha	ikappabalpha	NN	NN	_	13	nmod	_	_
3	,	,	,	,	_	13	punct	_	_
4	Tax-mediated	tax-mediated	JJ	JJ	_	5	amod	_	_
5	breakdown	breakdown	NN	NN	_	13	nsubjpass	_	_
6	of	of	IN	IN	_	7	case	_	_
7	IkappaBbeta	ikappabbeta	NN	NN	_	5	nmod	_	_
8	in	in	IN	IN	_	11	case	_	_
9	transfected	transfect	VBN	VBN	_	11	amod	_	_
10	T	t	NN	NN	_	11	compound	_	_
11	lymphocytes	lymphocyte	NNS	NNS	_	5	nmod	_	_
12	is	be	VBZ	VBZ	_	13	auxpass	_	_
13	blocked	block	VBN	VBN	_	0	root	_	_
14	either	either	CC	CC	_	18	cc:preconj	_	_
15	by	by	IN	IN	_	18	case	_	_
16	cell-permeable	cell-permeable	JJ	JJ	_	18	amod	_	_
17	proteasome	proteasome	NN	NN	_	18	compound	_	_
18	inhibitors	inhibitor	NNS	NNS	_	13	nmod	_	_
19	or	or	CC	CC	_	18	cc	_	_
20	by	by	IN	IN	_	21	case	_	_
21	mutation	mutation	NN	NN	_	18	conj	_	_
22	Of	of	IN	IN	_	23	case	_	_
23	IkappaBbeta	ikappabbeta	NN	NN	_	21	nmod	_	_
24	at	at	IN	IN	_	27	case	_	_
25	two	two	CD	CD	_	27	nummod	_	_
26	serine	serine	NN	NN	_	27	compound	_	_
27	residues	residue	NNS	NNS	_	21	nmod	_	_
28	present	present	JJ	JJ	_	27	amod	_	_
29	within	within	IN	IN	_	32	case	_	_
30	its	its	PRP$	PRP$	_	32	nmod:poss	_	_
31	N-terminal	n-terminal	JJ	JJ	_	32	amod	_	_
32	region	region	NN	NN	_	28	nmod	_	_
33	.	.	.	.	_	13	punct	_	_

1	Despite	despite	IN	IN	_	4	case	_	_
2	the	the	DT	DT	_	4	det	_	_
3	dual	dual	JJ	JJ	_	4	amod	_	_
4	specificity	specificity	NN	NN	_	19	nmod	_	_
5	of	of	IN	IN	_	6	case	_	_
6	HTLV-1	htlv-1	NN	NN	_	4	nmod	_	_
7	Tax	tax	NN	NN	_	6	dep	_	_
8	for	for	IN	IN	_	9	case	_	_
9	IkappaBalpha	ikappabalpha	NN	NN	_	4	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	IkappaBbeta	ikappabbeta	NN	NN	_	9	conj	_	_
12	at	at	IN	IN	_	15	case	_	_
13	the	the	DT	DT	_	15	det	_	_
14	protein	protein	NN	NN	_	15	compound	_	_
15	level	level	NN	NN	_	4	nmod	_	_
16	,	,	,	,	_	19	punct	_	_
17	Tax	tax	NN	NN	_	19	nsubj	_	_
18	selectively	selectively	RB	RB	_	19	advmod	_	_
19	stimulates	stimulate	VBZ	VBZ	_	0	root	_	_
20	NF-kappaB-directed	nf-kappab-directed	JJ	JJ	_	21	amod	_	_
21	transcription	transcription	NN	NN	_	19	dobj	_	_
22	of	of	IN	IN	_	25	case	_	_
23	the	the	DT	DT	_	25	det	_	_
24	IkappaBalpha	ikappabalpha	NN	NN	_	25	compound	_	_
25	gene	gene	NN	NN	_	21	nmod	_	_
26	.	.	.	.	_	19	punct	_	_

1	Consequently	consequently	RB	RB	_	8	advmod	_	_
2	,	,	,	,	_	8	punct	_	_
3	IkappaBbeta	ikappabbeta	NN	NN	_	5	compound	_	_
4	protein	protein	NN	NN	_	5	compound	_	_
5	expression	expression	NN	NN	_	8	nsubjpass	_	_
6	is	be	VBZ	VBZ	_	8	auxpass	_	_
7	chronically	chronically	RB	RB	_	8	advmod	_	_
8	downregulated	downregulate	VBN	VBN	_	0	root	_	_
9	in	in	IN	IN	_	12	case	_	_
10	HTLV-1-infected	htlv-1-infected	JJ	JJ	_	12	amod	_	_
11	T	t	NN	NN	_	12	compound	_	_
12	lymphocytes	lymphocyte	NNS	NNS	_	8	nmod	_	_
13	.	.	.	.	_	8	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	findings	finding	NNS	NNS	_	5	nsubj	_	_
3	with	with	IN	IN	_	4	case	_	_
4	IkappaBbeta	ikappabbeta	NN	NN	_	2	nmod	_	_
5	provide	provide	VBP	VBP	_	0	root	_	_
6	a	a	DT	DT	_	8	det	_	_
7	potential	potential	JJ	JJ	_	8	amod	_	_
8	mechanism	mechanism	NN	NN	_	5	dobj	_	_
9	for	for	IN	IN	_	12	case	_	_
10	the	the	DT	DT	_	12	det	_	_
11	constitutive	constitutive	JJ	JJ	_	12	amod	_	_
12	activation	activation	NN	NN	_	8	nmod	_	_
13	of	of	IN	IN	_	14	case	_	_
14	NF-kappaB	nf-kappab	NN	NN	_	12	nmod	_	_
15	in	in	IN	IN	_	17	case	_	_
16	Tax-expressing	tax-expressing	JJ	JJ	_	17	amod	_	_
17	cells	cell	NNS	NNS	_	12	nmod	_	_
18	.	.	.	.	_	5	punct	_	_

1	Genetic	genetic	JJ	JJ	_	2	amod	_	_
2	characterization	characterization	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	4	case	_	_
4	transactivation	transactivation	NN	NN	_	2	nmod	_	_
5	of	of	IN	IN	_	13	case	_	_
6	the	the	DT	DT	_	13	det	_	_
7	human	human	JJ	JJ	_	13	amod	_	_
8	T-cell	t-cell	NN	NN	_	13	compound	_	_
9	leukemia	leukemia	NN	NN	_	13	compound	_	_
10	virus	virus	NN	NN	_	13	compound	_	_
11	type	type	NN	NN	_	13	compound	_	_
12	1	1	CD	CD	_	13	nummod	_	_
13	promoter	promoter	NN	NN	_	4	nmod	_	_
14	:	:	:	:	_	2	punct	_	_
15	Binding	binding	NN	NN	_	23	nsubjpass	_	_
16	of	of	IN	IN	_	17	case	_	_
17	Tax	tax	NN	NN	_	15	nmod	_	_
18	to	to	TO	TO	_	20	case	_	_
19	Tax-responsive	tax-responsive	JJ	JJ	_	20	amod	_	_
20	element	element	NN	NN	_	15	nmod	_	_
21	1	1	CD	CD	_	20	nummod	_	_
22	is	be	VBZ	VBZ	_	23	auxpass	_	_
23	mediated	mediate	VBN	VBN	_	2	dep	_	_
24	by	by	IN	IN	_	28	case	_	_
25	the	the	DT	DT	_	28	det	_	_
26	cyclic	cyclic	JJ	JJ	_	28	amod	_	_
27	AMP-responsive	amp-responsive	JJ	JJ	_	28	amod	_	_
28	members	member	NNS	NNS	_	23	nmod	_	_
29	of	of	IN	IN	_	32	case	_	_
30	the	the	DT	DT	_	32	det	_	_
31	CREB/ATF	creb/atf	NN	NN	_	32	compound	_	_
32	family	family	NN	NN	_	28	nmod	_	_
33	of	of	IN	IN	_	35	case	_	_
34	transcription	transcription	NN	NN	_	35	compound	_	_
35	factors	factor	NNS	NNS	_	32	nmod	_	_
36	.	.	.	.	_	2	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	achieve	achieve	VB	VB	_	0	root	_	_
3	a	a	DT	DT	_	5	det	_	_
4	better	better	JJR	JJR	_	5	amod	_	_
5	understanding	understanding	NN	NN	_	2	dobj	_	_
6	of	of	IN	IN	_	8	case	_	_
7	the	the	DT	DT	_	8	det	_	_
8	mechanism	mechanism	NN	NN	_	5	nmod	_	_
9	of	of	IN	IN	_	10	case	_	_
10	transactivation	transactivation	NN	NN	_	8	nmod	_	_
11	by	by	IN	IN	_	12	case	_	_
12	Tax	tax	NN	NN	_	10	nmod	_	_
13	of	of	IN	IN	_	18	case	_	_
14	human	human	JJ	JJ	_	18	amod	_	_
15	T-cell	t-cell	NN	NN	_	18	compound	_	_
16	leukemia	leukemia	NN	NN	_	18	compound	_	_
17	virus	virus	NN	NN	_	18	compound	_	_
18	type	type	NN	NN	_	10	nmod	_	_
19	1	1	CD	CD	_	18	nummod	_	_
20	Tax-responsive	tax-responsive	JJ	JJ	_	21	amod	_	_
21	element	element	NN	NN	_	18	dep	_	_
22	1	1	CD	CD	_	21	nummod	_	_
23	(	(	-LRB-	-LRB-	_	24	punct	_	_
24	TRE-1	tre-1	NN	NN	_	21	appos	_	_
25	)	)	-RRB-	-RRB-	_	24	punct	_	_
26	,	,	,	,	_	2	punct	_	_
27	we	we	PRP	PRP	_	28	nsubj	_	_
28	developed	develop	VBD	VBD	_	2	parataxis	_	_
29	a	a	DT	DT	_	31	det	_	_
30	genetic	genetic	JJ	JJ	_	31	amod	_	_
31	approach	approach	NN	NN	_	28	dobj	_	_
32	with	with	IN	IN	_	34	case	_	_
33	Saccharomyces	saccharomyces	NN	NN	_	34	compound	_	_
34	cerevisiae	cerevisiae	NN	NN	_	31	nmod	_	_
35	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	constructed	construct	VBD	VBD	_	0	root	_	_
3	a	a	DT	DT	_	6	det	_	_
4	yeast	yeast	NN	NN	_	6	compound	_	_
5	reporter	reporter	NN	NN	_	6	compound	_	_
6	strain	strain	NN	NN	_	2	dobj	_	_
7	containing	contain	VBG	VBG	_	6	acl	_	_
8	the	the	DT	DT	_	10	det	_	_
9	lacZ	lacz	NN	NN	_	10	compound	_	_
10	gene	gene	NN	NN	_	7	dobj	_	_
11	under	under	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	control	control	NN	NN	_	10	nmod	_	_
14	of	of	IN	IN	_	17	case	_	_
15	the	the	DT	DT	_	17	det	_	_
16	CYC1	cyc1	NN	NN	_	17	compound	_	_
17	promoter	promoter	NN	NN	_	13	nmod	_	_
18	associated	associate	VBN	VBN	_	17	acl	_	_
19	with	with	IN	IN	_	21	case	_	_
20	three	three	CD	CD	_	21	nummod	_	_
21	copies	copy	NNS	NNS	_	18	nmod	_	_
22	of	of	IN	IN	_	23	case	_	_
23	TRE-1	tre-1	NN	NN	_	21	nmod	_	_
24	.	.	.	.	_	2	punct	_	_

1	Expression	expression	NN	NN	_	29	nsubj	_	_
2	of	of	IN	IN	_	9	case	_	_
3	either	either	CC	CC	_	9	cc:preconj	_	_
4	the	the	DT	DT	_	9	det	_	_
5	cyclic	cyclic	JJ	JJ	_	9	amod	_	_
6	AMP	amp	NN	NN	_	9	compound	_	_
7	response	response	NN	NN	_	9	compound	_	_
8	element-binding	element-binding	NN	NN	_	9	compound	_	_
9	protein	protein	NN	NN	_	1	nmod	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	CREB	creb	NN	NN	_	9	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	or	or	CC	CC	_	9	cc	_	_
14	CREB	creb	NN	NN	_	9	conj	_	_
15	fused	fuse	VBN	VBN	_	14	acl	_	_
16	to	to	TO	TO	_	20	case	_	_
17	the	the	DT	DT	_	20	det	_	_
18	GAL4	gal4	NN	NN	_	20	compound	_	_
19	activation	activation	NN	NN	_	20	compound	_	_
20	domain	domain	NN	NN	_	15	nmod	_	_
21	(	(	-LRB-	-LRB-	_	22	punct	_	_
22	GAD	gad	NN	NN	_	20	appos	_	_
23	)	)	-RRB-	-RRB-	_	22	punct	_	_
24	in	in	IN	IN	_	26	case	_	_
25	this	this	DT	DT	_	26	det	_	_
26	strain	strain	NN	NN	_	1	nmod	_	_
27	did	do	VBD	VBD	_	29	aux	_	_
28	not	not	RB	RB	_	29	neg	_	_
29	modify	modify	VB	VB	_	0	root	_	_
30	the	the	DT	DT	_	31	det	_	_
31	expression	expression	NN	NN	_	29	dobj	_	_
32	of	of	IN	IN	_	35	case	_	_
33	the	the	DT	DT	_	35	det	_	_
34	reporter	reporter	NN	NN	_	35	compound	_	_
35	gene	gene	NN	NN	_	31	nmod	_	_
36	.	.	.	.	_	29	punct	_	_

1	Tax	tax	NN	NN	_	5	nsubj	_	_
2	alone	alone	RB	RB	_	1	advmod	_	_
3	was	be	VBD	VBD	_	5	cop	_	_
4	also	also	RB	RB	_	5	advmod	_	_
5	inactive	inactive	JJ	JJ	_	0	root	_	_
6	.	.	.	.	_	5	punct	_	_

1	However	however	RB	RB	_	9	advmod	_	_
2	,	,	,	,	_	9	punct	_	_
3	expression	expression	NN	NN	_	9	nsubjpass	_	_
4	of	of	IN	IN	_	7	case	_	_
5	the	the	DT	DT	_	7	det	_	_
6	reporter	reporter	NN	NN	_	7	compound	_	_
7	gene	gene	NN	NN	_	3	nmod	_	_
8	was	be	VBD	VBD	_	9	auxpass	_	_
9	induced	induce	VBN	VBN	_	0	root	_	_
10	by	by	IN	IN	_	11	case	_	_
11	coexpression	coexpression	NN	NN	_	9	nmod	_	_
12	of	of	IN	IN	_	13	case	_	_
13	Tax	tax	NN	NN	_	11	nmod	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	CREB	creb	NN	NN	_	13	conj	_	_
16	.	.	.	.	_	9	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	effect	effect	NN	NN	_	4	nsubj	_	_
3	was	be	VBD	VBD	_	4	cop	_	_
4	stronger	stronger	JJR	JJR	_	0	root	_	_
5	with	with	IN	IN	_	9	case	_	_
6	the	the	DT	DT	_	9	det	_	_
7	GAD-CREB	gad-creb	NN	NN	_	9	compound	_	_
8	fusion	fusion	NN	NN	_	9	compound	_	_
9	protein	protein	NN	NN	_	4	nmod	_	_
10	.	.	.	.	_	4	punct	_	_

1	Analysis	analysis	NN	NN	_	10	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	different	different	JJ	JJ	_	5	amod	_	_
4	CREB	creb	NN	NN	_	5	compound	_	_
5	mutants	mutant	NNS	NNS	_	1	nmod	_	_
6	with	with	IN	IN	_	9	case	_	_
7	this	this	DT	DT	_	9	det	_	_
8	genetic	genetic	JJ	JJ	_	9	amod	_	_
9	system	system	NN	NN	_	5	nmod	_	_
10	indicated	indicate	VBD	VBD	_	0	root	_	_
11	that	that	IN	IN	_	30	mark	_	_
12	the	the	DT	DT	_	17	det	_	_
13	C-terminal	c-terminal	JJ	JJ	_	17	amod	_	_
14	92	92	CD	CD	_	17	nummod	_	_
15	amino	amino	NN	NN	_	17	compound	_	_
16	acid	acid	NN	NN	_	17	compound	_	_
17	residues	residue	NNS	NNS	_	30	nsubj	_	_
18	,	,	,	,	_	17	punct	_	_
19	which	which	WDT	WDT	_	20	nsubj	_	_
20	include	include	VBP	VBP	_	17	acl:relcl	_	_
21	the	the	DT	DT	_	23	det	_	_
22	basic	basic	JJ	JJ	_	23	amod	_	_
23	domain	domain	NN	NN	_	20	dobj	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	the	the	DT	DT	_	27	det	_	_
26	leucine	leucine	NN	NN	_	27	compound	_	_
27	zipper	zipper	NN	NN	_	23	conj	_	_
28	,	,	,	,	_	17	punct	_	_
29	are	be	VBP	VBP	_	30	cop	_	_
30	necessary	necessary	JJ	JJ	_	10	ccomp	_	_
31	and	and	CC	CC	_	30	cc	_	_
32	sufficient	sufficient	JJ	JJ	_	30	conj	_	_
33	to	to	TO	TO	_	34	mark	_	_
34	mediate	mediate	VB	VB	_	30	xcomp	_	_
35	transactivation	transactivation	NN	NN	_	34	dobj	_	_
36	by	by	IN	IN	_	37	case	_	_
37	Tax	tax	NN	NN	_	35	nmod	_	_
38	.	.	.	.	_	10	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	identify	identify	VB	VB	_	0	root	_	_
3	cellular	cellular	JJ	JJ	_	4	amod	_	_
4	proteins	protein	NNS	NNS	_	2	dobj	_	_
5	binding	bind	VBG	VBG	_	4	acl	_	_
6	to	to	TO	TO	_	7	case	_	_
7	TRE-1	tre-1	NN	NN	_	5	nmod	_	_
8	in	in	IN	IN	_	11	case	_	_
9	a	a	DT	DT	_	11	det	_	_
10	Tax-dependent	tax-dependent	JJ	JJ	_	11	amod	_	_
11	manner	manner	NN	NN	_	5	nmod	_	_
12	,	,	,	,	_	2	punct	_	_
13	this	this	DT	DT	_	14	det	_	_
14	strain	strain	NN	NN	_	17	nsubjpass	_	_
15	was	be	VBD	VBD	_	17	auxpass	_	_
16	also	also	RB	RB	_	17	advmod	_	_
17	used	use	VBN	VBN	_	2	parataxis	_	_
18	to	to	TO	TO	_	19	mark	_	_
19	screen	screen	VB	VB	_	17	xcomp	_	_
20	a	a	DT	DT	_	21	det	_	_
21	library	library	NN	NN	_	19	dobj	_	_
22	of	of	IN	IN	_	24	case	_	_
23	human	human	JJ	JJ	_	24	amod	_	_
24	cDNAs	cdna	NNS	NNS	_	21	nmod	_	_
25	fused	fuse	VBN	VBN	_	24	acl	_	_
26	to	to	TO	TO	_	27	case	_	_
27	GAD	gad	NN	NN	_	25	nmod	_	_
28	.	.	.	.	_	2	punct	_	_

1	Of	of	IN	IN	_	4	case	_	_
2	five	five	CD	CD	_	4	nummod	_	_
3	positive	positive	JJ	JJ	_	4	amod	_	_
4	clones	clone	NNS	NNS	_	15	nmod	_	_
5	isolated	isolate	VBN	VBN	_	4	acl	_	_
6	from	from	IN	IN	_	11	case	_	_
7	0.75	0.75	CD	CD	_	11	nummod	_	_
8	x	x	CC	CC	_	7	cc	_	_
9	10(6)	10(6)	CD	CD	_	7	conj	_	_
10	yeast	yeast	NN	NN	_	11	compound	_	_
11	colonies	colony	NNS	NNS	_	5	nmod	_	_
12	,	,	,	,	_	15	punct	_	_
13	four	four	CD	CD	_	15	nsubj	_	_
14	were	be	VBD	VBD	_	15	cop	_	_
15	members	member	NNS	NNS	_	0	root	_	_
16	of	of	IN	IN	_	24	case	_	_
17	the	the	DT	DT	_	24	det	_	_
18	CREB/activating	creb/activating	JJ	JJ	_	24	amod	_	_
19	transcription	transcription	NN	NN	_	24	compound	_	_
20	factor	factor	NN	NN	_	24	compound	_	_
21	(	(	-LRB-	-LRB-	_	24	punct	_	_
22	ATF	atf	NN	NN	_	24	compound	_	_
23	)	)	-RRB-	-RRB-	_	24	punct	_	_
24	family	family	NN	NN	_	15	nmod	_	_
25	:	:	:	:	_	15	punct	_	_
26	CREB	creb	NN	NN	_	15	dep	_	_
27	,	,	,	,	_	26	punct	_	_
28	two	two	CD	CD	_	35	nummod	_	_
29	isoforms	isoform	NNS	NNS	_	35	compound	_	_
30	of	of	IN	IN	_	35	amod	_	_
31	the	the	DT	DT	_	35	det	_	_
32	cyclic	cyclic	JJ	JJ	_	35	amod	_	_
33	AMP-responsive	amp-responsive	JJ	JJ	_	35	amod	_	_
34	element	element	NN	NN	_	35	compound	_	_
35	modulator	modulator	NN	NN	_	26	conj	_	_
36	(	(	-LRB-	-LRB-	_	37	punct	_	_
37	CREM	crem	NN	NN	_	35	appos	_	_
38	)	)	-RRB-	-RRB-	_	37	punct	_	_
39	,	,	,	,	_	26	punct	_	_
40	and	and	CC	CC	_	26	cc	_	_
41	ATF-1	atf-1	NN	NN	_	26	conj	_	_
42	.	.	.	.	_	15	punct	_	_

1	Interestingly	interestingly	RB	RB	_	8	advmod	_	_
2	,	,	,	,	_	8	punct	_	_
3	these	these	DT	DT	_	5	det	_	_
4	three	three	CD	CD	_	5	nummod	_	_
5	proteins	protein	NNS	NNS	_	8	nsubjpass	_	_
6	can	can	MD	MD	_	8	aux	_	_
7	be	be	VB	VB	_	8	auxpass	_	_
8	phosphorylated	phosphorylate	VBN	VBN	_	0	root	_	_
9	by	by	IN	IN	_	12	case	_	_
10	protein	protein	NN	NN	_	12	compound	_	_
11	kinase	kinase	NN	NN	_	12	compound	_	_
12	A	a	NN	NN	_	8	nmod	_	_
13	and	and	CC	CC	_	8	cc	_	_
14	thus	thus	RB	RB	_	15	advmod	_	_
15	form	form	VB	VB	_	8	conj	_	_
16	a	a	DT	DT	_	18	det	_	_
17	particular	particular	JJ	JJ	_	18	amod	_	_
18	subgroup	subgroup	NN	NN	_	15	dobj	_	_
19	within	within	IN	IN	_	22	case	_	_
20	the	the	DT	DT	_	22	det	_	_
21	CREB/ATF	creb/atf	NN	NN	_	22	compound	_	_
22	family	family	NN	NN	_	15	nmod	_	_
23	.	.	.	.	_	8	punct	_	_

1	Expression	expression	NN	NN	_	9	nsubj	_	_
2	of	of	IN	IN	_	3	case	_	_
3	ATF-2	atf-2	NN	NN	_	1	nmod	_	_
4	in	in	IN	IN	_	6	case	_	_
5	S.	s.	FW	FW	_	6	compound	_	_
6	cerevisiae	cerevisiae	FW	FW	_	1	nmod	_	_
7	did	do	VBD	VBD	_	9	aux	_	_
8	not	not	RB	RB	_	9	neg	_	_
9	activate	activate	VB	VB	_	0	root	_	_
10	TRE-1	tre-1	NN	NN	_	9	dobj	_	_
11	in	in	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	presence	presence	NN	NN	_	9	nmod	_	_
14	of	of	IN	IN	_	15	case	_	_
15	Tax	tax	NN	NN	_	13	nmod	_	_
16	.	.	.	.	_	9	punct	_	_

1	This	this	DT	DT	_	2	nsubj	_	_
2	shows	show	VBZ	VBZ	_	0	root	_	_
3	that	that	IN	IN	_	11	mark	_	_
4	in	in	IN	IN	_	7	case	_	_
5	a	a	DT	DT	_	7	det	_	_
6	eukaryotic	eukaryotic	JJ	JJ	_	7	amod	_	_
7	nucleus	nucleus	NN	NN	_	11	nmod	_	_
8	,	,	,	,	_	11	punct	_	_
9	Tax	tax	NN	NN	_	11	nsubj	_	_
10	specifically	specifically	RB	RB	_	11	advmod	_	_
11	interacts	interact	VBZ	VBZ	_	2	ccomp	_	_
12	with	with	IN	IN	_	17	case	_	_
13	the	the	DT	DT	_	17	det	_	_
14	basic	basic	JJ	JJ	_	17	amod	_	_
15	domain-leucine	domain-leucine	JJ	JJ	_	17	amod	_	_
16	zipper	zipper	NN	NN	_	17	compound	_	_
17	region	region	NN	NN	_	11	nmod	_	_
18	of	of	IN	IN	_	19	case	_	_
19	ATF-1	atf-1	NN	NN	_	17	nmod	_	_
20	,	,	,	,	_	19	punct	_	_
21	CREB	creb	NN	NN	_	19	conj	_	_
22	,	,	,	,	_	19	punct	_	_
23	and	and	CC	CC	_	19	cc	_	_
24	CREM	crem	NN	NN	_	19	conj	_	_
25	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	fifth	fifth	JJ	JJ	_	3	amod	_	_
3	clone	clone	NN	NN	_	8	nsubj	_	_
4	identified	identify	VBN	VBN	_	3	acl	_	_
5	in	in	IN	IN	_	7	case	_	_
6	this	this	DT	DT	_	7	det	_	_
7	screening	screening	NN	NN	_	4	nmod	_	_
8	corresponded	correspond	VBD	VBD	_	0	root	_	_
9	to	to	TO	TO	_	14	case	_	_
10	the	the	DT	DT	_	14	det	_	_
11	Ku	ku	NN	NN	_	14	compound	_	_
12	autoantigen	autoantigen	NN	NN	_	14	compound	_	_
13	p70	p70	NN	NN	_	14	compound	_	_
14	subunit	subunit	NN	NN	_	8	nmod	_	_
15	.	.	.	.	_	8	punct	_	_

1	When	when	WRB	WRB	_	2	advmod	_	_
2	fused	fuse	VBN	VBN	_	12	advcl	_	_
3	to	to	TO	TO	_	4	case	_	_
4	GAD	gad	NN	NN	_	2	nmod	_	_
5	,	,	,	,	_	12	punct	_	_
6	the	the	DT	DT	_	8	det	_	_
7	C-terminal	c-terminal	JJ	JJ	_	8	amod	_	_
8	region	region	NN	NN	_	12	nsubj	_	_
9	of	of	IN	IN	_	10	case	_	_
10	Ku	ku	NN	NN	_	8	nmod	_	_
11	was	be	VBD	VBD	_	12	cop	_	_
12	able	able	JJ	JJ	_	0	root	_	_
13	to	to	TO	TO	_	14	mark	_	_
14	activate	activate	VB	VB	_	12	xcomp	_	_
15	transcription	transcription	NN	NN	_	14	dobj	_	_
16	via	via	IN	IN	_	17	case	_	_
17	TRE-1	tre-1	NN	NN	_	14	nmod	_	_
18	but	but	CC	CC	_	12	cc	_	_
19	this	this	DT	DT	_	20	det	_	_
20	activation	activation	NN	NN	_	23	nsubj	_	_
21	was	be	VBD	VBD	_	23	cop	_	_
22	not	not	RB	RB	_	23	neg	_	_
23	dependent	dependent	JJ	JJ	_	12	conj	_	_
24	on	on	IN	IN	_	25	case	_	_
25	Tax	tax	NN	NN	_	23	nmod	_	_
26	.	.	.	.	_	12	punct	_	_

1	Role	role	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	3	case	_	_
3	EGR1	egr1	NN	NN	_	1	nmod	_	_
4	in	in	IN	IN	_	5	case	_	_
5	regulation	regulation	NN	NN	_	1	nmod	_	_
6	of	of	IN	IN	_	9	case	_	_
7	stimulus-dependent	stimulus-dependent	JJ	JJ	_	9	amod	_	_
8	CD44	cd44	NN	NN	_	9	compound	_	_
9	transcription	transcription	NN	NN	_	5	nmod	_	_
10	in	in	IN	IN	_	12	case	_	_
11	B	b	NN	NN	_	12	compound	_	_
12	lymphocytes	lymphocyte	NNS	NNS	_	9	nmod	_	_
13	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	immediate-early	immediate-early	JJ	JJ	_	3	amod	_	_
3	gene	gene	NN	NN	_	5	nsubj	_	_
4	egr-1	egr-1	NN	NN	_	3	dep	_	_
5	encodes	encode	VBZ	VBZ	_	0	root	_	_
6	a	a	DT	DT	_	8	det	_	_
7	transcription	transcription	NN	NN	_	8	compound	_	_
8	factor	factor	NN	NN	_	5	dobj	_	_
9	(	(	-LRB-	-LRB-	_	10	punct	_	_
10	EGR1	egr1	NN	NN	_	8	appos	_	_
11	)	)	-RRB-	-RRB-	_	10	punct	_	_
12	that	that	WDT	WDT	_	13	nsubj	_	_
13	links	link	VBZ	VBZ	_	8	acl:relcl	_	_
14	B-cell	b-cell	NN	NN	_	16	compound	_	_
15	antigen	antigen	NN	NN	_	16	compound	_	_
16	receptor	receptor	NN	NN	_	20	compound	_	_
17	(	(	-LRB-	-LRB-	_	18	punct	_	_
18	BCR	bcr	NN	NN	_	16	appos	_	_
19	)	)	-RRB-	-RRB-	_	18	punct	_	_
20	signals	signal	NNS	NNS	_	13	dobj	_	_
21	to	to	TO	TO	_	24	case	_	_
22	downstream	downstream	JJ	JJ	_	24	amod	_	_
23	activation	activation	NN	NN	_	24	compound	_	_
24	events	event	NNS	NNS	_	13	nmod	_	_
25	through	through	IN	IN	_	27	case	_	_
26	the	the	DT	DT	_	27	det	_	_
27	regulation	regulation	NN	NN	_	13	nmod	_	_
28	of	of	IN	IN	_	32	case	_	_
29	previously	previously	RB	RB	_	30	advmod	_	_
30	unidentified	unidentified	JJ	JJ	_	32	amod	_	_
31	target	target	NN	NN	_	32	compound	_	_
32	genes	gene	NNS	NNS	_	27	nmod	_	_
33	.	.	.	.	_	5	punct	_	_

1	Here	here	RB	RB	_	3	advmod	_	_
2	we	we	PRP	PRP	_	3	nsubj	_	_
3	identify	identify	VBP	VBP	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	gene	gene	NN	NN	_	3	dobj	_	_
6	encoding	encode	VBG	VBG	_	5	acl	_	_
7	the	the	DT	DT	_	9	det	_	_
8	lymphocyte	lymphocyte	NN	NN	_	9	compound	_	_
9	homing	homing	NN	NN	_	6	dobj	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	migration	migration	NN	NN	_	12	compound	_	_
12	protein	protein	NN	NN	_	9	conj	_	_
13	CD44	cd44	NN	NN	_	9	dep	_	_
14	as	as	IN	IN	_	16	case	_	_
15	a	a	DT	DT	_	16	det	_	_
16	target	target	NN	NN	_	3	nmod	_	_
17	of	of	IN	IN	_	19	case	_	_
18	EGR1	egr1	NN	NN	_	19	compound	_	_
19	regulation	regulation	NN	NN	_	16	nmod	_	_
20	in	in	IN	IN	_	22	case	_	_
21	B	b	NN	NN	_	22	compound	_	_
22	cells	cell	NNS	NNS	_	19	nmod	_	_
23	.	.	.	.	_	3	punct	_	_

1	BCR-induced	bcr-induced	JJ	JJ	_	2	amod	_	_
2	increases	increase	NNS	NNS	_	11	nsubjpass	_	_
3	in	in	IN	IN	_	5	case	_	_
4	CD44	cd44	NN	NN	_	5	compound	_	_
5	mRNA	mrna	NN	NN	_	2	nmod	_	_
6	expression	expression	NN	NN	_	5	dep	_	_
7	and	and	CC	CC	_	5	cc	_	_
8	transcription	transcription	NN	NN	_	5	conj	_	_
9	levels	level	NNS	NNS	_	5	dep	_	_
10	are	be	VBP	VBP	_	11	auxpass	_	_
11	shown	show	VBN	VBN	_	0	root	_	_
12	to	to	TO	TO	_	13	mark	_	_
13	occur	occur	VB	VB	_	11	xcomp	_	_
14	in	in	IN	IN	_	15	case	_	_
15	EGR1-expressing	egr1-expressing	JJ	JJ	_	13	nmod	_	_
16	but	but	CC	CC	_	15	cc	_	_
17	not	not	RB	RB	_	20	neg	_	_
18	in	in	IN	IN	_	20	case	_	_
19	nonexpressing	nonexpressing	JJ	JJ	_	20	amod	_	_
20	subclones	subclone	NNS	NNS	_	15	conj	_	_
21	of	of	IN	IN	_	24	case	_	_
22	the	the	DT	DT	_	24	det	_	_
23	B-cell	b-cell	NN	NN	_	24	compound	_	_
24	line	line	NN	NN	_	15	nmod	_	_
25	WEHI-231	wehi-231	NN	NN	_	24	dep	_	_
26	.	.	.	.	_	11	punct	_	_

1	Kinetics	kinetics	NNS	NNS	_	12	nsubj	_	_
2	of	of	IN	IN	_	4	case	_	_
3	egr-1	egr-1	NN	NN	_	4	compound	_	_
4	transcription	transcription	NN	NN	_	1	nmod	_	_
5	and	and	CC	CC	_	1	cc	_	_
6	the	the	DT	DT	_	7	det	_	_
7	appearance	appearance	NN	NN	_	1	conj	_	_
8	of	of	IN	IN	_	11	case	_	_
9	nuclear	nuclear	JJ	JJ	_	11	amod	_	_
10	EGR1	egr1	NN	NN	_	11	compound	_	_
11	protein	protein	NN	NN	_	7	nmod	_	_
12	precede	precede	VBP	VBP	_	0	root	_	_
13	CD44	cd44	NN	NN	_	14	compound	_	_
14	induction	induction	NN	NN	_	12	dobj	_	_
15	and	and	CC	CC	_	12	cc	_	_
16	occur	occur	VB	VB	_	12	conj	_	_
17	within	within	IN	IN	_	19	case	_	_
18	30	30	CD	CD	_	19	nummod	_	_
19	min	min	NN	NN	_	16	nmod	_	_
20	after	after	IN	IN	_	21	case	_	_
21	stimulation	stimulation	NN	NN	_	19	nmod	_	_
22	in	in	IN	IN	_	25	case	_	_
23	the	the	DT	DT	_	25	det	_	_
24	EGR1-expressing	egr1-expressing	JJ	JJ	_	25	amod	_	_
25	subclone	subclone	NN	NN	_	21	nmod	_	_
26	.	.	.	.	_	12	punct	_	_

1	A	a	DT	DT	_	5	det	_	_
2	single	single	JJ	JJ	_	5	amod	_	_
3	EGR1	egr1	NN	NN	_	5	compound	_	_
4	binding	binding	NN	NN	_	5	compound	_	_
5	motif	motif	NN	NN	_	7	nsubjpass	_	_
6	is	be	VBZ	VBZ	_	7	auxpass	_	_
7	demonstrated	demonstrate	VBN	VBN	_	0	root	_	_
8	at	at	IN	IN	_	9	case	_	_
9	bp	bp	NN	NN	_	7	nmod	_	_
10	-301	-301	CD	CD	_	9	nummod	_	_
11	of	of	IN	IN	_	15	case	_	_
12	the	the	DT	DT	_	15	det	_	_
13	human	human	JJ	JJ	_	15	amod	_	_
14	CD44	cd44	NN	NN	_	15	compound	_	_
15	promoter	promoter	NN	NN	_	9	nmod	_	_
16	.	.	.	.	_	7	punct	_	_

1	Cotransfection	cotransfection	NN	NN	_	14	nsubj	_	_
2	of	of	IN	IN	_	8	case	_	_
3	a	a	DT	DT	_	8	det	_	_
4	CD44	cd44	NN	NN	_	8	compound	_	_
5	promoter-chloramphenicol	promoter-chloramphenicol	JJ	JJ	_	8	amod	_	_
6	acetyltransferase	acetyltransferase	NN	NN	_	8	compound	_	_
7	reporter	reporter	NN	NN	_	8	compound	_	_
8	construct	construct	NN	NN	_	1	nmod	_	_
9	with	with	IN	IN	_	13	case	_	_
10	an	a	DT	DT	_	13	det	_	_
11	egr-1	egr-1	NN	NN	_	13	compound	_	_
12	expression	expression	NN	NN	_	13	compound	_	_
13	vector	vector	NN	NN	_	1	nmod	_	_
14	resulted	result	VBD	VBD	_	0	root	_	_
15	in	in	IN	IN	_	20	case	_	_
16	a	a	DT	DT	_	20	det	_	_
17	6.5-	6.5-	CD	CD	_	19	compound	_	_
18	to	to	TO	TO	_	19	dep	_	_
19	8.5-fold	8.5-fold	JJ	JJ	_	20	amod	_	_
20	induction	induction	NN	NN	_	14	nmod	_	_
21	of	of	IN	IN	_	23	case	_	_
22	transcriptional	transcriptional	JJ	JJ	_	23	amod	_	_
23	activity	activity	NN	NN	_	20	nmod	_	_
24	relative	relative	JJ	JJ	_	23	amod	_	_
25	to	to	TO	TO	_	29	case	_	_
26	an	a	DT	DT	_	29	det	_	_
27	empty	empty	JJ	JJ	_	29	amod	_	_
28	expression	expression	NN	NN	_	29	compound	_	_
29	vector	vector	NN	NN	_	24	nmod	_	_
30	.	.	.	.	_	14	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	EGR1	egr1	NN	NN	_	4	compound	_	_
3	binding	binding	NN	NN	_	4	compound	_	_
4	motif	motif	NN	NN	_	6	nsubjpass	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	shown	show	VBN	VBN	_	0	root	_	_
7	to	to	TO	TO	_	9	mark	_	_
8	be	be	VB	VB	_	9	cop	_	_
9	necessary	necessary	JJ	JJ	_	6	xcomp	_	_
10	for	for	IN	IN	_	12	case	_	_
11	stimulus-induced	stimulus-induced	JJ	JJ	_	12	amod	_	_
12	expression	expression	NN	NN	_	9	nmod	_	_
13	of	of	IN	IN	_	15	case	_	_
14	a	a	DT	DT	_	15	det	_	_
15	CD44	cd44	NN	NN	_	12	nmod	_	_
16	promoter-chloramphenicol	promoter-chloramphenicol	JJ	JJ	_	19	amod	_	_
17	acetyltransferase	acetyltransferase	NN	NN	_	19	compound	_	_
18	reporter	reporter	NN	NN	_	19	compound	_	_
19	construct	construct	NN	NN	_	15	dep	_	_
20	in	in	IN	IN	_	23	case	_	_
21	nontransformed	nontransformed	JJ	JJ	_	23	amod	_	_
22	B	b	NN	NN	_	23	compound	_	_
23	lymphocytes	lymphocyte	NNS	NNS	_	12	nmod	_	_
24	and	and	CC	CC	_	6	cc	_	_
25	was	be	VBD	VBD	_	26	auxpass	_	_
26	required	require	VBN	VBN	_	6	conj	_	_
27	for	for	IN	IN	_	28	case	_	_
28	transactivation	transactivation	NN	NN	_	26	nmod	_	_
29	by	by	IN	IN	_	33	case	_	_
30	an	a	DT	DT	_	33	det	_	_
31	EGR1	egr1	NN	NN	_	33	compound	_	_
32	expression	expression	NN	NN	_	33	compound	_	_
33	vector	vector	NN	NN	_	28	nmod	_	_
34	in	in	IN	IN	_	37	case	_	_
35	a	a	DT	DT	_	37	det	_	_
36	B-cell	b-cell	NN	NN	_	37	compound	_	_
37	line	line	NN	NN	_	28	nmod	_	_
38	.	.	.	.	_	6	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	studies	study	NNS	NNS	_	3	nsubj	_	_
3	identify	identify	VBP	VBP	_	0	root	_	_
4	EGR1	egr1	NN	NN	_	3	dobj	_	_
5	as	as	IN	IN	_	7	case	_	_
6	an	a	DT	DT	_	7	det	_	_
7	intermediary	intermediary	JJ	JJ	_	3	nmod	_	_
8	linking	link	VBG	VBG	_	7	acl	_	_
9	BCR-derived	bcr-derived	JJ	JJ	_	10	amod	_	_
10	signals	signal	NNS	NNS	_	8	dobj	_	_
11	to	to	TO	TO	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	induction	induction	NN	NN	_	8	nmod	_	_
14	of	of	IN	IN	_	15	case	_	_
15	CD44	cd44	NN	NN	_	13	nmod	_	_
16	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	relevance	relevance	NN	NN	_	17	nsubjpass	_	_
3	of	of	IN	IN	_	6	case	_	_
4	these	these	DT	DT	_	6	det	_	_
5	molecular	molecular	JJ	JJ	_	6	amod	_	_
6	events	event	NNS	NNS	_	2	nmod	_	_
7	to	to	TO	TO	_	10	case	_	_
8	BCR	bcr	NN	NN	_	10	compound	_	_
9	signal	signal	NN	NN	_	10	compound	_	_
10	transduction	transduction	NN	NN	_	2	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	antigen-stimulated	antigen-stimulated	JJ	JJ	_	15	amod	_	_
13	B-cell-mediated	b-cell-mediated	JJ	JJ	_	12	dep	_	_
14	immune	immune	JJ	JJ	_	15	amod	_	_
15	responses	response	NNS	NNS	_	10	conj	_	_
16	is	be	VBZ	VBZ	_	17	auxpass	_	_
17	discussed	discuss	VBN	VBN	_	0	root	_	_
18	.	.	.	.	_	17	punct	_	_

1	Expression	expression	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	3	case	_	_
3	Id2	id2	NN	NN	_	1	nmod	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	Id3	id3	NN	NN	_	3	conj	_	_
6	mRNA	mrna	NN	NN	_	3	dep	_	_
7	in	in	IN	IN	_	9	case	_	_
8	human	human	JJ	JJ	_	9	amod	_	_
9	lymphocytes	lymphocyte	NNS	NNS	_	1	nmod	_	_
10	.	.	.	.	_	1	punct	_	_

1	Helix-loop-helix	helix-loop-helix	JJ	JJ	_	6	amod	_	_
2	(	(	-LRB-	-LRB-	_	6	punct	_	_
3	HLH	hlh	JJ	JJ	_	6	amod	_	_
4	)	)	-RRB-	-RRB-	_	6	punct	_	_
5	transcription	transcription	NN	NN	_	6	compound	_	_
6	factors	factor	NNS	NNS	_	8	nsubjpass	_	_
7	are	be	VBP	VBP	_	8	auxpass	_	_
8	involved	involve	VBN	VBN	_	0	root	_	_
9	in	in	IN	IN	_	11	case	_	_
10	cellular	cellular	JJ	JJ	_	11	amod	_	_
11	growth	growth	NN	NN	_	8	nmod	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	differentiation	differentiation	NN	NN	_	11	conj	_	_
14	.	.	.	.	_	8	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	Id	id	NN	NN	_	20	nsubj	_	_
3	(	(	-LRB-	-LRB-	_	4	punct	_	_
4	inhibitor	inhibitor	NN	NN	_	2	dep	_	_
5	of	of	IN	IN	_	6	case	_	_
6	DNA	dna	NN	NN	_	4	nmod	_	_
7	binding	binding	NN	NN	_	6	dep	_	_
8	and	and	CC	CC	_	6	cc	_	_
9	differentiation	differentiation	NN	NN	_	6	conj	_	_
10	)	)	-RRB-	-RRB-	_	4	punct	_	_
11	HLH	hlh	JJ	JJ	_	12	amod	_	_
12	proteins	protein	NNS	NNS	_	2	dep	_	_
13	,	,	,	,	_	2	punct	_	_
14	in	in	IN	IN	_	18	case	_	_
15	a	a	DT	DT	_	18	det	_	_
16	dominantly	dominantly	RB	RB	_	17	advmod	_	_
17	negative	negative	JJ	JJ	_	18	amod	_	_
18	fashion	fashion	NN	NN	_	20	nmod	_	_
19	,	,	,	,	_	20	punct	_	_
20	regulate	regulate	VBP	VBP	_	0	root	_	_
21	transcriptional	transcriptional	JJ	JJ	_	22	amod	_	_
22	activities	activity	NNS	NNS	_	20	dobj	_	_
23	of	of	IN	IN	_	26	case	_	_
24	basic	basic	JJ	JJ	_	26	amod	_	_
25	HLH	hlh	JJ	JJ	_	26	amod	_	_
26	proteins	protein	NNS	NNS	_	22	nmod	_	_
27	.	.	.	.	_	20	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	examined	examine	VBD	VBD	_	0	root	_	_
3	by	by	IN	IN	_	5	case	_	_
4	northern	northern	JJ	JJ	_	5	amod	_	_
5	hybridization	hybridization	NN	NN	_	2	nmod	_	_
6	the	the	DT	DT	_	7	det	_	_
7	expression	expression	NN	NN	_	2	dobj	_	_
8	of	of	IN	IN	_	9	case	_	_
9	Id2	id2	NN	NN	_	7	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	Id3	id3	NN	NN	_	9	conj	_	_
12	mRNA	mrna	NN	NN	_	9	dep	_	_
13	in	in	IN	IN	_	16	case	_	_
14	human	human	JJ	JJ	_	16	amod	_	_
15	leukemia/lymphoma	leukemia/lymphoma	NN	NN	_	16	compound	_	_
16	lines	line	NNS	NNS	_	7	nmod	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	patient	patient	NN	NN	_	19	compound	_	_
19	samples	sample	NNS	NNS	_	16	conj	_	_
20	,	,	,	,	_	16	punct	_	_
21	as	as	RB	RB	_	16	cc	_	_
22	well	well	RB	RB	_	21	mwe	_	_
23	as	as	IN	IN	_	21	mwe	_	_
24	resting	rest	VBG	VBG	_	16	conj	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	activated	activate	VBN	VBN	_	29	amod	_	_
27	normal	normal	JJ	JJ	_	29	amod	_	_
28	human	human	JJ	JJ	_	29	amod	_	_
29	lymphocytes	lymphocyte	NNS	NNS	_	24	conj	_	_
30	from	from	IN	IN	_	32	case	_	_
31	peripheral	peripheral	JJ	JJ	_	32	amod	_	_
32	blood	blood	NN	NN	_	24	nmod	_	_
33	(	(	-LRB-	-LRB-	_	34	punct	_	_
34	PBL	pbl	NN	NN	_	32	appos	_	_
35	)	)	-RRB-	-RRB-	_	34	punct	_	_
36	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	Id2	id2	NN	NN	_	3	compound	_	_
3	mRNA	mrna	NN	NN	_	6	nsubjpass	_	_
4	was	be	VBD	VBD	_	6	auxpass	_	_
5	abundantly	abundantly	RB	RB	_	6	advmod	_	_
6	expressed	express	VBN	VBN	_	0	root	_	_
7	in	in	IN	IN	_	9	case	_	_
8	5/12	5/12	CD	CD	_	9	nummod	_	_
9	T-cell	t-cell	NN	NN	_	6	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	3/4	3/4	CD	CD	_	13	nummod	_	_
12	B-cell	b-cell	NN	NN	_	13	compound	_	_
13	lines	line	NNS	NNS	_	9	conj	_	_
14	,	,	,	,	_	6	punct	_	_
15	and	and	CC	CC	_	6	cc	_	_
16	Id3	id3	NN	NN	_	17	compound	_	_
17	mRNA	mrna	NN	NN	_	19	nsubjpass	_	_
18	was	be	VBD	VBD	_	19	auxpass	_	_
19	detected	detect	VBN	VBN	_	6	conj	_	_
20	in	in	IN	IN	_	22	case	_	_
21	4/12	4/12	CD	CD	_	22	nummod	_	_
22	T-cell	t-cell	NN	NN	_	19	nmod	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	3/4	3/4	CD	CD	_	26	nummod	_	_
25	B-cell	b-cell	NN	NN	_	26	compound	_	_
26	lines	line	NNS	NNS	_	22	conj	_	_
27	.	.	.	.	_	6	punct	_	_

1	Interestingly	interestingly	RB	RB	_	12	advmod	_	_
2	,	,	,	,	_	12	punct	_	_
3	Id2	id2	NN	NN	_	12	nsubjpass	_	_
4	,	,	,	,	_	3	punct	_	_
5	but	but	CC	CC	_	6	cc	_	_
6	not	not	RB	RB	_	3	cc	_	_
7	Id3	id3	NN	NN	_	3	conj	_	_
8	,	,	,	,	_	3	punct	_	_
9	mRNA	mrna	NN	NN	_	3	conj	_	_
10	was	be	VBD	VBD	_	12	auxpass	_	_
11	strongly	strongly	RB	RB	_	12	advmod	_	_
12	expressed	express	VBN	VBN	_	0	root	_	_
13	in	in	IN	IN	_	16	case	_	_
14	4/5	4/5	CD	CD	_	16	nummod	_	_
15	T-cell	t-cell	NN	NN	_	16	compound	_	_
16	lines	line	NNS	NNS	_	12	nmod	_	_
17	infected	infect	VBN	VBN	_	16	acl	_	_
18	with	with	IN	IN	_	22	case	_	_
19	human	human	JJ	JJ	_	22	amod	_	_
20	T-cell	t-cell	NN	NN	_	22	compound	_	_
21	leukemia	leukemia	NN	NN	_	22	compound	_	_
22	virus	virus	NN	NN	_	17	nmod	_	_
23	type	type	NN	NN	_	26	compound	_	_
24	I	i	CD	CD	_	26	nummod	_	_
25	(	(	-LRB-	-LRB-	_	26	punct	_	_
26	HTLV-I	htlv-i	NN	NN	_	22	dep	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	(	(	-LRB-	-LRB-	_	29	punct	_	_
29	ATL-1k	atl-1k	NN	NN	_	16	dep	_	_
30	,	,	,	,	_	29	punct	_	_
31	MT-2	mt-2	NN	NN	_	29	appos	_	_
32	,	,	,	,	_	29	punct	_	_
33	S-LB1	s-lb1	NN	NN	_	29	appos	_	_
34	)	)	-RRB-	-RRB-	_	29	punct	_	_
35	and	and	CC	CC	_	16	cc	_	_
36	type	type	NN	NN	_	16	conj	_	_
37	II	ii	CD	CD	_	36	nummod	_	_
38	(	(	-LRB-	-LRB-	_	39	punct	_	_
39	Mo	mo	NN	NN	_	36	appos	_	_
40	)	)	-RRB-	-RRB-	_	39	punct	_	_
41	.	.	.	.	_	12	punct	_	_

1	Another	another	DT	DT	_	3	det	_	_
2	unexpected	unexpected	JJ	JJ	_	3	amod	_	_
3	finding	finding	NN	NN	_	4	nsubj	_	_
4	was	be	VBD	VBD	_	0	root	_	_
5	that	that	IN	IN	_	12	mark	_	_
6	T-cell	t-cell	NN	NN	_	7	compound	_	_
7	leukemias	leukemia	NNS	NNS	_	12	nsubj	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	T-cell	t-cell	NN	NN	_	10	compound	_	_
10	lines	line	NNS	NNS	_	7	conj	_	_
11	often	often	RB	RB	_	12	advmod	_	_
12	expressed	express	VBD	VBD	_	4	ccomp	_	_
13	either	either	CC	CC	_	14	cc:preconj	_	_
14	Id2	id2	NN	NN	_	12	dobj	_	_
15	or	or	CC	CC	_	14	cc	_	_
16	Id3	id3	NN	NN	_	17	compound	_	_
17	mRNA	mrna	NN	NN	_	14	conj	_	_
18	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	addition	addition	NN	NN	_	7	nmod	_	_
3	,	,	,	,	_	7	punct	_	_
4	resting	rest	VBG	VBG	_	5	amod	_	_
5	PBL	pbl	NN	NN	_	7	nsubj	_	_
6	constitutively	constitutively	RB	RB	_	7	advmod	_	_
7	expressed	express	VBD	VBD	_	0	root	_	_
8	prominent	prominent	JJ	JJ	_	9	amod	_	_
9	levels	level	NNS	NNS	_	7	dobj	_	_
10	of	of	IN	IN	_	12	case	_	_
11	Id2	id2	NN	NN	_	12	compound	_	_
12	mRNA	mrna	NN	NN	_	9	nmod	_	_
13	,	,	,	,	_	12	punct	_	_
14	but	but	CC	CC	_	15	cc	_	_
15	not	not	RB	RB	_	12	cc	_	_
16	Id3	id3	NN	NN	_	17	compound	_	_
17	mRNA	mrna	NN	NN	_	12	conj	_	_
18	.	.	.	.	_	7	punct	_	_

1	Upon	upon	IN	IN	_	2	case	_	_
2	PHA-stimulation	pha-stimulation	NN	NN	_	6	nmod	_	_
3	,	,	,	,	_	6	punct	_	_
4	Id2	id2	NN	NN	_	5	compound	_	_
5	expression	expression	NN	NN	_	6	nsubj	_	_
6	decreased	decrease	VBD	VBD	_	0	root	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	Id3	id3	NN	NN	_	9	compound	_	_
9	levels	level	NNS	NNS	_	10	nsubj	_	_
10	increased	increase	VBD	VBD	_	6	conj	_	_
11	with	with	IN	IN	_	13	case	_	_
12	biphasic	biphasic	JJ	JJ	_	13	amod	_	_
13	kinetics	kinetics	NNS	NNS	_	10	nmod	_	_
14	.	.	.	.	_	6	punct	_	_

1	Taken	take	VBN	VBN	_	0	root	_	_
2	together	together	RB	RB	_	1	advmod	_	_
3	,	,	,	,	_	1	punct	_	_
4	our	we	PRP$	PRP$	_	5	nmod:poss	_	_
5	studies	study	NNS	NNS	_	6	nsubj	_	_
6	revealed	reveal	VBD	VBD	_	1	parataxis	_	_
7	three	three	CD	CD	_	9	nummod	_	_
8	unexpected	unexpected	JJ	JJ	_	9	amod	_	_
9	findings	finding	NNS	NNS	_	6	dobj	_	_
10	which	which	WDT	WDT	_	11	nsubj	_	_
11	require	require	VBP	VBP	_	9	acl:relcl	_	_
12	further	further	JJ	JJ	_	13	amod	_	_
13	analysis	analysis	NN	NN	_	11	dobj	_	_
14	:	:	:	:	_	1	punct	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	1	1	LS	LS	_	24	dep	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	expression	expression	NN	NN	_	24	nsubjpass	_	_
19	of	of	IN	IN	_	21	case	_	_
20	Id2	id2	NN	NN	_	21	compound	_	_
21	mRNA	mrna	NN	NN	_	18	nmod	_	_
22	is	be	VBZ	VBZ	_	24	auxpass	_	_
23	often	often	RB	RB	_	24	advmod	_	_
24	associated	associate	VBN	VBN	_	1	parataxis	_	_
25	with	with	IN	IN	_	27	case	_	_
26	lymphocytic	lymphocytic	JJ	JJ	_	27	amod	_	_
27	transformation	transformation	NN	NN	_	24	nmod	_	_
28	by	by	IN	IN	_	29	case	_	_
29	HTLV-I	htlv-i	NN	NN	_	27	nmod	_	_
30	or	or	CC	CC	_	29	cc	_	_
31	-II	-ii	CD	CD	_	29	conj	_	_
32	;	;	:	:	_	24	punct	_	_
33	(	(	-LRB-	-LRB-	_	34	punct	_	_
34	2	2	LS	LS	_	38	dep	_	_
35	)	)	-RRB-	-RRB-	_	34	punct	_	_
36	T-cells	t-cell	NNS	NNS	_	38	nsubj	_	_
37	usually	usually	RB	RB	_	38	advmod	_	_
38	express	express	VBP	VBP	_	24	parataxis	_	_
39	either	either	CC	CC	_	40	cc:preconj	_	_
40	Id2	id2	NN	NN	_	38	dobj	_	_
41	or	or	CC	CC	_	40	cc	_	_
42	Id3	id3	NN	NN	_	43	compound	_	_
43	mRNA	mrna	NN	NN	_	40	conj	_	_
44	,	,	,	,	_	38	punct	_	_
45	but	but	CC	CC	_	38	cc	_	_
46	B-cells	b-cell	NNS	NNS	_	48	nsubj	_	_
47	often	often	RB	RB	_	48	advmod	_	_
48	express	express	VBP	VBP	_	38	conj	_	_
49	both	both	DT	DT	_	48	dobj	_	_
50	simultaneously	simultaneously	RB	RB	_	48	advmod	_	_
51	;	;	:	:	_	24	punct	_	_
52	(	(	-LRB-	-LRB-	_	53	punct	_	_
53	3	3	LS	LS	_	59	dep	_	_
54	)	)	-RRB-	-RRB-	_	53	punct	_	_
55	non-dividing	non-dividing	JJ	JJ	_	58	amod	_	_
56	,	,	,	,	_	55	punct	_	_
57	normal	normal	JJ	JJ	_	55	dep	_	_
58	PBL	pbl	NN	NN	_	59	nsubj	_	_
59	express	express	VBP	VBP	_	24	parataxis	_	_
60	high	high	JJ	JJ	_	61	amod	_	_
61	levels	level	NNS	NNS	_	59	dobj	_	_
62	of	of	IN	IN	_	63	case	_	_
63	Id2	id2	NN	NN	_	61	nmod	_	_
64	and	and	CC	CC	_	61	cc	_	_
65	no	no	DT	DT	_	67	neg	_	_
66	Id3	id3	NN	NN	_	67	compound	_	_
67	mRNA	mrna	NN	NN	_	61	conj	_	_
68	;	;	:	:	_	59	punct	_	_
69	and	and	CC	CC	_	59	cc	_	_
70	with	with	IN	IN	_	72	case	_	_
71	the	the	DT	DT	_	72	det	_	_
72	onset	onset	NN	NN	_	81	nmod	_	_
73	of	of	IN	IN	_	75	case	_	_
74	cellular	cellular	JJ	JJ	_	75	amod	_	_
75	proliferation	proliferation	NN	NN	_	72	nmod	_	_
76	,	,	,	,	_	81	punct	_	_
77	levels	level	NNS	NNS	_	81	nsubj	_	_
78	of	of	IN	IN	_	80	case	_	_
79	Id2	id2	NN	NN	_	80	compound	_	_
80	mRNA	mrna	NN	NN	_	77	nmod	_	_
81	decrease	decrease	VBP	VBP	_	59	conj	_	_
82	while	while	IN	IN	_	87	mark	_	_
83	levels	level	NNS	NNS	_	87	nsubj	_	_
84	of	of	IN	IN	_	86	case	_	_
85	Id3	id3	NN	NN	_	86	compound	_	_
86	mRNA	mrna	NN	NN	_	83	nmod	_	_
87	increase	increase	VBP	VBP	_	81	advcl	_	_
88	,	,	,	,	_	81	punct	_	_
89	suggesting	suggest	VBG	VBG	_	81	xcomp	_	_
90	that	that	IN	IN	_	100	mark	_	_
91	regulation	regulation	NN	NN	_	100	nsubj	_	_
92	of	of	IN	IN	_	93	case	_	_
93	expression	expression	NN	NN	_	91	nmod	_	_
94	of	of	IN	IN	_	98	case	_	_
95	these	these	DT	DT	_	98	det	_	_
96	closely	closely	RB	RB	_	97	advmod	_	_
97	related	related	JJ	JJ	_	98	amod	_	_
98	genes	gene	NNS	NNS	_	93	nmod	_	_
99	is	be	VBZ	VBZ	_	100	cop	_	_
100	disparate	disparate	JJ	JJ	_	89	ccomp	_	_
101	.	.	.	.	_	1	punct	_	_

1	CNI-1493	cni-1493	NN	NN	_	2	nsubj	_	_
2	inhibits	inhibit	VBZ	VBZ	_	0	root	_	_
3	monocyte/macrophage	monocyte/macrophage	JJ	JJ	_	6	amod	_	_
4	tumor	tumor	NN	NN	_	6	compound	_	_
5	necrosis	necrosis	NN	NN	_	6	compound	_	_
6	factor	factor	NN	NN	_	2	dobj	_	_
7	by	by	IN	IN	_	8	case	_	_
8	suppression	suppression	NN	NN	_	2	nmod	_	_
9	of	of	IN	IN	_	11	case	_	_
10	translation	translation	NN	NN	_	11	compound	_	_
11	efficiency	efficiency	NN	NN	_	8	nmod	_	_
12	.	.	.	.	_	2	punct	_	_

1	Tumor	tumor	NN	NN	_	3	compound	_	_
2	necrosis	necrosis	NN	NN	_	3	compound	_	_
3	factor	factor	NN	NN	_	7	nsubj	_	_
4	(	(	-LRB-	-LRB-	_	5	punct	_	_
5	TNF	tnf	NN	NN	_	3	appos	_	_
6	)	)	-RRB-	-RRB-	_	5	punct	_	_
7	mediates	mediate	VBZ	VBZ	_	0	root	_	_
8	a	a	DT	DT	_	10	det	_	_
9	wide	wide	JJ	JJ	_	10	amod	_	_
10	variety	variety	NN	NN	_	7	dobj	_	_
11	of	of	IN	IN	_	13	case	_	_
12	disease	disease	NN	NN	_	13	compound	_	_
13	states	state	NNS	NNS	_	10	nmod	_	_
14	including	include	VBG	VBG	_	16	case	_	_
15	septic	septic	JJ	JJ	_	16	amod	_	_
16	shock	shock	NN	NN	_	10	nmod	_	_
17	,	,	,	,	_	16	punct	_	_
18	acute	acute	JJ	JJ	_	16	conj	_	_
19	and	and	CC	CC	_	18	cc	_	_
20	chronic	chronic	JJ	JJ	_	18	conj	_	_
21	inflammation	inflammation	NN	NN	_	18	dep	_	_
22	,	,	,	,	_	16	punct	_	_
23	and	and	CC	CC	_	16	cc	_	_
24	cachexia	cachexia	NN	NN	_	16	conj	_	_
25	.	.	.	.	_	7	punct	_	_

1	Recently	recently	RB	RB	_	17	advmod	_	_
2	,	,	,	,	_	17	punct	_	_
3	a	a	DT	DT	_	5	det	_	_
4	multivalent	multivalent	JJ	JJ	_	5	amod	_	_
5	guanylhydrazone	guanylhydrazone	NN	NN	_	17	nsubjpass	_	_
6	(	(	-LRB-	-LRB-	_	7	punct	_	_
7	CNI-1493	cni-1493	NN	NN	_	5	appos	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	developed	develop	VBN	VBN	_	5	acl	_	_
10	as	as	IN	IN	_	12	case	_	_
11	an	a	DT	DT	_	12	det	_	_
12	inhibitor	inhibitor	NN	NN	_	9	nmod	_	_
13	of	of	IN	IN	_	15	case	_	_
14	macrophage	macrophage	NN	NN	_	15	compound	_	_
15	activation	activation	NN	NN	_	12	nmod	_	_
16	was	be	VBD	VBD	_	17	auxpass	_	_
17	shown	show	VBN	VBN	_	0	root	_	_
18	to	to	TO	TO	_	19	mark	_	_
19	suppress	suppress	VB	VB	_	17	xcomp	_	_
20	TNF	tnf	NN	NN	_	21	compound	_	_
21	production	production	NN	NN	_	19	dobj	_	_
22	and	and	CC	CC	_	19	cc	_	_
23	protect	protect	NN	NN	_	19	conj	_	_
24	against	against	IN	IN	_	26	case	_	_
25	tissue	tissue	NN	NN	_	26	compound	_	_
26	inflammation	inflammation	NN	NN	_	23	nmod	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	endotoxin	endotoxin	NN	NN	_	29	compound	_	_
29	lethality	lethality	NN	NN	_	26	conj	_	_
30	-LSB-	-lsb-	-LRB-	-LRB-	_	33	punct	_	_
31	Bianchi	Bianchi	NNP	NNP	_	33	compound	_	_
32	,	,	,	,	_	33	punct	_	_
33	M.	M.	NNP	NNP	_	17	dep	_	_
34	,	,	,	,	_	33	punct	_	_
35	Ulrich	Ulrich	NNP	NNP	_	37	compound	_	_
36	,	,	,	,	_	37	punct	_	_
37	P.	P.	NNP	NNP	_	33	conj	_	_
38	,	,	,	,	_	33	punct	_	_
39	Bloom	Bloom	NNP	NNP	_	41	compound	_	_
40	,	,	,	,	_	41	punct	_	_
41	O.	O.	NNP	NNP	_	33	conj	_	_
42	,	,	,	,	_	33	punct	_	_
43	Meistrell	Meistrell	NNP	NNP	_	45	compound	_	_
44	,	,	,	,	_	45	punct	_	_
45	M.	M.	NNP	NNP	_	33	conj	_	_
46	,	,	,	,	_	33	punct	_	_
47	Zimmerman	Zimmerman	NNP	NNP	_	49	compound	_	_
48	,	,	,	,	_	49	punct	_	_
49	G.A.	G.A.	NNP	NNP	_	33	conj	_	_
50	,	,	,	,	_	33	punct	_	_
51	Schmidtmayerova	Schmidtmayerova	NNP	NNP	_	53	compound	_	_
52	,	,	,	,	_	53	punct	_	_
53	H.	H.	NNP	NNP	_	33	conj	_	_
54	,	,	,	,	_	33	punct	_	_
55	Bukrinsky	Bukrinsky	NNP	NNP	_	57	compound	_	_
56	,	,	,	,	_	57	punct	_	_
57	M.	M.	NNP	NNP	_	33	conj	_	_
58	,	,	,	,	_	33	punct	_	_
59	Donnelley	Donnelley	NNP	NNP	_	61	compound	_	_
60	,	,	,	,	_	61	punct	_	_
61	T.	T.	NNP	NNP	_	33	conj	_	_
62	,	,	,	,	_	33	punct	_	_
63	Bucala	Bucala	NNP	NNP	_	65	compound	_	_
64	,	,	,	,	_	65	punct	_	_
65	R.	R.	NNP	NNP	_	33	conj	_	_
66	,	,	,	,	_	33	punct	_	_
67	Sherry	Sherry	NNP	NNP	_	69	compound	_	_
68	,	,	,	,	_	69	punct	_	_
69	B.	B.	NNP	NNP	_	33	conj	_	_
70	,	,	,	,	_	33	punct	_	_
71	Manogue	Manogue	NNP	NNP	_	73	compound	_	_
72	,	,	,	,	_	73	punct	_	_
73	K.R.	K.R.	NNP	NNP	_	33	conj	_	_
74	,	,	,	,	_	33	punct	_	_
75	Tortolani	Tortolani	NNP	NNP	_	77	compound	_	_
76	,	,	,	,	_	77	punct	_	_
77	A.J.	A.J.	NNP	NNP	_	33	conj	_	_
78	,	,	,	,	_	33	punct	_	_
79	Cerami	Cerami	NNP	NNP	_	81	compound	_	_
80	,	,	,	,	_	81	punct	_	_
81	A.	A.	NNP	NNP	_	33	conj	_	_
82	&amp;	&amp;	CC	CC	_	33	cc	_	_
83	Tracey	Tracey	NNP	NNP	_	85	compound	_	_
84	,	,	,	,	_	85	punct	_	_
85	K.J.	K.J.	NNP	NNP	_	33	conj	_	_
86	(	(	-LRB-	-LRB-	_	87	punct	_	_
87	1995	1995	CD	CD	_	33	appos	_	_
88	)	)	-RRB-	-RRB-	_	87	punct	_	_
89	Mol.Med.1	Mol.Med.1	NNP	NNP	_	33	dep	_	_
90	,	,	,	,	_	33	punct	_	_
91	254-266	254-266	CD	CD	_	33	amod	_	_
92	,	,	,	,	_	33	punct	_	_
93	and	and	CC	CC	_	33	cc	_	_
94	Bianchi	Bianchi	NNP	NNP	_	96	compound	_	_
95	,	,	,	,	_	96	punct	_	_
96	M.	M.	NNP	NNP	_	33	conj	_	_
97	,	,	,	,	_	96	punct	_	_
98	Bloom	Bloom	NNP	NNP	_	100	compound	_	_
99	,	,	,	,	_	100	punct	_	_
100	O.	O.	NNP	NNP	_	96	conj	_	_
101	,	,	,	,	_	96	punct	_	_
102	Raabe	Raabe	NNP	NNP	_	104	compound	_	_
103	,	,	,	,	_	104	punct	_	_
104	T.	T.	NNP	NNP	_	96	conj	_	_
105	,	,	,	,	_	96	punct	_	_
106	Cohen	Cohen	NNP	NNP	_	109	compound	_	_
107	,	,	,	,	_	109	punct	_	_
108	P.	P.	NNP	NNP	_	109	appos	_	_
109	S.	S.	NNP	NNP	_	96	conj	_	_
110	,	,	,	,	_	96	punct	_	_
111	Chesney	Chesney	NNP	NNP	_	113	compound	_	_
112	,	,	,	,	_	113	punct	_	_
113	J.	J.	NNP	NNP	_	96	conj	_	_
114	,	,	,	,	_	96	punct	_	_
115	Sherry	Sherry	NNP	NNP	_	117	compound	_	_
116	,	,	,	,	_	117	punct	_	_
117	B.	B.	NNP	NNP	_	96	conj	_	_
118	,	,	,	,	_	96	punct	_	_
119	Schmidtmayerova	Schmidtmayerova	NNP	NNP	_	121	compound	_	_
120	,	,	,	,	_	121	punct	_	_
121	H.	H.	NNP	NNP	_	96	conj	_	_
122	,	,	,	,	_	96	punct	_	_
123	Zhang	Zhang	NNP	NNP	_	125	compound	_	_
124	,	,	,	,	_	125	punct	_	_
125	X.	X.	NNP	NNP	_	96	conj	_	_
126	,	,	,	,	_	96	punct	_	_
127	Bukrinsky	Bukrinsky	NNP	NNP	_	129	compound	_	_
128	,	,	,	,	_	129	punct	_	_
129	M.	M.	NNP	NNP	_	96	conj	_	_
130	,	,	,	,	_	96	punct	_	_
131	Ulrich	Ulrich	NNP	NNP	_	133	compound	_	_
132	,	,	,	,	_	133	punct	_	_
133	P.	P.	NNP	NNP	_	96	conj	_	_
134	,	,	,	,	_	96	punct	_	_
135	Cerami	Cerami	NNP	NNP	_	137	compound	_	_
136	,	,	,	,	_	137	punct	_	_
137	A.	A.	NNP	NNP	_	96	conj	_	_
138	&amp;	&amp;	CC	CC	_	96	cc	_	_
139	Tracey	Tracey	NNP	NNP	_	141	compound	_	_
140	,	,	,	,	_	141	punct	_	_
141	J.	J.	NNP	NNP	_	96	conj	_	_
142	(	(	-LRB-	-LRB-	_	143	punct	_	_
143	1996	1996	CD	CD	_	96	appos	_	_
144	)	)	-RRB-	-RRB-	_	143	punct	_	_
145	J.Exp.Med.	J.Exp.Med.	NNP	NNP	_	96	dep	_	_
146	,	,	,	,	_	96	punct	_	_
147	in	in	IN	IN	_	148	case	_	_
148	press	press	NN	NN	_	96	nmod	_	_
149	-RSB-	-rsb-	-RRB-	-RRB-	_	33	punct	_	_
150	.	.	.	.	_	17	punct	_	_

1	We	we	PRP	PRP	_	4	nsubj	_	_
2	have	have	VBP	VBP	_	4	aux	_	_
3	now	now	RB	RB	_	4	advmod	_	_
4	elucidated	elucidate	VBN	VBN	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	mechanism	mechanism	NN	NN	_	4	dobj	_	_
7	by	by	IN	IN	_	8	case	_	_
8	which	which	WDT	WDT	_	10	nmod	_	_
9	CNI-1493	cni-1493	NN	NN	_	10	nsubj	_	_
10	inhibits	inhibit	VBZ	VBZ	_	6	acl:relcl	_	_
11	macrophage	macrophage	NN	NN	_	13	compound	_	_
12	TNF	tnf	NN	NN	_	13	compound	_	_
13	synthesis	synthesis	NN	NN	_	10	dobj	_	_
14	and	and	CC	CC	_	4	cc	_	_
15	show	show	VBP	VBP	_	4	conj	_	_
16	here	here	RB	RB	_	15	advmod	_	_
17	that	that	IN	IN	_	19	mark	_	_
18	it	it	PRP	PRP	_	19	nsubj	_	_
19	acts	act	VBZ	VBZ	_	15	ccomp	_	_
20	through	through	IN	IN	_	21	case	_	_
21	suppression	suppression	NN	NN	_	19	nmod	_	_
22	of	of	IN	IN	_	25	case	_	_
23	TNF	tnf	NN	NN	_	25	compound	_	_
24	translation	translation	NN	NN	_	25	compound	_	_
25	efficiency	efficiency	NN	NN	_	21	nmod	_	_
26	.	.	.	.	_	4	punct	_	_

1	CNI-1493	cni-1493	NN	NN	_	2	nsubj	_	_
2	blocked	block	VBD	VBD	_	0	root	_	_
3	neither	neither	CC	CC	_	10	cc:preconj	_	_
4	the	the	DT	DT	_	10	det	_	_
5	lipopolysaccharide	lipopolysaccharide	NN	NN	_	10	compound	_	_
6	(	(	-LRB-	-LRB-	_	7	punct	_	_
7	LPS	lps	NN	NN	_	5	appos	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	-induced	-induced	JJ	JJ	_	10	amod	_	_
10	increases	increase	NNS	NNS	_	2	dobj	_	_
11	in	in	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	expression	expression	NN	NN	_	10	nmod	_	_
14	of	of	IN	IN	_	16	case	_	_
15	TNF	tnf	NN	NN	_	16	compound	_	_
16	mRNA	mrna	NN	NN	_	13	nmod	_	_
17	nor	nor	CC	CC	_	10	cc	_	_
18	the	the	DT	DT	_	19	det	_	_
19	translocation	translocation	NN	NN	_	10	conj	_	_
20	of	of	IN	IN	_	24	case	_	_
21	nuclear	nuclear	JJ	JJ	_	24	amod	_	_
22	factor	factor	NN	NN	_	24	compound	_	_
23	NF-kappa	nf-kappa	NN	NN	_	24	compound	_	_
24	B	b	NN	NN	_	19	nmod	_	_
25	to	to	TO	TO	_	27	case	_	_
26	the	the	DT	DT	_	27	det	_	_
27	nucleus	nucleus	NN	NN	_	19	nmod	_	_
28	in	in	IN	IN	_	29	case	_	_
29	macrophages	macrophage	NNS	NNS	_	19	nmod	_	_
30	activated	activate	VBN	VBN	_	29	acl	_	_
31	by	by	IN	IN	_	33	case	_	_
32	15	15	CD	CD	_	33	nummod	_	_
33	min	min	NN	NN	_	30	nmod	_	_
34	of	of	IN	IN	_	36	case	_	_
35	LPS	lps	NN	NN	_	36	compound	_	_
36	stimulation	stimulation	NN	NN	_	33	nmod	_	_
37	,	,	,	,	_	2	punct	_	_
38	indicating	indicate	VBG	VBG	_	2	advcl	_	_
39	that	that	IN	IN	_	43	mark	_	_
40	CNI-1493	cni-1493	NN	NN	_	43	nsubj	_	_
41	does	do	VBZ	VBZ	_	43	aux	_	_
42	not	not	RB	RB	_	43	neg	_	_
43	interfere	interfere	VB	VB	_	38	ccomp	_	_
44	with	with	IN	IN	_	49	case	_	_
45	early	early	JJ	JJ	_	49	amod	_	_
46	NF-kappa	nf-kappa	NN	NN	_	49	compound	_	_
47	B-mediated	b-mediated	JJ	JJ	_	49	amod	_	_
48	transcriptional	transcriptional	JJ	JJ	_	49	amod	_	_
49	regulation	regulation	NN	NN	_	43	nmod	_	_
50	of	of	IN	IN	_	51	case	_	_
51	TNF	tnf	NN	NN	_	49	nmod	_	_
52	.	.	.	.	_	2	punct	_	_

1	However	however	RB	RB	_	13	advmod	_	_
2	,	,	,	,	_	13	punct	_	_
3	synthesis	synthesis	NN	NN	_	13	nsubjpass	_	_
4	of	of	IN	IN	_	8	case	_	_
5	the	the	DT	DT	_	8	det	_	_
6	26-kDa	26-kda	JJ	JJ	_	8	amod	_	_
7	membrane	membrane	NN	NN	_	8	compound	_	_
8	form	form	NN	NN	_	3	nmod	_	_
9	of	of	IN	IN	_	10	case	_	_
10	TNF	tnf	NN	NN	_	8	nmod	_	_
11	was	be	VBD	VBD	_	13	auxpass	_	_
12	effectively	effectively	RB	RB	_	13	advmod	_	_
13	blocked	block	VBN	VBN	_	0	root	_	_
14	by	by	IN	IN	_	15	case	_	_
15	CNI-1493	cni-1493	NN	NN	_	13	nmod	_	_
16	.	.	.	.	_	13	punct	_	_

1	Further	further	RB	RB	_	2	advmod	_	_
2	evidence	evidence	NN	NN	_	10	nsubjpass	_	_
3	for	for	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	translational	translational	JJ	JJ	_	6	amod	_	_
6	suppression	suppression	NN	NN	_	2	nmod	_	_
7	of	of	IN	IN	_	8	case	_	_
8	TNF	tnf	NN	NN	_	6	nmod	_	_
9	is	be	VBZ	VBZ	_	10	auxpass	_	_
10	given	give	VBN	VBN	_	0	root	_	_
11	by	by	IN	IN	_	12	case	_	_
12	experiments	experiment	NNS	NNS	_	10	nmod	_	_
13	using	use	VBG	VBG	_	12	acl	_	_
14	chloram-phenicol	chloram-phenicol	NN	NN	_	17	compound	_	_
15	acetyltransferase	acetyltransferase	NN	NN	_	17	compound	_	_
16	(	(	-LRB-	-LRB-	_	17	punct	_	_
17	CAT	cat	NN	NN	_	13	dobj	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	constructs	construct	VBZ	VBZ	_	17	dep	_	_
20	containing	contain	VBG	VBG	_	17	acl	_	_
21	elements	element	NNS	NNS	_	20	dobj	_	_
22	of	of	IN	IN	_	25	case	_	_
23	the	the	DT	DT	_	25	det	_	_
24	TNF	tnf	NN	NN	_	25	compound	_	_
25	gene	gene	NN	NN	_	21	nmod	_	_
26	that	that	WDT	WDT	_	28	nsubjpass	_	_
27	are	be	VBP	VBP	_	28	auxpass	_	_
28	involved	involve	VBN	VBN	_	21	acl:relcl	_	_
29	in	in	IN	IN	_	32	case	_	_
30	TNF	tnf	NN	NN	_	32	compound	_	_
31	translational	translational	JJ	JJ	_	32	amod	_	_
32	regulation	regulation	NN	NN	_	28	nmod	_	_
33	.	.	.	.	_	10	punct	_	_

1	Both	both	CC	CC	_	3	cc:preconj	_	_
2	the	the	DT	DT	_	3	dep	_	_
3	5'	5'	JJ	JJ	_	13	nsubjpass	_	_
4	and	and	CC	CC	_	3	cc	_	_
5	3'	3'	JJ	JJ	_	3	conj	_	_
6	untranslated	untranslated	JJ	JJ	_	7	amod	_	_
7	regions	region	NNS	NNS	_	3	dep	_	_
8	of	of	IN	IN	_	11	case	_	_
9	the	the	DT	DT	_	11	det	_	_
10	TNF	tnf	NN	NN	_	11	compound	_	_
11	gene	gene	NN	NN	_	3	nmod	_	_
12	were	be	VBD	VBD	_	13	auxpass	_	_
13	required	require	VBN	VBN	_	0	root	_	_
14	to	to	TO	TO	_	15	mark	_	_
15	elicit	elicit	VB	VB	_	13	xcomp	_	_
16	maximal	maximal	JJ	JJ	_	18	amod	_	_
17	translational	translational	JJ	JJ	_	18	amod	_	_
18	suppression	suppression	NN	NN	_	15	dobj	_	_
19	by	by	IN	IN	_	20	case	_	_
20	CNI-1493	cni-1493	NN	NN	_	18	nmod	_	_
21	.	.	.	.	_	13	punct	_	_

1	Identification	identification	NN	NN	_	13	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	molecular	molecular	JJ	JJ	_	5	amod	_	_
5	target	target	NN	NN	_	1	nmod	_	_
6	through	through	IN	IN	_	7	case	_	_
7	which	which	WDT	WDT	_	9	nmod	_	_
8	CNI-1493	cni-1493	NN	NN	_	9	nsubj	_	_
9	inhibits	inhibit	VBZ	VBZ	_	5	acl:relcl	_	_
10	TNF	tnf	NN	NN	_	11	compound	_	_
11	translation	translation	NN	NN	_	9	dobj	_	_
12	should	should	MD	MD	_	13	aux	_	_
13	provide	provide	VB	VB	_	0	root	_	_
14	insight	insight	NN	NN	_	13	dobj	_	_
15	into	into	IN	IN	_	17	case	_	_
16	the	the	DT	DT	_	17	det	_	_
17	regulation	regulation	NN	NN	_	14	nmod	_	_
18	of	of	IN	IN	_	20	case	_	_
19	macrophage	macrophage	NN	NN	_	20	compound	_	_
20	activation	activation	NN	NN	_	17	nmod	_	_
21	and	and	CC	CC	_	17	cc	_	_
22	mechanisms	mechanism	NNS	NNS	_	17	conj	_	_
23	of	of	IN	IN	_	24	case	_	_
24	inflammation	inflammation	NN	NN	_	22	nmod	_	_
25	.	.	.	.	_	13	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	RAR-RXR	rar-rxr	JJ	JJ	_	10	nsubjpass	_	_
3	as	as	RB	RB	_	2	cc	_	_
4	well	well	RB	RB	_	3	mwe	_	_
5	as	as	IN	IN	_	3	mwe	_	_
6	the	the	DT	DT	_	7	det	_	_
7	RXR-RXR	rxr-rxr	JJ	JJ	_	2	conj	_	_
8	pathway	pathway	NN	NN	_	2	dep	_	_
9	is	be	VBZ	VBZ	_	10	auxpass	_	_
10	involved	involve	VBN	VBN	_	0	root	_	_
11	in	in	IN	IN	_	14	case	_	_
12	signaling	signaling	NN	NN	_	14	compound	_	_
13	growth	growth	NN	NN	_	14	compound	_	_
14	inhibition	inhibition	NN	NN	_	10	nmod	_	_
15	of	of	IN	IN	_	20	case	_	_
16	human	human	JJ	JJ	_	20	amod	_	_
17	CD34+	cd34+	JJ	JJ	_	20	amod	_	_
18	erythroid	erythroid	JJ	JJ	_	20	amod	_	_
19	progenitor	progenitor	NN	NN	_	20	compound	_	_
20	cells	cell	NNS	NNS	_	14	nmod	_	_
21	.	.	.	.	_	10	punct	_	_

1	Previous	previous	JJ	JJ	_	2	amod	_	_
2	studies	study	NNS	NNS	_	4	nsubj	_	_
3	have	have	VBP	VBP	_	4	aux	_	_
4	shown	show	VBN	VBN	_	0	root	_	_
5	that	that	IN	IN	_	22	mark	_	_
6	retinoic	retinoic	JJ	JJ	_	7	amod	_	_
7	acid	acid	NN	NN	_	22	nsubj	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	RA	ra	NN	NN	_	7	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	,	,	,	,	_	7	punct	_	_
12	similar	similar	JJ	JJ	_	7	amod	_	_
13	to	to	TO	TO	_	16	case	_	_
14	tumor	tumor	NN	NN	_	16	compound	_	_
15	necrosis	necrosis	NN	NN	_	16	compound	_	_
16	factor-alpha	factor-alpha	NN	NN	_	12	nmod	_	_
17	(	(	-LRB-	-LRB-	_	18	punct	_	_
18	TNF-alpha	tnf-alpha	NN	NN	_	16	appos	_	_
19	)	)	-RRB-	-RRB-	_	18	punct	_	_
20	,	,	,	,	_	7	punct	_	_
21	can	can	MD	MD	_	22	aux	_	_
22	act	act	VB	VB	_	4	ccomp	_	_
23	as	as	IN	IN	_	26	case	_	_
24	a	a	DT	DT	_	26	det	_	_
25	bifunctional	bifunctional	JJ	JJ	_	26	amod	_	_
26	regulator	regulator	NN	NN	_	22	nmod	_	_
27	of	of	IN	IN	_	29	case	_	_
28	the	the	DT	DT	_	29	det	_	_
29	growth	growth	NN	NN	_	26	nmod	_	_
30	of	of	IN	IN	_	33	case	_	_
31	bone	bone	NN	NN	_	33	compound	_	_
32	marrow	marrow	NN	NN	_	33	compound	_	_
33	progenitors	progenitor	NNS	NNS	_	29	nmod	_	_
34	,	,	,	,	_	22	punct	_	_
35	in	in	IN	IN	_	39	mark	_	_
36	that	that	IN	IN	_	39	mark	_	_
37	it	it	PRP	PRP	_	39	nsubj	_	_
38	can	can	MD	MD	_	39	aux	_	_
39	stimulate	stimulate	VB	VB	_	22	advcl	_	_
40	granulocyte-macrophage	granulocyte-macrophage	JJ	JJ	_	42	amod	_	_
41	colony-stimulating	colony-stimulating	JJ	JJ	_	42	amod	_	_
42	factor	factor	NN	NN	_	39	dobj	_	_
43	(	(	-LRB-	-LRB-	_	44	punct	_	_
44	GM-CSF	gm-csf	NN	NN	_	42	appos	_	_
45	)	)	-RRB-	-RRB-	_	44	punct	_	_
46	-	-	:	:	_	42	punct	_	_
47	or	or	CC	CC	_	42	cc	_	_
48	interleukin-3	interleukin-3	NN	NN	_	42	conj	_	_
49	(	(	-LRB-	-LRB-	_	50	punct	_	_
50	IL-3	il-3	NN	NN	_	48	appos	_	_
51	)	)	-RRB-	-RRB-	_	50	punct	_	_
52	-induced	-induced	JJ	JJ	_	48	amod	_	_
53	GM	gm	NN	NN	_	55	compound	_	_
54	colony	colony	NN	NN	_	55	compound	_	_
55	formation	formation	NN	NN	_	42	dep	_	_
56	,	,	,	,	_	39	punct	_	_
57	but	but	CC	CC	_	39	cc	_	_
58	potently	potently	RB	RB	_	59	advmod	_	_
59	inhibit	inhibit	VBP	VBP	_	39	conj	_	_
60	G-CSF-induced	g-csf-induced	JJ	JJ	_	61	amod	_	_
61	growth	growth	NN	NN	_	59	dobj	_	_
62	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	present	present	JJ	JJ	_	3	amod	_	_
3	study	study	NN	NN	_	20	nsubj	_	_
4	,	,	,	,	_	3	punct	_	_
5	using	use	VBG	VBG	_	20	dep	_	_
6	highly	highly	RB	RB	_	7	advmod	_	_
7	enriched	enrich	VBN	VBN	_	9	amod	_	_
8	human	human	JJ	JJ	_	9	amod	_	_
9	CD34+	cd34+	JJ	JJ	_	5	dobj	_	_
10	as	as	RB	RB	_	9	cc	_	_
11	well	well	RB	RB	_	10	mwe	_	_
12	as	as	IN	IN	_	10	mwe	_	_
13	Lin-	lin-	JJ	JJ	_	18	amod	_	_
14	murine	murine	JJ	JJ	_	18	amod	_	_
15	bone	bone	NN	NN	_	18	compound	_	_
16	marrow	marrow	NN	NN	_	18	compound	_	_
17	progenitor	progenitor	NN	NN	_	18	compound	_	_
18	cells	cell	NNS	NNS	_	9	conj	_	_
19	,	,	,	,	_	20	punct	_	_
20	demonstrates	demonstrate	VBZ	VBZ	_	0	root	_	_
21	a	a	DT	DT	_	24	det	_	_
22	potent	potent	JJ	JJ	_	23	amod	_	_
23	inhibitory	inhibitory	JJ	JJ	_	24	amod	_	_
24	effect	effect	NN	NN	_	20	dobj	_	_
25	of	of	IN	IN	_	26	case	_	_
26	9-cis-RA	9-cis-ra	NN	NN	_	24	nmod	_	_
27	on	on	IN	IN	_	34	case	_	_
28	burst-forming	burst-forming	JJ	JJ	_	29	amod	_	_
29	unit-erythroid	unit-erythroid	JJ	JJ	_	34	compound	_	_
30	(	(	-LRB-	-LRB-	_	31	punct	_	_
31	BFU-E	bfu-e	NN	NN	_	29	appos	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	colony	colony	NN	NN	_	34	compound	_	_
34	formation	formation	NN	NN	_	24	nmod	_	_
35	regardless	regardless	RB	RB	_	20	advmod	_	_
36	of	of	IN	IN	_	40	case	_	_
37	the	the	DT	DT	_	40	det	_	_
38	cytokine	cytokine	NN	NN	_	40	compound	_	_
39	stimulating	stimulating	NN	NN	_	40	compound	_	_
40	growth	growth	NN	NN	_	35	nmod	_	_
41	.	.	.	.	_	20	punct	_	_

1	Specifically	specifically	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	9-cis-RA	9-cis-ra	NN	NN	_	5	nsubj	_	_
4	potently	potently	RB	RB	_	5	advmod	_	_
5	inhibited	inhibit	VBD	VBD	_	0	root	_	_
6	the	the	DT	DT	_	7	det	_	_
7	growth	growth	NN	NN	_	5	dobj	_	_
8	of	of	IN	IN	_	10	case	_	_
9	BFU-E	bfu-e	NN	NN	_	10	compound	_	_
10	response	response	NN	NN	_	7	nmod	_	_
11	to	to	TO	TO	_	12	case	_	_
12	erythropoietin	erythropoietin	NN	NN	_	10	nmod	_	_
13	(	(	-LRB-	-LRB-	_	14	punct	_	_
14	Epo	epo	NN	NN	_	12	appos	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	(	(	-LRB-	-LRB-	_	18	punct	_	_
17	100	100	CD	CD	_	18	nummod	_	_
18	%	%	NN	NN	_	7	appos	_	_
19	)	)	-RRB-	-RRB-	_	18	punct	_	_
20	,	,	,	,	_	7	punct	_	_
21	stem	stem	NN	NN	_	23	compound	_	_
22	cell	cell	NN	NN	_	23	compound	_	_
23	factor	factor	NN	NN	_	7	conj	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	SCF	scf	NN	NN	_	23	appos	_	_
26	)	)	-RRB-	-RRB-	_	25	punct	_	_
27	+	+	CC	CC	_	23	cc	_	_
28	Epo	epo	NN	NN	_	23	conj	_	_
29	(	(	-LRB-	-LRB-	_	31	punct	_	_
30	92	92	CD	CD	_	31	nummod	_	_
31	%	%	NN	NN	_	23	appos	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	,	,	,	,	_	7	punct	_	_
34	IL-3	il-3	NN	NN	_	7	conj	_	_
35	+	+	CC	CC	_	34	cc	_	_
36	Epo	epo	NN	NN	_	34	conj	_	_
37	(	(	-LRB-	-LRB-	_	39	punct	_	_
38	97	97	CD	CD	_	39	nummod	_	_
39	%	%	NN	NN	_	34	appos	_	_
40	)	)	-RRB-	-RRB-	_	39	punct	_	_
41	,	,	,	,	_	7	punct	_	_
42	IL-4	il-4	NN	NN	_	7	conj	_	_
43	+	+	CC	CC	_	42	cc	_	_
44	Epo	epo	NN	NN	_	42	conj	_	_
45	(	(	-LRB-	-LRB-	_	47	punct	_	_
46	88	88	CD	CD	_	47	nummod	_	_
47	%	%	NN	NN	_	42	appos	_	_
48	)	)	-RRB-	-RRB-	_	47	punct	_	_
49	,	,	,	,	_	7	punct	_	_
50	and	and	CC	CC	_	7	cc	_	_
51	IL-9	il-9	NN	NN	_	7	conj	_	_
52	+	+	CC	CC	_	51	cc	_	_
53	Epo	epo	NN	NN	_	51	conj	_	_
54	(	(	-LRB-	-LRB-	_	56	punct	_	_
55	100	100	CD	CD	_	56	nummod	_	_
56	%	%	NN	NN	_	51	appos	_	_
57	)	)	-RRB-	-RRB-	_	56	punct	_	_
58	.	.	.	.	_	5	punct	_	_

1	Erythroid	erythroid	JJ	JJ	_	3	amod	_	_
2	colony	colony	NN	NN	_	3	compound	_	_
3	growth	growth	NN	NN	_	6	nsubjpass	_	_
4	was	be	VBD	VBD	_	6	auxpass	_	_
5	also	also	RB	RB	_	6	advmod	_	_
6	inhibited	inhibit	VBN	VBN	_	0	root	_	_
7	when	when	WRB	WRB	_	11	advmod	_	_
8	CD34+	cd34+	JJ	JJ	_	9	amod	_	_
9	progenitors	progenitor	NNS	NNS	_	11	nsubjpass	_	_
10	were	be	VBD	VBD	_	11	auxpass	_	_
11	seeded	seed	VBN	VBN	_	6	advcl	_	_
12	at	at	IN	IN	_	14	case	_	_
13	one	one	CD	CD	_	14	nummod	_	_
14	cell	cell	NN	NN	_	11	nmod	_	_
15	per	per	IN	IN	_	16	case	_	_
16	well	well	NN	NN	_	11	nmod	_	_
17	,	,	,	,	_	6	punct	_	_
18	suggesting	suggest	VBG	VBG	_	6	xcomp	_	_
19	a	a	DT	DT	_	21	det	_	_
20	direct	direct	JJ	JJ	_	21	amod	_	_
21	action	action	NN	NN	_	18	dobj	_	_
22	of	of	IN	IN	_	23	case	_	_
23	RA	ra	NN	NN	_	21	nmod	_	_
24	.	.	.	.	_	6	punct	_	_

1	Using	use	VBG	VBG	_	0	root	_	_
2	synthetic	synthetic	JJ	JJ	_	3	amod	_	_
3	ligands	ligand	NNS	NNS	_	1	dobj	_	_
4	to	to	TO	TO	_	7	case	_	_
5	retinoic	retinoic	JJ	JJ	_	7	amod	_	_
6	acid	acid	NN	NN	_	7	compound	_	_
7	receptors	receptor	NNS	NNS	_	3	nmod	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	RARs	rar	NNS	NNS	_	7	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	and	and	CC	CC	_	7	cc	_	_
12	retinoid	retinoid	NN	NN	_	14	compound	_	_
13	X	x	NN	NN	_	14	compound	_	_
14	receptors	receptor	NNS	NNS	_	7	conj	_	_
15	(	(	-LRB-	-LRB-	_	16	punct	_	_
16	RXRs	rxr	NNS	NNS	_	14	appos	_	_
17	)	)	-RRB-	-RRB-	_	16	punct	_	_
18	that	that	WDT	WDT	_	20	nsubj	_	_
19	selectively	selectively	RB	RB	_	20	advmod	_	_
20	bind	bind	VBP	VBP	_	7	acl:relcl	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	activate	activate	VBP	VBP	_	20	conj	_	_
23	RAR-RXR	rar-rxr	NN	NN	_	20	dobj	_	_
24	or	or	CC	CC	_	23	cc	_	_
25	RXR-RXR	rxr-rxr	JJ	JJ	_	23	conj	_	_
26	dimers	dimer	NNS	NNS	_	23	dep	_	_
27	,	,	,	,	_	20	punct	_	_
28	respectively	respectively	RB	RB	_	20	advmod	_	_
29	,	,	,	,	_	1	punct	_	_
30	we	we	PRP	PRP	_	31	nsubj	_	_
31	dissected	dissect	VBD	VBD	_	1	parataxis	_	_
32	the	the	DT	DT	_	33	det	_	_
33	involvement	involvement	NN	NN	_	31	dobj	_	_
34	of	of	IN	IN	_	39	case	_	_
35	the	the	DT	DT	_	39	det	_	_
36	two	two	CD	CD	_	39	nummod	_	_
37	retinoid	retinoid	NN	NN	_	39	compound	_	_
38	response	response	NN	NN	_	39	compound	_	_
39	pathways	pathway	NNS	NNS	_	33	nmod	_	_
40	in	in	IN	IN	_	42	case	_	_
41	the	the	DT	DT	_	42	det	_	_
42	regulation	regulation	NN	NN	_	33	nmod	_	_
43	of	of	IN	IN	_	45	case	_	_
44	normal	normal	JJ	JJ	_	45	amod	_	_
45	myeloid	myeloid	JJ	JJ	_	42	nmod	_	_
46	and	and	CC	CC	_	45	cc	_	_
47	erythroid	erythroid	JJ	JJ	_	48	amod	_	_
48	progenitor	progenitor	NN	NN	_	45	conj	_	_
49	cell	cell	NN	NN	_	50	compound	_	_
50	growth	growth	NN	NN	_	45	dep	_	_
51	.	.	.	.	_	1	punct	_	_

1	Transactivation	transactivation	NN	NN	_	2	compound	_	_
2	studies	study	NNS	NNS	_	3	nsubj	_	_
3	showed	show	VBD	VBD	_	0	root	_	_
4	that	that	IN	IN	_	24	mark	_	_
5	both	both	CC	CC	_	7	cc:preconj	_	_
6	the	the	DT	DT	_	7	det	_	_
7	RAR	rar	NN	NN	_	24	nsubj	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	Ro	ro	NN	NN	_	7	appos	_	_
10	13-7410	13-7410	CD	CD	_	9	nummod	_	_
11	)	)	-RRB-	-RRB-	_	9	punct	_	_
12	and	and	CC	CC	_	7	cc	_	_
13	RXR	rxr	NN	NN	_	7	conj	_	_
14	(	(	-LRB-	-LRB-	_	15	punct	_	_
15	Ro	ro	NN	NN	_	13	dep	_	_
16	25-6603	25-6603	CD	CD	_	15	nummod	_	_
17	and	and	CC	CC	_	15	cc	_	_
18	Ro	ro	NN	NN	_	15	conj	_	_
19	25-7386	25-7386	CD	CD	_	18	nummod	_	_
20	)	)	-RRB-	-RRB-	_	15	punct	_	_
21	ligands	ligand	NNS	NNS	_	7	dep	_	_
22	were	be	VBD	VBD	_	24	cop	_	_
23	highly	highly	RB	RB	_	24	advmod	_	_
24	selective	selective	JJ	JJ	_	3	ccomp	_	_
25	at	at	IN	IN	_	27	case	_	_
26	100	100	CD	CD	_	27	nummod	_	_
27	nmol/L	nmol/l	NN	NN	_	24	nmod	_	_
28	.	.	.	.	_	3	punct	_	_

1	At	at	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	concentration	concentration	NN	NN	_	8	nmod	_	_
4	,	,	,	,	_	8	punct	_	_
5	Ro	ro	NN	NN	_	8	nsubj	_	_
6	13-7410	13-7410	CD	CD	_	5	nummod	_	_
7	potently	potently	RB	RB	_	8	advmod	_	_
8	inhibited	inhibit	VBD	VBD	_	0	root	_	_
9	G-CSF-stimulated	g-csf-stimulated	JJ	JJ	_	10	amod	_	_
10	myeloid	myeloid	JJ	JJ	_	8	dobj	_	_
11	as	as	RB	RB	_	10	cc	_	_
12	well	well	RB	RB	_	11	mwe	_	_
13	as	as	IN	IN	_	11	mwe	_	_
14	SCF	scf	NN	NN	_	17	amod	_	_
15	+	+	CC	CC	_	14	cc	_	_
16	Epo-induced	epo-induced	JJ	JJ	_	14	conj	_	_
17	erythroid	erythroid	JJ	JJ	_	10	conj	_	_
18	colony	colony	NN	NN	_	19	compound	_	_
19	growth	growth	NN	NN	_	10	dep	_	_
20	.	.	.	.	_	8	punct	_	_

1	At	at	IN	IN	_	4	case	_	_
2	the	the	DT	DT	_	4	det	_	_
3	same	same	JJ	JJ	_	4	amod	_	_
4	concentration	concentration	NN	NN	_	11	nmod	_	_
5	,	,	,	,	_	11	punct	_	_
6	Ro	ro	NN	NN	_	11	nsubj	_	_
7	25-6603	25-6603	CD	CD	_	6	nummod	_	_
8	and	and	CC	CC	_	6	cc	_	_
9	Ro	ro	NN	NN	_	6	conj	_	_
10	25-7386	25-7386	CD	CD	_	9	nummod	_	_
11	had	have	VBD	VBD	_	0	root	_	_
12	little	little	JJ	JJ	_	11	dobj	_	_
13	or	or	CC	CC	_	12	cc	_	_
14	no	no	DT	DT	_	12	conj	_	_
15	effect	effect	NN	NN	_	12	dep	_	_
16	on	on	IN	IN	_	19	case	_	_
17	G-CSF-induced	g-csf-induced	JJ	JJ	_	19	amod	_	_
18	colony	colony	NN	NN	_	19	compound	_	_
19	formation	formation	NN	NN	_	11	nmod	_	_
20	,	,	,	,	_	11	punct	_	_
21	whereas	whereas	IN	IN	_	23	mark	_	_
22	they	they	PRP	PRP	_	23	nsubj	_	_
23	inhibited	inhibit	VBD	VBD	_	11	advcl	_	_
24	75	75	CD	CD	_	25	nummod	_	_
25	%	%	NN	NN	_	23	dobj	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	53	53	CD	CD	_	28	nummod	_	_
28	%	%	NN	NN	_	25	conj	_	_
29	,	,	,	,	_	25	punct	_	_
30	respectively	respectively	RB	RB	_	25	advmod	_	_
31	,	,	,	,	_	25	punct	_	_
32	of	of	IN	IN	_	38	case	_	_
33	SCF	scf	NN	NN	_	38	amod	_	_
34	+	+	CC	CC	_	33	cc	_	_
35	Epo-stimulated	epo-stimulated	JJ	JJ	_	33	conj	_	_
36	BFU-E	bfu-e	NN	NN	_	38	compound	_	_
37	colony	colony	NN	NN	_	38	compound	_	_
38	growth	growth	NN	NN	_	25	conj	_	_
39	.	.	.	.	_	11	punct	_	_

1	Thus	thus	RB	RB	_	8	advmod	_	_
2	,	,	,	,	_	8	punct	_	_
3	the	the	DT	DT	_	6	det	_	_
4	RAR-RXR	rar-rxr	JJ	JJ	_	6	compound	_	_
5	response	response	NN	NN	_	6	compound	_	_
6	pathway	pathway	NN	NN	_	8	nsubj	_	_
7	can	can	MD	MD	_	8	aux	_	_
8	signal	signal	VB	VB	_	0	root	_	_
9	growth	growth	NN	NN	_	10	compound	_	_
10	inhibition	inhibition	NN	NN	_	8	dobj	_	_
11	of	of	IN	IN	_	14	case	_	_
12	normal	normal	JJ	JJ	_	14	amod	_	_
13	bone	bone	NN	NN	_	14	compound	_	_
14	marrow	marrow	NN	NN	_	10	nmod	_	_
15	myeloid	myeloid	JJ	JJ	_	14	amod	_	_
16	and	and	CC	CC	_	14	cc	_	_
17	erythroid	erythroid	JJ	JJ	_	18	amod	_	_
18	progenitor	progenitor	NN	NN	_	14	conj	_	_
19	cells	cell	NNS	NNS	_	14	dep	_	_
20	.	.	.	.	_	8	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	addition	addition	NN	NN	_	5	nmod	_	_
3	,	,	,	,	_	5	punct	_	_
4	we	we	PRP	PRP	_	5	nsubj	_	_
5	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
6	a	a	DT	DT	_	8	det	_	_
7	unique	unique	JJ	JJ	_	8	amod	_	_
8	involvement	involvement	NN	NN	_	5	dobj	_	_
9	of	of	IN	IN	_	12	case	_	_
10	the	the	DT	DT	_	12	det	_	_
11	RXR-RXR	rxr-rxr	JJ	JJ	_	12	compound	_	_
12	pathway	pathway	NN	NN	_	8	nmod	_	_
13	in	in	IN	IN	_	14	mark	_	_
14	mediating	mediate	VBG	VBG	_	8	acl	_	_
15	growth	growth	NN	NN	_	16	compound	_	_
16	inhibition	inhibition	NN	NN	_	14	dobj	_	_
17	of	of	IN	IN	_	18	case	_	_
18	erythroid	erythroid	JJ	JJ	_	16	nmod	_	_
19	but	but	CC	CC	_	20	cc	_	_
20	not	not	RB	RB	_	18	cc	_	_
21	myeloid	myeloid	JJ	JJ	_	23	amod	_	_
22	progenitor	progenitor	NN	NN	_	23	compound	_	_
23	cells	cell	NNS	NNS	_	18	conj	_	_
24	.	.	.	.	_	5	punct	_	_

1	Expression	expression	NN	NN	_	12	nsubj	_	_
2	of	of	IN	IN	_	3	case	_	_
3	A-myb	a-myb	NN	NN	_	1	nmod	_	_
4	,	,	,	,	_	3	punct	_	_
5	but	but	CC	CC	_	6	cc	_	_
6	not	not	RB	RB	_	3	cc	_	_
7	c-myb	c-myb	NN	NN	_	3	conj	_	_
8	and	and	CC	CC	_	7	cc	_	_
9	B-myb	b-myb	NN	NN	_	7	conj	_	_
10	,	,	,	,	_	1	punct	_	_
11	is	be	VBZ	VBZ	_	12	cop	_	_
12	restricted	restricted	JJ	JJ	_	0	root	_	_
13	to	to	TO	TO	_	16	case	_	_
14	Burkitt	burkitt	NN	NN	_	16	nmod:poss	_	_
15	's	's	POS	POS	_	16	case	_	_
16	lymphoma	lymphoma	NN	NN	_	12	nmod	_	_
17	,	,	,	,	_	16	punct	_	_
18	sIg+	sig+	NN	NN	_	21	compound	_	_
19	B-acute	b-acute	JJ	JJ	_	21	amod	_	_
20	lymphoblastic	lymphoblastic	JJ	JJ	_	21	amod	_	_
21	leukemia	leukemia	NN	NN	_	16	conj	_	_
22	,	,	,	,	_	16	punct	_	_
23	and	and	CC	CC	_	16	cc	_	_
24	a	a	DT	DT	_	25	det	_	_
25	subset	subset	NN	NN	_	16	conj	_	_
26	of	of	IN	IN	_	29	case	_	_
27	chronic	chronic	JJ	JJ	_	28	amod	_	_
28	lymphocytic	lymphocytic	JJ	JJ	_	29	amod	_	_
29	leukemias	leukemia	NNS	NNS	_	25	nmod	_	_
30	.	.	.	.	_	12	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	A-myb	a-myb	NN	NN	_	3	compound	_	_
3	gene	gene	NN	NN	_	4	nsubj	_	_
4	encodes	encode	VBZ	VBZ	_	0	root	_	_
5	a	a	DT	DT	_	7	det	_	_
6	transcription	transcription	NN	NN	_	7	compound	_	_
7	factor	factor	NN	NN	_	4	dobj	_	_
8	that	that	WDT	WDT	_	10	nsubj	_	_
9	is	be	VBZ	VBZ	_	10	cop	_	_
10	related	related	JJ	JJ	_	7	acl:relcl	_	_
11	both	both	CC	CC	_	13	cc:preconj	_	_
12	functionally	functionally	RB	RB	_	13	advmod	_	_
13	and	and	CC	CC	_	10	advmod	_	_
14	structurally	structurally	RB	RB	_	13	advmod	_	_
15	to	to	TO	TO	_	18	case	_	_
16	the	the	DT	DT	_	18	det	_	_
17	v-myb	v-myb	NN	NN	_	18	compound	_	_
18	oncogene	oncogene	NN	NN	_	10	nmod	_	_
19	.	.	.	.	_	4	punct	_	_

1	Following	follow	VBG	VBG	_	3	case	_	_
2	our	we	PRP$	PRP$	_	3	nmod:poss	_	_
3	observations	observation	NNS	NNS	_	31	nmod	_	_
4	that	that	IN	IN	_	7	mark	_	_
5	A-myb	a-myb	NN	NN	_	7	nsubjpass	_	_
6	is	be	VBZ	VBZ	_	7	auxpass	_	_
7	expressed	express	VBN	VBN	_	3	ccomp	_	_
8	in	in	IN	IN	_	11	case	_	_
9	a	a	DT	DT	_	11	det	_	_
10	restricted	restricted	JJ	JJ	_	11	amod	_	_
11	subset	subset	NN	NN	_	7	nmod	_	_
12	of	of	IN	IN	_	17	case	_	_
13	normal	normal	JJ	JJ	_	17	amod	_	_
14	mature	mature	JJ	JJ	_	17	amod	_	_
15	human	human	JJ	JJ	_	17	amod	_	_
16	B	b	NN	NN	_	17	compound	_	_
17	lymphocytes	lymphocyte	NNS	NNS	_	11	nmod	_	_
18	,	,	,	,	_	7	punct	_	_
19	with	with	IN	IN	_	21	case	_	_
20	the	the	DT	DT	_	21	det	_	_
21	phenotype	phenotype	NN	NN	_	7	nmod	_	_
22	CD38+	cd38+	NN	NN	_	21	dep	_	_
23	,	,	,	,	_	21	punct	_	_
24	CD39-	cd39-	NN	NN	_	21	appos	_	_
25	,	,	,	,	_	21	punct	_	_
26	slgM-	slgm-	JJ	JJ	_	21	appos	_	_
27	,	,	,	,	_	31	punct	_	_
28	we	we	PRP	PRP	_	31	nsubj	_	_
29	have	have	VBP	VBP	_	31	aux	_	_
30	now	now	RB	RB	_	31	advmod	_	_
31	investigated	investigate	VBN	VBN	_	0	root	_	_
32	the	the	DT	DT	_	33	det	_	_
33	pattern	pattern	NN	NN	_	31	dobj	_	_
34	of	of	IN	IN	_	36	case	_	_
35	A-myb	a-myb	NN	NN	_	36	compound	_	_
36	expression	expression	NN	NN	_	33	nmod	_	_
37	in	in	IN	IN	_	40	case	_	_
38	neoplastic	neoplastic	JJ	JJ	_	40	amod	_	_
39	B	b	NN	NN	_	40	compound	_	_
40	cells	cell	NNS	NNS	_	36	nmod	_	_
41	representating	representate	VBG	VBG	_	40	acl	_	_
42	the	the	DT	DT	_	44	det	_	_
43	whole	whole	JJ	JJ	_	44	amod	_	_
44	spectrum	spectrum	NN	NN	_	41	dobj	_	_
45	of	of	IN	IN	_	47	case	_	_
46	B-cell	b-cell	NN	NN	_	47	compound	_	_
47	differentiation	differentiation	NN	NN	_	44	nmod	_	_
48	and	and	CC	CC	_	31	cc	_	_
49	compared	compare	VBD	VBD	_	31	conj	_	_
50	it	it	PRP	PRP	_	49	dobj	_	_
51	to	to	TO	TO	_	52	case	_	_
52	that	that	DT	DT	_	49	nmod	_	_
53	of	of	IN	IN	_	54	case	_	_
54	c-myb	c-myb	NN	NN	_	52	nmod	_	_
55	and	and	CC	CC	_	54	cc	_	_
56	B-myb	b-myb	NN	NN	_	54	conj	_	_
57	.	.	.	.	_	31	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	a	a	DT	DT	_	3	det	_	_
3	panel	panel	NN	NN	_	10	nmod	_	_
4	of	of	IN	IN	_	7	case	_	_
5	32	32	CD	CD	_	7	nummod	_	_
6	B-cell	b-cell	NN	NN	_	7	compound	_	_
7	lines	line	NNS	NNS	_	3	nmod	_	_
8	,	,	,	,	_	10	punct	_	_
9	A-myb	a-myb	NN	NN	_	10	nsubj	_	_
10	was	be	VBD	VBD	_	0	root	_	_
11	very	very	RB	RB	_	12	advmod	_	_
12	strongly	strongly	RB	RB	_	13	advmod	_	_
13	expressed	express	VBN	VBN	_	10	advmod	_	_
14	in	in	IN	IN	_	23	case	_	_
15	most	most	JJS	JJS	_	23	amod	_	_
16	Burkitt	burkitt	NN	NN	_	18	nmod:poss	_	_
17	's	's	POS	POS	_	18	case	_	_
18	lymphoma	lymphoma	NN	NN	_	23	compound	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	BL	bl	NN	NN	_	18	appos	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	cell	cell	NN	NN	_	23	compound	_	_
23	lines	line	NNS	NNS	_	13	nmod	_	_
24	,	,	,	,	_	13	punct	_	_
25	but	but	CC	CC	_	13	cc	_	_
26	weak	weak	JJ	JJ	_	13	conj	_	_
27	or	or	CC	CC	_	26	cc	_	_
28	negative	negative	JJ	JJ	_	26	conj	_	_
29	in	in	IN	IN	_	31	case	_	_
30	2	2	CD	CD	_	31	nummod	_	_
31	pre-B	pre-b	NN	NN	_	26	nmod	_	_
32	acute	acute	JJ	JJ	_	34	amod	_	_
33	lymphoblastic	lymphoblastic	JJ	JJ	_	34	amod	_	_
34	leukemia	leukemia	NN	NN	_	31	dep	_	_
35	(	(	-LRB-	-LRB-	_	36	punct	_	_
36	ALL	all	NN	NN	_	34	appos	_	_
37	)	)	-RRB-	-RRB-	_	36	punct	_	_
38	,	,	,	,	_	31	punct	_	_
39	4	4	CD	CD	_	42	nummod	_	_
40	non-Hodgkin	non-hodgkin	JJ	JJ	_	42	amod	_	_
41	's	's	POS	POS	_	42	case	_	_
42	lymphoma	lymphoma	NN	NN	_	31	conj	_	_
43	(	(	-LRB-	-LRB-	_	44	punct	_	_
44	NHL	nhl	NN	NN	_	42	appos	_	_
45	)	)	-RRB-	-RRB-	_	44	punct	_	_
46	,	,	,	,	_	31	punct	_	_
47	6	6	CD	CD	_	52	nummod	_	_
48	Epstein-Barr	epstein-barr	JJ	JJ	_	52	amod	_	_
49	virus-immortalized	virus-immortalized	JJ	JJ	_	52	amod	_	_
50	lymphoblastoid	lymphoblastoid	JJ	JJ	_	52	amod	_	_
51	cell	cell	NN	NN	_	52	compound	_	_
52	lines	line	NNS	NNS	_	31	conj	_	_
53	,	,	,	,	_	31	punct	_	_
54	and	and	CC	CC	_	31	cc	_	_
55	6	6	CD	CD	_	57	nummod	_	_
56	myeloma	myeloma	NN	NN	_	57	compound	_	_
57	lines	line	NNS	NNS	_	31	conj	_	_
58	.	.	.	.	_	10	punct	_	_

1	Protein	protein	NN	NN	_	2	compound	_	_
2	expression	expression	NN	NN	_	3	nsubj	_	_
3	paralleled	parallel	VBD	VBD	_	0	root	_	_
4	that	that	DT	DT	_	3	dobj	_	_
5	of	of	IN	IN	_	7	case	_	_
6	the	the	DT	DT	_	7	det	_	_
7	RNA	rna	NN	NN	_	4	nmod	_	_
8	.	.	.	.	_	3	punct	_	_

1	We	we	PRP	PRP	_	4	nsubj	_	_
2	have	have	VBP	VBP	_	4	aux	_	_
3	also	also	RB	RB	_	4	advmod	_	_
4	investigated	investigate	VBN	VBN	_	0	root	_	_
5	A-myb	a-myb	NN	NN	_	6	compound	_	_
6	expression	expression	NN	NN	_	4	dobj	_	_
7	in	in	IN	IN	_	10	case	_	_
8	49	49	CD	CD	_	10	nummod	_	_
9	fresh	fresh	JJ	JJ	_	10	amod	_	_
10	cases	case	NNS	NNS	_	6	nmod	_	_
11	of	of	IN	IN	_	13	case	_	_
12	B	b	NN	NN	_	13	compound	_	_
13	leukemias	leukemias	NN	NN	_	10	nmod	_	_
14	.	.	.	.	_	4	punct	_	_

1	Among	among	IN	IN	_	3	case	_	_
2	24	24	CD	CD	_	3	nummod	_	_
3	ALL	all	NN	NN	_	9	nmod	_	_
4	,	,	,	,	_	9	punct	_	_
5	6	6	CD	CD	_	9	nsubj	_	_
6	were	be	VBD	VBD	_	9	cop	_	_
7	of	of	IN	IN	_	9	case	_	_
8	the	the	DT	DT	_	9	det	_	_
9	null	null	JJ	JJ	_	0	root	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	11	11	CD	CD	_	9	conj	_	_
12	of	of	IN	IN	_	15	case	_	_
13	the	the	DT	DT	_	15	det	_	_
14	common	common	JJ	JJ	_	15	amod	_	_
15	type	type	NN	NN	_	11	dep	_	_
16	and	and	CC	CC	_	9	cc	_	_
17	all	all	DT	DT	_	18	dep	_	_
18	these	these	DT	DT	_	20	nsubj	_	_
19	were	be	VBD	VBD	_	20	cop	_	_
20	negative	negative	JJ	JJ	_	9	conj	_	_
21	for	for	IN	IN	_	23	case	_	_
22	A-myb	a-myb	NN	NN	_	23	compound	_	_
23	expression	expression	NN	NN	_	20	nmod	_	_
24	;	;	:	:	_	9	punct	_	_
25	on	on	IN	IN	_	28	case	_	_
26	the	the	DT	DT	_	28	det	_	_
27	other	other	JJ	JJ	_	28	amod	_	_
28	hand	hand	NN	NN	_	50	nmod	_	_
29	,	,	,	,	_	50	punct	_	_
30	all	all	DT	DT	_	33	det	_	_
31	7	7	CD	CD	_	33	nummod	_	_
32	B-ALL	b-all	NN	NN	_	33	compound	_	_
33	cases	case	NNS	NNS	_	50	nsubj	_	_
34	(	(	-LRB-	-LRB-	_	35	punct	_	_
35	slg+	slg+	JJ	JJ	_	33	dep	_	_
36	)	)	-RRB-	-RRB-	_	35	punct	_	_
37	,	,	,	,	_	33	punct	_	_
38	as	as	RB	RB	_	33	cc	_	_
39	well	well	RB	RB	_	38	mwe	_	_
40	as	as	IN	IN	_	38	mwe	_	_
41	one	one	CD	CD	_	44	nummod	_	_
42	fresh	fresh	JJ	JJ	_	44	amod	_	_
43	BL	bl	NN	NN	_	44	compound	_	_
44	case	case	NN	NN	_	33	conj	_	_
45	with	with	IN	IN	_	48	case	_	_
46	bone	bone	NN	NN	_	48	compound	_	_
47	marrow	marrow	NN	NN	_	48	compound	_	_
48	infiltration	infiltration	NN	NN	_	44	nmod	_	_
49	,	,	,	,	_	33	punct	_	_
50	expressed	express	VBD	VBD	_	9	parataxis	_	_
51	A-myb	a-myb	NN	NN	_	50	dobj	_	_
52	.	.	.	.	_	9	punct	_	_

1	A-myb	a-myb	NN	NN	_	3	nsubj	_	_
2	was	be	VBD	VBD	_	3	cop	_	_
3	undetectable	undetectable	JJ	JJ	_	0	root	_	_
4	in	in	IN	IN	_	7	case	_	_
5	4	4	CD	CD	_	7	nummod	_	_
6	prolymphocytic	prolymphocytic	JJ	JJ	_	7	amod	_	_
7	leukemias	leukemia	NNS	NNS	_	3	nmod	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	PLL	pll	NN	NN	_	7	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	but	but	CC	CC	_	3	cc	_	_
12	was	be	VBD	VBD	_	14	auxpass	_	_
13	strongly	strongly	RB	RB	_	14	advmod	_	_
14	expressed	express	VBN	VBN	_	3	conj	_	_
15	in	in	IN	IN	_	16	case	_	_
16	5/20	5/20	CD	CD	_	14	nmod	_	_
17	(	(	-LRB-	-LRB-	_	19	punct	_	_
18	25	25	CD	CD	_	19	nummod	_	_
19	%	%	NN	NN	_	16	appos	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	of	of	IN	IN	_	28	case	_	_
22	chronic	chronic	JJ	JJ	_	24	amod	_	_
23	lymphocytic	lymphocytic	JJ	JJ	_	24	amod	_	_
24	leukemia	leukemia	NN	NN	_	28	compound	_	_
25	(	(	-LRB-	-LRB-	_	26	punct	_	_
26	CLL	cll	NN	NN	_	24	appos	_	_
27	)	)	-RRB-	-RRB-	_	26	punct	_	_
28	samples	sample	NNS	NNS	_	16	nmod	_	_
29	.	.	.	.	_	3	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	the	the	DT	DT	_	3	det	_	_
3	latter	latter	JJ	JJ	_	7	nmod	_	_
4	A-myb	a-myb	NN	NN	_	7	nsubj	_	_
5	did	do	VBD	VBD	_	7	aux	_	_
6	not	not	RB	RB	_	7	neg	_	_
7	correlate	correlate	VB	VB	_	0	root	_	_
8	with	with	IN	IN	_	9	case	_	_
9	phenotype	phenotype	NN	NN	_	7	nmod	_	_
10	or	or	CC	CC	_	9	cc	_	_
11	clinical	clinical	JJ	JJ	_	12	amod	_	_
12	stage	stage	NN	NN	_	9	conj	_	_
13	.	.	.	.	_	7	punct	_	_

1	Finally	finally	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	we	we	PRP	PRP	_	5	nsubj	_	_
4	have	have	VBP	VBP	_	5	aux	_	_
5	studied	study	VBN	VBN	_	0	root	_	_
6	the	the	DT	DT	_	7	det	_	_
7	progression	progression	NN	NN	_	5	dobj	_	_
8	of	of	IN	IN	_	10	case	_	_
9	one	one	CD	CD	_	10	nummod	_	_
10	case	case	NN	NN	_	7	nmod	_	_
11	of	of	IN	IN	_	12	case	_	_
12	CLL	cll	NN	NN	_	10	nmod	_	_
13	into	into	IN	IN	_	16	case	_	_
14	Richter	richter	NN	NN	_	16	nmod:poss	_	_
15	's	's	POS	POS	_	16	case	_	_
16	syndrome	syndrome	NN	NN	_	7	nmod	_	_
17	and	and	CC	CC	_	5	cc	_	_
18	have	have	VBP	VBP	_	19	aux	_	_
19	found	find	VBN	VBN	_	5	conj	_	_
20	that	that	IN	IN	_	25	mark	_	_
21	the	the	DT	DT	_	24	det	_	_
22	Richter	richter	NN	NN	_	24	nmod:poss	_	_
23	's	's	POS	POS	_	24	case	_	_
24	cells	cell	NNS	NNS	_	25	nsubj	_	_
25	expressed	express	VBD	VBD	_	19	ccomp	_	_
26	about	about	RB	RB	_	27	advmod	_	_
27	25-fold	25-fold	RB	RB	_	28	nmod:npmod	_	_
28	less	less	JJR	JJR	_	30	amod	_	_
29	A-myb	a-myb	NN	NN	_	30	compound	_	_
30	RNA	rna	NN	NN	_	25	dobj	_	_
31	than	than	IN	IN	_	34	case	_	_
32	the	the	DT	DT	_	34	det	_	_
33	CLL	cll	NN	NN	_	34	compound	_	_
34	cells	cell	NNS	NNS	_	30	nmod	_	_
35	from	from	IN	IN	_	38	case	_	_
36	the	the	DT	DT	_	38	det	_	_
37	same	same	JJ	JJ	_	38	amod	_	_
38	patient	patient	NN	NN	_	34	nmod	_	_
39	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	pattern	pattern	NN	NN	_	9	nsubj	_	_
3	of	of	IN	IN	_	4	case	_	_
4	c-myb	c-myb	NN	NN	_	2	nmod	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	B-myb	b-myb	NN	NN	_	4	conj	_	_
7	was	be	VBD	VBD	_	9	cop	_	_
8	clearly	clearly	RB	RB	_	9	advmod	_	_
9	distinct	distinct	JJ	JJ	_	0	root	_	_
10	from	from	IN	IN	_	11	case	_	_
11	that	that	DT	DT	_	9	nmod	_	_
12	of	of	IN	IN	_	13	case	_	_
13	A-myb	a-myb	NN	NN	_	11	nmod	_	_
14	.	.	.	.	_	9	punct	_	_

1	C-myb	c-myb	NN	NN	_	5	nsubjpass	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	B-myb	b-myb	NN	NN	_	1	conj	_	_
4	were	be	VBD	VBD	_	5	auxpass	_	_
5	expressed	express	VBN	VBN	_	0	root	_	_
6	in	in	IN	IN	_	9	case	_	_
7	all	all	DT	DT	_	9	det	_	_
8	neoplastic	neoplastic	JJ	JJ	_	9	amod	_	_
9	groups	group	NNS	NNS	_	5	nmod	_	_
10	,	,	,	,	_	5	punct	_	_
11	except	except	IN	IN	_	14	case	_	_
12	in	in	IN	IN	_	14	case	_	_
13	CLL	cll	NN	NN	_	14	compound	_	_
14	cells	cell	NNS	NNS	_	5	nmod	_	_
15	.	.	.	.	_	5	punct	_	_

1	Thus	thus	RB	RB	_	14	advmod	_	_
2	,	,	,	,	_	14	punct	_	_
3	A-myb	a-myb	NN	NN	_	4	compound	_	_
4	expression	expression	NN	NN	_	14	nsubj	_	_
5	,	,	,	,	_	4	punct	_	_
6	unlike	unlike	IN	IN	_	7	case	_	_
7	that	that	DT	DT	_	14	nmod	_	_
8	of	of	IN	IN	_	9	case	_	_
9	c-myb	c-myb	NN	NN	_	7	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	B-myb	b-myb	NN	NN	_	9	conj	_	_
12	,	,	,	,	_	14	punct	_	_
13	is	be	VBZ	VBZ	_	14	cop	_	_
14	restricted	restricted	JJ	JJ	_	0	root	_	_
15	to	to	TO	TO	_	28	case	_	_
16	a	a	DT	DT	_	17	det	_	_
17	subset	subset	NN	NN	_	28	compound	_	_
18	of	of	IN	IN	_	20	case	_	_
19	B-cell	b-cell	NN	NN	_	20	compound	_	_
20	neoplasias	neoplasias	NN	NN	_	17	nmod	_	_
21	(	(	-LRB-	-LRB-	_	24	punct	_	_
22	in	in	IN	IN	_	23	case	_	_
23	particular	particular	JJ	JJ	_	24	nmod	_	_
24	BL	bl	NN	NN	_	17	dep	_	_
25	and	and	CC	CC	_	24	cc	_	_
26	slg+B-ALL	slg+b-all	NN	NN	_	24	conj	_	_
27	)	)	-RRB-	-RRB-	_	24	punct	_	_
28	representative	representative	NN	NN	_	14	nmod	_	_
29	of	of	IN	IN	_	32	case	_	_
30	a	a	DT	DT	_	32	det	_	_
31	specific	specific	JJ	JJ	_	32	amod	_	_
32	stage	stage	NN	NN	_	28	nmod	_	_
33	of	of	IN	IN	_	35	case	_	_
34	B-cell	b-cell	NN	NN	_	35	compound	_	_
35	differentiation	differentiation	NN	NN	_	32	nmod	_	_
36	.	.	.	.	_	14	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	expression	expression	NN	NN	_	6	nsubj	_	_
3	may	may	NN	NN	_	6	dep	_	_
4	in	in	IN	IN	_	5	case	_	_
5	part	part	NN	NN	_	6	nmod	_	_
6	reflect	reflect	VBP	VBP	_	0	root	_	_
7	expression	expression	NN	NN	_	6	dobj	_	_
8	of	of	IN	IN	_	9	case	_	_
9	A-myb	a-myb	NN	NN	_	7	nmod	_	_
10	by	by	IN	IN	_	14	case	_	_
11	the	the	DT	DT	_	14	det	_	_
12	normal	normal	JJ	JJ	_	14	amod	_	_
13	germinal	germinal	JJ	JJ	_	14	amod	_	_
14	center	center	NN	NN	_	7	nmod	_	_
15	B	b	NN	NN	_	16	compound	_	_
16	cells	cell	NNS	NNS	_	14	dep	_	_
17	that	that	WDT	WDT	_	21	nsubj	_	_
18	are	be	VBP	VBP	_	21	cop	_	_
19	the	the	DT	DT	_	21	det	_	_
20	normal	normal	JJ	JJ	_	21	amod	_	_
21	counterpart	counterpart	NN	NN	_	14	acl:relcl	_	_
22	of	of	IN	IN	_	26	case	_	_
23	these	these	DT	DT	_	26	det	_	_
24	transformed	transform	VBN	VBN	_	26	amod	_	_
25	B	b	NN	NN	_	26	compound	_	_
26	cells	cell	NNS	NNS	_	21	nmod	_	_
27	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	5	nsubj	_	_
3	presented	present	VBN	VBN	_	2	acl	_	_
4	strongly	strongly	RB	RB	_	5	advmod	_	_
5	support	support	VBP	VBP	_	0	root	_	_
6	a	a	DT	DT	_	7	det	_	_
7	role	role	NN	NN	_	5	dobj	_	_
8	for	for	IN	IN	_	11	case	_	_
9	this	this	DT	DT	_	11	det	_	_
10	transcription	transcription	NN	NN	_	11	compound	_	_
11	factor	factor	NN	NN	_	7	nmod	_	_
12	in	in	IN	IN	_	14	case	_	_
13	B-cell	b-cell	NN	NN	_	14	compound	_	_
14	differentiation	differentiation	NN	NN	_	7	nmod	_	_
15	and	and	CC	CC	_	14	cc	_	_
16	perhaps	perhaps	RB	RB	_	19	advmod	_	_
17	in	in	IN	IN	_	19	case	_	_
18	B-cell	b-cell	NN	NN	_	19	compound	_	_
19	transformation	transformation	NN	NN	_	14	conj	_	_
20	in	in	IN	IN	_	22	case	_	_
21	some	some	DT	DT	_	22	det	_	_
22	neoplasias	neoplasia	NNS	NNS	_	19	nmod	_	_
23	.	.	.	.	_	5	punct	_	_

1	Lymphoid	lymphoid	JJ	JJ	_	3	amod	_	_
2	cell	cell	NN	NN	_	3	compound	_	_
3	resistance	resistance	NN	NN	_	0	root	_	_
4	to	to	TO	TO	_	5	case	_	_
5	glucocorticoids	glucocorticoid	NNS	NNS	_	3	nmod	_	_
6	in	in	IN	IN	_	8	case	_	_
7	HIV	hiv	NN	NN	_	8	compound	_	_
8	infection	infection	NN	NN	_	3	nmod	_	_
9	.	.	.	.	_	3	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	humans	human	NNS	NNS	_	13	nmod	_	_
3	infected	infect	VBN	VBN	_	2	acl	_	_
4	with	with	IN	IN	_	7	case	_	_
5	the	the	DT	DT	_	7	det	_	_
6	HIV-1	hiv-1	NN	NN	_	7	compound	_	_
7	virus	virus	NN	NN	_	3	nmod	_	_
8	there	there	EX	EX	_	13	expl	_	_
9	may	may	MD	MD	_	13	aux	_	_
10	be	be	VB	VB	_	13	cop	_	_
11	a	a	DT	DT	_	13	det	_	_
12	disproportionate	disproportionate	JJ	JJ	_	13	amod	_	_
13	severity	severity	NN	NN	_	0	root	_	_
14	of	of	IN	IN	_	15	case	_	_
15	signs	sign	NNS	NNS	_	13	nmod	_	_
16	and	and	CC	CC	_	15	cc	_	_
17	symptoms	symptom	NNS	NNS	_	15	conj	_	_
18	of	of	IN	IN	_	19	case	_	_
19	illness	illness	NN	NN	_	15	nmod	_	_
20	compared	compare	VBN	VBN	_	23	case	_	_
21	to	to	TO	TO	_	23	case	_	_
22	the	the	DT	DT	_	23	det	_	_
23	fraction	fraction	NN	NN	_	13	advcl	_	_
24	of	of	IN	IN	_	28	case	_	_
25	CD4+	cd4+	JJ	JJ	_	28	amod	_	_
26	infected	infected	JJ	JJ	_	28	amod	_	_
27	T-lymphoid	t-lymphoid	NN	NN	_	28	compound	_	_
28	cells	cell	NNS	NNS	_	23	nmod	_	_
29	.	.	.	.	_	13	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	part	part	NN	NN	_	7	nmod	_	_
3	,	,	,	,	_	7	punct	_	_
4	this	this	DT	DT	_	7	nsubj	_	_
5	may	may	MD	MD	_	7	aux	_	_
6	be	be	VB	VB	_	7	cop	_	_
7	due	due	JJ	JJ	_	0	root	_	_
8	to	to	TO	TO	_	12	case	_	_
9	altered	altered	JJ	JJ	_	12	amod	_	_
10	intercellular	intercellular	JJ	JJ	_	12	amod	_	_
11	signalling	signalling	NN	NN	_	12	compound	_	_
12	systems	system	NNS	NNS	_	7	nmod	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	intracellular	intracellular	JJ	JJ	_	16	amod	_	_
15	signal	signal	NN	NN	_	16	compound	_	_
16	transduction	transduction	NN	NN	_	12	conj	_	_
17	.	.	.	.	_	7	punct	_	_

1	Glucocorticoids	glucocorticoid	NNS	NNS	_	4	nsubj	_	_
2	are	be	VBP	VBP	_	4	cop	_	_
3	well	well	RB	RB	_	4	advmod	_	_
4	known	known	JJ	JJ	_	0	root	_	_
5	for	for	IN	IN	_	7	case	_	_
6	their	they	PRP$	PRP$	_	7	nmod:poss	_	_
7	effects	effect	NNS	NNS	_	4	nmod	_	_
8	on	on	IN	IN	_	10	case	_	_
9	the	the	DT	DT	_	10	dep	_	_
10	vitality	vitality	NN	NN	_	7	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	function	function	NN	NN	_	10	conj	_	_
13	of	of	IN	IN	_	15	case	_	_
14	lymphoid	lymphoid	JJ	JJ	_	15	amod	_	_
15	cells	cell	NNS	NNS	_	10	nmod	_	_
16	.	.	.	.	_	4	punct	_	_

1	Patients	patient	NNS	NNS	_	6	nsubj	_	_
2	with	with	IN	IN	_	4	case	_	_
3	HIV	hiv	NN	NN	_	4	compound	_	_
4	infections	infection	NNS	NNS	_	1	nmod	_	_
5	often	often	RB	RB	_	6	advmod	_	_
6	show	show	VBP	VBP	_	0	root	_	_
7	elevated	elevated	JJ	JJ	_	8	amod	_	_
8	circulating	circulating	JJ	JJ	_	9	amod	_	_
9	levels	level	NNS	NNS	_	6	dobj	_	_
10	of	of	IN	IN	_	11	case	_	_
11	cortisol	cortisol	NN	NN	_	9	nmod	_	_
12	,	,	,	,	_	6	punct	_	_
13	suggesting	suggest	VBG	VBG	_	6	advcl	_	_
14	some	some	DT	DT	_	15	det	_	_
15	misfunction	misfunction	NN	NN	_	13	dobj	_	_
16	in	in	IN	IN	_	19	case	_	_
17	the	the	DT	DT	_	19	det	_	_
18	regulatory	regulatory	JJ	JJ	_	19	amod	_	_
19	systems	system	NNS	NNS	_	15	nmod	_	_
20	that	that	WDT	WDT	_	21	nsubj	_	_
21	maintain	maintain	VBP	VBP	_	19	acl:relcl	_	_
22	the	the	DT	DT	_	23	det	_	_
23	levels	level	NNS	NNS	_	21	dobj	_	_
24	of	of	IN	IN	_	27	case	_	_
25	this	this	DT	DT	_	27	det	_	_
26	critical	critical	JJ	JJ	_	27	amod	_	_
27	hormone	hormone	NN	NN	_	23	nmod	_	_
28	.	.	.	.	_	6	punct	_	_

1	At	at	IN	IN	_	4	case	_	_
2	the	the	DT	DT	_	4	det	_	_
3	cellular	cellular	JJ	JJ	_	4	amod	_	_
4	level	level	NN	NN	_	8	nmod	_	_
5	,	,	,	,	_	8	punct	_	_
6	it	it	PRP	PRP	_	8	nsubjpass	_	_
7	is	be	VBZ	VBZ	_	8	auxpass	_	_
8	known	know	VBN	VBN	_	0	root	_	_
9	that	that	IN	IN	_	17	mark	_	_
10	both	both	CC	CC	_	13	cc:preconj	_	_
11	acute	acute	JJ	JJ	_	13	amod	_	_
12	HIV	hiv	NN	NN	_	13	compound	_	_
13	infection	infection	NN	NN	_	17	nsubj	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	glucocorticoids	glucocorticoid	NNS	NNS	_	13	conj	_	_
16	can	can	MD	MD	_	17	aux	_	_
17	cause	cause	VB	VB	_	8	ccomp	_	_
18	apoptotic	apoptotic	JJ	JJ	_	20	amod	_	_
19	cell	cell	NN	NN	_	20	compound	_	_
20	death	death	NN	NN	_	17	dobj	_	_
21	in	in	IN	IN	_	23	case	_	_
22	thymic	thymic	JJ	JJ	_	23	amod	_	_
23	lymphocytes	lymphocyte	NNS	NNS	_	20	nmod	_	_
24	.	.	.	.	_	8	punct	_	_

1	However	however	RB	RB	_	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	chronically	chronically	RB	RB	_	5	advmod	_	_
4	HIV-infected	hiv-infected	JJ	JJ	_	5	amod	_	_
5	cells	cell	NNS	NNS	_	6	nsubj	_	_
6	appear	appear	VBP	VBP	_	0	root	_	_
7	to	to	TO	TO	_	9	mark	_	_
8	be	be	VB	VB	_	9	cop	_	_
9	resistant	resistant	JJ	JJ	_	6	xcomp	_	_
10	to	to	TO	TO	_	13	case	_	_
11	glucocorticoid-evoked	glucocorticoid-evoked	JJ	JJ	_	13	amod	_	_
12	cell	cell	NN	NN	_	13	compound	_	_
13	death	death	NN	NN	_	9	nmod	_	_
14	.	.	.	.	_	6	punct	_	_

1	Glucocorticoid	glucocorticoid	NN	NN	_	4	compound	_	_
2	receptor-ligand	receptor-ligand	NN	NN	_	4	compound	_	_
3	binding	binding	NN	NN	_	4	compound	_	_
4	studies	study	NNS	NNS	_	10	nsubj	_	_
5	on	on	IN	IN	_	8	case	_	_
6	patients	patient	NNS	NNS	_	8	nmod:poss	_	_
7	'	'	POS	POS	_	8	case	_	_
8	cells	cell	NNS	NNS	_	4	nmod	_	_
9	have	have	VBP	VBP	_	10	aux	_	_
10	shown	show	VBN	VBN	_	0	root	_	_
11	reduced	reduce	VBN	VBN	_	12	amod	_	_
12	affinity	affinity	NN	NN	_	10	dobj	_	_
13	between	between	IN	IN	_	17	case	_	_
14	the	the	DT	DT	_	17	dep	_	_
15	receptor	receptor	NN	NN	_	17	compound	_	_
16	binding	binding	NN	NN	_	17	compound	_	_
17	sites	site	NNS	NNS	_	12	nmod	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	test	test	NN	NN	_	20	compound	_	_
20	steroids	steroid	NNS	NNS	_	17	conj	_	_
21	.	.	.	.	_	10	punct	_	_

1	In	in	FW	FW	_	2	compound	_	_
2	vitro	vitro	FW	FW	_	12	advmod	_	_
3	,	,	,	,	_	12	punct	_	_
4	chronically	chronically	RB	RB	_	6	advmod	_	_
5	HIV-infected	hiv-infected	JJ	JJ	_	6	amod	_	_
6	cells	cell	NNS	NNS	_	12	nsubj	_	_
7	of	of	IN	IN	_	11	case	_	_
8	the	the	DT	DT	_	11	det	_	_
9	lymphoid	lymphoid	JJ	JJ	_	11	amod	_	_
10	CEM	cem	NN	NN	_	11	compound	_	_
11	line	line	NN	NN	_	6	nmod	_	_
12	displayed	display	VBD	VBD	_	0	root	_	_
13	resistance	resistance	NN	NN	_	12	dobj	_	_
14	to	to	TO	TO	_	16	case	_	_
15	glucocorticoid-induced	glucocorticoid-induced	JJ	JJ	_	16	amod	_	_
16	apoptosis	apoptosis	NN	NN	_	13	nmod	_	_
17	.	.	.	.	_	12	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	cells	cell	NNS	NNS	_	3	nsubj	_	_
3	showed	show	VBD	VBD	_	0	root	_	_
4	reduced	reduce	VBN	VBN	_	5	amod	_	_
5	numbers	number	NNS	NNS	_	3	dobj	_	_
6	of	of	IN	IN	_	8	case	_	_
7	binding	bind	VBG	VBG	_	8	amod	_	_
8	sites	site	NNS	NNS	_	5	nmod	_	_
9	with	with	IN	IN	_	11	case	_	_
10	little	little	JJ	JJ	_	11	amod	_	_
11	alteration	alteration	NN	NN	_	3	nmod	_	_
12	in	in	IN	IN	_	14	case	_	_
13	apparent	apparent	JJ	JJ	_	14	amod	_	_
14	affinity	affinity	NN	NN	_	11	nmod	_	_
15	between	between	IN	IN	_	16	case	_	_
16	ligand	ligand	NN	NN	_	14	nmod	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	receptor	receptor	NN	NN	_	16	conj	_	_
19	.	.	.	.	_	3	punct	_	_

1	Thus	thus	RB	RB	_	3	advmod	_	_
2	it	it	PRP	PRP	_	3	nsubj	_	_
3	appears	appear	VBZ	VBZ	_	0	root	_	_
4	that	that	IN	IN	_	9	mark	_	_
5	there	there	EX	EX	_	9	expl	_	_
6	may	may	MD	MD	_	9	aux	_	_
7	often	often	RB	RB	_	9	advmod	_	_
8	be	be	VB	VB	_	9	cop	_	_
9	malfunction	malfunction	NN	NN	_	3	ccomp	_	_
10	of	of	IN	IN	_	14	case	_	_
11	the	the	DT	DT	_	14	det	_	_
12	normal	normal	JJ	JJ	_	14	amod	_	_
13	glucocorticoid	glucocorticoid	NN	NN	_	14	compound	_	_
14	response	response	NN	NN	_	9	nmod	_	_
15	in	in	IN	IN	_	17	case	_	_
16	HIV-infected	hiv-infected	JJ	JJ	_	17	amod	_	_
17	cells	cell	NNS	NNS	_	9	nmod	_	_
18	probably	probably	RB	RB	_	9	advmod	_	_
19	due	due	JJ	JJ	_	9	amod	_	_
20	to	to	TO	TO	_	22	case	_	_
21	altered	altered	JJ	JJ	_	22	amod	_	_
22	interactions	interaction	NNS	NNS	_	19	nmod	_	_
23	between	between	IN	IN	_	26	case	_	_
24	the	the	DT	DT	_	26	det	_	_
25	glucocorticoid	glucocorticoid	NN	NN	_	26	compound	_	_
26	receptor	receptor	NN	NN	_	22	nmod	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	its	its	PRP$	PRP$	_	29	nmod:poss	_	_
29	hormone	hormone	NN	NN	_	26	conj	_	_
30	.	.	.	.	_	3	punct	_	_

1	Such	such	JJ	JJ	_	2	amod	_	_
2	alterations	alteration	NNS	NNS	_	4	nsubj	_	_
3	may	may	MD	MD	_	4	aux	_	_
4	have	have	VB	VB	_	0	root	_	_
5	clinical	clinical	JJ	JJ	_	6	amod	_	_
6	consequences	consequence	NNS	NNS	_	4	dobj	_	_
7	,	,	,	,	_	6	punct	_	_
8	including	include	VBG	VBG	_	10	case	_	_
9	the	the	DT	DT	_	10	det	_	_
10	possibility	possibility	NN	NN	_	6	nmod	_	_
11	of	of	IN	IN	_	16	case	_	_
12	a	a	DT	DT	_	16	det	_	_
13	relatively	relatively	RB	RB	_	14	advmod	_	_
14	longer	longer	JJR	JJR	_	16	amod	_	_
15	life	life	NN	NN	_	16	compound	_	_
16	span	span	NN	NN	_	10	nmod	_	_
17	of	of	IN	IN	_	20	case	_	_
18	infected	infected	JJ	JJ	_	20	amod	_	_
19	CD4+	cd4+	JJ	JJ	_	20	amod	_	_
20	T-lymphocytes	t-lymphocyte	NNS	NNS	_	16	nmod	_	_
21	,	,	,	,	_	10	punct	_	_
22	as	as	RB	RB	_	10	cc	_	_
23	well	well	RB	RB	_	22	mwe	_	_
24	as	as	IN	IN	_	22	mwe	_	_
25	systemic	systemic	JJ	JJ	_	26	amod	_	_
26	effects	effect	NNS	NNS	_	10	conj	_	_
27	of	of	IN	IN	_	31	case	_	_
28	chronically	chronically	RB	RB	_	29	advmod	_	_
29	elevated	elevated	JJ	JJ	_	31	amod	_	_
30	cortisol	cortisol	NN	NN	_	31	compound	_	_
31	level	level	NN	NN	_	26	nmod	_	_
32	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	6	det	_	_
2	Epstein-Barr	epstein-barr	JJ	JJ	_	6	amod	_	_
3	virus-encoded	virus-encoded	JJ	JJ	_	6	amod	_	_
4	nuclear	nuclear	JJ	JJ	_	6	amod	_	_
5	antigen	antigen	NN	NN	_	6	compound	_	_
6	EBNA-5	ebna-5	NN	NN	_	7	nsubj	_	_
7	accumulates	accumulate	VBZ	VBZ	_	0	root	_	_
8	in	in	IN	IN	_	10	case	_	_
9	PML-containing	pml-containing	JJ	JJ	_	10	amod	_	_
10	bodies	body	NNS	NNS	_	7	nmod	_	_
11	.	.	.	.	_	7	punct	_	_

1	EBNA-5	ebna-5	NN	NN	_	3	nsubj	_	_
2	is	be	VBZ	VBZ	_	3	cop	_	_
3	one	one	CD	CD	_	0	root	_	_
4	of	of	IN	IN	_	13	case	_	_
5	the	the	DT	DT	_	13	det	_	_
6	Epstein-Barr	epstein-barr	JJ	JJ	_	13	amod	_	_
7	virus	virus	NN	NN	_	13	compound	_	_
8	(	(	-LRB-	-LRB-	_	13	punct	_	_
9	EBV	ebv	NN	NN	_	13	compound	_	_
10	)	)	-RRB-	-RRB-	_	13	punct	_	_
11	-encoded	-encoded	JJ	JJ	_	13	amod	_	_
12	nuclear	nuclear	JJ	JJ	_	13	amod	_	_
13	proteins	protein	NNS	NNS	_	3	nmod	_	_
14	required	require	VBN	VBN	_	13	acl	_	_
15	for	for	IN	IN	_	16	case	_	_
16	immortalization	immortalization	NN	NN	_	14	nmod	_	_
17	of	of	IN	IN	_	20	case	_	_
18	human	human	JJ	JJ	_	20	amod	_	_
19	B	b	NN	NN	_	20	compound	_	_
20	lymphocytes	lymphocyte	NNS	NNS	_	16	nmod	_	_
21	.	.	.	.	_	3	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	the	the	DT	DT	_	3	det	_	_
3	nuclei	nucleus	NNS	NNS	_	12	nmod	_	_
4	of	of	IN	IN	_	8	case	_	_
5	EBV-transformed	ebv-transformed	JJ	JJ	_	8	amod	_	_
6	lymphoblastoid	lymphoblastoid	JJ	JJ	_	8	amod	_	_
7	cell	cell	NN	NN	_	8	compound	_	_
8	lines	line	NNS	NNS	_	3	nmod	_	_
9	EBNA-5	ebna-5	NN	NN	_	12	nsubjpass	_	_
10	is	be	VBZ	VBZ	_	12	auxpass	_	_
11	preferentially	preferentially	RB	RB	_	12	advmod	_	_
12	targetted	targett	VBN	VBN	_	0	root	_	_
13	to	to	TO	TO	_	16	case	_	_
14	distinct	distinct	JJ	JJ	_	16	amod	_	_
15	nuclear	nuclear	JJ	JJ	_	16	amod	_	_
16	foci	focus	NNS	NNS	_	12	nmod	_	_
17	.	.	.	.	_	12	punct	_	_

1	Previously	previously	RB	RB	_	4	advmod	_	_
2	we	we	PRP	PRP	_	4	nsubj	_	_
3	have	have	VBP	VBP	_	4	aux	_	_
4	shown	show	VBN	VBN	_	0	root	_	_
5	(	(	-LRB-	-LRB-	_	7	punct	_	_
6	W.Q.	W.Q.	NNP	NNP	_	7	compound	_	_
7	Jiang	Jiang	NNP	NNP	_	4	dep	_	_
8	,	,	,	,	_	7	punct	_	_
9	L.Szekely	L.Szekely	NNP	NNP	_	7	conj	_	_
10	,	,	,	,	_	7	punct	_	_
11	V.Wendel-Hansen	V.Wendel-Hansen	NNP	NNP	_	7	conj	_	_
12	,	,	,	,	_	7	punct	_	_
13	N.Ringertz	N.Ringertz	NNP	NNP	_	7	conj	_	_
14	,	,	,	,	_	7	punct	_	_
15	G.Klein	G.Klein	NNP	NNP	_	7	conj	_	_
16	,	,	,	,	_	7	punct	_	_
17	and	and	CC	CC	_	7	cc	_	_
18	A.	A.	NNP	NNP	_	19	compound	_	_
19	Rosen	Rosen	NNP	NNP	_	7	conj	_	_
20	,	,	,	,	_	7	punct	_	_
21	Exp.Cell	Exp.Cell	NNP	NNP	_	22	compound	_	_
22	Res	Res	NNP	NNP	_	7	appos	_	_
23	.	.	.	.	_	4	punct	_	_

1	Heat	heat	NN	NN	_	2	compound	_	_
2	shock	shock	NN	NN	_	3	nsubj	_	_
3	induces	induce	VBZ	VBZ	_	0	root	_	_
4	HIV-1	hiv-1	NN	NN	_	5	compound	_	_
5	replication	replication	NN	NN	_	3	dobj	_	_
6	in	in	IN	IN	_	12	case	_	_
7	chronically	chronically	RB	RB	_	8	advmod	_	_
8	infected	infected	JJ	JJ	_	12	amod	_	_
9	promyelocyte	promyelocyte	JJ	JJ	_	12	amod	_	_
10	cell	cell	NN	NN	_	12	compound	_	_
11	line	line	NN	NN	_	12	compound	_	_
12	OM10.1	om10.1	NN	NN	_	5	nmod	_	_
13	.	.	.	.	_	3	punct	_	_

1	A	a	DT	DT	_	3	det	_	_
2	long	long	JJ	JJ	_	3	amod	_	_
3	period	period	NN	NN	_	12	nsubj	_	_
4	of	of	IN	IN	_	6	case	_	_
5	clinical	clinical	JJ	JJ	_	6	amod	_	_
6	latency	latency	NN	NN	_	3	nmod	_	_
7	before	before	IN	IN	_	8	case	_	_
8	development	development	NN	NN	_	6	nmod	_	_
9	of	of	IN	IN	_	10	case	_	_
10	symptoms	symptom	NNS	NNS	_	8	nmod	_	_
11	is	be	VBZ	VBZ	_	12	cop	_	_
12	characteristic	characteristic	JJ	JJ	_	0	root	_	_
13	of	of	IN	IN	_	22	case	_	_
14	human	human	JJ	JJ	_	17	amod	_	_
15	immunodeficiency	immunodeficiency	NN	NN	_	17	compound	_	_
16	virus	virus	NN	NN	_	17	compound	_	_
17	type	type	NN	NN	_	22	compound	_	_
18	1	1	CD	CD	_	17	nummod	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	HIV-1	hiv-1	NN	NN	_	17	appos	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	infection	infection	NN	NN	_	12	nmod	_	_
23	.	.	.	.	_	12	punct	_	_

1	OM10.1	om10.1	NN	NN	_	14	nsubjpass	_	_
2	,	,	,	,	_	1	punct	_	_
3	a	a	DT	DT	_	6	det	_	_
4	promyelocyte	promyelocyte	JJ	JJ	_	6	amod	_	_
5	cell	cell	NN	NN	_	6	compound	_	_
6	line	line	NN	NN	_	1	appos	_	_
7	latently	latently	RB	RB	_	8	advmod	_	_
8	infected	infect	VBN	VBN	_	6	acl	_	_
9	with	with	IN	IN	_	10	case	_	_
10	HIV-1	hiv-1	NN	NN	_	8	nmod	_	_
11	,	,	,	,	_	1	punct	_	_
12	has	have	VBZ	VBZ	_	14	aux	_	_
13	been	be	VBN	VBN	_	14	auxpass	_	_
14	developed	develop	VBN	VBN	_	0	root	_	_
15	as	as	IN	IN	_	17	case	_	_
16	a	a	DT	DT	_	17	det	_	_
17	model	model	NN	NN	_	14	nmod	_	_
18	for	for	IN	IN	_	19	mark	_	_
19	studying	study	VBG	VBG	_	17	acl	_	_
20	the	the	DT	DT	_	21	det	_	_
21	mechanism	mechanism	NN	NN	_	19	dobj	_	_
22	of	of	IN	IN	_	24	case	_	_
23	viral	viral	JJ	JJ	_	24	amod	_	_
24	latency	latency	NN	NN	_	21	nmod	_	_
25	and	and	CC	CC	_	21	cc	_	_
26	the	the	DT	DT	_	27	det	_	_
27	activation	activation	NN	NN	_	21	conj	_	_
28	of	of	IN	IN	_	30	case	_	_
29	virus	virus	NN	NN	_	30	compound	_	_
30	expression	expression	NN	NN	_	27	nmod	_	_
31	.	.	.	.	_	14	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	found	find	VBD	VBD	_	0	root	_	_
3	that	that	IN	IN	_	19	mark	_	_
4	this	this	DT	DT	_	8	det	_	_
5	latently	latently	RB	RB	_	6	advmod	_	_
6	infected	infected	JJ	JJ	_	8	amod	_	_
7	cell	cell	NN	NN	_	8	compound	_	_
8	line	line	NN	NN	_	19	nsubj	_	_
9	with	with	IN	IN	_	11	case	_	_
10	heat	heat	NN	NN	_	11	compound	_	_
11	shock	shock	NN	NN	_	8	nmod	_	_
12	at	at	IN	IN	_	15	case	_	_
13	42	42	CD	CD	_	15	nummod	_	_
14	degrees	degree	NNS	NNS	_	15	compound	_	_
15	C	c	NN	NN	_	11	nmod	_	_
16	for	for	IN	IN	_	18	case	_	_
17	2	2	CD	CD	_	18	nummod	_	_
18	h	h	NN	NN	_	11	nmod	_	_
19	resulted	result	VBD	VBD	_	2	ccomp	_	_
20	in	in	IN	IN	_	23	case	_	_
21	a	a	DT	DT	_	23	det	_	_
22	high	high	JJ	JJ	_	23	amod	_	_
23	level	level	NN	NN	_	19	nmod	_	_
24	of	of	IN	IN	_	26	case	_	_
25	HIV-1	hiv-1	NN	NN	_	26	compound	_	_
26	production	production	NN	NN	_	23	nmod	_	_
27	without	without	IN	IN	_	28	case	_	_
28	addition	addition	NN	NN	_	23	nmod	_	_
29	of	of	IN	IN	_	31	case	_	_
30	any	any	DT	DT	_	31	det	_	_
31	cytokines	cytokine	NNS	NNS	_	28	nmod	_	_
32	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	mechanism	mechanism	NN	NN	_	6	nsubjpass	_	_
3	of	of	IN	IN	_	4	case	_	_
4	activation	activation	NN	NN	_	2	nmod	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	analyzed	analyze	VBN	VBN	_	0	root	_	_
7	by	by	IN	IN	_	8	mark	_	_
8	using	use	VBG	VBG	_	6	advcl	_	_
9	anti-TNF-alpha	anti-tnf-alpha	JJ	JJ	_	10	amod	_	_
10	antibody	antibody	NN	NN	_	8	dobj	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	various	various	JJ	JJ	_	13	amod	_	_
13	inhibitors	inhibitor	NNS	NNS	_	10	conj	_	_
14	.	.	.	.	_	6	punct	_	_

1	Although	although	IN	IN	_	11	mark	_	_
2	the	the	DT	DT	_	4	det	_	_
3	TNF-alpha	tnf-alpha	NN	NN	_	4	compound	_	_
4	level	level	NN	NN	_	11	nsubj	_	_
5	in	in	IN	IN	_	7	case	_	_
6	culture	culture	NN	NN	_	7	compound	_	_
7	supernatants	supernatant	NNS	NNS	_	4	nmod	_	_
8	was	be	VBD	VBD	_	11	cop	_	_
9	below	below	IN	IN	_	11	case	_	_
10	the	the	DT	DT	_	11	det	_	_
11	sensitivity	sensitivity	NN	NN	_	27	advcl	_	_
12	of	of	IN	IN	_	16	case	_	_
13	an	a	DT	DT	_	16	det	_	_
14	ELISA	elisa	NN	NN	_	16	compound	_	_
15	assay	assay	NN	NN	_	16	compound	_	_
16	system	system	NN	NN	_	11	nmod	_	_
17	,	,	,	,	_	27	punct	_	_
18	addition	addition	NN	NN	_	27	nsubj	_	_
19	of	of	IN	IN	_	21	case	_	_
20	anti-TNF-alpha	anti-tnf-alpha	JJ	JJ	_	21	amod	_	_
21	antibody	antibody	NN	NN	_	18	nmod	_	_
22	in	in	IN	IN	_	24	case	_	_
23	culture	culture	NN	NN	_	24	compound	_	_
24	medium	medium	NN	NN	_	21	nmod	_	_
25	could	could	MD	MD	_	27	aux	_	_
26	partially	partially	RB	RB	_	27	advmod	_	_
27	suppress	suppress	VB	VB	_	0	root	_	_
28	the	the	DT	DT	_	33	det	_	_
29	heat	heat	NN	NN	_	33	compound	_	_
30	shock	shock	NN	NN	_	33	compound	_	_
31	induced	induced	JJ	JJ	_	33	amod	_	_
32	HIV-1	hiv-1	NN	NN	_	33	compound	_	_
33	production	production	NN	NN	_	27	dobj	_	_
34	.	.	.	.	_	27	punct	_	_

1	Staurosporine	staurosporine	NN	NN	_	22	nsubj	_	_
2	(	(	-LRB-	-LRB-	_	4	punct	_	_
3	PKC	pkc	NN	NN	_	4	compound	_	_
4	inhibitor	inhibitor	NN	NN	_	1	appos	_	_
5	)	)	-RRB-	-RRB-	_	4	punct	_	_
6	,	,	,	,	_	1	punct	_	_
7	pentoxifylline	pentoxifylline	NN	NN	_	1	conj	_	_
8	(	(	-LRB-	-LRB-	_	11	punct	_	_
9	NF-kappa	nf-kappa	NN	NN	_	11	compound	_	_
10	B	b	NN	NN	_	11	compound	_	_
11	inhibitor	inhibitor	NN	NN	_	7	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	,	,	,	,	_	1	punct	_	_
14	and	and	CC	CC	_	1	cc	_	_
15	Ro5-3335	ro5-3335	NN	NN	_	1	conj	_	_
16	(	(	-LRB-	-LRB-	_	19	punct	_	_
17	HIV-1	hiv-1	NN	NN	_	19	compound	_	_
18	Tat	tat	NN	NN	_	19	compound	_	_
19	inhibitor	inhibitor	NN	NN	_	15	appos	_	_
20	)	)	-RRB-	-RRB-	_	19	punct	_	_
21	also	also	RB	RB	_	22	advmod	_	_
22	inhibited	inhibit	VBD	VBD	_	0	root	_	_
23	significantly	significantly	RB	RB	_	22	advmod	_	_
24	the	the	DT	DT	_	29	det	_	_
25	heat	heat	NN	NN	_	29	compound	_	_
26	shock	shock	NN	NN	_	29	compound	_	_
27	induced	induced	JJ	JJ	_	29	amod	_	_
28	virus	virus	NN	NN	_	29	compound	_	_
29	activation	activation	NN	NN	_	22	dobj	_	_
30	.	.	.	.	_	22	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	particular	particular	JJ	JJ	_	5	nmod	_	_
3	,	,	,	,	_	5	punct	_	_
4	staurosporine	staurosporine	NN	NN	_	5	nsubj	_	_
5	achieved	achieve	VBD	VBD	_	0	root	_	_
6	approximately	approximately	RB	RB	_	7	advmod	_	_
7	90	90	CD	CD	_	8	dep	_	_
8	%	%	NN	NN	_	9	dep	_	_
9	inhibition	inhibition	NN	NN	_	5	dobj	_	_
10	of	of	IN	IN	_	14	case	_	_
11	the	the	DT	DT	_	14	det	_	_
12	HIV-1	hiv-1	NN	NN	_	14	compound	_	_
13	antigen	antigen	NN	NN	_	14	compound	_	_
14	expression	expression	NN	NN	_	9	nmod	_	_
15	in	in	IN	IN	_	18	case	_	_
16	heat	heat	NN	NN	_	18	compound	_	_
17	shock-treated	shock-treated	JJ	JJ	_	18	amod	_	_
18	OM10.1	om10.1	NN	NN	_	14	nmod	_	_
19	at	at	IN	IN	_	22	case	_	_
20	a	a	DT	DT	_	22	det	_	_
21	non-toxic	non-toxic	JJ	JJ	_	22	amod	_	_
22	concentration	concentration	NN	NN	_	18	nmod	_	_
23	.	.	.	.	_	5	punct	_	_

1	Although	although	IN	IN	_	14	mark	_	_
2	the	the	DT	DT	_	3	det	_	_
3	mechanism	mechanism	NN	NN	_	14	nsubjpass	_	_
4	of	of	IN	IN	_	6	case	_	_
5	HIV-1	hiv-1	NN	NN	_	6	compound	_	_
6	activation	activation	NN	NN	_	3	nmod	_	_
7	with	with	IN	IN	_	9	case	_	_
8	heat	heat	NN	NN	_	9	compound	_	_
9	shock	shock	NN	NN	_	6	nmod	_	_
10	has	have	VBZ	VBZ	_	14	aux	_	_
11	not	not	RB	RB	_	14	neg	_	_
12	been	be	VBN	VBN	_	14	auxpass	_	_
13	fully	fully	RB	RB	_	14	advmod	_	_
14	elucidated	elucidate	VBN	VBN	_	19	advcl	_	_
15	yet	yet	RB	RB	_	14	advmod	_	_
16	,	,	,	,	_	19	punct	_	_
17	it	it	PRP	PRP	_	19	nsubjpass	_	_
18	is	be	VBZ	VBZ	_	19	auxpass	_	_
19	presumed	presume	VBN	VBN	_	0	root	_	_
20	PKC	pkc	NN	NN	_	19	dobj	_	_
21	plays	play	VBZ	VBZ	_	19	dep	_	_
22	an	a	DT	DT	_	24	det	_	_
23	important	important	JJ	JJ	_	24	amod	_	_
24	role	role	NN	NN	_	21	dobj	_	_
25	in	in	IN	IN	_	27	case	_	_
26	HIV-1	hiv-1	NN	NN	_	27	compound	_	_
27	activation	activation	NN	NN	_	21	nmod	_	_
28	.	.	.	.	_	19	punct	_	_

1	Thus	thus	RB	RB	_	7	advmod	_	_
2	,	,	,	,	_	7	punct	_	_
3	the	the	DT	DT	_	5	det	_	_
4	present	present	JJ	JJ	_	5	amod	_	_
5	observations	observation	NNS	NNS	_	7	nsubj	_	_
6	will	will	MD	MD	_	7	aux	_	_
7	provide	provide	VB	VB	_	0	root	_	_
8	a	a	DT	DT	_	10	det	_	_
9	further	further	JJ	JJ	_	10	amod	_	_
10	insight	insight	NN	NN	_	7	dobj	_	_
11	into	into	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	pathogenesis	pathogenesis	NN	NN	_	10	nmod	_	_
14	of	of	IN	IN	_	16	case	_	_
15	HIV-1	hiv-1	NN	NN	_	16	compound	_	_
16	infections	infection	NNS	NNS	_	13	nmod	_	_
17	.	.	.	.	_	7	punct	_	_

1	Expression	expression	NN	NN	_	8	nsubjpass	_	_
2	of	of	IN	IN	_	6	case	_	_
3	Retinoid	retinoid	NN	NN	_	6	compound	_	_
4	X	x	NN	NN	_	6	compound	_	_
5	Receptor	receptor	NN	NN	_	6	compound	_	_
6	alpha	alpha	NN	NN	_	1	nmod	_	_
7	is	be	VBZ	VBZ	_	8	auxpass	_	_
8	increased	increase	VBN	VBN	_	0	root	_	_
9	upon	upon	IN	IN	_	12	case	_	_
10	monocytic	monocytic	JJ	JJ	_	12	amod	_	_
11	cell	cell	NN	NN	_	12	compound	_	_
12	differentiation	differentiation	NN	NN	_	8	nmod	_	_
13	.	.	.	.	_	8	punct	_	_

1	1	1	CD	CD	_	3	nummod	_	_
2	alpha,25-Dihydroxyvitamin	alpha,25-dihydroxyvitamin	NN	NN	_	3	compound	_	_
3	D3	d3	NN	NN	_	10	nsubj	_	_
4	(	(	-LRB-	-LRB-	_	5	punct	_	_
5	VD	vd	NN	NN	_	3	appos	_	_
6	)	)	-RRB-	-RRB-	_	5	punct	_	_
7	is	be	VBZ	VBZ	_	10	cop	_	_
8	a	a	DT	DT	_	10	det	_	_
9	potent	potent	JJ	JJ	_	10	amod	_	_
10	inducer	inducer	NN	NN	_	0	root	_	_
11	of	of	IN	IN	_	13	case	_	_
12	monocytic	monocytic	JJ	JJ	_	13	amod	_	_
13	differentiation	differentiation	NN	NN	_	10	nmod	_	_
14	of	of	IN	IN	_	16	case	_	_
15	both	both	CC	CC	_	16	cc:preconj	_	_
16	normal	normal	JJ	JJ	_	13	nmod	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	leukemic	leukemic	JJ	JJ	_	16	conj	_	_
19	cells	cell	NNS	NNS	_	16	dep	_	_
20	.	.	.	.	_	10	punct	_	_

1	Its	its	PRP$	PRP$	_	2	nmod:poss	_	_
2	effects	effect	NNS	NNS	_	4	nsubjpass	_	_
3	are	be	VBP	VBP	_	4	auxpass	_	_
4	mediated	mediate	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	_	8	case	_	_
6	its	its	PRP$	PRP$	_	8	nmod:poss	_	_
7	nuclear	nuclear	JJ	JJ	_	8	amod	_	_
8	receptor	receptor	NN	NN	_	4	nmod	_	_
9	(	(	-LRB-	-LRB-	_	10	punct	_	_
10	VDR	vdr	NN	NN	_	8	appos	_	_
11	)	)	-RRB-	-RRB-	_	10	punct	_	_
12	.	.	.	.	_	4	punct	_	_

1	Efficient	efficient	JJ	JJ	_	3	amod	_	_
2	gene	gene	NN	NN	_	3	compound	_	_
3	activation	activation	NN	NN	_	4	nsubj	_	_
4	requires	require	VBZ	VBZ	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	heterodimerization	heterodimerization	NN	NN	_	4	dobj	_	_
7	of	of	IN	IN	_	8	case	_	_
8	VDR	vdr	NN	NN	_	6	nmod	_	_
9	with	with	IN	IN	_	12	case	_	_
10	Retinoid	retinoid	NN	NN	_	12	compound	_	_
11	X	x	NN	NN	_	12	compound	_	_
12	Receptors	receptor	NNS	NNS	_	6	nmod	_	_
13	(	(	-LRB-	-LRB-	_	14	punct	_	_
14	RXR	rxr	NN	NN	_	12	appos	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	.	.	.	.	_	4	punct	_	_

1	In	in	IN	IN	_	4	case	_	_
2	the	the	DT	DT	_	4	det	_	_
3	present	present	JJ	JJ	_	4	amod	_	_
4	study	study	NN	NN	_	10	nmod	_	_
5	using	use	VBG	VBG	_	4	acl	_	_
6	specific	specific	JJ	JJ	_	7	amod	_	_
7	antibodies	antibody	NNS	NNS	_	5	dobj	_	_
8	,	,	,	,	_	10	punct	_	_
9	we	we	PRP	PRP	_	10	nsubj	_	_
10	analyzed	analyze	VBD	VBD	_	0	root	_	_
11	the	the	DT	DT	_	12	det	_	_
12	expression	expression	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	17	case	_	_
14	the	the	DT	DT	_	17	det	_	_
15	RXR	rxr	NN	NN	_	17	compound	_	_
16	alpha	alpha	NN	NN	_	17	compound	_	_
17	protein	protein	NN	NN	_	12	nmod	_	_
18	in	in	IN	IN	_	21	case	_	_
19	blood	blood	NN	NN	_	21	compound	_	_
20	mononuclear	mononuclear	JJ	JJ	_	21	amod	_	_
21	cells	cell	NNS	NNS	_	12	nmod	_	_
22	from	from	IN	IN	_	25	case	_	_
23	acute	acute	JJ	JJ	_	25	amod	_	_
24	myeloid	myeloid	JJ	JJ	_	25	amod	_	_
25	patients	patient	NNS	NNS	_	21	nmod	_	_
26	(	(	-LRB-	-LRB-	_	27	punct	_	_
27	AML	aml	NN	NN	_	25	appos	_	_
28	)	)	-RRB-	-RRB-	_	27	punct	_	_
29	(	(	-LRB-	-LRB-	_	31	punct	_	_
30	10	10	CD	CD	_	31	nummod	_	_
31	cases	case	NNS	NNS	_	25	appos	_	_
32	)	)	-RRB-	-RRB-	_	31	punct	_	_
33	and	and	CC	CC	_	25	cc	_	_
34	from	from	IN	IN	_	37	case	_	_
35	myelomonocytic	myelomonocytic	JJ	JJ	_	37	amod	_	_
36	cell	cell	NN	NN	_	37	compound	_	_
37	lines	line	NNS	NNS	_	25	conj	_	_
38	arrested	arrest	VBN	VBN	_	37	acl	_	_
39	at	at	IN	IN	_	41	case	_	_
40	different	different	JJ	JJ	_	41	amod	_	_
41	stages	stage	NNS	NNS	_	38	nmod	_	_
42	of	of	IN	IN	_	43	case	_	_
43	differentiation	differentiation	NN	NN	_	41	nmod	_	_
44	.	.	.	.	_	10	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	observed	observe	VBD	VBD	_	0	root	_	_
3	that	that	IN	IN	_	8	mark	_	_
4	the	the	DT	DT	_	7	det	_	_
5	RXR	rxr	NN	NN	_	6	compound	_	_
6	alpha	alpha	NN	NN	_	7	compound	_	_
7	expression	expression	NN	NN	_	8	nsubj	_	_
8	increased	increase	VBD	VBD	_	2	ccomp	_	_
9	during	during	IN	IN	_	11	case	_	_
10	myelomonocytic	myelomonocytic	JJ	JJ	_	11	amod	_	_
11	differentiation	differentiation	NN	NN	_	8	nmod	_	_
12	,	,	,	,	_	2	punct	_	_
13	since	since	IN	IN	_	18	mark	_	_
14	the	the	DT	DT	_	16	det	_	_
15	highest	highest	JJS	JJS	_	16	amod	_	_
16	levels	level	NNS	NNS	_	18	nsubjpass	_	_
17	were	be	VBD	VBD	_	18	auxpass	_	_
18	found	find	VBN	VBN	_	2	advcl	_	_
19	in	in	IN	IN	_	21	case	_	_
20	AML	aml	NN	NN	_	21	compound	_	_
21	samples	sample	NNS	NNS	_	18	nmod	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	in	in	IN	IN	_	26	case	_	_
24	myelomonocytic	myelomonocytic	JJ	JJ	_	26	amod	_	_
25	cell	cell	NN	NN	_	26	compound	_	_
26	lines	line	NNS	NNS	_	21	conj	_	_
27	having	have	VBG	VBG	_	26	acl	_	_
28	the	the	DT	DT	_	30	det	_	_
29	highest	highest	JJS	JJS	_	30	amod	_	_
30	amounts	amount	NNS	NNS	_	27	dobj	_	_
31	of	of	IN	IN	_	33	case	_	_
32	monocytic	monocytic	JJ	JJ	_	33	amod	_	_
33	precursors	precursor	NNS	NNS	_	30	nmod	_	_
34	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	demonstrated	demonstrate	VBD	VBD	_	0	root	_	_
4	that	that	IN	IN	_	22	mark	_	_
5	fresh	fresh	JJ	JJ	_	7	amod	_	_
6	leukemic	leukemic	JJ	JJ	_	7	amod	_	_
7	cells	cell	NNS	NNS	_	22	nsubj	_	_
8	,	,	,	,	_	7	punct	_	_
9	whatever	whatever	WDT	WDT	_	7	acl:relcl	_	_
10	their	they	PRP$	PRP$	_	11	nmod:poss	_	_
11	stage	stage	NN	NN	_	9	dep	_	_
12	of	of	IN	IN	_	13	case	_	_
13	differentiation	differentiation	NN	NN	_	11	nmod	_	_
14	,	,	,	,	_	7	punct	_	_
15	as	as	RB	RB	_	7	cc	_	_
16	well	well	RB	RB	_	15	mwe	_	_
17	as	as	IN	IN	_	15	mwe	_	_
18	myelomonocytic	myelomonocytic	JJ	JJ	_	20	amod	_	_
19	cell	cell	NN	NN	_	20	compound	_	_
20	lines	line	NNS	NNS	_	7	conj	_	_
21	,	,	,	,	_	7	punct	_	_
22	respond	respond	VB	VB	_	3	ccomp	_	_
23	to	to	TO	TO	_	24	case	_	_
24	VD	vd	NN	NN	_	22	nmod	_	_
25	by	by	IN	IN	_	27	case	_	_
26	an	a	DT	DT	_	27	det	_	_
27	increase	increase	NN	NN	_	22	nmod	_	_
28	in	in	IN	IN	_	31	case	_	_
29	RXR	rxr	NN	NN	_	30	compound	_	_
30	alpha	alpha	NN	NN	_	31	compound	_	_
31	levels	level	NNS	NNS	_	27	nmod	_	_
32	.	.	.	.	_	3	punct	_	_

1	Combinations	combination	NNS	NNS	_	16	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	all-trans	all-trans	JJ	JJ	_	5	amod	_	_
4	retinoic	retinoic	JJ	JJ	_	5	amod	_	_
5	acid	acid	NN	NN	_	1	nmod	_	_
6	(	(	-LRB-	-LRB-	_	7	punct	_	_
7	RA	ra	NN	NN	_	5	appos	_	_
8	)	)	-RRB-	-RRB-	_	7	punct	_	_
9	and	and	CC	CC	_	5	cc	_	_
10	VD	vd	NN	NN	_	5	conj	_	_
11	,	,	,	,	_	1	punct	_	_
12	in	in	IN	IN	_	14	case	_	_
13	some	some	DT	DT	_	14	det	_	_
14	cases	case	NNS	NNS	_	16	nmod	_	_
15	,	,	,	,	_	16	punct	_	_
16	increased	increase	VBD	VBD	_	0	root	_	_
17	this	this	DT	DT	_	18	det	_	_
18	effect	effect	NN	NN	_	16	dobj	_	_
19	.	.	.	.	_	16	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	response	response	NN	NN	_	3	nsubj	_	_
3	suggests	suggest	VBZ	VBZ	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	involvement	involvement	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	8	case	_	_
7	RXR	rxr	NN	NN	_	8	compound	_	_
8	alpha	alpha	NN	NN	_	5	nmod	_	_
9	in	in	IN	IN	_	11	case	_	_
10	monocytic	monocytic	JJ	JJ	_	11	amod	_	_
11	differentiation	differentiation	NN	NN	_	5	nmod	_	_
12	upon	upon	IN	IN	_	14	case	_	_
13	VD	vd	NN	NN	_	14	compound	_	_
14	treatment	treatment	NN	NN	_	5	nmod	_	_
15	.	.	.	.	_	3	punct	_	_

1	Putative	putative	JJ	JJ	_	4	amod	_	_
2	steroid	steroid	NN	NN	_	4	compound	_	_
3	binding	binding	NN	NN	_	4	compound	_	_
4	domain	domain	NN	NN	_	22	nsubj	_	_
5	of	of	IN	IN	_	9	case	_	_
6	the	the	DT	DT	_	9	det	_	_
7	human	human	JJ	JJ	_	9	amod	_	_
8	mineralocorticoid	mineralocorticoid	NN	NN	_	9	compound	_	_
9	receptor	receptor	NN	NN	_	4	nmod	_	_
10	,	,	,	,	_	4	punct	_	_
11	expressed	express	VBN	VBN	_	4	acl	_	_
12	in	in	IN	IN	_	14	case	_	_
13	E.	e.	FW	FW	_	14	compound	_	_
14	coli	coli	FW	FW	_	11	nmod	_	_
15	in	in	IN	IN	_	17	case	_	_
16	the	the	DT	DT	_	17	det	_	_
17	presence	presence	NN	NN	_	11	nmod	_	_
18	of	of	IN	IN	_	21	case	_	_
19	heat	heat	NN	NN	_	21	compound	_	_
20	shock	shock	NN	NN	_	21	compound	_	_
21	proteins	protein	NNS	NNS	_	17	nmod	_	_
22	shows	show	VBZ	VBZ	_	0	root	_	_
23	typical	typical	JJ	JJ	_	26	amod	_	_
24	native	native	JJ	JJ	_	23	dep	_	_
25	receptor	receptor	NN	NN	_	26	compound	_	_
26	characteristics	characteristic	NNS	NNS	_	22	dobj	_	_
27	.	.	.	.	_	22	punct	_	_

1	Domain	domain	NN	NN	_	2	compound	_	_
2	E	e	NN	NN	_	23	nsubjpass	_	_
3	,	,	,	,	_	2	punct	_	_
4	considered	consider	VBN	VBN	_	2	acl	_	_
5	as	as	IN	IN	_	10	case	_	_
6	the	the	DT	DT	_	10	det	_	_
7	putative	putative	JJ	JJ	_	10	amod	_	_
8	hormone	hormone	NN	NN	_	10	compound	_	_
9	binding	binding	NN	NN	_	10	compound	_	_
10	domain	domain	NN	NN	_	4	nmod	_	_
11	(	(	-LRB-	-LRB-	_	12	punct	_	_
12	HBD	hbd	NN	NN	_	10	appos	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	of	of	IN	IN	_	18	case	_	_
15	the	the	DT	DT	_	18	det	_	_
16	human	human	JJ	JJ	_	18	amod	_	_
17	mineralocorticoid	mineralocorticoid	NN	NN	_	18	compound	_	_
18	receptor	receptor	NN	NN	_	10	nmod	_	_
19	(	(	-LRB-	-LRB-	_	20	punct	_	_
20	hMR	hmr	NN	NN	_	18	appos	_	_
21	)	)	-RRB-	-RRB-	_	20	punct	_	_
22	was	be	VBD	VBD	_	23	auxpass	_	_
23	expressed	express	VBN	VBN	_	0	root	_	_
24	in	in	IN	IN	_	26	case	_	_
25	Escherichia	escherichia	FW	FW	_	26	compound	_	_
26	coli	coli	FW	FW	_	23	nmod	_	_
27	as	as	IN	IN	_	30	case	_	_
28	a	a	DT	DT	_	30	det	_	_
29	fusion	fusion	NN	NN	_	30	compound	_	_
30	protein	protein	NN	NN	_	23	nmod	_	_
31	with	with	IN	IN	_	35	case	_	_
32	either	either	CC	CC	_	35	cc:preconj	_	_
33	maltose	maltose	NN	NN	_	35	compound	_	_
34	binding	binding	NN	NN	_	35	compound	_	_
35	protein	protein	NN	NN	_	30	nmod	_	_
36	(	(	-LRB-	-LRB-	_	37	punct	_	_
37	MBP	mbp	NN	NN	_	35	appos	_	_
38	)	)	-RRB-	-RRB-	_	37	punct	_	_
39	or	or	CC	CC	_	35	cc	_	_
40	glutathione	glutathione	NN	NN	_	41	compound	_	_
41	S-transferase	s-transferase	NN	NN	_	35	conj	_	_
42	(	(	-LRB-	-LRB-	_	43	punct	_	_
43	GST	gst	NN	NN	_	41	appos	_	_
44	)	)	-RRB-	-RRB-	_	43	punct	_	_
45	.	.	.	.	_	23	punct	_	_

1	These	these	DT	DT	_	4	det	_	_
2	bacterially-produced	bacterially-produced	JJ	JJ	_	4	amod	_	_
3	MR	mr	NN	NN	_	4	compound	_	_
4	constructs	construct	NNS	NNS	_	5	nsubj	_	_
5	had	have	VBD	VBD	_	0	root	_	_
6	no	no	DT	DT	_	9	neg	_	_
7	steroid	steroid	NN	NN	_	9	compound	_	_
8	binding	binding	NN	NN	_	9	compound	_	_
9	activity	activity	NN	NN	_	5	dobj	_	_
10	per	per	FW	FW	_	11	compound	_	_
11	se	se	FW	FW	_	5	advmod	_	_
12	.	.	.	.	_	5	punct	_	_

1	In	in	IN	IN	_	2	case	_	_
2	fact	fact	NN	NN	_	12	nmod	_	_
3	,	,	,	,	_	12	punct	_	_
4	heat	heat	NN	NN	_	6	compound	_	_
5	shock	shock	NN	NN	_	6	compound	_	_
6	protein	protein	NN	NN	_	7	compound	_	_
7	association	association	NN	NN	_	12	nsubjpass	_	_
8	(	(	-LRB-	-LRB-	_	9	punct	_	_
9	hsp	hsp	NN	NN	_	7	appos	_	_
10	)	)	-RRB-	-RRB-	_	9	punct	_	_
11	is	be	VBZ	VBZ	_	12	auxpass	_	_
12	required	require	VBN	VBN	_	0	root	_	_
13	for	for	IN	IN	_	16	case	_	_
14	high	high	JJ	JJ	_	16	amod	_	_
15	affinity	affinity	NN	NN	_	16	compound	_	_
16	ligand-binding	ligand-binding	NN	NN	_	12	nmod	_	_
17	of	of	IN	IN	_	19	case	_	_
18	the	the	DT	DT	_	19	det	_	_
19	MR	mr	NN	NN	_	16	nmod	_	_
20	.	.	.	.	_	12	punct	_	_

1	After	after	IN	IN	_	2	case	_	_
2	incubation	incubation	NN	NN	_	23	nmod	_	_
3	of	of	IN	IN	_	5	case	_	_
4	purified	purify	VBN	VBN	_	5	amod	_	_
5	MBP-	mbp-	NN	NN	_	2	nmod	_	_
6	or	or	CC	CC	_	5	cc	_	_
7	GST-HBD	gst-hbd	NN	NN	_	5	conj	_	_
8	with	with	IN	IN	_	11	case	_	_
9	rabbit	rabbit	NN	NN	_	11	compound	_	_
10	reticulocyte	reticulocyte	NN	NN	_	11	compound	_	_
11	lysate	lysate	NN	NN	_	2	nmod	_	_
12	,	,	,	,	_	11	punct	_	_
13	known	know	VBN	VBN	_	11	acl	_	_
14	to	to	TO	TO	_	16	mark	_	_
15	be	be	VB	VB	_	16	cop	_	_
16	rich	rich	JJ	JJ	_	13	xcomp	_	_
17	in	in	IN	IN	_	20	case	_	_
18	heat	heat	NN	NN	_	20	compound	_	_
19	shock	shock	NN	NN	_	20	compound	_	_
20	proteins	protein	NNS	NNS	_	16	nmod	_	_
21	,	,	,	,	_	23	punct	_	_
22	we	we	PRP	PRP	_	23	nsubj	_	_
23	obtained	obtain	VBD	VBD	_	0	root	_	_
24	saturable	saturable	JJ	JJ	_	25	amod	_	_
25	binding	binding	NN	NN	_	23	dobj	_	_
26	of	of	IN	IN	_	27	case	_	_
27	-LSB-3H-RSB-aldosterone	-lsb-3h-rsb-aldosterone	NN	NN	_	25	nmod	_	_
28	.	.	.	.	_	23	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	Kd	kd	NN	NN	_	3	compound	_	_
3	value	value	NN	NN	_	8	nsubj	_	_
4	for	for	IN	IN	_	5	case	_	_
5	aldosterone	aldosterone	NN	NN	_	3	nmod	_	_
6	was	be	VBD	VBD	_	8	cop	_	_
7	0.3	0.3	CD	CD	_	8	nummod	_	_
8	nM	nm	NN	NN	_	0	root	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	the	the	DT	DT	_	11	det	_	_
11	Bmax	bmax	NN	NN	_	12	nsubj	_	_
12	=	=	VBD	VBD	_	8	conj	_	_
13	32	32	CD	CD	_	14	nummod	_	_
14	pmol/mg	pmol/mg	NN	NN	_	12	dobj	_	_
15	.	.	.	.	_	8	punct	_	_

1	Hormone	hormone	NN	NN	_	3	compound	_	_
2	binding	binding	NN	NN	_	3	compound	_	_
3	specificity	specificity	NN	NN	_	5	nsubjpass	_	_
4	was	be	VBD	VBD	_	5	auxpass	_	_
5	assessed	assess	VBN	VBN	_	0	root	_	_
6	by	by	IN	IN	_	8	case	_	_
7	competition	competition	NN	NN	_	8	compound	_	_
8	studies	study	NNS	NNS	_	5	nmod	_	_
9	with	with	IN	IN	_	12	case	_	_
10	various	various	JJ	JJ	_	12	amod	_	_
11	steroid	steroid	NN	NN	_	12	compound	_	_
12	ligands	ligand	NNS	NNS	_	8	nmod	_	_
13	.	.	.	.	_	5	punct	_	_

1	Sucrose	sucrose	NN	NN	_	3	compound	_	_
2	gradient	gradient	NN	NN	_	3	compound	_	_
3	assays	assay	NNS	NNS	_	7	nsubj	_	_
4	performed	perform	VBN	VBN	_	3	acl	_	_
5	with	with	IN	IN	_	6	case	_	_
6	-LSB-3H-RSB-aldosterone-MBP-HBD	-lsb-3h-rsb-aldosterone-mbp-hbd	NN	NN	_	4	nmod	_	_
7	revealed	reveal	VBD	VBD	_	0	root	_	_
8	complex	complex	NN	NN	_	7	dobj	_	_
9	sedimenting	sediment	VBG	VBG	_	8	acl	_	_
10	at	at	IN	IN	_	11	case	_	_
11	8.3S	8.3s	NN	NN	_	9	nmod	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	4.9S	4.9s	NN	NN	_	11	conj	_	_
14	with	with	IN	IN	_	15	case	_	_
15	-LSB-3H-RSB-progesterone-MBP-HBD	-lsb-3h-rsb-progesterone-mbp-hbd	NN	NN	_	9	nmod	_	_
16	.	.	.	.	_	7	punct	_	_

1	Western-blot	western-blot	JJ	JJ	_	2	amod	_	_
2	analysis	analysis	NN	NN	_	7	nsubj	_	_
3	of	of	IN	IN	_	6	case	_	_
4	the	the	DT	DT	_	6	det	_	_
5	sedimentation	sedimentation	NN	NN	_	6	compound	_	_
6	peak	peak	NN	NN	_	2	nmod	_	_
7	showed	show	VBD	VBD	_	0	root	_	_
8	the	the	DT	DT	_	10	det	_	_
9	concomitant	concomitant	JJ	JJ	_	10	amod	_	_
10	presence	presence	NN	NN	_	7	dobj	_	_
11	of	of	IN	IN	_	12	case	_	_
12	MBP-HBD	mbp-hbd	NN	NN	_	10	nmod	_	_
13	by	by	IN	IN	_	17	case	_	_
14	a	a	DT	DT	_	17	det	_	_
15	monoclonal	monoclonal	JJ	JJ	_	17	amod	_	_
16	anti-MBP	anti-mbp	JJ	JJ	_	17	amod	_	_
17	antibody	antibody	NN	NN	_	12	nmod	_	_
18	,	,	,	,	_	12	punct	_	_
19	and	and	CC	CC	_	12	cc	_	_
20	hsp90	hsp90	NN	NN	_	12	conj	_	_
21	by	by	IN	IN	_	25	case	_	_
22	a	a	DT	DT	_	25	det	_	_
23	monoclonal	monoclonal	JJ	JJ	_	25	amod	_	_
24	anti-hsp	anti-hsp	JJ	JJ	_	25	amod	_	_
25	antibody	antibody	NN	NN	_	12	nmod	_	_
26	.	.	.	.	_	7	punct	_	_

1	Moreover	moreover	RB	RB	_	14	advmod	_	_
2	,	,	,	,	_	14	punct	_	_
3	following	follow	VBG	VBG	_	4	case	_	_
4	incubation	incubation	NN	NN	_	14	nmod	_	_
5	with	with	IN	IN	_	10	case	_	_
6	the	the	DT	DT	_	10	det	_	_
7	anti-rabbit	anti-rabbit	JJ	JJ	_	10	amod	_	_
8	hsp90	hsp90	NN	NN	_	10	compound	_	_
9	monoclonal	monoclonal	JJ	JJ	_	10	amod	_	_
10	antibody	antibody	NN	NN	_	4	nmod	_	_
11	the	the	DT	DT	_	13	det	_	_
12	sedimenting	sedimenting	NN	NN	_	13	compound	_	_
13	gradient	gradient	NN	NN	_	14	nsubj	_	_
14	showed	show	VBD	VBD	_	0	root	_	_
15	a	a	DT	DT	_	18	det	_	_
16	10.4S	10.4s	NN	NN	_	18	compound	_	_
17	sedimenting	sedimenting	NN	NN	_	18	compound	_	_
18	complex	complex	NN	NN	_	14	dobj	_	_
19	.	.	.	.	_	14	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	analyses	analysis	NNS	NNS	_	3	nsubj	_	_
3	demonstrated	demonstrate	VBD	VBD	_	0	root	_	_
4	that	that	IN	IN	_	11	mark	_	_
5	the	the	DT	DT	_	7	det	_	_
6	-LSB-3H-RSB-aldosterone-MBP-HBD	-lsb-3h-rsb-aldosterone-mbp-hbd	NN	NN	_	7	compound	_	_
7	complex	complex	NN	NN	_	11	nsubjpass	_	_
8	is	be	VBZ	VBZ	_	11	auxpass	_	_
9	at	at	IN	IN	_	11	advmod	_	_
10	least	least	JJS	JJS	_	9	mwe	_	_
11	associated	associate	VBN	VBN	_	3	ccomp	_	_
12	with	with	IN	IN	_	13	case	_	_
13	hsp90	hsp90	NN	NN	_	11	nmod	_	_
14	in	in	IN	IN	_	16	case	_	_
15	reticulocyte	reticulocyte	NN	NN	_	16	compound	_	_
16	lysate	lysate	NN	NN	_	11	nmod	_	_
17	and	and	CC	CC	_	11	cc	_	_
18	that	that	IN	IN	_	24	mark	_	_
19	the	the	DT	DT	_	20	det	_	_
20	HBD	hbd	NN	NN	_	24	nsubj	_	_
21	of	of	IN	IN	_	22	case	_	_
22	hMR	hmr	NN	NN	_	20	nmod	_	_
23	is	be	VBZ	VBZ	_	24	cop	_	_
24	sufficient	sufficient	JJ	JJ	_	11	conj	_	_
25	to	to	TO	TO	_	26	mark	_	_
26	bind	bind	VB	VB	_	24	xcomp	_	_
27	hsp90	hsp90	NN	NN	_	26	dobj	_	_
28	.	.	.	.	_	3	punct	_	_

1	Deletions	deletion	NNS	NNS	_	20	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	a	a	DT	DT	_	6	det	_	_
4	relatively	relatively	RB	RB	_	5	advmod	_	_
5	short	short	JJ	JJ	_	6	amod	_	_
6	amino-	amino-	NN	NN	_	1	nmod	_	_
7	(	(	-LRB-	-LRB-	_	8	punct	_	_
8	729-766	729-766	CD	CD	_	6	appos	_	_
9	)	)	-RRB-	-RRB-	_	8	punct	_	_
10	or	or	CC	CC	_	6	cc	_	_
11	carboxy-terminal	carboxy-terminal	JJ	JJ	_	6	conj	_	_
12	(	(	-LRB-	-LRB-	_	13	punct	_	_
13	940-984	940-984	CD	CD	_	11	appos	_	_
14	)	)	-RRB-	-RRB-	_	13	punct	_	_
15	region	region	NN	NN	_	6	dep	_	_
16	of	of	IN	IN	_	19	case	_	_
17	the	the	DT	DT	_	19	det	_	_
18	HBD	hbd	NN	NN	_	19	compound	_	_
19	fragment	fragment	NN	NN	_	6	nmod	_	_
20	eliminated	eliminate	VBD	VBD	_	0	root	_	_
21	all	all	DT	DT	_	23	det	_	_
22	steroid-binding	steroid-binding	JJ	JJ	_	23	amod	_	_
23	properties	property	NNS	NNS	_	20	dobj	_	_
24	.	.	.	.	_	20	punct	_	_

1	Overall	overall	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	these	these	DT	DT	_	4	det	_	_
4	results	result	NNS	NNS	_	5	nsubj	_	_
5	indicate	indicate	VBP	VBP	_	0	root	_	_
6	that	that	IN	IN	_	13	mark	_	_
7	the	the	DT	DT	_	8	det	_	_
8	integrity	integrity	NN	NN	_	13	nsubj	_	_
9	of	of	IN	IN	_	11	case	_	_
10	domain	domain	NN	NN	_	11	compound	_	_
11	E	e	NN	NN	_	8	nmod	_	_
12	is	be	VBZ	VBZ	_	13	cop	_	_
13	necessary	necessary	JJ	JJ	_	5	ccomp	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	sufficient	sufficient	JJ	JJ	_	13	conj	_	_
16	to	to	TO	TO	_	17	mark	_	_
17	bind	bind	VB	VB	_	13	xcomp	_	_
18	steroid	steroid	NN	NN	_	19	compound	_	_
19	ligands	ligand	NNS	NNS	_	17	dobj	_	_
20	,	,	,	,	_	19	punct	_	_
21	agonists	agonist	NNS	NNS	_	19	appos	_	_
22	or	or	CC	CC	_	21	cc	_	_
23	antagonists	antagonist	NNS	NNS	_	21	conj	_	_
24	,	,	,	,	_	17	punct	_	_
25	with	with	IN	IN	_	26	case	_	_
26	characteristics	characteristic	NNS	NNS	_	17	nmod	_	_
27	similar	similar	JJ	JJ	_	26	amod	_	_
28	to	to	TO	TO	_	32	case	_	_
29	the	the	DT	DT	_	32	det	_	_
30	entire	entire	JJ	JJ	_	31	amod	_	_
31	native	native	JJ	JJ	_	32	amod	_	_
32	MR	mr	NN	NN	_	27	nmod	_	_
33	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	myeloid-cell-specific	myeloid-cell-specific	JJ	JJ	_	4	amod	_	_
3	c-fes	c-fes	NN	NN	_	4	compound	_	_
4	promoter	promoter	NN	NN	_	6	nsubjpass	_	_
5	is	be	VBZ	VBZ	_	6	auxpass	_	_
6	regulated	regulate	VBN	VBN	_	0	root	_	_
7	by	by	IN	IN	_	8	case	_	_
8	Sp1	sp1	NN	NN	_	6	nmod	_	_
9	,	,	,	,	_	8	punct	_	_
10	PU.1	pu.1	NN	NN	_	8	conj	_	_
11	,	,	,	,	_	8	punct	_	_
12	and	and	CC	CC	_	8	cc	_	_
13	a	a	DT	DT	_	16	det	_	_
14	novel	novel	JJ	JJ	_	16	amod	_	_
15	transcription	transcription	NN	NN	_	16	compound	_	_
16	factor	factor	NN	NN	_	8	conj	_	_
17	.	.	.	.	_	6	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	protein	protein	NN	NN	_	3	compound	_	_
3	product	product	NN	NN	_	13	nsubjpass	_	_
4	of	of	IN	IN	_	10	case	_	_
5	the	the	DT	DT	_	10	det	_	_
6	c-fps/fes	c-fps/fes	NN	NN	_	10	compound	_	_
7	(	(	-LRB-	-LRB-	_	10	punct	_	_
8	c-fes	c-fes	NN	NN	_	10	compound	_	_
9	)	)	-RRB-	-RRB-	_	10	punct	_	_
10	proto-oncogene	proto-oncogene	NN	NN	_	3	nmod	_	_
11	has	have	VBZ	VBZ	_	13	aux	_	_
12	been	be	VBN	VBN	_	13	auxpass	_	_
13	implicated	implicate	VBN	VBN	_	0	root	_	_
14	in	in	IN	IN	_	17	case	_	_
15	the	the	DT	DT	_	17	det	_	_
16	normal	normal	JJ	JJ	_	17	amod	_	_
17	development	development	NN	NN	_	13	nmod	_	_
18	of	of	IN	IN	_	20	case	_	_
19	myeloid	myeloid	JJ	JJ	_	20	amod	_	_
20	cells	cell	NNS	NNS	_	17	nmod	_	_
21	(	(	-LRB-	-LRB-	_	22	punct	_	_
22	macrophages	macrophage	NNS	NNS	_	20	dep	_	_
23	and	and	CC	CC	_	22	cc	_	_
24	neutrophils	neutrophil	NNS	NNS	_	22	conj	_	_
25	)	)	-RRB-	-RRB-	_	22	punct	_	_
26	.	.	.	.	_	13	punct	_	_

1	mRNA	mrna	NN	NN	_	6	nsubjpass	_	_
2	for	for	IN	IN	_	3	case	_	_
3	c-fes	c-fes	NN	NN	_	1	nmod	_	_
4	has	have	VBZ	VBZ	_	6	aux	_	_
5	been	be	VBN	VBN	_	6	auxpass	_	_
6	detected	detect	VBN	VBN	_	0	root	_	_
7	exclusively	exclusively	RB	RB	_	10	advmod	_	_
8	in	in	IN	IN	_	10	case	_	_
9	myeloid	myeloid	JJ	JJ	_	10	amod	_	_
10	cells	cell	NNS	NNS	_	6	nmod	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	vascular	vascular	JJ	JJ	_	14	amod	_	_
13	endothelial	endothelial	JJ	JJ	_	14	amod	_	_
14	cells	cell	NNS	NNS	_	10	conj	_	_
15	in	in	IN	IN	_	17	case	_	_
16	adult	adult	JJ	JJ	_	17	amod	_	_
17	mammals	mammal	NNS	NNS	_	10	nmod	_	_
18	.	.	.	.	_	6	punct	_	_

1	Although	although	IN	IN	_	10	mark	_	_
2	a	a	DT	DT	_	9	det	_	_
3	13-kilobase-pair	13-kilobase-pair	NN	NN	_	9	compound	_	_
4	(	(	-LRB-	-LRB-	_	9	punct	_	_
5	kb	kb	NN	NN	_	9	compound	_	_
6	)	)	-RRB-	-RRB-	_	9	punct	_	_
7	human	human	JJ	JJ	_	9	amod	_	_
8	c-fes	c-fes	NN	NN	_	9	compound	_	_
9	transgene	transgene	NN	NN	_	10	nsubj	_	_
10	exhibits	exhibit	VBZ	VBZ	_	32	advcl	_	_
11	high	high	JJ	JJ	_	12	amod	_	_
12	levels	level	NNS	NNS	_	10	dobj	_	_
13	of	of	IN	IN	_	14	case	_	_
14	expression	expression	NN	NN	_	12	nmod	_	_
15	in	in	IN	IN	_	16	case	_	_
16	mice	mouse	NNS	NNS	_	10	nmod	_	_
17	,	,	,	,	_	32	punct	_	_
18	the	the	DT	DT	_	19	det	_	_
19	sequences	sequence	NNS	NNS	_	32	nsubjpass	_	_
20	that	that	WDT	WDT	_	21	nsubj	_	_
21	confer	confer	VBP	VBP	_	19	acl:relcl	_	_
22	myeloid-cell-specific	myeloid-cell-specific	JJ	JJ	_	23	amod	_	_
23	expression	expression	NN	NN	_	21	dobj	_	_
24	of	of	IN	IN	_	28	case	_	_
25	the	the	DT	DT	_	28	det	_	_
26	human	human	JJ	JJ	_	28	amod	_	_
27	c-fes	c-fes	NN	NN	_	28	compound	_	_
28	gene	gene	NN	NN	_	23	nmod	_	_
29	have	have	VBP	VBP	_	32	aux	_	_
30	not	not	RB	RB	_	32	neg	_	_
31	been	be	VBN	VBN	_	32	auxpass	_	_
32	defined	define	VBN	VBN	_	0	root	_	_
33	.	.	.	.	_	32	punct	_	_

1	Transient-transfection	transient-transfection	NN	NN	_	2	compound	_	_
2	experiments	experiment	NNS	NNS	_	3	nsubj	_	_
3	demonstrated	demonstrate	VBD	VBD	_	0	root	_	_
4	that	that	IN	IN	_	20	mark	_	_
5	plasmids	plasmid	NNS	NNS	_	20	nsubj	_	_
6	containing	contain	VBG	VBG	_	5	acl	_	_
7	446	446	CD	CD	_	8	nummod	_	_
8	bp	bp	NN	NN	_	6	dobj	_	_
9	of	of	IN	IN	_	12	case	_	_
10	c-fes	c-fes	NN	NN	_	12	compound	_	_
11	5'-flanking	5'-flanking	JJ	JJ	_	12	amod	_	_
12	sequences	sequence	NNS	NNS	_	8	nmod	_	_
13	linked	link	VBN	VBN	_	8	acl	_	_
14	to	to	TO	TO	_	18	case	_	_
15	a	a	DT	DT	_	18	det	_	_
16	luciferase	luciferase	NN	NN	_	18	compound	_	_
17	reporter	reporter	NN	NN	_	18	compound	_	_
18	gene	gene	NN	NN	_	13	nmod	_	_
19	were	be	VBD	VBD	_	20	cop	_	_
20	active	active	JJ	JJ	_	3	ccomp	_	_
21	exclusively	exclusively	RB	RB	_	24	advmod	_	_
22	in	in	IN	IN	_	24	case	_	_
23	myeloid	myeloid	JJ	JJ	_	24	amod	_	_
24	cells	cell	NNS	NNS	_	20	nmod	_	_
25	.	.	.	.	_	3	punct	_	_

1	No	no	DT	DT	_	4	neg	_	_
2	other	other	JJ	JJ	_	4	amod	_	_
3	DNA	dna	NN	NN	_	4	compound	_	_
4	element	element	NN	NN	_	11	nsubj	_	_
5	within	within	IN	IN	_	10	case	_	_
6	the	the	DT	DT	_	10	det	_	_
7	13-kb	13-kb	JJ	JJ	_	10	amod	_	_
8	human	human	JJ	JJ	_	10	amod	_	_
9	c-fes	c-fes	NN	NN	_	10	compound	_	_
10	locus	locus	NN	NN	_	4	nmod	_	_
11	contained	contain	VBD	VBD	_	0	root	_	_
12	positive	positive	JJ	JJ	_	14	amod	_	_
13	cis-acting	cis-acting	JJ	JJ	_	14	amod	_	_
14	elements	element	NNS	NNS	_	11	dobj	_	_
15	,	,	,	,	_	11	punct	_	_
16	with	with	IN	IN	_	18	case	_	_
17	the	the	DT	DT	_	18	det	_	_
18	exception	exception	NN	NN	_	11	nmod	_	_
19	of	of	IN	IN	_	23	case	_	_
20	a	a	DT	DT	_	23	det	_	_
21	weakly	weakly	RB	RB	_	22	advmod	_	_
22	active	active	JJ	JJ	_	23	amod	_	_
23	region	region	NN	NN	_	18	nmod	_	_
24	within	within	IN	IN	_	27	case	_	_
25	the	the	DT	DT	_	27	det	_	_
26	3'-flanking	3'-flanking	JJ	JJ	_	27	amod	_	_
27	sequences	sequence	NNS	NNS	_	23	nmod	_	_
28	.	.	.	.	_	11	punct	_	_

1	DNase	dnase	NN	NN	_	4	compound	_	_
2	I	i	CD	CD	_	4	nummod	_	_
3	footprinting	footprinting	NN	NN	_	4	compound	_	_
4	assays	assay	NNS	NNS	_	5	nsubj	_	_
5	revealed	reveal	VBD	VBD	_	0	root	_	_
6	four	four	CD	CD	_	8	nummod	_	_
7	distinct	distinct	JJ	JJ	_	8	amod	_	_
8	sites	site	NNS	NNS	_	5	dobj	_	_
9	that	that	WDT	WDT	_	10	nsubj	_	_
10	bind	bind	VBP	VBP	_	8	acl:relcl	_	_
11	myeloid	myeloid	JJ	JJ	_	13	amod	_	_
12	nuclear	nuclear	JJ	JJ	_	13	amod	_	_
13	proteins	protein	NNS	NNS	_	10	dobj	_	_
14	(	(	-LRB-	-LRB-	_	17	punct	_	_
15	-408	-408	CD	CD	_	17	nummod	_	_
16	to	to	TO	TO	_	17	dep	_	_
17	-386	-386	CD	CD	_	8	dep	_	_
18	,	,	,	,	_	17	punct	_	_
19	-293	-293	CD	CD	_	21	nummod	_	_
20	to	to	TO	TO	_	21	dep	_	_
21	-254	-254	CD	CD	_	17	conj	_	_
22	,	,	,	,	_	17	punct	_	_
23	-76	-76	CD	CD	_	25	nummod	_	_
24	to	to	TO	TO	_	25	dep	_	_
25	-65	-65	CD	CD	_	17	conj	_	_
26	,	,	,	,	_	17	punct	_	_
27	and	and	CC	CC	_	17	cc	_	_
28	-34	-34	CD	CD	_	30	nummod	_	_
29	to	to	TO	TO	_	30	dep	_	_
30	+3	+3	CD	CD	_	17	conj	_	_
31	)	)	-RRB-	-RRB-	_	17	punct	_	_
32	.	.	.	.	_	5	punct	_	_

1	However	however	RB	RB	_	7	advmod	_	_
2	,	,	,	,	_	7	punct	_	_
3	the	the	DT	DT	_	6	det	_	_
4	first	first	JJ	JJ	_	6	amod	_	_
5	two	two	CD	CD	_	6	nummod	_	_
6	footprints	footprint	NNS	NNS	_	7	nsubj	_	_
7	resided	reside	VBD	VBD	_	0	root	_	_
8	in	in	IN	IN	_	9	case	_	_
9	sequences	sequence	NNS	NNS	_	7	nmod	_	_
10	that	that	WDT	WDT	_	13	nsubj	_	_
11	were	be	VBD	VBD	_	13	cop	_	_
12	largely	largely	RB	RB	_	13	advmod	_	_
13	dispensable	dispensable	JJ	JJ	_	9	acl:relcl	_	_
14	for	for	IN	IN	_	16	case	_	_
15	transient	transient	JJ	JJ	_	16	amod	_	_
16	activity	activity	NN	NN	_	13	nmod	_	_
17	.	.	.	.	_	7	punct	_	_

1	Plasmids	plasmid	NNS	NNS	_	8	nsubj	_	_
2	containing	contain	VBG	VBG	_	1	acl	_	_
3	151	151	CD	CD	_	4	nummod	_	_
4	bp	bp	NN	NN	_	2	dobj	_	_
5	of	of	IN	IN	_	7	case	_	_
6	5'-flanking	5'-flanking	JJ	JJ	_	7	amod	_	_
7	sequences	sequence	NNS	NNS	_	4	nmod	_	_
8	confer	confer	VBP	VBP	_	0	root	_	_
9	myeloid-cell-specific	myeloid-cell-specific	JJ	JJ	_	11	amod	_	_
10	gene	gene	NN	NN	_	11	compound	_	_
11	expression	expression	NN	NN	_	8	dobj	_	_
12	.	.	.	.	_	8	punct	_	_

1	Electrophoretic	electrophoretic	JJ	JJ	_	4	amod	_	_
2	mobility	mobility	NN	NN	_	4	compound	_	_
3	shift	shift	NN	NN	_	4	compound	_	_
4	analyses	analysis	NNS	NNS	_	5	nsubj	_	_
5	demonstrated	demonstrate	VBD	VBD	_	0	root	_	_
6	that	that	IN	IN	_	10	mark	_	_
7	the	the	DT	DT	_	9	det	_	_
8	151-bp	151-bp	JJ	JJ	_	9	amod	_	_
9	region	region	NN	NN	_	10	nsubj	_	_
10	contains	contain	VBZ	VBZ	_	5	ccomp	_	_
11	nuclear	nuclear	JJ	JJ	_	14	amod	_	_
12	protein	protein	NN	NN	_	14	compound	_	_
13	binding	binding	NN	NN	_	14	compound	_	_
14	sites	site	NNS	NNS	_	10	dobj	_	_
15	for	for	IN	IN	_	16	case	_	_
16	Sp1	sp1	NN	NN	_	14	nmod	_	_
17	,	,	,	,	_	16	punct	_	_
18	PU.1	pu.1	NN	NN	_	16	conj	_	_
19	,	,	,	,	_	16	punct	_	_
20	and/or	and/or	CC	CC	_	16	cc	_	_
21	Elf-1	elf-1	NN	NN	_	16	conj	_	_
22	,	,	,	,	_	16	punct	_	_
23	and	and	CC	CC	_	16	cc	_	_
24	a	a	DT	DT	_	26	det	_	_
25	novel	novel	JJ	JJ	_	26	amod	_	_
26	factor	factor	NN	NN	_	16	conj	_	_
27	.	.	.	.	_	5	punct	_	_

1	This	this	DT	DT	_	3	det	_	_
2	unidentified	unidentified	JJ	JJ	_	3	amod	_	_
3	factor	factor	NN	NN	_	4	nsubj	_	_
4	binds	bind	VBZ	VBZ	_	0	root	_	_
5	immediately	immediately	RB	RB	_	6	advmod	_	_
6	3'	3'	JJ	JJ	_	4	dobj	_	_
7	of	of	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	PU.1/Elf-1	pu.1/elf-1	JJ	JJ	_	10	amod	_	_
10	sites	site	NNS	NNS	_	6	nmod	_	_
11	and	and	CC	CC	_	4	cc	_	_
12	appears	appear	VBZ	VBZ	_	4	conj	_	_
13	to	to	TO	TO	_	17	mark	_	_
14	be	be	VB	VB	_	17	cop	_	_
15	myeloid	myeloid	JJ	JJ	_	17	amod	_	_
16	cell	cell	NN	NN	_	17	nmod:npmod	_	_
17	specific	specific	JJ	JJ	_	12	xcomp	_	_
18	.	.	.	.	_	4	punct	_	_

1	Mutation	mutation	NN	NN	_	20	nsubj	_	_
2	of	of	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	PU.1/Elf-1	pu.1/elf-1	JJ	JJ	_	5	compound	_	_
5	site	site	NN	NN	_	1	nmod	_	_
6	or	or	CC	CC	_	5	cc	_	_
7	the	the	DT	DT	_	9	det	_	_
8	3'	3'	JJ	JJ	_	9	amod	_	_
9	site	site	NN	NN	_	5	conj	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	FP4-3'	fp4-3'	NN	NN	_	9	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	within	within	IN	IN	_	15	case	_	_
14	the	the	DT	DT	_	15	det	_	_
15	context	context	NN	NN	_	1	nmod	_	_
16	of	of	IN	IN	_	19	case	_	_
17	the	the	DT	DT	_	19	det	_	_
18	c-fes	c-fes	NN	NN	_	19	compound	_	_
19	promoter	promoter	NN	NN	_	15	nmod	_	_
20	resulted	result	VBD	VBD	_	0	root	_	_
21	in	in	IN	IN	_	24	case	_	_
22	substantially	substantially	RB	RB	_	23	advmod	_	_
23	reduced	reduce	VBN	VBN	_	24	amod	_	_
24	activity	activity	NN	NN	_	20	nmod	_	_
25	in	in	IN	IN	_	27	case	_	_
26	transient	transient	JJ	JJ	_	27	amod	_	_
27	transfections	transfection	NNS	NNS	_	24	nmod	_	_
28	.	.	.	.	_	20	punct	_	_

1	Furthermore	furthermore	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	transient-cotransfection	transient-cotransfection	JJ	JJ	_	4	amod	_	_
4	assay	assay	NN	NN	_	5	nsubj	_	_
5	demonstrated	demonstrate	VBD	VBD	_	0	root	_	_
6	that	that	IN	IN	_	14	mark	_	_
7	PU.1	pu.1	NN	NN	_	14	nsubj	_	_
8	(	(	-LRB-	-LRB-	_	11	punct	_	_
9	and	and	CC	CC	_	11	cc	_	_
10	not	not	RB	RB	_	11	dep	_	_
11	Elf-1	elf-1	NN	NN	_	7	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	can	can	MD	MD	_	14	aux	_	_
14	transactivate	transactivate	VB	VB	_	5	ccomp	_	_
15	the	the	DT	DT	_	17	det	_	_
16	c-fes	c-fes	NN	NN	_	17	compound	_	_
17	promoter	promoter	NN	NN	_	14	dobj	_	_
18	in	in	IN	IN	_	21	case	_	_
19	nonmyeloid	nonmyeloid	JJ	JJ	_	21	amod	_	_
20	cell	cell	NN	NN	_	21	compound	_	_
21	lines	line	NNS	NNS	_	17	nmod	_	_
22	.	.	.	.	_	5	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	conclude	conclude	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	8	mark	_	_
4	the	the	DT	DT	_	7	det	_	_
5	human	human	JJ	JJ	_	7	amod	_	_
6	c-fes	c-fes	NN	NN	_	7	compound	_	_
7	gene	gene	NN	NN	_	8	nsubj	_	_
8	contains	contain	VBZ	VBZ	_	2	ccomp	_	_
9	a	a	DT	DT	_	12	det	_	_
10	strong	strong	JJ	JJ	_	12	amod	_	_
11	myeloid-cell-specific	myeloid-cell-specific	JJ	JJ	_	12	amod	_	_
12	promoter	promoter	NN	NN	_	8	dobj	_	_
13	that	that	WDT	WDT	_	15	nsubjpass	_	_
14	is	be	VBZ	VBZ	_	15	auxpass	_	_
15	regulated	regulate	VBN	VBN	_	12	acl:relcl	_	_
16	by	by	IN	IN	_	17	case	_	_
17	Sp1	sp1	NN	NN	_	15	nmod	_	_
18	,	,	,	,	_	17	punct	_	_
19	PU.1	pu.1	NN	NN	_	17	conj	_	_
20	,	,	,	,	_	17	punct	_	_
21	and	and	CC	CC	_	17	cc	_	_
22	a	a	DT	DT	_	25	det	_	_
23	novel	novel	JJ	JJ	_	25	amod	_	_
24	transcription	transcription	NN	NN	_	25	compound	_	_
25	factor	factor	NN	NN	_	17	conj	_	_
26	.	.	.	.	_	2	punct	_	_

1	DNA	dna	NN	NN	_	3	compound	_	_
2	triplex	triplex	NN	NN	_	3	compound	_	_
3	formation	formation	NN	NN	_	5	nsubj	_	_
4	selectively	selectively	RB	RB	_	5	advmod	_	_
5	inhibits	inhibit	VBZ	VBZ	_	0	root	_	_
6	granulocyte-macrophage	granulocyte-macrophage	JJ	JJ	_	9	amod	_	_
7	colony-stimulating	colony-stimulating	JJ	JJ	_	9	amod	_	_
8	factor	factor	NN	NN	_	9	compound	_	_
9	gene	gene	NN	NN	_	10	compound	_	_
10	expression	expression	NN	NN	_	5	dobj	_	_
11	in	in	IN	IN	_	14	case	_	_
12	human	human	JJ	JJ	_	14	amod	_	_
13	T	t	NN	NN	_	14	compound	_	_
14	cells	cell	NNS	NNS	_	10	nmod	_	_
15	.	.	.	.	_	5	punct	_	_

1	Granulocyte-macrophage	granulocyte-macrophage	JJ	JJ	_	3	amod	_	_
2	colony-stimulating	colony-stimulating	JJ	JJ	_	3	amod	_	_
3	factor	factor	NN	NN	_	11	nsubj	_	_
4	(	(	-LRB-	-LRB-	_	5	punct	_	_
5	GM-CSF	gm-csf	NN	NN	_	3	appos	_	_
6	)	)	-RRB-	-RRB-	_	5	punct	_	_
7	is	be	VBZ	VBZ	_	11	cop	_	_
8	a	a	DT	DT	_	11	det	_	_
9	hemopoietic	hemopoietic	JJ	JJ	_	11	amod	_	_
10	growth	growth	NN	NN	_	11	compound	_	_
11	factor	factor	NN	NN	_	0	root	_	_
12	that	that	WDT	WDT	_	14	nsubjpass	_	_
13	is	be	VBZ	VBZ	_	14	auxpass	_	_
14	expressed	express	VBN	VBN	_	11	acl:relcl	_	_
15	in	in	IN	IN	_	18	case	_	_
16	activated	activate	VBN	VBN	_	18	amod	_	_
17	T	t	NN	NN	_	18	compound	_	_
18	cells	cell	NNS	NNS	_	14	nmod	_	_
19	,	,	,	,	_	18	punct	_	_
20	fibroblasts	fibroblast	NNS	NNS	_	18	conj	_	_
21	,	,	,	,	_	18	punct	_	_
22	macrophages	macrophage	NNS	NNS	_	18	conj	_	_
23	,	,	,	,	_	18	punct	_	_
24	and	and	CC	CC	_	18	cc	_	_
25	endothelial	endothelial	JJ	JJ	_	26	amod	_	_
26	cells	cell	NNS	NNS	_	18	conj	_	_
27	.	.	.	.	_	11	punct	_	_

1	Although	although	IN	IN	_	5	mark	_	_
2	GM-CSF	gm-csf	NN	NN	_	5	nsubj	_	_
3	does	do	VBZ	VBZ	_	5	aux	_	_
4	not	not	RB	RB	_	5	neg	_	_
5	appear	appear	VB	VB	_	18	advcl	_	_
6	to	to	TO	TO	_	8	mark	_	_
7	be	be	VB	VB	_	8	cop	_	_
8	essential	essential	JJ	JJ	_	5	xcomp	_	_
9	for	for	IN	IN	_	11	case	_	_
10	normal	normal	JJ	JJ	_	11	amod	_	_
11	hemopoiesis	hemopoiesis	NN	NN	_	8	nmod	_	_
12	,	,	,	,	_	18	punct	_	_
13	overexpression	overexpression	NN	NN	_	18	nsubjpass	_	_
14	of	of	IN	IN	_	15	case	_	_
15	GM-CSF	gm-csf	NN	NN	_	13	nmod	_	_
16	has	have	VBZ	VBZ	_	18	aux	_	_
17	been	be	VBN	VBN	_	18	auxpass	_	_
18	implicated	implicate	VBN	VBN	_	0	root	_	_
19	in	in	IN	IN	_	21	case	_	_
20	the	the	DT	DT	_	21	det	_	_
21	pathogenesis	pathogenesis	NN	NN	_	18	nmod	_	_
22	of	of	IN	IN	_	24	case	_	_
23	some	some	DT	DT	_	24	det	_	_
24	diseases	disease	NNS	NNS	_	21	nmod	_	_
25	such	such	JJ	JJ	_	28	case	_	_
26	as	as	IN	IN	_	25	mwe	_	_
27	myeloid	myeloid	JJ	JJ	_	28	amod	_	_
28	leukemia	leukemia	NN	NN	_	24	nmod	_	_
29	and	and	CC	CC	_	28	cc	_	_
30	chronic	chronic	JJ	JJ	_	31	amod	_	_
31	inflammation	inflammation	NN	NN	_	28	conj	_	_
32	.	.	.	.	_	18	punct	_	_

1	An	a	DT	DT	_	4	det	_	_
2	NF-kappaB/Rel	nf-kappab/rel	NN	NN	_	4	compound	_	_
3	binding	binding	NN	NN	_	4	compound	_	_
4	site	site	NN	NN	_	14	nsubj	_	_
5	within	within	IN	IN	_	8	case	_	_
6	the	the	DT	DT	_	8	det	_	_
7	GM-CSF	gm-csf	NN	NN	_	8	compound	_	_
8	promoter	promoter	NN	NN	_	4	nmod	_	_
9	,	,	,	,	_	4	punct	_	_
10	termed	term	VBN	VBN	_	4	acl	_	_
11	the	the	DT	DT	_	13	det	_	_
12	kappaB	kappab	NN	NN	_	13	compound	_	_
13	element	element	NN	NN	_	10	xcomp	_	_
14	appears	appear	VBZ	VBZ	_	0	root	_	_
15	to	to	TO	TO	_	17	mark	_	_
16	be	be	VB	VB	_	17	cop	_	_
17	important	important	JJ	JJ	_	14	xcomp	_	_
18	for	for	IN	IN	_	19	mark	_	_
19	controlling	control	VBG	VBG	_	17	advcl	_	_
20	expression	expression	NN	NN	_	19	dobj	_	_
21	in	in	IN	IN	_	24	case	_	_
22	reporter	reporter	NN	NN	_	23	compound	_	_
23	gene	gene	NN	NN	_	24	compound	_	_
24	assays	assay	NNS	NNS	_	20	nmod	_	_
25	in	in	IN	IN	_	26	case	_	_
26	response	response	NN	NN	_	20	nmod	_	_
27	to	to	TO	TO	_	29	case	_	_
28	a	a	DT	DT	_	29	det	_	_
29	number	number	NN	NN	_	26	nmod	_	_
30	of	of	IN	IN	_	31	case	_	_
31	stimuli	stimulus	NNS	NNS	_	29	nmod	_	_
32	in	in	IN	IN	_	34	case	_	_
33	T	t	NN	NN	_	34	compound	_	_
34	cells	cell	NNS	NNS	_	29	nmod	_	_
35	.	.	.	.	_	14	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	investigated	investigate	VBD	VBD	_	0	root	_	_
3	oligonucleotide-directed	oligonucleotide-directed	JJ	JJ	_	6	amod	_	_
4	triple	triple	JJ	JJ	_	3	dep	_	_
5	helix	helix	NN	NN	_	6	compound	_	_
6	formation	formation	NN	NN	_	2	dobj	_	_
7	across	across	IN	IN	_	10	case	_	_
8	this	this	DT	DT	_	10	det	_	_
9	regulatory	regulatory	JJ	JJ	_	10	amod	_	_
10	sequence	sequence	NN	NN	_	6	nmod	_	_
11	as	as	IN	IN	_	14	case	_	_
12	a	a	DT	DT	_	14	det	_	_
13	potential	potential	JJ	JJ	_	14	amod	_	_
14	tool	tool	NN	NN	_	2	nmod	_	_
15	to	to	TO	TO	_	16	mark	_	_
16	inhibit	inhibit	VB	VB	_	14	acl	_	_
17	GM-CSF	gm-csf	NN	NN	_	19	compound	_	_
18	gene	gene	NN	NN	_	19	compound	_	_
19	transcription	transcription	NN	NN	_	16	dobj	_	_
20	.	.	.	.	_	2	punct	_	_

1	A	a	DT	DT	_	3	det	_	_
2	15-base	15-base	NN	NN	_	3	compound	_	_
3	oligonucleotide	oligonucleotide	NN	NN	_	8	nsubjpass	_	_
4	,	,	,	,	_	3	punct	_	_
5	GM3	gm3	NN	NN	_	3	appos	_	_
6	,	,	,	,	_	3	punct	_	_
7	was	be	VBD	VBD	_	8	auxpass	_	_
8	targeted	target	VBN	VBN	_	0	root	_	_
9	to	to	TO	TO	_	12	case	_	_
10	a	a	DT	DT	_	12	det	_	_
11	purine-rich	purine-rich	JJ	JJ	_	12	amod	_	_
12	region	region	NN	NN	_	8	nmod	_	_
13	in	in	IN	IN	_	17	case	_	_
14	the	the	DT	DT	_	17	det	_	_
15	GM-CSF	gm-csf	NN	NN	_	17	compound	_	_
16	proximal	proximal	JJ	JJ	_	17	amod	_	_
17	promoter	promoter	NN	NN	_	12	nmod	_	_
18	,	,	,	,	_	12	punct	_	_
19	which	which	WDT	WDT	_	20	nsubj	_	_
20	overlaps	overlap	VBZ	VBZ	_	12	acl:relcl	_	_
21	the	the	DT	DT	_	23	det	_	_
22	kappaB	kappab	NN	NN	_	23	compound	_	_
23	element	element	NN	NN	_	20	dobj	_	_
24	.	.	.	.	_	8	punct	_	_

1	Gel	gel	NN	NN	_	4	compound	_	_
2	mobility	mobility	NN	NN	_	4	compound	_	_
3	shift	shift	NN	NN	_	4	compound	_	_
4	assays	assay	NNS	NNS	_	9	nsubj	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	DNase	dnase	NN	NN	_	8	compound	_	_
7	I	i	CD	CD	_	6	nummod	_	_
8	footprinting	footprinting	NN	NN	_	4	conj	_	_
9	demonstrated	demonstrate	VBD	VBD	_	0	root	_	_
10	that	that	IN	IN	_	12	mark	_	_
11	GM3	gm3	NN	NN	_	12	nsubj	_	_
12	formed	form	VBD	VBD	_	9	ccomp	_	_
13	a	a	DT	DT	_	16	det	_	_
14	sequence-specific	sequence-specific	JJ	JJ	_	16	amod	_	_
15	collinear	collinear	NN	NN	_	16	compound	_	_
16	triplex	triplex	NN	NN	_	12	dobj	_	_
17	with	with	IN	IN	_	21	case	_	_
18	its	its	PRP$	PRP$	_	21	nmod:poss	_	_
19	double-stranded	double-stranded	JJ	JJ	_	21	amod	_	_
20	DNA	dna	NN	NN	_	21	compound	_	_
21	target	target	NN	NN	_	12	nmod	_	_
22	.	.	.	.	_	9	punct	_	_

1	Triplex	triplex	JJ	JJ	_	2	amod	_	_
2	formation	formation	NN	NN	_	5	nsubj	_	_
3	by	by	IN	IN	_	4	case	_	_
4	GM3	gm3	NN	NN	_	2	nmod	_	_
5	blocked	block	VBD	VBD	_	0	root	_	_
6	recombinant	recombinant	JJ	JJ	_	5	dobj	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	nuclear	nuclear	JJ	JJ	_	6	conj	_	_
9	NF-kappaB	nf-kappab	NN	NN	_	10	compound	_	_
10	proteins	protein	NNS	NNS	_	6	dep	_	_
11	binding	bind	VBG	VBG	_	10	amod	_	_
12	to	to	TO	TO	_	15	case	_	_
13	the	the	DT	DT	_	15	det	_	_
14	GM-CSF	gm-csf	NN	NN	_	15	compound	_	_
15	element	element	NN	NN	_	6	nmod	_	_
16	.	.	.	.	_	5	punct	_	_

1	GM3	gm3	NN	NN	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	caused	cause	VBD	VBD	_	0	root	_	_
4	selective	selective	JJ	JJ	_	5	amod	_	_
5	inhibition	inhibition	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	15	case	_	_
7	the	the	DT	DT	_	15	det	_	_
8	human	human	JJ	JJ	_	12	amod	_	_
9	T-cell	t-cell	NN	NN	_	12	compound	_	_
10	lymphotrophic	lymphotrophic	JJ	JJ	_	12	amod	_	_
11	virus-1	virus-1	NN	NN	_	12	compound	_	_
12	Tax	tax	NN	NN	_	15	compound	_	_
13	transactivator-induced	transactivator-induced	JJ	JJ	_	15	amod	_	_
14	luciferase	luciferase	NN	NN	_	15	compound	_	_
15	activity	activity	NN	NN	_	5	nmod	_	_
16	from	from	IN	IN	_	19	case	_	_
17	a	a	DT	DT	_	19	det	_	_
18	reporter	reporter	NN	NN	_	19	compound	_	_
19	construct	construct	NN	NN	_	15	nmod	_	_
20	driven	drive	VBN	VBN	_	19	acl	_	_
21	by	by	IN	IN	_	24	case	_	_
22	the	the	DT	DT	_	24	det	_	_
23	GM-CSF	gm-csf	NN	NN	_	24	compound	_	_
24	promoter	promoter	NN	NN	_	20	nmod	_	_
25	in	in	IN	IN	_	28	case	_	_
26	Jurkat	jurkat	NN	NN	_	28	compound	_	_
27	T	t	NN	NN	_	28	compound	_	_
28	cells	cell	NNS	NNS	_	24	nmod	_	_
29	.	.	.	.	_	3	punct	_	_

1	Finally	finally	RB	RB	_	5	advmod	_	_
2	,	,	,	,	_	5	punct	_	_
3	GM3	gm3	NN	NN	_	5	nsubj	_	_
4	greatly	greatly	RB	RB	_	5	advmod	_	_
5	reduced	reduce	VBD	VBD	_	0	root	_	_
6	the	the	DT	DT	_	7	det	_	_
7	concentration	concentration	NN	NN	_	5	dobj	_	_
8	of	of	IN	IN	_	11	case	_	_
9	endogenous	endogenous	JJ	JJ	_	11	amod	_	_
10	GM-CSF	gm-csf	NN	NN	_	11	compound	_	_
11	mRNA	mrna	NN	NN	_	7	nmod	_	_
12	induced	induce	VBN	VBN	_	11	acl	_	_
13	by	by	IN	IN	_	15	case	_	_
14	different	different	JJ	JJ	_	15	amod	_	_
15	stimuli	stimulus	NNS	NNS	_	12	nmod	_	_
16	in	in	IN	IN	_	19	case	_	_
17	Jurkat	jurkat	NN	NN	_	19	compound	_	_
18	T	t	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	15	nmod	_	_
20	but	but	CC	CC	_	5	cc	_	_
21	did	do	VBD	VBD	_	23	aux	_	_
22	not	not	RB	RB	_	23	neg	_	_
23	affect	affect	VB	VB	_	5	conj	_	_
24	interleukin	interleukin	NN	NN	_	26	compound	_	_
25	3	3	CD	CD	_	26	nummod	_	_
26	mRNA	mrna	NN	NN	_	27	compound	_	_
27	levels	level	NNS	NNS	_	23	dobj	_	_
28	in	in	IN	IN	_	31	case	_	_
29	the	the	DT	DT	_	31	det	_	_
30	same	same	JJ	JJ	_	31	amod	_	_
31	cells	cell	NNS	NNS	_	27	nmod	_	_
32	.	.	.	.	_	5	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	conclude	conclude	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	11	mark	_	_
4	the	the	DT	DT	_	6	det	_	_
5	kappaB	kappab	NN	NN	_	6	compound	_	_
6	element	element	NN	NN	_	11	nsubj	_	_
7	in	in	IN	IN	_	10	case	_	_
8	the	the	DT	DT	_	10	det	_	_
9	GM-CSF	gm-csf	NN	NN	_	10	compound	_	_
10	promoter	promoter	NN	NN	_	6	nmod	_	_
11	plays	play	VBZ	VBZ	_	2	ccomp	_	_
12	a	a	DT	DT	_	14	det	_	_
13	central	central	JJ	JJ	_	14	amod	_	_
14	role	role	NN	NN	_	11	dobj	_	_
15	in	in	IN	IN	_	18	case	_	_
16	the	the	DT	DT	_	18	det	_	_
17	transcriptional	transcriptional	JJ	JJ	_	18	amod	_	_
18	activation	activation	NN	NN	_	11	nmod	_	_
19	of	of	IN	IN	_	23	case	_	_
20	the	the	DT	DT	_	23	det	_	_
21	endogenous	endogenous	JJ	JJ	_	23	amod	_	_
22	GM-CSF	gm-csf	NN	NN	_	23	compound	_	_
23	gene	gene	NN	NN	_	18	nmod	_	_
24	.	.	.	.	_	2	punct	_	_

1	Colinear	colinear	JJ	JJ	_	3	amod	_	_
2	triplex	triplex	NN	NN	_	3	compound	_	_
3	formation	formation	NN	NN	_	4	nsubj	_	_
4	acts	act	VBZ	VBZ	_	0	root	_	_
5	as	as	IN	IN	_	9	case	_	_
6	a	a	DT	DT	_	9	det	_	_
7	selective	selective	JJ	JJ	_	9	amod	_	_
8	transcriptional	transcriptional	JJ	JJ	_	9	amod	_	_
9	repressor	repressor	NN	NN	_	4	nmod	_	_
10	of	of	IN	IN	_	13	case	_	_
11	the	the	DT	DT	_	13	det	_	_
12	GM-CSF	gm-csf	NN	NN	_	13	compound	_	_
13	gene	gene	NN	NN	_	9	nmod	_	_
14	and	and	CC	CC	_	4	cc	_	_
15	may	may	MD	MD	_	16	aux	_	_
16	have	have	VB	VB	_	4	conj	_	_
17	potential	potential	JJ	JJ	_	18	amod	_	_
18	therapeutic	therapeutic	JJ	JJ	_	19	amod	_	_
19	application	application	NN	NN	_	16	dobj	_	_
20	in	in	IN	IN	_	21	case	_	_
21	cases	case	NNS	NNS	_	16	nmod	_	_
22	of	of	IN	IN	_	24	case	_	_
23	undesirable	undesirable	JJ	JJ	_	24	amod	_	_
24	overexpression	overexpression	NN	NN	_	21	nmod	_	_
25	of	of	IN	IN	_	27	case	_	_
26	this	this	DT	DT	_	27	det	_	_
27	protein	protein	NN	NN	_	24	nmod	_	_
28	.	.	.	.	_	4	punct	_	_

1	Induction	induction	NN	NN	_	0	root	_	_
2	of	of	IN	IN	_	3	case	_	_
3	CIITA	ciita	NN	NN	_	1	nmod	_	_
4	and	and	CC	CC	_	1	cc	_	_
5	modification	modification	NN	NN	_	1	conj	_	_
6	of	of	IN	IN	_	11	case	_	_
7	in	in	FW	FW	_	11	amod	_	_
8	vivo	vivo	FW	FW	_	7	dep	_	_
9	HLA-DR	hla-dr	NN	NN	_	10	compound	_	_
10	promoter	promoter	NN	NN	_	11	compound	_	_
11	occupancy	occupancy	NN	NN	_	5	nmod	_	_
12	in	in	IN	IN	_	16	case	_	_
13	normal	normal	JJ	JJ	_	16	amod	_	_
14	thymic	thymic	JJ	JJ	_	16	amod	_	_
15	epithelial	epithelial	JJ	JJ	_	16	amod	_	_
16	cells	cell	NNS	NNS	_	1	nmod	_	_
17	treated	treat	VBN	VBN	_	16	acl	_	_
18	with	with	IN	IN	_	19	case	_	_
19	IFN-gamma	ifn-gamma	NN	NN	_	17	nmod	_	_
20	:	:	:	:	_	1	punct	_	_
21	similarities	similarity	NNS	NNS	_	1	dep	_	_
22	and	and	CC	CC	_	21	cc	_	_
23	distinctions	distinction	NNS	NNS	_	21	conj	_	_
24	with	with	IN	IN	_	25	case	_	_
25	respect	respect	NN	NN	_	21	nmod	_	_
26	to	to	TO	TO	_	29	case	_	_
27	HLA-DR-constitutive	hla-dr-constitutive	JJ	JJ	_	29	amod	_	_
28	B	b	NN	NN	_	29	compound	_	_
29	cells	cell	NNS	NNS	_	25	nmod	_	_
30	.	.	.	.	_	1	punct	_	_

1	In	in	IN	IN	_	3	case	_	_
2	this	this	DT	DT	_	3	det	_	_
3	study	study	NN	NN	_	25	nmod	_	_
4	,	,	,	,	_	25	punct	_	_
5	the	the	DT	DT	_	7	det	_	_
6	IFN-gamma	ifn-gamma	NN	NN	_	7	compound	_	_
7	induction	induction	NN	NN	_	25	nsubjpass	_	_
8	of	of	IN	IN	_	13	case	_	_
9	MHC	mhc	NN	NN	_	12	compound	_	_
10	class	class	NN	NN	_	12	compound	_	_
11	II	ii	CD	CD	_	12	nummod	_	_
12	gene	gene	NN	NN	_	13	compound	_	_
13	expression	expression	NN	NN	_	7	nmod	_	_
14	in	in	IN	IN	_	16	case	_	_
15	primary	primary	JJ	JJ	_	16	amod	_	_
16	cultures	culture	NNS	NNS	_	7	nmod	_	_
17	of	of	IN	IN	_	20	case	_	_
18	thymic	thymic	JJ	JJ	_	20	amod	_	_
19	epithelial	epithelial	JJ	JJ	_	20	amod	_	_
20	cells	cell	NNS	NNS	_	16	nmod	_	_
21	(	(	-LRB-	-LRB-	_	22	punct	_	_
22	TEC	tec	NN	NN	_	20	appos	_	_
23	)	)	-RRB-	-RRB-	_	22	punct	_	_
24	was	be	VBD	VBD	_	25	auxpass	_	_
25	analyzed	analyze	VBN	VBN	_	0	root	_	_
26	.	.	.	.	_	25	punct	_	_

1	This	this	DT	DT	_	3	det	_	_
2	cellular	cellular	JJ	JJ	_	3	amod	_	_
3	system	system	NN	NN	_	4	nsubj	_	_
4	offers	offer	VBZ	VBZ	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	advantage	advantage	NN	NN	_	4	dobj	_	_
7	that	that	IN	IN	_	13	mark	_	_
8	MHC	mhc	NN	NN	_	9	compound	_	_
9	class	class	NN	NN	_	11	compound	_	_
10	II	ii	CD	CD	_	9	nummod	_	_
11	induction	induction	NN	NN	_	13	nsubjpass	_	_
12	is	be	VBZ	VBZ	_	13	auxpass	_	_
13	studied	study	VBN	VBN	_	6	ccomp	_	_
14	in	in	IN	IN	_	19	case	_	_
15	a	a	DT	DT	_	19	det	_	_
16	``	``	``	``	_	19	punct	_	_
17	physiologic	physiologic	JJ	JJ	_	19	amod	_	_
18	cell	cell	NN	NN	_	19	compound	_	_
19	lineage	lineage	NN	NN	_	13	nmod	_	_
20	that	that	WDT	WDT	_	33	nsubjpass	_	_
21	,	,	,	,	_	33	punct	_	_
22	as	as	IN	IN	_	24	case	_	_
23	a	a	DT	DT	_	24	det	_	_
24	result	result	NN	NN	_	33	nmod	_	_
25	of	of	IN	IN	_	27	case	_	_
26	this	this	DT	DT	_	27	det	_	_
27	expression	expression	NN	NN	_	24	nmod	_	_
28	within	within	IN	IN	_	30	case	_	_
29	the	the	DT	DT	_	30	det	_	_
30	thymus	thymus	NN	NN	_	27	nmod	_	_
31	,	,	,	,	_	33	punct	_	_
32	is	be	VBZ	VBZ	_	33	auxpass	_	_
33	thought	think	VBN	VBN	_	19	acl:relcl	_	_
34	to	to	TO	TO	_	35	mark	_	_
35	participate	participate	VB	VB	_	33	xcomp	_	_
36	to	to	TO	TO	_	38	case	_	_
37	the	the	DT	DT	_	38	dep	_	_
38	selection	selection	NN	NN	_	35	nmod	_	_
39	and	and	CC	CC	_	38	cc	_	_
40	maturation	maturation	NN	NN	_	38	conj	_	_
41	of	of	IN	IN	_	44	case	_	_
42	the	the	DT	DT	_	44	det	_	_
43	T	t	NN	NN	_	44	compound	_	_
44	cells	cell	NNS	NNS	_	38	nmod	_	_
45	.	.	.	.	_	4	punct	_	_

1	It	it	PRP	PRP	_	3	nsubjpass	_	_
2	was	be	VBD	VBD	_	3	auxpass	_	_
3	found	find	VBN	VBN	_	0	root	_	_
4	that	that	IN	IN	_	12	mark	_	_
5	the	the	DT	DT	_	10	det	_	_
6	MHC	mhc	NN	NN	_	9	compound	_	_
7	class	class	NN	NN	_	9	compound	_	_
8	II	ii	CD	CD	_	9	nummod	_	_
9	gene	gene	NN	NN	_	10	compound	_	_
10	expression	expression	NN	NN	_	12	nsubjpass	_	_
11	was	be	VBD	VBD	_	12	auxpass	_	_
12	associated	associate	VBN	VBN	_	3	ccomp	_	_
13	with	with	IN	IN	_	17	case	_	_
14	the	the	DT	DT	_	17	det	_	_
15	de	de	FW	FW	_	17	amod	_	_
16	novo	novo	FW	FW	_	15	dep	_	_
17	transcription	transcription	NN	NN	_	12	nmod	_	_
18	of	of	IN	IN	_	20	case	_	_
19	the	the	DT	DT	_	20	det	_	_
20	gene	gene	NN	NN	_	17	nmod	_	_
21	encoding	encode	VBG	VBG	_	20	acl	_	_
22	the	the	DT	DT	_	24	det	_	_
23	CIITA	ciita	NN	NN	_	24	compound	_	_
24	trans-activator	trans-activator	NN	NN	_	21	dobj	_	_
25	,	,	,	,	_	24	punct	_	_
26	a	a	DT	DT	_	33	det	_	_
27	crucial	crucial	JJ	JJ	_	33	amod	_	_
28	MHC	mhc	NN	NN	_	33	compound	_	_
29	class	class	NN	NN	_	33	compound	_	_
30	II	ii	CD	CD	_	33	nummod	_	_
31	gene	gene	NN	NN	_	33	compound	_	_
32	regulatory	regulatory	JJ	JJ	_	33	amod	_	_
33	factor	factor	NN	NN	_	24	appos	_	_
34	.	.	.	.	_	3	punct	_	_

1	Furthermore	furthermore	RB	RB	_	19	advmod	_	_
2	,	,	,	,	_	19	punct	_	_
3	the	the	DT	DT	_	4	det	_	_
4	anatomy	anatomy	NN	NN	_	19	nsubjpass	_	_
5	of	of	IN	IN	_	6	case	_	_
6	interaction	interaction	NN	NN	_	4	nmod	_	_
7	between	between	IN	IN	_	13	case	_	_
8	the	the	DT	DT	_	13	dep	_	_
9	MHC	mhc	NN	NN	_	13	compound	_	_
10	class	class	NN	NN	_	13	compound	_	_
11	II	ii	CD	CD	_	13	nummod	_	_
12	DRA	dra	NN	NN	_	13	compound	_	_
13	promoter	promoter	NN	NN	_	6	nmod	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	corresponding	corresponding	JJ	JJ	_	17	amod	_	_
16	binding	bind	VBG	VBG	_	17	amod	_	_
17	factors	factor	NNS	NNS	_	13	conj	_	_
18	was	be	VBD	VBD	_	19	auxpass	_	_
19	analyzed	analyze	VBN	VBN	_	0	root	_	_
20	by	by	IN	IN	_	25	case	_	_
21	in	in	FW	FW	_	25	amod	_	_
22	vivo	vivo	FW	FW	_	21	dep	_	_
23	DNAse	dnase	NN	NN	_	24	compound	_	_
24	I	i	NN	NN	_	25	compound	_	_
25	footprint	footprint	NN	NN	_	19	nmod	_	_
26	.	.	.	.	_	19	punct	_	_

1	It	it	PRP	PRP	_	3	nsubjpass	_	_
2	was	be	VBD	VBD	_	3	auxpass	_	_
3	found	find	VBN	VBN	_	0	root	_	_
4	that	that	IN	IN	_	8	mark	_	_
5	treatment	treatment	NN	NN	_	8	nsubj	_	_
6	with	with	IN	IN	_	7	case	_	_
7	IFN-gamma	ifn-gamma	NN	NN	_	5	nmod	_	_
8	induces	induce	VBZ	VBZ	_	3	ccomp	_	_
9	changes	change	NNS	NNS	_	8	dobj	_	_
10	in	in	IN	IN	_	12	case	_	_
11	the	the	DT	DT	_	12	det	_	_
12	occupancy	occupancy	NN	NN	_	9	nmod	_	_
13	of	of	IN	IN	_	18	case	_	_
14	the	the	DT	DT	_	18	det	_	_
15	DRA	dra	NN	NN	_	18	compound	_	_
16	gene	gene	NN	NN	_	18	compound	_	_
17	regulatory	regulatory	JJ	JJ	_	18	amod	_	_
18	sequences	sequence	NNS	NNS	_	12	nmod	_	_
19	by	by	IN	IN	_	21	case	_	_
20	nuclear	nuclear	JJ	JJ	_	21	amod	_	_
21	factors	factor	NNS	NNS	_	12	nmod	_	_
22	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	resulting	result	VBG	VBG	_	3	amod	_	_
3	occupancy	occupancy	NN	NN	_	4	nsubj	_	_
4	displays	display	VBZ	VBZ	_	0	root	_	_
5	strong	strong	JJ	JJ	_	6	amod	_	_
6	similarities	similarity	NNS	NNS	_	4	dobj	_	_
7	with	with	IN	IN	_	9	case	_	_
8	the	the	DT	DT	_	9	det	_	_
9	one	one	CD	CD	_	6	nmod	_	_
10	observed	observe	VBN	VBN	_	9	acl	_	_
11	in	in	IN	IN	_	17	case	_	_
12	the	the	DT	DT	_	17	det	_	_
13	MHC	mhc	NN	NN	_	17	compound	_	_
14	class	class	NN	NN	_	17	compound	_	_
15	II-constitutive	ii-constitutive	JJ	JJ	_	17	amod	_	_
16	B	b	NN	NN	_	17	compound	_	_
17	cells	cell	NNS	NNS	_	10	nmod	_	_
18	,	,	,	,	_	17	punct	_	_
19	represented	represent	VBN	VBN	_	17	acl	_	_
20	by	by	IN	IN	_	26	case	_	_
21	both	both	CC	CC	_	26	cc:preconj	_	_
22	the	the	DT	DT	_	26	dep	_	_
23	Burkitt	burkitt	NN	NN	_	26	compound	_	_
24	lymphoma	lymphoma	NN	NN	_	26	compound	_	_
25	line	line	NN	NN	_	26	compound	_	_
26	Raji	raji	NN	NN	_	19	nmod	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	normal	normal	JJ	JJ	_	31	amod	_	_
29	tonsil-derived	tonsil-derived	JJ	JJ	_	31	amod	_	_
30	B	b	NN	NN	_	31	compound	_	_
31	cells	cell	NNS	NNS	_	26	conj	_	_
32	.	.	.	.	_	4	punct	_	_

1	However	however	RB	RB	_	7	advmod	_	_
2	,	,	,	,	_	7	punct	_	_
3	some	some	DT	DT	_	5	det	_	_
4	peculiar	peculiar	JJ	JJ	_	5	amod	_	_
5	differences	difference	NNS	NNS	_	7	nsubjpass	_	_
6	were	be	VBD	VBD	_	7	auxpass	_	_
7	observed	observe	VBN	VBN	_	0	root	_	_
8	between	between	IN	IN	_	10	case	_	_
9	the	the	DT	DT	_	10	det	_	_
10	TEC	tec	NN	NN	_	7	nmod	_	_
11	,	,	,	,	_	10	punct	_	_
12	either	either	CC	CC	_	13	cc:preconj	_	_
13	IFN-gamma-induced	ifn-gamma-induced	JJ	JJ	_	10	amod	_	_
14	or	or	CC	CC	_	13	cc	_	_
15	not	not	RB	RB	_	13	conj	_	_
16	,	,	,	,	_	10	punct	_	_
17	and	and	CC	CC	_	10	cc	_	_
18	the	the	DT	DT	_	21	det	_	_
19	constitutive	constitutive	JJ	JJ	_	21	amod	_	_
20	B	b	NN	NN	_	21	compound	_	_
21	cells	cell	NNS	NNS	_	10	conj	_	_
22	.	.	.	.	_	7	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	23	mark	_	_
5	both	both	CC	CC	_	7	cc:preconj	_	_
6	common	common	JJ	JJ	_	7	amod	_	_
7	mechanisms	mechanism	NNS	NNS	_	23	nsubj	_	_
8	,	,	,	,	_	7	punct	_	_
9	such	such	JJ	JJ	_	12	case	_	_
10	as	as	IN	IN	_	9	mwe	_	_
11	the	the	DT	DT	_	12	det	_	_
12	one	one	CD	CD	_	7	nmod	_	_
13	mediated	mediate	VBN	VBN	_	12	acl	_	_
14	by	by	IN	IN	_	17	case	_	_
15	the	the	DT	DT	_	17	det	_	_
16	CIITA	ciita	NN	NN	_	17	compound	_	_
17	trans-activator	trans-activator	NN	NN	_	13	nmod	_	_
18	,	,	,	,	_	7	punct	_	_
19	and	and	CC	CC	_	7	cc	_	_
20	distinct	distinct	JJ	JJ	_	21	amod	_	_
21	tissue-specific	tissue-specific	JJ	JJ	_	22	amod	_	_
22	constraints	constraint	NNS	NNS	_	7	conj	_	_
23	contribute	contribute	VBP	VBP	_	3	ccomp	_	_
24	to	to	TO	TO	_	27	case	_	_
25	the	the	DT	DT	_	27	det	_	_
26	transcriptional	transcriptional	JJ	JJ	_	27	amod	_	_
27	control	control	NN	NN	_	23	nmod	_	_
28	of	of	IN	IN	_	36	case	_	_
29	constitutive	constitutive	JJ	JJ	_	36	amod	_	_
30	and	and	CC	CC	_	29	cc	_	_
31	IFN-gamma-induced	ifn-gamma-induced	JJ	JJ	_	29	conj	_	_
32	MHC	mhc	NN	NN	_	35	compound	_	_
33	class	class	NN	NN	_	35	compound	_	_
34	II	ii	CD	CD	_	35	nummod	_	_
35	gene	gene	NN	NN	_	36	compound	_	_
36	expression	expression	NN	NN	_	27	nmod	_	_
37	.	.	.	.	_	3	punct	_	_

1	Antisense	antisense	JJ	JJ	_	2	amod	_	_
2	inhibition	inhibition	NN	NN	_	8	nsubj	_	_
3	of	of	IN	IN	_	7	case	_	_
4	vitamin	vitamin	NN	NN	_	6	compound	_	_
5	D	d	NN	NN	_	6	compound	_	_
6	receptor	receptor	NN	NN	_	7	compound	_	_
7	expression	expression	NN	NN	_	2	nmod	_	_
8	induces	induce	VBZ	VBZ	_	0	root	_	_
9	apoptosis	apoptosis	NN	NN	_	8	dobj	_	_
10	in	in	IN	IN	_	13	case	_	_
11	monoblastoid	monoblastoid	JJ	JJ	_	13	amod	_	_
12	U937	u937	NN	NN	_	13	compound	_	_
13	cells	cell	NNS	NNS	_	8	nmod	_	_
14	.	.	.	.	_	8	punct	_	_

1	The	the	DT	DT	_	6	det	_	_
2	active	active	JJ	JJ	_	6	amod	_	_
3	vitamin	vitamin	NN	NN	_	6	compound	_	_
4	D3	d3	NN	NN	_	6	compound	_	_
5	metabolite	metabolite	NN	NN	_	6	compound	_	_
6	1,25-dihydroxycholecalciferol	1,25-dihydroxycholecalciferol	NN	NN	_	10	nsubj	_	_
7	(	(	-LRB-	-LRB-	_	8	punct	_	_
8	1,25(OH)2D3	1,25(oh)2d3	NN	NN	_	6	appos	_	_
9	)	)	-RRB-	-RRB-	_	8	punct	_	_
10	acts	act	VBZ	VBZ	_	0	root	_	_
11	as	as	IN	IN	_	16	case	_	_
12	an	a	DT	DT	_	16	det	_	_
13	antiproliferative	antiproliferative	JJ	JJ	_	16	amod	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	differentiating	differentiate	VBG	VBG	_	13	conj	_	_
16	agent	agent	NN	NN	_	10	nmod	_	_
17	for	for	IN	IN	_	22	case	_	_
18	the	the	DT	DT	_	22	det	_	_
19	monoblastoid	monoblastoid	JJ	JJ	_	22	amod	_	_
20	cell	cell	NN	NN	_	22	compound	_	_
21	line	line	NN	NN	_	22	compound	_	_
22	U937	u937	NN	NN	_	16	nmod	_	_
23	and	and	CC	CC	_	16	cc	_	_
24	as	as	IN	IN	_	28	case	_	_
25	an	a	DT	DT	_	28	det	_	_
26	important	important	JJ	JJ	_	28	amod	_	_
27	immunologic	immunologic	JJ	JJ	_	26	dep	_	_
28	mediator	mediator	NN	NN	_	16	conj	_	_
29	implicated	implicate	VBN	VBN	_	28	acl	_	_
30	particularly	particularly	RB	RB	_	33	advmod	_	_
31	in	in	IN	IN	_	33	case	_	_
32	the	the	DT	DT	_	33	det	_	_
33	function	function	NN	NN	_	29	nmod	_	_
34	of	of	IN	IN	_	35	case	_	_
35	cells	cell	NNS	NNS	_	33	nmod	_	_
36	belonging	belong	VBG	VBG	_	35	acl	_	_
37	to	to	TO	TO	_	40	case	_	_
38	the	the	DT	DT	_	40	det	_	_
39	monocyte/macrophage	monocyte/macrophage	NN	NN	_	40	compound	_	_
40	lineage	lineage	NN	NN	_	36	nmod	_	_
41	.	.	.	.	_	10	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	effects	effect	NNS	NNS	_	4	nsubjpass	_	_
3	are	be	VBP	VBP	_	4	auxpass	_	_
4	controlled	control	VBN	VBN	_	0	root	_	_
5	by	by	IN	IN	_	9	case	_	_
6	the	the	DT	DT	_	9	det	_	_
7	vitamin	vitamin	NN	NN	_	9	compound	_	_
8	D	d	NN	NN	_	9	compound	_	_
9	receptor	receptor	NN	NN	_	4	nmod	_	_
10	(	(	-LRB-	-LRB-	_	11	punct	_	_
11	VDR	vdr	NN	NN	_	9	appos	_	_
12	)	)	-RRB-	-RRB-	_	11	punct	_	_
13	,	,	,	,	_	9	punct	_	_
14	a	a	DT	DT	_	15	det	_	_
15	member	member	NN	NN	_	9	appos	_	_
16	of	of	IN	IN	_	21	case	_	_
17	the	the	DT	DT	_	21	det	_	_
18	steroid	steroid	NN	NN	_	21	compound	_	_
19	hormone	hormone	NN	NN	_	21	compound	_	_
20	receptor	receptor	NN	NN	_	21	compound	_	_
21	family	family	NN	NN	_	15	nmod	_	_
22	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	objective	objective	NN	NN	_	6	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	this	this	DT	DT	_	5	det	_	_
5	study	study	NN	NN	_	2	nmod	_	_
6	was	be	VBD	VBD	_	0	root	_	_
7	to	to	TO	TO	_	8	mark	_	_
8	develop	develop	VB	VB	_	6	ccomp	_	_
9	U937	u937	NN	NN	_	10	compound	_	_
10	transfectants	transfectant	NNS	NNS	_	8	dobj	_	_
11	expressing	express	VBG	VBG	_	10	acl	_	_
12	antisense	antisense	JJ	JJ	_	14	amod	_	_
13	VDR	vdr	NN	NN	_	14	compound	_	_
14	mRNA	mrna	NN	NN	_	11	dobj	_	_
15	,	,	,	,	_	8	punct	_	_
16	and	and	CC	CC	_	8	cc	_	_
17	to	to	TO	TO	_	18	mark	_	_
18	use	use	VB	VB	_	8	conj	_	_
19	these	these	DT	DT	_	18	dobj	_	_
20	to	to	TO	TO	_	21	mark	_	_
21	examine	examine	VB	VB	_	18	xcomp	_	_
22	the	the	DT	DT	_	23	det	_	_
23	role	role	NN	NN	_	21	dobj	_	_
24	of	of	IN	IN	_	26	case	_	_
25	1,25(OH)2D3-VDR	1,25(oh)2d3-vdr	JJ	JJ	_	26	amod	_	_
26	interaction	interaction	NN	NN	_	23	nmod	_	_
27	in	in	IN	IN	_	29	case	_	_
28	this	this	DT	DT	_	29	det	_	_
29	lineage	lineage	NN	NN	_	23	nmod	_	_
30	.	.	.	.	_	6	punct	_	_

1	A	a	DT	DT	_	5	det	_	_
2	2-kb	2-kb	JJ	JJ	_	5	amod	_	_
3	VDR	vdr	NN	NN	_	5	compound	_	_
4	cDNA	cdna	NN	NN	_	5	compound	_	_
5	insert	insert	NN	NN	_	15	nsubjpass	_	_
6	(	(	-LRB-	-LRB-	_	12	punct	_	_
7	including	include	VBG	VBG	_	12	case	_	_
8	the	the	DT	DT	_	12	det	_	_
9	complete	complete	JJ	JJ	_	12	amod	_	_
10	VDR	vdr	NN	NN	_	12	compound	_	_
11	coding	coding	NN	NN	_	12	compound	_	_
12	region	region	NN	NN	_	5	nmod	_	_
13	)	)	-RRB-	-RRB-	_	12	punct	_	_
14	was	be	VBD	VBD	_	15	auxpass	_	_
15	cloned	clone	VBN	VBN	_	0	root	_	_
16	in	in	IN	IN	_	19	case	_	_
17	an	a	DT	DT	_	19	det	_	_
18	antisense	antisense	JJ	JJ	_	19	amod	_	_
19	orientation	orientation	NN	NN	_	15	nmod	_	_
20	into	into	IN	IN	_	25	case	_	_
21	the	the	DT	DT	_	25	det	_	_
22	EBV	ebv	NN	NN	_	25	compound	_	_
23	episomal	episomal	NN	NN	_	25	compound	_	_
24	vector	vector	NN	NN	_	25	compound	_	_
25	pMEP4	pmep4	NN	NN	_	15	nmod	_	_
26	under	under	IN	IN	_	28	case	_	_
27	the	the	DT	DT	_	28	det	_	_
28	control	control	NN	NN	_	15	nmod	_	_
29	of	of	IN	IN	_	32	case	_	_
30	an	a	DT	DT	_	32	det	_	_
31	inducible	inducible	JJ	JJ	_	32	amod	_	_
32	promoter	promoter	NN	NN	_	28	nmod	_	_
33	and	and	CC	CC	_	15	cc	_	_
34	transfected	transfect	VBN	VBN	_	15	conj	_	_
35	into	into	IN	IN	_	36	case	_	_
36	U937	u937	NN	NN	_	34	nmod	_	_
37	.	.	.	.	_	15	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	resultant	resultant	JJ	JJ	_	4	amod	_	_
3	cell	cell	NN	NN	_	4	compound	_	_
4	line	line	NN	NN	_	10	nsubj	_	_
5	,	,	,	,	_	4	punct	_	_
6	DH42	dh42	NN	NN	_	4	appos	_	_
7	,	,	,	,	_	4	punct	_	_
8	was	be	VBD	VBD	_	10	cop	_	_
9	hygromycin	hygromycin	NN	NN	_	10	nmod:npmod	_	_
10	resistant	resistant	JJ	JJ	_	0	root	_	_
11	,	,	,	,	_	10	punct	_	_
12	contained	contain	VBD	VBD	_	10	conj	_	_
13	VDR	vdr	NN	NN	_	14	compound	_	_
14	cDNA	cdna	NN	NN	_	12	dobj	_	_
15	,	,	,	,	_	10	punct	_	_
16	expressed	express	VBD	VBD	_	10	conj	_	_
17	fewer	fewer	JJR	JJR	_	16	dobj	_	_
18	VDRs	vdr	NNS	NNS	_	17	dep	_	_
19	than	than	IN	IN	_	20	mark	_	_
20	controls	control	NNS	NNS	_	17	dep	_	_
21	,	,	,	,	_	10	punct	_	_
22	and	and	CC	CC	_	10	cc	_	_
23	showed	show	VBD	VBD	_	10	conj	_	_
24	a	a	DT	DT	_	26	det	_	_
25	substantial	substantial	JJ	JJ	_	26	amod	_	_
26	decrease	decrease	NN	NN	_	23	dobj	_	_
27	in	in	IN	IN	_	29	case	_	_
28	antiproliferative	antiproliferative	JJ	JJ	_	29	amod	_	_
29	response	response	NN	NN	_	26	nmod	_	_
30	to	to	TO	TO	_	31	case	_	_
31	1,25(OH)2D3	1,25(oh)2d3	NN	NN	_	29	nmod	_	_
32	.	.	.	.	_	10	punct	_	_

1	However	however	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	1,25(OH)2D3	1,25(oh)2d3	NN	NN	_	4	nsubj	_	_
4	increased	increase	VBD	VBD	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	number	number	NN	NN	_	4	dobj	_	_
7	of	of	IN	IN	_	8	case	_	_
8	cells	cell	NNS	NNS	_	6	nmod	_	_
9	expressing	express	VBG	VBG	_	8	acl	_	_
10	macrophage	macrophage	NN	NN	_	13	compound	_	_
11	cell	cell	NN	NN	_	13	compound	_	_
12	surface	surface	NN	NN	_	13	compound	_	_
13	Ags	ags	NN	NN	_	9	dobj	_	_
14	,	,	,	,	_	13	punct	_	_
15	including	include	VBG	VBG	_	16	case	_	_
16	CD14	cd14	NN	NN	_	13	nmod	_	_
17	and	and	CC	CC	_	16	cc	_	_
18	CD11b	cd11b	NN	NN	_	16	conj	_	_
19	.	.	.	.	_	4	punct	_	_

1	A	a	DT	DT	_	2	det	_	_
2	subpopulation	subpopulation	NN	NN	_	8	nsubj	_	_
3	of	of	IN	IN	_	5	case	_	_
4	smaller	smaller	JJR	JJR	_	5	amod	_	_
5	cells	cell	NNS	NNS	_	2	nmod	_	_
6	did	do	VBD	VBD	_	8	aux	_	_
7	not	not	RB	RB	_	8	neg	_	_
8	express	express	VB	VB	_	0	root	_	_
9	the	the	DT	DT	_	11	det	_	_
10	differentiation	differentiation	NN	NN	_	11	compound	_	_
11	markers	marker	NNS	NNS	_	8	dobj	_	_
12	after	after	IN	IN	_	14	case	_	_
13	cadmium	cadmium	NN	NN	_	14	compound	_	_
14	stimulation	stimulation	NN	NN	_	8	nmod	_	_
15	.	.	.	.	_	8	punct	_	_

1	Cell	cell	NN	NN	_	3	compound	_	_
2	cycle	cycle	NN	NN	_	3	compound	_	_
3	analysis	analysis	NN	NN	_	4	nsubj	_	_
4	showed	show	VBD	VBD	_	0	root	_	_
5	shifts	shift	NNS	NNS	_	4	dobj	_	_
6	in	in	IN	IN	_	8	case	_	_
7	the	the	DT	DT	_	8	det	_	_
8	distribution	distribution	NN	NN	_	5	nmod	_	_
9	of	of	IN	IN	_	10	case	_	_
10	cells	cell	NNS	NNS	_	8	nmod	_	_
11	from	from	IN	IN	_	12	case	_	_
12	G1	g1	NN	NN	_	8	nmod	_	_
13	to	to	TO	TO	_	15	case	_	_
14	S	s	NN	NN	_	15	compound	_	_
15	phase	phase	NN	NN	_	8	nmod	_	_
16	,	,	,	,	_	5	punct	_	_
17	which	which	WDT	WDT	_	20	nsubj	_	_
18	were	be	VBD	VBD	_	20	cop	_	_
19	more	more	RBR	RBR	_	20	advmod	_	_
20	pronounced	pronounced	JJ	JJ	_	5	acl:relcl	_	_
21	after	after	IN	IN	_	23	case	_	_
22	cadmium	cadmium	NN	NN	_	23	compound	_	_
23	treatment	treatment	NN	NN	_	20	nmod	_	_
24	.	.	.	.	_	4	punct	_	_

1	A	a	DT	DT	_	3	det	_	_
2	considerable	considerable	JJ	JJ	_	3	amod	_	_
3	proportion	proportion	NN	NN	_	9	nsubj	_	_
4	of	of	IN	IN	_	5	case	_	_
5	cells	cell	NNS	NNS	_	3	nmod	_	_
6	were	be	VBD	VBD	_	9	cop	_	_
7	outside	outside	IN	IN	_	9	case	_	_
8	the	the	DT	DT	_	9	det	_	_
9	cycle	cycle	NN	NN	_	0	root	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	DNA	dna	NN	NN	_	12	compound	_	_
12	fragmentation	fragmentation	NN	NN	_	13	nsubj	_	_
13	confirmed	confirm	VBD	VBD	_	9	conj	_	_
14	apoptosis	apoptosis	NN	NN	_	13	dobj	_	_
15	.	.	.	.	_	9	punct	_	_

1	Thus	thus	RB	RB	_	11	advmod	_	_
2	,	,	,	,	_	11	punct	_	_
3	the	the	DT	DT	_	5	det	_	_
4	functional	functional	JJ	JJ	_	5	amod	_	_
5	outcome	outcome	NN	NN	_	11	nsubj	_	_
6	of	of	IN	IN	_	10	case	_	_
7	the	the	DT	DT	_	10	det	_	_
8	VDR	vdr	NN	NN	_	10	compound	_	_
9	antisense	antisense	JJ	JJ	_	10	amod	_	_
10	transfection	transfection	NN	NN	_	5	nmod	_	_
11	suggests	suggest	VBZ	VBZ	_	0	root	_	_
12	that	that	IN	IN	_	21	mark	_	_
13	in	in	IN	IN	_	16	case	_	_
14	the	the	DT	DT	_	16	det	_	_
15	myelomonocytic	myelomonocytic	JJ	JJ	_	16	amod	_	_
16	lineage	lineage	NN	NN	_	21	nmod	_	_
17	,	,	,	,	_	21	punct	_	_
18	VDR	vdr	NN	NN	_	19	compound	_	_
19	expression	expression	NN	NN	_	21	nsubj	_	_
20	may	may	MD	MD	_	21	aux	_	_
21	act	act	VB	VB	_	11	ccomp	_	_
22	as	as	IN	IN	_	25	case	_	_
23	a	a	DT	DT	_	25	det	_	_
24	protective	protective	JJ	JJ	_	25	amod	_	_
25	mechanism	mechanism	NN	NN	_	21	nmod	_	_
26	against	against	IN	IN	_	29	case	_	_
27	programmed	program	VBN	VBN	_	29	amod	_	_
28	cell	cell	NN	NN	_	29	compound	_	_
29	death	death	NN	NN	_	25	nmod	_	_
30	.	.	.	.	_	11	punct	_	_

1	Binding	binding	NN	NN	_	0	root	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	cooperative	cooperative	JJ	JJ	_	4	amod	_	_
4	interactions	interaction	NNS	NNS	_	1	conj	_	_
5	between	between	IN	IN	_	10	case	_	_
6	two	two	CD	CD	_	10	nummod	_	_
7	B	b	NN	NN	_	10	compound	_	_
8	cell-specific	cell-specific	JJ	JJ	_	10	amod	_	_
9	transcriptional	transcriptional	JJ	JJ	_	10	amod	_	_
10	coactivators	coactivator	NNS	NNS	_	1	nmod	_	_
11	.	.	.	.	_	1	punct	_	_

1	The	the	DT	DT	_	4	det	_	_
2	class	class	NN	NN	_	4	compound	_	_
3	II	ii	CD	CD	_	4	nummod	_	_
4	transactivator	transactivator	NN	NN	_	23	nsubj	_	_
5	(	(	-LRB-	-LRB-	_	6	punct	_	_
6	CIITA	ciita	NN	NN	_	4	appos	_	_
7	)	)	-RRB-	-RRB-	_	6	punct	_	_
8	and	and	CC	CC	_	4	cc	_	_
9	B	b	NN	NN	_	16	compound	_	_
10	cell	cell	NN	NN	_	16	compound	_	_
11	octamer-binding	octamer-binding	JJ	JJ	_	16	amod	_	_
12	protein	protein	NN	NN	_	16	compound	_	_
13	1/octamer-binding	1/octamer-binding	JJ	JJ	_	16	amod	_	_
14	factor	factor	NN	NN	_	16	compound	_	_
15	1/Oct	1/oct	NN	NN	_	16	compound	_	_
16	coactivator	coactivator	NN	NN	_	4	conj	_	_
17	from	from	IN	IN	_	19	case	_	_
18	B	b	NN	NN	_	19	compound	_	_
19	cells	cell	NNS	NNS	_	16	nmod	_	_
20	(	(	-LRB-	-LRB-	_	21	punct	_	_
21	Bob1/OBF-1/OCA-B	bob1/obf-1/oca-b	NN	NN	_	16	appos	_	_
22	)	)	-RRB-	-RRB-	_	21	punct	_	_
23	represent	represent	VBP	VBP	_	0	root	_	_
24	two	two	CD	CD	_	28	nummod	_	_
25	B	b	NN	NN	_	28	compound	_	_
26	cell-specific	cell-specific	JJ	JJ	_	28	amod	_	_
27	transcriptional	transcriptional	JJ	JJ	_	28	amod	_	_
28	coactivators	coactivator	NNS	NNS	_	23	dobj	_	_
29	.	.	.	.	_	23	punct	_	_

1	CIITA	ciita	NN	NN	_	4	nsubj	_	_
2	and	and	CC	CC	_	1	cc	_	_
3	Bob1	bob1	NN	NN	_	1	conj	_	_
4	interact	interact	VBP	VBP	_	0	root	_	_
5	with	with	IN	IN	_	6	case	_	_
6	proteins	protein	NNS	NNS	_	4	nmod	_	_
7	that	that	WDT	WDT	_	8	nsubj	_	_
8	bind	bind	VBP	VBP	_	6	acl:relcl	_	_
9	to	to	TO	TO	_	12	case	_	_
10	conserved	conserve	VBN	VBN	_	12	amod	_	_
11	upstream	upstream	JJ	JJ	_	12	amod	_	_
12	sequences	sequence	NNS	NNS	_	8	nmod	_	_
13	in	in	IN	IN	_	14	case	_	_
14	promoters	promoter	NNS	NNS	_	12	nmod	_	_
15	of	of	IN	IN	_	20	case	_	_
16	class	class	NN	NN	_	20	compound	_	_
17	II	ii	CD	CD	_	20	nummod	_	_
18	major	major	JJ	JJ	_	20	amod	_	_
19	histocompatibility	histocompatibility	NN	NN	_	20	compound	_	_
20	genes	gene	NNS	NNS	_	14	nmod	_	_
21	and	and	CC	CC	_	12	cc	_	_
22	octamer-binding	octamer-binding	JJ	JJ	_	24	amod	_	_
23	transcription	transcription	NN	NN	_	24	compound	_	_
24	factors	factor	NNS	NNS	_	12	conj	_	_
25	Oct-1	oct-1	NN	NN	_	24	dep	_	_
26	and	and	CC	CC	_	25	cc	_	_
27	Oct-2	oct-2	NN	NN	_	25	conj	_	_
28	,	,	,	,	_	8	punct	_	_
29	respectively	respectively	RB	RB	_	8	advmod	_	_
30	.	.	.	.	_	4	punct	_	_

1	Both	both	CC	CC	_	2	cc:preconj	_	_
2	CIITA	ciita	NN	NN	_	5	nsubj	_	_
3	and	and	CC	CC	_	2	cc	_	_
4	Bob1	bob1	NN	NN	_	2	conj	_	_
5	increase	increase	VBP	VBP	_	0	root	_	_
6	the	the	DT	DT	_	7	det	_	_
7	expression	expression	NN	NN	_	5	dobj	_	_
8	from	from	IN	IN	_	11	case	_	_
9	the	the	DT	DT	_	11	det	_	_
10	DRA	dra	NN	NN	_	11	compound	_	_
11	promoter	promoter	NN	NN	_	7	nmod	_	_
12	,	,	,	,	_	11	punct	_	_
13	which	which	WDT	WDT	_	19	nsubj	_	_
14	is	be	VBZ	VBZ	_	19	cop	_	_
15	a	a	DT	DT	_	19	det	_	_
16	prototypic	prototypic	JJ	JJ	_	19	amod	_	_
17	class	class	NN	NN	_	19	compound	_	_
18	II	ii	CD	CD	_	19	nummod	_	_
19	promoter	promoter	NN	NN	_	11	acl:relcl	_	_
20	.	.	.	.	_	5	punct	_	_

1	Moreover	moreover	RB	RB	_	17	advmod	_	_
2	,	,	,	,	_	17	punct	_	_
3	in	in	IN	IN	_	5	case	_	_
4	the	the	DT	DT	_	5	det	_	_
5	presence	presence	NN	NN	_	17	nmod	_	_
6	of	of	IN	IN	_	7	case	_	_
7	CIITA	ciita	NN	NN	_	5	nmod	_	_
8	,	,	,	,	_	17	punct	_	_
9	interactions	interaction	NNS	NNS	_	17	nsubj	_	_
10	between	between	IN	IN	_	13	case	_	_
11	class	class	NN	NN	_	13	compound	_	_
12	II	ii	CD	CD	_	13	nummod	_	_
13	promoters	promoter	NNS	NNS	_	9	nmod	_	_
14	and	and	CC	CC	_	13	cc	_	_
15	Bob1	bob1	NN	NN	_	13	conj	_	_
16	are	be	VBP	VBP	_	17	cop	_	_
17	independent	independent	JJ	JJ	_	0	root	_	_
18	of	of	IN	IN	_	21	case	_	_
19	the	the	DT	DT	_	21	det	_	_
20	octamer-binding	octamer-binding	JJ	JJ	_	21	amod	_	_
21	site	site	NN	NN	_	17	nmod	_	_
22	.	.	.	.	_	17	punct	_	_

1	Using	use	VBG	VBG	_	0	root	_	_
2	in	in	FW	FW	_	1	dobj	_	_
3	vivo	vivo	FW	FW	_	2	dep	_	_
4	and	and	CC	CC	_	2	cc	_	_
5	in	in	FW	FW	_	2	conj	_	_
6	vitro	vitro	FW	FW	_	5	dep	_	_
7	binding	binding	NN	NN	_	8	compound	_	_
8	assays	assay	NNS	NNS	_	2	dep	_	_
9	,	,	,	,	_	1	punct	_	_
10	we	we	PRP	PRP	_	11	nsubj	_	_
11	confirm	confirm	VBP	VBP	_	1	parataxis	_	_
12	that	that	IN	IN	_	14	mark	_	_
13	Bob1	bob1	NN	NN	_	14	nsubj	_	_
14	binds	bind	VBZ	VBZ	_	11	ccomp	_	_
15	to	to	TO	TO	_	16	case	_	_
16	CIITA	ciita	NN	NN	_	14	nmod	_	_
17	.	.	.	.	_	1	punct	_	_

1	Thus	thus	RB	RB	_	6	advmod	_	_
2	,	,	,	,	_	6	punct	_	_
3	CIITA	ciita	NN	NN	_	6	nsubj	_	_
4	not	not	RB	RB	_	5	neg	_	_
5	only	only	RB	RB	_	6	cc:preconj	_	_
6	activates	activate	VBZ	VBZ	_	0	root	_	_
7	the	the	DT	DT	_	8	det	_	_
8	expression	expression	NN	NN	_	6	dobj	_	_
9	of	of	IN	IN	_	12	case	_	_
10	class	class	NN	NN	_	12	compound	_	_
11	II	ii	CD	CD	_	12	nummod	_	_
12	genes	gene	NNS	NNS	_	8	nmod	_	_
13	but	but	CC	CC	_	6	cc	_	_
14	recruits	recruit	VBZ	VBZ	_	6	conj	_	_
15	another	another	DT	DT	_	18	det	_	_
16	B	b	NN	NN	_	18	compound	_	_
17	cell-specific	cell-specific	JJ	JJ	_	18	amod	_	_
18	coactivator	coactivator	NN	NN	_	14	dobj	_	_
19	to	to	TO	TO	_	20	mark	_	_
20	increase	increase	VB	VB	_	6	xcomp	_	_
21	transcriptional	transcriptional	JJ	JJ	_	22	amod	_	_
22	activity	activity	NN	NN	_	20	dobj	_	_
23	of	of	IN	IN	_	26	case	_	_
24	class	class	NN	NN	_	26	compound	_	_
25	II	ii	CD	CD	_	26	nummod	_	_
26	promoters	promoter	NNS	NNS	_	22	nmod	_	_
27	in	in	IN	IN	_	29	case	_	_
28	B	b	NN	NN	_	29	compound	_	_
29	cells	cell	NNS	NNS	_	22	nmod	_	_
30	.	.	.	.	_	6	punct	_	_

1	Activation	activation	NN	NN	_	3	nmod:npmod	_	_
2	protein	protein	NN	NN	_	3	nmod:npmod	_	_
3	1-dependent	1-dependent	JJ	JJ	_	5	amod	_	_
4	transcriptional	transcriptional	JJ	JJ	_	3	dep	_	_
5	activation	activation	NN	NN	_	0	root	_	_
6	of	of	IN	IN	_	9	case	_	_
7	interleukin	interleukin	NN	NN	_	9	compound	_	_
8	2	2	CD	CD	_	9	nummod	_	_
9	gene	gene	NN	NN	_	5	nmod	_	_
10	by	by	IN	IN	_	14	case	_	_
11	Ca2+/calmodulin	ca2+/calmodulin	NN	NN	_	14	compound	_	_
12	kinase	kinase	NN	NN	_	14	compound	_	_
13	type	type	NN	NN	_	14	compound	_	_
14	IV/Gr	iv/gr	NN	NN	_	5	nmod	_	_
15	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	9	det	_	_
2	Ca2+/calmodulin-dependent	ca2+/calmodulin-dependent	JJ	JJ	_	9	amod	_	_
3	protein	protein	NN	NN	_	9	compound	_	_
4	kinase	kinase	NN	NN	_	9	compound	_	_
5	(	(	-LRB-	-LRB-	_	9	punct	_	_
6	CaMK	camk	NN	NN	_	9	compound	_	_
7	)	)	-RRB-	-RRB-	_	9	punct	_	_
8	type	type	NN	NN	_	9	compound	_	_
9	IV/Gr	iv/gr	NN	NN	_	12	nsubjpass	_	_
10	is	be	VBZ	VBZ	_	12	auxpass	_	_
11	selectively	selectively	RB	RB	_	12	advmod	_	_
12	expressed	express	VBN	VBN	_	0	root	_	_
13	in	in	IN	IN	_	15	case	_	_
14	T	t	NN	NN	_	15	compound	_	_
15	lymphocytes	lymphocyte	NNS	NNS	_	12	nmod	_	_
16	and	and	CC	CC	_	12	cc	_	_
17	is	be	VBZ	VBZ	_	18	auxpass	_	_
18	activated	activate	VBN	VBN	_	12	conj	_	_
19	after	after	IN	IN	_	20	case	_	_
20	signaling	signal	VBG	VBG	_	18	nmod	_	_
21	via	via	IN	IN	_	26	case	_	_
22	the	the	DT	DT	_	26	det	_	_
23	T	t	NN	NN	_	26	compound	_	_
24	cell	cell	NN	NN	_	26	compound	_	_
25	antigen	antigen	NN	NN	_	26	compound	_	_
26	receptor	receptor	NN	NN	_	20	nmod	_	_
27	(	(	-LRB-	-LRB-	_	28	punct	_	_
28	TCR	tcr	NN	NN	_	26	appos	_	_
29	)	)	-RRB-	-RRB-	_	28	punct	_	_
30	,	,	,	,	_	12	punct	_	_
31	indicating	indicate	VBG	VBG	_	12	advcl	_	_
32	that	that	IN	IN	_	34	mark	_	_
33	it	it	PRP	PRP	_	34	nsubj	_	_
34	mediates	mediate	VBZ	VBZ	_	31	ccomp	_	_
35	some	some	DT	DT	_	34	dobj	_	_
36	of	of	IN	IN	_	40	case	_	_
37	the	the	DT	DT	_	40	det	_	_
38	Ca(2+)-dependent	ca(2+)-dependent	JJ	JJ	_	40	amod	_	_
39	transcriptional	transcriptional	JJ	JJ	_	38	dep	_	_
40	events	event	NNS	NNS	_	35	nmod	_	_
41	that	that	WDT	WDT	_	42	nsubj	_	_
42	follow	follow	VBP	VBP	_	40	acl:relcl	_	_
43	TCR	tcr	NN	NN	_	44	compound	_	_
44	engagement	engagement	NN	NN	_	42	dobj	_	_
45	.	.	.	.	_	12	punct	_	_

1	Here	here	RB	RB	_	3	advmod	_	_
2	we	we	PRP	PRP	_	3	nsubj	_	_
3	show	show	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	6	mark	_	_
5	CaMKIV/Gr	camkiv/gr	NN	NN	_	6	nsubj	_	_
6	induces	induce	VBZ	VBZ	_	3	ccomp	_	_
7	the	the	DT	DT	_	11	det	_	_
8	transcription	transcription	NN	NN	_	11	compound	_	_
9	factor	factor	NN	NN	_	11	compound	_	_
10	activation	activation	NN	NN	_	11	compound	_	_
11	protein	protein	NN	NN	_	6	dobj	_	_
12	1	1	CD	CD	_	11	nummod	_	_
13	(	(	-LRB-	-LRB-	_	14	punct	_	_
14	AP-1	ap-1	NN	NN	_	11	appos	_	_
15	)	)	-RRB-	-RRB-	_	14	punct	_	_
16	alone	alone	RB	RB	_	17	advmod	_	_
17	or	or	CC	CC	_	6	advmod	_	_
18	in	in	IN	IN	_	19	case	_	_
19	synergy	synergy	NN	NN	_	17	conj	_	_
20	with	with	IN	IN	_	23	case	_	_
21	T	t	NN	NN	_	23	compound	_	_
22	cell	cell	NN	NN	_	23	compound	_	_
23	mitogens	mitogen	NNS	NNS	_	19	nmod	_	_
24	and	and	CC	CC	_	23	cc	_	_
25	with	with	IN	IN	_	28	case	_	_
26	the	the	DT	DT	_	28	det	_	_
27	p21ras	p21ras	NN	NN	_	28	compound	_	_
28	oncoprotein	oncoprotein	NN	NN	_	23	conj	_	_
29	.	.	.	.	_	3	punct	_	_

1	CaMKIV/	camkiv/	NN	NN	_	2	compound	_	_
2	Gr	gr	NN	NN	_	3	compound	_	_
3	signaling	signaling	NN	NN	_	5	nsubjpass	_	_
4	is	be	VBZ	VBZ	_	5	auxpass	_	_
5	associated	associate	VBN	VBN	_	0	root	_	_
6	with	with	IN	IN	_	8	case	_	_
7	transcriptional	transcriptional	JJ	JJ	_	8	amod	_	_
8	activation	activation	NN	NN	_	5	nmod	_	_
9	of	of	IN	IN	_	10	case	_	_
10	c-fos	c-fos	NN	NN	_	8	nmod	_	_
11	but	but	CC	CC	_	5	cc	_	_
12	is	be	VBZ	VBZ	_	13	cop	_	_
13	independent	independent	JJ	JJ	_	5	conj	_	_
14	of	of	IN	IN	_	15	case	_	_
15	p21ras	p21ras	NN	NN	_	13	nmod	_	_
16	or	or	CC	CC	_	15	cc	_	_
17	calcineurin	calcineurin	NN	NN	_	15	conj	_	_
18	.	.	.	.	_	5	punct	_	_

1	AP-1	ap-1	NN	NN	_	5	nsubj	_	_
2	is	be	VBZ	VBZ	_	5	cop	_	_
3	an	a	DT	DT	_	5	det	_	_
4	integral	integral	JJ	JJ	_	5	amod	_	_
5	component	component	NN	NN	_	0	root	_	_
6	of	of	IN	IN	_	18	case	_	_
7	the	the	DT	DT	_	18	det	_	_
8	nuclear	nuclear	JJ	JJ	_	18	amod	_	_
9	factor	factor	NN	NN	_	18	compound	_	_
10	of	of	IN	IN	_	18	amod	_	_
11	activated	activate	VBN	VBN	_	18	amod	_	_
12	T	t	NN	NN	_	18	compound	_	_
13	cells	cell	NNS	NNS	_	18	compound	_	_
14	(	(	-LRB-	-LRB-	_	18	punct	_	_
15	NFAT	nfat	NN	NN	_	18	compound	_	_
16	)	)	-RRB-	-RRB-	_	18	punct	_	_
17	transcriptional	transcriptional	JJ	JJ	_	18	amod	_	_
18	complex	complex	NN	NN	_	5	nmod	_	_
19	,	,	,	,	_	5	punct	_	_
20	which	which	WDT	WDT	_	22	nsubjpass	_	_
21	is	be	VBZ	VBZ	_	22	auxpass	_	_
22	required	require	VBN	VBN	_	5	acl:relcl	_	_
23	for	for	IN	IN	_	27	case	_	_
24	interleukin	interleukin	NN	NN	_	26	compound	_	_
25	2	2	CD	CD	_	26	nummod	_	_
26	gene	gene	NN	NN	_	27	compound	_	_
27	expression	expression	NN	NN	_	22	nmod	_	_
28	in	in	IN	IN	_	30	case	_	_
29	T	t	NN	NN	_	30	compound	_	_
30	cells	cell	NNS	NNS	_	27	nmod	_	_
31	.	.	.	.	_	5	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	demonstrate	demonstrate	VBP	VBP	_	0	root	_	_
3	that	that	IN	IN	_	5	mark	_	_
4	CaMKIV/Gr	camkiv/gr	NN	NN	_	5	nsubj	_	_
5	reconstitutes	reconstitute	VBZ	VBZ	_	2	ccomp	_	_
6	the	the	DT	DT	_	7	det	_	_
7	capacity	capacity	NN	NN	_	5	dobj	_	_
8	of	of	IN	IN	_	11	case	_	_
9	the	the	DT	DT	_	11	det	_	_
10	cytosolic	cytosolic	JJ	JJ	_	11	amod	_	_
11	component	component	NN	NN	_	7	nmod	_	_
12	of	of	IN	IN	_	13	case	_	_
13	NFAT	nfat	NN	NN	_	11	nmod	_	_
14	to	to	TO	TO	_	15	mark	_	_
15	direct	direct	VB	VB	_	7	acl	_	_
16	transcription	transcription	NN	NN	_	15	dobj	_	_
17	from	from	IN	IN	_	19	case	_	_
18	NFAT	nfat	NN	NN	_	19	compound	_	_
19	sites	site	NNS	NNS	_	16	nmod	_	_
20	in	in	IN	IN	_	22	case	_	_
21	non-T	non-t	NN	NN	_	22	compound	_	_
22	cells	cell	NNS	NNS	_	19	nmod	_	_
23	.	.	.	.	_	2	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	results	result	NNS	NNS	_	3	nsubj	_	_
3	reveal	reveal	VBP	VBP	_	0	root	_	_
4	a	a	DT	DT	_	6	det	_	_
5	central	central	JJ	JJ	_	6	amod	_	_
6	role	role	NN	NN	_	3	dobj	_	_
7	for	for	IN	IN	_	8	case	_	_
8	CaMKIV/Gr	camkiv/gr	NN	NN	_	6	nmod	_	_
9	as	as	IN	IN	_	12	case	_	_
10	a	a	DT	DT	_	12	det	_	_
11	Ca(2+)-regulated	ca(2+)-regulated	JJ	JJ	_	12	amod	_	_
12	activator	activator	NN	NN	_	6	nmod	_	_
13	of	of	IN	IN	_	15	case	_	_
14	gene	gene	NN	NN	_	15	compound	_	_
15	transcription	transcription	NN	NN	_	12	nmod	_	_
16	in	in	IN	IN	_	18	case	_	_
17	T	t	NN	NN	_	18	compound	_	_
18	lymphocytes	lymphocyte	NNS	NNS	_	12	nmod	_	_
19	.	.	.	.	_	3	punct	_	_

1	Cytokine-modulating	cytokine-modulating	JJ	JJ	_	2	amod	_	_
2	activity	activity	NN	NN	_	0	root	_	_
3	of	of	IN	IN	_	4	case	_	_
4	tepoxalin	tepoxalin	NN	NN	_	2	nmod	_	_
5	,	,	,	,	_	4	punct	_	_
6	a	a	DT	DT	_	9	det	_	_
7	new	new	JJ	JJ	_	9	amod	_	_
8	potential	potential	JJ	JJ	_	7	dep	_	_
9	antirheumatic	antirheumatic	NN	NN	_	4	appos	_	_
10	.	.	.	.	_	2	punct	_	_

1	Tepoxalin	tepoxalin	NN	NN	_	8	nsubj	_	_
2	is	be	VBZ	VBZ	_	8	cop	_	_
3	a	a	DT	DT	_	8	det	_	_
4	new	new	JJ	JJ	_	8	amod	_	_
5	dual	dual	JJ	JJ	_	8	amod	_	_
6	cyclooxygenase/5-lipoxygenase	cyclooxygenase/5-lipoxygenase	NN	NN	_	8	compound	_	_
7	anti-inflammatory	anti-inflammatory	JJ	JJ	_	8	amod	_	_
8	compound	compound	NN	NN	_	0	root	_	_
9	currently	currently	RB	RB	_	12	advmod	_	_
10	under	under	IN	IN	_	12	case	_	_
11	clinical	clinical	JJ	JJ	_	12	amod	_	_
12	investigation	investigation	NN	NN	_	8	nmod	_	_
13	.	.	.	.	_	8	punct	_	_

1	It	it	PRP	PRP	_	4	nsubjpass	_	_
2	has	have	VBZ	VBZ	_	4	aux	_	_
3	been	be	VBN	VBN	_	4	auxpass	_	_
4	shown	show	VBN	VBN	_	0	root	_	_
5	to	to	TO	TO	_	6	mark	_	_
6	possess	possess	VB	VB	_	4	ccomp	_	_
7	anti-inflammatory	anti-inflammatory	JJ	JJ	_	8	amod	_	_
8	activity	activity	NN	NN	_	6	dobj	_	_
9	in	in	IN	IN	_	11	case	_	_
10	a	a	DT	DT	_	11	det	_	_
11	variety	variety	NN	NN	_	6	nmod	_	_
12	of	of	IN	IN	_	14	case	_	_
13	animal	animal	NN	NN	_	14	compound	_	_
14	models	model	NNS	NNS	_	11	nmod	_	_
15	and	and	CC	CC	_	6	cc	_	_
16	more	more	RBR	RBR	_	17	advmod	_	_
17	recently	recently	RB	RB	_	19	advmod	_	_
18	to	to	TO	TO	_	19	mark	_	_
19	inhibit	inhibit	VB	VB	_	6	conj	_	_
20	IL-2	il-2	NN	NN	_	23	compound	_	_
21	induced	induced	JJ	JJ	_	23	amod	_	_
22	signal	signal	NN	NN	_	23	compound	_	_
23	transduction	transduction	NN	NN	_	19	dobj	_	_
24	.	.	.	.	_	4	punct	_	_

1	The	the	DT	DT	_	3	det	_	_
2	current	current	JJ	JJ	_	3	amod	_	_
3	study	study	NN	NN	_	5	nsubjpass	_	_
4	was	be	VBD	VBD	_	5	auxpass	_	_
5	conducted	conduct	VBN	VBN	_	0	root	_	_
6	to	to	TO	TO	_	7	mark	_	_
7	evaluate	evaluate	VB	VB	_	5	xcomp	_	_
8	the	the	DT	DT	_	11	det	_	_
9	cytokine	cytokine	NN	NN	_	11	compound	_	_
10	modulating	modulating	NN	NN	_	11	compound	_	_
11	activity	activity	NN	NN	_	7	dobj	_	_
12	of	of	IN	IN	_	13	case	_	_
13	tepoxalin	tepoxalin	NN	NN	_	11	nmod	_	_
14	and	and	CC	CC	_	11	cc	_	_
15	the	the	DT	DT	_	16	det	_	_
16	role	role	NN	NN	_	11	conj	_	_
17	of	of	IN	IN	_	18	case	_	_
18	iron	iron	NN	NN	_	16	nmod	_	_
19	in	in	IN	IN	_	21	case	_	_
20	these	these	DT	DT	_	21	det	_	_
21	effects	effect	NNS	NNS	_	16	nmod	_	_
22	.	.	.	.	_	5	punct	_	_

1	In	in	IN	IN	_	6	case	_	_
2	human	human	JJ	JJ	_	6	amod	_	_
3	peripheral	peripheral	JJ	JJ	_	6	amod	_	_
4	blood	blood	NN	NN	_	6	compound	_	_
5	mononuclear	mononuclear	JJ	JJ	_	6	amod	_	_
6	cells	cell	NNS	NNS	_	15	nmod	_	_
7	(	(	-LRB-	-LRB-	_	8	punct	_	_
8	PBMC	pbmc	NN	NN	_	6	appos	_	_
9	)	)	-RRB-	-RRB-	_	8	punct	_	_
10	stimulated	stimulate	VBN	VBN	_	6	acl	_	_
11	with	with	IN	IN	_	12	case	_	_
12	OKT3/PMA	okt3/pma	NN	NN	_	10	nmod	_	_
13	,	,	,	,	_	15	punct	_	_
14	tepoxalin	tepoxalin	NN	NN	_	15	nsubj	_	_
15	inhibited	inhibit	VBD	VBD	_	0	root	_	_
16	lymphocyte	lymphocyte	NN	NN	_	17	compound	_	_
17	proliferation	proliferation	NN	NN	_	15	dobj	_	_
18	with	with	IN	IN	_	20	case	_	_
19	an	a	DT	DT	_	20	det	_	_
20	IC50	ic50	NN	NN	_	17	nmod	_	_
21	of	of	IN	IN	_	23	case	_	_
22	6	6	CD	CD	_	23	nummod	_	_
23	microM	microm	NN	NN	_	20	nmod	_	_
24	.	.	.	.	_	15	punct	_	_

1	Additionally	additionally	RB	RB	_	4	advmod	_	_
2	,	,	,	,	_	4	punct	_	_
3	it	it	PRP	PRP	_	4	nsubj	_	_
4	inhibited	inhibit	VBD	VBD	_	0	root	_	_
5	the	the	DT	DT	_	6	det	_	_
6	production	production	NN	NN	_	4	dobj	_	_
7	of	of	IN	IN	_	8	case	_	_
8	LTB4	ltb4	NN	NN	_	6	nmod	_	_
9	(	(	-LRB-	-LRB-	_	10	punct	_	_
10	IC50	ic50	NN	NN	_	8	dep	_	_
11	=	=	JJ	JJ	_	10	amod	_	_
12	0.5	0.5	CD	CD	_	13	nummod	_	_
13	microM	microm	NN	NN	_	11	dep	_	_
14	)	)	-RRB-	-RRB-	_	10	punct	_	_
15	and	and	CC	CC	_	8	cc	_	_
16	the	the	DT	DT	_	17	det	_	_
17	cytokines	cytokine	NNS	NNS	_	8	conj	_	_
18	IL-2	il-2	NN	NN	_	17	dep	_	_
19	,	,	,	,	_	18	punct	_	_
20	IL-6	il-6	NN	NN	_	18	conj	_	_
21	and	and	CC	CC	_	18	cc	_	_
22	TNF	tnf	NN	NN	_	23	compound	_	_
23	alpha	alpha	NN	NN	_	18	conj	_	_
24	(	(	-LRB-	-LRB-	_	25	punct	_	_
25	IC50	ic50	NN	NN	_	23	dep	_	_
26	=	=	JJ	JJ	_	25	amod	_	_
27	10-12	10-12	CD	CD	_	28	nummod	_	_
28	microM	microm	NN	NN	_	26	dep	_	_
29	)	)	-RRB-	-RRB-	_	25	punct	_	_
30	.	.	.	.	_	4	punct	_	_

1	Cytotoxicity	cytotoxicity	NN	NN	_	4	nsubjpass	_	_
2	was	be	VBD	VBD	_	4	auxpass	_	_
3	not	not	RB	RB	_	4	neg	_	_
4	demonstrated	demonstrate	VBN	VBN	_	0	root	_	_
5	at	at	IN	IN	_	7	case	_	_
6	these	these	DT	DT	_	7	det	_	_
7	concentrations	concentration	NNS	NNS	_	4	nmod	_	_
8	.	.	.	.	_	4	punct	_	_

1	Add-back	add-back	JJ	JJ	_	2	amod	_	_
2	experiments	experiment	NNS	NNS	_	16	nsubj	_	_
3	with	with	IN	IN	_	5	case	_	_
4	either	either	CC	CC	_	5	cc:preconj	_	_
5	cytokines	cytokine	NNS	NNS	_	2	nmod	_	_
6	(	(	-LRB-	-LRB-	_	7	punct	_	_
7	IL-2	il-2	NN	NN	_	5	dep	_	_
8	or	or	CC	CC	_	7	cc	_	_
9	IL-6	il-6	NN	NN	_	7	conj	_	_
10	)	)	-RRB-	-RRB-	_	7	punct	_	_
11	,	,	,	,	_	5	punct	_	_
12	LTB4	ltb4	NN	NN	_	5	conj	_	_
13	or	or	CC	CC	_	5	cc	_	_
14	conditioned	conditioned	JJ	JJ	_	15	amod	_	_
15	media	media	NNS	NNS	_	5	conj	_	_
16	failed	fail	VBD	VBD	_	0	root	_	_
17	to	to	TO	TO	_	18	mark	_	_
18	restore	restore	VB	VB	_	16	xcomp	_	_
19	the	the	DT	DT	_	21	det	_	_
20	proliferative	proliferative	JJ	JJ	_	21	amod	_	_
21	response	response	NN	NN	_	18	dobj	_	_
22	in	in	IN	IN	_	24	case	_	_
23	the	the	DT	DT	_	24	det	_	_
24	presence	presence	NN	NN	_	18	nmod	_	_
25	of	of	IN	IN	_	26	case	_	_
26	tepoxalin	tepoxalin	NN	NN	_	24	nmod	_	_
27	.	.	.	.	_	16	punct	_	_

1	However	however	RB	RB	_	22	advmod	_	_
2	,	,	,	,	_	22	punct	_	_
3	the	the	DT	DT	_	5	det	_	_
4	concurrent	concurrent	JJ	JJ	_	5	amod	_	_
5	addition	addition	NN	NN	_	22	nsubj	_	_
6	of	of	IN	IN	_	7	case	_	_
7	iron	iron	NN	NN	_	5	nmod	_	_
8	(	(	-LRB-	-LRB-	_	11	punct	_	_
9	in	in	IN	IN	_	11	case	_	_
10	the	the	DT	DT	_	11	det	_	_
11	form	form	NN	NN	_	7	nmod	_	_
12	of	of	IN	IN	_	13	case	_	_
13	ferrous	ferrous	JJ	JJ	_	11	nmod	_	_
14	or	or	CC	CC	_	13	cc	_	_
15	ferric	ferric	JJ	JJ	_	13	conj	_	_
16	chloride	chloride	NN	NN	_	13	dep	_	_
17	and	and	CC	CC	_	13	cc	_	_
18	other	other	JJ	JJ	_	20	amod	_	_
19	iron	iron	NN	NN	_	20	compound	_	_
20	salts	salt	NNS	NNS	_	13	conj	_	_
21	)	)	-RRB-	-RRB-	_	11	punct	_	_
22	reversed	reverse	VBD	VBD	_	0	root	_	_
23	the	the	DT	DT	_	24	det	_	_
24	inhibition	inhibition	NN	NN	_	22	dobj	_	_
25	of	of	IN	IN	_	26	case	_	_
26	proliferation	proliferation	NN	NN	_	24	nmod	_	_
27	caused	cause	VBN	VBN	_	24	acl	_	_
28	by	by	IN	IN	_	29	case	_	_
29	tepoxalin	tepoxalin	NN	NN	_	27	nmod	_	_
30	.	.	.	.	_	22	punct	_	_

1	Tepoxalin	tepoxalin	NN	NN	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	inhibits	inhibit	VBZ	VBZ	_	0	root	_	_
4	the	the	DT	DT	_	5	det	_	_
5	activation	activation	NN	NN	_	3	dobj	_	_
6	of	of	IN	IN	_	9	case	_	_
7	NF	nf	NN	NN	_	9	compound	_	_
8	kappa	kappa	NN	NN	_	9	compound	_	_
9	B	b	NN	NN	_	5	nmod	_	_
10	,	,	,	,	_	9	punct	_	_
11	a	a	DT	DT	_	13	det	_	_
12	transcription	transcription	NN	NN	_	13	compound	_	_
13	factor	factor	NN	NN	_	9	appos	_	_
14	which	which	WDT	WDT	_	15	nsubj	_	_
15	acts	act	VBZ	VBZ	_	13	acl:relcl	_	_
16	on	on	IN	IN	_	19	case	_	_
17	several	several	JJ	JJ	_	19	amod	_	_
18	cytokine	cytokine	NN	NN	_	19	compound	_	_
19	genes	gene	NNS	NNS	_	15	nmod	_	_
20	.	.	.	.	_	3	punct	_	_

1	Tepoxalin	tepoxalin	NN	NN	_	3	nmod:poss	_	_
2	's	's	POS	POS	_	3	case	_	_
3	effect	effect	NN	NN	_	10	nsubjpass	_	_
4	on	on	IN	IN	_	7	case	_	_
5	NF	nf	NN	NN	_	7	compound	_	_
6	kappa	kappa	NN	NN	_	7	compound	_	_
7	B	b	NN	NN	_	3	nmod	_	_
8	is	be	VBZ	VBZ	_	10	auxpass	_	_
9	also	also	RB	RB	_	10	advmod	_	_
10	reversed	reverse	VBN	VBN	_	0	root	_	_
11	by	by	IN	IN	_	13	case	_	_
12	the	the	DT	DT	_	13	det	_	_
13	addition	addition	NN	NN	_	10	nmod	_	_
14	of	of	IN	IN	_	16	case	_	_
15	iron	iron	NN	NN	_	16	compound	_	_
16	salts	salt	NNS	NNS	_	13	nmod	_	_
17	.	.	.	.	_	10	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	suggest	suggest	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	20	mark	_	_
5	the	the	DT	DT	_	6	det	_	_
6	action	action	NN	NN	_	20	nsubj	_	_
7	of	of	IN	IN	_	8	case	_	_
8	tepoxalin	tepoxalin	NN	NN	_	6	nmod	_	_
9	to	to	TO	TO	_	10	mark	_	_
10	inhibit	inhibit	VB	VB	_	6	acl	_	_
11	proliferation	proliferation	NN	NN	_	10	dobj	_	_
12	in	in	IN	IN	_	13	case	_	_
13	PBMC	pbmc	NN	NN	_	11	nmod	_	_
14	may	may	MD	MD	_	20	aux	_	_
15	be	be	VB	VB	_	20	cop	_	_
16	at	at	IN	IN	_	19	advmod	_	_
17	least	least	JJS	JJS	_	16	mwe	_	_
18	in	in	IN	IN	_	19	case	_	_
19	part	part	NN	NN	_	20	nmod	_	_
20	due	due	JJ	JJ	_	3	ccomp	_	_
21	to	to	TO	TO	_	31	mark	_	_
22	its	its	PRP$	PRP$	_	23	nmod:poss	_	_
23	ability	ability	NN	NN	_	31	nsubj	_	_
24	to	to	TO	TO	_	25	mark	_	_
25	reduce	reduce	VB	VB	_	23	acl	_	_
26	the	the	DT	DT	_	27	det	_	_
27	amount	amount	NN	NN	_	25	dobj	_	_
28	of	of	IN	IN	_	30	case	_	_
29	available	available	JJ	JJ	_	30	amod	_	_
30	iron	iron	NN	NN	_	27	nmod	_	_
31	resulting	result	VBG	VBG	_	20	advcl	_	_
32	in	in	IN	IN	_	34	case	_	_
33	decreased	decrease	VBN	VBN	_	34	amod	_	_
34	activation	activation	NN	NN	_	31	nmod	_	_
35	of	of	IN	IN	_	38	case	_	_
36	NF	nf	NN	NN	_	38	compound	_	_
37	kappa	kappa	NN	NN	_	38	compound	_	_
38	B	b	NN	NN	_	34	nmod	_	_
39	and	and	CC	CC	_	34	cc	_	_
40	subsequent	subsequent	JJ	JJ	_	41	amod	_	_
41	inhibition	inhibition	NN	NN	_	34	conj	_	_
42	of	of	IN	IN	_	44	case	_	_
43	cytokine	cytokine	NN	NN	_	44	compound	_	_
44	production	production	NN	NN	_	41	nmod	_	_
45	.	.	.	.	_	3	punct	_	_

1	Interleukin-7	interleukin-7	NN	NN	_	2	compound	_	_
2	signaling	signaling	NN	NN	_	16	nsubj	_	_
3	in	in	IN	IN	_	11	case	_	_
4	human	human	JJ	JJ	_	11	amod	_	_
5	B	b	NN	NN	_	11	compound	_	_
6	cell	cell	NN	NN	_	11	compound	_	_
7	precursor	precursor	NN	NN	_	11	compound	_	_
8	acute	acute	JJ	JJ	_	11	amod	_	_
9	lymphoblastic	lymphoblastic	JJ	JJ	_	11	amod	_	_
10	leukemia	leukemia	NN	NN	_	11	compound	_	_
11	cells	cell	NNS	NNS	_	2	nmod	_	_
12	and	and	CC	CC	_	11	cc	_	_
13	murine	murine	JJ	JJ	_	15	amod	_	_
14	BAF3	baf3	NN	NN	_	15	compound	_	_
15	cells	cell	NNS	NNS	_	11	conj	_	_
16	involves	involve	VBZ	VBZ	_	0	root	_	_
17	activation	activation	NN	NN	_	16	dobj	_	_
18	of	of	IN	IN	_	19	case	_	_
19	STAT1	stat1	NN	NN	_	17	nmod	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	STAT5	stat5	NN	NN	_	19	conj	_	_
22	mediated	mediate	VBN	VBN	_	17	acl	_	_
23	via	via	IN	IN	_	28	case	_	_
24	the	the	DT	DT	_	28	det	_	_
25	interleukin-7	interleukin-7	NN	NN	_	28	compound	_	_
26	receptor	receptor	NN	NN	_	28	compound	_	_
27	alpha	alpha	NN	NN	_	28	compound	_	_
28	chain	chain	NN	NN	_	22	nmod	_	_
29	.	.	.	.	_	16	punct	_	_

1	Interleukin-7	interleukin-7	NN	NN	_	5	nsubj	_	_
2	(	(	-LRB-	-LRB-	_	3	punct	_	_
3	IL-7	il-7	NN	NN	_	1	appos	_	_
4	)	)	-RRB-	-RRB-	_	3	punct	_	_
5	stimulates	stimulate	VBZ	VBZ	_	0	root	_	_
6	the	the	DT	DT	_	7	det	_	_
7	proliferation	proliferation	NN	NN	_	5	dobj	_	_
8	of	of	IN	IN	_	9	case	_	_
9	normal	normal	JJ	JJ	_	7	nmod	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	leukemic	leukemic	JJ	JJ	_	9	conj	_	_
12	B	b	NN	NN	_	9	dep	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	T	t	NN	NN	_	12	conj	_	_
15	cell	cell	NN	NN	_	16	compound	_	_
16	precursors	precursor	NNS	NNS	_	12	dep	_	_
17	and	and	CC	CC	_	12	cc	_	_
18	T	t	NN	NN	_	19	compound	_	_
19	lymphocytes	lymphocyte	NNS	NNS	_	12	conj	_	_
20	.	.	.	.	_	5	punct	_	_

1	Activation	activation	NN	NN	_	8	nsubjpass	_	_
2	of	of	IN	IN	_	5	case	_	_
3	the	the	DT	DT	_	5	det	_	_
4	JAK/STAT	jak/stat	NN	NN	_	5	compound	_	_
5	pathway	pathway	NN	NN	_	1	nmod	_	_
6	has	have	VBZ	VBZ	_	8	aux	_	_
7	been	be	VBN	VBN	_	8	auxpass	_	_
8	implicated	implicate	VBN	VBN	_	0	root	_	_
9	in	in	IN	IN	_	11	case	_	_
10	IL-7R	il-7r	NN	NN	_	11	compound	_	_
11	signaling	signaling	NN	NN	_	8	nmod	_	_
12	.	.	.	.	_	8	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	investigated	investigate	VBD	VBD	_	0	root	_	_
3	which	which	WDT	WDT	_	5	det	_	_
4	STAT	stat	NN	NN	_	5	compound	_	_
5	complexes	complex	NNS	NNS	_	7	nsubjpass	_	_
6	are	be	VBP	VBP	_	7	auxpass	_	_
7	formed	form	VBN	VBN	_	2	ccomp	_	_
8	upon	upon	IN	IN	_	9	case	_	_
9	stimulation	stimulation	NN	NN	_	7	nmod	_	_
10	of	of	IN	IN	_	20	case	_	_
11	B	b	NN	NN	_	20	compound	_	_
12	cell	cell	NN	NN	_	20	compound	_	_
13	precursor	precursor	NN	NN	_	20	compound	_	_
14	acute	acute	JJ	JJ	_	20	amod	_	_
15	lymphoblastic	lymphoblastic	JJ	JJ	_	20	amod	_	_
16	leukemia	leukemia	NN	NN	_	20	compound	_	_
17	(	(	-LRB-	-LRB-	_	20	punct	_	_
18	BCP-ALL	bcp-all	NN	NN	_	20	compound	_	_
19	)	)	-RRB-	-RRB-	_	20	punct	_	_
20	cells	cell	NNS	NNS	_	9	nmod	_	_
21	with	with	IN	IN	_	22	case	_	_
22	IL-7	il-7	NN	NN	_	9	nmod	_	_
23	.	.	.	.	_	2	punct	_	_

1	Gel	gel	NN	NN	_	3	compound	_	_
2	retardation	retardation	NN	NN	_	3	compound	_	_
3	assays	assay	NNS	NNS	_	7	nsubj	_	_
4	with	with	IN	IN	_	6	case	_	_
5	STAT-binding	stat-binding	JJ	JJ	_	6	amod	_	_
6	oligonucleotides	oligonucleotide	NNS	NNS	_	3	nmod	_	_
7	showed	show	VBD	VBD	_	0	root	_	_
8	that	that	IN	IN	_	10	mark	_	_
9	IL-7	il-7	NN	NN	_	10	nsubj	_	_
10	induces	induce	VBZ	VBZ	_	7	ccomp	_	_
11	the	the	DT	DT	_	12	det	_	_
12	formation	formation	NN	NN	_	10	dobj	_	_
13	of	of	IN	IN	_	17	case	_	_
14	two	two	CD	CD	_	17	nummod	_	_
15	major	major	JJ	JJ	_	17	amod	_	_
16	STAT	stat	NN	NN	_	17	compound	_	_
17	complexes	complex	NNS	NNS	_	12	nmod	_	_
18	in	in	IN	IN	_	20	case	_	_
19	BCP-ALL	bcp-all	NN	NN	_	20	compound	_	_
20	cells	cell	NNS	NNS	_	10	nmod	_	_
21	.	.	.	.	_	7	punct	_	_

1	Supershifts	supershift	NNS	NNS	_	5	nsubj	_	_
2	with	with	IN	IN	_	4	case	_	_
3	anti-STAT	anti-stat	JJ	JJ	_	4	amod	_	_
4	antibodies	antibody	NNS	NNS	_	1	nmod	_	_
5	identified	identify	VBD	VBD	_	0	root	_	_
6	these	these	DT	DT	_	5	dobj	_	_
7	as	as	IN	IN	_	8	case	_	_
8	STAT1	stat1	NN	NN	_	5	nmod	_	_
9	and	and	CC	CC	_	8	cc	_	_
10	STAT5	stat5	NN	NN	_	11	compound	_	_
11	complexes	complex	NNS	NNS	_	8	conj	_	_
12	.	.	.	.	_	5	punct	_	_

1	This	this	DT	DT	_	2	det	_	_
2	pattern	pattern	NN	NN	_	7	nsubjpass	_	_
3	of	of	IN	IN	_	5	case	_	_
4	STAT	stat	NN	NN	_	5	compound	_	_
5	activation	activation	NN	NN	_	2	nmod	_	_
6	was	be	VBD	VBD	_	7	auxpass	_	_
7	seen	see	VBN	VBN	_	0	root	_	_
8	in	in	IN	IN	_	11	case	_	_
9	all	all	DT	DT	_	11	det	_	_
10	BCP-ALL	bcp-all	NN	NN	_	11	compound	_	_
11	cases	case	NNS	NNS	_	7	nmod	_	_
12	that	that	WDT	WDT	_	13	nsubj	_	_
13	respond	respond	VBP	VBP	_	11	acl:relcl	_	_
14	to	to	TO	TO	_	15	case	_	_
15	IL-7	il-7	NN	NN	_	13	nmod	_	_
16	in	in	IN	IN	_	18	case	_	_
17	proliferation	proliferation	NN	NN	_	18	compound	_	_
18	assays	assay	NNS	NNS	_	13	nmod	_	_
19	.	.	.	.	_	7	punct	_	_

1	IL-7	il-7	NN	NN	_	3	nsubj	_	_
2	also	also	RB	RB	_	3	advmod	_	_
3	induced	induce	VBD	VBD	_	0	root	_	_
4	STAT/DNA	stat/dna	NN	NN	_	5	compound	_	_
5	binding	binding	NN	NN	_	3	dobj	_	_
6	in	in	IN	IN	_	8	case	_	_
7	BCP-ALL	bcp-all	NN	NN	_	8	compound	_	_
8	cases	case	NNS	NNS	_	3	nmod	_	_
9	that	that	WDT	WDT	_	10	nsubj	_	_
10	failed	fail	VBD	VBD	_	8	acl:relcl	_	_
11	to	to	TO	TO	_	12	mark	_	_
12	proliferate	proliferate	VB	VB	_	10	xcomp	_	_
13	in	in	IN	IN	_	14	case	_	_
14	response	response	NN	NN	_	12	nmod	_	_
15	to	to	TO	TO	_	16	case	_	_
16	IL-7	il-7	NN	NN	_	14	nmod	_	_
17	,	,	,	,	_	3	punct	_	_
18	suggesting	suggest	VBG	VBG	_	3	advcl	_	_
19	that	that	IN	IN	_	33	mark	_	_
20	the	the	DT	DT	_	21	det	_	_
21	ability	ability	NN	NN	_	33	nsubj	_	_
22	of	of	IN	IN	_	23	case	_	_
23	IL-7R	il-7r	NN	NN	_	21	nmod	_	_
24	to	to	TO	TO	_	25	mark	_	_
25	activate	activate	VB	VB	_	21	acl	_	_
26	the	the	DT	DT	_	28	det	_	_
27	JAK/STAT	jak/stat	NN	NN	_	28	compound	_	_
28	pathway	pathway	NN	NN	_	25	dobj	_	_
29	per	per	FW	FW	_	30	compound	_	_
30	se	se	FW	FW	_	25	advmod	_	_
31	is	be	VBZ	VBZ	_	33	cop	_	_
32	not	not	RB	RB	_	33	neg	_	_
33	sufficient	sufficient	JJ	JJ	_	18	ccomp	_	_
34	for	for	IN	IN	_	36	case	_	_
35	proliferation	proliferation	NN	NN	_	36	compound	_	_
36	induction	induction	NN	NN	_	33	nmod	_	_
37	.	.	.	.	_	3	punct	_	_

1	To	to	TO	TO	_	2	mark	_	_
2	determine	determine	VB	VB	_	0	root	_	_
3	the	the	DT	DT	_	4	det	_	_
4	contribution	contribution	NN	NN	_	2	dobj	_	_
5	of	of	IN	IN	_	8	case	_	_
6	the	the	DT	DT	_	8	det	_	_
7	cytoplasmic	cytoplasmic	JJ	JJ	_	8	amod	_	_
8	domain	domain	NN	NN	_	4	nmod	_	_
9	of	of	IN	IN	_	14	case	_	_
10	the	the	DT	DT	_	14	det	_	_
11	IL-7	il-7	NN	NN	_	14	compound	_	_
12	receptor	receptor	NN	NN	_	14	compound	_	_
13	alpha	alpha	NN	NN	_	14	compound	_	_
14	chain	chain	NN	NN	_	8	nmod	_	_
15	(	(	-LRB-	-LRB-	_	17	punct	_	_
16	IL-7R	il-7r	NN	NN	_	17	compound	_	_
17	alpha	alpha	NN	NN	_	14	appos	_	_
18	)	)	-RRB-	-RRB-	_	17	punct	_	_
19	to	to	TO	TO	_	20	case	_	_
20	activation	activation	NN	NN	_	4	nmod	_	_
21	of	of	IN	IN	_	23	case	_	_
22	STAT	stat	NN	NN	_	23	compound	_	_
23	proteins	protein	NNS	NNS	_	20	nmod	_	_
24	,	,	,	,	_	2	punct	_	_
25	transfectants	transfectant	NNS	NNS	_	34	nsubjpass	_	_
26	of	of	IN	IN	_	32	case	_	_
27	the	the	DT	DT	_	32	det	_	_
28	murine	murine	JJ	JJ	_	32	amod	_	_
29	pro-B	pro-b	NN	NN	_	32	compound	_	_
30	cell	cell	NN	NN	_	32	compound	_	_
31	line	line	NN	NN	_	32	compound	_	_
32	BAF3	baf3	NNS	NNS	_	25	nmod	_	_
33	were	be	VBD	VBD	_	34	auxpass	_	_
34	made	make	VBN	VBN	_	2	parataxis	_	_
35	that	that	WDT	WDT	_	36	nsubj	_	_
36	express	express	NN	NN	_	34	dep	_	_
37	chimeric	chimeric	JJ	JJ	_	38	amod	_	_
38	receptors	receptor	NNS	NNS	_	36	dobj	_	_
39	consisting	consist	VBG	VBG	_	38	acl	_	_
40	of	of	IN	IN	_	43	case	_	_
41	the	the	DT	DT	_	43	det	_	_
42	extracellular	extracellular	JJ	JJ	_	43	amod	_	_
43	domain	domain	NN	NN	_	39	nmod	_	_
44	of	of	IN	IN	_	49	case	_	_
45	human	human	JJ	JJ	_	49	amod	_	_
46	granulocyte	granulocyte	NN	NN	_	49	compound	_	_
47	colony-stimulating	colony-stimulating	JJ	JJ	_	49	amod	_	_
48	factor	factor	NN	NN	_	49	compound	_	_
49	receptor	receptor	NN	NN	_	43	nmod	_	_
50	(	(	-LRB-	-LRB-	_	51	punct	_	_
51	G-CSF-R	g-csf-r	NN	NN	_	49	appos	_	_
52	)	)	-RRB-	-RRB-	_	51	punct	_	_
53	and	and	CC	CC	_	43	cc	_	_
54	the	the	DT	DT	_	55	dep	_	_
55	transmembrane	transmembrane	NN	NN	_	43	conj	_	_
56	and	and	CC	CC	_	55	cc	_	_
57	intracellular	intracellular	JJ	JJ	_	55	conj	_	_
58	domains	domain	NNS	NNS	_	55	dep	_	_
59	of	of	IN	IN	_	62	case	_	_
60	human	human	JJ	JJ	_	62	amod	_	_
61	IL-7R	il-7r	NN	NN	_	62	compound	_	_
62	alpha	alpha	NN	NN	_	55	nmod	_	_
63	.	.	.	.	_	2	punct	_	_

1	Activation	activation	NN	NN	_	9	nsubj	_	_
2	of	of	IN	IN	_	6	case	_	_
3	the	the	DT	DT	_	6	det	_	_
4	chimeric	chimeric	JJ	JJ	_	6	amod	_	_
5	G-CSF-R/IL-7R	g-csf-r/il-7r	NN	NN	_	6	compound	_	_
6	alpha	alpha	NN	NN	_	1	nmod	_	_
7	with	with	IN	IN	_	8	case	_	_
8	G-CSF	g-csf	NN	NN	_	6	nmod	_	_
9	resulted	result	VBD	VBD	_	0	root	_	_
10	in	in	IN	IN	_	14	case	_	_
11	a	a	DT	DT	_	14	det	_	_
12	full	full	JJ	JJ	_	14	amod	_	_
13	proliferative	proliferative	JJ	JJ	_	12	dep	_	_
14	response	response	NN	NN	_	9	nmod	_	_
15	and	and	CC	CC	_	9	cc	_	_
16	induced	induce	VBD	VBD	_	9	conj	_	_
17	the	the	DT	DT	_	18	det	_	_
18	phosphorylation	phosphorylation	NN	NN	_	16	dobj	_	_
19	of	of	IN	IN	_	20	case	_	_
20	JAK1	jak1	NN	NN	_	18	nmod	_	_
21	but	but	CC	CC	_	22	cc	_	_
22	not	not	RB	RB	_	20	cc	_	_
23	JAK2	jak2	NN	NN	_	20	conj	_	_
24	.	.	.	.	_	9	punct	_	_

1	Major	major	JJ	JJ	_	3	amod	_	_
2	STAT	stat	NN	NN	_	3	compound	_	_
3	complexes	complex	NNS	NNS	_	8	nsubj	_	_
4	activated	activate	VBN	VBN	_	3	acl	_	_
5	by	by	IN	IN	_	7	case	_	_
6	G-CSF-R/IL-7R	g-csf-r/il-7r	NN	NN	_	7	compound	_	_
7	alpha	alpha	NN	NN	_	4	nmod	_	_
8	contained	contain	VBD	VBD	_	0	root	_	_
9	STAT1	stat1	NN	NN	_	8	dobj	_	_
10	or	or	CC	CC	_	9	cc	_	_
11	STAT5	stat5	NN	NN	_	9	conj	_	_
12	,	,	,	,	_	8	punct	_	_
13	while	while	IN	IN	_	21	mark	_	_
14	some	some	DT	DT	_	15	det	_	_
15	formation	formation	NN	NN	_	21	nsubjpass	_	_
16	of	of	IN	IN	_	18	case	_	_
17	STAT3-containing	stat3-containing	JJ	JJ	_	18	amod	_	_
18	complexes	complex	NNS	NNS	_	15	nmod	_	_
19	was	be	VBD	VBD	_	21	auxpass	_	_
20	also	also	RB	RB	_	21	advmod	_	_
21	seen	see	VBN	VBN	_	8	advcl	_	_
22	.	.	.	.	_	8	punct	_	_

1	These	these	DT	DT	_	2	det	_	_
2	findings	finding	NNS	NNS	_	3	nsubj	_	_
3	establish	establish	VBP	VBP	_	0	root	_	_
4	that	that	IN	IN	_	14	mark	_	_
5	STAT1	stat1	NN	NN	_	14	nsubjpass	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	STAT5	stat5	NN	NN	_	5	conj	_	_
8	,	,	,	,	_	5	punct	_	_
9	and	and	CC	CC	_	5	cc	_	_
10	possibly	possibly	RB	RB	_	11	advmod	_	_
11	STAT3	stat3	NN	NN	_	5	conj	_	_
12	,	,	,	,	_	5	punct	_	_
13	are	be	VBP	VBP	_	14	auxpass	_	_
14	activated	activate	VBN	VBN	_	3	ccomp	_	_
15	upon	upon	IN	IN	_	16	case	_	_
16	stimulation	stimulation	NN	NN	_	14	nmod	_	_
17	of	of	IN	IN	_	20	case	_	_
18	precursor	precursor	JJ	JJ	_	20	amod	_	_
19	B	b	NN	NN	_	20	compound	_	_
20	cells	cell	NNS	NNS	_	16	nmod	_	_
21	with	with	IN	IN	_	22	case	_	_
22	IL-7	il-7	NN	NN	_	16	nmod	_	_
23	.	.	.	.	_	3	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	4	nsubj	_	_
3	further	further	RB	RB	_	4	advmod	_	_
4	indicate	indicate	VBP	VBP	_	0	root	_	_
5	that	that	IN	IN	_	12	mark	_	_
6	the	the	DT	DT	_	9	det	_	_
7	IL-7R	il-7r	NN	NN	_	9	compound	_	_
8	alpha	alpha	NN	NN	_	9	compound	_	_
9	chains	chain	NNS	NNS	_	12	nsubjpass	_	_
10	are	be	VBP	VBP	_	12	auxpass	_	_
11	directly	directly	RB	RB	_	12	advmod	_	_
12	involved	involve	VBN	VBN	_	4	ccomp	_	_
13	in	in	IN	IN	_	15	case	_	_
14	the	the	DT	DT	_	15	det	_	_
15	activation	activation	NN	NN	_	12	nmod	_	_
16	of	of	IN	IN	_	17	case	_	_
17	JAKs	jak	NNS	NNS	_	15	nmod	_	_
18	and	and	CC	CC	_	17	cc	_	_
19	STATs	stats	NNS	NNS	_	17	conj	_	_
20	and	and	CC	CC	_	12	cc	_	_
21	have	have	VB	VB	_	12	conj	_	_
22	a	a	DT	DT	_	24	det	_	_
23	major	major	JJ	JJ	_	24	amod	_	_
24	role	role	NN	NN	_	21	dobj	_	_
25	in	in	IN	IN	_	27	case	_	_
26	proliferative	proliferative	JJ	JJ	_	27	amod	_	_
27	signaling	signaling	NN	NN	_	21	nmod	_	_
28	in	in	IN	IN	_	31	case	_	_
29	precursor	precursor	NN	NN	_	31	compound	_	_
30	B	b	NN	NN	_	31	compound	_	_
31	cells	cell	NNS	NNS	_	27	nmod	_	_
32	.	.	.	.	_	4	punct	_	_

